PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Minami, H; Isomoto, H; Nakayama, T; Hayashi, T; Yamaguchi, N; Matsushima, K; Akazawa, Y; Ohnita, K; Takeshima, F; Inoue, H; Nakao, K				Minami, Hitomi; Isomoto, Hajime; Nakayama, Toshiyuki; Hayashi, Tomayoshi; Yamaguchi, Naoyuki; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Inoue, Haruhiro; Nakao, Kazuhiko			Background Coloration of Squamous Epithelium in Esophago-Pharyngeal Squamous Cell Carcinoma: What Causes the Color Change?	PLOS ONE			English	Article							MICROVASCULAR ARCHITECTURE; NEOPLASIA; HEMOGLOBIN; EXPRESSION; FEATURES; HEAD	Objectives: This study aims to clarify the cause of background coloration in the epithelia between each dilated intra papillary capillary loop in esophago-pharyngeal squamous cell carcinoma. Design: This is a single center retrospective study including 124 patients with 160 lesions who underwent esophagogastroduodenoscopy in Nagasaki University Hospital from September 2007 to March 2012; a detailed comparison between endoscopic images and pathology was performed. Immunohistological assessment using anti-human hemoglobin antibody (anti-Hb Ab) was performed to verify the presence of hemoglobin (Hb) component in the cancer cells. Real-time polymerase chain reaction (RT-PCR) and in situ hybridization (ISH) on Hb-beta mRNA were performed to assess the production of Hb component within the cancer cells. Results: A strong positivity for anti-Hb Ab was observed in the squamous cell carcinoma area, whereas non-cancerous mucosa showed no immunopositivity for Hb. The concordance rate between anti-Hb Ab immunoreactivity and the presence of BC was as high as 80.9%. The amount of Hb-beta mRNA expression was three times higher in cancer tissues compared with the surrounding non-cancerous mucosa. ISH images showed that the expression exclusively occurred in cancer cells, indicating that Hb is probably produced within cancer cells. Conclusions: The background coloration observed is partly due to an extravascular component of Hb. RT-PCR and ISH analyses indicate that Hb is produced within cancer cells.	[Minami, Hitomi; Isomoto, Hajime; Yamaguchi, Naoyuki; Matsushima, Kayoko; Akazawa, Yuko; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan; [Nakayama, Toshiyuki; Hayashi, Tomayoshi] Nagasaki Univ Hosp, Dept Pathol, Nagasaki, Japan; [Inoue, Haruhiro] Showa Univ Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan	Nagasaki University; Nagasaki University	Isomoto, H (corresponding author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan.	hajimei2002@yahoo.co.jp		Nakayama, Toshiyuki/0000-0002-3865-7169				Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Inoue H, 2007, MAGNIFYING ENDOSCOPI, P49; Ishihara R, 2010, J GASTROEN HEPATOL, V25, P1410, DOI 10.1111/j.1440-1746.2010.06378.x; Kaga M, 2011, ONCOL REP, V26, P1063, DOI 10.3892/or.2011.1398; Kanzaki H, 2013, J GASTROEN HEPATOL, V28, P274, DOI 10.1111/jgh.12059; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Minami H, 2012, J GASTROENT IN PRESS; Minami H, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/529782; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ogane N, 2010, ANN DIAGN PATHOL, V14, P23, DOI 10.1016/j.anndiagpath.2009.10.003; OHMORI T, 2001, GASTROENTEROLOGICA S, V43, pS1613; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Shimizu Y, 2008, J GASTROEN HEPATOL, V23, P546, DOI 10.1111/j.1440-1746.2007.04990.x	18	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85553	10.1371/journal.pone.0085553	http://dx.doi.org/10.1371/journal.pone.0085553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489662	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000014
J	Okamoto, R; Gery, S; Gombart, AF; Wang, XP; Castellani, LW; Akagi, T; Chen, S; Arditi, M; Ho, Q; Lusis, AJ; Li, QL; Koeffler, HP				Okamoto, Ryoko; Gery, Sigal; Gombart, Adrian F.; Wang, Xuping; Castellani, Lawrence W.; Akagi, Tadayuki; Chen, Shuang; Arditi, Moshe; Quoc Ho; Lusis, Aldons J.; Li, Quanlin; Koeffler, H. Phillip			Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR-/- Mice	PLOS ONE			English	Article							C/EBP-EPSILON; APOLIPOPROTEIN-E; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NEUTROPHIL; LOCUS; AP2; PATHOGENESIS; CYTOKINE; ENHANCER	The CCAAT/enhancer binding proteins (C/EBPs) are transcription factors involved in hematopoietic cell development and induction of several inflammatory mediators. C/EBP epsilon is expressed only in myeloid cells including monocytes/macrophages. Atherosclerosis is an inflammatory disorder of the vascular wall and circulating immune cells such as monocytes/ macrophages. Mice deficient in the low density lipoprotein (LDL) receptor (Ldlr(-/-)) fed on a high cholesterol diet (HCD) show elevated blood cholesterol levels and are widely used as models to study human atherosclerosis. In this study, we generated Ldlr and Cebpe double-knockout (llee) mice and compared their atherogenic phenotypes to Ldlr single deficient (llEE) mice after HCD. Macrophages from llee mice have reduced lipid uptake by foam cells and impaired phagokinetic motility in vitro compared to macrophages from llEE mice. Also, compared to llEE mice, llee mice have alterations of lipid metabolism, and reduced atheroma and obesity, particularly the males. Peritoneal macrophages of llee male mice have reduced mRNA expression of FABP4, a fatty acid binding protein implicated in atherosclerosis. Overall, our study suggests that the myeloid specific factor C/EBP epsilon is involved in systemic lipid metabolism and that silencing of C/EBP epsilon could decrease the development of atherosclerosis.	[Okamoto, Ryoko; Gery, Sigal; Gombart, Adrian F.; Akagi, Tadayuki; Quoc Ho; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [Gombart, Adrian F.] Oregon State Univ, Dept Biochem & Biophys, Linus Pauling Inst, Corvallis, OR 97331 USA; [Wang, Xuping; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Dept Med, Los Angeles, CA 90095 USA; [Wang, Xuping; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Castellani, Lawrence W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Li, Quanlin] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Koeffler, H. Phillip] Natl Univ Singapore, Natl Canc Inst, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; National University of Singapore; National University of Singapore	Gery, S (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA.	gerys@cshs.org	Akagi, Tadayuki/E-1078-2011; Li, Quanlin/H-2358-2015; Gombart, Adrian/AAV-4738-2020	Akagi, Tadayuki/0000-0002-1733-9452; Li, Quanlin/0000-0002-3876-0617; Gombart, Adrian/0000-0001-7830-0693	National Institutes of Health (NIH) [2R01 CA026038-32, 5R01AI65604-6]; SWLF; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; East Meets West Cedars-Sinai Fund; A*STAR of Singapore; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065604] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SWLF; Tom Collier Memorial Regatta Foundation; Parker Hughes Fund; East Meets West Cedars-Sinai Fund; A*STAR of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants (2R01 CA026038-32, 5R01AI65604-6), SWLF, the Tom Collier Memorial Regatta Foundation, Parker Hughes Fund, East Meets West Cedars-Sinai Fund, as well as, A*STAR of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; CHENEVAL D, 1991, P NATL ACAD SCI USA, V88, P8465, DOI 10.1073/pnas.88.19.8465; Chumakov AM, 1997, MOL CELL BIOL, V17, P1375, DOI 10.1128/MCB.17.3.1375; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Engelbertsen D, 2012, EXP DIABETES RES, V17, P61; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gombart AF, 2005, J LEUKOCYTE BIOL, V78, P1153, DOI 10.1189/jlb.0504286; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Smith DD, 2010, J PHYSIOL PHARMACOL, V61, P309; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Surra JC, 2010, J ATHEROSCLER THROMB, V17, P712; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Volger OL, 2007, AM J PATHOL, V171, P326, DOI 10.2353/ajpath.2007.061196; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; Wolfrum S, 2010, ARTERIOSCL THROM VAS, V30, P1583, DOI 10.1161/ATVBAHA.110.205757; Zhang YQ, 2006, ARTERIOSCL THROM VAS, V26, P2316, DOI 10.1161/01.ATV.0000235697.35431.05	37	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85341	10.1371/journal.pone.0085341	http://dx.doi.org/10.1371/journal.pone.0085341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489659	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000012
J	Helbig, A; Kaasen, A; Malt, UF; Haugen, G				Helbig, Anne; Kaasen, Anne; Malt, Ulrik Fredrik; Haugen, Guttorm			Maternal Psychological Distress and Placental Circulation in Pregnancies after a Previous Offspring with Congenital Malformation	PLOS ONE			English	Article							VEIN BLOOD-FLOW; UTERINE ARTERY RESISTANCE; UMBILICAL VEIN; POSTNATAL DEPRESSION; BIRTH-WEIGHT; EVENT SCALE; ANXIETY; STRESS; GROWTH; IMPACT	Introduction: Antenatal maternal psychological distress may be associated with reduced placental circulation, which could lead to lower birthweight. Studies investigating this in humans show mixed results, which may be partially due to type, strength and timing of distress. In addition, the arterial vascular resistance measures often used as outcome measures do not detect smaller changes in placental volume blood flow. We aimed to investigate the effect of a specific stressor, with increased levels of stress early in pregnancy, on the fetoplacental volume blood flow in third trimester. Methods: This was a prospective observational study of 74 pregnant women with a congenital malformation in a previous fetus or child. Psychological distress was assessed twice, around 16 and 30 weeks' gestation. Psychometric measures were the General Health Questionnaire-28 (subscales anxiety and depression), Edinburgh Postnatal Depression Scale, and Impact of Event Scale-22 (subscales intrusion, avoidance, and arousal). Placental circulation was examined at 30 weeks, using Doppler ultrasonography, primarily as fetoplacental volume blood flow in the umbilical vein, normalized for abdominal circumference; secondarily as vascular resistance measures, obtained from the umbilical and the uterine arteries. Results: Maternal distress in second but not third trimester was associated with increased normalized fetoplacental blood flow (P-values 0.006 and 0.013 for score > mean for depression and intrusion, respectively). Post-hoc explorations suggested that a reduced birthweight/placental weight ratio may mediate this association. Psychological distress did not affect vascular resistance measures in the umbilical and uterine arteries, regardless of adjustment for confounders. Conclusions: In pregnant women with a previous fetus or child with a congenital malformation, higher distress levels in second trimester were associated with third trimester fetoplacental blood flow that was higher than expected for the size of the fetus. The results do not support placental blood flow reduction as a pathway between maternal distress and reduced birthweight.	[Helbig, Anne; Kaasen, Anne] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Helbig, Anne; Haugen, Guttorm] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Kaasen, Anne] Oslo & Akershus Univ Coll Appl Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Malt, Ulrik Fredrik] Oslo Univ Hosp, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway; [Malt, Ulrik Fredrik; Haugen, Guttorm] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway	University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Helbig, A (corresponding author), Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway.	helbig@frisurf.no	Kaasen, Anne/ABE-1562-2020	Kaasen, Anne/0000-0001-9291-0105; Malt, Ulrik/0000-0002-9881-2511	Norwegian Resource Centre for Women's Health; Norwegian Women's Public Health Association	Norwegian Resource Centre for Women's Health; Norwegian Women's Public Health Association	This study was financially supported by the Norwegian Resource Centre for Women's Health (http://www.oslo-universitetssykehus.no/omoss/avdelinger/kvinnehelse/Sider/enhet.aspx) and the Norwegian Women's Public Health Association (http://www.sanitetskvinnene.no/filestore/N.K.S.Hovedbrosjyre_Engelsk_Korr3.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, PRENATAL DIAG, V25, P99, DOI 10.1002/pd.1091; Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Blackmore ER, 2011, BRIT J PSYCHIAT, V198, P373, DOI 10.1192/bjp.bp.110.083105; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Di Naro E, 2002, ACTA OBSTET GYN SCAN, V81, P527, DOI 10.1034/j.1600-0412.2002.810609.x; Dunkel Schetter C, 2011, HDB HLTH PSYCHOL, P431; Ebbing C, 2011, ULTRASOUND OBST GYN, V38, P303, DOI 10.1002/uog.9046; Eberhard-Gran M, 2001, NORD J PSYCHIAT, V55, P113, DOI 10.1080/08039480151108525; Eid J, 2009, NORD J PSYCHIAT, V63, P426, DOI 10.1080/08039480903118190; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Harville EW, 2008, ULTRASOUND OBST GYN, V32, P23, DOI 10.1002/uog.5344; Helbig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057071; Henrichs J, 2010, PSYCHOL MED, V40, P633, DOI 10.1017/S0033291709990894; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kaasen A, 2010, BJOG-INT J OBSTET GY, V117, P1127, DOI 10.1111/j.1471-0528.2010.02622.x; Kent A, 2002, ULTRASOUND OBST GYN, V19, P177, DOI 10.1046/j.0960-7692.2001.00546.x; Kersting A, 2009, ARCH WOMEN MENT HLTH, V12, P193, DOI 10.1007/s00737-009-0063-8; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; Korenromp MJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.007; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Lee JY, 2012, J ANIM SCI, V90, P4846, DOI 10.2527/jas.2012-5090; Littleton HL, 2010, J PSYCHOSOM OBST GYN, V31, P219, DOI 10.3109/0167482X.2010.518776; Lumey LH, 1998, PLACENTA, V19, P105; Mendelson T, 2011, J PSYCHOSOM OBST GYN, V32, P3, DOI 10.3109/0167482X.2010.544427; Monk C, 2012, BIOL PSYCHIAT, V72, P483, DOI 10.1016/j.biopsych.2012.05.006; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Sjostrom K, 1997, EUR J OBSTET GYN R B, V74, P149, DOI 10.1016/S0301-2115(97)00100-0; Skari H, 2006, PRENATAL DIAG, V26, P1001, DOI 10.1002/pd.1542; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Skreden M, 2010, AM J MED GENET A, V152A, P2193, DOI 10.1002/ajmg.a.33605; Tegethoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014478; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Vythilingum B, 2010, ARCH WOMEN MENT HLTH, V13, P359, DOI 10.1007/s00737-010-0144-8; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Willmott SA, 2004, SOC PSYCH PSYCH EPID, V39, P613, DOI 10.1007/s00127-004-0801-1	44	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86597	10.1371/journal.pone.0086597	http://dx.doi.org/10.1371/journal.pone.0086597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475155	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300091
J	Liu, ZQ; Han, YC; Zhang, X; Chu, L; Fang, JM; Zhao, HX; Chen, YJ; Xu, Q				Liu, Zhu-Qing; Han, Ying-Chao; Zhang, Xi; Chu, Li; Fang, Jue-Min; Zhao, Hua-Xin; Chen, Yi-Jing; Xu, Qing			Prognostic Value of Human Equilibrative NucleosideTransporter1 in Pancreatic Cancer Receiving Gemcitabin-Based Chemotherapy: A Meta-Analysis	PLOS ONE			English	Article							NUCLEOSIDE TRANSPORTER 1; PHASE-III TRIAL; ADJUVANT CHEMOTHERAPY; PREDICTS SURVIVAL; RANDOMIZED-TRIAL; DRUG-RESISTANCE; HENT1 PREDICTS; ADENOCARCINOMA; EXPRESSION; RESECTION	Background: The potential prognostic value of human equilibrative nucleoside transporter1 in pancreatic cancer receiving gemcitabine-based chemotherapy is variably reported. Objective: The objective of this study was to conduct a systematic review of literature evaluating human equilibrative nucleoside transporter1 expression as a prognostic factor in pancreatic cancer receiving gemcitabine-based chemotherapy and to conduct a subsequent meta-analysis to quantify the overall prognostic effect. Methods: Related studies were identified and evaluated for quality through multiple search strategies. Only studies analyzing pancreatic cancer receiving gemcitabine-based chemotherapy were eligible for inclusion. Data were collected from studies comparing overall, disease-free and progression-free survival (OS, DFS and PFS) in patients with low human equilibrative nucleoside transporter1 levels and those having high levels. The hazard ratio (HR) and its 95% confidence interval (95%CI) were used to assess the strength of associations. Hazard ratios greater than 1 reflect adverse survival associated with low human equilibrative nucleoside transporter1 levels. Results: A total of 12 studies (n = 875) were involved in this meta-analysis (12 for OS, 5 for DFS, 3 for PFS). For overall and disease-free survival, the pooled HRs of human equilibrative nucleoside transporter1 were significant at 2.93 (95% confidence interval [95% CI], 2.37-3.64) and 2.67 (95% CI, 1.87-3.81), respectively. For progression-free survival, the pooled HR in higher human equilibrative nucleoside transporter1 expression in pancreatic cancer receiving gemcitabine-based chemotherapy was 2.76 (95% CI, 1.76-4.34). No evidence of significant heterogeneity or publication bias was seen in any of these studies. Conclusion: These results support the case for a low human equilibrative nucleoside transporter1 level representing a significant and reproducible marker of adverse prognosis in pancreatic cancer receiving gemcitabine-based chemotherapy.	[Liu, Zhu-Qing; Zhang, Xi; Chu, Li; Fang, Jue-Min; Zhao, Hua-Xin; Chen, Yi-Jing; Xu, Qing] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Med Oncol, Shanghai 200092, Peoples R China; [Han, Ying-Chao] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine Surg, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Xu, Q (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Med Oncol, Shanghai 200092, Peoples R China.	qingxumed@163.com		XU, QING/0000-0002-4785-2994	National Natural Science Foundation of China [30872591]; Shanghai Science and Technology Commission [11411950602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This article is supported by the National Natural Science Foundation of China (NO 30872591) and Shanghai Science and Technology Commission (NO: 11411950602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chua YJ, 2005, J CLIN ONCOL, V23, P4532, DOI 10.1200/JCO.2005.17.954; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; Delmotte P, 2002, REV MAL RESPIR, V19, P577; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eto K, 2013, BRIT J CANCER, V108, P1488, DOI 10.1038/bjc.2013.108; Farrell JJ, 2009, GASTROENTEROLOGY, V136, P187, DOI 10.1053/j.gastro.2008.09.067; Fujita H, 2010, NEOPLASIA, V12, P807, DOI 10.1593/neo.10458; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Goh LB, 1995, ANTICANCER RES, V15, P2575; Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3; Kawada N, 2012, J HEPATO-BIL-PAN SCI, V19, P717, DOI 10.1007/s00534-012-0514-x; Kim R, 2011, CANCER-AM CANCER SOC, V117, P3126, DOI 10.1002/cncr.25883; Kondo N, 2012, ANN SURG ONCOL, V19, pS646, DOI 10.1245/s10434-011-2140-2; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Mackey JR, 1998, CANCER RES, V58, P4349; Mackey JR, 1998, DRUG RESIST UPDATE, V1, P310, DOI 10.1016/S1368-7646(98)80047-2; Malats W, 2005, LANCET ONCOL, V6, P678; Mallery JS, 2002, GASTROINTEST ENDOSC, V56, P218, DOI 10.1067/mge.2002.125826; Marechal R, 2012, GASTROENTEROLOGY, V143, P664, DOI 10.1053/j.gastro.2012.06.006; Marechal R, 2009, CLIN CANCER RES, V15, P2913, DOI 10.1158/1078-0432.CCR-08-2080; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Morinaga S, 2012, ANN SURG ONCOL, V19, pS558, DOI 10.1245/s10434-011-2054-z; Murata Y, 2012, J HEPATO-BIL-PAN SCI, V19, P413, DOI 10.1007/s00534-011-0440-3; Nakagawa N, 2013, SURGERY, V153, P565, DOI 10.1016/j.surg.2012.10.010; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Neoptolemos JP, 2012, JAMA-J AM MED ASSOC, V308, P147, DOI 10.1001/jama.2012.7352; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Okai T, 1999, GASTROINTEST ENDOSC, V50, P797, DOI 10.1016/S0016-5107(99)70161-6; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tada M, 2002, AM J GASTROENTEROL, V97, P2263; Vaccaro V, 2011, NEW ENGL J MED, V365, P768, DOI 10.1056/NEJMc1107627; Xiao JC, 2013, HEPATO-GASTROENTEROL, V60, P258, DOI 10.5754/hge12687	40	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87103	10.1371/journal.pone.0087103	http://dx.doi.org/10.1371/journal.pone.0087103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475233	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300140
J	Madala, SK; Edukulla, R; Phatak, M; Schmidt, S; Davidson, C; Acciani, TH; Korfhagen, TR; Medvedovic, M; LeCras, TD; Wagner, K; Hardie, WD				Madala, Satish K.; Edukulla, Ramakrishna; Phatak, Mukta; Schmidt, Stephanie; Davidson, Cynthia; Acciani, Thomas H.; Korfhagen, Thomas R.; Medvedovic, Mario; LeCras, Timothy D.; Wagner, Kimberly; Hardie, William D.			Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CONDITIONAL EXPRESSION; MOLECULAR-MECHANISMS; FACTOR-ALPHA; ACTIVATION; CONTRACTION; INHIBITION; SURVIVAL; KINASE; TISSUE	Pulmonary fibrosis is often triggered by an epithelial injury resulting in the formation of fibrotic lesions in the lung, which progress to impair gas exchange and ultimately cause death. Recent clinical trials using drugs that target either inflammation or a specific molecule have failed, suggesting that multiple pathways and cellular processes need to be attenuated for effective reversal of established and progressive fibrosis. Although activation of MAPK and PI3K pathways have been detected in human fibrotic lung samples, the therapeutic benefits of in vivo modulation of the MAPK and PI3K pathways in combination are unknown. Overexpression of TGF alpha in the lung epithelium of transgenic mice results in the formation of fibrotic lesions similar to those found in human pulmonary fibrosis, and previous work from our group shows that inhibitors of either the MAPK or PI3K pathway can alter the progression of fibrosis. In this study, we sought to determine whether simultaneous inhibition of the MAPK and PI3K signaling pathways is a more effective therapeutic strategy for established and progressive pulmonary fibrosis. Our results showed that inhibiting both pathways had additive effects compared to inhibiting either pathway alone in reducing fibrotic burden, including reducing lung weight, pleural thickness, and total collagen in the lungs of TGF alpha mice. This study demonstrates that inhibiting MEK and PI3K in combination abolishes proliferative changes associated with fibrosis and myfibroblast accumulation and thus may serve as a therapeutic option in the treatment of human fibrotic lung disease where these pathways play a role.	[Madala, Satish K.; Edukulla, Ramakrishna; Schmidt, Stephanie; Davidson, Cynthia; Wagner, Kimberly; Hardie, William D.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Acciani, Thomas H.; Korfhagen, Thomas R.; LeCras, Timothy D.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Phatak, Mukta; Medvedovic, Mario] Univ Cincinnati, Lab Stat Genom & Syst Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hardie, WD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA.	william.hardie@cchmc.org		Le Cras, Timothy/0000-0001-8538-2703	National Institutes of Health [HL107159]; Parker B. Francis Fellowship; NIAMS [1R03AR062832]; AHA [12SDG9130040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL107159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AHA(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant HL107159 (WDH), Parker B. Francis Fellowship (SKM), NIAMS 1R03AR062832 (SKM) and AHA 12SDG9130040 (SKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Conte E, 2013, LAB INVEST, V93, P566, DOI 10.1038/labinvest.2013.6; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Duffield JS, 2012, ANN REV PATHOL; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Hardie WD, 2004, AM J PHYSIOL-LUNG C, V286, pL741, DOI 10.1152/ajplung.00208.2003; Hardie WD, 2007, AM J RESP CELL MOL, V37, P309, DOI 10.1165/rcmb.2006-0455OC; Hardie WD, 2010, CELL CYCLE, V9, P2769, DOI 10.4161/cc.9.14.12268; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Le Cras TD, 2010, AM J PATHOL, V176, P679, DOI 10.2353/ajpath.2010.090123; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Madala SK, 2013, AM J RESP C IN PRESS; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo P, 2006, METH MOL B, V341, P103; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Papiris SA, 2010, CRIT CARE, V14, DOI 10.1186/cc9241; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Sisson Thomas H, 2012, Adv Biosci Biotechnol, V3, P657; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Thannickal Victor J, 2005, Expert Opin Emerg Drugs, V10, P707, DOI 10.1517/14728214.10.4.707; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; White ES, 2012, J PATHOL; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208	41	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86536	10.1371/journal.pone.0086536	http://dx.doi.org/10.1371/journal.pone.0086536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475138	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300076
J	Mayama, C; Tsutsumi, T; Saito, H; Asaoka, R; Tomidokoro, A; Iwase, A; Otani, S; Miyata, K; Araie, M				Mayama, Chihiro; Tsutsumi, Tae; Saito, Hitomi; Asaoka, Ryo; Tomidokoro, Atsuo; Iwase, Aiko; Otani, Shinichiro; Miyata, Kazunori; Araie, Makoto			Glaucoma-Induced Optic Disc Morphometric Changes and Glaucoma Diagnostic Ability of Heidelberg Retina Tomograph II in Highly Myopic Eyes	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; ADULT CHINESE POPULATION; JAPANESE POPULATION; CLINICAL-ASSESSMENT; REFRACTIVE ERRORS; PREVALENCE; SINGAPORE; OPHTHALMOSCOPY; PHOTOGRAPHS; CHILDREN	Purpose: This study was performed to first investigate the morphological differences in the optic nerve head between highly myopic non-glaucomatous controls and highly myopic glaucomatous eyes in comparison with the differences between emmetropic non-glaucomatous controls and emmetropic glaucomatous eyes using confocal scanning laser ophthalmoscopy. Further, the ability of the apparatus in glaucoma diagnosis in highly myopic eyes was compared with that in emmetropic eyes. Methods: Healthy subjects and age-matched patients with early-stage open-angle glaucoma were divided into two groups: emmetropic eyes (-1.0 to +1.0 diopters) and highly myopic eyes (-12.0 to -5.0 diopters). The participants were comprised of 65 emmetropic normal eyes, 59 emmetropic glaucomatous eyes, 62 highly myopic normal eyes, and 68 highly myopic glaucomatous eyes and eyes with pathologic myopia were carefully excluded. Confocal scanning laser tomographic parameters were compared among all subjects after adjustment for age and disc area. The ROC curves and sensitivity and specificity for glaucoma detection using several clinical methods were then compared between the emmetropic and highly myopic eyes. Results: Rim area, cup/disc area ratio, mean cup depth, and cup shape measure of glaucoma eyes are significantly different from those of normal eyes in both highly myopic eyes and emmetropic eyes. Methodological overestimation of retinal nerve fiber layer cross sectional area due to optic disc tilting was suggested in the highly myopic eyes. The diagnostic performance of glaucoma using several discriminant methods significantly deteriorated in the highly myopic eyes. Conclusions: In the highly myopic glaucomatous eyes, confocal scanning laser tomographic parameters were significantly different from that of non-glaucomatous highly myopic eyes but diagnostic performance of glaucoma was deteriorated than that in emmetropic eyes. These findings demonstrate the utility and limitations of the apparatus in diagnosing glaucoma in highly myopic patients.	[Mayama, Chihiro; Tsutsumi, Tae; Saito, Hitomi; Asaoka, Ryo; Tomidokoro, Atsuo; Araie, Makoto] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Iwase, Aiko] Tajimi Municipal Hosp, Dept Ophthalmol, Tajimi, Japan; [Otani, Shinichiro; Miyata, Kazunori] Miyata Eye Hosp, Miyakonojo, Miyazaki, Japan; [Araie, Makoto] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan	University of Tokyo	Mayama, C (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	cmayama-tky@umin.ac.jp						Abe H, 2009, OPHTHALMOLOGY, V116, P223, DOI 10.1016/j.ophtha.2008.09.013; Anderson DR., 1999, AUTOMATED STATIC PER; Andreou PA, 2007, EYE, V21, P1050, DOI 10.1038/sj.eye.6702394; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; Dichtl A, 1998, BRIT J OPHTHALMOL, V82, P286, DOI 10.1136/bjo.82.3.286; How ACS, 2009, ARCH OPHTHALMOL-CHIC, V127, P894, DOI 10.1001/archophthalmol.2009.134; Hwang YH, 2011, J GLAUCOMA; Iester M, 2000, BRIT J OPHTHALMOL, V84, P464, DOI 10.1136/bjo.84.5.464; Iester M, 1997, CAN J OPHTHALMOL, V32, P382; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; Mikelberg F S, 1995, J Glaucoma, V4, P242; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; Reus NJ, 2007, BRIT J OPHTHALMOL, V91, P313, DOI 10.1136/bjo.2006.096586; Rudnicka AR, 2010, INVEST OPHTH VIS SCI, V51, P6270, DOI 10.1167/iovs.10-5528; Samarawickrama C, 2011, OPHTHALMOLOGY, V118, P2050, DOI 10.1016/j.ophtha.2011.02.040; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Shimizu N, 2003, JPN J OPHTHALMOL, V47, P6, DOI 10.1016/S0021-5155(02)00620-2; Stamper RL, 1998, J GLAUCOMA, V7, P149; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Swindale NV, 2000, INVEST OPHTH VIS SCI, V41, P1730; Tsutsumi T, 2009, INVEST OPHTH VIS SCI, V50, P5281, DOI 10.1167/iovs.08-3301; Uchida H, 2005, JPN J OPHTHALMOL, V49, P469, DOI 10.1007/s10384-005-0248-2; Wollstein G, 2000, OPHTHALMOLOGY, V107, P2272, DOI 10.1016/S0161-6420(00)00363-8; Wollstein G, 1998, OPHTHALMOLOGY, V105, P1557, DOI 10.1016/S0161-6420(98)98047-2; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Zangwill LM, 2001, ARCH OPHTHALMOL-CHIC, V119, P985, DOI 10.1001/archopht.119.7.985	28	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86417	10.1371/journal.pone.0086417	http://dx.doi.org/10.1371/journal.pone.0086417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475117	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300063
J	Zhang, J; Wang, HC; Wang, LM; Liu, SY				Zhang, Jian; Wang, Haocheng; Wang, Limin; Liu, Shuyi			Is There Any Overtrading in Stock Markets? The Moderating Role of Big Five Personality Traits and Gender in a Unilateral Trend Stock Market	PLOS ONE			English	Article							INDIVIDUAL INVESTORS; JOB-PERFORMANCE; INVESTMENT; OUTCOMES; DISPOSITION; PREDICT; RISK	Overtrading is a common anomaly among stock investors. This study examines the relationship between overtrading and investment returns and the impact of the Big Five traits and gender on overtrading in a unilateral trend stock market using a simulated stock investment system. The data were derived from a sample of undergraduates from six universities who performed in a simulated stock investment situation and had their personality traits measured by the Big Five Personality Questionnaire. The results indicate that: (1) Overtrading was significant in rising stock markets, but not significant in falling markets. (2) The degree of female investors who overtraded was significant in rising markets. (3) The degree of overtrading investors who were high in extroversion or agreeableness was significant in rising markets. The implications of these results for more effective investment strategies are discussed.	[Zhang, Jian; Wang, Haocheng; Liu, Shuyi] Univ Sci & Technol Beijing, Dongling Sch Econ & Management, Dept Business Adm, Beijing 100083, Peoples R China; [Wang, Limin] Univ Sci & Technol Beijing, Dongling Sch Econ & Management, Dept Financial Engn, Beijing 100083, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing	Wang, HC (corresponding author), Univ Sci & Technol Beijing, Dongling Sch Econ & Management, Dept Business Adm, Beijing 100083, Peoples R China.	hebeigeng@126.com	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137	National Natural Science Fund [71071017]; Central University Foundation [FRF-BR-09-019]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Central University Foundation	This research was supported by National Natural Science Fund (71071017) and Central University Foundation Research Funds (FRF-BR-09-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Alpert M., 1982, JUDGMENT UNCERTAINTY, P294, DOI DOI 10.1017/CBO9780511809477.022; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Barber BM, 2000, J FINANC, V55, P773, DOI 10.1111/0022-1082.00226; Barber BM, 2009, REV FINANC STUD, V22, P609, DOI 10.1093/rfs/hhn046; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Behling O., 1998, ACAD MANAGEMENT EXEC, P77, DOI 10.5465/ame.1998.254980; Borgatta EF, 1964, BEHAV SCI, V12, P8, DOI 10. 1002/ bs. 3830090103; Chamorro-Premuzic T, 2003, J RES PERS, V37, P319, DOI 10.1016/S0092-6566(02)00578-0; Chen W, 2010, 2010 ANN M AC BEH FI; COSTA PT, 1998, ADV PERSONALITY, P103; Costa PT, 2007, REVISED NEO PERSONAL; DEBONDT WFM, 1995, HDBK OPER R, V9, P385; Epstein I., 1992, PSYCHOL SMART INVEST; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Hampson SE, 2006, HEALTH PSYCHOL, V25, P57, DOI 10.1037/0278-6133.25.1.57; HIEMSTRA C, 1994, J FINANC, V49, P1639, DOI 10.2307/2329266; Hogan J, 2003, J APPL PSYCHOL, V88, P100, DOI 10.1037/0021-9010.88.1.100; Hogan R, 1982, PERSONALITY CURRENT, P55; Jesen MC, 1968, J FINACE, V23, P389, DOI [10.1111/j.1540-6261.1968.tb00815.x., DOI 10.1111/J.1540-6261.1968.TB00815.X]; John O.P., 1989, PERSONALITY PSYCHOL, P261, DOI DOI 10.1007/978-1-4684-0634-4_20; Judge TA, 2002, J APPL PSYCHOL, V87, P765, DOI 10.1037/0021-9010.87.4.765; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lei W, 2003, PSYCHOL SCI, V26, P24; LEWELLEN WG, 1977, J BUS, V50, P296, DOI 10.1086/295947; Li S, 2008, J RISK RES, V11, P673, DOI 10.1080/13669870802086497; LUNDEBERG MA, 1994, J EDUC PSYCHOL, V86, P114, DOI 10.1037/0022-0663.86.1.114; OBrien TB, 1996, J PERS, V64, P775, DOI 10.1111/j.1467-6494.1996.tb00944.x; Robbins SB, 2006, J EDUC PSYCHOL, V98, P598, DOI 10.1037/0022-0663.98.3.598; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; SHEFRIN H, 1985, J FINANC, V40, P777, DOI 10.2307/2327802; Shua L, 2006, EC RES J, V8, P58; Songtao T, 2006, EC RES J, V10, P83; Watson D., 1996, J PERS, V64, P735, DOI 10.1111/j.1467-6494.1996.tb00943.x; Weber M, 1998, J ECON BEHAV ORGAN, V33, P167, DOI 10.1016/S0167-2681(97)00089-9; Xinghui P., 1995, PSYCHOL SCI, V18, P94	38	4	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87111	10.1371/journal.pone.0087111	http://dx.doi.org/10.1371/journal.pone.0087111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475235	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300142
J	Zhao, DY; Jiang, N				Zhao, Dongyan; Jiang, Ning			Nested Insertions and Accumulation of Indels Are Negatively Correlated with Abundance of Mutator-Like Transposable Elements in Maize and Rice	PLOS ONE			English	Article							DELETION DERIVATIVES; ARABIDOPSIS-THALIANA; EXPRESSION PATTERN; GENOME EVOLUTION; GENE-EXPRESSION; SEQUENCE; RETROTRANSPOSONS; DIVERSITY; HISTORY; FAMILY	Mutator-like transposable elements (MULEs) are widespread in plants and were first discovered in maize where there are a total of 12,900 MULEs. In comparison, rice, with a much smaller genome, harbors over 30,000 MULEs. Since maize and rice are close relatives, the differential amplification of MULEs raised an inquiry into the underlying mechanism. We hypothesize this is partly attributed to the differential copy number of autonomous MULEs with the potential to generate the transposase that is required for transposition. To this end, we mined the two genomes and detected 530 and 476 MULEs containing transposase sequences (candidate coding-MULEs) in maize and rice, respectively. Over 1/3 of the candidate coding-MULEs harbor nested insertions and the ratios are similar in the two genomes. Among the maize elements with nested insertions, 24% have insertions in coding regions and over half of them harbor two or more insertions. In contrast, only 12% of the rice elements have insertions in coding regions and 19% have multiple insertions, suggesting that nested insertions in maize are more disruptive. This is because most nested insertions in maize are from LTR retrotransposons, which are large in size and are prevalent in the maize genome. Our results suggest that the amplification of retrotransposons may limit the amplification of DNA transposons but not vice versa. In addition, more indels are detected among maize elements than rice elements whereas defects caused by point mutations are comparable between the two species. Taken together, more disruptive nested insertions combined with higher frequency of indels resulted in few (6%) coding-MULEs that may encode functional transposases in maize. In contrast, 35% of the coding-MULEs in rice retain putative intact transposase. This is in addition to the higher expression frequency of rice coding-MULEs, which may explain the higher occurrence of MULEs in rice than that in maize.	[Zhao, Dongyan; Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA	Michigan State University	Jiang, N (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.	jiangn@msu.edu	Jiang, Ning/G-6546-2012	Zhao, Dongyan/0000-0002-2080-8416	National Science Foundation [DBI-0607123, MCB-1121650]	National Science Foundation(National Science Foundation (NSF))	This study is supported by grants DBI-0607123 and MCB-1121650 from National Science Foundation to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Benito MI, 1997, MOL CELL BIOL, V17, P5165, DOI 10.1128/MCB.17.9.5165; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; BENNETZEN JL, 1984, P NATL ACAD SCI-BIOL, V81, P4125, DOI 10.1073/pnas.81.13.4125; Boutin TS, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-5; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; Comelli P, 1999, PLANT MOL BIOL, V41, P615, DOI 10.1023/A:1006382725952; Cowan RK, 2005, MOL BIOL EVOL, V22, P2084, DOI 10.1093/molbev/msi202; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; Dolgin ES, 2008, GENET RES, V90, P317, DOI 10.1017/S0016672308009440; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson AA, 2013, PLANT PHYSIOL, V163, P1419, DOI 10.1104/pp.113.223271; Ferguson AA, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/695827; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Gao DY, 2012, MOL GENET GENOMICS, V287, P261, DOI 10.1007/s00438-012-0676-x; Hastings KEM, 1996, J MOL EVOL, V42, P631, DOI 10.1007/BF02338796; Hennig S, 2010, J BACTERIOL, V192, P4153, DOI 10.1128/JB.00226-10; Hua-Van A, 2008, J MOL EVOL, V67, P670, DOI 10.1007/s00239-008-9178-1; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Ilic K, 2003, P NATL ACAD SCI USA, V100, P12265, DOI 10.1073/pnas.1434476100; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Jiang N, 2013, GENETICS GENOMICS RI, DOI [10.1007/978-1-4614-7903-1_5, DOI 10.1007/978-1-4614-7903-1_]; Kim SH, 2003, PLANT CELL, V15, P2430, DOI 10.1105/tpc.014605; Kronmiller BA, 2008, PLANT PHYSIOL, V146, P45, DOI 10.1104/pp.107.110353; Kronmiller BA, 2009, PLANT PHYSIOL, V151, P483, DOI 10.1104/pp.109.143370; Li YB, 2013, PLANT CELL, V25, P3251, DOI 10.1105/tpc.113.116517; Lisch D, 2005, BIOESSAYS, V27, P353, DOI 10.1002/bies.20219; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Lisch D, 1999, GENETICS, V151, P331; Lisch DR, 2001, PLANT PHYSIOL, V125, P1293, DOI 10.1104/pp.125.3.1293; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Lockton S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-10; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Marquez CP, 2010, GENETICS, V185, P1507, DOI 10.1534/genetics.110.116673; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nesmelova IV, 2010, ADV DRUG DELIVER REV, V62, P1187, DOI 10.1016/j.addr.2010.06.006; Neuveglise C, 2005, EUKARYOT CELL, V4, P615, DOI 10.1128/EC.4.3.615-624.2005; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Rossi M, 2004, MOL GENET GENOMICS, V272, P194, DOI 10.1007/s00438-004-1036-2; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2012, MOL BIOL EVOLUTION P, P35; Tam SM, 2007, J EVOLUTION BIOL, V20, P1056, DOI 10.1111/j.1420-9101.2007.01293.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tian ZX, 2009, GENOME RES, V19, P2221, DOI 10.1101/gr.083899.108; Vicient CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-601; Vitte C, 2006, P NATL ACAD SCI USA, V103, P17638, DOI 10.1073/pnas.0605618103; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Wright S, 2001, CURR BIOL, V11, pR296, DOI 10.1016/S0960-9822(01)00168-3; Wright SI, 2001, GENETICS, V158, P1279; Wright SI, 1999, GENETICA, V107, P139, DOI 10.1023/A:1003953126700; Xu ZN, 2004, PLANT CELL, V16, P1105, DOI 10.1105/tpc.019802; Yu ZH, 2000, GENETICS, V156, P2019; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	70	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87069	10.1371/journal.pone.0087069	http://dx.doi.org/10.1371/journal.pone.0087069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475224	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300132
J	Tuttle, TR; Hugo, ER; Tong, WS; Ben-Jonathan, N				Tuttle, Traci R.; Hugo, Eric R.; Tong, Wilson S.; Ben-Jonathan, Nira			Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; MESSENGER-RNA; GENE-EXPRESSION; CHORIONIC-GONADOTROPIN; ECTOPIC PRODUCTION; MAMMALIAN-CELLS; QUANTIFICATION; PREGNANCY; LOCUS; CHORIOCARCINOMA	Introduction: Several studies reported that the pregnancy-specific hormone placental lactogen (hPL) is expressed at both mRNA and protein levels in breast cancer. The overall objective was to establish hPL, the product of the CSH1 and CSH2 genes, as a biomarker for breast cancer. Methods: CSH expression was determined at the mRNA level in breast cancer cell lines (BCC) and primary carcinomas by real-time and conventional PCR and the products verified as CSH1 by sequencing. Expression of hPL protein was examined by western blots and immuno-histochemistry, using commercial and custom-made polyclonal and monoclonal antibodies. Results: Variable levels of CSH mRNA were detected in several BCC, and in some primary tumors. We detected a protein, slightly larger than recombinant hPL by western blotting using several antibodies, leading us to postulate that it represents an hPL variant ('hPL'). Furthermore, some monoclonal antibodies detected 'hPL' by immunohistochemistry in breast carcinomas but not in normal breast. However, further examination revealed that these antibodies were non-specific, as efficient suppression of CSH mRNA by shRNA did not abolish the 'hPL' band. Custom-made monoclonal antibodies against recombinant hPL detected hPL of the correct size in placental lysate and hPL-overexpressing BCC, but not in unmodified cells or primary carcinomas. hPL protein was detected only when mRNA was increased several thousand fold. Conclusions: We call into question previous reports of hPL expression in breast cancer which relied on mRNA levels as surrogates for protein and/or used improperly validated antibodies to measure hPL protein levels. Our data suggests that an inhibitory mechanism(s) prevents translation of CSH mRNA in breast cancer when not highly expressed. The mechanism by which translation of CSH mRNA is inhibited is intriguing and should be further investigated.	[Tuttle, Traci R.; Hugo, Eric R.; Tong, Wilson S.; Ben-Jonathan, Nira] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Ben-Jonathan, N (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.	Nira.Ben-Jonathan@uc.edu	Hugo, Eric/ADA-3523-2022	Hugo, Eric/0000-0002-2990-6362	NIH [ES02909, CA096613, DOD BC05725, AR110050]; CCTST(Center for Clinical and Translational Science and Training); Ride Cincinnati Pilot Grants; NRSA(National Research Service Award) predoctoral fellowship [T32 ES007250]; NATIONAL CANCER INSTITUTE [R01CA096613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCTST(Center for Clinical and Translational Science and Training); Ride Cincinnati Pilot Grants; NRSA(National Research Service Award) predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants ES02909, CA096613, DOD BC05725, and AR110050; CCTST(Center for Clinical and Translational Science and Training); Ride Cincinnati Pilot Grants (to N.B.J); and an NRSA(National Research Service Award) predoctoral fellowship T32 ES007250 (to T.R.T). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; BARSH GS, 1983, NUCLEIC ACIDS RES, V11, P3939, DOI 10.1093/nar/11.12.3939; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; FUKUNAGA M, 1993, HUM PATHOL, V24, P1098, DOI 10.1016/0046-8177(93)90190-R; Galsgaard ED, 2009, J ENDOCRINOL, V201, P115, DOI 10.1677/JOE-08-0479; HORNE CHW, 1976, LANCET, V2, P279; Latham C, 2001, CANCER GENET CYTOGEN, V127, P16, DOI 10.1016/S0165-4608(00)00427-1; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; LIEBLICH JM, 1976, J NATL CANCER I, V56, P911, DOI 10.1093/jnci/56.5.911; LYTRAS A, 1994, ENDOCRINOLOGY, V134, P2461, DOI 10.1210/en.134.6.2461; Madersbacher S, 1998, EXP CLIN ENDOCR DIAB, V106, P61, DOI 10.1055/s-0029-1211952; MONTEIRO JCMP, 1983, EUR J CANCER CLIN ON, V19, P173, DOI 10.1016/0277-5379(83)90414-5; MONTEIRO JCMP, 1982, BRIT J CANCER, V46, P279, DOI 10.1038/bjc.1982.193; NACHTIGAL MW, 1993, J BIOL CHEM, V268, P8473; NICKEL BE, 1993, MOL CELL ENDOCRINOL, V91, P159, DOI 10.1016/0303-7207(93)90268-O; PATTILLO RA, 1971, ANN NY ACAD SCI, V172, P288, DOI 10.1111/j.1749-6632.1971.tb34942.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAMAAN N, 1966, J CLIN ENDOCR METAB, V26, P1303, DOI 10.1210/jcem-26-12-1303; Sarro SM, 2010, LEUKEMIA RES, V34, P1670, DOI 10.1016/j.leukres.2010.06.031; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SELVANAYAGAM CS, 1984, J BIOL CHEM, V259, P4642; Sesterhenn Isabell A, 2004, Cancer Control, V11, P374; SHETH NA, 1977, CANCER, V39, P1693, DOI 10.1002/1097-0142(197704)39:4<1693::AID-CNCR2820390445>3.0.CO;2-Z; Stark AM, 2006, NEUROL RES, V28, P787, DOI 10.1179/016164106X110364; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; WALKER WH, 1990, J BIOL CHEM, V265, P12940; Walsh STR, 2006, J MOL BIOL, V358, P773, DOI 10.1016/j.jmb.2006.02.038; Wu ZS, 2011, J CLIN ENDOCR METAB, V96, pE1619, DOI 10.1210/jc.2011-1245	33	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87325	10.1371/journal.pone.0087325	http://dx.doi.org/10.1371/journal.pone.0087325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475273	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800095
J	Xu, HW; Xu, BS; Yang, Q; Li, XL; Ma, XL; Xia, Q; Zhang, Y; Zhang, CQ; Wu, YH; Zhang, YY				Xu, Haiwei; Xu, Baoshan; Yang, Qiang; Li, Xiulan; Ma, Xinlong; Xia, Qun; Zhang, Yang; Zhang, Chunqiu; Wu, Yaohong; Zhang, Yuanyuan			Comparison of Decellularization Protocols for Preparing a Decellularized Porcine Annulus Fibrosus Scaffold	PLOS ONE			English	Article							LUMBAR ANULUS FIBROSUS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; INTERVERTEBRAL DISC; TENSILE PROPERTIES; HEART-VALVES; TISSUE; MODEL; REGENERATION; BEHAVIOR	Tissue-specific extracellular matrix plays an important role in promoting tissue regeneration and repair. We hypothesized that decellularized annular fibrosus matrix may be an appropriate scaffold for annular fibrosus tissue engineering. We aimed to determine the optimal decellularization method suitable for annular fibrosus. Annular fibrosus tissue was treated with 3 different protocols with Triton X-100, sodium dodecyl sulfate (SDS) and trypsin. After the decellularization process, we examined cell removal and preservation of the matrix components, microstructure and mechanical function with the treatments to determine which method is more efficient. All 3 protocols achieved decellularization; however, SDS or trypsin disturbed the structure of the annular fibrosus. All protocols maintained collagen content, but glycosaminoglycan content was lost to different degrees, with the highest content with TritonX-100 treatment. Furthermore, SDS decreased the tensile mechanical property of annular fibrosus as compared with the other 2 protocols. MTT assay revealed that the decellularized annular fibrosus was not cytotoxic. Annular fibrosus cells seeded into the scaffold showed good viability. The Triton X-100-treated annular fibrosus retained major extracellular matrix components after thorough cell removal and preserved the concentric lamellar structure and tensile mechanical properties. As well, it possessed favorable biocompatibility, so it may be a suitable candidate as a scaffold for annular fibrosus tissue engineering.	[Xu, Haiwei; Xu, Baoshan; Yang, Qiang; Ma, Xinlong; Xia, Qun; Wu, Yaohong] Tianjin Hosp, Dept Spine Surg, Tianjin, Peoples R China; [Xu, Haiwei; Yang, Qiang; Wu, Yaohong] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Li, Xiulan; Zhang, Yang] Tianjin Hosp, Inst Orthopaed, Cell Engn Lab, Tianjin, Peoples R China; [Zhang, Chunqiu] Tianjin Univ Technol, Sch Mech Engn, Tianjin, Peoples R China; [Zhang, Yuanyuan] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Tianjin Medical University; Tianjin University of Technology; Wake Forest University; Wake Forest Baptist Medical Center	Xu, BS (corresponding author), Tianjin Hosp, Dept Spine Surg, Tianjin, Peoples R China.	xubaoshan99@126.com; yangqiang1980@126.com	zhang, yuanyuan/GYA-4428-2022; yang, qiang/GYJ-0971-2022	Xu, Baoshan/0000-0003-4121-1835	National Natural Science Foundation of China [31000432, 81272046]; China Postdoctoral Science Foundation [2011M500530, 2012T50235]; Research Foundation of the Tianjin Health Bureau [2010KR08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Foundation of the Tianjin Health Bureau	This work was supported by the National Natural Science Foundation of China (grant numbers 31000432 and 81272046), China Postdoctoral Science Foundation funded project (grant numbers 2011M500530, 2012T50235), and the Research Foundation of the Tianjin Health Bureau (grant number 2010KR08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambard D, 2009, ANN BIOMED ENG, V37, P2256, DOI 10.1007/s10439-009-9761-7; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015; Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.0.CO;2-D; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85; Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005; Cheng HLM, 2010, MAGN RESON MED, V64, P341, DOI 10.1002/mrm.22404; Devereaux M, 2009, MED CLIN N AM, V93, P477, DOI 10.1016/j.mcna.2008.09.013; Dong SW, 2009, BIOSCI BIOTECH BIOCH, V73, P2226, DOI 10.1271/bbb.90329; Dong XC, 2009, J MATER SCI-MATER M, V20, P2327, DOI 10.1007/s10856-009-3791-4; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Ebara S, 1996, SPINE, V21, P452, DOI 10.1097/00007632-199602150-00009; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Han WM, 2012, ANN BIOMED ENG, V40, P1610, DOI 10.1007/s10439-012-0525-4; Hsu EW, 1999, MAGNET RESON MED, V41, P992, DOI 10.1002/(SICI)1522-2594(199905)41:5<992::AID-MRM19>3.0.CO;2-Y; Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421, DOI 10.1177/039139880302600508; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; Liao J, 2008, BIOMATERIALS, V29, P1065, DOI 10.1016/j.biomaterials.2007.11.007; Liu GF, 2008, CHINESE MED J-PEKING, V121, P1398, DOI 10.1097/00029330-200808010-00013; Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x; Mercuri JJ, 2011, J BIOMED MATER RES A, V96A, P422, DOI 10.1002/jbm.a.33001; Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384; Schroeder Y, 2008, J ORTHOP RES, V26, P1141, DOI 10.1002/jor.20632; Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/jbm.a.31030; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; Stapleton TW, 2011, TISSUE ENG PT A, V17, P231, DOI [10.1089/ten.tea.2009.0807, 10.1089/ten.TEA.2009.0807]; Sun XH, 2009, CELL MOL NEUROBIOL, V29, P347, DOI 10.1007/s10571-008-9326-6; Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309; Wagner DR, 2004, J ORTHOP RES, V22, P901, DOI 10.1016/j.orthres.2003.12.012; Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031; Yang Q, 2013, ORTHOP SURG, V5, P60, DOI 10.1111/os.12020; Yin LZ, 2005, J BIOMECH, V38, P1674, DOI 10.1016/j.jbiomech.2004.07.017; Zhao YL, 2012, ARTIF ORGANS, V36, P247, DOI 10.1111/j.1525-1594.2011.01343.x; Zhao YL, 2011, J MATER SCI-MATER M, V22, P1407, DOI 10.1007/s10856-011-4326-3	39	207	212	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86723	10.1371/journal.pone.0086723	http://dx.doi.org/10.1371/journal.pone.0086723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475172	Green Submitted, gold, Green Published			2022-12-27	WOS:000330339800057
J	Yoshii, Y; Matsumoto, H; Yoshimoto, M; Furukawa, T; Morokoshi, Y; Sogawa, C; Zhang, MR; Wakizaka, H; Yoshii, H; Fujibayashi, Y; Saga, T				Yoshii, Yukie; Matsumoto, Hiroki; Yoshimoto, Mitsuyoshi; Furukawa, Takako; Morokoshi, Yukie; Sogawa, Chizuru; Zhang, Ming-Rong; Wakizaka, Hidekatsu; Yoshii, Hiroshi; Fujibayashi, Yasuhisa; Saga, Tsuneo			Controlled Administration of Penicillamine Reduces Radiation Exposure in Critical Organs during Cu-64-ATSM Internal Radiotherapy: A Novel Strategy for Liver Protection	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HYPOXIA IMAGING AGENT; TUMOR HYPOXIA; IN-VITRO; CU-ATSM; PET; CANCER; CU-60-ATSM; EXPRESSION; MECHANISM	Purpose: Cu-64-diacetyl-bis (N-4-methylthiosemicarbazone) (Cu-64-ATSM) is a promising theranostic agent that targets hypoxic regions in tumors related to malignant characteristics. Its diagnostic usefulness has been recognized in clinical studies. Internal radiotherapy (IRT) with Cu-64-ATSM is reportedly effective in preclinical studies; however, for clinical applications, improvements to reduce radiation exposure in non-target organs, particularly the liver, are required. We developed a strategy to reduce radiation doses to critical organs while preserving tumor radiation doses by controlled administration of copper chelator penicillamine during Cu-64-ATSM IRT. Methods: Biodistribution was evaluated in HT-29 tumor-bearing mice injected with Cu-64-ATSM (185 kBq) with or without oral penicillamine administration. The appropriate injection interval between Cu-64-ATSM and penicillamine was determined. Then, the optimal penicillamine administration schedule was selected from single (100, 300, and 500 mg/kg) and fractionated doses (100 mg/kgx3 at 1- or 2-h intervals from 1 h after Cu-64-ATSM injection). PET imaging was performed to confirm the effect of penicillamine with a therapeutic Cu-64-ATSM dose (37 MBq). Dosimetry analysis was performed to estimate human absorbed doses. Results: Penicillamine reduced Cu-64 accumulation in the liver and small intestine. Tumor uptake was not affected by penicillamine administration at 1 h after Cu-64-ATSM injection, when radioactivity was almost cleared from the blood and tumor uptake had plateaued. Of the single doses, 300 mg/kg was most effective. Fractionated administration at 2-h intervals further decreased liver accumulation at later time points. PET indicated that penicillamine acts similarly with the therapeutic Cu-64-ATSM dose. Dosimetry demonstrated that appropriately scheduled penicillamine administration reduced radiation doses to critical organs (liver, ovaries, and red marrow) below tolerance levels. Laxatives reduced radiation doses to the large intestine. Conclusions: We developed a novel strategy to reduce radiation exposure in critical organs during Cu-64-ATSM IRT, thus promoting its clinical applications. This method could be beneficial for other Cu-64-labeled compounds.	[Yoshii, Yukie; Furukawa, Takako; Morokoshi, Yukie; Sogawa, Chizuru; Zhang, Ming-Rong; Wakizaka, Hidekatsu; Fujibayashi, Yasuhisa; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Matsumoto, Hiroki] Nihon Mediphys Co Ltd, Res Ctr, Chiba, Japan; [Yoshimoto, Mitsuyoshi] East Hosp, Natl Canc Ctr, Div Funct Imaging, Chiba, Japan; [Yoshii, Hiroshi] Natl Inst Radiol Sci, Emergency Radiat Exposure Med Care Res Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology; National Cancer Center - Japan; National Institutes for Quantum Science & Technology	Yoshii, Y (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	yukiey@nirs.go.jp		Yoshimoto, Mitsuyoshi/0000-0003-2083-9148	Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by the Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aft RL, 2003, CANCER RES, V63, P5496; Anderson CJ, 2001, J NUCL MED, V42, P213; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bowen SR, 2011, NUCL MED BIOL, V38, P771, DOI 10.1016/j.nucmedbio.2011.02.002; Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291; Dehdashti F, 2008, J NUCL MED, V49, P201, DOI 10.2967/jnumed.107.048520; Dietz DW, 2008, DIS COLON RECTUM, V51, P1641, DOI 10.1007/s10350-008-9420-3; Fauci A., 1998, HARRISONS PRINCIPLES, P525; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; Holland JP, 2009, PHYS MED BIOL, V54, P2103, DOI 10.1088/0031-9155/54/7/017; Jalilian AR, 2009, ACTA PHARMACEUT, V59, P45, DOI 10.2478/v10007-009-0008-9; KHALILMANESH F, 1983, TOXICOLOGY, V26, P325, DOI 10.1016/0300-483X(83)90093-8; KIRSCHNER AS, 1975, J NUCL MED, V16, P248; Laforest R, 2005, EUR J NUCL MED MOL I, V32, P764, DOI 10.1007/s00259-004-1756-x; Lewis JS, 2008, J NUCL MED, V49, P1177, DOI 10.2967/jnumed.108.051326; Lewis JS, 2001, P NATL ACAD SCI USA, V98, P1206, DOI 10.1073/pnas.98.3.1206; Lewis JS, 2001, J NUCL MED, V42, P655; Lewis JS, 1999, J NUCL MED, V40, P177; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; Nozu T, 1977, OYO YAKURI, V14, P265; Obata A, 2001, ANN NUCL MED, V15, P499, DOI 10.1007/BF02988502; Obata A, 2005, NUCL MED BIOL, V32, P21, DOI 10.1016/j.nucmedbio.2004.08.012; Obata A, 2003, NUCL MED BIOL, V30, P535, DOI 10.1016/S0969-8051(03)00024-6; Oh M, 2009, NUCL MED BIOL, V36, P419, DOI 10.1016/j.nucmedbio.2009.01.016; Paudyal P, 2010, CANCER SCI, V101, P1045, DOI 10.1111/j.1349-7006.2010.01480.x; SHIMADA H, 1993, TOXICOLOGY, V77, P157, DOI 10.1016/0300-483X(93)90146-J; Siegel GG, 1999, BASIC NEUROCHEMISTRY; Stabin MG, 2005, J NUCL MED, V46, P1023; Tamura K, 2012, J CLIN ONCOL, V30; Tanaka T, 2006, NUCL MED BIOL, V33, P743, DOI 10.1016/j.nucmedbio.2006.05.005; Tsuji AB, 2012, NUCL MED COMMUN, V33, P1058, DOI 10.1097/MNM.0b013e328356efb0; Tsuji AB, 2009, J NUCL MED, V50, P827, DOI 10.2967/jnumed.108.058925; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Walker LR, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/385767; WALSHE JM, 1964, CLIN SCI, V26, P461; Wong TZ, 2008, AM J ROENTGENOL, V190, P427, DOI 10.2214/AJR.07.2876; Yoshii Y, 2012, NUCL MED BIOL, V39, P177, DOI 10.1016/j.nucmedbio.2011.08.008; Yoshii Y, 2011, NUCL MED BIOL, V38, P151, DOI 10.1016/j.nucmedbio.2010.08.009; Yoshii Y, 2010, NUCL MED BIOL, V37, P395, DOI 10.1016/j.nucmedbio.2009.12.011	41	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86996	10.1371/journal.pone.0086996	http://dx.doi.org/10.1371/journal.pone.0086996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466309	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100241
J	Boersma, PD; Rebstock, GA				Boersma, P. Dee; Rebstock, Ginger A.			Climate Change Increases Reproductive Failure in Magellanic Penguins	PLOS ONE			English	Article							POPULATION-DYNAMICS; NEST-SITE; ATMOSPHERIC CIRCULATION; SPHENISCUS-HUMBOLDTI; TEMPERATURE EXTREMES; SURVIVAL ANALYSIS; JACKASS PENGUIN; OBSERVED TRENDS; HEAT-STRESS; EL-NINO	Climate change is causing more frequent and intense storms, and climate models predict this trend will continue, potentially affecting wildlife populations. Since 1960 the number of days with >20 mm of rain increased near Punta Tombo, Argentina. Between 1983 and 2010 we followed 3496 known-age Magellanic penguin (Spheniscus magellanicus) chicks at Punta Tombo to determine how weather impacted their survival. In two years, rain was the most common cause of death killing 50% and 43% of chicks. In 26 years starvation killed the most chicks. Starvation and predation were present in all years. Chicks died in storms in 13 of 28 years and in 16 of 233 storms. Storm mortality was additive; there was no relationship between the number of chicks killed in storms and the numbers that starved (P = 0.75) or that were eaten (P = 0.39). However, when more chicks died in storms, fewer chicks fledged (P = 0.05, R-2 = 0.14). More chicks died when rainfall was higher and air temperature lower. Most chicks died from storms when they were 9-23 days old; the oldest chick killed in a storm was 41 days old. Storms with heavier rainfall killed older chicks as well as more chicks. Chicks up to 70 days old were killed by heat. Burrow nests mitigated storm mortality (N = 1063). The age span of chicks in the colony at any given time increased because the synchrony of egg laying decreased since 1983, lengthening the time when chicks are vulnerable to storms. Climate change that increases the frequency and intensity of storms results in more reproductive failure of Magellanic penguins, a pattern likely to apply to many species breeding in the region. Climate variability has already lowered reproductive success of Magellanic penguins and is likely undermining the resilience of many other species.	[Boersma, P. Dee; Rebstock, Ginger A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Boersma, P. Dee; Rebstock, Ginger A.] Wildlife Conservat Soc, Bronx, NY USA	University of Washington; University of Washington Seattle; Wildlife Conservation Society	Boersma, PD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	boersma@u.washington.edu		Chiaradia, Andre/0000-0002-6178-4211	WCS; Exxonmobil Foundation; Pew Fellows Program in Marine Conservation; Disney Worldwide Conservation Fund; National Geographic Society; Chase Foundation; Cunningham Foundation; MKCG Foundation; Offield Foundation; Peach Foundation; Thorne Foundation; Tortuga Foundation; Kellogg Foundation; Wadsworth Endowed Chair in Conservation Science	WCS; Exxonmobil Foundation(Exxon Mobil Corporation); Pew Fellows Program in Marine Conservation; Disney Worldwide Conservation Fund; National Geographic Society(National Geographic Society); Chase Foundation; Cunningham Foundation; MKCG Foundation; Offield Foundation; Peach Foundation; Thorne Foundation; Tortuga Foundation; Kellogg Foundation; Wadsworth Endowed Chair in Conservation Science	The Penguin Project has been funded by: WCS, Exxonmobil Foundation, The Pew Fellows Program in Marine Conservation, The Disney Worldwide Conservation Fund, The National Geographic Society, The Chase Foundation, The Cunningham Foundation, The MKCG Foundation, The Offield Foundation, The Peach Foundation, The Thorne Foundation, The Tortuga Foundation, The Kellogg Foundation, The Wadsworth Endowed Chair in Conservation Science, and Friends of the Penguins. Trimble provided six rugged tablets. Canon provided two pairs of binoculars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta EA, 2008, J CLIMATE, V21, P4365, DOI 10.1175/2008JCLI2137.1; BIRKHEAD TR, 1976, BRIT BIRDS, V69, P490; Boersma D., 1975, P101; Boersma P.D., 1990, P15; Boersma P.D., 1992, P INT ORNITHOLOGICAL, P961; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 2009, AUK, V126, P335, DOI 10.1525/auk.2009.08144; Boersma PD, 2009, MAR ECOL PROG SER, V375, P263, DOI 10.3354/meps07753; Boersma PD, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P3; BOERSMA PD, 1986, PHYSIOL ZOOL, V59, P10, DOI 10.1086/physzool.59.1.30156084; Boersma PD, 2004, AUK, V121, P148, DOI 10.1642/0004-8038(2004)121[0148:WPEAT]2.0.CO;2; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Boulanger JP, 2006, CLIM DYNAM, V27, P233, DOI 10.1007/s00382-006-0134-8; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burton NHK, 2007, CONDOR, V109, P441, DOI 10.1650/0010-5422(2007)109[441:ILVINO]2.0.CO;2; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Chapman EW, 2011, MAR ECOL PROG SER, V436, P273, DOI 10.3354/meps09242; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; de Bary Pereda S, 1990, INFLUENCE NEST SITE; Boersma PD, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P233; Demongin L, 2010, ORNITOL NEOTROP, V21, P439; Drummond BA, 2010, AVIAN CONSERV ECOL, V5; Duchamp C, 2002, COMP BIOCHEM PHYS A, V131, P765, DOI 10.1016/S1095-6433(02)00014-4; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2013, GLOBAL CHANGE BIOL, V19, P364, DOI 10.1111/gcb.12072; Frere Esteban, 1992, Marine Ornithology, V20, P1; FROST PGH, 1976, J ZOOL, V179, P165, DOI 10.1111/j.1469-7998.1976.tb02289.x; GANDINI P, 1994, AUK, V111, P20, DOI 10.2307/4088501; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P321; Garcia-Borboroglu P, 2006, MAR POLLUT BULL, V52, P193, DOI 10.1016/j.marpolbul.2005.11.004; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Grimm AM, 2000, J CLIMATE, V13, P35, DOI 10.1175/1520-0442(2000)013<0035:CVISSA>2.0.CO;2; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; HARRISON P., 1983, SEABIRDS IDENTIFICAT; Hass T, 2012, MAR ECOL PROG SER, V454, P251, DOI 10.3354/meps09723; Haylock MR, 2006, J CLIMATE, V19, P1490, DOI 10.1175/JCLI3695.1; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jamroz D, 2004, J ANIM PHYSIOL AN N, V88, P239, DOI 10.1111/j.1439-0396.2004.00481.x; Jenouvrier S, 2009, OIKOS, V118, P1292, DOI 10.1111/j.1600-0706.2009.17498.x; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Legendre P., 2012, NUMERICAL ECOLOGY; Levine JM, 2011, ECOLOGY, V92, P2236, DOI 10.1890/11-0471.1; Li J, 2013, NAT CLIM CHANGE; Lombard CD, 2010, CONDOR, V112, P56, DOI 10.1525/cond.2010.090042; Long J. S., 2006, REGRESSION MODELS CA, V7; Mallory ML, 2009, ARCTIC, V62, P333; Mallory ML, 2009, POLAR BIOL, V32, P529, DOI 10.1007/s00300-008-0547-4; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Menendez CG, 2010, CLIMATIC CHANGE, V98, P359, DOI 10.1007/s10584-009-9735-7; Moller AP, 2011, HDB BIRDS WORLD, P13; Moreno J, 2011, CURR ZOOL, V57, P375, DOI 10.1093/czoolo/57.3.375; Noy Y, 1999, J APPL POULTRY RES, V8, P16, DOI 10.1093/japr/8.1.16; Nunez MN, 2009, CLIM DYNAM, V32, P1081, DOI 10.1007/s00382-008-0449-8; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Onley D., 2007, ALBATROSSES PETRELS; Oswald SA, 2012, INTEGR ZOOL, V7, P121, DOI 10.1111/j.1749-4877.2012.00287.x; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Paredes R, 2001, BIOL CONSERV, V100, P199, DOI 10.1016/S0006-3207(01)00023-4; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; Rebstock GA, 2011, CONDOR, V113, P316, DOI 10.1525/cond.2011.100162; Renner M, 2001, IBIS, V143, P369, DOI 10.1111/j.1474-919X.2001.tb04938.x; Russo S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016260; Rusticucci M, 2004, J CLIMATE, V17, P4099, DOI 10.1175/1520-0442(2004)017<4099:OTACIT>2.0.CO;2; SAGAR P M, 1989, Notornis, V36, P171; SALZMAN AG, 1982, ECOLOGY, V63, P742, DOI 10.2307/1936795; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Schiavini Adrián, 2005, Hornero, V20, P5; Schreiber E.A., 2002, P179; SEDDON PJ, 1991, AUK, V108, P548, DOI 10.2307/4088094; Sherley RB, 2012, EMU, V112, P97, DOI 10.1071/MU11055; Sherley RB, 2012, J ORNITHOL, V153, P441, DOI 10.1007/s10336-011-0760-8; Simeone A, 2004, J ORNITHOL, V145, P35, DOI 10.1007/s10336-003-0005-6; Simeone A, 2002, MAR ECOL PROG SER, V227, P43, DOI 10.3354/meps227043; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stevenson S, 2012, J CLIMATE, V25, P2129, DOI 10.1175/JCLI-D-11-00252.1; Stokes DL, 1998, AUK, V115, P34, DOI 10.2307/4089109; STOKES DL, 1991, AUK, V108, P923; Suryan RM, 2006, PROG OCEANOGR, V68, P303, DOI 10.1016/j.pocean.2006.02.006; Suryan RM, 2001, AUK, V118, P636, DOI 10.1642/0004-8038(2001)118[0636:CAPDOB]2.0.CO;2; TAYLOR JRE, 1985, J COMP PHYSIOL B, V155, P615, DOI 10.1007/BF00694453; THOMPSON KR, 1991, J ZOOL, V225, P427, DOI 10.1111/j.1469-7998.1991.tb03826.x; Tulp I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038041; Turner J, 2005, ANN GLACIOL-SER, V41, P85, DOI 10.3189/172756405781813177; Vincent LA, 2005, J CLIMATE, V18, P5011, DOI 10.1175/JCLI3589.1; Visser G. Henk, 2002, P439; Wingfield JC, 1997, ARDEA, V85, P155; Woods RW, 1997, ATLAS BREEDING BIRDS; Yang HM, 2009, ITAL J ANIM SCI, V8, P585, DOI 10.4081/ijas.2009.585; Yorio P, 1998, ATLES DISTRIBUCION R	95	70	71	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85602	10.1371/journal.pone.0085602	http://dx.doi.org/10.1371/journal.pone.0085602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489663	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000012
J	Doyon, G; Sobolewski, MD; Huber, K; McMahon, D; Mellors, JW; Sluis-Cremer, N				Doyon, Genevieve; Sobolewski, Michele D.; Huber, Kelly; McMahon, Deborah; Mellors, John W.; Sluis-Cremer, Nicolas			Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase p110 alpha That Reactivates Latent HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL CLONE; PERIPHERAL-BLOOD; DEACETYLASE INHIBITORS; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; EXPRESSION; LYMPHOCYTES; TYPE-1; COMBINATION	Combination antiretroviral therapy (cART) can effectively suppress HIV-1 replication, but the latent viral reservoir in resting memory CD4(+) T cells is impervious to cART and represents a major barrier to curing HIV-1 infection. Reactivation of latent HIV-1 represents a possible strategy for elimination of this reservoir. In this study we describe the discovery of 1,2,9,10-tetramethoxy-7H-dibenzo[de,g]quinolin-7-one (57704) which reactivates latent HIV-1 in several cell-line models of latency (J89GFP, U1 and ACH-2). 57704 also increased HIV-1 expression in 3 of 4 CD8(+)-depleted blood mononuclear cell preparations isolated from HIV-1-infected individuals on suppressive cART. In contrast, vorinostat increased HIV-1 expression in only 1 of the 4 donors tested. Importantly, 57704 does not induce global T cell activation. Mechanistic studies revealed that 57704 reactivates latent HIV-1 via the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. 57704 was found to be an agonist of PI3K with specificity to the p110 alpha isoform, but not the p110 beta, delta or gamma isoforms. Taken together, our work suggests that 57704 could serve as a scaffold for the development of more potent activators of latent HIV-1. Furthermore, it highlights the involvement of the PI3K/Akt pathway in the maintenance of HIV-1 latency.	[Doyon, Genevieve; Sobolewski, Michele D.; Huber, Kelly; McMahon, Deborah; Mellors, John W.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sluis-Cremer, N (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA.	nps2@pitt.edu	Huber, Kelly/AAE-3449-2020		University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This study was funded by funds from the University of Pittsburgh to NSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2005, J INFECT DIS, V191, P1164, DOI 10.1086/428588; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Morgan RJ, 2012, INVEST NEW DRUG, V30, P723, DOI 10.1007/s10637-010-9557-5; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; PSALLIDOPOULOS MC, 1989, J VIROL, V63, P4626, DOI 10.1128/JVI.63.11.4626-4631.1989; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10	26	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e84964	10.1371/journal.pone.0084964	http://dx.doi.org/10.1371/journal.pone.0084964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489654	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330570000008
J	de Waal, H; Stam, CJ; Lansbergen, MM; Wieggers, RL; Kamphuis, PJGH; Scheltens, P; Maestu, F; van Straaten, ECW				de Waal, Hanneke; Stam, Cornelis J.; Lansbergen, Marieke M.; Wieggers, Rico L.; Kamphuis, Patrick J. G. H.; Scheltens, Philip; Maestu, Fernando; van Straaten, Elisabeth C. W.			The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer's Disease: A Randomised Controlled Study	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; DOCOSAHEXAENOIC ACID; COGNITIVE IMPAIRMENT; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; CONTROLLED-TRIAL; EEG; CONNECTIVITY; DEMENTIA; OSCILLATIONS	Background: Synaptic loss is a major hallmark of Alzheimer's disease (AD). Disturbed organisation of large-scale functional brain networks in AD might reflect synaptic loss and disrupted neuronal communication. The medical food Souvenaid, containing the specific nutrient combination Fortasyn Connect, is designed to enhance synapse formation and function and has been shown to improve memory performance in patients with mild AD in two randomised controlled trials. Objective: To explore the effect of Souvenaid compared to control product on brain activity-based networks, as a derivative of underlying synaptic function, in patients with mild AD. Design: A 24-week randomised, controlled, double-blind, parallel-group, multi-country study. Participants: 179 drug-naive mild AD patients who participated in the Souvenir II study. Intervention: Patients were randomised 1: 1 to receive Souvenaid or an iso-caloric control product once daily for 24 weeks. Outcome: In a secondary analysis of the Souvenir II study, electroencephalography (EEG) brain networks were constructed and graph theory was used to quantify complex brain structure. Local brain network connectivity (normalised clustering coefficient gamma) and global network integration (normalised characteristic path length lambda) were compared between study groups, and related to memory performance. Results: The network measures in the beta band were significantly different between groups: they decreased in the control group, but remained relatively unchanged in the active group. No consistent relationship was found between these network measures and memory performance. Conclusions: The current results suggest that Souvenaid preserves the organisation of brain networks in patients with mild AD within 24 weeks, hypothetically counteracting the progressive network disruption over time in AD. The results strengthen the hypothesis that Souvenaid affects synaptic integrity and function. Secondly, we conclude that advanced EEG analysis, using the mathematical framework of graph theory, is useful and feasible for assessing the effects of interventions.	[de Waal, Hanneke; Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [de Waal, Hanneke; Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Stam, Cornelis J.; van Straaten, Elisabeth C. W.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Lansbergen, Marieke M.; Wieggers, Rico L.; Kamphuis, Patrick J. G. H.; van Straaten, Elisabeth C. W.] Nutricia Res, Utrecht, Netherlands; [Maestu, Fernando] UCM UPM Ctr Biomed Technol, Lab Cognit & Computat Neurosci, Madrid, Spain	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Danone Nutricia	de Waal, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	h.dewaal@vumc.nl	Scheltens, Philip/AAL-9631-2020; maestu, fernando/M-7480-2019; Maestu, Fernando/E-3213-2012	Scheltens, Philip/0000-0002-1046-6408; maestu, fernando/0000-0002-3195-0071; Maestu, Fernando/0000-0002-3195-0071; Stam, Cornelis/0000-0001-9163-7274	NL Food & Nutrition Delta project, FND [10003]	NL Food & Nutrition Delta project, FND	Study design and planning were carried out in conjunction with the sponsor, Danone Research BV, on behalf of Nutricia Advanced Medical Nutrition, Danone's specialised healthcare unit. The sponsor also provided the study products and funding for the research and data collection. Statistical analysis was conducted by staff of Danone Research. The Souvenir II study was supported by the NL Food & Nutrition Delta project, FND No10003 (http://www.foodnutritiondelta.nl).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Babiloni C, 2006, BRAIN RES BULL, V69, P63, DOI 10.1016/j.brainresbull.2005.10.013; Basar E, 2013, INT J PSYCHOPHYSIOL, V90, P99, DOI 10.1016/j.ijpsycho.2013.07.005; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bokde ALW, 2009, PROG NEUROBIOL, V89, P125, DOI 10.1016/j.pneurobio.2009.06.004; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G., 2006, RHYTHMS BRAIN; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; de Haan W, 2011, NEUROIMAGE; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; de Wilde MC, 2011, EUR J PHARMACOL, V668, pS59, DOI 10.1016/j.ejphar.2011.07.011; DIERKS T, 1995, J NEURAL TRANSM-GEN, V99, P55, DOI 10.1007/BF01271469; DUNKIN JJ, 1995, CLIN ELECTROENCEPHAL, V26, P47, DOI 10.1177/155005949502600107; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Holguin S, 2008, FASEB J, V22, P3938, DOI 10.1096/fj.08-112425; HUBBARD O, 1976, ELECTROEN CLIN NEURO, V40, P407, DOI 10.1016/0013-4694(76)90192-9; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Park YM, 2008, NEUROSCI RES, V62, P112, DOI 10.1016/j.neures.2008.06.009; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Sakamoto T, 2007, BRAIN RES, V1182, P50, DOI 10.1016/j.brainres.2007.08.089; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Savelkoul PJM, 2012, J NEUROCHEM, V120, P631, DOI 10.1111/j.1471-4159.2011.07616.x; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sijben JWC, 2011, OCL OILS FAT CROP LI, V18, P267, DOI 10.1051/ocl.2011.0410; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; van Steen M, 2010, GRAPH THEORY COMPLEX; van Wijk N, 2014, J ALZHEIMERS DIS, V38, P459, DOI 10.3233/JAD-130998; van Wijk N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-49; van Wijk N, 2012, BRIT J NUTR, V107, P1408, DOI 10.1017/S0007114511004570; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; Wurtman RJ, 2009, ANNU REV NUTR, V29, P59, DOI 10.1146/annurev-nutr-080508-141059	54	87	87	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86558	10.1371/journal.pone.0086558	http://dx.doi.org/10.1371/journal.pone.0086558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475144	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300081
J	Lacroix, S; Hamilton, LK; Vaugeois, A; Beaudoin, S; Breault-Dugas, C; Pineau, I; Levesque, SA; Gregoire, CA; Fernandes, KJL				Lacroix, Steve; Hamilton, Laura K.; Vaugeois, Alexandre; Beaudoin, Stefanny; Breault-Dugas, Christian; Pineau, Isabelle; Levesque, Sebastien A.; Gregoire, Catherine-Alexandra; Fernandes, Karl J. L.			Central Canal Ependymal Cells Proliferate Extensively in Response to Traumatic Spinal Cord Injury but Not Demyelinating Lesions	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ADULT-RAT; PROGENITOR CELLS; MICE; DIFFERENTIATION; ACTIVATION; TISSUE; CNS	The adult mammalian spinal cord has limited regenerative capacity in settings such as spinal cord injury (SCI) and multiple sclerosis (MS). Recent studies have revealed that ependymal cells lining the central canal possess latent neural stem cell potential, undergoing proliferation and multi-lineage differentiation following experimental SCI. To determine whether reactive ependymal cells are a realistic endogenous cell population to target in order to promote spinal cord repair, we assessed the spatiotemporal dynamics of ependymal cell proliferation for up to 35 days in three models of spinal pathologies: contusion SCI using the Infinite Horizon impactor, focal demyelination by intraspinal injection of lysophosphatidylcholine (LPC), and autoimmune-mediated multi-focal demyelination using the active experimental autoimmune encephalomyelitis (EAE) model of MS. Contusion SCI at the T9-10 thoracic level stimulated a robust, longlasting and long-distance wave of ependymal proliferation that peaked at 3 days in the lesion segment, 14 days in the rostral segment, and was still detectable at the cervical level, where it peaked at 21 days. This proliferative wave was suppressed distal to the contusion. Unlike SCI, neither chemical-nor autoimmune-mediated demyelination triggered ependymal cell proliferation at any time point, despite the occurrence of demyelination (LPC and EAE), remyelination (LPC) and significant locomotor defects (EAE). Thus, traumatic SCI induces widespread and enduring activation of reactive ependymal cells, identifying them as a robust cell population to target for therapeutic manipulation after contusion; conversely, neither demyelination, remyelination nor autoimmunity appears sufficient to trigger proliferation of quiescent ependymal cells in models of MS-like demyelinating diseases.	[Hamilton, Laura K.; Vaugeois, Alexandre; Beaudoin, Stefanny; Breault-Dugas, Christian; Gregoire, Catherine-Alexandra; Fernandes, Karl J. L.] CRCHUM, Fac Med, Dept Neurosci, Quebec City, PQ, Canada; [Hamilton, Laura K.; Vaugeois, Alexandre; Beaudoin, Stefanny; Breault-Dugas, Christian; Gregoire, Catherine-Alexandra; Fernandes, Karl J. L.] Univ Montreal, GRSNC, Quebec City, PQ, Canada; [Lacroix, Steve; Pineau, Isabelle; Levesque, Sebastien A.] CHUL, Ctr Hosp Univ CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Lacroix, Steve; Pineau, Isabelle; Levesque, Sebastien A.] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Universite de Montreal; Laval University; Laval University	Fernandes, KJL (corresponding author), CRCHUM, Fac Med, Dept Neurosci, Quebec City, PQ, Canada.	karl.jl.fernandes@umontreal.ca		Lacroix, Steve/0000-0003-0781-6371; Levesque, Sebastien A./0000-0002-3608-4045	Canadian Institutes of Health Research [111095]; Multiple Sclerosis Society of Canada; Fonds de recherche du Quebec en Sante; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Fonds de recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This investigation was supported by grants from the Canadian Institutes of Health Research (grant no. 111095) and the Multiple Sclerosis Society of Canada. Salary support was provided by the Fonds de recherche du Quebec en Sante (SL), a postdoctoral fellowship from the Multiple Sclerosis Society of Canada (SAL), and a Canada Research Chair (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2008, P NATL ACAD SCI USA, V105, P11358, DOI 10.1073/pnas.0804632105; Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BRUNI JE, 1987, J ANAT, V152, P55; Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.3.CO;2-T; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Fu H, 2003, J COMP NEUROL, V456, P237, DOI 10.1002/cne.10481; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Ghasemlou N, 2007, GLIA, V55, P294, DOI 10.1002/glia.20449; Girolamo F, 2011, NEUROBIOL DIS, V43, P678, DOI 10.1016/j.nbd.2011.05.021; Guo FZ, 2011, J NEUROSCI, V31, P11914, DOI 10.1523/JNEUROSCI.1759-11.2011; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horner PJ, 2000, J NEUROSCI, V20, P2218; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mchedlishvili L, 2012, P NATL ACAD SCI USA, V109, pE2258, DOI 10.1073/pnas.1116738109; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; RAFOLS JA, 1985, ANAT REC, V211, P75, DOI 10.1002/ar.1092110112; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Sabelstrom H, 2013, EXP NEUROL; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Yu K, 2013, DEVELOPMENT, V140, P1594, DOI 10.1242/dev.090845	39	68	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85916	10.1371/journal.pone.0085916	http://dx.doi.org/10.1371/journal.pone.0085916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475059	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300029
J	Maekawa, K; Baba, T; Otomo, S; Morishita, S; Tamura, N				Maekawa, Kengo; Baba, Tomoko; Otomo, Sumi; Morishita, Shoji; Tamura, Nobushige			Low Pre-Existing Gray Matter Volume in the Medial Temporal Lobe and White Matter Lesions Are Associated with Postoperative Cognitive Dysfunction after Cardiac Surgery	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; BYPASS; IMPAIRMENT; DEMENTIA; EDUCATION; OUTCOMES; BRAIN	Postoperative cognitive dysfunction (POCD) is recognized as a complication in the elderly after cardiac surgery. Imaging of the brain provides evidence of neurodegeneration in elderly patients; however, abnormalities in brain structure and their relation to POCD are uncertain. This pilot study investigated whether loss of gray matter in the bilateral medial temporal lobe (MTL), seen in preoperative MRI, was associated with POCD. Methods: Data were collected prospectively on 28 elderly patients scheduled for elective cardiac surgery. MRI of the brains of all patients were assessed for prior cerebral infarctions, and carotid and intracranial arterial stenosis. Patients also completed six neuropsychological tests of memory, attention and executive function before and after surgery. POCD was defined as an individual decrease in more than two tests of at least 1 standard deviation from the group baseline mean for that test. The degree of gray matter loss in the MTL of each patient was calculated using voxel-based morphometry with three-dimensional, T1-weighted MRI. This represented the degree of gray matter change as a Z score. Results: Postoperative cognitive dysfunction was identified in 8 of the 28 patients (29%). Patients with POCD had significantly more white matter lesions on MRI, and greater loss of gray matter in the bilateral MTL (average Z score 2.0 +/- 0.9) than patients without POCD. An analysis by stepwise logistic regression identified gray matter loss in the MTL and cerebral infarctions on MRI as independent predictors of POCD. Conclusions: These preliminary findings suggested that reduced gray matter in the bilateral MTL and white matter lesions existed in brains of elderly cardiac surgery patients who experienced POCD. Additional studies with larger sample sizes are needed to confirm these findings.	[Maekawa, Kengo] Kumamoto Univ, Grad Sch Med Sci, Dept Anesthesiol, Kumamoto, Japan; [Maekawa, Kengo; Baba, Tomoko; Otomo, Sumi] Kumamoto City Hosp, Dept Anesthesiol, Kumamoto, Japan; [Morishita, Shoji] Kumamoto City Hosp, Dept Radiol, Kumamoto, Japan; [Tamura, Nobushige] Kumamoto City Hosp, Dept Cardiovasc Surg, Kumamoto, Japan	Kumamoto University	Maekawa, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Anesthesiol, Kumamoto, Japan.	kenchom@par.odn.ne.jp						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; ATLAS SW, 1994, RADIOLOGY, V193, P1; Barber R, 2000, NEUROLOGY, V54, P1304, DOI 10.1212/WNL.54.6.1304; Bekker A, 2010, AM J SURG, V199, P782, DOI 10.1016/j.amjsurg.2009.07.042; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Evered LA, 2011, ANESTHESIOLOGY, V114, P1297, DOI 10.1097/ALN.0b013e31821b1aab; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Floyd TF, 2006, ANN THORAC SURG, V81, P2160, DOI 10.1016/j.athoracsur.2006.01.080; Goto T, 2003, ANN THORAC SURG, V75, P1912, DOI 10.1016/S0003-4975(03)00029-8; Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Hogue CW, 2006, ANESTH ANALG, V102, P1602, DOI 10.1213/01.ANE.0000219591.10826.17; Hudetz JA, 2012, EUR J ANAESTH, V29, P320, DOI 10.1097/EJA.0b013e328354223d; Keizer AMA, 2005, ACTA ANAESTH SCAND, V49, P1232, DOI 10.1111/j.1399-6576.2005.00835.x; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; Lewis MS, 2006, ACTA ANAESTH SCAND, V50, P50, DOI 10.1111/j.1399-6576.2006.00893.x; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scott DA, 2002, J CARDIOTHOR VASC AN, V16, P715, DOI 10.1053/jcan.2002.128413; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Silbert BS, 2007, ANESTH ANALG, V104, P1023, DOI 10.1213/01.ane.0000263285.03361.3a; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P431, DOI 10.1097/00000542-200703000-00006; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Testa C, 2004, J MAGN RESON IMAGING, V19, P274, DOI 10.1002/jmri.20001; Trzepacz PT, 1999, PSYCHOSOMATICS, V40, P193, DOI 10.1016/S0033-3182(99)71235-1; van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901; van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x	37	23	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87375	10.1371/journal.pone.0087375	http://dx.doi.org/10.1371/journal.pone.0087375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475280	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300175
J	Xu, QD; Xu, FH; Fan, L; Xiong, LP; Li, HY; Cao, SR; Lin, XY; Zheng, ZH; Yu, XQ; Mao, HP				Xu, Qingdong; Xu, Fenghua; Fan, Li; Xiong, Liping; Li, Huiyan; Cao, Shirong; Lin, Xiaoyan; Zheng, Zhihua; Yu, Xueqing; Mao, Haiping			Serum Potassium Levels and Its Variability in Incident Peritoneal Dialysis Patients: Associations with Mortality	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; CARDIAC DEATH; CAPD PATIENTS; RISK-FACTORS; HYPOKALEMIA; OUTCOMES; TRANSPORT; SURVIVAL	Background: Abnormal serum potassium is associated with an increased risk of mortality in dialysis patients. However, the impacts of serum potassium levels on short-and long-term mortality and association of potassium variability with death in peritoneal dialysis (PD) patients are uncertain. Methods: We examined mortality-predictability of serum potassium at baseline and its variability in PD patients treated in our center January 2006 through December 2010 with follow-up through December 2012. The hazard ratios (HRs) were used to assess the relationship between baseline potassium levels and short-term (<= 1 year) as well as long-term (>1 year) survival. Variability of serum potassium was defined as the coefficient of variation of serum potassium (CVSP) during the first year of PD. Results: A total of 886 incident PD patients were enrolled, with 248 patients (27.9%) presented hypokalemia (serum potassium <3.5 mEq/L). During a median follow-up of 31 months (range: 0.5-81.0 months), adjusted all-cause mortality hazard ratio (HR) and 95% confidence interval (CI) for baseline serum potassium of <3.0, 3.0 to <3.5, 3.5 to <4.0, 4.5 to <5.0, and >= 5.0 mEq/L, compared with 4.0 to <4.5 (reference), were 1.79 (1.02-3.14), 1.15 (0.72-1.86), 1.31 (0.82-2.08), 1.33 (0.71-2.48), 1.28 (0.53-3.10), respectively. The increased risk of lower potassium with mortality was evident during the first year of follow-up, but vanished thereafter. Adjusted all-cause mortality HR for CVSP increments of 7.5% to <12.0%; 12.0% to <16.7% and >= 16.7%, compared with <7.5% (reference), were 1.35 (0.67-2.71), 2.00 (1.05-3.83) and 2.18 (1.18-4.05), respectively. Similar association was found between serum potassium levels and its variability and cardiovascular mortality. Conclusions: A lower serum potassium level was associated with all-cause and cardiovascular mortality during the first year of follow-up in incident PD patients. In addition, higher variability of serum potassium levels conferred an increased risk of death in this population.	[Xu, Qingdong; Xu, Fenghua; Fan, Li; Xiong, Liping; Li, Huiyan; Cao, Shirong; Lin, Xiaoyan; Zheng, Zhihua; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Nephrol, Dept Nephrol,Minist Hlth China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Mao, HP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Nephrol, Dept Nephrol,Minist Hlth China, Guangzhou 510275, Guangdong, Peoples R China.	haipingmao@126.com	cao, shirong/AAX-5688-2021	Mao, Haiping/0000-0002-3608-3851	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B05]; National Science Fund for Distinguished Young Scholars of China [30925019]; 5010 Clinical Program of Sun Yat-sen University [2007007]; Guangzhou Committee of Science and Technology of China [2010U1-E00831]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 5010 Clinical Program of Sun Yat-sen University; Guangzhou Committee of Science and Technology of China	This work was supported by grants from the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No. 2011BAI10B05), the National Science Fund for Distinguished Young Scholars of China (No. 30925019), 5010 Clinical Program of Sun Yat-sen University (No. 2007007) and the Guangzhou Committee of Science and Technology of China (No. 2010U1-E00831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2002, AM J MED, V112, P696, DOI 10.1016/S0002-9343(02)01097-5; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; Chan CT, 2008, NEPHROL DIAL TRANSPL, V23, P3061, DOI 10.1093/ndt/gfn280; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chuang YW, 2009, NEPHROL DIAL TRANSPL, V24, P1603, DOI 10.1093/ndt/gfn709; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Dekker FW, 2008, KIDNEY INT, V74, P994, DOI 10.1038/ki.2008.328; Di Iorio B, 2012, NEPHROL DIAL TRANSPL, V27, P4404, DOI 10.1093/ndt/gfs328; Fleischmann EH, 2001, ASAIO J, V47, P74, DOI 10.1097/00002480-200101000-00016; Gao HB, 1999, AM J NEPHROL, V19, P7, DOI 10.1159/000013418; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Harrison TR, 1930, J CLIN INVEST, V8, P325, DOI 10.1172/JCI100267; Jung Ji Yong, 2009, Electrolyte Blood Press, V7, P73, DOI 10.5049/EBP.2009.7.2.73; Kainz A, 2010, NEPHROL DIAL TRANSPL, V25, P3701, DOI 10.1093/ndt/gfq287; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Khan AN, 1996, PERITON DIALYSIS INT, V16, P652; Konings CJAM, 2003, NEPHROL DIAL TRANSPL, V18, P797, DOI 10.1093/ndt/gfg147; Korgaonkar S, 2010, CLIN J AM SOC NEPHRO, V5, P762, DOI 10.2215/CJN.05850809; Kovesdy CP, 2007, CLIN J AM SOC NEPHRO, V2, P999, DOI 10.2215/CJN.04451206; Kwan BCH, 2012, NAT REV NEPHROL, V8, P501, DOI 10.1038/nrneph.2012.159; Li PKT, 2003, ANN INTERN MED, V139, P105, DOI 10.7326/0003-4819-139-2-200307150-00010; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; Newman L N, 2000, Adv Perit Dial, V16, P134; OREOPOULOS DG, 1982, NEPHRON, V30, P293, DOI 10.1159/000182504; ROCCO MV, 1994, J AM SOC NEPHROL, V5, P1333; ROSTAND SG, 1983, ARCH INTERN MED, V143, P377, DOI 10.1001/archinte.143.2.377; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Sica D A, 2002, J Clin Hypertens (Greenwich), V4, P198, DOI 10.1111/j.1524-6175.2002.01728.x; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; Tziviskou Effie, 2003, International Urology and Nephrology, V35, P429, DOI 10.1023/B:UROL.0000022867.93739.03; vanOlden RW, 1996, J AM SOC NEPHROL, V7, P745; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83	34	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86750	10.1371/journal.pone.0086750	http://dx.doi.org/10.1371/journal.pone.0086750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475176	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300107
J	Felisbino-Mendes, MS; Villamor, E; Velasquez-Melendez, G				Felisbino-Mendes, Mariana Santos; Villamor, Eduardo; Velasquez-Melendez, Gustavo			Association of Maternal and Child Nutritional Status in Brazil: A Population Based Cross-Sectional Study	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; OBESITY; UNDERNUTRITION; MORTALITY; INFANT; HEIGHT; HEALTH	Background: Although child undernutrition and stunting has been decreasing worldwide while obesity rates increase, these extreme conditions might coexist in families from low-and middle-income countries. We examined the association between maternal and child anthropometric indicators using a population representative sample. Methods: 4,258 non-pregnant women and their children <60 months who participated in the 2006 Brazilian Demographic Health Survey. We compared the distributions of two nutritional indexes of children, height-for-age (HAZ) and body mass index-for age (BAZ) z-scores, by categories of maternal height, body mass index (BMI), and waist circumference (WC). Adjusted mean differences and 95% confidence intervals (95% CI) were estimated from linear regression, taking into account the complex survey design. We also examined the associations of maternal anthropometry with the prevalence of child stunting (HAZ<-22) and overweight/obesity (BAZ>2). Results: HAZ was positively associated with maternal height and WC in a linear fashion. After adjustment, for sociodemographic characteristics, children whose mothers' height was <145 cm had 1.2 lower HAZ than children whose mothers were >= 160 cm tall (p-trend<0.0001). After further adjustment for maternal height and maternal BMI, children of mothers with a waist circumference >= 88 cm had 0.3 higher HAZ than those of mothers with WC<80 cm (p-trend<0.01). Adjusted prevalence ratios and 95% CI for stunting by the categories of maternal height (<145, 145-149, 150-154, 155-159 and >= 160 cm) were, respectively, 2.95 (1.51; 5.77), 2.29 (1.33; 3.93), 1.09 (0.63; 1.87), and 0.89 (0.45; 1.77), (p-trend = 0.001). BAZ was positively associated with maternal BMI and WC. Conclusion: We observed a strong, positive association of maternal and child nutritional status. Mothers of low stature had children with lower stature, mothers with central obesity had taller children, and mothers with overall or abdominal obesity had children with higher BAZ.	[Felisbino-Mendes, Mariana Santos; Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Escola Enfermagem, Belo Horizonte, MG, Brazil; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Universidade Federal de Minas Gerais; University of Michigan System; University of Michigan	Velasquez-Melendez, G (corresponding author), Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Escola Enfermagem, Belo Horizonte, MG, Brazil.	guveme@ufmg.br	Felisbino-Mendes, Mariana Santos/F-9910-2014	S Felisbino-Mendes, Mariana/0000-0001-5321-5708	FAPEMIG; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Brazil	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MSFM received a PhD scholarship from FAPEMIG and would also like to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Brazil, for a scholarship that supported a fellowship at the University of Michigan, USA. GVM is a research fellow from the Brazilian National Council for Scientific and Technological Development (CNPq) and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brazilian Ministry of Health, 2008, DEM HLTH SURV REP; Brazilian Ministry of Health, 2009, PESQ NAC DEM SAUD CR; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deierlein AL, 2011, J PEDIATR-US, V158, P221, DOI 10.1016/j.jpeds.2010.08.008; Ferreira HS, 2009, BRIT J NUTR, V101, P1239, DOI 10.1017/S0007114508059357; Hambidge KM, 2012, J PEDIATR GASTR NUTR, V54, P117, DOI 10.1097/MPG.0b013e3182331748; HART N, 1993, POP STUD-J DEMOG, V47, P27, DOI 10.1080/0032472031000146716; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; LARSSON G, 1986, DIABETES CARE, V9, P359, DOI 10.2337/diacare.9.4.359; Leibowitz KL, 2012, WORLD J PEDIATR, V8, P76, DOI 10.1007/s12519-011-0292-6; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; MARTORELL R, 1989, HUM ORGAN, V48, P15, DOI 10.17730/humo.48.1.x20u5450x51h5211; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Perez-Escamilla R, 2004, J NUTR, V134, P1923, DOI 10.1093/jn/134.8.1923; Perez-Escamilla R, 2008, REV NUTR, V21, P15; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; Symonds ME, 2013, ANN NUTR METAB, V62, P137, DOI 10.1159/000345598; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; World Health Organization, 2000, TRS894 WHO; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2006, CHILD GROWTH STAND T; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z	32	34	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87486	10.1371/journal.pone.0087486	http://dx.doi.org/10.1371/journal.pone.0087486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475297	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800096
J	Jadiya, P; Nazir, A				Jadiya, Pooja; Nazir, Aamir			A Pre- and Co-Knockdown of RNAseT Enzyme, Eri-1, Enhances the Efficiency of RNAi Induced Gene Silencing in Caenorhabditis elegans	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; FUNCTIONAL-ANALYSIS; AXON GUIDANCE; RAC GTPASE; INTERFERENCE; POTENT; CELL	Background: The approach of RNAi mediated gene knockdown, employing exogenous dsRNA, is being beneficially exploited in various fields of functional genomics. The immense utility of the approach came to fore from studies with model system C. elegans, but quickly became applicable with varied research models ranging from in vitro to various in vivo systems. Previously, there have been reports on the refractoriness of the neuronal cells to RNAi mediated gene silencing following which several modulators like eri-1 and lin-15 were described in C. elegans which, when present, would negatively impact the gene knockdown. Methodology/Principal Findings: Taking a clue from these findings, we went on to screen hypothesis-driven-methodologies towards exploring the efficiency in the process of RNAi under various experimental conditions, wherein these genes would be knocked down preceding to, or concurrently with, the knocking down of a gene of interest. For determining the efficiency of gene knockdown, we chose to study visually stark phenotypes of uncoordinated movement, dumpy body morphology and blistered cuticle obtained by knocking down of genes unc-73, dpy-9 and bli-3 respectively, employing the RNAi-by-feeding protocol in model system C. elegans. Conclusions/Significance: Our studies led to a very interesting outcome as the results reveal that amongst various methods tested, pre-incubation with eri-1 dsRNA synthesizing bacteria followed by co-incubation with eri-1 and gene-of-interest dsRNA synthesizing bacteria leads to the most efficient gene silencing as observed by the analysis of marker phenotypes. This provides an approach for effectively employing RNAi induced gene silencing while working with different genetic backgrounds including transgenic and mutant strains.	[Jadiya, Pooja; Nazir, Aamir] Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi, India; [Jadiya, Pooja; Nazir, Aamir] CSIR Cent Drug Res Inst, Lab Funct Genom & Mol Toxicol, Div Toxicol, Lucknow, Uttar Pradesh, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nazir, A (corresponding author), Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi, India.	anazir@cdri.res.in		Jadiya, Pooja/0000-0003-4807-9304; Nazir, Aamir/0000-0002-2503-1335	NIH National Center for Research Resources (NCRR); CSIR network project EpiHeD [BSC0118]; CSIR [113558/2K11/1]	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CSIR network project EpiHeD; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Nematode strains used in this work were provided by the C. elegans Genetics Center (CGC) University of Minnesota, MN, USA, which is funded by the NIH National Center for Research Resources (NCRR). AN acknowledges the funding support from CSIR network project EpiHeD (BSC0118). PJ is thankful to CSIR for Senior Research Fellowship (Ref: 113558/2K11/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BRENNER S, 1974, GENETICS, V77, P71; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hong J, 2005, BIOCHEM J, V390, P675, DOI 10.1042/BJ20050647; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P976; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kubiseski TJ, 2003, MOL CELL BIOL, V23, P6823, DOI 10.1128/MCB.23.19.6823-6835.2003; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; LEVY AD, 1993, MOL BIOL CELL, V4, P803, DOI 10.1091/mbc.4.8.803; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Stiernagle Theresa, 2006, WormBook, P1; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	29	3	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87635	10.1371/journal.pone.0087635	http://dx.doi.org/10.1371/journal.pone.0087635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475317	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800098
J	Jia, CY; Carson, MB; Wang, Y; Lin, YF; Lu, H				Jia, Caiyan; Carson, Matthew B.; Wang, Yang; Lin, Youfang; Lu, Hui			A New Exhaustive Method and Strategy for Finding Motifs in ChIP-Enriched Regions	PLOS ONE			English	Article							FACTOR-BINDING SITES; SEQ DATA; TRANSCRIPTION; DISCOVERY; DNA; GENOME; IDENTIFICATION; ALGORITHMS; SEQUENCES; DATABASE	ChIP-seq, which combines chromatin immunoprecipitation (ChIP) with next-generation parallel sequencing, allows for the genome-wide identification of protein-DNA interactions. This technology poses new challenges for the development of novel motif-finding algorithms and methods for determining exact protein-DNA binding sites from ChIP-enriched sequencing data. State-of-the-art heuristic, exhaustive search algorithms have limited application for the identification of short (l, d) motifs (l <= 10, d <= 2) contained in ChIP-enriched regions. In this work we have developed a more powerful exhaustive method (FMotif) for finding long (l, d) motifs in DNA sequences. In conjunction with our method, we have adopted a simple ChIP-enriched sampling strategy for finding these motifs in large-scale ChIP-enriched regions. Empirical studies on synthetic samples and applications using several ChIP data sets including 16 TF (transcription factor) ChIP-seq data sets and five TF ChIP-exo data sets have demonstrated that our proposed method is capable of finding these motifs with high efficiency and accuracy. The source code for FMotif is available at http://211.71.76.45/FMotif/.	[Jia, Caiyan; Wang, Yang; Lin, Youfang] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China; [Jia, Caiyan; Wang, Yang; Lin, Youfang] Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal, Beijing, Peoples R China; [Jia, Caiyan; Lu, Hui] Univ Illinois, Dept Bioengn Bioinformat, Chicago, IL USA; [Carson, Matthew B.] Northwestern Univ, Ctr Healthcare Studies, Inst Publ Hlth & Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Carson, Matthew B.] Northwestern Univ, Div Hlth & Biomed Informat, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Lu, Hui] Shanghai Jiao Tong Univ, Shanghai Inst Med Genet, Shanghai Childrens Hosp, Shanghai, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shanghai Jiao Tong University	Jia, CY (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China.	cyjia@bjtu.edu.cn; huilu.bioinfo@gmail.com	Lu, Hui/K-3264-2019	Lin, Youfang/0000-0002-5143-3645; Lu, Hui/0000-0001-8347-0830; Carson, Matthew/0000-0003-4105-9220	National Nature Science Foundation of China [60905029, 61105055, 61105056, 81230086, 31071167]; Beijing Natural Science Foundation [4112046]; Fundamental Research Funds for the Central Universities	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by National Nature Science Foundation of China (Grant No. 60905029, 61105055, 61105056, 81230086, and 31071167), the Beijing Natural Science Foundation (Grant No. 4112046), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boeva V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq217; Buhler J, 2002, J COMPUT BIOL, V9, P225, DOI 10.1089/10665270252935430; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin HCL, 2005, P 3 AS PAC BIOINF C, P261; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davila J, 2007, IEEE ACM T COMPUT BI, V4, P544, DOI 10.1109/TCBB.2007.70241; Eskin E, 2002, BIOINFORMATICS, V18, pS354, DOI DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S354.; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S18; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Ho ES, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-14; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Huang CW, 2011, IEEE ACM T COMPUT BI, V8, P959, DOI 10.1109/TCBB.2010.92; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Keich U, 2002, BIOINFORMATICS, V18, P1382, DOI 10.1093/bioinformatics/18.10.1382; Kuksa PP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S1; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li G, 2010, IEEE ACM T COMPUT BI, V7, P654, DOI 10.1109/TCBB.2009.25; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma XT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1135; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Reid JE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr574; Rhee S H, 2011, CELL, V147, P480; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sagot MF, 1998, LECT NOTES COMPUTER, V1380, P111; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Sun HQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S8; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Heeringen SJ, 2011, BIOINFORMATICS, V27, P270, DOI 10.1093/bioinformatics/btq636; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Zambelli F, 2013, BRIEF BIOINFORM, V14, P225, DOI 10.1093/bib/bbs016; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zia A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-151	48	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86044	10.1371/journal.pone.0086044	http://dx.doi.org/10.1371/journal.pone.0086044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475069	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800023
J	Sutcliffe, CG; van Dijk, JH; Hamangaba, F; Mayani, F; Moss, WJ				Sutcliffe, Catherine G.; van Dijk, Janneke H.; Hamangaba, Francis; Mayani, Felix; Moss, William J.			Turnaround Time for Early Infant HIV Diagnosis in Rural Zambia: A Chart Review	PLOS ONE			English	Review							INFECTION; CARE	Background: Early infant HIV diagnosis is challenging in sub-Saharan Africa, particularly in rural areas where laboratory capacity is limited. Specimens must be transported to central laboratories for testing, leading to delays in diagnosis and initiation of antiretroviral therapy. This study was undertaken in rural Zambia to measure the turnaround time for confirmation of HIV infection and identify delays in diagnosis. Methods: Chart reviews were conducted from 2010-2012 for children undergoing early infant HIV diagnosis at Macha Hospital in Zambia. Relevant dates, receipt of drugs by mother and child for the prevention of mother-to-child transmission (PMTCT), and test results were abstracted. Results: 403 infants provided 476 samples for early infant diagnosis. The median age at the "6-week'' and "6-month'' assessments was 8.1 weeks and 7.0 months, respectively. The majority of mothers (80%) and infants (67%) received PMTCT. The median time between sample collection and arrival at the central laboratory in Lusaka was 17 days (IQR: 10, 28); arrival at the central laboratory to testing was 6 days (IQR: 5, 11); testing to return of results to the clinic was 29 days (IQR: 17, 36); arrival of results at the clinic to return of results to the caregiver was 45 days (IQR: 24, 79). The total median time from sample collection to return of results to the caregiver was 92 days (IQR: 84, 145). The proportion of HIV PCR positive samples was 12%. The total median turnaround time was shorter for HIV PCR positive as compared to negative or invalid samples (85 vs. 92 days; p = 0.08). Conclusions: Delays in processing and communicating test results were identified, particularly in returning results from the central laboratory to the clinic and from the clinic to the caregiver. A more efficient process is needed so that caregivers can be provided test results more rapidly, potentially resulting in earlier treatment initiation and better outcomes for HIV-infected infants.	[Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [van Dijk, Janneke H.; Hamangaba, Francis; Mayani, Felix] Macha Res Trust, Macha Hosp, Choma, Zambia; [van Dijk, Janneke H.] Erasmus Univ, Dept Immunol & Infect Dis, Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Erasmus University Rotterdam	Sutcliffe, CG (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	csutclif@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [5U2GPS001930-05]	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement 5U2GPS001930-05 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Dube Q, 2012, B WORLD HEALTH ORGAN, V90, P699, DOI 10.2471/BLT.11.100776; Ginwalla R, 2010, EARL INF DIAGN IMPR; Hungu J, 2010, EARL INF DIAGN IMPR; Kiyaga C, 2010, EARL INF DIAGN IMPR; McNairy ML, 2012, J ACQ IMMUN DEF SYND, V62, pe70; Ministry of Health Republic of Zambia, 2010, INT PREV MOTH TO CHI; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; SISON AV, 1992, CLIN MICROBIOL REV, V5, P238, DOI 10.1128/CMR.5.3.238-247.1992; Sutcliffe CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029294; UNAIDS, 2012, TOG WE WILL END AIDS; UNICEF, 2012, ZAMB 15 AUG 2012 RAP; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO/UNAIDS/UNICEF, 2012, GLOB HIV AIDS RESP E; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization, 2010, UN ACC SCAL PRIOR HI	21	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87028	10.1371/journal.pone.0087028	http://dx.doi.org/10.1371/journal.pone.0087028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475214	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800079
J	Eser, J; Zheng, PS; Triesch, J				Eser, Juergen; Zheng, Pengsheng; Triesch, Jochen			Nonlinear Dynamics Analysis of a Self-Organizing Recurrent Neural Network: Chaos Waning	PLOS ONE			English	Article							PREDICTION; SYSTEMS; MODELS; EDGE	Self-organization is thought to play an important role in structuring nervous systems. It frequently arises as a consequence of plasticity mechanisms in neural networks: connectivity determines network dynamics which in turn feed back on network structure through various forms of plasticity. Recently, self-organizing recurrent neural network models (SORNs) have been shown to learn non-trivial structure in their inputs and to reproduce the experimentally observed statistics and fluctuations of synaptic connection strengths in cortex and hippocampus. However, the dynamics in these networks and how they change with network evolution are still poorly understood. Here we investigate the degree of chaos in SORNs by studying how the networks' self-organization changes their response to small perturbations. We study the effect of perturbations to the excitatory-to-excitatory weight matrix on connection strengths and on unit activities. We find that the network dynamics, characterized by an estimate of the maximum Lyapunov exponent, becomes less chaotic during its self-organization, developing into a regime where only few perturbations become amplified. We also find that due to the mixing of discrete and (quasi-)continuous variables in SORNs, small perturbations to the synaptic weights may become amplified only after a substantial delay, a phenomenon we propose to call deferred chaos.	[Eser, Juergen; Zheng, Pengsheng; Triesch, Jochen] Frankfurt Inst Adv Studies, Frankfurt, Germany		Triesch, J (corresponding author), Frankfurt Inst Adv Studies, Frankfurt, Germany.	triesch@fias.uni-frankfurt.de			European Commission [ICT-IP-231722]; LOEWE-Program Neuronal Coordination Research Focus Frankfurt (NeFF)	European Commission(European CommissionEuropean Commission Joint Research Centre); LOEWE-Program Neuronal Coordination Research Focus Frankfurt (NeFF)	This work was supported by the European Commission 7th Framework Programme (FP7/2007-2013), Challenge 2 - Cognitive Systems, Interaction, Robotics, grant agreement No. ICT-IP-231722, project "IM-CLeVeR-Intrinsically Motivated Cumulative Learning Versatile Robots" and by the LOEWE-Program Neuronal Coordination Research Focus Frankfurt (NeFF, http://www.neff-ffm.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2010, PHILOS T R SOC A, V368, P4893, DOI 10.1098/rsta.2010.0237; Albers DJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.057201; Albers DJ, 1998, INT J BIFURCAT CHAOS, V8, P1463, DOI 10.1142/S0218127498001121; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Bick C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.244101; CESSAC B, 1994, PHYSICA D, V74, P24, DOI 10.1016/0167-2789(94)90024-8; Chen LN, 1997, PHYSICA D, V104, P286, DOI 10.1016/S0167-2789(96)00302-8; Dauce E, 1998, NEURAL NETWORKS, V11, P521, DOI 10.1016/S0893-6080(97)00131-7; DOYON B, 1994, ACTA BIOTHEOR, V42, P215, DOI 10.1007/BF00709492; Jahnke S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048102; Kitzbichler MG, 2013, PLOS COMPUTATIONAL B, V5; Lazar A, 2007, NEURAL NETWORKS, V20, P312, DOI 10.1016/j.neunet.2007.04.020; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Pasemann F, 2002, NETWORK-COMP NEURAL, V13, P195, DOI 10.1088/0954-898X/13/2/303; Potapov A, 2000, PHYS LETT A, V277, P310, DOI 10.1016/S0375-9601(00)00726-X; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Siri B, 2007, J PHYSIOL-PARIS, V101, P136, DOI 10.1016/j.jphysparis.2007.10.003; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sprott JC, 2008, AM J PHYS, V76, P474, DOI 10.1119/1.2830540; Sprott JC, 2008, CHAOS, V18, DOI 10.1063/1.2945229; Suzuki H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01610; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Zheng PS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002848	26	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86962	10.1371/journal.pone.0086962	http://dx.doi.org/10.1371/journal.pone.0086962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466301	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000177
J	Stanevich, V; Zheng, AP; Guo, F; Jiang, L; Wlodarchak, N; Xing, YN				Stanevich, Vitali; Zheng, Aiping; Guo, Feng; Jiang, Li; Wlodarchak, Nathan; Xing, Yongna			Mechanisms of the Scaffold Subunit in Facilitating Protein Phosphatase 2A Methylation	PLOS ONE			English	Article							A-ALPHA SUBUNIT; CATALYTIC SUBUNIT; TUMOR-ANTIGENS; IN-VIVO; PP2A; BINDING; DEPHOSPHORYLATION; POLYOMAVIRUS; HOLOENZYME; MUTATIONS	The function of the biologically essential protein phosphatase 2A (PP2A) relies on formation of diverse heterotrimeric holoenzymes, which involves stable association between PP2A scaffold (A) and catalytic (C or PP2Ac) subunits and binding of variable regulatory subunits. Holoenzyme assembly is highly regulated by carboxyl methylation of PP2Ac-tail; methylation of PP2Ac and association of the A and C subunits are coupled to activation of PP2Ac. Here we showed that PP2A-specific methyltransferase, LCMT-1, exhibits a higher activity toward the core enzyme (A-C heterodimer) than free PP2Ac, and the A-subunit facilitates PP2A methylation via three distinct mechanisms: 1) stabilization of a proper protein fold and an active conformation of PP2Ac; 2) limiting the space of PP2Ac-tail movement for enhanced entry into the LCMT-1 active site; and 3) weak electrostatic interactions between LCMT-1 and the N-terminal HEAT repeats of the A-subunit. Our results revealed a new function and novel mechanisms of the A-subunit in PP2A methylation, and coherent control of PP2A activity, methylation, and holoenzyme assembly.	[Stanevich, Vitali; Zheng, Aiping; Guo, Feng; Jiang, Li; Wlodarchak, Nathan; Xing, Yongna] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Stanevich, Vitali; Xing, Yongna] Univ Wisconsin, Biophys Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Xing, YN (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	xing@oncology.wisc.edu	Zheng, Aiping/U-5313-2019; Wlodarchak, Nathan/GXH-3756-2022	Zheng, Aiping/0000-0003-4982-0109	American Cancer Society Research Scholar Grant NIH, Clinical and Translational Science Award (CTSA) program [R01 GM096060-01, UL1TR000427]; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER	American Cancer Society Research Scholar Grant NIH, Clinical and Translational Science Award (CTSA) program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Cancer Society Research Scholar Grant NIH R01 GM096060-01 Clinical and Translational Science Award (CTSA) program UL1TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guo F, 2014, CELL RES, V24, P190, DOI 10.1038/cr.2013.138; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86955	10.1371/journal.pone.0086955	http://dx.doi.org/10.1371/journal.pone.0086955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466300	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000176
J	Valdivia, S; Patrone, A; Reynaldo, M; Perello, M				Valdivia, Spring; Patrone, Anabela; Reynaldo, Mirta; Perello, Mario			Acute High Fat Diet Consumption Activates the Mesolimbic Circuit and Requires Orexin Signaling in a Mouse Model	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; FOOD REWARD; EATING-DISORDERS; BULIMIA-NERVOSA; INDUCED OBESITY; DRUG-ADDICTION; BRAIN DOPAMINE; NEURONS; OREXIN/HYPOCRETIN	Overconsumption of palatable energy-dense foods has negative health implications and it is associated with obesity and several eating disorders. Currently, little is known about the neuronal circuitries activated by the acute ingestion of a rewarding stimulus. Here, we used a combination of immunohistochemistry, pharmacology and neuronal tracing analyses to examine the role of the mesolimbic system in general, and the orexin neurons in particular, in a simple experimental test in which naive mice are allowed to spontaneously eat a pellet of a high fat diet (HFD) for 2 h. We found that acute HFD activates c-Fos expression in several reward-related brain areas, including the ventral tegmental area (VTA), nucleus accumbens, central amygdala and lateral hypothalamic area. We also found that: i-HFD-mediated orosensory stimulation was required for the mesolimbic pathway activation, ii- acute HFD differentially activates dopamine neurons of the paranigral, parabrachial pigmented and interfascicular sub-regions of the VTA, and iii- orexin neurons of the lateral hypothalamic area are responsive to acute HFD. Moreover, orexin signaling blockade, with the orexin 1 receptor antagonist SB-334867, reduces acute HFD consumption and c-Fos induction in the VTA but not in the other mesolimbic nuclei under study. Finally, we found that most orexin neurons responsive to acute HFD innervate the VTA. Our results show that acute HFD consumption recruits the mesolimbic system and that the full manifestation of this eating behavior requires the activation of orexin signaling.	[Valdivia, Spring; Patrone, Anabela; Reynaldo, Mirta; Perello, Mario] Multidisciplinary Inst Cell Biol CONICET CICPBA, Neurophysiol Lab, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Perello, M (corresponding author), Multidisciplinary Inst Cell Biol CONICET CICPBA, Neurophysiol Lab, La Plata, Buenos Aires, Argentina.	marioperello@yahoo.com		Valdivia, Lesly Spring/0000-0002-4282-2390; Perello, Mario/0000-0003-2114-6765	National Agency of Scientific and Technological Promotion of Argentina [PICT2010-1954, PICT2011-2142]; NIH [R03TW008925-01A1]; FOGARTY INTERNATIONAL CENTER [R03TW008925] Funding Source: NIH RePORTER	National Agency of Scientific and Technological Promotion of Argentina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants of the National Agency of Scientific and Technological Promotion of Argentina (PICT2010-1954 and PICT2011-2142) and the NIH (R03TW008925-01A1) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Avena NM, 2010, APPETITE, V55, P734, DOI 10.1016/j.appet.2010.09.010; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Boehm SL, 2002, NEUROSCIENCE, V115, P185, DOI 10.1016/S0306-4522(02)00378-0; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Cabral A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031462; Choi DL, 2010, NEUROSCIENCE, V167, P11, DOI 10.1016/j.neuroscience.2010.02.002; Clegg DJ, 2002, ENDOCRINOLOGY, V143, P2995, DOI 10.1210/en.143.8.2995; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; Corwin RL, 2004, PHYSIOL BEHAV, V82, P123, DOI 10.1016/j.physbeh.2004.04.036; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026; Di Leone RJ, 2012, NAT NEUROSCI, V15, P1330, DOI 10.1038/nn.3202; Egecioglu E, 2011, REV ENDOCR METAB DIS, V12, P141, DOI 10.1007/s11154-011-9166-4; Ericson M, 2008, J PHARMACOL EXP THER, V326, P76, DOI 10.1124/jpet.108.137489; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Ferreira JGP, 2008, NEUROSCIENCE, V153, P196, DOI 10.1016/j.neuroscience.2008.02.003; Friederich HC, 2013, INT J EAT DISORDER, V46, P425, DOI 10.1002/eat.22099; Hagan MM, 1997, INT J EAT DISORDER, V22, P411, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;411::AID-EAT6&gt;3.0.CO;2-P; Hasue RH, 2002, J COMP NEUROL, V454, P15, DOI 10.1002/cne.10420; Hay P, 2013, INT J EAT DISORDER, V46, P462, DOI 10.1002/eat.22103; Huang H, 2006, J NEUROPHYSIOL, V95, P1656, DOI 10.1152/jn.00927.2005; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kaye WH, 2013, BIOL PSYCHIAT, V73, P836, DOI 10.1016/j.biopsych.2013.01.002; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Korotkova TM, 2003, J NEUROSCI, V23, P7; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lin JY, 2012, BRAIN RES, V1448, P82, DOI 10.1016/j.brainres.2012.02.013; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Mahler SV, 2012, PROG BRAIN RES, V198, P79, DOI 10.1016/B978-0-444-59489-1.00007-0; Manabe Y, 2010, PREFERENCE HIGH FAT; Margolis EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015222; Nathan PJ, 2009, INT J NEUROPSYCHOPH, V12, P995, DOI 10.1017/S146114570900039X; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Paxinos G., 2001, MOUSE BRAIN; Pecina S, 2010, PHARMACOL BIOCHEM BE, V97, P34, DOI 10.1016/j.pbb.2010.05.016; Perello M, 2010, J NEUROSCI, V30, P11549, DOI 10.1523/JNEUROSCI.2578-10.2010; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Peyron C, 1998, J NEUROSCI, V18, P9996; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Rodd ZA, 2005, NEUROPSYCHOPHARMACOL, V30, P330, DOI 10.1038/sj.npp.1300561; Sakurai T, 1998, Cell, V92, P696; Salamone JD, 2013, BIOL PSYCHIAT, V73, pE15, DOI 10.1016/j.biopsych.2012.09.027; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Shabat-Simon M, 2008, J NEUROSCI, V28, P8406, DOI 10.1523/JNEUROSCI.1958-08.2008; Warwick ZS, 1996, NEUROSCI BIOBEHAV R, V20, P155, DOI 10.1016/0149-7634(95)00034-C; White CL, 2005, PEPTIDES, V26, P2331, DOI 10.1016/j.peptides.2005.03.042; Will MJ, 2003, J NEUROSCI, V23, P2882; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	66	69	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87478	10.1371/journal.pone.0087478	http://dx.doi.org/10.1371/journal.pone.0087478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466352	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000208
J	Espinosa, I; Cuthill, IC				Espinosa, Irene; Cuthill, Innes C.			Disruptive Colouration and Perceptual Grouping	PLOS ONE			English	Article							BACKGROUND COMPLEXITY; VISUAL-PERCEPTION; CAMOUFLAGE; CRYPSIS; PREY; DETECTABILITY; MARKINGS; CONTRAST	Camouflage is the primary defence of many animals and includes multiple strategies that interfere with figure-ground segmentation and object recognition. While matching background colours and textures is widespread and conceptually straightforward, less well explored are the optical 'tricks', collectively called disruptive colouration, that exploit perceptual grouping mechanisms. Adjacent high contrast colours create false edges, but this is not sufficient for an object's shape to be broken up; some colours must blend with the background. We test the novel hypothesis that this will be particularly effective when the colour patches on the animal appear to belong to, not merely different background colours, but different background objects. We used computer-based experiments where human participants had to find cryptic targets on artificial backgrounds. Creating what appeared to be bi-coloured foreground objects on bi-coloured backgrounds, we generated colour boundaries that had identical local contrast but either lay within or between (illusory) objects. As predicted, error rates for targets matching what appeared to be different background objects were higher than for targets which had otherwise identical local contrast to the background but appeared to belong to single background objects. This provides evidence for disruptive colouration interfering with higher-level feature integration in addition to previously demonstrated low-level effects involving contour detection. In addition, detection was impeded in treatments where targets were on or in close proximity to multiple background colour or tone boundaries. This is consistent with other studies which show a deleterious influence of visual 'clutter' or background complexity on search.	[Espinosa, Irene; Cuthill, Innes C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Espinosa, I (corresponding author), Prescott Coll Kino Bay Ctr Cultural & Ecol Studie, Bahia De Kino, Sonora, Mexico.	i.espinosa.gonzalezgarza@gmail.com			Biotechnology and Biological Sciences Research Council; CONACyT; Biotechnology and Biological Sciences Research Council [BB/E02100X/1] Funding Source: researchfish; BBSRC [BB/E02100X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council grant to ICC, Tom Troscianko and Neill Campbell, and a CONACyT studentship to IE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2012, AM NAT, V180, P762, DOI 10.1086/668011; Bates D., 2011, PACKAGE LME4 LINEAR; Cott H. B., 1940, ADAPTIVE COLOURATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2011, COLOUR ART DESIGN NA; DeVantier L., 2004, CONCEALING COLORATIO; Dimitrova M, 2012, BEHAV ECOL, V23, P384, DOI 10.1093/beheco/arr201; Dimitrova M, 2010, BEHAV ECOL, V21, P176, DOI 10.1093/beheco/arp174; Dimitrova M, 2009, P R SOC B, V276, P1905, DOI 10.1098/rspb.2009.0052; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Fraser S, 2007, P ROY SOC B-BIOL SCI, V274, P1325, DOI 10.1098/rspb.2007.0153; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Merilaita Sami, 2011, P17; Osorio D., 2013, OXFORD HDB PERCEPTUA; PALMER SE, 1992, COGNITIVE PSYCHOL, V24, P436, DOI 10.1016/0010-0285(92)90014-S; Poulton EB, 1890, COLOURS ANIMALS THEI; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Rowland HM, 2009, PHILOS T R SOC B, V364, P519, DOI 10.1098/rstb.2008.0261; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2013, BEHAV ECOL, V24, P213, DOI 10.1093/beheco/ars156; Thayer A. H., 1909, CONCEALING COLORATIO; Thayer Abbott H., 1896, AUK, V13, P124, DOI DOI 10.2307/4068693; Tripathy SP, 2002, VISION RES, V42, P2357, DOI 10.1016/S0042-6989(02)00197-9; Troscianko T, 2009, PHILOS T R SOC B, V364, P449, DOI 10.1098/rstb.2008.0218; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Westland S, 2004, COMPUTATIONAL COLOUR	33	18	18	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87153	10.1371/journal.pone.0087153	http://dx.doi.org/10.1371/journal.pone.0087153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466337	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100251
J	John, F; Philipp, M; Leiber, RM; Errafi, S; Ringli, C				John, Florian; Philipp, Matthias; Leiber, Ruth-Maria; Errafi, Sanae; Ringli, Christoph			Ubiquitin-Related Modifiers of Arabidopsis thaliana Influence Root Development	PLOS ONE			English	Article							CELL-WALL FORMATION; TRANSFER-RNA; PROTEIN CONJUGATION; SULFUR TRANSFER; URM1; YEAST; PATHWAY; SYSTEM; GROWTH; MUTANT	Ubiquitins are small peptides that allow for posttranslational modification of proteins. Ubiquitin-related modifier (URM) proteins belong to the class of ubiquitin-like proteins. A primary function of URM proteins has been shown to be the sulfur transfer reaction leading to thiolation of tRNAs, a process that is important for accurate and effective protein translation. Recent analyses revealed that the Arabidopsis genome codes for two URM proteins, URM11 and URM12, which both are active in the tRNA thiolation process. Here, we show that URM11 and URM12 have overlapping expression patterns and are required for tRNA thiolation. The characterization of urm11 and urm12 mutants reveals that the lack of tRNA thiolation induces changes in general root architecture by influencing the rate of lateral root formation. In addition, they synergistically influence root hair cell growth. During the sulfur transfer reaction, URM proteins of different organisms interact with a thiouridylase, a protein-protein interaction that also takes place in Arabidopsis, since URM11 and URM12 interact with the Arabidopsis thiouridylase ROL5. Hence, the sulfur transfer reaction is conserved between distantly related species such as yeast, humans, and plants, and in Arabidopsis has an impact on root development.	[John, Florian; Philipp, Matthias; Leiber, Ruth-Maria; Errafi, Sanae; Ringli, Christoph] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	University of Zurich	Ringli, C (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	chringli@botinst.uzh.ch			Swiss National Science Foundation [122157, 138472/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding by Swiss National Science Foundation Grant Nrs 122157 and 138472/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumberger N, 2003, PLANT J, V35, P71, DOI 10.1046/j.1365-313X.2003.01784.x; Baumberger N, 2001, GENE DEV, V15, P1128, DOI 10.1101/gad.200201; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Smet I, 2012, NEW PHYTOL, V193, P867, DOI 10.1111/j.1469-8137.2011.03996.x; Diet A, 2004, PLANT CELL PHYSIOL, V45, P734, DOI 10.1093/pcp/pch084; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huynh LN, 2010, CELL CYCLE, V9, P3112, DOI 10.4161/cc.9.15.12525; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Krause K, 2009, TRENDS PLANT SCI, V14, P194, DOI 10.1016/j.tplants.2009.01.005; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; MINET M, 1992, GENE, V121, P393, DOI 10.1016/0378-1119(92)90150-N; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Nakai Y, 2012, J BIOL CHEM, V287, P30874, DOI 10.1074/jbc.M112.350090; Nibau C, 2008, NEW PHYTOL, V179, P595, DOI 10.1111/j.1469-8137.2008.02472.x; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Park HJ, 2011, MOL CELLS, V32, P305, DOI 10.1007/s10059-011-0122-7; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Petroski MD, 2011, P NATL ACAD SCI USA, V108, P1749, DOI 10.1073/pnas.1019043108; Ren MZ, 2012, PLANT CELL, V24, P4850, DOI 10.1105/tpc.112.107144; Ringli C, 2005, PLANT BIOSYST, V139, P32, DOI 10.1080/11263500500059892; Ringli C, 2010, PLANT J, V63, P662, DOI 10.1111/j.1365-313X.2010.04270.x; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Vierstra RD, 2012, PLANT PHYSIOL, V160, P2, DOI 10.1104/pp.112.200667; Wang FB, 2011, PROTEIN CELL, V2, P612, DOI 10.1007/s13238-011-1074-6; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Xu F, 2012, PLANT J, V70, P916, DOI 10.1111/j.1365-313X.2012.04906.x; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86862	10.1371/journal.pone.0086862	http://dx.doi.org/10.1371/journal.pone.0086862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466270	Green Accepted, Green Published, gold			2022-12-27	WOS:000330283100226
J	Takahashi, Y; Soejima, Y; Kumagai, A; Watanabe, M; Uozaki, H; Fukusato, T				Takahashi, Yoshihisa; Soejima, Yurie; Kumagai, Arisa; Watanabe, Masato; Uozaki, Hiroshi; Fukusato, Toshio			Inhibitory Effects of Japanese Herbal Medicines Sho-saiko-to and Juzen-taiho-to on Nonalcoholic Steatohepatitis in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ENZYME-ALTERED LESIONS; GROWTH-FACTOR-BETA; ACID-DEFINED DIET; METABOLIC SYNDROME; FIBROSIS; INFLAMMATION; KAMPO; RATS; HEPATOCARCINOGENESIS	Although Japanese herbal medicines (JHMs) are widely used in Japan, only a few studies have investigated their effects on nonalcoholic steatohepatitis (NASH). In the present study, we examined the effect of 4 kinds of JHMs [sho-saiko-to (TJ-9), inchin-ko-to (TJ-135), juzen-taiho-to (TJ-48), and keishi-bukuryo-gan (TJ-25)] on a mouse model of NASH. Db/db mice were divided into 6 groups: control diet (control), methionine-and choline-deficient diet (MCD), and MCD diet supplemented with TJ-9, TJ-135, TJ-48, and TJ-25 (TJ-9, TJ-135, TJ-48, and TJ-25, respectively). All mice were sacrificed after 4 weeks of treatment, and biochemical, pathological, and molecular analyses were performed. Serum alanine aminotransferase levels and liver histology, including necroinflammation and fibrosis, were significantly alleviated in the TJ-9 and TJ-48 groups compared with the MCD group. The expression level of transforming growth factor (TGF)-beta 1 mRNA in the liver was significantly suppressed by TJ-48. Although the differences were not statistically significant, the expression levels of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 were lower, and those of peroxisome proliferators-activated receptor (PPAR)gamma were higher in the TJ-9 and/or TJ-48 groups than in the MCD group. Similarly, even though the results were not statistically significant, malondialdehyde levels in liver tissues were lower in the TJ-9 and TJ-48 groups than in the MCD group. We showed that JHMs, especially TJ-9 and TJ-48, inhibited the necroinflammation and fibrosis in the liver of a mouse model of NASH, even though the mechanisms were not fully elucidated. Further studies are needed in the future to investigate the possibility of clinical application of these medicines in the treatment for NASH.	[Takahashi, Yoshihisa; Soejima, Yurie; Kumagai, Arisa; Watanabe, Masato; Uozaki, Hiroshi; Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan	Teikyo University	Takahashi, Y (corresponding author), Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan.	ytakaha-tky@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) [23790753]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research Grant Number 23790753 (URL: http://www.jsps.go.jp/j-grantsinaid/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Asakawa T, 2012, PEDIATR SURG INT, V28, P379, DOI 10.1007/s00383-011-2974-5; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fujimoto M, 2008, EXP BIOL MED, V233, P328, DOI 10.3181/0707-RM-207; Fujimoto M, 2010, ANN NY ACAD SCI, V1190, P151, DOI 10.1111/j.1749-6632.2009.05265.x; Guo HX, 2009, ACTA PHARMACOL SIN, V30, P1505, DOI 10.1038/aps.2009.150; Iizuka A, 2000, J Atheroscler Thromb, V6, P49; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kusunose M, 2002, BIOL PHARM BULL, V25, P1417, DOI 10.1248/bpb.25.1417; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Machado M, 2006, CURR OPIN CLIN NUTR, V9, P637, DOI 10.1097/01.mco.0000241677.40170.17; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mochiki E, 2010, SURG TODAY, V40, P1105, DOI 10.1007/s00595-010-4388-8; Motoo Y, 2011, CHIN J INTEGR MED, V17, P85, DOI 10.1007/s11655-011-0653-y; Nagai T, 2011, EVID-BASED COMPL ALT, V2011; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Qin S, 2012, J ETHNOPHARMACOL, V140, P131, DOI 10.1016/j.jep.2011.12.046; RAMADORI G, 1991, VIRCHOWS ARCH B, V61, P147; Sakaida I, 2003, J HEPATOL, V38, P762, DOI 10.1016/S0168-8278(03)00094-1; Sakaida I, 1998, J HEPATOL, V28, P298, DOI 10.1016/0168-8278(88)80017-5; Shek FW, 2004, EUR J GASTROEN HEPAT, V16, P123, DOI 10.1097/00042737-200402000-00001; Shiota G, 2002, HEPATOLOGY, V35, P1125, DOI 10.1053/jhep.2002.33066; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tojima H, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P904; Tomioka H, 1999, Nihon Kokyuki Gakkai Zasshi, V37, P1013; Tsuchiya M, 2008, INT J CANCER, V123, P2503, DOI 10.1002/ijc.23828; Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012; Yamaoka K, 1990, BYOUIN YAKUGAKU, V16, P168; Yamashiki M, 2000, CLIN SCI, V99, P421, DOI 10.1042/CS20000031; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	38	22	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87279	10.1371/journal.pone.0087279	http://dx.doi.org/10.1371/journal.pone.0087279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466347	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100253
J	Druart, C; Neyrinck, AM; Vlaeminck, B; Fievez, V; Cani, PD; Delzenne, NM				Druart, Celine; Neyrinck, Audrey M.; Vlaeminck, Bruno; Fievez, Veerle; Cani, Patrice D.; Delzenne, Nathalie M.			Role of the Lower and Upper Intestine in the Production and Absorption of Gut Microbiota-Derived PUFA Metabolites	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FATTY-ACIDS; HUMAN HEALTH; DIETARY-FAT; MILK-FAT; ISOMERS; BIOSYNTHESIS; BACTERIA; OBESITY; CLA	In vitro studies have suggested that isolated gut bacteria are able to metabolize PUFA into CLA (conjugated linoleic acids) and CLnA (conjugated linolenic acids). However, the bioavailability of fatty acid metabolites produced in vivo by the gut microbes remains to be studied. Therefore, we measured intestinal concentration and plasma accumulation of bacterial metabolites produced from dietary PUFA in mice, first injected with a lipoprotein lipase inhibitor, then force-fed with either sunflower oil (200 mu l) rich in n-6 PUFA or linseed oil (200 mu l) rich in n-3 PUFA. The greatest production of bacterial metabolites was observed in the caecum and colon, and at a much lesser extent in the jejunum and ileum. In the caecal content, CLA proportions were higher in sunflower oil force-fed mice whereas CLnA proportions were higher in linseed oil force-fed mice. The accumulation of the main metabolites (CLA cis-9, trans-11-18: 2 and CLnA cis-9, trans-11, cis-15-18:3) in the caecal tissue was not associated with their increase in the plasma, therefore suggesting that, if endogenously produced CLA and CLnA have any biological role in host metabolism regulation, their effect would be confined at the intestinal level, where the microbiota is abundant.	[Druart, Celine; Neyrinck, Audrey M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Vlaeminck, Bruno; Fievez, Veerle] Univ Ghent, Fac Biosci Engn, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; Ghent University; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Fievez, Veerle/E-2333-2016; Neyrinck, Audrey/AAE-7929-2019; Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016	Fievez, Veerle/0000-0001-5042-6200; Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Druart, Celine/0000-0002-7786-9172	Danone Institute grant; Scientific Research-Flanders (Belgium); ERC Starting grant	Danone Institute grant(Danone Nutricia); Scientific Research-Flanders (Belgium)(FWO); ERC Starting grant(European Research Council (ERC))	CD benefits from a Danone Institute grant. BV is a Postdoctoral Fellow of the Fund for Scientific Research-Flanders (Belgium). PDC is a research associate from the FRS-FNRS (Fonds de la Recherche Scientifique, Belgium). PDC and NMD are recipients of FSR and FRSM subsidies (Fonds speciaux de recherches, UCL, Belgium; Fonds de la recherche scientifique medicale, Belgium). PDC is a recipient of ERC Starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031238; BORENSZTAJN J, 1976, BIOCHEM J, V156, P539, DOI 10.1042/bj1560539; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Chilliard Y, 2007, EUR J LIPID SCI TECH, V109, P828, DOI 10.1002/ejlt.200700080; Churruca I, 2009, BIOFACTORS, V35, P105, DOI 10.1002/biof.13; Coakley M, 2003, J APPL MICROBIOL, V94, P138, DOI 10.1046/j.1365-2672.2003.01814.x; Coakley M, 2009, LIPIDS, V44, P249, DOI 10.1007/s11745-008-3269-z; Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67; de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011; Destaillats F, 2007, J CHROMATOGR A, V1145, P222, DOI 10.1016/j.chroma.2007.01.062; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Druart C, 2013, BR J NUTR, V18, P1, DOI DOI 10.1017/S000711451300278X; Dubois V, 2007, EUR J LIPID SCI TECH, V109, P710, DOI 10.1002/ejlt.200700040; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Evans ME, 2002, J NUTR BIOCHEM, V13, P508, DOI 10.1016/S0955-2863(02)00211-5; Field CJ, 2009, APPL PHYSIOL NUTR ME, V34, P979, DOI 10.1139/H09-079; Gorissen L, 2010, APPL MICROBIOL BIOT, V87, P2257, DOI 10.1007/s00253-010-2713-1; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Huang EY, 2013, JPEN-PARENTER ENTER, V37, P746, DOI 10.1177/0148607113486931; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kramer JKG, 2008, LIPIDS, V43, P259, DOI 10.1007/s11745-007-3143-4; Lerch S, 2012, J DAIRY SCI, V95, P7269, DOI 10.3168/jds.2012-5654; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Miranda J, 2011, LIPIDS, V46, P1005, DOI 10.1007/s11745-011-3615-4; Mujico JR, 2013, BR J NUTR, P1; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; O'Shea EF, 2012, INT J FOOD MICROBIOL, V152, P189, DOI 10.1016/j.ijfoodmicro.2011.05.025; Or-Rashid MM, 2011, APPL MICROBIOL BIOT, V89, P387, DOI 10.1007/s00253-010-2865-z; Park Y, 2005, BBA-MOL CELL BIOL L, V1687, P120, DOI 10.1016/j.bbalip.2004.11.010; Precht D, 2001, LIPIDS, V36, P213, DOI 10.1007/s11745-001-0710-z; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schmidt J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C110.200477; Stefanov I, 2010, J AGR FOOD CHEM; SZENTKUTI L, 1995, HISTOCHEM J, V27, P466; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tricon S, 2006, CURR OPIN CLIN NUTR, V9, P105, DOI 10.1097/01.mco.0000214567.44568.fb; Tricon S, 2005, P NUTR SOC, V64, P171, DOI 10.1079/PNS2005418; Vinolo MAR, 2012, CURR OPIN CLIN NUTR, V15, P112, DOI 10.1097/MCO.0b013e32834f4598; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	48	53	56	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87560	10.1371/journal.pone.0087560	http://dx.doi.org/10.1371/journal.pone.0087560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475308	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300201
J	Ma, D; Cardoso, MJ; Modat, M; Powell, N; Wells, J; Holmes, H; Wiseman, F; Tybulewicz, V; Fisher, E; Lythgoe, MF; Ourselin, S				Ma, Da; Cardoso, Manuel J.; Modat, Marc; Powell, Nick; Wells, Jack; Holmes, Holly; Wiseman, Frances; Tybulewicz, Victor; Fisher, Elizabeth; Lythgoe, Mark F.; Ourselin, Sebastien			Automatic Structural Parcellation of Mouse Brain MRI Using Multi-Atlas Label Fusion	PLOS ONE			English	Article							IN-VIVO; NONRIGID REGISTRATION; SEGMENTATION; IMAGE; DATABASE; PROPAGATION; COMBINATION; STRATEGIES; ASYMMETRY; FRAMEWORK	Multi-atlas segmentation propagation has evolved quickly in recent years, becoming a state-of-the-art methodology for automatic parcellation of structural images. However, few studies have applied these methods to preclinical research. In this study, we present a fully automatic framework for mouse brain MRI structural parcellation using multi-atlas segmentation propagation. The framework adopts the similarity and truth estimation for propagated segmentations (STEPS) algorithm, which utilises a locally normalised cross correlation similarity metric for atlas selection and an extended simultaneous truth and performance level estimation (STAPLE) framework for multi-label fusion. The segmentation accuracy of the multi-atlas framework was evaluated using publicly available mouse brain atlas databases with pre-segmented manually labelled anatomical structures as the gold standard, and optimised parameters were obtained for the STEPS algorithm in the label fusion to achieve the best segmentation accuracy. We showed that our multi-atlas framework resulted in significantly higher segmentation accuracy compared to single-atlas based segmentation, as well as to the original STAPLE framework.	[Ma, Da; Cardoso, Manuel J.; Modat, Marc; Powell, Nick; Ourselin, Sebastien] UCL, Ctr Med Imaging Comp, London, England; [Ma, Da; Powell, Nick; Wells, Jack; Holmes, Holly; Lythgoe, Mark F.] UCL, Div Med, Ctr Adv Biomed Imaging, London, England; [Wiseman, Frances; Fisher, Elizabeth] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England; [Tybulewicz, Victor] MRC Natl Inst Med Res, Div Immune Cell Biol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; MRC National Institute for Medical Research	Ma, D (corresponding author), UCL, Ctr Med Imaging Comp, London, England.	d.ma.11@ucl.ac.uk	Wiseman, Frances K/M-4701-2014; Holmes, Holly/Q-4675-2016; Ma, Da/H-3215-2019; Ma, Da/L-4497-2013; Fisher, Elizabeth MC/C-2168-2008; Ourselin, Sebastien/K-6960-2015; Cardoso, M. Jorge/N-5511-2018	Holmes, Holly/0000-0001-8832-8171; Ma, Da/0000-0002-3542-7798; Ma, Da/0000-0002-3542-7798; Fisher, Elizabeth MC/0000-0003-2850-9936; Powell, Nick/0000-0003-4120-0642; Tybulewicz, Victor/0000-0003-2439-0798; Wells, Jack/0000-0002-4171-3539; Ourselin, Sebastien/0000-0002-5694-5340; Cardoso, M. Jorge/0000-0003-1284-2558; Modat, Marc/0000-0002-5277-8530; Lythgoe, Mark/0000-0002-4945-0171; Wiseman, Frances/0000-0001-9323-3548	Faculty of Engineering funding scheme; Engineering and Physical Science Research Council [EP/H046410/1]; Comprehensive Biomedical Research Centre [168]; National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs); Medical Research Council Doctoral Training Program funding scheme; MRC [U117527252]; Wellcome Trust [080174, 098328]; Engineering and Physical Sciences Research Council [EP/H046410/1] Funding Source: researchfish; Medical Research Council [G0601056, MC_U117527252] Funding Source: researchfish; National Centre for the Replacement [NC/K500276/1] Funding Source: researchfish; EPSRC [EP/H046410/1] Funding Source: UKRI; MRC [MC_U117527252, G0601056] Funding Source: UKRI	Faculty of Engineering funding scheme; Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Comprehensive Biomedical Research Centre; National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Council Doctoral Training Program funding scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at UCL, which received a proportion of funding from Faculty of Engineering funding scheme. M. Jorge Cardoso, Marc Modat and Sebastien Ourselin were supported by Engineering and Physical Science Research Council (EP/H046410/1) and the Comprehensive Biomedical Research Centre (Ref. 168). Jack Wells was supported by the Engineering and Physical Science Research Council (EP/H046410/1). Holly Holmes was supported by the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs). Nick Powell was supported by Medical Research Council Doctoral Training Program funding scheme. Victor Tybulewicz was supported by MRC programme (U117527252) and Wellcome Trust grants (080174 and 098328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2012, PROC SPIE, V8314, DOI 10.1117/12.911552; Aljabar P, 2007, LECT NOTES COMPUT SC, V4791, P523; Artaechevarria X, 2008, P SPIE INT SOC OPT P, V69141W-69141W-9; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Bai J, 2012, MAGN RESON IMAGING, V30, P789, DOI 10.1016/j.mri.2012.02.010; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Boccardi M, 2013, ALZHEIMERS DEMENT, P1; Bock NA, 2005, MAGNET RESON MED, V54, P1311, DOI 10.1002/mrm.20683; Bowden DM, 2011, J NEUROSCI METH, V195, P170, DOI 10.1016/j.jneumeth.2010.11.028; Calmon G, 2000, MAGN RESON IMAGING, V18, P439, DOI 10.1016/S0730-725X(99)00118-6; Cardoso MJ, 2013, MED IMAGE ANAL, V17, P671, DOI 10.1016/j.media.2013.02.006; Chakravarty MM, 2011, INT SOC MAGN RESON M, V15, P2011; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Cleary JO, 2011, NEUROIMAGE, V54, P769, DOI 10.1016/j.neuroimage.2010.07.039; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Jiang Y, 2011, NEUROIMAGE, V56, P1235, DOI 10.1016/j.neuroimage.2011.03.031; John JP, 2006, PSYCHIAT RES-NEUROIM, V148, P151, DOI 10.1016/j.pscychresns.2006.05.006; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kempton MJ, 2011, NEUROIMAGE, V58, P1051, DOI 10.1016/j.neuroimage.2011.06.080; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lee J, 2009, P SPIE INT SOC OPT P, V7259; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Liu YX, 1998, P SOC PHOTO-OPT INS, V3338, P1528, DOI 10.1117/12.310886; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; Maes F, 1999, LECT NOTES COMPUT SC, V1679, P348; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Natt O, 2002, J NEUROSCI METH, V120, P203, DOI 10.1016/S0165-0270(02)00211-X; Nestor SM, 2013, NEUROIMAGE, V66, P50, DOI 10.1016/j.neuroimage.2012.10.081; Ourselin S, 2000, LECT NOTES COMPUT SC, V1935, P557; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Prima S, 1998, LECT NOTES COMPUT SC, V1496, P770, DOI 10.1007/BFb0056264; Richards K, 2011, NEUROIMAGE, V58, P732, DOI 10.1016/j.neuroimage.2011.06.025; Rohlfing T, 2004, IEEE T MED IMAGING, V23, P983, DOI 10.1109/TMI.2004.830803; Rohlfing T, 2007, IEEE T IMAGE PROCESS, V16, P153, DOI 10.1109/TIP.2006.884936; Rueckert D, 1998, LECT NOTES COMPUT SC, V1496, P1144, DOI 10.1007/BFb0056304; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Scheenstra AEH, 2009, MOL IMAGING, V8, P35, DOI 10.2310/7290.2009.00004; Sharief AA, 2008, NEUROIMAGE, V39, P136, DOI 10.1016/j.neuroimage.2007.08.028; Sinclair B, 2011, P INT SOC MAG RESON, V19, P702; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spring S, 2010, NEUROIMAGE, V50, P409, DOI 10.1016/j.neuroimage.2009.12.043; Ullmann JFP, 2013, NEUROIMAGE, V78, P196, DOI 10.1016/j.neuroimage.2013.04.008; Ullmann JFP, 2012, NEUROIMAGE, V62, P1408, DOI 10.1016/j.neuroimage.2012.05.061; Ullmann JP, 2013, BRAIN STRUCT FUNCT, P1; van Eede MC, 2013, NEUROIMAGE, V82, P226, DOI 10.1016/j.neuroimage.2013.06.004; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069; Zhuang XH, 2010, IEEE T MED IMAGING, V29, P1612, DOI 10.1109/TMI.2010.2047112	59	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86576	10.1371/journal.pone.0086576	http://dx.doi.org/10.1371/journal.pone.0086576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475148	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300084
J	Vreeman, RC; Scanlon, ML; Mwangi, A; Turissini, M; Ayaya, SO; Tenge, C; Nyandiko, WM				Vreeman, Rachel C.; Scanlon, Michael L.; Mwangi, Ann; Turissini, Matthew; Ayaya, Samuel O.; Tenge, Constance; Nyandiko, Winstone M.			A Cross-Sectional Study of Disclosure of HIV Status to Children and Adolescents in Western Kenya	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; HUMAN-IMMUNODEFICIENCY-VIRUS; OF-THE-LITERATURE; ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; ADHERENCE; DEPRESSION; HEALTH; PERCEPTIONS; DIAGNOSIS	Introduction: Disclosure of HIV status to children is essential for disease management but is not well characterized in resource-limited settings. This study aimed to describe the prevalence of disclosure and associated factors among a cohort of HIV-infected children and adolescents in Kenya. Methods: We conducted a cross-sectional study, randomly sampling HIV-infected children ages 6-14 years attending 4 HIV clinics in western Kenya. Data were collected from questionnaires administered by clinicians to children and their caregivers, supplemented with chart review. Descriptive statistics and disclosure prevalence were calculated. Univariate analyses and multivariate logistic regression were performed to assess the association between disclosure and key child-level demographic, clinical and psychosocial characteristics. Results: Among 792 caregiver-child dyads, mean age of the children was 9.7 years (SD = 2.6) and 51% were female. Prevalence of disclosure was 26% and varied significantly by age; while 62% of 14-year-olds knew their status, only 42% of 11-year-olds and 21% of 8-year-olds knew. In multivariate regression, older age (OR 1.49, 95% CI 1.35-1.63), taking antiretroviral drugs (OR 2.27, 95% CI 1.29-3.97), and caregiver-reported depression symptoms (OR 2.63, 95% CI 1.12-6.20) were significantly associated with knowing one's status. Treatment site was associated with disclosure for children attending one of the rural clinics compared to the urban clinic (OR 3.44, 95% CI 1.75-6.76). Conclusions: Few HIV-infected children in Kenya know their HIV status. The likelihood of disclosure is associated with clinical and psychosocial factors. More data are needed on the process of disclosure and its impact on children.	[Vreeman, Rachel C.; Scanlon, Michael L.; Turissini, Matthew] Indiana Univ Sch Med, Dept Pediat, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.; Scanlon, Michael L.; Mwangi, Ann; Turissini, Matthew; Ayaya, Samuel O.; Tenge, Constance; Nyandiko, Winstone M.] USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Mwangi, Ann] Moi Univ, Sch Med, Dept Behav Sci, Coll Hlth Sci, Eldoret, Kenya; [Ayaya, Samuel O.; Tenge, Constance; Nyandiko, Winstone M.] Moi Univ, Sch Med, Dept Child Hlth & Paediat, Coll Hlth Sci, Eldoret, Kenya	Indiana University System; Indiana University Bloomington; United States Agency for International Development (USAID); Moi University; Moi University	Vreeman, RC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Childrens Hlth Serv Res, Indianapolis, IN 46202 USA.	rvreeman@iupui.edu	Scanlon, Michael L/P-3556-2016; Cuscó, Xavier Garcia/S-7576-2019	Scanlon, Michael L/0000-0002-0334-5640; Cuscó, Xavier Garcia/0000-0001-7199-6931	NIMH [K23MH087225]; USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099747, K23MH087225] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by a grant (K23MH087225) to Dr. Rachel Vreeman from the NIMH and by the USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROGR REP 2011 GLOB; Bachanas PJ, 2001, J PEDIATR PSYCHOL, V26, P343, DOI 10.1093/jpepsy/26.6.343; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Brackis-Cott Elizabeth, 2003, J Pediatr Health Care, V17, P252, DOI 10.1016/S0891-5245(02)88313-4; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; FunckBrentano I, 1995, PSYCHIAT ENFANT, V38, P109; FunckBrentano I, 1997, ARCH PEDIAT ADOL MED, V151, P978, DOI 10.1001/archpedi.1997.02170470012002; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Hammami N, 2004, PEDIATRICS, V114, pE591, DOI 10.1542/peds.2004-0085; HAVENS JF, 2002, CHILD ADOL PSYCH CL, P828; John-Stewart GC, 2013, AIDS CARE, V25, P1067, DOI 10.1080/09540121.2012.749333; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Madiba S., 2012, WORLD J AIDS, V2, P212, DOI [10.4236/wja.2012.23027, DOI 10.4236/WJA.2012.23027]; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Marhefka SL, 2006, AIDS PATIENT CARE ST, V20, P429, DOI 10.1089/apc.2006.20.429; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Riekert KA, 1999, CHILD HEALTH CARE, V28, P201, DOI 10.1207/s15326888chc2803_1; Sirikum C., 2013, 5 INT WORKSH HIV PED; Turissini ML, 2013, J PEDIATR INFECT DIS, V2, P136, DOI 10.1093/jpids/pit024; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS	36	62	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86616	10.1371/journal.pone.0086616	http://dx.doi.org/10.1371/journal.pone.0086616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475159	Green Published, gold			2022-12-27	WOS:000330507300095
J	Wang, JY; Jiang, JC; Wang, HF; Kang, HM; Zhang, Q; Liu, JF				Wang, Jiying; Jiang, Jicai; Wang, Haifei; Kang, Huimin; Zhang, Qin; Liu, Jian-Feng			Enhancing Genome-Wide Copy Number Variation Identification by High Density Array CGH Using Diverse Resources of Pig Breeds	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; POLYMORPHISM; SELECTION; VARIANTS; TRAITS	Copy number variations (CNVs) are important forms of genomic variation, and have attracted extensive attentions in humans as well as domestic animals. In the study, using a custom-designed 2.1 M array comparative genomic hybridization (aCGH), genome-wide CNVs were identified among 12 individuals from diverse pig breeds, including one Asian wild population, six Chinese indigenous breeds and two modern commercial breeds (Yorkshire and Landrace), with one individual of the other modern commercial breed, Duroc, as the reference. A total of 1,344 CNV regions (CNVRs) were identified, covering 47.79 Mb (similar to 1.70%) of the pig genome. The length of these CNVRs ranged from 3.37 Kb to 1,319.0 Kb with a mean of 35.56 Kb and a median of 11.11 Kb. Compared with similar studies reported, most of the CNVRs (74.18%) were firstly identified in present study. In order to confirm these CNVRs, 21 CNVRs were randomly chosen to be validated by quantitative real time PCR (qPCR) and a high rate (85.71%) of confirmation was obtained. Functional annotation of CNVRs suggested that the identified CNVRs have important function, and may play an important role in phenotypic and production traits difference among various breeds. Our results are essential complementary to the CNV map in the pig genome, which will provide abundant genetic markers to investigate association studies between various phenotypes and CNVs in pigs.	[Wang, Jiying; Jiang, Jicai; Wang, Haifei; Kang, Huimin; Zhang, Qin; Liu, Jian-Feng] China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Coll Anim Sci & Technol,Minist Agr, Beijing 100094, Peoples R China; [Wang, Jiying] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Prov Key Lab Anim Dis Control & Breeding, Jinan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences	Liu, JF (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod, Coll Anim Sci & Technol,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn		Jiang, Jicai/0000-0001-6890-7539; Liu, Jian-Feng/0000-0002-5766-7864	Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; National High Technology Research and Development Program of China (863 Program) [2011AA100302, 2013AA102503]; National Natural Science Foundations of China [31272419]; New-Century Training Program Foundation for the Talents by the State Education Commission of China [NETC-10-0783]	Program for Changjiang Scholar and Innovation Research Team in University; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); New-Century Training Program Foundation for the Talents by the State Education Commission of China	This work was financially supported by the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the National High Technology Research and Development Program of China (863 Program 2011AA100302, 2013AA102503), the National Natural Science Foundations of China (31272419) and the New-Century Training Program Foundation for the Talents by the State Education Commission of China (NETC-10-0783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; de Smith AJ, 2008, CYTOGENET GENOME RES, V123, P17, DOI 10.1159/000184688; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Jiang YZ, 2012, GENET MOL RES, V11, P4447, DOI 10.4238/2012.September.19.6; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2012, FUNCT INTEGR GENOMIC, V12, P609, DOI 10.1007/s10142-012-0289-9; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu P, 2008, FOOD CHEM, V107, P1529, DOI 10.1016/j.foodchem.2007.10.010; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiner G, 2002, VET PARASITOL, V106, P99, DOI 10.1016/S0304-4017(02)00041-9; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Wang Jiying, 2013, PLoS One, V8, pe68683, DOI 10.1371/journal.pone.0068683; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zhang CY, 2011, CURR GENOMICS, V12, P138, DOI 10.2174/138920211795564386; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang ZG, 1986, PIG BREEDS CHINA, P17	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87571	10.1371/journal.pone.0087571	http://dx.doi.org/10.1371/journal.pone.0087571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475311	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300204
J	Wu, WP; Lai, MN; Lin, CH; Li, YF; Lin, CY; Wu, MJ				Wu, Wen-Pyng; Lai, Ming-Nan; Lin, Ching-Heng; Li, Yu-Fen; Lin, Ching-Yuang; Wu, Ming-Ju			Addition of Immunosuppressive Treatment to Hemoperfusion Is Associated with Improved Survival after Paraquat Poisoning: A Nationwide Study	PLOS ONE			English	Article							INTRAVENOUS CYCLOPHOSPHAMIDE; PULSE THERAPY; CANCER-RISK; LUNG INJURY; METHYLPREDNISOLONE; DEXAMETHASONE; PROTECTS; EFFICACY; MODERATE; SINGLE	Paraquat poisoning associates very high mortality rate. Early treatment with hemoperfusion is strongly suggested by animal and human studies. Although the survival benefit of additional immunosuppressive treatment (IST) in combination with hemoperfusion is also reported since 1971, the large-scale randomized control trials to confirm the effects of IST is difficult to be executed. Therefore, we designed this nationwide large-scale population-based retrospective cohort study to investigate the outcome of paraquat poisoning with hemoperfusion and the additional effects of IST combined with hemoperfusion. This nationwide retrospective cohort study utilized data retrieved from the National Health Insurance Research Database (NHIRD) of Taiwan. A total of 1811 hospitalized patients with a diagnosis of paraquat poisoning who received hemoperfusion between 1997 and 2009 were enrolled. The mean age of all 1811 study subjects was 47.3 years. 70% was male. The overall survival rate was only 26.4%. Respiratory failure and renal failure were diagnosed in 56.2% and 36% patients. The average frequency of hemoperfusion was twice. IST was added in 42.2% patients. IST significantly increases survival rate (from 24.3% to 29.3%, P<0.001). The combined IST with methylprednisolone, cyclophosphamide and dexamethasone associates with the highest survival rate (48%, P<0.001). Moreover, patients younger than 45 years of age in the IST group had the best survival (41.0% vs. 33.7%, p<0.001). Our results support the use of IST with hemoperfusion for paraquat-poisoned patients. The best survival effect of IST is the combination of methylprednisolone, cyclophosphamide and daily dexamethasone, especially in patients with younger age.	[Wu, Wen-Pyng; Lin, Ching-Yuang; Wu, Ming-Ju] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wu, Wen-Pyng] Chang Bing Show Chwan Mem Hosp, Div Nephrol, Changhua, Taiwan; [Lai, Ming-Nan] Feng Chia Univ, Dept Stat, Taichung 40724, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Li, Yu-Fen] China Med Univ, Inst Biostat, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Wu, Ming-Ju] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Ming-Ju] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Ju] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan; [Wu, Ming-Ju] Taichung Vet Gen Hosp, Div Nephrol, Dept Med, Taichung, Taiwan	China Medical University Taiwan; Chang Bing Show Chwan Memorial Hospital; Feng Chia University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Chung Shan Medical University; National Chung Hsing University; Taichung Veterans General Hospital	Lin, CY (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	cylin@mail.cmuh.org.tw; wmj530@gmail.com	LI, YU-FEN/F-4770-2010	LI, YU-FEN/0000-0002-3960-6101				ADDO E, 1986, LANCET, V1, P1117, DOI 10.1016/S0140-6736(86)91836-2; Afzali S, 2008, ARCH IRAN MED, V11, P387, DOI 08114/AIM.009; Agarwal R., 2006, SMJ Singapore Medical Journal, V47, P1033; BATEMAN DN, 1987, HUM TOXICOL, V6, P57, DOI 10.1177/096032718700600109; BISMUTH C, 1987, HUM TOXICOL, V6, P63, DOI 10.1177/096032718700600110; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025; Dinis-Oliveira RJ, 2006, PEDIATR EMERG CARE, V22, P537, DOI 10.1097/01.pec.0000223179.07633.8a; Eddleston M, 2003, QJM-INT J MED, V96, P809, DOI 10.1093/qjmed/hcg137; GADEK JE, 1984, ENVIRON HEALTH PERSP, V55, P297, DOI 10.2307/3429709; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; HAMPSON ECGM, 1990, J PHARMACOL EXP THER, V254, P732; HOFFMAN GS, 1990, AM J MED, V89, P403, DOI 10.1016/0002-9343(90)90367-M; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048397; Ito T., 2008, J RURAL MED, V3, P5; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lang JD, 2002, CHEST, V122, p314S, DOI 10.1378/chest.122.6_suppl.314S; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Li LR, 2012, COCHRANE DB SYST REV, V7; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Malone J D, 1971, J Ir Med Assoc, V64, P59; MCCUNE WJ, 1988, NEW ENGL J MED, V318, P1423, DOI 10.1056/NEJM198806023182203; MEREDITH TJ, 1987, HUM TOXICOL, V6, P49, DOI 10.1177/096032718700600108; PERRIENS JH, 1992, HUM EXP TOXICOL, V11, P129, DOI 10.1177/096032719201100212; POND SM, 1993, J TOXICOL-CLIN TOXIC, V31, P229, DOI 10.3109/15563659309000391; Sittipunt Chanchai, 2005, Respir Care, V50, P383; Sun CY, 2006, ACTA NEPHROLOGICA, V20, P98; Suntres Z. E., 1995, Biomedical and Environmental Sciences, V8, P289; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; TABEI K, 1982, ARTIF ORGANS, V6, P37, DOI 10.1111/j.1525-1594.1982.tb04055.x; TALBOT AR, 1988, HUM TOXICOL, V7, P325, DOI 10.1177/096032718800700405; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Yamashita M, 2000, HUM EXP TOXICOL, V19, P99, DOI 10.1191/096032700678815729	40	31	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87568	10.1371/journal.pone.0087568	http://dx.doi.org/10.1371/journal.pone.0087568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475310	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300203
J	Chen, YH; Lin, WW; Liu, CS; Hsu, LS; Lin, YM; Su, SL				Chen, Ya-Hui; Lin, Wei-Wen; Liu, Chin-San; Hsu, Li-Sung; Lin, Yueh-Min; Su, Shih-Li			Caveolin-1 Provides Palliation for Adverse Hepatic Reactions in Hypercholesterolemic Rabbits	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MEDIATED CHOLESTEROL EFFLUX; MITOCHONDRIAL BIOGENESIS; CELLULAR CHOLESTEROL; SELECTIVE UPTAKE; SR-BI; ENDOTHELIAL-CELL; EXPRESSION; ATHEROSCLEROSIS; TRANSPORT	Caveolins are an essential component of cholesterol-rich invaginations of the plasma membrane known as caveolae. These flask-shaped, invaginated structures participate in a number of important cellular processes, including vesicular transport, cholesterol homeostasis, and signal transduction. We investigated the effects of CAV-1 on mitochondrial biogenesis and antioxidant enzymes in hypercholesterolemia-affected target organs. A total of eighteen male New Zealand white rabbits were divided into three groups: a normal-diet group, an untreated hypercholesterolemia-induced group, and a hypercholesterolemia-induced group that received intravenous administration of antennapedia-CAV-1 (AP-CAV-1) peptide every 2 days for 2 weeks. Serum biochemistry, CAV-1 distribution, neutral lipid distribution, mitochondrial morphology, biogenesis-mediated protein content, oxidative stress balance, antioxidant enzyme levels, and apoptotic cell death of liver tissue were analysed. Hepatic and circulating cholesterol and low-density lipoprotein cholesterol (LDL-C) levels differed significantly between the three groups (P<0.05). Immunohistochemical staining intensity of CAV-1 was greater in AP-CAV-1-treated rabbits than in untreated rabbits, especially in the vicinity of the liver vasculature. The high levels of neutral lipids, malondialdehyde, peroxisome proliferator-activated receptor-gamma coactive 1 alpha (PGC-1 alpha), and nuclear respiratory factor-1 (NRF-1) seen in untreated hypercholesteremic animals were attenuated by administration of AP-CAV-1 (P<0.05). In addition, mitochondria in animals that received treatment exhibited darker electron-dense matrix and integrated cristae. Furthermore, the levels of ROS modulator 1 (Romo1) and superoxide dismutase (SOD)-2, as well as catalase activity were significantly lower in CAV-1-treated hypercholesterolemic rabbits (P<0.05). AP-CAV-1 treatment also restored mitochondrial respiratory chain subunit protein content (OXPHOS complexes I-V), thereby preserving mitochondrial function (P<0.05). Furthermore, AP-CAV-1 treatment significantly suppressed apoptotic cell death, as evidenced by a reduction in the number of TUNEL-positive cells. Our results indirectly indicate that CAV-1 mediates the negative effects of PGC-1 alpha on hepatic mitochondrial respiratory chain function, promotes the antioxidant enzyme defence system, and maintains mitochondrial biogenesis.	[Chen, Ya-Hui; Liu, Chin-San; Su, Shih-Li] Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan; [Chen, Ya-Hui; Hsu, Li-Sung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Wei-Wen] Taichung Vet Gen Hosp, Dept Internal Med, Div Cardiovasc Ctr, Taichung, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Su, Shih-Li] Changhua Christian Hosp, Div Endocrinol & Metab, Dept Internal Med, Changhua, Taiwan; [Su, Shih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; China Medical University Taiwan; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University	Su, SL (corresponding author), Changhua Christian Hosp, Vasc & Genom Ctr, Changhua, Taiwan.	89933@cch.org.tw			Changhua Christian Hospital [98-CCH-IRP-54-92262, 98-CCH-IRP-04-92179]	Changhua Christian Hospital	This work was supported by the Changhua Christian Hospital under grants 98-CCH-IRP-54-92262 and 98-CCH-IRP-04-92179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa R, 2000, J LIPID RES, V41, P1952; Arduini Alessandro, 2012, Front Biosci (Elite Ed), V4, P2233; Arduini A, 2011, AM J PHYSIOL-GASTR L, V301, pG119, DOI 10.1152/ajpgi.00253.2010; Bosch M, 2011, TRAFFIC, V12, P1483, DOI 10.1111/j.1600-0854.2011.01259.x; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811; Chowdhury SK, 2012, NEUROBIOL DIS; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Fielding CJ, 1999, BIOCHEMISTRY-US, V38, P2506, DOI 10.1021/bi981012o; Frank PG, 2004, CURR OPIN LIPIDOL, V15, P523, DOI 10.1097/00041433-200410000-00005; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Frank PG, 2001, BIOCHEMISTRY-US, V40, P10892, DOI 10.1021/bi0106437; Frank PG, 2008, AM J PHYSIOL-CELL PH, V295, pC242, DOI 10.1152/ajpcell.00185.2008; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Frank PG, 2010, AM J PATHOL, V177, P544, DOI 10.2353/ajpath.2010.100247; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Jasmin JF, 2006, CIRCULATION, V114, P912, DOI 10.1161/CIRCULATIONAHA.106.634709; Jasmin JF, 2012, ADV EXP MED BIOL, V729, P1, DOI 10.1007/978-1-4614-1222-9; Joyce C, 2003, ARTERIOSCL THROM VAS, V23, P965, DOI 10.1161/01.ATV.0000055194.85073.FF; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lin WW, 2006, J HISTOCHEM CYTOCHEM, V54, P897, DOI 10.1369/jhc.5A6869.2006; Lin YC, 2007, CARDIOVASC RES, V75, P575, DOI 10.1016/j.cardiores.2007.04.012; Matveev S, 2001, EUR J BIOCHEM, V268, P5609, DOI 10.1046/j.1432-1033.2001.02496.x; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Moreno M, 2003, HEPATOLOGY, V38, P1477, DOI 10.1016/j.hep.2003.09.011; Pangare Meenal, 2012, Journal of Smooth Muscle Research, V48, P1; Pavlides S, 2012, ADV EXP MED BIOL, V729, P127, DOI 10.1007/978-1-4614-1222-9_9; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Rhainds D, 2003, BIOCHEMISTRY-US, V42, P7527, DOI 10.1021/bi026949a; Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214	45	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e71862	10.1371/journal.pone.0071862	http://dx.doi.org/10.1371/journal.pone.0071862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475013	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800001
J	Shi, M; Yao, YF; Han, F; Li, YQ; Li, Y				Shi, Ming; Yao, Yuanfei; Han, Fang; Li, Yiqun; Li, Yu			MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; AUTOPHAGY; PROLIFERATION; FLAGELLIN; MOUSE; TOLL-LIKE-RECEPTOR-5; TUMORIGENESIS; MACROPHAGES; ACTIVATION; CARCINOMA	Targeting TLR5 signaling in breast cancer represents a novel strategy in cancer immunotherapy. However, the underlying mechanism by which TLR5 signaling inhibits cancer cell proliferation and tumor growth has not been elucidated. In this study, we found TLR5 agonist flagellin inhibited the cell state of activation and induced autophagy, and reported that autophagy protein MAP1S regulated the flagellin/TLR5 signaling pathway in breast cancer cells through enhancement of NF-kappa B activity and cytokine secretion. Remarkably, MAP1S played a critical role in tumor suppression induced by flagellin, and knockdown of MAP1S almost completely abrogated the suppression of tumor growth and migration by flagellin treatment. In addition, elevated expression of MAP1S in response to flagellin feed-back regulated tumor inflammatory microenvironment in the late stages of TLR5 signaling through degradation of MyD88 in autophagy process. These results indicate a mechanism of antitumor activity that involves MAP1S-controlled TLR5 signaling in breast cancer.	[Shi, Ming; Yao, Yuanfei; Han, Fang; Li, Yiqun; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China	Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@hit.edu.cn						Bhattacharya D, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/716564; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P699, DOI 10.4161/onci.20696; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Ouedraogo R, 2012, J PROTEOMICS, V75, P5523, DOI 10.1016/j.jprot.2012.07.046; Ouedraogo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013691; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmausser B, 2005, INT J MED MICROBIOL, V295, P179, DOI 10.1016/j.ijmm.2005.02.009; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Shcheblyakov DV, 2010, ACTA NATURAE, V2, P21, DOI 10.32607/20758251-2010-2-3-21-29; Song EJ, 2011, INT J MOL MED, V28, P115, DOI 10.3892/ijmm.2011.656; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wolska A, 2009, CELL MOL BIOL LETT, V14, P248, DOI 10.2478/s11658-008-0048-z; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yu L, 2008, CANCER IMMUNOL IMMUN, V57, P1271, DOI 10.1007/s00262-008-0459-8; Yu YT, 2012, CANCER SCI, V103, P716, DOI 10.1111/j.1349-7006.2012.02220.x; Zeng FL, 2011, MOL CELLS, V31, P267, DOI 10.1007/s10059-011-0037-3; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	31	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86839	10.1371/journal.pone.0086839	http://dx.doi.org/10.1371/journal.pone.0086839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466264	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000156
J	Graham, AN; Kalitsis, P				Graham, Alison N.; Kalitsis, Paul			Chromosome Y Centromere Array Deletion Leads to Impaired Centromere Function	PLOS ONE			English	Article							ALPHA-SATELLITE ARRAY; CENP-A; MOUSE; DNA; MICRONUCLEI; MUTATIONS; PROTEINS; IDENTITY	The centromere is an essential chromosomal structure that is required for the faithful distribution of replicated chromosomes to daughter cells. Defects in the centromere can compromise the stability of chromosomes resulting in segregation errors. We have characterised the centromeric structure of the spontaneous mutant mouse strain, BALB/cWt, which exhibits a high rate of Y chromosome instability. The Y centromere DNA array shows a de novo interstitial deletion and a reduction in the level of the foundation centromere protein, CENP-A, when compared to the non-deleted centromere array in the progenitor strain. These results suggest there is a lower threshold limit of centromere size that ensures full kinetochore function during cell division.	[Graham, Alison N.; Kalitsis, Paul] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Kalitsis, Paul] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne	Kalitsis, P (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	paul.kalitsis@mcri.edu.au	Kalitsis, Paul/C-1916-2015	Kalitsis, Paul/0000-0001-5569-0609	National Health and Medical Research Council of Australia [APP1010884]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council of Australia, project grant APP1010884 and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzo MA, 1996, HUM GENET, V97, P819; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Beamer W G, 1978, Basic Life Sci, V12, P195; Bean CJ, 2001, HUM MOL GENET, V10, P963, DOI 10.1093/hmg/10.9.963; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Catalan J, 1998, AM J HUM GENET, V63, P1464, DOI 10.1086/302092; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; De Rop V, 2012, CHROMOSOMA, V121, P527, DOI 10.1007/s00412-012-0386-5; EICHER EM, 1980, CYTOGENET CELL GENET, V28, P104, DOI 10.1159/000131518; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; GAUDET A, 1987, MOL CELL BIOL, V7, P68, DOI 10.1128/MCB.7.1.68; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Hasson D, 2011, CHROMOSOMA, V120, P621, DOI 10.1007/s00412-011-0337-6; HEGEMANN JH, 1986, MOL GEN GENET, V205, P305, DOI 10.1007/BF00430443; Hori T, 2012, CHROMOSOME RES, V20, P547, DOI 10.1007/s10577-012-9289-9; Hunt PA, 2008, CHROMOSOME RES, V16, P623, DOI 10.1007/s10577-008-1216-8; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Irvine DV, 2004, CHROMOSOME RES, V12, P805, DOI 10.1007/s10577-005-5377-4; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Kalitsis P, 2006, P NATL ACAD SCI USA, V103, P8786, DOI 10.1073/pnas.0600250103; Kalitsis P, 2012, CHROMOSOMA, V121, P327, DOI 10.1007/s00412-012-0369-6; KIPLING D, 1991, GENOMICS, V11, P235, DOI 10.1016/0888-7543(91)90128-2; Lo AWI, 1999, GENOME RES, V9, P895, DOI 10.1101/gr.9.10.895; Mann J.R., 2001, METH MOL B, V181, P21; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; NATH J, 1995, CHROMOSOMA, V103, P725, DOI 10.1007/s004120050085; OAKEY R, 1990, GENOMICS, V7, P325, DOI 10.1016/0888-7543(90)90165-Q; PANZERI L, 1985, EMBO J, V4, P1867, DOI 10.1002/j.1460-2075.1985.tb03862.x; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pertile MD, 2009, GENOME RES, V19, P2202, DOI 10.1101/gr.092080.109; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; SPENCER F, 1992, P NATL ACAD SCI USA, V89, P8908, DOI 10.1073/pnas.89.19.8908; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; WHITTEN WK, 1971, SCIENCE, V171, P406, DOI 10.1126/science.171.3969.406; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zeng K, 2004, CHROMOSOMA, V113, P84, DOI 10.1007/s00412-004-0299-z; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86875	10.1371/journal.pone.0086875	http://dx.doi.org/10.1371/journal.pone.0086875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466276	Green Published, gold			2022-12-27	WOS:000330283100229
J	Liu, FF; Wu, X; Zhang, Y; Wang, Y; Jiang, F				Liu, Fang Fang; Wu, Xiao; Zhang, Yun; Wang, Yan; Jiang, Fan			TRAIL/DR5 Signaling Promotes Macrophage Foam Cell Formation by Modulating Scavenger Receptor Expression	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; APOPTOSIS-INDUCING LIGAND; NECROSIS-FACTOR-ALPHA; REGULATE SR-A; NF-KAPPA-B; ENDOTHELIAL-CELLS; SOLUBLE TRAIL; P38 MAPK; ATHEROSCLEROSIS; PROLIFERATION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) has been shown to have protective effects against atherosclerosis. However, whether TRAIL has any effects on expression of macrophage scavenger receptors and lipid uptake has not yet been studied. Macrophage lines RAW264.7 and THP-1, and mouse primary peritoneal macrophages, were cultured in vitro and treated with recombinant human TRAIL. Real-time PCR and western blot were performed to measure mRNA and protein expressions. Foam cell formation was assessed by internalization of acetylated and oxidized low-density lipoproteins (LDL). Apoptosis was measured by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. We found that TRAIL treatment increased expression of scavenger receptor (SR)-AI and SR-BI in a time- and dose-dependent manner, and this effect was accompanied by increased foam cell formation. These effects of TRAIL were abolished by a TRAIL neutralizing antibody or in DR5 receptor-deficient macrophages. The increased LDL uptake by TRAIL was blocked by SR-AI gene silencing or the SR-AI inhibitor poly(I:C), while SR-BI blockade with BLT-1 had no effect. TRAIL-induced SR-AI expression was blocked by the inhibitor of p38 mitogen-activated protein kinase, but not by inhibitors of ERK1/2 or JNK. TRAIL also induced apoptosis in macrophages. In contrast to macrophages, TRAIL showed little effects on SR expression or apoptosis in vascular smooth muscle cells. In conclusion, our results demonstrate that TRAIL promotes macrophage lipid uptake via SR-AI upregulation through activation of the p38 pathway.	[Liu, Fang Fang; Wu, Xiao; Zhang, Yun; Jiang, Fan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Wang, Yan] Beijing Hosp, Dept Cardiol, Beijing, Peoples R China	Shandong University; Beijing Hospital	Wang, Y (corresponding author), Beijing Hosp, Dept Cardiol, Beijing, Peoples R China.	wywy14598@hotmail.com; fjiang@sdu.edu.cn	Jiang, Fan/B-7753-2013	Jiang, Fan/0000-0001-9466-2192	National 973 Basic Research Program of China [2010CB732605, 2011CB503906]; National Natural Science Foundation of China [81070164, 30900523, 81341013]; National High-Tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work was partially supported by the following research grants: the National 973 Basic Research Program of China (2010CB732605 for FJ, 2011CB503906 for YZ); National Natural Science Foundation of China (81070164 for FJ; 30900523 and 81341013 for YW); National High-Tech Research and Development Program of China (2012AA02A510 for YZ); Program of Introducing Talents of Discipline to Universities (B07035 for YZ); and State Program of National Natural Science Foundation of China for Innovative Research Group (81021001 for YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi S, 2012, CURR DRUG TARGETS, V13, P1215, DOI 10.2174/138945012802002357; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cowburn AS, 2005, BLOOD, V105, P2970, DOI 10.1182/blood-2004-07-2870; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; FALCONE DJ, 1989, J CELL PHYSIOL, V140, P219, DOI 10.1002/jcp.1041400205; Fitzgerald ML, 2000, J IMMUNOL, V164, P2692, DOI 10.4049/jimmunol.164.5.2692; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Han LH, 2002, WORLD J GASTROENTERO, V8, P1077, DOI 10.3748/wjg.v8.i6.1077; Hashizume M, 2012, EUR J PHARMACOL, V689, P249, DOI 10.1016/j.ejphar.2012.05.035; Hofbauer LC, 2006, RHEUMATOLOGY, V45, P1218, DOI 10.1093/rheumatology/kel108; Horiuchi S, 2003, AMINO ACIDS, V25, P283, DOI 10.1007/s00726-003-0029-5; Hsu HY, 1996, J BIOL CHEM, V271, P7767, DOI 10.1074/jbc.271.13.7767; Jiang F, 2009, BRIT J PHARMACOL, V157, P597, DOI 10.1111/j.1476-5381.2009.00199.x; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nikolic D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-37; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Song S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.103; Spencer DM, 2013, INNATE IMMU IN PRESS; Steinwede K, 2012, J EXP MED, V209, P1937, DOI 10.1084/jem.20120983; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van Berkel TJC, 2005, CURR OPIN LIPIDOL, V16, P525, DOI 10.1097/01.mol.0000183943.20277.26; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; Wang ZB, 2005, AM J PHYSIOL-HEART C, V288, pH293, DOI 10.1152/ajpheart.00165.2004; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Xiang Q, 2009, J INT MED RES, V37, P491, DOI 10.1177/147323000903700225; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Yen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038048; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	53	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87059	10.1371/journal.pone.0087059	http://dx.doi.org/10.1371/journal.pone.0087059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466325	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100248
J	Zawada, DG; Mazel, CH				Zawada, David G.; Mazel, Charles H.			Fluorescence-Based Classification of Caribbean Coral Reef Organisms and Substrates	PLOS ONE			English	Article							CENSUS TECHNIQUES; PROTEIN; DISCRIMINATION; PIGMENTATION; EMISSION; SPECTRA; HOST	A diverse group of coral reef organisms, representing several phyla, possess fluorescent pigments. We investigated the potential of using the characteristic fluorescence emission spectra of these pigments to enable unsupervised, optical classification of coral reef habitats. We compiled a library of characteristic fluorescence spectra through in situ and laboratory measurements from a variety of specimens throughout the Caribbean. Because fluorescent pigments are not species-specific, the spectral library is organized in terms of 15 functional groups. We investigated the spectral separability of the functional groups in terms of the number of wavebands required to distinguish between them, using the similarity measures Spectral Angle Mapper (SAM), Spectral Information Divergence (SID), SID-SAM mixed measure, and Mahalanobis distance. This set of measures represents geometric, stochastic, joint geometric-stochastic, and statistical approaches to classifying spectra. Our hyperspectral fluorescence data were used to generate sets of 4-, 6-, and 8-waveband spectra, including random variations in relative signal amplitude, spectral peak shifts, and water-column attenuation. Each set consisted of 2 different band definitions: 'optimally-picked' and 'evenly-spaced.' The optimally-picked wavebands were chosen to coincide with as many peaks as possible in the functional group spectra. Reference libraries were formed from half of the spectra in each set and used for training purposes. Average classification accuracies ranged from 76.3% for SAM with 4 evenly-spaced wavebands to 93.8% for Mahalanobis distance with 8 evenly-spaced wavebands. The Mahalanobis distance consistently outperformed the other measures. In a second test, empirically-measured spectra were classified using the same reference libraries and the Mahalanobis distance for just the 8 evenly-spaced waveband case. Average classification accuracies were 84% and 87%, corresponding to the extremes in modeled water-column attenuation. The classification results from both tests indicate that a high degree of separability among the 15 fluorescent-spectra functional groups is possible using only a modest number of spectral bands.	[Zawada, David G.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA; [Mazel, Charles H.] Phys Sci Inc, Andover, MA 01810 USA	United States Department of the Interior; United States Geological Survey; Physical Sciences Inc.	Zawada, DG (corresponding author), US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA.	dzawada@usgs.gov		Zawada, David/0000-0003-4547-4878	Environmental Optics Program of the Office of Naval Research; U.S. Geological Survey Coastal Marine and Geology Program	Environmental Optics Program of the Office of Naval Research(Office of Naval Research); U.S. Geological Survey Coastal Marine and Geology Program(United States Geological Survey)	This research was supported by funding from the Environmental Optics Program of the Office of Naval Research (CHM and DGZ, when previously employed by Physical Sciences Incorporated) and the U.S. Geological Survey Coastal Marine and Geology Program (DGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; CATALASTUCKI R, 1959, NATURE, V183, P949, DOI 10.1038/183949a0; Chang CI, 2000, IEEE T INFORM THEORY, V46, P1927, DOI 10.1109/18.857802; D'Angelo C, 2012, CORAL REEFS, V31, P1045, DOI 10.1007/s00338-012-0926-8; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duckworth J., 1998, APPL SPECTROSCOPY CO, P165, DOI [10.1016/B978-012764070-9/50007-X, DOI 10.1016/B978-012764070-9/50007-X]; Gnanadesikan R, 1997, METHODS STAT DATA AN, P81; Hedley JD, 2002, ADV MAR BIOL, V43, P277, DOI 10.1016/S0065-2881(02)43006-4; Jaramillo S, 2011, CORAL REEFS, V30, P11, DOI 10.1007/s00338-011-0731-9; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LIMBAUGH C, 1956, NATURE, V178, P497, DOI 10.1038/178497b0; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Matz MV, 2002, BIOESSAYS, V24, P953, DOI 10.1002/bies.10154; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P522, DOI 10.4319/lo.2003.48.1_part_2.0522; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Phillips CES, 1927, NATURE, V119, P747, DOI 10.1038/119747c0; Piniak GA, 2005, CORAL REEFS, V24, P496, DOI 10.1007/s00338-005-0495-1; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Torres, 2004, SUBSURFACE SENSING T, V5, P25, DOI DOI 10.1023/B:SSTA.0000018445.25977.F3; Treiber M, 2010, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84996-235-3; WARD WW, 2002, BIOLUMINESCENCE CHEM, P123; Zawada DG, 2008, REV BIOL TROP, V56, P51; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	34	19	19	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84570	10.1371/journal.pone.0084570	http://dx.doi.org/10.1371/journal.pone.0084570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24482676	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100025
J	Cukuroglu, E; Gursoy, A; Nussinov, R; Keskin, O				Cukuroglu, Engin; Gursoy, Attila; Nussinov, Ruth; Keskin, Ozlem			Non-Redundant Unique Interface Structures as Templates for Modeling Protein Interactions	PLOS ONE			English	Article							HOT-SPOTS; BINDING-ENERGY; SEQUENCE; CLASSIFICATION; SIMILARITIES; PREDICTION; DATABASE; MOTIFS; SITES; ARCHITECTURES	Improvements in experimental techniques increasingly provide structural data relating to protein-protein interactions. Classification of structural details of protein-protein interactions can provide valuable insights for modeling and abstracting design principles. Here, we aim to cluster protein-protein interactions by their interface structures, and to exploit these clusters to obtain and study shared and distinct protein binding sites. We find that there are 22604 unique interface structures in the PDB. These unique interfaces, which provide a rich resource of structural data of protein-protein interactions, can be used for template-based docking. We test the specificity of these non-redundant unique interface structures by finding protein pairs which have multiple binding sites. We suggest that residues with more than 40% relative accessible surface area should be considered as surface residues in template-based docking studies. This comprehensive study of protein interface structures can serve as a resource for the community. The dataset can be accessed at http://prism.ccbb.ku.edu.tr/piface.	[Cukuroglu, Engin; Gursoy, Attila; Keskin, Ozlem] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey; [Cukuroglu, Engin; Gursoy, Attila; Keskin, Ozlem] Koc Univ, Coll Engn, Istanbul, Turkey; [Nussinov, Ruth] NCI, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Frederick, MD 21701 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, Sackler Inst Mol Med, IL-69978 Tel Aviv, Israel	Koc University; Koc University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Gursoy, A (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	agursoy@ku.edu.tr; okeskin@ku.edu.tr	Gursoy, Attila/Z-4394-2019; Gursoy, Attila/E-9565-2015	Gursoy, Attila/0000-0002-2297-2113; Gursoy, Attila/0000-0002-2297-2113; Nussinov, Ruth/0000-0002-8115-6415	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010441, ZIABC010440] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benoit V, 2008, BIOCHIMIE, V90, P640, DOI 10.1016/j.biochi.2007.11.008; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bordner AJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-234; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; Dafas P, 2004, BIOINFORMATICS, V20, P1486, DOI 10.1093/bioinformatics/bth106; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; Engin HB, 2012, J CHEM INF MODEL, V52, P2273, DOI 10.1021/ci300072q; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Gao Y, 2004, J MOL MODEL, V10, P44, DOI 10.1007/s00894-003-0168-3; Garma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038913; Ghoorah AW, 2011, BIOINFORMATICS, V27, P2820, DOI 10.1093/bioinformatics/btr493; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gunther S, 2007, PROTEINS, V69, P839, DOI 10.1002/prot.21746; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hamp T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002623; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Headd JJ, 2007, J PROTEOME RES, V6, P2576, DOI 10.1021/pr070018+; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Hugo W, 2010, BIOINFORMATICS, V26, P1036, DOI 10.1093/bioinformatics/btq065; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Keskin O, 2005, PHYS BIOL, V2, pS24, DOI 10.1088/1478-3975/2/2/S03; Keskin O, 2005, PROTEIN ENG DES SEL, V18, P11, DOI 10.1093/protein/gzh095; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109; Kundrotas PJ, 2013, PROTEINS; Kuzu G, 2013, J PROTEOME RES, V12, P2641, DOI 10.1021/pr400006k; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Ozbabacan SEA, 2012, J STRUCT BIOL, V179, P338, DOI 10.1016/j.jsb.2012.02.002; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saha RP, 2005, J PROTEOME RES, V4, P1600, DOI 10.1021/pr050118k; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Teyra J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-9; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Tseng YY, 2012, NUCLEIC ACIDS RES, V40, pW435, DOI 10.1093/nar/gks495; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2012, PROTEINS, V80, P1239, DOI 10.1002/prot.24022; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tyagi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028896; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Yogurtcu ON, 2008, BIOPHYS J, V94, P3475, DOI 10.1529/biophysj.107.114835; Zhu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001926	71	51	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86738	10.1371/journal.pone.0086738	http://dx.doi.org/10.1371/journal.pone.0086738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475173	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300105
J	de Souza, RD; Batista, MT; Luiz, WB; Cavalcante, RCM; Amorim, JH; Bizerra, RSP; Martins, EG; Ferreira, LCD				de Souza, Renata Damasio; Batista, Milene Tavares; Luiz, Wilson Barros; Marques Cavalcante, Rafael Ciro; Amorim, Jaime Henrique; Pereira Bizerra, Raiza Sales; Martins, Eduardo Gimenes; de Souza Ferreira, Luis Carlos			Bacillus subtilis Spores as Vaccine Adjuvants: Further Insights into the Mechanisms of Action	PLOS ONE			English	Article							IMMUNE-RESPONSE; ENDOSPORES; DELIVERY	Bacillus subtilis spores have received growing attention regarding potential biotechnological applications, including the use as probiotics and in vaccine formulations. B. subtilis spores have also been shown to behave as particulate vaccine adjuvants, promoting the increase of antibody responses after co-administration with antigens either admixed or adsorbed on the spore surface. In this study, we further evaluated the immune modulatory properties of B. subtilis spores using a recombinant HIV gag p24 protein as a model antigen. The adjuvant effects of B. subtilis spores were not affected by the genetic background of the mouse lineage and did not induce significant inflammatory or deleterious effects after parenteral administration. Our results demonstrated that co-administration, but not adsorption to the spore surface, enhanced the immunogenicity of that target antigen after subcutaneous administration to BALB/c and C57BL/6 mice. Spores promoted activation of antigen presenting cells as demonstrated by the upregulation of MHC and CD40 molecules and enhanced secretion of pro-inflammatory cytokines by murine dendritic cells. In addition, in vivo studies indicated a direct role of the innate immunity on the immunomodulatory properties of B. subtilis spores, as demonstrated by the lack of adjuvant effects on MyD88 and TLR2 knockout mouse strains.	[de Souza, Renata Damasio; Batista, Milene Tavares; Luiz, Wilson Barros; Amorim, Jaime Henrique; Pereira Bizerra, Raiza Sales; Martins, Eduardo Gimenes; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Vaccine Dev Lab, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Marques Cavalcante, Rafael Ciro] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ferreira, LCD (corresponding author), Univ Sao Paulo, Vaccine Dev Lab, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.	lcsf@usp.br	Luiz, Wilson/L-7575-2015; Luiz, Wilson/H-2073-2012; Amorim, Jaime Henrique/O-9222-2017; Ferreira, Luis/M-3954-2014	Luiz, Wilson/0000-0003-3265-8547; Luiz, Wilson/0000-0001-5219-6699; Amorim, Jaime Henrique/0000-0002-0623-2879; Ferreira, Luis/0000-0002-4883-1693	Foundation of the State of SApoundo Paulo(FAPESP); National Counsel of Technological and Scientific Development (CNPq)	Foundation of the State of SApoundo Paulo(FAPESP); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Foundation of the State of SA o pound Paulo(FAPESP) and the National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034; Amuguni H, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.20694; Barnes AGC, 2007, EUR J IMMUNOL, V37, P1538, DOI 10.1002/eji.200636875; Bozzacco L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041897; Breyhan H, 2009, ACTA NEUROPATHOL, V117, P677, DOI 10.1007/s00401-009-0539-7; Christmas P., 2010, NAT ED, V3, P85; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; DEUERLING E, 1995, J BACTERIOL, V177, P4105, DOI 10.1128/jb.177.14.4105-4112.1995; Fierens K, 2012, CURR PHARM DESIGN, V18, P2305, DOI 10.2174/138161212800166004; Heegaard PMH, 2011, ARCH VIROL, V156, P183, DOI 10.1007/s00705-010-0863-1; Huang JM, 2008, FEMS IMMUNOL MED MIC, V53, P195, DOI 10.1111/j.1574-695X.2008.00415.x; Huang JM, 2010, VACCINE, V28, P1021, DOI 10.1016/j.vaccine.2009.10.127; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Li XM, 2012, CLIN VACCINE IMMUNOL, V19, P723, DOI 10.1128/CVI.05700-11; Liard C, 2011, VACCINE, V29, P6379, DOI 10.1016/j.vaccine.2011.04.080; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Miyaji EN, 2011, BRAZ J MED BIOL RES, V44, P500, DOI 10.1590/S0100-879X2011007500064; Montomoli E, 2011, EXPERT REV VACCINES, V10, P1053, DOI [10.1586/erv.11.48, 10.1586/ERV.11.48]; Negri A, 2013, J MED MICROBIOL, V62, P1379, DOI 10.1099/jmm.0.057372-0; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Paccez JD, 2007, VACCINE, V25, P4671, DOI 10.1016/j.vaccine.2007.04.021; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rodrigues JF, 2011, J BIOL CHEM, V286, P5222, DOI 10.1074/jbc.M110.173682; Song M, 2012, VACCINE, V30, P3266, DOI 10.1016/j.vaccine.2012.03.016; Tagliamonte M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043318; Tavares MB, 2013, CURR MICROBIOL, V66, P279, DOI 10.1007/s00284-012-0269-2; Tavares MB, 2010, FEMS IMMUNOL MED MIC, V59, P131, DOI 10.1111/j.1574-695X.2010.00669.x; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	33	32	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87454	10.1371/journal.pone.0087454	http://dx.doi.org/10.1371/journal.pone.0087454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475289	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300184
J	Lin, TH; Yang, SF; Chiu, CC; Su, HM; Voon, WC; Chai, CY; Lai, WT; Sheu, SH				Lin, Tsung-Hsien; Yang, Sheau-Fang; Chiu, Chaw-Chi; Su, Ho-Ming; Voon, Wen-Chol; Chai, Chee-Yin; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Mitral Tissue Inhibitor of Metalloproteinase 2 Is Associated with Mitral Valve Surgery Outcome	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CHORDAE TENDINAE RUPTURE; EXTRACELLULAR-MATRIX; HUMAN HEART; TIMP-2; REGURGITATION; EXPRESSION; HYPERTENSION; PREDICTION; MECHANISM	Background: Matrix metalloproteinases play a role in regulating cardiac remodeling. We previously reported an association between tissue inhibitor of metalloproteinase 2 (TIMP-2) expression and mitral valve (MV) disease. However, the determinants and prognostic value of mitral TIMP2 after MV surgery are unknown. Methods: This retrospective study of 164 patients after MV surgery in a tertiary medical center in Taiwan assessed mitral TIMP2 on a semiquantitative scale (0-2) by immunohistochemical staining. The primary endpoints were the composite of cardiovascular death and heart failure admission. Results: Mean age was 50.4613.7 years. After a mean follow-up period of 101 +/- 59 months, primary endpoints had occurred in 25 (15.2%) subjects. Patients with and without primary endpoint events significantly differed in terms of age (56.6 +/- 14.4 vs. 49.2613.4 years, respectively; p = 0.013) and left ventricular end-systolic diameter (LVESD) (39.7 +/- 8.2 vs. 35.5 +/- 7.5 mm, p = 0.010) at surgery. The TIMP2 had a significant dose-dependent association with development of a primary endpoint (p = 0.002). Kaplan-Meier analysis showed that TIMP2 expression has a significant positive association with primary endpoint-free survival (log-rank test; p = 0.004). Cox regression analysis showed that independent predictors of primary endpoints were TIMP2 (hazard ratio [HR] 0.28; 95% confidence interval [CI] 0.12-0.65; p = 0.003), age (HR 1.05; 95% CI 1.02-1.09; p = 0.003) and LVESD (HR 1.05; 95% CI 1.01-1.10; p = 0.020). Conclusions: The lack of mitral TIMP2 expression is associated with increases in cardiovascular death and heart failure following MV surgery.	[Lin, Tsung-Hsien; Su, Ho-Ming; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Yang, Sheau-Fang; Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Kaohsiung, Taiwan; [Chiu, Chaw-Chi] Kaohsiung Med Univ, Dept Surg, Div Cardiovasc Surg, Kaohsiung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Pathol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Lin, Tsung-Hsien; Yang, Sheau-Fang; Chiu, Chaw-Chi; Voon, Wen-Chol; Chai, Chee-Yin; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University	Sheu, SH (corresponding author), Kaohsiung Med Univ, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	sheush@kmu.edu.tw	蘇, 河名/AAE-9843-2019	Yang, Sheau-Fang/0000-0002-1773-3716; Su, Ho-Ming/0000-0003-0247-3250; Lin, Tsung-Hsien/0000-0002-7226-8730; Chai, Chee-Yin/0000-0003-0486-9742	Kaohsiung Medical University [Q097025]	Kaohsiung Medical University	This work was supported by a research grant from the Kaohsiung Medical University (Q097025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; CORCORAN ML, 1995, J BIOL CHEM, V270, P13453, DOI 10.1074/jbc.270.22.13453; Dreger SA, 2002, J HEART VALVE DIS, V11, P875; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; Haan CK, 2004, ANN THORAC SURG, V78, P820, DOI 10.1016/j.athoracsur.2004.04.003; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; He YY, 2013, J CELL BIOCHEM, V114, P1634, DOI 10.1002/jcb.24505; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Icardo JM, 2013, INT J CARDIOL, V167, P1603, DOI 10.1016/j.ijcard.2012.04.092; Kandalam V, 2011, CIRCULATION, V124, P2094, DOI 10.1161/CIRCULATIONAHA.111.030338; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; KOLKENBROCK H, 1991, EUR J BIOCHEM, V198, P775, DOI 10.1111/j.1432-1033.1991.tb16080.x; Lin TH, 2006, AM J HYPERTENS, V19, P75, DOI 10.1016/j.amjhyper.2005.06.020; Lin TH, 2009, J HYPERTENS, V27, P2079, DOI 10.1097/HJH.0b013e32832f50d8; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86287	10.1371/journal.pone.0086287	http://dx.doi.org/10.1371/journal.pone.0086287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475101	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300050
J	Lo, CY; Tjong, YW; Ho, JCY; Siu, CW; Cheung, SY; Tang, NL; Yu, S; Tse, HF; Yao, XQ				Lo, Chun-Yin; Tjong, Yung-Wui; Ho, Jenny Chung-Yee; Siu, Chung-Wah; Cheung, Sin-Ying; Tang, Nelson L.; Yu, Shan; Tse, Hung-Fat; Yao, Xiaoqiang			An Upregulation in the Expression of Vanilloid Transient Potential Channels 2 Enhances Hypotonicity-Induced Cytosolic Ca2+ Rise in Human Induced Pluripotent Stem Cell Model of Hutchinson Gillford Progeria	PLOS ONE			English	Article							CALCIUM; LAMIN; GENERATION; TRPV2; INHIBITION; MUTATIONS; MECHANISM; INFLUX; ION	Hutchinson-Gillford Progeria Syndrome (HGPS) is a fatal genetic disorder characterized by premature aging in multiple organs including the skin, musculoskeletal and cardiovascular systems. It is believed that an increased mechanosensitivity of HGPS cells is a causative factor for vascular cell death and vascular diseases in HGPS patients. However, the exact mechanism is unknown. Transient receptor potential (TRP) channels are cationic channels that can act as cellular sensors for mechanical stimuli. The aim of this present study was to examine the expression and functional role of TRP channels in human induced pluripotent stem cell-derived endothelial cells (IPSC-ECs) from the patients with HGPS. The mRNA and protein expression of TRP channels in HGPS and control (IMR90) iPSC-ECs were examined by semi-quantitative RT-PCRs and immunoblots, respectively. Hypotonicity-induced cytosolic Ca2+ ([Ca2+](i)) rise in iPSC-ECs was measured by confocal microscopy. RT-PCRs and immunoblots showed higher expressional levels of TRPV2 in iPSC-ECs from HGPS patients than those from normal individuals. In functional studies, hypotonicity induced a transient [Ca2+](i) rise in iPSC-ECs from normal individuals but a sustained [Ca2+](i) elevation in iPSC-ECs from HGPS patients. A nonselective TRPV inhibitor, ruthenium red (RuR, 20 mu M), and a specific TRPV2 channel inhibitor, tranilast (100 mu M), abolished the sustained phase of hypotonicity-induced [Ca2+](i) rise in iPSC-ECs from HGPS patients, and also markedly attenuated the transient phase of the [Ca2+](i) rise in these cells. Importantly, a short 10 min hypotonicity treatment caused a substantial increase in caspase 8 activity in iPSC-ECs from HGPS patients but not in cells from normal individuals. Tranilast could also inhibit the hypotonicity-induced increase in caspase 8 activity. Taken together, our data suggest that an up-regulation in TRPV2 expression causes a sustained [Ca2+](i) elevation in HGPS-iPSC-ECs under hypotonicity, consequently resulting in apoptotic cell death. This mechanism may contribute to the pathogenesis of vascular diseases in HGPS patients.	[Lo, Chun-Yin; Tjong, Yung-Wui; Cheung, Sin-Ying; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Ho, Jenny Chung-Yee; Siu, Chung-Wah; Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L.] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Yu, Shan] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University	Tse, HF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	hftse@hku.hk; yao2068@cuhk.edu.hk	Siu, Chung Wah/C-6947-2011; Yao, Xiaoqiang/I-5413-2016; Tang, Nelson L/P-5018-2017; Tse, Hung-Fat/C-4426-2009	Yao, Xiaoqiang/0000-0002-0687-8186; Tang, Nelson L/0000-0002-3607-5819; Tse, Hung-Fat/0000-0002-9578-7808; Lo, Chun-Yin/0000-0001-7554-6014; Tse, Hung Fat/0000-0003-4665-7887	Hong Kong Research Grant Council [HKU8/CRF/09, T13-706/11, CUHK2/CRF/11G, CUHK478710]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was supported by HKU8/CRF/09, T13-706/11, CUHK2/CRF/11G and CUHK478710 from the Hong Kong Research Grant Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1986, FEBS LETT, V207, P95, DOI 10.1016/0014-5793(86)80019-9; Ho JCY, 2012, DIABETES-METAB RES, V28, P462, DOI 10.1002/dmrr.2304; Ho JCY, 2011, AGING-US, V3, P380, DOI 10.18632/aging.100277; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Jin M, 2011, TRP CHANNELS, P353; Kalinowski A, 2013, BIOPHYS J, V104, P2246, DOI 10.1016/j.bpj.2013.04.016; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Lai WH, 2010, CELL REPROGRAM, V12, P641, DOI 10.1089/cell.2010.0051; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; McHugh J, 2010, HYPERTENSION, V55, P1438, DOI 10.1161/HYPERTENSIONAHA.110.151860; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, P1; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pollex RL, 2004, CLIN GENET, V66, P375, DOI 10.1111/j.1399-0004.2004.00315.x; Reddy S, 2012, EXP CELL RES, V318, P1, DOI 10.1016/j.yexcr.2011.08.009; Sato M, 2013, J ENDODONT, V39, P779, DOI 10.1016/j.joen.2013.01.012; Silvera VM, 2013, AM J NEURORADIOL, V34, P1091, DOI 10.3174/ajnr.A3341; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043186; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	33	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87273	10.1371/journal.pone.0087273	http://dx.doi.org/10.1371/journal.pone.0087273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475260	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300159
J	Lv, RX; Qiao, WG; Wu, ZY; Wang, YJ; Dai, SX; Liu, Q; Zheng, XB				Lv, Ruxi; Qiao, Weiguang; Wu, Zhiyong; Wang, Yinjun; Dai, Shixue; Liu, Qiang; Zheng, Xuebao			Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RESCUE THERAPY; INFLIXIMAB THERAPY; CLINICAL-RESPONSE; FOLLOW-UP; REMISSION; CYCLOSPORINE; INDUCTION; EFFICACY; OUTCOMES	Background: Efficacy of tumor necrosis factor alpha (TNF-alpha) blockers for treatment of ulcerative colitis that is unresponsive to conventional therapy is unclear due to recent studies yielding conflicting results. Aim: To assess the efficacy and safety of anti-TNF-alpha agents for treatment of ulcerative colitis patients who were intolerant or refractory to conventional medical therapy. Methods: Pubmed, Embase, and the Cochrane database were searched. Analysis was performed on randomized controlled trials that assessed anti-TNF-alpha therapy on ulcerative colitis patients that had previously failed therapy with corticosteroids and/or immunosuppressants. The primary outcome focused on was the frequency of patients that achieved clinical remission. Further trial outcomes of interest included rates of remission without patient use of corticosteroids during the trial, extent of mucosal healing, and the number of cases that resulted in colectomy and serious side effects. Results: Eight trials from seven studies (n = 2122) met the inclusion criteria and were thus included during analysis. TNF-alpha blockers demonstrated clinical benefit as compared to placebo control as evidenced by an increased frequency of clinical remission (p < 0.00001), steroid-free remission (p = 0.01), endoscopic remission (p < 0.00001) and a decrease in frequency of colectomy (p = 0.03). No difference was found concerning serious side effects (p = 0.05). Three small trials (n = 57) comparing infliximab to corticosteroid treatment, showed no difference in frequency of clinical remission (p = 0.93), mucosal healing (p = 0.80), and requirement for a colectomy (p = 0.49). One trial compared infliximab to cyclosporine (n = 115), wherein no difference was found in terms of mucosal healing (p = 0.85), colectomy frequency (p = 0.60) and serious side effects (p = 0.23). Conclusion: TNF-alpha blockers are effective and safe therapies for the induction and maintenance of long-term remission and prevention of treatment by colectomy for patients with refractory ulcerative colitis where conventional treatment was previously ineffective. Furthermore, infliximab and cyclosporine were found to be comparable for treating acute severe steroid-refractory ulcerative colitis.	[Lv, Ruxi; Wu, Zhiyong; Zheng, Xuebao] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Lv, Ruxi; Wang, Yinjun; Liu, Qiang; Zheng, Xuebao] Guangdong Med Coll, Res Inst Tradit Chinese Med, Zhanjiang, Guangdong, Peoples R China; [Qiao, Weiguang] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Dai, Shixue] Southern Med Univ, Nanfang Hosp, Emergency Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Medical University; Southern Medical University - China; Southern Medical University - China	Liu, Q (corresponding author), Guangdong Med Coll, Res Inst Tradit Chinese Med, Zhanjiang, Guangdong, Peoples R China.	lvrucy@126.com; xuebaozheng1964@gmail.com	wu, zhi/GXH-3041-2022		National Natural Science Foundation of China [81173240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China, grant number [No. 81173240]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armuzzi A, 2004, Eur Rev Med Pharmacol Sci, V8, P231; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455, DOI 10.1016/0016-5085(94)90398-0; Chang KH, 2013, INT J COLORECTAL DIS, V28, P287, DOI 10.1007/s00384-012-1602-8; Croft A, 2013, ALIMENT PHARM THER, V38, P294, DOI 10.1111/apt.12375; Feagan BG, 2007, AM J GASTROENTEROL, V102, P794, DOI 10.1111/j.1572-0241.2007.01094.x; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Gavalas E, 2007, HEPATO-GASTROENTEROL, V54, P1074; Gustavsson A, 2010, ALIMENT PHARM THER, V32, P984, DOI 10.1111/j.1365-2036.2010.04435.x; Huang X, 2011, EUR J CLIN PHARMACOL, V67, P759, DOI 10.1007/s00228-011-1079-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Laharie D, 2012, LANCET, V380, P1909, DOI 10.1016/S0140-6736(12)61084-8; Lawson MM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005112.pub2; Lee KM, 2013, J GASTROEN HEPATOL, V28, P1829, DOI 10.1111/jgh.12324; MACDONALD TT, 1990, CLIN EXP IMMUNOL, V81, P301; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Ochsenkuhn T, 2004, EUR J GASTROEN HEPAT, V16, P1167, DOI 10.1097/00042737-200411000-00014; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Panaccione R, 2008, ALIMENT PHARM THER, V28, P674, DOI 10.1111/j.1365-2036.2008.03753.x; Probert CSJ, 2003, GUT, V52, P998, DOI 10.1136/gut.52.7.998; Probert CSJ, 2002, GASTROENTEROLOGY, V122, pA99; Rahimi R, 2007, MED SCI MONITOR, V13, pPI13; Reinisch W, 2012, J CROHNS COLITIS, V6, P248, DOI 10.1016/j.crohns.2011.11.001; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Samuel S, 2013, INFLAMM BOWEL DIS, V19, P1858, DOI 10.1097/MIB.0b013e31828c84c5; Sandborn WJ, 2013, ALIMENT PHARM THER, V37, P204, DOI 10.1111/apt.12145; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI 10.1053/j.gastro.2009.06.061; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P96, DOI 10.1053/j.gastro.2013.06.010; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; Sands BE, 1996, GASTROENTEROLOGY, V110, pA1008; Sjoberg M, 2013, ALIMENT PHARM THER, V38, P377, DOI 10.1111/apt.12387; TarsiIla M., 2010, J MULTIDISCIPLINARY, V6, P142	37	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86692	10.1371/journal.pone.0086692	http://dx.doi.org/10.1371/journal.pone.0086692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475168	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300103
J	Marcolino-Gomes, J; Rodrigues, FA; Fuganti-Pagliarini, R; Bendix, C; Nakayama, TJ; Celaya, B; Molinari, HBC; de Oliveira, MCN; Harmon, FG; Nepomuceno, A				Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Bendix, Claire; Nakayama, Thiago Jonas; Celaya, Brandon; Correa Molinari, Hugo Bruno; Neves de Oliveira, Maria Cristina; Harmon, Frank G.; Nepomuceno, Alexandre			Diurnal Oscillations of Soybean Circadian Clock and Drought Responsive Genes	PLOS ONE			English	Article							ABSCISIC-ACID; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; ABIOTIC-STRESS; ARABIDOPSIS; PROTEIN; EXPRESSION; PLANT; TIME; COMPONENTS	Rhythms produced by the endogenous circadian clock play a critical role in allowing plants to respond and adapt to the environment. While there is a well-established regulatory link between the circadian clock and responses to abiotic stress in model plants, little is known of the circadian system in crop species like soybean. This study examines how drought impacts diurnal oscillation of both drought responsive and circadian clock genes in soybean. Drought stress induced marked changes in gene expression of several circadian clock-like components, such as LCL1-, GmELF4- and PRR-like genes, which had reduced expression in stressed plants. The same conditions produced a phase advance of expression for the GmTOC1-like, GmLUX-like and GmPRR7-like genes. Similarly, the rhythmic expression pattern of the soybean drought-responsive genes DREB-, bZIP-, GOLS-, RAB18- and Remorin-like changed significantly after plant exposure to drought. In silico analysis of promoter regions of these genes revealed the presence of cis-elements associated both with stress and circadian clock regulation. Furthermore, some soybean genes with upstream ABRE elements were responsive to abscisic acid treatment. Our results indicate that some connection between the drought response and the circadian clock may exist in soybean since (i) drought stress affects gene expression of circadian clock components and (ii) several stress responsive genes display diurnal oscillation in soybeans.	[Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Neves de Oliveira, Maria Cristina; Nepomuceno, Alexandre] Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil; [Marcolino-Gomes, Juliana] Univ Estadual Londrina, Dept Biol, Londrina, Parana, Brazil; [Bendix, Claire; Celaya, Brandon; Harmon, Frank G.] USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; [Bendix, Claire; Celaya, Brandon; Harmon, Frank G.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Nakayama, Thiago Jonas] Univ Fed Vicosa, Dept Crop Sci, Vicosa, MG, Brazil; [Correa Molinari, Hugo Bruno; Nepomuceno, Alexandre] USDA ARS, Ctr Plant Gene Express, Embrapa LABEX US Plant Biotechnol, Albany, CA 94710 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Londrina; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Universidade Federal de Vicosa; United States Department of Agriculture (USDA)	Nepomuceno, A (corresponding author), Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil.	alexandre.nepomuceno@embrapa.br	Fuganti-Pagliarini, Renata/S-6089-2019	Fuganti-Pagliarini, Renata/0000-0001-9282-2826; Bendix, Claire/0000-0002-4723-8652	Embrapa LABEX USA program (Embrapa) [10200.10/0215-9]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [8075/11-5]; an agency of the Ministry of Education of Brazil. Renata Fuganti-Pagliarini [202639/2011-8]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [202211/2011-8]; Direct For Biological Sciences [1238048] Funding Source: National Science Foundation; ARS [ARS-0425045] Funding Source: Federal RePORTER	Embrapa LABEX USA program (Embrapa); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); an agency of the Ministry of Education of Brazil. Renata Fuganti-Pagliarini; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Embrapa LABEX USA program (Embrapa cod. 10200.10/0215-9). Juliana Marcolino-Gomes was supported by a scholarship from the CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) (Process #8075/11-5), an agency of the Ministry of Education of Brazil. Renata Fuganti-Pagliarini (Process #202639/2011-8) and Fabiana A. Rodrigues (Process #202211/2011-8) were supported by scholarships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, PLANT MOL BIOL REP, V27, P417, DOI 10.1007/s11105-009-0100-9; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Bento dos Santos T, 2011, PLANT PHYSIOL BIOCH, V49, P441, DOI 10.1016/j.plaphy.2011.01.023; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Boneh U, 2012, PLANT SCI, V187, P89, DOI 10.1016/j.plantsci.2012.01.015; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gao SQ, 2011, PLANT MOL BIOL, V75, P537, DOI 10.1007/s11103-011-9738-4; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Ibanez C, 2010, PLANT PHYSIOL, V153, P1823, DOI 10.1104/pp.110.158220; Jankanpaa HJ, 2012, PLANT CELL ENVIRON, V35, P1824, DOI 10.1111/j.1365-3040.2012.02519.x; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Khanna-Chopra R, 2007, ENVIRON EXP BOT, V60, P276, DOI 10.1016/j.envexpbot.2006.11.004; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Liu B, 2012, PLANT CELL REP, V31, P1021, DOI 10.1007/s00299-011-1220-x; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Marcolino-Gomes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062294; Marsh HW, 1998, STRUCT EQU MODELING, V5, P22, DOI 10.1080/10705519809540087; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Porter S, 2009, ANAL GENE EXPRESSION; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Rugnone ML, 2013, P NATL ACAD SCI USA, V110, P12120, DOI 10.1073/pnas.1302170110; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez A, 2011, PLANT SIGNAL BEHAV, V6, P223, DOI 10.4161/psb.6.2.14893; Severin AJ, 2011, PLANT CELL, V23, P3129, DOI 10.1105/tpc.111.089573; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Tomii K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-11; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; Wilkins O, 2010, PLANT J, V63, P715, DOI 10.1111/j.1365-313X.2010.04274.x; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	80	79	87	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86402	10.1371/journal.pone.0086402	http://dx.doi.org/10.1371/journal.pone.0086402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475115	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300061
J	Yu, XF; Li, YY; Wang, XY				Yu, Xuefei; Li, Yanyan; Wang, Xiaoyuan			The Role of ACT-Like Subdomain in Bacterial Threonine Dehydratases	PLOS ONE			English	Article							L-ISOLEUCINE PRODUCTION; DEAMINASE; EVOLUTION; DOMAIN	In bacteria, threonine dehydratases could convert L-threonine to 2-ketobutyrate. Some threonine dehydratases contain only a catalytic domain, while others contain an N-terminal catalytic domain and a C-terminal regulatory domain composed of one or two ACT-like subdomains. However, the role of the ACT-like subdomain in threonine dehydratases is not clear. Here, nine different bacterial threonine dehydratases were studied. Three of the nine contain no ACT-like subdomain, four of them contain a single ACT-like subdomain, and two of them contain two ACT-like subdomains. The nine genes encoding these threonine dehydratases were individually overexpressed in E. coli BL21(DE3), and the enzymes were purified to homogeneity. Activities of the purified enzymes were analyzed after incubation at different temperatures and different pHs. The results showed that threonine dehydratases with a single ACT-like subdomain are more stable at higher temperatures and a broad range of pH than those without ACT-like subdomain or with two ACT-like subdomains. Furthermore, the specific activity of threonine dehydratases increases with the increase of the number of ACT-like subdomains they contain. The results suggest that the ACT-like subdomain plays an important role in bacterial threonine dehydratases.	[Yu, Xuefei; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Yu, Xuefei; Li, Yanyan] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China; [Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	xiaoyuanwang@hotmail.com			National Key Basic Research Program of China [2012CB725202]	National Key Basic Research Program of China(National Basic Research Program of China)	This project was financially supported by grants from National Key Basic Research Program of China (2012CB725202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2013, APPL MICROBIOL BIOT, V97, P2939, DOI 10.1007/s00253-012-4176-z; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fondi M, 2009, RES MICROBIOL, V160, P502, DOI 10.1016/j.resmic.2009.05.001; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Guillouet S, 1999, APPL ENVIRON MICROB, V65, P3100; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hashiguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P105, DOI 10.1271/bbb.61.105; PETERSEN JGL, 1988, GENETICS, V119, P527; Shulman A, 2008, BIOCHEMISTRY-US, V47, P11783, DOI 10.1021/bi800901n; Simanshu DK, 2007, J BIOSCIENCES, V32, P1195, DOI 10.1007/s12038-007-0121-1; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; SZAMOSI I, 1993, PLANT PHYSIOL, V101, P999, DOI 10.1104/pp.101.3.999; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Yin LH, 2012, METAB ENG, V14, P542, DOI 10.1016/j.ymben.2012.06.002	21	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87550	10.1371/journal.pone.0087550	http://dx.doi.org/10.1371/journal.pone.0087550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475306	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800097
J	De Regge, N; Madder, M; Deblauwe, I; Losson, B; Fassotte, C; Demeulemeester, J; Smeets, F; Tomme, M; Cay, AB				De Regge, Nick; Madder, Maxime; Deblauwe, Isra; Losson, Bertrand; Fassotte, Christiane; Demeulemeester, Julie; Smeets, Francois; Tomme, Marie; Cay, Ann Brigitte			Schmallenberg Virus Circulation in Culicoides in Belgium in 2012: Field Validation of a Real Time RT-PCR Approach to Assess Virus Replication and Dissemination in Midges	PLOS ONE			English	Article							BLUETONGUE VIRUS; BITING MIDGES; EXPERIMENTAL-INFECTION; ARBOVIRUSES; CATTLE; ORTHOBUNYAVIRUS; VECTOR; EUROPE; TRANSMISSION; RUMINANTS	Indigenous Culicoides biting midges are suggested to be putative vectors for the recently emerged Schmallenberg virus (SBV) based on SBV RNA detection in field-caught midges. Furthermore, SBV replication and dissemination has been evidenced in C. sonorensis under laboratory conditions. After SBV had been detected in Culicoides biting midges from Belgium in August 2011, it spread all over the country by the end of 2011, as evidenced by very high between-herd seroprevalence rates in sheep and cattle. This study investigated if a renewed SBV circulation in midges occurred in 2012 in the context of high seroprevalence in the animal host population and evaluated if a recently proposed realtime RT-PCR approach that is meant to allow assessing the vector competence of Culicoides for SBV and bluetongue virus under laboratory conditions was applicable to field-caught midges. Therefore midges caught with 12 OVI traps in four different regions in Belgium between May and November 2012, were morphologically identified, age graded, pooled and tested for the presence of SBV RNA by realtime RT-PCR. The results demonstrate that although no SBV could be detected in nulliparous midges caught in May 2012, a renewed but short lived circulation of SBV in parous midges belonging to the subgenus Avaritia occured in August 2012 at all four regions. The infection prevalence reached up to 2.86% in the south of Belgium, the region where a lower seroprevalence was found at the end of 2011 than in the rest of the country. Furthermore, a frequency analysis of the Ct values obtained for 31 SBV-S segment positive pools of Avaritia midges showed a clear bimodal distribution with peaks of Ct values between 21-24 and 33-36. This closely resembles the laboratory results obtained for SBV infection of C. sonorensis and implicates indigenous midges belonging to the subgenus Avaritia as competent vectors for SBV.	[De Regge, Nick; Cay, Ann Brigitte] CODA CERVA, Brussels, Belgium; [Madder, Maxime; Deblauwe, Isra; Demeulemeester, Julie] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Losson, Bertrand; Smeets, Francois] Univ Liege, Dept Infect & Parasit Dis, Liege, Belgium; [Fassotte, Christiane; Tomme, Marie] Walloon Agr Res Ctr CRA W, Dept Life Sci, Gembloux, Belgium; [Madder, Maxime] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa	Institute of Tropical Medicine (ITM); University of Liege; University of Pretoria	De Regge, N (corresponding author), CODA CERVA, Brussels, Belgium.	nick.deregge@coda-cerva.be	Deblauwe, Isra/C-9725-2010; Deblauwe, Isra/AAH-7680-2019	Deblauwe, Isra/0000-0001-7268-8965	Belgian Federal Agency for the Safety of the Food Chain (FAVV-AFSCA); Federal Public Service of Health, Food Chain Safety and Environment [RF12/6270]; European Union [2012/349/EU]; Union for studies on Schmallenberg virus	Belgian Federal Agency for the Safety of the Food Chain (FAVV-AFSCA); Federal Public Service of Health, Food Chain Safety and Environment; European Union(European Commission); Union for studies on Schmallenberg virus	Monitoring of Culicoides in Belgium in 2012 was financed by the Belgian Federal Agency for the Safety of the Food Chain (FAVV-AFSCA). rRT-PCR analysis of Culicoides for presence of SBV was funded by the Federal Public Service of Health, Food Chain Safety and Environment (RF12/6270) and the European Union as outlined in Council Decision 2012/349/EU concerning a financial contribution by the Union for studies on Schmallenberg virus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUSAIDY SM, 1991, EPIDEMIOL INFECT, V106, P403, DOI 10.1017/S095026880004855X; Bayrou C, 2013, VET REC, V172, P296, DOI 10.1136/vr.f1637; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Bryant JE, 2005, AM J TROP MED HYG, V73, P470, DOI 10.4269/ajtmh.2005.73.470; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Chaintoutis SC, 2013, TROP ANIM H IN PRESS; Claine F, 2013, EMERG INFECT DIS, V19, P1115, DOI 10.3201/eid1907.121768; Conraths FJ, 2013, NEW ZEAL VET J, V61, P63, DOI 10.1080/00480169.2012.738403; Conraths FJ, 2013, EMERG INFECT DIS, V19, P513, DOI 10.3201/eid1903.121324; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DELECOLLE J.-C., 1985, THESIS U STRASBOURG; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Doceul V, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-31; Elbers ARW, 2015, TRANSBOUND EMERG DIS, V62, P339, DOI 10.1111/tbed.12128; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; European Food Safety Authority, 2013, SUPP PUBL 2013; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; GEORGE TDS, 1978, AUST VET J, V54, P558, DOI 10.1111/j.1751-0813.1978.tb02412.x; Goffredo M, 2013, PREV VET MED, V111, P230, DOI 10.1016/j.prevetmed.2013.05.014; Herder V, 2012, VET PATHOL, V49, P588, DOI 10.1177/0300985812447831; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Larska M, 2013, TRANSBOUND EMERG DIS, V60, P97, DOI 10.1111/tbed.12057; Larska M, 2013, VET MICROBIOL, V166, P467, DOI 10.1016/j.vetmic.2013.07.015; Linden A, 2012, EMERG INFECT DIS, V18, P2006, DOI 10.3201/eid1812.121067; Losson B, 2007, VET REC, V160, P451, DOI 10.1136/vr.160.13.451-b; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Meroc E, 2014, TRANSBOUND EMERG DIS, V61, P425, DOI 10.1111/tbed.12050; Meroc E, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12042; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Sailleau C, 2013, EMERG INFECT DIS, V19, P321, DOI 10.3201/eid1902.121281; Scholte EJ, 2014, MED VET ENTOMOL, V28, P110, DOI 10.1111/mve.12010; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106; Vanbinst T, 2009, TRANSBOUND EMERG DIS, V56, P170, DOI 10.1111/j.1865-1682.2009.01077.x; Venter GJ, 2009, VET PARASITOL, V166, P299, DOI 10.1016/j.vetpar.2009.08.020; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wernike K, 2013, EMERG INFECT DIS, V19, P1701, DOI 10.3201/eid1910.130622; Wernike K, 2013, VET MICROBIOL, V166, P461, DOI 10.1016/j.vetmic.2013.06.030; Wernike K, 2013, VACCINE, V31, P3558, DOI 10.1016/j.vaccine.2013.05.062; Wernike K, 2013, VET MICROBIOL, V165, P155, DOI 10.1016/j.vetmic.2013.01.040; Wernike K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-84; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2	46	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87005	10.1371/journal.pone.0087005	http://dx.doi.org/10.1371/journal.pone.0087005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466312	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000184
J	Galicia-Vazquez, G; Di Marco, S; Lian, XJ; Ma, JF; Gallouzi, IE; Pelletier, J				Galicia-Vazquez, Gabriela; Di Marco, Sergio; Lian, Xian J.; Ma, Jennifer F.; Gallouzi, Imed E.; Pelletier, Jerry			Regulation of Eukaryotic Initiation Factor 4AII by MyoD during Murine Myogenic Cell Differentiation	PLOS ONE			English	Article							RNA HELICASE EIF4A; TRANSLATION INITIATION; SKELETAL-MUSCLE; MAMMALIAN TRANSLATION; FUNCTIONAL GENES; EXPRESSION; INHIBITOR; RAPAMYCIN; TARGET; GROWTH	Gene expression during muscle cell differentiation is tightly regulated at multiple levels, including translation initiation. The PI3K/mTOR signalling pathway exerts control over protein synthesis by regulating assembly of eukaryotic initiation factor (eIF) 4F, a heterotrimeric complex that stimulates recruitment of ribosomes to mRNA templates. One of the subunits of eIF4F, eIF4A, supplies essential helicase function during this phase of translation. The presence of two cellular eIF4A isoforms, eIF4AI and eIF4AII, has long thought to impart equivalent functions to eIF4F. However, recent experiments have alluded to distinct activities between them. Herein, we characterize distinct regulatory mechanisms between the eIF4A isoforms during muscle cell differentiation. We find that eIF4AI levels decrease during differentiation whereas eIF4AII levels increase during myofiber formation in a MyoD-dependent manner. This study characterizes a previously undefined mechanism for eIF4AII regulation in differentiation and highlights functional differences between eIF4AI and eIF4AII. Finally, RNAi-mediated alterations in eIF4AI and eIF4AII levels indicate that the myogenic process can tolerate short term reductions in eIF4AI or eIF4AII levels, but not both.	[Galicia-Vazquez, Gabriela; Di Marco, Sergio; Lian, Xian J.; Ma, Jennifer F.; Gallouzi, Imed E.; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada	McGill University; McGill University	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca		GALICIA VAZQUEZ, GABRIELA/0000-0001-6706-7742; Di Marco, Sergio/0000-0002-4039-0600	Canadian Cancer Society Operating grant [NCIC 018125]; Canadian Institutes of Health Research (CIHR) operating grants [MOP-89798, MOP-106530]; Cole Foundation Fellowship; CIHR Strategic Training Initiative in Chemical Biology	Canadian Cancer Society Operating grant; Canadian Institutes of Health Research (CIHR) operating grants(Canadian Institutes of Health Research (CIHR)); Cole Foundation Fellowship; CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Cancer Society Operating grant (NCIC 018125) and Canadian Institutes of Health Research (CIHR) operating grants (MOP-89798 to I. E. G. and MOP-106530 to J.P.). G. G. V. was a recipient of a Cole Foundation Fellowship and was also supported by a CIHR Strategic Training Initiative in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; GUO K, 1995, MOL CELL BIOL, V15, P3823; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang J, 1996, MOL CELL BIOL, V16, P3893; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Li W, 2001, J BIOL CHEM, V276, P29111, DOI 10.1074/jbc.C100284200; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; NIELSEN PJ, 1993, MAMM GENOME, V4, P185, DOI 10.1007/BF00352237; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Smale S.T., 2009, COLD SPRING HARB PRO; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Willett M, 2009, CELL SIGNAL, V21, P1504, DOI 10.1016/j.cellsig.2009.05.009; WilliamsHill DM, 1997, ARCH BIOCHEM BIOPHYS, V338, P111, DOI 10.1006/abbi.1996.9804; Yan B, 2013, J EXP BIOL, V216, P447, DOI 10.1242/jeb.076315; YODERHILL J, 1993, J BIOL CHEM, V268, P5566	32	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87237	10.1371/journal.pone.0087237	http://dx.doi.org/10.1371/journal.pone.0087237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466343	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000200
J	Rondet, C; Lapostolle, A; Soler, M; Grillo, F; Parizot, I; Chauvin, P				Rondet, Claire; Lapostolle, Annabelle; Soler, Marion; Grillo, Francesca; Parizot, Isabelle; Chauvin, Pierre			Are Immigrants and Nationals Born to Immigrants at Higher Risk for Delayed or No Lifetime Breast and Cervical Cancer Screening? The Results from a Population-Based Survey in Paris Metropolitan Area in 2010	PLOS ONE			English	Article							HEALTH-CARE; WOMEN; MAMMOGRAPHY; FRANCE; NEVER	Objectives: This study aims to compare breast cancer screening (BCS) and cervical cancer screening (CCS) practices of French women born to French parents with those of immigrants and nationals born to immigrants, taking their socioeconomic status into account. Methods: The study is based on data collected in 2010 in the Paris metropolitan area among a representative sample of 3000 French-speaking adults. For women with no history of breast or cervical cancer, multivariate logistic regressions and structural equation models were used to investigate the factors associated with never having undergone BCS or CCS. Results: We confirmed the existence of a strong gradient, with respect to migration origin, for delaying or never having undergone BCS or CCS. Thus, being a foreign immigrant or being French of immigrant parentage were risk factors for delayed and no lifetime screening. Interestingly, we found that this gradient persisted (at least partially) after adjusting for the women's socioeconomic characteristics. Only the level of income seemed to play a mediating role, but only partially. We observed differences between BCS and CCS which suggest that organized CCS could be effective in reducing socioeconomic and/or ethnic inequities. Conclusion: Socioeconomic status partially explained the screening nonparticipation on the part of French women of immigrant origin and foreign immigrants. This was more so the case with CCS than with BCS, which suggests that organized prevention programs might reduce social inequalities.	[Rondet, Claire; Lapostolle, Annabelle; Soler, Marion; Grillo, Francesca; Chauvin, Pierre] INSERM, Perre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, Paris, France; [Rondet, Claire; Lapostolle, Annabelle; Soler, Marion; Grillo, Francesca; Chauvin, Pierre] Univ Paris 06, Sorbonne Univ, Dept Social Epidemiol, Pierre Louis Inst Epidemiol & Publ Hlth, Paris, France; [Rondet, Claire] Univ Paris 06, Sch Med, Dept Gen Practice, Paris, France; [Parizot, Isabelle] CNRS, Ctr Maurice Halbwachs, Res Team Social Inequal, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS)	Rondet, C (corresponding author), INSERM, Perre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, Paris, France.	rondet@u707.jussieu.fr	Chauvin, Pierre/S-2981-2019; Chauvin, Pierre/G-1095-2015	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406	French National Cancer Institute (INCa) [2009-1-SHS SP-05-INSERM 6-1]; Institute for Public Health Research (IReSP) [2008-87]; French Interministerial Committee for Urban Affairs [2009-273]	French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); Institute for Public Health Research (IReSP); French Interministerial Committee for Urban Affairs	This research project on women's cancer prevention was supported by the French National Cancer Institute (INCa) (grant number 2009-1-SHS SP-05-INSERM 6-1; URL: http://www.e-cancer.fr). The SIRS survey was also supported by the Institute for Public Health Research (IReSP) (grant number 2008-87; URL: http://www.iresp.net), and the French Interministerial Committee for Urban Affairs (grant number 2009-273; URL: http://www.ville.gouv.fr/?le-comite-interministeriel-des). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDEM, 1995, PRAT FROTT CERV DEP; Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; BOSTICK RM, 1993, PREV MED, V22, P65, DOI 10.1006/pmed.1993.1005; Commission europeenne, 2011, RED IN SANT UN; Consedine NS, 2012, J IMMIGR MINOR HEALT, V14, P570, DOI 10.1007/s10903-011-9524-z; Coughlin Steven S, 2004, Prev Chronic Dis, V1, pA04; De Alba I, 2005, PREV MED, V40, P747, DOI 10.1016/j.ypmed.2004.09.018; Dourgnon Paul Jusot Florence Sermet Catherine Silva Jerome, 2009, REC SOINS VILL IMM F; Duport N, 2012, REV EPIDEMIOL SANTE, V60, P421, DOI 10.1016/j.respe.2012.05.006; Duport N, 2008, EUR J CANCER PREV, V17, P218, DOI 10.1097/CEJ.0b013e3282b6fde5; Everett T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002834.pub2; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Gautier arnaud, 2009, BAR MED GEN 2009; Grillo F, 2012, PREV MED, V54, P259, DOI 10.1016/j.ypmed.2012.01.013; Guilbert P, 2006, 2005 HLTH BAROMETER; Han HR, 2011, PSYCHO-ONCOLOGY, V20, P341, DOI 10.1002/pon.1754; Hiatt RA, 2001, PREV MED, V33, P190, DOI 10.1006/pmed.2001.0871; Jones Beth A., 2003, Cancer, V97, P258, DOI 10.1002/cncr.11022; Karliner LS, 2012, MED CARE, V50, P171, DOI 10.1097/MLR.0b013e31822dcf2d; Katz SJ, 2000, AM J PUBLIC HEALTH, V90, P799, DOI 10.2105/AJPH.90.5.799; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; LEGALES C, 1990, BEH, V1, P3; Lopez EDS, 2009, WOMEN HEALTH ISS, V19, P434, DOI 10.1016/j.whi.2009.07.008; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Martin-Fernandez J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-937; Observatoire regional d'Ile de France, 2011, CANC SEIN IL FRANC; Phillips Janice M, 2005, Semin Oncol Nurs, V21, P278, DOI 10.1016/j.soncn.2005.06.001; Renahy E, 2008, REV EPIDEMIOL SANTE, V56, P117, DOI 10.1016/j.respe.2008.01.009; Rondet C, 2013, PREV MED, V57, P386, DOI 10.1016/j.ypmed.2013.06.016; Vallee J, 2010, HEALTH PLACE, V16, P838, DOI 10.1016/j.healthplace.2010.04.009	31	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87046	10.1371/journal.pone.0087046	http://dx.doi.org/10.1371/journal.pone.0087046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466323	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100246
J	Marquez, LB; Velazquez, N; Repetto, HA; Paton, AW; Paton, JC; Ibarra, C; Silberstein, C				Marquez, Laura B.; Velazquez, Natalia; Repetto, Horacio A.; Paton, Adrienne W.; Paton, James C.; Ibarra, Cristina; Silberstein, Claudia			Effects of Escherichia Coli Subtilase Cytotoxin and Shiga Toxin 2 on Primary Cultures of Human Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENDOPLASMIC-RETICULUM STRESS; CHAPERONE BIP; CYCLE ARREST; AB(5) TOXIN; VERO CELLS; APOPTOSIS; DAMAGE; ACTIVATION; RECEPTORS	Shiga toxin (Stx)-producing Escherichia coli (STEC) cause post-diarrhea Hemolytic Uremic Syndrome (HUS), which is the most common cause of acute renal failure in children in many parts of the world. Several non-O157 STEC strains also produce Subtilase cytotoxin (SubAB) that may contribute to HUS pathogenesis. The aim of the present work was to examine the cytotoxic effects of SubAB on primary cultures of human cortical renal tubular epithelial cells (HRTEC) and compare its effects with those produced by Shiga toxin type 2 (Stx2), in order to evaluate their contribution to renal injury in HUS. For this purpose, cell viability, proliferation rate, and apoptosis were assayed on HRTEC incubated with SubAB and/or Stx2 toxins. SubAB significantly reduced cell viability and cell proliferation rate, as well as stimulating cell apoptosis in HRTEC cultures in a time dependent manner. However, HRTEC cultures were significantly more sensitive to the cytotoxic effects of Stx2 than those produced by SubAB. No synergism was observed when HRTEC were co-incubated with both SubAB and Stx2. When HRTEC were incubated with the inactive SubA(A272)B toxin, results were similar to those in untreated control cells. Similar stimulation of apoptosis was observed in Vero cells incubated with SubAB or/and Stx2, compared to HRTEC. In conclusion, primary cultures of HRTEC are significantly sensitive to the cytotoxic effects of SubAB, although, in a lesser extent compared to Stx2.	[Marquez, Laura B.; Velazquez, Natalia; Silberstein, Claudia] Univ Buenos Aires, Fac Med, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Lab Invest Biomed,Dept Fisiol, Buenos Aires, DF, Argentina; [Repetto, Horacio A.] Univ Buenos Aires, Fac Med, Dept Pediat, Buenos Aires, DF, Argentina; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Ibarra, Cristina] Univ Buenos Aires, Fac Med, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Lab Fisiopatogenia,Dept Fisiol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Adelaide; University of Buenos Aires	Silberstein, C (corresponding author), Univ Buenos Aires, Fac Med, Inst Fisiol & Biofis Bernardo Houssay IFIBIO Hous, Lab Invest Biomed,Dept Fisiol, Buenos Aires, DF, Argentina.	csilber@fmed.uba.ar	Ibarra, Cristina/D-6242-2016		Universidad de Buenos Aires [UBACYT M637, M057, M095]; National Agency for Promotion of Science and Technology [ANPCYT- PICT08- 642]	Universidad de Buenos Aires(University of Buenos Aires); National Agency for Promotion of Science and Technology(ANPCyT)	This work was supported by grants to C. Silberstein and C. Ibarra from the Universidad de Buenos Aires (UBACYT M637, M057, and M095), and National Agency for Promotion of Science and Technology (ANPCYT- PICT08- 642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070431; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Bhattacharjee RN, 2005, FEBS LETT, V579, P6604, DOI 10.1016/j.febslet.2005.10.053; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Creydt VP, 2006, MICROBES INFECT, V8, P410, DOI 10.1016/j.micinf.2005.07.005; Endo Y, 1988, EUR J BIOCHEM, V171, P335; Galli L, 2010, VET MICROBIOL, V143, P307, DOI 10.1016/j.vetmic.2009.11.028; GIANANTONIO CA, 1964, J PEDIATR-US, V64, P478, DOI 10.1016/S0022-3476(64)80337-1; Irino K, 2010, J CLIN MICROBIOL, V48, P988, DOI 10.1128/JCM.00010-10; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaneko K, 2001, NEPHRON, V87, P182, DOI 10.1159/000045909; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Kurmanova A, 2007, BIOCHEM BIOPH RES CO, V357, P144, DOI 10.1016/j.bbrc.2007.03.110; Lentz EK, 2011, INFECT IMMUN, V79, P3527, DOI 10.1128/IAI.05139-11; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Matsuura G, 2009, INFECT IMMUN, V77, P2919, DOI 10.1128/IAI.01510-08; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357, DOI 10.1128/JCM.37.10.3357-3361.1999; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Saydam G, 2003, LEUKEMIA RES, V27, P709, DOI 10.1016/S0145-2126(02)00347-8; Silberstein C., 2008, J EPITHEL BIOL PHARM, V1, P71, DOI DOI 10.2174/1875044300801010071; Silberstein C, 2008, PEDIATR NEPHROL, V23, P1981, DOI 10.1007/s00467-008-0896-9; Silberstein C, 2011, PEDIATR RES, V69, P390, DOI 10.1203/PDR.0b013e318211dd57; SMITH R, 2009, CONSUM REP, V74, P6; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Taguchi T, 1998, KIDNEY INT, V53, P1681, DOI 10.1046/j.1523-1755.1998.00939.x; Talukder KA, 2012, MICROB PATHOGENESIS, V52, P311, DOI 10.1016/j.micpath.2012.02.007; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tesh VL, 2012, CELL MICROBIOL, V14, P1, DOI 10.1111/j.1462-5822.2011.01684.x; Tozzoli R, 2010, J CLIN MICROBIOL, V48, P178, DOI 10.1128/JCM.01648-09; Uchida H, 1999, PEDIATR RES, V45, P133, DOI 10.1203/00006450-199901000-00022; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yahiro K, 2006, MOL MICROBIOL, V62, P480, DOI 10.1111/j.1365-2958.2006.05379.x; Yahiro K, 2011, INFECT IMMUN, V79, P617, DOI 10.1128/IAI.01020-10; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zotta E, 2008, PEDIATR NEPHROL, V23, P559, DOI 10.1007/s00467-007-0727-4	48	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87022	10.1371/journal.pone.0087022	http://dx.doi.org/10.1371/journal.pone.0087022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466317	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500289
J	Lucassen, EA; Piaggi, P; Dsurney, J; de Jonge, L; Zhao, XC; Mattingly, MS; Ramer, A; Gershengorn, J; Csako, G; Cizza, G				Lucassen, Eliane A.; Piaggi, Paolo; Dsurney, John; de Jonge, Lilian; Zhao, Xiong-ce; Mattingly, Megan S.; Ramer, Angela; Gershengorn, Janet; Csako, Gyorgy; Cizza, Giovanni		Sleep Extension Study Grp	Sleep Extension Improves Neurocognitive Functions in Chronically Sleep-Deprived Obese Individuals	PLOS ONE			English	Article							PERFORMANCE; DURATION; QUALITY; DEPRIVATION; IMPAIRMENT; DEFICITS; MEMORY; ADULTS; INDEX; APNEA	Background: Sleep deprivation and obesity, are associated with neurocognitive impairments. Effects of sleep deprivation and obesity on cognition are unknown, and the cognitive long-term effects of improvement of sleep have not been prospectively assessed in short sleeping, obese individuals. Objective: To characterize neurocognitive functions and assess its reversibility. Design: Prospective cohort study. Setting: Tertiary Referral Research Clinical Center. Patients: A cohort of 121 short-sleeping (<6.5 h/night) obese (BMI 30-55 kg/m(2)) men and pre-menopausal women. Intervention: Sleep extension (468 +/- 88 days) with life-style modifications. Measurements: Neurocognitive functions, sleep quality and sleep duration. Results: At baseline, 44% of the individuals had an impaired global deficit score (t-score 0-39). Impaired global deficit score was associated with worse subjective sleep quality (p = 0.02), and lower urinary dopamine levels (p = 0.001). Memory was impaired in 33%; attention in 35%; motor skills in 42%; and executive function in 51% of individuals. At the final evaluation (N = 74), subjective sleep quality improved by 24% (p<0.001), self-reported sleep duration increased by 11% by questionnaires (p<0.001) and by 4% by diaries (p = 0.04), and daytime sleepiness tended to improve (p = 0.10). Global cognitive function and attention improved by 7% and 10%, respectively (both p = 0.001), and memory and executive functions tended to improve (p = 0.07 and p = 0.06). Serum cortisol increased by 17% (p = 0.02). In a multivariate mixed model, subjective sleep quality and sleep efficiency, urinary free cortisol and dopamine and plasma total ghrelin accounted for 1/5 of the variability in global cognitive function. Limitations: Drop-out rate. Conclusions: Chronically sleep-deprived obese individuals exhibit substantial neurocognitive deficits that are partially reversible upon improvement of sleep in a non-pharmacological way. These findings have clinical implications for large segments of the US population.	[Lucassen, Eliane A.; Dsurney, John; Csako, Gyorgy] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Lucassen, Eliane A.] Leiden Univ, Neurophysiol Lab, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Dsurney, John] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Zhao, Xiong-ce] NIDDK, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [de Jonge, Lilian; Mattingly, Megan S.; Ramer, Angela; Gershengorn, Janet; Cizza, Giovanni] NIDDK, Sect Neuroendocrinol Obes, NIH, Bethesda, MD 20892 USA; [Piaggi, Paolo] Univ Hosp Pisa, Endocrinol Unit, Obes Res Ctr, Pisa, Italy; [Csako, Gyorgy] NIH, Ctr Clin, Dept Lab Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pisa; Azienda Ospedaliero Universitaria Pisana; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Cizza, G (corresponding author), NIDDK, Sect Neuroendocrinol Obes, NIH, Bethesda, MD 20892 USA.	gcizza@gmail.com	Piaggi, Paolo/E-2539-2011	Piaggi, Paolo/0000-0003-2774-9161; de Jonge, Lilian/0000-0001-5900-0695	National Institutes of Health (NIH), Intramural Research Programs at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH), Clinical Center; Fulbright; VSBfonds; Leiden University Fund	National Institutes of Health (NIH), Intramural Research Programs at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH), Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright; VSBfonds; Leiden University Fund	This study was supported by the National Institutes of Health (NIH), Intramural Research Programs at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Clinical Center. EAL received scholarships from Fulbright, VSBfonds and the Leiden University Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ayappa I, 2008, J CLIN SLEEP MED, V4, P26; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benton L, 1994, CONTROLLED ORAL WORD; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cizza G, 2011, J ENDOCRINOL INVEST, V34, P793, DOI 10.3275/7808; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; de Jonge L, 2012, J CLIN ENDOCR METAB, V97, P2881, DOI 10.1210/jc.2011-2858; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duchesne M, 2010, REV BRAS PSIQUIATR, V32, P381, DOI 10.1590/S1516-44462010000400011; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gahete MD, 2011, PEPTIDES, V32, P2225, DOI 10.1016/j.peptides.2011.09.019; Goder R, 2007, SLEEP MED, V8, P503, DOI 10.1016/j.sleep.2006.11.014; Gradisar M, 2008, SLEEP BIOL RHYTHMS, V6, P146, DOI 10.1111/j.1479-8425.2008.00353.x; Heaton RK., 2004, DEMOGRAPHICALLY ADJU; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson NL, 2007, SLEEP, V30, P899, DOI 10.1093/sleep/30.7.899; Kanoski SE, 2012, PHYSIOL BEHAV, V106, P337, DOI 10.1016/j.physbeh.2012.01.007; Kim HJ, 2011, SLEEP MED, V12, P390, DOI 10.1016/j.sleep.2010.09.010; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lucassen EA, 2012, ANN NY ACAD SCI, V1264, P110, DOI 10.1111/j.1749-6632.2012.06655.x; Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281; Mahajan N, 2010, J ATTEN DISORD, V14, P132, DOI 10.1177/1087054709347170; Mobbs O, 2010, PATIENT EDUC COUNS, V79, P372, DOI 10.1016/j.pec.2010.03.003; Osterrieth PA., 1944, ARCH PSYCHOL-GENEVE, V30, P286; Pearson VE, 2006, SLEEP MED, V7, P25, DOI 10.1016/j.sleep.2005.05.006; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Potkin KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042191; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Saunamaki T, 2009, EUR NEUROL, V62, P237, DOI 10.1159/000232156; St-Onge MP, 2012, AM J CLIN NUTR, V95, P818, DOI 10.3945/ajcn.111.027383; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Waldstein SR, 2006, INT J OBESITY, V30, P201, DOI 10.1038/sj.ijo.0803114; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610	43	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84832	10.1371/journal.pone.0084832	http://dx.doi.org/10.1371/journal.pone.0084832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24482677	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100035
J	Lundberg, KB; Payne, BK				Lundberg, Kristjen B.; Payne, B. Keith			Decisions among the Undecided: Implicit Attitudes Predict Future Voting Behavior of Undecided Voters	PLOS ONE			English	Article							US PRESIDENTIAL-ELECTION; EXPLICIT ATTITUDES; ASSOCIATION TEST; PREJUDICE; METAANALYSIS; COGNITION; MODEL	Implicit attitudes have been suggested as a key to unlock the hidden preferences of undecided voters. Past research, however, offered mixed support for this hypothesis. The present research used a large nationally representative sample and a longitudinal design to examine the predictive utility of implicit and explicit attitude measures in the 2008 U. S. presidential election. In our analyses, explicit attitudes toward candidates predicted voting better for decided than undecided voters, but implicit candidate attitudes were predictive of voting for both decided and undecided voters. Extending our examination to implicit and explicit racial attitudes, we found the same pattern. Taken together, these results provide convergent evidence that implicit attitudes predict voting about as well for undecided as for decided voters. We also assessed a novel explanation for these effects by evaluating whether implicit attitudes may predict the choices of undecided voters, in part, because they are neglected when people introspect about their confidence. Consistent with this idea, we found that the extremity of explicit but not implicit attitudes was associated with greater confidence. These analyses shed new light on the utility of implicit measures in predicting future behavior among individuals who feel undecided. Considering the prior studies together with this new evidence, the data seem to be consistent that implicit attitudes may be successful in predicting the behavior of undecided voters.	[Lundberg, Kristjen B.; Payne, B. Keith] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Lundberg, KB (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27515 USA.	kristjen@live.unc.edu						Arcuri L, 2008, POLIT PSYCHOL, V29, P369, DOI 10.1111/j.1467-9221.2008.00635.x; Cameron CD, 2012, PERS SOC PSYCHOL REV, V16, P330, DOI 10.1177/1088868312440047; DeBell M., 2010, METHODOLOGY REPORT U; Ditonto TM, 2013, POLIT PSYCHOL, V34, P487, DOI 10.1111/pops.12013; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Friese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044130; Galdi S, 2008, SCIENCE, V321, P1100, DOI 10.1126/science.1160769; Galdi S, 2012, PERS SOC PSYCHOL B, V38, P559, DOI 10.1177/0146167211435981; Gawronski B, 2013, POLIT PSYCH IN PRESS; Gawronski B, 2008, J EXP SOC PSYCHOL, V44, P1355, DOI 10.1016/j.jesp.2008.04.005; Gawronski B, 2006, PSYCHOL BULL, V132, P692, DOI 10.1037/0033-2909.132.5.692; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, ANAL SOC ISS PUB POL, V9, P241, DOI 10.1111/j.1530-2415.2009.01195.x; Grumm M, 2009, J EXP SOC PSYCHOL, V45, P327, DOI 10.1016/j.jesp.2008.10.006; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Jones JM, 2012, US TODAY GALLUP; Jordan CH, 2007, J PERS SOC PSYCHOL, V93, P1067, DOI 10.1037/0022-3514.93.6.1067; Kalmoe NP, 2013, PUBLIC OPIN QUART, V77, P305, DOI 10.1093/poq/nfs051; Pasek J, 2009, PUBLIC OPIN QUART, V73, P943, DOI 10.1093/poq/nfp079; Payne BK, 2008, COGNITION EMOTION, V22, P238, DOI 10.1080/02699930701357394; Payne BK, 2010, J EXP SOC PSYCHOL, V46, P367, DOI 10.1016/j.jesp.2009.11.001; Payne BK, 2008, SOC PERSONAL PSYCHOL, V2, P1073, DOI 10.1111/j.1751-9004.2008.00091.x; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Perugini M., 2010, HDB IMPLICIT SOCIAL, P255; Petty RE, 2007, SOC COGNITION, V25, P657, DOI 10.1521/soco.2007.25.5.657; Ranganath KA, 2008, J EXP SOC PSYCHOL, V44, P386, DOI 10.1016/j.jesp.2006.12.008; Smith CT, 2011, SOC PSYCHOL-GERMANY, V42, P300, DOI 10.1027/1864-9335/a000072	28	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85680	10.1371/journal.pone.0085680	http://dx.doi.org/10.1371/journal.pone.0085680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489666	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000013
J	Mirkina, I; Hadzijusufovic, E; Krepler, C; Mikula, M; Mechtcheriakova, D; Strommer, S; Stella, A; Jensen-Jarolim, E; Holler, C; Wacheck, V; Pehamberger, H; Valent, P				Mirkina, Irina; Hadzijusufovic, Emir; Krepler, Clemens; Mikula, Mario; Mechtcheriakova, Diana; Strommer, Sabine; Stella, Alexander; Jensen-Jarolim, Erika; Hoeller, Christoph; Wacheck, Volker; Pehamberger, Hubert; Valent, Peter			Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; INITIATING CELLS; THERAPIES; SURVIVAL; KINASES; GROWTH	Malignant melanoma is a life-threatening skin cancer increasingly diagnosed in the western world. In advanced disease the prognosis is grave. Growth and metastasis formation in melanomas are regulated by a network of cytokines, cytokine-receptors, and adhesion molecules. However, little is known about surface antigens and target expression profiles in human melanomas. We examined the cell surface antigen profile of human skin melanoma cells by multicolor flow cytometry, and compared their phenotype with 4 melanoma cell lines (A375, 607B, Mel-Juso, SK-Mel28). Melanoma cells were defined as CD45-/CD31- cells co-expressing one or more melanoma-related antigens (CD63, CD146, CD166). In most patients, melanoma cells exhibited ErbB3/Her3, CD44/Pgp-1, ICAM-1/CD54 and IGF-1-R/CD221, but did not express CD20, ErbB2/Her2, KIT/CD117, AC133/CD133 or MDR-1/CD243. Melanoma cell lines were found to display a similar phenotype. In most patients, a distinct subpopulation of melanoma cells (4-40%) expressed the erythropoietin receptor (EPO-R) and ErbB4 together with PD-1 and NGF-R/CD271. Both the EPO-R+ and EPO-R2 subpopulations produced melanoma lesions in NOD/SCID IL-2Rgamma(null) (NSG) mice in first and secondary recipients. Normal skin melanocytes did not express ErbB4 or EPO-R, but expressed a functional KIT receptor (CD117) as well as NGF-R, ErbB3/Her3, IGF-1-R and CD44. In conclusion, melanoma cells display a unique composition of surface target antigens and cytokine receptors. Malignant transformation of melanomas is accompanied by loss of KIT and acquisition of EPO-R and ErbB4, both of which are co-expressed with NGF-R and PD-1 in distinct subfractions of melanoma cells. However, expression of EPO-R/ErbB4/PD-1 is not indicative of a selective melanoma-initiating potential.	[Mirkina, Irina; Hadzijusufovic, Emir; Krepler, Clemens; Mechtcheriakova, Diana; Jensen-Jarolim, Erika; Pehamberger, Hubert; Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Hadzijusufovic, Emir; Valent, Peter] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Hadzijusufovic, Emir] Univ Vet Med Vienna, Clin Unit Internal Med, Clin Small Anim, Dept Clin Compan Anim & Horses, Vienna, Austria; [Krepler, Clemens; Mikula, Mario; Hoeller, Christoph; Pehamberger, Hubert] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Mikula, Mario; Strommer, Sabine] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Mechtcheriakova, Diana; Jensen-Jarolim, Erika] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Stella, Alexander; Wacheck, Volker] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Vienna, Austria; [Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria	Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Valent, P (corresponding author), Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria.	peter.valent@meduniwien.ac.at	Test, PV/U-9451-2019; Valent, Peter/B-8533-2016; Hadzijusufovic, Emir/B-8109-2016; Zelle, Mast/V-2890-2019; Test, Test/Y-7921-2019; Jensen-Jarolim, Erika/C-5120-2018; Wacheck, Volker/ABD-4893-2021; Gamperl, Susi/V-2715-2019	Valent, Peter/0000-0003-0456-5095; Hadzijusufovic, Emir/0000-0001-7409-4204; Zelle, Mast/0000-0001-7409-4204; Jensen-Jarolim, Erika/0000-0003-4019-5765; Gamperl, Susi/0000-0003-0456-5095; Mechtcheriakova, Diana/0000-0002-8737-3592; Mikula, Mario/0000-0001-5782-0681	Research Grant on Tumor Stem Cells of the Medical University of Vienna	Research Grant on Tumor Stem Cells of the Medical University of Vienna	Supported by a Research Grant on Tumor Stem Cells of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonitsis N., 2006, Experimental Oncology, V28, P187; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Djerf EA, 2009, MELANOMA RES, V19, P156, DOI 10.1097/CMR.0b013e32832c6339; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Heine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028030; Kumar SM, 2012, ONCOGENE, V31, P1649, DOI 10.1038/onc.2011.366; Kumar SM, 2005, AM J PATHOL, V166, P823, DOI 10.1016/S0002-9440(10)62303-6; Kumar SM, 2006, MELANOMA RES, V16, P275, DOI 10.1097/01.cmr.0000222594.60611.c3; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lindholm C, 2004, CANCER-AM CANCER SOC, V101, P2067, DOI 10.1002/cncr.20602; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; McWilliams RR, 2008, EXPERT REV ANTICANC, V8, P743, DOI 10.1586/14737140.8.5.743; Mechtcheriakova D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025611; Mirmohammadsadegh A, 2010, J INVEST DERMATOL, V130, P201, DOI 10.1038/jid.2009.162; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Murakami T, 2004, J DERMATOL SCI, V36, P71, DOI 10.1016/j.jdermsci.2004.03.002; Natarajan N, 2011, DRUGS, V71, P1233, DOI 10.2165/11591380-000000000-00000; Nikolaou VA, 2012, J INVEST DERMATOL, V132, P854, DOI 10.1038/jid.2011.421; Passegue E, 2009, NAT MED, V15, P612, DOI [10.1038/nm0109-23, 10.1038/nm0609-612]; Pho L, 2006, CURR OPIN ONCOL, V18, P173, DOI 10.1097/01.cco.0000208791.22442.09; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Radford KJ, 1996, BIOCHEM BIOPH RES CO, V222, P13, DOI 10.1006/bbrc.1996.0690; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Selzer E, 2000, MELANOMA RES, V10, P421, DOI 10.1097/00008390-200010000-00003; Smalley KSM, 2009, INT J CANCER, V124, P1245, DOI 10.1002/ijc.24129; Swart GWM, 2005, CANCER METAST REV, V24, P223, DOI 10.1007/s10555-005-1573-0; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368	36	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e84417	10.1371/journal.pone.0084417	http://dx.doi.org/10.1371/journal.pone.0084417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489649	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000007
J	Desai, A; Kevala, K; Kim, HY				Desai, Abhishek; Kevala, Karl; Kim, Hee-Yong			Depletion of Brain Docosahexaenoic Acid Impairs Recovery from Traumatic Brain Injury	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; OMEGA-3-FATTY-ACIDS; NEUROPROTECTION; PROMOTES; IMPACT; CELLS; MODEL; LEADS; RATS	Omega-3 fatty acids are crucial for proper development and function of the brain where docosahexaenoic acid (DHA), the primary omega-3 fatty acid in the brain, is retained avidly by the neuronal membranes. We investigated the effect of DHA depletion in the brain on the outcome of traumatic brain injury (TBI). Pregnant mice were put on an omega-3 fatty acid adequate or deficient diet from gestation day 14 and the pups were raised on the respective diets. Continuation of this dietary regime for three generations resulted in approximately 70% loss of DHA in the brain. Controlled cortical impact was delivered to both groups of mice to produce severe TBI and the functional recovery was compared. Compared to the omega-3 adequate mice, the DHA depleted mice exhibited significantly slower recovery from motor deficits evaluated by the rotarod and the beam walk tests. Furthermore, the DHA deficient mice showed greater anxiety-like behavior tested in the open field test as well as cognitive deficits evaluated by the novel object recognition test. The level of alpha spectrin II breakdown products, the markers of TBI, was significantly elevated in the deficient mouse cortices, indicating that the injury is greater in the deficient brains. This observation was further supported by the reduction of NeuN positive cells around the site of injury in the deficient mice, indicating exacerbated neuronal death after injury. These results suggest an important influence of the brain DHA status on TBI outcome.	[Desai, Abhishek; Kevala, Karl; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA.	hykim@nih.gov			Defense Medical Research and Development Program (DMRDP) [W81XWH-11-2-0074]; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000501] Funding Source: NIH RePORTER	Defense Medical Research and Development Program (DMRDP); National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Defense Medical Research and Development Program (DMRDP) (W81XWH-11-2-0074) and Intramural Research Program of the National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Berman DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.020; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Carrie I, 2000, J LIPID RES, V41, P473; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Danthi SJ, 2005, BIOCHEM BIOPH RES CO, V327, P485, DOI 10.1016/j.bbrc.2004.12.033; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; ENNACEUR A, 1992, BEHAV BRAIN RES, V51, P83, DOI 10.1016/S0166-4328(05)80315-8; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kim HY, 2012, PROSTAGLANDINS LEUKO, V88, P121; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Lim SY, 2005, J NEUROCHEM, V95, P848, DOI 10.1111/j.1471-4159.2005.03427.x; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; NAKASHIMA Y, 1993, J LIPID RES, V34, P239; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Wen ZM, 2004, J NEUROCHEM, V89, P1368, DOI 10.1111/j.1471-4159.2004.02433.x; Wu A, 2004, J NEUROTRAUM, V28, P2113; Xiao Y, 2005, BRIT J NUTR, V94, P544, DOI 10.1079/BJN20051539; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081	49	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86472	10.1371/journal.pone.0086472	http://dx.doi.org/10.1371/journal.pone.0086472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475126	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300068
J	Leu, WJ; Chang, HS; Chan, SH; Hsu, JL; Yu, CC; Hsu, LC; Chen, IS; Guh, JH				Leu, Wohn-Jenn; Chang, Hsun-Shuo; Chan, She-Hung; Hsu, Jui-Ling; Yu, Chia-Chun; Hsu, Lih-Ching; Chen, Ih-Sheng; Guh, Jih-Hwa			Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle	PLOS ONE			English	Article							CARDIAC-GLYCOSIDES; NA+/K+-ATPASE; BETA-SUBUNIT; DNA-DAMAGE; APOPTOSIS; PROLIFERATION; NA,K-ATPASE; OLEANDRIN; ACTIVATION; PATHWAY	In the past decade, there has been a profound increase in the number of studies revealing that cardenolide glycosides display inhibitory activity on the growth of human cancer cells. The use of potential cardenolide glycosides may be a worthwhile approach in anticancer research. Reevesioside A, a cardenolide glycoside isolated from the root of Reevesia formosana, displayed potent anti-proliferative activity against human hormone-refractory prostate cancers. A good correlation (r(2) = 0.98) between the expression of Na+/K+-ATPase alpha(3) subunit and anti-proliferative activity suggested the critical role of the alpha(3) subunit. Reevesioside A induced G1 arrest of the cell cycle and subsequent apoptosis in a thymidine block-mediated synchronization model. The data were supported by the down-regulation of several related cell cycle regulators, including cyclin D1, cyclin E and CDC25A. Reevesioside A also caused a profound decrease of RB phosphorylation, leading to an increased association between RB and E2F1 and the subsequent suppression of E2F1 activity. The protein and mRNA levels of c-myc, which can activate expression of many downstream cell cycle regulators, were dramatically inhibited by reevesioside A. Transient transfection of c-myc inhibited the down-regulation of both cyclin D1 and cyclin E protein expression to reevesioside A action, suggesting that c-myc functioned as an upstream regulator. Flow cytometric analysis of JC-1 staining demonstrated that reevesioside A also induced the significant loss of mitochondrial membrane potential. In summary, the data suggest that reevesioside A inhibits c-myc expression and down-regulates the expression of CDC25A, cyclin D1 and cyclin E, leading to a profound decrease of RB phosphorylation. G1 arrest is, therefore, induced through E2F1 suppression. Consequently, reevesioside A causes mitochondrial damage and an ultimate apoptosis in human hormone-refractory prostate cancer cells.	[Leu, Wohn-Jenn; Chan, She-Hung; Hsu, Jui-Ling; Yu, Chia-Chun; Hsu, Lih-Ching; Guh, Jih-Hwa] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Chang, Hsun-Shuo; Chen, Ih-Sheng] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan	National Taiwan University; Kaohsiung Medical University	Guh, JH (corresponding author), Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan.	jhguh@ntu.edu.tw		HSU, LIH-CHING/0000-0002-7816-3825; GUH, JIH-HWA/0000-0002-6738-6054; Chang, Hsun-Shuo/0000-0003-2745-139X	National Science Council of the Republic of China [101-2320-B-002-018-MY3, 101-2811-B-002-095]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors acknowledge the support provided by the National Science Council of the Republic of China (101-2320-B-002-018-MY3 and 101-2811-B-002-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, LEUKEMIA LYMPHOMA, V52, P1544, DOI 10.3109/10428194.2011.570821; Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Chang HS, 2013, PHYTOCHEMISTRY, V87, P86, DOI 10.1016/j.phytochem.2012.11.024; Chiu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064739; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Demeterco C, 2002, J CLIN ENDOCR METAB, V87, P3475, DOI 10.1210/jc.87.7.3475; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Hogstrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031366; Hsu JL, 2011, J UROLOGY, V185, P1967, DOI 10.1016/j.juro.2010.12.091; Kim SH, 2013, PROG NEURO-PSYCHOPH, V45, P73, DOI 10.1016/j.pnpbp.2013.04.018; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin WC, 2001, GENE DEV, V15, P1833; Lin Yun, 2010, J Exp Ther Oncol, V8, P271; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Lu PH, 2007, EUR J PHARMACOL, V556, P45, DOI 10.1016/j.ejphar.2006.10.061; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma YH, 2003, MOL CANCER THER, V2, P73; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manna SK, 2000, CANCER RES, V60, P3838; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Mijatovic T, 2013, PLANTA MED, V79, P189, DOI 10.1055/s-0032-1328243; Nasu K, 2005, MOL HUM REPROD, V11, P817, DOI 10.1093/molehr/gah249; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2007, INTEGR CANCER THER, V6, P354, DOI 10.1177/1534735407309623; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Qiu DZ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-185; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Santander VS, 2006, MOL CELL BIOCHEM, V291, P167, DOI 10.1007/s11010-006-9212-9; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009; Wang JQ, 2012, CANCER RES, V72, P4765, DOI 10.1158/0008-5472.CAN-12-0820; Watabe M, 1997, CELL GROWTH DIFFER, V8, P871; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yang PY, 2009, MOL CANCER THER, V8, P2319, DOI 10.1158/1535-7163.MCT-08-1085	50	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87323	10.1371/journal.pone.0087323	http://dx.doi.org/10.1371/journal.pone.0087323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475272	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300168
J	Schroder, H; Ribas, L; Koebnick, C; Funtikova, A; Gomez, SF; Fito, M; Perez-Rodrigo, C; Serra-Majem, L				Schroeder, Helmut; Ribas, Lourdes; Koebnick, Corinna; Funtikova, Anna; Gomez, Santiago F.; Fito, Montserat; Perez-Rodrigo, Carmen; Serra-Majem, Lluis			Prevalence of Abdominal Obesity in Spanish Children and Adolescents. Do We Need Waist Circumference Measurements in Pediatric Practice?	PLOS ONE			English	Article							TO-HEIGHT RATIO; BODY-MASS INDEX; TRUNK FAT MASS; CARDIOMETABOLIC RISK; CENTRAL ADIPOSITY; CARDIOVASCULAR-DISEASE; SCREENING TOOL; OVERWEIGHT; TRENDS; PREDICTORS	Background: Evidence indicates that central adiposity has increased to a higher degree than general adiposity in children and adolescents in recent decades. However, waist circumference is not a routine measurement in clinical practice. Objective: This study aimed to determine the prevalence of abdominal obesity based on waist circumferences (WC) and waist to height ratio (WHtR) in Spanish children and adolescents aged 6 to 17 years. Further, the prevalence of abdominal obesity (AO) among normal and overweight individuals was analyzed. Design: Data were obtained from a study conducted from 1998 to 2000 in a representative national sample of 1521 children and adolescents aged 6 to 17 years (50.0% female) in Spain. WC and WHtR measurements were obtained in addition to BMI. AO was defined as WHtR >= 0.50 (WHtR-AO), sex and age specific WC >= 90th percentile (WC-AO1), and sex and age specific WC cut-off values associated with high trunk fat measured by by dual-energy X-ray absorptiometry (WC-AO2). Results: IOTF-based overweight and obsity prevalence was 21.5% and 6.6% in children and 17.4% and 5.2% in adolescents, respectively. Abdominal obesity (AO) was defined as WHtR >= 0.50 (WHtR-AO), sex-and age-specific WC >= 90th percentile (WC-AO1), and sex- and age-specific WC cut-off values associated with high trunk fat measured by dual-energy X-ray absorptiometry (WC-AO2). The respective prevalence of WHtR-AO, WC-AO1, and WC-AO2 was 21.3% (24.6% boys; 17.9% girls), 9.4% (9.1% boys; 9.7% girls), and 26.8% (30.6% boys; 22.9% girls) in children and 14.3% (20.0% boys; 8.7% girls), 9.6% (9.8% boys; 9.5% girls), and 21.1% (28.8% boys; 13.7% girls) in adolescents. Conclusion: The prevalence of AO in Spanish children and adolescents is of concern. The high proportion of AO observed in young patients who are normal weight or overweight indicates a need to include waist circumference measurements in routine clinical practice.	[Schroeder, Helmut; Funtikova, Anna; Gomez, Santiago F.; Fito, Montserat] Hosp del Mar Med Res Inst IMIM, REGICOR Study Grp, Cardiovasc Risk & Nutr Res, Res Programme Inflammatory & Cardiovasc Disorders, Barcelona, Spain; [Schroeder, Helmut; Funtikova, Anna] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Ribas, Lourdes; Serra-Majem, Lluis] Nutr Res Fdn, Barcelona, Spain; [Ribas, Lourdes; Fito, Montserat; Serra-Majem, Lluis] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain; [Koebnick, Corinna] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Gomez, Santiago F.] Fdn THAO, Barcelona, Spain; [Perez-Rodrigo, Carmen] Bilbao Dept Publ Hlth, Community Nutr Unit, Bilbao, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Kaiser Permanente; Universidad de Las Palmas de Gran Canaria	Schroder, H (corresponding author), Hosp del Mar Med Res Inst IMIM, REGICOR Study Grp, Cardiovasc Risk & Nutr Res, Res Programme Inflammatory & Cardiovasc Disorders, Barcelona, Spain.	hschroeder@imim.es	Schroder, Helmut/G-2586-2015; Santos, Santiago Felipe Gómez/H-9478-2017; Koebnick, Corinna/P-4767-2016; Perez-Rodrigo, Carmen/N-3251-2018; Fito, Montserrat/C-1822-2012; Serra-Majem, Lluis/I-6708-2019	Schroder, Helmut/0000-0003-2231-5081; Santos, Santiago Felipe Gómez/0000-0003-3352-2510; Koebnick, Corinna/0000-0001-8274-0309; Fito, Montserrat/0000-0002-1817-483X; Serra-Majem, Lluis/0000-0002-9658-9061; Perez-Rodrigo, Carmen/0000-0002-4554-6184	Instituto de Salud Carlos III-FEDER [PI11/01900]; Spanish Ministry of Health, Fundacion Dieta Mediterranea, Spain; Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacion Nutricional [Miguel Servet CP03/00115]; Instituto de Salud Carlos III; Health Department of the Catalan Government (Generalitat de Catalunya)	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Health, Fundacion Dieta Mediterranea, Spain; Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacion Nutricional; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya)	This work was supported by grants from Instituto de Salud Carlos III-FEDER, (PI11/01900), the Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain; and Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria and the Fundacion para la Investigacion Nutricional and by a joint contract (Miguel Servet CP03/00115) with the Instituto de Salud Carlos III and the Health Department of the Catalan Government (Generalitat de Catalunya). The CIBERESP and the CIBEROBN and the RETIC Predimed are initiatives of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bibiloni Mdel M, 2013, PLOS ONE, V8; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Moraes ACF, 2011, OBES REV, V12, P69, DOI 10.1111/j.1467-789X.2010.00753.x; Elizondo-Montemayor L, 2011, METAB SYNDR RELAT D, V9, P183, DOI 10.1089/met.2010.0116; Garnett SP, 2011, OBES REV, V12, P887, DOI 10.1111/j.1467-789X.2011.00899.x; Graves L, 2013, PEDIAT OBES; Guntsche Z, 2010, J PEDIATR ENDOCR MET, V23, P245; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; Hernandez M., 1988, CURVAS TABLAS CRECIM; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; KOENKER R, 1994, BIOMETRIKA, V81, P673; Koenker R, 2010, LECT NOTES STAT, V196, P23; Koenker R., QUANTREG QUANTILE RE; Kromeyer-Hauschild K, 2013, OBESITY FACTS, V6, P165, DOI 10.1159/000351066; Kruger HS, 2013, NUTRITION, V29, P502, DOI 10.1016/j.nut.2012.08.009; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2005, INT J OBESITY, V29, P157, DOI 10.1038/sj.ijo.0802849; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; Ministerio de Ciencia e Innovacion Espana, 2009, GUIA PRACT CLIN PREV; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Okosun IS, 2006, ETHNIC DIS, V16, P338; Ortega FB, 2008, INT J PEDIATR OBES, V3, P212, DOI 10.1080/17477160802068965; Perez-Farinos N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/163687; R Core Team, 2021, R LANGUAGE ENV STAT; Sanchez-Cruz JJ, 2013, REV ESP CARDIOL, V66, P371, DOI [10.1016/j.rec.2012.10.012, 10.1016/j.recesp.2012.10.016]; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Taylor RW, 2011, OBESITY, V19, P1062, DOI 10.1038/oby.2010.217; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Tzotzas T, 2011, HIPPOKRATIA, V15, P48; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	36	76	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87549	10.1371/journal.pone.0087549	http://dx.doi.org/10.1371/journal.pone.0087549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475305	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300199
J	Skowronski, DM; Hamelin, ME; De Serres, G; Janjua, NZ; Li, GY; Sabaiduc, S; Bouhy, X; Couture, C; Leung, A; Kobasa, D; Embury-Hyatt, C; de Bruin, E; Balshaw, R; Lavigne, S; Petric, M; Koopmans, M; Boivin, G				Skowronski, Danuta M.; Hamelin, Marie-Eve; De Serres, Gaston; Janjua, Naveed Z.; Li, Guiyun; Sabaiduc, Suzana; Bouhy, Xavier; Couture, Christian; Leung, Anders; Kobasa, Darwyn; Embury-Hyatt, Carissa; de Bruin, Erwin; Balshaw, Robert; Lavigne, Sophie; Petric, Martin; Koopmans, Marion; Boivin, Guy			Randomized Controlled Ferret Study to Assess the Direct Impact of 2008-09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk	PLOS ONE			English	Article							H1N1 2009 VACCINE; PANDEMIC INFLUENZA; VIRUS-INFECTION; PROTECTIVE EFFICACY; ANTIBODY-RESPONSE; IMMUNE-RESPONSES; NWS VIRUS; IMMUNIZATION; ASSOCIATION; EXPRESSION	During spring-summer 2009, several observational studies from Canada showed increased risk of medically-attended, laboratory-confirmed A(H1N1)pdm09 illness among prior recipients of 2008-09 trivalent inactivated influenza vaccine (TIV). Explanatory hypotheses included direct and indirect vaccine effects. In a randomized placebo-controlled ferret study, we tested whether prior receipt of 2008-09 TIV may have directly influenced A(H1N1) pdm09 illness. Thirty-two ferrets (16/group) received 0.5 mL intra-muscular injections of the Canadian-manufactured, commercially-available, non-adjuvanted, split 2008-09 Fluviral or PBS placebo on days 0 and 28. On day 49 all animals were challenged (Ch0) with A(H1N1) pdm09. Four ferrets per group were randomly selected for sacrifice at day 5 post-challenge (Ch+5) and the rest followed until Ch+14. Sera were tested for antibody to vaccine antigens and A(H1N1) pdm09 by hemagglutination inhibition (HI), microneutralization (MN), nucleoprotein-based ELISA and HA1-based microarray assays. Clinical characteristics and nasal virus titers were recorded pre-challenge then post-challenge until sacrifice when lung virus titers, cytokines and inflammatory scores were determined. Baseline characteristics were similar between the two groups of influenza-naive animals. Antibody rise to vaccine antigens was evident by ELISA and HA1-based microarray but not by HI or MN assays; virus challenge raised antibody to A(H1N1) pdm09 by all assays in both groups. Beginning at Ch+2, vaccinated animals experienced greater loss of appetite and weight than placebo animals, reaching the greatest between-group difference in weight loss relative to baseline at Ch+ 5 (7.4% vs. 5.2%; p = 0.01). At Ch+5 vaccinated animals had higher lung virus titers (log-mean 4.96 vs. 4.23pfu/mL, respectively; p = 0.01), lung inflammatory scores (5.8 vs. 2.1, respectively; p = 0.051) and cytokine levels (p>0.05). At Ch+14, both groups had recovered. Findings in influenza-naive, systematically-infected ferrets may not replicate the human experience. While they cannot be considered conclusive to explain human observations, these ferret findings are consistent with direct, adverse effect of prior 2008-09 TIV receipt on A(H1N1) pdm09 illness. As such, they warrant further in-depth investigation and search for possible mechanistic explanations.	[Skowronski, Danuta M.; Janjua, Naveed Z.; Li, Guiyun; Sabaiduc, Suzana; Balshaw, Robert; Petric, Martin] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.; Sabaiduc, Suzana; Balshaw, Robert; Petric, Martin] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hamelin, Marie-Eve; De Serres, Gaston; Bouhy, Xavier; Boivin, Guy] Univ Hosp Ctr Quebec, Quebec City, PQ, Canada; [Hamelin, Marie-Eve; De Serres, Gaston; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada; [De Serres, Gaston] Natl Inst Hlth Quebec, Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Couture, Christian; Lavigne, Sophie] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Leung, Anders; Kobasa, Darwyn] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Kobasa, Darwyn] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Embury-Hyatt, Carissa] Canadian Food Inspect Agcy, Winnipeg, MB, Canada; [de Bruin, Erwin; Koopmans, Marion] Natl Inst Publ Hlth & Environm, Rijksinst Volksgezondheid Milieu RIVM, CIDC, Lab Infect Dis Res Diagnost & Screening, NL-3720 BA Bilthoven, Netherlands; [Balshaw, Robert] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Koopmans, Marion] Erasmus MC, Virosci Dept, Rotterdam, Netherlands	University of British Columbia; Laval University; Institut national de sante publique du Quebec (INSPQ); Public Health Agency of Canada; University of Manitoba; Canadian Food Inspection Agency; Netherlands National Institute for Public Health & the Environment; Simon Fraser University; Erasmus University Rotterdam; Erasmus MC	Skowronski, DM (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	danuta.skowronski@bccdc.ca	Koopmans, Marion/Y-9170-2019; Zafar, Naveed/A-2712-2008	Koopmans, Marion/0000-0002-5204-2312; Zafar, Naveed/0000-0001-5681-719X; Balshaw, Robert/0000-0002-2455-8792; Boivin, Guy/0000-0003-3027-4662	Michael Smith Foundation for Health Research [OT-GIA-00012091]; Canadian Institutes of Health Research - Institute of Infection and Immunity [229733]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research - Institute of Infection and Immunity(Canadian Institutes of Health Research (CIHR))	This work was supported by grants provided by the Michael Smith Foundation for Health Research (OT-GIA-00012091) and the Canadian Institutes of Health Research - Institute of Infection and Immunity (229733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, J INFECT DIS, V204, P1008, DOI 10.1093/infdis/jir483; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Chen GL, 2011, J INFECT DIS, V203, P930, DOI 10.1093/infdis/jiq144; Choi YS, 2011, CLIN VACCINE IMMUNOL, V18, P1519, DOI 10.1128/CVI.05053-11; Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262; Cowling BJ, 2012, CLIN INFECT DIS, V55, P695, DOI 10.1093/cid/cis518; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Crowe JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007118; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Danesh A, 2011, VIROLOGY, V409, P102, DOI 10.1016/j.virol.2010.10.002; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; Dutry I., 2011, BMC P, V5, pP62, DOI DOI 10.1186/1753-6561-5-S1-P62; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Ellebedy AH, 2011, VACCINE, V29, P3335, DOI 10.1016/j.vaccine.2010.08.067; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gauger PC, 2012, VET PATHOL, V49, P900, DOI 10.1177/0300985812439724; Gauger PC, 2011, VACCINE, V29, P2712, DOI 10.1016/j.vaccine.2011.01.082; Gilca R, 2011, PEDIATRICS, V128, pE1084, DOI 10.1542/peds.2010-3492; GOTOFF R, 1994, J INFECT DIS, V169, P200, DOI 10.1093/infdis/169.1.200; Hamelin ME, 2007, J GEN VIROL, V88, P3391, DOI 10.1099/vir.0.83250-0; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Huijskens EGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054890; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; KELLY H, 2010, EURO SURVEILL, V15; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Khurana S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006366; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Langley JM, 2012, J PEDIATR INFECT DIS, V1, P55, DOI [10.1093/JPIDS/PIS012, 10.1093/jpids/pis012]; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; McElhaney JE, 2005, VACCINE, V23, P3294, DOI 10.1016/j.vaccine.2005.01.080; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; MCLAREN C, 1974, J HYG-CAMBRIDGE, V72, P91, DOI 10.1017/S0022172400023251; MCLAREN C, 1974, INFECT IMMUN, V9, P985, DOI 10.1128/IAI.9.6.985-990.1974; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Nakata M, 2008, J VET MED SCI, V70, P543, DOI 10.1292/jvms.70.543; National Advisory Committee on Immunization (NACI), 2009, Can Commun Dis Rep, V35, P1; OCHIAI H, 1992, J MED VIROL, V36, P217, DOI 10.1002/jmv.1890360312; OCHIAI H, 1990, J MED VIROL, V30, P258, DOI 10.1002/jmv.1890300406; OCHIAI H, 1988, J VIROL, V62, P20, DOI 10.1128/JVI.62.1.20-26.1988; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Oldfield WLG, 2001, J IMMUNOL, V167, P1734, DOI 10.4049/jimmunol.167.3.1734; Pearce MB, 2011, VACCINE, V29, P2887, DOI 10.1016/j.vaccine.2011.02.014; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTER CW, 1972, BRIT J EXP PATHOL, V53, P168; POTTER CW, 1972, BRIT J EXP PATHOL, V53, P153; POTTER CW, 1973, J HYG-CAMBRIDGE, V71, P97, DOI 10.1017/S0022172400046258; Qiu C, 2012, CLIN INFECT DIS, V54, P17, DOI 10.1093/cid/cir753; Rockman S, 2012, VACCINE, V30, P3618, DOI 10.1016/j.vaccine.2012.03.043; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Skowronski DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038929; Skowronski DM, 2011, CLIN INFECT DIS, V52, P831, DOI 10.1093/cid/cir036; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308; Svitek N, 2007, VIROLOGY, V362, P404, DOI 10.1016/j.virol.2007.01.002; SWEET C, 1974, BRIT J EXP PATHOL, V55, P296; To KKW, 2012, CLIN VACCINE IMMUNOL, V19, P1012, DOI 10.1128/CVI.00081-12; Tsuchihashi Y, 2012, CLIN INFECT DIS, V54, P381, DOI 10.1093/cid/cir787; Uno S, 2011, MICROBIOL IMMUNOL, V55, P783, DOI 10.1111/j.1348-0421.2011.00381.x; van den Brand JMA, 2011, J VIROL, V85, P2851, DOI 10.1128/JVI.01939-10; Vincent AL, 2008, VET MICROBIOL, V126, P310, DOI 10.1016/j.vetmic.2007.07.011; Vincent AL, 2012, J VIROL, V86, P10597, DOI 10.1128/JVI.01439-12; WHO, 2011, MAN LAB DIAGN VIR SU; World Health Organization, WHO REC COMP INFL VI	76	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86555	10.1371/journal.pone.0086555	http://dx.doi.org/10.1371/journal.pone.0086555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475142	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300079
J	Tiong, KH; Yunus, NAM; Yiap, BC; Tan, EL; Ismail, R; Ong, CE				Tiong, Kai Hung; Yunus, Nafees Ahemad Mohammed; Yiap, Beow Chin; Tan, Eng Lai; Ismail, Rusli; Ong, Chin Eng			Inhibitory Potency of 8-Methoxypsoralen on Cytochrome P450 2A6 (CYP2A6) Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22: Differential Susceptibility Due to Different Sequence Locations of the Mutations	PLOS ONE			English	Article							COUMARIN 7-HYDROXYLASE ACTIVITY; HUMAN-LIVER-MICROSOMES; MECHANISM-BASED INACTIVATION; MOLECULAR DOCKING; BINDING-AFFINITY; P450 2A6; ENZYME; PHOTOCHEMOTHERAPY; METHOXSALEN; METABOLISM	Human cytochrome P450 2A6 (CYP2A6) is a highly polymorphic isoform of CYP2A subfamily. Our previous kinetic study on four CYP2A6 allelic variants (CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22) have unveiled the functional significance of sequence mutations in these variants on coumarin 7-hydroxylation activity. In the present study, we further explored the ability of a typical CYP2A6 inhibitor, 8-methoxypsoralen (8-MOP), in inhibition of these alleles and we hypothesized that translational mutations in these variants are likely to give impact on 8-MOP inhibitory potency. The CYP2A6 variant and the wild type proteins were subjected to 8-MOP inhibition to yield IC50 values. In general, a similar trend of change in the IC50 and Km values was noted among the four mutants towards coumarin oxidation. With the exception of CYP2A6*16, differences in IC50 values were highly significant which implied compromised interaction of the mutants with 8-MOP. Molecular models of CYP2A6 were subsequently constructed and ligand-docking experiments were performed to rationalize experimental data. Our docking study has shown that mutations have induced enlargement of the active site volume in all mutants with the exception of CYP2A6*16. Furthermore, loss of hydrogen bond between 8-MOP and active site residue Asn297 was evidenced in all mutants. Our data indicate that the structural changes elicited by the sequence mutations could affect 8-MOP binding to yield differential enzymatic activities in the mutant CYP2A6 proteins.	[Tiong, Kai Hung; Yiap, Beow Chin; Tan, Eng Lai] Int Med Univ, Sch Pharm & Hlth Sci, Kuala Lumpur 57000, Malaysia; [Yunus, Nafees Ahemad Mohammed] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Selangor, Malaysia; [Ismail, Rusli] Univ Malaya, CERiA, Kuala Lumpur, Malaysia; [Ong, Chin Eng] Monash Univ Malaysia, Discipline Pharm, Bandar Sunway, Selangor, Malaysia	International Medical University Malaysia; Monash University; Monash University Sunway; Universiti Malaya; Monash University; Monash University Sunway	Ong, CE (corresponding author), Monash Univ Malaysia, Discipline Pharm, Bandar Sunway, Selangor, Malaysia.	ceong98@hotmail.com	Tan, Eng Lai/GVS-4496-2022; Ismail, Rusli/B-1863-2018	, Chin Eng/0000-0001-5926-7250; Ismail, Rusli/0000-0001-5831-1504	Science and Technology Research Grant from the Malaysia Toray Science Foundation [269817-K]; International Medical University Research Fund from the International Medical University, Kuala Lumpur, Malaysia [IMU 1122006]	Science and Technology Research Grant from the Malaysia Toray Science Foundation; International Medical University Research Fund from the International Medical University, Kuala Lumpur, Malaysia	This work was supported by the Science and Technology Research Grant from the Malaysia Toray Science Foundation (269817-K) as well as the International Medical University Research Fund (IMU 1122006) from the International Medical University, Kuala Lumpur, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TF, 1980, ANNU REV PHARMACOL, V20, P235, DOI 10.1146/annurev.pa.20.040180.001315; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAMUS AM, 1993, MOL CARCINOGEN, V7, P268, DOI 10.1002/mc.2940070410; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Draper AJ, 1997, ARCH BIOCHEM BIOPHYS, V341, P47, DOI 10.1006/abbi.1997.9964; Fukami T, 2004, CLIN PHARMACOL THER, V76, P519, DOI 10.1016/j.clpt.2004.08.014; Ghosal A, 2003, BIOPHARM DRUG DISPOS, V24, P375, DOI 10.1002/bdd.374; Haberl M, 2005, PHARMACOGENET GENOM, V15, P609, DOI 10.1097/01.fpc.0000171517.22258.f1; Hadidi H, 1997, FOOD CHEM TOXICOL, V35, P903, DOI 10.1016/S0278-6915(97)00066-5; Hasler Julia A., 1999, Molecular Aspects of Medicine, V20, P1, DOI 10.1016/S0098-2997(99)00005-9; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Kim D, 2005, J BIOL CHEM, V280, P40319, DOI 10.1074/jbc.M508171200; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P10047, DOI 10.1021/bi980003c; Koenigs LL, 1997, DRUG METAB DISPOS, V25, P1407; Lewis DFV, 2003, TOXICOL IN VITRO, V17, P179, DOI 10.1016/S0887-2333(02)00132-7; Lewis DFV, 2003, ARCH BIOCHEM BIOPHYS, V409, P32, DOI 10.1016/S0003-9861(02)00349-1; MILES JS, 1990, BIOCHEM J, V267, P365, DOI 10.1042/bj2670365; Mo SL, 2012, CURR PHARM BIOTECHNO, V13, P1640, DOI 10.2174/138920112800958779; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; PELKONEN O, 1985, BRIT J CLIN PHARMACO, V19, P59, DOI 10.1111/j.1365-2125.1985.tb02613.x; Pelkonen O, 2000, TOXICOLOGY, V144, P139, DOI 10.1016/S0300-483X(99)00200-0; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Raunio H, 2001, BRIT J CLIN PHARMACO, V52, P357, DOI 10.1046/j.0306-5251.2001.01500.x; SCOTT BR, 1976, MUTAT RES, V39, P29, DOI 10.1016/0165-1110(76)90012-9; Shimada T, 1996, XENOBIOTICA, V26, P395, DOI 10.3109/00498259609046718; SHOICHET BK, 1991, J MOL BIOL, V221, P327, DOI 10.1016/0022-2836(91)80222-G; Singh R, 2008, DRUG METAB PHARMACOK, V23, P165, DOI 10.2133/dmpk.23.165; Tiong KH, 2010, DRUG METAB DISPOS, V38, P745, DOI 10.1124/dmd.109.031054; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; YUN CH, 1991, MOL PHARMACOL, V40, P679	31	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86230	10.1371/journal.pone.0086230	http://dx.doi.org/10.1371/journal.pone.0086230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475091	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300045
J	Wang, W; Huang, MH; Dong, XL; Chai, CL; Pan, CX; Tang, H; Chen, YH; Dai, FY; Pan, MH; Lu, C				Wang, Wei; Huang, Mao-Hua; Dong, Xiao-Long; Chai, Chun-Li; Pan, Cai-Xia; Tang, Hui; Chen, Yan-Hong; Dai, Fang-Yin; Pan, Min-Hui; Lu, Cheng			Combined Effect of Cameo2 and CBP on the Cellular Uptake of Lutein in the Silkworm, Bombyx mori	PLOS ONE			English	Article							CAROTENOID-BINDING-PROTEIN; TRANSMEMBRANE PROTEIN; START DOMAIN; TRANSPORT; GENE; CHOLESTEROL; COLORATION; DROSOPHILA; MUTANTS; LARVAE	Formation of yellow-red color cocoons in the silkworm, Bombyx mori, occurs as the result of the selective delivery of carotenoids from the midgut to the silk gland via the hemolymph. This process of pigment transport is thought to be mediated by specific cellular carotenoids carrier proteins. Previous studies indicated that two proteins, Cameo2 and CBP, are associated with the selective transport of lutein from the midgut into the silk gland in Bombyx mori. However, the exact roles of Cameo2 and CBP during the uptake and transport of carotenoids are still unknown. In this study, we investigated the respective contributions of these two proteins to lutein and beta-carotene transport in Bombyx mori as well as commercial cell-line. We found that tissues, expressed both Cameo2 and CBP, accumulate lutein. Cells, co-expressed Cameo2 and CBP, absorb 2 fold more lutein (P<0.01) than any other transfected cells, and the rate of cellular uptake of lutein was concentration-dependent and reached saturation. From immunofluorescence staining, confocal microscopy observation and western blot analysis, Cameo2 was localized at the membrane and CBP was expressed in the cytosol. What's more, bimolecular fluorescence complementation analysis showed that these two proteins directly interacted at cellular level. Therefore, Cameo2 and CBP are necessarily expressed in midguts and silk glands for lutein uptake in Bombyx mori. Cameo2 and CBP, as the membrane protein and the cytosol protein, respectively, have the combined effect to facilitate the cellular uptake of lutein.	[Wang, Wei; Huang, Mao-Hua; Dong, Xiao-Long; Chai, Chun-Li; Pan, Cai-Xia; Tang, Hui; Chen, Yan-Hong; Dai, Fang-Yin; Pan, Min-Hui; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Dai, Fang-Yin; Pan, Min-Hui; Lu, Cheng] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing, Peoples R China; [Wang, Wei] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China; Southwest University - China	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	pmh0476@hotmail.com; lucheng@swu.edu.cn			National High-tech R&D Program of China [2013AA102507]; China Agriculture Research System [CARS-22]; National Natural Science Foundation of China [31001035]; Chongqing Natural Science Foundation of China [cstc2013jcyjA80019]; Central Universities Basic Research Funds [XDJK2012C093]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation of China; Central Universities Basic Research Funds	This work was supported by grants from National High-tech R&D Program of China (No. 2013AA102507), China Agriculture Research System (CARS-22), National Natural Science Foundation of China (No. 31001035), Chongqing Natural Science Foundation of China (No. cstc2013jcyjA80019) and the Central Universities Basic Research Funds (No. XDJK2012C093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2009, M S-MED SCI, V25, P181, DOI 10.1051/medsci/2009252181; Bhosale P, 2007, ARCH BIOCHEM BIOPHYS, V458, P121, DOI 10.1016/j.abb.2006.10.005; Chen XC, 2010, J PHYSIOL-LONDON, V588, P3539, DOI 10.1113/jphysiol.2010.192310; Chino H, 1985, COMPREHENSIVE INSECT; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; HARIZUKA MASAKI, 1953, BULL SERICUL EXPT STA [JAPAN], V14, P141; Hoekstra M, 2010, WORLD J GASTROENTERO, V16, P5916, DOI 10.3748/wjg.v16.i47.5916; Hu CD, 2006, CURR PROTOC CELL BIO, V21, P21; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; LODISH H, 2003, MOL CELL BIOL; Manunta C., 1937, Archivio Zoologico Italiano Torino, V24, P385; Nakajima M., 1963, B FAC AGR TOKYO, V8, P1; Niu Yan-Shan, 2010, Yichuan, V32, P942, DOI 10.3724/SP.J.1005.2010.00942; O'Sullivan SM, 2004, BRIT J NUTR, V91, P757, DOI 10.1079/BJN20041094; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Sakudoh T, 2005, BIOCHEM BIOPH RES CO, V336, P1125, DOI 10.1016/j.bbrc.2005.08.241; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sakudoh T, 2013, J LIPID RES, V54, P482, DOI 10.1194/jlr.M032771; Sakudoh T, 2010, J BIOL CHEM, V285, P7739, DOI 10.1074/jbc.M109.074435; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tazima Y, 1964, GENETICS SILKWORM; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P975, DOI 10.1016/j.jinsphys.2004.08.001; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P363, DOI 10.1016/j.jinsphys.2004.02.006; Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u	30	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86594	10.1371/journal.pone.0086594	http://dx.doi.org/10.1371/journal.pone.0086594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475153	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300089
J	Mann, E; Schmitz-Esser, S; Zebeli, Q; Wagner, M; Ritzmann, M; Metzler-Zebeli, BU				Mann, Evelyne; Schmitz-Esser, Stephan; Zebeli, Qendrim; Wagner, Martin; Ritzmann, Mathias; Metzler-Zebeli, Barbara U.			Mucosa-Associated Bacterial Microbiome of the Gastrointestinal Tract of Weaned Pigs and Dynamics Linked to Dietary Calcium-Phosphorus	PLOS ONE			English	Article							LACTOBACILLUS-AMYLOVORUS; SP NOV.; PHOSPHATE; ADHESION; HEALTH; AMPLIFICATION; PREVOTELLA; DIVERSITY; INFECTION; NUTRIENTS	Dietary composition largely influences pig's gastrointestinal microbiota and represents a useful prophylactic tool against enteric disturbances in young pigs. Despite the importance for host-microbe interactions and bacterial colonization, dietary responses of the mucosa-associated bacterial communities are less well investigated. In the present study, we characterized the mucosa-associated bacterial communities at the Pars non-glandularis of the stomach, ileum and colon, and identified shifts in these communities in response to different dietary calcium-phosphorus (Ca-P) contents (100% versus 190% of the Ca and P requirements) in combination with two basal diets (wheat-barley-or corn-based) in weaned pigs. Pyrosequencing of 16S rRNA genes from 93 mucosal samples yielded 447,849 sequences, clustering into 997 operational taxonomic units (OTUs) at 97% similarity level. OTUs were assigned to 198 genera belonging to 14 different phyla. Correlation-based networks revealed strong interactions among OTUs at the various gastrointestinal sites. Our data describe a previously not reported high diversity and species richness at the Pars non-glandularis of the stomach in weaned pigs. Moreover, high versus adequate Ca-P content significantly promoted Lactobacillus by 14.9% units (1.4 fold change) at the gastric Pars non-glandularis (P = 0.035). Discriminant analysis revealed dynamic changes in OTU composition in response to dietary cereals and Ca-P contents at all gastrointestinal sites which were less distinguishable at higher taxonomic levels. Overall, this study revealed a distinct mucosa-associated bacterial community at the different gut sites, and a strong effect of high Ca-P diets on the gastric community, thereby markedly expanding our comprehension on mucosa-associated microbiota and their diet-related dynamics in weaned pigs.	[Mann, Evelyne; Schmitz-Esser, Stephan; Wagner, Martin] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Milk Hyg, Vienna, Austria; [Zebeli, Qendrim] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Ritzmann, Mathias; Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Swine, Vienna, Austria; [Mann, Evelyne; Schmitz-Esser, Stephan; Zebeli, Qendrim; Wagner, Martin; Ritzmann, Mathias; Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria; [Ritzmann, Mathias] Univ Munich, Clin Swine, Munich, Germany	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Munich	Metzler-Zebeli, BU (corresponding author), Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Swine, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at	Selberherr, Evelyne/AAM-9702-2021; Selberherr, Evelyne/I-3795-2014; Schmitz-Esser, Stephan/AAA-7287-2019	Selberherr, Evelyne/0000-0002-2253-5247; Schmitz-Esser, Stephan/0000-0002-1907-0709; Ritzmann, Mathias/0000-0001-9791-1668; Zebeli, Qendrim/0000-0001-5188-9004	University of Veterinary Medicine Vienna; Austrian Promotion Agency (FFG) [825339]	University of Veterinary Medicine Vienna; Austrian Promotion Agency (FFG)	Financial support was provided by profile line start up funding program at the University of Veterinary Medicine Vienna and Austrian Promotion Agency (FFG) Project Number 825339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; Breves G, 2007, LIVEST SCI, V109, P4, DOI 10.1016/j.livsci.2007.01.021; Buzoianu SG, 2012, APPL ENVIRON MICROB, V78, P4217, DOI 10.1128/AEM.00307-12; CHAUVIERE G, 1992, J GEN MICROBIOL, V138, P1689, DOI 10.1099/00221287-138-8-1689; Collado MC, 2007, J FOOD PROTECT, V70, P2799, DOI 10.4315/0362-028X-70.12.2799; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; DeVuyst L, 1996, MICROBIOL-UK, V142, P817, DOI 10.1099/00221287-142-4-817; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; DORSCH M, 1992, J MICROBIOL METH, V16, P271, DOI 10.1016/0167-7012(92)90017-X; DURAND M, 1988, J NUTR, V118, P249, DOI 10.1093/jn/118.2.249; GfE, 2006, EMPFEHLUNGEN ENERGIE; GOVERS MJAP, 1993, GUT, V34, P365, DOI 10.1136/gut.34.3.365; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hayashi H, 2007, INT J SYST EVOL MICR, V57, P941, DOI 10.1099/ijs.0.64778-0; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lawlor PG, 2005, IRISH VET J, V58, P447, DOI 10.1186/2046-0481-58-8-447; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lim SM, 2012, J MICROBIOL BIOTECHN, V22, P1731, DOI 10.4014/jmb.1208.08049; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; Mann E, 2014, APPL ENVIRON MICROB, V80, P193, DOI 10.1128/AEM.03089-13; Metzler BU, 2009, J ANIM PHYSIOL AN N, V93, P130, DOI 10.1111/j.1439-0396.2007.00793.x; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P147, DOI 10.2527/jas.2008-1560; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Mikkelsen LL, 2007, LIVEST SCI, V109, P153, DOI 10.1016/j.livsci.2007.01.130; NAKAMURA LK, 1981, INT J SYST BACTERIOL, V31, P56, DOI 10.1099/00207713-31-1-56; O'Rourke JL, 2001, GUT, V49, P601, DOI 10.1136/gut.49.5.601; Park SC, 2006, WORLD J MICROB BIOT, V22, P35, DOI 10.1007/s11274-005-4856-2; PARTRIDGE IG, 1978, BRIT J NUTR, V39, P527, DOI 10.1079/BJN19780068; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pryde SE, 1999, APPL ENVIRON MICROB, V65, P5372; Roos S, 2000, INT J SYST EVOL MICR, V50, P251, DOI 10.1099/00207713-50-1-251; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt Bettina, 2011, PLoS One, V6, pe28284, DOI 10.1371/journal.pone.0028284; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; VDLUFA, 1976, METH BUCH 3 CHEM U N; Vermoote M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-51; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yen J.T., 2001, SWINE NUTR, P21; Zarate G, 2002, CAN J MICROBIOL, V48, P449, DOI 10.1139/W02-036	54	79	84	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86950	10.1371/journal.pone.0086950	http://dx.doi.org/10.1371/journal.pone.0086950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466298	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000174
J	Rutten-Jacobs, LCA; Keurlings, PAJ; Arntz, RM; Maaijwee, NAM; Schoonderwaldt, HC; Dorresteijn, LD; van der Vlugt, MJ; van Dijk, EJ; de Leeuw, FE				Rutten-Jacobs, Loes C. A.; Keurlings, Pim A. J.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; Dorresteijn, Lucille D.; van der Vlugt, Maureen J.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik			High Incidence of Diabetes after Stroke in Young Adults and Risk of Recurrent Vascular Events: The FUTURE Study	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; FOLLOW-UP; DISEASE; PREVENTION; RATIONALE; PROGNOSIS	Background: Diabetes diagnosed prior to stroke in young adults is strongly associated with recurrent vascular events. The relevance of impaired fasting glucose (IFG) and incidence of diabetes after young stroke is unknown. We investigated the long-term incidence of diabetes after young stroke and evaluated the association of diabetes and impaired fasting glucose with recurrent vascular events. Methods: This study was part of the FUTURE study. All consecutive patients between January 1, 1980, and November 1, 2010 with TIA or ischemic stroke, aged 18-50, were recruited. A follow-up assessment was performed in survivors between November 1, 2009 and January 1, 2012 and included an evaluation for diabetes, fasting venous plasma glucose and recurrent vascular events. The association of diabetes and IFG with recurrent vascular events was assessed by logistic regression analysis, adjusted for age, sex and follow-up duration. Results: 427 survivors without a medical history of diabetes were included in the present analysis (mean follow-up of 10.1 (SD 8.4) years; age 40.3 (SD 7.9) years). The incidence rate of diabetes was 7.9 per 1000 person-years and the prevalence of IFG was 21.1%. Patients with diabetes and IFG were more likely to have experienced any vascular event than those with normal fasting glucose values (OR 3.5 (95% CI 1.5-8.4) for diabetes and OR 2.5 (95% CI 1.3-4.8) for IFG). Conclusions: Diabetes or IFG in young stroke survivors is frequent and is associated with recurrent vascular events. Regular screening for IFG and diabetes in this population, yields potential for secondary prevention.	[Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Maaijwee, Noortje A. M.; Schoonderwaldt, Henny C.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Keurlings, Pim A. J.] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Dorresteijn, Lucille D.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [van der Vlugt, Maureen J.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Medical Spectrum Twente; Radboud University Nijmegen	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	FrankErik.deLeeuw@radboudumc.nl	de Leeuw, Frank-Erik/E-4795-2012; Vlugt, M.J./L-4723-2015; Rutten-Jacobs, Loes/C-7746-2013; van Dijk, Ewoud J/J-7951-2012; de Leeuw, H.F./L-4479-2015	Rutten-Jacobs, Loes/0000-0003-3223-885X; 				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; Bousser MG, 2009, CEREBROVASC DIS, V27, P509, DOI 10.1159/000212671; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Davis SM, 2012, NEW ENGL J MED, V366, P1914, DOI 10.1056/NEJMcp1107281; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Poos MJJC, 2011, DIABETES MELLITUS PR; Putaala J, 2011, NEUROLOGY, V76, P1831, DOI 10.1212/WNL.0b013e31821cccc2; Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Rutten-Jacobs LC, 2013, ANN NEUROL; Rutten-Jacobs LCA, 2013, JAMA-J AM MED ASSOC, V309, P1136, DOI 10.1001/jama.2013.842; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Vermeer SE, 2006, STROKE, V37, P1413, DOI 10.1161/01.STR.0000221766.73692.0b; von Sarnowski B, 2013, STROKE, V44, P119, DOI 10.1161/STROKEAHA.112.665190; Waje-Andreassen U, 2007, CEREBROVASC DIS, V24, P277, DOI 10.1159/000105680	22	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87171	10.1371/journal.pone.0087171	http://dx.doi.org/10.1371/journal.pone.0087171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466339	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000197
J	Zhang, L; Wang, XF; Ma, YS; Xia, Q; Zhang, F; Fu, D; Wang, YC				Zhang, Liang; Wang, Xiao-Feng; Ma, Yu-Shui; Xia, Qing; Zhang, Feng; Fu, Da; Wang, Yi-Chao			Quantitative Assessment of the Influence of TP63 Gene Polymorphisms and Lung Cancer Risk: Evidence Based on 93,751 Subjects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; TUMOR-SUPPRESSOR; IDENTIFIES 2; METAANALYSIS; SMOKING; P63; ADENOCARCINOMA; POPULATION; JAPANESE	Background: Several genome-wide association studies on lung cancer (LC) have reported similar findings of a new susceptibility locus, 3q28. After that, a number of studies reported that the rs10937405, and rs4488809 polymorphism in chromosome 3q28 has been implicated in LC risk. However, the studies have yielded contradictory results. Methods: PubMed, ISI web of science, EMBASE and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. Data were abstracted independently by two reviewers. A meta-analysis was performed to examine the association between rs10937405, rs4488809 polymorphism at 3q28 and susceptibility to LC. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Heterogeneity and publication bias were also tested. Results: A total of 9 studies including 35,961 LC cases and 57,790 controls were involved in this meta-analysis. An overall random-effects per-allele OR of 1.19 (95% CI: 1.14-1.25; P<10(-5)) and 1.19 (95% CI: 1.13-1.25; P<10(-5)) was found for the rs10937405 and rs4488809 polymorphism respectively. Similar results were also observed using dominant or recessive genetic model. After stratified by ethnicity, significant associations were found among East Asians (per-allele OR = 1.22, 95% CI: 1.17-1.27; P<10(-5)); whereas no significant associations were found among Caucasians for rs10937405. In the sub-group analysis by sample size, significantly increased risks were found for these polymorphisms in all genetic models. When analyzed according to histological type, the effects of rs10937405, and rs4488809 at 3q28 on the risk of lung cancer were significant mostly for lung adenocarcinoma. Conclusions: Our findings demonstrated that rs10937405-G allele and rs4488809-G allele might be risk-conferring factors for the development of lung cancer, especially for East Asian populations.	[Zhang, Liang; Wang, Xiao-Feng; Xia, Qing; Zhang, Feng; Fu, Da; Wang, Yi-Chao] Fudan Univ, Zhongshan Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China; [Ma, Yu-Shui] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Fu, Da] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200030, Peoples R China	Fudan University; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Fu, D (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.	superdafu@hotmail.com; wang_yichao001@126.com	ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022		National Natural Science Foundation of China [81201535, 81302065]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP203]; Shanghai Natural Science Foundation [12ZR1436000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	National Natural Science Foundation of China (81201535, 81302065), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP203) and Shanghai Natural Science Foundation (12ZR1436000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Daigo Y, 2008, GEN THORAC CARDIOVAS, V56, P43, DOI 10.1007/s11748-007-0211-x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Finlan LE, 2007, CELL CYCLE, V6, P1062, DOI 10.4161/cc.6.9.4162; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hosgood HD, 2012, HUM GENET, V131, P1197, DOI 10.1007/s00439-012-1144-8; Hsiao YH, 2010, INT J BIOL SCI, V6, P428; Hu QY, 2014, TUMOR BIOL, V35, P1863, DOI 10.1007/s13277-013-1248-3; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Osann K E, 1998, Curr Opin Pulm Med, V4, P198, DOI 10.1097/00063198-199807000-00002; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Walser Tonya, 2008, Proc Am Thorac Soc, V5, P811, DOI 10.1513/pats.200809-100TH; Wang YF, 2011, CANCER EPIDEM BIOMAR, V20, P1453, DOI 10.1158/1055-9965.EPI-11-0042; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu J, 2010, J CELL BIOCHEM, V109, P702, DOI 10.1002/jcb.22449; Zhang YJ, 2012, GENE, V497, P93, DOI 10.1016/j.gene.2012.01.053	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87004	10.1371/journal.pone.0087004	http://dx.doi.org/10.1371/journal.pone.0087004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466311	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000183
J	Lu, HL; Liu, GF				Lu, Heli; Liu, Guifang			Recent Observations of Human-induced Asymmetric Effects on Climate in Very High-Altitude Area	PLOS ONE			English	Article							TIME-SERIES; TEMPERATURE TRENDS; VEGETATION INDEX; LAND DEGRADATION; QUALITY-CONTROL; NETWORK; IMPACT; MAXIMUM; DEFORESTATION; URBANIZATION	Like urban heat islands (UHI), human-induced land degradation (HLD) is a phenomenon attributed to human activities, but this phenomenon occurs in non-urban areas. Although a large body of work has demonstrated that land-cover change influences local climate systems, little work has been done on separating the impact of HLD from naturally-occurring fluctuations in very high-altitude areas. We developed an innovative NDVI-difference method in order to evaluate HLD effects upon the climate system in the central Tibet Plateau. The results show that the minimum temperature increased at a significantly faster pace than the maximum temperature in the growing season at HLD meteorological stations, but this was reversed at stations with natural forces only. Further analysis revealed that abrupt changes of minimum temperature occurred five years earlier and amplitudes of these changes were 1.4 times larger than at stations with natural forces only. Therefore, our results complement other evidence that points to the fact that local effects from UHI contribute to climatic asymmetry observed between minimum and maximum temperature trends. Accordingly, we stress the need for consideration of non-urban factors from anthropogenic activities, such as human-induced land degradation, in understanding these asymmetric diurnal changes.	[Lu, Heli; Liu, Guifang] Henan Univ, Inst Nat Resources & Environm Sci, Kaifeng, Peoples R China; [Lu, Heli; Liu, Guifang] Henan Univ, Coll Environm & Planning, Kaifeng, Peoples R China; [Lu, Heli] Henan Collaborat Innovat Ctr Coordinated Dev Cent, Zhengzhou, Peoples R China; [Lu, Heli] United Nations Univ Inst Adv Studies, Yokohama, Kanagawa, Japan	Henan University; Henan University; United Nations University	Lu, HL (corresponding author), Henan Univ, Inst Nat Resources & Environm Sci, Kaifeng, Peoples R China.	cluheli@gmail.com		LU, Heli/0000-0002-9443-4031	National Natural Science Foundation of China [41371525]; National Basic Research Program of China (973 Program) [2012CB955800 (2012CB955804)]; China Postdoctoral Science Foundation [2012M521390, 2013T60696]; Scientific Research Foundation for Returned Scholars [2013(693)];  [2013B065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); 	This project is funded with support from National Natural Science Foundation of China under Project 41371525, National Basic Research Program of China (973 Program) 2012CB955800 (2012CB955804), China Postdoctoral Science Foundation funded project (2012M521390 & 2013T60696), Scientific Research Foundation for Returned Scholars 2013(693) and 2013B065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E., 2003, 53 WCDMP WORLD MET O; Andersson E, 1999, Q J ROY METEOR SOC, V125, P697, DOI 10.1256/smsqj.55415; Andersson E, 2011, ANNU REV ENV RESOUR, V36, P295, DOI 10.1146/annurev-environ-033110-092827; Balling RC, 1998, CLIMATIC CHANGE, V40, P669, DOI 10.1023/A:1005370115396; BALLING RC, 1991, B AM METEOROL SOC, V72, P232; Barrow C. J., 1991, LAND DEGRADATION DEV; Beniston M, 1996, 5001035179 SWISS NAT; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Brown ME, 2005, QUANTITATIVE COMP 4; Chattopadhyay S, 2011, METEOROL APPL, V18, P70, DOI 10.1002/met.211; Cornelis WM, 2009, LAND USE LAND COVER, V3; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Dingguo Y, 1992, P CHENGD S IAHS, P471; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fast JD, 2005, J APPL METEOROL, V44, P3, DOI 10.1175/JAM-2176.1; Feng S, 2004, INT J CLIMATOL, V24, P853, DOI 10.1002/joc.1047; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; Gallo KP, 1996, J CLIMATE, V9, P2941, DOI 10.1175/1520-0442(1996)009<2941:TIOLUC>2.0.CO;2; Gallo KP, 1999, J CLIMATE, V12, P1344, DOI 10.1175/1520-0442(1999)012<1344:TTOTUS>2.0.CO;2; Gallo KP, 2005, J CLIMATE, V18, P1629, DOI 10.1175/JCLI3358.1; Gerstengarbe FW, 1999, CLIMATE RES, V11, P97, DOI 10.3354/cr011097; Gilbert R. O., 1987, STAT METHODS ENV POL; Goossens C, 1987, NATO ASI SERIES C, V216, P31, DOI DOI 10.1007/978-94-009-3993-6_3; Hale RC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009548; Hawkins TW, 2004, J APPL METEOROL, V43, P476, DOI 10.1175/1520-0450(2004)043&lt;0476:TRORVI&gt;2.0.CO;2; Hollander M., 1973, NONPARAMETRIC STAT M; IPCC, 1996, FULL TEXT CLIM CHANG; IPCC Climate Change, 2022, CLIMATE CHANGE 2022; JONES PD, 1990, NATURE, V347, P169, DOI 10.1038/347169a0; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lin ZY., 1981, ACTA GEOGR SIN, V36, P22, DOI DOI 10.11821/XB198101003; Liu XY, 2002, ONGOING NATL PROVENC; LORENC AC, 1988, Q J ROY METEOR SOC, V114, P515, DOI 10.1002/qj.49711448012; Ma Y, 2009, HYDROL EARTH SYST SC, V13, P1103, DOI 10.5194/hess-13-1103-2009; Marland G, 2003, CLIM POLICY, V3, P149, DOI 10.1016/S1469-3062(03)00028-7; Modarres R, 2007, J ARID ENVIRON, V70, P344, DOI 10.1016/j.jaridenv.2006.12.024; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; Owen TW, 2000, J CLIMATE, V13, P4028, DOI 10.1175/1520-0442(2001)013<4028:UPMFUS>2.0.CO;2; Owen TW, 1998, INT J REMOTE SENS, V19, P3451, DOI 10.1080/014311698214127; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; PINZON J, 2002, SCI 2002 C P JUL 14; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Spronken-Smith RA, 1998, INT J REMOTE SENS, V19, P2085, DOI 10.1080/014311698214884; Tabari H, 2011, ENVIRON MONIT ASSESS, V177, P273, DOI 10.1007/s10661-010-1633-y; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Theil H., 1950, NEDERL AKAD WETENSCH, V53, P512; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; WMO, 2005, 989 WMO; Yao TD, 2000, CHINESE SCI BULL, V45, P1236, DOI 10.1007/BF02886087; Zhou LM, 2007, P NATL ACAD SCI USA, V104, P17937, DOI 10.1073/pnas.0700290104; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	58	25	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e81535	10.1371/journal.pone.0081535	http://dx.doi.org/10.1371/journal.pone.0081535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489643	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000004
J	Ahrendt, E; Kyle, B; Braun, AP; Braun, JEA				Ahrendt, Eva; Kyle, Barry; Braun, Andrew P.; Braun, Janice E. A.			Cysteine String Protein Limits Expression of the Large Conductance, Calcium-Activated K+ (BK) Channel	PLOS ONE			English	Article							CSP-ALPHA; SUBUNIT; REVEALS; ROLES; HSC70	Large-conductance, calcium-activated K+ (BK) channels are widely distributed throughout the nervous system and play an essential role in regulation of action potential duration and firing frequency, along with neurotransmitter release at the presynaptic terminal. We have previously demonstrated that select mutations in cysteine string protein (CSP alpha), a presynaptic J-protein and co-chaperone, increase BK channel expression. This observation raised the possibility that wildtype CSP alpha normally functions to limit neuronal BK channel expression. Here we show by Western blot analysis of transfected neuroblastoma cells that when BK channels are present at elevated levels, CSP alpha acts to reduce expression. Moreover, we demonstrate that the accessory subunits, BK beta 4 and BK beta 1 do not alter CSP alpha-mediated reduction of expressed BK alpha subunits. Structure-function analysis reveals that the N-terminal J-domain of CSP alpha is critical for the observed regulation of BK channels levels. Finally, we demonstrate that CSP alpha limits BK current amplitude, while the loss-of-function homologue CSP alpha(HPD-AAA) increases BK current. Our observations indicate that CSP alpha has a role in regulating synaptic excitability and neurotransmission by limiting expression of BK channels.	[Ahrendt, Eva; Braun, Janice E. A.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Kyle, Barry; Braun, Andrew P.] Univ Calgary, Fac Med, Libin Cardiovasc Inst, Calgary, AB, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Braun, JEA (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	braunj@ucalgary.ca		Kyle, Barry/0000-0003-4304-5762	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an NSERC grant to (JEAB) and an NSERC grant to (APB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Boal F, 2011, FASEB J, V25, P132, DOI 10.1096/fj.09-152033; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Kyle BD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02447; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86586	10.1371/journal.pone.0086586	http://dx.doi.org/10.1371/journal.pone.0086586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475152	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300088
J	Chiu, HE; Hong, YC; Chang, KC; Shih, CC; Hung, JW; Liu, CW; Tan, TY; Huang, CC				Chiu, Hsienhsueh Elley; Hong, Yu-Chiang; Chang, Ku-Chou; Shih, Chun-Chuan; Hung, Jen-Wen; Liu, Chia-Wei; Tan, Teng-Yeow; Huang, Chih-Cheng			Favorable Circulatory System Outcomes as Adjuvant Traditional Chinese Medicine (TCM) Treatment for Cerebrovascular Diseases in Taiwan	PLOS ONE			English	Article							ACUPUNCTURE; STROKE	Background: This study searches the National Health Insurance Research Database (NHIRD) used in a previous project, aiming for reconstructing possible cerebrovascular disease-related groups (DRG), and estimating the costs between cerebrovascular disease and related diseases. Methods and Materials: We conducted a nationwide retrospective cohort study in stroke inpatients, we examined the overall costs in 3 municipalities in Taiwan, by evaluating the possible costs of the expecting diagnosis related group (DRG) by using the international classification of diseases version-9 (ICD-9) system, and the overall analysis of the re-admission population that received traditional Chinese medicine (TCM) treatment and those who did not. Results: The trend demonstrated that the non-participant costs were consistent with the ICD-9 categories (430 to 437) because similarities existed between years 2006 to 2007. Among the TCM patients, a wide variation and additional costs were found compared to non-TCM patients during these 2 years. The average re-admission duration was significantly shorter for TCM patients, especially those initially diagnosed with ICD 434 during the first admission. In addition, TCM patients demonstrated more severe general symptoms, which incurred high conventional treatment costs, and could result in re-admission for numerous reasons. However, in Disease 7 of ICD-9 category, representing the circulatory system was most prevalent in non-TCM inpatients, which was the leading cause of re-admission. Conclusion: We concluded that favorable circulatory system outcomes were in adjuvant TCM treatment inpatients, there were less re-admission for circulatory system events and a two-third reduction of re-admission within ICD-9 code 430 to 437, compared to non-TCM ones. However, there were shorter re-admission duration other than circulatory system events by means of unfavorable baseline condition.	[Chiu, Hsienhsueh Elley; Hong, Yu-Chiang; Huang, Chih-Cheng] Chang Gung Univ Coll Med, Dept TCM, Kaohsiung, Taiwan; [Chiu, Hsienhsueh Elley; Chang, Ku-Chou; Liu, Chia-Wei; Tan, Teng-Yeow] Chang Gung Univ Coll Med, Dept Neurol, Kaohsiung, Taiwan; [Hung, Jen-Wen] Chang Gung Univ Coll Med, Dept Rehabil, Kaohsiung, Taiwan; [Chiu, Hsienhsueh Elley; Hong, Yu-Chiang; Chang, Ku-Chou; Hung, Jen-Wen; Liu, Chia-Wei; Tan, Teng-Yeow] Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; I Shou University	Chiu, HE (corresponding author), Chang Gung Univ Coll Med, Dept TCM, Kaohsiung, Taiwan.	elleychiu@hotmail.com			Chung Gung Research Project [CMRPG 890961]	Chung Gung Research Project	This study was supported by the Chung Gung Research Project, CMRPG 890961. The corresponding author and the first author had full access to all data in the study and had final responsibility for the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 1997, J Stroke Cerebrovasc Dis, V6, P361, DOI 10.1016/S1052-3057(97)80219-4; Hackett ML, 2000, STROKE, V31, P440, DOI 10.1161/01.STR.31.2.440; HAN JS, 1982, ANNU REV PHARMACOL, V22, P193, DOI 10.1146/annurev.pa.22.040182.001205; Hess Dean R, 2004, Respir Care, V49, P1171; JANSEN G, 1989, NEUROSCI LETT, V97, P305, DOI 10.1016/0304-3940(89)90615-0; MAGNUSSON M, 1994, STROKE, V25, P1176, DOI 10.1161/01.STR.25.6.1176; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NAESER MA, 1994, ACUPUNCTURE ELECTRO, V19, P227, DOI 10.3727/036012994816357231; O'Mahony PG, 1999, J PUBLIC HEALTH MED, V21, P166, DOI 10.1093/pubmed/21.2.166; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Southampton and South West Hampshire Health Commission, 1994, ANN REPORT; Sun H.L., 2001, CHIN ACUPUNCT MOXIBU, V21, P275; Wei YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/689813; Wu J N, 1996, J Altern Complement Med, V2, P19, DOI 10.1089/acm.1996.2.19	14	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86351	10.1371/journal.pone.0086351	http://dx.doi.org/10.1371/journal.pone.0086351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475108	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300056
J	Cui, CH; Kim, JK; Kim, SC; Im, WT				Cui, Chang-Hao; Kim, Jin-Kwang; Kim, Sun-Chang; Im, Wan-Taek			Characterization of a Ginsenoside-Transforming beta-glucosidase from Paenibacillus mucilaginosus and Its Application for Enhanced Production of Minor Ginsenoside F-2	PLOS ONE			English	Article							PANAX-GINSENG; BIOCONVERSION; RD; PHARMACOLOGY; GLYCOSIDASE; EXPRESSION; SEPARATION; CLONING; XVII; RB1	A novel beta-glucosidase (BglPm) was identified from Paenibacillus mucilaginosus KCTC 3870(T) which has ginsenoside converting activity. The gene, termed bglPm, consists of 1,260 bp and belongs to glycoside hydrolase family 1 (GH1). After being overexpressed and purified from Escherichia coli, the enzymatic properties of BglPm were investigated. The enzyme exhibited an optimal activity at 45 degrees C and pH 7.5 and showed high bioconversion ability for major ginsenoside Rb-1 and Rd into ginsenoside F-2. Thus, it was used for mass production of relatively high pure F-2 from relatively abundant protopanaxadiol type ginsenosides mixture (PPDGM) with combined usage of ginsenoside Rc-hydrolyzing enzyme. Scale-up of production using 250 g of the PPDGM resulted in 152 g of F-2 with 80.1% chromatography purity and 95.7% recovery. These results suggest that this enzyme would be useful in the preparation of pharmacologically active ginsenoside F-2 in the functional food and pharmaceutical industries.	[Cui, Chang-Hao; Kim, Sun-Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Jin-Kwang; Kim, Sun-Chang; Im, Wan-Taek] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Taejon 305701, South Korea; [Kim, Sun-Chang] Intelligent Synthet Biol Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, SC (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	sunkim@kaist.ac.kr; wandra@kaist.ac.kr	Kim, Sun Chang/C-2026-2011; Cui, Changhao/ABC-8055-2021; Kim, Sun/GSN-4867-2022		Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology, Republic of Korea [2011-0031967]	Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031967), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2011, INT J SYST EVOL MICR, V61, P2606, DOI 10.1099/ijs.0.028431-0; An DS, 2010, APPL ENVIRON MICROB, V76, P5827, DOI 10.1128/AEM.00106-10; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Cleland W W, 1979, Methods Enzymol, V63, P103; Cui CH, 2013, APPL MICROBIOL BIOT, V97, P649, DOI 10.1007/s00253-012-4324-5; Hong H, 2012, J GINSENG RES, V36, P418, DOI 10.5142/jgr.2012.36.4.418; Jia L, 2009, CURR MED CHEM, V16, P2924, DOI 10.2174/092986709788803204; Kang S, 2012, J GINSENG RES, V36, P354, DOI 10.5142/jgr.2012.36.4.354; Kim DH, 2012, J GINSENG RES, V36, P1, DOI 10.5142/jgr.2012.36.1.1; Kim JK, 2013, FOOD CHEM, V141, P1369, DOI 10.1016/j.foodchem.2013.04.012; Kim JK, 2012, J BIOTECHNOL, V161, P294, DOI 10.1016/j.jbiotec.2012.06.021; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Lee JH, 2011, J GINSENG RES, V35, P375, DOI 10.5142/jgr.2011.35.3.375; Leung K.W., 2010, CHINESE MED, V5, P20; Liu QM, 2013, ANTON LEEUW INT J G, V103, P747, DOI 10.1007/s10482-012-9856-2; Noh KH, 2009, BIOSCI BIOTECH BIOCH, V73, P316, DOI 10.1271/bbb.80525; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Park HJ, 2012, J GINSENG RES, V36, P225, DOI 10.5142/jgr.2012.36.3.225; Park MW, 2008, BIOL PHARM BULL, V31, P748, DOI 10.1248/bpb.31.748; Shi Y, 2013, FOOD ANAL METHOD, V6, P112, DOI 10.1007/s12161-012-9406-6; Shin JY, 2012, J GINSENG RES, V36, P86, DOI 10.5142/jgr.2012.36.1.86; Mai TT, 2012, CANCER LETT, V321, P144, DOI 10.1016/j.canlet.2012.01.045; Wan JB, 2008, SEP PURIF TECHNOL, V60, P198, DOI 10.1016/j.seppur.2007.08.007; Wang L, 2012, J MICROBIOL BIOTECHN, V22, P311, DOI 10.4014/jmb.1106.06041; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Ye L, 2010, BIORESOURCE TECHNOL, V28, P857; Yu HS, 2007, CHEM PHARM BULL, V55, P231, DOI 10.1248/cpb.55.231; Yuan CS, 2002, AM J CLIN NUTR, V75, P600, DOI 10.1093/ajcn/75.3.600; Zhao Y, 2007, SEP PURIF TECHNOL, V52, P533, DOI 10.1016/j.seppur.2006.06.008	32	36	38	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85727	10.1371/journal.pone.0085727	http://dx.doi.org/10.1371/journal.pone.0085727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475050	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300023
J	Griffing, D; Larson, S; Hollander, J; Carpenter, T; Christiansen, J; Doss, C				Griffing, Denise; Larson, Shawn; Hollander, Joel; Carpenter, Tim; Christiansen, Jeff; Doss, Charles			Observations on Abundance of Bluntnose Sixgill Sharks, Hexanchus griseus, in an Urban Waterway in Puget Sound, 2003-2005	PLOS ONE			English	Article							NOTORYNCHUS-CEPEDIANUS; HYDROLAGUS-COLLIEI; MOVEMENTS; RATFISH; GEORGIA; STRAIT	The bluntnose sixgill shark, Hexanchus griseus, is a widely distributed but poorly understood large, apex predator. Anecdotal reports of diver-shark encounters in the late 1990's and early 2000's in the Pacific Northwest stimulated interest in the normally deep-dwelling shark and its presence in the shallow waters of Puget Sound. Analysis of underwater video documenting sharks at the Seattle Aquarium's sixgill research site in Elliott Bay and mark-resight techniques were used to answer research questions about abundance and seasonality. Seasonal changes in relative abundance in Puget Sound from 2003-2005 are reported here. At the Seattle Aquarium study site, 45 sixgills were tagged with modified Floy visual marker tags, along with an estimated 197 observations of untagged sharks plus 31 returning tagged sharks, for a total of 273 sixgill observations recorded. A mark-resight statistical model based on analysis of underwater video estimated a range of abundance from a high of 98 sharks seen in July of 2004 to a low of 32 sharks seen in March of 2004. Both analyses found sixgills significantly more abundant in the summer months at the Seattle Aquarium's research station.	[Griffing, Denise; Larson, Shawn; Hollander, Joel; Carpenter, Tim; Christiansen, Jeff] Seattle Aquarium, Life Sci, Seattle, WA 98101 USA; [Doss, Charles] Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Larson, S (corresponding author), Seattle Aquarium, Life Sci, Seattle, WA 98101 USA.	s.larson@seattleaquarium.org		Doss, Charles Raouf/0000-0003-1364-5222	Royal Caribbean Ocean Fund; Foley Frischkorn Conservation Fund; Seattle Aquarium	Royal Caribbean Ocean Fund; Foley Frischkorn Conservation Fund; Seattle Aquarium	The authors acknowledge The Seattle Aquarium, a grant from Royal Caribbean Ocean Fund, and a grant from the Foley Frischkorn Conservation Fund for financial support of this project. In kind contributions were provided by staff at The NOAA Northwest Fisheries Science Center, the Washington Department of Fish and Wildlife, Ocean Systems Inc. (Splashcam), and City Fish in Pike Place Market, Seattle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KS, 2007, CAN J ZOOL, V85, P1136, DOI 10.1139/Z07-088; Andrews KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012549; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Castro J. I., 1983, SHARKS N AM WATERS; Celona Antonio, 2005, Bollettino del Museo Civico di Storia Naturale di Venezia, V56, P137; Compagno L.J.V., 1984, FAO SPECIES CATALOGU, V4; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dunbrack R, 2003, CAN J ZOOL, V81, P1107, DOI 10.1139/Z03-087; Dunbrack R, 2005, CAN FIELD NAT, V119, P537, DOI 10.22621/cfn.v119i4.184; Dunbrack R, 2008, CAN FIELD NAT, V122, P124, DOI 10.22621/cfn.v122i2.570; Ebert D. A., 1986, INDOPACIFIC FISH BIO, P437; Fowler SL, 2005, SHARKS RAYS CHIMAERA; Gallucci V. F., 2009, BIOL MANAGEMENT SPIN, P1; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; Kabasakal Hakan, 2006, Annales Series Historia Naturalis, V16, P29; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Klimley AP, 1985, S CAL ACAD SCI MEM, V9, P15; Klimley AP, 1982, THESIS U CALIFORNIA; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Larson S, 2011, CONSERV GENET, V12, P679, DOI 10.1007/s10592-010-0174-9; Levin PS, 2012, CURR ZOOL, V58, P103, DOI 10.1093/czoolo/58.1.103; Lucifora LO, 2005, MAR ECOL PROG SER, V289, P237, DOI 10.3354/meps289237; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; McClintock BT, 2009, ECOLOGY, V90, P313, DOI 10.1890/08-0973.1; Nakano H., 1994, B NATL RES I FAR SEA, V31, P141; QUINN TP, 1980, FISH B-NOAA, V78, P816; Reum JCP, 2008, ESTUAR COAST, V31, P790, DOI 10.1007/s12237-008-9064-5; Ruckelshaus M.H., 2007, SOUND SCI SYNTHESIZI; Springer S, 1950, TEX J SCI, V1950, P349; Strickland RM, 1983, FERTILE FJORD PLANKT; White G. C., 2012, PROGRAM MARK; Williams GD, 2012, J FISH BIOL, V80, P1380, DOI 10.1111/j.1095-8649.2011.03179.x; Williams GD, 2010, T AM FISH SOC, V139, P108, DOI 10.1577/T09-045.1; [No title captured]	34	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87081	10.1371/journal.pone.0087081	http://dx.doi.org/10.1371/journal.pone.0087081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475229	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300136
J	Howe, SE; Lickteig, DJ; Plunkett, KN; Ryerse, JS; Konjufca, V				Howe, Savannah E.; Lickteig, Duane J.; Plunkett, Kyle N.; Ryerse, Jan S.; Konjufca, Vjollca			The Uptake of Soluble and Particulate Antigens by Epithelial Cells in the Mouse Small Intestine	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSPORT; MUCUS; PERMEABILITY; BACTERIA; PATCH; MACROMOLECULES; NANOPARTICLES; ENTEROCYTES; ENDOCYTOSIS	Intestinal epithelial cells (IECs) overlying the villi play a prominent role in absorption of digested nutrients and establish a barrier that separates the internal milieu from potentially harmful microbial antigens. Several mechanisms by which antigens of dietary and microbial origin enter the body have been identified; however whether IECs play a role in antigen uptake is not known. Using in vivo imaging of the mouse small intestine, we investigated whether epithelial cells (enterocytes) play an active role in the uptake (sampling) of lumen antigens. We found that small molecular weight antigens such as chicken ovalbumin, dextran, and bacterial LPS enter the lamina propria, the loose connective tissue which lies beneath the epithelium via goblet cell associated passageways. However, epithelial cells overlying the villi can internalize particulate antigens such as bacterial cell debris and inert nanoparticles (NPs), which are then found co-localizing with the CD11c+ dendritic cells in the lamina propria. The extent of NP uptake by IECs depends on their size: 20-40 nm NPs are taken up readily, while NPs larger than 100 nm are taken up mainly by the epithelial cells overlying Peyer's patches. Blocking NPs with small proteins or conjugating them with ovalbumin does not inhibit their uptake. However, the uptake of 40 nm NPs can be inhibited when they are administered with an endocytosis inhibitor (chlorpromazine). Delineating the mechanisms of antigen uptake in the gut is essential for understanding how tolerance and immunity to lumen antigens are generated, and for the development of mucosal vaccines and therapies.	[Howe, Savannah E.; Lickteig, Duane J.; Konjufca, Vjollca] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Plunkett, Kyle N.] So Illinois Univ, Dept Chem, Carbondale, IL 62901 USA; [Ryerse, Jan S.] St Louis Univ Sch Med, Dept Pathol, St Louis, MO USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Saint Louis University	Konjufca, V (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097	Southern Illinois University	Southern Illinois University	This work was supported by the start up funds provided to Vjollca Konjufca by Southern Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bozzola John J, 2007, Methods Mol Biol, V369, P449; Bu HF, 2010, J CELL PHYSIOL, V222, P658, DOI 10.1002/jcp.21985; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fihn BM, 2000, GASTROENTEROLOGY, V119, P1029, DOI 10.1053/gast.2000.18148; GIOCONDI MC, 1995, BBA-BIOMEMBRANES, V1234, P197, DOI 10.1016/0005-2736(94)00284-V; Heyman M, 2000, ANN NY ACAD SCI, V915, P304; HEYMAN M, 1982, AM J PHYSIOL, V242, pG558, DOI 10.1152/ajpgi.1982.242.6.G558; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; JANI P, 1990, J PHARM PHARMACOL, V42, P821, DOI 10.1111/j.2042-7158.1990.tb07033.x; JANI P, 1989, J PHARM PHARMACOL, V41, P809, DOI 10.1111/j.2042-7158.1989.tb06377.x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kyd JM, 2008, VACCINE, V26, P6221, DOI 10.1016/j.vaccine.2008.09.061; Lai SK, 2007, BIOMATERIALS, V28, P2876, DOI 10.1016/j.biomaterials.2007.02.021; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; NEUTRA MR, 1987, CELL TISSUE RES, V247, P537, DOI 10.1007/BF00215747; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Primard C, 2010, BIOMATERIALS, V31, P6060, DOI 10.1016/j.biomaterials.2010.04.021; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SAVIDGE TC, 1994, PFLUG ARCH EUR J PHY, V428, P391, DOI 10.1007/BF00724523; Tavelin S, 2003, PHARMACEUT RES, V20, P397, DOI 10.1023/A:1022699920043; Zhu Q, 2012, NATURE MED	33	55	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86656	10.1371/journal.pone.0086656	http://dx.doi.org/10.1371/journal.pone.0086656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475164	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300099
J	Perot, G; Soubeyran, I; Ribeiro, A; Bonhomme, B; Savagner, F; Boutet-Bouzamondo, N; Hostein, I; Bonichon, F; Godbert, Y; Chibon, F				Perot, Gaelle; Soubeyran, Isabelle; Ribeiro, Agnes; Bonhomme, Benjamin; Savagner, Frederique; Boutet-Bouzamondo, Nathalie; Hostein, Isabelle; Bonichon, Francoise; Godbert, Yann; Chibon, Frederic			Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas	PLOS ONE			English	Article							LUNG-CANCER; PAPILLARY; PROTEIN; ALK; PATIENT; GENES; NPM	Thyroid carcinoma is the most common endocrine malignant tumor and accounts for 1% of all new malignant diseases. Among all types and subtypes of thyroid cancers that have been described so far, papillary thyroid carcinoma is the most frequent. The standard management treatment of these tumors consists of surgery, followed by radioiodine treatment in case of high risk of relapse. The most aggressive forms are commonly treated by chemotherapy, radiotherapy or experimental drug testing. We recently reported the case of a patient presenting an anaplastic thyroid carcinoma with lung metastases. Fluorescence in situ hybridization analysis allowed us to detect a rearrangement of the anaplastic lymphoma kinase (ALK) gene in both tumors. The patient was treated with crizotinib and presented an excellent drug response. We present here the subsequent investigations carried out to further characterize this genetic alteration and to assess the prevalence of ALK rearrangements in thyroid lesions. High resolution array-comparative genomic hybridization data complemented by RT-PCR and sequencing analyses, allowed us to demonstrate the presence of a STRN/ALK fusion. The STRN/ALK transcript consisted of the fusion between exon 3 of STRN and exon 20 of ALK. Subsequent screening of 75 various thyroid tumors by RT-PCR revealed that 2 out of 29 papillary thyroid carcinomas exhibited the same fusion transcript. None was detected in other types of malignant or benign thyroid lesions analyzed. These findings could pave the way for the development of new targeted therapeutic strategies in the treatment of papillary thyroid carcinomas and point to ALK inhibitors as promising agents that merit rapid evaluation.	[Perot, Gaelle; Soubeyran, Isabelle; Ribeiro, Agnes; Bonhomme, Benjamin; Hostein, Isabelle] Inst Bergonie, Dept Biopathol, Bordeaux, France; [Perot, Gaelle; Soubeyran, Isabelle; Chibon, Frederic] Inst Bergonie, INSERM, U916, Bordeaux, France; [Savagner, Frederique; Boutet-Bouzamondo, Nathalie] Inst Biol Sante, INSERM, U694, Angers, France; [Bonichon, Francoise; Godbert, Yann] Inst Bergonie, Dept Nucl Med, Bordeaux, France; [Chibon, Frederic] Inst Bergonie, Bordeaux, France	UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie	Chibon, F (corresponding author), Inst Bergonie, INSERM, U916, Bordeaux, France.	f.chibon@bordeaux.unicancer.fr	Pérot, Gaëlle/W-8038-2019; Pérot, Gaëlle/J-3912-2014; chibon, frederic/A-2651-2013	chibon, Frederic/0000-0002-6548-2181				Baudin E, 2007, LANCET ONCOL, V8, P148, DOI 10.1016/S1470-2045(07)70034-7; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Boonyaratanakornkit V, 2011, STEROIDS, V76, P877, DOI 10.1016/j.steroids.2011.02.017; Brose MS, 2013, ASCO M, V31, P4; Curtis CE, 2007, BRIT J HAEMATOL, V138, P77, DOI 10.1111/j.1365-2141.2007.06628.x; D'Avanzo A, 2004, CANCER-AM CANCER SOC, V100, P1123, DOI 10.1002/cncr.20081; DeLellis R, 2004, WHO CLASSIFICATION T; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Godbert Y, J CLIN ONCO IN PRESS; Hamatani K, 2012, THYROID, V22, P1153, DOI 10.1089/thy.2011.0511; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Martinez P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052261; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Perot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040015; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Schlumberger M, 2012, EUR J ENDOCRINOL, V166, P5, DOI 10.1530/EJE-11-0631; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; SHIOTA M, 1994, ONCOGENE, V9, P1567; Smallridge RC, 2012, J CLIN ENDOCR METAB, V97, P2566, DOI 10.1210/jc.2012-1314; Terrier-Lacombe MJ, 2009, MODERN PATHOL, V22, P87, DOI 10.1038/modpathol.2008.156; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431	27	59	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87170	10.1371/journal.pone.0087170	http://dx.doi.org/10.1371/journal.pone.0087170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475247	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300149
J	Rabenau, HF; Steinmann, J; Rapp, I; Schwebke, I; Eggers, M				Rabenau, Holger F.; Steinmann, Jochen; Rapp, Ingrid; Schwebke, Ingeborg; Eggers, Maren			Evaluation of a Virucidal Quantitative Carrier Test for Surface Disinfectants	PLOS ONE			English	Article							CHEMICAL DISINFECTION; MURINE NOROVIRUS; HEMATOLOGY UNIT; EFFICACY; OUTBREAK; TRANSMISSION; INACTIVATION; DEPENDENCE	Surface disinfectants are part of broader preventive strategies preventing the transmission of bacteria, fungi and viruses in medical institutions. To evaluate their virucidal efficacy, these products must be tested with appropriate model viruses with different physico-chemical properties under conditions representing practical application in hospitals. The aim of this study was to evaluate a quantitative carrier assay. Furthermore, different putative model viruses like adenovirus type 5 (AdV5) and different animal parvoviruses were evaluated with respect to their tenacity and practicability in laboratory handling. To evaluate the robustness of the method, some of the viruses were tested in parallel in different laboratories in a multicenter study. Different biocides, which are common active ingredients of surface disinfectants, were used in the test. After drying on stainless steel discs as the carrier, model viruses were exposed to different concentrations of three alcohols, peracetic acid (PAA) or glutaraldehyde (GDA), with a fixed exposure time of 5 minutes. Residual virus was determined after treatment by endpoint titration. All parvoviruses exhibited a similar stability with respect to GDA, while AdV-5 was more susceptible. For PAA, the porcine parvovirus was more sensitive than the other parvoviruses, and again, AdV-5 presented a higher susceptibility than the parvoviruses. All parvoviruses were resistant to alcohols, while AdV-5 was only stable when treated with 2-propanol. The analysis of the results of the multi-center study showed a high reproducibility of this test system. In conclusion, two viruses with different physico-chemical properties can be recommended as appropriate model viruses for the evaluation of the virucidal efficacy of surface disinfectants: AdV-5, which has a high clinical impact, and murine parvovirus (MVM) with the highest practicability among the parvoviruses tested.	[Rabenau, Holger F.] Hosp Johann Wolfgang Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany; [Steinmann, Jochen] MikroLab GmbH, Bremen, Germany; [Rapp, Ingrid] Lab Dr Merk & Kollegen, Ochsenhausen, Germany; [Schwebke, Ingeborg] Robert Koch Inst, Berlin, Germany; [Eggers, Maren] Lab Prof G Enders & Kollegen MVZ, Stuttgart, Germany; [Eggers, Maren] Inst Virol Infect Dis & Epidemiol eV, Stuttgart, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Robert Koch Institute	Eggers, M (corresponding author), Lab Prof G Enders & Kollegen MVZ, Stuttgart, Germany.	eggers@labor-enders.de		Eggers, Maren/0000-0001-8485-9485				[Anonymous], 13697 EN; [Anonymous], 2008, 216WI00216037 CEN; [Anonymous], 13727 EN; [Anonymous], 14476 EN; [Anonymous], 1995, BUNDESGESUNDHEITSBLA, V6, P242; Baert L, 2009, J FOOD PROTECT, V72, P1047, DOI 10.4315/0362-028X-72.5.1047; Blumel J, 2009, HYGMED, V34, P293; Buchbinder N, 2011, J HOSP INFECT, V79, P155, DOI 10.1016/j.jhin.2011.04.019; Doerr HW, 2012, MED MICROBIOL IMMUN, V201, P1, DOI 10.1007/s00430-011-0219-9; Eggers M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-347; Eterpi M, 2009, J HOSP INFECT, V73, P64, DOI 10.1016/j.jhin.2009.05.016; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; Girard M, 2010, J FOOD PROTECT, V73, P400, DOI 10.4315/0362-028X-73.2.400; Jalal H, 2005, J CLIN MICROBIOL, V43, P2575, DOI 10.1128/JCM.43.6.2575-2580.2005; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Krug PW, 2011, BIOLOGICALS, V39, P231, DOI 10.1016/j.biologicals.2011.06.016; Li D, 2011, APPL ENVIRON MICROB, V77, P1399, DOI 10.1128/AEM.02131-10; Magulski T, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-107; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Peters J, 1998, ZBL HYG UMWELTMED, V201, P311; Peters J, 1995, HYG MED, V20, P20; Poschetto LF, 2007, APPL ENVIRON MICROB, V73, P5494, DOI 10.1128/AEM.00482-07; Rabenau HF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-185; Rogers M, 2000, AM J INFECT CONTROL, V28, P378, DOI 10.1067/mic.2000.109908; SAKNIMIT M, 1988, EXP ANIM TOKYO, V37, P341, DOI 10.1538/expanim1978.37.3_341; Scagnolari C, 2012, MED MICROBIOL IMMUN, V201, P311, DOI 10.1007/s00430-012-0233-6; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; SPICHER G, 1995, ZBL HYG UMWELTMED, V196, P545; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; van Klingeren B, 1998, INT BIODETER BIODEGR, V41, P289, DOI 10.1016/S0964-8305(98)00020-1; van Klingeren B., 2007, GMS KRANKENHAUSHYG I, V2; VANKLINGEREN B, 1995, J HOSP INFECT, V30, P397, DOI 10.1016/0195-6701(95)90044-6; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196	35	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86128	10.1371/journal.pone.0086128	http://dx.doi.org/10.1371/journal.pone.0086128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475079	Green Published, gold			2022-12-27	WOS:000330507300038
J	Shepheard, SR; Chataway, T; Schultz, DW; Rush, RA; Rogers, ML				Shepheard, Stephanie R.; Chataway, Tim; Schultz, David W.; Rush, Robert A.; Rogers, Mary-Louise			The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PREDICTS SURVIVAL-TIME; SUBUNIT PNF-H; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; CSF BIOMARKERS; SPINAL-CORD; MOUSE MODEL; DIAGNOSIS; IDENTIFICATION	Objective biomarkers for amyotrophic lateral sclerosis would facilitate the discovery of new treatments. The common neurotrophin receptor p75 is up regulated and the extracellular domain cleaved from injured neurons and peripheral glia in amyotrophic lateral sclerosis. We have tested the hypothesis that urinary levels of extracellular neurotrophin receptor p75 serve as a biomarker for both human motor amyotrophic lateral sclerosis and the SOD1(G93A) mouse model of the disease. The extracellular domain of neurotrophin receptor p75 was identified in the urine of amyotrophic lateral sclerosis patients by an immuno-precipitation/western blot procedure and confirmed by mass spectrometry. An ELISA was established to measure urinary extracellular neurotrophin receptor p75. The mean value for urinary extracellular neurotrophin receptor p75 from 28 amyotrophic lateral sclerosis patients measured by ELISA was 7.9 +/- 0.5 ng/mg creatinine and this was significantly higher (p<0.001) than 12 controls (2.6 +/- 0.2 ng/mg creatinine) and 19 patients with other neurological disease (Parkinson's disease and Multiple Sclerosis; 4.1 +/- 0.2 ng/mg creatinine). Pilot data of disease progression rates in 14 MND patients indicates that p75NTR(ECD) levels were significantly higher (p = 0.0041) in 7 rapidly progressing patients as compared to 7 with slowly progressing disease. Extracellular neurotrophin receptor p75 was also readily detected in SOD1(G93A) mice by immuno-precipitation/western blot before the onset of clinical symptoms. These findings indicate a significant relation between urinary extracellular neurotrophin receptor p75 levels and disease progression and suggests that it may be a useful marker of disease activity and progression in amyotrophic lateral sclerosis.	[Shepheard, Stephanie R.; Chataway, Tim; Rush, Robert A.; Rogers, Mary-Louise] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Shepheard, Stephanie R.; Chataway, Tim; Rush, Robert A.; Rogers, Mary-Louise] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Schultz, David W.] Flinders Med Ctr, Dept Neurol, Bedford Pk, SA, Australia; [Schultz, David W.] Flinders Med Ctr, MND Clin, Bedford Pk, SA, Australia	Flinders University South Australia; Flinders University South Australia; Flinders Medical Centre; Flinders Medical Centre	Rogers, ML (corresponding author), Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia.	mary-louise.rogers@flinders.edu.au		Chataway, Tim/0000-0003-0254-8099; Shepheard, Stephanie/0000-0002-2358-7348; Schultz, David/0000-0001-6319-7574; Rogers, Mary-Louise/0000-0002-3482-8741	Motor Neuron Disease Research Institute of Australia; FMC Foundation South Australia; Australian Rotary Health; Flinders University	Motor Neuron Disease Research Institute of Australia; FMC Foundation South Australia; Australian Rotary Health; Flinders University	This study was supported by grants from the Motor Neuron Disease Research Institute of Australia (MLR, RAR), FMC Foundation South Australia (MLR, RAR, TC and DWS) and a Flinders University PhD scholarship supported by Australian Rotary Health (SRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SG, 2007, AM STAT, V61, P343, DOI 10.1198/000313007X247643; Bowser R, 2011, NAT REV NEUROL, V7, P631, DOI 10.1038/nrneurol.2011.151; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cellura E, 2012, CLIN NEUROL NEUROSUR, V114, P550, DOI 10.1016/j.clineuro.2011.11.026; Copray JCVM, 2003, NEUROSCIENCE, V116, P685, DOI 10.1016/S0306-4522(02)00755-8; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; DISTEFANO PS, 1991, ANN NEUROL, V29, P13, DOI 10.1002/ana.410290105; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferri CC, 1998, J NEUROBIOL, V34, P1; Foerster BR, 2012, ACAD RADIOL, V19, P1075, DOI 10.1016/j.acra.2012.04.012; Ganesalingam J, 2013, AMYOTROPH LAT SCL FR, V14, P146, DOI 10.3109/21678421.2012.729596; Ganesalingam J, 2011, J NEUROCHEM, V117, P528, DOI 10.1111/j.1471-4159.2011.07224.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Huh CYL, 2008, J NEUROSCI, V28, P1404, DOI 10.1523/JNEUROSCI.4851-07.2008; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Kaufmann P, 2005, NEUROLOGY, V64, P38, DOI 10.1212/01.WNL.0000148648.38313.64; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; KERKHOFF H, 1991, ACTA NEUROPATHOL, V81, P649, DOI 10.1007/BF00296375; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Kruger T, 2013, PROTEOM CLIN APPL, V7, P123, DOI 10.1002/prca.201200067; Leitner M, 2009, WORKING ALS MICE GUI, P1; LINDNER MD, 1993, ARCH NEUROL-CHICAGO, V50, P1054, DOI 10.1001/archneur.1993.00540100049013; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; Mannen T, 1991, Rinsho Shinkeigaku, V31, P1281; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; MUFSON EJ, 1991, BRAIN RES, V539, P19, DOI 10.1016/0006-8993(91)90682-L; Ono S, 1999, ACTA NEUROL SCAND, V100, P111; Otto M, 2012, AMYOTROPH LATERAL SC, V13, P1, DOI 10.3109/17482968.2011.627589; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; ROGERS M, 2006, LIBR J, V131, P158; Rogers ML, 2010, J NEUROIMMUNOL, V226, P93, DOI 10.1016/j.jneuroim.2010.05.040; SEEBURGER JL, 1993, BRAIN RES, V621, P111, DOI 10.1016/0006-8993(93)90304-6; Silani V, 2011, ARCH ITAL BIOL, V149, P5, DOI 10.4449/aib.v149i1.1260; Thongboonkerd V, 2006, J PROTEOME RES, V5, P183, DOI 10.1021/pr0502525; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; Turner MR, 2013, AMYOTROPH LAT SCL FR, V14, P19, DOI 10.3109/21678421.2013.778554; Wilson CH, 2011, PROTEOMICS, V11, P4385, DOI 10.1002/pmic.201100053; Yamamoto T, 2010, CANADA PROTEOMICS, V10, P2069; YAN Q, 1988, J NEUROSCI, V8, P3481; ZUPAN AA, 1989, J BIOL CHEM, V264, P11714	48	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87398	10.1371/journal.pone.0087398	http://dx.doi.org/10.1371/journal.pone.0087398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475283	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300178
J	Yan, WJ; Li, XB; Wang, SJ; Zhao, GY; Liu, YJ; Chen, YH; Fu, XL				Yan, Wen-Jing; Li, Xiaobai; Wang, Su-Jing; Zhao, Guoying; Liu, Yong-Jin; Chen, Yu-Hsin; Fu, Xiaolan			CASME II: An Improved Spontaneous Micro-Expression Database and the Baseline Evaluation	PLOS ONE			English	Article								A robust automatic micro-expression recognition system would have broad applications in national safety, police interrogation, and clinical diagnosis. Developing such a system requires high quality databases with sufficient training samples which are currently not available. We reviewed the previously developed micro-expression databases and built an improved one (CASME II), with higher temporal resolution (200 fps) and spatial resolution (about 280x340 pixels on facial area). We elicited participants' facial expressions in a well-controlled laboratory environment and proper illumination (such as removing light flickering). Among nearly 3000 facial movements, 247 micro-expressions were selected for the database with action units (AUs) and emotions labeled. For baseline evaluation, LBP-TOP and SVM were employed respectively for feature extraction and classifier with the leave-one-subject-out cross-validation method. The best performance is 63.41% for 5-class classification.	[Yan, Wen-Jing; Wang, Su-Jing; Chen, Yu-Hsin; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Yan, Wen-Jing; Chen, Yu-Hsin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Xiaobai; Zhao, Guoying] Univ Oulu, Dept Comp Sci & Engn, Ctr Machine Vis Res, Oulu, Finland; [Liu, Yong-Jin] Tsinghua Univ, Dept Comp Sci & Technol, TNList, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Oulu; Tsinghua University	Fu, XL (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	fuxl@psych.ac.cn	Zhao, Guoying/ABE-7716-2020; Liu, Yong/GWQ-6163-2022	Zhao, Guoying/0000-0003-3694-206X; Wang, Su-Jing/0000-0002-8774-6328	National Natural Science Foundation of China [61075042, 61322206, 61375009, 61379095]; 973 Program [2011CB302201]; China Postdoctoral Science Foundation [2012M580428]; Academy of Finland and Infotech Oulu;  [NCET-11-0273]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Academy of Finland and Infotech Oulu; 	This work is partly supported by the National Natural Science Foundation of China (61075042, 61322206, 61375009, 61379095); 973 Program (2011CB302201), China Postdoctoral Science Foundation (2012M580428); NCET-11-0273; GZ and XL were supported by Academy of Finland and Infotech Oulu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifanti N, 2010, 11 INT WORKSH IM AN, P1; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; EKMAN P, 1969, PSYCHIATR, V32, P88, DOI 10.1080/00332747.1969.11023575; Ekman P., 2009, TELLING LIES CLUES D; Ekman P., 2002, FACS INVESTIGATORS G; Frank MG, 1997, J PERS SOC PSYCHOL, V72, P1429, DOI 10.1037/0022-3514.72.6.1429; GODAVARTHY S., 2010, MICROEXPRESSION SPOT; GOSHTASBY A, 1988, IMAGE VISION COMPUT, V6, P255, DOI 10.1016/0262-8856(88)90016-9; Li XB, 2013, IEEE INT CONF AUTOMA, DOI 10.1109/FG.2013.6553717; Lucey P., 2010, 2010 IEEE COMPUTER S, P94, DOI [10.1109/cvprw.2010.5543262, DOI 10.1109/CVPRW.2010.5543262, 10.1109/CVPRW.2010.5543262]; Lyons M, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P200, DOI 10.1109/AFGR.1998.670949; Matsumoto D, 2011, MOTIV EMOTION, V35, P181, DOI 10.1007/s11031-011-9212-2; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pfister T, 2011, IEEE I CONF COMP VIS, P1449, DOI 10.1109/ICCV.2011.6126401; Polikovsky S., 2009, P IET SEM 2009, P1, DOI DOI 10.1049/IC.2009.0244; Porter S, 2008, PSYCHOL SCI, V19, P508, DOI 10.1111/j.1467-9280.2008.02116.x; Ruiz-Hernandez JA, 2013, 10 P INT C AUT FAC G, DOI [10.1109/FG.2013.6553709, DOI 10.1109/FG.2013.6553709]; Shreve Matthew, 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P51, DOI 10.1109/FG.2011.5771451; Valstar M.F., 2010, P 3 INT WORKSH EMOTI, P65; Wang SJ, 2014, NEURAL PROCESS LETT, V39, P25, DOI 10.1007/s11063-013-9288-7; Wu Q, 2011, LECT NOTES COMPUT SC, V6975, P152, DOI 10.1007/978-3-642-24571-8_16; Yan W.-J., 2013, 2013 10 IEEE INT C W, P1, DOI DOI 10.1109/FG.2013.6553799; Yan WJ, 2013, J NONVERBAL BEHAV, V37, P217, DOI 10.1007/s10919-013-0159-8; Yin L., 2008, AUTOMATIC FACE GESTU, V08, P1, DOI DOI 10.1109/AFGR.2008.4813324; Yin LJ, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P211; Zhao GY, 2007, IEEE T PATTERN ANAL, V29, P915, DOI 10.1109/TPAMI.2007.1110	28	360	394	8	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86041	10.1371/journal.pone.0086041	http://dx.doi.org/10.1371/journal.pone.0086041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475068	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300034
J	Lou, WC; Wang, XQ; Chen, F; Chen, YX; Jiang, B; Zhang, H				Lou, Wangchao; Wang, Xiaoqing; Chen, Fan; Chen, Yixiao; Jiang, Bo; Zhang, Hua			Sequence Based Prediction of DNA-Binding Proteins Based on Hybrid Feature Selection Using Random Forest and Gaussian Naive Bayes	PLOS ONE			English	Article							RIBOSOMAL-RNA-BINDING; SECONDARY STRUCTURE; EVOLUTIONARY CONSERVATION; FOLD RECOGNITION; IDENTIFICATION; COVARIANCE; RESOLUTION; ACCURATE; RECEPTORS; DOMAINS	Developing an efficient method for determination of the DNA-binding proteins, due to their vital roles in gene regulation, is becoming highly desired since it would be invaluable to advance our understanding of protein functions. In this study, we proposed a new method for the prediction of the DNA-binding proteins, by performing the feature rank using random forest and the wrapper-based feature selection using forward best-first search strategy. The features comprise information from primary sequence, predicted secondary structure, predicted relative solvent accessibility, and position specific scoring matrix. The proposed method, called DBPPred, used Gaussian naive Bayes as the underlying classifier since it outperformed five other classifiers, including decision tree, logistic regression, k-nearest neighbor, support vector machine with polynomial kernel, and support vector machine with radial basis function. As a result, the proposed DBPPred yields the highest average accuracy of 0.791 and average MCC of 0.583 according to the five-fold cross validation with ten runs on the training benchmark dataset PDB594. Subsequently, blind tests on the independent dataset PDB186 by the proposed model trained on the entire PDB594 dataset and by other five existing methods (including iDNA-Prot, DNA-Prot, DNAbinder, DNABIND and DBD-Threader) were performed, resulting in that the proposed DBPPred yielded the highest accuracy of 0.769, MCC of 0.538, and AUC of 0.790. The independent tests performed by the proposed DBPPred on completely a large non-DNA binding protein dataset and two RNA binding protein datasets also showed improved or comparable quality when compared with the relevant prediction methods. Moreover, we observed that majority of the selected features by the proposed method are statistically significantly different between the mean feature values of the DNA-binding and the non DNA-binding proteins. All of the experimental results indicate that the proposed DBPPred can be an alternative perspective predictor for large-scale determination of DNA-binding proteins.	[Lou, Wangchao; Wang, Xiaoqing; Chen, Fan; Chen, Yixiao; Jiang, Bo; Zhang, Hua] Zhejiang Gongshang Univ, Sch Comp & Informat Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Gongshang University	Zhang, H (corresponding author), Zhejiang Gongshang Univ, Sch Comp & Informat Engn, Hangzhou, Zhejiang, Peoples R China.	zerozhua@126.com			National Natural Science Foundation of China [61170099]; Zhejiang Provincial Natural Science Foundation of China [Y1110840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (grant no. 61170099) and the Zhejiang Provincial Natural Science Foundation of China (grant no. Y1110840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Boulesteix AL, 2012, BRIEF BIOINFORM, V13, P292, DOI 10.1093/bib/bbr053; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; CAJONE F, 1989, BIOCHEM J, V262, P977, DOI 10.1042/bj2620977; Cao J, 2003, BIOINFORMATICS, V19, P234, DOI 10.1093/bioinformatics/19.2.234; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; Dey S, 2012, NUCLEIC ACIDS RES, V40, P7150, DOI 10.1093/nar/gks405; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Eickholt J, 2012, BIOINFORMATICS, V28, P3066, DOI 10.1093/bioinformatics/bts598; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; FREEMAN K, 1995, GENETICS, V141, P1253; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000567; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guo YZ, 2006, PROTEINS, V65, P55, DOI 10.1002/prot.21097; Han LY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-549; Huang HL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S47; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Langlois RE, 2010, NUCLEIC ACIDS RES, V38, P3149, DOI 10.1093/nar/gkq061; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu LA, 2012, CURR OPIN STRUC BIOL, V22, P397, DOI 10.1016/j.sbi.2012.06.002; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Murakami Y, 2010, BIOINFORMATICS, V26, P1841, DOI 10.1093/bioinformatics/btq302; Nanni L, 2008, AMINO ACIDS, V34, P635, DOI 10.1007/s00726-007-0016-3; Nanni L, 2009, AMINO ACIDS, V36, P167, DOI 10.1007/s00726-008-0044-7; Nimrod G, 2010, BIOINFORMATICS, V26, P692, DOI 10.1093/bioinformatics/btq019; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raizada RDS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069566; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Shazman S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000146; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Szaboova A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S3; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tegge AN, 2009, NUCLEIC ACIDS RES, V37, pW515, DOI 10.1093/nar/gkp305; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhang H, 2012, AMINO ACIDS, V42, P271, DOI 10.1007/s00726-010-0805-y; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang T, 2010, CURR PROTEIN PEPT SC, V11, P609, DOI 10.2174/138920310794109193; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060559; Zhao HY, 2011, RNA BIOL, V8, P988, DOI 10.4161/rna.8.6.17813; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	63	107	107	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86703	10.1371/journal.pone.0086703	http://dx.doi.org/10.1371/journal.pone.0086703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475169	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800055
J	Moskalev, A; Shaposhnikov, M; Snezhkina, A; Kogan, V; Plyusnina, E; Peregudova, D; Melnikova, N; Uroshlev, L; Mylnikov, S; Dmitriev, A; Plusnin, S; Fedichev, P; Kudryavtseva, A				Moskalev, Alexey; Shaposhnikov, Mikhail; Snezhkina, Anastasia; Kogan, Valeria; Plyusnina, Ekaterina; Peregudova, Darya; Melnikova, Nataliya; Uroshlev, Leonid; Mylnikov, Sergey; Dmitriev, Alexey; Plusnin, Sergey; Fedichev, Peter; Kudryavtseva, Anna			Mining Gene Expression Data for Pollutants (Dioxin, Toluene, Formaldehyde) and Low Dose of Gamma-Irradiation	PLOS ONE			English	Article							DROSOPHILA SEMINAL FLUID; MELANOGASTER CYTOCHROME-P450 GENES; ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR-BETA; INSECTICIDE-RESISTANCE; OXIDATIVE STRESS; LIFE-SPAN; NEUROBLAST PROLIFERATION; INHALED FORMALDEHYDE; MOLECULAR EVOLUTION	General and specific effects of molecular genetic responses to adverse environmental factors are not well understood. This study examines genome-wide gene expression profiles of Drosophila melanogaster in response to ionizing radiation, formaldehyde, toluene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin. We performed RNA-seq analysis on 25,415 transcripts to measure the change in gene expression in males and females separately. An analysis of the genes unique to each treatment yielded a list of genes as a gene expression signature. In the case of radiation exposure, both sexes exhibited a reproducible increase in their expression of the transcription factors sugarbabe and tramtrack. The influence of dioxin up-regulated metabolic genes, such as anachronism, CG16727, and several genes with unknown function. Toluene activated a gene involved in the response to the toxins, Cyp12d1-p; the transcription factor Fer3's gene; the metabolic genes CG2065, CG30427, and CG34447; and the genes Spn28Da and Spn3, which are responsible for reproduction and immunity. All significantly differentially expressed genes, including those shared among the stressors, can be divided into gene groups using Gene Ontology Biological Process identifiers. These gene groups are related to defense response, biological regulation, the cell cycle, metabolic process, and circadian rhythms. KEGG molecular pathway analysis revealed alteration of the Notch signaling pathway, TGF-beta signaling pathway, proteasome, basal transcription factors, nucleotide excision repair, Jak-STAT signaling pathway, circadian rhythm, Hippo signaling pathway, mTOR signaling pathway, ribosome, mismatch repair, RNA polymerase, mRNA surveillance pathway, Hedgehog signaling pathway, and DNA replication genes. Females and, to a lesser extent, males actively metabolize xenobiotics by the action of cytochrome P450 when under the influence of dioxin and toluene. Finally, in this work we obtained gene expression signatures pollutants (dioxin, toluene), low dose of gamma-irradiation and common molecular pathways for different kind of stressors.	[Moskalev, Alexey; Shaposhnikov, Mikhail; Plyusnina, Ekaterina; Peregudova, Darya; Plusnin, Sergey] RAS, Lab Mol Radiobiol & Gerontol, Inst Biol, Komi Sci Ctr, Syktyvkar, Russia; [Snezhkina, Anastasia; Melnikova, Nataliya; Uroshlev, Leonid; Dmitriev, Alexey; Kudryavtseva, Anna] RAS, Grp Postgen Studies, Engelhardt Inst Mol Biol, Moscow 117901, Russia; [Moskalev, Alexey; Shaposhnikov, Mikhail; Plyusnina, Ekaterina; Plusnin, Sergey] Syktyvkar State Univ, Dept Ecol, Syktyvkar, Russia; [Moskalev, Alexey; Kogan, Valeria; Fedichev, Peter] Moscow Inst Phys & Technol, Lab Genet Aging & Longev, Dolgoprudnyi, Russia; [Uroshlev, Leonid] Vavilov Inst Gen Genet, Dept Computat Syst Biol, Moscow, Russia; [Mylnikov, Sergey] St Petersburg State Univ, Dept Genet, St Petersburg 199034, Russia; [Kogan, Valeria; Fedichev, Peter] Quantum Pharmaceut, Moscow, Russia	Russian Academy of Sciences; Institute of Biology, Komi Scientific Centre, Ural Branch RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Syktyvkar State University; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Vavilov Institute of General Genetics; Saint Petersburg State University	Moskalev, A (corresponding author), RAS, Lab Mol Radiobiol & Gerontol, Inst Biol, Komi Sci Ctr, Syktyvkar, Russia.	amoskalev@ib.komisc.ru	Uroshlev, Leonid/E-7814-2014; Melnikova, Nataliya V./E-5894-2014; Moskalev, Alexey/H-4856-2013; Peregudova, Darya/O-3467-2014; Kudryavtseva, Anna V/C-9032-2014; Proshkina, Ekaterina N/F-7948-2014; Shaposhnikov, Mikhail/M-7514-2013; Mylnikov, Sergey/D-1970-2013; Snezhkina, Anastasiya V./E-6765-2014; Dmitriev, Alexey A./D-6109-2011	Melnikova, Nataliya V./0000-0001-8083-3018; Moskalev, Alexey/0000-0002-3248-1633; Peregudova, Darya/0000-0001-6872-1013; Kudryavtseva, Anna V/0000-0002-3722-8207; Proshkina, Ekaterina N/0000-0003-4558-1796; Shaposhnikov, Mikhail/0000-0002-4625-6488; Mylnikov, Sergey/0000-0001-8611-8218; Dmitriev, Alexey A./0000-0002-6827-9584; fedichev, peter/0000-0003-0404-808X	Ministry of Education and Science [N 14.B37.21.0560]; Presidium of the RAS [N 12-P-4-1005]; CrowdAge.org initiative; Russian Federation for young scientists [MD-1090.2014.4]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Presidium of the RAS(Russian Academy of Sciences); CrowdAge.org initiative; Russian Federation for young scientists	The work was supported by grant N 14.B37.21.0560 of Federal Target Program "Sientific and scientific-pedagogical personnel of innovative Russia'' by Ministry of Education and Science, grant N 12-P-4-1005, 2012-2014 of Presidium of the RAS "Ecological genetics of the lifespan of model animals (Drosophila melanogaster, Mus musculus)'' and by the CrowdAge.org initiative. Supported by grant of President Of Russian Federation for young scientists MD-1090.2014.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen ME, 2008, TOXICOL SCI, V105, P368, DOI 10.1093/toxsci/kfn097; [Anonymous], 1990, COLO MED, V87, P81; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; ATSDR, 2001, TOL TOX, P32; Bajpe PK, 2008, MOL CELL BIOL, V28, P1606, DOI 10.1128/MCB.01567-07; Banhegyi G, 2003, BIOFACTORS, V17, P37, DOI 10.1002/biof.5520170105; Bartoletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049958; Belyaeva OV, 2009, BBA-GEN SUBJECTS, V1790, P1266, DOI 10.1016/j.bbagen.2009.06.002; BIGELOW SW, 1985, ARCH TOXICOL, V56, P219, DOI 10.1007/BF00295157; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bruskov VI, 2012, FREE RADICAL RES, V46, P1280, DOI 10.3109/10715762.2012.709316; Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292; CASANOVA M, 1991, FUND APPL TOXICOL, V17, P409, DOI 10.1016/0272-0590(91)90230-2; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen YJ, 2011, INT J RADIAT ONCOL, V80, P851, DOI 10.1016/j.ijrobp.2011.01.003; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Consonni D, 2012, ENVIRON INT, V44, P151, DOI 10.1016/j.envint.2012.01.004; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daniels RD, 2011, OCCUP ENVIRON MED, V68, P457, DOI 10.1136/oem.2009.054684; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Dorer DR, 2003, GENETICS, V165, P613; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Fachin AL, 2007, RADIAT RES, V168, P650, DOI 10.1667/RR0487.1; Fakhouri M, 2006, DEV BIOL, V293, P127, DOI 10.1016/j.ydbio.2006.01.028; Faust D, 2013, ARCH TOXICOL, V87, P681, DOI 10.1007/s00204-012-0979-z; Feinendegen LE, 2001, J NUCL MED, V42, p17N; Feng G, 2012, METHODS MOL BIOL, V802, P101, DOI 10.1007/978-1-61779-400-1_7; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fletcher N, 2005, TOXICOL SCI, V86, P264, DOI 10.1093/toxsci/kfi183; Fluegel ML, 2006, GENETICS, V172, P185, DOI 10.1534/genetics.105.046565; FSTRAC, 1990, SUMM STAT FED DRINK; GARNER CD, 1995, J TOXICOL ENV HEALTH, V44, P43, DOI 10.1080/15287399509531942; Garrett M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-489; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Goncalves AC, 2013, TOXICOL IN VITRO, V27, P1542, DOI 10.1016/j.tiv.2013.03.009; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; IARC, 1997, POL DIB PAR DIOX POL; Illumina, 2012, TRUSEQ RNA SAMPL PRE, P136; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Janssen D, 2010, J NEUROPHYSIOL, V103, P2587, DOI 10.1152/jn.00466.2009; Jordan KC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-16; Karpac J, 2013, CELL REP, V4, P1250, DOI 10.1016/j.celrep.2013.08.004; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim KH, 2011, J ENVIRON SCI HEAL C, V29, P277, DOI 10.1080/10590501.2011.629972; Krasnov G S, 2011, Mol Biol (Mosk), V45, P238; Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001; Liu Y, 2009, J RADIAT RES, V50, P233, DOI 10.1269/jrr.08112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Moro AM, 2012, MUTAT RES-GEN TOX EN, V746, P42, DOI 10.1016/j.mrgentox.2012.02.007; Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5; Moskalev AA, 2011, BIOGERONTOLOGY, V12, P253, DOI 10.1007/s10522-011-9320-0; Moskalev A, 2007, BIOGERONTOLOGY, V8, P499, DOI 10.1007/s10522-007-9090-x; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; Nielsen GD, 2013, ARCH TOXICOL, V87, P73, DOI 10.1007/s00204-012-0975-3; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Paik D, 2012, MECH AGEING DEV, V133, P234, DOI 10.1016/j.mad.2012.02.001; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Picchio L, 2013, HUM MOL GENET, V22, P2795, DOI 10.1093/hmg/ddt127; Plyusnina EN, 2011, BIOGERONTOLOGY, V12, P211, DOI 10.1007/s10522-010-9311-6; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Royland JE, 2012, TOXICOL SCI, V126, P193, DOI 10.1093/toxsci/kfr340; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Segev E, 2001, MECH DEVELOP, V106, P197, DOI 10.1016/S0925-4773(01)00437-3; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Shaham J, 2003, OCCUP ENVIRON MED, V60, P403, DOI 10.1136/oem.60.6.403; Singh MP, 2011, TOXICOL APPL PHARM, V253, P14, DOI 10.1016/j.taap.2011.03.006; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; STUMMTEGETHOFF BF, 1969, THEOR APPL GENET, V39, P330, DOI 10.1007/BF00281915; Su WX, 2012, INT J RADIAT BIOL, V88, P635, DOI 10.3109/09553002.2012.703362; Sul D, 2007, ARCH TOXICOL, V81, P589, DOI 10.1007/s00204-007-0182-9; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tsang H, 2012, REPROD TOXICOL, V33, P60, DOI 10.1016/j.reprotox.2011.11.002; Tuchscherer J, 2013, CAN J EMERG MED, V15, P249, DOI 10.2310/8000.2013.130974; UNSCEAR, 2010, REP UN SCI COMM EFF, P106; van Bergeijk P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036539; VARTERASIAN M, 1993, CELL GROWTH DIFFER, V4, P885; Verzi MP, 2002, DEV BIOL, V249, P174, DOI 10.1006/dbio.2002.0753; Vickrey TL, 2011, ACS CHEM NEUROSCI, V2, P723, DOI 10.1021/cn200057k; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Weng RF, 2012, DEVELOPMENT, V139, P1427, DOI 10.1242/dev.075143; Win-Shwe TT, 2010, TOXICOL LETT, V198, P93, DOI 10.1016/j.toxlet.2010.06.022; Wong A, 2012, MOL BIOL EVOL, V29, P229, DOI 10.1093/molbev/msr197; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Yang J, 2013, J TOXICOL SCI, V38, P833; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	108	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86051	10.1371/journal.pone.0086051	http://dx.doi.org/10.1371/journal.pone.0086051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475070	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800024
J	Rizio, AA; Dennis, NA				Rizio, Avery A.; Dennis, Nancy A.			The Cognitive Control of Memory: Age Differences in the Neural Correlates of Successful Remembering and Intentional Forgetting	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVITY; OLDER-ADULTS; HEMISPHERIC-ASYMMETRY; INHIBITORY CONTROL; PARIETAL CORTEX; SUPPRESSION; RETRIEVAL; TRUE; FMRI	Successful memory encoding depends on the ability to intentionally encode relevant information (via differential encoding) and intentionally forget that which is irrelevant (via inhibition). Both cognitive processes have been shown to decline in aging and are theorized to underlie age-related deficits in the cognitive control of memory. The current study uses the Directed Forgetting paradigm in conjunction with fMRI to investigate age-related differences in both cognitive processes, with the specific aim of elucidating neural evidence supporting these theorized deficits. Results indicate relatively preserved differential encoding, with age differences consistent with previous models of age-related compensation (i.e., increased frontal and bilateral recruitment). Older adults did display noticeable differences in the recruitment of brain regions related to intentional forgetting, specifically exhibiting reduced activity in the right superior prefrontal cortex, a region shown to be critical to inhibitory processing. However, older adults exhibited increased reliance on processing in right inferior parietal lobe associated with successful forgetting. Activity in this region was negatively correlated with activity in the medial temporal lobe, suggesting a shift in the locus of inhibition compared to the frontally mediated inhibition observed in younger adults. Finally, while previous studies found intentional and incidental forgetting to be dissociable in younger adults, this differentiation appears to be reduced in older adults. The current results are the first to provide neural evidence for an age-related reduction in processes that support intentional forgetting.	[Rizio, Avery A.; Dennis, Nancy A.] Penn State Univ, Dept Psychol, State Coll, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dennis, NA (corresponding author), Penn State Univ, Dept Psychol, State Coll, University Pk, PA 16802 USA.	nad12@psu.edu		Rizio, Avery/0000-0003-1881-4523	NSF [1025709]; American Federation for Aging Research	NSF(National Science Foundation (NSF)); American Federation for Aging Research	Awarded to N.A.D.: Grant Sponsor: NSF; Grant number: 1025709 Portions of this research were conducted while N.A.D. was an AFAR Research Grant recipient from the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2012, NEBR SYM MOTIV, V58, P53, DOI 10.1007/978-1-4614-1195-6_3; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; Bastin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029905; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P255, DOI 10.1016/S0022-5371(70)80059-7; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Collette F, 2009, MEMORY, V17, P104, DOI 10.1080/09658210802574146; CONNELLY SL, 1991, PSYCHOL AGING, V6, P533, DOI 10.1037/0882-7974.6.4.533; Daselaar SM., 2007, CLIN APPL FUNCTIONAL, P115; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DEMB JB, 1995, J NEUROSCI, V15, P5870; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Dennis NA, NEUROBIOLOG IN PRESS; Dennis NA, 2008, J COGNITIVE NEUROSCI, V20, P1390, DOI 10.1162/jocn.2008.20096; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Dennis NA, 2007, NEUROBIOL AGING, V28, P1749, DOI 10.1016/j.neurobiolaging.2006.07.006; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dew ITZ, 2012, CEREB CORTEX, V22, P2542, DOI 10.1093/cercor/bhr334; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Dulaney CL, 2004, EXP AGING RES, V30, P95, DOI 10.1080/03610730490251504; Earles JL, 2002, PSYCHON B REV, V9, P383, DOI 10.3758/BF03196297; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Garoff-Eaton RJ, 2007, LEARN MEMORY, V14, P684, DOI 10.1101/lm.695707; Goh JOS, 2011, AGING DIS, V2, P30; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; HARTMAN M, 1991, PSYCHOL AGING, V6, P587, DOI 10.1037/0882-7974.6.4.587; Hasher L, 1997, MEM COGNITION, V25, P286, DOI 10.3758/BF03211284; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hayes SM, 2008, HDB COGNITIVE AGING, P308; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hogge M, 2008, AGING NEUROPSYCHOL C, V15, P471, DOI 10.1080/13825580701878065; Hsieh LT, 2009, BRAIN RES, V1250, P190, DOI 10.1016/j.brainres.2008.11.016; Langenecker SA, 2003, NEUROIMAGE, V20, P1384, DOI 10.1016/S1053-8119(03)00372-0; Levy BJ, 2012, J NEUROSCI, V32, P16785, DOI 10.1523/JNEUROSCI.2640-12.2012; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Morrone I, 2010, PSYCHOL AGING, V25, P697, DOI 10.1037/a0019578; Nielson KA, 2002, PSYCHOL AGING, V17, P56, DOI 10.1037//0882-7974.17.1.56; Nowicka A, 2011, CEREB CORTEX, V21, P539, DOI 10.1093/cercor/bhq117; Okado Y, 2003, COGN AFFECT BEHAV NE, V3, P323, DOI 10.3758/CABN.3.4.323; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Paz-Alonso PM, 2013, J NEUROSCI, V33, P5017, DOI 10.1523/JNEUROSCI.3459-12.2013; Paz-Caballero MD, 2004, CLIN NEUROPHYSIOL, V115, P369, DOI 10.1016/j.clinph.2003.09.011; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Prakash RS, 2009, BRAIN COGNITION, V71, P328, DOI 10.1016/j.bandc.2009.07.005; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Reber PJ, 2002, J NEUROSCI, V22, P9541; Rizio AA, 2013, J COGNITIVE NEUROSCI, V25, P297, DOI 10.1162/jocn_a_00310; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P2874, DOI 10.1016/j.neuropsychologia.2006.06.021; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stebbins GT, 2002, PSYCHOL AGING, V17, P44, DOI 10.1037//0882-7974.17.1.44; Talairach J., 1988, COPLANAR STEREOTAXIC; Ullsperger M, 2000, J COGNITIVE NEUROSCI, V12, P924, DOI 10.1162/08989290051137477; Vallesi A, 2011, J COGNITIVE NEUROSCI, V23, P801, DOI 10.1162/jocn.2010.21490; Van Hooff JC, 2009, BRAIN COGNITION, V71, P153, DOI 10.1016/j.bandc.2009.05.001; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	70	20	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87010	10.1371/journal.pone.0087010	http://dx.doi.org/10.1371/journal.pone.0087010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475211	Green Published, gold			2022-12-27	WOS:000330339800076
J	Tully, PJ; Wittert, G; Selkow, T; Baumeister, H				Tully, Phillip J.; Wittert, Gary; Selkow, Terina; Baumeister, Harald			The Real World Mental Health Needs of Heart Failure Patients Are Not Reflected by the Depression Randomized Controlled Trial Evidence	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; GENERALIZED ANXIETY DISORDER; CORONARY-ARTERY-DISEASE; CLINICAL-PRACTICE; DOUBLE-BLIND; RISK-FACTORS; MYOCARDIAL-INFARCTION; SUICIDAL IDEATION; EUROPEAN-SOCIETY	Introduction: International depression screening guidelines in heart failure (HF) are partly based on depression treatment efficacy from randomized controlled trials (RCTs). Our aim was to test the external validity of depression RCT criteria in a sample of real-world HF patients. Methods: HF patients admitted to 3 hospitals in South Australia were referred to a HF psychologist if not already receiving current psychiatric management by psychologist or psychiatrist elsewhere. Screening and referral protocol consisted of the following; (a). Patient Health Questionnaire >= 10; (b). Generalized Anxiety Disorder Questionnaire >= 7); (c). positive response to 1 item panic attack screener; (d). evidence of suicidality. Patients were evaluated against the most common RCT exclusion criteria personality disorder, high suicide risk, cognitive impairment, psychosis, alcohol or substance abuse or dependency, bi-polar depression. Results: Total 81 HF patients were referred from 404 HF admissions, and 73 were assessed (age 60.6 +/- 13.4, 47.9% female). Nearly half (47%) met at least 1 RCT exclusion criterion, most commonly personality disorder (28.5%), alcohol/substance abuse (17.8%) and high suicide risk (11.0%). RCT ineligibility criteria was more frequent among patients with major depression (76.5% vs. 46.2%, p<.01) and dysthymia (26.5% vs. 7.7%, p = .03) but not significantly associated with anxiety disorders. RCT ineligible patients reported greater severity of depression (M = 16.6 +/- 5.0 vs. M=12.9 +/- 7.2, p = .02) and were higher consumers of HF psychotherapy services (M = 11.5 +/- 4.7 vs. M=8.5 +/- 4.8, p = .01). Conclusion: In this real-world sample comparable in size to recent RCT intervention arms, patients with depression disorders presented with complex psychiatric needs including comorbid personality disorders, alcohol/substance use and suicide risk. These findings suggest external validity of depression screening and RCTs could serve as a basis for level A guideline recommendations in cardiovascular diseases.	[Tully, Phillip J.; Baumeister, Harald] Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, D-79106 Freiburg, Germany; [Tully, Phillip J.; Baumeister, Harald] Univ Freiburg, Fac Med, D-79106 Freiburg, Germany; [Tully, Phillip J.; Wittert, Gary] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Discipline Med, Sch Med, Adelaide, SA, Australia; [Tully, Phillip J.; Selkow, Terina] Queen Elizabeth Hosp, Heart Failure Support Serv, Woodville, SA 5011, Australia	University of Freiburg; University of Freiburg; University of Adelaide	Tully, PJ (corresponding author), Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, Hugstetter Str 55, D-79106 Freiburg, Germany.	phillip.tully@adelaide.edu.au	Tully, Phillip/I-6256-2018; wittert, gary/AAE-2398-2019	Tully, Phillip/0000-0003-2807-1313; Baumeister, Harald/0000-0002-2040-661X; Wittert, Gary/0000-0001-6818-6065	National Health and Medical Research Council of Australia [1053578]; Albert Ludwigs University of Freiburg	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Albert Ludwigs University of Freiburg	Dr Phillip John Tully is supported by the National Health and Medical Research Council of Australia (Neil Hamilton Fairley - Clinical Overseas Fellowship # 1053578). The article processing charge which funded by the Open Access publication fund of the Albert Ludwigs University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus C, 2004, EUR J CARDIOV PREV R, V11, P75, DOI 10.1097/01.hjr.0000116823.84388.6c; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Annunziato RA, 2008, PSYCHOSOMATICS, V49, P386, DOI 10.1176/appi.psy.49.5.386; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P24; Baumeister H, 2011, PSYCHOTHER PSYCHOSOM, V80, P275, DOI 10.1159/000323404; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Caro MA, 2012, J CARDIOL, V60, P72, DOI 10.1016/j.jjcc.2012.01.016; Chronic Heart Failure Guidelines Expert Writing Panel, 2011, GUID PREV DET MAN CH; Collins PY, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001434; Cully JA, 2010, PRIM CARE COMPANION, V12; Dharmarajan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078222; Doerfler LA, 2005, CAN J CARDIOL, V21, P689; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M. B., 2007, STRUCTURED CLIN INTE; First M. B., 1997, STRUCTURED CLIN INTE; Fraguas R, 2009, CONTEMP CLIN TRIALS, V30, P205, DOI 10.1016/j.cct.2009.01.007; Gary RA, 2010, J PSYCHOSOM RES, V69, P119, DOI 10.1016/j.jpsychores.2010.01.013; Gottlieb SS, 2007, AM HEART J, V153, P868, DOI 10.1016/j.ahj.2007.02.024; Hasnain M, 2011, J PSYCHOSOM RES, V71, P6, DOI 10.1016/j.jpsychores.2010.10.009; Haworth JE, 2005, EUR J HEART FAIL, V7, P803, DOI 10.1016/j.ejheart.2005.03.001; Herrmann-Lingen C, 2011, J PSYCHOSOM RES, V70, P111, DOI 10.1016/j.jpsychores.2010.09.019; Hoertel N, 2013, J AFFECT DISORDERS, V146, P383, DOI 10.1016/j.jad.2012.09.023; Holzapfel N, 2007, PSYCHOSOMATICS, V48, P112, DOI 10.1176/appi.psy.48.2.112; Holzapfel N, 2009, HEART LUNG, V38, P392, DOI 10.1016/j.hrtlng.2008.11.001; Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329; Jaarsma Tiny, 2010, Curr Opin Support Palliat Care, V4, P233, DOI 10.1097/SPC.0b013e328340744d; Jaarsma T, 2010, J AM COLL CARDIOL, V55, P1837, DOI 10.1016/j.jacc.2009.11.082; Jakobsen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028299; Jani BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074610; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jiang W, 2008, AM HEART J, V156, P437, DOI 10.1016/j.ahj.2008.05.003; Jiang W, 2011, AM J CARDIOL, V107, P545, DOI 10.1016/j.amjcard.2010.10.013; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Khan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041778; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lainscak M, 2011, EUR J HEART FAIL, V13, P115, DOI 10.1093/eurjhf/hfq219; Lekakis J, 2010, INT J CARDIOL, V139, P150, DOI 10.1016/j.ijcard.2008.10.010; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lossnitzer N, 2009, DEPRESS ANXIETY, V26, P764, DOI 10.1002/da.20587; Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2; Luttik MLA, 2011, EUR J CARDIOVASC NUR, V10, P228, DOI 10.1016/j.ejcnurse.2010.08.005; Luukinen H, 2010, SCAND J CLIN LAB INV, V70, P75, DOI 10.3109/00365510903410548; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Mulder RT, 2003, AUST NZ J PSYCHIAT, V37, P265, DOI 10.1046/j.1440-1614.2003.01176.x; O'Connor CM, 2008, ARCH INTERN MED, V168, P2232, DOI 10.1001/archinte.168.20.2232; O'Hea E, 2009, HEART FAIL REV, V14, P13, DOI 10.1007/s10741-008-9081-2; Orth-Gomer K, 2005, INT J BEHAV MED, V12, P132, DOI 10.1207/s15327558ijbm1203_2; Pedersen SS, 2001, SCAND J PSYCHOL, V42, P445, DOI 10.1111/1467-9450.00257; Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Ruscio AM, 2006, CLIN PSYCHOL-SCI PR, V13, P146, DOI 10.1111/j.1468-2850.2006.00017.x; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Samartzis L, 2013, J CARD FAIL, V19, P125, DOI 10.1016/j.cardfail.2012.12.004; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Serber ER, 2009, J CARDIOPULM REHABIL, V29, P161, DOI 10.1097/HCR.0b013e3181a33365; Shemesh E, 2011, J CLIN PSYCHIAT, V72, P168, DOI 10.4088/JCP.09m05116blu; Shemesh E, 2009, AM J CARDIOL, V104, P1194, DOI 10.1016/j.amjcard.2009.06.033; Smith DH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-434; Smolderen KG, 2011, CIRC-CARDIOVASC QUAL, V4, P283, DOI 10.1161/CIRCOUTCOMES.110.960013; Sowden G, 2010, AM HEART J, V159, P780, DOI 10.1016/j.ahj.2010.02.029; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sullivan MJ, 2009, AM HEART J, V157, P84, DOI 10.1016/j.ahj.2008.08.033; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Tully PJ, 2013, J HEALTH PSYCHOL, V18, P1601, DOI 10.1177/1359105312467390; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355; Tully PJ, SOC PSYCH P IN PRESS; van der Lem R, 2012, PSYCHOTHER PSYCHOSOM, V81, P226, DOI 10.1159/000330890; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Wade Victoria, 2005, Aust Fam Physician, V34, P985; Woltz PC, 2012, HEART LUNG, V41, P469, DOI 10.1016/j.hrtlng.2012.06.002; Yeager KR, 2011, HEART FAIL CLIN, V7, P69, DOI 10.1016/j.hfc.2010.08.007; Yu DSF, 2007, GERONTOLOGY, V53, P74, DOI 10.1159/000096427; Zetin M, 2007, J CLIN PSYCHOPHARM, V27, P295, DOI 10.1097/JCP.0b013e318058263f	83	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85928	10.1371/journal.pone.0085928	http://dx.doi.org/10.1371/journal.pone.0085928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475060	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800019
J	Wang, XJ; Guo, JF; Fei, EK; Mu, YF; He, S; Che, XQ; Tan, JQ; Xia, K; Zhang, ZH; Wang, GH; Tang, BS				Wang, Xuejing; Guo, Jifeng; Fei, Erkang; Mu, Yingfeng; He, Shuang; Che, Xiangqian; Tan, Jieqiong; Xia, Kun; Zhang, Zhuohua; Wang, Guanghui; Tang, Beisha			BAG5 Protects against Mitochondrial Oxidative Damage through Regulating PINK1 Degradation	PLOS ONE			English	Article							WILD-TYPE PINK1; UBIQUITIN LIGASE; MUTATIONS; PARKIN; APOPTOSIS; DOMAIN; LOCALIZATION; FREQUENCY; GENOTYPES; SURVIVAL	Mutations in PTEN-induced kinase 1 (PINK1) gene cause PARK6 familial Parkinsonism, and loss of the stability of PINK1 may also contribute to sporadic Parkinson's disease (PD). Degradation of PINK1 occurs predominantly through the ubiquitin proteasome system (UPS), however, to date, few of the proteins have been found to regulate the degradation of PINK1. Using the yeast two-hybrid system and pull-down methods, we identified bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacted with PINK1. We showed that BAG5 stabilized PINK1 by decreasing the ubiquitination of PINK1. Interestingly, BAG5 rescued MPP+-and rotenone-induced mitochondria dysfunction by up-regulating PINK1 in vitro. In PINK1-null mice and MPTP-treated mice, BAG5 significantly increased in the substantia nigra pars compacta (SNpc) although PINK1 was decreased. Our findings indicated that BAG5, as a key protein to stabilize PINK1, is a promising therapeutic tool for preventing mitochondrial dysfunction following oxidative stress.	[Wang, Xuejing; Guo, Jifeng; Mu, Yingfeng; He, Shuang; Che, Xiangqian; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Guo, Jifeng; Tan, Jieqiong; Xia, Kun; Zhang, Zhuohua; Tang, Beisha] State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Fei, Erkang; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Fei, Erkang; Wang, Guanghui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Guo, Jifeng; Tang, Beisha] Cent S Univ, Human Key Lab Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Guo, Jifeng; Tang, Beisha] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha, Hunan, Peoples R China	Central South University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Central South University; Central South University	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wghui@ustc.edu.cn; bstang7398@163.com	XIA, KUN/AAO-3525-2020; FEI, Erkang/AAI-9825-2021	FEI, Erkang/0000-0002-3581-9521	Major State Basic Research Development Program of China (973 Program) [2011CB510000]; National Natural Science Foundation of China [30900469, 81171198, 81200870, 81000542, 81130021, 81371405, 81361120404]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the Major State Basic Research Development Program of China (973 Program) (2011CB510000), grant from the National Natural Science Foundation of China(30900469,81171198, 81200870, 81000542, 81130021, 81371405, 81361120404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Klein C, 2006, NEUROLOGY, V66, P1129, DOI 10.1212/01.wnl.0000220157.81513.85; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moriya R, 2000, FEBS LETT, V484, P253, DOI 10.1016/S0014-5793(00)02167-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Xiromerisiou G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09220; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008	36	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86276	10.1371/journal.pone.0086276	http://dx.doi.org/10.1371/journal.pone.0086276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475098	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800038
J	Camacho-Rivera, M; Kawachi, I; Bennett, GG; Subramanian, SV				Camacho-Rivera, Marlene; Kawachi, Ichiro; Bennett, Gary G.; Subramanian, S. V.			Perceptions of Neighborhood Safety and Asthma among Children and Adolescents in Los Angeles: A Multilevel Analysis	PLOS ONE			English	Article							CHILDHOOD ASTHMA; SOCIAL-ENVIRONMENT; COMMUNITY VIOLENCE; INDOOR ALLERGENS; AIR-POLLUTION; MORBIDITY; EXPOSURE; STRESS; DISPARITIES; FAMILY	Background: Research examining the impact of neighborhoods on asthma has shown an increased interest in the role of the psychosocial environment. We examined the associations between various measures of neighborhood safety, individual and family characteristics, and asthma outcomes among children in Los Angeles. Methods: Multilevel logistic regression models were used to analyze data on 3,114 children across 65 neighborhoods from Wave 1 of the Los Angeles Family and Neighborhood Survey (2000 to 2002). Primary caregivers reported asthma outcome and all individual covariates; home environmental characteristics were observed by the interviewer. Results: In fully adjusted models, parents who reported their neighborhood fairly safe or somewhat dangerous had lower odds of reported lifetime asthma compared to those who reported their neighborhood completely safe (OR 0.71; 95% CI 0.52-0.96 and OR 0.60; 95% CI 0.42-0.88 respectively). Conversely, parents who reported they could not trust their neighbors to keep their children safe had a nearly 40% increase in lifetime asthma compared to those who reported they could trust their neighbors to keep their children safe (OR 1.39; 95% CI 1.07-1.81). Conclusions: The study demonstrates a complex pattern between various measures of neighborhood safety and asthma and suggests that these relationships may operate differently in Los Angeles. As an increasing proportion of children are growing up in newer Western and Southwestern cities, which have different physical layouts and residential segregation patterns compared to Northeast and Midwestern cities, future studies should continue to examine neighborhood psychosocial stressors and asthma in diverse contexts.	[Camacho-Rivera, Marlene] North Shore LIJ Hlth Syst, Dept Populat Hlth, Great Neck, NY USA; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Bennett, Gary G.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Northwell Health; Harvard University; Harvard T.H. Chan School of Public Health; Duke University	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu		Camacho-Rivera, Marlene/0000-0003-2343-2941	National Institutes of Health [NHLBI K25 HL081275]; U.S. Department of Health and Human Services (HRSA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services (HRSA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVS is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). MCR is supported by the U.S. Department of Health and Human Services (HRSA) Public Health Traineeship Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Blumberg Stephen J, 2012, Vital Health Stat 1, P1; Cagney KA, 2004, J GEN INTERN MED, V19, P229, DOI 10.1111/j.1525-1497.2004.30359.x; Chen E, 2007, AM J RESP CRIT CARE, V176, P644, DOI 10.1164/rccm.200610-1473OC; Clark CR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-162; Clougherty JE, 2007, ENVIRON HEALTH PERSP, V115, P1140, DOI 10.1289/ehp.9863; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Juhn YJ, 2005, SOC SCI MED, V60, P2453, DOI 10.1016/j.socscimed.2004.11.034; Klinnert MD, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e69; Matsui EC, 2006, ANN ALLERG ASTHMA IM, V97, P514, DOI 10.1016/S1081-1206(10)60943-X; Miller RL, 2001, AM J RESP CRIT CARE, V164, P995, DOI 10.1164/ajrccm.164.6.2011107; Mrazek DA, 1999, PEDIATR PULM, V27, P85, DOI 10.1002/(SICI)1099-0496(199902)27:2<85::AID-PPUL4>3.0.CO;2-B; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Rietveld S, 2000, CLIN EXP ALLERGY, V30, P1058; Sastry N, 2003, WORKING PAPER; Sastry N, 2006, SOC SCI RES, V35, P1000, DOI 10.1016/j.ssresearch.2005.08.002; Shankardass K, 2011, J EPIDEMIOL COMMUN H, V65, P859, DOI 10.1136/jech.2009.102806; Sternthal MJ, 2010, EUR RESPIR J, V36, P1400, DOI 10.1183/09031936.00003010; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Subramanian SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006091; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Suglia SF, 2010, J EPIDEMIOL COMMUN H, V64, P636, DOI 10.1136/jech.2008.082842; Turyk ME, 2008, PEDIAT ALLERG IMM-UK, V19, P255, DOI 10.1111/j.1399-3038.2007.00603.x; Vangeepuram N, 2012, J URBAN HEALTH, V89, P758, DOI 10.1007/s11524-012-9679-5; Weil CM, 1999, PEDIATRICS, V104, P1274, DOI 10.1542/peds.104.6.1274; Wilhelm M, 2009, HEALTH PLACE, V15, P25, DOI 10.1016/j.healthplace.2008.02.002; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wright RJ, 2001, ENVIRON HEALTH PERSP, V109, P1085, DOI 10.2307/3454965; Wright RJ, 2007, CHEST, V132, p757S, DOI 10.1378/chest.07-1904; Wright RJ, 2006, CLIN CHEST MED, V27, P413, DOI 10.1016/j.ccm.2006.04.003	32	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87524	10.1371/journal.pone.0087524	http://dx.doi.org/10.1371/journal.pone.0087524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466355	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000211
J	Guo, ZH; Cao, YQ				Guo, Zhaohua; Cao, Yu-Qing			Over-Expression of TRESK K+ Channels Reduces the Excitability of Trigeminal Ganglion Nociceptors	PLOS ONE			English	Article							POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; SENSORY NEURONS; RECEPTOR; PAIN; MIGRAINE; TRPV1; ACTIVATION; MUTATION; CURRENTS	TWIK-related spinal cord K+ (TRESK) channel is abundantly expressed in trigeminal ganglion (TG) and dorsal root ganglion neurons and is one of the major background K+ channels in primary afferent neurons. Mutations in TRESK channels are associated with familial and sporadic migraine. In rats, both chronic nerve injury and inflammation alter the expression level of TRESK mRNA. Functional studies indicate that reduction of endogenous TRESK channel activity results in hyper-excitation of primary afferent neurons, suggesting that TRESK is a potential target for the development of new analgesics. However, whether and how enhancing TRESK channel activity would decrease the excitability of primary afferent neurons has not been directly tested. Here, we over-expressed TRESK subunits in cultured mouse TG neurons by lipofectamine-mediated transfection and investigated how this altered the membrane properties and the excitability of the small-diameter TG population. To account for the heterogeneity of neurons, we further divided small TG neurons into two groups, based on their ability to bind to fluorescently-labeled isolectin B (IB4). The transfected TG neurons showed a 2-fold increase in the level of TRESK proteins. This was accompanied by a significant increase in the fraction of lamotrigine-sensitive persistent K+ currents as well as the size of total background K+ currents. Consequently, both IB4-positive and IB4-negative TG neurons over-expressing TRESK subunits exhibited a lower input resistance and a 2-fold increase in the current threshold for action potential initiation. IB4-negative TG neurons over-expressing TRESK subunits also showed a significant reduction of the spike frequency in response to supra-threshold stimuli. Importantly, an increase in TRESK channel activity effectively inhibited capsaicin-evoked spikes in TG neurons. Taken together, our results suggest that potent and specific TRESK channel openers likely would reduce the excitability of primary afferent neurons and therefore are potential therapeutics for the treatment of migraine and other chronic pain symptoms.	Washington Univ, Sch Med, Washington Univ Pain Ctr, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Guo, ZH (corresponding author), Washington Univ, Sch Med, Washington Univ Pain Ctr, St Louis, MO 63130 USA.	caoy@anest.wustl.edu			National Institutes of Health-National Institute of Neurological Disorders and Stroke [R21NS074198]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074198] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health-National Institute of Neurological Disorders and Stroke (Grant #R21NS074198), http://www.ninds.nih.gov/funding/index.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Choi JS, 2007, J NEUROPHYSIOL, V97, P1258, DOI 10.1152/jn.01033.2006; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Evans MS, 2012, HEADACHE, V52, P773, DOI 10.1111/j.1526-4610.2011.02053.x; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Huang DY, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-66; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kim S, 2013, BBA-BIOMEMBRANES, V1828, P1131, DOI 10.1016/j.bbamem.2012.11.021; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Liu P, 2013, J NEUROSCI, V33, P12810, DOI 10.1523/JNEUROSCI.1237-13.2013; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Shimizu T, 2007, BRAIN RES, V1173, P84, DOI 10.1016/j.brainres.2007.07.068; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; Tao J, 2012, J NEUROPHYSIOL, V107, P1666, DOI 10.1152/jn.00551.2011; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zhou J, 2013, NEUROREPORT, V24, P131, DOI 10.1097/WNR.0b013e32835d8431; Zhou J, 2012, MOL MED REP, V5, P1049, DOI 10.3892/mmr.2012.778	36	109	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87029	10.1371/journal.pone.0087029	http://dx.doi.org/10.1371/journal.pone.0087029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466320	Green Published, gold			2022-12-27	WOS:000330288000187
J	Wu, WZ; Wang, ZW; Xia, HJ; Liu, YX; Qiu, Y; Liu, YJ; Hu, YY; Zhou, X				Wu, Wenzhe; Wang, Zhaowei; Xia, Hongjie; Liu, Yongxiang; Qiu, Yang; Liu, Yujie; Hu, Yuanyang; Zhou, Xi			Flock House Virus RNA Polymerase Initiates RNA Synthesis De Novo and Possesses a Terminal Nucleotidyl Transferase Activity	PLOS ONE			English	Article							HEPATITIS-C VIRUS; VIRAL-RNA; MEMBRANE ASSOCIATION; DROSOPHILA-CELLS; NODAVIRUS RNA; GENOMIC RNA; PROTEIN-A; SUBGENOMIC RNA3; DNA-POLYMERASE; ANIMAL VIRUS	Flock House virus (FHV) is a positive-stranded RNA virus with a bipartite genome of RNAs, RNA1 and RNA2, and belongs to the family Nodaviridae. As the most extensively studied nodavirus, FHV has become a well-recognized model for studying various aspects of RNA virology, particularly viral RNA replication and antiviral innate immunity. FHV RNA1 encodes protein A, which is an RNA-dependent RNA polymerase (RdRP) and functions as the sole viral replicase protein responsible for RNA replication. Although the RNA replication of FHV has been studied in considerable detail, the mechanism employed by FHV protein A to initiate RNA synthesis has not been determined. In this study, we characterized the RdRP activity of FHV protein A in detail and revealed that it can initiate RNA synthesis via a de novo (primer-independent) mechanism. Moreover, we found that FHV protein A also possesses a terminal nucleotidyl transferase (TNTase) activity, which was able to restore the nucleotide loss at the 39-end initiation site of RNA template to rescue RNA synthesis initiation in vitro, and may function as a rescue and protection mechanism to protect the 39 initiation site, and ensure the efficiency and accuracy of viral RNA synthesis. Altogether, our study establishes the de novo initiation mechanism of RdRP and the terminal rescue mechanism of TNTase for FHV protein A, and represents an important advance toward understanding FHV RNA replication.	[Wu, Wenzhe; Wang, Zhaowei; Xia, Hongjie; Liu, Yongxiang; Qiu, Yang; Liu, Yujie; Hu, Yuanyang; Zhou, Xi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhou, X (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	zhouxi@whu.edu.cn	Xia, Hongjie/M-9241-2019; Qiu, Yang/AAQ-4435-2020	Xia, Hongjie/0000-0002-2520-7038; 	National Basic Research Program of China (973 Program) [2014CB542603]; National Natural Science Foundation of China the National Natural Science Foundation of China [31270190, 81201292, 31270189]; Chinese111 Project [B06018]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China the National Natural Science Foundation of China; Chinese111 Project	This work was supported by the National Basic Research Program of China (973 Program, 2014CB542603), the National Natural Science Foundation of China the National Natural Science Foundation of China (31270190 to XZ, 81201292 to XZ, and 31270189 to YH), and the Chinese111 Project grant No. B06018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Arnold JJ, 1999, J BIOL CHEM, V274, P37060, DOI 10.1074/jbc.274.52.37060; BALL LA, 1993, J VIROL, V67, P3544, DOI 10.1128/JVI.67.6.3544-3551.1993; BALL LA, 1995, J VIROL, V69, P2722, DOI 10.1128/JVI.69.4.2722-2722.1995; Beerens N, 2007, J VIROL, V81, P8384, DOI 10.1128/JVI.00564-07; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Binne UK, 2002, J VIROL, V76, P10282, DOI 10.1128/JVI.76.20.10282-10289.2002; Cai DW, 2010, VIRUS RES, V151, P153, DOI 10.1016/j.virusres.2010.04.010; Castorena Kathryn M, 2010, BMC Genomics, V11, P183, DOI 10.1186/1471-2164-11-183; DeFrancesco R, 1996, METHOD ENZYMOL, V275, P58; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dye BT, 2005, J VIROL, V79, P8909, DOI 10.1128/JVI.79.14.8909-8919.2005; Fukushi S, 2004, J VIROL, V78, P3889, DOI 10.1128/JVI.78.8.3889-3896.2004; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; GALLAGHER TM, 1983, J VIROL, V46, P481, DOI 10.1128/JVI.46.2.481-489.1983; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; Ishii K, 1999, HEPATOLOGY, V29, P1227, DOI 10.1002/hep.510290448; Johnson KN, 2001, J GEN VIROL, V82, P1855, DOI 10.1099/0022-1317-82-8-1855; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kampmueller KM, 2005, J VIROL, V79, P6827, DOI 10.1128/JVI.79.11.6827-6837.2005; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Kovalev N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002537; LARDER BA, 1987, EMBO J, V6, P169, DOI 10.1002/j.1460-2075.1987.tb04735.x; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lindenbach BD, 2002, J VIROL, V76, P3905, DOI 10.1128/JVI.76.8.3905-3919.2002; Liu CF, 2006, VIRUS RES, V120, P28, DOI 10.1016/j.virusres.2005.09.003; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MAO JCH, 1975, J VIROL, V15, P1281, DOI 10.1128/JVI.15.5.1281-1283.1975; Miller DJ, 2002, J VIROL, V76, P9856, DOI 10.1128/JVI.76.19.9856-9867.2002; Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001; MILLER WA, 1985, NATURE, V313, P68, DOI 10.1038/313068a0; NEUFELD KL, 1994, J VIROL, V68, P5811, DOI 10.1128/JVI.68.9.5811-5818.1994; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Poranen MM, 2008, J VIROL, V82, P9254, DOI 10.1128/JVI.01044-08; Qi N, 2012, J VIROL, V86, P5763, DOI 10.1128/JVI.07229-11; Qi N, 2011, J VIROL, V85, P9543, DOI 10.1128/JVI.00785-11; Qiu Y, 2013, VIROLOGY, V439, P140, DOI 10.1016/j.virol.2013.02.010; Qiu Y, 2011, J VIROL, V85, P4440, DOI 10.1128/JVI.02410-10; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; Reigadas S, 2001, EUR J BIOCHEM, V268, P5857, DOI 10.1046/j.0014-2956.2001.02532.x; RODRIGUEZ PL, 1992, J VIROL, V66, P1971, DOI 10.1128/JVI.66.4.1971-1976.1992; Sarin LP, 2012, VIROLOGY, V432, P184, DOI 10.1016/j.virol.2012.05.035; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; SELLING BH, 1990, P NATL ACAD SCI USA, V87, P434, DOI 10.1073/pnas.87.1.434; Stapleford KA, 2009, J VIROL, V83, P4498, DOI 10.1128/JVI.00040-09; TADDIE JA, 1991, J VIROL, V65, P869, DOI 10.1128/JVI.65.2.869-879.1991; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06; Vazquez AL, 2001, ARCH VIROL, V146, P59, DOI 10.1007/s007050170191; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; Wang ZW, 2013, J BIOL CHEM, V288, P30785, DOI 10.1074/jbc.M113.492728; Weeks SA, 2010, J VIROL, V84, P330, DOI 10.1128/JVI.01808-09; Wright S, 2012, J VIROL, V86, P2837, DOI 10.1128/JVI.05168-11; WU SX, 1992, P NATL ACAD SCI USA, V89, P11136, DOI 10.1073/pnas.89.23.11136; WU SX, 1991, VIROLOGY, V183, P392, DOI 10.1016/0042-6822(91)90153-3	65	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86876	10.1371/journal.pone.0086876	http://dx.doi.org/10.1371/journal.pone.0086876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466277	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000162
J	Cazzoli, D; Antoniades, CA; Kennard, C; Nyffeler, T; Bassetti, CL; Muri, RM				Cazzoli, Dario; Antoniades, Chrystalina A.; Kennard, Christopher; Nyffeler, Thomas; Bassetti, Claudio L.; Mueri, Rene M.			Eye Movements Discriminate Fatigue Due to Chronotypical Factors and Time Spent on Task - A Double Dissociation	PLOS ONE			English	Article							TOTAL SLEEP-DEPRIVATION; SACCADIC VELOCITY; PERFORMANCE; OCULOMOTOR; VARIABILITY; IMPAIRMENT; ACTIVATION; PARAMETERS; ATTENTION; RESPONSES	Systematic differences in circadian rhythmicity are thought to be a substantial factor determining inter-individual differences in fatigue and cognitive performance. The synchronicity effect (when time of testing coincides with the respective circadian peak period) seems to play an important role. Eye movements have been shown to be a reliable indicator of fatigue due to sleep deprivation or time spent on cognitive tasks. However, eye movements have not been used so far to investigate the circadian synchronicity effect and the resulting differences in fatigue. The aim of the present study was to assess how different oculomotor parameters in a free visual exploration task are influenced by: a) fatigue due to chronotypical factors (being a 'morning type' or an 'evening type'); b) fatigue due to the time spent on task. Eighteen healthy participants performed a free visual exploration task of naturalistic pictures while their eye movements were recorded. The task was performed twice, once at their optimal and once at their non-optimal time of the day. Moreover, participants rated their subjective fatigue. The non-optimal time of the day triggered a significant and stable increase in the mean visual fixation duration during the free visual exploration task for both chronotypes. The increase in the mean visual fixation duration correlated with the difference in subjectively perceived fatigue at optimal and non-optimal times of the day. Conversely, the mean saccadic speed significantly and progressively decreased throughout the duration of the task, but was not influenced by the optimal or non-optimal time of the day for both chronotypes. The results suggest that different oculomotor parameters are discriminative for fatigue due to different sources. A decrease in saccadic speed seems to reflect fatigue due to time spent on task, whereas an increase in mean fixation duration a lack of synchronicity between chronotype and time of the day.	[Cazzoli, Dario; Antoniades, Chrystalina A.; Kennard, Christopher] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Cazzoli, Dario; Nyffeler, Thomas; Bassetti, Claudio L.; Mueri, Rene M.] Univ Bern, Inselspital, Univ Hosp Bern, Percept & Eye Movement Lab,Dept Neurol, CH-3010 Bern, Switzerland; [Cazzoli, Dario; Nyffeler, Thomas; Bassetti, Claudio L.; Mueri, Rene M.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Nyffeler, Thomas] Luzerner Kantonsspital, Dept Internal Med, Ctr Neurol & Neurorehabil, Luzern, Switzerland	University of Oxford; University of Bern; University Hospital of Bern; University of Bern; Lucerne Cantonal Hospital	Cazzoli, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	dario.cazzoli@gmail.com	Müri, René M/E-9320-2012	Müri, René M/0000-0001-6990-4188; Antoniades, Chrystalina/0000-0002-1192-3834; Cazzoli, Dario/0000-0001-7217-7153; Nyffeler, Thomas/0000-0003-2504-8935; Bassetti, Claudio/0000-0002-4535-0245	Swiss National Science Foundation [PBBEP3_134978, 320000-108146]; Janggen-Pohn-Foundation; Holcim Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Janggen-Pohn-Foundation; Holcim Foundation	DC was supported by the Swiss National Science Foundation (Grant No. PBBEP3_134978), the Janggen-Pohn-Foundation, and the Holcim Foundation. This work was supported by the Swiss National Science Foundation (Grant No. 320000-108146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2000, J SLEEP RES, V9, P395; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; App E, 1998, ERGONOMICS, V41, P689, DOI 10.1080/001401398186856; Bocca ML, 2006, CLIN NEUROPHYSIOL, V117, P894, DOI 10.1016/j.clinph.2006.01.003; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Christodoulou C, 2005, ISS CLIN COGN NEUROP, P19; De Gennaro L, 2000, CLIN NEUROPHYSIOL, V111, P1771, DOI 10.1016/S1388-2457(00)00393-X; De Gennaro L, 2001, PHYSIOL BEHAV, V74, P197, DOI 10.1016/S0031-9384(01)00551-0; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Finke C, 2012, J NEUROL, V259, P2656, DOI 10.1007/s00415-012-6565-8; Galley N, 1998, ERGONOMICS, V41, P698, DOI 10.1080/001401398186865; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; Griefahn B, 2001, SOMNOLOGIE, V5, P71, DOI [10.1046/j.1439-054X.2001.01149.x, DOI 10.1046/J.1439-054X.2001.01149.X]; Hirvonen K, 2010, J NEUROSCI METH, V187, P199, DOI 10.1016/j.jneumeth.2010.01.010; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; Lavine RA, 2002, AVIAT SPACE ENVIR MD, V73, P367; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lorist MM, 2000, PSYCHOPHYSIOLOGY, V37, P614, DOI 10.1111/1469-8986.3750614; Marek T, 2010, CHRONOBIOL INT, V27, P945, DOI 10.3109/07420528.2010.489400; May CP, 1999, PSYCHON B REV, V6, P142, DOI 10.3758/BF03210822; May CP, 1998, J EXP PSYCHOL HUMAN, V24, P363, DOI 10.1037/0096-1523.24.2.363; MUNOZ DP, 2003, OCULOMOTOR SYSTEM NE, P55; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Rowland LM, 2005, AVIAT SPACE ENVIR MD, V76, pC104; Russo A, 2003, CLIN NEUROPHYSIOL, V114, P723, DOI 10.1016/S1388-2457(03)00008-7; SAITO S, 1992, ERGONOMICS, V35, P607, DOI 10.1080/00140139208967840; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; Van Donger P, 2000, PRINCIPLES PRACTICE, P391; West R, 2002, J GERONTOL B-PSYCHOL, V57, pP3, DOI 10.1093/geronb/57.1.P3	37	26	28	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87146	10.1371/journal.pone.0087146	http://dx.doi.org/10.1371/journal.pone.0087146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24466334	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100250
J	Ciss, M; Parisey, N; Fournier, G; Taupin, P; Dedryver, CA; Pierre, JS				Ciss, Mamadou; Parisey, Nicolas; Fournier, Gwenaeelle; Taupin, Pierre; Dedryver, Charles-Antoine; Pierre, Jean-Sebastien			Response of Insect Relative Growth Rate to Temperature and Host-Plant Phenology: Estimation and Validation from Field Data	PLOS ONE			English	Article							APHID SITOBION-AVENAE; CLIMATE-CHANGE; METOPOLOPHIUM-DIRHODUM; DERIVATIVE ESTIMATION; NATURAL ENEMIES; CONSEQUENCES; REGRESSION; PERFORMANCE; DYNAMICS; MODELS	Between 1975 to 2011, aphid Relative Growth Rates (RGR) were modelled as a function of mean outdoor temperature and host plant phenology. The model was applied to the grain aphid Sitobion avenae using data on aphid counts in winter wheat at two different climate regions in France (oceanic climate, Rennes (western France); continental climate, Paris). Mean observed aphid RGR was higher in Paris compared to the Rennes region. RGR increased with mean temperature, which is explained by aphid reproduction, growth and development being dependent on ambient temperature. From the stem extension to the heading stage in wheat, there was either a plateau in RGR values (Rennes) or an increase with a maximum at heading (Paris) due to high intrinsic rates of increase in aphids and also to aphid immigration. From the wheat flowering to the ripening stage, RGR decreased in both regions due to the low intrinsic rate of increase in aphids and high emigration rate linked to reduced nutrient quality in maturing wheat. The model validation process showed that the fitted models have more predictive power in the Paris region than in the Rennes region.	[Ciss, Mamadou; Parisey, Nicolas; Dedryver, Charles-Antoine] Inst Natl Rech Agronom, IGEPP UMR 1349, Le Rheu, France; [Ciss, Mamadou; Fournier, Gwenaeelle; Pierre, Jean-Sebastien] Univ Rennes 1, UMR CNRS ECOBIO 6553, Rennes, France; [Ciss, Mamadou; Fournier, Gwenaeelle; Taupin, Pierre] Serv Genet Physiol & Protect Plantes, Arvalis Inst Du Vegetal, Boigneville, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Ciss, M (corresponding author), Inst Natl Rech Agronom, IGEPP UMR 1349, Le Rheu, France.	mamadouciss@hotmail.com		Parisey, Nicolas/0000-0003-2439-3809; CISS, Mamadou/0000-0002-4816-9812	Association Nationale de la Recherche Technique (French National Association for Applied Research); INRA; French Ministry of National Education	Association Nationale de la Recherche Technique (French National Association for Applied Research); INRA; French Ministry of National Education	This research was funded by a CIFRE grant from the Association Nationale de la Recherche Technique (French National Association for Applied Research) and contracted with Arvalis-Institut du Vegetal. This work also benefited from grants provided by INRA and the French Ministry of National Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hassan Diab, 2012, European Journal of Environmental Sciences, V2, P89; [Anonymous], 2012, LANG ENV STAT COMP; Bates D., 2007, NONLINEAR REGRESSION; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Carter N, 1982, CEREAL APHID POPULAT; Ciss M, 2013, ECOL INFORM, V14, P59, DOI 10.1016/j.ecoinf.2012.11.004; Ciss M, 2013, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-11013-12245-11351, DOI 10.1007/S11356-11013-12245-11351]; De Brabanter K, 2013, J MACH LEARN RES, V14, P281; DEAN GJ, 1974, B ENTOMOL RES, V63, P401, DOI 10.1017/S0007485300040888; Dedryver CA, 1982, ACTA OECOL, V3, P341; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Dixon A.F.G., 1987, Agricultural Zoology Reviews, V2, P1; Dixon AF G, 1998, APHID ECOLOGY; Eubank R.L, 1999, NONPARAMETRIC REGRES; Fabre F, 2010, ECOL MODEL, V221, P1770, DOI 10.1016/j.ecolmodel.2010.04.006; Fievet V, 2007, AGR FOREST ENTOMOL, V9, P125, DOI 10.1111/j.1461-9563.2007.00331.x; Harrington R, 2004, SCI UPDATE, P45; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Hulle M, 2010, CR BIOL, V333, P497, DOI 10.1016/j.crvi.2010.03.005; KIECKHEFER RW, 1989, ANN ENTOMOL SOC AM, V82, P701, DOI 10.1093/aesa/82.6.701; Kindlmann P, 1999, J APPL ENTOMOL, V123, P397, DOI 10.1046/j.1439-0418.1999.00390.x; Knott G, 1999, INTERPOLATING CUBIC; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Loxdale HD, 1999, PHILOS T R SOC B, V354, P1479, DOI 10.1098/rstb.1999.0492; McCallum H, 2000, ECOLOGICAL METHODS C; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Morgan Derek, 2000, Agricultural and Forest Entomology, V2, P297, DOI 10.1046/j.1461-9563.2000.00079.x; PIERRE JS, 1984, ACTA OECOL-OEC APPL, V5, P153; Plantegenest M, 2001, ECOL ENTOMOL, V26, P404, DOI 10.1046/j.1365-2311.2001.00330.x; Plantegenest M, 1995, THESIS U F RABELAIS; Ramsay JO, 1998, STATLIB S NEWS  0312; STONE CJ, 1985, ANN STAT, V13, P689, DOI 10.1214/aos/1176349548; van Asch M, 2007, GLOBAL CHANGE BIOL, V13, P1596, DOI 10.1111/j.1365-2486.2007.01400.x; Vereijken P.H., 1979, FEEDING MULTIPLICATI; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; WATT AD, 1981, ECOL ENTOMOL, V6, P441, DOI 10.1111/j.1365-2311.1981.tb00636.x; WATT AD, 1979, ANN APPL BIOL, V91, P147, DOI 10.1111/j.1744-7348.1979.tb06485.x; Wegensteiner R, 2010, AGR FOREST ENTOMOL, V12, P49, DOI 10.1111/j.1461-9563.2009.00449.x; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Zadoks J. C., 1977, Phytiatrie-Phytopharmacie, V26, P129; Zhou SG, 2000, STAT SINICA, V10, P93	42	6	6	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86825	10.1371/journal.pone.0086825	http://dx.doi.org/10.1371/journal.pone.0086825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466259	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100222
J	Hocking, DJ; Babbitt, KJ				Hocking, Daniel J.; Babbitt, Kimberly J.			Effects of Red-Backed Salamanders on Ecosystem Functions	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; BROOK EXPERIMENTAL FOREST; FLOOR FOOD WEBS; TROPHIC CASCADES; ELEUTHERODACTYLUS-COQUI; DETECTION PROBABILITY; EXPERIMENTAL VENUE; BOTTOM-UP; INVERTEBRATES; TERRESTRIAL	Ecosystems provide a vast array of services for human societies, but understanding how various organisms contribute to the functions that maintain these services remains an important ecological challenge. Predators can affect ecosystem functions through a combination of top-down trophic cascades and bottom-up effects on nutrient dynamics. As the most abundant vertebrate predator in many eastern US forests, woodland salamanders (Plethodon spp.) likely affect ecosystems functions. We examined the effects of red-backed salamanders (Plethodon cinereus) on a variety of forest ecosystem functions using a combined approach of large-scale salamander removals (314-m(2) plots) and small-scale enclosures (2 m(2)) where we explicitly manipulated salamander density (0, 0.5, 1, 2, 4 m(-2)). In these experiments, we measured the rates of litter and wood decomposition, potential nitrogen mineralization and nitrification rates, acorn germination, and foliar insect damage on red oak seedlings. Across both experimental venues, we found no significant effect of red-backed salamanders on any of the ecosystem functions. We also found no effect of salamanders on intraguild predator abundance (carabid beetles, centipedes, spiders). Our study adds to the already conflicting evidence on effects of red-backed salamander and other amphibians on terrestrial ecosystem functions. It appears likely that the impact of terrestrial amphibians on ecosystem functions is context dependent. Future research would benefit from explicitly examining terrestrial amphibian effects on ecosystem functions under a variety of environmental conditions and in different forest types.	[Hocking, Daniel J.; Babbitt, Kimberly J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Hocking, DJ (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	dhocking@unh.edu	Hocking, Daniel J./O-3658-2018	Hocking, Daniel J./0000-0003-1889-9184	New Hampshire Agricultural Experiment Station; University of New Hampshire Graduate School	New Hampshire Agricultural Experiment Station; University of New Hampshire Graduate School	Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2500. DJH received funding through the University of New Hampshire Graduate School. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2010, SALAMANDERS US CANAD; Auchmoody LR, 1994, PLANTING NO RED OAK, P5; Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P14, DOI 10.2193/0022-541X(2004)068[0014:SATVID]2.0.CO;2; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Beard KH, 2003, J TROP ECOL, V19, P607, DOI 10.1017/S0266467403006011; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; BURTON TM, 1975, ECOLOGY, V56, P1068, DOI 10.2307/1936147; BURTON TM, 1975, COPEIA, P541; Casper G.S., 2005, AMPHIBIAN DECLINES C, P796; Chalcraft DR, 2005, ECOLOGY, V86, P1061, DOI 10.1890/04-0725; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Daily GC., 1997, ISSUES ECOL, V2, P1; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Davis TM, 2001, J HERPETOL, V35, P217, DOI 10.2307/1566111; Fox J, 2002, COX PROPORTIONAL HAZ; Frank DA, 2008, OIKOS, V117, P1718, DOI 10.1111/j.1600-0706.2008.16846.x; Gillette Jennifer R., 2001, Herpetological Review, V32, P233; GOSZ JR, 1972, ECOLOGY, V53, P769, DOI 10.2307/1934293; Hairston N. G., 1987, COMMUNITY ECOLOGY SA; HAIRSTON NG, 1980, ECOLOGY, V61, P817, DOI 10.2307/1936752; HANLON RDG, 1981, OIKOS, V36, P362, DOI 10.2307/3544634; Harmon ME, 1999, LT EC RES NETWK SER, V2, P202; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Heemeyer Jennifer L., 2007, Herpetological Review, V38, P425; Hickerson CAM, 2004, BEHAV ECOL, V15, P679, DOI 10.1093/beheco/arh064; Hickerson CAM, 2012, AM MIDL NAT, V168, P30, DOI 10.1674/0003-0031-168.1.30; Homyack JA, 2010, J HERPETOL, V44, P447, DOI 10.1670/09-107.1; Homyack JA, 2010, J THERM BIOL, V35, P143, DOI 10.1016/j.jtherbio.2010.01.006; Huang CY, 2007, J TROP ECOL, V23, P161, DOI 10.1017/S0266467406003932; Irmler U, 2000, PEDOBIOLOGIA, V44, P105, DOI 10.1078/S0031-4056(04)70032-3; Jung RE, 2000, ENVIRON MONIT ASSESS, V63, P65, DOI 10.1023/A:1006413603057; Lenoir L, 2007, BIOL FERT SOILS, V43, P281, DOI 10.1007/s00374-006-0103-8; Maerz JC, 2005, DIVERS DISTRIB, V11, P83, DOI 10.1111/j.1366-9516.2005.00125.x; Milton Y, 2007, OECOLOGIA, V153, P163, DOI 10.1007/s00442-007-0710-6; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Morin Peter J., 1998, P50; Paul E.A., 2007, SOIL MICROBIOLOGY EC; Peterman William E., 2006, Herpetological Review, V37, P303; Petranka JW, 2001, J HERPETOL, V35, P36, DOI 10.2307/1566020; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Ransom TS, 2012, ECOLOGY, V93, P2198, DOI 10.1890/11-2024.1; Ransom TS, 2011, OECOLOGIA, V165, P745, DOI 10.1007/s00442-010-1775-1; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Rooney TP, 2000, P ENTOMOL SOC WASH, V102, P308; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2002, ECOL LETT, V5, P168, DOI 10.1046/j.1461-0248.2002.00311.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Sin H, 2008, BIOL INVASIONS, V10, P335, DOI 10.1007/s10530-007-9133-x; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Southwood TRE, 2000, ECOLOGICAL METHODS; Walton BM, 2006, PEDOBIOLOGIA, V50, P313, DOI 10.1016/j.pedobi.2006.04.001; Walton BM, 2005, PEDOBIOLOGIA, V49, P381, DOI 10.1016/j.pedobi.2005.04.001; Walton BM, 2005, PEDOBIOLOGIA, V49, P51, DOI 10.1016/j.pedobi.2004.07.012; Wyman RL, 1998, BIODIVERS CONSERV, V7, P641, DOI 10.1023/A:1008856402258	61	19	21	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86854	10.1371/journal.pone.0086854	http://dx.doi.org/10.1371/journal.pone.0086854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466269	Green Published, gold			2022-12-27	WOS:000330283100225
J	Van Parys, AS; Verhamme, A; Temmerman, M; Verstraelen, H				Van Parys, An-Sofie; Verhamme, Annelien; Temmerman, Marleen; Verstraelen, Hans			Intimate Partner Violence and Pregnancy: A Systematic Review of Interventions	PLOS ONE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; DOMESTIC VIOLENCE; WOMEN; PREVALENCE; HEALTH; RISK; CARE; ASSOCIATIONS; DISCLOSURE; MANAGEMENT	Background: Intimate partner violence (IPV) around the time of pregnancy is a widespread global health problem with many negative consequences. Nevertheless, a lot remains unclear about which interventions are effective and might be adopted in the perinatal care context. Objective: The objective is to provide a clear overview of the existing evidence on effectiveness of interventions for IPV around the time of pregnancy. Methods: Following databases PubMed, Web of Science, CINAHL and the Cochrane Library were systematically searched and expanded by hand search. The search was limited to English peer-reviewed randomized controlled trials published from 2000 to 2013. This review includes all types of interventions aiming to reduce IPV around the time of pregnancy as a primary outcome, and as secondary outcomes to enhance physical and/or mental health, quality of life, safety behavior, help seeking behavior, and/or social support. Results: We found few randomized controlled trials evaluating interventions for IPV around the time of pregnancy. Moreover, the nine studies identified did not produce strong evidence that certain interventions are effective. Nonetheless, home visitation programs and some multifaceted counseling interventions did produce promising results. Five studies reported a statistically significant decrease in physical, sexual and/or psychological partner violence (odds ratios from 0.47 to 0.92). Limited evidence was found for improved mental health, less postnatal depression, improved quality of life, fewer subsequent miscarriages, and less low birth weight/prematurity. None of the studies reported any evidence of a negative or harmful effect of the interventions. Conclusions and implications: Strong evidence of effective interventions for IPV during the perinatal period is lacking, but some interventions show promising results. Additional large-scale, high-quality research is essential to provide further evidence about the effect of certain interventions and clarify which interventions should be adopted in the perinatal care context.	[Van Parys, An-Sofie; Verhamme, Annelien; Temmerman, Marleen; Verstraelen, Hans] Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ghent University	Van Parys, AS (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	ansofie.vanparys@ugent.be	Verstraelen, Hans/A-5602-2008; Verstraelen, Hans/AAA-8694-2019	Verstraelen, Hans/0000-0002-4070-1587; Verhamme, Anne/0000-0002-2201-1865	Research Foundation Flanders [69579]	Research Foundation Flanders(FWO)	ASVP received a PhD bursary for her studies from the Research Foundation Flanders (www.fwo.be, grant number 69579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchus L, 2004, EUR J OBSTET GYN R B, V113, P6, DOI 10.1016/S0301-2115(03)00326-9; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Bair-Merritt MH, 2010, ARCH PEDIAT ADOL MED, V164, P16, DOI 10.1001/archpediatrics.2009.237; Campbell JC, 2001, CAN MED ASSOC J, V164, P1578; Chambliss LR, 2008, CLIN OBSTET GYNECOL, V51, P385, DOI 10.1097/GRF.0b013e31816f29ce; Charles P, 2007, J FAM VIOLENCE, V22, P609, DOI 10.1007/s10896-007-9112-0; Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x; Cripe SM, 2010, J INTERPERS VIOLENCE, V25, P2054, DOI 10.1177/0886260509354517; Curry MA, 2006, JOGNN-J OBST GYN NEO, V35, P181, DOI 10.1111/J.1552-6909.2006.00027.x; Daoud N, 2012, AM J PUBLIC HEALTH, V102, P1893, DOI 10.2105/AJPH.2012.300843; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Dunn LL, 2004, JOGNN, V33, P54, DOI 10.1177/0884217503261080; Fanslow JL, 2010, J INTERPERS VIOLENCE, V25, P929, DOI 10.1177/0886260509336963; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Hegarty KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-2; Hellmuth JC, 2013, ARCH WOMEN MENT HLTH, V16, P19, DOI 10.1007/s00737-012-0309-8; Higgings JPT, 2013, COCHRANE HDB SYSTEMA; Humphreys J, 2011, WOMEN HEALTH ISS, V21, P136, DOI 10.1016/j.whi.2010.09.006; Jahanfar S, 2013, COCHRANE DATABASE SY; Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322; Johnson JK, 2003, BJOG-INT J OBSTET GY, V110, P272, DOI [10.1046/j.1471-0528.2003.02216.x, 10.1016/S1470-0328(02)02926-4]; Kan ML, 2010, VIOLENCE VICTIMS, V25, P319, DOI 10.1891/0886-6708.25.3.319; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Martin SL, 2004, J FAM VIOLENCE, V19, P201, DOI 10.1023/B:JOFV.0000032630.50593.93; McFarlane JM, 2006, NURS RES, V55, P52, DOI 10.1097/00006199-200601000-00007; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P634, DOI 10.1177/1077801208319283; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; O'Campo P, 2011, SOC SCI MED, V72, P855, DOI 10.1016/j.socscimed.2010.12.019; O'Reilly R, 2010, TRAUMA VIOLENCE ABUS, V11, P190, DOI 10.1177/1524838010378298; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Rodrigues T, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.015; Roelens K, 2008, EUR J OBSTET GYN R B, V137, P37, DOI 10.1016/j.ejogrb.2007.04.013; Rose L, 2010, INT J QUAL METH, V9, P382; Saltzman Linda E, 2003, Matern Child Health J, V7, P31, DOI 10.1023/A:1022589501039; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052; Spangaro JM, 2010, HEALTH SOC CARE COMM, V18, P671, DOI 10.1111/j.1365-2524.2010.00943.x; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Taft AJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-159; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Zink T, 2004, ANN FAM MED, V2, P231, DOI 10.1370/afm.74; Zlotnick C, 2011, ARCH WOMEN MENT HLTH, V14, P55, DOI 10.1007/s00737-010-0195-x	52	80	81	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85084	10.1371/journal.pone.0085084	http://dx.doi.org/10.1371/journal.pone.0085084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24482679	Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000023
J	Root, JJ; Shriner, SA; Bentler, KT; Gidlewski, T; Mooers, NL; Ellis, JW; Spraker, TR; VanDalen, KK; Sullivan, HJ; Franklin, AB				Root, J. Jeffrey; Shriner, Susan A.; Bentler, Kevin T.; Gidlewski, Thomas; Mooers, Nicole L.; Ellis, Jeremy W.; Spraker, Terry R.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.			Extended Viral Shedding of a Low Pathogenic Avian Influenza Virus by Striped Skunks (Mephitis mephitis)	PLOS ONE			English	Article							UNITED-STATES; INFECTION	Background: Striped skunks (Mephitis mephitis) are susceptible to infection with some influenza A viruses. However, the viral shedding capability of this peri-domestic mammal and its potential role in influenza A virus ecology are largely undetermined. Methodology/Principal Findings: Striped skunks were experimentally infected with a low pathogenic (LP) H4N6 avian influenza virus (AIV) and monitored for 20 days post infection (DPI). All of the skunks exposed to H4N6 AIV shed large quantities of viral RNA, as detected by real-time RT-PCR and confirmed for live virus with virus isolation, from nasal washes and oral swabs (maximum <= 10(6.02) PCR EID50 equivalent/mL and <= 10(5.19) PCR EID50 equivalent/mL, respectively). Some evidence of potential fecal shedding was also noted. Following necropsy on 20 DPI, viral RNA was detected in the nasal turbinates of one individual. All treatment animals yielded evidence of a serological response by 20 DPI. Conclusions/Significance: These results indicate that striped skunks have the potential to shed large quantities of viral RNA through the oral and nasal routes following exposure to a LP AIV. Considering the peri-domestic nature of these animals, along with the duration of shedding observed in this species, their presence on poultry and waterfowl operations could influence influenza A virus epidemiology. For example, this species could introduce a virus to a naive poultry flock or act as a trafficking mechanism of AIV to and from an infected poultry flock to naive flocks or wild bird populations.	[Root, J. Jeffrey; Shriner, Susan A.; Bentler, Kevin T.; Mooers, Nicole L.; Ellis, Jeremy W.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.] Wildlife Serv, USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA; [Gidlewski, Thomas] Wildlife Serv, USDA, Natl Wildlife Dis Program, Ft Collins, CO USA; [Spraker, Terry R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Colorado State University	Root, JJ (corresponding author), Wildlife Serv, USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA.	Jeff.root@aphis.usda.gov		Franklin, Alan/0000-0001-9491-795X; Shriner, Susan/0000-0003-0349-7182; Ellis, Jeremy/0000-0003-4512-0906	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Armstrong DM, 2011, MAMMALS OF COLORADO, 2ND EDITION, P1; AVMA, 2011, 2009 H1N1 FLU OUTBR; Bailey CF, 1983, EXPT INFECT RACCOON; BEARD CW, 1970, B WORLD HEALTH ORGAN, V42, P779; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; CRABTREE RL, 1988, WILDLIFE SOC B, V16, P163; Dragoo JW, 1997, J MAMMAL, V78, P426, DOI 10.2307/1382896; FITZGERALD J, 1994, MAMMALS COLORADO; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; Halvorson D.A., 2008, AVIAN INFLUENZA, V439, P513; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; KLINGEBORN B, 1985, ARCH VIROL, V86, P347, DOI 10.1007/BF01309839; Lariviere S, 1999, AM MIDL NAT, V142, P96, DOI 10.1674/0003-0031(1999)142[0096:SBSSMM]2.0.CO;2; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; NVSL, 2008, AVPRO1510042008 NVSL; NVSL, 2003, AVPRO010005 NVSL; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; ProMED-mail, 2006, AV INFL WORLDW 70 AS; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Root JJ, 2013, ECOLOGICAL ROUTES AV; Rosatte R., 2003, WILD MAMMALS N AM BI, P692; Schrenzel MD, 2011, EMERG INFECT DIS, V17, P747, DOI [10.3201/eid1706.101355, 10.3201/eid1704.101355]; Shriner SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039206; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Szretter K.J., 2006, CURRENT PROTOCOLS MI, V3, DOI [10.1002/0471729256.mc15g01-3, DOI 10.1002/0471729256.MC15G01-3, 10.1002/0471729256.mc15g01s3, DOI 10.1002/0471729256.MC15G01S3]; Vandalen KK, 2009, MAMMAL REV, V39, P167, DOI 10.1111/j.1365-2907.2009.00144.x; WADESMITH J, 1982, MAMMALIAN SPECIES, V173, P1, DOI DOI 10.2307/3503883; WHO, 2006, AV INFL H5N1 INF FOU; Yoon KJ, 2012, J VET DIAGN INVEST, V24, P388, DOI 10.1177/1040638711428349	32	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e70639	10.1371/journal.pone.0070639	http://dx.doi.org/10.1371/journal.pone.0070639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489638	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000001
J	Poulin, C; Shiner, B; Thompson, P; Vepstas, L; Young-Xu, Y; Goertzel, B; Watts, B; Flashman, L; McAllister, T				Poulin, Chris; Shiner, Brian; Thompson, Paul; Vepstas, Linas; Young-Xu, Yinong; Goertzel, Benjamin; Watts, Bradley; Flashman, Laura; McAllister, Thomas			Predicting the Risk of Suicide by Analyzing the Text of Clinical Notes	PLOS ONE			English	Article							UNITED-STATES; HEALTH; DEPRESSION; VETERANS; THOUGHTS; CARE; COMORBIDITY; IDEATION; ALTITUDE; OUTCOMES	We developed linguistics-driven prediction models to estimate the risk of suicide. These models were generated from unstructured clinical notes taken from a national sample of U. S. Veterans Administration (VA) medical records. We created three matched cohorts: veterans who committed suicide, veterans who used mental health services and did not commit suicide, and veterans who did not use mental health services and did not commit suicide during the observation period (n = 70 in each group). From the clinical notes, we generated datasets of single keywords and multi-word phrases, and constructed prediction models using a machine-learning algorithm based on a genetic programming framework. The resulting inference accuracy was consistently 65% or more. Our data therefore suggests that computerized text analytics can be applied to unstructured medical records to estimate the risk of suicide. The resulting system could allow clinicians to potentially screen seemingly healthy patients at the primary care level, and to continuously evaluate the suicide risk among psychiatric patients.	[Poulin, Chris; Thompson, Paul; Flashman, Laura; McAllister, Thomas] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Poulin, Chris; Thompson, Paul; Flashman, Laura; McAllister, Thomas] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Poulin, Chris; Thompson, Paul; Vepstas, Linas] Durkheim Project, Portsmouth, NH USA; [Shiner, Brian; Young-Xu, Yinong; Watts, Bradley] US Dept Vet Affairs, White River Junct VA Med Ctr, White River Jct, VT USA; [Goertzel, Benjamin] Novamente LLC, Rockville, MD USA	Dartmouth College; Dartmouth College; US Department of Veterans Affairs	Poulin, C (corresponding author), Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA.	chris@durkheimproject.org		Vepstas, Linas/0000-0002-2557-740X	Defense Advanced Research Projects Agency (DARPA); Space Warfare Systems Center Pacific [N66001-11-4006]; Intelligence Advanced Research Projects Activity (IARPA) via the Department of Interior National Business Center [N10PC20221]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Space Warfare Systems Center Pacific; Intelligence Advanced Research Projects Activity (IARPA) via the Department of Interior National Business Center	This material is based upon work supported by the Defense Advanced Research Projects Agency (DARPA), and Space Warfare Systems Center Pacific under Contract N66001-11-4006. Also supported by, the Intelligence Advanced Research Projects Activity (IARPA) via the Department of Interior National Business Center contract number N10PC20221. The opinions, findings and conclusions or recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the Defense Advanced Research Projects Agency (DARPA) and the Space Naval Warfare Systems Center Pacific, or IARPA, DOI/NBC, or the U. S. Government. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Almeida OP, 2012, BRIT J PSYCHIAT, V201, P466, DOI 10.1192/bjp.bp.112.110130; [Anonymous], 2003, Am J Psychiatry, V160, P1; Aubin HJ, 2011, AM J PSYCHIAT, V168, P326, DOI 10.1176/appi.ajp.2010.10101501; Bahmanyar S, 2009, J EPIDEMIOL COMMUN H, V63, P1016, DOI 10.1136/jech.2008.086348; Bauer AM, 2013, J GEN INTERN MED, V28, P363, DOI 10.1007/s11606-012-2194-2; Betz ME, 2011, SUICIDE LIFE-THREAT, V41, P562, DOI 10.1111/j.1943-278X.2011.00054.x; Borges G, 2006, PSYCHOL MED, V36, P1747, DOI 10.1017/S0033291706008786; Bossarte R, 2010, MIL MED, V175, P461, DOI 10.7205/MILMED-D-10-00050; Busch KA, 2004, PSYCHIAT ANN, V34, P357, DOI 10.3928/0048-5713-20040501-16; Busch KA, 2003, J CLIN PSYCHIAT, V64, P14, DOI 10.4088/JCP.v64n0105; Conner KR, 2013, J ABNORM PSYCHOL, V122, P256, DOI 10.1037/a0030163; Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davila SLR, 2010, AM J HOSP PALLIAT ME, V27, P63, DOI 10.1177/1049909109341874; Denneson LM, 2010, PSYCHIAT SERV, V61, P1192, DOI 10.1176/ps.2010.61.12.1192; Goertzel B, 2013, P AGI 13; Haney EM., 2012, SUICIDE RISK FACTORS; Hawton K, 2013, AFFECT DISORD NHAWTO, DOI [10.1016/j.jad.2013.01.004., DOI 10.1016/J.JAD.2013.01.004.[]; Inagaki M, 2013, ASS INTERLEUKIN 6 VE; Kales HC, 2010, J AM GERIATR SOC, V58, P908, DOI 10.1111/j.1532-5415.2010.02810.x; Kaplan MS, 2012, AM J PUBLIC HEALTH, V102, pS131, DOI 10.2105/AJPH.2011.300445; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kim HM, 2010, HEALTH SERV RES, V45, P1205, DOI 10.1111/j.1475-6773.2010.01132.x; Kim N, 2011, AM J PSYCHIAT, V168, P49, DOI 10.1176/appi.ajp.2010.10020289; KOVACS M, 1976, ARCH GEN PSYCHIAT, V33, P198; Looks M, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P626; Lossnitzer N, 2009, EXPLORING POTENTIAL; Mills PD, 2010, JT COMM J QUAL PATIE, V36, P87, DOI 10.1016/S1553-7250(10)36015-6; Ming Li, 1997, INTRO KOLMOGOROV COM; Nissim R, 2009, SOC SCI MED, V69, P165, DOI 10.1016/j.socscimed.2009.04.021; O'Connor E, 2013, ANN INTERN MED, DOI [10.7326/0003-4819-158-10-201305210-00642., DOI 10.7326/0003-4819-158-10-201305210-00642.[]; Pan YJ, 2009, GEN HOSP PSYCHIAT, V31, P181, DOI 10.1016/j.genhosppsych.2008.12.010; Penagaluri P, 2010, CRISIS, V31, P53, DOI 10.1027/0227-5910/a000002; Saha S, 2011, SCHIZOPHR RES, V132, P197, DOI 10.1016/j.schres.2011.07.012; Valenstein M, 2009, PSYCHIAT SERV, V60, P439, DOI 10.1176/appi.ps.60.4.439; Watts BV, 2007, QUAL SAF HEALTH CARE, V16, P378, DOI 10.1136/qshc.2007.022418; Zivin K, 2007, AM J PUBLIC HEALTH, V97, P2193, DOI 10.2105/AJPH.2007.115477	36	94	94	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85733	10.1371/journal.pone.0085733	http://dx.doi.org/10.1371/journal.pone.0085733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489669	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000018
J	Vandal, G; Geiling, B; Dankort, D				Vandal, Guillaume; Geiling, Benjamin; Dankort, David			Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation	PLOS ONE			English	Article							CELL-CYCLE ARREST; GROWTH-FACTOR RECEPTOR; EML4-ALK FUSION GENE; ONCOGENIC RAS; IN-VIVO; K-RAS; PROTEIN-KINASE; PROMOTER HYPERMETHYLATION; TRANSGENIC MICE; CANCER MODELS	Lung cancer is currently the most deadly malignancy in industrialized countries and accounts for 18% of all cancer-related deaths worldwide. Over 70% of patients with non-small cell lung cancer (NSCLC) are diagnosed at a late stage, with a 5-year survival below 10%. KRAS and the EGFR are frequently mutated in NSCLC and while targeted therapies for patients with EGFR mutations exist, oncogenic KRAS is thus far not druggable. KRAS activates multiple signalling pathways, including the PI3K/Akt pathway, the Raf-Mek-Erk pathway and the RalGDS/Ral pathway. Lung-specific expression of BrafV600E, the most prevalent BRAF mutation found in human tumors, results in Raf-Mek-Erk pathway activation and in the formation of benign adenomas that undergo widespread senescence in a Cre-activated Braf mouse model (Braf(CA)). However, oncogenic KRAS expression in mice induces adenocarcinomas, suggesting additional KRAS-activated pathways cooperate with sustained RAF-MEK-ERK signalling to bypass the oncogene-induced senescence proliferation arrest. To determine which KRAS effectors were responsible for tumor progression, we created four effector domain mutants (S35, G37, E38 and C40) in G12V-activated KRAS and expressed these alone or with BrafV600E in mouse lungs. The S35 and E38 mutants bind to Raf proteins but not PI3K or RalGDS; the G37 mutant binds to RalGDS and not Raf or PI3K and the C40 mutant is specific to PI3K. We designed lentiviral vectors to code for Cre recombinase along with KRAS mutants (V12, V12/S35, V12/G37, V12/E38 or V12/C40) or EGFP as a negative control.. These lentiviruses were used to infect Braf(CA) and wild-type mice. Surprisingly there was a significant decrease in tumor number and penetrance with each KRAS effector domain mutant relative to controls, suggesting that KRAS directly activates effectors with tumor suppressive functions.	[Vandal, Guillaume; Geiling, Benjamin; Dankort, David] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Dankort, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	david.dankort@mcgill.ca		Dankort, David/0000-0002-5862-6829	Canadian Institutes of Health Research [MOP-97925]; Melanoma Research Alliance; Canadian Cancer Society [2011-700876]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Melanoma Research Alliance; Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research [operating grant MOP-97925 to DD, Graduate scholarship to GV]; the Melanoma Research Alliance [New Investigator Award]; and the Canadian Cancer Society [CCSRI# 2011-700876]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadi C, 2012, GENE DEV, V26, P1945, DOI 10.1101/gad.193458.112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Dumur CI, 2003, GENOMICS, V81, P260, DOI 10.1016/S0888-7543(03)00020-X; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Farago AF, 2012, CELL, V149, P246, DOI 10.1016/j.cell.2012.03.015; Ferlay J, 2010, IARC CANCERBASE, V2; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Gandhi L, 2012, CLIN CANCER RES, V18, P3737, DOI 10.1158/1078-0432.CCR-11-2393; Gaughan Elizabeth M, 2011, Ther Adv Med Oncol, V3, P113, DOI 10.1177/1758834010397569; Geiling B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076279; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Irimia M, 2004, ONCOGENE, V23, P8695, DOI 10.1038/sj.onc.1207914; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacquemart IC, 2009, INT J ONCOL, V34, P517, DOI 10.3892/ijo_00000177; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Johnson LG, 2003, HUM GENE THER, V14, P729, DOI 10.1089/104303403765255138; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Laurent-Puig P, 2009, CLIN CANCER RES, V15, P1133, DOI 10.1158/1078-0432.CCR-08-0905; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Little AG, 2005, ANN THORAC SURG, V80, P2051, DOI 10.1016/j.athoracsur.2005.06.071; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Maldonado JL, 2004, AM J PATHOL, V164, P1783, DOI 10.1016/S0002-9440(10)63736-4; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Musteanu M, 2012, NAT METHODS, V9, P897, DOI 10.1038/nmeth.2130; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rodig SJ, 2010, CURR OPIN INVEST DR, V11, P1477; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seo JS, 2012, GENOME RES; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song H, 2010, BIOCHEM BIOPH RES CO, V391, P969, DOI 10.1016/j.bbrc.2009.11.175; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tommasi S, 2005, CANCER RES, V65, P92; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Trejo CL, 2012, CANCER RES, V72, P3048, DOI 10.1158/0008-5472.CAN-11-3649; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	84	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84745	10.1371/journal.pone.0084745	http://dx.doi.org/10.1371/journal.pone.0084745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489653	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000009
J	Bekhuis, T; Tseytlin, E; Mitchell, KJ; Demner-Fushman, D				Bekhuis, Tanja; Tseytlin, Eugene; Mitchell, Kevin J.; Demner-Fushman, Dina			Feature Engineering and a Proposed Decision-Support System for Systematic Reviewers of Medical Evidence	PLOS ONE			English	Review							ALGORITHM; WORKLOAD; ROBUST	Objectives: Evidence-based medicine depends on the timely synthesis of research findings. An important source of synthesized evidence resides in systematic reviews. However, a bottleneck in review production involves dual screening of citations with titles and abstracts to find eligible studies. For this research, we tested the effect of various kinds of textual information (features) on performance of a machine learning classifier. Based on our findings, we propose an automated system to reduce screeing burden, as well as offer quality assurance. Methods: We built a database of citations from 5 systematic reviews that varied with respect to domain, topic, and sponsor. Consensus judgments regarding eligibility were inferred from published reports. We extracted 5 feature sets from citations: alphabetic, alphanumeric(+), indexing, features mapped to concepts in systematic reviews, and topic models. To simulate a two-person team, we divided the data into random halves. We optimized the parameters of a Bayesian classifier, then trained and tested models on alternate data halves. Overall, we conducted 50 independent tests. Results: All tests of summary performance (mean F3) surpassed the corresponding baseline, P<0.0001. The ranks for mean F3, precision, and classification error were statistically different across feature sets averaged over reviews; P-values for Friedman's test were.045,.002, and.002, respectively. Differences in ranks for mean recall were not statistically significant. Alphanumeric(+) features were associated with best performance; mean reduction in screening burden for this feature type ranged from 88% to 98% for the second pass through citations and from 38% to 48% overall. Conclusions: A computer-assisted, decision support system based on our methods could substantially reduce the burden of screening citations for systematic review teams and solo reviewers. Additionally, such a system could deliver quality assurance both by confirming concordant decisions and by naming studies associated with discordant decisions for further consideration.	[Bekhuis, Tanja; Tseytlin, Eugene; Mitchell, Kevin J.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Demner-Fushman, Dina] US Natl Inst Hlth, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bethesda, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Bekhuis, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	tcb24@pitt.edu	Bekhuis, Tanja/D-4357-2015	Bekhuis, Tanja/0000-0002-8537-9077	US National Library of Medicine, National Institutes of Health [4R00LM010943]; NATIONAL LIBRARY OF MEDICINE [R00LM010943, ZIHLM200888] Funding Source: NIH RePORTER	US National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was suppported by the US National Library of Medicine, National Institutes of Health, grant number 4R00LM010943. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; [Anonymous], IBM SPSS STAT COMP P; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Bekhuis T, 2013, EDDA STUDY DESIGN TE; Bekhuis T, 2013, 21 COCHR C QUEB CAN; Bekhuis T, 2009, COCHRANE DB SYST REV, DOI 101002/14651858CD003975pub2; Bekhuis T, 2013, J MED LIBR ASSOC, V101, P92, DOI 10.3163/1536-5050.101.2.004; Bekhuis T, 2012, ARTIF INTELL MED, V55, P197, DOI 10.1016/j.artmed.2012.05.002; Bekhuis T, 2010, STUD HEALTH TECHNOL, V160, P146, DOI 10.3233/978-1-60750-588-4-146; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boudin F, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-29; Chandler J, 2012, METHODOLOGICAL STAND; Cohen AM, 2009, J AM MED INFORM ASSN, V16, P690, DOI 10.1197/jamia.M3162; Cohen Aaron M, 2010, P 1 ACM INT HLTH INF, P376, DOI [10.1145/1882992.1883046, DOI 10.1145/1882992.1883046]; Cohen AM, 2006, J AM MED INFORM ASSN, V13, P206, DOI 10.1197/jamia.M1929; Cohen AM, 2008, AMIA ANN S P; Dalal SR, 2013, MED DECIS MAKING, V33, P343, DOI 10.1177/0272989X12457243; Del Fiol G, 2008, J BIOMED INFORM, V41, P655, DOI 10.1016/j.jbi.2007.11.007; EMBASE, BIOM ANSW; Frunza O, 2011, ARTIF INTELL MED, V51, P17, DOI 10.1016/j.artmed.2010.10.005; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Huang Xiaoli, 2006, AMIA Annu Symp Proc, P359; Institute of Medicine of the National Academies, 2011, FIND WHAT WORKS HLTH; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 101002/14651858CD004876pub3; Jimeno-Yepes Antonio, 2011, AMIA Annu Symp Proc, V2011, P1583; Keerthi SS, 2005, MACH LEARN, V61, P151, DOI 10.1007/s10994-005-0768-5; Kilicoglu H, 2009, J AM MED INFORM ASSN, V16, P25, DOI 10.1197/jamia.M2996; Klinkenberg R., 2000, ICML, P487; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; Luce BR, 2010, MILBANK Q, V88, P256, DOI 10.1111/j.1468-0009.2010.00598.x; Matwin S, 2010, J AM MED INFORM ASSN, V17, P446, DOI 10.1136/jamia.2010.004325; McCallum A. K., MALLET MACHINE LEARN; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Mierswa I, 2006, P ACM SIGKDD INT C K; National Institutes of Health, 2012, NLM ADM INF SERV N S; Oremus M, 2008, AHRQ PUBLICATION; Patient Centered Outcomes Research Institute, 2012, PCORI METH STAND, P1; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Rennie J.D.M., 2003, P 20 INT C MACH LEAR, P616; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Steyvers M, 2007, HDB LATENT SEMANTIC; US National Library of Medicine, MESH; US National Library of Medicine, 2009, UMLS REF MAN; Wallace BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-55; Wilczynski Nancy L, 2005, BMC Med Inform Decis Mak, V5, P20, DOI 10.1186/1472-6947-5-20; Wilczynski NL, 2013, J AM MED INFORM ASSN, V20, P363, DOI 10.1136/amiajnl-2012-001075; Wilczynski Nancy L, 2011, AMIA Annu Symp Proc, V2011, P1506; Yaffe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036626; Zeng Qing T, 2012, AMIA Annu Symp Proc, V2012, P1050; Zou Qinghua, 2003, AMIA Annu Symp Proc, P763	53	21	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86277	10.1371/journal.pone.0086277	http://dx.doi.org/10.1371/journal.pone.0086277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475099	Green Published, gold			2022-12-27	WOS:000330507300049
J	Burney, PR; White, N; Pfaendtner, J				Burney, Patrick R.; White, Nathan; Pfaendtner, Jim			Structural Effects of Methionine Oxidation on Isolated Subdomains of Human Fibrin D and alpha C Regions	PLOS ONE			English	Article							ACUTE TRAUMATIC COAGULOPATHY; FREE-ENERGY LANDSCAPE; MOLECULAR-DYNAMICS; PLASMA-FIBRINOGEN; METHYLENE-BLUE; FORCE-FIELD; SIMULATION; CHAIN; METADYNAMICS; ASSOCIATION	Oxidation of key methionine residues on fibrin leads to altered fibrin polymerization producing severely altered fibrin gel structure and function. This is important because fibrinogen and its modification by oxidative stress have been implicated as key contributors to both pathological thrombotic and hemorrhagic diseases ranging from cardiovascular thrombosis to the acute coagulopathy of trauma. However, how oxidation leads to altered fibrin polymerization remains poorly understood at the molecular level. We have applied a powerful and novel well-tempered ensemble parallel tempering (PT-WTE) technique along with conventional molecular dynamics (MD) simulation to investigate the molecular-level consequences of selective methionine oxidation of fibrinogen. We offer new insights into molecular mechanisms of oxidation-induced changes in fibrin polymerization, while focusing on the D region knob 'B' and hole 'b' interaction and alpha C-domain interactions, both of which are hypothesized to contribute to the lateral aggregation mechanism of fibrin fibrils. Methionine oxidation did not alter the native state or the stability of a bound knob 'B' surrogate when interacting with hole 'b' in the D region. However, applying PT-WTE simulation to a human homology model of the bovine N-terminal subdomain fragment from the alpha C-domain revealed that methionine oxidation altered the conformation of the hairpin-linking region to favor open rather than closed hairpin structures. We attribute this alteration to the disruption of the hairpin-linking region's conformation, with oxidation increasing the radius of gyration for this segment. This result is in agreement with experimental data demonstrating decreased fibrin protofibril lateral aggregation when methionine oxidation is present in the same alpha C-domain fragment. Therefore, single methionine oxidation within the alpha C-domain is a likely molecular mechanism.	[Burney, Patrick R.; Pfaendtner, Jim] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [White, Nathan] Univ Washington, Puget Sound Blood Ctr Res Inst, Seattle, WA 98195 USA; [White, Nathan] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pfaendtner, J (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	jpfaendt@u.washington.edu			National Science Foundation through TeraGrid resources provided by NICS; HYAK super computer at the University of Washington; National Institutes of Health NCCR-NCATS [KL2 TR000421]; Washington Life Sciences Discovery Fund; University of Washington Coulter Translational Research Award; University of Washington Institute for Translational Health Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000421] Funding Source: NIH RePORTER	National Science Foundation through TeraGrid resources provided by NICS; HYAK super computer at the University of Washington; National Institutes of Health NCCR-NCATS; Washington Life Sciences Discovery Fund; University of Washington Coulter Translational Research Award; University of Washington Institute for Translational Health Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The simulations performed for this research were supported in part by the National Science Foundation through TeraGrid resources provided by NICS and the HYAK super computer at the University of Washington. NJW is supported by National Institutes of Health NCCR-NCATS KL2 TR000421, Washington Life Sciences Discovery Fund, University of Washington Coulter Translational Research Award, University of Washington Institute for Translational Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Burton RA, 2007, BIOCHEMISTRY-US, V46, P8550, DOI 10.1021/bi700606v; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; CARR ME, 1995, BLOOD COAGUL FIBRIN, V6, P79, DOI 10.1097/00001721-199502000-00013; CARR ME, 1989, THROMB HAEMOSTASIS, V61, P230; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Deighan M, 2013, LANGMUIR, V29, P7999, DOI 10.1021/la4010664; Deighan M, 2012, J CHEM THEORY COMPUT, V8, P2189, DOI 10.1021/ct300297t; Descamps-Latscha A, 2005, AM J KIDNEY DIS, V45, P39, DOI 10.1053/j.ajkd.2004.09.011; Devore T.L., 2000, PROBABILITY STAT; Doolittle RF, 2007, BIOCHEMISTRY-US, V46, P10033, DOI 10.1021/bi7010916; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Heffron SP, 2009, FREE RADICAL BIO MED, V47, P1140, DOI 10.1016/j.freeradbiomed.2009.07.025; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Le DSNT, 2008, DIABETES RES CLIN PR, V82, P317, DOI 10.1016/j.diabres.2008.08.019; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Medved L, 2009, J THROMB HAEMOST, V7, P355, DOI 10.1111/j.1538-7836.2008.03242.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; MOSESSON MW, 1987, BLOOD, V69, P1073; Nalian A, 2008, THROMB HAEMOSTASIS, V100, P18, DOI 10.1160/TH07-12-0750; Nowak P, 2007, THROMB RES, V121, P163, DOI 10.1016/j.thromres.2007.03.017; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Ping LF, 2011, BIOCHEMISTRY-US, V50, P9066, DOI 10.1021/bi201094v; Prakash MK, 2011, J CHEM THEORY COMPUT, V7, P2025, DOI 10.1021/ct200208h; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Selmeci L, 2006, FREE RADICAL RES, V40, P952, DOI 10.1080/10715760600818789; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Simons KT, 1999, PROTEINS, P171; Suontaka AM, 2003, TRANSFUSION, V43, P568, DOI 10.1046/j.1537-2995.2003.00377.x; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Trzesniak D, 2007, CHEMPHYSCHEM, V8, P162, DOI 10.1002/cphc.200600527; Tsurupa G, 2012, BIOCHEMISTRY-US, V51, P2526, DOI 10.1021/bi2017848; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; WATT KWK, 1979, BIOCHEMISTRY-US, V18, P5410, DOI 10.1021/bi00591a024; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639	64	25	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86981	10.1371/journal.pone.0086981	http://dx.doi.org/10.1371/journal.pone.0086981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475207	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300123
J	Duan, LJ; Takeda, K; Fong, GH				Duan, Li-Juan; Takeda, Kotaro; Fong, Guo-Hua			Hypoxia Inducible Factor-2 alpha Regulates the Development of Retinal Astrocytic Network by Maintaining Adequate Supply of Astrocyte Progenitors	PLOS ONE			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; PRECURSOR CELLS APCS; OPTIC-NERVE; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; VEGF EXPRESSION; BONE-MARROW; MICE; ANGIOGENESIS; HIF-1-ALPHA	Here we investigate the role of hypoxia inducible factor (HIF)-2 alpha in coordinating the development of retinal astrocytic and vascular networks. Three Cre mouse lines were used to disrupt floxed Hif-2 alpha, including Rosa26(CreERT2), Tie2(Cre), and GFAP(Cre). Global Hif-2 alpha disruption by Rosa26(CreERT2) led to reduced astrocytic and vascular development in neonatal retinas, whereas endothelial disruption by Tie2(Cre) had no apparent effects. Hif-2 alpha deletion in astrocyte progenitors by GFAP(Cre) significantly interfered with the development of astrocytic networks, which failed to reach the retinal periphery and were incapable of supporting vascular development. Perplexingly, the abundance of strongly GFAP(+) mature astrocytes transiently increased at P0 before they began to lag behind the normal controls by P3. Pax2(+) and PDGFR alpha(+) astrocytic progenitors and immature astrocytes were dramatically diminished at all stages examined. Despite decreased number of astrocyte progenitors, their proliferation index or apoptosis was not altered. The above data can be reconciled by proposing that HIF-2 alpha is required for maintaining the supply of astrocyte progenitors by slowing down their differentiation into non-proliferative mature astrocytes. HIF-2 alpha deficiency in astrocyte progenitors may accelerate their differentiation into astrocytes, a change which greatly interferes with the replenishment of astrocyte progenitors due to insufficient time for proliferation. Rapidly declining progenitor supply may lead to premature cessation of astrocyte development. Given that HIF-2 alpha protein undergoes oxygen dependent degradation, an interesting possibility is that retinal blood vessels may regulate astrocyte differentiation through their oxygen delivery function. While our findings support the consensus that retinal astrocytic template guides vascular development, they also raise the possibility that astrocytic and vascular networks may mutually regulate each other's development, mediated at least in part by HIF-2 alpha.	[Duan, Li-Juan; Takeda, Kotaro; Fong, Guo-Hua] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Dept Cell Biol, Farmington, CT USA	University of Connecticut	Fong, GH (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Dept Cell Biol, Farmington, CT USA.	fong@nso2.uchc.edu			NIH [5R01EY019721]; NATIONAL EYE INSTITUTE [R01EY019721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by NIH grant 5R01EY019721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Caprara C, 2011, INVEST OPHTH VIS SCI, V52, P2109, DOI 10.1167/iovs.10-6222; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; Chu Y, 2001, FASEB J, V15, P2013, DOI 10.1096/fj.00-0868fje; Criscimanna A, 2013, CANC RES; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Duan LJ, 2011, AM J PATHOL, V178, P1881, DOI 10.1016/j.ajpath.2010.12.016; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Ho VC, 2012, CIRCULATION, V126, P741, DOI 10.1161/CIRCULATIONAHA.112.091603; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mi HY, 1999, J NEUROSCI, V19, P1049; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Miyawaki T, 2004, J NEUROSCI, V24, P8124, DOI 10.1523/JNEUROSCI.2235-04.2004; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Mowat FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011103; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	50	21	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e84736	10.1371/journal.pone.0084736	http://dx.doi.org/10.1371/journal.pone.0084736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475033	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300014
J	Houben, R; Schmid, CP; Maier, M; Wobser, M; Motschenbacher, S; Becker, JC; Vetter-Kauczok, CS; Weyandt, G; Hesbacher, S; Haferkamp, S				Houben, Roland; Schmid, Corinna P.; Maier, Melissa; Wobser, Marion; Motschenbacher, Stephanie; Becker, Juergen C.; Vetter-Kauczok, Claudia S.; Weyandt, Gerhard; Hesbacher, Sonja; Haferkamp, Sebastian			p53 Regulation by TRP2 Is Not Pervasive in Melanoma	PLOS ONE			English	Article							HUMAN-MALIGNANT MELANOMA; CELL-LINES; DOPACHROME-TAUTOMERASE; EXPRESSION; MUTATION; GENE; AMPLIFICATION; PROGRESSION; TYROSINASE; MOLECULES	p53 is a central tumor suppressor protein and its inhibition is believed to be a prerequisite for cancer development. In approximately 50% of all malignancies this is achieved by inactivating mutations in the p53 gene. However, in several cancer entities, including melanoma, p53 mutations are rare. It has been recently proposed that tyrosinase related protein 2 (TRP2), a protein involved in melanin synthesis, may act as suppressor of the p53 pathway in melanoma. To scrutinize this notion we analyzed p53 and TRP2 expression by immunohistochemistry in 172 melanoma tissues and did not find any correlation. Furthermore, we applied three different TRP2 shRNAs to five melanoma cell lines and could not observe a target specific effect of the TRP2 knockdown on either p53 expression nor p53 reporter gene activity. Likewise, ectopic expression of TRP2 in a TRP2 negative melanoma cell line had no impact on p53 expression. In conclusion our data suggest that p53 repression critically controlled by TRP2 is not a general event in melanoma.	[Houben, Roland; Schmid, Corinna P.; Maier, Melissa; Wobser, Marion; Motschenbacher, Stephanie; Vetter-Kauczok, Claudia S.; Weyandt, Gerhard; Hesbacher, Sonja; Haferkamp, Sebastian] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Becker, Juergen C.] Med Univ Graz, Dept Gen Dermatol, Graz, Austria	University of Wurzburg; Medical University of Graz	Haferkamp, S (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany.	haferkamp_s@ukw.de	Haferkamp, Sebastian/ABD-7390-2021; Haferkamp, Sebastian/AAN-3649-2021	Haferkamp, Sebastian/0000-0002-3894-8345; Houben, Roland/0000-0003-4538-2324	German Cancer Aid (Melanoma Research Network); Interdisciplinary Center for Clinical Research [IZKF B-193]; University of Wurzburg; German Research Foundation (DFG)	German Cancer Aid (Melanoma Research Network)(Deutsche Krebshilfe); Interdisciplinary Center for Clinical Research; University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	This work is supported by research grants from the German Cancer Aid (Melanoma Research Network) and the Interdisciplinary Center for Clinical Research (IZKF B-193) Wurzburg. SH is a Else-Kroner-Research-Fellow. CPS and MM are supported by Medical Faculty scholarships of the University of Wurzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Bakker ABH, 1998, J IMMUNOL, V160, P5239; BECKER JC, 1991, J IMMUNOL, V147, P4398; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cregger M, 2006, ARCH PATHOL LAB MED, V130, P1026; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Eberle J, 2010, PIGM CELL MELANOMA R, V23, P296, DOI 10.1111/j.1755-148X.2010.00684.x; Essmann F, 2012, BRIT J PHARMACOL, V165, P328, DOI 10.1111/j.1476-5381.2011.01570.x; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gembarska A, 2012, NAT MED; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; HERLYN M, 1985, J NATL CANCER I, V74, P283; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; JARA JR, 1990, BIOCHIM BIOPHYS ACTA, V1035, P276, DOI 10.1016/0304-4165(90)90089-F; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee JT, 2012, J INVEST DERMATOL, V132, P263, DOI 10.1038/jid.2011.362; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; Matin RN, 2013, J EXP MED, V210, P581, DOI 10.1084/jem.20121439; MUNGER K, 1992, CANCER SURV, V12, P197; Muthusamy V, 2006, GENE CHROMOSOME CANC, V45, P447, DOI 10.1002/gcc.20310; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Olivares C, 2001, BIOCHEM J, V354, P131, DOI 10.1042/0264-6021:3540131; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Polsky D, 2001, CANCER RES, V61, P7642; Reid YA, 2011, METHODS MOL BIOL, V731, P35, DOI 10.1007/978-1-61779-080-5_4; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Smith SL, 2009, J VIROL METHODS, V157, P47, DOI 10.1016/j.jviromet.2008.12.002; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takeuchi H, 2003, CANCER RES, V63, P441; Tuve S, 2004, INT J CANCER, V108, P162, DOI 10.1002/ijc.11552; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; WESTERMARK B, 1986, P NATL ACAD SCI USA, V83, P7197, DOI 10.1073/pnas.83.19.7197	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87440	10.1371/journal.pone.0087440	http://dx.doi.org/10.1371/journal.pone.0087440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475287	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300182
J	Kovacs, K; Banoczi, G; Varga, A; Szabo, I; Holczinger, A; Hornyanszky, G; Zagyva, I; Paizs, C; Vertessy, BG; Poppe, L				Kovacs, Klaudia; Banoczi, Gergely; Varga, Andrea; Szabo, Izabella; Holczinger, Andras; Hornyanszky, Gabor; Zagyva, Imre; Paizs, Csaba; Vertessy, Beata G.; Poppe, Laszlo			Expression and Properties of the Highly Alkalophilic Phenylalanine Ammonia-Lyase of Thermophilic Rubrobacter xylanophilus	PLOS ONE			English	Article							4-METHYLIDENEIMIDAZOLE-5-ONE-CONTAINING TYROSINE AMINOMUTASE; ACTIVE-SITE; BIOCHEMICAL-CHARACTERIZATION; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINO-ACIDS; ENZYME; HISTIDINE; MECHANISM	The sequence of a phenylalanine ammonia-lyase (PAL; EC: 4.3.1.24) of the thermophilic and radiotolerant bacterium Rubrobacter xylanophilus (RxPAL) was identified by screening the genomes of bacteria for members of the phenylalanine ammonia-lyase family. A synthetic gene encoding the RxPAL protein was cloned and overexpressed in Escherichia coli TOP 10 in a soluble form with an N-terminal His(6)-tag and the recombinant RxPAL protein was purified by Ni-NTA affinity chromatography. The activity assay of RxPAL with L-phenylalanine at various pH values exhibited a local maximum at pH 8.5 and a global maximum at pH 11.5. Circular dichroism (CD) studies showed that RxPAL is associated with an extensive alpha-helical character (far UV CD) and two distinctive near-UV CD peaks. These structural characteristics were well preserved up to pH 11.0. The extremely high pH optimum of RxPAL can be rationalized by a three-dimensional homology model indicating possible disulfide bridges, extensive salt-bridge formation and an excess of negative electrostatic potential on the surface. Due to these properties, RxPAL may be a candidate as biocatalyst in synthetic biotransformations leading to unnatural L-or D-amino acids or as therapeutic enzyme in treatment of phenylketonuria or leukemia.	[Kovacs, Klaudia; Banoczi, Gergely; Hornyanszky, Gabor; Poppe, Laszlo] Budapest Univ Technol & Econ, Dept Organ Chem & Technol, Budapest, Hungary; [Kovacs, Klaudia; Zagyva, Imre; Vertessy, Beata G.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Varga, Andrea; Szabo, Izabella; Paizs, Csaba] Univ Babes Bolyai, Biocatalysis Res Grp, R-3400 Cluj Napoca, Romania; [Holczinger, Andras] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary	Budapest University of Technology & Economics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Babes Bolyai University from Cluj; Budapest University of Technology & Economics	Poppe, L (corresponding author), Budapest Univ Technol & Econ, Dept Organ Chem & Technol, Budapest, Hungary.	poppe@mail.bme.hu	Paizs, Csaba/C-2111-2011; Poppe, László/B-8398-2008; Vertessy, Beata G/H-6202-2012; Varga, Andrea/ABA-9998-2020	Paizs, Csaba/0000-0002-7403-7098; Poppe, László/0000-0002-8358-1378; Varga, Andrea/0000-0002-4290-9226; Vertessy, Beata G./0000-0002-1288-2982	Hungarian OTKA Foundation [NN-103242]; New Hungary Development Plan; Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-IDPCE-2011-3-0799]	Hungarian OTKA Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	LP and BGV thank the financial support from the Hungarian OTKA Foundation, (http://www.otka.hu/en; Grant: NN-103242) and from the New Hungary Development Plan (http://www.nfu.hu/the_new_hungary_development_plan_; Project: "Development of quality-oriented and harmonized R+D+I strategy and functional model at BME": TAMOP-4.2.1/B-09/1/KMR-2010-0002). CP thanks the financial support from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://www.cncs-nrc.ro/home/; Grant: PN-II-IDPCE-2011-3-0799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL CW, 1973, CANCER RES, V33, P2529; ABELL CW, 1972, CANCER RES, V32, P285; ALLA MMN, 1995, J EXP BOT, V46, P1731, DOI 10.1093/jxb/46.11.1731; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; [Anonymous], 2012, MACROMODEL VERS 9 9; [Anonymous], 2012, MAESTR VERS 9 3 SCHR; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; APPERT C, 1994, EUR J BIOCHEM, V225, P491, DOI 10.1111/j.1432-1033.1994.00491.x; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Babich OO, 2013, BIOTECHNOL APPL BIOC, V60, P316, DOI 10.1002/bab.1089; Barredo J.L., 2005, MICROBIAL ENZYMES BI; Bartsch S, 2010, PROTEIN ENG DES SEL, V23, P929, DOI 10.1093/protein/gzq089; Belanger-Quintana A, 2011, MOL GENET METAB, V104, pS19, DOI 10.1016/j.ymgme.2011.08.009; Bezsudnova EY, 2012, BIOCHIMIE, V94, P2628, DOI 10.1016/j.biochi.2012.07.024; Calabrese JC, 2004, BIOCHEMISTRY-US, V43, P11403, DOI 10.1021/bi049053+; Carreto L, 1996, INT J SYST BACTERIOL, V46, P460, DOI 10.1099/00207713-46-2-460; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chesters C, 2012, ANGEW CHEM INT EDIT, V51, P4344, DOI 10.1002/anie.201200669; Christenson SD, 2003, BIOCHEMISTRY-US, V42, P12708, DOI 10.1021/bi035223r; Christenson SD, 2003, J AM CHEM SOC, V125, P6062, DOI 10.1021/ja034609m; Christianson CV, 2007, BIOCHEMISTRY-US, V46, P7205, DOI 10.1021/bi7003685; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; CONSEVAGE MW, 1990, J BACTERIOL, V172, P2224, DOI 10.1128/jb.172.5.2224-2229.1990; Daniel RM, 2008, EXTREMOPHILES, V12, P51, DOI 10.1007/s00792-007-0089-7; de Lange B, 2011, CHEMCATCHEM, V3, P289, DOI 10.1002/cctc.201000435; Ding YR, 2012, EXTREMOPHILES, V16, P67, DOI 10.1007/s00792-011-0406-z; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; EMES AV, 1970, CAN J BIOCHEM CELL B, V48, P613, DOI 10.1139/o70-099; Faber K., 2011, BIOTRANSFORMATIONS O, V6th; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Gloge A, 1998, ARCH BIOCHEM BIOPHYS, V359, P1, DOI 10.1006/abbi.1998.0860; HAMILTON BK, 1985, TRENDS BIOTECHNOL, V3, P64, DOI 10.1016/0167-7799(85)90079-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyun Min Woo, 2011, Mycobiology, V39, P257, DOI 10.5941/MYCO.2011.39.4.257; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; KLAUSNER A, 1985, BIO-TECHNOL, V3, P301, DOI 10.1038/nbt0485-301; Kovari J, 2008, PROTEINS, V71, P308, DOI 10.1002/prot.21757; LANGER M, 1994, BIOCHEMISTRY-US, V33, P6462, DOI 10.1021/bi00187a011; Magarvey NA, 2008, ACS CHEM BIOL, V3, P542, DOI 10.1021/cb800085g; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MAVANDAD M, 1990, PLANT PHYSIOL, V94, P671, DOI 10.1104/pp.94.2.671; McGrath B., 2006, DIRECTORY THERAPEUTI; Moffitt MC, 2007, BIOCHEMISTRY-US, V46, P1004, DOI 10.1021/bi061774g; Mutatu W, 2007, BIOCHEMISTRY-US, V46, P9785, DOI 10.1021/bi700691p; Paizs C, 2006, EUR J ORG CHEM, V2006, P1113, DOI 10.1002/ejoc.200500902; Paizs C, 2006, CHEM-EUR J, V12, P2739, DOI 10.1002/chem.200501034; Paizs C, 2011, HETEROCYCLES, V82, P1217, DOI 10.3987/COM-10-S(E)60; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Pilbak S, 2006, FEBS J, V273, P1004, DOI 10.1111/j.1742-4658.2006.05127.x; Poppe L, 2005, ANGEW CHEM INT EDIT, V44, P3668, DOI 10.1002/anie.200461377; Poppe L, 2003, CURR ORG CHEM, V7, P1297, DOI 10.2174/1385272033486440; Poppe L, 2012, METHODS MOL BIOL, V794, P3, DOI 10.1007/978-1-61779-331-8_1; Ratnayake ND, 2011, J AM CHEM SOC, V133, P8531, DOI 10.1021/ja2030728; Rehm HJ, 1998, BIOTECHNOLOGY A, V8a; Rehm HJ, 2000, BIOTECHNOLOGY B, V8b; RENARD G, 1992, BIOTECHNOL LETT, V14, P673, DOI 10.1007/BF01021641; Ritter H, 2004, PLANT CELL, V16, P3426, DOI 10.1105/tpc.104.025288; Rother D, 2000, ANGEW CHEM INT EDIT, V39, P2462, DOI 10.1002/1521-3773(20000717)39:14<2462::AID-ANIE2462>3.0.CO;2-H; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHUSTER B, 1994, FEBS LETT, V349, P252, DOI 10.1016/0014-5793(94)00681-4; Schwede TF, 1999, BIOCHEMISTRY-US, V38, P5355, DOI 10.1021/bi982929q; SHEN RS, 1977, CANCER RES, V37, P1051; Steele CL, 2005, ARCH BIOCHEM BIOPHYS, V438, P1, DOI 10.1016/j.abb.2005.04.012; STITH WJ, 1973, CANCER RES, V33, P966; Teeling H, 2012, BRIEF BIOINFORM, V13, P728, DOI 10.1093/bib/bbs039; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Vinther JM, 2011, J AM CHEM SOC, V133, P271, DOI 10.1021/ja105388k; Wahler D, 2001, CURR OPIN CHEM BIOL, V5, P152, DOI 10.1016/S1367-5931(00)00184-8; Walker KD, 2004, J BIOL CHEM, V279, P53947, DOI 10.1074/jbc.M411215200; Wang L, 2005, MOL GENET METAB, V86, P134, DOI 10.1016/j.ymgme.2005.05.012; Wang L, 2008, J MOL BIOL, V380, P623, DOI 10.1016/j.jmb.2008.05.025; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; Wu BA, 2010, CHEM COMMUN, V46, P8157, DOI 10.1039/c0cc02768e; Xiang LK, 2005, J BACTERIOL, V187, P4286, DOI 10.1128/JB.187.12.4286-4289.2005; YOSHINAKA T, 1973, AGR BIOL CHEM TOKYO, V37, P2269, DOI 10.1080/00021369.1973.10861003; Zhao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014608; ZIMMERMANN A, 1975, ARCH BIOCHEM BIOPHYS, V166, P54, DOI 10.1016/0003-9861(75)90364-1	88	23	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85943	10.1371/journal.pone.0085943	http://dx.doi.org/10.1371/journal.pone.0085943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475062	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300031
J	Yap, CH; Liu, XQ; Pekkan, K				Yap, Choon Hwai; Liu, Xiaoqin; Pekkan, Kerem			Characterizaton of the Vessel Geometry, Flow Mechanics and Wall Shear Stress in the Great Arteries of Wildtype Prenatal Mouse	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; BLOOD-FLOW; ENDOTHELIAL-CELLS; GENE-EXPRESSION; OUTFLOW TRACT; PRIMARY CILIA; AORTIC-VALVE; ARCH; DEFORMATION; HYPOPLASIA	Introduction: Abnormal fluid mechanical environment in the pre-natal cardiovascular system is hypothesized to play a significant role in causing structural heart malformations. It is thus important to improve our understanding of the prenatal cardiovascular fluid mechanical environment at multiple developmental time-points and vascular morphologies. We present such a study on fetal great arteries on the wildtype mouse from embryonic day 14.5 (E14.5) to near-term (E18.5). Methods: Ultrasound bio-microscopy (UBM) was used to measure blood velocity of the great arteries. Subsequently, specimens were cryo-embedded and sectioned using episcopic fluorescent image capture (EFIC) to obtain high-resolution 2D serial image stacks, which were used for 3D reconstructions and quantitative measurement of great artery and aortic arch dimensions. EFIC and UBM data were input into subject-specific computational fluid dynamics (CFD) for modeling hemodynamics. Results: In normal mouse fetuses between E14.5-18.5, ultrasound imaging showed gradual but statistically significant increase in blood velocity in the aorta, pulmonary trunk (with the ductus arteriosus), and descending aorta. Measurement by EFIC imaging displayed a similar increase in cross sectional area of these vessels. However, CFD modeling showed great artery average wall shear stress and wall shear rate remain relatively constant with age and with vessel size, indicating that hemodynamic shear had a relative constancy over gestational period considered here. Conclusion: Our EFIC-UBM-CFD method allowed reasonably detailed characterization of fetal mouse vascular geometry and fluid mechanics. Our results suggest that a homeostatic mechanism for restoring vascular wall shear magnitudes may exist during normal embryonic development. We speculate that this mechanism regulates the growth of the great vessels.	[Yap, Choon Hwai] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Liu, Xiaoqin] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Pekkan, Kerem] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Pekkan, K (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	kpekkan@andrew.cmu.edu	Pekkan, Kerem/P-5038-2019	Pekkan, Kerem/0000-0001-7637-4445				Al-Roubaie S, 2011, AM J PHYSIOL-HEART C, V301, pH2473, DOI 10.1152/ajpheart.00475.2011; Antiga L, 2002, PATIENT SPECI FIC MO; Antiga L., 2009, VASCULAR MODELING TO; Brouzes E, 2004, CURR OPIN GENET DEV, V14, P367, DOI 10.1016/j.gde.2004.06.005; Corrigan N, 2010, REPROD SCI, V17, P147, DOI 10.1177/1933719109348923; Dean WR, 1928, PHILOS MAG, V5, P673; Dean WR, 1927, PHILOS MAG, V4, P208; DeCampli WM, 2012, CARDIOL YOUNG, V22, P800, DOI 10.1017/S1047951112002028; Dempere-Marco L, 2006, LECT NOTES COMPUT SC, V4191, P438; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Groenendijk BCW, 2005, CIRC RES, V96, P1291, DOI 10.1161/01.RES.0000171901.40952.0d; Hickey EJ, 2012, J AM COLL CARDIOL, V59, pS43, DOI 10.1016/j.jacc.2011.04.046; Hierck BP, 2008, DEV DYNAM, V237, P725, DOI 10.1002/dvdy.21472; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOGERS B, 1995, CIRC RES, V76, P871, DOI 10.1161/01.RES.76.5.871; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; JOHNSTON PM, 1955, AM J PHYSIOL, V183, P365; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Jopling J, 2009, PEDIATRICS, V123, pE333, DOI 10.1542/peds.2008-2654; Kim TD, 2004, KOREA-AUST RHEOL J, V16, P75; Kohl T, 2000, AM J CARDIOL, V85, P1230, DOI 10.1016/S0002-9149(00)00733-5; Kowalski WJ, 2012, BIOMECH MODEL MECHAN, V11, P1057, DOI 10.1007/s10237-012-0373-z; Langille BL, 1996, CAN J PHYSIOL PHARM, V74, P834, DOI 10.1139/cjpp-74-7-834; Leatherbury Linda, 2003, Birth Defects Research, V69, P83, DOI 10.1002/bdrc.10005; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; LINDERKAMP O, 1992, PEDIATR RES, V32, P97, DOI 10.1203/00006450-199207000-00019; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Phoon CKL, 2000, ULTRASOUND MED BIOL, V26, P1275, DOI 10.1016/S0301-5629(00)00278-7; Piccinelli M, 2009, IEEE T MED IMAGING, V28, P1141, DOI 10.1109/TMI.2009.2021652; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Rosenthal Julie, 2004, Birth Defects Res C Embryo Today, V72, P213, DOI 10.1002/bdrc.20023; Roy D, 2009, ANAT REC, V292, P342, DOI 10.1002/ar.20849; Rudolph AM, 2001, CONGENITAL DIS HEART, V2nd; Spurney CF, 2004, J AM SOC ECHOCARDIOG, V17, P893, DOI 10.1016/j.echo.2004.04.028; Steinman David A., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P183, DOI 10.2174/1568006043336302; Taylor CA, 2004, ANNU REV FLUID MECH, V36, P197, DOI 10.1146/annurev.fluid.36.050802.121944; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tobita K, 2000, AM J PHYSIOL-HEART C, V279, pH959, DOI 10.1152/ajpheart.2000.279.3.H959; Torii R, 2009, BRIT J RADIOL, V82, pS24, DOI 10.1259/bjr/62450556; TURNBULL DH, 1995, P NATL ACAD SCI USA, V92, P2239, DOI 10.1073/pnas.92.6.2239; Tworetzky W, 2004, CIRCULATION, V110, P2125, DOI 10.1161/01.CIR.0000144357.29279.54; Vincent PE, 2011, J R SOC INTERFACE, V8, P1708, DOI 10.1098/rsif.2011.0116; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; Weinberg PD, 2007, J BIOMECH, V40, P1594, DOI 10.1016/j.jbiomech.2006.07.020; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Yu Q, 2008, ULTRASOUND MED BIOL, V34, P741, DOI 10.1016/j.ultrasmedbio.2007.11.001	56	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86878	10.1371/journal.pone.0086878	http://dx.doi.org/10.1371/journal.pone.0086878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475188	Green Published, Green Accepted, gold			2022-12-27	WOS:000330507300112
J	Kaur, S; Powell, S; He, LL; Pierson, CR; Parikh, NA				Kaur, Supreet; Powell, Samuel; He, Lili; Pierson, Christopher R.; Parikh, Nehal A.			Reliability and Repeatability of Quantitative Tractography Methods for Mapping Structural White Matter Connectivity in Preterm and Term Infants at Term-Equivalent Age	PLOS ONE			English	Article							TENSOR IMAGING TRACTOGRAPHY; HUMAN BRAIN; IN-VIVO; CORPUS-CALLOSUM; FIBER TRACTOGRAPHY; PREMATURE-INFANTS; AXONAL TRACKING; DT-MRI; DIFFUSION; TRACT	Premature infants exhibit widespread insults and delays in white matter maturation that can be sensitively detected early using diffusion tensor imaging. Diffusion tensor tractography facilitates in vivo visualization of white matter tracts and has the potential to be more sensitive than simpler two-dimensional DTI-based measures. However, the reliability and reproducibility of performing tractography for major white matter tracts in preterm infants is not known. The main objective of our study was to develop highly reliable and repeatable methods for ten white matter tracts in extremely low birth weight infants (birth weight <= 1000 g) at term-equivalent age. To demonstrate clinical utility, we also compared fiber microstructural and macrostructural parameters between preterm and healthy term controls. Twenty-nine ELBW infants and a control group of 15 healthy term newborns were studied. A team of researchers experienced in neuroanatomy/neuroimaging established the manual segmentation protocol based on a priori anatomical knowledge and an extensive training period to identify sources of variability. Intra-and inter-rater reliability and repeatability was tested using intra-class correlation coefficient, within-subject standard deviation (SD), repeatability, and Dice similarity index. Our results support our primary goal of developing highly reliable and reproducible comprehensive methods for manual segmentation of 10 white matter tracts in ELBW infants. The within-subject SD was within 1-2% and repeatability within 3-7% of the mean values for all 10 tracts. The intra-rater Dice index was excellent with a range of 0.97 to 0.99, and as expected, the inter-rater Dice index was lower (range: 0.80 to 0.91), but still within a very good reliability range. ELBW infants exhibited fewer fiber numbers and/or abnormal microstructure in a majority of the ten quantified tracts, consistent with injury/delayed development. This protocol could serve as a valuable tool for prompt evaluation of the impact of neuroprotective therapies and as a prognostic biomarker for neurodevelopmental impairments.	[Kaur, Supreet; Powell, Samuel; He, Lili; Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA; [Pierson, Christopher R.; Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Pierson, Christopher R.; Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Pierson, Christopher R.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Parikh, NA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA.	Nehal.Parikh@nationwidechildrens.org	Parikh, Nehal/AAB-9981-2022; Pierson, Christopher/E-3869-2011	Powell, Samuel/0000-0001-7002-2756; Parikh, Nehal/0000-0002-1375-1247	Research Institute at Nationwide Children's Hospital; National Center for Research Resources/Eunice Kennedy Shriver National Institute of Child Health, and Human Development grant [UL1 RR024148-04S3]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); National Center for Research Resources/Eunice Kennedy Shriver National Institute of Child Health, and Human Development grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Research Institute at Nationwide Children's Hospital, the National Center for Research Resources/Eunice Kennedy Shriver National Institute of Child Health, and Human Development grant UL1 RR024148-04S3 (Best Pharmaceuticals for Children Act) (to NAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J PEDIATR-US, V156, P882, DOI 10.1016/j.jpeds.2009.12.030; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Bartha AL, 2007, AM J NEURORADIOL, V28, P1015, DOI 10.3174/ajnr.A0521; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bayer AS, 2004, ATLAS HUMAN CENTRAL; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; de Bruine FT, 2011, EUR RADIOL, V21, P538, DOI 10.1007/s00330-010-1945-x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Hoon AH, 2002, NEUROLOGY, V59, P752, DOI 10.1212/WNL.59.5.752; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Lee SK, 2004, AM J NEURORADIOL, V25, P25; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Ment LR, 2002, PEDIATR RADIOL, V32, P620; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; NOLTE J, 2002, HUMAN BRAIN INTRO FU; Oishi K, 2011, MRI ATLAS HUMAN WHIT, VSecond; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pogribna U, 2013, PLOS ONE IN PRESS; Pogribna U, 2013, AJRN AM J N IN PRESS; Rollins N, 2005, AM J NEURORADIOL, V26, P2148; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; RUTHERFORD MA, 1991, J COMPUT ASSIST TOMO, V15, P188, DOI 10.1097/00004728-199103000-00002; SAKUMA H, 1991, RADIOLOGY, V180, P229, DOI 10.1148/radiology.180.1.2052700; Staudt M, 2000, NEUROPEDIATRICS, V31, P257, DOI 10.1055/s-2000-9239; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Thompson DK, 2011, NEUROIMAGE, V55, P479, DOI 10.1016/j.neuroimage.2010.12.025; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yoo SS, 2005, INVEST RADIOL, V40, P110, DOI 10.1097/01.rli.0000149491.69201.cb; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874; Zhai GH, 2003, RADIOLOGY, V229, P673, DOI 10.1148/radiol.2293021462	62	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85807	10.1371/journal.pone.0085807	http://dx.doi.org/10.1371/journal.pone.0085807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475054	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800017
J	Pegoraro, M; Noreen, S; Bhutani, S; Tsolou, A; Schmid, R; Kyriacou, CP; Tauber, E				Pegoraro, Mirko; Noreen, Shumaila; Bhutani, Supriya; Tsolou, Avgi; Schmid, Ralf; Kyriacou, Charalambos P.; Tauber, Eran			Molecular Evolution of a Pervasive Natural Amino-Acid Substitution in Drosophila cryptochrome	PLOS ONE			English	Article							CLOCK GENE; CIRCADIAN-RHYTHMS; DNA POLYMORPHISM; MELANOGASTER; SELECTION; PROTEIN; LIGHT; PHOTORECEPTOR; MUTATION; PERIOD	Genetic variations in circadian clock genes may serve as molecular adaptations, allowing populations to adapt to local environments. Here, we carried out a survey of genetic variation in Drosophila cryptochrome (cry), the fly's dedicated circadian photoreceptor. An initial screen of 10 European cry alleles revealed substantial variation, including seven non-synonymous changes. The SNP frequency spectra and the excessive linkage disequilibrium in this locus suggested that this variation is maintained by natural selection. We focused on a non-conservative SNP involving a leucine - histidine replacement (L232H) and found that this polymorphism is common, with both alleles at intermediate frequencies across 27 populations surveyed in Europe, irrespective of latitude. Remarkably, we were able to reproduce this natural observation in the laboratory using replicate population cages where the minor allele frequency was initially set to 10%. Within 20 generations, the two allelic variants converged to approximately equal frequencies. Further experiments using congenic strains, showed that this SNP has a phenotypic impact, with variants showing significantly different eclosion profiles. At the long term, these phase differences in eclosion may contribute to genetic differentiation among individuals, and shape the evolution of wild populations.	[Pegoraro, Mirko; Noreen, Shumaila; Kyriacou, Charalambos P.; Tauber, Eran] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Bhutani, Supriya] Natl Brain Res Ctr, Dept Mol & Cellular Neurosci, Manesar, Haryana, India; [Tsolou, Avgi] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Democritus University of Thrace; University of Leicester	Tauber, E (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	et22@le.ac.uk	Tsolou, Avgi/L-7776-2017; Tauber, Eran/AAA-1562-2022; Tauber, Eran/F-9826-2011; Schmid, Ralf/E-6722-2011; Schmid, Ralf/ABE-1065-2020	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Pegoraro, Mirko/0000-0001-9381-5249; Bhutani, Supriya/0000-0002-0855-2139	NERC [NE/D012058/1]; BBSRC [BB/K001922/1]; Royal Society Wolfson Research Merit Award; Faculty Development Program (FDP) Scholarships, University of Peshawar; Biotechnology and Biological Sciences Research Council [BB/G02085X/1, BB/K001922/1, BB/F014082/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NE/D012058/1] Funding Source: researchfish; BBSRC [BB/G02085X/1, BBS/E/D/20310000, BB/F014082/1] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Faculty Development Program (FDP) Scholarships, University of Peshawar; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from NERC (NE/D012058/1) and BBSRC (BB/K001922/1) to ET and CPK. CPK also acknowledges a Royal Society Wolfson Research Merit Award. SN was funded by the Faculty Development Program (FDP) Scholarships, University of Peshawar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bhutani S, 2009, THESIS U LEICESTER L; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fuchikawa T, 2010, HEREDITY, V104, P387, DOI 10.1038/hdy.2009.167; GLOOR GB, 1993, GENETICS, V135, P81; Hardin Paul E, 2003, Novartis Found Symp, V253, P140; HARDIN PE, 2003, NOVART FDN SYMP, V253, P150; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Kyriacou CP, 2008, TRENDS GENET, V24, P124, DOI 10.1016/j.tig.2007.12.003; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Long AD, 1998, GENETICS, V149, P999; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mealey-Ferrara ML, 2003, J NEUROGENET, V17, P171, DOI 10.1080/01677060390256422; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Nachman MW, 1996, GENETICS, V142, P953; NEI M, 1981, GENETICS, V97, P145; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Pegoraro M, 2011, WIRES RNA, V2, P312, DOI 10.1002/wrna.58; Rosato E, 1997, GENET RES, V69, P89, DOI 10.1017/S001667239700267X; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; TAJIMA F, 1989, GENETICS, V123, P585; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962	51	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86483	10.1371/journal.pone.0086483	http://dx.doi.org/10.1371/journal.pone.0086483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475129	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000330339800048
J	Angheben, JMM; Schoorlemmer, GHM; Rossi, MV; Silva, TA; Cravo, SL				Angheben, Juliana M. M.; Schoorlemmer, Guus H. M.; Rossi, Marcio V.; Silva, Thiago A.; Cravo, Sergio L.			Cardiovascular Responses Induced by Obstructive Apnea Are Enhanced in Hypertensive Rats Due to Enhanced Chemoreceptor Responsivity	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; CAROTID-BODY; SLEEP-APNEA; CARDIORESPIRATORY ALTERATIONS; DENERVATED RATS; BLOOD-PRESSURE; HEART-FAILURE; CHEMOREFLEX; DRIVE; VARIABILITY	Spontaneously hypertensive rats (SHR), like patients with sleep apnea, have hypertension, increased sympathetic activity, and increased chemoreceptor drive. We investigated the role of carotid chemoreceptors in cardiovascular responses induced by obstructive apnea in awake SHR. A tracheal balloon and vascular cannulas were implanted, and a week later, apneas of 15 s each were induced. The effects of apnea were more pronounced in SHR than in control rats (Wistar Kyoto; WKY). Blood pressure increased by 57 +/- 3 mmHg during apnea in SHR and by 28 +/- 3 mmHg in WKY (p < 0.05, n = 14/13). The respiratory effort increased by 53 +/- 6 mmHg in SHR and by 34 +/- 5 mmHg in WKY. The heart rate fell by 209 +/- 19 bpm in SHR and by 155 +/- 16 bpm in WKY. The carotid chemoreceptors were then inactivated by the ligation of the carotid body artery, and apneas were induced two days later. The inactivation of chemoreceptors reduced the responses to apnea and abolished the difference between SHR and controls. The apnea-induced hypertension was 11 +/- 4 mmHg in SHR and 8 +/- 4 mmHg in WKY. The respiratory effort was 15 +/- 2 mmHg in SHR and 15 +/- 2 mmHg in WKY. The heart rate fell 63 +/- 18 bpm in SHR and 52 +/- 14 bpm in WKY. Similarly, when the chemoreceptors were unloaded by the administration of 100% oxygen, the responses to apnea were reduced. In conclusion, arterial chemoreceptors contribute to the responses induced by apnea in both strains, but they are more important in SHR and account for the exaggerated responses of this strain to apnea.	[Angheben, Juliana M. M.; Schoorlemmer, Guus H. M.; Rossi, Marcio V.; Silva, Thiago A.; Cravo, Sergio L.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Schoorlemmer, GHM (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Physiol, Sao Paulo, Brazil.	g.schoorlemmer@unifesp.br		Schoorlemmer, Gus/0000-0002-2966-1457	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/19705-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472187/2010-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 2010/19705-6 to S. Cravo); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant 472187/2010-4 to G. Schoorlemmer); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, scholarship to J. Angheben). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala AP, 2012, J PHYSIOL-LONDON, V590, P4269, DOI 10.1113/jphysiol.2012.237800; Del Rio R, 2010, EUR RESPIR J, V36, P143, DOI 10.1183/09031936.00158109; Del Rio R, 2013, J AM COLL CARDIOL, V62, P2422, DOI 10.1016/j.jacc.2013.07.079; Del Rio R, 2012, EUR RESPIR J, V39, P1492, DOI 10.1183/09031936.00141511; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; FRANCHINI KG, 1992, AM J PHYSIOL, V262, pR677, DOI 10.1152/ajpregu.1992.262.4.R677; Hayward LF, 2012, AUTON NEUROSCI-BASIC, V171, P58, DOI 10.1016/j.autneu.2012.10.008; Hayward LF, 1999, AM J PHYSIOL-HEART C, V276, pH1215, DOI 10.1152/ajpheart.1999.276.4.H1215; Kato K, 2012, AUTON NEUROSCI-BASIC, V169, P49, DOI 10.1016/j.autneu.2012.03.005; LEUENBERGER U, 1995, J APPL PHYSIOL, V79, P581, DOI 10.1152/jappl.1995.79.2.581; Moraes DJA, 2012, HYPERTENSION, V60, P1374, DOI 10.1161/HYPERTENSIONAHA.111.189332; Narkiewicz K, 1998, CIRCULATION, V97, P943; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Peng YJ, 2004, J APPL PHYSIOL, V96, P1236, DOI 10.1152/japplphysiol.00820.2003; Peng YJ, 2003, J APPL PHYSIOL, V94, P2342, DOI 10.1152/japplphysiol.00613.2002; Rey S, 2006, BRAIN RES, V1086, P152, DOI 10.1016/j.brainres.2006.02.082; Sabino JPJ, 2013, CLINICS, V68, P395, DOI 10.6061/clinics/2013(03)OA18; Schoorlemmer GHM, 2011, EXP PHYSIOL, V96, P1010, DOI 10.1113/expphysiol.2011.059014; Seitz MJ, 2013, EXP PHYSIOL, V98, P405, DOI 10.1113/expphysiol.2012.067421; Smith ML, 2007, EXP PHYSIOL, V92, P45, DOI 10.1113/expphysiol.2006.033753; SOMERS VK, 1988, HYPERTENSION, V11, P608, DOI 10.1161/01.HYP.11.6.608; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Sugimura M, 2008, AUTON NEUROSCI-BASIC, V141, P94, DOI 10.1016/j.autneu.2008.05.008; Sun SY, 1999, J APPL PHYSIOL, V86, P1264, DOI 10.1152/jappl.1999.86.4.1264; Tan ZY, 2010, CIRC RES, V106, P536, DOI 10.1161/CIRCRESAHA.109.206946; Weil JV, 1998, AM J PHYSIOL-LUNG C, V274, pL767, DOI 10.1152/ajplung.1998.274.5.L767; Wolk R, 2003, HYPERTENSION, V42, P1067, DOI 10.1161/01.HYP.0000101686.98973.A3	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86868	10.1371/journal.pone.0086868	http://dx.doi.org/10.1371/journal.pone.0086868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466272	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000160
J	Bjorklund, E; Larsson, TNL; Jacobsson, SOP; Fowler, CJ				Bjorklund, Emmelie; Larsson, Therese N. L.; Jacobsson, Stig O. P.; Fowler, Christopher J.			Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ENDOCANNABINOID SYSTEM; THROMBOXANE SYNTHESIS; ENZYMATIC-HYDROLYSIS; TRANSPORT; PROSTATE; CANCER; CANNABINOIDS; RECEPTOR; AGENTS	Background: The antifungal compound ketoconazole has, in addition to its ability to interfere with fungal ergosterol synthesis, effects upon other enzymes including human CYP3A4, CYP17, lipoxygenase and thromboxane synthetase. In the present study, we have investigated whether ketoconazole affects the cellular uptake and hydrolysis of the endogenous cannabinoid receptor ligand anandamide (AEA). Methodology/Principal Findings: The effects of ketoconazole upon endocannabinoid uptake were investigated using HepG2, CaCo2, PC-3 and C6 cell lines. Fatty acid amide hydrolase (FAAH) activity was measured in HepG2 cell lysates and in intact C6 cells. Ketoconazole inhibited the uptake of AEA by HepG2 cells and CaCo2 cells with IC50 values of 17 and 18 mu M, respectively. In contrast, it had modest effects upon AEA uptake in PC-3 cells, which have a low expression of FAAH. In cell-free HepG2 lysates, ketoconazole inhibited FAAH activity with an IC50 value (for the inhibitable component) of 34 mu M. Conclusions/Significance: The present study indicates that ketoconazole can inhibit the cellular uptake of AEA at pharmacologically relevant concentrations, primarily due to its effects upon FAAH. Ketoconazole may be useful as a template for the design of dual-action FAAH/CYP17 inhibitors as a novel strategy for the treatment of prostate cancer.	[Bjorklund, Emmelie; Larsson, Therese N. L.; Jacobsson, Stig O. P.; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden	Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Council [12158]; Medical Faculty, Umea University	Swedish Science Council; Medical Faculty, Umea University	The authors thank the Swedish Science Council (Grant no. 12158, medicine) and the Research Funds of the Medical Faculty, Umea University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battista N, 2012, MOL CELL ENDOCRINOL, V355, P1, DOI 10.1016/j.mce.2012.01.014; BEETENS JR, 1986, BIOCHEM PHARMACOL, V35, P883, DOI 10.1016/0006-2952(86)90072-9; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Chicca A, 2012, J BIOL CHEM, V287, P34660, DOI 10.1074/jbc.M112.373241; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Diaz-Laviada I, 2011, NAT REV UROL, V8, P553, DOI 10.1038/nrurol.2011.130; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Hillard CJ, 2005, NEUROPHARMACOLOGY, V48, P1072, DOI 10.1016/j.neuropharm.2004.12.012; Idris Aymen I, 2012, Front Endocrinol (Lausanne), V3, P136, DOI 10.3389/fendo.2012.00136; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Karlsson M, 2004, EUR J PHARM SCI, V22, P181, DOI 10.1016/j.ejps.2004.03.009; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; LELCUK S, 1984, J TRAUMA, V24, P393, DOI 10.1097/00005373-198405000-00004; Leung K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079355; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Pisanti S, 2013, TRENDS PHARMACOL SCI, V34, P273, DOI 10.1016/j.tips.2013.03.003; POTTER GA, 1995, J MED CHEM, V38, P2463, DOI 10.1021/jm00013a022; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Sai Y, 2000, XENOBIOTICA, V30, P327, DOI 10.1080/004982500237541; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Sekar VJ, 2008, BRIT J CLIN PHARMACO, V66, P215, DOI 10.1111/j.1365-2125.2008.03191.x; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Snider NT, 2009, MOL PHARMACOL, V75, P965, DOI 10.1124/mol.108.053439; Starowicz K, 2013, EUR J PHARMACOL, V716, P41, DOI 10.1016/j.ejphar.2013.01.075; Thors L, 2006, BRIT J PHARMACOL, V149, P73, DOI 10.1038/sj.bjp.0706831; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Tolle A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-302; TOLMAN EL, 1983, BIOCHEM PHARMACOL, V32, P3488, DOI 10.1016/0006-2952(83)90383-0; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Vandevoorde S, 2003, J MED CHEM, V46, P1440, DOI 10.1021/jm0209679; Vasaitis TS, 2011, J STEROID BIOCHEM, V125, P23, DOI 10.1016/j.jsbmb.2010.11.005; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Warrilow AG, 2013, ANTIMICROB AGENTS CH, V57, P1352, DOI 10.1128/AAC.02067-12; Worthington HV, 2010, COCHRANE DB SYST REV, V2010; Zee YK, 2012, FUTURE ONCOL, V8, P731, DOI [10.2217/fon.12.53, 10.2217/FON.12.53]	57	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87542	10.1371/journal.pone.0087542	http://dx.doi.org/10.1371/journal.pone.0087542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466356	Green Submitted, gold, Green Published			2022-12-27	WOS:000330288000212
J	Fang, WT; Chou, JY; Lu, SY				Fang, Wei-Ta; Chou, Jui-Yu; Lu, Shiau-Yun			Simple Patchy-Based Simulators Used to Explore Pondscape Systematic Dynamics	PLOS ONE			English	Article							LAND-USE CHANGE; LOGISTIC-REGRESSION; DRIVING FORCES; COVER CHANGE; SPECIES RICHNESS; SPATIAL-ANALYSIS; PROXIMATE CAUSES; LANDSCAPE; DETERMINANTS; CONSERVATION	Thousands of farm ponds disappeared on the tableland in Taoyuan County, Taiwan since 1920s. The number of farm ponds that have disappeared is 1,895 (37%), 2,667 ponds remain (52%), and only 537 (11%) new ponds were created within a 757 km(2) areain Taoyuan, Taiwan between 1926 and 1960. In this study, a geographic information system (GIS) and logistic stepwise regression model were used to detect pond-loss rates and to understand the driving forces behind pondscape changes. The logistic stepwise regression model was used to develop a series of relationships between pondscapes affected by intrinsic driving forces (patch size, perimeter, and patch shape) and external driving forces (distance from the edge of the ponds to the edges of roads, rivers, and canals). The authors concluded that the loss of ponds was caused by pond intrinsic factors, such as pond perimeter; a large perimeter increases the chances of pond loss, but also increases the possibility of creating new ponds. However, a large perimeter is closely associated with circular shapes (lower value of the mean pond-patch fractal dimension [MPFD]), which characterize the majority of newly created ponds. The method used in this study might be helpful to those seeking to protect this unique landscape by enabling the monitoring of patch-loss problems by using simple patchy-based simulators.	[Fang, Wei-Ta] Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei, Taiwan; [Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan; [Lu, Shiau-Yun] Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan	National Taiwan Normal University; National Changhua University of Education; National Sun Yat Sen University	Fang, WT (corresponding author), Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei, Taiwan.	wtfang@ntnu.edu.tw			National Science Council grants [NSC99-2410-H-216-007, NSC100-2628-H-003-161-MY2, NSC102-2311-B-018-001-MY2]	National Science Council grants	This work was supported by National Science Council grants (NSC99-2410-H-216-007 and NSC100-2628-H-003-161-MY2 to WF; NSC102-2311-B-018-001-MY2 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Aspinall R, 2004, J ENVIRON MANAGE, V72, P91, DOI 10.1016/j.jenvman.2004.02.009; Berkson J, 1944, J AM STAT ASSOC, V39, P357, DOI 10.2307/2280041; Bhattarai K, 2009, J ENVIRON MANAGE, V91, P471, DOI 10.1016/j.jenvman.2009.09.016; Boothby J, 2003, LAND DEGRAD DEV, V14, P227, DOI 10.1002/ldr.551; Braimoh AK, 2007, LAND USE POLICY, V24, P502, DOI 10.1016/j.landusepol.2006.09.001; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; CHATFIELD C, 1995, J ROY STAT SOC A STA, V158, P419, DOI 10.2307/2983440; Chowdhury RR, 2006, APPL GEOGR, V26, P129, DOI 10.1016/j.apgeog.2005.11.004; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Curado N, 2011, BIOL CONSERV, V144, P1610, DOI 10.1016/j.biocon.2011.02.011; Fang WT, 2012, PROCEDIA ENVIRON SCI, V12, P505, DOI 10.1016/j.proenv.2012.01.310; Fang WT, 2011, ECOL RES MONOGR, P187, DOI 10.1007/978-4-431-87799-8_13; Fang WT, 2009, PADDY WATER ENVIRON, V7, P209, DOI 10.1007/s10333-009-0164-z; Forman RT, 1995, LAND MOSAICS ECOLOGY, DOI 10.1017/9781107050327; Francl KE, 2002, ENVIRON MONIT ASSESS, V73, P67, DOI 10.1023/A:1012615314061; Froneman A, 2001, BIODIVERS CONSERV, V10, P251, DOI 10.1023/A:1008904421948; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gobin A, 2002, AGR ECOSYST ENVIRON, V89, P213, DOI 10.1016/S0167-8809(01)00163-3; Hartel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063649; HEATH DJ, 1992, AQUAT CONSERV, V2, P267, DOI 10.1002/aqc.3270020306; Helmer EH, 2004, LANDSCAPE ECOL, V19, P29, DOI 10.1023/B:LAND.0000018364.68514.fb; Hersperger AM, 2010, ECOL SOC, V15; Houlahan JE, 2003, CAN J FISH AQUAT SCI, V60, P1078, DOI [10.1139/f03-095, 10.1139/F03-095]; Hull Andrew, 1997, P101; Kadoya T, 2004, ECOL RES, V19, P461, DOI 10.1111/j.1440-1703.2004.00659.x; Lambin EF, 1997, PROG PHYS GEOG, V21, P375, DOI 10.1177/030913339702100303; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leitao AB, 2002, LANDSCAPE URBAN PLAN, V59, P65, DOI 10.1016/S0169-2046(02)00005-1; Lemmens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072538; Linton S, 2000, AQUAT CONSERV, V10, P77, DOI 10.1002/(SICI)1099-0755(200003/04)10:2<77::AID-AQC391>3.0.CO;2-Y; LUDEKE AK, 1990, J ENVIRON MANAGE, V31, P247, DOI 10.1016/S0301-4797(05)80038-6; MAC ARTHUR ROBERT H., 1967; Machemer PL, 2006, LANDSCAPE RES, V31, P277, DOI 10.1080/01426390600783426; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Mladenoff DJ, 1999, ECOL APPL, V9, P37, DOI 10.1890/1051-0761(1999)009[0037:PGWLRL]2.0.CO;2; Nong Y, 2011, GEO-SPAT INF SCI, V14, P62, DOI 10.1007/s11806-011-0427-x; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Pampel FC, 2000, QUANTITATIVE APPL SO; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; PEARMAN PB, 1995, OECOLOGIA, V102, P1, DOI 10.1007/BF00333303; Pontius RG, 2005, ENVIRON PLANN B, V32, P211, DOI 10.1068/b31152; Pontius RG, 2008, ANN REGIONAL SCI, V42, P11, DOI 10.1007/s00168-007-0138-2; Schneider LC, 2001, AGR ECOSYST ENVIRON, V85, P83, DOI 10.1016/S0167-8809(01)00189-X; Serneels S, 2001, AGR ECOSYST ENVIRON, V85, P65, DOI 10.1016/S0167-8809(01)00188-8; Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001; SIMBERLOFF DS, 1976, SCIENCE, V191, P285, DOI 10.1126/science.191.4224.285; Smith SV, 2002, SCI TOTAL ENVIRON, V299, P21, DOI 10.1016/S0048-9697(02)00222-X; Stephenson CM, 2006, ECOL MODEL, V193, P747, DOI 10.1016/j.ecolmodel.2005.09.007; Strand GH, 2011, ENVIRON MODELL SOFTW, V26, P1150, DOI 10.1016/j.envsoft.2011.03.005; TURNER MG, 1988, APPL MATH COMPUT, V27, P39, DOI 10.1016/0096-3003(88)90097-5; Vanwalleghem T, 2008, GEOMORPHOLOGY, V95, P504, DOI 10.1016/j.geomorph.2007.07.003; Vanwalleghem T, 2008, GEOMORPHOLOGY, V95; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Verburg P. H., 2004, GeoJournal, V61, P309, DOI 10.1007/s10708-004-4946-y; Verburg P.H., 2004, COMPUTERS ENV URBAN, V28, P667, DOI [10.1016/j.compenvurbsys.2003.07.001, DOI 10.1016/J.COMPENVURBSYS.2003.07.001]; Verburg PH, 2004, ENVIRON PLANN B, V31, P125, DOI 10.1068/b307; WARD D, 1994, J BIOGEOGR, V21, P595, DOI 10.2307/2846034; Wimberly MC, 2004, LANDSCAPE ECOL, V19, P631, DOI 10.1023/B:LAND.0000042904.42355.f3; Zheng XQ, 2012, LANDSCAPE URBAN PLAN, V106, P51, DOI 10.1016/j.landurbplan.2012.02.006	60	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86888	10.1371/journal.pone.0086888	http://dx.doi.org/10.1371/journal.pone.0086888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466281	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000165
J	Hodzic, E; Imai, D; Feng, SL; Barthold, SW				Hodzic, Emir; Imai, Denise; Feng, Sunlian; Barthold, Stephen W.			Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice	PLOS ONE			English	Article							WHITE-FOOTED MICE; LYME-DISEASE; PRACTICE GUIDELINES; GENE-EXPRESSION; INFECTED MICE; ARTHRITIS; PCR; SPIROCHETE; DYNAMICS; JOINTS	The agent of Lyme borreliosis, Borrelia burgdorferi, evades host immunity and establishes persistent infections in its varied mammalian hosts. This persistent biology may pose challenges to effective antibiotic treatment. Experimental studies in dogs, mice, and non-human primates have found persistence of B. burgdorferi DNA following treatment with a variety of antibiotics, but persisting spirochetes are non-cultivable. Persistence of B. burgdorferi DNA has been documented in humans following treatment, but the significance remains unknown. The present study utilized a ceftriaxone treatment regimen in the C3H mouse model that resulted in persistence of non-cultivable B. burgdorferi in order to determine their long-term fate, and to examine their effects on the host. Results confirmed previous studies, in which B. burgdorferi could not be cultured from tissues, but low copy numbers of B. burgdorferi flaB DNA were detectable in tissues at 2, 4 and 8 months after completion of treatment, and the rate of PCR-positive tissues appeared to progressively decline over time. However, there was resurgence of spirochete flaB DNA in multiple tissues at 12 months, with flaB DNA copy levels nearly equivalent to those found in saline-treated mice. Despite the continued non-cultivable state, RNA transcription of multiple B. burgdorferi genes was detected in host tissues, flaB DNA was acquired by xenodiagnostic ticks, and spirochetal forms could be visualized within ticks and mouse tissues by immunofluorescence and immunohistochemistry, respectively. A number of host cytokines were up- or down-regulated in tissues of both saline-and antibiotic-treated mice in the absence of histopathology, indicating host response to the presence of non-cultivable, despite the lack of inflammation in tissues.	[Hodzic, Emir] Univ Calif Davis, Ctr Comparat Med, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Ctr Comparat Med, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hodzic, E (corresponding author), Univ Calif Davis, Ctr Comparat Med, Sch Med, Davis, CA 95616 USA.	ehodzic@ucdavis.edu; swbarthold@ucdavis.edu			National Institutes of Health (NIH) [R01 AI26815, T32 OD 011147]; National Research Fund for Tick-Borne Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026815] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011147] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Fund for Tick-Borne Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants R01 AI26815 (SWB, EH) and T32 OD 011147 (DI), and in part by the National Research Fund for Tick-Borne Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN 20; ARMSTRONG AL, 1992, AM J TROP MED HYG, V47, P249, DOI 10.4269/ajtmh.1992.47.249; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold S.W., 2010, BORRELIA MOL BIOL HO, P359; Barthold SW, 2006, INFECT IMMUN, V74, P4817, DOI 10.1128/IAI.00469-06; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; Barthold SW, 1997, CLIN INFECT DIS, V25, pS9, DOI 10.1086/516166; Barthold SW, 1996, LAB INVEST, V74, P57; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; BATTAFARANO DF, 1993, CLIN ORTHOP RELAT R, P238; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Bockenstedt LK, 2002, J INFECT DIS, V186, P1430, DOI 10.1086/345284; BRADLEY JF, 1994, ANN INTERN MED, V120, P487, DOI 10.7326/0003-4819-120-6-199403150-00007; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Embers M, 2012, PATHOGENIC SPIROCHET, P229; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; GOODMAN JL, 1991, J CLIN MICROBIOL, V29, P894, DOI 10.1128/JCM.29.5.894-896.1991; Hefty PS, 2002, J CLIN MICROBIOL, V40, P4256, DOI 10.1128/JCM.40.11.4256-4265.2002; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hodzic E, 2002, INFECT IMMUN, V70, P3382, DOI 10.1128/IAI.70.7.3382-3388.2002; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Hodzic E, 2013, VECTOR-BORNE ZOONOT, V13, P694, DOI 10.1089/vbz.2012.1189; Imai DM, 2013, LAB INVEST, V93, P900, DOI 10.1038/labinvest.2013.81; Koomanachai P, 2009, ANTIMICROB AGENTS CH, V53, P5060, DOI 10.1128/AAC.00985-09; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; MACDONALD AB, 1990, ACTA TROP, V48, P89, DOI 10.1016/0001-706X(90)90047-4; MOODY KD, 1994, ANTIMICROB AGENTS CH, V38, P1567, DOI 10.1128/AAC.38.7.1567; MOODY KD, 1990, AM J TROP MED HYG, V42, P165, DOI 10.4269/ajtmh.1990.42.165; MURSIC VP, 1990, INFECTION, V18, P332, DOI 10.1007/BF01646399; Oksi J, 1999, ANN MED, V31, P225, DOI 10.3109/07853899909115982; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Picha D, 2008, INT J DERMATOL, V47, P1004, DOI 10.1111/j.1365-4632.2008.03709.x; Priem S, 1998, ANN RHEUM DIS, V57, P118, DOI 10.1136/ard.57.2.118; ROBERTS ED, 1995, LAB INVEST, V72, P146; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1988, J CLIN MICROBIOL, V26, P893, DOI 10.1128/JCM.26.5.893-895.1988; SONNESYN SW, 1993, INFECT IMMUN, V61, P4777, DOI 10.1128/IAI.61.11.4777-4784.1993; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; Straubinger RK, 1998, WIEN KLIN WOCHENSCHR, V110, P874; Straubinger RK, 2000, J INFECT DIS, V181, P1069, DOI 10.1086/315340; Tunev SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002066; Wang EJ, 2005, J ANTIMICROB CHEMOTH, V55, P721, DOI 10.1093/jac/dki085; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Yrjanainen H, 2007, J INFECT DIS, V195, P1489, DOI 10.1086/513873; Yrjanainen H, 2006, MICROBES INFECT, V8, P2044, DOI 10.1016/j.micinf.2006.03.008; Yrjanainen H, 2010, APMIS, V118, P665, DOI 10.1111/j.1600-0463.2010.02615.x	50	71	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86907	10.1371/journal.pone.0086907	http://dx.doi.org/10.1371/journal.pone.0086907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466286	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000169
J	Smith, S; Fox, J; Mejia, M; Ruangpradit, W; Saberi, A; Kim, S; Choi, Y; Oh, S; Wang, YC; Choi, K; Li, L; Hendrickson, EA; Takeda, S; Muller, M; Myung, K				Smith, Stephanie; Fox, Jennifer; Mejia, Marco; Ruangpradit, Wanvipa; Saberi, Alihossein; Kim, Sunmi; Choi, Yongjun; Oh, Sehyun; Wang, Yucai; Choi, Kyungho; Li, Lei; Hendrickson, Eric A.; Takeda, Shunichi; Muller, Mark; Myung, Kyungjae			Histone Deacetylase Inhibitors Selectively Target Homology Dependent DNA Repair Defective Cells and Elevate Non-Homologous Endjoining Activity	PLOS ONE			English	Article							STRAND-BREAK-REPAIR; PROTEIN-KINASE; V(D)J RECOMBINATION; CATALYTIC SUBUNIT; MAMMALIAN-CELLS; CANCER-CELLS; HUMAN ELG1; PHOSPHORYLATION; DAMAGE; STABILITY	Background: We have previously used the ATAD5-luciferase high-throughput screening assay to identify genotoxic compounds with potential chemotherapeutic capabilities. The successful identification of known genotoxic agents, including the histone deacetylase inhibitor (HDACi) trichostatin A (TSA), confirmed the specificity of the screen since TSA has been widely studied for its ability to cause apoptosis in cancer cells. Because many cancers have acquired mutations in DNA damage checkpoints or repair pathways, we hypothesized that these cancers may be susceptible to treatments that target compensatory pathways. Here, we used a panel of isogenic chicken DT40 B lymphocyte mutant and human cell lines to investigate the ability of TSA to define selective pathways that promote HDACi toxicity. Results: HDACi induced a DNA damage response and reduced viability in all repair deficient DT40 mutants although ATM-nulls were least affected. The most dramatic sensitivity was observed in mutants lacking the homology dependent repair (HDR) factor BLM or the non-homologous end-joining (NHEJ) and HDR factors, KU/RAD54, suggesting an involvement of either HDR or NHEJ in HDACi-induced cell death. To extend these findings, we measured the frequencies of HDR and NHEJ after HDACi treatment and monitored viability in human cell lines comparably deficient in HDR or NHEJ. Although no difference in HDR frequency was observed between HDACi treated and untreated cells, HDR-defective human cell lines were clearly more sensitive than wild type. Unexpectedly, cells treated with HDACis showed a significantly elevated NHEJ frequency. Conclusions: HDACi targeting drugs induced significant increases in NHEJ activity in human cell lines but did not alter HDR frequency. Moreover, HDR is required for cellular resistance to HDACi therapy; therefore, NHEJ does not appear to be a critical axis for HDACi resistance. Rather, HDACi compounds induced DNA damage, most likely double strand breaks (DSBs), and HDR proficiency is correlated with cell survival.	[Smith, Stephanie; Fox, Jennifer; Kim, Sunmi; Choi, Yongjun; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Mejia, Marco; Ruangpradit, Wanvipa; Muller, Mark] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL USA; [Saberi, Alihossein; Kim, Sunmi; Takeda, Shunichi] Kyoto Univ, Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan; [Kim, Sunmi; Choi, Kyungho] Seoul Natl Univ, Dept Environm Hlth Sch Publ Hearth, Seoul, South Korea; [Wang, Yucai; Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Expt Clin Oncol, Houston, TX 77030 USA; [Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Yucai] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Oh, Sehyun; Hendrickson, Eric A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University System of Florida; University of Central Florida; Kyoto University; Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities	Myung, K (corresponding author), NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.	kmyung@mail.nih.gov	choi, kyungho/D-5732-2012; Kim, Sunmi/G-8114-2015	choi, kyungho/0000-0001-7460-792X; Takeda, Shunichi/0000-0002-7924-7991; saberi, Alihossein/0000-0003-4360-9118; Oh, Sehyun/0000-0002-9490-3061; Kim, Sunmi/0000-0001-9699-6532	NIH [GM088351, CA154461, CA127945, CA097175, R03 MH092164-01]; UCF College of Medicine; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT) [20241012]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [357-2011-D00133]; National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [R01CA127945, R01CA154461, P01CA097175] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCF College of Medicine; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the NIH grants GM088351, CA154461 to EAH, the NIH grants CA127945, CA097175 to LL, the UCF College of Medicine to MTM, a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MEXT, number 20241012) to ST, the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (357-2011-D00133), the intramural Research Programs of the National Human Genome Research Institute and NIH R03 MH092164-01 to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ai T, 2012, CURR MED CHEM, V19, P475, DOI 10.2174/092986712798918842; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Evans TJ, 2010, DNA REPAIR, V9, P1292, DOI 10.1016/j.dnarep.2010.09.017; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fox JT, 2012, P NATL ACAD SCI USA, V109, P5423, DOI 10.1073/pnas.1114278109; Goodarzi AA, 2006, DNA PK AUTOPHOSPHORY; GUNN A, 2012, DNA REPAIR PROTOCOLS, V920, P379; Ho AS, 2013, EPIGENETIC THERAPY U; Hsiao K-Y, 2013, J MOL CELL BIOL; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Jasek E, 2012, ANTICANCER RES, V32, P2791; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Krijger PHL, 2011, DNA REPAIR, V10, P438, DOI 10.1016/j.dnarep.2010.12.008; Kuchma MH, 2012, PROTEIN J, V31, P195, DOI 10.1007/s10930-011-9388-z; Lee BY, 2012, NUCLEIC ACIDS RES, V40, P2481, DOI 10.1093/nar/gkr1115; Lee GE, 2010, J BIOL CHEM, V285, P37630, DOI 10.1074/jbc.M110.148536; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Merolla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036177; MILLER RD, 1995, P NATL ACAD SCI USA, V92, P10792, DOI 10.1073/pnas.92.23.10792; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Murr R, 2006, HISTONE ACETYLATION; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nalabothula N, 2011, EPIGENOMICS-UK, V3, P145, DOI 10.2217/EPI.11.12; Oh S, 2013, NUCLEIC ACIDS RES, V41, P1734, DOI 10.1093/nar/gks1326; Olaharski AJ, 2006, TOXICOL SCI, V93, P341, DOI 10.1093/toxsci/kfl068; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; Smith S, 2009, YEAST MODEL HUMAN DI, P249; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Tikoo Shweta, 2010, Genome Integr, V1, P14, DOI 10.1186/2041-9414-1-14; Wang YG, 2004, J BIOL CHEM, V279, P37282, DOI 10.1074/jbc.M401217200; Wang YC, 2013, MOL CELL, V49, P997, DOI 10.1016/j.molcel.2012.12.010; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5	54	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87203	10.1371/journal.pone.0087203	http://dx.doi.org/10.1371/journal.pone.0087203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466340	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000198
J	El Kebir, D; Damlaj, A; Filep, JG				El Kebir, Driss; Damlaj, Anas; Filep, Janos G.			Toll-Like Receptor 9 Signaling Delays Neutrophil Apoptosis by Increasing Transcription of Mcl-1	PLOS ONE			English	Article							BACTERIAL-DNA; CPG MOTIFS; GRANULOCYTE APOPTOSIS; UP-REGULATION; RESOLUTION; INFLAMMATION; INHIBITION; EXPRESSION; SEPSIS; LUNG	Neutrophils detect bacterial constituents, including bacterial DNA (CpG DNA), which elicits innate immunity and prolongs the functional life span of neutrophils through suppression of apoptosis. Both the anti-apoptotic protein Mcl-1 and activation of NF-kappa B have been implicated in neutrophil survival, but there is no evidence that these are linked in neutrophils. We hypothesized that CpG DNA could simultaneously activate these pathways. High purity CpG DNA (0.4-3.2 mu g/ml) extended the life span of human neutrophils in vitro by delaying apoptosis through altering the rate of Mcl-1 turnover. CpG DNA slightly decreased Mcl-1 protein level in the presence of cyclohexmide and the proteasome inhibitor MG132 had little effect on Mcl-1 expression in CpG DNA-treated neutrophils. In contrast, CpG DNA evoked rapid increases in DNA binding by NF-kappa B/p65 and Mcl-1 mRNA. NF-kappa B inhibitors and the telomere-derived TLR9 inhibitory oligonucleotide 5'-TTT AGG GTT AGG GTT AGG G-3' markedly reduced Mcl-1 protein levels and subsequently abrogated suppression of apoptosis by CpG DNA. Furthermore, CpG DNA attenuated the decreases in Mcl-1 in both cell lysate and nucleus of neutrophils undergoing spontaneous apoptosis and increased Mcl-1 translocation to the mitochondria, leading to preservation of mitochondrial transmembrane potential. These results demonstrate that CpG DNA through toll-like receptor 9 links two survival signaling pathways by delaying apoptosis through induction of NF-kappa B-mediated Mcl-1 gene transcription and promoting Mcl-1 translocation to the mitochondria.	[Filep, Janos G.] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Filep, JG (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	janos.g.filep@umontreal.ca			Canadian Institutes of Health Research [MOP-97742]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by grant MOP-97742 (to JGF) from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Ertel W, 1998, J TRAUMA, V44, P767, DOI 10.1097/00005373-199805000-00005; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Garlichs CD, 2004, J LEUKOCYTE BIOL, V75, P828, DOI 10.1189/jlb.0703358; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Knuefermann P, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-72; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lehtiniemi J, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01440.x; Leitch AE, 2012, CELL DEATH DIFFER, V19, P1950, DOI 10.1038/cdd.2012.80; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Negrotto S, 2006, J PHARMACOL EXP THER, V319, P972, DOI 10.1124/jpet.106.109389; Pryde JG, 2000, J BIOL CHEM, V275, P33574, DOI 10.1074/jbc.M001008200; Ratanarat R, 2007, BLOOD PURIFICAT, V25, P106, DOI 10.1159/000096406; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schwartz DA, 1997, J CLIN INVEST, V100, P68, DOI 10.1172/JCI119523; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Sunil VR, 2002, RESP RES, V3, DOI 10.1186/rr171; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Trevani AS, 2003, EUR J IMMUNOL, V33, P3164, DOI 10.1002/eji.200324334; Ward C, 2004, BIOCHEM SOC T, V32, P465, DOI 10.1042/BST0320465; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; Weighardt H, 2000, J IMMUNOL, V165, P4537, DOI 10.4049/jimmunol.165.8.4537; Yi AK, 1998, J IMMUNOL, V160, P4755; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	53	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87006	10.1371/journal.pone.0087006	http://dx.doi.org/10.1371/journal.pone.0087006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466313	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100242
J	Salhia, B; Kiefer, J; Ross, JTD; Metapally, R; Martinez, RA; Johnson, KN; DiPerna, DM; Paquette, KM; Jung, S; Nasser, S; Wallstrom, G; Tembe, W; Baker, A; Carpten, J; Resau, J; Ryken, T; Sibenaller, Z; Petricoin, EF; Liotta, LA; Ramanathan, RK; Berens, ME; Tran, NL				Salhia, Bodour; Kiefer, Jeff; Ross, Julianna T. D.; Metapally, Raghu; Martinez, Rae Anne; Johnson, Kyle N.; DiPerna, Danielle M.; Paquette, Kimberly M.; Jung, Sungwon; Nasser, Sara; Wallstrom, Garrick; Tembe, Waibhav; Baker, Angela; Carpten, John; Resau, Jim; Ryken, Timothy; Sibenaller, Zita; Petricoin, Emanuel F.; Liotta, Lance A.; Ramanathan, Ramesh K.; Berens, Michael E.; Tran, Nhan L.			Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOLECULAR PORTRAITS; INTRINSIC SUBTYPES; TUMOR PROGRESSION; GENE; PROGNOSIS; RELAPSE; MAP	The brain is a common site of metastatic disease in patients with breast cancer, which has few therapeutic options and dismal outcomes. The purpose of our study was to identify common and rare events that underlie breast cancer brain metastasis. We performed deep genomic profiling, which integrated gene copy number, gene expression and DNA methylation datasets on a collection of breast brain metastases. We identified frequent large chromosomal gains in 1q, 5p, 8q, 11q, and 20q and frequent broad-level deletions involving 8p, 17p, 21p and Xq. Frequently amplified and overexpressed genes included ATAD2, BRAF, DERL1, DNMTRB and NEK2A. The ATM, CRYAB and HSPB2 genes were commonly deleted and underexpressed. Knowledge mining revealed enrichment in cell cycle and G2/M transition pathways, which contained AURKA, AURKB and FOXM1. Using the PAM50 breast cancer intrinsic classifier, Luminal B, Her2+/ER negative, and basal-like tumors were identified as the most commonly represented breast cancer subtypes in our brain metastasis cohort. While overall methylation levels were increased in breast cancer brain metastasis, basal-like brain metastases were associated with significantly lower levels of methylation. Integrating DNA methylation data with gene expression revealed defects in cell migration and adhesion due to hypermethylation and downregulation of PENK, EDN3, and ITGAM. Hypomethylation and upregulation of KRT8 likely affects adhesion and permeability. Genomic and epigenomic profiling of breast brain metastasis has provided insight into the somatic events underlying this disease, which have potential in forming the basis of future therapeutic strategies.	[Salhia, Bodour; Martinez, Rae Anne; Johnson, Kyle N.; DiPerna, Danielle M.; Jung, Sungwon; Baker, Angela; Carpten, John] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA; [Kiefer, Jeff; Metapally, Raghu; Tembe, Waibhav] Translat Genom Res Inst, Collaborat Ctr Bioinformat, Phoenix, AZ USA; [Ross, Julianna T. D.; Paquette, Kimberly M.; Berens, Michael E.; Tran, Nhan L.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Nasser, Sara] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Wallstrom, Garrick] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Resau, Jim] Van Andel Res Inst, Grand Rapids, MI USA; [Ryken, Timothy] Iowa Spine & Brain Inst, Iowa City, IA USA; [Sibenaller, Zita] Univ Iowa, Dept Radiat Biol, Iowa City, IA USA; [Petricoin, Emanuel F.; Liotta, Lance A.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Ramanathan, Ramesh K.] Scottsdale Healthcare, Virginia G Piper Canc Ctr, Scottsdale, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; Van Andel Institute; University of Iowa; George Mason University; Scottsdale Healthcare Osborn	Salhia, B (corresponding author), Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA.	bsalhia@tgen.org; ntran@tgen.org	Jeff/ABB-2636-2021	Jeff/0000-0002-1238-3120; Martinez, Rae Anne M./0000-0003-0262-1049	National Institutes of Health [R01 CA130940]; C. A. R. E. Board of Trustees, Scottsdale, Arizona; TGen-Van Andel Integration Grant; NATIONAL CANCER INSTITUTE [R01CA130940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C. A. R. E. Board of Trustees, Scottsdale, Arizona; TGen-Van Andel Integration Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grant R01 CA130940 (NLT), a grant from the C. A. R. E. Board of Trustees, Scottsdale, Arizona (NLT, RKR), TGen-Van Andel Integration Grant (NLT, JC, BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysal BE, 2001, EUR J HUM GENET, V9, P121, DOI 10.1038/sj.ejhg.5200585; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; El Gammal AT, 2010, CLIN CANCER RES, V16, P56, DOI 10.1158/1078-0432.CCR-09-1423; Gori S, 2007, ONCOLOGIST, V12, P766, DOI 10.1634/theoncologist.12-7-766; Hamilton A, 2013, MOL CELL NEUROSCI, V53, P42, DOI 10.1016/j.mcn.2012.10.004; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Ishiwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042118; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Merico D, 2011, METHODS MOL BIOL, V781, P257, DOI 10.1007/978-1-61779-276-2_12; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Shao MM, 2011, MED MOL MORPHOL, V44, P15, DOI 10.1007/s00795-010-0495-2; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; Wang CJ, 2009, GENE CHROMOSOME CANC, V48, P1091, DOI 10.1002/gcc.20711; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Wang SL, 2012, J CELL BIOCHEM, V113, P1904, DOI 10.1002/jcb.24059; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	31	76	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85448	10.1371/journal.pone.0085448	http://dx.doi.org/10.1371/journal.pone.0085448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489661	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000011
J	Kawamura, T; Stephens, B; Qin, L; Yin, X; Dores, MR; Smith, TH; Grimsey, N; Abagyan, R; Trejo, J; Kufareva, I; Fuster, MM; Salanga, CL; Handel, TM				Kawamura, Tetsuya; Stephens, Bryan; Qin, Ling; Yin, Xin; Dores, Michael R.; Smith, Thomas H.; Grimsey, Neil; Abagyan, Ruben; Trejo, JoAnn; Kufareva, Irina; Fuster, Mark M.; Salanga, Catherina L.; Handel, Tracy M.			A General Method for Site Specific Fluorescent Labeling of Recombinant Chemokines	PLOS ONE			English	Article							ENDOTHELIAL HEPARAN-SULFATE; PHOSPHOPANTETHEINYL TRANSFERASES; LYMPHATIC ENDOTHELIUM; RECEPTOR; PROTEIN; CXCR4; CELLS; BINDING; IDENTIFICATION; BIOCHEMISTRY	Chemokines control cell migration in many contexts including development, homeostasis, immune surveillance and inflammation. They are also involved in a wide range of pathological conditions ranging from inflammatory diseases and cancer, to HIV. Chemokines function by interacting with two types of receptors: G protein-coupled receptors on the responding cells, which transduce signaling pathways associated with cell migration and activation, and glycosaminogly-cans on cell surfaces and the extracellular matrix which organize and present some chemokines on immobilized surface gradients. To probe these interactions, imaging methods and fluorescence-based assays are becoming increasingly desired. Herein, a method for site-specific fluorescence labeling of recombinant chemokines is described. It capitalizes on previously reported 11-12 amino acid tags and phosphopantetheinyl transferase enzymes to install a fluorophore of choice onto a specific serine within the tag through a coenzyme A-fluorophore conjugate. The generality of the method is suggested by our success in labeling several chemokines (CXCL12, CCL2, CCL21 and mutants thereof) and visualizing them bound to chemokine receptors and glycosaminoglycans. CXCL12 and CCL2 showed the expected co-localization on the surface of cells with their respective receptors CXCR4 and CCR2 at 4 degrees C, and co-internalization with their receptors at 37 degrees C. By contrast, CCL21 showed the presence of large discrete puncta that were dependent on the presence of both CCR7 and glycosaminoglycans as co-receptors. These data demonstrate the utility of this labeling approach for the detection of chemokine interactions with GAGs and receptors, which can vary in a chemokine-specific manner as shown here. For some applications, the small size of the fluorescent adduct may prove advantageous compared to other methods (e.g. antibody labeling, GFP fusion) by minimally perturbing native interactions. Other advantages of the method are the ease of bacterial expression, the versatility of labeling with any maleimide-fluorophore conjugate of interest, and the covalent nature of the fluorescent adduct.	[Kawamura, Tetsuya; Stephens, Bryan; Qin, Ling; Abagyan, Ruben; Kufareva, Irina; Salanga, Catherina L.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Stephens, Bryan; Smith, Thomas H.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Yin, Xin] Huaihai Inst Technol, Marine Drug Res Inst, Lianyungang, Peoples R China; [Yin, Xin; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Yin, Xin; Fuster, Mark M.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92093 USA; [Dores, Michael R.; Smith, Thomas H.; Grimsey, Neil; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Jiangsu Ocean University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Grimsey, Neil/AAB-9153-2020; Grimsey, Neil/B-1634-2015	Grimsey, Neil/0000-0002-0481-4920; Grimsey, Neil/0000-0002-0481-4920; TREJO, JOANN/0000-0003-4405-6228; Stephens, Bryan/0000-0002-5398-7406; Kufareva, Irina/0000-0001-9083-7039; Smith, Thomas/0000-0002-8798-7228	National Institute of Health (NIH) [U01 GM094612, R01 AI37113]; Cellular and Molecular Pharmacology [T32-GM007752]; San Diego IRACDA NIH [K12 GM06852]; American Heart Association Postdoctoral Fellowship; NIH [R01 GM071872, U54 GM094618, R01 GM090689]; NIH/National Heart, Lung, and Blood Institute (NHLBI) [R01-HL107652-01A1, P01 HL57345-14]; Veterans Affairs Merit Review Program (VA-Merit) [I01BX000987-01]; American Cancer Society [RSG-08-153-01-CSM]; NIH/NHLBI [T32-HL098062-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444, R01HL107652, T32HL098062, P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872, T32GM008326, K12GM068524, U01GM094612, U54GM094618, T32GM007752, R01GM090689] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Pharmacology; San Diego IRACDA NIH; American Heart Association Postdoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs Merit Review Program (VA-Merit); American Cancer Society(American Cancer Society); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of Health (NIH) grant U01 GM094612 and R01 AI37113 to TMH. BS was supported by the Cellular and Molecular Pharmacology Training Grant T32-GM007752. MRD was supported by San Diego IRACDA NIH K12 GM06852. NG was supported by an American Heart Association Postdoctoral Fellowship. RA acknowledges NIH R01 GM071872 and U54 GM094618. JT acknowledges NIH R01 GM090689. MMF acknowledges NIH/National Heart, Lung, and Blood Institute (NHLBI) R01-HL107652-01A1, P01 HL57345-14, the Veterans Affairs Merit Review Program (VA-Merit I01BX000987-01) and the American Cancer Society (RSG-08-153-01-CSM) for support. XY is supported by an NIH/NHLBI training grant T32-HL098062-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Ford Laura B, 2013, Methods Mol Biol, V1013, P203, DOI 10.1007/978-1-62703-426-5_13; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Hatse S, 2004, CYTOM PART A, V61A, P178, DOI 10.1002/cyto.a.20070; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Humpert ML, 2012, PROTEOMICS, V12, P1938, DOI 10.1002/pmic.201100581; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kramp BK, 2011, EXP CELL RES, V317, P655, DOI 10.1016/j.yexcr.2010.11.014; Lechertier T, 2004, ANTICANCER RES, V24, P4011; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Rodriguez-Frade JM, 2009, METHODS MOL BIOL, V571, P179, DOI 10.1007/978-1-60761-198-1_12; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; O'Hayre M, 2009, METHOD ENZYMOL, V460, P331, DOI 10.1016/S0076-6879(09)05216-1; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Rostand KS, 1997, INFECT IMMUN, V65, P1; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Sunbul M, 2009, METHOD ENZYMOL, V458, P255, DOI 10.1016/S0076-6879(09)04810-1; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thelen M, 2010, CURR OPIN PHARMACOL, V10, P38, DOI 10.1016/j.coph.2009.09.004; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yin X, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-316; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	35	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e81454	10.1371/journal.pone.0081454	http://dx.doi.org/10.1371/journal.pone.0081454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489642	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000002
J	Kiyoshi, M; Caaveiro, JMM; Miura, E; Nagatoishi, S; Nakakido, M; Soga, S; Shirai, H; Kawabata, S; Tsumoto, K				Kiyoshi, Masato; Caaveiro, Jose M. M.; Miura, Eri; Nagatoishi, Satoru; Nakakido, Makoto; Soga, Shinji; Shirai, Hiroki; Kawabata, Shigeki; Tsumoto, Kouhei			Affinity Improvement of a Therapeutic Antibody by Structure-Based Computational Design: Generation of Electrostatic Interactions in the Transition State Stabilizes the Antibody-Antigen Complex	PLOS ONE			English	Article							SINGLE-CHAIN; CYTOCHROME-C; BINDING; ASSOCIATION; RESIDUES; ATHEROSCLEROSIS; THERMODYNAMICS; RECOGNITION; SPECIFICITY; MATURATION	The optimization of antibodies is a desirable goal towards the development of better therapeutic strategies. The antibody 11K2 was previously developed as a therapeutic tool for inflammatory diseases, and displays very high affinity (4.6 pM) for its antigen the chemokine MCP-1 (monocyte chemo-attractant protein-1). We have employed a virtual library of mutations of 11K2 to identify antibody variants of potentially higher affinity, and to establish benchmarks in the engineering of a mature therapeutic antibody. The most promising candidates identified in the virtual screening were examined by surface plasmon resonance to validate the computational predictions, and to characterize their binding affinity and key thermodynamic properties in detail. Only mutations in the light-chain of the antibody are effective at enhancing its affinity for the antigen in vitro, suggesting that the interaction surface of the heavy-chain (dominated by the hot-spot residue Phe101) is not amenable to optimization. The single-mutation with the highest affinity is L-N31R (4.6-fold higher affinity than wild-type antibody). Importantly, all the single-mutations showing increase affinity incorporate a charged residue (Arg, Asp, or Glu). The characterization of the relevant thermodynamic parameters clarifies the energetic mechanism. Essentially, the formation of new electrostatic interactions early in the binding reaction coordinate (transition state or earlier) benefits the durability of the antibody-antigen complex. The combination of in silico calculations and thermodynamic analysis is an effective strategy to improve the affinity of a matured therapeutic antibody.	[Kiyoshi, Masato; Miura, Eri; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Caaveiro, Jose M. M.; Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Caaveiro, Jose M. M.; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Lab Med Prote, Minato Ku, Tokyo, Japan; [Soga, Shinji; Shirai, Hiroki; Kawabata, Shigeki] Astellas Pharma Inc, Drug Discovery Res, Mol Med Res Labs, Tsukuba, Ibaraki, Japan; [Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Astellas Pharmaceuticals; University of Tokyo	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	tsumoto@bioeng.t.u-tokyo.ac.jp	Miura-Fujiwara, Eri/A-1023-2010; Caaveiro, Jose/J-2790-2013; Satoru, NAGATOISHI/AAY-8198-2021	Miura-Fujiwara, Eri/0000-0002-7672-3534; Caaveiro, Jose/0000-0001-5568-2369; Satoru, NAGATOISHI/0000-0002-0794-3963; Kiyoshi, Masato/0000-0002-5969-8138; Nakakido, Makoto/0000-0003-0328-9914	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the program for world-leading innovative R&D on science and technology (FIRST) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acchione M, 2012, MABS-AUSTIN, V4, P362, DOI 10.4161/mabs.19449; ADAIR JR, 1992, IMMUNOL REV, V130, P5, DOI 10.1111/j.1600-065X.1992.tb01519.x; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Baron R, 2013, ANNU REV PHYS CHEM, V64, P151, DOI 10.1146/annurev-physchem-040412-110047; Beck A, 2011, MABS-AUSTIN, V3, P107, DOI 10.4161/mabs.3.2.14785; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Constantinou A, 2008, BIOCONJUGATE CHEM, V19, P643, DOI 10.1021/bc700319r; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Hagihara Yoshihisa, 2012, Methods Mol Biol, V911, P399, DOI 10.1007/978-1-61779-968-6_24; Hayashida K, 2001, ARTHRITIS RES, V3, P118, DOI 10.1186/ar149; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; Kabat EA, 1991, SEQUENCES PROTEINS I; Kawa S, 2011, MABS-AUSTIN, V3, P479, DOI 10.4161/mabs.3.5.17228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Kusano KF, 2004, CIRC J, V68, P671, DOI 10.1253/circj.68.671; Lawson ADG, 2012, NAT REV DRUG DISCOV, V11, P519, DOI 10.1038/nrd3756; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lipschultz CA, 2002, J MOL RECOGNIT, V15, P44, DOI 10.1002/jmr.559; Lutgens E, 2005, CIRCULATION, V111, P3443, DOI 10.1161/CIRCULATIONAHA.104.510073; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Muda M, 2011, PROTEIN ENG DES SEL, V24, P447, DOI 10.1093/protein/gzq123; Nagao C, 2012, PROTEINS, V80, P2426, DOI 10.1002/prot.24127; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Park H, 2011, J MOL GRAPH MODEL, V29, P643, DOI 10.1016/j.jmgm.2010.11.010; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Renaut Laurence, 2012, Methods Mol Biol, V907, P451, DOI 10.1007/978-1-61779-974-7_26; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sakamoto S, 2009, J MOL BIOL, V389, P880, DOI 10.1016/j.jmb.2009.04.050; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	45	58	63	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87099	10.1371/journal.pone.0087099	http://dx.doi.org/10.1371/journal.pone.0087099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475232	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300139
J	Gonzalez, MS; De Brasi, CD; Bianchini, M; Gargallo, P; Stanganelli, C; Zalcberg, I; Larripa, IB				Selena Gonzalez, Mariana; Daniel De Brasi, Carlos; Bianchini, Michele; Gargallo, Patricia; Stanganelli, Carmen; Zalcberg, Ilana; Beatriz Larripa, Irene			Improved Diagnosis of the Transition to JAK2(V617F) Homozygosity: The Key Feature for Predicting the Evolution of Myeloproliferative Neoplasms	PLOS ONE			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ALLELE BURDEN; ESSENTIAL THROMBOCYTHEMIA; V617F MUTATION; DISORDERS; IDENTIFICATION; JAK2V617F; DISEASE; ASSAYS	Most cases of BCR-ABL1-negative myeloproliferative neoplasms (MPNs), essential thrombocythemia, polycythemia vera and primary myelofibrosis are associated with JAK2(V617F) mutations. The outcomes of these cases are critically influenced by the transition from JAK2(V617F) heterozygosity to homozygosity. Therefore, a technique providing an unbiased assessment of the critical allele burden, 50% JAK2(V617F), is highly desirable. In this study, we present an approach to assess the JAK2(V617F) burden from genomic DNA (gDNA) and complementary DNA (cDNA) using one-plus-one template references for allele-specific quantitative-real-time-PCR (qPCR). Plasmidic gDNA and cDNA constructs encompassing one PCR template for JAK2(V617F) spaced from one template for JAK2 Wild Type were constructed by multiple fusion PCR amplifications. Repeated assessments of the 50% JAK2(V617F) burden within the dynamic range of serial dilutions of gDNA and cDNA constructs resulted in 52.53 +/- 4.2% and 51.46 +/- 4.21%, respectively. The mutation-positive cutoff was estimated to be 3.65% (mean +2 standard deviation) using 20 samples from a healthy population. This qPCR approach was compared with the qualitative ARMS-PCR technique and with two standard methods based on qPCR, and highly significant correlations were obtained in all cases. qPCR assays were performed on paired gDNA/cDNA samples from 20 MPN patients, and the JAK2(V617F) expression showed a significant correlation with the allele burden. Our data demonstrate that the qPCR method using one-plus-one template references provides an improved assessment of the clinically relevant transition of JAK2(V617F) from heterozygosity to homozygosity.	[Selena Gonzalez, Mariana; Daniel De Brasi, Carlos; Beatriz Larripa, Irene] Acad Nacl Med ANM, Natl Res Council CONICET, Inst Med Expt IMEX, Buenos Aires, DF, Argentina; [Daniel De Brasi, Carlos; Gargallo, Patricia; Stanganelli, Carmen; Beatriz Larripa, Irene] ANM, Inst Invest Hematol IIHEMA, Buenos Aires, DF, Argentina; [Bianchini, Michele] Inst Alexander Fleming, Ctr Invest Oncol Fdn Canc CIO FUCA, Buenos Aires, DF, Argentina; [Zalcberg, Ilana] Inst Nacl Canc, Rio De Janeiro, Brazil	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; National Cancer Institute (Inca)	Gonzalez, MS (corresponding author), Acad Nacl Med ANM, Natl Res Council CONICET, Inst Med Expt IMEX, Buenos Aires, DF, Argentina.	marianag6@yahoo.com.ar		De Brasi, Carlos Daniel/0000-0003-2379-4379	National Research Council (CONICET); National Agency for Promotion of Science and Technology (ANPCyT)	National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Promotion of Science and Technology (ANPCyT)(ANPCyT)	This study was supported by grants from the National Research Council (CONICET) and the National Agency for Promotion of Science and Technology (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bousquet M, 2006, HUM PATHOL, V37, P1458, DOI 10.1016/j.humpath.2006.05.006; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carobbio A, 2009, EXP HEMATOL, V37, P1016, DOI 10.1016/j.exphem.2009.06.006; Chen G, 2006, BEST PRACT RES CL HA, V19, P387, DOI 10.1016/j.beha.2005.07.003; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Jovanovic JV, 2013, LEUKEMIA, V27, P2032, DOI 10.1038/leu.2013.219; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Passamonti F, 2009, HAEMATOL-HEMATOL J, V94, P7, DOI 10.3324/haematol.2008.001271; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Tefferi A, 2005, NEW ENGL J MED, V353, P1416; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Vannucchi AM, 2007, LEUKEMIA, V21, P1952, DOI 10.1038/sj.leu.2404854; Vannucchi AM, 2006, LEUKEMIA, V20, P1055, DOI 10.1038/sj.leu.2404209; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86401	10.1371/journal.pone.0086401	http://dx.doi.org/10.1371/journal.pone.0086401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475114	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300060
J	van den Borne, P; van der Laan, SW; Bovens, SM; Koole, D; Kowala, MC; Michael, LF; Schoneveld, AH; van de Weg, SM; Velema, E; de Vries, JP; de Borst, GJ; Moll, FL; de Kleijn, DPV; Quax, PHA; Hoefer, IE; Pasterkamp, G				van den Borne, Pleunie; van der Laan, Sander W.; Bovens, Sandra M.; Koole, Dave; Kowala, Mark C.; Michael, Laura F.; Schoneveld, Arjan H.; van de Weg, Sander M.; Velema, Evelyn; de Vries, Jean-Paul; de Borst, Gert J.; Moll, Frans L.; de Kleijn, Dominique P. V.; Quax, Paul H. A.; Hoefer, Imo E.; Pasterkamp, Gerard			Leukotriene B4 Levels in Human Atherosclerotic Plaques and Abdominal Aortic Aneurysms	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; BLT1-DEFICIENT MICE; EXPRESSION; RECEPTORS; B-4; 5-LIPOXYGENASE; INFLAMMATION; INSTABILITY; MECHANISMS; PATHWAY	Background: Leukotriene B4 (LTB4) has been associated with the initiation and progression of atherosclerosis and abdominal aortic aneurysm (AAA) formation. However, associations of LTB4 levels with tissue characteristics and adverse clinical outcome of advanced atherosclerosis and AAA are scarcely studied. We hypothesized that LTB4 levels are associated with a vulnerable plaque phenotype and adverse clinical outcome. Furthermore, that LTB4 levels are associated with inflammatory AAA and adverse clinical outcome. Methods: Atherosclerotic plaques and AAA specimens were selected from two independent databases for LTB4 measurements. Plaques were isolated during carotid endarterectomy from asymptomatic (n = 58) or symptomatic (n = 317) patients, classified prior to surgery. LTB4 levels were measured without prior lipid extraction and levels were corrected for protein content. LTB4 levels were related to plaque phenotype, baseline patient characteristics and clinical outcome within three years following surgery. Seven non-diseased mammary artery specimens served as controls. AAA specimens were isolated during open repair, classified as elective (n = 189), symptomatic (n = 29) or ruptured (n = 23). LTB4 levels were measured similar to the plaque measurements and were related to tissue characteristics, baseline patient characteristics and clinical outcome. Twenty-six non-diseased aortic specimens served as controls. Results: LTB4 levels corrected for protein content were not significantly associated with histological characteristics specific for vulnerable plaques or inflammatory AAA as well as clinical presentation. Moreover, it could not predict secondary manifestations independently investigated in both databases. However, LTB4 levels were significantly lower in controls compared to plaque (p = 0.025) or AAA (p = 0.017). Conclusions: LTB4 levels were not associated with a vulnerable plaque phenotype or inflammatory AAA or clinical presentation. This study does not provide supportive evidence for a role of LTB4 in atherosclerotic plaque destabilization or AAA expansion. However, these data should be interpreted with care, since LTB4 measurements were performed without prior lipid extractions.	[van den Borne, Pleunie; van der Laan, Sander W.; Bovens, Sandra M.; Schoneveld, Arjan H.; van de Weg, Sander M.; Velema, Evelyn; de Kleijn, Dominique P. V.; Hoefer, Imo E.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [van der Laan, Sander W.; Bovens, Sandra M.; Schoneveld, Arjan H.; de Kleijn, Dominique P. V.; Hoefer, Imo E.; Pasterkamp, Gerard] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Koole, Dave; de Borst, Gert J.; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Kowala, Mark C.; Michael, Laura F.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [de Vries, Jean-Paul] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [de Kleijn, Dominique P. V.] Natl Univ Singapore Hosp, Cardiovasc Res Inst & Surg, Singapore 117548, Singapore; [Quax, Paul H. A.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Utrecht University; Utrecht University Medical Center; Eli Lilly; St. Antonius Hospital Utrecht; National University of Singapore; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	van den Borne, P (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.	p.vandenborne-2@umcutrecht.nl	Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019; van der Laan, Sander W./N-1330-2019	Quax, Paul/0000-0002-6853-5760; van der Laan, Sander W./0000-0001-6888-1404	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation(Netherlands Heart Foundation)	This research forms part of the Project P1.03 PENT of the research program of the Biomedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Dutch Heart Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2007, J IMMUNOL, V179, P691, DOI 10.4049/jimmunol.179.1.691; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Allen S, 1998, CIRCULATION, V97, P2406, DOI 10.1161/01.CIR.97.24.2406; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Back M, 2006, ANN MED, V38, P493, DOI 10.1080/07853890600982737; Capra V, 2012, MED RES REV, P1, DOI [10.1002/med, DOI 10.1002/MED]; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; de Kleijn DPV, 2010, ARTERIOSCL THROM VAS, V30, P612, DOI 10.1161/ATVBAHA.109.194944; DECATERINA R, 1988, BIOMED BIOCHIM ACTA, V47, pS182; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Huang L, 2004, ARTERIOSCL THROM VAS, V24, P1783, DOI 10.1161/01.ATV.0000140063.06341.09; Hurks R, 2010, EUR SURG RES, V45, P34, DOI 10.1159/000318160; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhou YJ, 2007, BIOCHEM BIOPH RES CO, V363, P30, DOI 10.1016/j.bbrc.2007.08.134	31	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86522	10.1371/journal.pone.0086522	http://dx.doi.org/10.1371/journal.pone.0086522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475136	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300074
J	Abuduxikuer, K; Wang, JS				Abuduxikuer, Kuerbanjiang; Wang, Jian-She			Zinc Mono-Therapy in Pre-Symptomatic Chinese Children with Wilson Disease: A Single Center, Retrospective Study	PLOS ONE			English	Article							LONG-TERM TREATMENT; ALKALINE-PHOSPHATASE; PEDIATRIC-PATIENTS; DIAGNOSIS; METALLOTHIONEIN; LIVER; TIME; PENICILLAMINE; MONOTHERAPY; EXPERIENCE	Background: There is no official consensus regarding zinc therapy in pre-symptomatic children with Wilson Disease (WD); more data is needed. Objective: To investigate the safety and efficacy of zinc gluconate therapy for Chinese children with pre-symptomatic WD. Methods: We retrospectively analyzed pre-symptomatic children receiving zinc gluconate in a single Chinese center specialized in pediatric hepatology. Short-term follow-up data on safety and efficacy were presented, and effects of different zinc dosages were compared. Results: 30 children (21 males) aged 2.7 to 16.8 years were followed for up to 4.4 years; 26 (87%) children had abnormal ALT at baseline. Most patients (73%) received higher than the currently recommended dose of elemental zinc. Zinc gluconate significantly reduced mean ALT (p<0.0001), AST (p<0.0001), GGT (p<0.0001) levels after 1 month, and urinary copper excretion after 6 months (p<0.0054). Mean direct bilirubin levels dropped significantly at 1 month (p = 0.0175), 3 months (p = 0.0010), and 6 months (p = 0.0036). Serum zinc levels gradually increased and reached a significantly higher level after 6 months (p<0.0026), reflecting good compliance with the therapy. Complete blood count parameters did not change throughout the analysis period. 8 children experienced mild and transient gastrointestinal side effects. The higher zinc dose did not affect treatment response and was not associated with different or increased side effects when compared to conventional zinc dose. Conclusion: In our cohort, zinc gluconate therapy for Chinese children with pre-symptomatic WD was effective, and higher initial dose of elemental zinc had the same level of efficacy as the conventional dose.	[Abuduxikuer, Kuerbanjiang] Fudan Univ, Childrens Hosp, Ctr Liver, Shanghai 200433, Peoples R China; [Wang, Jian-She] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, JS (corresponding author), Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China.	jshwang@shmu.edu.cn	Abuduxikuer, Kuerbanjiang/T-6521-2019; wang, Jian-She/F-1154-2011	Abuduxikuer, Kuerbanjiang/0000-0003-0298-3269; wang, jianshe/0000-0003-0823-586X	National Natural Science Foundation of China [81070281]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, No. 81070281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, METABOLIC BASIS INHE; Brewer G J, 2001, Expert Opin Pharmacother, V2, P1473, DOI 10.1517/14656566.2.9.1473; BREWER G J, 1990, Journal of Trace Elements in Experimental Medicine, V3, P227; BREWER GJ, 1992, MEDICINE, V71, P139, DOI 10.1097/00005792-199205000-00004; BREWER GJ, 1994, J LAB CLIN MED, V123, P849; BREWER GJ, 1983, ANN INTERN MED, V99, P314, DOI 10.7326/0003-4819-99-3-314; Brewer GJ, 1998, J LAB CLIN MED, V132, P264, DOI 10.1016/S0022-2143(98)90039-7; Brewer GJ, 2001, J LAB CLIN MED, V137, P191, DOI 10.1067/mlc.2001.113037; Brewer GJ., 2001, WILSONS DIS CLIN GUI; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Castilla-Higuero L, 2000, HEPATOLOGY, V32, P877, DOI 10.1053/jhep.2000.17917; Czlonkowska A, 1996, J NEUROL, V243, P269, DOI 10.1007/BF00868525; Dhawan A, 2005, LIVER INT, V25, P680, DOI 10.1111/j.1478-3231.2005.01072.x; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2012, J HEPATOL, V56, P671, DOI 10.1016/j.jhep.2011.11.007; Friedman L S, 1993, Gastroenterology, V104, P1566; GOERING PL, 1985, TOXICOL APPL PHARM, V80, P467, DOI 10.1016/0041-008X(85)90391-6; HOOGENRAAD TU, 1987, J NEUROL SCI, V77, P137, DOI 10.1016/0022-510X(87)90116-X; Hoogenraad TU, 2006, BRAIN DEV-JPN, V28, P141, DOI 10.1016/j.braindev.2005.08.008; Hoogenraad TU, 1998, J LAB CLIN MED, V132, P240, DOI 10.1016/S0022-2143(98)90034-8; HOOGENRAAD TU, 1979, EUR NEUROL, V18, P205, DOI 10.1159/000115077; Lang CJG, 1933, ARCH NEUROL-CHICAGO, V50, P1007; LEE DY, 1989, J LAB CLIN MED, V114, P639; Linn FHH, 2009, HEPATOLOGY, V50, P1442, DOI 10.1002/hep.23182; Marcellini M, 2005, J LAB CLIN MED, V145, P139, DOI 10.1016/j.lab.2005.01.007; Medici V, 2007, DIGEST LIVER DIS, V39, P601, DOI 10.1016/j.dld.2006.12.095; Medici V, 2006, J CLIN GASTROENTEROL, V40, P936, DOI 10.1097/01.mcg.0000225670.91722.59; Mishra D, 2008, INDIAN PEDIATR, V45, P151; Mizuochi T, 2011, J PEDIATR GASTR NUTR, V53, P365, DOI 10.1097/MPG.0b013e31821d5abe; MULDER TPJ, 1992, J HEPATOL, V16, P346, DOI 10.1016/S0168-8278(05)80667-1; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Sadighi A, 2008, SAUDI MED J, V29, P1276; WALSHE JM, 1995, ARCH NEUROL-CHICAGO, V52, P10, DOI 10.1001/archneur.1995.00540250012003; Wiggelinkhuizen M, 2009, ALIMENT PHARM THER, V29, P947, DOI 10.1111/j.1365-2036.2009.03959.x; Wu ZY, 2003, ARCH NEUROL-CHICAGO, V60, P737, DOI 10.1001/archneur.60.5.737; YUZBASIYANGURKAN V, 1992, J LAB CLIN MED, V120, P380; YUZBASIYANGURKAN V, 1989, J LAB CLIN MED, V114, P520	37	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86168	10.1371/journal.pone.0086168	http://dx.doi.org/10.1371/journal.pone.0086168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475083	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800031
J	Haverkamp, THA; Hammer, O; Jakobsen, KS				Haverkamp, Thomas H. A.; Hammer, Oyvind; Jakobsen, Kjetill S.			Linking Geology and Microbiology: Inactive Pockmarks Affect Sediment Microbial Community Structure	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; DISSOLVED ORGANIC-MATTER; FRESH-WATER; RARE BIOSPHERE; BACTERIAL COMMUNITIES; MARINE-SEDIMENTS; INNER OSLOFJORD; BIOGEOCHEMICAL PROCESSES; GDANSK DEEP; BALTIC SEA	Pockmarks are geological features that are found on the bottom of lakes and oceans all over the globe. Some are active, seeping oil or methane, while others are inactive. Active pockmarks are well studied since they harbor specialized microbial communities that proliferate on the seeping compounds. Such communities are not found in inactive pockmarks. Interestingly, inactive pockmarks are known to have different macrofaunal communities compared to the surrounding sediments. It is undetermined what the microbial composition of inactive pockmarks is and if it shows a similar pattern as the macrofauna. The Norwegian Oslofjord contains many inactive pockmarks and they are well suited to study the influence of these geological features on the microbial community in the sediment. Here we present a detailed analysis of the microbial communities found in three inactive pockmarks and two control samples at two core depth intervals. The communities were analyzed using high-throughput amplicon sequencing of the 16S rRNA V3 region. Microbial communities of surface pockmark sediments were indistinguishable from communities found in the surrounding seabed. In contrast, pockmark communities at 40 cm sediment depth had a significantly different community structure from normal sediments at the same depth. Statistical analysis of chemical variables indicated significant differences in the concentrations of total carbon and non-particulate organic carbon between 40 cm pockmarks and reference sample sediments. We discuss these results in comparison with the taxonomic classification of the OTUs identified in our samples. Our results indicate that microbial communities at the sediment surface are affected by the water column, while the deeper (40 cm) sediment communities are affected by local conditions within the sediment.	[Haverkamp, Thomas H. A.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Hammer, Oyvind] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Jakobsen, Kjetill S.] Univ Oslo, Microbial Evolut Res Grp, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Haverkamp, THA (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	thhaverk@gmail.com	Hammer, Øyvind/A-6319-2017; Haverkamp, Thomas H.A./H-2783-2019	Haverkamp, Thomas H.A./0000-0002-3070-9745	VISTA [6503]	VISTA	This work was funded by VISTA grant nr 6503 to KSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arp HPH, 2011, ENVIRON TOXICOL CHEM, V30, P843, DOI 10.1002/etc.466; Arp HPH, 2009, ENVIRON SCI TECHNOL, V43, P5576, DOI 10.1021/es9012905; Baldi F, 2010, CONT SHELF RES, V30, P1614, DOI 10.1016/j.csr.2010.06.009; Bartlett R, 2010, HYDROL PROCESS, V24, P726, DOI 10.1002/hyp.7514; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Bohlen L, 2011, GEOCHIM COSMOCHIM AC, V75, P6094, DOI 10.1016/j.gca.2011.08.010; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Brothers LL, 2011, GEO-MAR LETT, V31, P237, DOI 10.1007/s00367-011-0228-0; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cambon-Bonavita MA, 2009, DEEP-SEA RES PT II, V56, P2248, DOI 10.1016/j.dsr2.2009.04.007; CAROQUINTERO A, 2012, MBIO, V3, DOI DOI 10.1128/MBI0.00025-12; Cathles LM, 2010, MAR PETROL GEOL, V27, P82, DOI 10.1016/j.marpetgeo.2009.09.010; Chand S, 2009, MAR PETROL GEOL, V26, P1035, DOI 10.1016/j.marpetgeo.2008.09.002; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dale AW, 2011, ESTUAR COAST SHELF S, V95, P14, DOI 10.1016/j.ecss.2011.05.016; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eide I, 2011, WATER AIR SOIL POLL, V218, P387, DOI 10.1007/s11270-010-0653-0; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Freitag TE, 2006, ENVIRON MICROBIOL, V8, P684, DOI 10.1111/j.1462-2920.2005.00947.x; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Gihring TM, 2010, LIMNOL OCEANOGR, V55, P740, DOI 10.4319/lo.2009.55.2.0740; Gittel A, 2012, SYST APPL MICROBIOL, V35, P165, DOI 10.1016/j.syapm.2012.01.003; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; Gutierrez T, 2013, APPL ENVIRON MICROB, V79, P205, DOI 10.1128/AEM.02833-12; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hammer O, 2010, NORW J GEOL, V90, P79; Hammer O, 2009, GEO-MAR LETT, V29, P269, DOI 10.1007/s00367-009-0140-z; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Havelsrud OE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-203; Hovland M, 2002, GEOFLUIDS, V2, P127, DOI 10.1046/j.1468-8123.2002.00028.x; Hovland M, 2010, MAR PETROL GEOL, V27, P1190, DOI 10.1016/j.marpetgeo.2010.02.005; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jackson CR, 2008, APPL ENVIRON MICROB, V74, P5237, DOI 10.1128/AEM.00923-08; Jacob M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072779; Janssen PH, 2002, INT J SYST EVOL MICR, V52, P1341, DOI 10.1099/ijs.0.02116-0; Jantti H, 2011, AQUAT MICROB ECOL, V63, P171, DOI 10.3354/ame01492; Jetten MSM, 2008, ENVIRON MICROBIOL, V10, P2903, DOI 10.1111/j.1462-2920.2008.01786.x; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Judd A., 2007, SEABED FLUID FLOW IM, DOI 10.1017/CBO9780511535918; Julies EM, 2010, GEOMICROBIOL J, V27, P303, DOI 10.1080/01490450903410464; KING LH, 1970, GEOL SOC AM BULL, V81, P3141, DOI 10.1130/0016-7606(1970)81[3141:POTSS]2.0.CO;2; Knab NJ, 2008, GEOCHIM COSMOCHIM AC, V72, P2868, DOI 10.1016/j.gca.2008.03.016; Koster M, 2001, MAR ECOL PROG SER, V214, P25, DOI 10.3354/meps214025; Kraigher B, 2011, J HAZARD MATER, V188, P78, DOI 10.1016/j.jhazmat.2011.01.072; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Magurran AE, 2007, MEASURING BIOL DIVER, V5; Manley PL, 2004, LAKE CHAMPLAIN: PARTNERSHIPS AND RESEARCH IN THE NEW MILLENNIUM, P299; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merkel AY, 2010, MICROBIOLOGY+, V79, P849, DOI 10.1134/S0026261710060196; Mermillod-Blondin F, 2004, AQUAT MICROB ECOL, V36, P271, DOI 10.3354/ame036271; Muller H, 2011, GEO-MAR LETT, V31, P123, DOI 10.1007/s00367-010-0220-0; Nascimento FJA, 2012, LIMNOL OCEANOGR, V57, P338, DOI 10.4319/lo.2012.57.1.0338; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nogaro G, 2013, HYDROBIOLOGIA, V701, P289, DOI 10.1007/s10750-012-1286-7; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Pachiadaki MG, 2011, MICROB ECOL, V62, P655, DOI 10.1007/s00248-011-9855-2; Papaspyrou S, 2005, AQUAT MICROB ECOL, V38, P181, DOI 10.3354/ame038181; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Pau M, 2013, MAR GEOL, V346, P262, DOI 10.1016/j.margeo.2013.09.012; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Pereira WE, 1999, MAR CHEM, V64, P99, DOI 10.1016/S0304-4203(98)00087-5; Pimenov NV, 2008, MICROBIOLOGY+, V77, P579, DOI 10.1134/S0026261708050111; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rebata-Landa V, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001355; Reed AJ, 2006, EXTREMOPHILES, V10, P199, DOI 10.1007/s00792-005-0488-6; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Reese BK, 2013, GEOMICROBIOL J, V30, P160, DOI 10.1080/01490451.2012.659331; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shivaji S, 2011, RES MICROBIOL, V162, P191, DOI 10.1016/j.resmic.2010.09.020; Shubenkova OV, 2010, MICROBIOLOGY+, V79, P799, DOI 10.1134/S0026261710060123; Subramani R, 2012, MICROBIOL RES, V167, P571, DOI 10.1016/j.micres.2012.06.005; Tadonleke RD, 2007, FEMS MICROBIOL ECOL, V59, P543, DOI 10.1111/j.1574-6941.2006.00222.x; Takaki Y, 2010, DNA RES, V17, P123, DOI 10.1093/dnares/dsq005; Tao S, 2000, WATER RES, V34, P1751, DOI 10.1016/S0043-1354(99)00324-3; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Thimsen CA, 1998, MAR CHEM, V62, P65, DOI 10.1016/S0304-4203(98)00018-8; Tsuboi S, 2013, WORLD J MICROB BIOT, V29, P759, DOI 10.1007/s11274-012-1231-y; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Webb KE, 2009, MAR ECOL PROG SER, V387, P15, DOI 10.3354/meps08079; Webb KE, 2009, GEO-MAR LETT, V29, P111, DOI 10.1007/s00367-008-0127-1; Wenzhofer F., 2012, BIOGEOSCIENCES DISCU, V9, P8337, DOI DOI 10.5194/BG-9-5031-2012; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Whiticar MJ, 2002, MAR GEOL, V182, P29, DOI 10.1016/S0025-3227(01)00227-4; Wildish DJ, 2008, MAR ECOL PROG SER, V357, P51, DOI 10.3354/meps07331; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zeppilli D, 2012, DIVERS DISTRIB, V18, P832, DOI 10.1111/j.1472-4642.2011.00859.x; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00324-13; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	115	9	10	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85990	10.1371/journal.pone.0085990	http://dx.doi.org/10.1371/journal.pone.0085990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475066	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800021
J	Kales, SC; Nau, MM; Merchant, AS; Lipkowitz, S				Kales, Stephen C.; Nau, Marion M.; Merchant, Anand S.; Lipkowitz, Stanley			Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; BREAST-CANCER; LIM DOMAIN; PROTEIN LIGASE; CELL-LINE; RET; ACTIVATION; MICE; PROTOONCOGENE; SUPPRESSION	The Cbl proteins (Cbl, Cbl-b, and Cbl-c) are a highly conserved family of RING finger ubiquitin ligases (E3s) that function as negative regulators of tyrosine kinases in a wide variety of signal transduction pathways. In this study, we identify a new Cbl-c interacting protein, Enigma (PDLIM7). This interaction is specific to Cbl-c as Enigma fails to bind either of its closely related homologues, Cbl and Cbl-b. The binding between Enigma and Cbl-c is mediated through the LIM domains of Enigma as removal of all three LIM domains abrogates this interaction, while only LIM1 is sufficient for binding. Here we show that Cbl-c binds wild-type and MEN2A isoforms of the receptor tyrosine kinase, RET, and that Cbl-c enhances ubiquitination and degradation of activated RET. Enigma blocks Cbl-c-mediated RETMEN2A ubiquitination and degradation. Cbl-c decreased downstream ERK activation by RETMEN2A and co-expression of Enigma blocked the Cbl-c-mediated decrease in ERK activation. Enigma showed no detectable effect on Cbl-c-mediated ubiquitination of activated EGFR suggesting that this effect is specific to RET. Through mapping studies, we show that Cbl-c and Enigma bind RETMEN2A at different residues. However, binding of Enigma to RETMENA prevents Cbl-c recruitment to RETMEN2A. Consistent with these biochemical data, exploratory analyses of breast cancer patients with high expression of RET suggest that high expression of Cbl-c correlates with a good outcome, and high expression of Enigma correlates with a poor outcome. Together, these data demonstrate that Cbl-c can ubiquitinate and downregulate RETMEN2A and implicate Enigma as a positive regulator of RETMEN2A through blocking of Cbl-mediated ubiquitination and degradation.	[Kales, Stephen C.; Nau, Marion M.; Lipkowitz, Stanley] NCI, Natl Inst Hlth, Ctr Canc Res, Womens Malignancies Branch, Bethesda, MD 20892 USA; [Merchant, Anand S.] SAIC Frederick, Adv Biomed Comp Ctr, Ctr Canc Res, Bioinformat Core, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Lipkowitz, S (corresponding author), NCI, Natl Inst Hlth, Ctr Canc Res, Womens Malignancies Branch, Bethesda, MD 20892 USA.	lipkowis@mail.nih.gov			NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC011532] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research wassupported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Borrello MG, 1995, ONCOGENE, V11, P2419; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Davies GC, 2006, ONCOGENE, V25, P6497, DOI 10.1038/sj.onc.1209662; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Durick K, 1998, MOL CELL BIOL, V18, P2298, DOI 10.1128/MCB.18.4.2298; Durick K, 1996, J BIOL CHEM, V271, P12691, DOI 10.1074/jbc.271.22.12691; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Gujral TS, 2006, ANN NY ACAD SCI, V1073, P234, DOI 10.1196/annals.1353.025; Guy PM, 1999, MOL BIOL CELL, V10, P1973, DOI 10.1091/mbc.10.6.1973; Hansford JR, 2000, J MED GENET, V37, P817, DOI 10.1136/jmg.37.11.817; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nau MM, 2008, CBL PROTEINS, P3; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Pierchala BA, 2006, J NEUROSCI, V26, P2777, DOI 10.1523/JNEUROSCI.3420-05.2006; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Ryan PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049428; Santarpia L, 2013, CURR PHARM DESIGN, V19, P864, DOI 10.2174/138161213804547240; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; TAHIRA T, 1990, ONCOGENE, V5, P97; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1993, ONCOGENE, V8, P2925; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; Wang CY, 2012, BREAST CANCER RES TR, V133, P487, DOI 10.1007/s10549-011-1775-9; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768	48	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87116	10.1371/journal.pone.0087116	http://dx.doi.org/10.1371/journal.pone.0087116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466333	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000193
J	Liu, AM; Xu, Z; Shek, FH; Wong, KF; Lee, NP; Poon, RT; Chen, JF; Luk, JM				Liu, Angela M.; Xu, Zhi; Shek, Felix H.; Wong, Kwong-Fai; Lee, Nikki P.; Poon, Ronnie T.; Chen, Jinfei; Luk, John M.			miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-CANCER; TUMOR; MICRORNA-122; ISOFORM; PKM2; REGULATOR; NETWORK	In contrast to normal differentiated cells that depend on mitochondrial oxidative phosphorylation for energy production, cancer cells have evolved to utilize aerobic glycolysis (Warburg's effect), with benefit of providing intermediates for biomass production. MicroRNA-122 (miR-122) is highly expressed in normal liver tissue regulating a wide variety of biological processes including cellular metabolism, but is reduced in hepatocellular carcinoma (HCC). Overexpression of miR-122 was shown to inhibit cancer cell proliferation, metastasis, and increase chemosensitivity, but its functions in cancer metabolism remains unknown. The present study aims to identify the miR-122 targeted genes and to investigate the associated regulatory mechanisms in HCC metabolism. We found the ectopic overexpression of miR-122 affected metabolic activities of HCC cells, evidenced by the reduced lactate production and increased oxygen consumption. Integrated gene expression analysis in a cohort of 94 HCC tissues revealed miR-122 level tightly associated with a battery of glycolytic genes, in which pyruvate kinase (PK) gene showed the strongest anti-correlation coefficient (Pearson r = -0.6938, p = <0.0001). In addition, reduced PK level was significantly associated with poor clinical outcomes of HCC patients. We found isoform M2 (PKM2) is the dominant form highly expressed in HCC and is a direct target of miR-122, as overexpression of miR-122 reduced both the mRNA and protein levels of PKM2, whereas PKM2 re-expression abrogated the miR-122-mediated glycolytic activities. The present study demonstrated the regulatory role of miR-122 on PKM2 in HCC, having an implication of therapeutic intervention targeting cancer metabolic pathways.	[Liu, Angela M.; Luk, John M.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Luk, John M.] Natl Univ Hlth Syst, Dept Surg, Singapore, Singapore; [Xu, Zhi; Chen, Jinfei; Luk, John M.] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Wong, Kwong-Fai; Luk, John M.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Liu, Angela M.; Shek, Felix H.; Lee, Nikki P.; Poon, Ronnie T.; Luk, John M.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	National University of Singapore; National University of Singapore; Nanjing Medical University; National University of Singapore; University of Hong Kong	Xu, Z (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	michelle.xuzhi@gmail.com; dr.johnluk@gmail.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940	National (973) Basic Science Research Program [2013CB911300]; National Natural Science Foundation of China [81128080, 81000880]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project	National (973) Basic Science Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project	This study was supported by grants from National (973) Basic Science Research Program (2013CB911300) (www.973.gov.cn), National Natural Science Foundation of China (www.nsfc.gov.cn) to Dr. JM Luk (Grant No. 81128080) and Dr. Z Xu (Grant No. 81000880), a grant from Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project (www.jswst.gov.cn) to Dr. J Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Walsh MJ, 2011, BIOORG MED CHEM LETT, V21, P6322, DOI 10.1016/j.bmcl.2011.08.114; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018	25	79	82	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86872	10.1371/journal.pone.0086872	http://dx.doi.org/10.1371/journal.pone.0086872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466275	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000161
J	Zhou, J; Yu, FB; Wang, XM; Yang, Y; Yu, CL; Liu, HJ; Cheng, Y; Yan, CQ; Chen, JP				Zhou, Jie; Yu, Feibo; Wang, Xuming; Yang, Yong; Yu, Chulang; Liu, Hongjia; Cheng, Ye; Yan, Chengqi; Chen, Jianping			Specific Expression of DR5 Promoter in Rice Roots Using a tCUP Derived Promoter-Reporter System	PLOS ONE			English	Article							ENHANCER TRAP LINES; AUXIN RESPONSE; PLANT TRANSFORMATION; CRYPTIC PROMOTER; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; TRANSGENIC PLANTS; MARKER GENE	Variation of transgene expression caused by either position effect at the insertion site or the promoter/enhancer elements employed for the expression of selectable marker genes has complicated phenotype characterization and caused misinterpretation. We have developed a reporter system in rice to analyze the influence of vector configuration, spacer and selectable marker gene promoter on the expression of the promoterless GUS reporter and DR5 promoter. Our results indicate that a spacer inserted between the reversed 35S promoter and the GUS reporter could reduce leaky expression of the reporter but was unable to block the nonspecific expression of DR5::GUS. Stacking the selectable marker unit in head to tail with the GUS reporter aided the gene specific expression of the GUS reporter under the DR5 promoter even when the 35S promoter is used for expression of the selectable marker. Compared to 35S under this configuration, a quick and distinctive expression of DR5:: GUS was observed in the root cap, quiescent center and xylem cells in the root apical meristem by using the tCUP derived promoter (tCUP1) for selection, that is similar to the pattern obtained by a sensitive DR5 variant (DR5rev) in Arabidopsis. These data suggest a conserved property of the tCUP promoter in preventing enhancer-promoter interactions in rice as it does in Arabidopsis, and also demonstrate that an analogous distal auxin maximum exists in roots of rice. Therefore, the tCUP promoter based selection system provides a new strategy for specific expression of transgenes in rice.	[Zhou, Jie; Wang, Xuming; Yang, Yong; Yu, Chulang; Liu, Hongjia; Cheng, Ye; Yan, Chengqi; Chen, Jianping] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, MOA Key Lab Plant Protect & Biotechnol, Zhejiang Prov Key Lab Plant Virol, Hangzhou, Zhejiang, Peoples R China; [Yu, Feibo] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University	Yan, CQ (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, MOA Key Lab Plant Protect & Biotechnol, Zhejiang Prov Key Lab Plant Virol, Hangzhou, Zhejiang, Peoples R China.	yanchengqi65@gmail.com; jpchen2001@126.com			Program for Zhejiang Leading Team of Science and Technology Innovation [2009R50032]; Program for Leading Team of Agricultural Research and Innovation of Ministry of Agriculture, China; Program of New Varieties of Genetically Modified Organism Cultivation of China [2011ZX08009-003-001]; National Natural Science Foundation of China for young scholars [30900263, 31101208, 31201482]; Zhejiang Provincial Foundation for Natural Science [LY12C14011, Y310059]	Program for Zhejiang Leading Team of Science and Technology Innovation; Program for Leading Team of Agricultural Research and Innovation of Ministry of Agriculture, China; Program of New Varieties of Genetically Modified Organism Cultivation of China; National Natural Science Foundation of China for young scholars(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Foundation for Natural Science(Natural Science Foundation of Zhejiang Province)	This work was supported by the Program for Zhejiang Leading Team of Science and Technology Innovation [2009R50032]; the Program for Leading Team of Agricultural Research and Innovation of Ministry of Agriculture, China; the Program of New Varieties of Genetically Modified Organism Cultivation of China [2011ZX08009-003-001]; National Natural Science Foundation of China for young scholars [30900263, 31101208, 31201482] and Zhejiang Provincial Foundation for Natural Science [LY12C14011, Y310059]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barges S, 2000, DEVELOPMENT, V127, P779; BEILMANN A, 1992, PLANT MOL BIOL, V18, P65, DOI 10.1007/BF00018457; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Campisi L, 1999, PLANT J, V17, P699, DOI 10.1046/j.1365-313X.1999.00409.x; Chen YN, 2012, PLANT BIOTECHNOL J, V10, P139, DOI 10.1111/j.1467-7652.2011.00637.x; Chen YR, 2013, PLANT CELL REP, V32, P453, DOI 10.1007/s00299-012-1378-x; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DeMason DA, 2009, INT J PLANT SCI, V170, P1, DOI 10.1086/593046; Dubrovsky JG, 2011, NEW PHYTOL, V191, P970, DOI 10.1111/j.1469-8137.2011.03757.x; Foster E, 1999, PLANT MOL BIOL, V41, P45, DOI 10.1023/A:1006229501860; FOX PC, 1992, PLANT MOL BIOL, V20, P219, DOI 10.1007/BF00014490; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; GAN S, 2002, Patent No. 20060174370; GEYER PK, 1986, EMBO J, V5, P2657, DOI 10.1002/j.1460-2075.1986.tb04548.x; Gudynaite-Savitch L, 2009, PLANT BIOTECHNOL J, V7, P472, DOI 10.1111/j.1467-7652.2009.00416.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hansen G, 1999, TRENDS PLANT SCI, V4, P226, DOI 10.1016/S1360-1385(99)01412-0; Hily JM, 2009, PLANT CELL REP, V28, P1095, DOI 10.1007/s00299-009-0700-8; Huo XY, 2006, J PLANT GROWTH REGUL, V25, P156, DOI 10.1007/s00344-005-0106-y; Jagannath A, 2001, MOL BREEDING, V8, P11, DOI 10.1023/A:1011916216191; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Malik K, 2002, THEOR APPL GENET, V105, P505, DOI 10.1007/s00122-002-0926-0; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santuari L, 2011, CURR BIOL, V21, P1918, DOI 10.1016/j.cub.2011.10.002; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; She WJ, 2010, GENETICS, V185, P1141, DOI 10.1534/genetics.110.117960; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Singer SD, 2011, PLANT CELL REP, V30, P2013, DOI 10.1007/s00299-011-1109-8; Singer SD, 2011, PLANT CELL REP, V30, P723, DOI 10.1007/s00299-010-0977-7; Tian L, 2002, PLANT CELL REP, V20, P1181, DOI 10.1007/s00299-002-0459-7; Tian LN, 2003, IN VITRO CELL DEV-PL, V39, P193, DOI 10.1079/IVP2002365; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Wang XF, 2011, MOL PLANT, V4, P289, DOI 10.1093/mp/ssq068; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Yang YZ, 2011, PLANT CELL TISS ORG, V105, P405, DOI 10.1007/s11240-010-9880-8; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Zheng XL, 2007, PLANT CELL REP, V26, P1195, DOI 10.1007/s00299-007-0307-x; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219; Zhou J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-29	57	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87008	10.1371/journal.pone.0087008	http://dx.doi.org/10.1371/journal.pone.0087008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466314	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100243
J	Lescroel, A; Ballard, G; Gremillet, D; Authier, M; Ainley, DG				Lescroel, Amelie; Ballard, Grant; Gremillet, David; Authier, Matthieu; Ainley, David G.			Antarctic Climate Change: Extreme Events Disrupt Plastic Phenotypic Response in Adelie Penguins	PLOS ONE			English	Article							ROSS SEA; REACTION NORMS; ENVIRONMENTAL-CHANGE; PYGOSCELIS-ADELIAE; FORAGING BEHAVIOR; ICE-SHELF; SURVIVAL; VARIABILITY; ICEBERGS; ECOLOGY	In the context of predicted alteration of sea ice cover and increased frequency of extreme events, it is especially timely to investigate plasticity within Antarctic species responding to a key environmental aspect of their ecology: sea ice variability. Using 13 years of longitudinal data, we investigated the effect of sea ice concentration (SIC) on the foraging efficiency of Adelie penguins (Pygoscelis adeliae) breeding in the Ross Sea. A 'natural experiment' brought by the exceptional presence of giant icebergs during 5 consecutive years provided unprecedented habitat variation for testing the effects of extreme events on the relationship between SIC and foraging efficiency in this sea-ice dependent species. Significant levels of phenotypic plasticity were evident in response to changes in SIC in normal environmental conditions. Maximum foraging efficiency occurred at relatively low SIC, peaking at 6.1% and decreasing with higher SIC. The 'natural experiment' uncoupled efficiency levels from SIC variations. Our study suggests that lower summer SIC than currently observed would benefit the foraging performance of Adelie penguins in their southernmost breeding area. Importantly, it also provides evidence that extreme climatic events can disrupt response plasticity in a wild seabird population. This questions the predictive power of relationships built on past observations, when not only the average climatic conditions are changing but the frequency of extreme climatic anomalies is also on the rise.	[Lescroel, Amelie] Univ Rennes 1, URU 420, Rennes, France; [Lescroel, Amelie; Gremillet, David; Authier, Matthieu] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Ballard, Grant] Point Blue Conservat Sci, Petaluma, CA USA; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Gremillet, David] Univ Cape Town, DST NRF Excellence Ctr, ZA-7700 Rondebosch, South Africa; [Ainley, David G.] HT Harvey & Associates, Los Gatos, CA USA	Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Cape Town; University of Cape Town	Lescroel, A (corresponding author), Univ Rennes 1, URU 420, Rennes, France.	amelie.lescroel@cefe.cnrs.fr	Gremillet, David/W-1946-2018	Gremillet, David/0000-0002-7711-9398; Authier, Matthieu/0000-0001-7394-1993	NSF [OPP 9526865, 9814882, 0125608, 0440643, 0944411]; CNRS; French Polar Institut (IPEV) within the ADACLIM program [388]; Office of Polar Programs (OPP) [0944411, 0944141] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Polar Institut (IPEV) within the ADACLIM program; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by NSF grants OPP 9526865, 9814882, 0125608, 0440643 and 0944411. DG is funded by CNRS and the French Polar Institut (IPEV) within the ADACLIM program (grant 388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2012, POLAR BIOL, V35, P1, DOI 10.1007/s00300-011-1042-x; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Juarez EIAY, 2012, TRENDS ECOL EVOL, V27, P272, DOI 10.1016/j.tree.2011.11.005; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Arrigo KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014160; Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Bates D, 2012, IME4 LINEAR MIXED EF; Canale CI, 2010, CLIM RES, V43, P135, DOI 10.3354/cr00897; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Chambert T, 2012, P ROY SOC B-BIOL SCI, V279, P4532, DOI 10.1098/rspb.2012.1733; Chapman EW, 2010, DEEP-SEA RES PT II, V57, P543, DOI 10.1016/j.dsr2.2009.10.005; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Christensen JH, 2007, CONTRIBUTION WORKING; Clarke J, 2003, MAR ECOL PROG SER, V248, P267, DOI 10.3354/meps248267; Clarke J, 2002, POLAR BIOL, V25, P21, DOI 10.1007/s003000100307; Clarke J, 1998, POLAR BIOL, V20, P248, DOI 10.1007/s003000050301; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Donnelly A, 2012, CLIM RES, V53, P245, DOI 10.3354/cr01102; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; Dunn MJ, 2011, POLAR BIOL, V34, P205, DOI 10.1007/s00300-010-0870-4; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Emslie SD, 2003, MAR ECOL PROG SER, V262, P19, DOI 10.3354/meps262019; Emslie SD, 2007, GEOLOGY, V35, P61, DOI 10.1130/G23011A.1; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Field C.B., 2012, MANAGING RISKS EXTRE; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; JACOBS SS, 1986, J GLACIOL, V32, P464, DOI 10.3189/S0022143000012181; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Kato A, 2009, POLAR BIOL, V32, P181, DOI 10.1007/s00300-008-0518-9; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; KEYS HJR, 1990, ANTARCT SCI, V2, P243; Kooyman GL, 2007, ANTARCT SCI, V19, P31, DOI 10.1017/S0954102007000065; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LAZZARA MA, 1999, POLAR GEOGR, V23, P201, DOI DOI 10.1080/10889379909377676; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; Lindquist MA, 2012, NEUROIMAGE, V59, P490, DOI 10.1016/j.neuroimage.2011.07.077; Lynch HJ, 2012, ECOLOGY, V93, P1367; Madhusoodanan MS, 2011, OCEAN DYNAM, V61, P873, DOI 10.1007/s10236-011-0386-7; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; Martin S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006700; Mulvaney R, 2012, NATURE, V489, P141, DOI 10.1038/nature11391; Nettles M, 2010, ANNU REV EARTH PL SC, V38, P467, DOI 10.1146/annurev-earth-040809-152414; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Pinheiro J, 2012, LINEAR NONLINEAR MIX; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pitman RL, 2010, POLAR BIOL, V33, P1589, DOI 10.1007/s00300-010-0853-5; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Rockova V, 2012, STAT MED, V31, P1221, DOI 10.1002/sim.4439; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shepherd LD, 2005, P NATL ACAD SCI USA, V102, P16717, DOI 10.1073/pnas.0502281102; Siniff DB, 2008, ANTARCT SCI, V20, P425, DOI 10.1017/S0954102008001351; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Thompson RM, 2013, ECOL LETT, DOI DOI 10.1111/ELE.12095/FULL; Thrush SF, 2011, MAR ECOL-EVOL PERSP, V32, P289, DOI 10.1111/j.1439-0485.2011.00462.x; Ujvari B, 2011, ECOLOGY, V92, P1858, DOI 10.1890/11-0129.1; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Vonesh EF, 1996, BIOMETRICS, V52, P572, DOI 10.2307/2532896; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Westneat DF, 2011, AM NAT, V178, P652, DOI 10.1086/662173; Zuur Alain F., 2009, P1	93	39	40	2	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85291	10.1371/journal.pone.0085291	http://dx.doi.org/10.1371/journal.pone.0085291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489657	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000009
J	Little, MP; Kukush, AG; Masiuk, SV; Shklyar, S; Carroll, RJ; Lubin, JH; Kwon, D; Brenner, AV; Tronko, MD; Mabuchi, K; Bogdanova, TI; Hatch, M; Zablotska, LB; Tereshchenko, VP; Ostroumova, E; Bouville, AC; Drozdovitch, V; Chepurny, MI; Kovgan, LN; Simon, SL; Shpak, VM; Likhtarev, IA				Little, Mark P.; Kukush, Alexander G.; Masiuk, Sergii V.; Shklyar, Sergiy; Carroll, Raymond J.; Lubin, Jay H.; Kwon, Deukwoo; Brenner, Alina V.; Tronko, Mykola D.; Mabuchi, Kiyohiko; Bogdanova, Tetiana I.; Hatch, Maureen; Zablotska, Lydia B.; Tereshchenko, Valeriy P.; Ostroumova, Evgenia; Bouville, Andre C.; Drozdovitch, Vladimir; Chepurny, Mykola I.; Kovgan, Lina N.; Simon, Steven L.; Shpak, Victor M.; Likhtarev, Ilya A.			Impact of Uncertainties in Exposure Assessment on Estimates of Thyroid Cancer Risk among Ukrainian Children and Adolescents Exposed from the Chernobyl Accident	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; MEASUREMENT ERROR PROBLEMS; MORTALITY DOSE-RESPONSE; REGRESSION CALIBRATION; CERVICAL-CANCER; RADIATION; MODELS; CURVATURE; I-131; EPIDEMIOLOGY	The 1986 accident at the Chernobyl nuclear power plant remains the most serious nuclear accident in history, and excess thyroid cancers, particularly among those exposed to releases of iodine-131 remain the best-documented sequelae. Failure to take dose-measurement error into account can lead to bias in assessments of dose-response slope. Although risks in the Ukrainian-US thyroid screening study have been previously evaluated, errors in dose assessments have not been addressed hitherto. Dose-response patterns were examined in a thyroid screening prevalence cohort of 13,127 persons aged <18 at the time of the accident who were resident in the most radioactively contaminated regions of Ukraine. We extended earlier analyses in this cohort by adjusting for dose error in the recently developed TD-10 dosimetry. Three methods of statistical correction, via two types of regression calibration, and Monte Carlo maximum-likelihood, were applied to the doses that can be derived from the ratio of thyroid activity to thyroid mass. The two components that make up this ratio have different types of error, Berkson error for thyroid mass and classical error for thyroid activity. The first regression-calibration method yielded estimates of excess odds ratio of 5.78 Gy(-1) (95% CI 1.92, 27.04), about 7% higher than estimates unadjusted for dose error. The second regression-calibration method gave an excess odds ratio of 4.78 Gy(-1) (95% CI 1.64, 19.69), about 11% lower than unadjusted analysis. The Monte Carlo maximum-likelihood method produced an excess odds ratio of 4.93 Gy(-1) (95% CI 1.67, 19.90), about 8% lower than unadjusted analysis. There are borderline-significant (p=0.101-0.112) indications of downward curvature in the dose response, allowing for which nearly doubled the low-dose linear coefficient. In conclusion, dose-error adjustment has comparatively modest effects on regression parameters, a consequence of the relatively small errors, of a mixture of Berkson and classical form, associated with thyroid dose assessment.	[Little, Mark P.; Kwon, Deukwoo; Brenner, Alina V.; Mabuchi, Kiyohiko; Hatch, Maureen; Ostroumova, Evgenia; Bouville, Andre C.; Drozdovitch, Vladimir; Simon, Steven L.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20892 USA; [Kukush, Alexander G.; Masiuk, Sergii V.; Shklyar, Sergiy; Chepurny, Mykola I.; Kovgan, Lina N.; Likhtarev, Ilya A.] Ukrainian Radiat Protect Inst, Kiev, Ukraine; [Kukush, Alexander G.; Shklyar, Sergiy] Taras Shevchenko Natl Univ Kyiv, Kiev, Ukraine; [Carroll, Raymond J.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Lubin, Jay H.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20892 USA; [Kwon, Deukwoo] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Tronko, Mykola D.; Bogdanova, Tetiana I.; Tereshchenko, Valeriy P.; Shpak, Victor M.] Ukraine Acad Med Sci, State Inst Inst Endocrinol & Metab, Kiev, Ukraine; [Zablotska, Lydia B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; National Academy of Medical Sciences of Ukraine; V. P. Komissarenko Institute of Endocrinology & Metabolism of the National Academy of Medical Science of Ukraine; University of California System; University of California San Francisco	Little, MP (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20892 USA.	mark.little@nih.gov	Tronko, Mykola/AAQ-3327-2021; Likhtarev, Ilja/E-6414-2018; Kukush, Alexander G./I-1313-2018; Shklyar, Sergiy/O-4680-2015	Tronko, Mykola/0000-0001-7421-0981; Likhtarev, Ilja/0000-0002-6168-5758; Shklyar, Sergiy/0000-0001-8726-7936; Bogdanova, Tetiana/0000-0001-5119-0236; Masiuk, Sergii/0000-0002-5123-9674; Kukush, Alexander/0000-0002-4143-8928; Little, Mark/0000-0003-0980-7567; Shpak, Viktor/0000-0002-6983-5490; Ostroumova, Evgenia/0000-0003-4729-1733; Drozdovitch, Vladimir/0000-0002-7952-379X; Chepurny, Mykola/0000-0001-9852-0669	National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics; National Cancer Institute [R37-CA057030]; NATIONAL CANCER INSTITUTE [R01CA057030, R37CA057030] Funding Source: NIH RePORTER	National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics. Professor RJC's research was supported by a grant from the National Cancer Institute (R37-CA057030). The National Cancer Institute approved the present paper for publication. The funders (NIH) had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex A, 2008, UNSCEAR 2006 REP, P13; Bateson TF, 2010, AM J EPIDEMIOL, V172, P344, DOI 10.1093/aje/kwq123; BAVERSTOCK K, 1992, NATURE, V359, P21, DOI 10.1038/359021b0; Bennett J, 2004, RADIAT ENVIRON BIOPH, V43, P233, DOI 10.1007/s00411-004-0258-3; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Burnham KP, 1998, MODEL SELECTION MULT, P1; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Carroll RJ, 2006, MODERN PERSPECTIVE, P1; Claeskens G., 2008, CAMBRIDGE SERIES STA, P1; CLAYTON D, 1988, STAT MED, V7, P819, DOI 10.1002/sim.4780070802; Davis S, 2004, JAMA-J AM MED ASSOC, V292, P2600, DOI 10.1001/jama.292.21.2600; Deschavanne PJ, 1996, INT J RADIAT ONCOL, V34, P251, DOI 10.1016/0360-3016(95)02029-2; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; Fearn T, 2008, STAT MED, V27, P2159, DOI 10.1002/sim.3163; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; Kukush A, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1281; Likhtarev I, 2006, RADIAT RES, V166, P271, DOI 10.1667/RR3545.1; Likhtarev I, 2003, RADIAT PROT DOSIM, V105, P601, DOI 10.1093/oxfordjournals.rpd.a006310; LIKHTAREV IA, 1995, HEALTH PHYS, V69, P6, DOI 10.1097/00004032-199507000-00002; Likhtarov I, 2013, HEALTH PHYS, V104, P78, DOI 10.1097/HP.0b013e31826e188e; Likhtarov I, 2014, HLTH PHYS IN PRESS; Likhtarov I, 2011, DOSIMETRY OPERATIONS; Likhtarov I, 2013, MATH LIFE SCI, P231; Little MP, 2008, RADIAT RES, V169, P660, DOI 10.1667/RR1091.1; Little MP, 1998, INT J RADIAT BIOL, V74, P471, DOI 10.1080/095530098141348; Little MP, 2000, INT J RADIAT BIOL, V76, P939, DOI 10.1080/09553000050050954; Little MP, 2004, RADIAT ENVIRON BIOPH, V43, P67, DOI 10.1007/s00411-004-0244-9; Little MP, 1997, INT J RADIAT BIOL, V71, P589, DOI 10.1080/095530097143923; Little MP, 1999, RADIAT RES, V152, P280, DOI 10.2307/3580328; Little MP, 1996, INT J RADIAT BIOL, V70, P83, DOI 10.1080/095530096145364; Little MP, 2000, RADIAT ENVIRON BIOPH, V39, P241, DOI 10.1007/s004110000070; LUNDELL M, 1994, RADIAT RES, V140, P334, DOI 10.2307/3579110; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Molitor J, 2007, ENVIRON HEALTH PERSP, V115, P1147, DOI 10.1289/ehp.9849; PIERCE DA, 1991, J RADIAT RES, V32, P108, DOI 10.1269/jrr.32.SUPPLEMENT_108; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; RICHARDSON S, 1993, STAT MED, V12, P1703, DOI 10.1002/sim.4780121806; RICHARDSON S, 1993, AM J EPIDEMIOL, V138, P430, DOI 10.1093/oxfordjournals.aje.a116875; Richardson S, 2002, J ROY STAT SOC A STA, V165, P549, DOI 10.1111/1467-985X.00252; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Sachs RK, 2005, P NATL ACAD SCI USA, V102, P13040, DOI 10.1073/pnas.0506648102; Schollnberger H, 2012, RADIAT ENVIRON BIOPH, V51, P165, DOI 10.1007/s00411-012-0410-4; SHORE RE, 1993, AM J EPIDEMIOL, V137, P1068, DOI 10.1093/oxfordjournals.aje.a116610; Sigurdson AJ, 2005, LANCET, V365, P2014, DOI 10.1016/S0140-6736(05)66695-0; Stezhko VA, 2004, RADIAT RES, V161, P481, DOI 10.1667/3148; Stram DO, 2003, RADIAT RES, V160, P408, DOI 10.1667/3046; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; THOMAS DC, 1992, BIOMETRICS, V48, P781, DOI 10.2307/2532344; Tronko MD, 2006, JNCI-J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 1993, UNSCEAR 1993 REP GEN, P1; Walsh L, 2013, RADIAT ENVIRON BIOPH, V52, P135, DOI 10.1007/s00411-012-0441-x; Walsh L, 2011, RADIAT ENVIRON BIOPH, V50, P21, DOI 10.1007/s00411-010-0337-6; Wang C, 2012, BIOMETRICS, V68, P661, DOI 10.1111/j.1541-0420.2011.01731.x; Yamashita S, 1997, P 5 CHERN SAS MED CO, P1; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967	55	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85723	10.1371/journal.pone.0085723	http://dx.doi.org/10.1371/journal.pone.0085723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489667	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000014
J	Aberle, T; Franke, K; Rist, E; Benz, K; Schlosshauer, B				Aberle, Timo; Franke, Katrin; Rist, Elke; Benz, Karin; Schlosshauer, Burkhard			Cell-Type Specific Four-Component Hydrogel	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GELATIN; FIBRIN; ANGIOGENESIS; MATRIX; CHONDROCYTES; SUBSTRATE; GELS	In the field of regenerative medicine we aim to develop implant matrices for specific tissue needs. By combining two per se, cell-permissive gel systems with enzymatic crosslinkers (gelatin/transglutaminase and fibrinogen/thrombin) to generate a blend (technical term: quattroGel), an unexpected cell-selectivity evolved. QuattroGels were porous and formed cavities in the cell diameter range, possessed gelation kinetics in the minute range, viscoelastic properties and a mechanical strength appropriate for general cell adhesion, and restricted diffusion. Cell proliferation of endothelial cells, chondrocytes and fibroblasts was essentially unaffected. In contrast, on quattroGels neither endothelial cells formed vascular tubes nor did primary neurons extend neurites in significant amounts. Only chondrocytes differentiated properly as judged by collagen isoform expression. The biophysical quattroGel characteristics appeared to leave distinct cell processes such as mitosis unaffected and favored differentiation of sessile cells, but hampered differentiation of migratory cells. This cell-type selectivity is of interest e. g. during articular cartilage or invertebral disc repair, where pathological innervation and angiogenesis represent adverse events in tissue engineering.	[Aberle, Timo; Franke, Katrin; Rist, Elke; Benz, Karin; Schlosshauer, Burkhard] Univ Tubingen, Nat Wissensch & Med Inst, Reutlingen, Germany	Eberhard Karls University of Tubingen	Schlosshauer, B (corresponding author), Univ Tubingen, Nat Wissensch & Med Inst, Reutlingen, Germany.	schlosshauer@nmi.de		Franke, Katrin/0000-0002-8649-4835	German Federal Ministry of Education and Research (BMBF) [01KQ0902R]; OtoPep [13N11302]; Nano4Neuro [13N11036]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); OtoPep; Nano4Neuro	Supported by the German Federal Ministry of Education and Research (BMBF) # 01KQ0902R (REGiNA TP15) and in part by 13N11302 (OtoPep) and 13N11036 (Nano4Neuro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781; Anders JO, 2009, J BONE JOINT SURG BR, V91B, P409, DOI 10.1302/0301-620X.91B3.20869; Anumolu SS, 2010, BIOMATERIALS, V31, P964, DOI 10.1016/j.biomaterials.2009.10.010; Benz K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-27; Bhang SH, 2013, BIOMATERIALS, V34, P7247, DOI 10.1016/j.biomaterials.2013.06.018; Calcaterra J, 2013, BIOMACROMOLECULES, V14, P169, DOI 10.1021/bm301579p; Chen TH, 2006, J BIOMED MATER RES B, V77B, P416, DOI 10.1002/jbm.b.30439; Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040; DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174; Dreesmann L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034119; Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040; DVORAK HF, 1987, LAB INVEST, V57, P673; Feng Xiaodong, 2013, Int J Cell Biol, V2013, P231279, DOI 10.1155/2013/231279; Forget A, 2013, P NATL ACAD SCI USA, V110, P12887, DOI 10.1073/pnas.1222880110; Franke K, 2013, NEUROSCI LETT, V541, P248, DOI 10.1016/j.neulet.2013.01.057; Gibas I, 2010, CHEM CHEM TECHOL, V4, P297; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Lippacher A, 2004, EUR J PHARM BIOPHARM, V58, P561, DOI 10.1016/j.ejpb.2004.04.009; Lippacher A, 2000, INT J PHARM, V196, P227, DOI 10.1016/S0378-5173(99)00428-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lum L., 2003, INJECTABLE HYDROGELS, V1; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030; Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4; Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1; Reno F, 2012, J MATER SCI-MATER M, V23, P565, DOI 10.1007/s10856-011-4519-9; Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007; Sazo REG, 2012, BIOMATERIALS, V33, P8529, DOI 10.1016/j.biomaterials.2012.07.028; Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Shainer R, 2010, REGEN MED, V5, P255, DOI 10.2217/RME.09.90; Singh D, 2011, J BIOMAT SCI-POLYM E, V22, P1733, DOI 10.1163/092050610X522486; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Vallon M, 2012, BIOCHEM J, V441, P937, DOI 10.1042/BJ20111682; Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092; Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3438::AID-POLB6>3.0.CO;2-9; Xie X, 2013, ACTA PHARMACOL SIN, V34, P983, DOI 10.1038/aps.2013.17; Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3; Yuan SJ, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0030-1; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	41	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86740	10.1371/journal.pone.0086740	http://dx.doi.org/10.1371/journal.pone.0086740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475174	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300106
J	Bayatti, N; Cooper-Knock, J; Bury, JJ; Wyles, M; Heath, PR; Kirby, J; Shaw, PJ				Bayatti, Nadhim; Cooper-Knock, Johnathan; Bury, Joanna J.; Wyles, Matthew; Heath, Paul R.; Kirby, Janine; Shaw, Pamela J.			Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							PERIPHERAL-BLOOD; MICROARRAY ANALYSIS; SAMPLES; COLLECTION; DISEASE; PATHWAYS; SURVIVAL; KINASE	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes death within a mean of 2-3 years from symptom onset. There is no diagnostic test and the delay from symptom onset to diagnosis averages 12 months. The identification of prognostic and diagnostic biomarkers in ALS would facilitate earlier diagnosis and faster monitoring of treatments. Gene expression profiling (GEP) can help to identify these markers as well as therapeutic targets in neurological diseases. One source of genetic material for GEP in ALS is peripheral blood, which is routinely accessed from patients. However, a high proportion of globin mRNA in blood can mask important genetic information. A number of methods allow safe collection, storage and transport of blood as well as RNA stabilisation, including the PAXGENE and TEMPUS systems for the collection of whole blood and LEUKOLOCK which enriches for the leukocyte population. Here we compared these three systems and assess their suitability for GEP in ALS. We collected blood from 8 sporadic ALS patients and 7 controls. PAXGENE and TEMPUS RNA extracted samples additionally underwent globin depletion using GlobinClear. RNA was amplified and hybridised onto Affymetrix U133 Plus 2.0 arrays. Lists of genes differentially regulated in ALS patients and controls were created for each method using the R package PUMA, and RT-PCR validation was carried out on selected genes. TEMPUS/GlobinClear, and LEUKOLOCK produced high quality RNA with sufficient yield, and consistent array expression profiles. PAXGENE/GlobinClear yield and quality were lower. Globin depletion for PAXGENE and TEMPUS uncovered the presence of over 60% more transcripts than when samples were not depleted. TEMPUS/GlobinClear and LEUKOLOCK gene lists respectively contained 3619 and 3047 genes differentially expressed between patients and controls. Real-time PCR validation revealed similar reliability between these two methods and gene ontology analyses revealed similar pathways differentially regulated in disease compared to controls.	[Bayatti, Nadhim; Cooper-Knock, Johnathan; Bury, Joanna J.; Wyles, Matthew; Heath, Paul R.; Kirby, Janine; Shaw, Pamela J.] Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Sheffield	Shaw, PJ (corresponding author), Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	pamela.shaw@sheffield.ac.uk	Kirby, Janine/B-3980-2009	Kirby, Janine/0000-0002-7468-5917; Shaw, Pamela/0000-0002-8925-2567; Bury, Joanna J/0000-0002-8735-2791; Cooper-Knock, Johnathan/0000-0002-0873-8689	European Union [259867]; EU; France, Agence Nationale de la Recherche (ANR); Germany, Bundesministerium fur Bildung und Forschung (BMBF); Ireland, Health Research Board (HRB); Italy, Ministero della Salute; Netherlands, The Netherlands Organisation for Health Research and Development (ZonMw); Poland, Narodowe Centrum Badan i Rozwoju; Portugal, Fundacao a Ciencia e a Tecnologia; Spain, Ministerio de Ciencia e Innovacion; Switzerland, Schweizerischer Nationalfonds zur Forderung der wissenschaftlichen Forschung (SNF); Turkey, Tubitak; United Kingdom, Medical Research Council (MRC); MND Association/MRC Lady Edith Wolfson Fellowship [MR/K003771/1]; MRC PhD studentship; NIHR; MRC [MR/K000039/1, MR/K003771/1] Funding Source: UKRI; Medical Research Council [MR/K000039/1, MR/K003771/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish	European Union(European Commission); EU(European Commission); France, Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Germany, Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Ireland, Health Research Board (HRB); Italy, Ministero della Salute; Netherlands, The Netherlands Organisation for Health Research and Development (ZonMw); Poland, Narodowe Centrum Badan i Rozwoju; Portugal, Fundacao a Ciencia e a Tecnologia; Spain, Ministerio de Ciencia e Innovacion; Switzerland, Schweizerischer Nationalfonds zur Forderung der wissenschaftlichen Forschung (SNF); Turkey, Tubitak(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); United Kingdom, Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MND Association/MRC Lady Edith Wolfson Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	PJS, JK and NB are supported by funding from the European Union: Seventh Framework Programme (FP7/2007-2013) under the Euro-MOTOR project (No: 259867, http://www.euromotorproject.eu/) and PJS and JK by the EU Joint Programme-Neurodegenerative Disease Research (JPND), Sampling and biomarker OPtimization and Harmonization In ALS and other motor neuron diseases (SOPHIA). This is an EU Joint Programme -Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND -www.jpnd.eu: France, Agence Nationale de la Recherche (ANR); Germany, Bundesministerium fur Bildung und Forschung (BMBF); Ireland, Health Research Board (HRB); Italy, Ministero della Salute; The Netherlands, The Netherlands Organisation for Health Research and Development (ZonMw); Poland, Narodowe Centrum Badan i Rozwoju; Portugal, Fundacao a Ciencia e a Tecnologia; Spain, Ministerio de Ciencia e Innovacion; Switzerland, Schweizerischer Nationalfonds zur Forderung der wissenschaftlichen Forschung (SNF); Turkey, Tubitak; United Kingdom, Medical Research Council (MRC). JCK holds a MND Association/MRC Lady Edith Wolfson Fellowship award (MR/K003771/1). JJB is funded by an MRC PhD studentship. PJS is supported as an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Debey-Pascher S, 2011, J MOL DIAGN, V13, P452, DOI 10.1016/j.jmoldx.2011.03.006; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Field LA, 2007, CLIN BIOCHEM, V40, P499, DOI 10.1016/j.clinbiochem.2007.01.004; Hammerle-Fickinger A, 2010, BIOTECHNOL LETT, V32, P35, DOI 10.1007/s10529-009-0130-2; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kirby J, 2011, BRAIN, V134, P506, DOI 10.1093/brain/awq345; Kudo LC, 2010, HUM MOL GENET, V19, P3233, DOI 10.1093/hmg/ddq232; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Matheson LA, 2008, J IMMUNOL METHODS, V339, P82, DOI 10.1016/j.jim.2008.08.003; Menke Andreas, 2012, BMC Res Notes, V5, P1, DOI 10.1186/1756-0500-5-1; Mougeot JLC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-74; Nikula T, 2013, TRANSL RES, V161, P181, DOI 10.1016/j.trsl.2012.10.003; Oster M, 2012, CONSERV GENET RESOUR, V4, P27, DOI 10.1007/s12686-011-9465-9; Pearson RD, 2009, BMC BIOINFORMATICS, P10; Prezeau N, 2006, LEUKEMIA RES, V30, P569, DOI 10.1016/j.leukres.2005.08.027; Rainen L, 2002, CLIN CHEM, V48, P1883; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419	26	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87508	10.1371/journal.pone.0087508	http://dx.doi.org/10.1371/journal.pone.0087508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475299	Green Published, Green Accepted, gold			2022-12-27	WOS:000330507300193
J	Chung, FH; Chiang, YR; Tseng, AL; Sung, YC; Lu, J; Huang, MC; Ma, NH; Lee, HC				Chung, Feng-Hsiang; Chiang, Yun-Ru; Tseng, Ai-Lun; Sung, Yung-Chuan; Lu, Jean; Huang, Min-Chang; Ma, Nianhan; Lee, Hoong-Chien			Functional Module Connectivity Map (FMCM): A Framework for Searching Repurposed Drug Compounds for Systems Treatment of Cancer and an Application to Colorectal Adenocarcinoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GINKGO-BILOBA EXTRACT; ETHACRYNIC-ACID; THAPSIGARGIN; MECHANISMS; OPINION; DEATH; PHARMACOKINETICS; RESISTANCE; INHIBITION	Drug repurposing has become an increasingly attractive approach to drug development owing to the ever-growing cost of new drug discovery and frequent withdrawal of successful drugs caused by side effect issues. Here, we devised Functional Module Connectivity Map (FMCM) for the discovery of repurposed drug compounds for systems treatment of complex diseases, and applied it to colorectal adenocarcinoma. FMCM used multiple functional gene modules to query the Connectivity Map (CMap). The functional modules were built around hub genes identified, through a gene selection by trend-of-disease-progression (GSToP) procedure, from condition-specific gene-gene interaction networks constructed from sets of cohort gene expression microarrays. The candidate drug compounds were restricted to drugs exhibiting predicted minimal intracellular harmful side effects. We tested FMCM against the common practice of selecting drugs using a genomic signature represented by a single set of individual genes to query CMap (IGCM), and found FMCM to have higher robustness, accuracy, specificity, and reproducibility in identifying known anti-cancer agents. Among the 46 drug candidates selected by FMCM for colorectal adenocarcinoma treatment, 65% had literature support for association with anti-cancer activities, and 60% of the drugs predicted to have harmful effects on cancer had been reported to be associated with carcinogens/immune suppressors. Compounds were formed from the selected drug candidates where in each compound the component drugs collectively were beneficial to all the functional modules while no single component drug was harmful to any of the modules. In cell viability tests, we identified four candidate drugs: GW-8510, etacrynic acid, ginkgolide A, and 6-azathymine, as having high inhibitory activities against cancer cells. Through microarray experiments we confirmed the novel functional links predicted for three candidate drugs: phenoxybenzamine (broad effects), GW-8510 (cell cycle), and imipenem (immune system). We believe FMCM can be usefully applied to repurposed drug discovery for systems treatment of other types of cancer and other complex diseases.	[Chung, Feng-Hsiang; Chiang, Yun-Ru; Tseng, Ai-Lun; Ma, Nianhan; Lee, Hoong-Chien] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan; [Chung, Feng-Hsiang; Lee, Hoong-Chien] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Zhongli, Taiwan; [Sung, Yung-Chuan] Cathay Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan; [Lu, Jean] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Min-Chang; Lee, Hoong-Chien] Chung Yuan Christian Univ, Dept Phys, Zhongli, Taiwan; [Lee, Hoong-Chien] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan; [Lee, Hoong-Chien] Natl Ctr Theoret Sci, Div Phys, Hsinchu, Taiwan	National Central University; National Central University; Cathay General Hospital; Academia Sinica - Taiwan; Chung Yuan Christian University; Cathay General Hospital	Chung, FH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan.	fabian415@gmail.com; mini7ma@gmail.com; hclee12345@gmail.com	Chiang, Yun/GRJ-5251-2022; Ma, Nianhan/AAB-9869-2020	Ma, Nianhan/0000-0003-1800-2306	Strive for the Top Project, Ministry of Education, ROC [101G907-2]; National Central University-Cathay General Hospital United Research Center [101CGH-NCU-A5]	Strive for the Top Project, Ministry of Education, ROC; National Central University-Cathay General Hospital United Research Center	This work is partially funded by grants from the Strive for the Top Project, Ministry of Education (grant no. 101G907-2), ROC, and the National Central University-Cathay General Hospital United Research Center (101CGH-NCU-A5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2003, PHARMACOPSYCHIATRY, V36, pS8; Aizawa S, 2003, CANCER SCI, V94, P886, DOI 10.1111/j.1349-7006.2003.tb01371.x; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2010, PHARM MED; Aponte MM, 2006, AACR M, V2006, pA106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Brambilla G, 2006, MUTAT RES-REV MUTAT, V612, P115, DOI 10.1016/j.mrrev.2005.12.002; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chung FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065683; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Dudley JT, 2011, SCI TRANSL MED, V3; ELLISON RR, 1960, CANCER RES, V20, P435; FREI E, 1958, BLOOD, V13, P1126, DOI 10.1182/blood.V13.12.1126.1126; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Goldkind L, 2006, PHARMACOEPIDEM DR S, V15, P213, DOI 10.1002/pds.1207; HAKII H, 1986, J CANCER RES CLIN, V111, P177, DOI 10.1007/BF00389230; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harmon CS, 1996, J INVEST DERMATOL, V107, P188, DOI 10.1111/1523-1747.ep12329592; Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022274; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Issa AM, 2007, CURR DRUG SAF, V2, P177, DOI 10.2174/157488607781668855; Jiang W, 2012, INTEGR CANC THER; Jiang W, 2011, EUR J CANCER PREV, V20, P508, DOI 10.1097/CEJ.0b013e328348fbb7; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Kent LL, 1999, BIOCHEM BIOPH RES CO, V260, P768, DOI 10.1006/bbrc.1999.0891; Khamas A, 2012, CANCER GENOM PROTEOM, V9, P67; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; LACRETA FP, 1994, J PHARMACOL EXP THER, V270, P1186; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee DI, 2007, ARCH BIOCHEM BIOPHYS, V464, P19, DOI 10.1016/j.abb.2007.03.040; Lin XS, 1997, PROSTATE, V33, P201, DOI 10.1002/(SICI)1097-0045(19971101)33:3<201::AID-PROS9>3.0.CO;2-L; Lu DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008294; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Oprea TI, 2012, AAPS J, V14, P759, DOI 10.1208/s12248-012-9390-1; Pereira M, 2002, MOL CELL BIOCHEM, V229, P163, DOI 10.1023/A:1017972622312; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; PRUSOFF WH, 1954, CANCER RES, V14, P570; RETTIG RA, 2006, HEALTH AFFAIR, V25, P1446; RHODES T, 1992, BRIT J CANCER, V65, P684, DOI 10.1038/bjc.1992.145; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seyfried J, 1999, NEUROSCI LETT, V264, P1, DOI 10.1016/S0304-3940(99)00107-X; Shi C, 2010, INT J MOL SCI, V11, P107, DOI 10.3390/ijms11010107; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TEW KD, 1988, CANCER RES, V48, P3622; Tombal B, 2000, PROSTATE, V43, P303; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaidyanathan S, 2006, SPINAL CORD, V44, P188, DOI 10.1038/sj.sc.3101789; Wang GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014573; Woelkart K, 2010, PHYTOTHER RES, V24, P445, DOI 10.1002/ptr.3074; Xia SH, 2007, CHINESE MED J-PEKING, V120, P922, DOI 10.1097/00029330-200705020-00013; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	65	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86299	10.1371/journal.pone.0086299	http://dx.doi.org/10.1371/journal.pone.0086299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475102	gold, Green Published			2022-12-27	WOS:000330507300051
J	Souza, LD; Camargo, R; Demasi, M; Santana, JM; de Sa, CM; de Freitas, SM				Souza, Larissa da Costa; Camargo, Ricardo; Demasi, Marilene; Santana, Jaime Martins; de Sa, Cezar Martins; de Freitas, Sonia Maria			Effects of an Anticarcinogenic Bowman-Birk Protease Inhibitor on Purified 20S Proteasome and MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; PEA VIGNA-SINENSIS; CHYMOTRYPSIN INHIBITOR; MULTICATALYTIC PROTEINASE; 26S PROTEASOME; BETA-SUBUNITS; S PROTEASOME; ACTIVE-SITES; TRYPSIN; APOPTOSIS	Proteasome inhibitors have been described as an important target for cancer therapy due to their potential to regulate the ubiquitin-proteasome system in the degradation pathway of cellular proteins. Here, we reported the effects of a Bowman-Birk-type protease inhibitor, the Black-eyed pea Trypsin/Chymotrypsin Inhibitor (BTCI), on proteasome 20S in MCF-7 breast cancer cells and on catalytic activity of the purified 20S proteasome from horse erythrocytes, as well as the structural analysis of the BTCI-20S proteasome complex. In vitro experiments and confocal microscopy showed that BTCI readily crosses the membrane of the breast cancer cells and co-localizes with the proteasome in cytoplasm and mainly in nucleus. Indeed, as indicated by dynamic light scattering, BTCI and 20S proteasome form a stable complex at temperatures up to 55 degrees C and at neutral and alkaline pHs. In complexed form, BTCI strongly inhibits the proteolytic chymotrypsin-, trypsin-and caspase-like activities of 20S proteasome, indicated by inhibition constants of 10(-7) M magnitude order. Besides other mechanisms, this feature can be associated with previously reported cytostatic and cytotoxic effects of BTCI in MCF-7 breast cancer cells by means of apoptosis.	[Souza, Larissa da Costa; de Freitas, Sonia Maria] Univ Brasilia, Dept Cellular Biol, Biophys Lab, Brasilia, DF, Brazil; [Camargo, Ricardo; de Sa, Cezar Martins] Univ Brasilia, Dept Cellular Biol, Microbiol Lab, Brasilia, DF, Brazil; [Demasi, Marilene] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Santana, Jaime Martins] Univ Brasilia, Dept Cellular Biol, Lab Pathogen Host Interface, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Instituto Butantan; Universidade de Brasilia	de Freitas, SM (corresponding author), Univ Brasilia, Dept Cellular Biol, Biophys Lab, Brasilia, DF, Brazil.	nina@unb.br	Santana, Jaime/H-5319-2013; Demasi, Marilene/E-5873-2012	Demasi, Marilene/0000-0002-3749-1160; Camargo, Ricardo/0000-0003-0592-8396	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF); Financiadora de Estudos e Projetos (FINEP)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF) and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Armstrong WB, 2000, CLIN CANCER RES, V6, P4684; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; BALDWIN ET, 1986, BIOPHYS J, V49, P47, DOI 10.1016/S0006-3495(86)83587-1; Barbosa JARG, 2007, BIOPHYS J, V92, P1638, DOI 10.1529/biophysj.106.090555; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boehm K, 2008, BIOCHEMISTRY-US, V47, P7116, DOI 10.1021/bi800554v; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Carrotta R, 2009, PHYS CHEM CHEM PHYS, V11, P4007, DOI 10.1039/b818687a; Carvalho AF, 2008, BRAZ J BIOL, V68, P149, DOI 10.1590/S1519-69842008000100021; Chen LH, 2008, INT J BIOL MACROMOL, V42, P441, DOI 10.1016/j.ijbiomac.2008.02.005; CHEN P, 1992, J BIOL CHEM, V267, P1990; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; CLEMENTE A, 2013, BOWMAN BIRK INHIBITO, DOI DOI 10.5772/51262; Clemente A, 2012, BRIT J NUTR, V108, pS135, DOI 10.1017/S000711451200075X; Clemente A, 2011, CURR PROTEIN PEPT SC, V12, P358, DOI 10.2174/138920311796391133; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; da Silva LP, 2001, PROTEIN PEPTIDE LETT, V8, P33, DOI 10.2174/0929866013409715; de Bettignies G, 2010, BIOCHIMIE, V92, P1530, DOI 10.1016/j.biochi.2010.06.023; De Leo F, 2002, NUCLEIC ACIDS RES, V30, P347, DOI 10.1093/nar/30.1.347; deFreitas SM, 1997, FEBS LETT, V409, P121, DOI 10.1016/S0014-5793(97)00419-5; Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Esteves GF, 2007, ACTA CRYSTALLOGR F, V63, P1087, DOI 10.1107/S1744309107056424; FACHETTI HCS, 1984, AN ACAD BRAS CIENC, V56, P311; Franco OL, 2003, PHYTOCHEMISTRY, V63, P343, DOI 10.1016/S0031-9422(03)00108-0; FREITAS SM, 1999, J PROTEIN CHEM, V18, P307; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Gavilan E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.95; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gokarn YR, 2009, PROTEIN SCI, V18, P169, DOI 10.1002/pro.20; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanlon AD, 2010, BIOPHYS J, V98, P297, DOI 10.1016/j.bpj.2009.09.061; Hassan PA, 2006, J COLLOID INTERF SCI, V300, P744, DOI 10.1016/j.jcis.2006.04.013; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; IKENAKA T, 1986, PROTEINASE INHIBITOR, V9, P361; Joanitti G.A., 2006, CURR ENZYM INHIB, V2, P199, DOI [10.2174/157340806777934801, DOI 10.2174/157340806777934801]; JOANITTI GA, 2012, THESIS UNB; Joanitti GA, 2010, CANCER LETT, V293, P73, DOI 10.1016/j.canlet.2009.12.017; Kato GJ, 1999, HUM MUTAT, V13, P87, DOI 10.1002/(SICI)1098-1004(1999)13:2<87::AID-HUMU1>3.0.CO;2-K; Kennedy AR, 1998, AM J CLIN NUTR, V68, p1406S, DOI 10.1093/ajcn/68.6.1406S; KENNEDY AR, 1995, CANC RES S, V54, P1999; KENNEDY AR, 1993, PROTEASE INHIBITORS, P9; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; KOPP F, 1986, BIOCHIM BIOPHYS ACTA, V872, P253, DOI 10.1016/0167-4838(86)90278-5; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li SX, 2004, J BIOL PHYS, V30, P313, DOI 10.1007/s10867-004-0997-z; Liang L, 2004, LANGMUIR, V20, P3333, DOI 10.1021/la035844l; Libich DS, 2003, PROTEIN SCI, V12, P1507, DOI 10.1110/ps.0303603; Loidl G, 1999, P NATL ACAD SCI USA, V96, P5418, DOI 10.1073/pnas.96.10.5418; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; McBride JD, 2001, CURR MED CHEM, V8, P909, DOI 10.2174/0929867013372832; Mello MO, 2003, MOL PHYLOGENET EVOL, V27, P103, DOI 10.1016/S1055-7903(02)00373-1; MESSINA M, 1991, JNCI-J NATL CANCER I, V83, P541, DOI 10.1093/jnci/83.8.541; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; MORHY L, 1987, AN ACAD BRAS CIENC, V59, P71; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; PEREIRA MEF, 1996, J BIOL CHEM, V271, P16455; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Richardson MJ., 1991, METHODS PLANT BIOCH, P259; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; Silva LP, 2005, PROTEINS, V61, P642, DOI 10.1002/prot.20646; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tardioli S, 2010, J COLLOID INTERF SCI, V347, P96, DOI 10.1016/j.jcis.2010.03.017; Thomas AR, 2002, BIOL CHEM, V383, P1267, DOI 10.1515/BC.2002.141; VENTURA MM, 1966, AN ACAD BRAS CIENC, V38, P553; VENTURA MM, 1975, AN ACAD BRAS CIENC, V47, P335; VENTURA MM, 1981, AN ACAD BRAS CIENC, V53, P195; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wehenkel M, 2012, BRIT J CANCER, V107, P53, DOI 10.1038/bjc.2012.243; Xavier Filho J., 1988, Comments of Agriculture and Food Chemistry, V1, P239; YOSHIMURA T, 1993, J STRUCT BIOL, V111, P200, DOI 10.1006/jsbi.1993.1050	99	34	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86600	10.1371/journal.pone.0086600	http://dx.doi.org/10.1371/journal.pone.0086600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475156	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300092
J	Tamers, SL; Okechukwu, C; Bohl, AA; Gueguen, A; Goldberg, M; Zins, M				Tamers, Sara L.; Okechukwu, Cassandra; Bohl, Alex A.; Gueguen, Alice; Goldberg, Marcel; Zins, Marie			The Impact of Stressful Life Events on Excessive Alcohol Consumption in the French Population: Findings from the GAZEL Cohort Study	PLOS ONE			English	Article							GENDER-DIFFERENCES; DRINKING BEHAVIOR; USE TRAJECTORIES; UNITED-STATES; OLDER WOMEN; ADULTS; PATTERNS; DEATH; STYLE; U.S.	Background: Major life changes may play a causative role in health through lifestyle factors, such as alcohol. The objective was to examine the impact of stressful life events on heavy alcohol consumption among French adults. Methods: Trajectories of excessive alcohol consumption in 20,625 employees of the French national gas and electricity company for up to 5 years before and 5 years after an event, with annual measurements from 1992. We used repeated measures analysis of time series data indexed to events, employing generalized estimating equations. Results: For women, excessive alcohol use increased before important purchase (p = 0.021), children leaving home (p<0.001), and death of loved ones (p = 0.03), and decreased before widowhood (p = 0.015); in the year straddling the event, increased consumption was observed for important purchase (p = 0.018) and retirement (p = 0.002); at the time of the event, consumption decreased for marriage (p = 0.002), divorce, widowhood, and death of loved one (all p<0.001), and increased for retirement (p = 0.035). For men, heavy alcohol consumption increased in the years up to and surrounding the death of loved ones, retirement, and important purchase (all p<0.001), and decreased after (all p<0.001, except death of loved one: p = 0.006); at the time of the event, consumption decreased for all events except for children leaving home and retirement, where we observed an increase (all p<0.001). For women and men, heavy alcohol consumption decreased prior to marriage and divorce and increased after (all p<0.001, except for women and marriage: p = 0.01). Conclusion: Stressful life events promote healthy and unhealthy alcohol consumption. Certain events impact alcohol intake temporarily while others have longer-term implications. Research should disentangle women's and men's distinct perceptions of events over time.	[Tamers, Sara L.; Okechukwu, Cassandra] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Tamers, Sara L.] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Bohl, Alex A.] Mathemat Policy Res, Cambridge, MA USA; [Gueguen, Alice; Goldberg, Marcel; Zins, Marie] Ctr Res Epidemiol & Populat Hlth, INSERM, UMRS 1018, Villejuif, France; [Gueguen, Alice; Goldberg, Marcel; Zins, Marie] Univ Versailles St Quentin, Versailles, France	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Mathematica; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Tamers, SL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	stamers@post.harvard.edu	Goldberg, Marcel/I-7834-2012; Zins, Marie/AAX-6551-2021	Goldberg, Marcel/0000-0002-6161-5880; 	EDF-GDF, l'INSERM, l'Association de la Recherche sur le Cancer, la Fondation de France, le Ministere de la Sante; NIH/NCI Harvard Education Program in Cancer Prevention [R25 CA057713]; NIH/NCI Reducing Social Disparities in Cancer Risk [K05 CA108663-05]; NATIONAL CANCER INSTITUTE [K05CA108663] Funding Source: NIH RePORTER	EDF-GDF, l'INSERM, l'Association de la Recherche sur le Cancer, la Fondation de France, le Ministere de la Sante; NIH/NCI Harvard Education Program in Cancer Prevention; NIH/NCI Reducing Social Disparities in Cancer Risk; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the EDF-GDF, l'INSERM, l'Association de la Recherche sur le Cancer, la Fondation de France, le Ministere de la Sante, the NIH/NCI Harvard Education Program in Cancer Prevention (R25 CA057713; PI: Glorian Sorensen, PhD), and the NIH/NCI Reducing Social Disparities in Cancer Risk (K05 CA108663-05 to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MIN EMPL SOL HAUT CO; Baumeister R.F., 2001, REV GEN PSYCHOL, V5; Bobo JK, 2011, INT J ENV RES PUB HE, V8, P3263, DOI 10.3390/ijerph8083263; Bobo JK, 2010, J AM GERIATR SOC, V58, P2375, DOI 10.1111/j.1532-5415.2010.03180.x; BORLAND DC, 1982, J MARRIAGE FAM, V44, P117, DOI 10.2307/351267; Brennan PL, 1999, ADDICTION, V94, P737, DOI 10.1046/j.1360-0443.1999.94573712.x; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; COLE G, 1990, PSYCHOL REP, V67, P587, DOI 10.2466/PR0.67.6.587-591; Com-Ruelle L, 2008, QUESTIONS EC SANTE A; Corrao G, 1991, Epidemiol Prev, V13, P45; CURLEE J, 1969, B MENNINGER CLIN, V33, P165; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; Dawson DA, 2007, J STUD ALCOHOL DRUGS, V68, P66, DOI 10.15288/jsad.2007.68.66; Ferreira MP, 2008, J AM DIET ASSOC, V108, P1668, DOI 10.1016/j.jada.2008.07.011; FISCHER HK, 1964, PSYCHOSOMATICS, V5, P280; Frederick S., 1999, HEDONIC ADAPTATION; Fredrickson BL, 2005, AM PSYCHOL, V60, P678, DOI 10.1037/0003-066X.60.7.678; GLASS TA, 1995, J GERONTOL B-PSYCHOL, V50, pS205, DOI 10.1093/geronb/50B.4.S205; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Graham D, 1963, PSYCHOL BASIS MED PR; GREENE WA, 1954, PSYCHOSOM MED, V16, P220, DOI 10.1097/00006842-195405000-00004; Guilbert P, 2007, BAROMETRE SANTE 2005; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P899; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hussong AM, 2003, ADDICT BEHAV, V28, P1515, DOI 10.1016/S0306-4603(03)00072-8; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Keyes KM, 2011, PSYCHOPHARMACOLOGY, V218, P1, DOI 10.1007/s00213-011-2236-1; King AC, 2003, ADDICT BEHAV, V28, P171, DOI 10.1016/S0306-4603(01)00264-7; KLATSKY AL, 1992, ANN INTERN MED, V117, P646, DOI 10.7326/0003-4819-117-8-646; Larsen RJ, 2008, REGULATION EMOTIONAL; Lief A., 1948, COMMONSENSE PSYCHIAT; Luhmann M, 2012, J PERS SOC PSYCHOL, V102, P592, DOI 10.1037/a0025948; Merrick EL, 2008, J AM GERIATR SOC, V56, P214, DOI 10.1111/j.1532-5415.2007.01539.x; Meyer IH, 2003, AM J PUBLIC HEALTH, V93, P262, DOI 10.2105/AJPH.93.2.262; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moos RH, 2011, ADDICTION, V106, P324, DOI 10.1111/j.1360-0443.2010.03115.x; Perreira KM, 2001, J STUD ALCOHOL, V62, P501, DOI 10.15288/jsa.2001.62.501; Platt A, 2010, J STUD ALCOHOL DRUGS, V71, P169, DOI 10.15288/jsad.2010.71.169; POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x; POST RM, 1992, AM J PSYCHIAT, V149, P999; RAHE RH, 1967, J PSYCHOSOM RES, V10, P355, DOI 10.1016/0022-3999(67)90072-4; RAHE RH, 1964, J PSYCHOSOM RES, V8, P35, DOI 10.1016/0022-3999(64)90020-0; RAHE RH, 1980, J HUM STRESS, V6, P22, DOI 10.1080/0097840X.1980.9936104; RAHE RH, 1966, PSYCHOSOM MED, V28, P181, DOI 10.1097/00006842-196603000-00008; ROMELSJO A, 1991, BRIT J ADDICT, V86, P157; Ross A, 2012, CANC NURS; Shah SM, 2013, AM J PUBLIC HEALTH, V103, P1140, DOI 10.2105/AJPH.2012.301050; Shaw BA, 2011, J STUD ALCOHOL DRUGS, V72, P917, DOI 10.15288/jsad.2011.72.917; StataCorp, 2007, STAT STAT SOFTW REL; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Turner RJ, 1997, CHECKLIST MEASUREMEN; UMBERSON D, 1994, AM SOCIOL REV, V59, P152, DOI 10.2307/2096138; Vahtera J, 2009, SLEEP, V32, P1459, DOI 10.1093/sleep/32.11.1459; VANRUYVEN M, 1993, ALCOHOL ALCOHOLISM, V28, P599; Veenstra MY, 2006, ALCOHOL ALCOHOLISM, V41, P455, DOI 10.1093/alcalc/agl023; Virtanen P, 2008, EUR J PUBLIC HEALTH, V18, P504, DOI 10.1093/eurpub/ckn037; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1; WOLFF HG, 1950, LIFE STRESS BODILY D; World Health Organization, 2000, INT GUID MON ALC CON; Zins M, 2003, J STUD ALCOHOL, V64, P784, DOI 10.15288/jsa.2003.64.784; Zins M, 1999, ADDICTION, V94, P385, DOI 10.1046/j.1360-0443.1999.9433858.x; Zins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026531; Zins M, 2009, ADV LIFE COURSE RES, V14, P135, DOI 10.1016/j.alcr.2010.02.003	63	28	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87653	10.1371/journal.pone.0087653	http://dx.doi.org/10.1371/journal.pone.0087653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475318	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300210
J	Wang, D; Zhong, X; Huang, DJ; Chen, R; Bai, GB; Li, Q; Yu, BL; Fan, Y; Sun, XF				Wang, Ding; Zhong, Xuan; Huang, Dongjian; Chen, Rui; Bai, Guibin; Li, Qing; Yu, Bolan; Fan, Yong; Sun, Xiaofang			Functional Polymorphisms of Interferon-gamma Affect Pneumonia-Induced Sepsis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; IFN-GAMMA; HEPATITIS-C; ORGAN FAILURE; RECEPTOR DEFICIENCY; GENE POLYMORPHISMS; INNATE RESISTANCE; SEPTIC SHOCK; NK-CELLS; T-CELLS	Objective: Sepsis is an inflammatory syndrome caused by infection, and both its incidence and mortality are high. Because interferon-gamma (IFN-gamma) plays an important role in inflammation, this work assessed IFN-gamma single nucleotide polymorphism (SNPs) that may be associated with sepsis. Methods: A total of 196 patients with pneumonia-induced sepsis and 213 age-and sex-matched healthy volunteers participated in our study from July 2012 to July 2013 in Guangzhou, China. Patient clinical information was collected. Clinical pathology was assessed in subgroups defined based on clinical criteria, APACHE II (acute physiology and chronic health evaluation) and SOFA (sepsis-related organ failure assessment) scores and discharge rate. Four functional SNPs, -1616T/C (rs2069705), -764G/C (rs2069707), +874A/T (rs2430561) and +3234C/T (rs2069718), were genotyped by Snapshot in both sepsis patients and healthy controls. Pearson's chi-square test or Fisher's exact test were used to analyze the distribution of the SNPs, and the probability values (P values), odds ratios (OR) and 95% confidence intervals (CIs) were calculated. Results: No mutations in the IFN-gamma -764G/C SNP were detected among the participants in our study. The +874A/T and +3234C/T SNPs were in strong linkage disequilibrium (LD) (r(2) = 0.894). The 21616 TC+TT, +874 AT+AA genotype and the TAC haplotype were significantly associated with sepsis susceptibility, while the CTT haplotype was associated with protection against sepsis incidence. Genotype of -1616 TT wasn't only protective against severity of sepsis, but also against higher APACHE II and SOFA scores as +874 AA and +3234 CC. The TAC haplotype was was protective against progression to severe sepsis either. Conclusion: Our results suggest that functional IFN-gamma SNPs and their haplotypes are associated with pneumonia-induced sepsis.	[Wang, Ding; Li, Qing; Yu, Bolan; Fan, Yong; Sun, Xiaofang] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Key Lab Reprod & Genet,Affiliated Hosp 3, Guangdong Higher Educ Inst,Expt Dept,Inst Gynecol, Guangzhou, Guangdong, Peoples R China; [Zhong, Xuan; Huang, Dongjian; Bai, Guibin] Guangzhou Med Univ, Dept Intens Care Unit, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Chen, Rui] Guangzhou Med Univ, Dept Reprod, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Wang, D (corresponding author), Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Key Lab Reprod & Genet,Affiliated Hosp 3, Guangdong Higher Educ Inst,Expt Dept,Inst Gynecol, Guangzhou, Guangdong, Peoples R China.	largestone_1984@163.com; xiaofangsun@hotmail.com			Guangdong Provincial Natural Science Foundation [S2013040012649]; Education Ministry [20134423120005]; National Natural Science Funds of China [81202604]; Department of Health of Guangdong Province for young scholars [B2012169]; Doctor startup foundation project from Guangzhou Medical University [2011C41]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Education Ministry; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Department of Health of Guangdong Province for young scholars; Doctor startup foundation project from Guangzhou Medical University	This work was supported by Guangdong Provincial Natural Science Foundation S2013040012649, the new teacher project of Education Ministry 20134423120005, the National Natural Science Funds of China 81202604, the Department of Health of Guangdong Province for young scholars B2012169, the Doctor startup foundation project from Guangzhou Medical University 2011C41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestig E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-124; Alimohammadian MH, 2007, MICROBIOL IMMUNOL, V51, P1003, DOI 10.1111/j.1348-0421.2007.tb03984.x; Ansari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027848; AYALA A, 1994, J SURG RES, V56, P579, DOI 10.1006/jsre.1994.1092; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bream JH, 2002, GENES IMMUN, V3, P165, DOI 10.1038/sj.gene.6363870; Carnaud C, 1999, J IMMUNOL, V163, P4647; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1992, IMMUNOGENETICS, V35, P378; Chang H, 2010, BLOOD CELL MOL DIS, V45, P313, DOI 10.1016/j.bcmd.2010.09.003; Chevillard C, 2003, J IMMUNOL, V171, P5596, DOI 10.4049/jimmunol.171.10.5596; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; Crispim JCO, 2010, TRANSPL P, V42, P4505, DOI 10.1016/j.transproceed.2010.10.014; D'Orazio SEF, 2006, J IMMUNOL, V177, P7146, DOI 10.4049/jimmunol.177.10.7146; Dai CY, 2006, TRANSL RES, V148, P128, DOI 10.1016/j.trsl.2006.04.005; Davis RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034091; de Albuquerque AC, 2012, EUR J CLIN MICROBIOL, V31, P2887, DOI 10.1007/s10096-012-1660-4; Djawe K, 2013, CLIN INFECT DIS, V56, P74, DOI 10.1093/cid/cis841; Erdei E, 2010, CYTOKINE, V51, P18, DOI 10.1016/j.cyto.2010.03.014; ESKDALE J, 1995, IMMUNOGENETICS, V42, P444; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Gao Qiu-ju, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P324; He JR, 2012, J INFECT DIS, V205, P64, DOI 10.1093/infdis/jir710; Ho KM, 2007, ANAESTH INTENS CARE, V35, P515, DOI 10.1177/0310057X0703500409; Huang Y, 2007, P NATL ACAD SCI USA, V104, P985, DOI 10.1073/pnas.0609954104; HUNTER CA, 1995, J IMMUNOL, V155, P4347; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Kang CI, 2011, J INFECTION, V62, P26, DOI 10.1016/j.jinf.2010.10.010; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Koutsounaki E, 2008, J CLIN IMMUNOL, V28, P495, DOI 10.1007/s10875-008-9201-8; Kumar A, 2008, GENES IMMUN, V9, P294, DOI 10.1038/gene.2008.17; Lee HC, 2010, J CLIN IMMUNOL, V30, P68, DOI 10.1007/s10875-009-9330-8; Lee JY, 2001, GENES IMMUN, V2, P254, DOI 10.1038/sj.gene.6363775; Lopez-Cortes LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028115; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; MELDRUM DR, 1991, J SURG RES, V51, P158, DOI 10.1016/0022-4804(91)90088-4; Nakao F, 2001, J ALLERGY CLIN IMMUN, V107, P499, DOI 10.1067/mai.2001.113051; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Qiu G, 2001, SHOCK, V16, P425, DOI 10.1097/00024382-200116060-00004; Robinson CM, 2010, J INNATE IMMUN, V2, P56, DOI 10.1159/000247156; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shen C, 2013, MOL BIOL REP; Stassen NA, 2002, SURGERY, V132, P289, DOI 10.1067/msy.2002.127167; Su SB, 2007, INVEST OPHTH VIS SCI, V48, P4616, DOI 10.1167/iovs.07-0233; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037275; TARLOW JK, 1993, HUM GENET, V91, P403; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walley KR, 2007, CRIT CARE MED, V35, P12, DOI 10.1097/01.CCM.0000249823.44726.4E; Wang Ming, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P74; Wang XS, 2007, J INTERF CYTOK RES, V27, P599, DOI 10.1089/jir.2006.0157; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zabolotskyh I. B., 2012, Anesteziologiya i Reanimatologiya, P55	62	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87049	10.1371/journal.pone.0087049	http://dx.doi.org/10.1371/journal.pone.0087049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475220	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800081
J	Savini, A; Vertino, A; Marchese, F; Beuck, L; Freiwald, A				Savini, Alessandra; Vertino, Agostina; Marchese, Fabio; Beuck, Lydia; Freiwald, Andre			Mapping Cold-Water Coral Habitats at Different Scales within the Northern Ionian Sea (Central Mediterranean): An Assessment of Coral Coverage and Associated Vulnerability	PLOS ONE			English	Article							LOPHELIA-PERTUSA; DEEP; REEFS; PROVINCE; CLASSIFICATION; BIODIVERSITY; BIOLOGY; IMPACTS; MARGIN; CIRCULATION	In this study, we mapped the distribution of Cold-Water Coral (CWC) habitats on the northern Ionian Margin (Mediterranean Sea), with an emphasis on assessing coral coverage at various spatial scales over an area of 2,000 km(2) between 120 and 1,400 m of water depth. Our work made use of a set of data obtained from ship-based research surveys. Multi-scale seafloor mapping data, video inspections, and previous results from sediment samples were integrated and analyzed using Geographic Information System (GIS)-based tools. Results obtained from the application of spatial and textural analytical techniques to acoustic meso-scale maps (i.e. a Digital Terrain Model (DTM) of the seafloor at a 40 m grid cell size and associated terrain parameters) and large-scale maps (i.e. Side-Scan Sonar (SSS) mosaics of 1 m in resolution ground-truthed using underwater video observations) were integrated and revealed that, at the meso-scale level, the main morphological pattern (i.e. the aggregation of mound-like features) associated with CWC habitat occurrences was widespread over a total area of 600 km(2). Single coral mounds were isolated from the DTM and represented the geomorphic proxies used to model coral distributions within the investigated area. Coral mounds spanned a total area of 68 km(2) where different coral facies (characterized using video analyses and mapped on SSS mosaics) represent the dominant macro-habitat. We also mapped and classified anthropogenic threats that were identifiable within the examined videos, and, here, discuss their relationship to the mapped distribution of coral habitats and mounds. The combined results (from multi-scale habitat mapping and observations of the distribution of anthropogenic threats) provide the first quantitative assessment of CWC coverage for a Mediterranean province and document the relevant role of seafloor geomorphology in influencing habitat vulnerability to different types of human pressures.	[Savini, Alessandra; Vertino, Agostina; Marchese, Fabio; Beuck, Lydia; Freiwald, Andre] Milano Bicocca Univ, Dept Geol Sci & Geotechnol, Milan, Italy; [Savini, Alessandra; Vertino, Agostina; Marchese, Fabio; Beuck, Lydia; Freiwald, Andre] Marine Res Dept, Wilhelmshaven, Germany	University of Milano-Bicocca	Savini, A (corresponding author), Milano Bicocca Univ, Dept Geol Sci & Geotechnol, Milan, Italy.	alessandra.savini@unimib.it	Freiwald, Andre/C-2061-2018; Marchese, Fabio/AAT-9175-2020; Savini, Alessandra/C-2264-2019	Freiwald, Andre/0000-0002-2335-4042; Marchese, Fabio/0000-0001-8384-3019; Savini, Alessandra/0000-0002-5818-5947	EU [213144, GOCE-CT-2005-511234]; CoNISMa project RBAU [01RKC7_004 APLABES]; Italian Ministry of University and Research (MIUR); ESF COCARDE Network; Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany	EU(European Commission); CoNISMa project RBAU; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); ESF COCARDE Network; Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany	The data were collected and analysed within the framework of the EU FP7 project CoralFish (Ecosystem-based management of corals, fish and fisheries in the deep waters of Europe and beyond, Grant agreement number: 213144 - www.eu-fp7-coralfish.net) and the National project MAGIC (Mapping Geohazard along the Italian Coasts - www.magicproject.it). ROV video footage were collected within the framework of the CoNISMa project RBAU 01RKC7_004 APLABES (2004-2006FIRB program) and of the EU FP6 project HERMES (Hotspot Ecosystem Research on the Margins of European Seas, Contract number GOCE-CT-2005-511234). The authors' work also benefited from the RITMARE project, funded by the Italian Ministry of University and Research (MIUR), the ESF COCARDE Network, and the Hessian initiative for the development of scientific and economic excellence (LOEWE) at the Biodiversity and Climate Research Centre (BiK-F), Frankfurt, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2008, ICES J MAR SCI, V65, P1004, DOI 10.1093/icesjms/fsn061; [Anonymous], 2009, IOC MARINE SPATIAL P; Argnani A, 2001, ANN GEOFIS, V44, P527; Baker EK, 2012, ELSEV INSIGHT, P23, DOI 10.1016/B978-0-12-385140-6.00002-5; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Blondel P, 2000, INT J REMOTE SENS, V21, P3115, DOI 10.1080/01431160050144983; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Budillon G, 2010, DEEP-SEA RES PT II, V57, P441, DOI 10.1016/j.dsr2.2009.08.017; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Corselli C, 2010, DEEP SEA RES 2, V57, P345; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; D'Onghia G, 2011, MAR ECOL PROG SER, V443, P95, DOI 10.3354/meps09432; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Dundas K, 2009, 200926 GA; Munoz PD, 2012, MAR POLICY, V36, P536, DOI 10.1016/j.marpol.2011.09.005; Munoz PD, 2011, MAR POLICY, V35, P615, DOI 10.1016/j.marpol.2011.01.023; Etiope G, 2010, DEEP-SEA RES PT II, V57, P431, DOI 10.1016/j.dsr2.2009.08.020; Evans I.S., 1990, GEOMORPHOLOGICAL TEC, P44; Fabri MC, 2014, DEEP-SEA RES PT II, V104, P184, DOI 10.1016/j.dsr2.2013.06.016; FAVALI P, 1993, TECTONOPHYSICS, V219, P109, DOI 10.1016/0040-1951(93)90290-Z; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Freiwald Andre, 2004, P1; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Gao DL, 1998, J GEOPHYS RES-SOL EA, V103, P20997, DOI 10.1029/98JB00165; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; Grehan AJ, 2005, AM FISH S S, V41, P819; Guarinello ML, 2010, ENVIRON MANAGE, V45, P793, DOI 10.1007/s00267-010-9430-5; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harris PT, 2012, ELSEV INSIGHT, P39, DOI 10.1016/B978-0-12-385140-6.00003-7; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Huang Z, 2011, ECOL INFORM, V6, P205, DOI 10.1016/j.ecoinf.2011.01.001; Huehnerbach V, 2008, GEOLOGICAL ASS CANAD, P291; Huvenne VAI, 2002, MAR GEOL, V189, P323, DOI 10.1016/S0025-3227(02)00420-6; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Lo Iacono C, 2008, MAR GEOL, V250, P1, DOI 10.1016/j.margeo.2007.11.004; Lo Iacono C, 2012, ELSEV INSIGHT, P457, DOI 10.1016/B978-0-12-385140-6.00032-3; Malinverno E, 2010, DEEP-SEA RES PT II, V57, P345, DOI 10.1016/j.dsr2.2009.08.025; Manca BB, 2006, CLIM RES, V31, P239, DOI 10.3354/cr031239; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Mastrototaro F, 2013, MAR ECOL-EVOL PERSP, V34, P313, DOI 10.1111/maec.12017; Merlini S., 2000, B SOC GEOL ITAL, V119, P227; Micallef A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000505; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; Mytilineou Ch, 2013, NEW COLD WATER CORAL, DOI DOI 10.1016/J.DSR2.2013.07.007I; Orejas C, 2009, MAR ECOL PROG SER, V397, P37, DOI 10.3354/meps08314; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; REED TB, 1989, J GEOPHYS RES-SOLID, V94, P7469, DOI 10.1029/JB094iB06p07469; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Reveillaud J, 2008, FACIES, V54, P317, DOI 10.1007/s10347-008-0138-4; Riding R, 2002, EARTH-SCI REV, V58, P163, DOI 10.1016/S0012-8252(01)00089-7; Roberts JM, 2009, COLD-WATER CORALS: THE BIOLOGY AND GEOLOGY OF DEEP-SEA CORAL HABITATS, P237, DOI 10.1017/CBO9780511581588.009; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2000, HYDROBIOLOGIA, V441, P173, DOI 10.1023/A:1017550612340; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Rosso A, 2010, DEEP-SEA RES PT II, V57, P360, DOI 10.1016/j.dsr2.2009.08.024; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Sanfilippo R, 2013, FACIES, V59, P663, DOI 10.1007/s10347-012-0356-7; Savini A, 2010, DEEP-SEA RES PT II, V57, P326, DOI 10.1016/j.dsr2.2009.08.014; Savini A, 2009, MAR PETROL GEOL, V26, P1831, DOI 10.1016/j.marpetgeo.2009.04.003; Savini A, 2004, THESIS U MILANO BICO; Schembri PJ, 2007, CAH BIOL MAR, V48, P77; Taviani M, 2005, FACIES, V50, P409, DOI 10.1007/s10347-004-0039-0; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wood J., 1996, GEOMORPHOLOGICAL CHA; Yoklavich MM, 2000, FISH B-NOAA, V98, P625	81	60	61	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87108	10.1371/journal.pone.0087108	http://dx.doi.org/10.1371/journal.pone.0087108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466332	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000192
J	Sugawara, N; Yasui-Furukori, N; Yamazaki, M; Shimoda, K; Mori, T; Sugai, T; Suzuki, Y; Someya, T				Sugawara, Norio; Yasui-Furukori, Norio; Yamazaki, Manabu; Shimoda, Kazutaka; Mori, Takao; Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki			Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia	PLOS ONE			English	Article							ANTIPSYCHOTIC MEDICATIONS; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; WEIGHT-GAIN; GLUCOSE; PHARMACOTHERAPY; RISPERIDONE; PREVALENCE; OLANZAPINE; INPATIENTS	Background: There is growing concern about the metabolic abnormalities in patients with schizophrenia. Aims: The aim of this study was to assess the attitudes of psychiatrists toward metabolic adverse events in patients with schizophrenia. Method: A brief questionnaire was constructed to cover the following broad areas: the psychiatrists' recognition of the metabolic risk of antipsychotic therapy, pattern of monitoring patients for physical risks, practice pattern for physical risks, and knowledge of metabolic disturbance. In March 2012, the questionnaire was mailed to 8,482 psychiatrists who were working at hospitals belonging to the Japan Psychiatric Hospitals Association. Results: The overall response rate was 2,583/8,482 (30.5%). Of the respondents, 85.2% (2,200/2,581) reported that they were concerned about prescribing antipsychotics that have a risk of elevating blood sugar; 47.6% (1,201/2,524) stated that their frequency of monitoring patients under antipsychotic treatment was based on their own experiences; and only 20.6% (5,22/2,534) of respondents answered that the frequency with which they monitored their patients was sufficient to reduce the metabolic risks. Conclusions: Psychiatrists practicing in Japan were generally aware and concerned about the metabolic risks for patients being treated with antipsychotics. Although psychiatrists should monitor their patients for metabolic abnormalities to balance these risks, a limited number of psychiatrists answered that the frequency with which they monitored patients to reduce the metabolic risks was sufficient. Promotion of the best practices of pharmacotherapy and monitoring is needed for psychiatrists treating patients with schizophrenia.	[Sugawara, Norio; Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Sugawara, Norio; Yasui-Furukori, Norio; Shimoda, Kazutaka; Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki] Japanese Soc Clin Neuropsychopharmacol, Tokyo, Japan; [Yamazaki, Manabu; Mori, Takao] Japan Psychiat Hosp Assoc, Tokyo, Japan; [Shimoda, Kazutaka] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan; [Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan	Hirosaki University; Dokkyo Medical University; Niigata University	Sugawara, N (corresponding author), Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan.	nsuga3@yahoo.co.jp	Someya, Toshiyuki/ABD-1878-2021		Eisai Co., Ltd.; Yoshitomi Pharmaceutical Industries, Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Astellas Pharma Inc.; Meiji Seika Pharma Co., Ltd.; Eli Lilly Japan, K.K.; Otsuka Pharmaceutical Co., Ltd.; GlaxoSmithKelin K.K.; Janssen Pharmaceutical K.K.; MSD K.K.; Shionogi Co., Ltd.; Asahi Kasei Pharma Corporation; Novartis Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Tsumura Co.	Eisai Co., Ltd.(Eisai Co Ltd); Yoshitomi Pharmaceutical Industries, Ltd.; Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Astellas Pharma Inc.(Astellas Pharmaceuticals); Meiji Seika Pharma Co., Ltd.; Eli Lilly Japan, K.K.(Eli Lilly); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); GlaxoSmithKelin K.K.; Janssen Pharmaceutical K.K.; MSD K.K.(Merck & Company); Shionogi Co., Ltd.; Asahi Kasei Pharma Corporation; Novartis Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd); Tsumura Co.(Tsumura & Company)	This work was partially supported by Eisai Co., Ltd., Yoshitomi Pharmaceutical Industries, Ltd., Dainippon Sumitomo Pharma Co., Ltd., Astellas Pharma Inc., Meiji Seika Pharma Co., Ltd., Eli Lilly Japan, K.K., Otsuka Pharmaceutical Co., Ltd., GlaxoSmithKelin K.K., Janssen Pharmaceutical K.K., MSD K.K., Shionogi & Co., Ltd., Asahi Kasei Pharma Corporation, Novartis Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Tsumura & Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobes J, 2007, SCHIZOPHR RES, V90, P162, DOI 10.1016/j.schres.2006.09.025; Buckley PF, 2005, SCHIZOPHR RES, V79, P281, DOI 10.1016/j.schres.2005.04.010; Chaggar PS, 2011, J CLIN PHARMACOL, V51, P631, DOI 10.1177/0091270010368678; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Ketter TA, 2006, CURR MED RES OPIN, V22, P2345, DOI 10.1185/030079906X148616; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Meagher DJ, 2010, INT PSYCHOGERIATR, V22, P938, DOI 10.1017/S1041610210000475; Meyer JM, 2002, J CLIN PSYCHIAT, V63, P425, DOI 10.4088/JCP.v63n0509; Meyer JM, 2005, SCHIZOPHR RES, V80, P9, DOI 10.1016/j.schres.2005.07.015; Nasrallah Henry A, 2004, J Clin Psychopharmacol, V24, pS7, DOI 10.1097/01.jcp.0000142282.62336.e9; Newcomer John W, 2004, J Clin Psychopharmacol, V24, pS1, DOI 10.1097/01.jcp.0000142281.85207.d5; Oshima I, 2007, PSYCHIAT CLIN NEUROS, V61, P71, DOI 10.1111/j.1440-1819.2007.01613.x; Sharp Lisa K, 2002, J Contin Educ Health Prof, V22, P103; Statistics and Information Department Minister's Secretariat, 2008, PAT SURV; Sugai T, 2012, J CLIN PSYCHOPHARM, V32, P390, DOI 10.1097/JCP.0b013e3182524393; Sugawara N, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-21; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Suzuki Y, 2013, HUM PSYCHOPHARM CLIN, V28, P188, DOI 10.1002/hup.2295; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yasui-Furukori N, 2009, J CLIN PSYCHIAT, V70, P95, DOI 10.4088/JCP.07m03829	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86826	10.1371/journal.pone.0086826	http://dx.doi.org/10.1371/journal.pone.0086826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466260	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000153
J	Lalanza, JF; Caimari, A; del Bas, JM; Torregrosa, D; Cigarroa, I; Pallas, M; Capdevila, L; Arola, L; Escorihuela, RM				Lalanza, Jaume F.; Caimari, Antoni; del Bas, Josep M.; Torregrosa, Daniel; Cigarroa, Igor; Pallas, Merce; Capdevila, Lluis; Arola, Lluis; Escorihuela, Rosa M.			Effects of a Post-Weaning Cafeteria Diet in Young Rats: Metabolic Syndrome, Reduced Activity and Low Anxiety-Like Behaviour	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; HIGH-FAT DIET; PALATABLE DIET; ENVIRONMENTAL ENRICHMENT; SOCIAL-INTERACTION; CHRONIC STRESS; OBESITY; CONSUMPTION; OVERWEIGHT; EXPRESSION	Among adolescents, overweight, obesity and metabolic syndrome are rapidly increasing in recent years as a consequence of unhealthy palatable diets. Animal models of diet-induced obesity have been developed, but little is known about the behavioural patterns produced by the consumption of such diets. The aim of the present study was to determine the behavioural and biochemical effects of a cafeteria diet fed to juvenile male and female rats, as well as to evaluate the possible recovery from these effects by administering standard feeding during the last week of the study. Two groups of male and female rats were fed with either a standard chow diet (ST) or a cafeteria (CAF) diet from weaning and for 8 weeks. A third group of males (CAF withdrawal) was fed with the CAF diet for 7 weeks and the ST in the 8th week. Both males and females developed metabolic syndrome as a consequence of the CAF feeding, showing overweight, higher adiposity and liver weight, increased plasma levels of glucose, insulin and triglycerides, as well as insulin resistance, in comparison with their respective controls. The CAF diet reduced motor activity in all behavioural tests, enhanced exploration, reduced anxiety-like behaviour and increased social interaction; this last effect was more pronounced in females than in males. When compared to animals only fed with a CAF diet, CAF withdrawal increased anxiety in the open field, slightly decreased body weight, and completely recovered the liver weight, insulin sensitivity and the standard levels of glucose, insulin and triglycerides in plasma. In conclusion, a CAF diet fed to young animals for 8 weeks induced obesity and metabolic syndrome, and produced robust behavioural changes in young adult rats, whereas CAF withdrawal in the last week modestly increased anxiety, reversed the metabolic alterations and partially reduced overweight.	[Lalanza, Jaume F.; Torregrosa, Daniel; Cigarroa, Igor; Escorihuela, Rosa M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain; [Lalanza, Jaume F.; Capdevila, Lluis] Univ Autonoma Barcelona, Dept Psicol Basica, Lab Psicol Esport, E-08193 Barcelona, Spain; [Caimari, Antoni; del Bas, Josep M.; Arola, Lluis] CEICS, TECNIO, CTNS, Reus, Spain; [Cigarroa, Igor] Univ Santo Tomas, Fac Salud, Santiago, Chile; [Pallas, Merce] Univ Barcelona, Fac Farm, Inst Biomed, Seccio Farmacol & Farmacognosia, E-08028 Barcelona, Spain; [Pallas, Merce] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Arola, Lluis] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Bioquim & Biotecnol, E-43007 Tarragona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Universidad Santo Tomas; University of Barcelona; CIBERNED; Universitat Rovira i Virgili	Escorihuela, RM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain.	rosamaria.escorihuela@uab.cat	cigarroa, igor/AAV-3527-2020; del Bas, Josep M/K-2327-2014; Escorihuela, Rosa M/L-4524-2014; Capdevila, Lluis/I-2530-2015; F. Lalanza, Jaume/C-9186-2011; del Bas, Josep Maria/K-9310-2019; Arola, Lluís/C-6074-2011; Pallas, Merce/H-3129-2016	cigarroa, igor/0000-0003-0418-8787; del Bas, Josep M/0000-0002-0700-2004; Escorihuela, Rosa M/0000-0001-9368-5173; Capdevila, Lluis/0000-0002-7319-4745; F. Lalanza, Jaume/0000-0003-2481-2188; del Bas, Josep Maria/0000-0002-0700-2004; Arola, Lluís/0000-0003-2767-1974; Pallas, Merce/0000-0003-3095-4254; Caimari, Antoni/0000-0001-6144-0294	Spanish Ministry of Economy and Competitiveness [PSI 2011-29807-C02/PSIC]; ACC1O [TECRD11-1-0012]; European Union [244995]; Generalitat de Catalunya [FI-DGR 2011]; Universidad Santo Tomas de Chile	Spanish Ministry of Economy and Competitiveness(Spanish Government); ACC1O; European Union(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Universidad Santo Tomas de Chile	The research leading to these results has received funding from the Spanish Ministry of Economy and Competitiveness (PSI 2011-29807-C02/PSIC), ACC1O (TECRD11-1-0012) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement nu 244995 (BIOCLAIMS Project). JFL received a fellowship from the Generalitat de Catalunya (FI-DGR 2011) and IC received a fellowship from the Universidad Santo Tomas de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsio J, 2009, GENES BRAIN BEHAV, V8, P193, DOI 10.1111/j.1601-183X.2008.00464.x; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Bennett J, 2013, APPETITE, V60, P187, DOI 10.1016/j.appet.2012.09.023; Benton D, 2010, CLIN NUTR, V29, P288, DOI 10.1016/j.clnu.2009.12.001; Buchenauer T, 2009, PHYSIOL BEHAV, V98, P563, DOI 10.1016/j.physbeh.2009.09.003; Caimari A, 2010, INT J OBESITY, V34, P831, DOI 10.1038/ijo.2010.17; Canetti L, 2002, BEHAV PROCESS, V60, P157, DOI 10.1016/S0376-6357(02)00082-7; Cooper SJ, 2005, APPETITE, V44, P133, DOI 10.1016/j.appet.2005.01.003; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P225, DOI 10.1016/S0091-3057(02)00784-0; FILE SE, 1980, J NEUROSCI METH, V2, P219, DOI 10.1016/0165-0270(80)90012-6; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Iemolo A, 2013, NEUROPSYCHOPHARMACOL, V38, P2456, DOI 10.1038/npp.2013.147; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Krolow R, 2010, APPETITE, V55, P108, DOI 10.1016/j.appet.2010.03.013; Krolow R, 2013, METABOLISM, V62, P1268, DOI 10.1016/j.metabol.2013.04.009; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Martire SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060407; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mela V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048915; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ong ZY, 2013, APPETITE, V65, P189, DOI 10.1016/j.appet.2013.01.014; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Pickering C, 2009, PSYCHOPHARMACOLOGY, V204, P431, DOI 10.1007/s00213-009-1474-y; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Quesada H, 2009, INT J OBESITY, V33, P1007, DOI 10.1038/ijo.2009.136; Ribot J, 2008, OBESITY, V16, P723, DOI 10.1038/oby.2008.113; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Ros-Simo C, 2012, PHARMACOL BIOCHEM BE, V102, P434, DOI 10.1016/j.pbb.2012.06.001; Sagae SC, 2012, PHYSIOL BEHAV, V105, P1104, DOI 10.1016/j.physbeh.2011.12.002; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Shafat A, 2009, APPETITE, V52, P34, DOI 10.1016/j.appet.2008.07.004; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; van Vliet M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-106; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zeeni N, 2013, STRESS, V16, P211, DOI 10.3109/10253890.2012.708952	55	62	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85049	10.1371/journal.pone.0085049	http://dx.doi.org/10.1371/journal.pone.0085049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24482678	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100052
J	Rabi, R; Minda, JP				Rabi, Rahel; Minda, John Paul			Rule-Based Category Learning in Children: The Role of Age and Executive Functioning	PLOS ONE			English	Article							WORKING-MEMORY; INHIBITORY CONTROL; TASK INTERFERENCE; CATEGORIZATION	Rule-based category learning was examined in 4-11 year-olds and adults. Participants were asked to learn a set of novel perceptual categories in a classification learning task. Categorization performance improved with age, with younger children showing the strongest rule-based deficit relative to older children and adults. Model-based analyses provided insight regarding the type of strategy being used to solve the categorization task, demonstrating that the use of the task appropriate strategy increased with age. When children and adults who identified the correct categorization rule were compared, the performance deficit was no longer evident. Executive functions were also measured. While both working memory and inhibitory control were related to rule-based categorization and improved with age, working memory specifically was found to marginally mediate the age-related improvements in categorization. When analyses focused only on the sample of children, results showed that working memory ability and inhibitory control were associated with categorization performance and strategy use. The current findings track changes in categorization performance across childhood, demonstrating at which points performance begins to mature and resemble that of adults. Additionally, findings highlight the potential role that working memory and inhibitory control may play in rule-based category learning.	[Rabi, Rahel; Minda, John Paul] Univ Western Ontario, Dept Psychol, Cognit & Percept Program, London, ON, Canada	Western University (University of Western Ontario)	Rabi, R (corresponding author), Univ Western Ontario, Dept Psychol, Cognit & Percept Program, London, ON, Canada.	rrabi@uwo.ca	Minda, John Paul/O-9083-2017; Rabi, Rahel/AAF-1963-2021	Minda, John Paul/0000-0002-4081-010X; 	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an NSERC award to RR. (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ashby F.G., 1992, MULTIVARIATE PROBABI; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Bayliss DM, 2005, DEV PSYCHOL, V41, P579, DOI 10.1037/0012-1649.41.4.579; Berlin L, 2002, J CLIN CHILD ADOLESC, V31, P242, DOI 10.1207/S15374424JCCP3102_09; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bunge SA, 2006, CURR DIR PSYCHOL SCI, V15, P118, DOI 10.1111/j.0963-7214.2006.00419.x; Carver AC, 2001, INT J NEUROSCI, V107, P43, DOI 10.3109/00207450109149756; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Hayes BK, 2003, COGNITION, V88, P171, DOI 10.1016/S0010-0277(03)00021-0; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Huang-Pollock CL, 2011, J EXP CHILD PSYCHOL, V109, P321, DOI 10.1016/j.jecp.2011.02.002; Lewandowsky S, 2011, J EXP PSYCHOL LEARN, V37, P720, DOI 10.1037/a0022639; Lindqvist S, 2009, CHILD NEUROPSYCHOL, V15, P1, DOI 10.1080/09297040701793647; Maddox WT, 2010, NEUROPSYCHOLOGIA, V48, P2998, DOI 10.1016/j.neuropsychologia.2010.06.008; MADDOX WT, 1993, PERCEPT PSYCHOPHYS, V53, P49, DOI 10.3758/BF03211715; Miles SJ, 2011, J EXP PSYCHOL LEARN, V37, P588, DOI 10.1037/a0022309; Minda JP, 2008, J EXP PSYCHOL LEARN, V34, P1518, DOI 10.1037/a0013355; Minda JP, 2001, J EXP PSYCHOL LEARN, V27, P775, DOI 10.1037//0278-7393.27.3.775; Mueller S. T, 2010, PSYCHOL EXPT BUILDIN; Murphy G. L., 2002, BIG BOOK CONCEPTS; Muthen B., 2010, MPLUS USERS GUIDE; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Sloutsky VM, 2004, J EXP PSYCHOL GEN, V133, P166, DOI 10.1037/0096-3445.133.2.166; Smith JD, 2004, J EXP PSYCHOL GEN, V133, P398, DOI 10.1037/0096-3445.133.3.398; Takane Y, 1992, STRUCTURE STIMULUS I; Visser I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00073; Waldron EM, 2001, PSYCHON B REV, V8, P168, DOI 10.3758/BF03196154; Wechsler D., 1997, WECHSLER ADULT INTEL; Wickens T. D., 1982, MODELS BEHAV STOCHAS; Zeithamova D, 2006, MEM COGNITION, V34, P387, DOI 10.3758/BF03193416	37	27	29	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85316	10.1371/journal.pone.0085316	http://dx.doi.org/10.1371/journal.pone.0085316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489658	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000010
J	Chen, CA; Lu, MY; Peng, SF; Lin, KH; Chang, HH; Yang, YL; Jou, ST; Lin, DT; Liu, YB; Horng, HE; Yang, HC; Wang, JK; Wu, MH; Wu, CC				Chen, Chun-An; Lu, Meng-Yao; Peng, Shinn-Forng; Lin, Kai-Hsin; Chang, Hsiu-Hao; Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Liu, Yen-Bin; Horng, Herng-Er; Yang, Hong-Chang; Wang, Jou-Kou; Wu, Mei-Hwan; Wu, Chau-Chung			Spatial Repolarization Heterogeneity Detected by Magnetocardiography Correlates with Cardiac Iron Overload and Adverse Cardiac Events in Beta-Thalassemia Major	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE; MYOCARDIAL IRON; QT DISPERSION; FETAL ARRHYTHMIAS; HEART-DISEASE; LONG QT; DIAGNOSIS; INTERVALS; SURVIVAL	Background: Patients with transfusion-dependent beta-thalassemia major (TM) are at risk for myocardial iron overload and cardiac complications. Spatial repolarization heterogeneity is known to be elevated in patients with certain cardiac diseases, but little is known in TM patients. The purpose of this study was to evaluate spatial repolarization heterogeneity in patients with TM, and to investigate the relationships between spatial repolarization heterogeneity, cardiac iron load, and adverse cardiac events. Methods and Results: Fifty patients with TM and 55 control subjects received 64-channel magnetocardiography (MCG) to determine spatial repolarization heterogeneity, which was evaluated by a smoothness index of QT(c) (SI-QT(c)), a standard deviation of QT(c) (SD-QT(c)), and a QT(c) dispersion. Left ventricular function and myocardial T2* values were assessed by cardiac magnetic resonance. Patients with TM had significantly greater SI-QT(c), SD-QT(c), and QT(c) dispersion compared to the control subjects (all p values<0.001). Spatial repolarization heterogeneity was even more pronounced in patients with significant iron overload (T2*<20 ms, n = 20) compared to those with normal T2* (all p values<0.001). Log(e) cardiac T2* correlated with SI-QT(c) (r = -0.609, p<0.001), SD-QT(c) (r = -0.572, p<0.001), and QT(c) dispersion (r = -0.622, p<0.001), while all these indices had no relationship with measurements of the left ventricular geometry or function. At the time of study, 10 patients had either heart failure or arrhythmia. All 3 indices of repolarization heterogeneity were related to the presence of adverse cardiac events, with areas under the receiver operating characteristic curves (ranged between 0.79 and 0.86), similar to that of cardiac T2*. Conclusions: Multichannel MCG demonstrated that patients with TM had increased spatial repolarization heterogeneity, which is related to myocardial iron load and adverse cardiac events.	[Chen, Chun-An; Lu, Meng-Yao; Lin, Kai-Hsin; Chang, Hsiu-Hao; Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Wang, Jou-Kou; Wu, Mei-Hwan] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Peng, Shinn-Forng] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Liu, Yen-Bin; Wu, Chau-Chung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Horng, Herng-Er] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan; [Yang, Hong-Chang] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan Normal University; National Taiwan University	Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	chauchungwu@ntu.edu.tw	Lin, Kuosui/F-7945-2011; Chen, Chun-An/AAR-5054-2021	Lin, Kuosui/0000-0003-2917-5261; CHANG, HSIU-HAO/0000-0003-1832-8509; YANG, YUNG-LI/0000-0002-3598-7218; LIN, DONG-TSAMN/0000-0002-5773-3200; CHEN, CHUN-AN/0000-0001-8880-7113; LU, MENG-YAO/0000-0003-4461-9967; LIN, KAI-HSIN/0000-0002-5833-7066; PENG, STEVEN SHINN-FORNG/0000-0002-8177-5187; WU, MEI-HWAN/0000-0002-7074-8087; JOU, SHIANN-TANG/0000-0003-1483-0403; Wang, Jou-Kou/0000-0002-3043-3873	National Science Council, Taiwan [NSC 99-2314-B-002-021-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (NSC 99-2314-B-002-021-MY3) from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Antzelevitch C, 2006, J INTERN MED, V259, P48, DOI 10.1111/j.1365-2796.2005.01587.x; ARNETT EN, 1975, AM HEART J, V90, P777, DOI 10.1016/0002-8703(75)90469-X; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; Bartfay WJ, 1999, CARDIOVASC RES, V43, P892, DOI 10.1016/S0008-6363(99)00040-1; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3; Buxton AE, 2006, CIRCULATION, V114, P2534, DOI 10.1161/CIRCULATIONAHA.106.180199; Chen CA, 2012, INT J CARDIOL; Chern JPS, 2007, PEDIATR BLOOD CANCER, V48, P550, DOI 10.1002/pbc.21028; Comani S, 2004, PACE, V27, P1647, DOI 10.1111/j.1540-8159.2004.00699.x; Davis BA, 2004, BLOOD, V104, P263, DOI 10.1182/blood-2003-08-2841; DAY CP, 1990, BRIT HEART J, V63, P342; Fenici R, 2013, INT J CARDIOL; Gapelyuk A, 2007, J ELECTROCARDIOL, V40, P401, DOI 10.1016/j.jelectrocard.2007.03.013; Ghugre NR, 2006, MAGN RESON MED, V56, P681, DOI 10.1002/mrm.20981; Hailer B, 1999, J ELECTROCARDIOL, V32, P207, DOI 10.1016/S1053-0770(99)90061-7; Kayrak Mehmet, 2012, Adv Hematol, V2012, P170510, DOI 10.1155/2012/170510; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kuryshev YA, 1999, CIRCULATION, V100, P675, DOI 10.1161/01.CIR.100.6.675; Kwong JS, 2013, INT J CARDIOL; Laurita KR, 2003, J LAB CLIN MED, V142, P83, DOI 10.1016/S0022-2143(03)00060-X; Lee YH, 2006, SUPERCOND SCI TECH, V19, pS284, DOI 10.1088/0953-2048/19/5/S25; Lim HK, 2009, AM J CARDIOL, V103, P448, DOI 10.1016/j.amjcard.2008.10.013; LINK G, 1989, J LAB CLIN MED, V113, P103; LOWN B, 1979, AM J CARDIOL, V43, P313, DOI 10.1016/S0002-9149(79)80021-1; Lu MY, 2013, TRANSFUSION MED, V23, P100, DOI 10.1111/tme.12014; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Magri D, 2007, EUR J HAEMATOL, V79, P322, DOI 10.1111/j.1600-0609.2007.00921.x; METZ CE, 1984, INFORMATION PROCESSI, P432; MIRVIS DM, 1985, J AM COLL CARDIOL, V5, P625, DOI 10.1016/S0735-1097(85)80387-9; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Ogata K, 2009, PACE, V32, P516, DOI 10.1111/j.1540-8159.2009.02313.x; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; PAUL T, 1990, AM HEART J, V119, P577, DOI 10.1016/S0002-8703(05)80280-7; Positano V, 2009, NMR BIOMED, V22, P707, DOI 10.1002/nbm.1382; Qureshi N, 2005, ANN NY ACAD SCI, V1054, P476, DOI 10.1196/annals.1345.064; Rothman SA, 2007, J CARDIOVASC ELECTR, V18, P241, DOI 10.1111/j.1540-8167.2006.00729.x; Russo V, 2011, EUR J HAEMATOL, V86, P324, DOI 10.1111/j.1600-0609.2011.01579.x; SANYAL SK, 1975, PEDIATRICS, V55, P336; Schwartz KA, 2002, J APPL PHYSIOL, V93, P746, DOI 10.1152/japplphysiol.01144.2001; Sonakul D, 1988, Birth Defects Orig Artic Ser, V23, P177; Sturm R, 2004, PRENATAL DIAG, V24, P1, DOI 10.1002/pd.764; Tseng WYI, 2002, J CARDIOV MAGN RESON, V4, P443, DOI 10.1081/JCMR-120016383; Ulger Z, 2006, AM J HEMATOL, V81, P901, DOI 10.1002/ajh.20679; Van Leeuwen P, 2003, PACE, V26, P1706, DOI 10.1046/j.1460-9592.2003.t01-1-00256.x; VanLeeuwen P, 1996, PACE, V19, P1894; Westwood M, 2003, J MAGN RESON IMAGING, V18, P33, DOI 10.1002/jmri.10332; Westwood MA, 2007, J MAGN RESON IMAGING, V25, P1147, DOI 10.1002/jmri.20915; Wood JC, 2005, ANN NY ACAD SCI, V1054, P386, DOI 10.1196/annals.1345.047; Wu YW, 2013, CIRC J, V77, P1783, DOI 10.1253/circj.CJ-12-1170; Zeitz O, 2002, CIRC RES, V90, P988, DOI 10.1161/01.RES.0000018625.25212.1E	52	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86524	10.1371/journal.pone.0086524	http://dx.doi.org/10.1371/journal.pone.0086524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475137	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300075
J	Halder, S; Cotmore, S; Heimburg-Molinaro, J; Smith, DF; Cummings, RD; Chen, X; Trollope, AJ; North, SJ; Haslam, SM; Dell, A; Tattersall, P; McKenna, R; Agbandje-McKenna, M				Halder, Sujata; Cotmore, Susan; Heimburg-Molinaro, Jamie; Smith, David F.; Cummings, Richard D.; Chen, Xi; Trollope, Alana J.; North, Simon J.; Haslam, Stuart M.; Dell, Anne; Tattersall, Peter; McKenna, Robert; Agbandje-McKenna, Mavis			Profiling of Glycan Receptors for Minute Virus of Mice in Permissive Cell Lines Towards Understanding the Mechanism of Cell Recognition	PLOS ONE			English	Article							SIALIC-ACID BINDING; BOVINE PARVOVIRUS; DEPENDENT EXPRESSION; CANCER METASTASIS; TISSUE TROPISM; GENE-TRANSFER; MOUSE-BRAIN; TRANSDUCTION; STRAIN; ENTRY	The recognition of sialic acids by two strains of minute virus of mice (MVM), MVMp (prototype) and MVMi (immunosuppressive), is an essential requirement for successful infection. To understand the potential for recognition of different modifications of sialic acid by MVM, three types of capsids, virus-like particles, wild type empty (no DNA) capsids, and DNA packaged virions, were screened on a sialylated glycan microarray (SGM). Both viruses demonstrated a preference for binding to 9-O-methylated sialic acid derivatives, while MVMp showed additional binding to 9-O-acetylated and 9-O-lactoylated sialic acid derivatives, indicating recognition differences. The glycans recognized contained a type-2 Gal beta 1-4GlcNAc motif (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc or 3'SIA-LN) and were biantennary complex-type N-glycans with the exception of one. To correlate the recognition of the 3'SIA-LN glycan motif as well as the biantennary structures to their natural expression in cell lines permissive for MVMp, MVMi, or both strains, the N- and O-glycans, and polar glycolipids present in three cell lines used for in vitro studies, A9 fibroblasts, EL4 T lymphocytes, and the SV40 transformed NB324K cells, were analyzed by MALDI-TOF/TOF mass spectrometry. The cells showed an abundance of the sialylated glycan motifs recognized by the viruses in the SGM and previous glycan microarrays supporting their role in cellular recognition by MVM. Significantly, the NB324K showed fucosylation at the non-reducing end of their biantennary glycans, suggesting that recognition of these cells is possibly mediated by the Lewis X motif as in 3'SIA-Le(X) identified in a previous glycan microarray screen.	[Halder, Sujata; McKenna, Robert; Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Cotmore, Susan; Tattersall, Peter] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Heimburg-Molinaro, Jamie; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Trollope, Alana J.; North, Simon J.; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	State University System of Florida; University of Florida; Yale University; Emory University; University of California System; University of California Davis; Imperial College London	Agbandje-McKenna, M (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	mckenna@ufl.edu	Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X; Dell, Anne/0000-0003-1380-2347	National Science Foundation [MCB-0718948]; University of Florida College of Medicine Research Funds; National Institute of Health [CA029303, GM085448, GM076360]; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA029303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103694, R01GM076360, R01GM085448] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Florida College of Medicine Research Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation [MCB-0718948 to R. M. and M.A-M.], University of Florida College of Medicine Research Funds to [M.A-M.], National Institute of Health [CA029303 to S. C. and P. T., GM085448 to D. F. S., and GM076360 to X. C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbandje-McKenna M, 1998, STRUCT FOLD DES, V6, P1369, DOI 10.1016/S0969-2126(98)00137-3; Allaume X, 2012, J VIROL, V86, P3452, DOI 10.1128/JVI.06208-11; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BALLGOODRICH LJ, 1992, J VIROL, V66, P3415, DOI 10.1128/JVI.66.6.3415-3423.1992; BARBIS DP, 1992, VIROLOGY, V191, P301, DOI 10.1016/0042-6822(92)90192-R; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Blackburn SD, 2005, ARCH VIROL, V150, P1477, DOI 10.1007/s00705-005-0496-y; Boisvert M, 2010, J VIROL, V84, P7782, DOI 10.1128/JVI.00479-10; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; D'Abramo AM, 2005, VIROLOGY, V340, P143, DOI 10.1016/j.virol.2005.06.019; Di Pasquale G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009336; GARDINER EM, 1988, J VIROL, V62, P2605, DOI 10.1128/JVI.62.8.2605-2613.1988; Handa A, 2000, J GEN VIROL, V81, P2077, DOI 10.1099/0022-1317-81-8-2077; Hernando E, 2000, VIROLOGY, V267, P299, DOI 10.1006/viro.1999.0123; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; IRIMURA T, 1993, SEMIN CANCER BIOL, V4, P319; Johnson FB, 2004, J GEN VIROL, V85, P2199, DOI 10.1099/vir.0.79899-0; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kamerling Johannis P., 2006, V347, P69; Kannagi R, 2003, GLYCOCONJUGATE J, V20, P353, DOI 10.1023/B:GLYC.0000033631.35357.41; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; KIMSEY PB, 1986, J VIROL, V59, P8, DOI 10.1128/JVI.59.1.8-13.1986; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; Kontou M, 2005, J VIROL, V79, P10931, DOI 10.1128/JVI.79.17.10931-10943.2005; LINSER P, 1977, J VIROL, V24, P211, DOI 10.1128/JVI.24.1.211-221.1977; Liu F, 2001, BRIT J CANCER, V84, P1556, DOI 10.1054/bjoc.2001.1815; Lopez-Bueno A, 2006, J VIROL, V80, P1563, DOI 10.1128/JVI.80.3.1563-1573.2006; MAXWELL IH, 1995, J VIROL, V69, P5829, DOI 10.1128/JVI.69.9.5829-5832.1995; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Previsani N, 1997, J VIROL, V71, P7769, DOI 10.1128/JVI.71.10.7769-7780.1997; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Ramirez JC, 1996, J VIROL, V70, P8109; RITTER G, 1990, CANCER RES, V50, P1403; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Segovia JC, 1999, J VIROL, V73, P1774, DOI 10.1128/JVI.73.3.1774-1784.1999; Seiler MP, 2006, HUM GENE THER, V17, P10, DOI 10.1089/hum.2006.17.10; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Song XZ, 2011, J BIOL CHEM, V286, P31610, DOI 10.1074/jbc.M111.274217; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; SPALHOLZ BA, 1983, J VIROL, V46, P937, DOI 10.1128/JVI.46.3.937-943.1983; Stanley P, 2009, ESSENTIALS GLYCOBIOL; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; TATTERSALL P, 1983, J VIROL, V46, P944, DOI 10.1128/JVI.46.3.944-955.1983; TATTERSALL P, 1977, J MOL BIOL, V111, P375, DOI 10.1016/S0022-2836(77)80060-0; Thacker TC, 1998, J GEN VIROL, V79, P2163, DOI 10.1099/0022-1317-79-9-2163; TRESNAN DB, 1995, VIROLOGY, V211, P123, DOI 10.1006/viro.1995.1385; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Wang SH, 2013, GLYCOBIOLOGY; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Yu Y, 2012, J BIOL CHEM, V287, P44784, DOI 10.1074/jbc.M112.425819	59	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86909	10.1371/journal.pone.0086909	http://dx.doi.org/10.1371/journal.pone.0086909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475195	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300117
J	Huri, HZ; Xin, CH; Sulaiman, CZ				Huri, Hasniza Zaman; Xin, Chong Hui; Sulaiman, Che Zuraini			Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; MEDICATION; POLYPHARMACY; STRATEGIES; INHIBITORS; SAFETY; MEN	Benign Prostatic Hyperplasia (BPH) patients are at risk of acquiring drug-related problems (DRPs), as it is present in the majority of aging men. To date, DRPs among BPH patients have not been well studied. We conducted this retrospective study in a tertiary hospital in Malaysia from January 2009 to June 2012 with the aim of identifying the factors associated with DRPs among BPH patients. The Pharmaceutical Care Network Europe Classification Version (PCNE) 5.01 was used as a tool to classify DRPs. We enrolled 203 patients from 259 hospital admissions. A total of 390 DRPs were found and there was an average of 1.5 +/- 1.3 problems per hospitalization. 76.1% of hospital admissions included at least one DRP. The most common DRP categories encountered were drug choice problems (45.9%), drug interactions (24.9%), and dosing problems (13.3%). Factors such as advanced age (p = 0.005), a hospital stay of more than 6 days (p = 0.001), polydrug treatments (p<0.001), multiple comorbidities (p<0.001), and comorbid cardiovascular disease (p = 0.011), diabetes mellitus(p = 0.001), hypertension (p, 0.001) and renal impairment (p = 0.011) were significantly associated with the occurrence of DRPs. These data indicated that the prevalence of DRPs is high among BPH patients. The identification of different subtypes of DRPs and the factors associated with DRPs may facilitate risk reduction for BPH patients.	[Huri, Hasniza Zaman; Xin, Chong Hui] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Sulaiman, Che Zuraini] Univ Malaya, Med Ctr, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Huri, HZ (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	hasnizazh@um.edu.my	HURI, HASNIZA ZAMAN/B-8612-2010	HURI, HASNIZA ZAMAN/0000-0002-6423-8515	Ministry of Science, Technology and Innovation, Malaysia [12-02-03-2097]; University of Malaya, Malaysia [RG428/12HTM]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); University of Malaya, Malaysia(Universiti Malaya)	The authors would like to thank the Ministry of Science, Technology and Innovation, Malaysia (Science fund: 12-02-03-2097) and University of Malaya, Malaysia (RG428/12HTM) for financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Dellemin Che, 2004, Malays J Med Sci, V11, P52; American Urological Association (AUA), 2010, GUID MAN BEN PROST H; *AUA PRACT GUID CO, 2003, AUA GUID MAN BEN PRO; Barat I, 2000, EUR J CLIN PHARMACOL, V56, P501, DOI 10.1007/s002280000157; Barber N, 2004, QUAL SAF HEALTH CARE, V13, P172, DOI 10.1136/qshc.2003.005926; Bjorkman IK, 2008, RES SOC ADMIN PHARM, V4, P320, DOI 10.1016/j.sapharm.2007.10.006; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM 62 BNF; Bryant RJ, 2008, SURGERY OXFORD, V26, P150; Chan DC, 2012, ARCH GERONTOL GERIAT, V54, P168, DOI 10.1016/j.archger.2011.02.005; Carneiro SCD, 2011, CLIN DERMATOL, V29, P43, DOI 10.1016/j.clindermatol.2010.07.006; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Dicpinigaitis PV, 2006, CHEST, V129, p169S, DOI 10.1378/chest.129.1_suppl.169S; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eichenberger PM, 2010, PHARM WORLD SCI, V32, P362, DOI 10.1007/s11096-010-9377-x; Emberton M, 2010, INT J CLIN PRACT, V64, P1425, DOI 10.1111/j.1742-1241.2010.02463.x; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fitzpatrick JM, 2006, EUR UROL SUPPL, V5, P997, DOI 10.1016/j.eursup.2006.08.009; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hanlon Joseph T, 2003, Am J Geriatr Pharmacother, V1, P38, DOI 10.1016/S1543-5946(03)80014-4; Ho CKC, 2011, MED HEALTH-KUALA LUM, V6, P98; Hoke GP, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.05.021; Huri HZ, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-2; Israels S, 2006, J CAN DENT ASSOC, V72, P827; Juan Yung-Shun, 2004, Kaohsiung Journal of Medical Sciences, V20, P90; Kaplan SA, 2008, J UROLOGY, V180, P47, DOI 10.1016/j.juro.2008.03.027; Koh Yvonne, 2005, Ther Clin Risk Manag, V1, P39, DOI 10.2147/tcrm.1.1.39.53597; LaPointe NMA, 2003, ARCH INTERN MED, V163, P1461, DOI 10.1001/archinte.163.12.1461; Lepor Herbert, 2011, Rev Urol, V13, P20; Levinson J R, 1991, Clin Geriatr Med, V7, P371; Manlucu J, 2005, NEPHROL DIAL TRANSPL, V20, P2376, DOI 10.1093/ndt/gfi025; Maruenda J, 1999, UROLOGY, V53, P7, DOI 10.1016/S0090-4295(98)00533-0; Matthews SJ, 2011, AM J GERIATR PHARMAC, V9, P286, DOI 10.1016/j.amjopharm.2011.07.002; Ministry of Health Malaysia, 2002, HLTH TECHN ASS REP M; Mizokami F, 2012, AM J GERIATR PHARMAC, V10, P123, DOI 10.1016/j.amjopharm.2012.02.003; Moura C, 2009, J PHARM PHARM SCI, V12, P266, DOI 10.18433/J35C7Z; Naslund MJ, 2007, CLIN THER, V29, P17, DOI 10.1016/j.clinthera.2007.01.018; Nichol MB, 2009, J UROLOGY, V181, P2214, DOI 10.1016/j.juro.2009.01.033; Nye HJ, 2011, NEPHRON CLIN PRACT, V118, pC380, DOI 10.1159/000323739; Page Robert L 2nd, 2006, Am J Geriatr Pharmacother, V4, P297; Pharmaceutical Care Network Europe, 2006, PCNE CLASS DRUG REL; Planas LG, 2005, SOC SCI MED, V60, P2393, DOI 10.1016/j.socscimed.2004.10.018; Riechelmann RP, 2005, CANCER CHEMOTH PHARM, V56, P286, DOI 10.1007/s00280-004-0998-4; Roehrborn CG, 2004, J UROLOGY, V171, P1029, DOI 10.1097/01.ju.0000097026.43866.cc; Roehrborn CG, 2002, EUR UROL, V42, P1, DOI 10.1016/S0302-2838(02)00210-5; Salomon L, 2003, INT J QUAL HEALTH C, V15, P331, DOI 10.1093/intqhc/mzg046; Stegemann S, 2010, AGEING RES REV, V9, P384, DOI 10.1016/j.arr.2010.04.005; Stemer G, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-35; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Tulner LR, 2010, DRUG AGING, V27, P831, DOI 10.2165/11539330-000000000-00000; van Roozendaal BW, 2009, PHARM WORLD SCI, V31, P580, DOI 10.1007/s11096-009-9312-1; Verhamme KMC, 2003, EUR UROL, V44, P539, DOI 10.1016/S0302-2838(03)00376-2; Viktil KK, 2007, BRIT J CLIN PHARMACO, V63, P187, DOI 10.1111/j.1365-2125.2006.02744.x; World Health Organization, 2013, Q AS HYP; World Health Organization, 2013, HLTH TOP CARD DIS; World Health Organization, 2013, HLTH TOP STROK CER A; World Health Organization, 2013, HLTH TOP DIAB	58	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86215	10.1371/journal.pone.0086215	http://dx.doi.org/10.1371/journal.pone.0086215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475089	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300044
J	Ichinose, N; Yada, T; Gotoh, O				Ichinose, Natsuhiro; Yada, Tetsushi; Gotoh, Osamu			Tetrahedral Gray Code for Visualization of Genome Information	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; DNA-SEQUENCES; METHYLATION	We propose a tetrahedral Gray code that facilitates visualization of genome information on the surfaces of a tetrahedron, where the relative abundance of each k-mer in the genomic sequence is represented by a color of the corresponding cell of a triangular lattice. For biological significance, the code is designed such that the k-mers corresponding to any adjacent pair of cells differ from each other by only one nucleotide. We present a simple procedure to draw such a pattern on the development surfaces of a tetrahedron. The thus constructed tetrahedral Gray code can demonstrate evolutionary conservation and variation of the genome information of many organisms at a glance. We also apply the tetrahedral Gray code to the honey bee (Apis mellifera) genome to analyze its methylation structure. The results indicate that the honey bee genome exhibits CpG overrepresentation in spite of its methylation ability and that two conserved motifs, CTCGAG and CGCGCG, in the unmethylated regions are responsible for the overrepresentation of CpG.	[Ichinose, Natsuhiro] Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Sakyo Ku, Kyoto, Japan; [Yada, Tetsushi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Gotoh, Osamu] Natl Inst Adv Ind Sci & Technol, CBRC, Koto Ku, Tokyo, Japan	Kyoto University; Kyushu Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Ichinose, N (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan.	ichinose@i.kyoto-u.ac.jp			Aihara Project; FIRST program from Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [221S0002, 22310124]	Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FIRST program from Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Aihara Project, the FIRST program from Japan Society for the Promotion of Science (JSPS), initiated by CSTP. This work was partially supported by JSPS KAKENHI Grant Numbers 221S0002 and 22310124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2006, COMP GEOM-THEOR APPL, V34, P2, DOI 10.1016/j.comgeo.2005.07.003; Akiyama J, 2007, AM MATH MON, V114, P602, DOI 10.1080/00029890.2007.11920450; Almeida JS, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-6; Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429; Basu S, 1997, J MOL GRAPH MODEL, V15, P279, DOI 10.1016/S1093-3263(97)00106-X; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Duzhin SV, 2004, TRANSFORMATION GROUP; ER MC, 1984, IEEE T COMPUT, V33, P739, DOI 10.1109/TC.1984.5009360; FELDMAN W, 1994, GENOMICS, V23, P233, DOI 10.1006/geno.1994.1482; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; Gray Frank, 1947, US Patent, Patent No. 2632058; Gutierrez JM, 2001, PHYSICA A, V300, P271, DOI 10.1016/S0378-4371(01)00333-8; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Ichinose N, 2012, BIOINFORMATICS, V28, P25, DOI 10.1093/bioinformatics/btr606; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Kent CF, 2012, P NATL ACAD SCI USA, V109, P18012, DOI 10.1073/pnas.1208094109; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506	22	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86133	10.1371/journal.pone.0086133	http://dx.doi.org/10.1371/journal.pone.0086133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475080	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300039
J	Ishida, S; Matsu-ura, T; Fukami, K; Michikawa, T; Mikoshiba, K				Ishida, Sachiko; Matsu-ura, Toru; Fukami, Kiyoko; Michikawa, Takayuki; Mikoshiba, Katsuhiko			Phospholipase C-beta 1 and beta 4 Contribute to Non-Genetic Cell-to-Cell Variability in Histamine-Induced Calcium Signals in HeLa Cells	PLOS ONE			English	Article							G-PROTEINS; OSCILLATIONS; HEPATOCYTES; PURIFICATION; ACTIVATION; SUBUNITS; ISOZYME; COMPLEX; GQ	A uniform extracellular stimulus triggers cell-specific patterns of Ca2+ signals, even in genetically identical cell populations. However, the underlying mechanism that generates the cell-to-cell variability remains unknown. We monitored cytosolic inositol 1,4,5-trisphosphate (IP3) concentration changes using a fluorescent IP3 sensor in single HeLa cells showing different patterns of histamine-induced Ca2+ oscillations in terms of the time constant of Ca2+ spike amplitude decay and the Ca2+ oscillation frequency. HeLa cells stimulated with histamine exhibited a considerable variation in the temporal pattern of Ca2+ signals and we found that there were cell-specific IP3 dynamics depending on the patterns of Ca2+ signals. RT-PCR and western blot analyses showed that phospholipase C (PLC)-beta 1, -beta 3, -beta 4, -gamma 1, -delta 3 and -epsilon were expressed at relatively high levels in HeLa cells. Small interfering RNA-mediated silencing of PLC isozymes revealed that PLC-beta 1 and PLC-beta 4 were specifically involved in the histamine-induced IP3 increases in HeLa cells. Modulation of IP3 dynamics by knockdown or overexpression of the isozymes PLC-beta 1 and PLC-beta 4 resulted in specific changes in the characteristics of Ca2+ oscillations, such as the time constant of the temporal changes in the Ca2+ spike amplitude and the Ca2+ oscillation frequency, within the range of the cell-to-cell variability found in wild-type cell populations. These findings indicate that the heterogeneity in the process of IP3 production, rather than IP3-induced Ca2+ release, can cause cell-to-cell variability in the patterns of Ca2+ signals and that PLC-beta 1 and PLC-beta 4 contribute to generate cell-specific Ca2+ signals evoked by G protein-coupled receptor stimulation.	[Ishida, Sachiko; Matsu-ura, Toru; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, ICORP SORST, Kawaguchi, Saitama, Japan; [Michikawa, Takayuki] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); RIKEN	Michikawa, T (corresponding author), RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan.	t-michikawa@brain.riken.jp; mikosiba@brain.riken.jp	Matsu-ura, Toru/P-3461-2017; Mikoshiba, Katsuhiko/N-7943-2015	Matsu-ura, Toru/0000-0002-9876-3086; Ishida, Sachiko/0000-0001-6463-3059	Ministry of Education, Culture, Sports, Science and Technology of Japan [22770227, 20370054, 2022007]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. Matsu-ura (22770227), T. Michikawa (20370054), and K. Mikoshiba (2022007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2013, CELL SIGNAL, V25, P255, DOI 10.1016/j.cellsig.2012.09.022; Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; AMBLER SK, 1988, J BIOL CHEM, V263, P1952; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1988, J PHYSIOL-LONDON, V403, P589, DOI 10.1113/jphysiol.1988.sp017266; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BLANK JL, 1991, J BIOL CHEM, V266, P18206; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COBBOLD PH, 1991, CELL CALCIUM, V12, P87, DOI 10.1016/0143-4160(91)90011-3; HAZAMA A, 1985, BIOCHIM BIOPHYS ACTA, V845, P249, DOI 10.1016/0167-4889(85)90183-1; Kim MJ, 1998, J BIOL CHEM, V273, P3618, DOI 10.1074/jbc.273.6.3618; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kuchtey J, 1996, J CELL PHYSIOL, V166, P643, DOI 10.1002/(SICI)1097-4652(199603)166:3<643::AID-JCP20>3.0.CO;2-6; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; MIN DS, 1993, J BIOL CHEM, V268, P12207; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; THOMAS AP, 1991, CELL CALCIUM, V12, P111, DOI 10.1016/0143-4160(91)90013-5; Uhlen Per, 2004, Sci STKE, V2004, ppl15, DOI 10.1126/stke.2582004pl15; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Wu DM, 2003, EUR J NEUROSCI, V17, P1571, DOI 10.1046/j.1460-9568.2003.02591.x; WU DQ, 1992, J BIOL CHEM, V267, P1811	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86410	10.1371/journal.pone.0086410	http://dx.doi.org/10.1371/journal.pone.0086410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475116	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300062
J	Mott, KR; Allen, SJ; Zandian, M; Akbari, O; Hamrah, P; Maazi, H; Wechsler, SL; Sharpe, AH; Freeman, GJ; Ghiasi, H				Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Akbari, Omid; Hamrah, Pedram; Maazi, Hadi; Wechsler, Steven L.; Sharpe, Arlene H.; Freeman, Gordon J.; Ghiasi, Homayon			Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN DENDRITIC CELLS; CD8(+) T-CELLS; IN-VIVO; TYPE-1 LATENCY; COSTIMULATORY MOLECULE; STROMAL KERATITIS; MICE; EXPRESSION; REPLICATION	CD80 plays a critical role in stimulation of T cells and subsequent control of infection. To investigate the effect of CD80 on HSV-1 infection, we constructed a recombinant HSV-1 virus that expresses two copies of the CD80 gene in place of the latency associated transcript (LAT). This mutant virus (HSV-CD80) expressed high levels of CD80 and had similar virus replication kinetics as control viruses in rabbit skin cells. In contrast to parental virus, this CD80 expressing recombinant virus replicated efficiently in immature dendritic cells (DCs). Additionally, the susceptibility of immature DCs to HSV-CD80 infection was mediated by CD80 binding to PD-L1 on DCs. This interaction also contributed to a significant increase in T cell activation. Taken together, these results suggest that inclusion of CD80 as a vaccine adjuvant may promote increased vaccine efficacy by enhancing the immune response directly and also indirectly by targeting to DC.	[Mott, Kevin R.; Allen, Sariah J.; Zandian, Mandana; Ghiasi, Homayon] Cedars Sinai Med Ctr, Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA; [Akbari, Omid; Maazi, Hadi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Hamrah, Pedram] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Dept Ophthalmol, Dept Microbiol & Mol Genet,Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Wechsler, Steven L.] Univ Calif Irvine, Sch Med, Ctr Virus Res, Irvine, CA 92717 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Womens Hosp Med Ctr, Boston, MA USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Med Oncol, Boston, MA 02115 USA	Cedars Sinai Medical Center; University of Southern California; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ghiasi, H (corresponding author), Cedars Sinai Med Ctr, Cedars Sinai Burns & Allen Res Inst, Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA 90048 USA.	ghiasih@CSHS.org	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Maazi, Hadi/0000-0002-8979-3769; Allen, Sariah J./0000-0001-8118-2413	Public Health Service [AI093941, EY13615, EY013191, P01 AI056299, 5P01AI078897]; NATIONAL EYE INSTITUTE [K08EY020575, R01EY022695, R01EY013191, R01EY013615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093941, P01AI056299, P01AI078897] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI093941, EY13615, EY013191, P01 AI056299 and 5P01AI078897 (GJF and AHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; ALBERS I, 1989, VIROLOGY, V169, P466, DOI 10.1016/0042-6822(89)90174-8; Allen SJ, 2011, J VIROL, V85, P9945, DOI 10.1128/JVI.05208-11; Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; Allen SJ, 2010, J VIROL, V84, P12315, DOI 10.1128/JVI.01600-10; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BARRON BA, 1994, OPHTHALMOLOGY, V101, P1871; Brahmer Julie R, 2012, Clin Adv Hematol Oncol, V10, P674; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Colonna M, 2006, NAT IMMUNOL, V7, P117, DOI 10.1038/ni0206-117; COREY L, 1986, NEW ENGL J MED, V314, P686, DOI 10.1056/NEJM198603133141105; Cunningham AL, 2008, EUR J IMMUNOL, V38, P2377, DOI 10.1002/eji.200838521; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghiasi H, 1996, VACCINE, V14, P107, DOI 10.1016/0264-410X(95)00169-2; Ghiasi H, 2002, J VIROL, V76, P9069, DOI 10.1128/JVI.76.18.9069-9078.2002; Ghiasi H, 2002, VIROLOGY, V302, P144, DOI 10.1006/viro.2002.1609; GHIASI H, 1994, J VIROL, V68, P2118, DOI 10.1128/JVI.68.4.2118-2126.1994; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Koelle DM, 2005, CURR EYE RES, V30, P929, DOI 10.1080/02713680500313153; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; LARSEN CP, 1994, J IMMUNOL, V152, P5208; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; Maazi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059599; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, MOL VIS, V13, P1802; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Osorio Y, 2005, EXP NEUROL, V193, P1, DOI 10.1016/j.expneurol.2004.12.004; Osorio Y, 2002, OCUL IMMUNOL INFLAMM, V10, P105, DOI 10.1076/ocii.10.2.105.13982; Paroli M, 2000, J NEUROIMMUNOL, V107, P201, DOI 10.1016/S0165-5728(00)00228-9; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; SARMIENTO M, 1990, J IMMUNOL, V144, P1942; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1980, J INVEST DERMATOL, V75, P14, DOI 10.1111/1523-1747.ep12521052; Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; TEUTE H, 1983, INTERVIROLOGY, V20, P32, DOI 10.1159/000149371; Tiwari V, 2012, GLYCOBIOLOGY, V22, P1402, DOI 10.1093/glycob/cws106; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van den Broeke LT, 2003, J IMMUNOL, V171, P5842, DOI 10.4049/jimmunol.171.11.5842; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wilhelmus KR, 1996, BRIT J OPHTHALMOL, V80, P969, DOI 10.1136/bjo.80.11.969; ZHOU LJ, 1995, J IMMUNOL, V154, P3821; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	68	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87617	10.1371/journal.pone.0087617	http://dx.doi.org/10.1371/journal.pone.0087617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475315	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300208
J	Su, J; Zhang, L; Zhang, W; Choi, DS; Wen, JG; Jiang, BN; Chang, CC; Zhou, XB				Su, Jing; Zhang, Le; Zhang, Wen; Choi, Dong Song; Wen, Jianguo; Jiang, Beini; Chang, Chung-Che; Zhou, Xiaobo			Targeting the Biophysical Properties of the Myeloma Initiating Cell Niches: A Pharmaceutical Synergism Analysis Using Multi-Scale Agent-Based Modeling	PLOS ONE			English	Article							CANCER STEM-CELLS; MULTIPLE-MYELOMA; DRUG-RESISTANCE; MATHEMATICAL-MODEL; MICROENVIRONMENT; TRANSPLANTATION; MECHANISMS; PARADIGM; LEUKEMIA; THERAPY	Multiple myeloma, the second most common hematological cancer, is currently incurable due to refractory disease relapse and development of multiple drug resistance. We and others recently established the biophysical model that myeloma initiating (stem) cells (MICs) trigger the stiffening of their niches via SDF-1/CXCR4 paracrine; The stiffened niches then promote the colonogenesis of MICs and protect them from drug treatment. In this work we examined in silico the pharmaceutical potential of targeting MIC niche stiffness to facilitate cytotoxic chemotherapies. We first established a multi-scale agent-based model using the Markov Chain Monte Carlo approach to recapitulate the niche stiffness centric, pro-oncogenetic positive feedback loop between MICs and myeloma-associated bone marrow stromal cells (MBMSCs), and investigated the effects of such intercellular chemo-physical communications on myeloma development. Then we used AMD3100 (to interrupt the interactions between MICs and their stroma) and Bortezomib (a recently developed novel therapeutic agent) as representative drugs to examine if the biophysical properties of myeloma niches are drugable. Results showed that our model recaptured the key experimental observation that the MBMSCs were more sensitive to SDF-1 secreted by MICs, and provided stiffer niches for these initiating cells and promoted their proliferation and drug resistance. Drug synergism analysis suggested that AMD3100 treatment undermined the capability of MICs to modulate the bone marrow microenvironment, and thus re-sensitized myeloma to Bortezomib treatments. This work is also the first attempt to virtually visualize in 3D the dynamics of the bone marrow stiffness during myeloma development. In summary, we established a multi-scale model to facilitate the translation of the niche-stiffness centric myeloma model as well as experimental observations to possible clinical applications. We concluded that targeting the biophysical properties of stem cell niches is of high clinical potential since it may re-sensitize tumor initiating cells to chemotherapies and reduce risks of cancer relapse.	[Su, Jing; Zhou, Xiaobo] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Zhang, Le] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Zhang, Le] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA; [Zhang, Wen] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Choi, Dong Song; Wen, Jianguo] Weill Cornell Med Coll, Methodist Hosp Res Inst, Dept Pathol, Houston, TX USA; [Jiang, Beini] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Zhou, Xiaobo] Univ Cent Florida, Dept Pathol, Florida Hosp, Orlando, FL 32816 USA	Wake Forest University; Southwest University - China; University of Rochester; Baylor College of Medicine; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Michigan Technological University; Adventist Health Services; AdventHealth; State University System of Florida; University of Central Florida	Zhang, L (corresponding author), Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China.	Le_Zhang@URMC.Rochester.edu; C.Jeff.Chang.MD@Flhosp.org; xizhou@wakehealth.edu	Zhang, Le/AAD-9104-2019; Zhang, Wen/I-7086-2018	Zhang, Le/0000-0002-3708-1727; Zhang, Wen/0000-0001-7370-4306; Su, Jing/0000-0003-4917-6173	NIH/NLM [5R01LM010185-04]; Natural Science Foundation of China [61372138]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NIH/NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank the funding resource: NIH/NLM 5R01LM010185-04. One of the authors, Dr. Le Zhang, is currently supported by the Natural Science Foundation of China under Grant No. 61372138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2004, J THEOR BIOL, V229, P395, DOI 10.1016/j.jtbi.2004.04.016; Alon U, 2006, INTRO SYSTEM BIOL DI; Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Bensinger WI, 2009, LEUKEMIA, V23, P442, DOI 10.1038/leu.2008.396; Blade J, 2009, HAEMATOL-HEMATOL J, V94, P163, DOI 10.3324/haematol.2008.002766; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chang CC, 2001, MODERN PATHOL, V14, P1015, DOI 10.1038/modpathol.3880427; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Feng YD, 2010, STEM CELLS DEV, V19, P1289, DOI 10.1089/scd.2010.0010; Feng YD, 2010, PROG BIOPHYS MOL BIO, V103, P148, DOI 10.1016/j.pbiomolbio.2009.10.004; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Ghosh N, 2008, CANC LETT; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Joe Conway C-CC, 2008, ARCH PATHOL IN PRESS; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Lozoya OA, 2011, BIOMATERIALS, V32, P7389, DOI 10.1016/j.biomaterials.2011.06.042; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Nara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056954; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Pilarski LM, 2002, EXP HEMATOL, V30, P221, DOI 10.1016/S0301-472X(01)00788-3; Podar K, 2009, EXPERT OPIN EMERG DR, V14, P99, DOI [10.1517/14728210802676278, 10.1517/14728210802676278 ]; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Serban MA, 2001, CURRENT PROTOCOLS CE; Shabaneh TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056132; Slepchenko BM, 2002, ANNU REV BIOPH BIOM, V31, P423, DOI 10.1146/annurev.biophys.31.101101.140930; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Su J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-350; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wen JG, 2010, LEUKEMIA RES, V34, P85, DOI 10.1016/j.leukres.2009.05.024; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhu X, 2010, J THEORETIC IN PRESS	48	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85059	10.1371/journal.pone.0085059	http://dx.doi.org/10.1371/journal.pone.0085059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475036	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300016
J	Trofimova, I				Trofimova, Ira			Observer Bias: An Interaction of Temperament Traits with Biases in the Semantic Perception of Lexical Material	PLOS ONE			English	Article							IMPRESSION-FORMATION; NEURAL BASIS; ACTION WORDS; PERSONALITY; EMOTION; ATTENTION; LANGUAGE; NEGATIVITY; MECHANISMS; OXYTOCIN	The lexical approach is a method in differential psychology that uses people's estimations of verbal descriptors of human behavior in order to derive the structure of human individuality. The validity of the assumptions of this method about the objectivity of people's estimations is rarely questioned. Meanwhile the social nature of language and the presence of emotionality biases in cognition are well-recognized in psychology. A question remains, however, as to whether such an emotionality-capacities bias is strong enough to affect semantic perception of verbal material. For the lexical approach to be valid as a method of scientific investigations, such biases should not exist in semantic perception of the verbal material that is used by this approach. This article reports on two studies investigating differences between groups contrasted by 12 temperament traits (i.e. by energetic and other capacities, as well as emotionality) in the semantic perception of very general verbal material. Both studies contrasted the groups by a variety of capacities: endurance, lability and emotionality separately in physical, social-verbal and mental aspects of activities. Hypotheses of "background emotionality" and a "projection through capacities" were supported. Non-evaluative criteria for categorization (related to complexity, organization, stability and probability of occurrence of objects) followed the polarity of evaluative criteria, and did not show independence from this polarity. Participants with stronger physical or social endurance gave significantly more positive ratings to a variety of concepts, and participants with faster physical tempo gave more positive ratings to timing-related concepts. The results suggest that people's estimations of lexical material related to human behavior have emotionality, language-and dynamical capacities-related biases and therefore are unreliable. This questions the validity of the lexical approach as a method for the objective study of stable individual differences.	McMaster Univ, Dept Psychiat & Behav Neurosci, Collect Intelligence Lab, Hamilton, ON, Canada	McMaster University	Trofimova, I (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Collect Intelligence Lab, Hamilton, ON, Canada.	iratrofimov@gmail.com	Trofimova, Irina/AAI-1695-2021	Trofimova, Irina/0000-0001-6758-1389				Abelson R., 1966, COGNITIVE CONSISTENC, P173; Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Akiskal HS, 1998, ACTA PSYCHIAT S S393, V98; ALEXANDROV Y, 1993, ECOL PSYCHOL, V5, P85; Anochin PK, 1975, BIOL NEUROPHYSIOLOGY; [Anonymous], 2022, THEORY PERSONALITY; Barrett LF, 2001, COGNITION EMOTION, V15, P713, DOI 10.1080/02699930143000239; Ben-Ari Y, 1981, AMYGDALOID COMPLEX; BENTLER PM, 1972, J VERB LEARN VERB BE, V11, P491, DOI 10.1016/S0022-5371(72)80032-X; Bernstein N.A., 1996, RES ECOL PS; Bernstein NA, 1947, POSTROENII DVIJENIY; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; BIRNBAUM MH, 1974, J EXP PSYCHOL, V102, P543, DOI 10.1037/h0036014; Bodnar RJ, 2011, PEPTIDES, V32, P2522, DOI 10.1016/j.peptides.2011.09.020; BORGATTA EF, 1964, BEHAV SCI, V9, P8, DOI 10.1002/bs.3830090103; Buss A., 1984, TEMPERAMENT EARLY DE; Cacioppo J.T., 1993, HDB EMOTION, P119; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Canbeyli R, 2010, BEHAV BRAIN RES, V207, P249, DOI 10.1016/j.bbr.2009.11.002; Cattell R.B, 1965, SCI ANAL PERSONALITY; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Clark US, 2011, BRAIN IMAGING IN BEHAVIORAL MEDICINE AND CLINICAL NEUROSCIENCE, P257, DOI 10.1007/978-1-4419-6373-4_16; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; Damasio A.R., 2000, FEELING WHAT HAPPENS; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Di Matteo V, 2008, PROG BRAIN RES, V172, P7, DOI 10.1016/S0079-6123(08)00902-3; DIGMAN JM, 1981, MULTIVAR BEHAV RES, V16, P149, DOI 10.1207/s15327906mbr1602_2; DUFFY E, 1957, PSYCHOL REV, V64, P265, DOI 10.1037/h0048837; Dworkin RH, 1998, ORIGINS AND DEVELOPMENT OF SCHIZOPHRENIA, P385, DOI 10.1037/10305-014; Egbert MD, 2010, SYNTHESIS SIMULATION, P213; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Eysenck HJ, 1967, BIOL BASIS PERSONALI; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; FISKE DW, 1949, J ABNORM SOC PSYCH, V44, P329, DOI 10.1037/h0057198; FISKE ST, 1980, J PERS SOC PSYCHOL, V38, P889, DOI 10.1037/0022-3514.38.6.889; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; Glenberg A. M., 2007, OXFORD HDB PSYCHOLIN, P361, DOI DOI 10.1093/OXFORDHB/9780198568971.001.0001; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Halgren Eric, 1995, P1137; HAMILTON DL, 1971, J PERS SOC PSYCHOL, V20, P200, DOI 10.1037/h0031698; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hensler J. G., 2006, BASIC NEUROCHEMISTRY, P227; Heymans G., 1929, INLEIDING SPECIALE P; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Joel D., 2000, CONCEPTUAL ADV BRAIN; John O. P., 2001, HDB PERSONALITY THEO; Jung C.G., 1923, PSYCHOL TYPES; Kagan J., 1994, GALENS PROPHECY TEMP, DOI DOI 10.4324/9780429500282; Kanouse D.E., 1972, ATTRIBUTION PERCEIV, P47; Kant I., 1798, ANTHR PRAGMATIC POIN; Kretschmer E., 1925, PHYS CHARACTER INVES; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Kring AM, 1996, J ABNORM PSYCHOL, V105, P249, DOI 10.1037/0021-843X.105.2.249; KUPFER D J, 1975, Neuropsychobiology, V1, P296, DOI 10.1159/000117503; Lamiell J.T., 2003, INDIVIDUAL GROUP DIF; Lazarus R.S., 1991, EMOTION ADAPTATION; LeDoux J. E., 1996, EMOTIONAL BRAIN; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MCCANN IL, 1984, J PERS SOC PSYCHOL, V46, P1142, DOI 10.1037/0022-3514.46.5.1142; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Nell V, 1999, NEUROPSYCHOL REV, V9, P45, DOI 10.1023/A:1025643004782; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; Oades RD, 2002, BEHAV BRAIN RES, V130, P97, DOI 10.1016/S0166-4328(01)00440-5; Osgood C.E., 1975, CROSS CULTURAL UNIVE; Panksepp, 1999, AFFECTIVE NEUROSCIEN; Pavlov I. P., 1928, LECT CONDITIONED REF; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Petrenko V., 1993, J RUSSIAN E EUROPEAN, V31, P5, DOI [10.2753/RPO1061-040531025, DOI 10.2753/RPO1061-040531025]; Posner M. I., 1975, INFORM PROCESSING CO; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Pribram K. H., 1973, PSYCHOPHYSIOLOGY FRO; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Robbins Trevor W., 1995, P703; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Robinson DK, 2001, WILHELM WUNDT HIST M; Rosch EH, 1978, COGNITION CATEGORIZA, P560; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; RUSALOV VM, 1989, PERS INDIV DIFFER, V10, P817, DOI 10.1016/0191-8869(89)90017-2; Rusalov VM., 2007, STRUCTURE TEMPERAMEN; Ruschemeyer SA, 2007, J COGNITIVE NEUROSCI, V19, P855, DOI 10.1162/jocn.2007.19.5.855; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Rusting CL, 1998, PERS SOC PSYCHOL B, V24, P200, DOI 10.1177/0146167298242008; Saffran E. M., 1999, NEUROCOGNITION LANGU, P241; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schrauf R.W., 2004, J MULTILING MULTICUL, V25, P266, DOI [DOI 10.1080/01434630408666532, 10.1080/01434630408666532]; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Siegel G. J., 2005, BASIC NEUROCHEMISTRY; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Strelau J., 1991, PERSPECTIVES INDIVID; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; Taylor LJ, 2008, BRAIN LANG, V107, P62, DOI 10.1016/j.bandl.2007.08.004; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; Teplov BM, 1963, J HIGHEST NERVOUS AC, V13, P789; Thomas A., 1977, TEMPERAMENT DEV; Tomkins, 1963, AFFECT IMAGERY CONSC, V2; Trofimova I, 1999, PSYCHOL REP, V85, P533, DOI 10.2466/pr0.1999.85.2.533; Trofimova I., 2010, OPEN BEHAV SCI PSYCH, V4, P1, DOI [10.2174/1874230001004010001, DOI 10.2174/1874230001004010001]; Trofimova I, 2010, INT J PSYCHOL PSYCH, V10, P179; Trofimova I, 2011, COG SYS RES, V15-16, P50, DOI 101016/jcogsys201107001.; Trofimova I, 2013, PSYCHOL B UNPUB; Trofimova I, 2012, PSYCHOL RES, DOI 101007/s00426-012-0462-8; Trofimova I., 2010, ADV BIOSCI BIOTECHNO, V1, P190, DOI [DOI 10.4236/ABB.2010.13027, 10.4236/abb.2010.13027]; Trofimova I, 2011, INT J PSYCHOL PSYCH, V11, P167; Trofimova I, 2013, PSYCHOL REV UNPUB; Trofimova I, 2010, AM J PSYCHOL, V123, P467; Trofimova IN, 2009, PSYCHOL REP, V105, P643, DOI 10.2466/PR0.105.2.643-658; van Dam WO, 2010, NEUROIMAGE, V53, P1318, DOI 10.1016/j.neuroimage.2010.06.071; Van de Kar LD, 2001, J NEUROSCI, V21, P3572, DOI 10.1523/JNEUROSCI.21-10-03572.2001; van Elk M, 2010, NEUROIMAGE, V50, P665, DOI 10.1016/j.neuroimage.2009.12.123; VANDERPLIGT J, 1980, EUR J SOC PSYCHOL, V10, P415, DOI 10.1002/ejsp.2420100408; Vigliocco G, 2004, COGNITIVE PSYCHOL, V48, P422, DOI 10.1016/j.cogpsych.2003.09.001; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P., 2003, HUMAN BRAIN FUNCTION, P419, DOI DOI 10.1016/B978-012264841-0/50022-6; WARR P, 1974, J PERS SOC PSYCHOL, V30, P191, DOI 10.1037/h0036649; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Way BM, 2009, P NATL ACAD SCI USA, V106, P15079, DOI 10.1073/pnas.0812612106; WYER RS, 1973, PSYCHOL REV, V80, P446, DOI 10.1037/h0035455; Zelenski JM, 1999, J PERS, V67, P761, DOI 10.1111/1467-6494.00072; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	140	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85677	10.1371/journal.pone.0085677	http://dx.doi.org/10.1371/journal.pone.0085677			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475048	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300022
J	Vandenhende, MA; Bellecave, P; Recordon-Pinson, P; Reigadas, S; Bidet, Y; Bruyand, M; Bonnet, F; Lazaro, E; Neau, D; Fleury, H; Dabis, F; Morlat, P; Masquelier, B				Vandenhende, Marie-Anne; Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Bidet, Yannick; Bruyand, Mathias; Bonnet, Fabrice; Lazaro, Estibaliz; Neau, Didier; Fleury, Herve; Dabis, Francois; Morlat, Philippe; Masquelier, Bernard			Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure	PLOS ONE			English	Article							TREATMENT-NAIVE; VARIANTS; TRANSMISSION; INFECTION; POPULATIONS; MORTALITY; ADHERENCE; MULTIPLE; RISK	Objectives: Clinical relevance of low-frequency HIV-1 variants carrying drug resistance associated mutations (DRMs) is still unclear. We aimed to study the prevalence of low-frequency DRMs, detected by Ultra-Deep Sequencing (UDS) before antiretroviral therapy (ART) and at virological failure (VF), in HIV-1 infected patients experiencing VF on first-line ART. Methods: Twenty-nine ART-naive patients followed up in the ANRS-CO3 Aquitaine Cohort, having initiated ART between 2000 and 2009 and experiencing VF (2 plasma viral loads (VL) >500 copies/ml or one VL >1000 copies/ml) were included. Reverse transcriptase and protease DRMs were identified using Sanger sequencing (SS) and UDS at baseline (before ART initiation) and VF. Results: Additional low-frequency variants with PI-, NNRTI- and NRTI-DRMs were found by UDS at baseline and VF, significantly increasing the number of detected DRMs by 1.35 fold (p<0.0001) compared to SS. These low-frequency DRMs modified ARV susceptibility predictions to the prescribed treatment for 1 patient at baseline, in whom low-frequency DRM was found at high frequency at VF, and 6 patients at VF. DRMs found at VF were rarely detected as low-frequency DRMs prior to treatment. The rare low-frequency NNRTI- and NRTI-DRMs detected at baseline that correlated with the prescribed treatment were most often found at high-frequency at VF. Conclusion: Low frequency DRMs detected before ART initiation and at VF in patients experiencing VF on first-line ART can increase the overall burden of resistance to PI, NRTI and NNRTI.	[Vandenhende, Marie-Anne; Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve; Masquelier, Bernard] Univ Bordeaux, UMR 5234, Bordeaux, France; [Vandenhende, Marie-Anne; Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve; Masquelier, Bernard] CNRS, UMR 5234, Bordeaux, France; [Bellecave, Pantxika; Recordon-Pinson, Patricia; Reigadas, Sandrine; Fleury, Herve; Masquelier, Bernard] Ctr Hosp Univ Bordeaux, Lab Virol, Bordeaux, France; [Vandenhende, Marie-Anne; Bonnet, Fabrice; Morlat, Philippe] Ctr Hosp Univ Bordeaux, Hop St Andre, Serv Med Interne & Malad Infect, Bordeaux, France; [Bidet, Yannick] Ctr Jean Perrin, Plateforme GINA, EA ERTICa 4677, Clermont Ferrand, France; [Vandenhende, Marie-Anne; Bonnet, Fabrice; Dabis, Francois; Morlat, Philippe] Univ Bordeaux, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Vandenhende, Marie-Anne; Bruyand, Mathias; Bonnet, Fabrice; Dabis, Francois; Morlat, Philippe] Ctr Hosp Univ Bordeaux, COREVIH Aquitaine, Bordeaux, France; [Bruyand, Mathias; Dabis, Francois] INSERM, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Lazaro, Estibaliz] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Med Interne & Malad Infect, Bordeaux, France; [Neau, Didier] Ctr Hosp Univ Bordeaux, Hop Pellegrin, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; UNICANCER; Centre Jean Perrin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux	Bellecave, P (corresponding author), Univ Bordeaux, UMR 5234, Bordeaux, France.	pantxika_bellecave@yahoo.fr	Recordon-Pinson, Patricia/AAV-1295-2021; Vandenhende, Marie-Anne/T-6625-2019; Bidet, Yannick/O-5753-2019; Bonnet, Fabrice/T-3254-2019; Bruyand, Mathias/AAP-6177-2020; DABIS, FRANCOIS/S-9298-2019	Recordon-Pinson, Patricia/0000-0001-6002-0941; Bidet, Yannick/0000-0002-9624-8195; DABIS, FRANCOIS/0000-0002-1614-8857	European Community [223131]; Agence Nationale de Recherche sur le SIDA et les Hepatites; University Bordeaux Segalen - Centre national de la recherche scientifique UMR	European Community(European Commission); Agence Nationale de Recherche sur le SIDA et les Hepatites; University Bordeaux Segalen - Centre national de la recherche scientifique UMR	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) (grant no. 223131), the Agence Nationale de Recherche sur le SIDA et les Hepatites and the University Bordeaux Segalen - Centre national de la recherche scientifique UMR 5234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codoner FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019461; De Luca A, 2003, J INFECT DIS, V187, P1934, DOI 10.1086/375355; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vandenbroucke Ina, 2008, Open Virol J, V2, P8, DOI 10.2174/1874357900802010008; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	31	35	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86771	10.1371/journal.pone.0086771	http://dx.doi.org/10.1371/journal.pone.0086771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475178	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300108
J	Bezzina, CN; Amiel, JJ; Shine, R				Bezzina, Chalene N.; Amiel, Joshua J.; Shine, Richard			Does Invasion Success Reflect Superior Cognitive Ability? A Case Study of Two Congeneric Lizard Species (Lampropholis, Scincidae)	PLOS ONE			English	Article							PHYLOGEOGRAPHIC DIVERGENCE; LONGITUDINAL DATA; BRAIN; BARRIERS; REVERSAL; BIRDS; SKINK	A species' intelligence may reliably predict its invasive potential. If this is true, then we might expect invasive species to be better at learning novel tasks than non-invasive congeners. To test this hypothesis, we exposed two sympatric species of Australian scincid lizards, Lampropholis delicata (invasive) and L. guichenoti (non-invasive) to standardized maze-learning tasks. Both species rapidly decreased the time they needed to find a food reward, but latencies were always higher for L. delicata than L. guichenoti. More detailed analysis showed that neither species actually learned the position of the food reward; they were as likely to turn the wrong way at the end of the study as at the beginning. Instead, their times decreased because they spent less time immobile in later trials; and L. guichenoti arrived at the reward sooner because they exhibited "freezing" (immobility) less than L. delicata. Hence, our data confirm that the species differ in their performance in this standardized test, but neither the decreasing time to find the reward, nor the interspecific disparity in those times, are reflective of cognitive abilities. Behavioural differences may well explain why one species is invasive and one is not, but those differences do not necessarily involve cognitive ability.	[Bezzina, Chalene N.; Amiel, Joshua J.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Bezzina, CN (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	cbez6563@uni.sydney.edu.au			Australian Research Council [FF0561365]; Natural Sciences and Engineering Research Council of Canada; University of Sydney	Australian Research Council(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Sydney(University of Sydney)	For funding the authors thank the Australian Research Council (grant #FF0561365), the Natural Sciences and Engineering Research Council of Canada and the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel JJ, 2013, ANIM COGN, DOI [10.1007/s10071-013-0665-4, DOI 10.1007/S10071-013-0665-4)]; Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blomberg S, 2004, REPTILES; Chapple DG, 2011, ECOL EVOL, V1, P278, DOI 10.1002/ece3.22; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Chapple DG, 2011, J BIOGEOGR, V38, P1761, DOI 10.1111/j.1365-2699.2011.02531.x; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; COOPER WE, 1994, J CHEM ECOL, V20, P439, DOI 10.1007/BF02064449; Cromie GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034732; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; Gill BJ, 2001, NEW ZEAL J ZOOL, V28, P351, DOI 10.1080/03014223.2001.9518274; GRAVES BM, 1993, J HERPETOL, V27, P33, DOI 10.2307/1564902; Kraus Fred, 2009, V4, P1; Leal M, 2012, BIOL LETTERS, V8, P28, DOI 10.1098/rsbl.2011.0480; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; MACPHAIL EM, 1985, PHILOS T ROY SOC B, V308, P37, DOI 10.1098/rstb.1985.0008; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; TORR GA, 1993, COPEIA, P850; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	27	20	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86271	10.1371/journal.pone.0086271	http://dx.doi.org/10.1371/journal.pone.0086271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475097	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800037
J	Howitt, J; Gysbers, AM; Ayton, S; Carew-Jones, F; Putz, U; Finkelstein, DI; Halliday, GM; Tan, SS				Howitt, Jason; Gysbers, Amanda M.; Ayton, Scott; Carew-Jones, Francine; Putz, Ulrich; Finkelstein, David I.; Halliday, Glenda M.; Tan, Seong-Seng			Increased Ndfip1 in the Substantia Nigra of Parkinsonian Brains Is Associated with Elevated Iron Levels	PLOS ONE			English	Article							METAL TRANSPORTER 1; ALPHA-SYNUCLEIN; NEURONAL SURVIVAL; DMT1 REGULATION; DISEASE; NEUROTOXICITY; HOMEOSTASIS; EXPRESSION; DIAGNOSIS; PATHWAYS	Iron misregulation is a central component in the neuropathology of Parkinson's disease. The iron transport protein DMT1 is known to be increased in Parkinson's brains linking functional transport mechanisms with iron accumulation. The regulation of DMT1 is therefore critical to the management of iron uptake in the disease setting. We previously identified post-translational control of DMT1 levels through a ubiquitin-mediated pathway led by Ndfip1, an adaptor for Nedd4 family of E3 ligases. Here we show that loss of Ndfip1 from mouse dopaminergic neurons resulted in misregulation of DMT1 levels and increased susceptibility to iron induced death. We report that in human Parkinson's brains increased iron concentrations in the substantia nigra are associated with upregulated levels of Ndfip1 in dopaminergic neurons containing a-synuclein deposits. Additionally, Ndfip1 was also found to be misexpressed in astrocytes, a cell type normally devoid of this protein. We suggest that in Parkinson's disease, increased iron levels are associated with increased Ndfip1 expression for the regulation of DMT1, including abnormal Ndfip1 activation in non-neuronal cell types such as astrocytes.	[Howitt, Jason; Ayton, Scott; Putz, Ulrich; Finkelstein, David I.; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Gysbers, Amanda M.; Carew-Jones, Francine; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Gysbers, Amanda M.; Carew-Jones, Francine; Halliday, Glenda M.] Univ New S Wales, Sydney, NSW, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Neuroscience Research Australia; University of New South Wales Sydney	Tan, SS (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	sst@unimelb.edu.au	Halliday, Glenda M/E-8555-2011; Carew-Jones, Francine/A-7419-2015; Ayton, Scott/J-8000-2015; Ayton, Scott/AAJ-3414-2021; Finkelstein, David/B-9617-2009	Halliday, Glenda M/0000-0003-0422-8398; Ayton, Scott/0000-0002-3479-2427; Finkelstein, David/0000-0002-8167-4917; Howitt, Jason/0000-0001-9922-7931	National Health and Medical Research Council (NHMRC); Victorian Government through the Operational Infrastructure Scheme	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government through the Operational Infrastructure Scheme	This work was supported by the National Health and Medical Research Council (NH&MRC) and the Victorian Government through the Operational Infrastructure Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; Faucheux BA, 2003, J NEUROCHEM, V86, P1142, DOI 10.1046/j.1471-4159.2003.01923.x; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Garrick MD, 2012, BIOMETALS; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lewy FH, 1912, HDB NEUROLOGIE; Lis A, 2005, BIOCHEM PHARMACOL, V69, P1647, DOI 10.1016/j.bcp.2005.03.023; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Michaeli S, 2007, MOVEMENT DISORD, V22, P334, DOI 10.1002/mds.21227; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Olanow CW, 1998, ANN NEUROL, V44, pS167; Paradkar PN, 2006, J NEUROCHEM, V96, P1768, DOI 10.1111/j.1471-4159.2006.03702.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Schieber C, 2011, J BIOL CHEM, V286, P8555, DOI 10.1074/jbc.M110.203448; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Song YJC, 2009, J NEUROPATH EXP NEUR, V68, P1073, DOI 10.1097/NEN.0b013e3181b66f1b; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Ye FQ, 1996, MOVEMENT DISORD, V11, P243, DOI 10.1002/mds.870110305	34	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87119	10.1371/journal.pone.0087119	http://dx.doi.org/10.1371/journal.pone.0087119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475238	gold, Green Published			2022-12-27	WOS:000330339800084
J	Li, HJ; Leung, KS; Ballester, PJ; Wong, MH				Li, Hongjian; Leung, Kwong-Sak; Ballester, Pedro J.; Wong, Man-Hon			istar: A Web Platform for Large-Scale Protein-Ligand Docking	PLOS ONE			English	Article							EMPIRICAL SCORING FUNCTIONS; BINDING-AFFINITY; PDBBIND DATABASE; AUTODOCK VINA; VALIDATION; DISCOVERY; OPTIMIZATION; CHEMISTRY; DESIGN; ZINC	Protein-ligand docking is a key computational method in the design of starting points for the drug discovery process. We are motivated by the desire to automate large-scale docking using our popular docking engine idock and thus have developed a publicly-accessible web platform called istar. Without tedious software installation, users can submit jobs using our website. Our istar website supports 1) filtering ligands by desired molecular properties and previewing the number of ligands to dock, 2) monitoring job progress in real time, and 3) visualizing ligand conformations and outputting free energy and ligand efficiency predicted by idock, binding affinity predicted by RF-Score, putative hydrogen bonds, and supplier information for easy purchase, three useful features commonly lacked on other online docking platforms like DOCK Blaster or iScreen. We have collected 17,224,424 ligands from the All Clean subset of the ZINC database, and revamped our docking engine idock to version 2.0, further improving docking speed and accuracy, and integrating RF-Score as an alternative rescoring function. To compare idock 2.0 with the state-of-the-art AutoDock Vina 1.1.2, we have carried out a rescoring benchmark and a redocking benchmark on the 2,897 and 343 protein-ligand complexes of PDBbind v2012 refined set and CSAR NRC HiQ Set 24Sept2010 respectively, and an execution time benchmark on 12 diverse proteins and 3,000 ligands of different molecular weight. Results show that, under various scenarios, idock achieves comparable success rates while outperforming AutoDock Vina in terms of docking speed by at least 8.69 times and at most 37.51 times. When evaluated on the PDBbind v2012 core set, our istar platform combining with RF-Score manages to reproduce Pearson's correlation coefficient and Spearman's correlation coefficient of as high as 0.855 and 0.859 respectively between the experimental binding affinity and the predicted binding affinity of the docked conformation. istar is freely available at http://istar.cse.cuhk.edu.hk/idock.	[Li, Hongjian; Leung, Kwong-Sak; Wong, Man-Hon] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Shatin, Hong Kong, Peoples R China; [Ballester, Pedro J.] European Bioinformat Inst, Cambridge, England	Chinese University of Hong Kong; European Molecular Biology Laboratory (EMBL)	Li, HJ (corresponding author), Chinese Univ Hong Kong, Dept Comp Sci & Engn, Shatin, Hong Kong, Peoples R China.	JackyLeeHongJian@Gmail.com; pedro.ballester@ebi.ac.uk	Wong, Man Hon/GOH-0560-2022; Ballester, Pedro/A-1148-2008	Ballester, Pedro/0000-0002-4078-743X				Abreu RMV, 2012, CHEM BIOL DRUG DES, V79, P530, DOI 10.1111/j.1747-0285.2011.01313.x; Abreu RMV, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-10; Baba N, 2011, BIOINFORMATION, V6, P387, DOI 10.6026/97320630006387; Ballester PJ, 2012, LECT NOTES COMPUT SC, V7632, P14, DOI 10.1007/978-3-642-34123-6_2; Ballester PJ, 2012, J R SOC INTERFACE, V9, P3196, DOI 10.1098/rsif.2012.0569; Ballester PJ, 2011, J CHEM INF MODEL, V51, P1739, DOI 10.1021/ci200057e; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Coleman RG, 2010, J CHEM INF MODEL, V50, P589, DOI 10.1021/ci900397t; Corbeil CR, 2007, J CHEM INF MODEL, V47, P435, DOI 10.1021/ci6002637; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Douguet D, 2005, J MED CHEM, V48, P2457, DOI 10.1021/jm0492296; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2146, DOI 10.1021/ci200363q; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Hongjian Li, 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P77, DOI 10.1109/CIBCB.2012.6217214; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kalyaanamoorthy S, 2011, DRUG DISCOV TODAY, V16, P831, DOI 10.1016/j.drudis.2011.07.006; Khodade P, 2007, J APPL CRYSTALLOGR, V40, P598, DOI 10.1107/S0021889807011053; Korb O, 2011, J CHEM INF MODEL, V51, P865, DOI 10.1021/ci100459b; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Li GB, 2013, J CHEM INF MODEL, V53, P592, DOI 10.1021/ci300493w; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Norgan AP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-12; Prakhov ND, 2010, BIOINFORMATICS, V26, P1374, DOI 10.1093/bioinformatics/btq149; Sandeep Gaddam, 2011, BMC Res Notes, V4, P445, DOI 10.1186/1756-0500-4-445; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Therrien E, 2012, J CHEM INF MODEL, V52, P210, DOI 10.1021/ci2004779; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Tsai TY, 2011, J COMPUT AID MOL DES, V25, P525, DOI 10.1007/s10822-011-9438-9; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882	48	75	78	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85678	10.1371/journal.pone.0085678	http://dx.doi.org/10.1371/journal.pone.0085678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475049	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800015
J	Pahlevan, NM; Gharib, M				Pahlevan, Niema M.; Gharib, Morteza			A Bio-Inspired Approach for the Reduction of Left Ventricular Workload	PLOS ONE			English	Article							WAVE REFLECTION; INPUT IMPEDANCE; HEART-FAILURE; PRESSURE; HYPERTENSION; MAMMALS; SIZE	Previous studies have demonstrated the existence of optimization criteria in the design and development of mammalians cardiovascular systems. Similarities in mammalian arterial wave reflection suggest there are certain design criteria for the optimization of arterial wave dynamics. Inspired by these natural optimization criteria, we investigated the feasibility of optimizing the aortic waves by modifying wave reflection sites. A hydraulic model that has physical and dynamical properties similar to a human aorta and left ventricle was used for a series of in-vitro experiments. The results indicate that placing an artificial reflection site (a ring) at a specific location along the aorta may create a constructive wave dynamic that could reduce LV pulsatile workload. This simple bio-inspired approach may have important implications for the future of treatment strategies for diseased aorta.	[Pahlevan, Niema M.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Gharib, Morteza] CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Gharib, M (corresponding author), CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA.	mgharib@caltech.edu	Pahlevan, Niema/AAY-4299-2020; Pahlevan, Niema M/ABF-7268-2021	Pahlevan, Niema/0000-0001-7498-0396; Gharib, Mohammed/0000-0001-9611-1693	American Heart Association (AHA) [12PRE9610015]	American Heart Association (AHA)(American Heart Association)	Niema M. Pahlevan acknowledges support from the American Heart Association (AHA) Predoctoral fellowship (Award Id: 12PRE9610015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attinger E.O., 1964, PULSATILE BLOOD FLOW; Avrahami I, 2008, J FLUID MECH, V608, P139, DOI 10.1017/S0022112008002012; Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050; ELZINGA G, 1991, CIRC RES, V68, P1495, DOI 10.1161/01.RES.68.6.1495; Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z; Ishikawa J, 2012, ARTERY RES, V6, P97, DOI 10.1016/j.artres.2012.01.002; Klingensmith ME., 2008, WASHINGTON MANUAL SU; Knight GEW, 1971, CIRCULATORY RESP MAS; LASKEY WK, 1987, CIRCULATION, V75, P711, DOI 10.1161/01.CIR.75.4.711; Li JK-J., 2018, DYNAMICS VASCULAR SY; LI JKJ, 1991, AM J PHYSIOL, V261, pR519, DOI 10.1152/ajpregu.1991.261.3.R519; LIU ZR, 1989, HYPERTENSION, V14, P129, DOI 10.1161/01.HYP.14.2.129; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Loumes L, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2856528; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; Milnor W. R., 1989, HAEMODYNAMICS; MILNOR WR, 1979, AM J PHYSIOL, V237, pR3, DOI 10.1152/ajpregu.1979.237.1.R3; Mitchell GF, 2001, HYPERTENSION, V38, P1433, DOI 10.1161/hy1201.098298; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nichols W, 1998, MCDONALDS BLOOD FLOW; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; O'ROURKE MICHAEL F., 1967, CARDIOVASC RES, V1, P313, DOI 10.1093/cvr/1.4.313; ORourke MF, 1996, CLIN EXP PHARMACOL P, V23, pS11, DOI 10.1111/j.1440-1681.1996.tb03035.x; OROURKE MF, 1984, ANN BIOMED ENG, V12, P119, DOI 10.1007/BF02584226; Pahlevan NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023106; Quick CM, 2001, AM J PHYSIOL-HEART C, V280, pH1519, DOI 10.1152/ajpheart.2001.280.4.H1519; Safar ME, 2006, HDB HYPERTENSION, V23; WESTERHOF N, 1991, AM J PHYSIOL, V261, pR126, DOI 10.1152/ajpregu.1991.261.1.R126; WESTERHOF N, 1995, J HYPERTENS, V13, P943, DOI 10.1097/00004872-199509000-00002; Westerhof N, 2005, SNAPSHOTS HEMODYNAMI; Zamir M, 1998, P ROY SOC B-BIOL SCI, V265, P439, DOI 10.1098/rspb.1998.0314; Zamir M., 2000, PHYS PULSATILE FLOW	32	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87122	10.1371/journal.pone.0087122	http://dx.doi.org/10.1371/journal.pone.0087122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475239	gold, Green Accepted, Green Published			2022-12-27	WOS:000330339800085
J	Su, HL; Liu, Y; Xu, ZH; Cheng, SQ; Ye, HY; Xu, Q; Liu, QB; Tan, SH; Xu, DP; Liu, YM				Su, Heling; Liu, Yan; Xu, Zhihui; Cheng, Shuquan; Ye, Haiyan; Xu, Qing; Liu, Qingbo; Tan, Shuhong; Xu, Dongping; Liu, Yongming			A Novel Complex A/C/G Intergenotypic Recombinant of Hepatitis B Virus Isolated in Southern China	PLOS ONE			English	Article							GENOTYPE-E STRAINS; VIROLOGICAL CHARACTERISTICS; HEPATOCELLULAR-CARCINOMA; GENOME; SUBGENOTYPES; IDENTIFICATION; REPLICATION; REGION	Hepatitis B virus (HBV) genotypes and subgenotypes may vary in geographical distribution and virological features. Previous investigations, including ours, showed that HBV genotypes B and C were respectively predominant in South and North China, while genotypes A and D were infrequently detected and genotype G was not found. In this study, a novel A/C/G intergenotype was identified in patients with chronic HBV infection in Guilin, a city in southern China. Initial phylogenetic analysis based on the S gene suggested the HBV recombinant to be genotype G. However, extended genotyping based on the entire HBV genome indicated it to be an A/C/G intergenotype with a closer relation to genotype C. Breakpoint analysis using the SIMPLOT program revealed that the recombinant had a recombination with a arrangement of genotypes A, G, A and C fragments. Compared with the HBV recombinants harboring one or two genotype G fragments found in Asian countries, this Guilin recombinant was highly similar to the Vietnam (98-99%) and Long An recombinants (96-99%), but had a relatively low similarity to the Thailand one (89%). Unlike those with the typical genotype G of HBV, the patients with the Guilin recombinant were seropositive for HBeAg. Moreover, a relatively high HBV DNA viral load (>2x10(6) IU/ml) was detected in the patients, and the analysis of viral replication capacity showed that the Guilin recombinant strains had a competent replication capacity similar to genotypes B and C strains. These findings can aid in not only the clarification of the phylogenetic origin of the HBV recombinants with the genotype G fragment found in Asian countries, but also the understanding of the virological properties of these complicated HBV recombinants.	[Su, Heling; Liu, Qingbo; Tan, Shuhong; Liu, Yongming] Guilin Med Univ, Dept Biochem & Mol Biol, Guilin, Guangxi, Peoples R China; [Liu, Yan; Xu, Zhihui; Xu, Dongping] Beijing 302 Hosp, Viral Hepatitis Res Lab, Inst Infect Dis, Liver Failure Med Ctr, Beijing, Peoples R China; [Cheng, Shuquan; Ye, Haiyan] Third Peoples Hosp Guilin, Div Hepatol, Guilin, Guangxi, Peoples R China; [Xu, Qing] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Guilin, Guangxi, Peoples R China	Guilin Medical University; Fifth Medical Center of Chinese PLA General Hospital; Guilin Medical University	Xu, DP (corresponding author), Beijing 302 Hosp, Viral Hepatitis Res Lab, Inst Infect Dis, Liver Failure Med Ctr, Beijing, Peoples R China.	xudongping@yahoo.com; liuym@glmc.edu.cn	SU, Heling/ABF-4467-2021		National Nature Science Foundation of China [81271847]; Nature Science Foundation of Guangxi Zhuang Autonomous Region of China [2012GXNSFAA053146]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangxi Zhuang Autonomous Region of China	This work is supported by the grants from the National Nature Science Foundation of China (No. 81271847) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Nature Science Foundation of Guangxi Zhuang Autonomous Region of China (No. 2012GXNSFAA053146) (http://www.gxst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo NM, 2013, J GEN VIROL, V94, P150, DOI 10.1099/vir.0.047324-0; Bowyer SM, 2000, J GEN VIROL, V81, P379, DOI 10.1099/0022-1317-81-2-379; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Mello FCD, 2012, MEM I OSWALDO CRUZ, V107, P317, DOI 10.1590/S0074-02762012000300005; Fang ZL, 2011, J GEN VIROL, V92, P402, DOI 10.1099/vir.0.026666-0; Garmiri P, 2009, J GEN VIROL, V90, P2442, DOI 10.1099/vir.0.012013-0; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; GUNTHER S, 1995, J VIROL, V69, P5437; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Ji D, 2011, CLIN CHIM ACTA, V412, P305, DOI 10.1016/j.cca.2010.10.028; Kato H, 2002, J VIROL, V76, P6131, DOI 10.1128/JVI.76.12.6131-6137.2002; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Li K, 2007, J VIROL, V81, P9202, DOI 10.1128/JVI.00390-07; Li XD, 2011, CHINESE MED J-PEKING, V124, P4178, DOI 10.3760/cma.j.issn.0366-6999.2011.24.011; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Owiredu WKBA, 2001, J MED VIROL, V64, P441, DOI 10.1002/jmv.1070; Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x; Sanchez LV, 2007, INTERVIROLOGY, V50, P9, DOI 10.1159/000096307; Shi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047271; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Su He-ling, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P340; Sugauchi F, 2003, GASTROENTEROLOGY, V124, P925, DOI 10.1053/gast.2003.50140; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Suwannakarn K, 2005, J GEN VIROL, V86, P3027, DOI 10.1099/vir.0.81241-0; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; World Health Organization, 2013, HEP B FACT SHEET; Yang JH, 2013, WORLD J GASTROENTERO, V19, P3861, DOI 10.3748/wjg.v19.i24.3861; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yuasa R, 2000, J MED VIROL, V61, P23, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;23::AID-JMV4&gt;3.0.CO;2-X; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84005	10.1371/journal.pone.0084005	http://dx.doi.org/10.1371/journal.pone.0084005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475029	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800005
J	Timoneda, O; Nunez-Hernandez, F; Balcells, I; Munoz, M; Castello, A; Vera, G; Perez, LJ; Egea, R; Mir, G; Cordoba, S; Rosell, R; Segales, J; Tomas, A; Sanchez, A; Nunez, JI				Timoneda, Oriol; Nunez-Hernandez, Fernando; Balcells, Ingrid; Munoz, Marta; Castello, Anna; Vera, Gonzalo; Perez, Lester J.; Egea, Raquel; Mir, Gisela; Cordoba, Sarai; Rosell, Rosa; Segales, Joaquim; Tomas, Anna; Sanchez, Armand; Nunez, Jose I.			The Role of Viral and Host MicroRNAs in the Aujeszky's Disease Virus during the Infection Process	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; PSEUDORABIES VIRUS; KYOTO ENCYCLOPEDIA; NONCODING RNAS; WEB SERVER; TARGETS; IDENTIFICATION; EXPRESSION; GENES; BIOGENESIS	Porcine production is a primary market in the world economy. Controlling swine diseases in the farm is essential in order to achieve the sector necessities. Aujeszky's disease is a viral condition affecting pigs and is endemic in many countries of the world, causing important economic losses in the swine industry. microRNAs (miRNAs) are non-coding RNAs which modulates gene expression in animals, plants and viruses. With the aim of understanding miRNA roles during the Aujeszky's disease virus [ADV] (also known as suid herpesvirus type 1 [SuHV-1]) infection, the expression profiles of host and viral miRNAs were determined through deep sequencing in SuHV-1 infected porcine cell line (PK-15) and in an animal experimental SuHV-1 infection with virulent (NIA-3) and attenuated (Begonia) strains. In the in vivo approach miR-206, miR-133a, miR-133b and miR-378 presented differential expression between virus strains infection. In the in vitro approach, most miRNAs were down-regulated in infected groups. miR-92a and miR-92b-3p were up-regulated in Begonia infected samples. Functional analysis of all this over expressed miRNAs during the infection revealed their association in pathways related to viral infection processes and immune response. Furthermore, 8 viral miRNAs were detected by stem loop RT-qPCR in both in vitro and in vivo approaches, presenting a gene regulatory network affecting 59 viral genes. Most described viral miRNAs were related to Large Latency Transcript (LLT) and to viral transcription activators EP0 and IE180, and also to regulatory genes regarding their important roles in the host - pathogen interaction during viral infection.	[Timoneda, Oriol; Balcells, Ingrid; Castello, Anna; Egea, Raquel; Sanchez, Armand] Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, E-08193 Barcelona, Spain; [Timoneda, Oriol; Balcells, Ingrid; Castello, Anna; Vera, Gonzalo; Cordoba, Sarai; Sanchez, Armand] Univ Autonoma Barcelona, Dept Genet Anim, CRAG, CSIC IRTA UAB UB, E-08193 Barcelona, Spain; [Nunez-Hernandez, Fernando; Munoz, Marta; Rosell, Rosa; Segales, Joaquim; Nunez, Jose I.] UAB IRTA, CReSA, Bellaterra, Cerdanyola Del, Spain; [Perez, Lester J.] Ctr Nacl Sanidad Agr CENSA, Havana, Cuba; [Mir, Gisela] Univ Autonoma Barcelona, CRAG Sci Serv, CRAG, CSIC IRTA UAB UB, E-08193 Barcelona, Spain; [Rosell, Rosa] Dept Agr Ramaderia Pesca Alimentacio & Medi Nat G, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Tomas, Anna] FISIB, Program Infect & Immun, Bunyola, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Autonomous University of Barcelona	Timoneda, O (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, E-08193 Barcelona, Spain.	oriol.timoneda@cragenomica.es	Egea, Raquel/F-9355-2016; Sanchez, Armand/L-7905-2015; Perez, Lester J./A-1339-2016; Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020; Farré, Anna Castelló/K-9637-2015; Vera, Gonzalo/L-1895-2014; Nuñez, Jose I/M-7141-2018	Egea, Raquel/0000-0002-6201-4112; Sanchez, Armand/0000-0001-9160-1124; Perez, Lester J./0000-0002-5717-5181; Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Farré, Anna Castelló/0000-0001-8497-6251; Vera, Gonzalo/0000-0001-6990-0216; Nuñez, Jose I/0000-0001-9890-7695; Cordoba, Sarai/0000-0002-8786-9889; Mir Arnau, Gisela/0000-0002-9005-3485; Rosell, Rosa/0000-0002-8294-1159	Ministerio de Ciencia e Innovacion [AGL2007-66371-C02, AGL2010-22358-C02, CDS2006-00007]; Spanish government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by the projects AGL2007-66371-C02, AGL2010-22358-C02 and CDS2006-00007 from Ministerio de Ciencia e Innovacion. OT is the recipient of a PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government. The funders had no role in the sutdy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina S, 2011, TRANSL RES, V157, P236, DOI 10.1016/j.trsl.2011.01.011; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Amills M, 2010, ORIGIN GENETIC DIVER; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besecker MI, 2009, J VIROL, V83, P3413, DOI 10.1128/JVI.02419-08; Bortoluzzi S, 2011, TRENDS MOL MED, V17, P473, DOI 10.1016/j.molmed.2011.05.005; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Enright AJ, 2004, GENOME BIOL, V5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hata A, 2013, ANNU REV PHYSIOL, V75, P69, DOI 10.1146/annurev-physiol-030212-183737; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jurak I, 2011, BBA-GENE REGUL MECH, V1809, P641, DOI 10.1016/j.bbagrm.2011.06.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanis E, 2005, J ANIM SCI, V83, P948; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Ma LM, 2013, J GENET GENOMICS, V40, P143, DOI 10.1016/j.jgg.2013.03.002; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pejsak ZK, 2006, DIS SWINE, P419; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Rederstorff M, 2010, CURR OPIN MOL THER, V12, P684; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Skovgaard K, 2013, INNATE IMMUN-LONDON, V19, P531, DOI 10.1177/1753425912473668; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	18	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86965	10.1371/journal.pone.0086965	http://dx.doi.org/10.1371/journal.pone.0086965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475202	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800072
J	Wu, B; Qi, X; Xu, K; Ji, H; Zhu, YF; Tang, FY; Zhou, MH				Wu, Bin; Qi, Xian; Xu, Ke; Ji, Hong; Zhu, Yefei; Tang, Fenyang; Zhou, Minghao			Genetic Characteristics of the Coxsackievirus A24 Variant Causing Outbreaks of Acute Hemorrhagic Conjunctivitis in Jiangsu, China, 2010	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; IDENTIFICATION; GUANGDONG; EPIDEMIC; TAIWAN	During September 2010, an outbreak of acute hemorrhagic conjunctivitis reemerged in Jiangsu, three years after the nationwide epidemic in China in 2007. In total, 2409 cases were reported, 2118 of which were reported in September; 79.8% of those affected were students or teachers, with a median age of 16 years. To identify and demonstrate the genetic characteristics of the etiological agent, 52 conjunctival swabs were randomly collected from four different cities. After detection and isolation, 43 patients were positive for coxsackievirus A24 variant according to PCR and 20 according to culture isolation. Neither adenovirus nor EV70 was detected. A phylogenetic study of the complete 3Cpro and VP1 regions showed that the Jiangsu isolates clustered into a new lineage, GIV-C5, with two uniform amino-acid mutations that distinguished them from all previous strains. Another new cluster, GIV-C4, formed by Indian isolates from 2007 and Brazilian isolates from 2009, was also identified in this study. Interestingly, our isolates shared greatest homology with the GIV-C4 strains, not with the isolates that were responsible for the nationwide acute hemorrhagic conjunctivitis epidemic in China in 2007. Although all our isolates were closely related, they could be differentiated into two subclusters within GIV-C5. In conclusion, our study suggests that a new cluster of coxsackievirus A24 variant that had already evolved into diverse strains was associated with the acute hemorrhagic conjunctivitis outbreaks in Jiangsu in September 2010. These viruses might have originated from the virus isolated in India in 2007, rather than from the epidemic strains isolated in China in 2007.	[Wu, Bin; Qi, Xian; Xu, Ke; Ji, Hong; Zhu, Yefei; Tang, Fenyang; Zhou, Minghao] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Zhu, YF (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	jszyf@jscdc.cn	zhou, minghao/GZA-7244-2022		Jiangsu Province Health Development Project with Science and Education [ZX201109, RC2011084, RC2011085]	Jiangsu Province Health Development Project with Science and Education	The study was supported by Jiangsu Province Health Development Project with Science and Education (ZX201109, RC2011084 and RC2011085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub EA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-96; BABALOLA OE, 1990, BRIT J OPHTHALMOL, V74, P89, DOI 10.1136/bjo.74.2.89; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1024; Chang CH, 2001, CORNEA, V20, P295, DOI 10.1097/00003226-200104000-00011; Chu PY, 2009, J CLIN VIROL, V45, P285, DOI 10.1016/j.jcv.2009.04.013; De W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-41; Fonseca MC, 2012, J CLIN VIROL, V53, P77, DOI 10.1016/j.jcv.2011.10.006; ISHIKO H, 1992, VIROLOGY, V187, P748, DOI 10.1016/0042-6822(92)90477-7; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Mitchell S, 2003, J CLIN VIROL, V26, P331, DOI 10.1016/S1386-6532(02)00082-3; Mu G F, 1989, Zhonghua Yan Ke Za Zhi, V25, P20; Oh MD, 2003, EMERG INFECT DIS, V9, P1010; Shukla D, 2013, ARCH VIROL, V158, P679, DOI 10.1007/s00705-012-1520-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023206; Tavares FN, 2006, EMERG INFECT DIS, V12, P495, DOI 10.3201/eid1203.051173; Triki H, 2007, CLIN MICROBIOL INFEC, V13, P176, DOI 10.1111/j.1469-0691.2006.01618.x; Wu D, 2008, J MED VIROL, V80, P1762, DOI 10.1002/jmv.21288; Yan DM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-138; Yan Ju-ying, 2011, Chinese Journal of Virology, V27, P421; Yang Jing, 2012, Chinese Journal of Virology, V28, P663	21	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86883	10.1371/journal.pone.0086883	http://dx.doi.org/10.1371/journal.pone.0086883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475191	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800068
J	Yu, DL; Pi, BR; Chen, Y; Wang, YF; Ruan, Z; Otto, M; Yu, YS				Yu, Dongliang; Pi, Borui; Chen, Yan; Wang, Yanfei; Ruan, Zhi; Otto, Michael; Yu, Yunsong			Characterization of the Staphylococcal Cassette Chromosome Composite Island of Staphylococcus haemolyticus SH32, a Methicillin-Resistant Clinical Isolate from China	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MEC SCCMEC; AUREUS; IDENTIFICATION; VIRULENCE; SEQUENCE; STRAINS; GENOME	Staphylococcal cassette chromosome (SCC) elements contribute considerably to virulence and resistance to antibiotic agents in staphylococci. SCC elements in coagulase-negative staphylococci (CoNS) are highly diverse and there is evidence suggesting that they serve as a reservoir for antibiotic resistance genes in methicillin-resistant Staphylococcus aureus (MRSA). However, only a small number of SCC elements have been characterized in CoNS and their exact roles in the emergence and evolution of MRSA remain to be demonstrated. Here, we determined the structure of an SCC composite island (CISH32) found in the clinical Staphylococcus haemolyticus isolate SH32 by whole-genome DNA sequencing. CISH32 was 48 kb in length and mainly composed of two imperfect SCC elements, namely (i) a Psi SCCmec(SH32) part containing a class C1 mec gene complex but lacking ccr genes and (ii) a SCCSH32 part with a ccrA5B3 gene complex but lacking mec genes. In addition, CISH32 contained a type III restriction-modification system and several resistance loci, for example genes conferring resistance to cadmium and arsenic. Psi SCCmec(SH32) is almost entirely identical to a pseudo SCCmec element found in S. haemolyticus WCH1 and shares pronounced sequence similarity to a Psi SCCmec element of S. haemolyticus JCSC1435. However, staphylococci other than S. haemolyticus, including S. aureus and S. epidermidis, contain homologs of SCCSH32 that are more similar to SCCSH32 than those elements found in S. haemolyticus, suggesting that CISH32 of S. haemolyticus SH32 was assembled in recent evolutionary events. Moreover, the composite structure of CISH32 indicates that the detection of class C1 mec and ccrA5B3 gene complexes in S. haemolyticus does not always indicate the existence of a UT9-type SCCmec element, which has remained questionable.	[Yu, Dongliang] Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Hangzhou, Zhejiang, Peoples R China; [Yu, Dongliang; Pi, Borui; Chen, Yan; Wang, Yanfei; Ruan, Zhi; Yu, Yunsong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yan; Otto, Michael] NIAID, NIH, Bethesda, MD 20892 USA	Hangzhou Normal University; Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	motto@niaid.nih.gov; yvys119@163.com	wang, yan/GSE-6489-2022; Yu, Dongliang/ABA-1393-2021; Wang, Yanbo/HFZ-8018-2022; Ruan, Zhi/P-3987-2015; Chen, Yan/U-1480-2018	Ruan, Zhi/0000-0001-8648-4592; Otto, Michael/0000-0002-2222-4115; Chen, Yan/0000-0002-7679-1713	National Natural Science Foundation of China [NSFC81201327]; Ministry of Health of the People's Republic of China [201002021]; Science Technology Department of Zhejiang Province [2008C13029-1]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904, ZIAAI001080] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of the People's Republic of China; Science Technology Department of Zhejiang Province; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China (no. NSFC81201327), the Ministry of Health of the People's Republic of China (no. 201002021), the Science Technology Department of Zhejiang Province (no. 2008C13029-1), and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aranda J, 2009, INT MICROBIOL, V12, P137, DOI 10.2436/20.1501.01.91; Bayer AS, 1999, INFECT IMMUN, V67, P740, DOI 10.1128/IAI.67.2.740-744.1999; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Shore AC, 2013, INT J MED M IN PRESS; Shore AC, 2012, ANTIMICROB AGENTS CH, V56, P5340, DOI 10.1128/AAC.01247-12; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zong ZY, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-64; Zong ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020191; Zong ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014016	25	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87346	10.1371/journal.pone.0087346	http://dx.doi.org/10.1371/journal.pone.0087346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466348	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000204
J	Baribeau, S; Chaudhry, P; Parent, S; Asselin, E				Baribeau, Sebastien; Chaudhry, Parvesh; Parent, Sophie; Asselin, Eric			Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; BREAST-CANCER; DOWN-REGULATION; SLUG; EXPRESSION; APOPTOSIS; REGULATORS; PHENOTYPE; REPRESSOR	Background: Many patients diagnosed with ovarian cancer experience recurrence and metastasis, two aspects that will often cause their demise. Epithelial-to-mesenchymal transition (EMT) is a key process involved in cancer progression. With increasing evidence linking Cisplatin and EMT, we wanted to identify a compound able to counter EMT progression when cancer cells are treated with Cisplatin. Methodology/Principal Findings: Cell death was evaluated by cytometry with Annexin V/PI staining in A2780 and A2780CP cells. Ovarian cancer cell lines were treated with Cisplatin (24 h, 10 mu M) and different concentrations of Resveratrol to evaluate its effect on Cisplatin-induced EMT using Western Blot and RT-PCR analysis. Morphological studies and wound healing assay to evaluate cell motility were performed using 72 h Cisplatin treatment with A2780 and A2780CP cells. Densitometry was done on Western Blot and PCR results, and statistical significance was determined using One-Way ANOVA followed by Tukey post-hoc test. Our results show that Cisplatin induced EMT-associated morphological changes in the A2780 ovarian cancer cell line and to a lesser extent in its Cisplatin-resistant counterpart A2780CP. Resveratrol caused cell death in A2780 and A2780CP cell lines in an apoptotic-independent manner. Resveratrol inhibited Cisplatin-induced Snail expression by reducing the Erk pathway activation, reverted morphological changes induced by Cisplatin and decreased cell migration. Conclusions: These results indicate that Resveratrol has interesting potential to prevent Cisplatin-induced EMT in ovarian cancer cells. By increasing cell death, it also represents an inviting approach as adjuvant therapy to be used with chemotherapy. Using Erk pathway inhibitors could also prove helpful in ovarian cancer treatment to reduce the risk of metastasis.	[Baribeau, Sebastien; Chaudhry, Parvesh; Parent, Sophie; Asselin, Eric] Univ Quebec Trois Rivieres, Dept Med Biol, Res Grp Mol Oncol & Endocrinol, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, Res Grp Mol Oncol & Endocrinol, Trois Rivieres, PQ GA9 5H7, Canada.	eric.asselin@uqtr.ca	Chaudhry, Parvesh/I-4417-2015		Canadian Institutes for Health Research [MOP-66987]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work has been supported by a grant from the Canadian Institutes for Health Research (MOP-66987). EA holds a Canadian Research Chair in Molecular-Gyneco-Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cal C., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P77, DOI 10.2174/1568011033353443; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chen QM, 2000, J CELL SCI, V113, P4087; Colombo PE, 2013, CRIT REV ONCOL HEMAT; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Du F, 2013, ONCOL REP; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Hajra KM, 2002, CANCER RES, V62, P1613; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hu F, 2010, BBA-MOL BASIS DIS, V1802, P301, DOI 10.1016/j.bbadis.2009.12.002; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; LOUIE KG, 1985, CANCER RES, V45, P2110; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Schmeiser K, 1998, FEBS LETT, V433, P51, DOI 10.1016/S0014-5793(98)00850-3; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Society CC, 2011, CAN CANC STAT; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Wang HY, 2013, TOXICOLOGY, V303, P139, DOI 10.1016/j.tox.2012.09.017; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142	39	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86987	10.1371/journal.pone.0086987	http://dx.doi.org/10.1371/journal.pone.0086987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466305	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100240
J	Dalen, M; Ivert, T; Holzmann, MJ; Sartipy, U				Dalen, Magnus; Ivert, Torbjorn; Holzmann, Martin J.; Sartipy, Ulrik			Bilateral versus Single Internal Mammary Coronary Artery Bypass Grafting in Sweden from 1997-2008	PLOS ONE			English	Article							30-YEAR FOLLOW-UP; THORACIC ARTERY; MYOCARDIAL REVASCULARIZATION; SURVIVAL BENEFIT; VALIDATION; LOCATION; SOCIETY; DISEASE	Background: Prior observational studies have suggested better outcomes in patients who receive bilateral internal mammary arteries (BIMA) during coronary artery bypass grafting (CABG) compared with patients who receive a single internal mammary artery (SIMA). The aim of this study was to analyze the association between BIMA use and long-term survival in patients who underwent primary isolated CABG. Methods and Results: Patients who underwent primary isolated non-emergent CABG in Sweden between 1997 and 2008 were identified. The SWEDEHEART registry and other national Swedish registers were used to acquire information about patient characteristics and outcomes. Unadjusted and multivariable adjusted regression models were used to estimate the association between BIMA use and early mortality, long-term survival, and a composite of death from any cause or rehospitalization for myocardial infarction, heart failure, or stroke in the overall cohort and in a propensity score-matched cohort. The study population consisted of 49702 patients who underwent CABG with at least one internal mammary artery, and 559 (1%) of those had BIMA grafting. In the adjusted analyses, BIMA use was not associated with better survival compared with SIMA use in the overall cohort (hazard ratio (HR) for death: 1.16, 95% confidence interval (CI): 0.97 to 1.37) or in the matched cohort (HR: 1.04, 95% CI: 0.78 to 1.40). The results were similar for early mortality and the composite endpoint. Reoperation for sternal wound complications was more common among BIMA patients (odds ratio: 1.71, 95% CI: 1.01 to 2.88). Conclusions: BIMA grafting was performed infrequently and was not associated with better outcomes compared with SIMA grafting in patients undergoing non-emergent primary isolated CABG in Sweden during 1997-2008.	[Dalen, Magnus; Ivert, Torbjorn; Sartipy, Ulrik] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Dalen, Magnus; Ivert, Torbjorn; Sartipy, Ulrik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Holzmann, Martin J.] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden; [Holzmann, Martin J.] Karolinska Inst, Dept Internal Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sartipy, U (corresponding author), Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden.	Ulrik.Sartipy@karolinska.se	Sartipy, Ulrik/E-9780-2014	Sartipy, Ulrik/0000-0003-2707-0263				Berreklouw E, 2001, ANN THORAC SURG, V72, P1535, DOI 10.1016/S0003-4975(01)03040-5; Bridgewater B, 2009, 6 NATL ADULT CARDIAC; Calafiore AM, 2005, ANN THORAC SURG, V80, P888, DOI 10.1016/j.athoracsur.2005.03.077; Carrel T, 1996, ANN THORAC SURG, V62, P1289, DOI 10.1016/0003-4975(96)00627-3; Dorman MJ, 2012, CIRCULATION, V126, P2935, DOI 10.1161/CIRCULATIONAHA.112.117606; ElBardissi AW, 2012, J THORAC CARDIOV SUR, V143, P273, DOI 10.1016/j.jtcvs.2011.10.029; Grau JB, 2012, EUR J CARDIO-THORAC, V41, P770, DOI 10.1093/ejcts/ezr213; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Hirotani T, 2003, ANN THORAC SURG, V76, P2017, DOI 10.1016/S0003-4975(03)01062-2; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Kelly R, 2012, J THORAC CARDIOV SUR, V144, P1408, DOI 10.1016/j.jtcvs.2012.01.030; Kurlansky PA, 2011, ANN THORAC SURG, V91, P1378, DOI 10.1016/j.athoracsur.2011.01.055; Kurlansky PA, 2010, ANN THORAC SURG, V90, P101, DOI 10.1016/j.athoracsur.2010.04.006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Locker C, 2012, CIRCULATION, V126, P1023, DOI 10.1161/CIRCULATIONAHA.111.084624; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6; Puskas JD, 2012, ANN THORAC SURG, V94, P710, DOI 10.1016/j.athoracsur.2012.03.082; Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827; Stevens LM, 2004, J THORAC CARDIOV SUR, V127, P1408, DOI 10.1016/j.jtcvs.2003.10.006; Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tatoulis J, 2011, ANN THORAC SURG, V92, P9, DOI 10.1016/j.athoracsur.2011.03.099; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618	31	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86929	10.1371/journal.pone.0086929	http://dx.doi.org/10.1371/journal.pone.0086929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466293	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500287
J	Hagger-Johnson, G; Deary, IJ; Davies, CA; Weiss, A; Batty, GD				Hagger-Johnson, Gareth; Deary, Ian J.; Davies, Carolyn A.; Weiss, Alexander; Batty, G. David			Reaction Time and Mortality from the Major Causes of Death: The NHANES-III Study	PLOS ONE			English	Article							ALL-CAUSE-MORTALITY; CARDIOVASCULAR-DISEASE MORTALITY; LATE ADOLESCENCE/EARLY ADULTHOOD; MENTAL SURVEY 1932; RISK-FACTORS; CHILDHOOD IQ; MIDDLE-AGE; PREMATURE MORTALITY; PUBLIC-HEALTH; LIFE	Objective: Studies examining the relation of information processing speed, as measured by reaction time, with mortality are scarce. We explored these associations in a representative sample of the US population. Methods: Participants were 5,134 adults (2,342 men) aged 20-59 years from the Third National Health and Nutrition Examination Survey (NHANES III, 1988-94). Results: Adjusted for age, sex, and ethnic minority status, a 1 SD slower reaction time was associated with a raised risk of mortality from all-causes (HR = 1.25, 95% CI 1.12, 1.39) and cardiovascular disease (CVD) (HR = 1.36, 95% CI 1.17, 1.58). Having 1 SD more variable reaction time was also associated with greater risk of all-cause (HR = 1.36, 95% CI 1.19, 1.55) and CVD (HR = 1.50, 95% CI 1.33, 1.70) mortality. No associations were observed for cancer mortality. The magnitude of the relationships was comparable in size to established risk factors in this dataset, such as smoking. Interpretation: Alongside better-established risk factors, reaction time is associated with increased risk of premature death and cardiovascular disease. It is a candidate risk factor for all-cause and cause-specific mortality.	[Hagger-Johnson, Gareth; Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England; [Deary, Ian J.; Weiss, Alexander; Batty, G. David] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Carolyn A.] Univ Glasgow, MRC, CSO, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of London; University College London; University of Edinburgh; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Hagger-Johnson, G (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	g.hagger-johnson@ucl.ac.uk	Batty, GD/Y-4401-2018; Deary, Ian J/C-6297-2009	Batty, GD/0000-0003-1822-5753; Deary, Ian J/0000-0002-1733-263X	Economic and Social Research Council (ESRC) National Centre for Research Methods (NCRM); Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); Medical Research Council (MRC); MRC [G0700704] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G0700704] Funding Source: researchfish	Economic and Social Research Council (ESRC) National Centre for Research Methods (NCRM)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Gareth Hagger-Johnson is supported by a grant from the Economic and Social Research Council (ESRC) National Centre for Research Methods (NCRM). The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE) is part of the cross council Lifelong Health and Wellbeing initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC) and Medical Research Council (MRC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER EL, 1985, J OCCUP ENVIRON MED, V27, P206; Batterham PJ, 2009, INTELLIGENCE, V37, P551, DOI 10.1016/j.intell.2008.10.004; Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2008, J EPIDEMIOL COMMUN H, V62, P522, DOI 10.1136/jech.2007.064881; Batty GD, 2007, ANN ONCOL, V18, P21, DOI 10.1093/annonc/mdl473; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P997, DOI 10.1136/jech.2006.054494; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2009, PSYCHO-ONCOLOGY, V18, P1122, DOI 10.1002/pon.1521; Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Batty GD, 2008, BRIT J PSYCHIAT, V193, P461, DOI 10.1192/bjp.bp.107.037424; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Corley J, 2009, INTELLIGENCE, V37, P238, DOI 10.1016/j.intell.2008.11.003; Deary I, 2012, GERONTOLOGY; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Deary IJ, 2010, PSYCHOL AGING, V25, P219, DOI 10.1037/a0017750; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Enders C. K., 2010, APPL MISSING DATA AN; Hagger-Johnson G, 2012, J GERONTOLOGY B; Hart CL, 2005, BRIT J HEALTH PSYCH, V10, P153, DOI 10.1348/135910704X14591; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hendrickson AE, 1982, MODEL INTELLIGENCE, P151, DOI DOI 10.1007/978-3-642-68664-1_6; Johnson W, 2011, INTELLIGENCE, V39, P405, DOI 10.1016/j.intell.2011.07.003; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Lager A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5282; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; Letz R, 1990, NEUROBEHAVIORAL EVAL; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Metter EJ, 2005, J GERONTOL A-BIOL, V60, P840, DOI 10.1093/gerona/60.7.840; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pearce MS, 2006, PUBLIC HEALTH, V120, P1020, DOI 10.1016/j.puhe.2006.06.015; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Roberts BA, 2009, INTELLIGENCE, V37, P561, DOI 10.1016/j.intell.2009.02.001; Shipley BA, 2006, PSYCHOSOM MED, V68, P17, DOI 10.1097/01.psy.0000195867.66643.0f; Shipley BA, 2008, J PSYCHOSOM RES, V65, P143, DOI 10.1016/j.jpsychores.2008.02.017; SINGHMANOUX A, 2012, BMJ-BRIT MED J, V5, P344; Starr JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-307; Suzuki L, 2005, PSYCHOL PUBLIC POL L, V11, P320, DOI 10.1037/1076-8971.11.2.320; U.S. Department of Health and Human Services (DHHS), 1996, 76200 US DHHS CDCP N; *US DEP HHS, 1996, 3 NAT HLTH NUTR EX S; Walker AJ, 2009, AUST PSYCHOL, V44, P216, DOI 10.1080/00050060902833469; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	47	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e82959	10.1371/journal.pone.0082959	http://dx.doi.org/10.1371/journal.pone.0082959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489645	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000330570000005
J	Davies, GF; Berg, A; Postnikoff, SDL; Wilson, HL; Arnason, TG; Kusalik, A; Harkness, TAA				Davies, Gerald F.; Berg, Arnie; Postnikoff, Spike D. L.; Wilson, Heather L.; Arnason, Terra G.; Kusalik, Anthony; Harkness, Troy A. A.			TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response	PLOS ONE			English	Article							TISSUE FACTOR PATHWAY; TUMOR MICROENVIRONMENT; ANTIANGIOGENIC THERAPY; HISTONE DEACETYLASES; ILLUMINA MICROARRAY; ENDOTHELIAL-CELLS; METASTATIC GROWTH; INHIBITOR; PROTEIN; PROGRESSION	Thrombin and hypoxia are important players in breast cancer progression. Breast cancers often develop drug resistance, but mechanisms linking thrombin and hypoxia to drug resistance remain unresolved. Our studies using Doxorubicin (DOX) resistant MCF7 breast cancer cells reveals a mechanism linking DOX exposure with hypoxic induction of DOX resistance. Global expression changes between parental and DOX resistant MCF7 cells were examined. Westerns, Northerns and immunocytochemistry were used to validate drug resistance and differentially expressed genes. A cluster of genes involved in the anticoagulation pathway, with Tissue Factor Pathway Inhibitor 1 (TFPI1) the top hit, was identified. Plasmids overexpressing TFPI1 were utilized, and 1% O-2 was used to test the effects of hypoxia on drug resistance. Lastly, microarray datasets from patients with drug resistant breast tumors were interrogated for TFPI1 expression levels. TFPI1 protein levels were found elevated in 3 additional DOX resistant cells lines, from humans and rats, indicating evolutionarily conservation of the effect. Elevated TFPI1 in DOX resistant cells was active, as thrombin protein levels were coincidentally low. We observed elevated HIF1 alpha protein in DOX resistant cells, and in cells with forced expression of TFPI1, suggesting TFPI1 induces HIF1 alpha. TFPI1 also induced c-MYC, c-SRC, and HDAC2 protein, as well as DOX resistance in parental cells. Growth of cells in 1% O-2 induced elevated HIF1 alpha, BCRP and MDR-1 protein, and these cells were resistant to DOX. Our in vitro results were consistent with in vivo patient datasets, as tumors harboring increased BCRP and MDR-1 expression also had increased TFPI1 expression. Our observations are clinically relevant indicating that DOX treatment induces an anticoagulation cascade, leading to inhibition of thrombin and the expression of HIF1 alpha. This in turn activates a pathway leading to drug resistance.	[Davies, Gerald F.; Postnikoff, Spike D. L.; Harkness, Troy A. A.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Arnason, Terra G.] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada; [Berg, Arnie; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Wilson, Heather L.] Univ Saskatchewan, VIDO, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Harkness, TAA (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada.	troy.harkness@usask.ca		Wilson, Heather/0000-0002-1261-0901; Harkness, Troy/0000-0002-8271-7229	Canadian Breast Cancer Foundation; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants to TAH and TGA from the Canadian Breast Cancer Foundation and the Canadian Foundation for Innovation, and to AK from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2012, SEMIN THROMB HEMOST, V38, P129, DOI 10.1055/s-0032-1301410; Amirkhosravi A, 2007, SEMIN THROMB HEMOST, V33, P643, DOI 10.1055/s-2007-991531; Bharadwaj LA, 2002, PHARMACOL RES, V45, P175, DOI 10.1006/phrs.2001.0911; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Castelli R, 2010, CURR VASC PHARMACOL, V8, P482, DOI 10.2174/157016110791330799; Conley SJ, 2012, CELL CYCLE, V11, P1265, DOI 10.4161/cc.19890; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Davies GF, 2010, CANCER LETT, V288, P236, DOI 10.1016/j.canlet.2009.07.011; Davies GF, 2009, DRUG DES DEV THER, V3, P79; Davies GF, 2005, LEUKEMIA LYMPHOMA, V46, P1199, DOI 10.1080/10428190500102555; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Donati MB, 2012, THROMB RES, V129, P348, DOI 10.1016/j.thromres.2011.12.022; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gandemer V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-385; Garnier D, 2012, THROMB RES, V129, pS22, DOI 10.1016/S0049-3848(12)70012-9; Girard TJ, 2007, THROMB RES, V121, P427, DOI 10.1016/j.thromres.2007.04.015; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Henkin J, 2011, EXPERT OPIN THER TAR, V15, P1369, DOI 10.1517/14728222.2011.640319; Henriquez S, 2011, J CELL PHYSIOL, V226, P3278, DOI 10.1002/jcp.22689; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Iversen N, 2002, THROMB RES, V105, P33, DOI 10.1016/S0049-3848(01)00404-2; Iversen N, 1998, BRIT J HAEMATOL, V102, P889, DOI 10.1046/j.1365-2141.1998.00875.x; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Khan DH, 2013, J BIOL CHEM, V288, P16518, DOI 10.1074/jbc.M112.440446; Kurer MA, 2007, MOL BIOL REP, V34, P221, DOI 10.1007/s11033-006-9036-4; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lin YF, 2007, APOPTOSIS, V12, P2163, DOI 10.1007/s10495-007-0136-y; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu Y, 2011, CANCER RES, V71, P6492, DOI 10.1158/0008-5472.CAN-11-1145; Liu YY, 1999, ARCH BIOCHEM BIOPHYS, V370, P112, DOI 10.1006/abbi.1999.1371; Lo Nigro C, 2013, J INVEST DERMATOL, V133, P1278, DOI 10.1038/jid.2012.493; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Maciejczyk A, 2013, ADV CLIN EXP MED, V22, P5; Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; Maroney SA, 2010, THROMB RES, V125, pS52, DOI 10.1016/j.thromres.2010.01.038; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Mast AE, 2000, J BIOL CHEM, V275, P31715, DOI 10.1074/jbc.M006595200; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; Naldini A, 2009, EUR J CANCER, V45, P454, DOI 10.1016/j.ejca.2008.10.012; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Piro O, 2005, J THROMB HAEMOST, V3, P2677, DOI 10.1111/j.1538-7836.2005.01636.x; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Ruf W, 2003, CANCER RES, V63, P5381; Ruf W, 2012, THROMB RES, V130, pS84, DOI 10.1016/j.thromres.2012.08.285; Schuepbach RA, 2011, BLOOD, V117, P6338, DOI 10.1182/blood-2010-10-316257; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sierko E, 2010, THROMB HAEMOSTASIS, V103, P198, DOI 10.1160/TH09-06-0416; Spek CA, 2012, THROMB RES, V129, pS80, DOI 10.1016/S0049-3848(12)70022-1; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047184; Stavik B, 2010, MOL CARCINOGEN, V49, P951, DOI 10.1002/mc.20679; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Stunkel W, 2011, J BIOMOL SCREEN, V16, P1153, DOI 10.1177/1087057111422103; Suzuki H, 2001, ONCOGENE, V20, P5779, DOI 10.1038/sj.onc.1204742; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Toffoli S, 2007, BBA-MOL CELL RES, V1773, P1558, DOI 10.1016/j.bbamcr.2007.06.002; Volpert OV, 1997, ONCOGENE, V14, P1495, DOI 10.1038/sj.onc.1200977; Waldmann T, 2013, CURR OPIN CELL BIOL, V25, P184, DOI 10.1016/j.ceb.2013.01.001; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; ZACHARSKI LR, 1981, JAMA-J AM MED ASSOC, V245, P831, DOI 10.1001/jama.245.8.831; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028	74	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84611	10.1371/journal.pone.0084611	http://dx.doi.org/10.1371/journal.pone.0084611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489651	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000007
J	Ramirez-Bajo, MJ; de Atauri, P; Ortega, F; Westerhoff, HV; Gelpi, JL; Centelles, JJ; Cascante, M				Jose Ramirez-Bajo, Maria; de Atauri, Pedro; Ortega, Fernando; Westerhoff, Hans V.; Lluis Gelpi, Josep; Centelles, Josep J.; Cascante, Marta			Effects of Cadmium and Mercury on the Upper Part of Skeletal Muscle Glycolysis in Mice	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; ENZYME-ACTIVITIES; SYSTEMS; COPPER; BIOACCUMULATION; THREONINE; TOXICITY; FLUX	The effects of pre-incubation with mercury (Hg2+) and cadmium (Cd2+) on the activities of individual glycolytic enzymes, on the flux and on internal metabolite concentrations of the upper part of glycolysis were investigated in mouse muscle extracts. In the range of metal concentrations analysed we found that only hexokinase and phosphofructokinase, the enzymes that shared the control of the flux, were inhibited by Hg2+ and Cd2+. The concentrations of the internal metabolites glucose-6-phosphate and fructose-6-phosphate did not change significantly when Hg2+ and Cd2+ were added. A mathematical model was constructed to explore the mechanisms of inhibition of Hg2+ and Cd2+ on hexokinase and phosphofructokinase. Equations derived from detailed mechanistic models for each inhibition were fitted to the experimental data. In a concentration-dependent manner these equations describe the observed inhibition of enzyme activity. Under the conditions analysed, the integral model showed that the simultaneous inhibition of hexokinase and phosphofructokinase explains the observation that the concentrations of glucose-6-phosphate and fructose-6-phosphate did not change as the heavy metals decreased the glycolytic flux.	[Jose Ramirez-Bajo, Maria; de Atauri, Pedro; Ortega, Fernando; Lluis Gelpi, Josep; Centelles, Josep J.; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Jose Ramirez-Bajo, Maria; de Atauri, Pedro; Ortega, Fernando; Lluis Gelpi, Josep; Centelles, Josep J.; Cascante, Marta] Univ Barcelona, Fac Biol, IBUB, Barcelona, Spain; [de Atauri, Pedro; Centelles, Josep J.; Cascante, Marta] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Westerhoff, Hans V.] Vrije Univ Amsterdam, Fac Biol, BioCtr Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester Interdisciplinary Bioctr 3 018, Manchester, Lancs, England; [Westerhoff, Hans V.] Univ Amsterdam, SILS, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Amsterdam, NISB, Amsterdam, Netherlands	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Amsterdam; Vrije Universiteit Amsterdam; University of Manchester; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain.	martacascante@ub.edu	Centelles, Josep J./K-2972-2014; Gelpí, Josep Ll./M-6401-2013; Ortega, Fernando/G-2129-2015; de Atauri, Pedro Ramón/R-3957-2019; CASCANTE, MARTA/AFK-5991-2022; de Atauri, Pedro/AAG-2384-2020; Westerhoff, Hans V/I-5762-2012; CASCANTE, MARTA/AAG-4355-2022	Centelles, Josep J./0000-0002-6289-9678; Gelpí, Josep Ll./0000-0002-0566-7723; Ortega, Fernando/0000-0002-3172-2095; de Atauri, Pedro Ramón/0000-0002-7754-7851; CASCANTE, MARTA/0000-0002-2062-4633; Westerhoff, Hans V/0000-0002-0443-6114; CASCANTE, MARTA/0000-0002-2062-4633; ramirez-bajo, maria jose/0000-0003-0119-1331	European Commission [270086]; Spanish Government; European Union [SAF2011-25726]; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spanish Government & European Regional Development Fund (ERDF) [RD06/0020/0046]; Generalitat de Catalunya-AGAUR [2009SGR1308]; ICREA foundation-Generalitat de Catalunya; BBSRC; EPSRC [BBD0190791, BBC0082191, BBF0035281, BBF0035521, BBF0035361, BBG5302251]; EU [91206069]; BBSRC [BB/F003544/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003544/1, BB/C008219/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission); Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spanish Government & European Regional Development Fund (ERDF); Generalitat de Catalunya-AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); ICREA foundation-Generalitat de Catalunya(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Commission Seventh Framework Programme FP7 (Synergy-COPD project grant agreement no. 270086); the Spanish Government and the European Union FEDER funds (SAF2011-25726) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion of Spanish Government & European Regional Development Fund (ERDF) "Una manera de hacer Europa'' ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya-AGAUR, (2009SGR1308). MC acknowledges the support received through the prize "ICREA Academia'' for excellence in research, funded by ICREA foundation-Generalitat de Catalunya. The authors thank the BBSRC, EPSRC (BBD0190791, BBC0082191, BBF0035281, BBF0035521, BBF0035521, BBF0035361, BBG5302251, SySMO), EU-FP7 (BioSim, NucSys, EC-MOAN), ZON-MW (91206069), and other funders for systems biology support (http://www.systembiology.net/support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeyer HU, 1984, METHODS ENZYMATIC AN, VIII; Bergmeyer HU, 1984, METHODS ENZYMATIC AN, VII; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND IA, 1974, J BIOL CHEM, V249, P7824; Chassagnole C, 2003, CR BIOL, V326, P501, DOI 10.1016/S1631-0691(03)00098-2; Ciapaite J, 2009, FEBS J, V276, P3656, DOI 10.1111/j.1742-4658.2009.07084.x; Diaz S, 2006, ENVIRON INT, V32, P711, DOI 10.1016/j.envint.2006.03.004; Fell D., 1997, UNDERSTANDING CONTRO; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; Forstner U., 1979, METAL POLLUTION AQUA; GROEN AK, 1982, J BIOL CHEM, V257, P2754; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; HILMY AM, 1985, COMP BIOCHEM PHYS C, V81, P139, DOI 10.1016/0742-8413(85)90105-7; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jalilehvand F, 2009, INORG CHEM, V48, P5758, DOI 10.1021/ic802278r; Jannaschk D, 1999, FEBS LETT, V445, P144, DOI 10.1016/S0014-5793(99)00117-9; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; KACSER H, 1993, EUR J BIOCHEM, V216, P361, DOI 10.1111/j.1432-1033.1993.tb18153.x; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KESSELER A, 1994, EUR J BIOCHEM, V225, P897, DOI 10.1111/j.1432-1033.1994.0897b.x; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Letelier ME, 2005, CHEM-BIOL INTERACT, V151, P71, DOI 10.1016/j.cbi.2004.12.004; Liliom K, 2000, EUR J BIOCHEM, V267, P4731, DOI 10.1046/j.1432-1327.2000.01526.x; Liliom K, 1999, BIOCHEM BIOPH RES CO, V264, P605, DOI 10.1006/bbrc.1999.1547; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Mas A, 1993, METALES SISTEMAS BIO; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Ovadi J, 1997, CHANNELLING INTERMED, P237; PASSOW H, 1961, PHARMACOL REV, V13, P185; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Puigjaner J, 1997, FEBS LETT, V418, P47, DOI 10.1016/S0014-5793(97)01347-1; Quig D, 1998, Altern Med Rev, V3, P262; Rais B, 1996, BIOTHERMOKINETICS LI, P174; RAPOPORT TA, 1974, EUR J BIOCHEM, V42, P107, DOI 10.1111/j.1432-1033.1974.tb03320.x; Rodriguez-Prados JC, 2009, BIOTECHNOL BIOENG, V103, P609, DOI 10.1002/bit.22271; SMALL JR, 1993, EUR J BIOCHEM, V213, P613, DOI 10.1111/j.1432-1033.1993.tb17801.x; Strydom C, 2006, WATER SA, V32, P543; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x	39	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e80018	10.1371/journal.pone.0080018	http://dx.doi.org/10.1371/journal.pone.0080018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489641	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000001
J	Bates, AJ; Sadler, JP; Grundy, D; Lowe, N; Davis, G; Baker, D; Bridge, M; Freestone, R; Gardner, D; Gibson, C; Hemming, R; Howarth, S; Orridge, S; Shaw, M; Tams, T; Young, H				Bates, Adam J.; Sadler, Jon P.; Grundy, Dave; Lowe, Norman; Davis, George; Baker, David; Bridge, Malcolm; Freestone, Roger; Gardner, David; Gibson, Chris; Hemming, Robin; Howarth, Stephen; Orridge, Steve; Shaw, Mark; Tams, Tom; Young, Heather			Garden and Landscape-Scale Correlates of Moths of Differing Conservation Status: Significant Effects of Urbanization and Habitat Diversity	PLOS ONE			English	Article							URBAN-DEVELOPMENT; CLIMATE-CHANGE; BIODIVERSITY; COMMON; LEPIDOPTERA; TEMPERATURE; BUTTERFLIES; EXTINCTION; IMPACT; CITY	Moths are abundant and ubiquitous in vegetated terrestrial environments and are pollinators, important herbivores of wild plants, and food for birds, bats and rodents. In recent years, many once abundant and widespread species have shown sharp declines that have been cited by some as indicative of a widespread insect biodiversity crisis. Likely causes of these declines include agricultural intensification, light pollution, climate change, and urbanization; however, the real underlying cause(s) is still open to conjecture. We used data collected from the citizen science Garden Moth Scheme (GMS) to explore the spatial association between the abundance of 195 widespread British species of moth, and garden habitat and landscape features, to see if spatial habitat and landscape associations varied for species of differing conservation status. We found that associations with habitat and landscape composition were species-specific, but that there were consistent trends in species richness and total moth abundance. Gardens with more diverse and extensive microhabitats were associated with higher species richness and moth abundance; gardens near to the coast were associated with higher richness and moth abundance; and gardens in more urbanized locations were associated with lower species richness and moth abundance. The same trends were also found for species classified as increasing, declining and vulnerable under IUCN (World Conservation Union) criteria. However, vulnerable species were more strongly negatively affected by urbanization than increasing species. Two hypotheses are proposed to explain this observation: (1) that the underlying factors causing declines in vulnerable species (e. g., possibilities include fragmentation, habitat deterioration, agrochemical pollution) across Britain are the same in urban areas, but that these deleterious effects are more intense in urban areas; and/or (2) that urban areas can act as ecological traps for some vulnerable species of moth, the light drawing them in from the surrounding landscape into sub-optimal urban habitats.	[Bates, Adam J.; Sadler, Jon P.] Univ Birmingham, Birmingham, W Midlands, England; [Grundy, Dave; Lowe, Norman; Davis, George; Baker, David; Bridge, Malcolm; Freestone, Roger; Gardner, David; Gibson, Chris; Hemming, Robin; Howarth, Stephen; Orridge, Steve; Shaw, Mark; Tams, Tom; Young, Heather] Garden Moth Scheme, Birmingham, W Midlands, England	University of Birmingham	Bates, AJ (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	a.j.bates@bham.ac.uk		Sadler, Jonathan/0000-0003-0443-4458; Bates, Adam/0000-0001-7854-5260	National Lottery (UK) through the Big Lottery Fund	National Lottery (UK) through the Big Lottery Fund	The analysis of this data forms part of the OPAL (Open Air Laboratories) project, which is funded by The National Lottery (UK) through the Big Lottery Fund (grant holder JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Altermatt F, 2012, GLOBAL CHANGE BIOL, V18, P2429, DOI 10.1111/j.1365-2486.2012.02727.x; [Anonymous], 2011, UK NATL ECOSYSTEM AS; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bates AJ, 2013, ENTOMOL EXP APPL, V146, P386, DOI 10.1111/eea.12038; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bergerot B, 2010, LANDSCAPE URBAN PLAN, V96, P98, DOI 10.1016/j.landurbplan.2010.02.007; Bone J, 2012, ENVIRON SCI TECHNOL, V46, P3687, DOI 10.1021/es203880p; BOWDEN J, 1982, B ENTOMOL RES, V72, P535, DOI 10.1017/S0007485300008579; Brodgar, 2010, SOFTWARE PACKAGE DAT; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton E, 2000, URBAN STUD, V37, P1969, DOI 10.1080/00420980050162184; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Butterfly Conservation, 2007, UK BIOD ACT PLAN MOT; Calkins CO, 1998, J AGR ENTOMOL, V15, P327; Cameron RWF, 2012, URBAN FOR URBAN GREE, V11, P129, DOI 10.1016/j.ufug.2012.01.002; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cinzano P, 2004, MON NOT R ASTRON SOC, V353, P1107, DOI 10.1111/j.1365-2966.2004.08132.x; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Conrad KF, 2004, J INSECT CONSERV, V8, P119; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Davies L, 2011, ENVIRON POLLUT, V159, P2203, DOI 10.1016/j.envpol.2011.02.053; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Dennis RLH, 2001, BIODIVERS CONSERV, V10, P1831, DOI 10.1023/A:1013161522916; Devoto M, 2011, ECOL ENTOMOL, V36, P25, DOI 10.1111/j.1365-2311.2010.01247.x; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Elkinton JS, 1996, ECOLOGY, V77, P2332, DOI 10.2307/2265735; FRANK K D, 1988, Journal of the Lepidopterists' Society, V42, P63; Fry R, 2001, AMATEUR ENTOMOLOGIST, V24, P1; Fuentes-Montemayor E, 2011, J APPL ECOL, V48, P532, DOI 10.1111/j.1365-2664.2010.01927.x; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gaston KJ, 2007, PROG PHYS GEOG, V31, P213, DOI 10.1177/0309133307076488; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Groenendijk D, 2011, J INSECT CONSERV, V15, P95, DOI 10.1007/s10841-010-9326-y; Hardy PB, 1999, BIODIVERS CONSERV, V8, P1261, DOI 10.1023/A:1008984905413; Hernandez J., 2009, CITIES ENV, V2; Howe M. A., 2010, Journal of Coastal Conservation, V14, P91, DOI 10.1007/s11852-009-0055-x; Isaac NJB, 2011, J INSECT CONSERV, V15, P233, DOI 10.1007/s10841-010-9340-0; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jokimaki J, 2011, LANDSCAPE URBAN PLAN, V100, P383, DOI 10.1016/j.landurbplan.2011.02.001; Kerr JT, 2000, CONSERV BIOL, V14, P1726, DOI [10.1046/j.1523-1739.2000.99275.x, 10.1111/j.1523-1739.2000.99275.x]; Kozlov MV, 1996, J BIOGEOGR, V23, P95, DOI 10.1046/j.1365-2699.1996.d01-219.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; Leps J, 2003, MULTIVARIATE ANAL EC; Levy JM, 2004, J INSECT CONSERV, V8, P323, DOI 10.1007/s10841-004-0796-7; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Mattila N, 2006, CONSERV BIOL, V20, P1161, DOI 10.1111/j.1523-1739.2006.00404.x; McCarthy K, 2011, URBAN ECOSYST, V14, P395, DOI 10.1007/s11252-011-0161-z; McGeoch MA, 1997, BIODIVERS CONSERV, V6, P979, DOI 10.1023/A:1018315614085; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; New TR, 2004, J INSECT CONSERV, V8, P79, DOI 10.1023/B:JICO.0000045807.04047.bd; Niemela J, 2009, LANDSCAPE URBAN PLAN, V92, P65, DOI 10.1016/j.landurbplan.2009.05.016; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Owen J., 2010, WILDLIFE GARDEN 30 Y; PETTERSSON MW, 1991, J ECOL, V79, P591, DOI 10.2307/2260655; Pinheiro J, 2001, MIXED EFFECTS MODELS; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2006, R LANG ENV STAT COMP; Rich C, 2006, ECOLOGICAL CONSQUENC; Ricketts TH, 2001, CONSERV BIOL, V15, P378, DOI 10.1046/j.1523-1739.2001.015002378.x; Rickman JK, 2003, ECOGRAPHY, V26, P777, DOI 10.1111/j.0906-7590.2003.03345.x; Robinson H. S., 1950, Entomologist's Gazette, V1, P3; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Rosch M, 2001, AFR ENTOMOL, V9, P85; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Summerville KS, 2004, ECOGRAPHY, V27, P3, DOI 10.1111/j.0906-7590.2004.03664.x; Taylor L.R., 1978, P31; Taylor ME, 2009, AGR ECOSYST ENVIRON, V130, P9, DOI 10.1016/j.agee.2008.11.004; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TURNER JRG, 1987, OIKOS, V48, P195, DOI 10.2307/3565855; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Waring P., 2009, FIELD GUIDE MOTHS GR; Warren MS, 2011, J INSECT CONSERV, V15, P321, DOI 10.1007/s10841-010-9356-5; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	92	44	47	4	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86925	10.1371/journal.pone.0086925	http://dx.doi.org/10.1371/journal.pone.0086925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475197	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300118
J	da Silva, JM; Herrel, A; Measey, GJ; Tolley, KA				da Silva, Jessica M.; Herrel, Anthony; Measey, G. John; Tolley, Krystal A.			Sexual Dimorphism in Bite Performance Drives Morphological Variation in Chameleons	PLOS ONE			English	Article							ANTILLEAN ANOLIS LIZARDS; DWARF CHAMELEONS; LACERTID LIZARDS; BODY-SIZE; ECOMORPHOLOGICAL VARIATION; HABITAT USE; HEAD SHAPE; TEMPORAL DIMENSIONS; FORCE PERFORMANCE; SPECIES-DIVERSITY	Phenotypic performance in different environments is central to understanding the evolutionary and ecological processes that drive adaptive divergence and, ultimately, speciation. Because habitat structure can affect an animal's foraging behaviour, anti-predator defences, and communication behaviour, it can influence both natural and sexual selection pressures. These selective pressures, in turn, act upon morphological traits to maximize an animal's performance. For performance traits involved in both social and ecological activities, such as bite force, natural and sexual selection often interact in complex ways, providing an opportunity to understand the adaptive significance of morphological variation with respect to habitat. Dwarf chameleons within the Bradypodion melanocephalum-Bradypodion thamnobates species complex have multiple phenotypic forms, each with a specific head morphology that could reflect its use of either open-or closed-canopy habitats. To determine whether these morphological differences represent adaptations to their habitats, we tested for differences in both absolute and relative bite performance. Only absolute differences were found between forms, with the closed-canopy forms biting harder than their open-canopy counterparts. In contrast, sexual dimorphism was found for both absolute and relative bite force, but the relative differences were limited to the closed-canopy forms. These results indicate that both natural and sexual selection are acting within both habitat types, but to varying degrees. Sexual selection seems to be the predominant force within the closed-canopy habitats, which are more protected from aerial predators, enabling chameleons to invest more in ornamentation for communication. In contrast, natural selection is likely to be the predominant force in the open-canopy habitats, inhibiting the development of conspicuous secondary sexual characteristics and, ultimately, enforcing their overall diminutive body size and constraining performance.	[da Silva, Jessica M.; Measey, G. John; Tolley, Krystal A.] South African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, Western Cape Pr, South Africa; [da Silva, Jessica M.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7600 Stellenbosch, Western Cape Pr, South Africa; [Herrel, Anthony] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversite, Paris, Ile De France, France; [Herrel, Anthony] Univ Ghent, Dept Biol, Evolutionary Morphol Vertebrates Res Grp, B-9000 Ghent, East Flanders, Belgium; [Measey, G. John] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, Eastern Cape Pr, South Africa; [Tolley, Krystal A.] Univ Stellenbosch, Dept Bot & Zool, ZA-7600 Stellenbosch, Western Cape Pr, South Africa	South African National Biodiversity Institute; Stellenbosch University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Ghent University; Nelson Mandela University; Stellenbosch University	da Silva, JM (corresponding author), South African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, Western Cape Pr, South Africa.	jessica.m.dasilva@gmail.com	Measey, John/F-2028-2010; da Silva, Jessica Marie/J-4290-2012; Herrel, Anthony/C-3712-2013; DA SILVA, JESSICA/HGA-0333-2022	Measey, John/0000-0001-9939-7615; da Silva, Jessica Marie/0000-0001-8385-1166; Herrel, Anthony/0000-0003-0991-4434; Tolley, Krystal/0000-0002-7778-1963	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative) [UID 69817]; National Research Foundation (NRF) of South Africa (Key International Science Capacity Fund Program) [FA2007022700016]; SANBI-NORAD Threatened Species Program; Jordan Wines; Stellenbosch University; NRF	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative); National Research Foundation (NRF) of South Africa (Key International Science Capacity Fund Program); SANBI-NORAD Threatened Species Program; Jordan Wines; Stellenbosch University; NRF	The authors thank the National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative - Grant Number UID 69817; Key International Science Capacity Fund Program - Grant Number FA2007022700016) and the SANBI-NORAD Threatened Species Program for financial support, as well as the South African National Biodiversity for logistical support for this work. Jordan Wines, Stellenbosch University, and NRF provided bursaries for JMdS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; ASPLUND KK, 1974, COPEIA, P695, DOI 10.2307/1442683; Bickel R, 2002, BIOL J LINN SOC, V76, P91, DOI 10.1046/j.1095-8312.2002.00051.x; Brana F, 1996, OIKOS, V75, P511, DOI 10.2307/3545893; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; BURRAGE B R, 1973, Annals of the South African Museum, V61, P1; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; Butler MA, 2007, NATURE, V447, P202, DOI 10.1038/nature05774; Clark TE, 1997, J INSECT CONSERV, V1, P221, DOI 10.1023/A:1018472118513; Cuadrado M, 2001, J ZOOL, V255, P425; Da Silva JM, 2013, BIOL J LINN SOC, V109, P113, DOI 10.1111/bij.12045; DeVries PJ, 1999, BIOL J LINN SOC, V68, P333, DOI 10.1111/j.1095-8312.1999.tb01175.x; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; Fleishman Leo J., 2000, P209; FLEISHMAN LJ, 1992, AM NAT, V139, pS36, DOI 10.1086/285304; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; Gray J. E., 1865, P ZOOL SOC LOND, V1864, P465; Grimbacher PS, 2007, AUSTRAL ECOL, V32, P77, DOI 10.1111/j.1442-9993.2007.01735.x; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P31, DOI 10.1086/498193; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Herrel A, 2008, ZOOLOGY, V111, P467, DOI 10.1016/j.zool.2008.01.002; Herrel A, 2007, BIOL J LINN SOC, V91, P111, DOI 10.1111/j.1095-8312.2007.00772.x; Herrel A, 2006, BIOL J LINN SOC, V89, P443, DOI 10.1111/j.1095-8312.2006.00685.x; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Husak JF, 2006, COPEIA, P301, DOI 10.1643/0045-8511(2006)6[301:BPPDIM]2.0.CO;2; Huyghe K, 2005, FUNCT ECOL, V19, P800, DOI 10.1111/j.1365-2435.2005.01038.x; Huyghe K, 2009, BIOL J LINN SOC, V96, P13, DOI 10.1111/j.1095-8312.2008.01103.x; Kaliontzopoulou A, 2010, J EVOLUTION BIOL, V23, P1234, DOI 10.1111/j.1420-9101.2010.01984.x; Kaliontzopoulou A, 2012, EVOL ECOL, V26, P825, DOI 10.1007/s10682-011-9538-y; Kotze DJ, 1999, BIODIVERS CONSERV, V8, P1339, DOI 10.1023/A:1008945302029; Kratochvil L, 2003, CAN J ZOOL, V81, P1112, DOI 10.1139/Z03-078; Lailvaux SP, 2007, AM NAT, V170, P573, DOI 10.1086/521234; Lappin AK, 2006, BIOL J LINN SOC, V88, P215, DOI 10.1111/j.1095-8312.2006.00615.x; Lawrence JM, 2002, BIODIVERS CONSERV, V11, P1163, DOI 10.1023/A:1016017114473; Leal M, 2004, AM NAT, V163, P26, DOI 10.1086/379794; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Measey GJ, 2011, J ZOOL, V285, P247, DOI 10.1111/j.1469-7998.2011.00861.x; Measey GJ, 2009, ZOOLOGY, V112, P217, DOI 10.1016/j.zool.2008.09.005; Miller AK, 2009, AFR ZOOL, V44, P45, DOI 10.3377/004.044.0105; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pryke SR, 2003, BIODIVERS CONSERV, V12, P1985, DOI 10.1023/A:1024103527611; RAND AS, 1961, COPEIA, P411; RAW L R G, 1976, Durban Museum Novitates, V11, P139; RIEPPEL O, 1981, REV SUISSE ZOOL, V88, P433, DOI 10.5962/bhl.part.82383; RiversMoore NA, 1996, BIODIVERS CONSERV, V5, P1545, DOI 10.1007/BF00052115; Samways MJ, 1996, AGR ECOSYST ENVIRON, V59, P19, DOI 10.1016/0167-8809(96)01047-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; Segall M, 2013, J EXP BIOL, V216, P3828, DOI 10.1242/jeb.092353; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Silva da JM, 2013, FUNCTIONAL ECOLOGY; SPSS Inc, 2008, SPSS WIND 17 0; Stuart-Fox D, 2007, J EVOLUTION BIOL, V20, P1073, DOI 10.1111/j.1420-9101.2007.01295.x; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Stuart-Fox D, 2007, AM NAT, V170, P916, DOI 10.1086/522835; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox DM, 2006, ANIM BEHAV, V71, P1263, DOI 10.1016/j.anbehav.2005.07.028; Stuart-Fox DM, 2005, BIOL LETTERS, V1, P231, DOI 10.1098/rsbl.2005.0299; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tilbury C.R., 2010, CHAMELEONS AFRICA AT; Tolley KA, 2006, MOL ECOL, V15, P781, DOI 10.1111/j.1365-294X.2006.02836.x; Tolley KA, 2004, MOL PHYLOGENET EVOL, V30, P354, DOI 10.1016/S1055-7903(03)00211-2; Tolley KA., 2007, CHAMELEONS SO AFRICA; Tolley KA, 2008, J BIOGEOGR, V35, P1402, DOI 10.1111/j.1365-2699.2008.01889.x; Tolley KA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0184; Vanhooydonck B, 2011, BIOL J LINN SOC, V102, P91, DOI 10.1111/j.1095-8312.2010.01563.x; Vanhooydonck B, 2010, BIOL J LINN SOC, V101, P461, DOI 10.1111/j.1095-8312.2010.01519.x; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; WASER PM, 1984, BEHAV ECOL SOCIOBIOL, V15, P73, DOI 10.1007/BF00310219	75	17	17	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86846	10.1371/journal.pone.0086846	http://dx.doi.org/10.1371/journal.pone.0086846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475183	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300111
J	Jacob, D; Ruffie, C; Dubois, M; Combredet, C; Amino, R; Formaglio, P; Gorgette, O; Pehau-Arnaudet, G; Guery, C; Puijalon, O; Barale, JC; Menard, R; Tangy, F; Sala, M				Jacob, Daria; Ruffie, Claude; Dubois, Myriam; Combredet, Chantal; Amino, Rogerio; Formaglio, Pauline; Gorgette, Olivier; Pehau-Arnaudet, Gerard; Guery, Charline; Puijalon, Odile; Barale, Jean-Christophe; Menard, Robert; Tangy, Frederic; Sala, Monica			Whole Pichia pastoris Yeast Expressing Measles Virus Nucleoprotein as a Production and Delivery System to Multimerize Plasmodium Antigens	PLOS ONE			English	Article							FALCIPARUM CIRCUMSPOROZOITE PROTEIN; RTS,S/AS01 MALARIA VACCINE; CD8+ T-CELLS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; IMMUNE-RESPONSES; PHASE-3 TRIAL; MICE; PROTECTION; ANTIBODIES	Yeasts are largely used as bioreactors for vaccine production. Usually, antigens are produced in yeast then purified and mixed with adjuvants before immunization. However, the purification costs and the safety concerns recently raised by the use of new adjuvants argue for alternative strategies. To this end, the use of whole yeast as both production and delivery system appears attractive. Here, we evaluated Pichia pastoris yeast as an alternative vaccine production and delivery system for the circumsporozoite protein (CS) of Plasmodium, the etiologic agent of malaria. The CS protein from Plasmodium berghei (Pb) was selected given the availability of the stringent C57Bl/6 mouse model of infection by Pb sporozoites, allowing the evaluation of vaccine efficacy in vivo. PbCS was multimerized by fusion to the measles virus (MV) nucleoprotein (N) known to auto-assemble in yeast in large-size ribonucleoprotein rods (RNPs). Expressed in P. pastoris, the N-PbCS protein generated highly multimeric and heterogenic RNPs bearing PbCS on their surface. Electron microscopy and immunofluorescence analyses revealed the shape of these RNPs and their localization in peripheral cytoplasmic inclusions. Subcutaneous immunization of C57Bl/6 mice with heat-inactivated whole P. pastoris expressing N-PbCS RNPs provided significant reduction of parasitemia after intradermal challenge with a high dose of parasites. Thus, in the absence of accessory adjuvants, a very low amount of PbCS expressed in whole yeast significantly decreased clinical damages associated with Pb infection in a highly stringent challenge model, providing a proof of concept of the intrinsic adjuvancy of this vaccine strategy. In addition to PbCS multimerization, the N protein contributed by itself to parasitemia delay and long-term mice survival. In the future, mixtures of whole recombinant yeasts expressing relevant Plasmodium antigens would provide a multivalent formulation applicable for antigen combination screening and possibly for large-scale production, distribution and delivery of a malaria vaccine in developing countries.	[Jacob, Daria; Ruffie, Claude; Dubois, Myriam; Combredet, Chantal; Guery, Charline; Tangy, Frederic; Sala, Monica] Inst Pasteur, Viral Genom & Vaccinat Unit, Paris, France; [Jacob, Daria; Ruffie, Claude; Dubois, Myriam; Combredet, Chantal; Guery, Charline; Tangy, Frederic; Sala, Monica] CNRS, URA3015, Paris, France; [Amino, Rogerio; Formaglio, Pauline; Menard, Robert] Inst Pasteur, Malaria Biol & Genet Unit, Paris, France; [Gorgette, Olivier; Puijalon, Odile; Barale, Jean-Christophe] Inst Pasteur, Mol Immunol Parasites Unit, Paris, France; [Gorgette, Olivier; Puijalon, Odile; Barale, Jean-Christophe] CNRS, URA2581, Paris, France; [Pehau-Arnaudet, Gerard] Inst Pasteur, PFMU, Paris, France; [Pehau-Arnaudet, Gerard] CNRS, UMR3528, Paris, France; [Gorgette, Olivier; Barale, Jean-Christophe] Inst Pasteur, Malaria Biol & Genet Unit, Team Malaria Targets & Drug Dev, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sala, M (corresponding author), Inst Pasteur, Viral Genom & Vaccinat Unit, Paris, France.	joo@pasteur.fr		Formaglio, Pauline/0000-0002-9612-3157	"Transversal Research Project'' from the Institut Pasteur [PTR365]	"Transversal Research Project'' from the Institut Pasteur	The work was funded by the "Transversal Research Project'' from the Institut Pasteur (PTR365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These statements are given in the Acknowledgments of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Arias MA, 2011, VACCINE, V29, P1258, DOI 10.1016/j.vaccine.2010.11.084; Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042870; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; Bazan SB, 2011, VACCINE, V29, P8165, DOI 10.1016/j.vaccine.2011.07.141; Bejon P, 2013, LANCET INFECT DIS; Bian GL, 2009, VACCINE, V28, P187, DOI 10.1016/j.vaccine.2009.09.101; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; BUCKLAND R, 1989, J GEN VIROL, V70, P435, DOI 10.1099/0022-1317-70-2-435; Bui MR, 2010, VACCINE, V28, P6028, DOI 10.1016/j.vaccine.2010.06.085; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Combredet C, 2003, J VIROL, V77, P11546, DOI 10.1128/JVI.77.21.11546-11554.2003; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; Daily JP, 2012, NEW ENGL J MED, V367, P2349, DOI 10.1056/NEJMe1213392; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Lacerda CMD, 2011, MYCOPATHOLOGIA, V171, P395, DOI 10.1007/s11046-011-9395-9; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Frachon E, 2006, APPL ENVIRON MICROB, V72, P5225, DOI 10.1128/AEM.00239-06; Francois G, 2005, PEDIATR INFECT DIS J, V24, P953, DOI 10.1097/01.inf.0000183853.16113.a6; Gonzalez MC, 2009, VIRUS RES, V146, P107, DOI 10.1016/j.virusres.2009.09.007; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Griffin D., 2001, FIELDS VIROLOGY, P1401; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Gueirard P, 2010, P NATL ACAD SCI USA, V107, P18640, DOI 10.1073/pnas.1009346107; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Jariyapong P, 2013, VACCINE, V31, P417, DOI 10.1016/j.vaccine.2012.10.073; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Keeling JWR, 2011, METHODS MOL BIOL, V782, P231, DOI 10.1007/978-1-61779-273-1_17; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kumar S, 2013, J IMMUNOL METHODS, V390, P99, DOI 10.1016/j.jim.2013.02.001; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu M, 2011, VACCINE, V29, P1745, DOI 10.1016/j.vaccine.2010.12.119; Liu RS, 2009, APPL BIOCHEM BIOTECH, V158, P432, DOI 10.1007/s12010-009-8527-x; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Lu YN, 2004, CANCER RES, V64, P5084, DOI 10.1158/0008-5472.CAN-04-1487; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Neumann AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000760; NUSSENZWEIG V, 1985, CELL, V42, P401, DOI 10.1016/0092-8674(85)90093-5; Piyasirisilp S, 2002, CURR OPIN NEUROL, V15, P333, DOI 10.1097/00019052-200206000-00018; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Regules JA, 2011, EXPERT REV VACCINES, V10, P589, DOI [10.1586/erv.11.57, 10.1586/ERV.11.57]; Ribeiro CMS, 2010, METHODS MOL BIOL, V626, P1, DOI 10.1007/978-1-60761-585-9_1; Roohvand F, 2012, EXPERT OPIN THER PAT, V22, P391, DOI 10.1517/13543776.2012.673589; Saiki M, 2005, J AUTOIMMUN, V24, P203, DOI 10.1016/j.jaut.2005.01.008; Salvador A, 2012, EXPERT REV VACCINES, V11, P1071, DOI [10.1586/ERV.12.87, 10.1586/erv.12.87]; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Slibinskas R, 2004, J BIOTECHNOL, V107, P115, DOI 10.1016/j.jbiotec.2003.10.018; Storni T, 2005, ADV DRUG DELIVER REV, V57, P333, DOI 10.1016/j.addr.2004.09.008; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Tomljenovic L, 2011, J ALZHEIMERS DIS, V23, P567, DOI 10.3233/JAD-2010-101494; Vietheer PT, 2007, ANTIVIR THER, V12, P477; WARNES A, 1995, GENE, V160, P173, DOI 10.1016/0378-1119(95)00227-W; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Zhang TT, 2011, VACCINE, V29, P8412, DOI 10.1016/j.vaccine.2011.08.007	68	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86658	10.1371/journal.pone.0086658	http://dx.doi.org/10.1371/journal.pone.0086658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475165	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300100
J	Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C				Pinter, Daniela; Sumowski, James; DeLuca, John; Fazekas, Franz; Pichler, Alexander; Khalil, Michael; Langkammer, Christian; Fuchs, Siegrid; Enzinger, Christian			Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis	PLOS ONE			English	Article							BRAIN ATROPHY; RESERVE; IMPAIRMENT	Background: Previous work suggested greater intellectual enrichment might moderate the negative impact of brain atrophy on cognition. This awaits confirmation in independent cohorts including investigation of the role of T2-lesion load (T2-LL), which is another important determinant of cognition in MS. We here thus aimed to test this cognitive reserve hypothesis by investigating whether educational attainment (EA) moderates the negative effects of both brain atrophy and T2-LL on cognitive function in a large sample of MS patients. Methods: 137 patients participated in the study. Cognition was assessed by the Brief Repeatable Battery of Neuropsychological Tests.''T2-LL, normalized brain volume (global volume loss) and third ventricle width (regional volume loss) served as MRI markers. Results: Both T2-LL and atrophy predicted worse cognition, with a stronger effect of T2-LL. Higher EA (as assessed by years of education) also predicted better cognition. Interactions showed that the negative effects of T2-LL and regional brain atrophy were moderated by EA. Conclusions: In a cohort with different stages of MS, higher EA attenuated the negative effects of white matter lesion burden and third ventricle width (suggestive of thalamic atrophy) on cognitive performance. Actively enhancing cognitive reserve might thus be a means to reduce or prevent cognitive problems in MS in parallel to disease modifying drugs.	[Pinter, Daniela; Fazekas, Franz; Pichler, Alexander; Khalil, Michael; Langkammer, Christian; Fuchs, Siegrid; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Sumowski, James] Kessler Fdn Res Ctr West Orange, Neuropsychol & Neurosci Lab, W Orange, NJ USA; [DeLuca, John] Kessler Fdn Res Ctr West Orange, Dept Phys Med & Rehabil & Neurol & Neurosci, W Orange, NJ USA; [Enzinger, Christian] Med Univ Graz, Div Neuroradiol, Graz, Austria	Medical University of Graz; Medical University of Graz	Enzinger, C (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	chris.enzinger@medunigraz.at	Langkammer, Christian/AAC-9044-2020	Langkammer, Christian/0000-0002-7097-9707; Khalil, Michael/0000-0002-5350-3328; Pinter, Daniela/0000-0003-3138-5225				Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Arnett PA, 2013, NEUROLOGY, V80, P1724, DOI 10.1212/WNL.0b013e3182919083; Arnett PA, 2010, NEUROLOGY, V74, P1934, DOI 10.1212/WNL.0b013e3181e4fc52; Beatty WW, 2002, CLIN NEUROPSYCHOL, V16, P472, DOI 10.1076/clin.16.4.472.13904; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Feinstein A, 2013, J NEUROL, V260, P2256, DOI 10.1007/s00415-013-6952-9; Filippi M, 2010, NEUROL SCI, V31, P231, DOI 10.1007/s10072-010-0367-5; Ghaffar O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047206; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller D, 2013, TRENDS COGN SCI, P1; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Plummer DL., 1992, REV NEU RORADIOL, V5, P489, DOI 10.1177/197140099200500413; Rao S, 1990, MANUAL BRIEF REPEATA; Scarpazza C, 2013, RESTOR NEUROL NEUROS, V31, P619, DOI 10.3233/RNN-120261; Schwartz CE, 2013, MULT SCLER J, V19, P87, DOI 10.1177/1352458512444914; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sumowski JF, 2010, NEUROLOGY, V75, P1428, DOI 10.1212/WNL.0b013e3181f881a6; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912	23	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87567	10.1371/journal.pone.0087567	http://dx.doi.org/10.1371/journal.pone.0087567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475309	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300202
J	Wang, LJ; Zeng, YY; Wang, TL; Liu, HY; Xiao, H; Xiang, H				Wang, Lijun; Zeng, Yanyan; Wang, Tianling; Liu, Hongyi; Xiao, Hong; Xiang, Hua			Evaluating the Potential Bioactivity of a Novel Compound ER1626	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ESTROGEN-RECEPTOR-BETA; BREAST-CANCER; POSTMENOPAUSAL WOMEN; CELL-GROWTH; ER-ALPHA; RALOXIFENE; TAMOXIFEN; RISK; EXPRESSION	Background: ER1626, a novel compound, is a derivate of indeno-isoquinoline ketone. This study was designed to evaluate the biological activity and potential anti-tumor mechanism of ER1626. Method: MTT assay, scratch assay and flow cytometry were used to determine cell proliferation, cell migration and cell cycle distribution as well as cell apoptosis on human breast cancer MCF-7 cells and endometrial cancer Ishikawa cells. We also explored the antiangiogenic effect of ER1626 on HUVEC cells and chicken embryos. The expression of estrogen receptor protein was investigated with western-blot analysis. Results: ER1626 down-regulated the expression of estrogen receptor alpha protein and up-regulated beta protein in MCF-7 and Ishikawa cells. The value of IC50 of ER1626 on MCF-7 and Ishikawa cells were respectively 8.52 and 3.08 mu mol/L. Meanwhile, ER1626 decreased VEGF secretion of MCF-7 and Ishikawa cells, disturbed the formation of VEGF-stimulated tubular structure in HUVEC cells, and inhibited the angiogenesis on the chicken chorioallantoic membrane. Scratch assay revealed that ER1626 suppressed the migration of MCF-7, Ishikawa and HUVEC cells. In addition to induction tumor cell apoptosis, ER1626 arrested cell cycle in G1/G0 phase in MCF-7 cells and G2/M phase in Ishikawa cells. Conclusion: In conclusion, our results demonstrated that ER1626 has favorable bioactivities to be a potential candidate against breast cancer and angiogenesis.	[Wang, Lijun; Zeng, Yanyan; Liu, Hongyi; Xiao, Hong] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Tianling; Xiang, Hua] China Pharmaceut Univ, Dept Pharmaceut Chem, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; China Pharmaceutical University	Xiao, H (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China.	xhnkyy123@163.com; cpuxianghua@sina.com		Xiao, Hong/0000-0003-4248-3146; Xiang, Hua/0000-0002-8937-4062	Twelfth Five-Year Original New Drug Research Program [2012ZX09103-101-048]; National Natural Science Foundation [81373279]; Jiangsu Province Technology Supporting Plan-Social Development [BE2012745]	Twelfth Five-Year Original New Drug Research Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Province Technology Supporting Plan-Social Development	This work was funded by Twelfth Five-Year Original New Drug Research Program (2012ZX09103-101-048), National Natural Science Foundation (81373279) and Jiangsu Province Technology Supporting Plan-Social Development (BE2012745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; Balfe PJ, 2004, EJSO-EUR J SURG ONC, V30, P1043, DOI 10.1016/j.ejso.2004.06.019; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Birkhauser Martin, 2012, Ther Umsch, V69, P163, DOI 10.1024/0040-5930/a000269; Brown K, 2009, MUTAGENESIS, V24, P391, DOI 10.1093/mutage/gep022; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Dalenc F, 2005, BREAST CANCER RES, V7, pR1159, DOI 10.1186/bcr1357; Dent SF, 2011, BREAST CANCER RES TR, V126, P295, DOI 10.1007/s10549-011-1351-3; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Esser S, 1998, J CELL SCI, V111, P1853; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Martin AG, 2010, BREAST CANCER RES TR, V123, P43, DOI 10.1007/s10549-010-1045-2; Guthrie N, 1997, J NUTR, V127, pS544, DOI 10.1093/jn/127.3.544S; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hodges-Gallagher L, 2008, BREAST CANCER RES TR, V109, P241, DOI 10.1007/s10549-007-9640-6; Hu K, 2005, INT J GYNECOL CANCER, V15, P537, DOI 10.1111/j.1525-1438.2005.15321.x; Hua X, 2011, International Patent, Patent No. [WO/2011/047515, 2011047515]; Hua X, 2010, China Patent CN, Patent No. [101693688 A, 101693688]; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Leygue E, 1998, CANCER RES, V58, P3197; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; MINCHENKO A, 1994, LAB INVEST, V71, P374; Morris AD, 1997, ANTI-CANCER DRUG, V8, P746, DOI 10.1097/00001813-199709000-00003; Musa MA, 2011, MED CHEM, V7, P112; Nilsson S, 2000, BREAST CANCER RES, V2, P360, DOI 10.1186/bcr81; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pinkerton JV, 2010, MENOPAUSE, V17, P642, DOI 10.1097/gme.0b013e3181c4f1d6; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Stefanick ML, 2006, NEW ENGL J MED, V355, P190, DOI 10.1056/NEJMe068120; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wan ZL, 2013, MINI-REV MED CHEM, V13, P1381; Williams-Brown MY, 2011, J STEROID BIOCHEM, V126, P78, DOI 10.1016/j.jsbmb.2011.05.001; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	40	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86509	10.1371/journal.pone.0086509	http://dx.doi.org/10.1371/journal.pone.0086509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475135	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300073
J	Chen, JP; Qin, ZZ; Jiang, Y; Wang, YR; He, YS; Dai, JC; Jin, GF; Ma, HX; Hu, ZB; Yin, YM; Shen, HB				Chen, Jiaping; Qin, Zhenzhen; Jiang, Yue; Wang, Yanru; He, Yisha; Dai, Juncheng; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Yin, Yongmei; Shen, Hongbing			Genetic Variations in the Flanking Regions of miR-101-2 Are Associated with Increased Risk of Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; MICRORNA-101; EZH2; BIOGENESIS; CARCINOMA; VARIANTS; HAIRPINS	Genetic variants in human microRNA (miRNA) genes may alter mature miRNA processing and/or target selection, and likely contribute to cancer susceptibility and disease progression. Previous studies have suggested that miR-101 may play important roles in the development of cancer by regulating key tumor-associated genes. However, the role of single nucleotide polymorphisms (SNPs) of miR-101 in breast cancer susceptibility remains unclear. In this study, we genotyped 11 SNPs of the miR-101 genes (including miR-101-1 and miR-101-2) in a case-control study of 1064 breast cancer cases and 1073 cancer-free controls. The results revealed that rs462480 and rs1053872 in the flank regions of pre-miR-101-2 were significantly associated with increased risk of breast cancer (rs462480 AC/CC vs AA: adjusted OR = 1.182, 95% CI: 1.030-1.357, P=0.017; rs1053872 CG/GG vs CC: adjusted OR = 1.179, 95% CI: 1.040-1.337, P=0.010). However, the remaining 9 SNPs were not significantly associated with risk of breast cancer. Additionally, combined analysis of the two high-risk SNPs revealed that subjects carrying the variant genotypes of rs462480 and rs1053872 had increased risk of breast cancer in a dose-response manner (P-trend = 0.002). Compared with individuals with "0-1" risk allele, those carrying "2-4" risk alleles had 1.29-fold risk of breast cancer. In conclusion, these findings suggested that the SNPs rs462480 and rs1053872 residing in miR-101-2 gene may have a solid impact on genetic susceptibility to breast cancer, which may improve our understanding of the potential contribution of miRNA SNPs to cancer pathogenesis.	[Chen, Jiaping; Jiang, Yue; Dai, Juncheng; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Qin, Zhenzhen; Jiang, Yue; He, Yisha; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jiaping; Jin, Guangfu; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Wang, Yanru] Southern Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Southern Medical University - China; Nanjing Medical University	Yin, YM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	ym.yin@hotmail.com; hbshen@njmu.edu.cn			National Natural Science Foundation of China [81102179, 81071715, 81230067]; Natural Science Foundation of Jiangsu Higher Education Institutions [09KJA330001]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0631]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	Funding support for this project was provided by National Natural Science Foundation of China (grant number 81102179; 81071715), Key Project of the National Natural Science Foundation of China (grant number 81230067), Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions (09KJA330001), The Program for Changjiang Scholars and Innovative Research Team in University (IRT0631) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bae JS, 2012, DIGEST LIVER DIS, V44, P849, DOI 10.1016/j.dld.2012.04.021; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carvalho J, 2012, J PATHOL, V228, P31, DOI 10.1002/path.4032; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Qin ZZ, 2013, GENE, V527, P491, DOI 10.1016/j.gene.2013.06.067; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Ryan BM, 2010, NAT REV CANCER, V10, DOI 10.1038/nrc2885; Sachdeva M, 2011, ONCOGENE, V30, P822, DOI 10.1038/onc.2010.463; Shi TY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-19; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang ML, 2012, CANCER RES, V72, P6173, DOI 10.1158/0008-5472.CAN-12-0688; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Yang Q, 2012, ONCOGENE, DOI [10.1038/onc.2012.569, DOI 10.1038/0NC.2012.569.[]; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	35	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86319	10.1371/journal.pone.0086319	http://dx.doi.org/10.1371/journal.pone.0086319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475105	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800040
J	Prause, M; Christensen, DP; Billestrup, N; Mandrup-Poulsen, T				Prause, Michala; Christensen, Dan Ploug; Billestrup, Nils; Mandrup-Poulsen, Thomas			JNK1 Protects against Glucolipotoxicity-Mediated Beta-Cell Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; N-TERMINAL KINASE; ACTIVATING TRANSCRIPTION FACTOR-3; OXIDATIVE STRESS; FATTY-ACID; TYPE-2; GENE; DEATH; PALMITATE; GLUCOSE	Pancreatic beta-cell dysfunction is central to type 2 diabetes pathogenesis. Prolonged elevated levels of circulating free-fatty acids and hyperglycemia, also termed glucolipotoxicity, mediate beta-cell dysfunction and apoptosis associated with increased c-Jun N-terminal Kinase (JNK) activity. Endoplasmic reticulum (ER) and oxidative stress are elicited by palmitate and high glucose concentrations further potentiating JNK activity. Our aim was to determine the role of the JNK subtypes JNK1, JNK2 and JNK3 in palmitate and high glucose-induced beta-cell apoptosis. We established insulin-producing INS1 cell lines stably expressing JNK subtype specific shRNAs to understand the differential roles of the individual JNK isoforms. JNK activity was increased after 3 h of palmitate and high glucose exposure associated with increased expression of ER and mitochondrial stress markers. JNK1 shRNA expressing INS1 cells showed increased apoptosis and cleaved caspase 9 and 3 compared to non-sense shRNA expressing control INS1 cells when exposed to palmitate and high glucose associated with increased CHOP expression, ROS formation and Puma mRNA expression. JNK2 shRNA expressing INS1 cells did not affect palmitate and high glucose induced apoptosis or ER stress markers, but increased Puma mRNA expression compared to non-sense shRNA expressing INS1 cells. Finally, JNK3 shRNA expressing INS1 cells did not induce apoptosis compared to non-sense shRNA expressing INS1 cells when exposed to palmitate and high glucose but showed increased caspase 9 and 3 cleavage associated with increased DP5 and Puma mRNA expression. These data suggest that JNK1 protects against palmitate and high glucose-induced beta-cell apoptosis associated with reduced ER and mitochondrial stress.	[Prause, Michala; Christensen, Dan Ploug; Mandrup-Poulsen, Thomas] Univ Copenhagen, Endocrinol Res Sect, Dept Biomed Sci, Copenhagen, Denmark; [Billestrup, Nils] Univ Copenhagen, Dept Biomed Sci, Sect Cellular & Metab Res, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Copenhagen; University of Copenhagen; Karolinska Institutet	Prause, M (corresponding author), Univ Copenhagen, Endocrinol Res Sect, Dept Biomed Sci, Copenhagen, Denmark.	michalapr@sund.ku.dk		Billestrup, Nils/0000-0002-4968-8067; Prause, Michala/0000-0002-5922-0396; Mandrup-Poulsen, Thomas/0000-0002-3215-9273	Novo Nordisk foundation; PhD program of Molecular metabolism	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); PhD program of Molecular metabolism	The work was funded by the Novo Nordisk foundation (http://www.novonordiskfonden.dk/) and The PhD program of Molecular metabolism (http://metabolism-endocrinology.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bachar E, 2010, DIABETOLOGIA, V53, P2177, DOI 10.1007/s00125-010-1833-6; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Duprez J, 2011, BIOCHEM BIOPH RES CO, V415, P294, DOI 10.1016/j.bbrc.2011.10.048; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Haase TN, 2013, DIABETOLOGIA, V56, P763, DOI 10.1007/s00125-012-2821-9; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee SM, 2011, MOL CELL BIOCHEM, V354, P207, DOI 10.1007/s11010-011-0820-7; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lin N, 2012, ENDOCRINE, V42, P107, DOI 10.1007/s12020-012-9633-z; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Maris M, 2013, J PROTEOME RES, V12, P347, DOI 10.1021/pr300596g; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Santin I, 2011, DIABETES, V60, P3279, DOI 10.2337/db11-0758; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Varona-Santos JL, 2008, DIABETOLOGIA, V51, P2271, DOI 10.1007/s00125-008-1169-7; Wang PZ, 2010, BMB REP, V43, P738, DOI 10.5483/BMBRep.2010.43.11.738; Wang Q, 2009, MOL CELL BIOCHEM, V324, P183, DOI 10.1007/s11010-008-9997-9; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	46	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87067	10.1371/journal.pone.0087067	http://dx.doi.org/10.1371/journal.pone.0087067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475223	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800082
J	Yang, TU; Cheong, HJ; Song, JY; Lee, JS; Wie, SH; Kim, YK; Choi, WS; Lee, J; Jeong, HW; Kim, WJ				Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Lee, Jin Soo; Wie, Seong-Heon; Kim, Young Keun; Choi, Won Suk; Lee, Jacob; Jeong, Hye Won; Kim, Woo Joo			Age- and Influenza Activity-Stratified Case Definitions of Influenza-Like Illness: Experience from Hospital-Based Influenza Surveillance in South Korea	PLOS ONE			English	Article							CLINICAL DECISION RULE; VIRUS-INFECTION; DIAGNOSIS; SYMPTOMS; SIGNS	Objectives: This study aims to identify clinical case definitions of influenza with higher accuracy in patients stratified by age group and influenza activity using hospital-based surveillance system. Methods: In seven tertiary hospitals across South Korea during 2011-2012 influenza season, respiratory specimens were obtained from patients presenting an influenza-like illness (ILI), defined as having fever plus at least one of following symptoms: cough, sore throat or rhinorrhea. Influenza was confirmed by reverse transcriptase-polymerase chain reaction. We performed multivariate logistic regression analyses to identify clinical variables with better relation with laboratory-confirmed influenza, and compared the accuracy of combinations. Results: Over the study period, we enrolled 1417 patients, of which 647 had laboratory-confirmed influenza. Patients with cough, rhinorrhea, sore throat or headache were more likely to have influenza (p<0.05). The most accurate criterion across the study population was the combination of cough, rhinorrhea, sore throat and headache (sensitivity 71.3%, specificity 60.1% and AUROC 0.66). The combination of rhinorrhea, sore throat and sputum during the peak influenza activity period in the young age group showed higher accuracy than that using the whole population (sensitivity 89.3%, specificity 72.1%, and AUROC 0.81). Conclusions: The accuracy of clinical case definitions of influenza differed across age groups and influenza activity periods. Categorizing the entire population into subgroups would improve the detection of influenza patients in the hospital-based surveillance system.	[Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Choi, Won Suk; Kim, Woo Joo] Korea Univ, Coll Med, Div Infect Dis, Dept Internal Med, Seoul 136705, South Korea; [Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Choi, Won Suk; Kim, Woo Joo] APII, Seoul, South Korea; [Lee, Jin Soo] Inha Univ, Sch Med, Dept Internal Med, Div Infect Dis, Inchon, South Korea; [Wie, Seong-Heon] Catholic Univ, Coll Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Suwon, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Div Infect Dis, Dept Internal Med, Wonju, South Korea; [Lee, Jacob] Hallym Univ, Coll Med, Div Infect Dis, Dept Internal Med, Chunchon, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Div Infect Dis, Dept Internal Med, Cheongju, South Korea	Korea University; Korea University Medicine (KU Medicine); Inha University; Catholic University of Korea; Yonsei University; Hallym University; Chungbuk National University	Kim, WJ (corresponding author), Korea Univ, Coll Med, Div Infect Dis, Dept Internal Med, Seoul 136705, South Korea.	wjkim@medimail.co.kr	Choi, Won Suk/V-2730-2017; Kim, Woo Joo/D-2733-2015	Choi, Won Suk/0000-0001-5874-4764; Kim, Young Keun/0000-0002-2120-6265; Cheong, Hee Jin/0000-0002-2532-1463; Song, Joon Young/0000-0002-0148-7194; Yang, Tae Un/0000-0001-8229-0977; Kim, Woo Joo/0000-0002-4546-3880	Ministry of Health and Welfare, Republic of Korea [A103001]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No.: A103001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT GLOB EP SURV STA; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Cheong HJ, 2009, DIS BURDEN SEASONAL; Ebell MH, 2012, J AM BOARD FAM MED, V25, P55, DOI 10.3122/jabfm.2012.01.110161; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P1, DOI 10.3122/jabfm.17.1.1; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Hak E, 2001, ARCH INTERN MED, V161, P1351, DOI 10.1001/archinte.161.10.1351; Health Insurance Review & Assessment Service, 2012, POL BEN STAND ANT AG; Korea Centers for Disease Control and Prevention, 2005, STUD POL DEV EFF INF; Mandell GL, 1995, MANDELL DOUGLAS BENN; Montalto NJ, 2003, AM FAM PHYSICIAN, V67, P111; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; van den Dool C, 2008, INFECT CONT HOSP EP, V29, P314, DOI 10.1086/529211; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; WHO, 2009, INFL SEAS; Woolpert T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-129	21	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84873	10.1371/journal.pone.0084873	http://dx.doi.org/10.1371/journal.pone.0084873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475034	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800008
J	Lin, OA; Karim, ZA; Vemana, HP; Espinosa, EVP; Khasawneh, FT				Lin, Olivia A.; Karim, Zubair A.; Vemana, Hari Priya; Espinosa, Enma V. P.; Khasawneh, Fadi T.			The Antidepressant 5-HT2A Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function	PLOS ONE			English	Article							DEPRESSED-PATIENTS; IN-VIVO; 5-HYDROXYTRYPTAMINE; AGGREGATION; THROMBOSIS; ARTERY; ANTIPLATELET; STIMULATION; PATHWAYS; DISEASE	There is considerable interest in defining new agents or targets for antithrombotic purposes. The 5-HT2A receptor is a G-protein coupled receptor (GPCR) expressed on many cell types, and a known therapeutic target for many disease states. This serotonin receptor is also known to regulate platelet function. Thus, in our FDA-approved drug repurposing efforts, we investigated the antiplatelet activity of cyproheptadine and pizotifen, two antidepressant 5-HT2A Receptor antagonists. Our results revealed that cyproheptadine and pizotifen reversed serotonin-enhanced ADP-induced platelet aggregation in vitro and ex vivo. And the inhibitory effects of these two agents were found to be similar to that of EMD 281014, a 5-HT2A Receptor antagonist under development. In separate experiments, our studies revealed that these 5-HT2A (r)eceptor antagonists have the capacity to reduce serotonin-enhanced ADP-induced elevation in intracellular calcium levels and tyrosine phosphorylation. Using flow cytometry, we also observed that cyproheptadine, pizotifen, and EMD 281014 inhibited serotonin-enhanced ADP-induced phosphatidylserine (PS) exposure, P-selectin expression, and glycoprotein IIb-IIIa activation. Furthermore, using a carotid artery thrombosis model, these agents prolonged the time for thrombotic occlusion in mice in vivo. Finally, the tail-bleeding time was investigated to assess the effect of cyproheptadine and pizotifen on hemostasis. Our findings indicated prolonged bleeding time in both cyproheptadine-and pizotifen-treated mice. Notably, the increases in occlusion and bleeding times associated with these two agents were comparable to that of EMD 281014, and to clopidogrel, a commonly used antiplatelet drug, again, in a fashion comparable to clopidogrel and EMD 281014. Collectively, our data indicate that the antidepressant 5-HT2A antagonists, cyproheptadine and pizotifen do exert antiplatelet and thromboprotective effects, but similar to clopidogrel and EMD 281014, their use may interfere with normal hemostasis.	[Lin, Olivia A.; Karim, Zubair A.; Vemana, Hari Priya; Espinosa, Enma V. P.; Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Khasawneh, FT (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	Fkhasawneh@westernu.edu			College of Pharmacy	College of Pharmacy	This research was supported by funds provided by the College of Pharmacy (to F. T. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2008, EUR J PHARMACOL, V586, P234, DOI 10.1016/j.ejphar.2007.11.056; Adams JW, 2009, J PHARMACOL EXP THER, V331, P96, DOI 10.1124/jpet.109.153189; Bampalis VG, 2011, J THROMB HAEMOST, V9, P2112, DOI 10.1111/j.1538-7836.2011.04476.x; Basaveswara Rao MV, 2012, CHROMATOGRAPHY RES I, V2012, P5; Bembenek JP, 2012, CLIN APPL THROMB-HEM, V18, P258, DOI 10.1177/1076029611424575; Berry CN, 2001, THROMB HAEMOSTASIS, V85, P521; Breet NJ, 2011, NETH HEART J, V19, P451, DOI 10.1007/s12471-011-0189-y; CENAJEK D, 1980, Acta Physiologica Polonica, V31, P561; Curial M, 2013, CARDIOLOGY RES PRACT, V2013, P8; Delisi SM, 1998, BIOL PSYCHIAT, V43, P327, DOI 10.1016/S0006-3223(97)00377-6; Dowal L, 2010, CURR VASC PHARMACOL, V8, P140, DOI 10.2174/157016110790886938; Droogmans S, 2009, AM J PHYSIOL-HEART C, V296, pH1940, DOI 10.1152/ajpheart.01177.2008; Duerschmied D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032656; ECKERT A, 1993, BIOL PSYCHIAT, V34, P565, DOI 10.1016/0006-3223(93)90201-N; Ergelen M, 2010, AM HEART J, V159, P672, DOI 10.1016/j.ahj.2009.12.032; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Ferreiro JL, 2012, CIRC-CARDIOVASC INTE, V5, P433, DOI 10.1161/CIRCINTERVENTIONS.111.966176; GLUSA E, 1984, BIOMED BIOCHIM ACTA, V43, P215; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hargrove V, 2009, J ANAL TOXICOL, V33, P564, DOI 10.1093/jat/33.8.564; HUCKER HB, 1983, J PHARM SCI, V72, P1069, DOI 10.1002/jps.2600720925; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Kinugawa Toru, 2002, Am Heart J, V144, pE1, DOI 10.1067/mhj.2002.124056; Konopka LM, 1996, BIOL PSYCHIAT, V39, P708, DOI 10.1016/0006-3223(95)00189-1; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Laddha G. P., 2012, PHARM LETT, V4, P443; Mamo D, 2004, PSYCHOPHARMACOLOGY, V175, P382, DOI 10.1007/s00213-004-1817-7; Mendelson SD, 2000, J AFFECT DISORDERS, V57, P13, DOI 10.1016/S0165-0327(99)00177-9; Miiller-Schweinitzer E, 1986, J CARDIOVASCULAR PHA, V8, P805; Moerland M, 2011, J CARDIOVASC PHARM, V58, P575, DOI 10.1097/FJC.0b013e31822f6b8d; MORAN A, 1994, BRIT J PHARMACOL, V113, P1358, DOI 10.1111/j.1476-5381.1994.tb17147.x; Murad JP, 2012, BIOCHEM BIOPH RES CO, V421, P456, DOI 10.1016/j.bbrc.2012.04.011; Nagatomo T, 2004, PHARMACOL THERAPEUT, V104, P59, DOI 10.1016/j.pharmthera.2004.08.005; Nascimento EB, 2011, PHARMACOL BIOCHEM BE, V99, P598, DOI 10.1016/j.pbb.2011.06.016; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Raote I, 2007, FRONT NEUROSCI, P105; Saeed SA, 2003, ACTA PHARMACOL SIN, V24, P958; Schins A, 2003, PSYCHOSOM MED, V65, P729, DOI 10.1097/01.PSY.0000088596.42029.10; Shad KF, 2007, EXP BRAIN RES, V183, P411, DOI 10.1007/s00221-007-1133-7; VANHOUTTE PM, 1991, J CARDIOVASC PHARM, V17, pS6; VANZWIETEN PA, 1990, CLIN PHYSIOL BIOCH, V8, P1; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Walsh MT, 2002, LIFE SCI, V70, P3155, DOI 10.1016/S0024-3205(02)01569-2; Watanabe T, 2012, ROLES SEROTONIN ATHE; Watemberg NM, 1999, PEDIATRICS, V103, P158, DOI 10.1542/peds.103.1.158; WILLERSON JT, 1991, J AM COLL CARDIOL, V17, pB101; Xiong YF, 2010, J MED CHEM, V53, P4412, DOI 10.1021/jm100044a; Zendehdel M, 2012, IRAN J VET RES, V13, P100	50	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87026	10.1371/journal.pone.0087026	http://dx.doi.org/10.1371/journal.pone.0087026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466319	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000186
J	Goettel, W; Liu, ZR; Xia, J; Zhang, WX; Zhao, PX; An, YQ				Goettel, Wolfgang; Liu, Zongrang; Xia, Jing; Zhang, Weixiong; Zhao, Patrick X.; An, Yong-Qiang (Charles)			Systems and Evolutionary Characterization of MicroRNAs and Their Underlying Regulatory Networks in Soybean Cotyledons	PLOS ONE			English	Article							SMALL RNAS; TARGET GENES; ARABIDOPSIS-LYRATA; PLANT; IDENTIFICATION; MIRNAS; GENOME; MIR159; BIOGENESIS; MECHANISMS	MicroRNAs (miRNAs) are an emerging class of small RNAs regulating a wide range of biological processes. Soybean cotyledons evolved as sink tissues to synthesize and store seed reserves which directly affect soybean seed yield and quality. However, little is known about miRNAs and their regulatory networks in soybean cotyledons. We sequenced 292 million small RNA reads expressed in soybean cotyledons, and discovered 130 novel miRNA genes and 72 novel miRNA families. The cotyledon miRNAs arose at various stages of land plant evolution. Evolutionary analysis of the miRNA genes in duplicated genome segments from the recent Glycine whole genome duplication revealed that the majority of novel soybean cotyledon miRNAs were young, and likely arose after the duplication event 13 million years ago. We revealed the evolutionary pathway of a soybean cotyledon miRNA family (soy-miR15/ 49) that evolved from a neutral invertase gene through an inverted duplication and a series of DNA amplification and deletion events. A total of 304 miRNA genes were expressed in soybean cotyledons. The miRNAs were predicted to target 1910 genes, and form complex miRNA networks regulating a wide range of biological pathways in cotyledons. The comprehensive characterization of the miRNAs and their underlying regulatory networks at gene, pathway and system levels provides a foundation for further studies of miRNAs in cotyledons.	[Goettel, Wolfgang; An, Yong-Qiang (Charles)] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63120 USA; [Liu, Zongrang] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA; [Xia, Jing; Zhang, Weixiong] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA; [Zhao, Patrick X.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington University (WUSTL); Noble Research Institute	An, YQ (corresponding author), ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63120 USA.	yong-qiang.an@ars.usda.gov		Zhao, Patrick Xuechun/0000-0002-3460-5564; Zhang, Weixiong/0000-0002-4998-9791	USDA-ARS; United Soybean Board; Direct For Biological Sciences [0960897] Funding Source: National Science Foundation	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United Soybean Board; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is supported by funds from USDA-ARS and the United Soybean Board to Yong-qiang Charles An. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen KG, 2006, J INTEGR PLANT BIOL, V48, P591, DOI 10.1111/j.1744-7909.2006.00270.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li H, 2010, PLANT PHYSIOL, V153, P1759, DOI 10.1104/pp.110.156950; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Lin JY, 2010, PLANT CELL, V22, P2545, DOI 10.1105/tpc.110.074229; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang Weixiong, 2012, Methods Mol Biol, V883, P221, DOI 10.1007/978-1-61779-839-9_17; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	66	29	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86153	10.1371/journal.pone.0086153	http://dx.doi.org/10.1371/journal.pone.0086153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475082	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300040
J	Kong, QS; Yuan, JX; Niu, PH; Xie, JJ; Jiang, W; Huang, Y; Bie, ZL				Kong, Qiusheng; Yuan, Jingxian; Niu, Penghui; Xie, Junjun; Jiang, Wei; Huang, Yuan; Bie, Zhilong			Screening Suitable Reference Genes for Normalization in Reverse Transcription Quantitative Real-Time PCR Analysis in Melon	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYSTEMATIC VALIDATION; EXPRESSION ANALYSIS; SELECTION; IDENTIFICATION; ARABIDOPSIS; SEQUENCE; CDNA; CATALASE; COLONIZATION	Melon (Cucumis melo. L) is not only an economically important cucurbitaceous crop but also an attractive model for studying many biological characteristics. Screening appropriate reference genes is essential to reverse transcription quantitative real-time PCR (RT-qPCR), which is key to many studies involving gene expression analysis. In this study, 14 candidate reference genes were selected, and the variations in their expression in roots and leaves of plants subjected to biotic stress, abiotic stress, and plant growth regulator treatment were assessed by RT-qPCR. The stability of the expression of the selected genes was determined and ranked using geNorm and NormFinder. geNorm identified the two most stable genes for each set of conditions: CmADP and CmUBlep across all samples, CmUBIep and CmRPL in roots, CmRAN and CmACT in leaves, CmADP and CmRPL under abiotic stress conditions, CmTUA and CmACT under biotic stress conditions, and CmRAN and CmACT under plant growth regulator treatments. NormFinder determined CmRPL to be the best reference gene in roots and under biotic stress conditions and CmADP under the other experimental conditions. CmUBC2 and CmPP2A were not found to be suitable under many experimental conditions. The catalase family genes CmCAT1, CmCAT2, and CmCAT3 were identified in melon genome and used as target genes to validate the reliability of identified reference genes. The catalase family genes showed the most upregulation 3 days after inoculation with Fusarium wilt in roots, after which they were downregulated. Their levels of expression were significantly overestimated when the unsuitable reference gene was used for normalization. These results not only provide guidelines for the selection of reference genes for gene expression analyses in melons but may also provide valuable information for studying the functions of catalase family genes in stress responses.	[Kong, Qiusheng; Yuan, Jingxian; Niu, Penghui; Xie, Junjun; Jiang, Wei; Huang, Yuan; Bie, Zhilong] Huazhong Agr Univ, Coll Hort & Forestry, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Bie, ZL (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	biezhilong@hotmail.com	Kong, Qiusheng/F-7710-2012	Kong, Qiusheng/0000-0003-0939-4424	earmarked fund for Modern Agro-industry Technology Research System [CARS-26-16]; National Science & Technology Pillar Program [2012BAD02B03-16]; Special Fund for Agro-scientific Research in the Public Interest [201003066-6]	earmarked fund for Modern Agro-industry Technology Research System; National Science & Technology Pillar Program; Special Fund for Agro-scientific Research in the Public Interest	This work was founded by the earmarked fund for Modern Agro-industry Technology Research System (CARS-26-16), National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD02B03-16) and Special Fund for Agro-scientific Research in the Public Interest (201003066-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bahar O, 2009, EUR J PLANT PATHOL, V123, P71, DOI 10.1007/s10658-008-9345-7; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Cheng H, 2012, MOL BIOL REP, V39, P1903, DOI 10.1007/s11033-011-0936-6; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dai N, 2011, PLANT MOL BIOL, V76, P1, DOI 10.1007/s11103-011-9757-1; Deng YW, 2010, MOL BIOTECHNOL, V44, P51, DOI 10.1007/s12033-009-9203-7; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fita A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035387; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Frugoli JA, 1996, PLANT PHYSIOL, V112, P327, DOI 10.1104/pp.112.1.327; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hao H, 2012, GENE, V503, P147, DOI 10.1016/j.gene.2012.04.059; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Liu Z, 2013, PLANT CELL TISS ORG, V113, P469, DOI 10.1007/s11240-013-0288-0; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Blanca JM, 2011, PLANT GENOME-US, V4, P118, DOI 10.3835/plantgenome2011.01.0003; Min MK, 2013, PLANT PHYSIOL, V161, P676, DOI 10.1104/pp.112.209148; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Oumouloud A, 2010, EUPHYTICA, V176, P183, DOI 10.1007/s10681-010-0201-4; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051502; Portnoy V, 2011, PLANT GENOME-US, V4, P36, DOI 10.3835/plantgenome2010.11.0026; Qin XQ, 2011, PLANTA, V234, P737, DOI 10.1007/s00425-011-1442-8; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sestili S, 2013, J PLANT BIOCHEM BIOT, V3, P1; Sestili S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-122; Shan WY, 2012, SCI HORTIC-AMSTERDAM, V139, P96, DOI 10.1016/j.scienta.2012.03.010; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Wei SW, 2013, MOL BIOL REP, V40, P2915, DOI 10.1007/s11033-012-2307-3; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zvirin T, 2010, PLANT PATHOL, V59, P576, DOI 10.1111/j.1365-3059.2009.02225.x	51	50	54	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87197	10.1371/journal.pone.0087197	http://dx.doi.org/10.1371/journal.pone.0087197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475250	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300151
J	Soler, M; Perez-Contreras, T; Peralta-Sanchez, JM				Soler, Manuel; Perez-Contreras, Tomas; Manuel Peralta-Sanchez, Juan			Mirror-Mark Tests Performed on Jackdaws Reveal Potential Methodological Problems in the Use of Stickers in Avian Mark-Test Studies	PLOS ONE			English	Article							SELF-RECOGNITION; CONVERGENT EVOLUTION; CROWS; CHIMPANZEES; BEHAVIOR; IMAGE; AWARENESS; RESPONSES; CORVIDS; BRAIN	Some animals are capable of recognizing themselves in a mirror, which is considered to be demonstrated by passing the mark test. Mirror self-recognition capacity has been found in just a few mammals having very large brains and only in one bird, the magpie (Pica pica). The results obtained in magpies have enormous biological and cognitive implications because the fact that magpies were able to pass the mark test meant that this species is at the same cognitive level with great apes, that mirror self-recognition has evolved independently in the magpie and great apes (which diverged 300 million years ago), and that the neocortex (which is not present in the bird's brains) is not a prerequisite for mirror self-recognition as previously believed. Here, we have replicated the experimental design used on magpies to determine whether jackdaws (Corvus monedula) are also capable of mirror self-recognition by passing the mark test. We found that our nine jackdaws showed a very high interest towards the mirror and exhibited self-contingent behavior as soon as mirrors were introduced. However, jackdaws were not able to pass the mark test: both sticker-directed actions and sticker removal were performed with a similar frequency in both the cardboard (control) and the mirror conditions. We conclude that our jackdaws' behaviour raises non-trivial questions about the methodology used in the avian mark test. Our study suggests that the use of self-adhesive stickers on sensitive throat feathers may open the way to artefactual results because birds might perceive the stickers tactilely.	[Soler, Manuel; Perez-Contreras, Tomas] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Soler, Manuel; Perez-Contreras, Tomas; Manuel Peralta-Sanchez, Juan] Univ Granada, CSIC, Unidad Asociada, Grp Coevoluc, Granada, Spain; [Manuel Peralta-Sanchez, Juan] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain; [Manuel Peralta-Sanchez, Juan] Knight Lab, Boulder, CO USA	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Granada	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	msoler@ugr.es	Pérez-Contreras, Tomás/M-8065-2014; Peralta-Sanchez, Juan M/L-3159-2017; Pérez-Contreras, Tomás/N-2523-2019	Pérez-Contreras, Tomás/0000-0002-2271-1706; Peralta-Sanchez, Juan M/0000-0003-4648-7988; Pérez-Contreras, Tomás/0000-0002-2271-1706	Ministerio de Educacion and Consejeria de Innovacion; C 420 iencia y Empresa under International Excellence Campus Program (CEI Granada); Ministerio de Educacion y Ciencia [CGL2011-25634]	Ministerio de Educacion and Consejeria de Innovacion; C 420 iencia y Empresa under International Excellence Campus Program (CEI Granada); Ministerio de Educacion y Ciencia(Spanish Government)	JMPS was funded by Ministerio de Educacion and Consejeria de Innovacion, C 420 iencia y Empresa under International Excellence Campus Program (CEI Granada) and TPC was funded by Ministerio de Educacion y Ciencia by a postdoctoral contract from the project CGL2011-25634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTENTHAL BI, 1978, DEV PSYCHOL, V14, P44; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; COOMBS F, 1978, CROWS STUDY CORVIDS; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Darwin C., 1871, P423; de Veer MW, 1999, ANIM BEHAV, V58, P459, DOI 10.1006/anbe.1999.1166; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gallup GG, 1998, BEHAV PROCESS, V42, P239, DOI 10.1016/S0376-6357(97)00079-X; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Griesser M, 2009, P R SOC B, V276, P2887, DOI 10.1098/rspb.2009.0551; Griffin D.R., 1992, ANIMAL MINDS; Gunturkun O, 2012, PSYCHOL RES-PSYCH FO, V76, P212, DOI 10.1007/s00426-011-0377-9; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; HEALY SD, 1992, P ROY SOC B-BIOL SCI, V248, P241, DOI 10.1098/rspb.1992.0068; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heschl A, 2009, INT J COMP PSYCHOL, V22, P221; Iglesias TL, 2012, ANIM BEHAV, V84, P1103, DOI 10.1016/j.anbehav.2012.08.007; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Kusayama T, 2000, ANIM COGN, V3, P61, DOI 10.1007/s100710050051; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; Lorenz K, 1982, HABLABA CON BESTIAS; Marzluff J. M., 2007, CO CROWS RAVENS; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; Medina FS, 2011, ANIM BEHAV, V82, P981, DOI 10.1016/j.anbehav.2011.07.033; Morin A, 2011, LATERALITY, V16, P367, DOI 10.1080/13576501003702648; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; PEPPERBERG IM, 1995, J COMP PSYCHOL, V109, P182, DOI 10.1037/0735-7036.109.2.182; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; R Core Team, 2021, R LANGUAGE ENV STAT; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Rajala AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012865; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; ROELL A, 1978, BEHAVIOUR, V64, P1; Schilhab TSS, 2004, BIOL PHILOS, V19, P111, DOI 10.1023/B:BIPH.0000013249.23475.1f; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Soler M, 2011, ADAPTIVE BEHAV UNDER; Suddendorf T, 2009, P R SOC B, V276, P1671, DOI 10.1098/rspb.2008.1754; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; WALRAVEN V, 1995, PRIMATES, V36, P145, DOI 10.1007/BF02381922; Watanabe S, 2002, BEHAV PROCESS, V60, P35, DOI 10.1016/S0376-6357(02)00094-3; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433	52	42	44	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86193	10.1371/journal.pone.0086193	http://dx.doi.org/10.1371/journal.pone.0086193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475085	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300042
J	Tsai, LL; Hu, FW; Lee, SS; Yu, CH; Yu, CC; Chang, YC				Tsai, Lo-Lin; Hu, Fang-Wei; Lee, Shiuan-Shinn; Yu, Chuan-Hang; Yu, Cheng-Chia; Chang, Yu-Chao			Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							CANCER STEM-LIKE; NECK-CANCER; GENES OCT4; EXPRESSION; NANOG; HEAD; PLURIPOTENCY; LINE; TRANSDIFFERENTIATION; IDENTIFICATION	Background: Overexpression of Oct4, an important transcription factor of embryonic stem cells (ESC), has been reported in several cancers. The aim of this study was to determine the emerging role of Oct4 in oral squamous cell carcinoma (OSCC) both in vitro and in vivo. Methodology/Principal Finding: Tumourigenic activity and molecular mechanisms of Oct4 overexpression or knockdown by lentiviral infection in OSCC was investigated in vitro and in vivo. Initially, we demonstrated that Oct4 expression was increased in OSCC cell lines as compared to a normal oral epithelial cell line SG. Overexpression of Oct4 was demonstrated to enhance cell proliferation, invasiveness, anchorage-independent growth and xenotransplantation tumourigenicity. These findings were coupled with epithelial-mesenchymal transition (EMT) transformation in OSCCs. In contrast, the silence of Oct4 significantly blocked the xenograft tumorigenesis of OSCC-derived cancer stem cells (OSCC-CSCs) and significantly improved the recipient survival. Clinically, the level of Oct4 expression was higher in recurrent and metastatic OSCC specimens but lower in primary OSCC specimens. Conclusion/Significance: Our results suggest that Oct4-mediated tumorigenecity is associated with the regulation of EMT. Oct4 might be a therapeutic target for OSCC.	[Tsai, Lo-Lin; Hu, Fang-Wei; Yu, Chuan-Hang; Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Tsai, Lo-Lin; Hu, Fang-Wei; Yu, Chuan-Hang; Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Lee, Shiuan-Shinn] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Yu, CC (corresponding author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.	ccyu@csmu.edu.tw; cyc@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021		Chung Shan Medical University Hospital [CSH-2013-C-015]; National Science Council in Taiwan, ROC [100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 -MY3]	Chung Shan Medical University Hospital; National Science Council in Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from Chung Shan Medical University Hospital (CSH-2013-C-015) and the National Science Council (100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 -MY3) in Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Chen HM, 2011, J ORAL PATHOL MED, V40, P483, DOI 10.1111/j.1600-0714.2010.00973.x; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Han XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073341; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lee SS, 2008, ORAL ONCOL, V44, P884, DOI 10.1016/j.oraloncology.2007.11.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin SC, 2004, J ORAL PATHOL MED, V33, P79, DOI 10.1111/j.1600-0714.2004.00034.x; Liu DB, 2011, TUMOR BIOL, V32, P941, DOI 10.1007/s13277-011-0196-z; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Okumura K, 1996, J CANCER RES CLIN, V122, P243, DOI 10.1007/BF01209653; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Shieh TM, 2007, CLIN CANCER RES, V13, P4378, DOI 10.1158/1078-0432.CCR-06-2685; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Srisopark S S, 1975, J Dent Assoc Thai, V25, P77; Ugolkov AV, 2011, PROSTATE, V71, P18, DOI 10.1002/pros.21217; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Way TD, 2013, EUR J CANC; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Yu FS, 2011, J DENT RES, V90, P168, DOI 10.1177/0022034510384619; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	47	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87207	10.1371/journal.pone.0087207	http://dx.doi.org/10.1371/journal.pone.0087207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475251	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300152
J	Tseng, CK; Lin, CK; Chang, HW; Wu, YH; Yen, FL; Chang, FR; Chen, WC; Yeh, CC; Lee, JC				Tseng, Chin-Kai; Lin, Chun-Kuang; Chang, Hsueh-Wei; Wu, Yu-Hsuan; Yen, Feng-Lin; Chang, Fang-Rong; Chen, Wei-Chun; Yeh, Chi-Chen; Lee, Jin-Ching			Aqueous Extract of Gracilaria tenuistipitata Suppresses LPS-Induced NF-kappa B and MAPK Activation in RAW 264.7 and Rat Peritoneal Macrophages and Exerts Hepatoprotective Effects on Carbon Tetrachloride-Treated Rat	PLOS ONE			English	Article							LIVER-INJURY; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; CELL-SURVIVAL; NITRIC-OXIDE; INFLAMMATION; LIPOPOLYSACCHARIDE; DAMAGE; HOMEOSTASIS; INHIBITION	In addition to the previous investigations of bioactivity of aqueous extract of the edible Gracilaria tenuistipitata (AEGT) against H2O2-induced DNA damage and hepatitis C virus replication, the purpose of this study is to evaluate the potential therapeutic properties of AEGT against inflammation and hepatotoxicity using lipopolysaccharide (LPS)-stimulated mouse RAW 264.7 cells, primary rat peritoneal macrophages and carbon tetrachloride (CCl4)-induced acute hepatitis model in rats. AEGT concentration-dependently inhibited the elevated RNA and protein levels of inducible nitric oxide synthase and cyclooxygenase-2, thereby reducing nitric oxide and prostaglandin E2 levels, respectively. Moreover, AEGT significantly suppressed the production of LPS-induced proinflammatory cytokines, including interleukin (IL)-1 beta, IL-6 and tumor necrosis factor-alpha. These inhibitory effects were associated with the suppression of nuclear factor-kappa B activation and mitogen-activated protein kinase phosphorylation by AEGT in LPS-stimulated cells. In addition, we highlighted the hepatoprotective and curative effects of AEGT in a rat model of CCl4-intoxicated acute liver injury, which was evident from reduction in the elevated serum aspartate aminotransferase and alanine aminotransferase levels as well as amelioration of histological damage by pre-treatment or post-treatment of AEGT. In conclusion, the results demonstrate that AEGT may serve as a potential supplement in the prevention or amelioration of inflammatory diseases.	[Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lin, Chun-Kuang] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Biomed Sci & Environm Biol, Ctr Canc, Kaohsiung, Taiwan; [Wu, Yu-Hsuan; Lee, Jin-Ching] Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan; [Yen, Feng-Lin] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Coll Pharm, Kaohsiung, Taiwan; [Chen, Wei-Chun] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chang, Fang-Rong; Yeh, Chi-Chen; Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Lee, JC (corresponding author), Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan.	jclee@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council of Taiwan [NSC 101-2311-B-037-002-MY3, NSC 101-2622-B-037-001-CC3]; Kaohsiung Medical University Research Foundation, Taiwan [KMUER014]; Department of Health, Executive Yuan, Taiwan [DOH102-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation, Taiwan; Department of Health, Executive Yuan, Taiwan	This work was funded by grants from the National Science Council of Taiwan (NSC 101-2311-B-037-002-MY3 and NSC 101-2622-B-037-001-CC3), Kaohsiung Medical University Research Foundation, Taiwan (KMUER014) and The Department of Health, Executive Yuan, Taiwan (DOH102-TD-C-111-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJISAKA T, 1993, HYDROBIOLOGIA, V261, P335; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057704; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gonciarz M, 2010, J PHYSIOL PHARMACOL, V61, P705; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Javed S, 2011, ALTERN MED REV, V16, P239; Jeong JB, 2011, ARCH PHARM RES, V34, P2109, DOI 10.1007/s12272-011-1214-9; JOHNSON SJ, 1992, J PATHOL, V166, P351, DOI 10.1002/path.1711660406; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim JK, 2012, INFLAMM RES, V61, P319, DOI 10.1007/s00011-011-0413-7; Kim MM, 2009, PHYTOTHER RES, V23, P628, DOI 10.1002/ptr.2674; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Krakauer Teresa, 2004, Current Drug Targets - Inflammation and Allergy, V3, P317; Lee CW, 2012, J AGR FOOD CHEM, V60, P4662, DOI 10.1021/jf2050137; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lin AW, 1996, J BIOL CHEM, V271, P11911, DOI 10.1074/jbc.271.20.11911; LIU RH, 1995, MUTAT RES-REV GENET, V339, P73, DOI 10.1016/0165-1110(95)90004-7; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muriel P, 2009, J APPL TOXICOL, V29, P91, DOI 10.1002/jat.1393; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Patrick L, 2006, ALTERN MED REV, V11, P114; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Pradhan SC, 2006, INDIAN J MED RES, V124, P491; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Ryan S, 2011, PHYTOTHER RES, V25, P765, DOI 10.1002/ptr.3309; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; SLATER TF, 1985, PHILOS T R SOC B, V311, P633, DOI 10.1098/rstb.1985.0169; SLATER TF, 1984, BIOCHEM J, V222, P1; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Veres B, 2004, J PHARMACOL EXP THER, V310, P247, DOI 10.1124/jpet.104.065151; Yang JI, 2012, MOLECULES, V17, P7241, DOI 10.3390/molecules17067241	40	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86557	10.1371/journal.pone.0086557	http://dx.doi.org/10.1371/journal.pone.0086557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475143	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300080
J	Brockman-Schneider, RA; Pickles, RJ; Gern, JE				Brockman-Schneider, Rebecca A.; Pickles, Raymond J.; Gern, James E.			Effects of Vitamin D on Airway Epithelial Cell Morphology and Rhinovirus Replication	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; PROLINE-RICH PROTEIN; ANTIMICROBIAL PEPTIDES; SQUAMOUS METAPLASIA; D DEFICIENCY; ANTAGONIZES; INDUCTION; CYTOKINES; DEFENSE; DISEASE	Vitamin D has been linked to reduced risk of viral respiratory illness. We hypothesized that vitamin D could directly reduce rhinovirus (RV) replication in airway epithelium. Primary human bronchial epithelial cells (hBEC) were treated with vitamin D, and RV replication and gene expression were evaluated by quantitative PCR. Cytokine/chemokine secretion was measured by ELISA, and transepithelial resistance (TER) was determined using a voltohmmeter. Morphology was examined using immunohistochemistry. Vitamin D supplementation had no significant effects on RV replication, but potentiated secretion of CXCL8 and CXCL10 from infected or uninfected cells. Treatment with vitamin D in the form of 1,25(OH)(2)D caused significant changes in cell morphology, including thickening of the cell layers (median of 46.5 mu m [35.0-69.0] vs. 30 mu m [24.5-34.2], p<0.01) and proliferation of cytokeratin-5-expressing cells, as demonstrated by immunohistochemical analysis. Similar effects were seen for 25(OH) D. In addition to altering morphology, higher concentrations of vitamin D significantly upregulated small proline-rich protein (SPRR1 beta) expression (6.3 fold-induction, p<0.01), suggestive of squamous metaplasia. Vitamin D treatment of hBECs did not alter repair of mechanically induced wounds. Collectively, these findings indicate that vitamin D does not directly affect RV replication in airway epithelial cells, but can influence chemokine synthesis and alters the growth and differentiation of airway epithelial cells.	[Brockman-Schneider, Rebecca A.; Gern, James E.] Univ Wisconsin, Dept Pediat & Med, Madison, WI 53715 USA; [Pickles, Raymond J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Brockman-Schneider, RA (corresponding author), Univ Wisconsin, Dept Pediat & Med, Madison, WI 53715 USA.	rabrockm@wisc.edu			NIH [P01 HL070831-06A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant #P01 HL070831-06A1 (http://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Banerjee A, 2012, CURR OPIN PHARMACOL, V12, P266, DOI 10.1016/j.coph.2012.01.014; Bartley J, 2010, J LARYNGOL OTOL, V124, P465, DOI 10.1017/S0022215109992684; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hayes DP, 2010, MED HYPOTHESES, V74, P831, DOI 10.1016/j.mehy.2009.12.002; Herfs M, 2012, AM J RESP CELL MOL, V47, P67, DOI 10.1165/rcmb.2011-0353OC; Hu R, 1998, LUNG CANCER, V20, P25, DOI 10.1016/S0169-5002(97)00097-4; IGARASHI Y, 1993, J ALLERGY CLIN IMMUN, V92, P722, DOI 10.1016/0091-6749(93)90016-9; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438; Lachowicz-Scroggins ME, 2010, AM J RESP CELL MOL, V43, P652, DOI 10.1165/rcmb.2009-0244OC; Lau Derick, 2003, Methods Mol Med, V75, P397; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Rohde CM, 2005, J NUTR, V135, P1647, DOI 10.1093/jn/135.7.1647; Rohde CM, 1999, J NUTR, V129, P2246, DOI 10.1093/jn/129.12.2246; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Schwalfenberg GK, 2011, MOL NUTR FOOD RES, V55, P96, DOI 10.1002/mnfr.201000174; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weiss ST, 2011, AM J RESP CRIT CARE, V183, P1286, DOI 10.1164/rccm.201101-0160ED; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	34	54	56	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86755	10.1371/journal.pone.0086755	http://dx.doi.org/10.1371/journal.pone.0086755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475177	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800060
J	Parkinson, RM; Collins, SL; Horton, MR; Powell, JD				Parkinson, Rose M.; Collins, Samuel L.; Horton, Maureen R.; Powell, Jonathan D.			Egr3 Induces a Th17 Response by Promoting the Development of gamma delta T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; INTERFERON-GAMMA; CUTTING EDGE; TGF-BETA; OPPOSING REGULATION; THYMIC SELECTION; DIFFERENTIATION; THYMOCYTES; INDUCTION; INFECTION	The transcription factor Early Growth Response 3 (Egr3) has been shown to play an important role in negatively regulating T cell activation and promoting T cell anergy in Th1 cells. However, its role in regulating other T helper subsets has yet to be described. We sought to determine the role of Egr3 in a Th17 response using transgenic mice that overexpress Egr3 in T cells (Egr3 TG). Splenocytes from Egr3 TG mice demonstrated more robust generation of Th17 cells even under non-Th17 skewing conditions. We found that while Egr3 TG T cells were not intrinsically more likely to become Th17 cells, the environment encountered by these cells was more conducive to Th17 development. Further analysis revealed a considerable increase in the number of gamma delta T cells in both the peripheral lymphoid organs and mucosal tissues of Egr3 TG mice, a cell type which normally accounts for only a small fraction of peripheral lymphocytes. Consistent with this marked increase in peripheral gamma delta T cells, thymocytes from Egr3 TG mice also appear biased toward gamma delta T cell development. Coculture of these Egr3-induced gamma delta T cells with wildtype CD4+ T cells increases Th17 differentiation, and Egr3 TG mice are more susceptible to bleomycin-induced lung inflammation. Overall our findings strengthen the role for Egr3 in promoting gamma delta T cell development and show that Egr3-induced gamma delta T cells are both functional and capable of altering the adaptive immune response in a Th17-biased manner. Our data also demonstrates that the role played by Egr3 in T cell activation and differentiation is more complex than previously thought.	[Parkinson, Rose M.; Powell, Jonathan D.] Johns Hopkins Sch Med, Sidney Kimmel Canc Res Ctr, Baltimore, MD 21218 USA; [Collins, Samuel L.; Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Div Pulm Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Powell, JD (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Canc Res Ctr, Baltimore, MD 21218 USA.	poweljo@jhmi.edu			National Institutes of Health [R01 CA098109, PO1 AI072677]; NATIONAL CANCER INSTITUTE [R01CA098109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI072677, T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 CA098109 and PO1 AI072677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Collins S, 2006, J IMMUNOL, V177, P8301, DOI 10.4049/jimmunol.177.12.8301; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Do JS, 2011, J IMMUNOL, V186, P4546, DOI 10.4049/jimmunol.1004021; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Haas J, 2009, NATION, V289, P6; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Han GC, 2010, IMMUNOLOGY, V129, P197, DOI 10.1111/j.1365-2567.2009.03166.x; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huang ZF, 2007, EXPERT OPIN THER TAR, V11, P737, DOI 10.1517/14728222.11.6.737; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; MAGES HW, 1993, INT IMMUNOL, V5, P63, DOI 10.1093/intimm/5.1.63; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; O'Brien RL, 2001, CHEM IMMUNOL, V79, P1; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pociask DA, 2011, AM J PATHOL, V178, P1167, DOI 10.1016/j.ajpath.2010.11.055; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	51	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87265	10.1371/journal.pone.0087265	http://dx.doi.org/10.1371/journal.pone.0087265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475259	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800091
J	Chagniel, L; Bergeron, Y; Bureau, G; Massicotte, G; Cyr, M				Chagniel, Laure; Bergeron, Yan; Bureau, Genevieve; Massicotte, Guy; Cyr, Michel			Regulation of Tyrosine Phosphatase STEP61 by Protein Kinase A during Motor Skill Learning in Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MOLECULAR CHARACTERIZATION; NUCLEUS-ACCUMBENS; DEPENDENT MEMORY; DORSAL STRIATUM; BASAL GANGLIA; ADULT-RAT; INHIBITION; EXPRESSION; PLASTICITY	Recently, striatal-enriched protein tyrosine phosphatase (STEP) and its upstream regulator protein kinase A (PKA) have been suspected to play a role in the intracellular mechanisms of fear conditioning and spatial memory. However, whether they contribute to the learning and memory of motor skills is totally unknown. In this study, we have investigated the role of STEP and PKA activities during motor skill learning associated with the accelerating rotarod task. We observed that learning the rotarod task differentially modulated the levels of phosphorylated STEP61 at serine 221, a site directly regulated by PKA, in the hippocampus, motor cortex and striatum. In a second set of experiments, we have pharmacologically inhibited PKA by the injection of Rp-cAMPS directly into the dorsal striatum of mice before rotarod trainings. PKA phosphorylation of STEP prevents the dephosphorylation of STEP substrates, whereas inhibition of PKA promotes STEP activity. Striatal PKA inhibitions dose-dependently impaired mice performances on the accelerating rotarod task. General motor abilities testing revealed an intact motor control in mice treated with 5 and 20 mu g of Rp-cAMPS, but not at the highest dose of 40 mu g. This suggested that motor learning was selectively affected by PKA inhibition at lower doses. Most notably, striatal inhibition of PKA reduced the levels of phosphorylated STEP61 at serine 221. Our data support that inactivation of STEP61 by the PKA activity is part of the molecular process associated with motor skill learning.	[Chagniel, Laure; Bergeron, Yan; Bureau, Genevieve; Massicotte, Guy; Cyr, Michel] Univ Quebec Trois Rivieres, Grp Rech Neurosci, Dept Med Biol, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Cyr, M (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Neurosci, Dept Med Biol, Trois Rivieres, PQ GA9 5H7, Canada.	cyrmi@uqtr.ca			Natural Sciences and Engineering Research Council of Canada [311763, 105942]; Canada Research Chair in Molecular Neuropharmacology; Fonds de Recherche du Quebec, Nature et Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Molecular Neuropharmacology; Fonds de Recherche du Quebec, Nature et Technologies (FQRNT)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (MC: #311763 and GM: #105942) and the Canada Research Chair in Molecular Neuropharmacology (MC). LC was the holder of a doctoral research merit scholarship from the Fonds de Recherche du Quebec, Nature et Technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; ABRAMS TW, 2009, ENCY NEUROSCIENCE, P265; Baldwin AE, 2002, NEUROBIOL LEARN MEM, V77, P44, DOI 10.1006/nlme.2000.4002; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Braithwaite SP, 2006, TRENDS NEUROSCI, V29, P452, DOI 10.1016/j.tins.2006.06.007; Brandon EP, 1998, J NEUROSCI, V18, P3639; Bureau G, 2010, NEUROBIOL LEARN MEM, V94, P107, DOI 10.1016/j.nlm.2010.04.008; Chagniel L, 2012, BEHAV BRAIN RES, V228, P9, DOI 10.1016/j.bbr.2011.11.019; D'Amours G, 2011, BEHAV BRAIN RES, V221, P108, DOI 10.1016/j.bbr.2011.02.030; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Fitzpatrick CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00047; Gerdjikov TV, 2007, PSYCHOPHARMACOLOGY, V190, P65, DOI 10.1007/s00213-006-0590-1; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; Isiegas C, 2006, J NEUROSCI, V26, P12700, DOI 10.1523/JNEUROSCI.2743-06.2006; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 1997, J NEUROSCI, V17, P717; Kleim JA, 1996, J NEUROSCI, V16, P4529; Lebel M, 2009, NEUROPHARMACOLOGY, V57, P392, DOI 10.1016/j.neuropharm.2009.06.041; Lemay-Clermont J, 2011, BEHAV NEUROSCI, V125, P714, DOI 10.1037/a0025213; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; OGAWA N, 1987, EUR NEUROL, V26, P16, DOI 10.1159/000116351; Olausson P, 2012, NEUROSCIENCE, V225, P1, DOI 10.1016/j.neuroscience.2012.07.069; Palkovits  M., 1983, BRAIN MICRODISSECTIO, P1; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Paul S, 2007, BIOL PSYCHIAT, V61, P1049, DOI 10.1016/j.biopsych.2006.08.005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Sedelis M, 2000, BEHAV GENET, V30, P171, DOI 10.1023/A:1001958023096; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Sharifzadeh M, 2005, J NEUROSCI RES, V79, P392, DOI 10.1002/jnr.20358; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Venkitaramani DV, 2011, EUR J NEUROSCI, V33, P2288, DOI 10.1111/j.1460-9568.2011.07687.x; Wachter T, 2010, EXP BRAIN RES, V200, P319, DOI 10.1007/s00221-009-2027-7; Willuhn I, 2006, NEUROPSYCHOPHARMACOL, V31, P2669, DOI 10.1038/sj.npp.1300995	44	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86988	10.1371/journal.pone.0086988	http://dx.doi.org/10.1371/journal.pone.0086988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466306	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000179
J	Han, ZH; Cao, JT; Song, DQ; Tian, L; Chen, K; Wang, Y; Gao, L; Yin, ZF; Fan, YQ; Wang, CQ				Han, Zhihua; Cao, Jiatian; Song, Dongqiang; Tian, Lei; Chen, Kan; Wang, Yue; Gao, Lin; Yin, Zhaofang; Fan, Yuqi; Wang, Changqian			Autophagy Is Involved in the Cardioprotection Effect of Remote Limb Ischemic Postconditioning on Myocardial Ischemia/Reperfusion Injury in Normal Mice, but Not Diabetic Mice	PLOS ONE			English	Article							REPERFUSION INJURY; HEART; INFARCTION; PROTECTS; RESVERATROL; INHIBITION; ACTIVATION; MECHANISMS; MODELS	Background: Recent animal study and clinical trial data suggested that remote limb ischemic postconditioning ( RIPostC) can invoke potent cardioprotection. However, during ischemia reperfusion injury (IR), the effect and mechanism of RIPostC on myocardium in subjects with or without diabetes mellitus (DM) are poorly understood. Autophagy plays a crucial role in alleviating myocardial IR injury. The aim of this study was to determine the effect of RIPostC on mice myocardial IR injury model with or without DM, and investigate the role of autophagy in this process. Methodology and Results: Streptozocin (STZ) induced DM mice model and myocardial IR model were established. Using a noninvasive technique, RIPostC was induced in normal mice (ND) and DM mice by three cycles of ischemia (5 min) and reperfusion (5 min) in the left hindlimb. In ND group, RIPostC significantly reduced infarct size (32.6 +/- 3.0% in ND-RIPostC vs. 50.6 +/- 2.4% in ND-IR, p<0.05) and improved cardiac ejection fraction (49.70 +/- 3.46% in ND-RIPostC vs. 31.30 +/- 3.95% in ND-IR, p<0.05). However, in DM group, no RIPostC mediated cardioprotetion effect was observed. To analyze the role of autophagy, western blot and immunohistochemistry was performed. Our data showed that a decreased sequestosome 1 (SQSTM1/p62) level, an increased Beclin-1 level, and higher ratio of LC3-II/LC3-I were observed in ND RIPostC group, but not DM RIPostC group. Conclusions: The current study suggested that RIPostC exerts cardioprotection effect on IR in normal mice, but not DM mice, and this difference is via, at least in part, the up-regulation of autophagy.	[Han, Zhihua; Cao, Jiatian; Song, Dongqiang; Tian, Lei; Chen, Kan; Wang, Yue; Gao, Lin; Yin, Zhaofang; Fan, Yuqi; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Fan, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	moricizine@gmail.com; changqianwang@hotmail.com			Chinese National Natural Science Foundation Grants [81270376, 31201010]; Shanghai Committee of Science and Technology of China [12ZR1419500, 114119a8700]; Shanghai's health bureau funding [ZYSNXD-CC-ZDYJ029]; Doctoral students innovation fund of Shanghai Jiaotong University School of Medicine [BXJ201229, BXJ201228]; Research Fund for the Doctoral Program of Higher Education of China [20130072110016]	Chinese National Natural Science Foundation Grants; Shanghai Committee of Science and Technology of China; Shanghai's health bureau funding; Doctoral students innovation fund of Shanghai Jiaotong University School of Medicine; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Chinese National Natural Science Foundation Grants (Grant No. 81270376 and 31201010), project supported by the Shanghai Committee of Science and Technology of China (Grant No. 12ZR1419500, 114119a8700), Shanghai's health bureau funding (Grant No. ZYSNXD-CC-ZDYJ029) and Doctoral students innovation fund of Shanghai Jiaotong University School of Medicine (BXJ201229, BXJ201228). Research Fund for the Doctoral Program of Higher Education of China (20130072110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2011, ANN SURG, V254, P178, DOI 10.1097/SLA.0b013e318221ff34; Badalzadeh R, 2012, J CARDIOVASC PHARM T, V17, P181, DOI 10.1177/1074248411416118; Borst O, 2011, CELL PHYSIOL BIOCHEM, V28, P1, DOI 10.1159/000331708; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Bouhidel O, 2008, AM J PHYSIOL-HEART C, V295, pH1580, DOI 10.1152/ajpheart.00379.2008; BRAUNWALD E, 1989, CIRCULATION, V79, P441, DOI 10.1161/01.CIR.79.2.441; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Eguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030450; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Gottlieb RA, 2011, AUTOPHAGY, V7, P434, DOI 10.4161/auto.7.4.14442; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Han B, 2009, AM J PHYSIOL-HEART C, V297, pH829, DOI 10.1152/ajpheart.00222.2009; Janosi A, 2013, ORVOSI HETILAP, V154, P1297, DOI 10.1556/OH.2013.29679; Kandala PK, 2012, ONCOTARGET, V3, P435; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kristiansen SB, 2004, DIABETOLOGIA, V47, P1716, DOI 10.1007/s00125-004-1514-4; Lekli I, 2010, J CELL MOL MED, V14, P2506, DOI 10.1111/j.1582-4934.2009.00921.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Okorie MI, 2011, EUR HEART J, V32, P1266, DOI 10.1093/eurheartj/ehr041; Paiva MA, 2011, AM J PHYSIOL-HEART C, V300, pH2123, DOI 10.1152/ajpheart.00707.2010; Qi ZF, 2012, CNS NEUROSCI THER, V18, P965, DOI 10.1111/cns.12016; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Sharma V, 2012, EXPERT OPIN PHARMACO, V13, P1153, DOI 10.1517/14656566.2012.685163; Takagi H, 2007, AUTOPHAGY, V3, P405, DOI 10.4161/auto.4281; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Venna VR, 2012, NEUROSCIENCE, V201, P280, DOI 10.1016/j.neuroscience.2011.11.014; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	35	48	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86838	10.1371/journal.pone.0086838	http://dx.doi.org/10.1371/journal.pone.0086838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466263	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000155
J	Ou, Y; Xu, SY; Zhu, DD; Yang, XG				Ou, Yu; Xu, Shuya; Zhu, Dandan; Yang, Xuegan			Molecular Mechanisms of Exopolysaccharide from Aphanothece halaphytica (EPSAH) Induced Apoptosis in HeLa Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL-MEMBRANE; TUMOR MICROENVIRONMENT; FAMILY-MEMBERS; CANCER; DEATH; PERMEABILIZATION; CHROOCOCCALES; GRP78/BIP; PATHWAYS	The present study aims to investigate the pharmacological effect of the exopolysaccharides from Aphanothece halophytica GR02 (EPSAH) on the HeLa human cervical cancer cell line. HeLa cells were cultured in RPMI-1640-10% FBS medium containing with or without different concentrations of EPSAH. Cell viability was assessed by methylthiazol tetrazolium (MTT) assay. Cell apoptosis was elevated with Wright-Giemsa staining, AO/EB double staining, and DNA fragmentation assay. Apoptosis-associated molecules from cultured HeLa cells were quantified using Western blot analysis. Our results suggest that EPASH induces apoptosis in HeLa cells by targeting a master unfolded protein response (UPR) regulator Grp78. Grp78 further promotes the expression of CHOP and downregulates expression of survivin, which leads to activate mitochondria-mediated downstream molecules and p53-survivin pathway, resulting in caspase-3 activation and causing apoptosis. These findings provide important clues for further evaluating the potential potency of EPSAH for use in cancer therapy.	[Ou, Yu; Xu, Shuya; Zhu, Dandan; Yang, Xuegan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Peoples R China	China Pharmaceutical University	Ou, Y (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Peoples R China.	ouyu2008@126.com			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Backer MV, 2011, METHOD ENZYMOL, V491, P37, DOI 10.1016/B978-0-12-385928-0.00003-1; Baytekin F, 2011, UROL ONCOL-SEMIN ORI, V29, P502, DOI 10.1016/j.urolonc.2009.09.001; Borowitzka M., 1988, MICROALGAL BIOTECHNO, P456; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Hong DY, 2011, INT J MOL SCI, V12, P7652, DOI 10.3390/ijms12117652; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Li PF, 2001, J APPL PHYCOL, V13, P71, DOI 10.1023/A:1008109501066; Li YA, 2012, TOXICOLOGY, V300, P121, DOI 10.1016/j.tox.2012.06.004; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Ou Y, 2009, CHEM-BIOL INTERACT, V179, P103, DOI 10.1016/j.cbi.2008.10.039; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanimura A, 2009, LEUKEMIA RES, V33, P924, DOI 10.1016/j.leukres.2009.01.027; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; YOPP JH, 1978, PHYCOLOGIA, V17, P172, DOI 10.2216/i0031-8884-17-2-172.1; Zheng WF, 2006, INT IMMUNOPHARMACOL, V6, P1093, DOI 10.1016/j.intimp.2006.01.020	28	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87223	10.1371/journal.pone.0087223	http://dx.doi.org/10.1371/journal.pone.0087223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466342	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000199
J	Brissos, V; Goncalves, N; Melo, EP; Martins, LO				Brissos, Vania; Goncalves, Nadia; Melo, Eduardo P.; Martins, Ligia O.			Improving Kinetic or Thermodynamic Stability of an Azoreductase by Directed Evolution	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MOLECULAR-CLONING; PROTEIN; STABILIZATION; ENZYMES; LACCASE; OLIGO-1,6-GLUCOSIDASE; THERMOSTABILIZATION; DETOXIFICATION; WASTEWATERS	Protein stability arises from a combination of factors which are often difficult to rationalise. Therefore its improvement is better addressed through directed evolution than by rational design approaches. In this study, five rounds of mutagenesis/recombination followed by high-throughput screening (approximate to 10,000 clones) yielded the hit 1B6 showing a 300-fold higher half life at 50 degrees C than that exhibited by the homodimeric wild type PpAzoR azoreductase from Pseudomonas putida MET94. The characterization using fluorescence, calorimetry and light scattering shows that 1B6 has a folded state slightly less stable than the wild type (with lower melting and optimal temperatures) but in contrast is more resistant to irreversible denaturation. The superior kinetic stability of 1B6 variant was therefore related to an increased resistance of the unfolded monomers to aggregation through the introduction of mutations that disturbed hydrophobic patches and increased the surface net charge of the protein. Variants 2A1 and 2A1-Y179H with increased thermodynamic stability (10 to 20 degrees C higher melting temperature than wild type) were also examined showing the distinctive nature of mutations that lead to improved structural robustness: these occur in residues that are mostly involved in strengthening the solvent-exposed loops or the inter-dimer interactions of the folded state.	[Brissos, Vania; Goncalves, Nadia; Martins, Ligia O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Melo, Eduardo P.] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Faro, Portugal	Universidade Nova de Lisboa; Universidade do Algarve	Martins, LO (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	lmartins@itqb.unl.pt	Brissos, Vania/M-5789-2013; Martins, Lígia O./C-2513-2009; Melo, Eduardo P/A-4743-2008	Brissos, Vania/0000-0002-8171-0113; Martins, Lígia O./0000-0003-0082-9591; Moreira Goncalves, Nadia/0000-0002-4580-2969; Pinho Melo, Eduardo/0000-0002-0974-8977	European Union [BIORENEW,, FP6-2004-NMP-NI-4/026456]; Fundacao para a Ciencia e Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/QUI-BIQ/119677/2010]; FCT, Portugal [SFRH/BPD/46808/2008]	European Union(European Commission); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by European Union grant BIORENEW, FP6-2004-NMP-NI-4/026456; Fundacao para a Ciencia e Tecnologia, Portugal: PEst-OE/EQB/LA0004/ 2011 and PTDC/QUI-BIQ/119677/2010. V. B. acknowledges a Post-doc fellowship (SFRH/BPD/46808/2008) from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Baik SH, 2005, APPL ENVIRON MICROB, V71, P3285, DOI 10.1128/AEM.71.6.3285-3293.2005; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Cervantes FJ, 2011, REV ENVIRON SCI BIO, V10, P125, DOI 10.1007/s11157-011-9228-9; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Cirino Patrick C., 2003, V230, P117; Correia B, 2011, ACTA CRYSTALLOGR F, V67, P121, DOI 10.1107/S1744309110048220; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fernandes AT, 2009, BBA-PROTEINS PROTEOM, V1794, P75, DOI 10.1016/j.bbapap.2008.09.006; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Goncalves AMD, 2013, FEBS J, V280, P6643, DOI 10.1111/febs.12568; Ito K, 2008, J BIOL CHEM, V283, P13889, DOI 10.1074/jbc.M710070200; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Joern John M, 2003, Methods Mol Biol, V231, P85; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lee B, 1997, CURR OPIN BIOTECH, V8, P423, DOI 10.1016/S0958-1669(97)80063-8; Leelakriangsak M, 2008, MOL MICROBIOL, V67, P1108, DOI 10.1111/j.1365-2958.2008.06110.x; Liu GF, 2009, J BACTERIOL, V191, P6394, DOI 10.1128/JB.00552-09; Liu ZJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P68, DOI 10.1016/j.abb.2007.03.003; Maier J, 2004, APPL ENVIRON MICROB, V70, P837, DOI 10.1128/AEM.70.2.837-844.2004; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Mendes S, 2011, APPL MICROBIOL BIOT, V92, P393, DOI 10.1007/s00253-011-3366-4; Mendes S, 2011, BIORESOURCE TECHNOL, V102, P9852, DOI 10.1016/j.biortech.2011.07.108; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Salazar O, 2003, CHEMBIOCHEM, V4, P891, DOI 10.1002/cbic.200300660; Salazar Oriana, 2003, V230, P85; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Shivange AV, 2012, APPL MICROBIOL BIOT, V95, P405, DOI 10.1007/s00253-011-3756-7; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Suzuki Y, 2001, J BIOL CHEM, V276, P9059, DOI 10.1074/jbc.M008083200; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; van den Burg B, 2002, CURR OPIN BIOTECH, V13, P333, DOI 10.1016/S0958-1669(02)00325-7; Vazquez-Figueroa E, 2008, PROTEIN ENG DES SEL, V21, P673, DOI 10.1093/protein/gzn048; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Volkin D.B., 1989, PROTEIN FUNCTION PRA, P1; Wang CJ, 2007, J MOL BIOL, V373, P1213, DOI 10.1016/j.jmb.2007.08.048; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Watanabe K, 1996, APPL ENVIRON MICROB, V62, P2066, DOI 10.1128/AEM.62.6.2066-2073.1996; Zhang NY, 2003, PROTEIN ENG, V16, P599, DOI 10.1093/protein/gzg074; Zhao HM, 1997, NUCLEIC ACIDS RES, V25, P1307, DOI 10.1093/nar/25.6.1307; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	57	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87209	10.1371/journal.pone.0087209	http://dx.doi.org/10.1371/journal.pone.0087209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475252	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300153
J	Cadet, JL; Brannock, C; Ladenheim, B; McCoy, MT; Krasnova, IN; Lehrmann, E; Becker, KG; Jayanthi, S				Cadet, Jean Lud; Brannock, Christie; Ladenheim, Bruce; McCoy, Michael T.; Krasnova, Irina N.; Lehrmann, Elin; Becker, Kevin G.; Jayanthi, Subramaniam			Enhanced Upregulation of CRH mRNA Expression in the Nucleus Accumbens of Male Rats after a Second Injection of Methamphetamine Given Thirty Days Later	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; CONDITIONED PLACE PREFERENCE; MESOLIMBIC DOPAMINERGIC SYSTEM; MEDIAL PREFRONTAL CORTEX; PITUITARY-ADRENAL AXIS; STRESS-INDUCED RELAPSE; BEHAVIORAL SENSITIZATION; RIBONUCLEIC-ACID; GENE-EXPRESSION	Methamphetamine (METH) is a widely abused amphetamine analog. Few studies have investigated the molecular effects of METH exposure in adult animals. Herein, we determined the consequences of an injection of METH (10 mg/kg) on transcriptional effects of a second METH (2.5 mg/kg) injection given one month later. We thus measured gene expression by microarray analyses in the nucleus accumbens (NAc) of 4 groups of rats euthanized 2 hours after the second injection: saline-pretreated followed by saline-challenged (SS) or METH-challenged (SM); and METH-pretreated followed by saline-challenged (MS) or METH-challenged (MM). Microarray analyses revealed that METH (2.5 mg/kg) produced acute changes (1.8-fold; P<0.01) in the expression of 412 (352 upregulated, 60 down-regulated) transcripts including cocaine and amphetamine regulated transcript, corticotropin-releasing hormone (Crh), oxytocin (Oxt), and vasopressin (Avp) that were upregulated. Injection of METH (10 mg/kg) altered the expression of 503 (338 upregulated, 165 down-regulated) transcripts measured one month later (MS group). These genes also included Cart and Crh. The MM group showed altered expression of 766 (565 upregulated, 201 down-regulated) transcripts including Avp, Cart, and Crh. The METH-induced increased Crh expression was enhanced in the MM group in comparison to SM and MS groups. Quantitative PCR confirmed the METH-induced changes in mRNA levels. Therefore, a single injection of METH produced long-lasting changes in gene expression in the rodent NAc. The long-term increases in Crh, Cart, and Avp mRNA expression suggest that METH exposure produced prolonged activation of the endogenous stress system. The METH-induced changes in oxytocin expression also suggest the possibility that this neuropeptide might play a significant role in the neuroplastic and affiliative effects of this drug.	[Cadet, Jean Lud; Brannock, Christie; Ladenheim, Bruce; McCoy, Michael T.; Krasnova, Irina N.; Jayanthi, Subramaniam] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Lehrmann, Elin; Becker, Kevin G.] NIA, Intramural Res Program, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cadet, JL (corresponding author), NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Lehrmann, Elin/0000-0002-9869-9475; Ladenheim, Bruce/0000-0001-9124-6994; Jayanthi, Subramaniam/0000-0002-5209-303X	Intramural Research Program of the DHHS/NIH/NIDA; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000551, ZIADA000552] Funding Source: NIH RePORTER	Intramural Research Program of the DHHS/NIH/NIDA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funds of the Intramural Research Program of the DHHS/NIH/NIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Arima H, 2000, J NEUROENDOCRINOL, V12, P833, DOI 10.1046/j.1365-2826.2000.00528.x; Armario A, 2010, TRENDS PHARMACOL SCI, V31, P318, DOI 10.1016/j.tips.2010.04.005; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Balkan B, 2012, BRAIN RES, V1432, P56, DOI 10.1016/j.brainres.2011.11.006; Baracz SJ, 2012, BEHAV BRAIN RES, V228, P185, DOI 10.1016/j.bbr.2011.11.038; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Boutrel B, 2008, BRIT J PHARMACOL, V154, P343, DOI 10.1038/bjp.2008.133; Burbach JPH, 1995, CELL MOL NEUROBIOL, V15, P573, DOI 10.1007/BF02071318; Burkett JP, 2012, PSYCHOPHARMACOLOGY, V224, P1, DOI 10.1007/s00213-012-2794-x; Bustamante D, 2002, J NEUROCHEM, V83, P645, DOI 10.1046/j.1471-4159.2002.01171.x; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Cadet JL, 2010, CNS NEUROL DISORD-DR, V9, P526; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carson DS, 2013, J PSYCHOPHARMACOL, V27, P231, DOI 10.1177/0269881112473788; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Carson DS, 2010, NEUROPHARMACOLOGY, V58, P38, DOI 10.1016/j.neuropharm.2009.06.018; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; Cornish JL, 1997, NEUROSCIENCE, V81, P69, DOI 10.1016/S0306-4522(97)00157-7; CORNISH JL, 1995, BRAIN RES, V701, P28, DOI 10.1016/0006-8993(95)00967-X; Cox BM, 2013, PSYCHONEUROENDOCRINO; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; DEVRY J, 1988, LIFE SCI, V42, P2709, DOI 10.1016/0024-3205(88)90247-0; Dominguez G, 2004, ANN NY ACAD SCI, V1025, P363, DOI 10.1196/annals.1316.044; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; DRAGO F, 1986, PHARMACOL BIOCHEM BE, V24, P1185, DOI 10.1016/0091-3057(86)90168-1; DUVIGNEAUD V, 1953, J BIOL CHEM, V205, P949; Fagergren P, 2007, PHYSIOL BEHAV, V92, P218, DOI 10.1016/j.physbeh.2007.05.027; Frankel PS, 2007, PHARMACOL BIOCHEM BE, V86, P511, DOI 10.1016/j.pbb.2007.01.012; Giardino WJ, 2011, GENES BRAIN BEHAV, V10, P78, DOI 10.1111/j.1601-183X.2010.00641.x; Giardino WJ, 2012, PSYCHOPHARMACOLOGY, V219, P1055, DOI 10.1007/s00213-011-2433-y; Grignaschi G, 2004, EUR J NEUROSCI, V20, P2833, DOI 10.1111/j.1460-9568.2004.03712.x; Gysling K, 2012, BIOCHEM PHARMACOL, V83, P1, DOI 10.1016/j.bcp.2011.07.101; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hubert GW, 2010, NEUROSCIENCE, V165, P179, DOI 10.1016/j.neuroscience.2009.10.013; Hubert GW, 2008, BIOCHEM PHARMACOL, V75, P57, DOI 10.1016/j.bcp.2007.07.028; Imaki T, 1996, MOL BRAIN RES, V38, P166, DOI 10.1016/0169-328X(96)00011-3; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; JOSEPH SA, 1983, NEUROSCI LETT, V35, P135, DOI 10.1016/0304-3940(83)90540-2; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; KELLER RW, 1992, SYNAPSE, V11, P28, DOI 10.1002/syn.890110105; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kim JH, 2003, NEUROPEPTIDES, V37, P369, DOI 10.1016/j.npep.2003.10.001; Kim S, 2007, REGUL PEPTIDES, V144, P6, DOI 10.1016/j.regpep.2007.07.003; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Koshimizu TA, 2012, PHYSIOL REV, V92, P1813, DOI 10.1152/physrev.00035.2011; KOVACS GL, 1990, NEUROPHARMACOLOGY, V29, P365, DOI 10.1016/0028-3908(90)90095-9; Krasnova IN, 2013, NEUROBIOL DIS, V58, P132, DOI 10.1016/j.nbd.2013.05.009; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Kuhar MJ, 2005, AAPS J, V7, pE259, DOI 10.1208/aapsj070125; Le AD, 2000, PSYCHOPHARMACOLOGY, V150, P317, DOI 10.1007/s002130000411; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Liberzon I, 1997, NEUROPSYCHOPHARMACOL, V17, P353, DOI 10.1016/S0893-133X(97)00070-5; Liu J, 2005, J NEUROSCI, V25, P577, DOI 10.1523/JNEUROSCI.4196-04.2005; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533; MAKINO S, 1995, ENDOCRINOLOGY, V136, P4517, DOI 10.1210/en.136.10.4517; MAKINO S, 1995, ENDOCRINOLOGY, V136, P3299, DOI 10.1210/en.136.8.3299; Mameli M, 2011, NEUROPHARMACOLOGY, V61, P1052, DOI 10.1016/j.neuropharm.2011.01.036; Mansi JA, 1996, ENDOCRINOLOGY, V137, P4619, DOI 10.1210/en.137.11.4619; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; Maze I, 2010, MOL INTERV, V10, P219, DOI 10.1124/mi.10.4.5; McCoy MT, 2011, PSYCHOPHARMACOLOGY, V215, P353, DOI 10.1007/s00213-010-2146-7; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; McGregor IS, 2012, HORM BEHAV, V61, P331, DOI 10.1016/j.yhbeh.2011.12.001; MERCHENTHALER I, 1982, AM J ANAT, V165, P385, DOI 10.1002/aja.1001650404; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nestler Eric J, 2012, Clin Psychopharmacol Neurosci, V10, P136, DOI 10.9758/cpn.2012.10.3.136; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Orozco-Cabal L, 2008, J NEUROSCI, V28, P529, DOI 10.1523/JNEUROSCI.2666-07.2008; PAULSON PE, 1995, SYNAPSE, V19, P56, DOI 10.1002/syn.890190108; PERIS J, 1987, PHARMACOL BIOCHEM BE, V27, P533, DOI 10.1016/0091-3057(87)90361-3; Piechota M, 2012, GENES BRAIN BEHAV, V11, P404, DOI 10.1111/j.1601-183X.2012.00777.x; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; Qi J, 2008, N-S ARCH PHARMACOL, V376, P441, DOI 10.1007/s00210-007-0245-8; Qi J, 2009, NEUROPHARMACOLOGY, V56, P856, DOI 10.1016/j.neuropharm.2009.01.010; RabadanDiehl C, 1996, ENDOCRINOLOGY, V137, P3808, DOI 10.1210/en.137.9.3808; RIVIER C, 1982, ENDOCRINOLOGY, V110, P272, DOI 10.1210/endo-110-1-272; ROBINSON TE, 1982, BRAIN RES, V253, P231, DOI 10.1016/0006-8993(82)90690-4; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rodriguez-Borrero E, 2010, NEUROPHARMACOLOGY, V58, P88, DOI 10.1016/j.neuropharm.2009.06.040; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Sabol KE, 2001, BRAIN RES, V892, P122, DOI 10.1016/S0006-8993(00)03244-3; SARNYAI Z, 1991, NEUROPEPTIDES, V19, P51, DOI 10.1016/0143-4179(91)90073-R; SARNYAI Z, 1994, PSYCHONEUROENDOCRINO, V19, P85, DOI 10.1016/0306-4530(94)90062-0; Segal DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1730, DOI 10.1038/sj.npp.1300247; Shahrokh DK, 2010, ENDOCRINOLOGY, V151, P2276, DOI 10.1210/en.2009-1271; Shalev U, 2010, BRAIN RES, V1314, P15, DOI 10.1016/j.brainres.2009.07.028; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Smith SM, 2004, ENDOCRINOLOGY, V145, P5202, DOI 10.1210/en.2004-0708; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; SWAAB DF, 1975, J NEURAL TRANSM, V36, P195, DOI 10.1007/BF01253126; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; VANREE JM, 1988, LIFE SCI, V42, P1091, DOI 10.1016/0024-3205(88)90565-6; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Wood SK, 2013, BIOL PSYCHIAT, V73, P1087, DOI 10.1016/j.biopsych.2013.01.026; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; Yang MH, 2008, MOL CELLS, V26, P121; Zhou Y, 2005, NEUROSCIENCE, V134, P1391, DOI 10.1016/j.neuroscience.2005.05.032; Zhou Y, 2011, NEUROPSYCHOPHARMACOL, V36, P2062, DOI 10.1038/npp.2011.97	122	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e84665	10.1371/journal.pone.0084665	http://dx.doi.org/10.1371/journal.pone.0084665			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475032	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300013
J	Dube, K; Zango, A; van de Wijgert, J; Meque, I; Ferro, JJ; Cumbe, F; Chen, PL; Ma, S; Jolles, E; Fumo, A; Robb, ML; Feldblum, PJ				Dube, Karine; Zango, Arlinda; van de Wijgert, Janneke; Meque, Ivete; Ferro, Josefo J.; Cumbe, Fidelina; Chen, Pai Lien; Ma, Sabrina; Jolles, Erik; Fumo, Afonso; Robb, Merlin L.; Feldblum, Paul J.			HIV Incidence in a Cohort of Women at Higher Risk in Beira, Mozambique: Prospective Study 2009-2012	PLOS ONE			English	Article							CONDOM USE; GENDER; SEX	Background: HIV is prevalent in Sofala Province, Mozambique. To inform future prevention research, we undertook a study in the provincial capital (Beira) to measure HIV incidence in women at higher risk of HIV and assess the feasibility of recruiting and retaining them as research participants. Methods: Women age 18-35 were recruited from schools and places where women typically meet potential sexual partners. Eligibility criteria included HIV-seronegative status and self-report of at least 2 sexual partners in the last month. History of injection drug use was an exclusion criterion, but pregnancy was not. Participants were scheduled for monthly follow-up for 12 months, when they underwent face-to-face interviews, HIV counseling and testing, and pregnancy testing. Results: 387 women were eligible and contributed follow-up data. Most were from 18-24 years old (median 21). Around one-third of participants (33.8%) reported at least one new sexual partner in the last month. Most women (65.5%) reported not using a modern method of contraception at baseline. Twenty-two women seroconverted for a prospective HIV incidence of 6.5 per 100 woman-years (WY; 95% confidence interval (CI): 4.1-9.9). Factors associated with HIV seroconversion in the multivariable analysis were: number of vaginal sex acts without using condoms with partners besides primary partner in the last 7 days (hazard ratio (HR) 1.7; 95% CI: 1.2-2.5) and using a form of contraception at baseline other than hormonal or condoms (vs. no method; HR 25.3; 95% CI: 2.5-253.5). The overall retention rate was 80.0% for the entire follow-up period. Conclusions: We found a high HIV incidence in a cohort of young women reporting risky sexual behavior in Beira, Mozambique. HIV prevention programs should be strengthened. Regular HIV testing and condom use should be encouraged, particularly among younger women with multiple sexual partners.	[Dube, Karine; Chen, Pai Lien; Ma, Sabrina; Jolles, Erik; Feldblum, Paul J.] FHI 360, Durham, NC USA; [Dube, Karine; Robb, Merlin L.] Henry M Jackson Fdn Adv Mil Med Inc HJF, US Mil HIV Res Program, Bethesda, MD USA; [Zango, Arlinda; Meque, Ivete; Ferro, Josefo J.; Cumbe, Fidelina; Fumo, Afonso] Univ Catolica Mocambique Catholic Univ Mozambique, Centro Investigac Doencas Infecciosas Res Ctr Inf, Beira, Mozambique; [van de Wijgert, Janneke] Amsterdam Inst Global Hlth & Dev AIGHD, Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	FHI 360; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	Dube, K (corresponding author), FHI 360, Durham, NC USA.	karinedube2003@gmail.com	Fumo, Afonso Mazine Tiago/R-4248-2018	Fumo, Afonso Mazine Tiago/0000-0002-3097-8785; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	U.S. Agency for International Development (USAID) [GPO-A-00-05-00022-00]; Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project; U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF);  [GHO-A-00-09-00016-00]; FOGARTY INTERNATIONAL CENTER [D43TW001038, D43TW009753] Funding Source: NIH RePORTER	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program; Preventive Technologies Agreement (PTA); European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project; U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The UCM/CIDI site development project and the HIV incidence study were partly funded by the U.S. Agency for International Development (USAID), under Cooperative Agreement No. GPO-A-00-05-00022-00, the Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) Program, and Cooperative Agreement No. GHO-A-00-09-00016-00, the Preventive Technologies Agreement (PTA). The study also received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) through the AfrEVacc project. The study also received funding from the U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; [Anonymous], 2011, WORLD AIDS DAY REP; Bandali S, 2011, CULT HEALTH SEX, V13, P575, DOI 10.1080/13691058.2011.561500; CIA, 2013, WORLD FACTBOOK; Collins C, 2006, MOZAMBIQUES HIV AIDS; Feldblum PJ, 2011, CONTEMP CLIN TRIALS, V32, P512, DOI 10.1016/j.cct.2011.03.008; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NAT SURV PREV BEH RI; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; Machel JZ, 2001, REPROD HEALTH MATTER, V9, P82, DOI 10.1016/S0968-8080(01)90011-4; MacPherson EE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17364; National Institute of Statistics, 2013, DEM IMP HIV AIDS MOZ; Pinkerton SD, 2002, JAIDS-J ACQ IMM DEF, V31, P71, DOI 10.1097/00126334-200209010-00010; Prata N, 2006, INT FAM PLAN PERSPEC, V32, P192, DOI 10.1363/3219206; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; *UNAIDS WHO, 1999, TRENDS HIV INC PREV; USAID Mozambique, 2013, HIV AIDS HLTH PROF; World Bank, 2010, CHANG HIV AIDS LANDS; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	19	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e84979	10.1371/journal.pone.0084979	http://dx.doi.org/10.1371/journal.pone.0084979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475035	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300015
J	Harjanto, S; Ng, LFP; Tong, JC				Harjanto, Sumitro; Ng, Lisa F. P.; Tong, Joo Chuan			Clustering HLA Class I Superfamilies Using Structural Interaction Patterns	PLOS ONE			English	Article							SECONDARY ANCHOR RESIDUES; T-CELL EPITOPE; PEPTIDE-BINDING; VACCINE DESIGN; MHC SUPERTYPES; IDENTIFICATION; SEQUENCE; DEFINITION; PREDICTION; HLA-A2.1	Human leukocyte antigen (HLA) class I molecules are critical components of the cell-mediated immune system that bind and present intracellular antigenic peptides to CD8(+) T cell receptors. To understand the interaction mechanism underlying human leukocyte antigen (HLA) class I specificity in detail, we studied the structural interaction characteristics of 16,393 nonameric peptides binding to 58 HLA-A and -B molecules. Our analysis showed for the first time that HLA-peptide intermolecular bonding patterns vary among different alleles and may be grouped in a superfamily dependent manner. Through the use of these HLA class I 'fingerprints', a high resolution HLA class I superfamily classification schema was developed. This classification is capable of separating HLA alleles into well resolved, non-overlapping clusters, which is consistent with known HLA superfamily definitions. Such structural interaction approach serves as an excellent alternative to the traditional methods of HLA superfamily definitions that use peptide binding motifs or receptor information, and will help identify appropriate antigens suitable for broad-based subunit vaccine design.	[Harjanto, Sumitro] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Ng, Lisa F. P.; Tong, Joo Chuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Tong, Joo Chuan] Agcy Sci Technol & Res, Inst High Performance Comp, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC)	Tong, JC (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	victor@bic.nus.edu.sg		Ng, Lisa/0000-0003-4071-5222	Agency for Science, Technology and Research (A*STAR); A*STAR's Joint Council Office (JCO) Research Grant [CCOGA02_008_2008]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); A*STAR's Joint Council Office (JCO) Research Grant(Agency for Science Technology & Research (A*STAR))	This study was supported by the intramural research funds by Agency for Science, Technology and Research (A*STAR), and also by A*STAR's Joint Council Office (JCO) Research Grant (grant number: CCOGA02_008_2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cano P, 1998, IMMUNOGENETICS, V48, P324, DOI 10.1007/s002510050439; Chelvanayagam G, 1996, IMMUNOGENETICS, V45, P15, DOI 10.1007/s002510050162; DELGUERCIO MF, 1995, J IMMUNOL, V154, P685; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hertz T, 2007, BIOINFORMATICS, V23, pE148, DOI 10.1093/Bioinformatics/btl324; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Kangueane P, 2005, FRONT BIOSCI-LANDMRK, V10, P879, DOI 10.2741/1582; Kobayashi H, 2001, CANCER RES, V61, P7577; KONDO A, 1995, J IMMUNOL, V155, P4307; Lefranc MP, 2001, T CELL RECEPTOR FACT; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McKenzie LM, 1999, GENES IMMUN, V1, P120, DOI 10.1038/sj.gene.6363648; Panigada M, 2002, INFECT IMMUN, V70, P79, DOI 10.1128/IAI.70.1.79-85.2002; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Reche Pedro A., 2007, V409, P163, DOI 10.1007/978-1-60327-118-9_11; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sette A, 2001, BIOLOGICALS, V29, P271, DOI 10.1006/biol.2001.0297; Sette A, 2002, TISSUE ANTIGENS, V59, P443, DOI 10.1034/j.1399-0039.2002.590601.x; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; Tong Joo Chuan, 2006, Appl Bioinformatics, V5, P111, DOI 10.2165/00822942-200605020-00005; Tong Joo Chuan, 2006, Immunome Res, V2, P1, DOI 10.1186/1745-7580-2-1; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245; Zhang C, 1998, J MOL BIOL, V281, P929, DOI 10.1006/jmbi.1998.1982; Zhao B, 2003, HUM IMMUNOL, V64, P718, DOI 10.1016/S0198-8859(03)00078-8; Zhu SF, 2006, BIOINFORMATICS, V22, P1648, DOI 10.1093/bioinformatics/btl141	42	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86655	10.1371/journal.pone.0086655	http://dx.doi.org/10.1371/journal.pone.0086655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475163	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300098
J	Jiang, PL; Pasaribu, B; Chen, CS				Jiang, Pei-Luen; Pasaribu, Buntora; Chen, Chii-Shiarng			Nitrogen-Deprivation Elevates Lipid Levels in Symbiodinium spp. by Lipid Droplet Accumulation: Morphological and Compositional Analyses	PLOS ONE			English	Article							NUTRIENT LIMITATION; OIL BODIES; ZOOXANTHELLAE; MICROALGA; PROTEINS; GROWTH; CORAL; CHLAMYDOMONAS; METABOLISM; SYMBIOSIS	Stable cnidarian-dinoflagellate (genus Symbiodinium) endosymbioses depend on the regulation of nutrient transport between Symbiodinium populations and their hosts. It has been previously shown that the host cytosol is a nitrogen-deficient environment for the intracellular Symbiodinium and may act to limit growth rates of symbionts during the symbiotic association. This study aimed to investigate the cell proliferation, as well as ultrastructural and lipid compositional changes, in free-living Symbiodinium spp. (clade B) upon nitrogen (N)-deprivation. The cell proliferation of the N-deprived cells decreased significantly. Furthermore, staining with a fluorescent probe, boron dipyrromethane 493/503 (BODIPY 493/503), indicated that lipid contents progressively accumulated in the N-deprived cells. Lipid analyses further showed that both triacylglycerol (TAG) and cholesterol ester (CE) were drastically enriched, with polyunsaturated fatty acids (PUFA; i.e., docosahexaenoic acid, heneicosapentaenoic acid, and oleic acid) became more abundant. Ultrastructural examinations showed that the increase in concentration of these lipid species was due to the accumulation of lipid droplets (LDs), a cellular feature that have previously shown to be pivotal in the maintenance of intact endosymbioses. Integrity of these stable LDs was maintained via electronegative repulsion and steric hindrance possibly provided by their surface proteins. Proteomic analyses of these LDs identified proteins putatively involved in lipid metabolism, signaling, stress response and energy metabolism. These results suggest that LDs production may be an adaptive response that enables Symbiodinium to maintain sufficient cellular energy stores for survival under the N-deprived conditions in the host cytoplasm.	[Jiang, Pei-Luen; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Jiang, Pei-Luen; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Taiwan Coral Res Ctr, Pingtung, Taiwan; [Pasaribu, Buntora] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; National Chung Hsing University; National Sun Yat Sen University	Chen, CS (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan.	cchen@nmmba.gov.tw	; Jiang, Pei-Luen/I-8706-2014	Pasaribu, Buntora/0000-0002-9639-1506; Jiang, Pei-Luen/0000-0003-1580-0484	National Science Council in Taiwan [NSC 101-2311-B-291-002-MY3, NSC 100-2313-B-291-003, NSC 102-2313-B-291-001]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This works was supported by National Science Council in Taiwan to C. S. Chen (NSC 101-2311-B-291-002-MY3) and PL Jiang (NSC 100-2313-B-291-003 and NSC 102-2313-B-291-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1998, ANAL BIOCHEM, V258, P149, DOI 10.1006/abio.1998.2580; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; BELDA CA, 1993, MAR BIOL, V117, P655, DOI 10.1007/BF00349778; Bigogno C, 2002, LIPIDS, V37, P209, DOI 10.1007/s11745-002-0882-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CARROLL S, 1984, BIOL BULL, V166, P409, DOI 10.2307/1541226; Chen DH, 2012, PLANT PHYSIOL BIOCH, V60, P18024; COOK CB, 1987, SYMBIOSIS, V4, P199; CORZO A, 1991, Scientia Marina, V55, P405; Danne JC, 2011, J MOL BIOL, V408, P643, DOI 10.1016/j.jmb.2011.02.057; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; Deng XD, 2011, AFR J MICROBIOL RES, V5, P260; Ferl RJ, 2002, GENOME BIOL, V3; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Fuchs B, 2007, ANAL BIOANAL CHEM, V389, P827, DOI 10.1007/s00216-007-1488-4; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haugland R, 1996, HDB FLUORESCENT PROB, P13; Hu HH, 2006, BIOTECHNOL LETT, V28, P987, DOI 10.1007/s10529-006-9026-6; Huang NL, 2013, PLANT PHYSIOL, V161, P1862, DOI 10.1104/pp.112.212514; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2010, NEW BIOTECHNOL, V27, P59, DOI 10.1016/j.nbt.2009.11.006; Lin IP, 2012, PLANT PHYSIOL BIOCH, V61, P80, DOI 10.1016/j.plaphy.2012.09.008; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; Minzangi K., 2011, African Journal of Food Science, V5, P219; MITCHELL SF, 1992, J PLANKTON RES, V14, P379, DOI 10.1093/plankt/14.3.379; Muller-Parker G, 1998, LIFE DEATH CORAL REE, P96; MullerParker G, 1996, J PHYCOL, V32, P987, DOI 10.1111/j.0022-3646.1996.00987.x; MUSCATINE L, 1980, CELLULAR INTERACTION, P229; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Norici A, 2011, PLANT CELL ENVIRON, V34, P1666, DOI 10.1111/j.1365-3040.2011.02362.x; Oku H, 2003, FISHERIES SCI, V69, P625, DOI 10.1046/j.1444-2906.2003.00665.x; Palmucci M, 2011, J PHYCOL, V47, P313, DOI 10.1111/j.1529-8817.2011.00963.x; Pasaribu B, 2014, BIOTECHNOL LETT, V36, P175, DOI 10.1007/s10529-013-1332-1; Peled E, 2011, LIPIDS, V46, P851, DOI 10.1007/s11745-011-3579-4; Peng SE, 2012, BIOL LETTERS, V8, P434, DOI 10.1098/rsbl.2011.0893; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Pereira H, 2012, MAR DRUGS, V10, P1920, DOI 10.3390/md10091920; PIORRECK M, 1984, PHYTOCHEMISTRY, V23, P207, DOI 10.1016/S0031-9422(00)80304-0; Praveenkumar R, 2012, BIOMASS BIOENERG, V37, P60, DOI 10.1016/j.biombioe.2011.12.035; Prescha A, 2001, J AGR FOOD CHEM, V49, P3638, DOI 10.1021/jf010258o; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Rodriguez-Roman A, 2005, MAR BIOL, V146, P1063, DOI 10.1007/s00227-004-1529-x; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; STEEN RG, 1986, BIOL BULL, V170, P267, DOI 10.2307/1541808; STERNER RW, 1993, LIMNOL OCEANOGR, V38, P857, DOI 10.4319/lo.1993.38.4.0857; SZMANTFROELICH A, 1984, MAR BIOL, V81, P153, DOI 10.1007/BF00393114; Takagi M, 2000, APPL MICROBIOL BIOT, V54, P112, DOI 10.1007/s002530000333; Tan R, 2013, PLOS ONE, V8; TILLBERG JE, 1989, PHYSIOL PLANTARUM, V75, P315, DOI 10.1111/j.1399-3054.1989.tb04633.x; Tzen JTC, 1997, J BIOCHEM-TOKYO, V121, P762, DOI 10.1093/oxfordjournals.jbchem.a021651; Tzen JTC, 2003, CURR TOPICS BIOCH RE, V5, P133; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; von Schacky C, 2008, CURR OPIN CLIN NUTR, V11, P94, DOI 10.1097/MCO.0b013e3282f44bdf; Wang JT, 1998, J EXP BIOL, V201, P2445; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yeesang C, 2011, BIORESOURCE TECHNOL, V102, P3034, DOI 10.1016/j.biortech.2010.10.013; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhu B., 2010, MAR ECO, V32, P15	70	44	45	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87416	10.1371/journal.pone.0087416	http://dx.doi.org/10.1371/journal.pone.0087416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475285	Green Submitted, Green Published			2022-12-27	WOS:000330507300180
J	Lim, YY; Villemagne, VL; Laws, SM; Ames, D; Pietrzak, RH; Ellis, KA; Harrington, K; Bourgeat, P; Bush, AI; Martins, RN; Masters, CL; Rowe, CC; Maruff, P				Lim, Yen Ying; Villemagne, Victor L.; Laws, Simon M.; Ames, David; Pietrzak, Robert H.; Ellis, Kathryn A.; Harrington, Karra; Bourgeat, Pierrick; Bush, Ashley I.; Martins, Ralph N.; Masters, Colin L.; Rowe, Christopher C.; Maruff, Paul		AIBL Res Grp	Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer's Disease: A Preliminary Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROTROPHIC FACTOR; AMYLOID-BETA; A-BETA; POLYMORPHISM; ASSOCIATION	Objective: Cross-sectional genetic association studies have reported equivocal results on the relationship between the brain-derived neurotrophic factor (BDNF) Val66Met and risk of Alzheimer's disease (AD). As AD is a neurodegenerative disease, genetic influences may become clearer from prospective study. We aimed to determine whether BDNF Val66Met polymorphism influences changes in memory performance, hippocampal volume, and A beta accumulation in adults with amnestic mild cognitive impairment (aMCI) and high A beta. Methods: Thirty-four adults with aMCI were recruited from the Australian, Imaging, Biomarkers and Lifestyle (AIBL) Study. Participants underwent PiB-PET and structural MRI neuroimaging, neuropsychological assessments and BDNF genotyping at baseline, 18 month, and 36 month assessments. Results: In individuals with aMCI and high A beta, Met carriers showed significant and large decline in episodic memory (d = 0.90, p = .020) and hippocampal volume (d = 0.98, p = .035). BDNF Val66Met was unrelated to the rate of A beta accumulation (d = -0.35, p = .401). Conclusions: Although preliminary due to the small sample size, results of this study suggest that high A beta levels and Met carriage may be useful prognostic markers of accelerated decline in episodic memory, and reductions in hippocampal volume in individuals in the prodromal or MCI stage of AD.	[Lim, Yen Ying; Villemagne, Victor L.; Ellis, Kathryn A.; Harrington, Karra; Bush, Ashley I.; Masters, Colin L.; Maruff, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Ctr PET, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Laws, Simon M.; Martins, Ralph N.] Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA, Australia; [Laws, Simon M.; Martins, Ralph N.] Hollywood Private Hosp, Sir James McCusker Alzheimers Dis Res Unit, Perth, WA, Australia; [Laws, Simon M.] Cooperat Res Ctr Mental Hlth, Carlton, Australia; [Ames, David; Ellis, Kathryn A.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, Kew, Vic, Australia; [Ames, David; Ellis, Kathryn A.] Natl Ageing Res Inst, Parkville, Vic, Australia; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Bourgeat, Pierrick] Australian E Hlth Res Ctr BioMedIA, Commonwealth Sci Ind Res Org Preventat Hlth Natl, Brisbane, Qld, Australia; [Maruff, Paul] CogState Ltd, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Edith Cowan University; University of Western Australia; University of Melbourne; National Ageing Research Institute; Yale University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); CogState Limited	Lim, YY (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	y.lim@mhri.edu.au	Rowe, Christopher/AAX-8748-2021; Bush, Ashley/Y-2457-2019; Bourgeat, Pierrick T/A-1419-2010; Bush, Ashley I/A-1186-2007; Villemagne, Victor/AAC-5406-2019; Maruff, Paul/ABA-1673-2020; Maruff, Paul/AAD-2454-2021; Laws, Simon/C-2858-2014	Bush, Ashley/0000-0001-8259-9069; Bourgeat, Pierrick T/0000-0002-2605-4766; Bush, Ashley I/0000-0001-8259-9069; Villemagne, Victor/0000-0002-5832-9875; Maruff, Paul/0000-0002-6947-9537; Laws, Simon/0000-0002-4355-7082; Lim, Yen Ying/0000-0002-0308-5156; Martins, Ralph/0000-0002-4828-9363; Suwal, Bhim Raj/0000-0003-4097-1154; Ellis, Kathryn/0000-0001-9097-9037	Australian Commonwealth Scientific Industrial and research Organization; Edith Cowan University; Mental Health Research institute; Alzheimer's Australia; National Ageing Research Institute; Austin Health; CogState Ltd.; Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council; Dementia Collaborative Research Centres program; Science and Industry Endowment Fund; Cooperative Research Centre for Mental Health; Australian Government	Australian Commonwealth Scientific Industrial and research Organization; Edith Cowan University; Mental Health Research institute; Alzheimer's Australia; National Ageing Research Institute; Austin Health; CogState Ltd.(CogState Limited); Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centres program; Science and Industry Endowment Fund; Cooperative Research Centre for Mental Health(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government(Australian GovernmentCGIAR)	Funding for the study was provided in part by the study partners [Australian Commonwealth Scientific Industrial and research Organization, Edith Cowan University, Mental Health Research institute, Alzheimer's Australia), National Ageing Research Institute, Austin Health, CogState Ltd., Hollywood Private Hospital, Sir Charles Gardner Hospital]. The study also received support from the National Health and Medical Research Council and the Dementia Collaborative Research Centres program, as well as ongoing funding from the Science and Industry Endowment Fund. The authors also acknowledge the financial support of the Cooperative Research Centre for Mental Health, from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PM is a full-time employee of CogState Ltd. SML is supported by the Cooperative Research Centre for Mental Health, which is an Australian Response to Reviewers government initiative. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Fahnestock M, 2011, FUTUR NEUROL, V6, P627, DOI 10.2217/FNL.11.44; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lim YY, 2013, NEUROBIOL AGING, V34, P2457, DOI 10.1016/j.neurobiolaging.2013.05.006; Lim YY, 2013, J ALZHEIMERS DIS, V33, P1167, DOI 10.3233/JAD-121771; Lim YY, BRAIN; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Masters C. L., 2012, BIOL ALZHEIMERS DIS, P181; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	27	60	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86498	10.1371/journal.pone.0086498	http://dx.doi.org/10.1371/journal.pone.0086498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475133	gold, Green Published			2022-12-27	WOS:000330507300072
J	Smalheiser, NR; Lugli, G; Zhang, H; Rizavi, H; Cook, EH; Dwivedi, Y				Smalheiser, Neil R.; Lugli, Giovanni; Zhang, Hui; Rizavi, Hooriyah; Cook, Edwin H.; Dwivedi, Yogesh			Expression of microRNAs and Other Small RNAs in Prefrontal Cortex in Schizophrenia, Bipolar Disorder and Depressed Subjects	PLOS ONE			English	Article							POSTSYNAPTIC DENSITIES; BRAIN; DYSREGULATION; INDIVIDUALS; HIPPOCAMPUS; NETWORKS; DICER	Because of the role played by miRNAs in post-transcriptional regulation of an array of genes, their impact in neuropsychiatric disease pathophysiology has increasingly been evident. In the present study, we assessed microRNA expression in prefrontal cortex (Brodmann area 10) of a well-characterized cohort of major depressed, bipolar, and schizophrenia subjects (obtained from Stanley Neuropathology Consortium; n = 15 in each group), using high throughput RT-PCR plates. Discrete miRNA alterations were observed in all disorders, as well as in suicide subjects (pooled across diagnostic categories) compared to all non-suicide subjects. The changes in the schizophrenia group were partially similar to those in the bipolar group, but distinct from changes in depression and suicide. Intriguingly, those miRNAs which were down-regulated in the schizophrenia group tended to be synaptically enriched, whereas up-regulated miRNAs tended not to be. To follow this up, we purified synaptosomes from pooled samples of the schizophrenia vs. control groups and subjected them to Illumina deep sequencing. There was a significant loss of small RNA expression in schizophrenia synaptosomes only for certain sequence lengths within the miRNA range. Moreover, 73 miRNAs were significantly downregulated whereas only one was up-regulated. Strikingly, across all expressed miRNAs in synaptosomes, there was a significant inverse correlation between the fold-change of a given miRNA seen in schizophrenia and its synaptic enrichment ratio observed in controls. Thus, synaptic miRNAs tended to be down-regulated in schizophrenia, and the more highly synaptically enriched miRNAs tended to show greater down-regulation. These findings point to some deficit in miRNA biogenesis, transport, processing or turnover in schizophrenia that is selective for the synaptic compartment. A novel class of ncRNA-derived small RNAs, shown to be strongly induced during an early phase of learning in mouse, is also expressed in man, and at least one representative (SNORD85) was strongly down-regulated in schizophrenia synaptosomes.	[Smalheiser, Neil R.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; Univ Illinois, Inst Psychiat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Smalheiser, NR (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	neils@uic.edu		Cook, Edwin/0000-0002-5848-5114; Smalheiser, Neil/0000-0003-1079-3406	NIH [P50 HD055751, R01082802, R21MH091509, R01MH100616];  [UIC-CCTS-0512-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091509, R01MH101890, R01MH100616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIH P50 HD055751, R01082802, R21MH091509, R01MH100616; UIC-CCTS-0512-03. Stanley Medical Research Institute. American Foundation for Suicide Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-163; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berrettini W, 2004, NEUROMOL MED, V5, P109, DOI 10.1385/NMM:5:1:109; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; de Faria Omar Jr., 2012, Frontiers in Genetics, V3, P46, DOI 10.3389/fgene.2012.00046; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Hsu R, 2012, MOL CELL NEUROSCI, V50, P283, DOI 10.1016/j.mcn.2012.06.002; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Humphreys DT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt485; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Lugli G, 2012, J NEUROCHEM, V123, P459, DOI 10.1111/j.1471-4159.2012.07921.x; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Nicolas FE, 2012, FEBS LETT, V586, P1226, DOI 10.1016/j.febslet.2012.03.026; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, MITOCHONDRION, V11, P994, DOI 10.1016/j.mito.2011.08.014; Smalheiser NR, 2011, RNA, V17, P166, DOI 10.1261/rna.2123811; Smalheiser NR, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-44; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0	37	122	130	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86469	10.1371/journal.pone.0086469	http://dx.doi.org/10.1371/journal.pone.0086469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475125	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300067
J	Wang, YL; Li, DS; Wang, Y; Wang, ZY; Ji, QH				Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Zhuo-Ying; Ji, Qing-Hai			Lymph Node Ratio for Postoperative Staging of Laryngeal Squamous Cell Carcinoma with Lymph Node Metastasis	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; LOCALLY ADVANCED HEAD; NECK CANCERS; SURGERY	Background: Lymph node metastasis has a significant impact on laryngeal cancer prognosis. The role of lymph node ratio (LNR, ratio of metastatic to examined nodes) in the staging of laryngeal cancer was not reported. Patients and Methods: Records of laryngeal cancer patients with lymph node involvement from Surveillance, Epidemiology, and End Results database (SEER, training set, N = 1963) and Fudan University Shanghai Cancer Center (FDSCC, validating set, N = 27) were analyzed for the prognostic value of LNR. Kaplan-Meier survival estimates, the Log-rank x 2 test and Cox proportional hazards model were used for univariate and multivariate analysis. Optimal LNR cutoff points were identified by X-tile. Results: Optimal LNR cutoff points classified patients into three risk groups R1 (<= 0.09), R2 (0.09-0.20) and R3 (>0.20), corresponding to 5-year cause-specific survival and overall survival in SEER patients of 55.1%, 40.2%, 28.8% and 43.1%, 31.5%, 21.8%, 2-year disease free survival and disease specific survival in FDSCC patients of 74.1%, 62.5%, 50.0%, and 67.7%, 43.2%, 25.0%, respectively. R3 stratified more high risk patients than N3 with the same survival rate, and R classification clearly separated N2 patients to 3 risk groups and N1 patients to 2 risk groups (R1-2 and R3). Conclusions: R classification is a significant prognostic factor of laryngeal cancer and should be used as a complementary staging system of N classification.	[Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Zhuo-Ying; Ji, Qing-Hai] Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China; [Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Zhuo-Ying; Ji, Qing-Hai] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ji, QH (corresponding author), Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China.	jiqinghai@shca.org.cn	Wang, Yu-Long/AEF-9362-2022	Wang, Yu-Long/0000-0002-3830-7257	National Science Foundation of China [81001204, 30872958]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (81001204 to YLW, 30872958 to QHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2005, ONCOLOGIST, V10, P215, DOI 10.1634/theoncologist.10-3-215; Buckley JG, 2000, HEAD NECK-J SCI SPEC, V22, P380, DOI 10.1002/1097-0347(200007)22:4<380::AID-HED11>3.0.CO;2-E; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; CANDELA FC, 1990, ARCH OTOLARYNGOL, V116, P432; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Howlader N, 2011, SEER CANC STAT REV 1; Hu M, 2012, LARYNGOSCOPE, V122, P565, DOI 10.1002/lary.22489; Langendijk JA, 2005, CANCER-AM CANCER SOC, V104, P1408, DOI 10.1002/cncr.21340; Pfister DG, 2011, J NATL COMPR CANC NE, V9, P596, DOI 10.6004/jnccn.2011.0053; Posner MR, 2010, ANN ONCOL, V21, P246, DOI 10.1093/annonc/mdq291; Redaelli de Zinis LO, 2002, HEAD NECK-J SCI SPEC, V24, P913, DOI 10.1002/hed.10152; Spillane AJ, 2011, ANN SURG, V253, P109, DOI 10.1097/SLA.0b013e3181f9b8b6; Suarez C, 2012, HEAD NECK; Vinh-Hung V, 2010, ONCOLOGIST, V15, P1050, DOI 10.1634/theoncologist.2010-0044; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716; Weinstein GS, 2012, LARYNGOSCOPE, V122, P1701, DOI 10.1002/lary.23294	19	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87037	10.1371/journal.pone.0087037	http://dx.doi.org/10.1371/journal.pone.0087037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475216	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300127
J	Yang, J; Zhang, JY; Chen, J; Xu, Y; Song, NH; Yin, CJ				Yang, Jie; Zhang, Jia-yi; Chen, Jing; Xu, Yang; Song, Ning-hong; Yin, Chang-jun			Prognostic Role of MicroRNA-221 in Various Human Malignant Neoplasms: A Meta-Analysis of 20 Related Studies	PLOS ONE			English	Article							PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; CIRCULATING MIR-221; INCREASED EXPRESSION; TUMOR-SUPPRESSOR; GASTRIC-CANCER; CELL-GROWTH; SURVIVAL; OVEREXPRESSION; PROLIFERATION	Background: MicroRNA-221 (miR-221) has been shown to play an important role in cancer prognosis. In order to evaluate the predictive value of miR-221, we compiled the evidence from 20 eligible studies to perform a meta-analysis. Design: All of relevant studies were identified by searching PubMed, Embase, and Web of Science, and were assessed by further quality evaluation. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) of total and stratified analyses, for overall survival (OS) and recurrence-free survival (RFS), were calculated to investigate the association between high miR-221 expression and cancer prognosis. Results: We found that high miR-221 expression can predict a poor OS in malignant tumors (pooled HR = 1.55, P = 0.017) but has no significant association with RFS (pooled HR = 1.02, P = 0.942). Further in stratified analyses, high miR-221 expression was significantly associated with a poor OS in Asians (pooled HR = 2.04, P = 0.010) or serum/plasma subgroup (pooled HR = 2.28, P<0.001), and even showed significantly poor OS (pooled HR = 1.80, P<0.001) and RFS (pooled HR = 2.43, P = 0.010) in hepatocellular carcinoma (HCC) subgroup, but was correlated to a favorable RFS in prostate cancer subgroup (pooled HR = 0.51, P = 0.004). Conclusions: Our findings demonstrate that miR-221 is more suitable to predict cancer prognosis in Asians, and it is a promising prognostic biomarker for HCC. The detection of miR-221 in serum or plasma samples may make it become an effective method for monitoring patients' prognosis and assessing therapeutic efficacy in the future.	[Yang, Jie; Zhang, Jia-yi; Xu, Yang; Song, Ning-hong; Yin, Chang-jun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Chen, Jing] Nanjing Med Univ, Nanjing Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yin, CJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	drcjyin@163.com						Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Amankwah EK, 2013, ASIAN J ANDROL, V15, P226, DOI 10.1038/aja.2012.160; Bai YF, 2013, EUR J CANCER, V49, P710, DOI 10.1016/j.ejca.2012.08.020; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Coskun E, 2013, LEUKEMIA RES, V37, P647, DOI 10.1016/j.leukres.2013.02.019; DeCastro AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.37; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Martino MT, 2013, ONCOTARGET, V4, P242, DOI 10.18632/oncotarget.820; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Duncavage E, 2010, J THORAC ONCOL, V5, P1755, DOI 10.1097/JTO.0b013e3181f3909d; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gimenes-Teixeira HL, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-10; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Guo HQ, 2010, DIS MARKERS, V29, P251, DOI [10.3233/DMA-2010-0755, 10.1155/2010/474692]; Hanna JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; Hong FZ, 2013, J INT MED RES, V41, P64, DOI 10.1177/0300060513475759; Huang JJ, 2012, MED ONCOL, V29, P2402, DOI 10.1007/s12032-012-0210-3; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Igoucheva O, 2009, BIOCHEM BIOPH RES CO, V379, P790, DOI 10.1016/j.bbrc.2008.12.152; Ilhan-Mutlu A, 2013, J NEURO-ONCOL, V112, P347, DOI 10.1007/s11060-013-1078-6; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Kang SG, 2012, ASIAN J ANDROL, V14, P752, DOI 10.1038/aja.2012.68; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lei HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060369; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Liu K, 2012, J INT MED RES, V40, P467, DOI 10.1177/147323001204000208; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu T, 2013, CANCER GENE THER, V20, P33, DOI 10.1038/cgt.2012.81; Luo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047914; Manavalan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062334; Nassirpour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062170; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rong MH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-21; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang YG, 2010, BLOOD CELL MOL DIS, V44, P191, DOI 10.1016/j.bcmd.2009.12.010; Wang ZH, 2013, ONCOTARGETS THER, V6, P281, DOI 10.2147/OTT.S43014; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459; Wiesner C, 2008, NEOPLASIA, V10, P996, DOI 10.1593/neo.08618; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Wurz K, 2010, GENE CHROMOSOME CANC, V49, P577, DOI 10.1002/gcc.20768; Yazici H., 2009, J ONCOL, V2009, DOI DOI 10.1155/2009/827532; Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060687; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-119; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhou YL, 2012, MED ONCOL, V29, P3360, DOI 10.1007/s12032-012-0315-8	67	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87606	10.1371/journal.pone.0087606	http://dx.doi.org/10.1371/journal.pone.0087606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475314	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300207
J	Jamroz-Wisniewska, A; Gertler, A; Solomon, G; Wood, ME; Whiteman, M; Beltowski, J				Jamroz-Wisniewska, Anna; Gertler, Arieh; Solomon, Gili; Wood, Mark E.; Whiteman, Matthew; Beltowski, Jerzy			Leptin-Induced Endothelium-Dependent Vasorelaxation of Peripheral Arteries in Lean and Obese Rats: Role of Nitric Oxide and Hydrogen Sulfide	PLOS ONE			English	Article							LARGE-SCALE PREPARATION; HYPERPOLARIZING FACTOR; RELAXATION; EDHF; HYPERTENSION; EXPRESSION; ADIPOKINES; RESISTANCE; ADIPONECTIN; DYSFUNCTION	Adipose tissue hormone leptin induces endothelium-dependent vasorelaxation mediated by nitric oxide (NO) and endothelium-derived hyperpolarizing factors (EDHF). Previously it has been demonstrated that in short-term obesity the NO-dependent and the EDHF-dependent components of vascular effect of leptin are impaired and up-regulated, respectively. Herein we examined the mechanism of the EDHF-dependent vasodilatory effect of leptin and tested the hypothesis that alterations of acute vascular effects of leptin in obesity are accounted for by chronic hyperleptinemia. The study was performed in 5 groups of rats: (1) control, (2) treated with exogenous leptin for 1 week to induce hyperleptinemia, (3) obese, fed highly-palatable diet for 4 weeks, (4) obese treated with pegylated superactive rat leptin receptor antagonist (PEG-SRLA) for 1 week, (5) fed standard chow and treated with PEG-SRLA. Acute effect of leptin on isometric tension of mesenteric artery segments was measured ex vivo. Leptin relaxed phenylephrine-preconstricted vascular segments in NO-and EDHF-dependent manner. The NO-dependent component was impaired and the EDHF-dependent component was increased in the leptin-treated and obese groups and in the latter group both these effects were abolished by PEG-SRLA. The EDHF-dependent vasodilatory effect of leptin was blocked by either the inhibitor of cystathionine gamma-lyase, propargylglycine, or a hydrogen sulfide (H2S) scavenger, bismuth (III) subsalicylate. The results indicate that NO deficiency is compensated by the up-regulation of EDHF in obese rats and both effects are accounted for by chronic hyperleptinemia. The EDHF-dependent component of leptin-induced vasorelaxation is mediated, at least partially, by H2S.	[Jamroz-Wisniewska, Anna; Beltowski, Jerzy] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Jamroz-Wisniewska, Anna] Med Univ Lublin, Dept Neurol, Lublin, Poland; [Gertler, Arieh; Solomon, Gili] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Wood, Mark E.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Whiteman, Matthew] Univ Exeter, Sch Med, Exeter, Devon, England	Medical University of Lublin; Medical University of Lublin; Hebrew University of Jerusalem; University of Exeter; University of Exeter	Beltowski, J (corresponding author), Med Univ Lublin, Dept Pathophysiol, Lublin, Poland.	jerzy.beltowski@umlub.pl	Whiteman, Matthew/C-6079-2009; Beltowski, Jerzy/AAH-4692-2020	Whiteman, Matthew/0000-0002-6583-6779; Beltowski, Jerzy/0000-0001-7903-8121; Wood, Mark/0000-0002-2674-6981	EU	EU(European Commission)	The study was supported by the EU Project "The equipment of innovative laboratories doing research on new medicines used in the therapy of civilization and neoplastic diseases" within the Operational Program Development of Eastern Poland 2007 - 2013, Priority Axis I Modern Economy, Operations I.3 Innovation Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baragatti B, 2013, AM J PHYSIOL-HEART C, V304, pH927, DOI 10.1152/ajpheart.00718.2012; Baylie RL, 2011, ACTA PHYSIOL, V203, P99, DOI 10.1111/j.1748-1716.2010.02217.x; Beltowski J, 2006, LIFE SCI, V79, P63, DOI 10.1016/j.lfs.2005.12.041; Beltowski J, 2010, PEPTIDES, V31, P155, DOI 10.1016/j.peptides.2009.10.012; Beltowski J, 2009, LIFE SCI, V85, P557, DOI 10.1016/j.lfs.2009.08.002; Benkhoff S, 2012, ARTERIOSCL THROM VAS, V32, P1605, DOI 10.1161/ATVBAHA.112.251140; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Chrostowska M, 2013, BEST PRACT RES CL EN, V27, P147, DOI 10.1016/j.beem.2013.01.004; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Finkel T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002943; Fortuno A, 2010, J HYPERTENS, V28, P1944, DOI 10.1097/HJH.0b013e32833c21af; Gertler A, 1998, FEBS LETT, V422, P137, DOI 10.1016/S0014-5793(97)01613-X; Haddock RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016423; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Han J, 2013, J PHARMACOL SCI, V121, P318, DOI 10.1254/jphs.12277FP; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Jackson-Weaver O, 2011, CIRC RES, V108, P1439; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; KAHN BB, 1993, ENDOCRINOLOGY, V132, P13, DOI 10.1210/en.132.1.13; Kohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041951; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Miehle K, 2012, CLIN ENDOCRINOL, V76, P2, DOI 10.1111/j.1365-2265.2011.04234.x; Momin AU, 2006, EUR HEART J, V27, P2294, DOI 10.1093/eurheartj/ehi831; Moon HS, 2013, ENDOCR REV, V34, P377, DOI 10.1210/er.2012-1053; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Niv-Spector L, 2012, PROTEIN EXPRES PURIF, V81, P186, DOI 10.1016/j.pep.2011.10.003; Ntaios G, 2013, ATHEROSCLEROSIS, V227, P216, DOI 10.1016/j.atherosclerosis.2012.12.029; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Payne GA, 2010, ARTERIOSCL THROM VAS, V30, P1711, DOI 10.1161/ATVBAHA.110.210070; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Schleifenbaum J, 2010, J HYPERTENS, V28, P1875, DOI 10.1097/HJH.0b013e32833c20d5; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Simonds SE, 2013, TRENDS NEUROSCI, V36, P121, DOI 10.1016/j.tins.2013.01.004; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; STIPANUK MH, 1979, J NUTR, V109, P2126, DOI 10.1093/jn/109.12.2126; Tang GH, 2013, ANTIOXID REDOX SIGN, V19, P1634, DOI 10.1089/ars.2012.4805; Tokuda F, 2008, INTERNAL MED, V47, P1843, DOI 10.2169/internalmedicine.47.1035; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Wojcicka G, 2011, PHARMACOL RES, V63, P68, DOI 10.1016/j.phrs.2010.10.011; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	51	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86744	10.1371/journal.pone.0086744	http://dx.doi.org/10.1371/journal.pone.0086744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475175	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800058
J	Wang, SH; Nan, R; Accardo, MC; Sentmanat, M; Dimitri, P; Elgin, SCR				Wang, Sidney H.; Nan, Ruth; Accardo, Maria C.; Sentmanat, Monica; Dimitri, Patrizio; Elgin, Sarah C. R.			A Distinct Type of Heterochromatin at the Telomeric Region of the Drosophila melanogaster Y Chromosome	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHROMATIN-STRUCTURE; EPIGENETIC REGULATION; SILENCING MECHANISM; GENE; PROTEIN; RNAI; DOMAINS; ROLES; HP1	Heterochromatin assembly and its associated phenotype, position effect variegation (PEV), provide an informative system to study chromatin structure and genome packaging. In the fruit fly Drosophila melanogaster, the Y chromosome is entirely heterochromatic in all cell types except the male germline; as such, Y chromosome dosage is a potent modifier of PEV. However, neither Y heterochromatin composition, nor its assembly, has been carefully studied. Here, we report the mapping and characterization of eight reporter lines that show male-specific PEV. In all eight cases, the reporter insertion sites lie in the telomeric transposon array (HeT-A and TART-B2 homologous repeats) of the Y chromosome short arm (Ys). Investigations of the impact on the PEV phenotype of mutations in known heterochromatin proteins (i.e., modifiers of PEV) show that this Ys telomeric region is a unique heterochromatin domain: it displays sensitivity to mutations in HP1a, EGG and SU(VAR)3-9, but no sensitivity to Su(z)2 mutations. It appears that the endo-siRNA pathway plays a major targeting role for this domain. Interestingly, an ectopic copy of 1360 is sufficient to induce a piRNA targeting mechanism to further enhance silencing of a reporter cytologically localized to the Ys telomere. These results demonstrate the diversity of heterochromatin domains, and the corresponding variation in potential targeting mechanisms.	[Wang, Sidney H.; Nan, Ruth; Sentmanat, Monica; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Accardo, Maria C.; Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Accardo, Maria C.; Dimitri, Patrizio] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Washington University (WUSTL); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Elgin, SCR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	selgin@biology.wustl.edu		Elgin, Sarah C. R./0000-0002-5176-2510	Howard A. Schneiderman Fellowship; NIH [GM068388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068388] Funding Source: NIH RePORTER	Howard A. Schneiderman Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Howard A. Schneiderman Fellowship (SHW) and by NIH grant GM068388 (to SCRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berloco M, 2005, CYTOGENET GENOME RES, V110, P124, DOI 10.1159/000084944; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Brower-Toland B, 2009, GENETICS, V181, P1303, DOI 10.1534/genetics.108.100271; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dimitri P, 2004, METH MOL B, V260, P29, DOI 10.1385/1-59259-755-6:029; DIMITRI P, 1989, GENETICS, V122, P793; Doheny JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003864; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; Gowen JW, 1934, GENETICS, V19, P0189; GRIGLIATTI T, 1991, METHOD CELL BIOL, V35, P587; Haynes KA, 2007, GENETICS, V175, P1539, DOI 10.1534/genetics.106.066407; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; LOCKE J, 1988, GENETICS, V120, P181; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; R Core Team, 2012, R LANG ENV STAT COMP; Riddle NC, 2008, GENETICS, V178, P1177, DOI 10.1534/genetics.107.081828; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Sentmanat MF, 2012, P NATL ACAD SCI USA, V109, P14104, DOI 10.1073/pnas.1207036109; Seum C, 2007, GENETICS, V177, P1955, DOI 10.1534/genetics.107.078220; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; Stabell M, 2006, HEREDITAS, V143, P177, DOI 10.1111/j.2006.0018-0661.01970.x; Stabell M, 2006, NUCLEIC ACIDS RES, V34, P4609, DOI 10.1093/nar/gkl640; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Tzeng TY, 2007, P NATL ACAD SCI USA, V104, P12691, DOI 10.1073/pnas.0705534104; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zhou J, 2012, P NATL ACAD SCI US	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86451	10.1371/journal.pone.0086451	http://dx.doi.org/10.1371/journal.pone.0086451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475122	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800046
J	Zhu, Z; Yin, FF; Liu, XP; Hou, DH; Wang, J; Zhang, L; Arif, B; Wang, HL; Deng, F; Hu, ZH				Zhu, Zheng; Yin, Feifei; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Arif, Basil; Wang, Hualin; Deng, Fei; Hu, Zhihong			Genome Sequence and Analysis of Buzura suppressaria Nucleopolyhedrovirus: A Group II Alphabaculovirus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; SINGLE-NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; FIBROBLAST-GROWTH-FACTOR; ENVELOPE FUSION PROTEIN; OS INFECTIVITY FACTOR; NUCLEOTIDE-SEQUENCE; DNA-REPLICATION; BACULOVIRUS; GENE	The genome of Buzura suppressaria nucleopolyhedrovirus (BusuNPV) was sequenced by 454 pyrosequencing technology. The size of the genome is 120,420 bp with 36.8% G+C content. It contains 127 hypothetical open reading frames (ORFs) covering 90.7% of the genome and includes the 37 conserved baculovirus core genes, 84 genes found in other baculoviruses, and 6 unique ORFs. No typical baculoviral homologous repeats (hrs) were present but the genome contained a region of repeated sequences. Gene Parity Plots revealed a 28.8 kb region conserved among the alpha- and beta-baculoviruses. Overall comparisons of BusuNPV to other baculoviruses point to a distinct species in group II Alphabaculovirus.	[Zhu, Zheng; Yin, Feifei; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Zhu, Zheng; Yin, Feifei; Liu, Xiaoping; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Hualin; Deng, Fei; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, China Ctr Virus Culture Collect, Wuhan, Peoples R China; [Arif, Basil] Great Lakes Forestry Ctr, Canadian Forest Serv, Sault Ste Marie, ON, Canada	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Hu, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	huzh@wh.iov.cn	Hu, Zhihong/AAS-2215-2020; ZHU, ZHENG/P-2173-2016	Hu, Zhihong/0000-0002-1560-0928; ZHU, ZHENG/0000-0002-2035-0804	National Science Foundation of China [31130058, 31321001]; Chinese Academy of Sciences [2012T1S0019]; Wuhan Institute of Virology for Virus Resources and Bioinformatics Center	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Wuhan Institute of Virology for Virus Resources and Bioinformatics Center	The research was supported in part by the National Science Foundation of China (31130058,31321001), Chinese Academy of Sciences visiting professorship for senior international scientists (2012T1S0019 to B. A.), and Wuhan Institute of Virology for Virus Resources and Bioinformatics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Carstens EB, 2007, J GEN VIROL, V88, P114, DOI 10.1099/vir.0.82384-0; CHISHOLM GE, 1988, J VIROL, V62, P3193, DOI 10.1128/JVI.62.9.3193-3200.1988; CHOI J, 1995, J VIROL, V69, P4548, DOI 10.1128/JVI.69.7.4548-4551.1995; CHUKHRY MG, 1989, ACTA VIROL, V33, P559; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Detvisitsakun C, 2007, VIROLOGY, V365, P70, DOI 10.1016/j.virol.2007.03.027; Ferrelli ML, 2012, BACULOVIRAL GENOME; Georgievska L, 2010, J INVERTEBR PATHOL, V104, P44, DOI 10.1016/j.jip.2010.01.008; GOMBART AF, 1989, VIROLOGY, V169, P182, DOI 10.1016/0042-6822(89)90054-8; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; Hu ZH, 1997, VIRUS RES, V47, P91, DOI 10.1016/S0168-1702(96)01406-2; Hu ZH, 1999, J GEN VIROL, V80, P1045, DOI 10.1099/0022-1317-80-4-1045; HU ZH, 1993, J GEN VIROL, V74, P1617, DOI 10.1099/0022-1317-74-8-1617; Hu ZH, 1998, VIRUS RES, V55, P71, DOI 10.1016/S0168-1702(98)00029-X; Huang H, 2013, J VIROLOGY; Huang HC, 2012, VIROLOGY, V427, P217, DOI 10.1016/j.virol.2012.01.022; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kang WY, 1999, J VIROL, V73, P10339, DOI 10.1128/JVI.73.12.10339-10345.1999; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Li K, 2010, J VIROL, V84, P7857, DOI 10.1128/JVI.00174-10; Luo SJN, 2011, J GEN VIROL, V92, P1324, DOI 10.1099/vir.0.029116-0; Luria N, 2012, VIRUSES-BASEL, V4, P761, DOI 10.3390/v4050761; Marek M, 2011, J VIROL, V85, P5350, DOI 10.1128/JVI.00035-11; Means JC, 2010, P NATL ACAD SCI USA, V107, P9825, DOI 10.1073/pnas.0913582107; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mikhailov VS, 2003, MOL BIOL+, V37, P250, DOI 10.1023/A:1023349706186; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; OREILLY DR, 1990, J VIROL, V64, P1321, DOI 10.1128/JVI.64.3.1321-1328.1990; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Pearson MN, 2000, J VIROL, V74, P6126, DOI 10.1128/JVI.74.13.6126-6131.2000; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Simon O, 2012, J INVERTEBR PATHOL, V111, P260, DOI 10.1016/j.jip.2012.08.013; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; Slavicek JM, 2005, J VIROL, V79, P10578, DOI 10.1128/JVI.79.16.10578-10588.2005; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thumbi DK, 2011, VIRUSES-BASEL, V3, P2301, DOI 10.3390/v3112301; van Oers MM, 1998, J GEN VIROL, V79, P1553, DOI 10.1099/0022-1317-79-6-1553; Vanarsdall AL, 2006, J VIROL, V80, P1724, DOI 10.1128/JVI.80.4.1724-1733.2006; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; WILLIAMS GV, 1989, J GEN VIROL, V70, P187, DOI 10.1099/0022-1317-70-1-187; Wu WB, 2010, J VIROL, V84, P12351, DOI 10.1128/JVI.01598-10; Wu YT, 1996, J VIROL, V70, P6967, DOI 10.1128/JVI.70.10.6967-6972.1996; Yang S, 1998, VIROLOGY, V245, P99, DOI 10.1006/viro.1998.9152; Yang X.Y., 1981, CHECK LIST FOREST IN; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhou JB, 2012, VIRUS GENES, V44, P539, DOI 10.1007/s11262-012-0721-1	63	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86450	10.1371/journal.pone.0086450	http://dx.doi.org/10.1371/journal.pone.0086450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475121	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800045
J	Montero-Marin, J; Demarzo, MMP; Pereira, JP; Olea, M; Garcia-Campayo, J				Montero-Marin, Jesus; Demarzo, Marcelo Marcos Piva; Pereira, Joao Paulo; Olea, Marina; Garcia-Campayo, Javier			Reassessment of the Psychometric Characteristics and Factor Structure of the 'Perceived Stress Questionnaire' (PSQ): Analysis in a Sample of Dental Students	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; CONNOR-DAVIDSON RESILIENCE; LEAST-SQUARES ESTIMATION; PARALLEL ANALYSIS; JOB STRESS; PROMOTING RESILIENCE; DEPRESSIVE SYMPTOMS; NURSING-STUDENTS; SPANISH VERSION; CD-RISC	Background: The training to become a dentist can create psychological distress. The present study evaluates the structure of the 'Perceived Stress Questionnaire' (PSQ), its internal consistency model and interrelatedness with burnout, anxiety, depression and resilience among dental students. Methods: The study employed a cross-sectional design. A sample of Spanish dental students (n = 314) completed the PSQ, the 'Goldberg Anxiety and Depression Scale' (GADS), 'Connor-Davidson Resilience Scale' (10-item CD-RISC) and 'Maslach Burnout Inventory-Student Survey' (MBI-SS). The structure was estimated using Parallel Analysis from polychoric correlations. Unweighted Least Squares was the method for factor extraction, using the Item Response Theory to evaluate the discriminative power of items. Internal consistency was assessed by squaring the correlation between the latent true variable and the observed variable. The relationships between the PSQ and the other constructs were analysed using Spearman's coefficient. Results: The results showed a PSQ structure through two sub-factors ('frustration' and 'tenseness') with regard to one general factor ('perceived stress'). Items that did not satisfy discriminative capacity were rejected. The model fit were acceptable (GFI = 0.98; RSMR = 0.06; AGFI = 0.98; NFI = 0.98; RFI = 0.98). All the factors showed adequate internal consistency as measured by the congeneric model (>= 0.91). High and significant associations were observed between perceived stress and burnout, anxiety, depression and resilience. Conclusions: The PSQ showed a hierarchical bi-factor structure among Spanish dental students. Using the questionnaire as a uni-dimensional scale may be useful in perceived stress level discrimination, while the sub-factors could help us to refine perceived stress analysis and improve therapeutic processes.	[Montero-Marin, Jesus; Olea, Marina] Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain; [Demarzo, Marcelo Marcos Piva] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Pereira, Joao Paulo] Inst Super Maia, Dept Psychol, Castelo Da Maia, Portugal; [Garcia-Campayo, Javier] Miguel Servet Univ Hosp, Zaragoza, Spain; [Montero-Marin, Jesus; Garcia-Campayo, Javier] Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain	University of Zaragoza; Universidade Federal de Sao Paulo (UNIFESP); Instituto Universitario da Maia (ISMAI); Miguel Servet University Hospital	Montero-Marin, J (corresponding author), Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain.	jmontero@unizar.es	Demarzo, Marcelo/A-7021-2010; Montero-Marin, Jesus/ABG-8919-2020	Demarzo, Marcelo/0000-0002-7447-1839; Montero-Marin, Jesus/0000-0001-5677-1662; Garcia-Campayo, Javier/0000-0002-3797-4218	Research Network on Preventative Activities and Health Promotion [RD06/0018/0017]; Aragon Health Sciences Institute; Faculty of Health and Sports (University of Zaragoza); Faculty of Medicine and Dentistry (University of Santiago de Compostela)	Research Network on Preventative Activities and Health Promotion; Aragon Health Sciences Institute; Faculty of Health and Sports (University of Zaragoza); Faculty of Medicine and Dentistry (University of Santiago de Compostela)	This study was supported by the Research Network on Preventative Activities and Health Promotion (RD06/0018/0017), Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza)and Faculty of Medicine and Dentistry (University of Santiago de Compostela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghazaleh SB, 2011, J DENT EDUC, V75, P1107; Ahola K, 2006, J OCCUP ENVIRON MED, V48, P1023, DOI 10.1097/01.jom.0000237437.84513.92; Alzahem AM, 2011, EUR J DENT EDUC, V15, P8, DOI 10.1111/j.1600-0579.2010.00640.x; Araya R, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-122; Barreto Ramon P, 1998, Aten Primaria, V22, P491; Bentler PM, 1977, PSYCHOMETRIKA, V59, P567, DOI DOI 10.1007/BF02294054; BOLLEN KA, 1986, PSYCHOMETRIKA, V51, P375, DOI 10.1007/BF02294061; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Byrne B. M., 2001, STRUCTURAL EQUATION; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campos Juliana Alvares Duarte Bonini, 2012, Rev. bras. epidemiol., V15, P155, DOI 10.1590/S1415-790X2012000100014; Carvalho VAMD, 2006, PSICOTHEMA, V18, P791; Dahlin M, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-92; de Oliveira GS, 2013, ANESTH ANALG, V117, P182, DOI 10.1213/ANE.0b013e3182917da9; Dragano N, 2008, SOC PSYCH PSYCH EPID, V43, P72, DOI 10.1007/s00127-007-0267-z; Dunn LB, 2008, ACAD PSYCHIATR, V32, P44, DOI 10.1176/appi.ap.32.1.44; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Everly George S Jr, 2008, Int J Emerg Ment Health, V10, P185; Fertleman C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5266; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Gil-Monte PR, 2007, BURNOUT SYNDROME PRO; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gorter RC, 2007, INT DENT J, V57, P279; Grafton E, 2010, ONCOL NURS FORUM, V37, P698, DOI 10.1188/10.ONF.698-705; Graham JM, 2006, EDUC PSYCHOL MEAS, V66, P930, DOI 10.1177/0013164406288165; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humphris G, 1998, Dent Update, V25, P392; Ferrando PJ, 2010, PAPEL PSICOL, V31, P18; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Larrabee JH, 2010, WESTERN J NURS RES, V32, P81, DOI 10.1177/0193945909343293; Lazarus R.S., 1984, EMOTION ADAPTATION; Ledasma R.D., 2007, PRACTICAL ASSESSMENT, V12, DOI [10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Levy J, 2006, MODELIZACION CON EST, P21; Lorenzo-Seva U, 2003, PSYCHOMETRIKA, V68, P49, DOI 10.1007/BF02296652; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Martinez Bernardos R, 1999, Aten Primaria, V23, P285; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; Mathias S, 2005, J AM DENT ASSOC, V136, P1388, DOI 10.14219/jada.archive.2005.0052; Mazurkiewicz R, 2012, PSYCHOL HEALTH MED, V17, P188, DOI 10.1080/13548506.2011.597770; Mealer M, 2012, INT J NURS STUD, V49, P292, DOI 10.1016/j.ijnurstu.2011.09.015; Monton C, 1993, Aten Primaria, V12, P345; Muniz J., 2005, ANALISIS ITEMS; MURAKI E, 1990, APPL PSYCH MEAS, V14, P59, DOI 10.1177/014662169001400106; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Notario-Pacheco B, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-63; Park SG, 2009, INT ARCH OCC ENV HEA, V82, P397, DOI 10.1007/s00420-008-0347-8; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Pines EW, 2012, J ADV NURS, V68, P1482, DOI 10.1111/j.1365-2648.2011.05875.x; Pohlmann K, 2005, Eur J Dent Educ, V9, P78, DOI 10.1111/j.1600-0579.2004.00359.x; Rada RE, 2004, J AM DENT ASSOC, V135, P788, DOI 10.14219/jada.archive.2004.0279; Rajab L D, 2001, J Dent Educ, V65, P232; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; RECKASE MD, 1985, APPL PSYCH MEAS, V9, P401, DOI 10.1177/014662168500900409; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Rodr?guez G., 2000, ANALISIS FACTORIAL; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Sanz-Carrillo C, 2002, J PSYCHOSOM RES, V52, P167, DOI 10.1016/S0022-3999(01)00275-6; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; SCHMID J, 1957, PSYCHOMETRIKA, V22, P53, DOI 10.1007/BF02289209; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Tisdelle D A, 1984, J Dent Educ, V48, P196; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Tsukamoto K, 1995, Sangyo Eiseigaku Zasshi, V37, P329; Watson R, 2008, INT J NURS STUD, V45, P1534, DOI 10.1016/j.ijnurstu.2007.11.003; Zhong J, 2009, PSYCHOL REP, V105, P1248, DOI 10.2466/PR0.105.F.1248-1254	79	37	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87071	10.1371/journal.pone.0087071	http://dx.doi.org/10.1371/journal.pone.0087071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297XI	24466330	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000191
J	Yuan, F; Snapp, EL; Novikoff, PM; Suadicani, SO; Spray, DC; Potvin, B; Wolkoff, AW; Stanley, P				Yuan, Fei; Snapp, Erik L.; Novikoff, Phyllis M.; Suadicani, Sylvia O.; Spray, David C.; Potvin, Barry; Wolkoff, Allan W.; Stanley, Pamela			Human Liver Cell Trafficking Mutants: Characterization and Whole Exome Sequencing	PLOS ONE			English	Article							TO-GOLGI TRANSPORT; RAB GTPASES; PROTEIN; MECHANISMS; MUTATION; GENOME	The HuH7 liver cell mutant Trf1 is defective in membrane trafficking and is complemented by the casein kinase 2 alpha subunit CK2 alpha ''. Here we identify characteristic morphologies, trafficking and mutational changes in six additional HuH7 mutants Trf2-Trf7. Trf1 cells were previously shown to be severely defective in gap junction functions. Using a Lucifer yellow transfer assay, remarkable attenuation of gap junction communication was revealed in each of the mutants Trf2-Trf7. Electron microscopy and light microscopy of thiamine pyrophosphatase showed that several mutants exhibited fragmented Golgi apparatus cisternae compared to parental HuH7 cells. Intracellular trafficking was investigated using assays of transferrin endocytosis and recycling and VSV G secretion. Surface binding of transferrin was reduced in all six Trf2-Trf7 mutants, which generally correlated with the degree of reduced expression of the transferrin receptor at the cell surface. The mutants displayed the same transferrin influx rates as HuH7, and for efflux rate, only Trf6 differed, having a slower transferrin efflux rate than HuH7. The kinetics of VSV G transport along the exocytic pathway were altered in Trf2 and Trf5 mutants. Genetic changes unique to particular Trf mutants were identified by exome sequencing, and one was investigated in depth. The novel mutation Ile34Phe in the GTPase RAB22A was identified in Trf4. RNA interference knockdown of RAB22A or overexpression of RAB22AI34F in HuH7 cells caused phenotypic changes characteristic of the Trf4 mutant. In addition, the Ile34Phe mutation reduced both guanine nucleotide binding and hydrolysis activities of RAB22A. Thus, the RAB22A Ile34Phe mutation appears to contribute to the Trf4 mutant phenotype.	[Yuan, Fei; Snapp, Erik L.; Novikoff, Phyllis M.; Spray, David C.; Potvin, Barry; Wolkoff, Allan W.; Stanley, Pamela] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, New York, NY 10019 USA; [Yuan, Fei; Potvin, Barry; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Snapp, Erik L.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA; [Novikoff, Phyllis M.] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Suadicani, Sylvia O.; Spray, David C.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Spray, David C.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Suadicani, Sylvia O.] Albert Einstein Coll Med, Dept Urol, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, New York, NY 10019 USA.	pamela.stanley@einstein.yu.edu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Spray, David/0000-0001-8368-5073	NIH; NIDDK; Liver Center [DK041296]; PPG [DK041918, RO1 DK023026]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK023026, R01DK098408, P01DK041918] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Liver Center; PPG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH funded by NIDDK (http://www2.niddk.nih.gov/) including Liver Center grant DK041296, PPG DK041918 and RO1 DK023026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gromov PS, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P454; Hilgard P, 2004, AM J PHYSIOL-GASTR L, V287, pG192, DOI 10.1152/ajpgi.00507.2003; Huang TM, 2002, J BIOL CHEM, V277, P37798, DOI 10.1074/jbc.M204786200; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kauppi M, 2002, J CELL SCI, V115, P899; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LO CW, 1979, CELL, V18, P399, DOI 10.1016/0092-8674(79)90059-X; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mesa R, 2001, J CELL SCI, V114, P4041; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NOVIKOFF AB, 1977, HISTOCHEM J, V9, P525, DOI 10.1007/BF01002901; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Persico A, 2009, FEBS LETT, V583, P3857, DOI 10.1016/j.febslet.2009.10.077; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rodriguez MA, 2000, MOL BIOCHEM PARASIT, V108, P199, DOI 10.1016/S0166-6851(00)00216-4; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Shi XY, 2001, J BIOL CHEM, V276, P2075, DOI 10.1074/jbc.M008583200; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stockert RJ, 2007, BBA-BIOMEMBRANES, V1768, P1741, DOI 10.1016/j.bbamem.2007.04.004; STOCKERT RJ, 1995, J BIOL CHEM, V270, P16107, DOI 10.1074/jbc.270.27.16107; Stockert RJ, 1999, HEPATOLOGY, V30, P740, DOI 10.1002/hep.510300304; Szperl AM, 2011, CLIN GENET, V80, P138, DOI 10.1111/j.1399-0004.2011.01714.x; Thi MM, 2010, AM J PHYSIOL-CELL PH, V299, pC994, DOI 10.1152/ajpcell.00544.2009; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Watson P, 2005, BBA-MOL CELL RES, V1744, P304, DOI 10.1016/j.bbamcr.2005.03.003; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Westbroek W, 2008, MOL GENET METAB, V94, P248, DOI 10.1016/j.ymgme.2008.02.009; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87043	10.1371/journal.pone.0087043	http://dx.doi.org/10.1371/journal.pone.0087043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466322	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000188
J	Martinez, A; Guitian, F; Lopez-Piriz, R; Bartolome, JF; Cabal, B; Esteban-Tejeda, L; Torrecillas, R; Moya, JS				Martinez, Arturo; Guitian, Francisco; Lopez-Piriz, Roberto; Bartolome, Jose F.; Cabal, Belen; Esteban-Tejeda, Leticia; Torrecillas, Ramon; Moya, Jose S.			Bone Loss at Implant with Titanium Abutments Coated by Soda Lime Glass Containing Silver Nanoparticles: A Histological Study in the Dog	PLOS ONE			English	Article							INDUCED PERI-IMPLANTITIS; SURFACE CHARACTERISTICS; BREAKDOWN; TISSUES; MUCOSA	The aim of the present study was to evaluate bone loss at implants connected to abutments coated with a soda-lime glass containing silver nanoparticles, subjected to experimental peri-implantitis. Also the aging and erosion of the coating in mouth was studied. Five beagle dogs were used in the experiments. Three implants were placed in each mandible quadrant: in 2 of them, Glass/n-Ag coated abutments were connected to implant platform, 1 was covered with a Ti-mechanized abutment. Experimental peri-implantitis was induced in all implants after the submarginal placement of cotton ligatures, and three months after animals were euthanatized. Thickness and morphology of coating was studied in abutment cross-sections by SEM. Histology and histo-morphometric studies were carried on in undecalfied ground slides. After the induced peri-implantitis: 1. The abutment coating shown losing of thickness and cracking. 2. The histometry showed a significant less bone loss in the implants with glass/n-Ag coated abutments. A more symmetric cone of bone resorption was observed in the coated group. There were no significant differences in the peri-implantitis histological characteristics between both groups of implants. Within the limits of this in-vivo study, it could be affirmed that abutments coated with biocide soda-lime-glass-silver nanoparticles can reduce bone loss in experimental peri-implantitis. This achievement makes this coating a suggestive material to control peri-implantitis development and progression.	[Martinez, Arturo] Univ Santiago de Compostela USC, Fac Med & Odontol, Galicia, Spain; [Guitian, Francisco] Univ Santiago de Compostela USC, Inst Ceram Galicia, Galicia, Spain; [Lopez-Piriz, Roberto; Cabal, Belen; Torrecillas, Ramon] Univ Oviedo, CSIC, Nanomat & Nanotechnol Res Ctr CINN, Llanera, Spain; [Bartolome, Jose F.; Esteban-Tejeda, Leticia; Moya, Jose S.] CSIC, ICMM, Madrid, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Bartolome, JF (corresponding author), CSIC, ICMM, Madrid, Spain.	jbartolo@icmm.csic.es	Torrecillas, Ramón/G-7851-2011; Guitian, Francisco/Z-1271-2019; Bartolomé, José/B-1977-2010; Cabal, Belén/G-2694-2019; López-Píriz, Roberto/W-8146-2019	Torrecillas, Ramón/0000-0003-3856-0217; Bartolomé, José/0000-0002-7515-4202; Cabal, Belén/0000-0002-4102-3810; López-Píriz, Roberto/0000-0003-2431-6950	Spanish Ministry of Science and Innovation (MICINN) [MAT2009-14542-C02-01, MAT2012-38645]; CSIC JAE-Doc Program	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC JAE-Doc Program	This work was supported by the Spanish Ministry of Science and Innovation (MICINN) under the projects MAT2009-14542-C02-01 and MAT2012-38645. B. Cabal thanks the CSIC JAE-Doc Program for a postdoctoral contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy JP, 2012, J CLIN PERIODONTOL, V39, P182, DOI 10.1111/j.1600-051X.2011.01820.x; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Baron M, 2000, INT J ORAL MAX IMPL, V15, P533; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x; Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; DENENBERG VH, 1981, BEHAV BRAIN SCI, V4, P1, DOI 10.1017/S0140525X00007330; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; ERICSSON I, 1975, SCAND J DENT RES, V83, P189; Esposito M, 2012, EUR J ORAL IMPLANTOL, V5, pS21; Esteban-Tejeda L, 2012, J EUR CERAM SOC, V32, P2723, DOI 10.1016/j.jeurceramsoc.2012.02.053; Esteban-Tejeda L, 2010, ADV ENG MATER, V12, pB292, DOI 10.1002/adem.200980077; Helton WS, 2012, EXP BRAIN RES, V219, P321, DOI 10.1007/s00221-012-3093-9; Huiliang C, 2010, WIRES NANOMED NANOBI, V2, P670; Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x; Martins MC, 2004, INT J ORAL MAX IMPL, V19, P839; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Persson LG, 1999, CLIN ORAL IMPLAN RES, V10, P195, DOI 10.1034/j.1600-0501.1999.100302.x; Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010; Renvert S, 2011, J CLIN PERIODONTOL, V38, P214, DOI 10.1111/j.1600-051X.2010.01661.x; Schrand AM, 2012, ADV EXP MED BIOL, V745, P58, DOI 10.1007/978-1-4614-3055-1_5; Schwartz F, 2007, PERIIMPLANT INFECT E, P78; Schwarz F, 2006, J BIOMED MATER RES A, V77A, P437, DOI 10.1002/jbm.a.30628; Simonis P, 2010, CLIN ORAL IMPLAN RES, V21, P772, DOI 10.1111/j.1600-0501.2010.01912.x; Sreenivasan P, 2002, J CLIN PERIODONTOL, V29, P965, DOI 10.1034/j.1600-051X.2002.291101.x; Tillmanns HWS, 1998, INT J ORAL MAX IMPL, V13, P59; Tomkins LM, 2012, J VET BEHAV, V7, P70, DOI 10.1016/j.jveb.2011.07.001; Zitzmann NU, 2002, J CLIN PERIODONTOL, V29, P456, DOI 10.1034/j.1600-051X.2002.290511.x	31	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86926	10.1371/journal.pone.0086926	http://dx.doi.org/10.1371/journal.pone.0086926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466292	Green Published, gold			2022-12-27	WOS:000330283100234
J	Murakami, T; Aida, Y				Murakami, Tomoyuki; Aida, Yoko			Visualizing Vpr-Induced G2 Arrest and Apoptosis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; NUCLEAR IMPORT; G(2) ARREST; CASPASE-3 ACTIVATION; ACCESSORY PROTEIN; UBIQUITIN LIGASE; HIV-1; GENE; INDUCTION	Vpr is an accessory protein of human immunodeficiency virus type 1 (HIV-1) with multiple functions. The induction of G2 arrest by Vpr plays a particularly important role in efficient viral replication because the transcriptional activity of the HIV-1 long terminal repeat is most active in G2 phase. The regulation of apoptosis by Vpr is also important for immune suppression and pathogenesis during HIV infection. However, it is not known whether Vpr-induced apoptosis depends on the ability of Vpr to induce G2 arrest, and the dynamics of Vpr-induced G2 arrest and apoptosis have not been visualized. We performed time-lapse imaging to examine the temporal relationship between Vpr-induced G2 arrest and apoptosis using HeLa cells containing the fluorescent ubiquitination-based cell cycle indicator2 (Fucci2). The dynamics of G2 arrest and subsequent long-term mitotic cell rounding in cells transfected with the Vpr-expression vector were visualized. These cells underwent nuclear mis-segregation after prolonged mitotic processes and then entered G1 phase. Some cells subsequently displayed evidence of apoptosis after prolonged mitotic processes and nuclear mis-segregation. Interestingly, Vpr-induced apoptosis was seldom observed in S or G2 phase. Likewise, visualization of synchronized HeLa/Fucci2 cells infected with an adenoviral vector expressing Vpr clearly showed that Vpr arrests the cell cycle at G2 phase, but does not induce apoptosis at S or G2 phase. Furthermore, time-lapse imaging of HeLa/Fucci2 cells expressing SCAT3.1, a caspase-3-sensitive fusion protein, clearly demonstrated that Vpr induces caspase-3-dependent apoptosis. Finally, to examine whether the effects of Vpr on G2 arrest and apoptosis were reversible, we performed live-cell imaging of a destabilizing domain fusion Vpr, which enabled rapid stabilization and destabilization by Shield1. The effects of Vpr on G2 arrest and subsequent apoptosis were reversible. This study is the first to characterize the dynamics of the morphological changes that occur during Vpr-induced G2 arrest and apoptosis.	[Murakami, Tomoyuki; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Murakami, Tomoyuki; Aida, Yoko] Univ Tokyo, Lab Viral Infect Dis, Dept Med Genome Sci, Grad Sch Frontier Sci, Wako, Saitama, Japan	RIKEN; University of Tokyo	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp			Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS: http://www.jhsf.or.jp/English/index_e. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 2009, CURR HIV RES, V7, P136, DOI 10.2174/157016209787581418; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Azuma A, 2006, MICROBES INFECT, V8, P670, DOI 10.1016/j.micinf.2005.09.002; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Kuramitsu M, 2005, MICROBES INFECT, V7, P1150, DOI 10.1016/j.micinf.2005.03.022; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Majumder B, 2009, CURR HIV RES, V7, P169, DOI 10.2174/157016209787581445; Maudet C, 2011, J BIOL CHEM, V286, P23742, DOI 10.1074/jbc.M111.220780; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Nishino Y, 1997, BIOCHEM BIOPH RES CO, V232, P550, DOI 10.1006/bbrc.1997.6186; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Shimura M, 1999, FASEB J, V13, P621, DOI 10.1096/fasebj.13.6.621; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699; Stivahtis GL, 1997, J VIROL, V71, P4331, DOI 10.1128/JVI.71.6.4331-4338.1997; Thieu KP, 2009, CURR HIV RES, V7, P153, DOI 10.2174/157016209787581454; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Wang JF, 2011, BLOOD, V117, P1260, DOI 10.1182/blood-2010-06-289215; Watanabe N, 2000, EXP CELL RES, V258, P261, DOI 10.1006/excr.2000.4908; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yasuda J, 2001, VIROLOGY, V285, P181, DOI 10.1006/viro.2001.0964; Zhang XF, 2009, CURR HIV RES, V7, P163; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	56	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86840	10.1371/journal.pone.0086840	http://dx.doi.org/10.1371/journal.pone.0086840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466265	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100223
J	Silverwood, RJ; Richards, M; Pierce, M; Hardy, R; Sattar, N; Ferro, C; Savage, C; Kuh, D; Nitsch, D				Silverwood, Richard J.; Richards, Marcus; Pierce, Mary; Hardy, Rebecca; Sattar, Naveed; Ferro, Charles; Savage, Caroline; Kuh, Diana; Nitsch, Dorothea		Teams, NS&DC	Cognitive and Kidney Function: Results from a British Birth Cohort Reaching Retirement Age	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; METABOLIC SYNDROME; SERUM CREATININE; CYSTATIN-C; DISEASE; ADULTS; IMPAIRMENT; DECLINE; RISK	Background: Previous studies have found associations between cognitive function and chronic kidney disease. We aimed to explore possible explanations for this association in the Medical Research Council National Survey of Health and Development, a prospective birth cohort representative of the general British population. Methods: Cognitive function at age 60-64 years was quantified using five measures (verbal memory, letter search speed and accuracy, simple and choice reaction times) and glomerular filtration rate (eGFR) at the same age was estimated using cystatin C. The cross-sectional association between cognitive function and eGFR was adjusted for background confounding factors (socioeconomic position, educational attainment), prior cognition, and potential explanations for any remaining association (smoking, diabetes, hypertension, inflammation, obesity). Results: Data on all the analysis variables were available for 1306-1320 study members (depending on cognitive measure). Verbal memory and simple and choice reaction times were strongly associated with eGFR. For example, the lowest quartile of verbal memory corresponded to a 4.1 (95% confidence interval 2.0, 6.2) ml/min/1.73 m(2) lower eGFR relative to the highest quartile. Some of this association was explained by confounding due to socioeconomic factors, but very little of it by prior cognition. Smoking, diabetes, hypertension, inflammation and obesity explained some but not all of the remaining association. Conclusions: These analyses support the notion of a shared pathophysiology of impaired cognitive and kidney function at older age, which precedes clinical disease. The implications of these findings for clinical care and research are important and under-recognised, though further confirmatory studies are required.	[Silverwood, Richard J.; Nitsch, Dorothea] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Richards, Marcus; Pierce, Mary; Hardy, Rebecca; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovascular Res Ctr, Glasgow, Lanark, Scotland; [Ferro, Charles] Queen Elizabeth Hosp, Dept Renal Med, Birmingham B15 2TH, W Midlands, England; [Savage, Caroline] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Glasgow; University of Birmingham; University of Birmingham	Silverwood, RJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Richard.Silverwood@lshtm.ac.uk	Silverwood, Richard/A-1249-2014; Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Silverwood, Richard/0000-0002-2744-1194; Kuh, Diana/0000-0001-7386-2857; Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Hardy, Rebecca/0000-0001-9949-0799; Richards, Marcus/0000-0001-9191-2192; Sattar, Naveed/0000-0002-1604-2593; Nitsch, Dorothea/0000-0001-5767-248X	Kidney Research UK [RP34/2009]; UK Medical Research Council [U123092720, G1001143]; MRC [G1001143, MC_UU_12019/3, MC_UU_12019/1] Funding Source: UKRI; Medical Research Council [MC_UU_12019/1, MC_UU_12019/3, G1001143] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-205] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Kidney Research UK (grant number RP34/2009) to RJS and DN, and the UK Medical Research Council to MP, RH and DK. The data collection was funded by the UK Medical Research Council (Unit Programme number U123092720), with additional analyses funded by the UK Medical Research Council (grant number G1001143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, CLASS OCC; Arismendi-Morillo G, 2010, ULTRASTRUCT PATHOL, V34, P214, DOI 10.3109/01913121003743690; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Clennell S, 2008, J EPIDEMIOL COMMUN H, V62, P1051, DOI 10.1136/jech.2007.068312; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; Feng L, 2012, J AM GERIATR SOC, V60, P1208, DOI 10.1111/j.1532-5415.2012.04043.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kuriyama N, 2013, ARCH GERONTOL GERIAT, V56, P55, DOI 10.1016/j.archger.2011.11.009; Lande MB, 2011, CLIN J AM SOC NEPHRO, V6, P1831, DOI 10.2215/CJN.00810111; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Munang L, 2007, AGE AGEING, V36, P323, DOI 10.1093/ageing/afl178; Murray AM, 2009, NEUROLOGY, V73, P916, DOI 10.1212/WNL.0b013e3181b99a2e; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Silverwood RJ, 2013, J AM SOC NEPHROL, V24, P813, DOI 10.1681/ASN.2012070675; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; StataCorp, 2011, STAT STAT SOFTW REL; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wills AK, 2012, EPIDEMIOLOGY, V23, P203, DOI 10.1097/EDE.0b013e3182456567; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237	28	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86743	10.1371/journal.pone.0086743	http://dx.doi.org/10.1371/journal.pone.0086743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24482683	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330283100205
J	Leung, JM; Rould, MA; Konradt, C; Hunter, CA; Ward, GE				Leung, Jacqueline M.; Rould, Mark A.; Konradt, Christoph; Hunter, Christopher A.; Ward, Gary E.			Disruption of TgPHIL1 Alters Specific Parameters of Toxoplasma gondii Motility Measured in a Quantitative, Three-Dimensional Live Motility Assay	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; HOST-CELL INVASION; GLIDING MOTILITY; REVEALS; INFECTION; MIGRATION; MYOSIN; TRAJECTORIES; CYTOSKELETON; INHIBITION	T. gondii uses substrate-dependent gliding motility to invade cells of its hosts, egress from these cells at the end of its lytic cycle and disseminate through the host organism during infection. The ability of the parasite to move is therefore critical for its virulence. T. gondii engages in three distinct types of gliding motility on coated two-dimensional surfaces: twirling, circular gliding and helical gliding. We show here that motility in a three-dimensional Matrigel-based environment is strikingly different, in that all parasites move in irregular corkscrew-like trajectories. Methods developed for quantitative analysis of motility parameters along the smoothed trajectories demonstrate a complex but periodic pattern of motility with mean and maximum velocities of 0.58 +/- 0.07 mu m/s and 2.01 +/- 0.17 mu m/s, respectively. To test how a change in the parasite's crescent shape might affect trajectory parameters, we compared the motility of Delta phil1 parasites, which are shorter and wider than wild type, to the corresponding parental and complemented lines. Although comparable percentages of parasites were moving for all three lines, the Delta phil1 mutant exhibited significantly decreased trajectory lengths and mean and maximum velocities compared to the parental parasite line. These effects were either partially or fully restored upon complementation of the Delta phil1 mutant. These results show that alterations in morphology may have a significant impact on T. gondii motility in an extracellular matrix-like environment, provide a possible explanation for the decreased fitness of Delta phil1 parasites in vivo, and demonstrate the utility of the quantitative three-dimensional assay for studying parasite motility.	[Leung, Jacqueline M.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Leung, Jacqueline M.] Univ Vermont, Program Cellular Mol & Biomed Sci, Burlington, VT USA; [Rould, Mark A.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT USA; [Konradt, Christoph; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Vermont; University of Vermont; University of Vermont; University of Pennsylvania	Ward, GE (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	gary.ward@uvm.edu		Ward, Gary/0000-0003-4138-3055	US Public Health Service grant [AI054961]; German Research Foundation, DFG [KO4609/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054961, R56AI054961] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); German Research Foundation, DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Public Health Service grant AI054961 (GEW) and research grant KO4609/1-1 from the German Research Foundation, DFG (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AM, 2012, MOL BIOCHEM PARASIT, V184, P39, DOI 10.1016/j.molbiopara.2012.03.006; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Barkhuff WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023977; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Child MA, 2013, NAT CHEM BIOL, V9, P651, DOI 10.1038/nchembio.1315; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Crenshaw HC, 2000, J EXP BIOL, V203, P961; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frixione E, 1996, CELL MOTIL CYTOSKEL, V34, P152, DOI 10.1002/(SICI)1097-0169(1996)34:2&lt;152::AID-CM6&gt;3.0.CO;2-D; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143; KIMSEY RB, 1990, J INFECT DIS, V162, P1205, DOI 10.1093/infdis/162.5.1205; Kreyszig E., 1991, DIFFERENTIAL GEOMETR; Kudryashev M, 2012, CELL MICROBIOL, V14, P1757, DOI 10.1111/j.1462-5822.2012.01836.x; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Ma C, 2007, MOL BIOL CELL, V18, P4711, DOI 10.1091/mbc.E07-04-0379; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; Press W.H., 1996, NUMERICAL RECIPES FO; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Schrodinger L., 2020, PYMOL; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; Sibley LD, 2010, CURR OPIN BIOTECH, V21, P592, DOI 10.1016/j.copbio.2010.05.009; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Su TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01664; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Volkmann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041409; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	54	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85763	10.1371/journal.pone.0085763	http://dx.doi.org/10.1371/journal.pone.0085763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489670	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000015
J	de Burgos-Lunar, C; Jimenez-Garcia, R; Salinero-Fort, MA; Gomez-Campelo, P; Gil, A; Abanades-Herranz, JC; Cardenas-Valladolid, J; del Cura-Gonzalez, I				de Burgos-Lunar, Carmen; Jimenez-Garcia, Rodrigo; Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma; Gil, Angel; Abanades-Herranz, Juan C.; Cardenas-Valladolid, Juan; del Cura-Gonzalez, Isabel			Trends in Hypertension Prevalence, Awareness, Treatment and Control in an Adult Type 2 Diabetes Spanish Population between 2003 and 2009	PLOS ONE			English	Article							BLOOD-PRESSURE; PRIMARY-CARE; ARTERIAL-HYPERTENSION; EUROPEAN-SOCIETY; MANAGEMENT; GUIDELINES; MELLITUS; SPAIN	In patients with type 2 diabetes, the prevalence of hypertension is higher than in non-diabetic subjects. Despite the high cardiovascular risk involving hypertension in these patients, its prevalence and control are not well known. The aims of this study were: to estimate the hypertension prevalence, awareness, treatment and control in Spanish adults with type 2 diabetes attended in Primary Care; and to analyse its time trend from 2003 to 2009. A serial cross-sectional study from 2003 to 2009 was performed in 21 Primary Care Centres in Madrid. The study population comprised all patients with diagnosed type 2 diabetes in their computerised medical history. Overall annual prevalence during the period 2003-2009 was calculated from and according to sex and age groups. Linear trend tests, regression lines and coefficients of determination were used. In 2003 89.78% (CI 87.92-91.64) of patients with type 2 diabetes suffered hypertension and 94.76% (CI: 92.85-96.67) in 2009. This percentage was greater for women and for patients over 65 years old. 30% of patients suffered previously undiagnosed hypertension in 2003 and 23.1% in 2009. 97% of diagnosed patients received pharmacological treatment and 28.79% reached the blood pressure objective in 2009. The average number of antihypertensive drugs taken was 2.72 in 2003 and 3.27 in 2009. Only 5.2% of patients with type 2 diabetes show blood pressure levels below 130/80 mmHg. Although significant improvements have been achieved in the diagnosis and control of hypertension in people with type 2 diabetes, these continue to remain far from optimum.	[de Burgos-Lunar, Carmen] Carlos III Hosp, Clin Epidemiol & Res Unit, Madrid, Spain; [de Burgos-Lunar, Carmen; Salinero-Fort, Miguel A.; del Cura-Gonzalez, Isabel] REDISSEC, Madrid, Spain; [Jimenez-Garcia, Rodrigo; Gil, Angel; del Cura-Gonzalez, Isabel] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Alcorcon, Spain; [Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma] Carlos III Hosp, Biomed Res Fdn, Madrid, Spain; [Abanades-Herranz, Juan C.; Cardenas-Valladolid, Juan; del Cura-Gonzalez, Isabel] Direcc Tecn Docencia & Invest, Res Unit, Madrid, Spain	Hospital Carlos III; Universidad Rey Juan Carlos; Hospital Carlos III	de Burgos-Lunar, C (corresponding author), Carlos III Hosp, Clin Epidemiol & Res Unit, Madrid, Spain.	carmenblunar@hotmail.com	Jimenez-Garcia, Rodrigo/D-4953-2019; Gil, Angel/ABA-7621-2020; SALINERO-FORT, MIGUEL A./GOP-2536-2022; del Cura-Gonzalez, Isabel/G-9040-2018	Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Gil, Angel/0000-0001-7663-0939; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Gomez Campelo, Paloma/0000-0003-2299-1741; Cardenas Valladolid, Juan/0000-0002-3321-7316; del Cura-Gonzalez, Isabel/0000-0002-3931-5304				Aleman JA, 2011, ATEN PRIM, V43, P297, DOI 10.1016/j.aprim.2010.05.016; Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; American Diabetes Association, 2003, DIABETES CARE, V26, pS80, DOI DOI 10.2337/DIACARE.26.2007.S80; [Anonymous], 2007, J HYPERT, V25, P1005; Banegas Banegas JR, 2005, HIPERTENSION, V22, P353, DOI DOI 10.1016/S0212-8241(05)71587-5; Banegas JR, 1998, HYPERTENSION, V32, P998, DOI 10.1161/01.HYP.32.6.998; Benitez Camps M, 2005, Aten Primaria, V35, P7, DOI 10.1157/13071038; Benitez M, 2001, Aten Primaria, V28, P373; Berlowitz DR, 2003, DIABETES CARE, V26, P355, DOI 10.2337/diacare.26.2.355; Campbell NRC, 2009, CAN J CARDIOL, V25, P299, DOI 10.1016/S0828-282X(09)70493-3; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coca Payeras A., 2005, HIPERTENSION, V22, P5, DOI DOI 10.1016/S1889-1837(05)71521-X; Dalfo Baque A, 2001, Aten Primaria, V28, P305; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Escobar C, 2007, REV CLIN ESP, V207, P221, DOI 10.1157/13102313; Fernandez Cuenca R, 1998, ANALISIS SERVICIOS S, P249; Geiss LS, 2002, AM J PREV MED, V22, P42, DOI 10.1016/S0749-3797(01)00399-3; Grupo de trabajo de la Guia de Practica Clinica sobre Diabetes tipo 2, 2008, GUIA PRACT CLIN DIAB; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Llisterri Caro JL, 2009, HIPERTENS RIESGO VAS, V26, P257; Llisterri JL, 2006, RCAP, V1, P19; Maahs DM, 2005, DIABETES CARE, V28, P301, DOI 10.2337/diacare.28.2.301; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Mehta SS, 1999, AM J HYPERTENS, V12, P333, DOI 10.1016/S0895-7061(00)86958-7; National Institute for Clinical Excellence (NICE), 2008, NAT COLL CTR CHRON C; Nilsson PM, 2003, J HUM HYPERTENS, V17, P37, DOI 10.1038/sj.jhh.1001503; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; SIMONSON DC, 1988, DIABETES CARE, V11, P821, DOI 10.2337/diacare.11.10.821; Soedamah-Muthu SS, 2002, DIABETOLOGIA, V45, P1362, DOI 10.1007/s00125-002-0914-6; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Vallejo OG, 2003, MED CLIN-BARCELONA, V120, P529, DOI 10.1016/S0025-7753(03)73765-8; Castell MV, 2010, MED CLIN-BARCELONA, V135, P671, DOI 10.1016/j.medcli.2009.03.016; Wexler R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-23; White F, 2010, EXP CLIN CARDIOL, V15, P5; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	41	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86713	10.1371/journal.pone.0086713	http://dx.doi.org/10.1371/journal.pone.0086713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475171	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300104
J	Diamant, E; Lachmi, BE; Keren, A; Barnea, A; Marcus, H; Cohen, S; Ben David, A; Zichel, R				Diamant, Eran; Lachmi, Bat-El; Keren, Adi; Barnea, Ada; Marcus, Hadar; Cohen, Shoshana; Ben David, Alon; Zichel, Ran			Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations	PLOS ONE			English	Article							MOUSE MONOCLONAL-ANTIBODIES; DOMAIN-BASED ASSAYS; NEUROTOXIN TYPE-A; IMMUNE-COMPLEXES; HIGH-AFFINITY; TOXIN; BINDING; SEQUENCE; IMMUNOASSAY; SEROTYPE	Botulinum neurotoxins (BoNT) are considered some of the most lethal known substances. There are seven botulinum serotypes, of which types A, B and E cause most human botulism cases. Anti-botulinum polyclonal antibodies (PAbs) are currently used for both detection and treatment of the disease. However, significant improvements in immunoassay specificity and treatment safety may be made using monoclonal antibodies (MAbs). In this study, we present an approach for the simultaneous generation of highly specific and neutralizing MAbs against botulinum serotypes A, B, and E in a single process. The approach relies on immunization of mice with a trivalent mixture of recombinant C-terminal fragment (Hc) of each of the three neurotoxins, followed by a parallel differential robotic hybridoma screening. This strategy enabled the cloning of seven to nine MAbs against each serotype. The majority of the MAbs possessed higher anti-botulinum ELISA titers than anti-botulinum PAbs and had up to five orders of magnitude greater specificity. When tested for their potency in mice, neutralizing MAbs were obtained for all three serotypes and protected against toxin doses of 10 MsLD50-500 MsLD50. A strong synergistic effect of up to 400-fold enhancement in the neutralizing activity was observed when serotype-specific MAbs were combined. Furthermore, the highly protective oligoclonal combinations were as potent as a horse-derived PAb pharmaceutical preparation. Interestingly, MAbs that failed to demonstrate individual neutralizing activity were observed to make a significant contribution to the synergistic effect in the oligoclonal preparation. Together, the trivalent immunization strategy and differential screening approach enabled us to generate highly specific MAbs against each of the A, B, and E BoNTs. These new MAbs may possess diagnostic and therapeutic potential.	[Diamant, Eran; Keren, Adi; Barnea, Ada; Marcus, Hadar; Cohen, Shoshana; Ben David, Alon; Zichel, Ran] Israel Inst Biol Res, Dept Biotechnol, IL-70450 Ness Ziona, Israel; [Lachmi, Bat-El] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Zichel, R (corresponding author), Israel Inst Biol Res, Dept Biotechnol, IL-70450 Ness Ziona, Israel.	ranz@iibr.gov.il			Israel Institute for Biological Research [SB/5122-89]	Israel Institute for Biological Research	This work was funded by Israel Institute for Biological Research grant SB/5122-89. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasova SG, 2011, RUSS J BIOORG CHEM+, V37, P307, DOI 10.1134/S1068162011030022; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Atassi MZ, 1999, CRIT REV IMMUNOL, V19, P219; Atassi MZ, 1996, J PROTEIN CHEM, V15, P691, DOI 10.1007/BF01886751; BINZ T, 1990, J BIOL CHEM, V265, P9153; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Brown DR, 1997, HYBRIDOMA, V16, P447, DOI 10.1089/hyb.1997.16.447; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Chiarella P, 2008, BIOTECHNOL LETT, V30, P1303, DOI 10.1007/s10529-008-9706-5; Chiarella P, 2011, BIOTECHNOL PROGR, V27, P571, DOI 10.1002/btpr.564; Chow SK, 2012, TOXINS, V4, P430, DOI 10.3390/toxins4060430; CLAYTON MA, 1995, INFECT IMMUN, V63, P2738, DOI 10.1128/IAI.63.7.2738-2742.1995; Corbett CR, 2007, J IMMUNOL METHODS, V328, P128, DOI 10.1016/j.jim.2007.08.017; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; EP, 2011, EUROPEAN PHARMACOPOE, V949; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Gessler F, 2005, APPL ENVIRON MICROB, V71, P7897, DOI 10.1128/AEM.71.12.7897-7903.2005; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Guglielmo-Viret V, 2005, J IMMUNOL METHODS, V301, P164, DOI 10.1016/j.jim.2005.04.003; Hatheway C.L., 1988, LAB DIAGNOSIS INFECT, P111; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Liu YYB, 2012, ANAL BIOCHEM, V425, P28, DOI 10.1016/j.ab.2012.02.038; Lovdal T, 2000, J CELL SCI, V113, P3255; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Mazor O, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P275, DOI 10.1007/978-90-481-9054-6_30; MELLING J, 1988, EYE, V2, P16, DOI 10.1038/eye.1988.5; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Meng Q, 2012, ANAL BIOCHEM, V421, P351, DOI 10.1016/j.ab.2011.09.030; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Prigent J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013245; Ravichandran E, 2007, INFECT IMMUN, V75, P3043, DOI 10.1128/IAI.01893-06; SHONE C, 1985, APPL ENVIRON MICROB, V50, P63, DOI 10.1128/AEM.50.1.63-67.1985; Smith LA, 2007, CRIT REV IMMUNOL, V27, P303, DOI 10.1615/CritRevImmunol.v27.i4.20; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Sugiyama H, 1980, MICROBIOL REV, V44; Teshima G, 2011, J CHROMATOGR A, V1218, P2091, DOI 10.1016/j.chroma.2010.10.107; VOLK WA, 1984, INFECT IMMUN, V45, P604, DOI 10.1128/IAI.45.3.604-609.1984; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006; WHELAN SM, 1992, EUR J BIOCHEM, V204, P657, DOI 10.1111/j.1432-1033.1992.tb16679.x; WHELAN SM, 1992, APPL ENVIRON MICROB, V58, P2345, DOI 10.1128/AEM.58.8.2345-2354.1992; Yang GH, 2004, TOXICON, V44, P19, DOI 10.1016/j.toxicon.2004.03.016; Yu YZ, 2010, BIOCHIMIE, V92, P1315, DOI 10.1016/j.biochi.2010.06.010; Zhao HY, 2012, JPN J INFECT DIS, V65, P138; Zichel R, 2010, CLIN VACCINE IMMUNOL, V17, P784, DOI 10.1128/CVI.00496-09; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001	54	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87089	10.1371/journal.pone.0087089	http://dx.doi.org/10.1371/journal.pone.0087089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475231	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300138
J	Ganz, HH; Law, C; Schmuki, M; Eichenseher, F; Calendar, R; Loessner, MJ; Getz, WM; Korlach, J; Beyer, W; Klumpp, J				Ganz, Holly H.; Law, Christina; Schmuki, Martina; Eichenseher, Fritz; Calendar, Richard; Loessner, Martin J.; Getz, Wayne M.; Korlach, Jonas; Beyer, Wolfgang; Klumpp, Jochen			Novel Giant Siphovirus from Bacillus anthracis Features Unusual Genome Characteristics	PLOS ONE			English	Article							BACTERIOPHAGE; CEREUS; SEQUENCE; THURINGIENSIS; INFERENCE; REVEALS; PLASMID; MRBAYES	Here we present vB_BanS-Tsamsa, a novel temperate phage isolated from Bacillus anthracis, the agent responsible for anthrax infections in wildlife, livestock and humans. Tsamsa phage is a giant siphovirus (order Caudovirales), featuring a long, flexible and non-contractile tail of 440 nm (not including baseplate structure) and an isometric head of 82 nm in diameter. We induced Tsamsa phage in samples from two different carcass sites in Etosha National Park, Namibia. The Tsamsa phage genome is the largest sequenced Bacillus siphovirus, containing 168,876 bp and 272 ORFs. The genome features an integrase/recombinase enzyme, indicative of a temperate lifestyle. Among bacterial strains tested, the phage infected only certain members of the Bacillus cereus sensu lato group (B. anthracis, B. cereus and B. thuringiensis) and exhibited moderate specificity for B. anthracis. Tsamsa lysed seven out of 25 B. cereus strains, two out of five B. thuringiensis strains and six out of seven B. anthracis strains tested. It did not lyse B. anthracis PAK-1, an atypical strain that is also resistant to both gamma phage and cherry phage. The Tsamsa endolysin features a broader lytic spectrum than the phage host range, indicating possible use of the enzyme in Bacillus biocontrol.	[Ganz, Holly H.; Law, Christina; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Schmuki, Martina; Eichenseher, Fritz; Loessner, Martin J.; Klumpp, Jochen] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Calendar, Richard] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA; [Beyer, Wolfgang] Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; University of Kwazulu Natal; University Hohenheim	Ganz, HH (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	holly.h.ganz@gmail.com	Klumpp, Jochen/A-5415-2011; Loessner, Martin J/B-4316-2012; Getz, Wayne/I-4521-2013	Klumpp, Jochen/0000-0003-3410-2702; Loessner, Martin J/0000-0002-8162-2631; Getz, Wayne/0000-0001-8784-9354	University of California, Berkeley (UCB), Biology Scholars Program; UCB College of Natural Resources-Biology Scholars Program; Rosberg-Geist Fellowship from the UCB Center for African Studies and an Undergraduate Merit Scholarship from the UCB Institute of International Studies; NIH [GM083863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	University of California, Berkeley (UCB), Biology Scholars Program; UCB College of Natural Resources-Biology Scholars Program; Rosberg-Geist Fellowship from the UCB Center for African Studies and an Undergraduate Merit Scholarship from the UCB Institute of International Studies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a Pre-Graduate Pathway Research Grant from the University of California, Berkeley (UCB), Biology Scholars Program, the UCB College of Natural Resources-Biology Scholars Program, a Rosberg-Geist Fellowship from the UCB Center for African Studies and an Undergraduate Merit Scholarship from the UCB Institute of International Studies to CL, and NIH Grant GM083863 to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MH, 1959, METHODS STUDY BACTER, P443; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; BATTISTI L, 1985, J BACTERIOL, V162, P543, DOI 10.1128/JB.162.2.543-550.1985; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; BUCK CA, 1963, J BACTERIOL, V85, P1423, DOI 10.1128/JB.85.6.1423-1430.1963; CARTER KC, 1988, B HIST MED, V62, P42; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fouts DE, 2006, J BACTERIOL, V188, P3402, DOI 10.1128/JB.188.9.3402-3408.2006; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Fulmer P, 2006, BACILLUS ANTHRACIS A; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hendrix RW, 2009, CURR TOP MICROBIOL, V328, P229; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kilcher S, 2010, J BACTERIOL, V192, P5441, DOI 10.1128/JB.00709-10; Klumpp J, 2008, J BACTERIOL, V190, P5753, DOI 10.1128/JB.00461-08; Klumpp J, 2010, ARCH VIROL, V155, P1547, DOI 10.1007/s00705-010-0783-0; Marti R, 2013, MOL MICROBIOL; Minakhin L, 2005, J MOL BIOL, V354, P1, DOI 10.1016/j.jmb.2005.09.052; Okstad OA, 2011, FOOD MICROBIOL FOOD, P29, DOI 10.1007/978-1-4419-7686-4_2; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Sambrook J., 2001, MOL CLONING LAB MANU; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Stromsten NJ, 2003, J BACTERIOL, V185, P6985, DOI 10.1128/JB.185.23.6985-6989.2003; THORNE CB, 1968, J VIROL, V2, P657, DOI 10.1128/JVI.2.7.657-662.1968; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7	39	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85972	10.1371/journal.pone.0085972	http://dx.doi.org/10.1371/journal.pone.0085972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475065	Green Published, gold			2022-12-27	WOS:000330507300033
J	Garcia, DE; Keasling, JD				Garcia, David E.; Keasling, Jay D.			Kinetics of Phosphomevalonate Kinase from Saccharomyces cerevisiae	PLOS ONE			English	Article							MEVALONATE PATHWAY; ISOPENTENYL DIPHOSPHATE; ADVANCED BIOFUELS; ESCHERICHIA-COLI; IDENTIFICATION; BIOSYNTHESIS; MECHANISM; RESIDUES; SYNTHASE; ENZYME	The mevalonate-based isoprenoid biosynthetic pathway is responsible for producing cholesterol in humans and is used commercially to produce drugs, chemicals, and fuels. Heterologous expression of this pathway in Escherichia coli has enabled high-level production of the antimalarial drug artemisinin and the proposed biofuel bisabolane. Understanding the kinetics of the enzymes in the biosynthetic pathway is critical to optimize the pathway for high flux. We have characterized the kinetic parameters of phosphomevalonate kinase (PMK, EC 2.7.4.2) from Saccharomyces cerevisiae, a previously unstudied enzyme. An E. coli codon-optimized version of the S. cerevisiae gene was cloned into pET-52b+, then the C-terminal 6X His-tagged protein was expressed in E. coli BL21(DE3) and purified on a Ni2+ column. The K-M of the ATP binding site was determined to be 98.3 mu M at 30 degrees C, the optimal growth temperature for S. cerevisiae, and 74.3 mu M at 37 degrees C, the optimal growth temperature for E. coli. The K-M of the mevalonate-5-phosphate binding site was determined to be 885 mu M at 30 degrees C and 880 mu M at 37 degrees C. The V-max was determined to be 4.51 mu mol/min/mg enzyme at 30 degrees C and 5.33 mu mol/min/mg enzyme at 37 degrees C. PMK is Mg2+ dependent, with maximal activity achieved at concentrations of 10 mM or greater. Maximum activity was observed at pH = 7.2. PMK was not found to be substrate inhibited, nor feedback inhibited by FPP at concentrations up to 10 mu M FPP.	[Garcia, David E.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Garcia, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Garcia, David E.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	Joint BioEnergy Institute (JBEI); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	Joint BioEnergy Institute (JBEI)(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was funded by the Joint BioEnergy Institute (JBEI), which is funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, under contract number DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MS, 1989, J BIOL CHEM, V264, P19169; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Chou HH, 2011, HOST CELLS METHODS P; Doun SS, 2005, PROTEIN SCI, V14, P1134, DOI 10.1110/ps.041210405; Eyzaguirre J, 2006, ARCH BIOCHEM BIOPHYS, V454, P189, DOI 10.1016/j.abb.2006.08.002; Herdendorf TJ, 2006, BIOCHEMISTRY-US, V45, P3235, DOI 10.1021/bi052231u; Krepkiy D, 2004, ABSTR PAP AM CHEM S, V228, pU187; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Kuzuyama T, 2012, P JPN ACAD B-PHYS, V88, P41, DOI 10.2183/pjab.88.41; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Ma SM, 2011, METAB ENG, V13, P588, DOI 10.1016/j.ymben.2011.07.001; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; MIDDLETON B, 1972, BIOCHEM J, V126, P35, DOI 10.1042/bj1260035; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Singh P, 2012, PROTEOMICS, V12, P1289, DOI 10.1002/pmic.201100482; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	26	11	15	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87112	10.1371/journal.pone.0087112	http://dx.doi.org/10.1371/journal.pone.0087112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475236	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300143
J	Massilamany, C; Gangaplara, A; Jia, T; Elowsky, C; Kang, GB; Riethoven, JJ; Li, QS; Zhou, Y; Reddy, J				Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Jia, Ting; Elowsky, Christian; Kang, Guobin; Riethoven, Jean-Jack; Li, Qingsheng; Zhou, You; Reddy, Jay			Direct Staining with Major Histocompatibility Complex Class II Dextramers Permits Detection of Antigen-Specific, Autoreactive CD4 T Cells In Situ	PLOS ONE			English	Article							MYELIN PROTEOLIPID PROTEIN; HEAVY CHAIN-ALPHA; CUTTING EDGE; A/J MICE; MHC; TETRAMERS; IDENTIFICATION; MYOCARDITIS; ACTIVATION; VISUALIZATION	We report here the utility of major histocompatibility complex (MHC) class II dextramers for in situ detection of self-reactive CD4 T cells in two target organs, the brain and heart. We optimized the conditions for in situ detection of antigen-specific CD4 T cells using brain sections obtained from SJL mice immunized with myelin proteolipid protein (PLP) 139-151; the sections were costained with IA(s)/PLP 139-151 (specific) or Theiler's murine encephalomyelitis virus (TMEV) 70-86 (control) dextramers and anti-CD4. Analysis of sections by laser scanning confocal microscope revealed detection of cells positive for PLP 139-151 but not for TMEV 70-86 dextramers to be colocalized with CD4-expressing T cells, indicating that the staining was specific to PLP 139-151 dextramers. Further, we devised a method to reliably enumerate the frequencies of antigen-specific T cells by counting the number of dextramer(+) CD4(+) T cells in the 'Z' serial images acquired sequentially. We next extended these observations to detect cardiac myosin-specific T cells in autoimmune myocarditis induced in A/J mice by immunizing with cardiac myosin heavy chain-alpha (Myhc) 334-352. Heart sections prepared from immunized mice were costained with Myhc 334-352 (specific) or bovine ribonuclease 43-56 (control) dextramers together with anti-CD4; the sections showed the infiltrations of Myhc-specific CD4 T cells. The data suggest that MHC class II dextramers are useful tools for enumerating the frequencies of antigen-specific CD4 T cells in situ by direct staining without having to amplify the fluorescent signals, an approach commonly employed with conventional MHC tetramers.	[Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Jia, Ting; Reddy, Jay] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Elowsky, Christian; Riethoven, Jean-Jack; Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Kang, Guobin; Li, Qingsheng] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Kang, Guobin; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Reddy, J (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	nreddy2@unl.edu	Massilamany, Chandirasegaran/D-9305-2016; Reddy, Jay/K-7200-2014; Gangaplara, Arunakumar/K-5922-2019	Massilamany, Chandirasegaran/0000-0002-0205-282X; Reddy, Jay/0000-0003-4082-9254; Gangaplara, Arunakumar/0000-0001-6307-9391; Riethoven, Jean-Jack/0000-0002-2709-7880	American Heart Association; Children's Cardiomyopathy Foundation [SDG2462390204001]; National Institutes of Health [HL114669]; Myocarditis Foundation, NJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Children's Cardiomyopathy Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myocarditis Foundation, NJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association and the Children's Cardiomyopathy Foundation (SDG2462390204001), and the National Institutes of Health (HL114669). CM is a recipient of a postdoctoral research fellowship grant awarded by the Myocarditis Foundation, NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Batard P, 2006, J IMMUNOL METHODS, V310, P136, DOI 10.1016/j.jim.2006.01.006; Buckner JH, 2002, J ALLERGY CLIN IMMUN, V110, P199, DOI 10.1067/mai.2002.125976; Cameron TO, 2001, J IMMUNOL, V166, P741, DOI 10.4049/jimmunol.166.2.741; Carneiro Jorge, 2009, V514, P95, DOI 10.1007/978-1-60327-527-9_7; Cecconi V, 2008, CYTOM PART A, V73A, P1010, DOI 10.1002/cyto.a.20603; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; DONERMEYER DL, 1995, J EXP MED, V182, P1291, DOI 10.1084/jem.182.5.1291; Ferlin W, 2000, CURR OPIN IMMUNOL, V12, P670, DOI 10.1016/S0952-7915(00)00161-8; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; Helms T, 2000, J IMMUNOL, V164, P3723, DOI 10.4049/jimmunol.164.7.3723; Kwok WW, 2002, J IMMUNOL METHODS, V268, P71, DOI 10.1016/S0022-1759(02)00201-6; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; LIAO L, 1993, J CLIN INVEST, V92, P2877, DOI 10.1172/JCI116909; Mallone R, 2004, CLIN IMMUNOL, V110, P232, DOI 10.1016/j.clim.2003.11.004; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; Massilamany C, 2011, CELL IMMUNOL, V271, P438, DOI 10.1016/j.cellimm.2011.08.013; Massilamany C, 2011, J IMMUNOL METHODS, V372, P107, DOI 10.1016/j.jim.2011.07.004; Massilamany C, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-40; Massilamany C, 2010, J NEUROIMMUNOL, V219, P17, DOI 10.1016/j.jneuroim.2009.11.006; Nepom GT, 2012, J IMMUNOL, V188, P2477, DOI 10.4049/jimmunol.1102398; Novak EJ, 2001, INT IMMUNOL, V13, P799, DOI 10.1093/intimm/13.6.799; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Reddy J, 2003, J IMMUNOL, V170, P870, DOI 10.4049/jimmunol.170.2.870; Skinner P. J., 2004, CURR PROTOC IMMUNOL; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Skinner PJ, 2002, J IMMUNOL METHODS, V268, P29, DOI 10.1016/S0022-1759(02)00197-7; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Vollers SS, 2008, IMMUNOLOGY, V123, P305, DOI 10.1111/j.1365-2567.2007.02801.x; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x	33	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87519	10.1371/journal.pone.0087519	http://dx.doi.org/10.1371/journal.pone.0087519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475302	Green Published, gold			2022-12-27	WOS:000330507300196
J	Prill, JM; Subr, V; Pasquarelli, N; Engler, T; Hoffmeister, A; Kochanek, S; Ulbrich, K; Kreppel, F				Prill, Jan-Michael; Subr, Vladimir; Pasquarelli, Noemi; Engler, Tatjana; Hoffmeister, Andrea; Kochanek, Stefan; Ulbrich, Karel; Kreppel, Florian			Traceless Bioresponsive Shielding of Adenovirus Hexon with HPMA Copolymers Maintains Transduction Capacity In Vitro and In Vivo	PLOS ONE			English	Article							POLYMER-COATED ADENOVIRUS; KUPFFER CELLS; GENE-TRANSFER; CAPSID MODIFICATIONS; NATURAL ANTIBODIES; CAR-BINDING; VECTORS; GLUTATHIONE; LIVER; COMPLEMENT	Capsid surface shielding of adenovirus vectors with synthetic polymers is an emerging technology to reduce unwanted interactions of the vector particles with cellular and non-cellular host components. While it has been shown that attachment of shielding polymers allows prevention of undesired interactions, it has become evident that a shield which is covalently attached to the vector surface can negatively affect gene transfer efficiency. Reasons are not only a limited receptor-binding ability of the shielded vectors but also a disturbance of intracellular trafficking processes, the latter depending on the interaction of the vector surface with the cellular transport machinery. A solution might be the development of bioresponsive shields that are stably maintained outside the host cell but released upon cell entry to allow for efficient gene delivery to the nucleus. Here we provide a systematic comparison of irreversible versus bioresponsive shields based on synthetic N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. In addition, the chemical strategy used for generation of the shield allowed for a traceless bioresponsive shielding, i.e., polymers could be released from the vector particles without leaving residual linker residues. Our data demonstrated that only a bioresponsive shield maintained the high gene transfer efficiency of adenovirus vectors both in vitro and in vivo. As an example for bioresponsive HPMA copolymer release, we analyzed the in vivo gene transfer in the liver. We demonstrated that both the copolymer's charge and the mode of shielding (irreversible versus traceless bioresponsive) profoundly affected liver gene transfer and that traceless bioresponsive shielding with positively charged HPMA copolymers mediated FX independent transduction of hepatocytes. In addition, we demonstrated that shielding with HPMA copolymers can mediate a prolonged blood circulation of vector particles in mice. Our results have significant implications for the future design of polymer-shielded Ad and provide a deeper insight into the interaction of shielded adenovirus vector particles with the host after systemic delivery.	[Prill, Jan-Michael; Pasquarelli, Noemi; Engler, Tatjana; Hoffmeister, Andrea; Kochanek, Stefan; Kreppel, Florian] Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany; [Subr, Vladimir; Ulbrich, Karel] Acad Sci Czech Republic, Inst Macromol Chem, Vvi, Dept Biomed Polymers, Prague, Czech Republic	Ulm University; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Kreppel, F (corresponding author), Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany.	florian.kreppel@uni-ulm.de	Šubr, Vladimír/G-3488-2014; Ulbrich, Karel/G-5145-2014		German Research Foundation [SPP1230]; European Union [512087]	German Research Foundation(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by the German Research Foundation (SPP1230) and the European Union (FP6-2003-GIANT-Project 512087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Baker AH, 2013, MOL THER, V21, P1109, DOI 10.1038/mt.2013.100; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Espenlaub S, 2010, HUM GENE THER, V21, P1155, DOI 10.1089/hum.2009.171; Etrych T, 2012, J CONTROL RELEASE, V164, P346, DOI 10.1016/j.jconrel.2012.06.029; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Gnaccarini C, 2006, J AM CHEM SOC, V128, P8063, DOI 10.1021/ja061036f; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; HOLFORD NHG, 1986, CLIN PHARMACOKINET, V11, P483, DOI 10.2165/00003088-198611060-00005; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khynriam D, 2003, BRAZ J MED BIOL RES, V36, P53, DOI 10.1590/S0100-879X2003000100008; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Koizumi N, 2007, J IMMUNOL, V178, P1767, DOI 10.4049/jimmunol.178.3.1767; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; Lyons M, 2006, MOL THER, V14, P118, DOI 10.1016/j.ymthe.2006.01.003; Mann KG, 2005, AM HEART J, V149, pS36, DOI 10.1016/j.ahj.2004.10.021; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; NC3Rs: National Center for the replacement refinement and reduction in research, BLOOD SAMPL MIC DEC; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Prill JM, 2010, MOL THER, V19, P83; Reschel T, 2002, J CONTROL RELEASE, V81, P201, DOI 10.1016/S0168-3659(02)00045-7; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Smith JS, 2008, HUM GENE THER, V19, P547, DOI 10.1089/hum.2008.004; Smith JS, 2008, J VIROL METHODS, V147, P54, DOI 10.1016/j.jviromet.2007.08.009; Subr V, 2006, REACT FUNCT POLYM, V66, P1525, DOI 10.1016/j.reactfunctpolym.2006.05.002; Subr V, 2009, J CONTROL RELEASE, V135, P152, DOI 10.1016/j.jconrel.2008.12.009; Taylor CG, 1997, J NUTR, V127, P44, DOI 10.1093/jn/127.1.44; Ulbrich K, 2000, J CONTROL RELEASE, V64, P63, DOI 10.1016/S0168-3659(99)00141-8; Ulbrich K, 2004, J DRUG TARGET, V12, P477, DOI 10.1080/10611860400011869; Vetter A, 2013, MOL PHARMACEUT, V10, P606, DOI 10.1021/mp300366f; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wiley, 2013, J GENE MED GENE THER; Wolff JA, 2008, MOL THER, V16, P8, DOI 10.1038/sj.mt.6300326; Wortmann A, 2008, MOL THER, V16, P154, DOI 10.1038/sj.mt.6300306; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	53	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82716	10.1371/journal.pone.0082716	http://dx.doi.org/10.1371/journal.pone.0082716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475024	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300010
J	Raddatz, BBR; Hansmann, F; Spitzbarth, I; Kalkuhl, A; Deschl, U; Baumgartner, W; Ulrich, R				Raddatz, Barbara B. R.; Hansmann, Florian; Spitzbarth, Ingo; Kalkuhl, Arno; Deschl, Ulrich; Baumgaertner, Wolfgang; Ulrich, Reiner			Transcriptomic Meta-Analysis of Multiple Sclerosis and Its Experimental Models	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; THEILERS MURINE ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; GENE-EXPRESSION; IN-VITRO; MICROARRAY ANALYSIS; ENRICHMENT ANALYSIS; APOPTOTIC CELLS; MOUSE MODELS; DEMYELINATION	Background: Multiple microarray analyses of multiple sclerosis (MS) and its experimental models have been published in the last years. Objective: Meta-analyses integrate the information from multiple studies and are suggested to be a powerful approach in detecting highly relevant and commonly affected pathways. Data sources: ArrayExpress, Gene Expression Omnibus and PubMed databases were screened for microarray gene expression profiling studies of MS and its experimental animal models. Study eligibility criteria: Studies comparing central nervous system (CNS) samples of diseased versus healthy individuals with n >1 per group and publically available raw data were selected. Material and Methods: Included conditions for re-analysis of differentially expressed genes (DEGs) were MS, myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in rats, proteolipid protein-induced EAE in mice, Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD), and a transgenic tumor necrosis factor-overexpressing mouse model (TNFtg). Since solely a single MS raw data set fulfilled the inclusion criteria, a merged list containing the DEGs from two MS-studies was additionally included. Cross-study analysis was performed employing list comparisons of DEGs and alternatively Gene Set Enrichment Analysis (GSEA). Results: The intersection of DEGs in MS, EAE, TMEV-IDD, and TNFtg contained 12 genes related to macrophage functions. The intersection of EAE, TMEV-IDD and TNFtg comprised 40 DEGs, functionally related to positive regulation of immune response. Over and above, GSEA identified substantially more differentially regulated pathways including coagulation and JAK/STAT-signaling. Conclusion: A meta-analysis based on a simple comparison of DEGs is over-conservative. In contrast, the more experimental GSEA approach identified both, a priori anticipated as well as promising new candidate pathways.	[Raddatz, Barbara B. R.; Hansmann, Florian; Spitzbarth, Ingo; Baumgaertner, Wolfgang; Ulrich, Reiner] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Raddatz, Barbara B. R.; Hansmann, Florian; Spitzbarth, Ingo; Baumgaertner, Wolfgang; Ulrich, Reiner] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany; [Kalkuhl, Arno; Deschl, Ulrich] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Nonclin Drug Safety, Biberach, Riss, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Boehringer Ingelheim	Ulrich, R (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.	Reiner.Ulrich@tiho-hannover.de		Hansmann, Florian/0000-0001-6064-7728	Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany	Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany	This study was in part supported by Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Bonetti B, 1997, J IMMUNOL, V159, P5733; Comabella M, 2007, J NEUROIMMUNOL, V187, P1, DOI 10.1016/j.jneuroim.2007.02.009; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EMBL-EBI, ARR EXPR E GEOD 4498; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Glowacka WK, 2012, J BIOL CHEM, V287, P27691, DOI 10.1074/jbc.M112.355917; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Han MH, 2012, J EXP MED, V209, P1325, DOI 10.1084/jem.20101974; Hansmann F, 2012, CELL TRANSPLANT, V21, P1161, DOI 10.3727/096368911X627444; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Herder V, 2011, NEUROPATH APPL NEURO, V37, P676, DOI 10.1111/j.1365-2990.2011.01168.x; Herder V, 2012, J NEUROIMMUNOL, V249, P27, DOI 10.1016/j.jneuroim.2012.04.010; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Inoue A, 1997, J NEUROIMMUNOL, V77, P185, DOI 10.1016/S0165-5728(97)00072-6; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Kumar A, 2005, 18th International Conference on Systems Engineering, Proceedings, P320, DOI 10.1109/ICSENG.2005.14; Kummerfeld M, 2012, INTERVIROLOGY, V55, P401, DOI 10.1159/000336563; Larsson O, 2006, NAT BIOTECHNOL, V24, P1322, DOI 10.1038/nbt1106-1322; Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381; Lassmann H, 2007, CURR NEUROL NEUROSCI, V7, P239, DOI 10.1007/s11910-007-0036-0; Lindberg RLP, 2004, J NEUROIMMUNOL, V152, P154, DOI 10.1016/j.jneuroim.2004.03.011; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lu Y, 2009, BIOINFORMATICS, V25, P1476, DOI 10.1093/bioinformatics/btp247; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Luo C, 2012, INFLAMMATION, V35, P1448, DOI 10.1007/s10753-012-9458-1; Ma J, 2007, NEUROCHEM RES, V32, P311, DOI 10.1007/s11064-006-9183-y; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mann MK, 2012, AUTOIMMUNITY, V45, P388, DOI 10.3109/08916934.2012.665523; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nordmann AJ, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13518; Otaegui D, 2007, MULT SCLER, V13, P454, DOI 10.1177/1352458506070454; Pachner AR, 2007, J NEUROIMMUNOL, V190, P112, DOI 10.1016/j.jneuroim.2007.09.001; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sajic M, 2012, MULT SCLER J, V18, P286, DOI 10.1177/1352458511424309; Schlitt BP, 2003, J VIROL, V77, P4383, DOI 10.1128/JVI.77.7.4383-4388.2003; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shen K, 2010, BIOINFORMATICS, V26, P1316, DOI 10.1093/bioinformatics/btq148; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajouri L, 2003, MOL BRAIN RES, V119, P170, DOI 10.1016/j.molbrainres.2003.09.008; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Tsunoda I, 1997, VIROLOGY, V228, P388, DOI 10.1006/viro.1996.8382; Tsunoda I, 2003, AM J PATHOL, V162, P1259, DOI 10.1016/S0002-9440(10)63922-3; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Tsunoda I, 2010, J NEUROIMMUNE PHARM, V5, P355, DOI 10.1007/s11481-009-9179-x; Ulrich R, 2008, NEUROPATH APPL NEURO, V34, P603, DOI 10.1111/j.1365-2990.2008.00956.x; Ulrich R, 2010, J CELL MOL MED, V14, P434, DOI 10.1111/j.1582-4934.2008.00646.x; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; White CA, 1998, J NEUROIMMUNOL, V82, P47, DOI 10.1016/S0165-5728(97)00187-2; YAMADA M, 1990, AM J PATHOL, V137, P1467; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Zoecklein LJ, 2003, BRAIN PATHOL, V13, P291	75	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86643	10.1371/journal.pone.0086643	http://dx.doi.org/10.1371/journal.pone.0086643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475162	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300097
J	Schneider, L				Schneider, Leonid			Survival of Neural Stem Cells Undergoing DNA Damage-Induced Astrocytic Differentiation in Self-Renewal-Promoting Conditions In Vitro	PLOS ONE			English	Article								We recently reported that neural stem cells (NSCs) become senescent and commit to astrocytic differentiation upon X-ray irradiation. Surprisingly, under self-renewing culture conditions, some of these senescent cells undergo p53-independent apoptosis, which can be suppressed by caspase inhibition and BCL2 overexpression. Inhibition of apoptosis proved beneficial for astroglial differentiation efficiency; hence the toxicity of DNA damage on NSCs was specifically tested in context of the culture conditions. In this regard, self-renewal-promoting culture conditions proved incompatible with terminal astrocyte differentiation and impacted negatively on the viability of NSCs following DNA damage-induced cell cycle exit. On the contrary, a switch to differentiation-supporting conditions ablated apoptosis and conveyed tolerance to DNA damage. Thus, stem cell death has likely not originated from DNA break toxicity, while the potentially confounding effect of stem cell niche should always be taken in consideration in stem cell irradiation experiments.	[Schneider, Leonid] IFOM Fdn, Milan, Italy; [Schneider, Leonid] Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany	IFOM - FIRC Institute of Molecular Oncology; Technical University of Darmstadt	Schneider, L (corresponding author), IFOM Fdn, Milan, Italy.	leonid.schneider@gmail.com	Schneider, Leonid/H-3275-2013	Schneider, Leonid/0000-0002-6204-9470	IFOM Foundation; IFOM-IEO-Campus facilities (Milan, Italy)	IFOM Foundation; IFOM-IEO-Campus facilities (Milan, Italy)	The author thanks Dr. Fabrizio d'Adda di Fagagna and the IFOM Foundation as well as IFOM-IEO-Campus facilities (Milan, Italy) for financing, help and support associated with this project.	Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fukuda H, 2004, CELL DEATH DIFFER, V11, P1166, DOI 10.1038/sj.cdd.4401472; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Schneider L, 2013, STEM CELL REPORTS, V1; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Taga T, 2005, CLIN REV ALLERG IMMU, V28, P249, DOI 10.1385/CRIAI:28:3:249; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	15	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87228	10.1371/journal.pone.0087228	http://dx.doi.org/10.1371/journal.pone.0087228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475256	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300157
J	Subasinghe, AK; Walker, KZ; Evans, RG; Srikanth, V; Arabshahi, S; Kartik, K; Kalyanram, K; Thrift, AG				Subasinghe, Asvini K.; Walker, Karen Z.; Evans, Roger G.; Srikanth, Velandai; Arabshahi, Simin; Kartik, Kamakshi; Kalyanram, Kartik; Thrift, Amanda G.			Association between Farming and Chronic Energy Deficiency in Rural South India	PLOS ONE			English	Article							HOOKWORM INFECTION; PREGNANT-WOMEN; RISK-FACTORS; NORTH-INDIA; PREVALENCE; ANEMIA; HYPERTENSION; CHILDREN; POPULATION; FOOD	Objective: To examine factors associated with chronic energy deficiency (CED) and anaemia in disadvantaged Indian adults who are mostly involved in subsistence farming. Design: A cross-sectional study in which we collected information on socio-demographic factors, physical activity, anthropometry, blood haemoglobin concentration, and daily household food intake. These data were used to calculate body mass index (BMI), basal metabolic rate (BMR), daily energy expenditure, and energy and nutrient intake. Multivariable backward stepwise logistic regression was used to assess socioeconomic and lifestyle factors associated with CED (defined as BMI<18 kg/m(2)) and anaemia. Setting: The study was conducted in 12 villages, in the Rishi Valley, Andhra Pradesh, India. Subjects: Individuals aged 18 years and above, residing in the 12 villages, were eligible to participate. Results: Data were available for 1178 individuals (45% male, median age 36 years (inter quartile range (IQR 27-50)). The prevalence of CED (38%) and anaemia (25%) was high. Farming was associated with CED in women (2.20, 95% CI: 1.39-3.49) and men (1.71, 95% CI: (1.06-2.74). Low income was also significantly associated with CED, while not completing high school was positively associated with anaemia. Median iron intake was high: 35.7 mg/day (IQR 26-46) in women and 43.4 mg/day (IQR 34-55) in men. Conclusions: Farming is an important risk factor associated with CED in this rural Indian population and low dietary iron is not the main cause of anaemia. Better farming practice may help to reduce CED in this population.	[Subasinghe, Asvini K.; Srikanth, Velandai; Arabshahi, Simin; Thrift, Amanda G.] Monash Univ, Dept Med, Monash Med Ctr, Southern Clin Sch, Melbourne, Vic 3004, Australia; [Walker, Karen Z.] Monash Univ, Dept Nutr & Dietet, Melbourne, Vic 3004, Australia; [Evans, Roger G.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Kartik, Kamakshi; Kalyanram, Kartik] Rishi Valley Rural Hlth Ctr, Bangalore, Andhra Pradesh, India; [Thrift, Amanda G.] Florey Neurosci Inst, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Florey Institute of Neuroscience & Mental Health	Subasinghe, AK (corresponding author), Monash Univ, Dept Med, Monash Med Ctr, Southern Clin Sch, Melbourne, Vic 3004, Australia.	asvini.subasinghe@monash.edu	Evans, Roger/N-8580-2019; Thrift, Amanda/I-6251-2012; Arabshahi, Simin/I-1991-2013	Evans, Roger/0000-0002-9241-0757; Thrift, Amanda/0000-0001-8533-4170; Srikanth, Velandai/0000-0002-8442-8981; Arabshahi, Simin/0000-0001-9381-2291	NHMRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	A.G.T. and R.G.E. were supported by fellowships from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LT, 2003, PUBLIC HEALTH NUTR, V6, P131, DOI 10.1079/PHN2002367; [Anonymous], INT J PUBLIC HLTH; [Anonymous], USDA NAT NUTR DAT ST; [Anonymous], NUTR REQ REC THEOR A; [Anonymous], MALN DAT MAPP PROV I; [Anonymous], 2002, DIET NUTR STAT RUR P; [Anonymous], FOOD COMPOSITION TRA; [Anonymous], ADDR FOOD INS PROTR; [Anonymous], 2006, DIET NUTR STAT POP P; [Anonymous], DATABASE IRON DEFICI; [Anonymous], 2008, WORLDW PREV AN 1993; Arlappa N., 2009, Journal of Nutrition for the Elderly, V28, P301, DOI 10.1080/01639360903140338; Chakraborty R, 2009, HOMO, V60, P45, DOI 10.1016/j.jchb.2008.06.007; Dongre AR, 2011, FOOD NUTR BULL, V32, P315, DOI 10.1177/156482651103200402; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS170, DOI 10.1177/15648265120333S205; GRIMM RH, 1985, ARCH INTERN MED, V145, P1191, DOI 10.1001/archinte.145.7.1191; Gulati A, 2012, FOOD NUTR BULL, V33, P74, DOI 10.1177/156482651203300108; GUPTA R, 1994, J HUM HYPERTENS, V8, P823; He FJ, 2012, REV PANAM SALUD PUBL, V32, P293, DOI 10.1590/S1020-49892012001000008; Iwaoka H, 2001, J NUTR SCI VITAMINOL, V47, P222, DOI 10.3177/jnsv.47.222; Malhotra P, 1999, J HUM HYPERTENS, V13, P467, DOI 10.1038/sj.jhh.1000864; Meshram II, 2011, ANN HUM BIOL, V38, P93, DOI 10.3109/03014460.2010.498387; Misra A, 2009, J Assoc Physicians India, V57, P163; Nair KM, 2009, INDIAN J MED RES, V130, P634; NATARAJAN VS, 1993, AGE AGEING, V22, P103, DOI 10.1093/ageing/22.2.103; Panwar B, 1998, INT J FOOD SCI NUTR, V49, P243, DOI 10.3109/09637489809086418; Pasricha SR, 2012, PATHOLOGY, V44, P139, DOI 10.1097/PAT.0b013e32834e8291; Pasricha SR, 2010, J PAEDIATR CHILD H, V46, P497, DOI 10.1111/j.1440-1754.2010.01839.x; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Rao S, 2011, PUBLIC HEALTH NUTR, V14, P365, DOI 10.1017/S1368980010002776; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Singh RB, 1997, CORONARY ARTERY DIS, V8, P463, DOI 10.1097/00019501-199707000-00009; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; SRINIVASAN V, 1987, T ROY SOC TROP MED H, V81, P973, DOI 10.1016/0035-9203(87)90369-5; Thrift AG, 2011, J HYPERTENS, V29, P443, DOI 10.1097/HJH.0b013e328341888c; Vedantam A, 2010, PUBLIC HEALTH NUTR, V13, P1328, DOI 10.1017/S1368980009991674; WHO, 2001, IRON DEFICIENCY ANAE	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87423	10.1371/journal.pone.0087423	http://dx.doi.org/10.1371/journal.pone.0087423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475286	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300181
J	Wang, H; Li, HY; Zhang, ZJ; Muehlbauer, JD; He, Q; Xu, XH; Yue, CL; Jiang, DQ				Wang, Hang; Li, HongYi; Zhang, ZhiJian; Muehlbauer, Jeffrey D.; He, Qiang; Xu, XinHua; Yue, ChunLei; Jiang, DaQian			Linking Stoichiometric Homeostasis of Microorganisms with Soil Phosphorus Dynamics in Wetlands Subjected to Microcosm Warming	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; ECOENZYMATIC STOICHIOMETRY; FRESH-WATER; ECOLOGICAL STOICHIOMETRY; SUBTROPICAL WETLANDS; ORGANIC-MATTER; TEMPERATURE; CARBON; ECOSYSTEM; SEDIMENT	Soil biogeochemical processes and the ecological stability of wetland ecosystems under global warming scenarios have gained increasing attention worldwide. Changes in the capacity of microorganisms to maintain stoichiometric homeostasis, or relatively stable internal concentrations of elements, may serve as an indicator of alterations to soil biogeochemical processes and their associated ecological feedbacks. In this study, an outdoor computerized microcosm was set up to simulate a warmed (+5 degrees C) climate scenario, using novel, minute-scale temperature manipulation technology. The principle of stoichiometric homeostasis was adopted to illustrate phosphorus (P) biogeochemical cycling coupled with carbon (C) dynamics within the soil-microorganism complex. We hypothesized that enhancing the flux of P from soil to water under warming scenarios is tightly coupled with a decrease in homeostatic regulation ability in wetland ecosystems. Results indicate that experimental warming impaired the ability of stoichiometric homeostasis (H) to regulate biogeochemical processes, enhancing the ecological role of wetland soil as an ecological source for both P and C. The potential P flux from soil to water ranged from 0.11 to 34.51 mg m(-2) d(-1) in the control and 0.07 to 61.26 mg m(-2) d(-1) in the warmed treatment. The synergistic function of C-P acquisition is an important mechanism underlying C: P stoichiometric balance for soil microorganisms under warming. For both treatment groups, strongly significant (p < 0.001) relationships fitting a negative allometric power model with a fractional exponent were found between n-H-C:P (the specialized homeostatic regulation ability as a ratio of soil highly labile organic carbon to dissolved reactive phosphorus in porewater) and potential P flux. Although many factors may affect soil P dynamics, the n-H-C:P term fundamentally reflects the stoichiometric balance or interactions between the energy landscape (i.e., C) and flow of resources (e. g., N and P), and can be a useful ecological tool for assessing potential P flux in ecosystems.	[Wang, Hang; Li, HongYi; Zhang, ZhiJian; Xu, XinHua] Zhejiang Univ, China Acad West Dev, Coll Nat Resource & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Muehlbauer, Jeffrey D.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA; [He, Qiang] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA; [Yue, ChunLei] Zhejiang Forestry Acad, Inst Ecol, Hangzhou, Peoples R China; [Jiang, DaQian] Columbia Univ, Henry Krumb Sch Mines, Dept Earth & Environm Engn, New York, NY 10027 USA	Zhejiang University; University of North Carolina; University of North Carolina Chapel Hill; University of Tennessee System; University of Tennessee Knoxville; Columbia University	Zhang, ZJ (corresponding author), Zhejiang Univ, China Acad West Dev, Coll Nat Resource & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangzhijian@zju.edu.cn	He, Qiang/G-9061-2011; Xu, Xinhua/ABG-6289-2021; Muehlbauer, Jeffrey/G-3607-2011	He, Qiang/0000-0002-7155-6474; Xu, Xinhua/0000-0001-7139-1246; Muehlbauer, Jeffrey/0000-0003-1808-580X	National Natural Science Foundation of China [41373073]; Zhejiang Science and Technology Program [2011F20025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Science and Technology Program	The authors wish to thank the National Natural Science Foundation of China (41373073) and Zhejiang Science and Technology Program (2011F20025) for providing the financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; Alvarez-Cobelas M, 2009, J N AM BENTHOL SOC, V28, P805, DOI 10.1899/09-073.1; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Cheng WG, 2010, HYDROBIOLOGIA, V656, P5, DOI 10.1007/s10750-010-0441-2; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feng XJ, 2009, SOIL BIOL BIOCHEM, V41, P804, DOI 10.1016/j.soilbio.2009.01.020; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hilbert DW, 2000, J ECOL, V88, P230, DOI 10.1046/j.1365-2745.2000.00438.x; IPCC, 2001, ADV CLIM CHANG RES; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Liikanen A, 2002, BIOGEOCHEMISTRY, V59, P269, DOI 10.1023/A:1016015526712; Logninow W, 1987, J SOIL SCI, V20; Marichal R, 2011, SOIL BIOL BIOCHEM, V43, P1528, DOI 10.1016/j.soilbio.2011.04.001; Mulder C, 2009, GLOBAL CHANGE BIOL, V15, P2730, DOI 10.1111/j.1365-2486.2009.01899.x; Newman S, 2003, J APPL PHYCOL, V15, P45, DOI 10.1023/A:1022971204435; Nicholls KH, 1999, J GREAT LAKES RES, V25, P250, DOI 10.1016/S0380-1330(99)70734-3; Noe GB, 2003, FRESHWATER BIOL, V48, P1993, DOI 10.1046/j.1365-2427.2003.01143.x; Olk DC, 2006, SOIL SCI SOC AM J, V70, P967, DOI 10.2136/sssaj2005.0111; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rinu K, 2010, MYCOSCIENCE, V51, P263, DOI 10.1007/s10267-010-0036-9; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Serpa D, 2007, BIOGEOCHEMISTRY, V82, P291, DOI 10.1007/s10533-007-9076-4; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2010, MICROB ECOL, V60, P885, DOI 10.1007/s00248-010-9696-4; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Small GE, 2010, OECOLOGIA, V162, P581, DOI 10.1007/s00442-009-1489-4; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Wang H, 2013, CHEMOSPHERE, V90, P1794, DOI 10.1016/j.chemosphere.2012.08.044; Wang H, 2012, APPL ENVIRON MICROB, V78, P7652, DOI 10.1128/AEM.01602-12; White JR, 2006, SOIL SCI SOC AM J, V70, P1242, DOI 10.2136/sssaj2003.0339; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang ZJ, 2012, HYDROL PROCESS, V26, P15, DOI 10.1002/hyp.8105; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	49	3	9	13	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85575	10.1371/journal.pone.0085575	http://dx.doi.org/10.1371/journal.pone.0085575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475045	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300021
J	Yang, YZ; Tan, BC				Yang, Yan-Zhuo; Tan, Bao-Cai			A Distal ABA Responsive Element in AtNCED3 Promoter Is Required for Positive Feedback Regulation of ABA Biosynthesis in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE GENE; MOLYBDENUM COFACTOR SULFURASE; OSMOTIC-STRESS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; ALDEHYDE OXIDASE; KEY ENZYME; G-BOX; EXPRESSION	The plant hormone abscisic acid (ABA) plays a crucial role in plant development and responses to abiotic stresses. Recent studies indicate that a positive feedback regulation by ABA exists in ABA biosynthesis in plants under dehydration stress. To understand the molecular basis of this regulation, we analyzed the cis-elements of the AtNCED3 promoter in Arabidopsis. AtNCED3 encodes the first committed and highly regulated dioxygenase in the ABA biosynthetic pathway. Through delineated and mutagenesis analyses in stable-transformed Arabidopsis, we revealed that a distal ABA responsive element (ABRE: GGCACGTG, -2372 to -2364 bp) is required for ABA-induced AtNCED3 expression. By analyzing the AtNCED3 expression in ABRE binding protein ABF3 over-expression transgenic plants and knock-out mutants, we provide evidence that the ABA feedback regulation of AtNCED3 expression is not mediated by ABF3.	[Yang, Yan-Zhuo; Tan, Bao-Cai] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Inst Plant Mol Biol & Agr Biotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Tan, BC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Inst Plant Mol Biol & Agr Biotechnol, Shatin, Hong Kong, Peoples R China.	bctan@cuhk.edu.hk			Research Grants Council of the Hong Kong Special Administrative Region [473512, 473611]; National Natural Science Foundation of China [31170298]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region to B.-C.T. (Project no. 473512 and 473611), and a grant from the National Natural Science Foundation of China to B.-C.T. (Project no. 31170298). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-69; Babak B, 2013, DNA RES, V20, P315, DOI 10.1093/dnares/dst012; Bang SW, 2013, PLANTA, V237, P211, DOI 10.1007/s00425-012-1764-1; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Cao XY, 2007, PLANT PHYSIOL, V143, P720, DOI 10.1104/pp.106.091454; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DONALD RGK, 1990, EMBO J, V9, P1717, DOI 10.1002/j.1460-2075.1990.tb08295.x; Endo A, 2008, PLANT PHYSIOL, V147, P1984, DOI 10.1104/pp.108.116632; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liang JH, 2009, BIOSCI BIOTECH BIOCH, V73, P2103, DOI 10.1271/bbb.90133; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; MASON HS, 1993, PLANT CELL, V5, P241, DOI 10.1105/tpc.5.3.241; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; QIN XF, 1994, PLANT CELL, V6, P863, DOI 10.1105/tpc.6.6.863; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang ZY, 2011, PLANT CELL, V23, P1971, DOI 10.1105/tpc.110.081943; Woo DH, 2011, J PLANT PHYSIOL, V168, P140, DOI 10.1016/j.jplph.2010.06.006; WRIGHT STC, 1969, NATURE, V224, P719, DOI 10.1038/224719a0; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	59	18	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87283	10.1371/journal.pone.0087283	http://dx.doi.org/10.1371/journal.pone.0087283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475264	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300162
J	Chen, ZH; Zhang, YC; Jiang, WF; Yang, C; Zou, GM; Kong, Y; Cai, W				Chen, Zhi-Hua; Zhang, Yong-Chang; Jiang, Wei-Fang; Yang, Cissy; Zou, Gang-Ming; Kong, Yu; Cai, Wei			Characterization of Interstitial Cajal Progenitors Cells and Their Changes in Hirschsprung's Disease	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; ENTERIC NERVOUS-SYSTEM; MOUSE SMALL-INTESTINE; STEM-CELLS; C-KIT; ELECTRICAL RHYTHMICITY; CHINESE POPULATION; HUMAN STOMACH; COLON; ICC	Interstitial cells of Cajal (ICC) are critical to gastrointestinal motility. The phenotypes of ICC progenitors have been observed in the mouse gut, but whether they exist in the human colon and what abnormal changes in their quantity and ultrastructure are present in Hirschsprung's disease (HSCR) colon remains uncertain. In this study, we collected the surgical resection of colons, both proximal and narrow segments, from HSCR patients and normal controls. First, we identified the progenitor of ICC in normal adult colon using immunofluorescent localization techniques with laser confocal microscopy. Next, the progenitors were sorted to observe their morphology. We further applied flow cytometry to examine the content of ICC progenitors in these fresh samples. The ultrastructural changes in the narrow and proximal parts of the HSCR colon were observed using transmission electron microscopy (TEM) and were compared with the normal adult colon. The presumed early progenitor (c-Kit(low)CD34(+)Igf1r(+)) and committed progenitor (c-Kit(+)CD34(+)Igf1r(+)) of ICC exist in adult normal colon as well as in the narrow and proximal parts of the HSCR colon. However, the proportions of mature, early and committed progenitors of ICC were dramatically reduced in the narrow segment of the HSCR colon. The proportions of mature and committed progenitors of ICC in the proximal segment of the HSCR colon were lower than in the adult normal colon. Ultrastructurally, ICC, enteric nerves, and smooth muscle in the narrow segment of the HSCR colon showed severe injury, including swollen vacuola or ted mitochondria, disappearance of mitochondrial cristae, dilated rough endoplasmic reticulum, vesiculation and degranulation, and disappearance of the caveolae on the ICC membrane surface. The contents of ICC and its progenitors in the narrow part of the HSCR colon were significantly decreased than those of adult colon, which may be associated with HSCR pathogenesis.	[Chen, Zhi-Hua; Zou, Gang-Ming; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China; [Zhang, Yong-Chang] Cent Univ, Xiang Ya Med Sch, Affiliated Tumor Hosp, Hunan Prov Tumor Hosp,Ward Oncol 32, Changsha, Hunan, Peoples R China; [Jiang, Wei-Fang; Kong, Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Yang, Cissy] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Stanford University	Cai, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	Caiw1978@163.com	Zou, Gang-Ming/F-1085-2016		Shanghai Jiao Tong University Innovation Team Fund	Shanghai Jiao Tong University Innovation Team Fund	This work was supported by a grant from Shanghai Jiao Tong University Innovation Team Fund (W. C). The authors state the funder had the role of study design, decision to publish, and preparation of the manuscript.	Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Bernardini N, 2012, J CELL MOL MED, V16, P318, DOI 10.1111/j.1582-4934.2011.01298.x; Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; FAUSSONEPELLEGRINI MS, 1985, ANAT EMBRYOL, V171, P163, DOI 10.1007/BF00341410; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Huizinga JD, 2008, GASTROENTEROLOGY, V134, P1252, DOI 10.1053/j.gastro.2008.02.074; Ishii S, 2009, J GASTROENTEROL, V44, P834, DOI 10.1007/s00535-009-0077-z; Komuro T, 1999, ARCH HISTOL CYTOL, V62, P295, DOI 10.1679/aohc.62.295; Li YM, 2011, J GASTROEN HEPATOL, V26, P1072, DOI 10.1111/j.1440-1746.2011.06670.x; Liu LWC, 1998, DEV DYNAM, V213, P271, DOI 10.1002/(SICI)1097-0177(199811)213:3<271::AID-AJA4>3.0.CO;2-R; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mei F, 2006, VIRCHOWS ARCH, V449, P348, DOI 10.1007/s00428-006-0258-6; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Miao XP, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.116145; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; Nakahara M, 2002, LIFE SCI, V70, P2367, DOI 10.1016/S0024-3205(02)01517-5; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Radenkovic G, 2010, J CELL MOL MED, V14, P1125, DOI 10.1111/j.1582-4934.2009.00725.x; Robinson TL, 2000, AM J PATHOL, V156, P1157, DOI 10.1016/S0002-9440(10)64984-X; Rolle U, 2002, ARCH PATHOL LAB MED, V126, P928; Sohal GS, 2002, INT J DEV NEUROSCI, V20, P619, DOI 10.1016/S0736-5748(02)00103-X; Solari V, 2003, PEDIATR SURG INT, V19, P349, DOI 10.1007/s00383-003-1009-2; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P190, DOI 10.1111/j.1365-2559.2006.02497.x; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P176, DOI 10.1111/j.1365-2559.2006.02493.x; Torihashi S, 1997, GASTROENTEROLOGY, V112, P144, DOI 10.1016/S0016-5085(97)70229-4; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P901, DOI 10.1016/S0016-5085(96)70057-4; Wang XY, 2009, J CELL MOL MED, V13, P3528, DOI 10.1111/j.1582-4934.2009.00689.x; Ward SM, 2001, ANAT RECORD, V262, P125; Wu JJ, 2000, J NEUROSCI RES, V59, P384, DOI 10.1002/(SICI)1097-4547(20000201)59:3<384::AID-JNR13>3.0.CO;2-4; Yanagida H, 2004, GASTROENTEROLOGY, V127, P1748, DOI 10.1053/j.gastro.2004.09.053; Yang J, 2013, MOL NEUROBIOL, V47, P957, DOI 10.1007/s12035-012-8392-4; Zhang DC, 2010, DEV BIOL, V339, P280, DOI 10.1016/j.ydbio.2009.12.014	40	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86100	10.1371/journal.pone.0086100	http://dx.doi.org/10.1371/journal.pone.0086100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475076	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800027
J	Taylor, K; Kleinhesselink, K; George, MD; Morgan, R; Smallwood, T; Hammonds, AS; Fuller, PM; Saelao, P; Alley, J; Gibbs, AG; Hoshizaki, DK; von Kalm, L; Fuller, CA; Beckingham, KM; Kimbrell, DA				Taylor, Katherine; Kleinhesselink, Kurt; George, Michael D.; Morgan, Rachel; Smallwood, Tangi; Hammonds, Ann S.; Fuller, Patrick M.; Saelao, Perot; Alley, Jeff; Gibbs, Allen G.; Hoshizaki, Deborah K.; von Kalm, Laurence; Fuller, Charles A.; Beckingham, Kathleen M.; Kimbrell, Deborah A.			Toll Mediated Infection Response Is Altered by Gravity and Spaceflight in Drosophila	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; IMMUNE-RESPONSE; MELANOGASTER	Space travel presents unlimited opportunities for exploration and discovery, but requires better understanding of the biological consequences of long-term exposure to spaceflight. Immune function in particular is relevant for space travel. Human immune responses are weakened in space, with increased vulnerability to opportunistic infections and immune-related conditions. In addition, microorganisms can become more virulent in space, causing further challenges to health. To understand these issues better and to contribute to design of effective countermeasures, we used the Drosophila model of innate immunity to study immune responses in both hypergravity and spaceflight. Focusing on infections mediated through the conserved Toll and Imd signaling pathways, we found that hypergravity improves resistance to Toll-mediated fungal infections except in a known gravitaxis mutant of the yuri gagarin gene. These results led to the first spaceflight project on Drosophila immunity, in which flies that developed to adulthood in microgravity were assessed for immune responses by transcription profiling on return to Earth. Spaceflight alone altered transcription, producing activation of the heat shock stress system. Space flies subsequently infected by fungus failed to activate the Toll pathway. In contrast, bacterial infection produced normal activation of the Imd pathway. We speculate on possible linkage between functional Toll signaling and the heat shock chaperone system. Our major findings are that hypergravity and spaceflight have opposing effects, and that spaceflight produces stress-related transcriptional responses and results in a specific inability to mount a Toll-mediated infection response.	[Taylor, Katherine; Kleinhesselink, Kurt; Saelao, Perot; Kimbrell, Deborah A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [George, Michael D.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Morgan, Rachel; Smallwood, Tangi; von Kalm, Laurence] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Hammonds, Ann S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Fuller, Patrick M.; Fuller, Charles A.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Alley, Jeff] Laverlam Int, Butte, MT USA; [Gibbs, Allen G.; Hoshizaki, Deborah K.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Beckingham, Kathleen M.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of California System; University of California Davis; University of California System; University of California Davis; State University System of Florida; University of Central Florida; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Rice University	Kimbrell, DA (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	dakimbrell@ucdavis.edu	Gibbs, Allen G/G-6939-2014	Gibbs, Allen G/0000-0001-5233-2056; SAELAO, PEROT/0000-0003-1171-9187	National Aeronautics and Space Administration [NNA04CC76A, NNA05CV40A]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was funded by grants from the National Aeronautics and Space Administration, NNA04CC76A and NNA05CV40A to DAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bernal AR, 2004, DROSOPH INF SERV, V87, P81; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; George MD, 2009, CLIN VACCINE IMMUNOL, V16, P277, DOI 10.1128/CVI.00265-08; Giuliano John S Jr, 2011, Open Inflamm J, V4, P49; Herranz R, 2010, MOL ECOL, V19, P4255, DOI 10.1111/j.1365-294X.2010.04795.x; Lee G, 2011, J COMP NEUROL, V519, P34, DOI 10.1002/cne.22498; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Park HH, 2006, ACTA CRYSTALLOGR F, V62, P597, DOI 10.1107/S1744309106018422; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stenmark H, 2001, GENOME BIOL, V2; Taylor K, 2007, FLY, V1, P197, DOI 10.4161/fly.5082; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	16	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86485	10.1371/journal.pone.0086485	http://dx.doi.org/10.1371/journal.pone.0086485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475130	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800049
J	Carbonetti, S; Oliver, BG; Glenn, J; Stamatatos, L; Sather, DN				Carbonetti, Sara; Oliver, Brian G.; Glenn, Jolene; Stamatatos, Leonidas; Sather, D. Noah			Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CD4 BINDING; SUBTYPE-C; BROAD NEUTRALIZATION; IMMUNE-RESPONSES; VACCINE EFFICACY; PARTIAL DELETION; RATIONAL DESIGN; V1/V2 DOMAIN	We evaluated four gp140 Envelope protein vaccine immunogens that were derived from an elite neutralizer, subject VC10042, whose plasma was able to potently neutralize a wide array of genetically distinct HIV-1 isolates. We sought to determine whether soluble Envelope proteins derived from the viruses circulating in VC10042 could be used as immunogens to elicit similar neutralizing antibody responses by vaccination. Each gp140 was tested in its trimeric and monomeric forms, and we evaluated two gp140 trimer vaccine regimens in which adjuvant was supplied at all four immunizations or at only the first two immunizations. Interestingly, all four Envelope immunogens elicited high titers of cross-reactive antibodies that recognize the variable regions V1V2 and are potentially similar to antibodies linked with a reduced risk of HIV-1 acquisition in the RV144 vaccine trial. Two of the four immunogens elicited neutralizing antibody responses that neutralized a wide array of HIV-1 isolates from across genetic clades, but those responses were of very low potency. There were no significant differences in the responses elicited by trimers or monomers, nor was there a significant difference between the two adjuvant regimens. Our study identified two promising Envelope immunogens that elicited anti-V1V2 antibodies and broad, but low potency, neutralizing antibody responses.	[Carbonetti, Sara; Oliver, Brian G.; Glenn, Jolene; Stamatatos, Leonidas; Sather, D. Noah] Seattle BioMed, Seattle, WA USA; [Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Sather, DN (corresponding author), Seattle BioMed, Seattle, WA USA.	noah.sather@seattlebiomed.org	Oliver, Brian/E-7939-2010	Oliver, Brian/0000-0002-7122-9262	NIH NIAID [R01-AI47708, R33-AI089405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI089405, R56AI047708, R01AI047708] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH NIAID research grants R01-AI47708 to L.S. and R33-AI089405 to D.N.S. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dong M, 2003, J VIROL, V77, P3119, DOI 10.1128/JVI.77.5.3119-3130.2003; Duenas-Decamp MJ, 2008, J VIROL, V82, P5807, DOI 10.1128/JVI.02585-07; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kensil C R, 1998, Expert Opin Investig Drugs, V7, P1475, DOI 10.1517/13543784.7.9.1475; Kensil CR, 2006, INFEC DIS, P221; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kraft Z, 2008, J VIROL, V82, P5912, DOI 10.1128/JVI.00389-08; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Quinnan GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059803; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sather DN, 2012, J VIROL, V86, P12676, DOI 10.1128/JVI.01893-12; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sellhorn G, 2012, J VIROL, V86, P128, DOI 10.1128/JVI.06363-11; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	60	17	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86905	10.1371/journal.pone.0086905	http://dx.doi.org/10.1371/journal.pone.0086905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466285	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000168
J	Hong, IS; Lee, HY; Kim, HP				Hong, In-Sun; Lee, Hwa-Yong; Kim, Hyun-Pyo			Anti-Oxidative Effects of Rooibos Tea (Aspalathus linearis) on Immobilization-Induced Oxidative Stress in Rat Brain	PLOS ONE			English	Article							HONEYBUSH CYCLOPIA-INTERMEDIA; CAMELLIA-SINENSIS TEAS; PULMONATE LAND SNAIL; AFRICAN HERBAL TEAS; NEURODEGENERATIVE DISEASES; LIPID-PEROXIDATION; PSYCHIATRIC-DISORDERS; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; CARBON-TETRACHLORIDE	Exposure to chronic psychological stress may be related to increased reactive oxygen species (ROS) or free radicals, and thus, long-term exposure to high levels of oxidative stress may cause the accumulation of oxidative damage and eventually lead to many neurodegenerative diseases. Compared with other organs, the brain appears especially susceptible to excessive oxidative stress due to its high demand for oxygen. In the case of excessive ROS production, endogenous defense mechanisms against ROS may not be sufficient to suppress ROS-associated oxidative damage. Dietary antioxidants have been shown to protect neurons against a variety of experimental neurodegenerative conditions. In particular, Rooibos tea might be a good source of antioxidants due to its larger proportion of polyphenolic compounds. An optimal animal model for stress should show the features of a stress response and should be able to mimic natural stress progression. However, most animal models of stress, such as cold-restraint, electric foot shock, and burn shock, usually involve physical abuse in addition to the psychological aspects of stress. Animals subjected to chronic restraint or immobilization are widely believed to be a convenient and reliable model to mimic psychological stress. Therefore, in the present study, we propose that immobilization-induced oxidative stress was significantly attenuated by treatment with Rooibos tea. This conclusion is demonstrated by Rooibos tea's ability to (i) reverse the increase in stress-related metabolites (5-HIAA and FFA), (ii) prevent lipid peroxidation (LPO), (iii) restore stress-induced protein degradation (PD), (iv) regulate glutathione metabolism (GSH and GSH/GSSG ratio), and (v) modulate changes in the activities of antioxidant enzymes (SOD and CAT).	[Hong, In-Sun; Lee, Hwa-Yong] Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea; [Hong, In-Sun; Lee, Hwa-Yong] Seoul Natl Univ, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea; [Kim, Hyun-Pyo] Jungwon Univ, Dept Biomed Sci, Chungbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Jungwon University	Kim, HP (corresponding author), Jungwon Univ, Dept Biomed Sci, Chungbuk, South Korea.	khpsss@jwu.ac.kr			Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs [Z-1541745-2012-13-09]	Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs	This study was supported by a grant (Project Code No., Z-1541745-2012-13-09) from Animal and Plant Quarantine Agency, Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOLA O, 1993, J ANIM SCI, V71, P968, DOI 10.2527/1993.714968x; Al-Abrash ASA, 2000, SAUDI MED J, V21, P826; Baba H, 2009, PEDIATR INT, V51, P700, DOI 10.1111/j.1442-200X.2009.02835.x; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; Benzie IFF, 1999, NUTR CANCER, V34, P83, DOI 10.1207/S15327914NC340112; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Bramati L, 2002, J AGR FOOD CHEM, V50, P5513, DOI 10.1021/jf025697h; Buege J A, 1978, Methods Enzymol, V52, P302; Byers JP, 2006, TOXICOLOGY, V228, P291, DOI 10.1016/j.tox.2006.09.009; Chen W, 2013, PHYTOMEDICINE, V20, P380, DOI 10.1016/j.phymed.2012.10.006; Claeyssen R, 2008, BIOL TRACE ELEM RES, V126, pS80, DOI 10.1007/s12011-008-8210-z; CORTAMIRA NO, 1991, BRIT J NUTR, V66, P423, DOI 10.1079/BJN19910045; Couto N, 2013, J PROTEOME RES, V12, P2885, DOI 10.1021/pr4001948; Das A, 2000, PHARMACOL RES, V42, P213, DOI 10.1006/phrs.2000.0678; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Esch T, 2002, NEUROENDOCRINOL LETT, V23, P199; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FORDYCE MK, 1975, J NUTR, V105, P1150, DOI 10.1093/jn/105.9.1150; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Fukasawa R, 2009, J OLEO SCI, V58, P275, DOI 10.5650/jos.58.275; GALASKO GTF, 1989, FOOD CHEM TOXICOL, V27, P49, DOI 10.1016/0278-6915(89)90092-6; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HERMESLIMA M, 1995, AM J PHYSIOL-REG I, V268, pR1386, DOI 10.1152/ajpregu.1995.268.6.R1386; Jorgensen H, 2002, EUR J ENDOCRINOL, V147, P815, DOI 10.1530/eje.0.1470815; Joshi D, 2005, J MED FOOD, V8, P392, DOI 10.1089/jmf.2005.8.392; Joubert E, 2009, J AGR FOOD CHEM, V57, P4204, DOI 10.1021/jf9005033; Kawano A, 2009, PHYTOMEDICINE, V16, P437, DOI 10.1016/j.phymed.2008.11.009; Kelly G S, 1999, Altern Med Rev, V4, P249; KOEPPEN BH, 1966, BIOCHEM J, V99, P604, DOI 10.1042/bj0990604; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Kovacs P, 1996, PHARMAZIE, V51, P51; Kucharska J, 2004, PHYSIOL RES, V53, P515; Kullisaar T, 2003, BRIT J NUTR, V90, P449, DOI 10.1079/BJN2003896; Kumar P, 2006, BEHAV PHARMACOL, V17, P485, DOI 10.1097/00008877-200609000-00014; Lamosova D, 1997, COMP BIOCHEM PHYS C, V116, P39, DOI 10.1016/S0742-8413(96)00138-7; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lepage O, 2003, J EXP BIOL, V206, P3589, DOI 10.1242/jeb.00614; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299; Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043; Lyle N, 2012, NEUROCHEM RES, V37, P2748, DOI 10.1007/s11064-012-0867-1; Madrigal JLM, 2001, J NEUROCHEM, V76, P532, DOI 10.1046/j.1471-4159.2001.00108.x; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Marnewick J, 2005, CANCER LETT, V224, P193, DOI 10.1016/j.canlet.2004.11.014; Marnewick JL, 2011, J ETHNOPHARMACOL, V133, P46, DOI 10.1016/j.jep.2010.08.061; Marnewick JL, 2009, FOOD CHEM TOXICOL, V47, P220, DOI 10.1016/j.fct.2008.11.004; Marnewick JL, 2000, MUTAT RES-GEN TOX EN, V471, P157, DOI 10.1016/S1383-5718(00)00128-5; Marnewick JL, 2004, MUTAT RES-GEN TOX EN, V558, P145, DOI 10.1016/j.mrgentox.2003.12.003; Marnewick JL, 2003, J AGR FOOD CHEM, V51, P8113, DOI 10.1021/jf0344643; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Miyamoto Y, 2003, BIOL CHEM, V384, P567, DOI 10.1515/BC.2003.064; MOHANDAS J, 1984, BIOCHEM PHARMACOL, V33, P1801, DOI 10.1016/0006-2952(84)90353-8; Mozaffarian D, 2007, EUR HEART J, V28, P2699, DOI 10.1093/eurheartj/ehm451; Nadaoka I, 2012, BIOMED RES-TOKYO, V33, P133, DOI 10.2220/biomedres.33.133; Naidu PS, 2004, PHARMACOLOGY, V70, P59, DOI 10.1159/000074669; Pastore A, 2001, CLIN CHEM, V47, P1467; Posmyk MM, 2005, J PLANT PHYSIOL, V162, P403, DOI 10.1016/j.jplph.2004.08.004; Poulsen HE, 1998, EUR J CANCER PREV, V7, P9; Ramos-Vasconcelos GR, 2003, J EXP BIOL, V206, P675, DOI 10.1242/jeb.00124; Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Suresh S, 2010, INT J ANDROL, V33, P22, DOI 10.1111/j.1365-2605.2008.00949.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Torres ILS, 2001, BRAZ J MED BIOL RES, V34, P241, DOI 10.1590/S0100-879X2001000200012; Trevisanato SI, 2000, NUTR REV, V58, P1, DOI 10.1111/j.1753-4887.2000.tb01818.x; Ulicna O, 2008, GEN PHYSIOL BIOPHYS, V27, P179; Ulicna O, 2006, PHYSIOL RES, V55, P157, DOI 10.33549/physiolres.930778; Uysal N, 2005, PHYSIOL RES, V54, P437, DOI 10.33549/physiolres.930632; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; WINBERG S, 1993, NEUROREPORT, V4, P399, DOI 10.1097/00001756-199304000-00014; Wolf R, 1998, J EUR ACAD DERMATOL, V10, P103, DOI 10.1111/j.1468-3083.1998.tb00709.x; YOSHIKAWA T, 1990, ADV EXP MED BIOL, V264, P171; Zaidi SMKR, 2004, CLIN CHIM ACTA, V340, P229, DOI 10.1016/j.cccn.2003.11.003	91	44	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87061	10.1371/journal.pone.0087061	http://dx.doi.org/10.1371/journal.pone.0087061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466326	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500290
J	Hsu, PC; Su, HM; Lee, HC; Juo, SH; Lin, TH; Voon, WC; Lai, WT; Sheu, SH				Hsu, Po-Chao; Su, Ho-Ming; Lee, Hsiang-Chun; Juo, Suh-Hang; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Coronary Collateral Circulation in Patients of Coronary Ectasia with Significant Coronary Artery Disease	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; OCCLUSION; PROGNOSIS	Objectives: Patients with coronary ectasia (CE) usually have coexisting coronary stenosis resulting in myoischemia. Coronary collateral plays an important role in protecting myocardium from ischemia and reducing cardiovascular events. However, limited studies investigate the role of CE in coronary collaterals development. Methods: We evaluated 1020 consecutive patients undergoing coronary angiography and 552 patients with significant coronary artery disease (SCAD), defined as diameter stenosis more than 70%, were finally analyzed. CE is defined as the ectatic diameter 1.5 times larger than adjacent reference segment. Rentrop collateral score was used to classify patients into poor (grades 0 and 1) or good (grades 2 and 3) collateral group. Results: 73 patients (13.2%) had CE lesions which were most located in the right coronary artery (53.4%). Patients with CE had a lower incidence of diabetes (43.8% vs 30.1%, p = 0.03), higher body mass index (25.4 +/- 3.5 vs 26.7 +/- 4.6, p = 0.027) and poorer coronary collateral (58.2% vs 71.2%, p = 0.040). Patients with poor collateral (n = 331) had a higher incidence of CE (15.7% vs 9.5%, p = 0.040) and fewer diseased vessels numbers (1.96 +/- 0.84 vs 2.48 +/- 0.69, p < 0.001). Multivariate analysis showed diabetes (odd ratio (OR) 0.630, p = 0.026), CE (OR = 0.544, p = 0.048), and number of diseased vessels (OR = 2.488, p < 0.001) were significant predictors of coronary collaterals development. Conclusion: The presence of CE was associated with poorer coronary collateral development in patients with SCAD.	[Hsu, Po-Chao; Su, Ho-Ming; Lee, Hsiang-Chun; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Hsu, Po-Chao; Lee, Hsiang-Chun] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Juo, Suh-Hang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Juo, Suh-Hang] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Hsu, Po-Chao; Su, Ho-Ming; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Su, Ho-Ming] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Lin, TH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	lth@kmu.edu.tw	蘇, 河名/AAE-9843-2019	Su, Ho-Ming/0000-0003-0247-3250; Lee, Hsiang-Chun/0000-0002-5877-9059; Lin, Tsung-Hsien/0000-0002-7226-8730				Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; ALHARTHI SS, 1991, INT J CARDIOL, V30, P191, DOI 10.1016/0167-5273(91)90094-6; BEFELER B, 1977, AM J MED, V62, P597, DOI 10.1016/0002-9343(77)90423-5; COHEN M, 1986, CIRCULATION, V74, P469, DOI 10.1161/01.CIR.74.3.469; DAOUD AS, 1963, AM J CARDIOL, V11, P228, DOI 10.1016/0002-9149(63)90064-X; Demopoulos VP, 1997, HEART, V78, P136, DOI 10.1136/hrt.78.2.136; FUJITA M, 1987, BRIT HEART J, V57, P139; Gulec S, 2006, EUR J CLIN INVEST, V36, P369, DOI 10.1111/j.1365-2362.2006.01641.x; HARTNELL GG, 1985, BRIT HEART J, V54, P392; HELFANT RH, 1970, ANN INTERN MED, V73, P189, DOI 10.7326/0003-4819-73-2-189; LEVIN DC, 1974, CIRCULATION, V50, P831, DOI 10.1161/01.CIR.50.4.831; Li JJ, 2009, CYTOKINE, V46, P61, DOI 10.1016/j.cyto.2008.12.012; Manginas A, 2006, EUR HEART J, V27, P1026, DOI 10.1093/eurheartj/ehi725; MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5; Mavrogeni S, 2010, HELL J CARDIOL, V51, P158; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; OLIVEROS RA, 1974, ARCH INTERN MED, V134, P1072; ONOUCHI Z, 1993, J AM COLL CARDIOL, V21, P158, DOI 10.1016/0735-1097(93)90731-F; Ozbay Y, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/89649; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Resar JR, 2005, CHEST, V128, P787, DOI 10.1378/chest.128.2.787; Rockstroh J, 2002, CIRCULATION, V105, P168, DOI 10.1161/hc0202.102120; RODBARD S, 1967, ANGIOLOGY, V18, P349, DOI 10.1177/000331976701800601; Sezen Y, 2010, CARDIOL J, V17, P488; Sezer M, 2007, INT J CARDIOL, V115, P366, DOI 10.1016/j.ijcard.2006.03.020; Sharma S N, 1990, Indian Heart J, V42, P365; SWANTON RH, 1978, BRIT HEART J, V40, P393; SWAYE PS, 1983, CIRCULATION, V67, P134, DOI 10.1161/01.CIR.67.1.134; TATARA K, 1991, AM HEART J, V121, P797, DOI 10.1016/0002-8703(91)90191-J; Tayebjee MH, 2004, QJM-INT J MED, V97, P259, DOI 10.1093/qjmed/hch053; Werner GS, 2003, CIRCULATION, V107, P1972, DOI 10.1161/01.CIR.0000061953.72662.3A; Yilmaz H, 2008, TURK KARDIYOL DERN A, V36, P530	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87001	10.1371/journal.pone.0087001	http://dx.doi.org/10.1371/journal.pone.0087001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475209	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300125
J	Morat, F; Letourneur, Y; Dierking, J; Pecheyran, C; Bareille, G; Blamart, D; Harmelin-Vivien, M				Morat, Fabien; Letourneur, Yves; Dierking, Jan; Pecheyran, Christophe; Bareille, Gilles; Blamart, Dominique; Harmelin-Vivien, Mireille			The Great Melting Pot. Common Sole Population Connectivity Assessed by Otolith and Water Fingerprints	PLOS ONE			English	Article							ELEMENTAL COMPOSITION; MEDITERRANEAN SEA; FISH POPULATIONS; NURSERY GROUNDS; RHONE RIVER; RECRUITMENT; STRONTIUM; MECHANISMS; BARIUM; GULF	Quantifying the scale and importance of individual dispersion between populations and life stages is a key challenge in marine ecology. The common sole (Solea solea), an important commercial flatfish in the North Sea, Atlantic Ocean and the Mediterranean Sea, has a marine pelagic larval stage, a benthic juvenile stage in coastal nurseries (lagoons, estuaries or shallow marine areas) and a benthic adult stage in deeper marine waters on the continental shelf. To date, the ecological connectivity among these life stages has been little assessed in the Mediterranean. Here, such an assessment is provided for the first time for the Gulf of Lions, NW Mediterranean, based on a dataset on otolith microchemistry and stable isotopic composition as indicators of the water masses inhabited by individual fish. Specifically, otolith Ba/Ca and Sr/Ca profiles, and delta C-13 and delta O-18 values of adults collected in four areas of the Gulf of Lions were compared with those of young-of-the-year collected in different coastal nurseries. Results showed that a high proportion of adults (>46%) were influenced by river inputs during their larval stage. Furthermore Sr/Ca ratios and the otolith length at one year of age revealed that most adults (similar to 70%) spent their juvenile stage in nurseries with high salinity, whereas the remainder used brackish environments. In total, data were consistent with the use of six nursery types, three with high salinity (marine areas and two types of highly saline lagoons) and three brackish (coastal areas near river mouths, and two types of brackish environments), all of which contributed to the replenishment of adult populations. These finding implicated panmixia in sole population in the Gulf of Lions and claimed for a habitat integrated management of fisheries.	[Morat, Fabien; Harmelin-Vivien, Mireille] Aix Marseille Univ, CNRS INSU, Mediterranean Inst Oceanog MIO UM 110, IRD, Marseille, France; [Morat, Fabien; Harmelin-Vivien, Mireille] Univ Toulon & Var, CNRS INSU, Mediterranean Inst Oceanog MIO UM 110, IRD, La Garde, France; [Letourneur, Yves] Univ Nouvelle Caledonie, Lab LIVE & LABEX Corail, Noumea, New Caledonia; [Dierking, Jan] Helmholtz Ctr Ocean Res GEOMAR, Kiel, Germany; [Pecheyran, Christophe; Bareille, Gilles] Univ Pau & Pays Adour, LCABIE, UMR CNRS IPREM 5254, Pau, France; [Blamart, Dominique] UMR 8212 CEA CNRS UVSQ, Lab Sci Climat & Environm, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Toulon; Universite Nouvelle Caledonie; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA	Morat, F (corresponding author), Aix Marseille Univ, CNRS INSU, Mediterranean Inst Oceanog MIO UM 110, IRD, Marseille, France.	fabien.morat@irstea.fr	Morat, Fabien/U-2682-2019; LETOURNEUR, Yves/B-4387-2012; Bareille, Gilles/AAS-3113-2020; Letourneur, Yves/V-6843-2019; Dierking, Jan/C-5170-2014; Morat, Fabien/F-9867-2010	Morat, Fabien/0000-0002-9925-1437; LETOURNEUR, Yves/0000-0003-3157-1976; Letourneur, Yves/0000-0003-3157-1976; Morat, Fabien/0000-0002-9925-1437; Dierking, Jan/0000-0002-4660-6919; PECHEYRAN, Christophe/0000-0001-6503-4859	region PACA; Total foundation; Agence de l'Eau Rhone Mediterranee Corse	region PACA(Region Provence-Alpes-Cote d'Azur); Total foundation(Total SA); Agence de l'Eau Rhone Mediterranee Corse	Fabien Morat was funded by Ph.D stipends of the region PACA, the Total foundation, and the Agence de l'Eau Rhone Mediterranee Corse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Amara R, 2000, OCEANOL ACTA, V23, P469, DOI 10.1016/S0399-1784(00)00134-1; Aucour AM, 2003, LIMNOL OCEANOGR, V48, P2186, DOI 10.4319/lo.2003.48.6.2186; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Blamart D, 2002, CR BIOL, V325, P99, DOI 10.1016/S1631-0691(02)01419-1; Borelli G, 2001, CALCIFIED TISSUE INT, V69, P356, DOI 10.1007/s00223-001-2016-8; Brown RJ, 2009, CAN J FISH AQUAT SCI, V66, P1790, DOI 10.1139/F09-112; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Celle-Jeanton H, 2004, J HYDROL, V289, P165, DOI 10.1016/j.jhydrol.2003.11.017; Champalbert Gisele, 1992, Marine Behaviour and Physiology, V21, P255; Chittaro PM, 2009, OECOLOGIA, V160, P49, DOI 10.1007/s00442-009-1282-4; COPLEN TB, 1983, NATURE, V302, P236, DOI 10.1038/302236a0; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cuveliers EL, 2012, MAR BIOL, V159, P1239, DOI 10.1007/s00227-012-1905-x; de Pontual H, 2003, J SEA RES, V50, P199, DOI 10.1016/S1385-1101(03)00080-7; Demaneche S, 2009, R3 IFREMER; Dierking J, 2009, MAR POLLUT BULL, V58, P1605, DOI 10.1016/j.marpolbul.2009.07.008; Dierking J, 2012, ESTUAR COAST SHELF S, V104, P23, DOI 10.1016/j.ecss.2011.03.018; Elsdon TS, 2005, MAR FRESHWATER RES, V56, P609, DOI 10.1071/MF04146; Estournel C., 2009, GOLFE LION OBSERVATO, P257; Farrell J, 1996, COMP BIOCHEM PHYS A, V115, P103, DOI 10.1016/0300-9629(96)00015-1; FOWLER AJ, 1995, CAN J FISH AQUAT SCI, V52, P1421, DOI 10.1139/f95-137; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Gaertner JC, 1998, AQUAT LIVING RESOUR, V11, P75, DOI 10.1016/S0990-7440(98)80063-6; Gillanders BM, 2002, CAN J FISH AQUAT SCI, V59, P669, DOI 10.1139/F02-040; Gillanders BM, 2000, MAR ECOL PROG SER, V201, P273, DOI 10.3354/meps201273; Hamer PA, 2006, ESTUAR COAST SHELF S, V68, P686, DOI 10.1016/j.ecss.2006.03.017; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hobson KA, 2007, ECOL METHOD CONCEPT, P155, DOI 10.1002/9780470691854.ch6; Hunter J. R., 1980, P C PHYS BEH MAN FOO, P512; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Jones MT, 2012, GEOCHIM COSMOCHIM AC, V77, P108, DOI 10.1016/j.gca.2011.10.044; KEARN GC, 1974, PARASITOLOGY, V68, P173, DOI 10.1017/S0031182000045716; KONOSU S, 1975, B JPN SOC SCI FISH, V41, P743; KOTOULAS G, 1995, MAR BIOL, V122, P361, DOI 10.1007/BF00350869; KOUTSIKOPOULOS C, 1995, J MAR BIOL ASSOC UK, V75, P109, DOI 10.1017/S002531540001523X; Lagardere F, 1999, ENVIRON BIOL FISH, V56, P213, DOI 10.1023/A:1007581818941; Lagardere F, 1997, MAR ECOL PROG SER, V155, P223, DOI 10.3354/meps155223; Le Pape O, 2003, J SEA RES, V50, P177, DOI 10.1016/S1385-1101(03)00061-3; Lecchini D, 2005, BEHAV ECOL SOCIOBIOL, V58, P18, DOI 10.1007/s00265-004-0905-3; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Letourneur Y, 2001, OCEANOL ACTA, V24, P273, DOI 10.1016/S0399-1784(01)01146-X; LOCHET F, 1990, HYDROBIOLOGIA, V207, P95, DOI 10.1007/BF00041445; MACQUARTMOULIN C, 1991, J EXP MAR BIOL ECOL, V153, P195, DOI 10.1016/0022-0981(91)90225-L; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; Mellon-Duval C, 2010, ICES J MAR SCI, V67, P62, DOI 10.1093/icesjms/fsp215; Merigot B, 2007, MAR BIOL, V151, P997, DOI 10.1007/s00227-006-0549-0; Millar RB, 1990, CAN TECH REP FISH AQ, V1753, P1; Miller J.M., 1988, American Fisheries Society Symposium, P68; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; MILLOT C, 1979, OCEANOL ACTA, V2, P261; Miralles J, 2006, MAR GEOL, V234, P179, DOI 10.1016/j.margeo.2006.09.004; Morat F, 2012, SCI MAR, V76, P647, DOI 10.3648/scimar.03648.09B; Ollivier P, 2011, CHEM GEOL, V285, P15, DOI 10.1016/j.chemgeo.2011.02.011; Panfili J., 2002, MANUEL SCLEROCHRONOL; Patterson HM, 2007, AUSTRAL ECOL, V32, P122, DOI 10.1111/j.1442-9993.2006.01669.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; POPPER AN, 1980, AM SCI, V68, P429; Rolland JL, 2007, MAR BIOL, V151, P327, DOI 10.1007/s00227-006-0484-0; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Sale PF, 2010, PRESERVING REEF CONN; Salen-Picard C, 2002, OECOLOGIA, V133, P380, DOI 10.1007/s00442-002-1032-3; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Solomon CT, 2006, CAN J FISH AQUAT SCI, V63, P79, DOI 10.1139/F05-200; SYMONDS DJ, 1995, J EXP MAR BIOL ECOL, V190, P243, DOI 10.1016/0022-0981(95)00043-Q; Tabouret H, 2010, MAR ENVIRON RES, V70, P35, DOI 10.1016/j.marenvres.2010.02.006; Tanner SE, 2012, MAR ECOL PROG SER, V452, P193, DOI 10.3354/meps09621; Tanner SE, 2013, J SEA RES, V76, P82, DOI 10.1016/j.seares.2012.11.005; Vasconcelos RP, 2008, ESTUAR COAST SHELF S, V79, P317, DOI 10.1016/j.ecss.2008.04.006; Vinagre C, 2011, ESTUAR COAST, V34, P663, DOI 10.1007/s12237-010-9315-0; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Webb SD, 2012, MAR ECOL PROG SER, V453, P189, DOI 10.3354/meps09653	79	17	20	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86585	10.1371/journal.pone.0086585	http://dx.doi.org/10.1371/journal.pone.0086585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475151	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000330507300087
J	Roignot, J; Bonacci, T; Ghigo, E; Iovanna, JL; Soubeyran, P				Roignot, Julie; Bonacci, Thomas; Ghigo, Eric; Iovanna, Juan L.; Soubeyran, Philippe			Oligomerization and Phosphorylation Dependent Regulation of ArgBP2 Adaptive Capabilities and Associated Functions	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STIMULATED GLUT4 TRANSLOCATION; CELL-MIGRATION; STRESS FIBERS; PROTEIN; VINEXIN; INTERACTS; ADHESION; FAMILY; DOMAIN	ArgBP2 (Arg-Binding Protein 2/SORBS2) is an adaptor protein involved in cytoskeleton associated signal transduction, thereby regulating cell migration and adhesion. These features are associated with its antitumoral role in pancreatic cancer cells. Tyrosine phosphorylation of ArgBP2, mediated by c-Abl kinase and counterbalanced by PTP-PEST phosphatase, regulates many of its interactions. However, the exact mechanisms of action and of regulation of ArgBP2 remain largely unknown. We found that ArgBP2 has the capacity to form oligomers which are destabilized by tyrosine phosphorylation. We could show that ArgBP2 oligomerization involves the binding of one of its SH3 domains to a specific proline rich cluster. ArgBP2 self-association increases its binding to some of its molecular partners and decreased its affinity for others. Hence, the phosphorylation/oligomerization state of ArgBP2 directly regulates its functions by modulating its adaptive capabilities. Importantly, using a human pancreatic cancer cell model (MiaPaCa-2 cells), we could validate that this property of ArgBP2 is critical for its cytoskeleton associated functions. In conclusions, we describe a new mechanism of regulation of ArgBP2 where tyrosine phosphorylation of the protein interfere with a SH3 mediated self-interaction, thereby controlling its panel of interacting partners and related functions.	[Roignot, Julie; Bonacci, Thomas; Iovanna, Juan L.; Soubeyran, Philippe] Aix Marseille Univ, CNRS, UMR 7258, CRCM,INSERM,UMR 1068, Marseille, France; [Roignot, Julie; Bonacci, Thomas; Iovanna, Juan L.; Soubeyran, Philippe] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Ghigo, Eric] Aix Marseille Univ, CNRS, UMR7278, URMITE IRD198,INSERM,U1095, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Soubeyran, P (corresponding author), Aix Marseille Univ, CNRS, UMR 7258, CRCM,INSERM,UMR 1068, Marseille, France.	philippe.soubeyran@inserm.fr	Iovanna, Juan/M-9805-2017; Soubeyran, Philippe/P-1758-2018; Eric, Ghigo/N-9427-2016	Iovanna, Juan/0000-0003-1822-2237; Soubeyran, Philippe/0000-0002-5876-3217	FRM (Fondation pour la recherche medicale)/Institut Lilly fellowship	FRM (Fondation pour la recherche medicale)/Institut Lilly fellowship	This work was supported by a FRM (Fondation pour la recherche medicale)/Institut Lilly fellowship to J.R., and T. B. was a fellow of La Ligue contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 1999, J BIOL CHEM, V274, P35933, DOI 10.1074/jbc.274.50.35933; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Backsch C, 2011, CARCINOGENESIS, V32, P1100, DOI 10.1093/carcin/bgr093; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Fernow I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-80; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Kioka N, 2010, EXP CELL RES, V316, P1728, DOI 10.1016/j.yexcr.2010.03.019; Martin M, 2013, EMBO J, V32, P2491, DOI 10.1038/emboj.2013.187; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Mitsushima M, 2006, GENES CELLS, V11, P971, DOI 10.1111/j.1365-2443.2006.00995.x; Mitsushima M, 2006, FEBS LETT, V580, P4288, DOI 10.1016/j.febslet.2006.06.072; Mizutani K, 2007, ONCOGENE, V26, P7122, DOI 10.1038/sj.onc.1210512; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Roignot J, 2009, CELL ADHES MIGR, V3, P167, DOI 10.4161/cam.3.2.7576; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tujague M, 2004, J BIOL CHEM, V279, P9255, DOI 10.1074/jbc.M312160200; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406	36	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87130	10.1371/journal.pone.0087130	http://dx.doi.org/10.1371/journal.pone.0087130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475245	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300148
J	Safren, N; El Ayadi, A; Chang, L; Terrillion, CE; Gould, TD; Boehning, DF; Monteiro, MJ				Safren, Nathaniel; El Ayadi, Amina; Chang, Lydia; Terrillion, Chantelle E.; Gould, Todd D.; Boehning, Darren F.; Monteiro, Mervyn J.			Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MUTANT HUNTINGTIN; ER STRESS; TRANSGENIC MICE; CAG REPEAT; AUTOPHAGY; PROTEINS; IDENTIFICATION; DEGRADATION; UBIQUITIN	Huntington's Disease (HD) is a neurodegenerative disorder that is caused by abnormal expansion of a polyglutamine tract in huntingtin (htt) protein. The expansion leads to increased htt aggregation and toxicity. Factors that aid in the clearance of mutant huntingtin proteins should relieve the toxicity. We previously demonstrated that overexpression of ubiqulin-1, which facilitates protein clearance through the proteasome and autophagy pathways, reduces huntingtin aggregates and toxicity in mammalian cell and invertebrate models of HD. Here we tested whether overexpression of ubiquilin-1 delays or prevents neurodegeneration in R6/2 mice, a well-established model of HD. We generated transgenic mice overexpressing human ubiquilin-1 driven by the neuron-specific Thy1.2 promoter. Immunoblotting and immunohistochemistry revealed robust and widespread overexpression of ubiquilin-1 in the brains of the transgenic mice. Similar analysis of R6/2 animals revealed that ubiquilin is localized in huntingtin aggregates and that ubiquilin levels decrease progressively to 30% during the end-stage of disease. We crossed our ubiquilin-1 transgenic line with R6/2 mice to assess whether restoration of ubiquilin levels would delay HD symptoms and pathology. In the double transgenic progeny, ubiquilin levels were fully restored, and this correlated with a 20% increase in lifespan and a reduction in htt inclusions in the hippocampus and cortex. Furthermore, immunoblots indicated that endoplasmic reticulum stress response that is elevated in the hippocampus of R6/2 animals was attenuated by ubiquilin-1 overexpression. However, ubiquilin-1 overexpression neither altered the load of htt aggregates in the striatum nor improved motor impairments in the mice.	[Safren, Nathaniel; Terrillion, Chantelle E.; Gould, Todd D.; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Neurosci Grad Program, Baltimore, MD 21201 USA; [Safren, Nathaniel; Chang, Lydia; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Safren, Nathaniel; Chang, Lydia; Gould, Todd D.; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [El Ayadi, Amina; Boehning, Darren F.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Terrillion, Chantelle E.; Gould, Todd D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Gould, Todd D.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Medical Branch Galveston; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Neurosci Grad Program, Baltimore, MD 21201 USA.	monteiro@umaryland.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922; El Ayadi, Amina/0000-0002-3657-0633; Safren, Nathaniel/0000-0003-4866-4837				BATES G, 2002, HUNTINGTONS DIS; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Finkbeiner S., 2011, HUNTINGTONS DIS; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Gong B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041450; Gonzalez-Perez P, 2012, NEUROBIOL DIS, V48, P391, DOI 10.1016/j.nbd.2012.06.018; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Li A, 2007, HUM MOL GENET, V16, P2626, DOI 10.1093/hmg/ddm219; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Monteiro MJ, 1996, EXP CELL RES, V223, P443, DOI 10.1006/excr.1996.0100; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Satoh J, 2013, NEUROPATH APPL NEURO, V39, P817, DOI 10.1111/nan.12036; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; STARR R, 1995, J NEUROCHEM, V64, P1860; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HM, 2007, BIOCHEM BIOPH RES CO, V360, P423, DOI 10.1016/j.bbrc.2007.06.097; Weissman Tamily A, 2011, Cold Spring Harb Protoc, V2011, P763, DOI 10.1101/pdb.top114; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; XIAO JS, 1994, J NEUROSCI, V14, P1820, DOI 10.1523/JNEUROSCI.14-03-01820.1994; Yan J, 2013, NEUROLOGY, V80; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	67	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87513	10.1371/journal.pone.0087513	http://dx.doi.org/10.1371/journal.pone.0087513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475300	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300194
J	Sandulache, VC; Chen, YY; Lee, J; Rubinstein, A; Ramirez, MS; Skinner, HD; Walker, CM; Williams, MD; Tailor, R; Court, LE; Bankson, JA; Lai, SY				Sandulache, Vlad C.; Chen, Yunyun; Lee, Jaehyuk; Rubinstein, Ashley; Ramirez, Marc S.; Skinner, Heath D.; Walker, Christopher M.; Williams, Michelle D.; Tailor, Ramesh; Court, Laurence E.; Bankson, James A.; Lai, Stephen Y.			Evaluation of Hyperpolarized [1-C-13]-Pyruvate by Magnetic Resonance to Detect Ionizing Radiation Effects in Real Time	PLOS ONE			English	Article							ANAPLASTIC THYROID-CANCER; NECK-CANCER; HUMAN HEAD; 2-DEOXY-D-GLUCOSE; RADIOTHERAPY; METABOLISM; CHEMOTHERAPY; INHIBITION; CISPLATIN; KINETICS	Ionizing radiation (IR) cytotoxicity is primarily mediated through reactive oxygen species (ROS). Since tumor cells neutralize ROS by utilizing reducing equivalents, we hypothesized that measurements of reducing potential using real-time hyperpolarized (HP) magnetic resonance spectroscopy (MRS) and spectroscopic imaging (MRSI) can serve as a surrogate marker of IR induced ROS. This hypothesis was tested in a pre-clinical model of anaplastic thyroid carcinoma (ATC), an aggressive head and neck malignancy. Human ATC cell lines were utilized to test IR effects on ROS and reducing potential in vitro and [1-C-13] pyruvate HP-MRS/MRSI imaging of ATC orthotopic xenografts was used to study in vivo effects of IR. IR increased ATC intra-cellular ROS levels resulting in a corresponding decrease in reducing equivalent levels. Exogenous manipulation of cellular ROS and reducing equivalent levels altered ATC radiosensitivity in a predictable manner. Irradiation of ATC xenografts resulted in an acute drop in reducing potential measured using HP-MRS, reflecting the shunting of reducing equivalents towards ROS neutralization. Residual tumor tissue post irradiation demonstrated heterogeneous viability. We have adapted HP-MRS/MRSI to non-invasively measure IR mediated changes in tumor reducing potential in real time. Continued development of this technology could facilitate the development of an adaptive clinical algorithm based on real-time adjustments in IR dose and dose mapping.	[Sandulache, Vlad C.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Sandulache, Vlad C.; Chen, Yunyun; Lai, Stephen Y.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Skinner, Heath D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lee, Jaehyuk; Ramirez, Marc S.; Walker, Christopher M.; Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Williams, Michelle D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Rubinstein, Ashley; Tailor, Ramesh; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Lai, Stephen Y.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lai, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	SYLai@mdanderson.org	Walker, Chris/AAV-1539-2021; Bankson, James A./J-9798-2014; Skinner, Heath/A-1669-2012	Bankson, James A./0000-0002-8574-154X; Court, Laurence/0000-0002-3241-6145; Rubinstein, Ashley/0000-0003-0221-4603; Williams, Michelle D./0000-0002-9133-7332; Sandulache, Vlad/0000-0002-9205-385X; Skinner, Heath/0000-0003-1836-151X; Lai, Stephen/0000-0001-8301-7286; Walker, Christopher/0000-0002-6381-8737	American Academy of Otolaryngology Head and Neck Foundation; Institutional Start-up Funds; NIH Cancer Center Support Grant [P30 CA016672]; Cancer Prevention and Research Institute of Texas [RP-101243P5]; Odyssey Program; Estate of C. G. Johnson, Jr. at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	American Academy of Otolaryngology Head and Neck Foundation; Institutional Start-up Funds; NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Odyssey Program; Estate of C. G. Johnson, Jr. at The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported in part by the American Academy of Otolaryngology Head and Neck Foundation Resident Research grant (VCS), Institutional Start-up Funds (SYL), the NIH Cancer Center Support Grant (P30 CA016672), and the Cancer Prevention and Research Institute of Texas (RP-101243P5). Funding for MSR as an Odyssey Fellow was supported by the Odyssey Program and The Estate of C. G. Johnson, Jr. at The University of Texas MD Anderson Cancer Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Amosson CM, 2003, INT J RADIAT ONCOL, V56, P136, DOI 10.1016/S0360-3016(03)00093-2; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Baujat B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002026.pub2; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; Bernier J, 2012, CURR OPIN ONCOL, V24, P223, DOI 10.1097/CCO.0b013e32834ea6fe; Bhatia A, 2010, HEAD NECK-J SCI SPEC, V32, P829, DOI 10.1002/hed.21257; Chen AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056551; de Oliveira MF, 2012, INT J CELL BIOL, V2012; Derbel O, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-469; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Forastiere AA, 2006, J CLIN ONCOL, V24, P2603, DOI 10.1200/JCO.2006.07.1464; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Gule MK, 2011, CLIN CANCER RES, V17, P2281, DOI 10.1158/1078-0432.CCR-10-2762; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Lee JH, 2007, J BIOL CHEM, V282, P13385, DOI 10.1074/jbc.M700303200; Matsumoto S., 2012, MAGN RESON MED; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; O'Sullivan B, 2012, Clin Oncol (R Coll Radiol), V24, P474, DOI 10.1016/j.clon.2012.05.006; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Pollycove M, 2003, HUM EXP TOXICOL, V22, P290, DOI 10.1191/0960327103ht365oa; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; Sandulache VC, 2012, CANCER-AM CANCER SOC, V118, P711, DOI 10.1002/cncr.26321; Sandulache VC, 2011, CANCER-AM CANCER SOC, V117, P2926, DOI 10.1002/cncr.25868; Sharma PK, 2012, FREE RADICAL BIO MED, V53, P1500, DOI 10.1016/j.freeradbiomed.2012.07.001; Sherman EJ, 2011, RADIOTHER ONCOL, V101, P425, DOI 10.1016/j.radonc.2011.09.004; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; Simons AL, 2009, J ONCOL, V2009, DOI 10.1155/2009/519563; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Smallridge RC, 2010, CLIN ONCOL-UK, V22, P486, DOI 10.1016/j.clon.2010.03.013; Staffurth J, 2010, CLIN ONCOL-UK, V22, P643, DOI 10.1016/j.clon.2010.06.013; Tan C, 2002, DIABETES, V51, P2989, DOI 10.2337/diabetes.51.10.2989; Thind K, 2012, MAGN RESON MED; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tsimberidou AM, 2009, J CLIN ENDOCR METAB, V94, P4423, DOI 10.1210/jc.2009-0743; Walker CM, 2013, PLOS ONE IN PRESS; Yen YF, 2011, MAGN RESON MED SCI, V10, P211, DOI 10.2463/mrms.10.211; Zhao M, 2011, CLIN CANC RES	43	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87031	10.1371/journal.pone.0087031	http://dx.doi.org/10.1371/journal.pone.0087031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475215	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300126
J	Steinsiek, S; Stagge, S; Bettenbrock, K				Steinsiek, Sonja; Stagge, Stefan; Bettenbrock, Katja			Analysis of Escherichia coli Mutants with a Linear Respiratory Chain	PLOS ONE			English	Article							CYX-APPA OPERON; OXYGEN AVAILABILITY; 2-COMPONENT SYSTEM; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; MEDIATING REPRESSION; GROWTH-CONDITIONS; REDOX REGULATION; ACETYL-COENZYME; DNA-BINDING	The respiratory chain of E. coli is branched to allow the cells' flexibility to deal with changing environmental conditions. It consists of the NADH: ubiquinone oxidoreductases NADH dehydrogenase I and II, as well as of three terminal oxidases. They differ with respect to energetic efficiency (proton translocation) and their affinity to the different quinone/quinol species and oxygen. In order to analyze the advantages of the branched electron transport chain over a linear one and to assess how usage of the different terminal oxidases determines growth behavior at varying oxygen concentrations, a set of isogenic mutant strains was created, which lack NADH dehydrogenase I as well as two of the terminal oxidases, resulting in strains with a linear respiratory chain. These strains were analyzed in glucose-limited chemostat experiments with defined oxygen supply, adjusting aerobic, anaerobic and different microaerobic conditions. In contrast to the wild-type strain MG1655, the mutant strains produced acetate even under aerobic conditions. Strain TBE032, lacking NADH dehydrogenase I and expressing cytochrome bd-II as sole terminal oxidase, showed the highest acetate formation rate under aerobic conditions. This supports the idea that cytochrome bd-II terminal oxidase is not able to catalyze the efficient oxidation of the quinol pool at higher oxygen conditions, but is functioning mainly under limiting oxygen conditions. Phosphorylation of ArcA, the regulator of the two-component system ArcBA, besides Fnr the main transcription factor for the response towards different oxygen concentrations, was studied. Its phosphorylation pattern was changed in the mutant strains. Dephosphorylation and therefore inactivation of ArcA started at lower aerobiosis levels than in the wild-type strain. Notably, not only the micro-and aerobic metabolism was affected by the mutations, but also the anaerobic metabolism, where the respiratory chain should not be important.	[Steinsiek, Sonja; Stagge, Stefan; Bettenbrock, Katja] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany	Max Planck Society	Bettenbrock, K (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	bettenbrock@mpi-magdeburg.mpg.de	Bettenbrock, Katja/AAN-5812-2020	Stagge, Stefan/0000-0003-4908-0913	BMBF, research program SysMO (Systems Biology of Microorganisms) within the project SUMO (Systems Understanding of Microbial Oxygen response)	BMBF, research program SysMO (Systems Biology of Microorganisms) within the project SUMO (Systems Understanding of Microbial Oxygen response)	Sonja Steinsiek was supported by the BMBF as part of the research program SysMO (Systems Biology of Microorganisms) within the project SUMO (Systems Understanding of Microbial Oxygen response). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; ATLUNG T, 1994, J BACTERIOL, V176, P5414, DOI 10.1128/JB.176.17.5414-5422.1994; AU DCT, 1984, J BACTERIOL, V157, P122, DOI 10.1128/JB.157.1.122-125.1984; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker S, 1997, ARCH MICROBIOL, V168, P290, DOI 10.1007/s002030050501; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bogachev AV, 1996, J BACTERIOL, V178, P6233, DOI 10.1128/jb.178.21.6233-6237.1996; BONGAERTS J, 1995, MOL MICROBIOL, V16, P521, DOI 10.1111/j.1365-2958.1995.tb02416.x; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brondsted L, 1996, J BACTERIOL, V178, P1556, DOI 10.1128/jb.178.6.1556-1564.1996; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; CALHOUN MW, 1993, J BACTERIOL, V175, P3020, DOI 10.1128/JB.175.10.3020-3025.1993; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Evans C. G. T., 1970, METHODS MICROBIOLOGY, V2, DOI [10.1016/S0580-9517(08)70227-7, DOI 10.1016/S0580-9517(08)70227-7]; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2009, CHEM PHYS LETT, V477, P340, DOI 10.1016/j.cplett.2009.07.002; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; IUCHI S, 1989, J BACTERIOL, V171, P868, DOI 10.1128/jb.171.2.868-873.1989; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; IUCHI S, 1992, J BACTERIOL, V174, P5617, DOI 10.1128/JB.174.17.5617-5623.1992; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kihira C, 2012, J BIOTECHNOL, V158, P215, DOI 10.1016/j.jbiotec.2011.06.029; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; LAMBDEN PR, 1976, J GEN MICROBIOL, V97, P145, DOI 10.1099/00221287-97-2-145; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MOSS F, 1952, AUST J EXP BIOL MED, V30, P531, DOI 10.1038/icb.1952.51; NEIJSSEL OM, 1994, MOL MICROBIOL, V13, P179, DOI 10.1111/j.1365-2958.1994.tb00413.x; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; RICE CW, 1978, J BACTERIOL, V134, P115, DOI 10.1128/JB.134.1.115-124.1978; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Sharma P, 2012, FEBS J, V279, P3364, DOI 10.1111/j.1742-4658.2012.08608.x; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Steinsiek S, 2011, J BIOTECHNOL, V154, P35, DOI 10.1016/j.jbiotec.2011.03.015; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Unden G, 2008, ESCHERICHIA COLI SAL; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8	59	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87307	10.1371/journal.pone.0087307	http://dx.doi.org/10.1371/journal.pone.0087307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475268	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300165
J	Untergehrer, G; Jordan, D; Kochs, EF; Ilg, R; Schneider, G				Untergehrer, Gisela; Jordan, Denis; Kochs, Eberhard F.; Ilg, Ruediger; Schneider, Gerhard			Fronto-Parietal Connectivity Is a Non-Static Phenomenon with Characteristic Changes during Unconsciousness	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; ANESTHETIC-INDUCED UNCONSCIOUSNESS; FUNCTIONAL CONNECTIVITY; CONSCIOUSNESS; BRAIN; SYNCHRONIZATION; NETWORKS; TIME; COMMUNICATION; INFORMATION	Background: It has been previously shown that loss of consciousness is associated with a breakdown of dominating frontoparietal feedback connectivity as assessed by electroencephalogram (EEG) recordings. Structure and strength of network connectivity may change over time. Aim of the current study is to investigate cortico-cortical connectivity at different time intervals during consciousness and unconsciousness. For this purpose, EEG symbolic transfer entropy (STEn) was calculated to indicate cortico-cortical information transfer at different transfer times. Methods: The study was performed in 15 male volunteers. 29-channel EEG was recorded during consciousness and propofol-induced unconsciousness. EEG data were analyzed by STEn, which quantifies intensity and directionality of the mutual information flow between two EEG channels. STEn was computed over fronto-parietal channel pair combinations (10 s length, 0.5-45 Hz total bandwidth) to analyze changes of intercortical directional connectivity. Feedback (fronto -> parietal) and feedforward (parieto -> frontal) connectivity was calculated for transfer times from 25 ms to 250 ms in 5 ms steps. Transfer times leading to maximum directed interaction were identified to detect changes of cortical information transfer (directional connectivity) induced by unconsciousness (p < 0.05). Results: The current analyses show that fronto-parietal connectivity is a non-static phenomenon. Maximum detected interaction occurs at decreased transfer times during propofol-induced unconsciousness (feedback interaction: 60 ms to 40 ms, p = 0.002; feedforward interaction: 65 ms to 45 ms, p = 0.001). Strength of maximum feedback interaction decreases during unconsciousness (p = 0.026), while no effect of propofol was observed on feedforward interaction. During both consciousness and unconsciousness, intensity of fronto-parietal interaction fluctuates with increasing transfer times. Conclusion: Non-stationarity of directional connectivity may play a functional role for cortical network communication as it shows characteristic changes during propofol-induced unconsciousness.	[Untergehrer, Gisela; Schneider, Gerhard] Univ Witten Herdecke, Helios Clin Wuppertal, Dept Anesthesiol, Wuppertal, Germany; [Untergehrer, Gisela; Jordan, Denis; Kochs, Eberhard F.; Schneider, Gerhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-80290 Munich, Germany; [Ilg, Ruediger] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	Witten Herdecke University; Technical University of Munich; Technical University of Munich	Untergehrer, G (corresponding author), Univ Witten Herdecke, Helios Clin Wuppertal, Dept Anesthesiol, Wuppertal, Germany.	g.untergehrer@gmx.de		Schneider, Gerhard/0000-0002-4903-0118				Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Andrada J, 2012, ANESTH ANALG, V114, P661, DOI 10.1213/ANE.0b013e3182405228; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Chang C, 2010, FILM COMMENT, V46, P81; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Fiset P, 1999, J NEUROSCI, V19, P5506; Gonzalez JR, 2009, 4 EUR C INT FED MED, V22, P1268; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hutchison RM, 2012, CEREB CORTEX, V22, P1294, DOI 10.1093/cercor/bhr181; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Jordan D, 2013, ANESTHESIOLOGY, V119, P1031, DOI 10.1097/ALN.0b013e3182a7ca92; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lee H, 2013, ANESTHESIOLOGY, V119, P1347, DOI 10.1097/ALN.0b013e3182a8ec8c; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Nicolaou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033869; Prado J, 2011, NEUROIMAGE, V54, P541, DOI 10.1016/j.neuroimage.2010.08.022; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Staniek M, 2009, BIOMED TECH, V54, P323, DOI 10.1515/BMT.2009.040; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Tagliazucchi E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00339; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809	36	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87498	10.1371/journal.pone.0087498	http://dx.doi.org/10.1371/journal.pone.0087498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475298	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300192
J	Xu, CG; Wang, YH; Han, N; Kou, YH; Yin, XF; Zhang, PX; Wang, TB; Zhang, DY; Jiang, BG				Xu, Chungui; Wang, Yanhua; Han, Na; Kou, Yuhui; Yin, Xiaofeng; Zhang, Peixun; Wang, Tianbing; Zhang, Dianying; Jiang, Baoguo			Comparison of Road Traffic Injury Characteristics between Local versus Floating Migrant Patients in a Tertiary Hospital between 2007 and 2010	PLOS ONE			English	Article							CHINA; POPULATION; SARS	Background: The aim of this study is to give a description of the road traffic injuries (RTIs) characteristics of floating migrant population by comparing with those of local residents in a harbor city of China. Methods: A population-based descriptive study was carried out between 2007 and 2010 with RTI patient records from the Fifth Center Hospital of Tianjin. Inpatient diagnoses of RTI patients were defined using the International Classification of Diseases, Tenth Revision (ICD-10) codes. We analyzed the demographics and general characteristics of RTI patients that were in the hospital during the four years. In order to compare the group differences between local resident patients and floating migrant patients, the distribution of their ages, diagnoses, severity of injuries, duration of inpatient stays, hospitalization cost were analyzed. Results: People between the ages of 16 and 55 were the most likely to suffer RTIs. The floating migrant patients between the ages of 16 and 45 had a higher incidence of accidents, while local resident patients between 46 and 55 had a higher incidence of accidents. Compared to local resident patients, floating migrant patients were more vulnerable to open injuries and severe traffic injuries. With the severity of injuries ranked from mild to severe, floating migrant patients had lower duration of inpatient stay, but higher hospitalization costs compared to local resident patients. Conclusions: Floating migrant patients had a different age distribution, severity of injuries, diseases, inpatient duration and hospitalization cost compared with local resident patients. Compared to local resident patients, floating migrants had a higher risk to RTIs and were more vulnerable to severer traffic accidents at lower ages.	[Xu, Chungui; Wang, Yanhua; Han, Na; Kou, Yuhui; Yin, Xiaofeng; Zhang, Peixun; Wang, Tianbing; Zhang, Dianying; Jiang, Baoguo] Peking Univ, Peoples Hosp, Dept Trauma & Orthopaed, Beijing 100871, Peoples R China	Peking University	Wang, TB (corresponding author), Peking Univ, Peoples Hosp, Dept Trauma & Orthopaed, Beijing 100871, Peoples R China.	wangtianbing@medmail.com.cn; jiangbaoguo@vip.sina.com	wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022	Jiang, Baoguo/0000-0001-8436-5266; Yin, Xiaofeng/0000-0001-9932-642X; Kou, Yuhui/0000-0003-1523-825X; Han, Na/0000-0002-2472-8245	Ministry of Health, China [201002014]; National Natural Science Fund of China [31171150, 31271284, 81171146, 30971526, 31100860, 31040043, 30801169]; Chinese Education Ministry New Century Excellent Talent Support Project [BMU20110270]; Chinese National Natural Science Fund for Outstanding Young [30625036]; Beijing City Science & Technology New Star Classification [A-2008-10]; Chinese 973 Project Planning [2005CB522604]	Ministry of Health, China; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Education Ministry New Century Excellent Talent Support Project; Chinese National Natural Science Fund for Outstanding Young; Beijing City Science & Technology New Star Classification; Chinese 973 Project Planning(National Basic Research Program of China)	This research project was funded by the Specific Research Project of Health Pro Bono Sectors, Ministry of Health, China (No. 201002014), the National Natural Science Fund of China (31171150, 31271284, 81171146, 30971526, 31100860, 31040043, 30801169) and the Chinese Education Ministry New Century Excellent Talent Support Project (BMU20110270), the Chinese National Natural Science Fund for Outstanding Young (30625036), the Beijing City Science & Technology New Star Classification A-2008-10 and the Chinese 973 Project Planning (2005CB522604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; [Anonymous], 2008, TIANJ STAT YB 2008; [Anonymous], 2012, REPORT CHINAS MIGRAN; [Anonymous], 2011, ANN ROAD TRAFF ACC P; [Anonymous], 2011, TIANJ BINH NEW AR ST; Fang LQ, 2009, TROP MED INT HEALTH, V14, P14, DOI 10.1111/j.1365-3156.2008.02189.x; Jiang BG, 2011, CHINESE MED J-PEKING, V124, P3850, DOI 10.3760/cma.j.issn.0366-6999.2011.23.003; Li XX, 2010, J IMMIGR MINOR HEALT, V12, P811, DOI 10.1007/s10903-010-9336-6; Liang Z, 2004, POPUL DEV REV, V30, P467, DOI 10.1111/j.1728-4457.2004.00024.x; Nagata T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-887; Peng Jian-ping, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P739; Tianjin Municipal Bureau of Statistics, 2009, TIANJ STAT YB 2009; Tianjin Municipal Bureau of Statistics Survey Office of the National Bureau of Statistics in Tianjin, 2010, TIANJ STAT YB 2010; Wang Chang, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P350; Wang JW, 2010, HEALTH PROMOT INT, V25, P394, DOI 10.1093/heapro/daq039; Wang Li-jun, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P309; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2004, WORLD REPORT ROAD TR; Xu T, 2013, MATERN CHILD HLTH J, V22; Yan-Hong Li, 2006, Int J Inj Contr Saf Promot, V13, P217, DOI 10.1080/17457300600580779; Zhang GN, 2013, ACCIDENT ANAL PREV, V59, P18, DOI 10.1016/j.aap.2013.05.004; Zhao JB, 2012, TRAFFIC INJ PREV, V13, P230, DOI 10.1080/15389588.2011.645959; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	24	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82640	10.1371/journal.pone.0082640	http://dx.doi.org/10.1371/journal.pone.0082640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475023	Green Published, gold			2022-12-27	WOS:000330507300009
J	Tremoureux, L; Raux, M; Hudson, AL; Ranohavimparany, A; Straus, C; Similowski, T				Tremoureux, Lysandre; Raux, Mathieu; Hudson, Anna L.; Ranohavimparany, Anja; Straus, Christian; Similowski, Thomas			Does the Supplementary Motor Area Keep Patients with Ondine's Curse Syndrome Breathing While Awake?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CENTRAL HYPOVENTILATION SYNDROME; VENTILATORY RESPONSE; RESPIRATORY RHYTHM; CORTEX ACTIVATION; VOLUNTARY CONTROL; HUMANS; DIAPHRAGM; SLEEP; CHEMOSENSITIVITY	Background: Congenital central hypoventilation syndrome (CCHS) is a rare neuro-respiratory disorder associated with mutations of the PHOX2B gene. Patients with this disease experience severe hypoventilation during sleep and are consequently ventilator-dependent. However, they breathe almost normally while awake, indicating the existence of cortical mechanisms compensating for the deficient brainstem generation of automatic breathing. Current evidence indicates that the supplementary motor area plays an important role in modulating ventilation in awake normal humans. We hypothesized that the wake-related maintenance of spontaneous breathing in patients with CCHS could involve supplementary motor area. Methods: We studied 7 CCHS patients (5 women; age: 20-30; BMI: 22.1 +/- 4 kg.m(-2)) during resting breathing and during exposure to carbon dioxide and inspiratory mechanical constraints. They were compared with 8 healthy individuals. Segments of electroencephalographic tracings were selected according to ventilatory flow signal, from 2.5 seconds to 1.5 seconds after the onset of inspiration. After artefact rejection, 80 or more such segments were ensemble averaged. A slow upward shift of the EEG signal starting between 2 and 0.5 s before inspiration (pre-inspiratory potential) was considered suggestive of supplementary motor area activation. Results: In the control group, pre-inspiratory potentials were generally absent during resting breathing and carbon dioxide stimulation, and consistently identified in the presence of inspiratory constraints (expected). In CCHS patients, pre-inspiratory potentials were systematically identified in all study conditions, including resting breathing. They were therefore significantly more frequent than in controls. Conclusions: This study provides a neurophysiological substrate to the wakefulness drive to breathe that is characteristic of CCHS and suggests that the supplementary motor area contributes to this phenomenon. Whether or not this "cortical breathing'' can be taken advantage of therapeutically, or has clinical consequences (like competition with attentional resources) remains to be determined.	[Tremoureux, Lysandre; Raux, Mathieu; Hudson, Anna L.; Ranohavimparany, Anja; Straus, Christian; Similowski, Thomas] Univ Paris 06, INSERM, UMR S1158, Paris, France; [Raux, Mathieu] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Dept Anesthesie Reanimat, Paris, France; [Hudson, Anna L.] Neurosci Res Australia, Sydney, NSW, Australia; [Hudson, Anna L.] Univ New S Wales, Sydney, NSW, Australia; [Straus, Christian] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Cent Explorat Fonct Resp Exercice & Dyspnee, Paris, France; [Straus, Christian; Similowski, Thomas] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Ctr Natl Reference Malad Rares Syndrome Ondine Ad, Paris, France; [Similowski, Thomas] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Neuroscience Research Australia; University of New South Wales Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Similowski, T (corresponding author), Univ Paris 06, INSERM, UMR S1158, Paris, France.	thomas.similowski@psl.aphp.fr	Hudson, Anna/C-1280-2012	Hudson, Anna/0000-0002-0192-776X; RAUX, Mathieu/0000-0003-2493-9146	"Legs Poix'' grant from the "Chancellerie de l'Universite de Paris,'' France; French national reference center for Congenital Central Alveolar Hypoventilation; French government [ANR-10-A-IHU06]; "Association Francaise du Syndrome d'Ondine'' -AFSO-; "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil'' -ADOREPS-; AFSO	"Legs Poix'' grant from the "Chancellerie de l'Universite de Paris,'' France; French national reference center for Congenital Central Alveolar Hypoventilation; French government; "Association Francaise du Syndrome d'Ondine'' -AFSO-; "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil'' -ADOREPS-; AFSO	This research was funded in part by a "Legs Poix'' grant from the "Chancellerie de l'Universite de Paris,'' France, the French national reference center for Congenital Central Alveolar Hypoventilation, and the program "Investissement d'Avenir ANR-10-A-IHU06'' of the French government. It was also funded by two non-profit associations ("Association Francaise du Syndrome d'Ondine'' -AFSO- and "Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil'' -ADOREPS-). Anja Ranohavimparany was supported in part by an AFSO grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINOFF MJ, 1971, J PHYSIOL-LONDON, V215, P557, DOI 10.1113/jphysiol.1971.sp009485; AXEN K, 1983, J APPL PHYSIOL, V55, P1211, DOI 10.1152/jappl.1983.55.4.1211; BLANCGRAS N, 1994, BIOL PSYCHOL, V37, P147, DOI 10.1016/0301-0511(94)90028-0; COHEN E, 1995, CLIN SCI, V88, P453, DOI 10.1042/cs0880453; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; CORFIELD DR, 1995, RESP PHYSIOL, V101, P145, DOI 10.1016/0034-5687(95)00026-A; DATTA AK, 1991, J PHYSIOL-LONDON, V440, P17, DOI 10.1113/jphysiol.1991.sp018693; Davey NJ, 1996, RESP PHYSIOL, V106, P127, DOI 10.1016/S0034-5687(96)00069-2; Denot-Ledunois S, 1998, INT J PSYCHOPHYSIOL, V29, P13, DOI 10.1016/S0167-8760(97)00086-X; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Eberhard A, 2001, ADV EXP MED BIOL, V499, P489; GALLEGO J, 1993, J PSYCHOSOM RES, V37, P63, DOI 10.1016/0022-3999(93)90124-X; GUILLEMINAULT C, 1982, PEDIATRICS, V70, P684; Haouzi P, 2011, J APPL PHYSIOL, V110, P854, DOI 10.1152/japplphysiol.00833.2010; Haouzi P, 2009, J APPL PHYSIOL, V106, P904, DOI 10.1152/japplphysiol.90675.2008; Hudson AL, 2011, J NEUROPHYSIOL, V106, P1622, DOI 10.1152/jn.00155.2011; Hudson AL, 2011, RESP PHYSIOL NEUROBI, V179, P23, DOI 10.1016/j.resp.2011.06.010; Hudson AL, 2010, J NEUROPHYSIOL, V103, P1622, DOI 10.1152/jn.00887.2009; Jutand L, 2012, ACTA PHYSIOL, V205, P356, DOI 10.1111/j.1748-1716.2012.02427.x; Laviolette L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062258; Li S, 2011, J NEUROPHYSIOL, V105, P512, DOI 10.1152/jn.00946.2010; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Mehiri S, 2006, RESP PHYSIOL NEUROBI, V154, P406, DOI 10.1016/j.resp.2005.12.003; MURPHY K, 1990, J PHYSIOL-LONDON, V420, P1; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Raux M, 2013, RESP PHYSL IN PRESS; Raux M, 2007, ANESTHESIOLOGY, V107, P746, DOI 10.1097/01.anes.0000287005.58761.e8; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; Raux M, 2010, RESP PHYSIOL NEUROBI, V171, P67, DOI 10.1016/j.resp.2010.01.002; Raux M, 2010, J APPL PHYSIOL, V108, P39, DOI 10.1152/japplphysiol.91454.2008; Sharshar T, 2004, J PHYSIOL-LONDON, V560, P897, DOI 10.1113/jphysiol.2004.061150; Shea SA, 1996, EXP PHYSIOL, V81, P1; Shea SA, 1997, RESP PHYSIOL, V110, P199, DOI 10.1016/S0034-5687(97)00084-4; SHEA SA, 1993, RESP PHYSIOL, V94, P251, DOI 10.1016/0034-5687(93)90022-3; Straus C, 2004, J APPL PHYSIOL, V97, P902, DOI 10.1152/japplphysiol.00989.2003; Straus C, 2011, RESP PHYSIOL NEUROBI, V178, P357, DOI 10.1016/j.resp.2011.07.007; Tremoureux L, 2010, J APPL PHYSIOL, V108, P1127, DOI 10.1152/japplphysiol.91449.2008; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; WIEGAND L, 1988, J APPL PHYSIOL, V64, P1186, DOI 10.1152/jappl.1988.64.3.1186; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; YANOS J, 1990, J APPL PHYSIOL, V68, P2511, DOI 10.1152/jappl.1990.68.6.2511	42	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84534	10.1371/journal.pone.0084534	http://dx.doi.org/10.1371/journal.pone.0084534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475031	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800007
J	Boyle, SA; Kennedy, CM; Torres, J; Colman, K; Perez-Estigarribia, PE; de la Sancha, NU				Boyle, Sarah A.; Kennedy, Christina M.; Torres, Julio; Colman, Karen; Perez-Estigarribia, Pastor E.; de la Sancha, Noe U.			High-Resolution Satellite Imagery Is an Important yet Underutilized Resource in Conservation Biology	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIPS; ATLANTIC-FOREST; PROTECTED AREAS; HABITAT ASSOCIATIONS; SPATIAL-RESOLUTION; LANDSCAPE MATRIX; BIODIVERSITY; LANDSAT; IKONOS; FRAGMENTS	Technological advances and increasing availability of high-resolution satellite imagery offer the potential for more accurate land cover classifications and pattern analyses, which could greatly improve the detection and quantification of land cover change for conservation. Such remotely-sensed products, however, are often expensive and difficult to acquire, which prohibits or reduces their use. We tested whether imagery of high spatial resolution (<= 5 m) differs from lower-resolution imagery (>= 30 m) in performance and extent of use for conservation applications. To assess performance, we classified land cover in a heterogeneous region of Interior Atlantic Forest in Paraguay, which has undergone recent and dramatic human-induced habitat loss and fragmentation. We used 4 m multispectral IKONOS and 30 m multispectral Landsat imagery and determined the extent to which resolution influenced the delineation of land cover classes and patch-level metrics. Higher-resolution imagery more accurately delineated cover classes, identified smaller patches, retained patch shape, and detected narrower, linear patches. To assess extent of use, we surveyed three conservation journals (Biological Conservation, Biotropica, Conservation Biology) and found limited application of high-resolution imagery in research, with only 26.8% of land cover studies analyzing satellite imagery, and of these studies only 10.4% used imagery <= 5 m resolution. Our results suggest that high-resolution imagery is warranted yet under-utilized in conservation research, but is needed to adequately monitor and evaluate forest loss and conversion, and to delineate potentially important stepping-stone fragments that may serve as corridors in a human-modified landscape. Greater access to low-cost, multiband, high-resolution satellite imagery would therefore greatly facilitate conservation management and decision-making.	[Boyle, Sarah A.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Kennedy, Christina M.] Nature Conservancy, Dev Design Program, Ft Collins, CO USA; [Torres, Julio] Ctr Nacl Patagon, Unidad Invest Sistemat Diversidad & Evoluc, Puerto Madryn, Chubut, Argentina; [Colman, Karen] Secretaria Ambiente, Direcc Vida Silvestre, Asuncion, Paraguay; [Perez-Estigarribia, Pastor E.] Univ Concepcion, Programa Magister Ciencias, Concepcion, Chile; [de la Sancha, Noe U.] Field Museum Nat Hist, Chicago, IL 60605 USA	Nature Conservancy; Centro Nacional Patagonico (CENPAT); Universidad de Concepcion; Field Museum of Natural History (Chicago)	Boyle, SA (corresponding author), Rhodes Coll, Dept Biol, Memphis, TN 38112 USA.	sarahannboyle@gmail.com	de la Sancha, Noé U/GZL-8489-2022; Boyle, Sarah/AAQ-6815-2021; de la Sancha, Noé/AAN-3617-2020	de la Sancha, Noé U/0000-0002-1342-5556; de la Sancha, Noé/0000-0002-1342-5556; Kennedy, Christina/0000-0001-8902-8728; Perez Estigarribia, Pastor Enmanuel/0000-0003-3143-0751	GeoEye Foundation; U.S. Fulbright "Creating Regional Partnerships in the America's''; LASPAU	GeoEye Foundation; U.S. Fulbright "Creating Regional Partnerships in the America's''; LASPAU	GeoEye Foundation provided a grant of IKONOS imagery (please note: the URL of GeoEye no longer exists as the company was purchased by DigitalGlobe). Fieldwork was supported by funding to SAB, CMK, and NUD by U.S. Fulbright "Creating Regional Partnerships in the America's'' Grant sponsored by LASPAU (http://www.laspau.harvard.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi MH, 2013, PARAGUAY CONSERVATIO; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Andrefouet S, 2003, REMOTE SENS ENVIRON, V88, P128, DOI 10.1016/j.rse.2003.04.005; Aplin P, 2005, PROG PHYS GEOG, V29, P104, DOI 10.1191/030913305pp437pr; Aplin P, 2011, INT J GEOGR INF SCI, V25, P869, DOI 10.1080/13658816.2011.566570; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2003, REMOTE SENS ENVIRON, V87, P521, DOI 10.1016/j.rse.2003.08.006; Asner GP, 2002, REMOTE SENS ENVIRON, V80, P483, DOI 10.1016/S0034-4257(01)00326-1; Asner GP, 2013, P NATL ACAD SCI USA, V110, P18454, DOI 10.1073/pnas.1318271110; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Benchimol M, 2013, DIVERS DISTRIB, V19, P1339, DOI 10.1111/ddi.12111; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Boyd DS, 2011, ECOL INFORM, V6, P25, DOI 10.1016/j.ecoinf.2010.07.007; Boyd DS, 2005, PROG PHYS GEOG, V29, P1, DOI 10.1191/0309133305pp432ra; Boyle SA, 2010, BIOL CONSERV, V143, P1134, DOI 10.1016/j.biocon.2010.02.008; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Capolsini P, 2003, CAN J REMOTE SENS, V29, P187, DOI 10.5589/m02-088; Casado F, 2010, J HERED, V101, P261, DOI 10.1093/jhered/esp119; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; D'Elia G, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1784.1.3; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; de la Sancha NU, 2012, MAMM BIOL, V77, P229, DOI 10.1016/j.mambio.2011.10.003; de la Sancha NU, 2011, MAMMALIA, V75, P269, DOI 10.1515/MAMM.2011.022; De La Sancha NU, MAMMALIA IN PRESS; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; DELASANCHA N, 2009, MAMMALIA, V73, P162; Dennison PE, 2010, REMOTE SENS ENVIRON, V114, P2431, DOI 10.1016/j.rse.2010.05.018; Desmet P, 2004, ECOL SOC, V9; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Estes AB, 2012, BIOL CONSERV, V147, P255, DOI 10.1016/j.biocon.2012.01.010; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fleytas C., 2007, BIODIVERSIDAD PARAGU, V1st, P77; Foody GM, 2003, INT J REMOTE SENS, V24, P4035, DOI 10.1080/0143116031000103853; Fragano F, 2003, STATE HOTS, P288; Galindo-Leal C, 2003, STATE HOTS, P3; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Giordano Anthony J., 2010, Neotropical Primates, V17, P74; Goetz S, 2007, SCIENCE, V315, P1767, DOI 10.1126/science.1142466; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Hall K, 2012, APPL VEG SCI, V15, P145, DOI 10.1111/j.1654-109X.2011.01143.x; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harcourt AH, 2005, J APPL ECOL, V42, P630, DOI 10.1111/j.1365-2664.2005.01037.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Hill JL, 2001, APPL GEOGR, V21, P157, DOI 10.1016/S0143-6228(01)00002-9; Huang CQ, 2007, REMOTE SENS ENVIRON, V106, P460, DOI 10.1016/j.rse.2006.09.016; Huang CQ, 2009, GLOBAL PLANET CHANGE, V67, P1, DOI 10.1016/j.gloplacha.2008.12.009; Hurtt G, 2003, REMOTE SENS ENVIRON, V88, P111, DOI 10.1016/j.rse.2003.04.004; Jensen J.R., 2015, INTRO DIGITAL IMAGE; Kennedy CM, 2011, ECOL APPL, V21, P1837, DOI 10.1890/10-1044.1; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Kennedy CM, 2009, THESIS U MARYLAND CO; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Koh LP, 2010, J APPL ECOL, V47, P1063, DOI 10.1111/j.1365-2664.2010.01860.x; Lahoz-Monfort JJ, 2010, J APPL ECOL, V47, P1094, DOI 10.1111/j.1365-2664.2010.01854.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lechner AM, 2009, REMOTE SENS ENVIRON, V113, P2194, DOI 10.1016/j.rse.2009.06.002; Loarie SR, 2007, TRENDS ECOL EVOL, V22, P630, DOI 10.1016/j.tree.2007.08.018; Lynch J, 2013, NATURE, V496, P293, DOI 10.1038/496293a; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Mandujano S, 2006, DEV PRIMATOL-PROG PR, P513, DOI 10.1007/0-387-25872-8_25; Masuoka PM, 2003, REMOTE SENS ENVIRON, V88, P187, DOI 10.1016/j.rse.2003.04.009; Matricardi EAT, 2010, REMOTE SENS ENVIRON, V114, P1117, DOI 10.1016/j.rse.2010.01.001; MCCULLOCH E. S., 2012, THESIS LOUISIANA STA; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Myers Philip, 2002, P453; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Nagendra H, 2008, BIODIVERS CONSERV, V17, P3431, DOI 10.1007/s10531-008-9479-0; Nagendra H, 2010, REMOTE SENS-BASEL, V2, P478, DOI 10.3390/rs2020478; Newton AC, 2009, PROG PHYS GEOG, V33, P528, DOI 10.1177/0309133309346882; O'Farrill G, 2013, INTEGR ZOOL, V8, P4, DOI 10.1111/j.1749-4877.2012.00316.x; Palacios F, 2013, RESULTADOS MONITOREO; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Pringle H, 2010, SCIENCE, V329, P1008, DOI 10.1126/science.329.5995.1008; Rempel R. S., 2012, PATCH ANAL PATCH GRI; Rocchini D, 2007, REMOTE SENS ENVIRON, V111, P423, DOI 10.1016/j.rse.2007.03.018; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; Saadat H, 2011, ISPRS J PHOTOGRAMM, V66, P608, DOI 10.1016/j.isprsjprs.2011.04.001; Sanchez-Azofeifa A, 2011, SENSORS-BASEL, V11, P3831, DOI 10.3390/s110403831; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Souza CM, 2005, REMOTE SENS ENVIRON, V98, P329, DOI 10.1016/j.rse.2005.07.013; Stevens Richard D., 2010, Mastozool. neotrop., V17, P195; Stickler CM, 2008, REMOTE SENS ENVIRON, V112, P2170, DOI 10.1016/j.rse.2007.10.013; Tang LN, 2010, BIOL CONSERV, V143, P1295, DOI 10.1016/j.biocon.2010.01.024; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Ulrich W, 2005, BIODIVERS CONSERV, V14, P3351, DOI 10.1007/s10531-004-9543-3; Wallace Jeremy, 2006, Ecological Management & Restoration, V7, pS31, DOI 10.1111/j.1442-8903.2006.00289.x; Wang K, 2010, SENSORS-BASEL, V10, P9647, DOI 10.3390/s101109647; Williams DL, 2006, PHOTOGRAMM ENG REM S, V72, P1171, DOI 10.14358/PERS.72.10.1171; Wulder MA, 2008, REMOTE SENS ENVIRON, V112, P955, DOI 10.1016/j.rse.2007.07.004; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003; Zuercher Gerald L., 2001, Endangered Species Update, V18, P115; Zuercher GL, 2005, ORYX, V39, P86, DOI 10.1017/S0030605305000153	102	56	57	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86908	10.1371/journal.pone.0086908	http://dx.doi.org/10.1371/journal.pone.0086908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466287	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000170
J	Desai, VD; Hsia, HC; Schwarzbauer, JE				Desai, Vivek D.; Hsia, Henry C.; Schwarzbauer, Jean E.			Reversible Modulation of Myofibroblast Differentiation in Adipose-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE ACTIN; FIBROBLAST-GROWTH-FACTOR; TGF-BETA; CARDIAC FIBROBLASTS; STROMAL CELLS; IN-VITRO; MATRIX CONTRACTION; TISSUE-REPAIR; SELF-RENEWAL; EXPRESSION	Unregulated activity of myofibroblasts, highly contractile cells that deposit abundant extracellular matrix (ECM), leads to fibrosis. To study the modulation of myofibroblast activity, we used human adipose-derived mesenchymal stem cells (ADSCs), which have much potential in regenerative medicine. We found that ADSCs treated with TGF-beta developed a myofibroblastic phenotype with increases in alpha-smooth muscle actin (alpha-SMA), a myofibroblast marker, and ECM proteins type I collagen and fibronectin. In contrast, treatment with bFGF had the opposite effect. bFGF-differentiated ADSCs showed marked down-regulation of alpha-SMA expression, collagen I, and fibronectin, and loss of focal adhesions and stress fibers. Functionally, bFGF-differentiated ADSCs were significantly more migratory, which correlated with up-regulation of tenascin-C, an anti-adhesive ECM protein, and vimentin, a pro-migratory cytoskeletal protein. On the other hand, TGF-beta-differentiated ADSCs were significantly more contractile than bFGF-differentiated cells. Interestingly, cells completely reversed their morphologies, marker expression, signaling pathways, and contractility versus migratory profiles when switched from culture with one growth factor to the other, demonstrating that the myofibroblast differentiation process is not terminal. Cell differentiation was associated with activation of Smad2 downstream of TGF-beta and of ERK/MAP kinase downstream of bFGF. Reversibility of the TGF-beta-induced myofibroblastic phenotype depends, in part, on bFGF-induced ERK/MAP kinase signaling. These findings show that ADSC differentiation into myofibroblasts and re-differentiation into fibroblast-like cells can be manipulated with growth factors, which may have implications in the development of novel therapeutic strategies to reduce the risk of fibrosis.	[Desai, Vivek D.; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Hsia, Henry C.] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hsia, HC (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA.	hsiahc@rwjms.rutgers.edu	Hsia, Henry/W-6140-2019	Hsia, Henry/0000-0001-8674-9140; Schwarzbauer, Jean/0000-0003-1012-7593	National Institutes of Health [R01 CA160611, K08 GM072546]; Feldstein Medical Foundation; NIGMS predoctoral training grant [T32 GM007388]; NATIONAL CANCER INSTITUTE [R01CA160611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM072546, T32GM007388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feldstein Medical Foundation; NIGMS predoctoral training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by the National Institutes of Health (R01 CA160611 to J.E.S and K08 GM072546 to H.C.H: http://www.nih.gov) and the Feldstein Medical Foundation (to H.C.H.: http://www.feldsteinmedicalfoundation.org). V.D.D. was funded by an NIGMS predoctoral training grant (T32 GM007388: http://www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alvarez PDA, 2008, THORAX, V63, P374, DOI 10.1136/thx.2007.083857; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Chung CY, 1996, MOL BIOL CELL, V7, P883, DOI 10.1091/mbc.7.6.883; Corbett SA, 1999, J BIOL CHEM, V274, P20943, DOI 10.1074/jbc.274.30.20943; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Dawes LJ, 2008, INVEST OPHTH VIS SCI, V49, P650, DOI 10.1167/iovs.07-0586; Deryugina EI, 1996, J CELL SCI, V109, P643; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hsia HC, 2006, J SURG RES, V136, P92, DOI 10.1016/j.jss.2006.05.030; Hunt GC, 2012, EXP CELL RES, V318, P1820, DOI 10.1016/j.yexcr.2012.06.009; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Jourdan-LeSaux C, 2010, LIFE SCI, V87, P391, DOI 10.1016/j.lfs.2010.07.010; Kabiri A, 2012, BIOCHEM BIOPH RES CO, V424, P234, DOI 10.1016/j.bbrc.2012.06.082; Kakudo N, 2012, HUM CELL, V25, P87, DOI 10.1007/s13577-012-0049-0; Kamada Y, 2009, AM J PHYSIOL-GASTR L, V296, pG157, DOI 10.1152/ajpgi.90463.2008; Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kolle SFT, 2012, J PLAST SURG HAND SU, V46, P59, DOI 10.3109/2000656X.2012.668326; KUROSAKA D, 1995, INVEST OPHTH VIS SCI, V36, P1701; Liu Y, 2013, EUR REV MED PHARMACO, V17, P1611; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Maharlooei MK, 2011, DIABETES RES CLIN PR, V93, P228, DOI 10.1016/j.diabres.2011.04.018; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Mehlhorn AT, 2007, CELL PROLIFERAT, V40, P809, DOI 10.1111/j.1365-2184.2007.00473.x; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1; Park J, 2013, ONCOGENE, P1; PELED A, 1991, BLOOD, V78, P304; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song HY, 2010, EXP MOL MED, V42, P565, DOI 10.3858/emm.2010.42.8.057; Tabit CJ, 2012, AESTHET PLAST SURG, V36, P704, DOI 10.1007/s00266-011-9835-4; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969; Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003; Wang J, 2001, TISSUE CELL, V33, P86, DOI 10.1054/tice.2000.0160; Wang J, 2000, AM J PHYSIOL-HEART C, V279, pH2776, DOI 10.1152/ajpheart.2000.279.6.H2776; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wierzbicka-Patynowski I, 2007, J CELL PHYSIOL, V210, P750, DOI 10.1002/jcp.20886; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	57	77	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86865	10.1371/journal.pone.0086865	http://dx.doi.org/10.1371/journal.pone.0086865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466271	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000159
J	Lim, TS; Kim, BK; Lee, JW; Lee, YK; Chang, S; Kim, SU; Kim, DY; Ahn, SH; Han, KH; Chon, CY; Park, JY				Lim, Tae Seop; Kim, Beom Kyung; Lee, Jong Wook; Lee, Young Ki; Chang, Sooyun; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong			Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; C-REACTIVE PROTEIN; CIRRHOTIC-PATIENTS; LIVER-CIRRHOSIS; SEPSIS; DISEASE; BACTEREMIA; MANAGEMENT; INFECTION; SURVIVAL	Background: Spontaneous bacterial peritonitis (SBP) is a common and life-threatening infection in patients with advanced cirrhosis. The prognostic value of a novel marker, the delta neutrophil index (DNI), was investigated relative to mortality in patients with SBP. Materials & Methods: Seventy-five patients with SBP were studied from April 2010 to May 2012. DNI at initial diagnosis of SBP was determined and compared with 30-day mortality rates. Results: Of the patients, 87.7% were men, and the median age of all patients was 59.0 yrs. The area under the receiver-operating characteristic (ROC) curve of DNI for 30-day mortality was 0.701 (95% confidence interval [CI], 0.553-0.849; p = 0.009), which was higher than that of C-reactive protein (0.640, 95% CI, 0.494-0.786; p = 0.076) or the model for end-stage liver disease score (0.592, 95% CI, 0.436-0.748; p = 0.235). From the ROC curve, with the sum of sensitivity and specificity, the cutoff value of DNI was determined to be 5.7%. In the high-DNI group (DNI $ 5.7%), septic shock and 30-day mortality were more prevalent compared with the low-DNI group (84.2% vs. 48.2%, p = 0.007; 57.9% vs. 14.3%, p < 0.001, respectively). Patients with an elevated DNI had a higher risk of 30-day mortality compared with those with a low DNI (4.225, 95% CI, 1.631-10.949; p = 0.003). Conclusion: A higher DNI at the time of SBP diagnosis is an independent predictor of 30-day mortality in patients with SBP.	[Lim, Tae Seop; Kim, Beom Kyung; Lee, Young Ki; Chang, Sooyun; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Lee, Jong Wook] Incheon Baek Hosp, Dept Lab Med, Inchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	drpjy@yuhs.ac	Park, Jun Yong/H-7127-2019	LIM, TAE SEOP/0000-0002-4578-8685; Kim, Beom Kyung/0000-0002-5363-2496; Ahn, Sang Hoon/0000-0002-3629-4624; Kim, Seung Up/0000-0002-9658-8050; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Bert F, 2008, CLIN MICROBIOL INFEC, V14, P1034, DOI 10.1111/j.1469-0691.2008.02088.x; Bert F, 2003, EUR J CLIN MICROBIOL, V22, P10, DOI 10.1007/s10096-002-0840-z; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Dias AMB, 2009, ANN NY ACAD SCI, V1173, P103, DOI 10.1111/j.1749-6632.2009.04872.x; Campillo B, 2002, CLIN INFECT DIS, V35, P1, DOI 10.1086/340617; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; Cho JH, 2007, SCAND J INFECT DIS, V39, P697, DOI 10.1080/00365540701299582; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Garcia-Tsao G, 2009, AM J GASTROENTEROL, V104, P1802, DOI 10.1038/ajg.2009.191; Harris Neil, 2005, Lab Hematol, V11, P62, DOI 10.1532/LH96.04064; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Jalan R, 2012, J HEPATOLOGY; Jalan R, 2009, HEPATOLOGY, V50, P555, DOI 10.1002/hep.22913; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2133; Jha SK, 2009, HEPATOL INT, V3, P384, DOI 10.1007/s12072-008-9110-1; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim HW, 2012, SCAND J INFECT DIS, V44, P475, DOI 10.3109/00365548.2012.657232; Kratz Alexander, 2006, Lab Hematol, V12, P63, DOI 10.1532/LH96.06010; LLOVET JM, 1993, AM J GASTROENTEROL, V88, P388; MIHAS AA, 1992, HEPATO-GASTROENTEROL, V39, P520; Mookerjee RP, 2007, HEPATOLOGY, V45, P62, DOI 10.1002/hep.21491; Musskopf MI, 2012, ANN HEPATOL, V11, P915; Navasa M, 1996, GASTROENTEROLOGY, V111, P1011, DOI 10.1016/S0016-5085(96)70069-0; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Nobre SR, 2008, EUR J GASTROEN HEPAT, V20, P1176, DOI 10.1097/MEG.0b013e32830607a2; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Park WB, 2005, DIAGN MICR INFEC DIS, V51, P227, DOI 10.1016/j.diagmicrobio.2004.11.014; Pyo JY, 2013, LUPUS, V22, P1102, DOI 10.1177/0961203313499957; RUNYON BA, 1991, GASTROENTEROLOGY, V100, P1737, DOI 10.1016/0016-5085(91)90677-D; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940; Suk KT, 2012, CLIN MOL HEPATOL, V18, P249, DOI 10.3350/cmh.2012.18.3.249; TERG R, 1992, DIGEST DIS SCI, V37, P1499, DOI 10.1007/BF01296493; WEINSTEIN MP, 1978, AM J MED, V64, P592, DOI 10.1016/0002-9343(78)90578-8; Wong F, 2005, GUT, V54, P718, DOI 10.1136/gut.2004.038679; Zanaty OM, 2012, ALEXANDRIA J MED	43	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86884	10.1371/journal.pone.0086884	http://dx.doi.org/10.1371/journal.pone.0086884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466280	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000164
J	McMichael, BK; Scherer, KF; Franklin, NC; Lee, BS				McMichael, Brooke K.; Scherer, Katharine F.; Franklin, Nicole C.; Lee, Beth S.			The RhoGAP Activity of Myosin IXB Is Critical for Osteoclast Podosome Patterning, Motility, and Resorptive Capacity	PLOS ONE			English	Article							UNCONVENTIONAL MYOSIN; BONE METABOLISM; CELIAC-DISEASE; SRC KINASE; PLUS-END; ORGANIZATION; ADHESION; EXPRESSION; PROTEIN; CELLS	Osteoclasts are large, multinucleated cells of the monocyte-macrophage lineage that generate specialized substrate adhesion complexes to facilitate their function as bone-degrading cells. The patterning and function of these actin-based complexes, podosomes and sealing zones, are regulated by the small GTPase Rho. Myosin IXB (Myo9b) is a unique actin-based motor protein that contains a RhoGAP domain, which, like other RhoGAPs, is inhibitory to Rho signaling. In this study, Myo9b is shown to be expressed in osteoclasts and act as a critical regulator of podosome patterning and osteoclast function. SiRNA-mediated knockdown of Myo9b results in increased activity of Rho but not Rac in osteoclasts. Knockdown in osteoclasts on glass results in altered podosome patterning and decreased motility, and this effect is reversed by addition of a Rho inhibitor. SiRNA-mediated suppression of Myo9b expression in osteoclasts on bone results in a dramatic loss of resorptive capacity even though sealing zones appear normal. This loss of resorption is also reversible with addition of a Rho inhibitor. Cells with diminished Myo9b levels display mislocalization and suppressed activation of Src, a tyrosine kinase with critical effects on osteoclast actin cytoskeletal rearrangement and function. In addition, siRNA-treated cells display poorly formed microtubule networks and a lack of tubulin acetylation, a marker of microtubule stability. However, short-term addition of TNF alpha to cells with suppressed Myo9b levels overcomes or circumvents these defects and causes increased sealing zone size and resorptive capacity. These results indicate that the RhoGAP activity of Myo9b plays a key role in regulating the actin-based structures necessary for osteoclast motility and resorption, and confirms that Myo9b can act as a motorized signaling molecule that links Rho signaling to the dynamic actin cytoskeleton.	[McMichael, Brooke K.; Scherer, Katharine F.; Franklin, Nicole C.; Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	Ohio State University	Lee, BS (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	NIH [R01 AR051515]; Ohio State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following: NIH R01 AR051515; and internal awards from The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028583; Bahler M, 2011, BIOCHEM SOC T, V39, P1166, DOI 10.1042/BST0391166; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Bianchi ML, 2010, ARCH BIOCHEM BIOPHYS, V503, P54, DOI 10.1016/j.abb.2010.06.026; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Chandhoke SK, 2012, MOL BIOL CELL, V23, P2468, DOI 10.1091/mbc.E11-09-0803; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chieregatti E, 1998, J CELL SCI, V111, P3597; Cooney R, 2009, INFLAMM BOWEL DIS, V15, P1014, DOI 10.1002/ibd.20885; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Geblinger D, 2012, J R SOC INTERFACE, V9, P1599, DOI 10.1098/rsif.2011.0659; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Kotadiya P, 2008, BONE, V43, P951, DOI 10.1016/j.bone.2008.06.017; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Latiano A, 2008, ALIMENT PHARM THER, V27, P241, DOI 10.1111/j.1365-2036.2007.03551.x; Leso V, 2010, EUR J GASTROEN HEPAT, V22, P779, DOI 10.1097/MEG.0b013e328331b654; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; McMichael BK, 2010, J BIOL CHEM, V285, P26641, DOI 10.1074/jbc.M110.119909; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Nunez C, 2007, GUT, V56, P1321, DOI 10.1136/gut.2007.121905; O'Connell CB, 2003, NAT CELL BIOL, V5, P171, DOI 10.1038/ncb924; O'Neill GM, 2008, SEMIN CANCER BIOL, V18, P35, DOI 10.1016/j.semcancer.2007.08.004; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ory S, 2000, J CELL SCI, V113, P1177; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Post PL, 1998, J CELL SCI, V111, P941; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Van Bodegraven AA, 2006, GASTROENTEROLOGY, V131, P1768, DOI 10.1053/j.gastro.2006.09.011; Veerappan SG, 2011, ALIMENT PHARM THER, V33, P1261, DOI 10.1111/j.1365-2036.2011.04667.x; Wirth JA, 1996, J CELL SCI, V109, P653; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; ZHANG D, 1995, J CELL SCI, V108, P2285	61	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87402	10.1371/journal.pone.0087402	http://dx.doi.org/10.1371/journal.pone.0087402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466350	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000206
J	Liu, YC; Popp, B; Schmidt, B				Liu, Yongchao; Popp, Bernt; Schmidt, Bertil			CUSHAW3: Sensitive and Accurate Base-Space and Color-Space Short-Read Alignment with Hybrid Seeding	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; GENOME; TOOL	The majority of next-generation sequencing short-reads can be properly aligned by leading aligners at high speed. However, the alignment quality can still be further improved, since usually not all reads can be correctly aligned to large genomes, such as the human genome, even for simulated data. Moreover, even slight improvements in this area are important but challenging, and usually require significantly more computational endeavor. In this paper, we present CUSHAW3, an open-source parallelized, sensitive and accurate short-read aligner for both base-space and color-space sequences. In this aligner, we have investigated a hybrid seeding approach to improve alignment quality, which incorporates three different seed types, i.e. maximal exact match seeds, exact-match k-mer seeds and variable-length seeds, into the alignment pipeline. Furthermore, three techniques: weighted seed-pairing heuristic, paired-end alignment pair ranking and read mate rescuing have been conceived to facilitate accurate paired-end alignment. For base-space alignment, we have compared CUSHAW3 to Novoalign, CUSHAW2, BWA-MEM, Bowtie2 and GEM, by aligning both simulated and real reads to the human genome. The results show that CUSHAW3 consistently outperforms CUSHAW2, BWA-MEM, Bowtie2 and GEM in terms of single-end and paired-end alignment. Furthermore, our aligner has demonstrated better paired-end alignment performance than Novoalign for short-reads with high error rates. For color-space alignment, CUSHAW3 is consistently one of the best aligners compared to SHRiMP2 and BFAST. The source code of CUSHAW3 and all simulated data are available at http://cushaw3.sourceforge.net.	[Liu, Yongchao; Schmidt, Bertil] Johannes Gutenberg Univ Mainz, Inst Informat, D-55122 Mainz, Germany; [Popp, Bernt] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany	Johannes Gutenberg University of Mainz; University of Erlangen Nuremberg	Liu, YC (corresponding author), Johannes Gutenberg Univ Mainz, Inst Informat, D-55122 Mainz, Germany.	liuy@uni-mainz.de; bertil.schmidt@uni-mainz.de	Popp, Bernt/M-2157-2019	Popp, Bernt/0000-0002-3679-1081; Liu, Yongchao/0000-0003-3440-9675				Burrows M, 1994, BLOCK SORTING LOSSLE; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferragina P., 2005, J ACM, V52, P4; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H., 2013, ARXIV13033997QBIOGN; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CM, 2012, BIOINFORMATICS, V28, P878, DOI 10.1093/bioinformatics/bts061; Liu YC, 2012, BIOINFORMATICS, V28, pI318, DOI 10.1093/bioinformatics/bts414; Liu YC, 2012, BIOINFORMATICS, V28, P1830, DOI 10.1093/bioinformatics/bts276; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Luo RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065632; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mu JC, 2012, BIOINFORMATICS, V28, P2366, DOI 10.1093/bioinformatics/bts450; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5	25	33	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86869	10.1371/journal.pone.0086869	http://dx.doi.org/10.1371/journal.pone.0086869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466273	Green Published, gold			2022-12-27	WOS:000330283100227
J	Bakkar, MM; Hardaker, L; March, P; Morgan, PB; Maldonado-Codina, C; Dobson, CB				Bakkar, May M.; Hardaker, Luke; March, Peter; Morgan, Philip B.; Maldonado-Codina, Carole; Dobson, Curtis B.			The Cellular Basis for Biocide-Induced Fluorescein Hyperfluorescence in Mammalian Cell Culture	PLOS ONE			English	Article								Clinical examination of the ocular surface is commonly carried out after application of sodium fluorescein in both veterinary and medical practice by assessing the resulting 'staining'. Although localized intensely stained regions of the cornea frequently occur after exposure to 'adverse' clinical stimuli, the cell biology underlying this staining is unknown, including whether intense fluorescein staining indicates the presence of damaged cells. Ocular exposure to certain contact lens multipurpose solutions (MPS) gives rise to intense fluorescein staining referred to as solution induced corneal staining (SICS), and we have made use of this phenomenon with Vero and L929 cell culture models to investigate the fundamental biology of fluorescein interactions with cells. We found that all cells take up fluorescein, however a sub-population internalize much higher levels, giving rise to brightly staining 'hyperfluorescent' cells within the treated cultures, which contain fluorescein throughout the cell cytoplasm and nucleus. The numbers of these hyperfluorescent cells are significantly increased after exposure to MPS associated with SICS. Surprisingly, hyperfluorescent cells did not show higher levels of staining with propidium iodide, a marker of lysed cells. Consistently, treatment with the cytolytic toxin benzalkonium chloride resulted in almost all cells staining with propidium iodide, and the complete abolition of fluorescein hyperfluorescence. Finally we found that internalization of fluorescein and its loss from treated cells both require cellular activity, as both processes were halted after incubation at 4 degrees C. We conclude that fluorescein hyperfluorescence can be replicated in three diverse cell cultures, and is increased by MPS-treatment, as occurs clinically. The process involves the concentration of fluorescein by a sub-population of cells that are active, and does not occur in lysed cells. Our data suggest that corneal staining in the clinic reflects active living cells, and is not directly caused by dead cells being produced in response to adverse clinical stimuli.	[Bakkar, May M.; Morgan, Philip B.; Maldonado-Codina, Carole] Univ Manchester, Eurolens Res, Fac Life Sci, Manchester, Lancs, England; [Bakkar, May M.; Hardaker, Luke; Morgan, Philip B.; Maldonado-Codina, Carole; Dobson, Curtis B.] Univ Manchester, Fac Life Sci, Med Device Biol Grp, Manchester, Lancs, England; [March, Peter] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Dobson, CB (corresponding author), Univ Manchester, Fac Life Sci, Med Device Biol Grp, Manchester, Lancs, England.	curtis.dobson@manchester.ac.uk		Morgan, Philip/0000-0003-0680-8169; Dobson, Curtis/0000-0002-6483-4608	Jordan University of Science and Technology	Jordan University of Science and Technology	This work was funded by Jordan University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandamwar KL, 2012, CONTACT LENS ANTERIO, V35, P81, DOI 10.1016/j.clae.2011.08.008; Barret R, 2005, INVEST OPHTHALMOL VI, V46; Berginc K, 2007, EUR J PHARM BIOPHARM, V66, P281, DOI 10.1016/j.ejpb.2006.10.023; Bright FV, 2012, CORNEA, V31, P1480, DOI 10.1097/ICO.0b013e31824a2083; Carnt N, 2007, CONTACT LENS SPECTRU, V22, P38; CERCEK L, 1978, BIOPHYS J, V23, P395, DOI 10.1016/S0006-3495(78)85458-7; Dumbleton Kathy, 2003, Eye Contact Lens, V29, pS186; FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605; Horsley MB, 2009, CLIN OPHTHALMOL, V3, P291; Jones L, 1997, Cont Lens Anterior Eye, V20, P23, DOI 10.1016/S1367-0484(97)80032-X; Jones L, 2002, OPTOMETRY VISION SCI, V79, P753, DOI 10.1097/00006324-200212000-00007; JOSEPHSON JE, 1988, INVEST OPHTH VIS SCI, V29, P1096; Kuwayama K, 2002, BIOCHEM PHARMACOL, V63, P81, DOI 10.1016/S0006-2952(01)00853-X; McMonnies Charles W, 2007, Cont Lens Anterior Eye, V30, P37, DOI 10.1016/j.clae.2006.12.002; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; Morgan PB, 2009, CONTACT LENS ANTERIO, V32, P48, DOI 10.1016/j.clae.2008.09.004; Peate WF, 2007, AM FAM PHYSICIAN, V75, P1017; Scarlett A, 2007, EMERG MED J, V24, P733, DOI 10.1136/emj.2006.045658; Tchao Ruy, 2002, CLAO Journal, V28, P151; van der Worp E, 2003, OPTOMETRY VISION SCI, V80, P280, DOI 10.1097/00006324-200304000-00005; Wilson G, 1995, J Am Optom Assoc, V66, P435; Wipperman JL, 2013, AM FAM PHYSICIAN, V87, P114	22	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84427	10.1371/journal.pone.0084427	http://dx.doi.org/10.1371/journal.pone.0084427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489650	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000006
J	Chan, TF; Lin, WT; Chen, YL; Huang, HL; Yang, WZ; Lee, CY; Chen, MH; Wang, TN; Huang, MC; Chiu, YW; Huang, CC; Tsai, S; Lin, CL; Lee, CH				Chan, Te-Fu; Lin, Wei-Ting; Chen, Yi-Ling; Huang, Hsiao-Ling; Yang, Wei-Zeng; Lee, Chun-Ying; Chen, Meng-Hsueh; Wang, Tsu-Nai; Huang, Meng-Chuan; Chiu, Yu-Wen; Huang, Chun-Chi; Tsai, Sharon; Lin, Chih-Lung; Lee, Chien-Hung			Elevated Serum Triglyceride and Retinol-Binding Protein 4 Levels Associated with Fructose-Sweetened Beverages in Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; URIC-ACID; CARDIOVASCULAR-DISEASE; VISCERAL ADIPOSITY; METABOLIC SYNDROME; RENAL DYSFUNCTION; OBESITY; RETINOL-BINDING-PROTEIN-4; CONSUMPTION	Background: The metabolic effect of fructose in sugar-sweetened beverages (SSB) has been linked to de novo lipogenesis and uric acid (UA) production. Objectives: This study investigated the biological effects of SSB consumption on serum lipid profiles and retinol-binding protein 4 (RBP4) among Taiwanese adolescents. Methods: We evaluated the anthropometric parameters and biochemical outcomes of 200 representative adolescents (98 boys and 102 girls) who were randomly selected from a large-scale cross-sectional study. Data were analyzed using multiple regression models adjusted for covariates. Results: Increased SSB consumption was associated with increased waist and hip circumferences, body mass index (BMI) values and serum UA, triglyceride (TG) and RBP4 levels. Adolescents who consumed >500 ml/day of beverages half-to-heavily sweetened with high-fructose corn syrup (HFCS) exhibited TG and RBP4 levels 22.7 mg/dl and 13.92 ng/ml higher than non-drinkers, respectively. HFCS drinkers with hyperuricemia had higher TG levels than HFCS drinkers with normal UA levels (98.6 vs. 81.6 mg/dl). The intake of HFCS-rich SSBs and high value of BMI (>= 24) interactively reinforced RBP4 levels among overweight/obese adolescents. Circulating RBP4 levels were significantly correlated with weight-related outcomes and TG and UA concentration among HFCS drinkers (r = 0.253 to 0.404), but not among non-drinkers. Conclusions: High-quantity HFCS-rich beverage consumption is associated with higher TG and RBP4 levels. Hyperuricemia is likely to intensify the influence of HFCS-rich SSB intake on elevated TG levels, and in overweight and obese adolescents, high BMI may modify the action of fructose on higher circulating levels of RBP4.	[Chan, Te-Fu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chan, Te-Fu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lin, Wei-Ting] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Chen, Yi-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Huang, Hsiao-Ling] Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, Kaohsiung, Taiwan; [Yang, Wei-Zeng; Lee, Chun-Ying; Chen, Meng-Hsueh; Wang, Tsu-Nai; Lee, Chien-Hung] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Lee, Chun-Ying] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ Hosp, Dept Nutr & Dietet, Kaohsiung, Taiwan; [Chiu, Yu-Wen] Louisiana State Univ, Hlth Policy & Syst Management Program, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Huang, Chun-Chi; Tsai, Sharon] Kaohsiung Municipal Hsiaokang Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lin, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan.	chihlung1@yahoo.com; cnhung@kmu.edu.tw	Chen, Yi/HIR-2608-2022; Lee, Chien-Hung/D-4437-2009	Lee, Chien-Hung/0000-0002-0988-264X; Wang, Tsu-Nai/0000-0002-0278-289X; Lin, Wei-Ting/0000-0001-5556-2754; Lee, Chun-ying/0000-0001-8475-5205	Taiwan National Science Council [NSC 96-2314-B-037-041-MY3, NSC 99-2314-B-037-057-MY3, NSC 99-2314-B-037-046-MY3, NSC 102-2314-B-037-060]; Kaohsiung Medical University Research foundation [KMUH 100-0R26]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research foundation	This work was supported by the Taiwan National Science Council (NSC 96-2314-B-037-041-MY3, NSC 99-2314-B-037-057-MY3, NSC 99-2314-B-037-046-MY3, and NSC 102-2314-B-037-060), and was partially supported by grants from the Kaohsiung Medical University Research foundation (KMUH 100-0R26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkharfy KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048612; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Bantle JP, 2000, AM J CLIN NUTR, V72, P1128; Broch M, 2010, PHYSIOL RES, V59, P299, DOI 10.33549/physiolres.931714; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Chang HY, 2001, J RHEUMATOL, V28, P1640; Chang YH, 2008, DIABETES-METAB RES, V24, P629, DOI 10.1002/dmrr.894; Chen CC, 2009, METABOLISM, V58, P1812, DOI 10.1016/j.metabol.2009.06.013; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Christou GA, 2012, HORM METAB RES, V44, P6, DOI 10.1055/s-0031-1295491; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Food and Drug Administration Department of Health, 1993, TAIW FOOD NUTR DAT; FOSSATI P, 1980, CLIN CHEM, V26, P227; Friebe D, 2011, INT J PEDIATR OBES, V6, pE345, DOI 10.3109/17477166.2010.491228; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lee CH, 2010, INT J CANCER, V127, P932, DOI 10.1002/ijc.25108; Lin WT, 2013, INT J OBESITY, V37, P532, DOI 10.1038/ijo.2012.121; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P481, DOI 10.1042/bst0230481; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Sachs Larissa, 2009, Med Health R I, V92, P353; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stanhope KL, 2008, AM J CLIN NUTR, V87, P1194, DOI 10.1093/ajcn/87.5.1194; Stanhope KL, 2008, CURR OPIN LIPIDOL, V19, P16, DOI 10.1097/MOL.0b013e3282f2b24a; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210; WHO/FAO, 2003, DIET NUTR PREVENTION, P54; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; Xia M, 2013, HEPATOLOGY, V58, P564, DOI 10.1002/hep.26227; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	44	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82004	10.1371/journal.pone.0082004	http://dx.doi.org/10.1371/journal.pone.0082004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475021	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300007
J	Cheah, FY; Baltic, S; Temple, SEL; Bhoola, K; Thompson, PJ				Cheah, Faang Y.; Baltic, Svetlana; Temple, Suzanna E. L.; Bhoola, Kanti; Thompson, Philip J.			Novel Kinin B-1 Receptor Splice Variant and 5 ' UTR Regulatory Elements Are Responsible for Cell Specific B-1 Receptor Expression	PLOS ONE			English	Article							BRADYKININ B1 RECEPTOR; HUMAN LUNG FIBROBLASTS; ACTIVATED PROTEIN-KINASE; RAT PAW EDEMA; UP-REGULATION; IN-VIVO; KAPPA-B; GENE-EXPRESSION; INFLAMMATORY CYTOKINES; TRANSLATION EFFICIENCY	The kinin B-1 receptor (B1R) is rapidly upregulated after tissue trauma or inflammation and is involved in cancer and inflammatory diseases such as asthma. However, the role of the: promoter; a postulated alternative promoter; and spliced variants in airway epithelial and other lung cells are poorly understood. We identified, in various lung cell lines and leucocytes, a novel, naturally occurring splice variant (SV) of human B1R gene with a shorter 5'untranslated region. This novel SV is approximate to 35% less stable than the wild-type (WT) transcript in lung adenocarcinoma cells (H2126), but does not influence translation efficiency. Cell-specific differences in splice variant expression were observed post des[Arg10]-kallidin stimulation with delayed upregulation of SV compared to WT suggesting potentially different regulatory responses to inflammation. Although an alternative promoter was not identified in our cell-lines, several cell-specific regulatory elements within the postulated alternative promoter region (negative response element (NRE) -1020 to -766 bp in H2126; positive response element (PRE) -766 to -410 bp in 16HBE; -410 to +1 region acts as a PRE in H2126 and NRE in 16HBE cells) were found. These findings reveal complex regulation of B1R receptor expression in pulmonary cells which may allow future therapeutic manipulation in chronic pulmonary inflammation and cancer.	[Cheah, Faang Y.; Baltic, Svetlana; Temple, Suzanna E. L.; Bhoola, Kanti; Thompson, Philip J.] LIWA, Mol Genet & Inflammat Unit, Perth, WA, Australia; [Cheah, Faang Y.; Baltic, Svetlana; Temple, Suzanna E. L.; Bhoola, Kanti; Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, CAARR, Perth, WA 6009, Australia; [Thompson, Philip J.] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; [Bhoola, Kanti] Univ Austral Chile, Dept Cellular Pathol, Valdivia, Chile	University of Western Australia; University of Western Australia; Universidad Austral de Chile	Thompson, PJ (corresponding author), LIWA, Mol Genet & Inflammat Unit, Perth, WA, Australia.	philip.thompson@liwa.uwa.edu.au		Baltic, Svetlana/0000-0002-3428-940X	Lung Institute of Western Australia; Cooperative Research Centre for Asthma and Airways	Lung Institute of Western Australia; Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The study was funded by The Lung Institute of Western Australia and The Cooperative Research Centre for Asthma and Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers M, 2000, J CELL BIOCHEM, V78, P278, DOI 10.1002/(SICI)1097-4644(20000801)78:2<278::AID-JCB10>3.0.CO;2-F; Angers M, 2005, BIOCHEM J, V389, P37, DOI 10.1042/BJ20042104; Belichard P, 1999, BRIT J PHARMACOL, V128, P213, DOI 10.1038/sj.bjp.0702769; Bertram C, 2007, INT IMMUNOPHARMACOL, V7, P1862, DOI 10.1016/j.intimp.2007.07.012; Bertram CM, 2007, J LEUKOCYTE BIOL, V81, P1445, DOI 10.1189/jlb.0106055; Bertram CM, 2009, J LEUKOCYTE BIOL, V85, P544, DOI 10.1189/jlb.0508283; BHOOLA KD, 1992, BRIT J RHEUMATOL, V31, P509; Blaukat A, 1999, BIOCHEMISTRY-US, V38, P1300, DOI 10.1021/bi981727r; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Campos MM, 1999, BRIT J PHARMACOL, V127, P1851, DOI 10.1038/sj.bjp.0702715; Campos MM, 1996, BRIT J PHARMACOL, V117, P793, DOI 10.1111/j.1476-5381.1996.tb15262.x; Campos MM, 1998, PEPTIDES, V19, P1269, DOI 10.1016/S0196-9781(98)00087-4; Chai KX, 1996, GENOMICS, V31, P51, DOI 10.1006/geno.1996.0008; Chan DC, 2002, CLIN CANCER RES, V8, P1280; Chee J, 2008, BIOL CHEM, V389, P1225, DOI 10.1515/BC.2008.139; Christiansen SC, 2002, J IMMUNOL, V169, P2054, DOI 10.4049/jimmunol.169.4.2054; Corvelo A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r141; Ellis KM, 2004, N-S ARCH PHARMACOL, V369, P166, DOI 10.1007/s00210-003-0857-6; Faussner A, 1999, IMMUNOPHARMACOLOGY, V45, P13, DOI 10.1016/S0162-3109(99)00052-1; Gera L, 2008, INT IMMUNOPHARMACOL, V8, P289, DOI 10.1016/j.intimp.2007.06.006; Goodyer CG, 2001, J MOL ENDOCRINOL, V27, P357, DOI 10.1677/jme.0.0270357; Gulliver R, 2011, AM J RESP CELL MOL, V45, P542, DOI 10.1165/rcmb.2010-0238OC; Haddad EB, 2000, MOL PHARMACOL, V57, P1123; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jones C, 1999, EUR J PHARMACOL, V374, P423, DOI 10.1016/S0014-2999(99)00315-5; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; KUBO M, 1989, J BACTERIOL, V171, P4080, DOI 10.1128/jb.171.7.4080-4082.1989; Landgraf RG, 2004, INFLAMM RES, V53, P78, DOI 10.1007/s00011-003-1226-0; Landry JR, 2001, GENOMICS, V76, P110, DOI 10.1006/geno.2001.6604; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin JCJ, 2010, PEPTIDES, V31, P1940, DOI 10.1016/j.peptides.2010.07.008; Loewen GM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-145; Marceau F, 1998, PHARMACOL REV, V50, P357; Medeiros R, 2004, CIRC RES, V94, P1375, DOI 10.1161/01.RES.0000128404.65887.08; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Newton R, 2002, EUR J PHARMACOL, V441, P193, DOI 10.1016/S0014-2999(01)01624-7; Ni A, 1998, BBA-GENE STRUCT EXPR, V1442, P177, DOI 10.1016/S0167-4781(98)00163-8; Ni AG, 1998, J BIOL CHEM, V273, P2784, DOI 10.1074/jbc.273.5.2784; Passos GF, 2004, J IMMUNOL, V172, P1839, DOI 10.4049/jimmunol.172.3.1839; Pastor T, 2009, NUCLEIC ACIDS RES, V37, P7258, DOI 10.1093/nar/gkp778; Phagoo SB, 2005, J PHARMACOL EXP THER, V313, P1231, DOI 10.1124/jpet.104.083030; Phagoo SB, 2001, J PHARMACOL EXP THER, V298, P77; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Scohy S, 2000, NUCLEIC ACIDS RES, V28, P3743, DOI 10.1093/nar/28.19.3743; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Wong J, 2011, PATH RES INT 2011; Wotherspoon G, 2000, NEUROSCI LETT, V294, P175, DOI 10.1016/S0304-3940(00)01561-5; Xu Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-13; Yang XG, 2001, J CELL BIOCHEM, V82, P163, DOI 10.1002/jcb.1116; Yang XH, 1998, J BIOL CHEM, V273, P10763, DOI 10.1074/jbc.273.17.10763; Yang XH, 1996, BIOCHEM BIOPH RES CO, V222, P718, DOI 10.1006/bbrc.1996.0810; Zhou XF, 1998, BIOCHEM J, V330, P361, DOI 10.1042/bj3300361	57	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87175	10.1371/journal.pone.0087175	http://dx.doi.org/10.1371/journal.pone.0087175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475248	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300150
J	Pakladok, T; Hosseinzadeh, Z; Almilaji, A; Lebedeva, A; Shumilina, E; Alesutan, I; Lang, F				Pakladok, Tatsiana; Hosseinzadeh, Zohreh; Almilaji, Ahmad; Lebedeva, Aleksandra; Shumilina, Ekaterina; Alesutan, Ioana; Lang, Florian			Up-Regulation of hERG K+ Channels by B-RAF	PLOS ONE			English	Article							LONG-QT SYNDROME; GLUCOSE-TRANSPORTER SGLT1; UBIQUITIN LIGASE NEDD4-2; DOWN-REGULATION; POTASSIUM CHANNELS; CANCER-CELLS; CARDIAC-ARRHYTHMIA; SIGNALING PATHWAYS; DENDRITIC CELLS; EXPRESSION	Human ether-a-go-go related-gene K+ channels (hERG) participate in the regulation of tumor cell proliferation and apoptosis. HERG channel activity is up-regulated by growth factors. Kinases sensitive to growth factor signaling include the serine/threonine protein kinase B-RAF. The present study thus explored whether B-RAF influences hERG channel expression and activity. To this end, hERG channels were expressed in Xenopus oocytes with or without wild-type B-RAF, hERG channel activity was determined utilizing dual-electrode voltage clamp and hERG protein abundance in the cell membrane was analyzed utilizing confocal microscopy as well as chemiluminescence. Moreover, in rhabdomyosarcoma RD cells the effect of B-RAF inhibitor PLX-4720 on hERG-mediated current was quantified by whole-cell patch clamp and hERG cell surface protein abundance by utilizing biotinylation of cell surface proteins as well as flow cytometry. As a result, co-expression of wild-type B-RAF in hERG-expressing Xenopus oocytes significantly increased hERG channel activity and hERG channel protein abundance in the cell membrane. Treatment for 24 hours of B-RAF and hERG-expressing Xenopus oocytes with B-RAF inhibitor PLX-4720 (10 mu M) significantly decreased hERG-mediated current and hERG cell surface expression. Similarly, in rhabdomyosarcoma RD cells, treatment for 24 hours with B-RAF inhibitor PLX-4720 significantly decreased hERG cell membrane protein abundance and hERG-mediated current. In conclusion, B-RAF is a powerful regulator of hERG channel activity and cell surface hERG protein abundance.	[Pakladok, Tatsiana; Hosseinzadeh, Zohreh; Almilaji, Ahmad; Lebedeva, Aleksandra; Shumilina, Ekaterina; Alesutan, Ioana; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Lebedeva, Aleksandra] Russian Acad Med Sci, Inst Expt Med, Dept Immunol, St Petersburg P-22, Russia	Eberhard Karls University of Tubingen; Institute of Experimental Medicine; Russian Academy of Medical Sciences	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Hosseinzadeh, Zohreh/X-8548-2019; Lebedeva, Aleksandra/ABI-2117-2020	Hosseinzadeh, Zohreh/0000-0003-3407-7754; 	Deutsche Forschungsgemeinschaft [GRK 1302/1, SE 1077/3, SFB 773]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (GRK 1302/1, SE 1077/3 and SFB 773)(URL: http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesutan I, 2012, CELL PHYSIOL BIOCHEM, V30, P458, DOI 10.1159/000339039; Almilaji A, 2013, PFLUGERS AR IN PRESS; Almilaji A, 2013, CELL PHYSIOL BIOCHEM, V31, P638, DOI 10.1159/000350083; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Bianchi L, 1998, CANCER RES, V58, P815; Bogatikov E, 2012, CELL PHYSIOL BIOCHEM, V30, P1538, DOI 10.1159/000343341; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; BROER S, 1994, BBA-BIOMEMBRANES, V1192, P95, DOI 10.1016/0005-2736(94)90147-3; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Cordes JS, 2005, BRIT J PHARMACOL, V145, P15, DOI 10.1038/sj.bjp.0706140; Cui Z, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461715; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Eisenhardt AE, 2011, INT J CANCER, V129, P2297, DOI 10.1002/ijc.25893; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Fuchs Ota, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P16; Glassmeier G, 2012, PFLUG ARCH EUR J PHY, V463, P365, DOI 10.1007/s00424-011-1045-z; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Henrion U, 2012, CELL PHYSIOL BIOCHEM, V29, P809, DOI 10.1159/000178470; Hosseinzadeh Z, 2013, CELL PHYSIOL BIOCHEM, V31, P673, DOI 10.1159/000350086; Hosseinzadeh Z, 2012, CELL PHYSIOL BIOCHEM, V30, P1473, DOI 10.1159/000343335; Hosseinzadeh Z, 2012, CELL PHYSIOL BIOCHEM, V29, P737, DOI 10.1159/000178560; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Huang FD, 2001, CIRCULATION, V104, P1071, DOI 10.1161/hc3501.093815; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Kamata T, 2011, AM J CANCER RES, V1, P955; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lamothe SM, 2013, J BIOL CHEM, V288, P15075, DOI 10.1074/jbc.M113.453670; Li GH, 2013, INT J NANOMED, V8, P1293, DOI 10.2147/IJN.S41555; Li HY, 2009, EXP CELL RES, V315, P2256, DOI 10.1016/j.yexcr.2009.04.017; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Masi A, 2005, BRIT J CANCER, V93, P781, DOI 10.1038/sj.bjc.6602775; Mia S, 2012, CELL PHYSIOL BIOCHEM, V30, P1039, DOI 10.1159/000341480; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Ouadid-Ahidouch H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00220; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Pakladok T, 2012, BIOCHEM BIOPH RES CO, V427, P689, DOI 10.1016/j.bbrc.2012.09.062; Pathare G, 2012, KIDNEY BLOOD PRESS R, V36, P149, DOI 10.1159/000343405; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Sisko JT, 2006, BIOORG MED CHEM LETT, V16, P1146, DOI 10.1016/j.bmcl.2005.11.089; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vincent GM, 1998, ANNU REV MED, V49, P263; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zheng F, 2012, MED ONCOL, V29, P2127, DOI 10.1007/s12032-011-0102-y; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	61	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87457	10.1371/journal.pone.0087457	http://dx.doi.org/10.1371/journal.pone.0087457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475291	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300186
J	Prieto, D; Roman, E; Correia, I; Pla, J				Prieto, Daniel; Roman, Elvira; Correia, Ines; Pla, Jesus			The HOG Pathway Is Critical for the Colonization of the Mouse Gastrointestinal Tract by Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE-STRESS-RESPONSE; GENE-EXPRESSION; CHLAMYDOSPORE FORMATION; VIRULENCE; FUNGI; MORPHOGENESIS; CONSTRUCTION; DIMORPHISM; TRIGGERS	The opportunistic pathogen Candida albicans is a frequent inhabitant of the human gastrointestinal tract where it usually behaves as a harmless commensal. In this particular niche, it needs to adapt to the different micro environments that challenge its survival within the host. In order to determine those factors involved in gut adaptation, we have used a gastrointestinal model of colonization in mouse to trace the behaviour of fungal cells. We have developed a genetic labelling system based on the complementary spectral properties of the fluorescent proteins GFP and a new C. albicans codon-adapted RFP (dTOM2) that allow a precise quantification of the fungal population in the gut via standard in vitro cultures or flow cytometry. This methodology has allowed us to determine the role of the three MAP kinase pathways of C. albicans (mediated by the MAPK Mkc1, Cek1 or Hog1) in mouse gut colonization via competitive assays with MAPK pathway mutants and their isogenic wild type strain. This approach reveals the signalling through HOG pathway as a critical factor influencing the establishment of C. albicans in the mouse gut. Less pronounced effects for mkc1 or cek1 mutants were found, only evident after 2-3 weeks of colonization. We have also seen that hog1 mutants is defective in adhesion to the gut mucosa and sensitive to bile salts. Finally, we have developed a genetic strategy for the in vivo excision (tetracycline-dependent) of any specific gene during the course of colonization in this particular niche, allowing the analysis of its role during gut colonization.	[Prieto, Daniel; Roman, Elvira; Correia, Ines; Pla, Jesus] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain	Complutense University of Madrid	Pla, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, Madrid, Spain.	jesuspla@farm.ucm.es	Pla, Jesús/G-8238-2015; GONZALEZ, ELVIRA ROMAN/U-3576-2019; Román, Elvira/H-8894-2015; Correia, Catarina/AAC-9702-2021; Pla, Jesús/ABG-9609-2020; Prieto, Daniel/P-2038-2017	Pla, Jesús/0000-0003-0897-1963; GONZALEZ, ELVIRA ROMAN/0000-0002-7335-7292; Román, Elvira/0000-0002-7335-7292; Prieto, Daniel/0000-0003-3931-5790; Correia, Ines/0000-0001-9723-8493	 [BIO2012-31839];  [PIM2010EPA-00658];  [P2010_BMD-2414]	; ; 	This work is supported by Grants BIO2012-31839, PIM2010EPA-00658, and P2010_BMD-2414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2009, CLIN MICROBIOL INFEC, V15, P17, DOI 10.1111/j.1469-0691.2008.02690.x; Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Antachopoulos C, 2007, EUR J PEDIATR, V166, P1099, DOI 10.1007/s00431-007-0527-7; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arana DM, 2005, MICROBIOL-SGM, V151, P1033, DOI 10.1099/mic.0.27723-0; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Bendel CM, 2002, PEDIATR RES, V51, P290, DOI 10.1203/00006450-200203000-00005; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; FONZI WA, 1993, GENETICS, V134, P717; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gratacap RL, 2013, DIS MODEL MECH, V6, P1260, DOI 10.1242/dmm.012039; Hernday AD, 2010, METHOD ENZYMOL, V470, P737, DOI 10.1016/S0076-6879(10)70031-8; de Dios CH, 2013, FUNGAL GENET BIOL, V50, P21, DOI 10.1016/j.fgb.2012.11.001; Iliev ID, 2013, CURR OPIN MICROBIOL, V16, P366, DOI 10.1016/j.mib.2013.05.004; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Kinneberg KM, 1999, J SURG RES, V87, P245, DOI 10.1006/jsre.1999.5755; Koh AY, 2013, EUKARYOT CELL, V12, P1416, DOI 10.1128/EC.00196-13; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Morschhauser J, 1998, MOL GEN GENET, V257, P412, DOI 10.1007/s004380050665; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Oh J, 2011, METHODS MOL BIOL, V765, P225, DOI 10.1007/978-1-61779-197-0_14; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Perez JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001510; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Staib P, 2000, ADV EXP MED BIOL, V485, P167; VANDERWAAIJ LA, 1994, CYTOMETRY, V16, P270, DOI 10.1002/cyto.990160312; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Wiesner SM, 2001, CLIN DIAGN LAB IMMUN, V8, P192, DOI 10.1128/CDLI.8.1.192-195.2001; Wu W, 2007, MOL MICROBIOL, V64, P1587, DOI 10.1111/j.1365-2958.2007.05759.x; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yin ZK, 2009, PROTEOMICS, V9, P4686, DOI 10.1002/pmic.200800958; Zucchi PC, 2010, MOL MICROBIOL, V76, P733, DOI 10.1111/j.1365-2958.2010.07137.x	70	64	67	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87128	10.1371/journal.pone.0087128	http://dx.doi.org/10.1371/journal.pone.0087128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475243	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330507300147
J	Pulte, D; Jansen, L; Gondos, A; Katalinic, A; Barnes, B; Ressing, M; Holleczek, B; Eberle, A; Brenner, H				Pulte, Dianne x; Jansen, Lina; Gondos, Adam; Katalinic, Alexander; Barnes, Benjamin; Ressing, Meike; Holleczek, Bernd; Eberle, Andrea; Brenner, Hermann		Gekid Canc Survival Working Grp	Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States	PLOS ONE			English	Article							UP-TO-DATE; CANCER SURVIVAL; PERIOD ANALYSIS; EMPIRICAL-EVALUATION; PATIENT SURVIVAL; TRENDS; TRIAL; DIAGNOSIS; CHILDREN; THERAPY	Background: Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood ALL, survival for adults with ALL is poor. Recently, new protocols, including use of pediatric protocols in young adults, have improved survival in clinical trials. Here, we examine population level survival in Germany and the United States (US) to gain insight into the extent to which changes in clinical trials have translated into better survival on the population level. Methods: Data were extracted from the Surveillance, Epidemiology, and End Results database in the US and 11 cancer registries in Germany. Patients age 15-69 diagnosed with ALL were included. Period analysis was used to estimate 5-year relative survival (RS). Results: Overall 5-year RS was estimated at 43.4% for Germany and 35.5% for the US (p = 0.004), with a decrease in survival with increasing age. Survival was higher in Germany than the US for men (43.6% versus 37.7%, p = 0.002) but not for women (42.4% versus 40.3%, p > 0.1). Five-year RS estimates increased in Germany and the US between 2002 and 2006 by 11.8 and 7.3 percent units, respectively (p = 0.02 and 0.04, respectively). Conclusions: Survival for adults with ALL continues to be low compared with that for children, but a substantial increase in 5-year survival estimates was seen from 2002 to 2006 in both Germany and the US. The reasons for the survival differences between both countries require clarification.	[Pulte, Dianne x; Jansen, Lina; Gondos, Adam; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Pulte, Dianne x] Thomas Jefferson Univ, Dept Med, Cardeza Fdn, Philadelphia, PA 19107 USA; [Pulte, Dianne x] Thomas Jefferson Univ, Dept Med, Div Hematol, Philadelphia, PA 19107 USA; [Katalinic, Alexander] Univ Lubeck, Inst Canc Epidemiol, Lubeck, Germany; [Barnes, Benjamin] Robert Koch Inst, Natl Ctr Canc Registry Data, Berlin, Germany; [Ressing, Meike] Johannes Gutenberg Univ Mainz, Canc Registry Rhineland Palatinate, Inst Med Biostatist Epidemiol & Informat, Mainz, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Eberle, Andrea] Leibniz Inst Prevent Res & Epidemiol BIPS, Canc Registry Bremen, Bremen, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Jefferson University; Jefferson University; University of Lubeck; Robert Koch Institute; Johannes Gutenberg University of Mainz; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Helmholtz Association; German Cancer Research Center (DKFZ)	Pulte, D (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.	pultedi@gmail.com	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Katalinic, Alexander/D-2512-2010; Jansen, Lina/D-7255-2016	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Katalinic, Alexander/0000-0003-0490-1554; Jansen, Lina/0000-0001-8004-4940; Barnes, Benjamin/0000-0002-2264-2042	German Cancer Aid (Deutsche Krebshilfe) [108257]; DKFZ	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); DKFZ(Helmholtz Association)	This work was supported in part by a grant from the German Cancer Aid (Deutsche Krebshilfe, no. 108257) and a visiting scientist grant from the DKFZ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias Elizabeth, 2002, Natl Vital Stat Rep, V51, P1; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brenner H, 2002, INT J EPIDEMIOL, V31, P456, DOI 10.1093/ije/31.2.456; Brenner H, 2002, J CLIN ONCOL, V20, P826, DOI 10.1200/JCO.20.3.826; Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243; Brenner H, 2011, CANCER EPIDEM BIOMAR, V20, P2480, DOI 10.1158/1055-9965.EPI-11-0697; CHESSELLS JM, 1995, BRIT J HAEMATOL, V89, P364, DOI 10.1111/j.1365-2141.1995.tb03313.x; Dores GM, 2012, BLOOD, V119, P34, DOI 10.1182/blood-2011-04-347872; Ederer F., 1959, INSTRUCTIONS IBM 650; Ferlay J, 2005, 42 IARC; Fielding Adele K, 2008, Hematology Am Soc Hematol Educ Program, P381, DOI 10.1182/asheducation-2008.1.381; Goldstone AH, 2008, BLOOD, V111, P1827, DOI 10.1182/blood-2007-10-116582; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; Hiripi E, 2012, ANN ONCOL, V23, P472, DOI 10.1093/annonc/mdr131; Juliusson G, 2010, BLOOD, V116, P1011, DOI 10.1182/blood-2010-03-272724; Kuhnl A, 2010, BLOOD, V115, P3737, DOI 10.1182/blood-2009-09-241943; Mariotto A, 2002, CANCER CAUSE CONTROL, V13, P101, DOI 10.1023/A:1014380323037; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 1999, J CLIN ONCOL, V17, P818, DOI 10.1200/JCO.1999.17.3.818; Pulte D, 2013, HAEMATOLOGICA, V98, P693, DOI 10.3324/haematol.2012.063602; Pulte D, 2008, JNCI-J NATL CANCER I, V100, P1301, DOI 10.1093/jnci/djn276; Pulte D, 2011, ONCOLOGIST, V16, P663, DOI 10.1634/theoncologist.2010-0393; Pulte D, 2009, CANCER-AM CANCER SOC, V115, P4973, DOI 10.1002/cncr.24548; Pulte D, 2009, BLOOD, V113, P1408, DOI 10.1182/blood-2008-06-164863; Rowe JM, 2010, BRIT J HAEMATOL, V150, P389, DOI 10.1111/j.1365-2141.2010.08246.x; Rowe JM, 2005, BLOOD, V106, P3760, DOI 10.1182/blood-2005-04-1623; Surveillance Epidemiology and End Results (SEER) Program, SURV EP END RES SEER; Toft N, 2012, BRIT J HAEMATOL, V157, P97, DOI 10.1111/j.1365-2141.2011.09020.x; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	32	70	71	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85554	10.1371/journal.pone.0085554	http://dx.doi.org/10.1371/journal.pone.0085554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475044	gold, Green Published			2022-12-27	WOS:000330507300020
J	Rahman, MA; Sobia, P; Gupta, N; Van Kaer, L; Das, G				Rahman, Md Aejazur; Sobia, Parveen; Gupta, Neeta; Van Kaer, Luc; Das, Gobardhan			Mycobacterium tuberculosis Subverts the TLR-2-MyD88 Pathway to Facilitate Its Translocation into the Cytosol	PLOS ONE			English	Article							CD8(+) T-CELLS; ALVEOLAR MACROPHAGES; PHAGOSOME MATURATION; CALMETTE-GUERIN; RD1 REGION; ESAT-6; SECRETION; MEMBRANES; ESAT-6/CFP-10; PHAGOLYSOSOME	Mycobacterium tuberculosis (M.tb) has evolved mechanisms to evade its destruction in phagolysosomes, where it successfully survives and replicates within phagocytes. Recent studies have shown that virulent strains of M.tb can translocate from the phagosome into the cytosol of dendritic cells (DC). The molecular mechanisms by which virulent M.tb strains can escape the phagosome remain unknown. Here we show that the virulent M.tb strain H37Rv, but not the vaccine strain Bacille Calmette-Guerin (BCG), escapes from the phagolysosome and enters the cytosol by interfering with the TLR-2-MyD88 signaling pathway. Using H37Rv mutants, we further demonstrate that the region of difference-1 (RD-1) locus and ESAT-6, a gene within the RD-1 locus, play an important role in the capacity of M.tb to migrate from the phagosome to the cytosol of macrophages. H37Rv, BCG, H37Rv Delta RD1, and H37Rv Delta ESAT6 were able to translocate to the cytosol in macrophages derived from TLR-2- and MyD88-deficient animals, whereas only virulent H37Rv was able to enter the cytosol in macrophages from wild type mice. Therefore, signaling through the TLR-2-MyD88 pathway in macrophages plays an important role in confining M.tb within phagolysomes. Virulent strains of M.tb have evolved mechanisms to subvert this pathway, thus facilitating their translocation to the cytosol and to escape the toxic microenvironment of the phagosome or phagolysosome.	[Rahman, Md Aejazur; Das, Gobardhan] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Rahman, Md Aejazur; Sobia, Parveen; Gupta, Neeta] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	University of Kwazulu Natal; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University	Das, G (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa.	gobardhan.das07@gmail.com	Rhaman, Aejazur/AAC-5104-2019; Van Kaer, Luc/H-1033-2015	Rhaman, Aejazur/0000-0002-2616-3372; Van Kaer, Luc/0000-0001-5275-2309	Wellcome Trust-Department of Biotechnology (DBT) alliance; DBT, Govt. of India; Ramalingaswamy fellowship; DBT Center of Excellence, Govt. of India; DBT Senior Research Fellowship, Govt. of India; DBT postdoctoral fellowship, Govt. of India;  [WT01/GD/09/339];  [DB05/PS/09/331]	Wellcome Trust-Department of Biotechnology (DBT) alliance(Department of Biotechnology (DBT) India); DBT, Govt. of India(Department of Biotechnology (DBT) India); Ramalingaswamy fellowship; DBT Center of Excellence, Govt. of India; DBT Senior Research Fellowship, Govt. of India; DBT postdoctoral fellowship, Govt. of India; ; 	This work was supported by grants from The Wellcome Trust-Department of Biotechnology (DBT) alliance and by the DBT, Govt. of India. Grant No. WT01/GD/09/339 URL: http://wellcomedbt.org/senior.html and Grant No. DB05/PS/09/331. URL: http://dbtindia.nic.in. AR is supported by a Ramalingaswamy fellowship and DBT Center of Excellence, Govt. of India. SP is supported by a DBT Senior Research Fellowship, Govt. of India. NG is supported by a DBT postdoctoral fellowship, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum D, 2009, IMMUNOLOGY, V128, P556, DOI 10.1111/j.1365-2567.2009.03141.x; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Junqueira-Kipnis AP, 2006, IMMUNOLOGY, V119, P224, DOI 10.1111/j.1365-2567.2006.02427.x; Kaku T, 2007, FEMS MICROBIOL LETT, V274, P189, DOI 10.1111/j.1574-6968.2007.00838.x; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Klein Michel R., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P313; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; LEAKE ES, 1984, INFECT IMMUN, V45, P443, DOI 10.1128/IAI.45.2.443-446.1984; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; MYRVIK QN, 1984, AM REV RESPIR DIS, V129, P322; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Shams H, 2003, J LEUKOCYTE BIOL, V74, P1008, DOI 10.1189/jlb.0403138; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Welin A, 2012, TUBERCULOSIS, V92, P113, DOI 10.1016/j.tube.2011.09.009; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	43	36	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86886	10.1371/journal.pone.0086886	http://dx.doi.org/10.1371/journal.pone.0086886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475192	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300114
J	Shao, YQ; Arias-Cordero, E; Guo, HJ; Bartram, S; Boland, W				Shao, Yongqi; Arias-Cordero, Erika; Guo, Huijuan; Bartram, Stefan; Boland, Wilhelm			In Vivo Pyro-SIP Assessing Active Gut Microbiota of the Cotton Leafworm, Spodoptera littoralis	PLOS ONE			English	Article							DIVERSITY; BACTERIA; SOIL; IDENTIFICATION; COMMUNITIES; HYDROLYSIS; PROTEIN; PROBES; LARVAE; BEES	The gut microbiota is of crucial importance for the host with considerable metabolic activity. Although great efforts have been made toward characterizing microbial diversity, measuring components' metabolic activity surprisingly hasn't kept pace. Here we combined pyrosequencing of amplified 16S rRNA genes with in vivo stable isotope probing (Pyro-SIP) to unmask metabolically active bacteria in the gut of cotton leafworm (Spodoptera littoralis), a polyphagous insect herbivore that consumes large amounts of plant material in a short time, liberating abundant glucose in the alimentary canal as a most important carbon and energy source for both host and active gut bacteria. With C-13 glucose as the trophic link, Pyro-SIP revealed that a relatively simple but distinctive gut microbiota co-developed with the host, both metabolic activity and composition shifting throughout larval stages. Pantoea, Citrobacter and Clostridium were particularly active in early-instar, likely the core functional populations linked to nutritional upgrading. Enterococcus was the single predominant genus in the community, and it was essentially stable and metabolically active in the larval lifespan. Based on that Enterococci formed biofilm-like layers on the gut epithelium and that the isolated strains showed antimicrobial properties, Enterococcus may be able to establish a colonization resistance effect in the gut against potentially harmful microbes from outside. Not only does this establish the first in-depth inventory of the gut microbiota of a model organism from the mostly phytophagous Lepidoptera, but this pilot study shows that Pyro-SIP can rapidly gain insight into the gut microbiota's metabolic activity with high resolution and high precision.	[Shao, Yongqi; Arias-Cordero, Erika; Guo, Huijuan; Bartram, Stefan; Boland, Wilhelm] Max Planck Inst Chem Oekol, Dept Bioorgan Chem, D-07745 Jena, Germany	Max Planck Society	Boland, W (corresponding author), Max Planck Inst Chem Oekol, Dept Bioorgan Chem, D-07745 Jena, Germany.	boland@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534; Bartram, Stefan/0000-0002-8574-2817	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work is supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Behr T, 2000, SYST APPL MICROBIOL, V23, P563, DOI 10.1016/S0723-2020(00)80031-4; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dumont MG, 2005, NAT REV MICROBIOL, V3, P499, DOI 10.1038/nrmicro1162; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Funke M, 2008, CHEMBIOCHEM, V9, P1953, DOI 10.1002/cbic.200700781; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Horn MA, 2003, APPL ENVIRON MICROB, V69, P1662, DOI 10.1128/AEM.69.3.1662-1669.2003; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Lenhart K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2049; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Manero A, 2002, J MICROBIOL METH, V50, P115, DOI 10.1016/S0167-7012(02)00027-1; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Pesek J, 2011, J BIOL CHEM, V286, P34872, DOI 10.1074/jbc.M111.246108; Pilloni G, 2011, FEMS MICROBIOL ECOL; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Poulsen M, 2012, MOL ECOL, V21, P2054, DOI 10.1111/j.1365-294X.2012.05510.x; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; Priya NG, 2012, PLOS ONE, V7; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reichardt N, 2011, APPL ENVIRON MICROB, V77, P8009, DOI 10.1128/AEM.05573-11; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Shao YQ, 2011, INSECT BIOCHEM MOLEC, V41, P273, DOI 10.1016/j.ibmb.2011.01.004; Silverman N, 2008, SCIENCE, V319, P734, DOI 10.1126/science.1154209; Sudakaran S, 2012, MOL ECOL; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wust PK, 2011, ISME J, V5, P92, DOI 10.1038/ismej.2010.99; Zhang W, 2007, SOIL BIOL BIOCHEM, V39, P2665, DOI 10.1016/j.soilbio.2007.04.003	58	75	78	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85948	10.1371/journal.pone.0085948	http://dx.doi.org/10.1371/journal.pone.0085948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475063	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300032
J	Troschinski, S; Di Lellis, MA; Sereda, S; Hauffe, T; Wilke, T; Triebskorn, R; Kohler, HR				Troschinski, Sandra; Di Lellis, Maddalena A.; Sereda, Sergej; Hauffe, Torsten; Wilke, Thomas; Triebskorn, Rita; Koehler, Heinz-R.			Intraspecific Variation in Cellular and Biochemical Heat Response Strategies of Mediterranean Xeropicta derbentina [Pulmonata, Hygromiidae]	PLOS ONE			English	Article							LAND SNAILS; DROSOPHILA-MELANOGASTER; DIGESTIVE GLAND; STRESS-PROTEINS; METABOLIC DEPRESSION; NATURAL-POPULATIONS; GENETIC-VARIATION; HSP70 EXPRESSION; SHOCK PROTEINS; TOLERANCE	Dry and hot environments challenge the survival of terrestrial snails. To minimize overheating and desiccation, physiological and biochemical adaptations are of high importance for these animals. In the present study, seven populations of the Mediterranean land snail species Xeropicta derbentina were sampled from their natural habitat in order to investigate the intraspecific variation of cellular and biochemical mechanisms, which are assigned to contribute to heat resistance. Furthermore, we tested whether genetic parameters are correlated with these physiological heat stress response patterns. Specimens of each population were individually exposed to elevated temperatures (25 to 52 degrees C) for 8 h in the laboratory. After exposure, the health condition of the snails' hepatopancreas was examined by means of qualitative description and semi-quantitative assessment of histopathological effects. In addition, the heat-shock protein 70 level (Hsp70) was determined. Generally, calcium cells of the hepatopancreas were more heat resistant than digestive cells - this phenomenon was associated with elevated Hsp70 levels at 40 degrees C. We observed considerable variation in the snails' heat response strategy: Individuals from three populations invested much energy in producing a highly elevated Hsp70 level, whereas three other populations invested energy in moderate stress protein levels - both strategies were in association with cellular functionality. Furthermore, one population kept cellular condition stable despite a low Hsp70 level until 40 degrees C exposure, whereas prominent cellular reactions were observed above this thermal limit. Genetic diversity (mitochondrial cytochrome c oxidase subunit I gene) within populations was low. Nevertheless, when using genetic indices as explanatory variables in a multivariate regression tree (MRT) analysis, population structure explained mean differences in cellular and biochemical heat stress responses, especially in the group exposed to 40 degrees C. Our study showed that, even in similar habitats within a close range, populations of the same species use different stress response strategies that all rendered survival possible.	[Troschinski, Sandra; Di Lellis, Maddalena A.; Triebskorn, Rita; Koehler, Heinz-R.] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Sereda, Sergej; Hauffe, Torsten; Wilke, Thomas] Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany	Eberhard Karls University of Tubingen; Justus Liebig University Giessen	Troschinski, S (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany.	s.trosch@web.de	Köhler, Heinz-R./AAL-1350-2021; Wilke, Thomas/G-1517-2012	Wilke, Thomas/0000-0001-8263-7758; Hauffe, Torsten/0000-0001-5711-9457; Sereda, Sergej/0000-0003-3212-8722	German Research Council (DFG) [KO 1978/5-3, WI 1902/10-3]	German Research Council (DFG)(German Research Foundation (DFG))	The study was financed by the German Research Council (DFG) under KO 1978/5-3 and WI 1902/10-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MVPART MULTIVARIATE; Arts MJSJ, 2004, ECOTOXICOLOGY, V13, P739, DOI 10.1007/s10646-003-4473-5; Avwioro G., 2011, JPCS, V1, P24; Bahrndorff S, 2010, CLIM RES, V43, P41, DOI 10.3354/cr00896; BARNHART MC, 1986, J COMP PHYSIOL B, V156, P347, DOI 10.1007/BF01101097; Bishop T, 2000, J EXP BIOL, V203, P3603; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton R.F., 1976, P7; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Di Lellis MA, 2012, CELL STRESS CHAPERON, V17, P717, DOI 10.1007/s12192-012-0344-4; Dieterich A, 2013, CELL STRESS CHAPERON, V18, P405, DOI 10.1007/s12192-012-0393-8; Dittbrenner N, 2009, J MOLLUS STUD, V75, P9, DOI 10.1093/mollus/eyn033; Eckwert H, 1997, ECOTOXICOLOGY, V6, P249, DOI 10.1023/A:1018682928839; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feder ME, 1998, AM ZOOL, V38, P503; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heckathorn SA, 1996, OECOLOGIA, V105, P413, DOI 10.1007/BF00328745; Heisler N, 1986, ACID BASE REGULATION; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jensen LT, 2010, J EXP ZOOL PART A, V313A, P35, DOI 10.1002/jez.573; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kammenga JE, 2000, REV ENVIRON CONTAM T, V164, P93; Kohler HR, 2009, J EXP ZOOL PART B, V312B, P136, DOI 10.1002/jez.b.21253; Kohler HR, 2000, J EVOLUTION BIOL, V13, P569, DOI 10.1046/j.1420-9101.2000.00210.x; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MACHIN J, 1964, J EXP BIOL, V41, P759; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mizrahi T, 2012, CELL STRESS CHAPERON, V17, P639, DOI 10.1007/s12192-012-0340-8; Mizrahi T, 2010, CELL STRESS CHAPERON, V15, P351, DOI 10.1007/s12192-009-0150-9; MOELLER PW, 1976, J FOOD SCI, V41, P216, DOI 10.1111/j.1365-2621.1976.tb01143.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parsell D.A., 1994, BIOL HEAT SHOCK PROT, P457; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pfenninger M, 2001, MOL ECOL, V10, P2541, DOI 10.1046/j.0962-1083.2001.01389.x; Pfenninger Markus, 2003, Malakologische Abhandlungen (Dresden), V21, P123; POMEROY D E, 1968, Australian Journal of Zoology, V16, P857, DOI 10.1071/ZO9680857; POSTE G, 1971, EXP CELL RES, V67, P11, DOI 10.1016/0014-4827(71)90615-X; R Core Team, 2021, R LANGUAGE ENV STAT; Riddle WA, 1983, MOLLUSCA, V6, P431; RYAN AJ, 1995, J APPL PHYSIOL, V78, P38, DOI 10.1152/jappl.1995.78.1.38; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Scheil AE, 2011, J MOLLUS STUD, V77, P165, DOI 10.1093/mollus/eyr003; SCHMIDTNIELSEN K, 1971, J EXP BIOL, V55, P385; Schrader M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002327; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Staikou AE, 1999, J MOLLUS STUD, V65, P171, DOI 10.1093/mollus/65.2.171; SUMNER AT, 1965, Q J MICROSC SCI, V106, P173; Taieb N, 1999, J MOLLUS STUD, V65, P385, DOI 10.1093/mollus/65.4.385; Tomanek L, 1999, J EXP BIOL, V202, P2925; Triebskorn R, 2005, WATER ENCY WATER QUA, P29, DOI DOI 10.1002/047147844X.WQ566; WALKER G, 1970, PROTOPLASMA, V71, P91, DOI 10.1007/BF01294305; YOM-TOV Y, 1971, Proceedings of the Malacological Society of London, V39, P319; Zaldibar B, 2007, AQUAT TOXICOL, V81, P183, DOI 10.1016/j.aquatox.2006.12.007; Zatsepina OG, 2001, J EXP BIOL, V204, P1869	71	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86613	10.1371/journal.pone.0086613	http://dx.doi.org/10.1371/journal.pone.0086613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475158	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300094
J	Yoo, BS; Oh, J; Hong, BK; Shin, DH; Bae, JH; Yang, DH; Shim, WJ; Kim, HS; Kim, SH; Choi, JO; Chun, WJ; Go, CW; Kang, HJ; Baek, SH; Cho, JH; Hong, SK; Shin, JH; Oh, SK; Pyun, WB; Kwan, J; Hong, YJ; Jeong, JO; Kang, SM; Choi, DJ				Yoo, Byung-Su; Oh, Jaewon; Hong, Bum-Kee; Shin, Dae-Hee; Bae, Jang-Ho; Yang, Dong Heon; Shim, Wan-Joo; Kim, Hyung-seop; Kim, Su-Hong; Choi, Jin-Oh; Chun, Woo-Jung; Go, Choong-Won; Kang, Hyun-Jae; Baek, Sang Hong; Cho, Jang-hyun; Hong, Suk-Keun; Shin, Joon-Han; Oh, Seok-Kyu; Pyun, Wook-Bum; Kwan, Jun; Hong, Young-Joon; Jeong, Jin-Ok; Kang, Seok-Min; Choi, Dong-Ju		SUGAR Study	SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): A Multi-Center, Retrospective, Observational Study	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; PERFORMANCE-MEASURES; CLINICAL-OUTCOMES; EJECTION FRACTION; TASK-FORCE; ASSOCIATION; MORTALITY; REGISTRY; PHARMACOTHERAPY; SPIRONOLACTONE	Background: Clinical practice guidelines have been slowly and inconsistently applied in clinical practice, and certain evidence-based, guideline-driven therapies for heart failure (HF) have been significantly underused. The purpose of this study was to survey guideline compliance and its effect on clinical outcomes in the treatment of systolic HF in Korea. Method and Results: The SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR) trial was a multi-center, retrospective, observational study on subjects with systolic HF (ejection fraction <45%) admitted to 23 university hospitals. The guideline adherence indicator (GAI) was defined as a performance measure on the basis of 3 pharmacological classes: angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor II blocker (ARB), beta-blocker (BB), and aldosterone antagonist (AA). Based on the overall adherence percentage, subjects were divided into 2 groups: those with good guideline adherence (GAI >= 50%) and poor guideline adherence (GAI <50%). We included 1319 regional participants as representatives of the standard population from the Korean national census in 2008. Adherence to drugs at discharge was as follows: ACEI or ARB, 89.7%; BB, 69.2%; and AA, 65.9%. Overall, 82.7% of the patients had good guideline adherence. Overall mortality and re-hospitalization rates at 1 year were 6.2% and 37.4%, respectively. Survival analysis by log-rank test showed a significant difference in event-free survival rate of mortality (94.7% vs. 89.8%, p = 0.003) and re-hospitalization (62.3% vs. 56.4%, p = 0.041) between the good and poor guideline-adherence groups. Conclusions: Among patients with systolic HF in Korea, adherence to pharmacologic treatment guidelines as determined by performance measures, including prescription of ACEI/ARB and BB at discharge, was associated with improved clinical outcomes.	[Yoo, Byung-Su] Yonsei Univ Wonju Severance Christian Hosp, Div Cardiol, Wonju, South Korea; [Oh, Jaewon; Kang, Seok-Min] Yonsei Univ Severance Hosp, Div Cardiol, Seoul, South Korea; [Hong, Bum-Kee] Gangnam Severance Hosp, Div Cardiol, Seoul, South Korea; [Shin, Dae-Hee] Gangneung Asan Hosp, Div Cardiol, Kangnung, South Korea; [Bae, Jang-Ho] Konyang Univ Hosp, Div Cardiol, Taejon, South Korea; [Yang, Dong Heon] Kyungpook Natl Univ Hosp, Div Cardiol, Taegu, South Korea; [Shim, Wan-Joo] Korea Univ Anam Hosp, Div Cardiol, Seoul, South Korea; [Kim, Hyung-seop] Keimyung Univ Dongsan Hosp, Div Cardiol, Taegu, South Korea; [Kim, Su-Hong] Busan Vet Hosp, Div Cardiol, Pusan, South Korea; [Choi, Jin-Oh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol, Seoul, South Korea; [Chun, Woo-Jung] Sungkyunkwan Univ Samsung Changwon Hosp, Div Cardiol, Chang Won, South Korea; [Go, Choong-Won] Inje Univ Sanggye Paik Hosp, Div Cardiol, Seoul, South Korea; [Kang, Hyun-Jae] Seoul Natl Univ Hosp, Div Cardiol, Seoul 110744, South Korea; [Baek, Sang Hong] Catholic Univ Korea, Seoul St Marys Hosp, Div Cardiol, Seoul, South Korea; [Cho, Jang-hyun] St Carollo Hosp, Div Cardiol, Sunchon, South Korea; [Hong, Suk-Keun] Sejong Gen Hosp, Div Cardiol, Puchon, South Korea; [Shin, Joon-Han] Ajou Univ Hosp, Div Cardiol, Suwon, South Korea; [Oh, Seok-Kyu] Wongwang Univ Hosp, Div Cardiol, Iksan, South Korea; [Pyun, Wook-Bum] Ewha Womans Univ Mokdong Hosp, Div Cardiol, Seoul, South Korea; [Kwan, Jun] Inha Univ Hosp, Div Cardiol, Inchon, South Korea; [Hong, Young-Joon] Chonnam Natl Univ Hosp, Div Cardiol, Kwangju, South Korea; [Jeong, Jin-Ok] Chungnam Natl Univ Hosp, Div Cardiol, Taejon, South Korea; [Choi, Dong-Ju] Seoul Natl Univ Bundang Hosp, Div Cardiol, Songnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital; Kyungpook National University; Kyungpook National University Hospital; Korea University; Korea University Medicine (KU Medicine); Keimyung University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Sejong General Hospital; Ajou University; Ajou University Hospital; Ewha Womans University; Inha University; Inha University Hospital; Chonnam National University; Chonnam National University Hospital; Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, DJ (corresponding author), Seoul Natl Univ Bundang Hosp, Div Cardiol, Songnam, South Korea.	djchoi@snubh.org	choi, jo/O-5940-2014; kang, Hyun-Jae/D-6121-2012	kang, Hyun-Jae/0000-0002-3500-1746; Seong, In-Whan/0000-0003-4628-0258; Jeong, Jin-Ok/0000-0003-0763-4754; Kim, Su Hong/0000-0001-5173-5304	GlaxoSmithKline Korea	GlaxoSmithKline Korea(GlaxoSmithKline)	This study was supported by a grant of GlaxoSmithKline Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2009, EUR J HEART FAIL, V11, P1135, DOI 10.1093/eurjhf/hfp151; Atherton JJ, 2012, J CARD FAIL, V18, P82, DOI 10.1016/j.cardfail.2011.09.003; Bonow RO, 2012, CIRCULATION, V125, P2382, DOI 10.1161/CIR.0b013e3182507bec; Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Fonarow GC, 2012, J AM HEART ASSOC, V1, P16, DOI 10.1161/JAHA.111.000018; Fonarow GC, 2011, CIRC J, V75, P1783, DOI 10.1253/circj.CJ-11-0582; Gjesing A, 2013, EUR J HEART FAIL; Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kim JY, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-60; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Lund LH, 2013, CIRC HEART FAIL; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Oh C, 2012, KOREAN CIRC J, V42, P659, DOI 10.4070/kcj.2012.42.10.659; Peters-Klimm F, 2008, CLIN RES CARDIOL, V97, P244, DOI 10.1007/s00392-007-0617-6; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rohde LE, 2006, J CARD FAIL, V12, P587, DOI 10.1016/j.cardfail.2006.06.475; Stork S, 2008, EUR J HEART FAIL, V10, P1236, DOI 10.1016/j.ejheart.2008.09.008; Tsuchihashi-Makaya M, 2010, HYPERTENS RES, V33, P197, DOI 10.1038/hr.2009.199; Tsuchihashi-Makaya M, 2009, CIRC J, V73, P1893, DOI 10.1253/circj.CJ-09-0254; Yamaji M, 2010, AM HEART J, V160, P915, DOI 10.1016/j.ahj.2010.04.024; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Youn YJ, 2012, CIRC J, V76, P1151, DOI 10.1253/circj.CJ-11-1093; Zannad F, 2012, EUR HEART J, V33, P2782, DOI 10.1093/eurheartj/ehs257; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zugck C, 2012, CLIN RES CARDIOL, V101, P263, DOI 10.1007/s00392-011-0388-y	32	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86596	10.1371/journal.pone.0086596	http://dx.doi.org/10.1371/journal.pone.0086596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475154	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300090
J	Krautbauer, S; Eisinger, K; Neumeier, M; Hader, Y; Buettner, R; Schmid, PM; Aslanidis, C; Buechler, C				Krautbauer, Sabrina; Eisinger, Kristina; Neumeier, Markus; Hader, Yvonne; Buettner, Roland; Schmid, Peter M.; Aslanidis, Charalampos; Buechler, Christa			Free Fatty Acids, Lipopolysaccharide and IL-1 alpha Induce Adipocyte Manganese Superoxide Dismutase Which Is Increased in Visceral Adipose Tissues of Obese Rodents	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; OXIDATIVE STRESS; METABOLIC SYNDROME; MITOCHONDRIAL DYSFUNCTION; ADIPONECTIN RELEASE; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; IN-VITRO; MICE	Excess fat storage in adipocytes is associated with increased generation of reactive oxygen species (ROS) and impaired activity of antioxidant mechanisms. Manganese superoxide dismutase (MnSOD) is a mitochondrial enzyme involved in detoxification of ROS, and objective of the current study is to analyze expression and regulation of MnSOD in obesity. MnSOD is increased in visceral but not subcutaneous fat depots of rodents kept on high fat diets (HFD) and ob/ob mice. MnSOD is elevated in visceral adipocytes of fat fed mice and exposure of differentiating 3T3-L1 cells to lipopolysaccharide, IL-1 alpha, saturated, monounsaturated and polyunsaturated free fatty acids (FFA) upregulates its level. FFA do not alter cytochrome oxidase 4 arguing against overall induction of mitochondrial enzymes. Upregulation of MnSOD in fat loaded cells is not mediated by IL-6, TNF or sterol regulatory element binding protein 2 which are induced in these cells. MnSOD is similarly abundant in perirenal fat of Zucker diabetic rats and non-diabetic animals with similar body weight and glucose has no effect on MnSOD in 3T3-L1 cells. To evaluate whether MnSOD affects adipocyte fat storage, MnSOD was knocked-down in adipocytes for the last three days of differentiation and in mature adipocytes. Knock-down of MnSOD does neither alter lipid storage nor viability of these cells. Heme oxygenase-1 which is induced upon oxidative stress is not altered while antioxidative capacity of the cells is modestly reduced. Current data show that inflammation and excess triglyceride storage raise adipocyte MnSOD which is induced in epididymal adipocytes in obesity.	[Krautbauer, Sabrina; Eisinger, Kristina; Neumeier, Markus; Hader, Yvonne; Buettner, Roland; Buechler, Christa] Regensburg Univ Hosp, Dept Internal Med 1, Regensburg, Germany; [Schmid, Peter M.] Regensburg Univ Hosp, Dept Internal Med 2, Regensburg, Germany; [Aslanidis, Charalampos] Regensburg Univ Hosp, Inst Clin Chem & Lab Med, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Buechler, C (corresponding author), Regensburg Univ Hosp, Dept Internal Med 1, Regensburg, Germany.	christa.buechler@klinik.uni-regensburg.de	Buechler, Christa/AAH-3004-2020		Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was partly supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2011, ENDOCRINOLOGY, V152, P26, DOI 10.1210/en.2010-1157; Behrend L, 2005, MOL CELL BIOL, V25, P7758, DOI 10.1128/MCB.25.17.7758-7769.2005; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Buechler C, 2013, INFLAMM ALL IN PRESS; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Cheguru P, 2012, PFLUG ARCH EUR J PHY, V463, P429, DOI 10.1007/s00424-011-1066-7; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Coate KC, 2010, NUTR RES, V30, P141, DOI 10.1016/j.nutres.2010.01.003; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Foster MT, 2012, ADIPOCYTE, V1, P192, DOI 10.4161/adip.21756; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; GIBBS LS, 1992, FREE RADICAL BIO MED, V12, P107, DOI 10.1016/0891-5849(92)90003-Y; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Kim YC, 1999, BIOCHEM BIOPH RES CO, V266, P1, DOI 10.1006/bbrc.1999.1704; Kobayashi H, 2009, AM J PHYSIOL-ENDOC M, V296, pE1326, DOI 10.1152/ajpendo.90921.2008; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kojima T, 2010, APOPTOSIS, V15, P83, DOI 10.1007/s10495-009-0415-x; Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Long EK, 2013, FREE RADICAL BIO MED, V63, P390, DOI 10.1016/j.freeradbiomed.2013.05.030; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam WS, 2012, BBA-MOL BASIS DIS, V1822, P1181, DOI 10.1016/j.bbadis.2012.04.003; Pei-Wen W, 2013, ANTIOXID RE IN PRESS; Pires KM, 2013, OBESITY SIL IN PRESS; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Um JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029524; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zhang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE77, DOI 10.1152/ajpendo.00380.2010	58	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86866	10.1371/journal.pone.0086866	http://dx.doi.org/10.1371/journal.pone.0086866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475187	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800066
J	Luo, RZ; Cai, PQ; Li, M; Fu, J; Zhang, ZY; Chen, JW; Cao, Y; Yun, JP; Xie, D; Cai, MY				Luo, Rong-Zhen; Cai, Pei-Qiang; Li, Mei; Fu, Jia; Zhang, Zhi-Yi; Chen, Jie-Wei; Cao, Yun; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan			Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TYROSINE PHOSPHATASES; PROTEIN; CANCER; MOTILITY; GENES	Background: Protein tyrosine phosphatase non-receptor type 12 (PTPN12), has been identified as a potent tumor suppressor in human cancers and a critical regulator of cell adhesion and migration. However, the PTPN12 expression and its prognostic significance in HCC have not been well elucidated. Methodology/Principal Findings: In this study, tissue microarray-based immunohistochemistry (IHC) was investigated in an HCC cohort with adjacent liver tissues as controls. The resulting data were analyzed using receiver operating characteristic curves, Spearman's rank correlation, Kaplan-Meier plots and Cox proportional hazards regression modeling. Our results showed that decreased expression of PTPN12 was more frequently observed in HCC tissues compared to the adjacent non-tumorous liver tissues. Further correlation analyses indicated that the decreased PTPN12 expression was closely correlated with tumor recurrence (P = 0.015). Univariate analysis showed a significant association between decreased expression of PTPN12 and adverse cancer-specific survival and recurrence-free survival (P < 0.001). In different subsets of overall patients, PTPN12 expression was also a prognostic indicator in patients with stage I/II or stage III/IV (P < 0.05). Importantly, multivariate analysis (P < 0.05) identified PTPN12 expression in HCC as an independent prognostic factor. Conclusions/Significance: Our findings provide a basis for the concept that PTPN12 protein expression is frequently decreased or lost in human HCC tissues and that decreased PTPN12 expression may represent an acquired recurrence phenotype of HCC and that PTPN12 expression may act as a biomarker of prognosis for patients with HCC.	[Luo, Rong-Zhen; Cai, Pei-Qiang; Li, Mei; Fu, Jia; Zhang, Zhi-Yi; Chen, Jie-Wei; Cao, Yun; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Rong-Zhen; Li, Mei; Fu, Jia; Zhang, Zhi-Yi; Chen, Jie-Wei; Cao, Yun; Yun, Jing-Ping; Xie, Dan; Cai, Mu-Yan] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Pei-Qiang] Sun Yat Sen Univ, Med Imaging & Minimally Invas Intervent Ctr, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Cai, MY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	caimuyan@hotmail.com	Zhang, Chris Zhiyi/F-9862-2013		Medical Science Technology Research Foundation of Guangdong [2013217]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [84000-3211701]; Program for Excellent Young Talents in Sun Yat-sen University Cancer Center [520101210101]	Medical Science Technology Research Foundation of Guangdong; Foundation for Distinguished Young Talents in Higher Education of Guangdong; Program for Excellent Young Talents in Sun Yat-sen University Cancer Center	This study was supported by the Medical Science Technology Research Foundation of Guangdong (No. 2013217), the Foundation for Distinguished Young Talents in Higher Education of Guangdong (No. 84000-3211701) and the Program for Excellent Young Talents in Sun Yat-sen University Cancer Center (No. 520101210101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Cao X, 2012, ANN THORAC SURG, V93, P1674, DOI 10.1016/j.athoracsur.2011.12.056; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Espejo R, 2010, AM J PHYSIOL-CELL PH, V299, pC454, DOI 10.1152/ajpcell.00148.2010; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hui AM, 1998, HEPATO-GASTROENTEROL, V45, P1635; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Moradpour D, 1994, J Viral Hepat, V1, P17, DOI 10.1111/j.1365-2893.1994.tb00058.x; NAGASUE N, 1993, GASTROENTEROLOGY, V105, P488, DOI 10.1016/0016-5085(93)90724-Q; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; TABOR E, 1994, J MED VIROL, V42, P357, DOI 10.1002/jmv.1890420406; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Villa-Moruzzi E, 2011, ANAL CELL PATHOL, V34, P101, DOI [10.1155/2011/870459, 10.3233/ACP-2011-0008]; Wu MQ, 2013, ASIAN PAC J CANCER P, V14, P287, DOI 10.7314/APJCP.2013.14.1.287; Yamamoto J, 1996, BRIT J SURG, V83, P1219; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan XY, 2012, BRAZ J MED BIOL RES, V45, P1334, DOI 10.1590/S0100-879X2012007500163; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	29	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85592	10.1371/journal.pone.0085592	http://dx.doi.org/10.1371/journal.pone.0085592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475046	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800013
J	Nebor, D; Bowers, A; Connes, P; Hardy-Dessources, MD; Knight-Madden, J; Cumming, V; Reid, M; Romana, M				Nebor, Danitza; Bowers, Andre; Connes, Philippe; Hardy-Dessources, Marie-Dominique; Knight-Madden, Jennifer; Cumming, Vanessa; Reid, Marvin; Romana, Marc			Plasma Concentration of Platelet-Derived Microparticles Is Related to Painful Vaso-Occlusive Phenotype Severity in Sickle Cell Anemia	PLOS ONE			English	Article							DISEASE; HEMOLYSIS; HYPERCOAGULABILITY; MICROVESICLES; COAGULATION; ACTIVATION; STATE; RISK	High plasma level of microparticles (MPs) deriving mainly from erythrocytes and platelets has been detected in sickle cell anemia (SCA) patients. Flow cytometry was used to determine the concentration of MPs in two groups of SCA patients exhibiting marked differences in painful vaso-occlusive crisis rates [a non-severe group (n = 17) and a severe group (n = 12)], and in a control group composed of healthy subjects (n = 20). A 3- to 4-fold increase of total MP plasma concentration was detected in SCA patients. Higher platelet-derived MPs concentration was detected in the severe SCA group while erythrocyte-derived MPs concentration was increased in the non-severe SCA patient group only. Our results suggest that plasma concentration of MPs shed by platelets is a biomarker of the vaso-occlusive phenotype-related severity.	[Nebor, Danitza; Connes, Philippe; Hardy-Dessources, Marie-Dominique; Romana, Marc] INSERM, U665, Pointe A Pitre, Guadeloupe, France; [Nebor, Danitza; Connes, Philippe; Hardy-Dessources, Marie-Dominique; Romana, Marc] Univ Antilles Guyane, Pointe a Pitre, France; [Bowers, Andre] Univ W Indies, Dept Basic Med Sci, Physiol Sect, Kingston 7, Jamaica; [Connes, Philippe; Hardy-Dessources, Marie-Dominique; Romana, Marc] Lab Excellence GR Ex, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe] Univ French West Indies, Lab ACTES, St Claude, Guadeloupe, France; [Connes, Philippe; Hardy-Dessources, Marie-Dominique; Knight-Madden, Jennifer; Reid, Marvin; Romana, Marc] CAribbean Network REsearchers Sickle Cell Dis & T, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France; [Knight-Madden, Jennifer; Cumming, Vanessa; Reid, Marvin] Univ W Indies, Sickle Cell Unit, Res Inst Trop Med, Kingston 7, Jamaica	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; University West Indies Mona Jamaica; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France; University West Indies Mona Jamaica	Romana, M (corresponding author), INSERM, U665, Pointe A Pitre, Guadeloupe, France.	marc.romana@inserm.fr	Connes, Philippe/J-7835-2019; , Hardy-dessources/K-9189-2017; Romana, Marc/K-6442-2017; Reid, Marvin/J-2884-2014	Connes, Philippe/0000-0002-9232-0268; , Hardy-dessources/0000-0003-0861-3648; Romana, Marc/0000-0002-8715-9836; Reid, Marvin/0000-0003-4005-9384; Philippe, Connes/0000-0001-8449-7998	French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR); French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR)	French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR); French Embassy in Jamaica; Universite des Antilles et de la Guyane; Fonds de Cooperation Regionale (FCR)	This study was supported in part by the French Embassy in Jamaica, the Universite des Antilles et de la Guyane and by the Fonds de Cooperation Regionale (FCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Camus SM, 2012, BLOOD, V120, P5050, DOI 10.1182/blood-2012-02-413138; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Lamarre Y, CLIN HEMORHEOL MICRO; Lamarre Y, 2013, CLIN HEMORHEOL MICRO; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Nebor D, 2013, HAEMATOLOGICA, V98, P862, DOI 10.3324/haematol.2012.073619; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Sparkenbaugh E, 2013, BRIT J HAEMATOL, V162, P3, DOI 10.1111/bjh.12336; Steinberg MH, 2005, BRIT J HAEMATOL, V129, P465, DOI 10.1111/j.1365-2141.2005.05411.x; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; van Tits LJ, 2009, BIOCHEM BIOPH RES CO, V390, P161, DOI 10.1016/j.bbrc.2009.09.102; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x; Willekens FLA, 2005, BLOOD, V105, P2141, DOI 10.1182/blood-2004-04-1578; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x	25	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87243	10.1371/journal.pone.0087243	http://dx.doi.org/10.1371/journal.pone.0087243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475257	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800090
J	Suen, VYM; Brown, MRG; Morck, RK; Silverstone, PH				Suen, Victoria Y. M.; Brown, Matthew R. G.; Morck, Randall K.; Silverstone, Peter H.			Regional Brain Changes Occurring during Disobedience to "Experts" in Financial Decision-Making	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; RISK-TAKING; ACTION SELECTION; HERD BEHAVIOR; MUTUAL FUNDS; NEURAL BASIS; ACTIVATION; REWARD; PERFORMANCE	It is well recognized that individuals follow "Expert'' advice, even when flawed and offers no advantage, and sometimes leads to disadvantages. The neurobiology underlying this is uncertain, and in particular there is an incomplete understanding of which brain regions are most involved when individuals chose to disobey an expert. To study this we examined functional magnetic resonance imaging (fMRI) differences during an investment game where subjects received differentially credible investment advice. Participants (n = 42; 32 males) played an investment game, in which they could Buy or Not Buy a sequence of stocks. The better they did, the more money they made. Participants received either "Expert'' advice or "Peer'' advice. Those receiving Expert advice were told the advice came from a certified financial "Expert''. Those receiving Peer Advice were told the advice was that of the student administering the scans, who deliberately dressed and acted casually. Both streams of advice were predetermined and identical. The advice was scripted to be helpful initially, but progressively worse as the task continued, becoming 100% wrong by the end of the task. Subjects receiving Expert Advice followed the advice significantly longer on average, even though this was progressively worse advice. Thus, following Expert advice had poorer consequences for individuals, but this did not dissuade them from continuing to follow the advice. In contrast, when subjects disobeyed Expert advice they exhibited significant anterior cingulate cortex (ACC) and superior frontal gyrus activation relative to those disobeying Peer advice. These findings may suggest that in subjects who defy authority, or believe they are doing so (in this case by disobeying an "Expert'') there is increased activation of these two brain regions. This may have relevance to several areas of behavior, and the potential role of these two brain regions in regard to disobedience behavior requires further study.	[Suen, Victoria Y. M.; Brown, Matthew R. G.; Silverstone, Peter H.] Univ Alberta, Dept Psychiat, Fac Med & Dent, Edmonton, AB, Canada; [Morck, Randall K.] Univ Alberta, Fac Business, Dept Finance & Stat Anal, Edmonton, AB, Canada	University of Alberta; University of Alberta	Silverstone, PH (corresponding author), Univ Alberta, Dept Psychiat, Fac Med & Dent, Edmonton, AB, Canada.	peter.silverstone@ualberta.ca	Morck, Randall/AAD-9048-2019	Morck, Randall/0000-0001-7412-0222	Alberta Gambling Research Institute, Alberta, Canada; Social Sciences and Humanities Research Council of Canada	Alberta Gambling Research Institute, Alberta, Canada; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was funded in part by the Alberta Gambling Research Institute, Alberta, Canada, and in part by a grant from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Bausell R. B., 2007, SNAKE OIL SCI; Bergstresser D, 2009, REV FINANC STUD, V22, P4129, DOI 10.1093/rfs/hhp022; Brown MRG, 2012, NEUROIMAGE, V63, P434, DOI 10.1016/j.neuroimage.2012.06.056; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Del Guercio D., 2010, 16312 NBER; Elliott R, 1998, NEUROIMAGE, V8, P17, DOI 10.1006/nimg.1998.0344; Engelmann JB, 2012, SOC COGN AFFECT NEUR, V7, P557, DOI 10.1093/scan/nss050; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; French KR, 2008, J FINANC, V63, P1537, DOI 10.1111/j.1540-6261.2008.01368.x; Gruber MJ, 1996, J FINANC, V51, P783, DOI 10.2307/2329222; Hargreaves IS, 2012, BRAIN LANG, V120, P73, DOI 10.1016/j.bandl.2011.10.004; Harrison G.W., 1994, EMPIR ECON, P43, DOI DOI 10.1007/BF01175873; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Inderst R, 2012, J EC LIT, V50; JENSEN MC, 1968, J FINANC, V23, P389, DOI 10.2307/2325404; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kim KK, 2011, EPILEPSY BEHAV, V20, P613, DOI 10.1016/j.yebeh.2010.11.010; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Loh RK, 2011, REV FINANC STUD, V24, P593, DOI 10.1093/rfs/hhq094; Luu P., 2004, COGNITIVE NEUROSCIEN; Malkiel B. G., 2003, RANDOM WALK WALL STR; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Meshi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049748; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Paulus MP, 2004, BIOL PSYCHIAT, V55, P1179, DOI 10.1016/j.biopsych.2004.02.023; Paulus MP, 2004, NEUROIMAGE, V21, P733, DOI 10.1016/j.neuroimage.2003.09.060; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; SCHARFSTEIN DS, 1990, AM ECON REV, V80, P465; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Singh S., 2008, TRICK TREATMENT ALTE; Sjoberg L, 2009, J BEHAV FINANC, V10, P33, DOI 10.1080/15427560902728712; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; TAYLOR JG, 1979, NATURE, V279, P631, DOI 10.1038/279631a0; TRUEMAN B, 1994, REV FINANC STUD, V7, P97, DOI 10.1093/rfs/7.1.97; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; WILCOX NT, 1993, ECON J, V103, P1397, DOI 10.2307/2234473	50	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87321	10.1371/journal.pone.0087321	http://dx.doi.org/10.1371/journal.pone.0087321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475270	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800094
J	Larocque, K; Ovadje, P; Djurdjevic, S; Mehdi, M; Green, J; Pandey, S				Larocque, Kristen; Ovadje, Pamela; Djurdjevic, Sinisa; Mehdi, Mariam; Green, James; Pandey, Siyaram			Novel Analogue of Colchicine Induces Selective Pro-Death Autophagy and Necrosis in Human Cancer Cells	PLOS ONE			English	Article							VASCULAR-TARGETING AGENT; PANCREATIC-CANCER; APOPTOSIS; ZD6126; DEATH; GEMCITABINE; INHIBITION; TRIAL	Colchicine, a natural product of Colchicum autumnae currently used for gout treatment, is a tubulin targeting compound which inhibits microtubule formation by targeting fast dividing cells. This tubulin-targeting property has lead researchers to investigate the potential of colchicine and analogs as possible cancer therapies. One major study conducted on an analogue of allocolchicine, ZD 6126, was halted in phase 2 clinical trials due to severe cardio-toxicity associated with treatment. This study involves the development and testing of novel allocolchicine analogues that hold non-toxic anti-cancer properties. Currently we have synthesized and evaluated the anti-cancer activities of two analogues; N-acetyl-O-methylcolchinol (NSC 51046 or NCME), which is structurally similar to ZD 6126, and (S)-3,8,9,10-tetramethoxyallocolchicine (Green 1), which is a novel derivative of allocolchicine that is isomeric in the A ring. NSC 51046 was found to be non-selective as it induced apoptosis in both BxPC-3 and PANC-1 pancreatic cancer cells and in normal human fibroblasts. Interestingly, we found that Green 1 was able to modestly induce pro-death autophagy in these pancreatic cancer cells and E6-1 leukemia cells but not in normal human fibroblasts. Unlike colchicine and NSC 51046, Green 1 does not appear to affect tubulin polymerization indicating that it has a different molecular target. Green 1 also caused increased reactive oxygen species (ROS) production in mitochondria isolated from pancreatic cancer cells. Furthermore, in vivo studies revealed that Green 1 was well tolerated in mice. Our findings suggest that a small change in the structure of colchicine has apparently changed the mechanism of action and lead to improved selectivity. This may lead to better selective treatments in cancer therapy.	[Larocque, Kristen; Ovadje, Pamela; Djurdjevic, Sinisa; Mehdi, Mariam; Green, James; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020	Green, James/0000-0003-2334-4503	Windsor and Essex County Cancer Center Foundation's Seeds4Hope Grant; NSERC Discovery Grant program	Windsor and Essex County Cancer Center Foundation's Seeds4Hope Grant; NSERC Discovery Grant program(Natural Sciences and Engineering Research Council of Canada (NSERC))	The Windsor and Essex County Cancer Center Foundation's Seeds4Hope Grant and NSERC Discovery Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Blakey DC, 2002, CLIN CANCER RES, V8, P1974; Boyer FD, 2010, BIOORG CHEM, V38, P149, DOI 10.1016/j.bioorg.2010.03.003; Buttner F, 2005, BIOORGAN MED CHEM, V13, P3497, DOI 10.1016/j.bmc.2005.02.059; Canada S, 2013, CANADIAN CANC STAT S, P1; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Davis PD, 2002, CANCER RES, V62, P7247; Djurdjevic S, 2010, J ORG CHEM, V75, P8241, DOI 10.1021/jo101953n; Eckel F, 2006, EXPERT OPIN INV DRUG, V15, P1395, DOI 10.1517/13543784.15.11.1395; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; GOLDFINGER SE, 1972, NEW ENGL J MED, V287, P1302; Goto H, 2004, CLIN CANCER RES, V10, P7671, DOI 10.1158/1078-0432.CCR-04-1171; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KERSHENOBICH D, 1988, NEW ENGL J MED, V318, P1709, DOI 10.1056/NEJM198806303182602; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; LoRusso PM, 2008, INVEST NEW DRUG, V26, P159, DOI 10.1007/s10637-008-9112-9; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; MACKAY MF, 1989, ACTA CRYSTALLOGR C, V45, P795, DOI 10.1107/S0108270188013794; MARGULIS TN, 1978, BIOCHEM BIOPH RES CO, V83, P472, DOI 10.1016/0006-291X(78)91014-8; Ovadje P, 2012, PANCREAS, V41, P1039, DOI 10.1097/MPA.0b013e31824b22a2; Rothenberg ML, 1996, ANN ONCOL, V7, P347; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; SU WPD, 1995, SEMIN DERMATOL, V14, P173; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	36	52	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87064	10.1371/journal.pone.0087064	http://dx.doi.org/10.1371/journal.pone.0087064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466327	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000189
J	Avisetti, DR; Babu, KS; Kalivendi, SV				Avisetti, Deepa R.; Babu, K. Suresh; Kalivendi, Shasi V.			Activation of p38/JNK Pathway Is Responsible for Embelin Induced Apoptosis in Lung Cancer Cells: Transitional Role of Reactive Oxygen Species	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; NUCLEAR-FACTOR; INHIBITOR; PROTEIN; SURVIVAL; BREAST; CONTRIBUTES; SUPPRESSION; CASCADES	The natural product embelin has been demonstrated to possess a wide range of therapeutic properties, however, the mechanisms by which it exerts anticancer effects are not yet clear. By monitoring the molecular changes associated during early apoptotic phase, we have identified the crucial role of oxidative stress induced MAP kinase signalling as a predominant mechanism for its anticancer effects. Treatment of A549 lung cancer cells with embelin resulted in the enhancement of phospho-p38 and phospho-JNK levels as early as 4h. Pretreatment of cells with specific inhibitors of p38 (PD169316) and JNK (SP600125) abrogated embelin-induced caspase-3 activation. Studies employing embelin in the presence or absence of specific MAP kinase inhibitors indicated that the observed changes in phosphorylation levels of p38, JNK and ERK 1/2 are solely due to embelin and not because of cross-talk between MAP kinases. Reactive oxygen species (ROS) play a crucial role in embelin induced alterations in MAP kinase phosphorylation and apoptosis as pretreatment of cells with FeTMPyP mitigated this effect. The observed changes are not due to the inhibitory effect of embelin on XIAP as cells treated with SMAC-N7-Ant peptide, a specific inhibitor of XIAP's BIR3 domain did not mimic embelin induced apoptotic effects. The findings of the present study clearly indicate the crucial role of p38 and JNK pathways in embelin induced apoptosis and provide us with new clues for improving its therapeutic efficacy.	[Avisetti, Deepa R.; Kalivendi, Shasi V.] CSIR Indian Inst Chem Technol CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India; [Avisetti, Deepa R.; Kalivendi, Shasi V.] CSIR Indian Inst Chem Technol CSIR IICT, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India; [Babu, K. Suresh] CSIR Indian Inst Chem Technol CSIR IICT, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Kalivendi, SV (corresponding author), CSIR Indian Inst Chem Technol CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India.	kalivendi@iict.res.in		Avisetti, Deepa/0000-0003-4744-1068	SMiLE project from CSIR, India; UGC, India	SMiLE project from CSIR, India; UGC, India(University Grants Commission, India)	This work was supported by SMiLE project from CSIR, India. Senior Research Fellowship to DRA from UGC, India, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Allensworth JL, 2012, MOL CANCER THER, V11, P1518, DOI 10.1158/1535-7163.MCT-11-0787; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chaudhari HS, 2012, PLANTA MED, V78, P651, DOI 10.1055/s-0031-1298379; CHITRA M, 1994, CHEMOTHERAPY, V40, P109, DOI 10.1159/000239181; Chitra M, 2003, FITOTERAPIA, V74, P401, DOI 10.1016/S0367-326X(03)00066-2; Chitra M., 2003, Indian Journal of Pharmacology, V35, P241; Dai Y, 2009, CANCER RES, V69, P4776, DOI 10.1158/0008-5472.CAN-08-4754; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Fandy TE, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-60; Gandhi GR, 2013, BBA-GEN SUBJECTS, V1830, P2243, DOI 10.1016/j.bbagen.2012.10.016; Githiori JB, 2003, VET PARASITOL, V118, P215, DOI 10.1016/j.vetpar.2003.10.006; Gurtu V, 1997, ANAL BIOCHEM, V251, P98, DOI 10.1006/abio.1997.2220; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hussain AR, 2010, J PATHOL, V222, P180, DOI 10.1002/path.2747; JOHRI RK, 1991, CONTRACEPTION, V44, P549, DOI 10.1016/0010-7824(91)90157-B; Joshi R, 2009, J MOL STRUCT, V928, P46, DOI 10.1016/j.molstruc.2009.03.010; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; Konorev EA, 2008, FREE RADICAL BIO MED, V45, P1723, DOI 10.1016/j.freeradbiomed.2008.09.006; Lin ZH, 2013, CHEM BIOL, V20, P253, DOI 10.1016/j.chembiol.2013.01.002; Lu JQ, 2013, BIOMATERIALS, V34, P1591, DOI 10.1016/j.biomaterials.2012.10.073; MAKAWITI DW, 1990, FEBS LETT, V266, P26, DOI 10.1016/0014-5793(90)81497-C; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Park SY, 2013, J PHARMACOL SCI, V121, P192, DOI 10.1254/jphs.12137FP; Schaible AM, 2013, BIOCHEM PHARMACOL, V86, P476, DOI 10.1016/j.bcp.2013.04.015; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	34	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87050	10.1371/journal.pone.0087050	http://dx.doi.org/10.1371/journal.pone.0087050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466324	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100247
J	Kunecke, J; Hildebrandt, A; Recio, G; Sommer, W; Wilhelm, O				Kuenecke, Janina; Hildebrandt, Andrea; Recio, Guillermo; Sommer, Werner; Wilhelm, Oliver			Facial EMG Responses to Emotional Expressions Are Related to Emotion Perception Ability	PLOS ONE			English	Article							ZYGOMATICUS-MAJOR; SOCIAL-CONTEXT; MIMICRY; FACE; INFORMATION; PERFORMANCE; SIMULATION; CONTAGION; JUDGMENT; MUSCLE	Although most people can identify facial expressions of emotions well, they still differ in this ability. According to embodied simulation theories understanding emotions of others is fostered by involuntarily mimicking the perceived expressions, causing a "reactivation" of the corresponding mental state. Some studies suggest automatic facial mimicry during expression viewing; however, findings on the relationship between mimicry and emotion perception abilities are equivocal. The present study investigated individual differences in emotion perception and its relationship to facial muscle responses recorded with electromyogram (EMG) - in response to emotional facial expressions. Nu = degrees 269 participants completed multiple tasks measuring face and emotion perception. EMG recordings were taken from a subsample (N degrees = degrees 110) in an independent emotion classification task of short videos displaying six emotions. Confirmatory factor analyses of the m. corrugator supercilii in response to angry, happy, sad, and neutral expressions showed that individual differences in corrugator activity can be separated into a general response to all faces and an emotion-related response. Structural equation modeling revealed a substantial relationship between the emotion-related response and emotion perception ability, providing evidence for the role of facial muscle activation in emotion perception from an individual differences perspective.	[Kuenecke, Janina; Hildebrandt, Andrea; Recio, Guillermo; Sommer, Werner] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Recio, Guillermo; Wilhelm, Oliver] Univ Ulm, Dept Psychol, D-89069 Ulm, Germany	Humboldt University of Berlin; Ulm University	Kunecke, J (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.	janina.kuenecke@hu-berlin.de	Sommer, Werner/N-1945-2019; Wilhelm, Oliver/K-6455-2012; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Wilhelm, Oliver/0000-0001-7980-1166	German Research Foundation [WI2667/2-4]	German Research Foundation(German Research Foundation (DFG))	This research was supported by the German Research Foundation, Grant No. WI2667/2-4 to Oliver Wilhelm and Werner Sommer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrosoft, 2010, FANTAMORPH VERS 5 0; Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019; Aguado L, 2013, SPAN J PSYCHOL, V16, DOI 10.1017/sjp.2013.31; Bailey PE, 2009, PSYCHOL AGING, V24, P224, DOI 10.1037/a0014112; Beffara B, 2012, COGN PROCESS, V13, pS103, DOI 10.1007/s10339-012-0468-6; BERENBAUM H, 1992, J ABNORM PSYCHOL, V101, P37, DOI 10.1037/0021-843X.101.1.37; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Carroll JM, 1997, J PERS SOC PSYCHOL, V72, P164, DOI 10.1037/0022-3514.72.1.164; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; Dezecache G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067371; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; EKMAN P, 1979, ANNU REV PSYCHOL, V30, P527, DOI 10.1146/annurev.ps.30.020179.002523; Ekman P., 2002, FACIAL ACTION CODING; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Fujimura T, 2010, INT J PSYCHOPHYSIOL, V76, P88, DOI 10.1016/j.ijpsycho.2010.02.008; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Herzmann G, 2008, BEHAV RES METHODS, V40, P840, DOI 10.3758/BRM.40.3.840; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hess U, 2010, BIOL PSYCHOL, V84, P514, DOI 10.1016/j.biopsycho.2009.11.001; Hildebrandt A, 2013, SPECIFICITY INDIVIDU; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hurley S, 2008, PHILOS PHENOMEN RES, V77, P755, DOI 10.1111/j.1933-1592.2008.00220.x; Kappas A, 2000, MOTIV EMOTION, V24, P259, DOI 10.1023/A:1010718815960; Kappas A, 2013, INT SOC RES EM ISRE; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Lishner DA, 2008, J NONVERBAL BEHAV, V32, P225, DOI 10.1007/s10919-008-0053-y; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; McDonald RP, 1999, TEST THEORY UNIFIED; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Muthen B., 2010, MPLUS USERS GUIDE; Neal DT, 2011, SOC PSYCHOL PERS SCI, V2, P673, DOI 10.1177/1948550611406138; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Pessa JE, 1998, CLIN ANAT, V11, P310, DOI 10.1002/(SICI)1098-2353(1998)11:5<310::AID-CA3>3.0.CO;2-T; Recio G, 2013, RECOGNIZING DY UNPUB; Recio G, 2009, BIOL PSYCHOL, V80, P246, DOI 10.1016/j.biopsycho.2008.10.007; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Silvestrini N, 2009, BIOL PSYCHOL, V82, P54, DOI 10.1016/j.biopsycho.2009.05.005; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Surakka V, 1998, INT J PSYCHOPHYSIOL, V29, P23, DOI 10.1016/S0167-8760(97)00088-3; VANBOXTEL A, 1993, PSYCHOPHYSIOLOGY, V30, P589, DOI 10.1111/j.1469-8986.1993.tb02085.x; VanBoxtel A, 1996, PSYCHOPHYSIOLOGY, V33, P576; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; WATERINK W, 1994, BIOL PSYCHOL, V37, P183, DOI 10.1016/0301-0511(94)90001-9; Wilhelm O, 2013, TASK BATTERY M UNPUB; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989	62	85	87	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84053	10.1371/journal.pone.0084053	http://dx.doi.org/10.1371/journal.pone.0084053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489647	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000004
J	Nigro, S; Cerasa, A; Zito, G; Perrotta, P; Chiaravalloti, F; Donzuso, G; Fera, F; Bilotta, E; Pantano, P; Quattrone, A				Nigro, Salvatore; Cerasa, Antonio; Zito, Giancarlo; Perrotta, Paolo; Chiaravalloti, Francesco; Donzuso, Giulia; Fera, Franceso; Bilotta, Eleonora; Pantano, Pietro; Quattrone, Aldo		Alzheimer's Dis Neuroimaging	Fully Automated Segmentation of the Pons and Midbrain Using Human T1 MR Brain Images	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CLASSIFICATION; DEFORMATION; NUCLEUS; DISEASE; REGION; PLANE; MODEL	Purpose: This paper describes a novel method to automatically segment the human brainstem into midbrain and pons, called LABS: Landmark-based Automated Brainstem Segmentation. LABS processes high-resolution structural magnetic resonance images (MRIs) according to a revised landmark-based approach integrated with a thresholding method, without manual interaction. Methods: This method was first tested on morphological T1-weighted MRIs of 30 healthy subjects. Its reliability was further confirmed by including neurological patients (with Alzheimer's Disease) from the ADNI repository, in whom the presence of volumetric loss within the brainstem had been previously described. Segmentation accuracies were evaluated against expert-drawn manual delineation. To evaluate the quality of LABS segmentation we used volumetric, spatial overlap and distance-based metrics. Results: The comparison between the quantitative measurements provided by LABS against manual segmentations revealed excellent results in healthy controls when considering either the midbrain (DICE measures higher that 0.9; Volume ratio around 1 and Hausdorff distance around 3) or the pons (DICE measures around 0.93; Volume ratio ranging 1.024-1.05 and Hausdorff distance around 2). Similar performances were detected for AD patients considering segmentation of the pons (DICE measures higher that 0.93; Volume ratio ranging from 0.97-0.98 and Hausdorff distance ranging 1.07-1.33), while LABS performed lower for the midbrain (DICE measures ranging 0.86-0.88; Volume ratio around 0.95 and Hausdorff distance ranging 1.71-2.15). Conclusions: Our study represents the first attempt to validate a new fully automated method for in vivo segmentation of two anatomically complex brainstem subregions. We retain that our method might represent a useful tool for future applications in clinical practice.	[Nigro, Salvatore; Cerasa, Antonio; Perrotta, Paolo; Donzuso, Giulia; Quattrone, Aldo] CNR, Inst Bioimaging & Mol Physiol, Catanzaro, Italy; [Cerasa, Antonio; Quattrone, Aldo] Magna Graecia Univ Catanzaro, Inst Neurol, Catanzaro, Italy; [Zito, Giancarlo] CNR, Lab Electrophysiol Translat Neurosci, Rome, Italy; [Zito, Giancarlo] S Giovanni Calibita Fatebenefratelli Hosp, Dept Clin Neurosci, Rome, Italy; [Chiaravalloti, Francesco; Bilotta, Eleonora; Pantano, Pietro] Univ Calabria, Evolutionary Syst Grp, I-87036 Cosenza, Italy; [Fera, Franceso] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); University of Calabria; Magna Graecia University of Catanzaro	Cerasa, A (corresponding author), CNR, Inst Bioimaging & Mol Physiol, Catanzaro, Italy.	a.cerasa@unicz.it	Donzuso, Giulia/AAY-8502-2020; cerasa, antonio/E-8614-2011; Chiaravalloti, Francesco/B-3974-2017; QUATTRONE, Aldo/A-6734-2016; Nigro, Salvatore/L-7210-2019	Donzuso, Giulia/0000-0003-4925-694X; cerasa, antonio/0000-0002-8022-4770; Chiaravalloti, Francesco/0000-0002-9394-5550; QUATTRONE, Aldo/0000-0003-2001-957X; Nigro, Salvatore/0000-0001-7566-7983; Bilotta, Eleonora/0000-0002-1902-813X; Zito, Giancarlo/0000-0002-6766-5483	Consiglio Nazionale delle Ricerche; ADNI (National Institutes of Health (NIH) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER	Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); ADNI (National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Core funding for this work was supported by the Consiglio Nazionale delle Ricerche "Ageing Project''. Data collection and sharing for the Alzheimer's Disease Neuroimaging Initiative (ADNI) data used in this project was funded by the ADNI (National Institutes of Health (NIH) Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the United States Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the NIH (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 1997, J NEUROL SCI, V152, P210, DOI 10.1016/S0022-510X(97)00166-4; Babalola KO, 2008, LECT NOTES COMPUT SC, V5241, P409, DOI 10.1007/978-3-540-85988-8_49; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; BRUMMER ME, 1991, IEEE T MED IMAGING, V10, P74, DOI 10.1109/42.75613; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Free SL, 2001, NEUROIMAGE, V13, P801, DOI 10.1006/nimg.2001.0748; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2009.00997.x, 10.1111/j.1365-2990.2008.00997.x]; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VI, P28, DOI DOI 10.1109/MRA.2011.941638; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Khan AR, 2008, NEUROIMAGE, V41, P735, DOI 10.1016/j.neuroimage.2008.03.024; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Lambert C, 2013, NEUROIMAGE-CLIN, V2, P684, DOI 10.1016/j.nicl.2013.04.017; LI CL, 1993, IEEE T MED IMAGING, V12, P740, DOI 10.1109/42.251125; Liang LC, 2007, NEUROIMAGE, V34, P1160, DOI 10.1016/j.neuroimage.2006.07.046; Liu YX, 2001, IEEE T MED IMAGING, V20, P175, DOI 10.1109/42.918469; Luft AR, 1999, CEREB CORTEX, V9, P712, DOI 10.1093/cercor/9.7.712; Maes F, 1999, LECT NOTES COMPUT SC, V1679, P348; Marais P, 2000, MED IMAGE ANAL, V4, P283, DOI 10.1016/S1361-8415(00)00020-7; Marais P, 1996, LECT NOTES COMPUT SC, V1131, P411, DOI 10.1007/BFb0046981; Massey LA, 2013, NEUROLOGY, V80, P1856, DOI 10.1212/WNL.0b013e318292a2d2; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patenaude B, 2007, THESIS OXFORD U OXFO; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Prima S, 2002, IEEE T MED IMAGING, V21, P122, DOI 10.1109/42.993131; Prima S, 2013, PROC SPIE, V8669, DOI 10.1117/12.2007075; Quattrone A, 2008, RADIOLOGY, V246, P214, DOI 10.1148/radiol.2453061703; Rohlfing T, 2004, IEEE T MED IMAGING, V23, P983, DOI 10.1109/TMI.2004.830803; Simic G, 2009, NEUROPATH APPL NEURO, V35, P532, DOI 10.1111/j.1365-2990.2009.01038.x; Sun CM, 1997, IEEE T PATTERN ANAL, V19, P164, DOI 10.1109/34.574800; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Xia Y, 2007, IEEE T MED IMAGING, V26, P509, DOI 10.1109/TMI.2006.891481; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	43	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85618	10.1371/journal.pone.0085618	http://dx.doi.org/10.1371/journal.pone.0085618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489664	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000015
J	Bray, A; Nieh, J				Bray, Allison; Nieh, James			Non-Consumptive Predator Effects Shape Honey Bee Foraging and Recruitment Dancing	PLOS ONE			English	Article							CRAB-SPIDERS; RISK; POLLINATORS; METAANALYSIS; ECOLOGY; FLOWERS; PLANT; COST; SIZE; FOOD	Predators can reduce bee pollination and plant fitness through successful predation and non-consumptive effects. In honey bees, evidence of predation or a direct attack can decrease recruitment dancing and thereby magnify the effects of individual predation attempts at a colony level. However, actual predation attempts and successes are relatively rare. It was not known if a far more common event, just detection of a predator, could inhibit recruitment. We began by testing honey bees' avoidance of the praying mantis (Tenodera sinensis). Larger predators (later mantis instars, >= 4.5 cm in body length) elicited significantly more avoidance (1.3 fold) than smaller mantis instars. Larger instars also attempted to capture honey bees significantly more often than did smaller instars. Foragers could detect and avoid mantises based upon mantis odor (74% of bees avoided an odor extract) or visual appearance (67% avoided a mantis model). Finally, foragers decreased recruitment dancing by 1.8 fold for a food source with a live adult mantis, even when they were not attacked. This reduction in recruitment dancing, elicited by predator presence alone, expands our understanding of predator non-consumptive effects and of cascading ecosystem effects for plants served by an important generalist pollinator.	[Bray, Allison; Nieh, James] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bray, A (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA.	alliebray@gmail.com	Nieh, James C/H-8705-2014	Nieh, James C/0000-0001-6237-0726	University of California Academic Senate	University of California Academic Senate(University of California System)	The University of California Academic Senate (http://senate.ucsd.edu/rgc/calls/bridge.htm) provided financial support for these experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; [Anonymous], ANN REPORT BOARD REG; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Bolbroe T, 2000, ANN ZOOL FENN, V37, P169; Brechbuhl R, 2010, BASIC APPL ECOL, V11, P76, DOI 10.1016/j.baae.2009.07.001; BROMLEY S. W., 1948, JOUR NEW YORK ENT SOC, V56, P195; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; CARTAR RV, 1991, ETHOLOGY, V87, P90, DOI 10.1111/j.1439-0310.1991.tb01191.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 2003, J COMP PHYSIOL A, V189, P47, DOI 10.1007/s00359-002-0374-y; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; EVANS CS, 1993, ANIM BEHAV, V46, P1, DOI 10.1006/anbe.1993.1156; Fagan WF, 2002, ECOL ENTOMOL, V27, P385, DOI 10.1046/j.1365-2311.2002.00425.x; Gardner KE, 2008, ANIM BEHAV, V75, P1291, DOI 10.1016/j.anbehav.2007.09.032; Ginzel MD, 2003, J CHEM ECOL, V29, P533, DOI 10.1023/A:1022894419521; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Haynes K.F., 1998, METHODS CHEM ECOLOGY; Heiling AM, 2004, P ROY SOC B-BIOL SCI, V271, pS196, DOI 10.1098/rsbl.2003.0138; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Horridge A, 2003, J INSECT PHYSIOL, V49, P1145, DOI 10.1016/j.jinsphys.2003.08.008; Hurd L.E., 1989, Entomologist, V108, P223; Ings TC, 2009, P ROY SOC B-BIOL SCI, V276, P2031, DOI 10.1098/rspb.2008.1748; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Jones EI, 2010, OIKOS, V119, P835, DOI 10.1111/j.1600-0706.2009.17841.x; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Lichtenberg EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P763, DOI 10.1007/s00265-010-1080-3; LOUDA SM, 1982, OECOLOGIA, V55, P185, DOI 10.1007/BF00384486; McMonigle O., 2008, PRAYING MANTIDS KEEP; MORSE DH, 1979, OECOLOGIA, V39, P309, DOI 10.1007/BF00345442; MORSE DH, 1986, OIKOS, V46, P223, DOI 10.2307/3565470; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Orrock JL, 2008, ECOLOGY, V89, P2426, DOI 10.1890/07-1024.1; Palleroni A, 2005, ANIM COGN, V8, P200, DOI 10.1007/s10071-004-0250-y; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; REITZE M, 1991, OECOLOGIA, V86, P568, DOI 10.1007/BF00318324; Robertson IC, 2005, OIKOS, V109, P577, DOI 10.1111/j.0030-1299.2005.13903.x; Rodriguez-Girones MA, 2012, OIKOS, V121, P1473, DOI 10.1111/j.1600-0706.2011.19473.x; Romero GQ, 2004, ECOLOGY, V85, P446, DOI 10.1890/02-0327; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; Schwarz C.J., 2011, SAMPLING REGRESSION, P57; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sen Sarma M, 2002, ZOOLOGY, V105, P215, DOI 10.1078/0944-2006-00064; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	57	17	17	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87459	10.1371/journal.pone.0087459	http://dx.doi.org/10.1371/journal.pone.0087459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475292	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300187
J	Bruells, CS; Bergs, I; Rossaint, R; Du, J; Bleilevens, C; Goetzenich, A; Weis, J; Wiggs, MP; Powers, SK; Hein, M				Bruells, Christian S.; Bergs, Ingmar; Rossaint, Rolf; Du, Jun; Bleilevens, Christian; Goetzenich, Andreas; Weis, Joachim; Wiggs, Michael P.; Powers, Scott K.; Hein, Marc			Recovery of Diaphragm Function following Mechanical Ventilation in a Rodent Model	PLOS ONE			English	Article							OXIDATIVE STRESS; DYSFUNCTION; EXPRESSION; CALPAIN; FAILURE; RAT	Background: Mechanical ventilation (MV) induces diaphragmatic muscle fiber atrophy and contractile dysfunction (ventilator induced diaphragmatic dysfunction, VIDD). It is unknown how rapidly diaphragm muscle recovers from VIDD once spontaneous breathing is restored. We hypothesized that following extubation, the return to voluntary breathing would restore diaphragm muscle fiber size and contractile function using an established rodent model. Methods: Following 12 hours of MV, animals were either euthanized or, after full wake up, extubated and returned to voluntary breathing for 12 hours or 24 hours. Acutely euthanized animals served as controls (each n = 8/group). Diaphragmatic contractility, fiber size, protease activation, and biomarkers of oxidative damage in the diaphragm were assessed. Results: 12 hours of MV induced VIDD. Compared to controls diaphragm contractility remained significantly depressed at 12 h after extubation but rebounded at 24 h to near control levels. Diaphragmatic levels of oxidized proteins were significantly elevated after MV (p = 0.002) and normalized at 24 hours after extubation. Conclusions: These findings indicate that diaphragm recovery from VIDD, as indexed by fiber size and contractile properties, returns to near control levels within 24 hours after returning to spontaneous breathing. Besides the down-regulation of proteolytic pathways and oxidative stress at 24 hours after extubation further repairing mechanisms have to be determined.	[Bruells, Christian S.; Bergs, Ingmar; Rossaint, Rolf; Du, Jun; Bleilevens, Christian; Hein, Marc] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Surg Intens & Intermediate Care, Aachen, Germany; [Bruells, Christian S.; Bergs, Ingmar; Rossaint, Rolf; Du, Jun; Bleilevens, Christian; Hein, Marc] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Goetzenich, Andreas] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Cardiothorac & Vasc Surg, Aachen, Germany; [Weis, Joachim] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Inst Neuropathol, Aachen, Germany; [Weis, Joachim] Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, JARA Translat Brain Med, Aachen, Germany; [Wiggs, Michael P.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; State University System of Florida; University of Florida	Bruells, CS (corresponding author), Univ Excellence, Rhein Westfal TH Aachen, Univ Hosp, Dept Surg Intens & Intermediate Care, Aachen, Germany.	cbruells@ukaachen.de	Bleilevens, Christian/AAG-8034-2020; Weis, Joachim/G-1984-2014	Bleilevens, Christian/0000-0002-2104-1843; Weis, Joachim/0000-0003-3280-6773	Deutsche Forschungsgemeinschaft [RO 2000/14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been funded by the Deutsche Forschungsgemeinschaft (RO 2000/14). CSB was research fellow of the medical faculty of the RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZUETO A, 1992, J APPL PHYSIOL, V72, P529, DOI 10.1152/jappl.1992.72.2.529; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC; Cholette J, 2009, CRIT CARE MED, V37, pA434, DOI 10.1097/CCM.0b013e3181b6e760; Criswell DS, 2003, CHEST, V124, P2302, DOI 10.1378/chest.124.6.2302; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Frutos-Vivar F, 2011, J CRIT CARE, V26, P502, DOI 10.1016/j.jcrc.2010.12.015; Gayan-Ramirez G, 2003, INTENS CARE MED, V29, P825, DOI 10.1007/s00134-003-1688-0; Huang TT, 2011, J THORAC CARDIOV SUR, V142, P1214, DOI 10.1016/j.jtcvs.2011.02.025; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Jaber S, 2008, ANESTHESIOLOGY, V108, P651, DOI 10.1097/ALN.0b013e31816725a6; Jaber S, 2011, CRIT CARE, V15, DOI 10.1186/cc10023; Jiang TX, 1998, AM J RESP CRIT CARE, V157, P736, DOI 10.1164/ajrccm.157.3.9707056; KILARSKI W, 1990, J ANAT, V168, P13; Levine S, 1997, NEW ENGL J MED, V337, P1799, DOI 10.1056/NEJM199712183372503; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; McClung JM, 2007, FASEB J, V21, pA1306; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Quinnell TG, 2006, CHEST, V129, P133, DOI 10.1378/chest.129.1.133; Richard C, 2005, INTENS CARE MED, V31, P1605, DOI 10.1007/s00134-005-2698-x; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Thomas D, 2013, J APPL PHYSIOL, V115, P775, DOI 10.1152/japplphysiol.00302.2012; Van Gammeren D, 2005, CHEST, V127, P2204, DOI 10.1378/chest.127.6.2204; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008	29	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87460	10.1371/journal.pone.0087460	http://dx.doi.org/10.1371/journal.pone.0087460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475293	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300188
J	Forcey, DS; Hocking, JS; Tabrizi, SN; Bradshaw, CS; Chen, MY; Fehler, G; Nash, JL; Fairley, CK				Forcey, Dana S.; Hocking, Jane S.; Tabrizi, Sepehr N.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fehler, Glenda; Nash, Jessica L.; Fairley, Christopher K.			Chlamydia Detection during the Menstrual Cycle: A Cross-Sectional Study of Women Attending a Sexual Health Service	PLOS ONE			English	Article							TRACHOMATIS; TIME; IMPACT; PERFORMANCE; AUSTRALIA; TRACT; LOAD; PCR	Background: We investigated the detection of chlamydia at different stages of the menstrual cycle. Methods: Electronic medical records for women attending Melbourne Sexual Health Centre between March 2011 and 31st December 2012, who were tested for chlamydia by nucleic acid amplification of high vaginal, cervical, or urinary samples, and who recorded a date of last normal menstrual period (LNMP) between 0-28 days were included in the analysis. Logistic regression was used to calculate adjusted odds ratio (aOR) and 95% confidence intervals (CI) for the association of chlamydia with menstrual cycle adjusted by demographics and behavioural variables. Chlamydia and beta globin load were determined on those with stored samples. Results: Of the 10,017 consultations that included a test for chlamydia and a valid LNMP, there were 417 in which chlamydia was detected. The proportion of samples with chlamydia was greater in the luteal phase (4.8%, 184/3831) than in the follicular phase (3.4%, 233/6816) both in the crude (OR 1.29 95% CI 1.1-1.6, p = 0.01) and adjusted odds ratio (aOR) 1.4 (95% CI 1.1-1.8, p = 0.004). Among women using hormonal contraception, there was no significant association with the luteal phase of the menstrual cycle (aOR 1.3, 95% CI 0.9, 1.8, p = 0.18). Among women not using hormonal contraception, there was a significant association with the luteal phase (aOR 1.6, (95% CI 1.1-2.3, p = 0.007). The chlamydia load was not significantly different in the 329 positive stored samples in weeks 3 and 4 vs weeks 1 and 2 for any site (P>0.12). Conclusions: The higher detection of chlamydia detection in the luteal phase of the menstrual cycle in only those not taking hormonal contraception suggest that hormonal factors influence chlamydia detection. The absence of a significantly highly chlamydia load in women during the luteal phase raises questions about the mechanism.	[Forcey, Dana S.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fehler, Glenda; Nash, Jessica L.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Forcey, Dana S.; Hocking, Jane S.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fehler, Glenda] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.] Royal Hosp Women, Dept Clin Microbiol & Infect Dis, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia	University of Melbourne; University of Melbourne; Monash University	Fairley, CK (corresponding author), Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	cfairley@mshc.org.au	Hocking, Jane/AAD-5203-2021	Hocking, Jane/0000-0001-9329-8501; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Health and Medical Research Council [568971]; NHMRC [568971]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study was provided by the National Health and Medical Research Council program grant (ID 568971) and an NHMRC Program grant (568971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Crowley T, 1997, INT J STD AIDS, V8, P25, DOI 10.1258/0956462971918724; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Horner PJ, 1998, LANCET, V351, P341, DOI 10.1016/S0140-6736(05)78335-5; Jensen NWJ, 1999, 99 GEN M AM SOC MICR; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Lee DM, 2005, SEX TRANSM INFECT, V81, P434, DOI 10.1136/sti.2004.014431; Marrazzo JM, 2005, J CLIN MICROBIOL, V43, P577, DOI 10.1128/JCM.43.2.577-584.2005; MCCORMACK WM, 1982, JAMA-J AM MED ASSOC, V247, P1292, DOI 10.1001/jama.247.9.1292; Meyers D, 2008, AM FAM PHYSICIAN, V77, P819; Moller JK, 1999, SEX TRANSM INFECT, V75, P228, DOI 10.1136/sti.75.4.228; Newman L, 2010, COMMUN DIS INTELL, V34, P157; O'Rourke KM, 2009, SEX TRANSM DIS, V36, P763, DOI 10.1097/OLQ.0b013e3181b12765; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; ROSENTHAL GE, 1990, J CLIN EPIDEMIOL, V43, P15, DOI 10.1016/0895-4356(90)90051-P; Sonnex C, 1998, SEX TRANSM INFECT, V74, P11, DOI 10.1136/sti.74.1.11; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; SWEET RL, 1986, JAMA-J AM MED ASSOC, V255, P2062, DOI 10.1001/jama.255.15.2062; USALA SJ, 1989, J REPROD MED, V34, P292; VANKOOIJ RJ, 1980, FERTIL STERIL, V34, P226; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; White HD, 1997, J IMMUNOL, V158, P3017; Wiggins R, 2009, J CLIN MICROBIOL, V47, P1824, DOI 10.1128/JCM.00005-09	25	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85263	10.1371/journal.pone.0085263	http://dx.doi.org/10.1371/journal.pone.0085263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475042	Green Published, gold			2022-12-27	WOS:000330507300019
J	Grahnert, A; Richter, T; Piehler, D; Eschke, M; Schulze, B; Muller, U; Protschka, M; Kohler, G; Sabat, R; Brombacher, F; Alber, G				Grahnert, Andreas; Richter, Tina; Piehler, Daniel; Eschke, Maria; Schulze, Bianca; Mueller, Uwe; Protschka, Martina; Koehler, Gabriele; Sabat, Robert; Brombacher, Frank; Alber, Gottfried			IL-4 Receptor-Alpha-Dependent Control of Cryptococcus neoformans in the Early Phase of Pulmonary Infection	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY-MYCOSIS; DENDRITIC CELL MATURATION; PROTECTIVE TH1 RESPONSE; NITRIC-OXIDE; INTERLEUKIN-4 RECEPTOR; INTERFERON-GAMMA; ACTIVATED MACROPHAGES; CYTOKINE PRODUCTION; LEISHMANIA-MAJOR; BINDING-PROTEIN	Cryptococcus neoformans is an opportunistic fungal pathogen that causes lung inflammation and meningoencephalitis in immunocompromised people. Previously we showed that mice succumb to intranasal infection by induction of pulmonary interleukin (IL)-4R alpha-dependent type 2 immune responses, whereas IL-12-dependent type 1 responses confer resistance. In the experiments presented here, IL-4R alpha(-/-) mice unexpectedly show decreased fungal control early upon infection with C. neoformans, whereas wild-type mice are able to control fungal growth accompanied by enhanced macrophage and dendritic cell recruitment to the site of infection. Lower pulmonary recruitment of macrophages and dendritic cells in IL-4R alpha(-/-) mice is associated with reduced pulmonary expression of CCL2 and CCL20 chemokines. Moreover, IFN-gamma and nitric oxide production are diminished in IL-4R alpha(-/-) mice compared to wild-type mice. To directly study the potential mechanism(s) responsible for reduced production of IFN-gamma, conventional dendritic cells were stimulated with C. neoformans in the presence of IL-4 which results in increased IL-12 production and reduced IL-10 production. Together, a beneficial role of early IL-4R alpha signaling is demonstrated in pulmonary cryptococcosis, which contrasts with the well-known IL-4R alpha-mediated detrimental effects in the late phase.	[Grahnert, Andreas; Richter, Tina; Piehler, Daniel; Eschke, Maria; Schulze, Bianca; Mueller, Uwe; Protschka, Martina; Alber, Gottfried] Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, D-04109 Leipzig, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Sabat, Robert] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol, Berlin, Germany; [Brombacher, Frank] ICGEB, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa	Leipzig University; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town	Alber, G (corresponding author), Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, D-04109 Leipzig, Germany.	alber@rz.uni-leipzig.de	Mendez, Fausto R./O-3512-2018	Mendez, Fausto R./0000-0002-5084-1276; Muller, Uwe/0000-0003-1502-9271	Deutsche Forschungsgemeinschaft (German Research Foundation) [AL 371/5-4, SA 1868/2-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation, grant AL 371/5-4 and grant SA 1868/2-1; http://dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre KM, 2000, MED MYCOL, V38, P343, DOI 10.1080/mmy.38.5.343.353; Alexander J, 2008, MICROBES INFECT, V10, P953, DOI 10.1016/j.micinf.2008.07.038; ALSPAUGH JA, 1991, INFECT IMMUN, V59, P2291, DOI 10.1128/IAI.59.7.2291-2296.1991; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Blackstock R, 2004, AM J RESP CELL MOL, V30, P109, DOI 10.1165/rcmb.2003-0156OC; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; Charlier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001950; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chen GH, 2007, AM J PATHOL, V170, P1028, DOI 10.2353/ajpath.2007.060595; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Flesch IEA, 1997, INT IMMUNOL, V9, P467, DOI 10.1093/intimm/9.4.467; Goldman DL, 2006, J INFECT DIS, V193, P1178, DOI 10.1086/501363; Gunn MD, 1997, J IMMUNOL, V158, P376; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hernandez Y, 2005, J IMMUNOL, V174, P1027, DOI 10.4049/jimmunol.174.2.1027; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hoag KA, 1997, AM J RESP CELL MOL, V17, P733, DOI 10.1165/ajrcmb.17.6.2879; HOAG KA, 1995, AM J RESP CELL MOL, V13, P487, DOI 10.1165/ajrcmb.13.4.7546779; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Husain S, 2001, EMERG INFECT DIS, V7, P375; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Kawakami K, 1997, INFECT IMMUN, V65, P1307, DOI 10.1128/IAI.65.4.1307-1312.1997; Kawakami K, 1999, CLIN EXP IMMUNOL, V117, P113; Kawakami K, 1999, CELL IMMUNOL, V197, P55, DOI 10.1006/cimm.1999.1557; LEE SC, 1994, J EXP MED, V180, P365, DOI 10.1084/jem.180.1.365; LOCKSLEY RM, 1991, RES IMMUNOL, V142, P28, DOI 10.1016/0923-2494(91)90007-6; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; Mohrs M, 1999, J IMMUNOL, V162, P7302; Muller U, 2012, MUCOSAL IMMUNOL, V5, P299, DOI 10.1038/mi.2012.9; Muller U, 2008, J INFECT DIS, V198, P1714, DOI 10.1086/593068; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Muller U, 2013, INT IMMUNOL; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; Osterholzer JJ, 2009, J IMMUNOL, V183, P8044, DOI 10.4049/jimmunol.0902823; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Piehler D, 2013, MUCOSAL IMMUNOL, V6, P405, DOI 10.1038/mi.2012.84; Pietrella D, 2005, INFECT IMMUN, V73, P820, DOI 10.1128/IAI.73.2.820-827.2005; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Suzuki Y, 1996, J IMMUNOL, V157, P2564; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Webb DC, 2007, J IMMUNOL, V178, P219, DOI 10.4049/jimmunol.178.1.219; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wozniak KL, 2008, INFECT IMMUN, V76, P4764, DOI 10.1128/IAI.00660-08; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324	59	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87341	10.1371/journal.pone.0087341	http://dx.doi.org/10.1371/journal.pone.0087341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475277	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300172
J	Hamm, JP; Crawford, TJ; Nebl, H; Kean, M; Williams, SCR; Ettinger, U				Hamm, Jeff P.; Crawford, Trevor J.; Nebl, Helmut; Kean, Matthew; Williams, Steven C. R.; Ettinger, Ulrich			Neural Correlates of Illusory Line Motion	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PRIMARY VISUAL-CORTEX; APPARENT MOTION; RESPONSE CONFLICT; HUMAN BRAIN; AREA MT/V5; ATTENTION; ILLUSION; INHIBITION; STIMULUS	Illusory line motion (ILM) refers to a motion illusion in which a flash at one end of a bar prior to the bar's instantaneous presentation or removal results in the percept of motion. While some theories attribute the origin of ILM to attention or early perceptual mechanisms, others have proposed that ILM results from impletion mechanisms that reinterpret the static bar as one in motion. The current functional magnetic resonance imaging study examined participants while they made decisions about the direction of motion in which a bar appeared to be removed. Preceding the instantaneous removal of the bar with a flash at one end resulted in a motion percept away from the flash. If this flash and the bar's removal overlapped in time, it appeared that the bar was removed towards the flash (reverse ILM). Independent of the motion type, brain responses indicated activations in areas associated with motion (MT+), endogenous and exogenous attention (intraparietal sulcus, frontal eye fields, and ventral frontal cortex), and response selection (ACC). ILM was associated with lower percept scores and higher activations in ACC relative to real motion, but no differences in shape-selective areas emerged. This pattern of brain activation is consistent with the attentional gradient model or bottom-up accounts of ILM in preference to impletion.	[Hamm, Jeff P.] Univ Auckland, Sch Psychol, Cognit Neurosci Res Grp, Auckland 1, New Zealand; [Crawford, Trevor J.] Univ Lancaster, Ctr Aging Res, Dept Psychol, Lancaster LA1 4YF, England; [Crawford, Trevor J.] Univ Lancaster, Ctr Human Learning & Dev, Dept Psychol, Lancaster LA1 4YF, England; [Nebl, Helmut] Univ Regensburg, Study Programme Psychol, D-93053 Regensburg, Germany; [Kean, Matthew] Univ Manchester, Manchester, Lancs, England; [Williams, Steven C. R.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Sci, London, England; [Ettinger, Ulrich] Univ Bonn, Dept Psychol, Bonn, Germany	University of Auckland; Lancaster University; Lancaster University; University of Regensburg; University of Manchester; University of London; King's College London; University of Bonn	Hamm, JP (corresponding author), Univ Auckland, Sch Psychol, Cognit Neurosci Res Grp, Auckland 1, New Zealand.	j.hamm@auckland.ac.nz; t.crawford@lancaster.ac.uk; helmut.nebl@ur.de; ulrich.ettinger@uni-bonn.de	Williams, Steve C/D-6979-2011; Ettinger, Ulrich/D-3731-2014; Crawford, Trevor J/N-4237-2015	Williams, Steve C/0000-0003-4299-1941; Ettinger, Ulrich/0000-0002-0160-0281; Crawford, Trevor J/0000-0001-5928-7307; opoku, anita/0000-0001-7243-8157	DFG [ET 31/2-1]; New Zealand Foundation for Research, Science Technology [LANC0401]	DFG(German Research Foundation (DFG)); New Zealand Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology)	Ulrich Ettinger is supported by DFG grant ET 31/2-1. Matt Kean was partly funded by the New Zealand Foundation for Research, Science & Technology (grant no. LANC0401). No further external funding was received for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baloch AA, 1997, VISION RES, V37, P3037, DOI 10.1016/S0042-6989(97)00103-X; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Cartwright D, 1941, AM J PSYCHOL, V54, P174, DOI 10.2307/1416790; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christie J, 2005, PERCEPT PSYCHOPHYS, V67, P1032, DOI 10.3758/BF03193629; Christie J, 2002, CONSCIOUS COGN, V11, P347, DOI 10.1006/ccog.2001.0539; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COWAN N, 1995, PERCEPT PSYCHOPHYS, V57, P546, DOI 10.3758/BF03213079; Crawford TJ, 2006, EXP BRAIN RES, V173, P498, DOI 10.1007/s00221-006-0392-z; Danziger S, 1999, PERCEPT PSYCHOPHYS, V61, P1024, DOI 10.3758/BF03207610; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Downing PE, 1997, J EXP PSYCHOL HUMAN, V23, P768; FAUBERT J, 1995, VISION RES, V35, P3119, DOI 10.1016/0042-6989(95)00061-4; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hamm JP, 2002, PERCEPT PSYCHOPHYS, V64, P279, DOI 10.3758/BF03195792; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; HIKOSAKA O, 1991, INVEST OPHTH VIS SCI, V32, P716; HIKOSAKA O, 1993, PERCEPTION, V22, P517, DOI 10.1068/p220517; HIKOSAKA O, 1993, NEUROSCI RES, V18, P11, DOI 10.1016/0168-0102(93)90100-5; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hubbard TL, 2011, ATTEN PERCEPT PSYCHO, V73, P1133, DOI 10.3758/s13414-010-0081-7; Huk AC, 2002, J NEUROSCI, V22, P7195; Indovina I, 2004, MAGN RESON IMAGING, V22, P1477, DOI 10.1016/j.mri.2004.10.016; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kawamoto M, 1997, NEUROSCI LETT, V231, P49, DOI 10.1016/S0304-3940(97)00539-9; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; LABERGE D, 1986, PERCEPT PSYCHOPHYS, V40, P188, DOI 10.3758/BF03203016; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Larsen A, 2006, J COGNITIVE NEUROSCI, V18, P1174, DOI 10.1162/jocn.2006.18.7.1174; Liu TS, 2004, NEUROIMAGE, V21, P1772, DOI 10.1016/j.neuroimage.2003.12.025; Markounikau V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000919; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Merchant H, 2005, EXP BRAIN RES, V161, P532, DOI 10.1007/s00221-004-2100-1; Muckli L, 2005, PLOS BIOL, V3, P1501, DOI 10.1371/journal.pbio.0030265; Muckli L, 2002, J NEUROSCI, V22; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rangan AV, 2005, P NATL ACAD SCI USA, V102, P18793, DOI 10.1073/pnas.0509481102; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Schmidt WC, 1997, PERCEPTION, V26, P857, DOI 10.1068/p260857; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; STEINMAN BA, 1995, VISION RES, V35, P1859, DOI 10.1016/0042-6989(94)00276-R; Sterzer P, 2006, NEUROIMAGE, V32, P1308, DOI 10.1016/j.neuroimage.2006.05.029; Tanabe HC, 2002, J INT SOC LIFE INFOR, V20, P627; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tse P, 1998, HIGH LEVEL MOTION PR; Tse PU, 2006, NEUROIMAGE, V31, P766, DOI 10.1016/j.neuroimage.2005.12.029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; vonGrunau M, 1996, VISION RES, V36, P2447, DOI 10.1016/0042-6989(95)00330-4; vonGrunau M, 1996, VISION RES, V36, P2433, DOI 10.1016/0042-6989(95)00326-6; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Wilms M, 2010, NEUROIMAGE, V49, P1171, DOI 10.1016/j.neuroimage.2009.09.063; Wohlschlager AM, 2005, NEUROIMAGE, V26, P73, DOI 10.1016/j.neuroimage.2005.01.021; Yan TY, 2011, J MAGN RESON IMAGING, V33, P441, DOI 10.1002/jmri.22404; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; Zhuo Y, 2003, SCIENCE, V299, P417, DOI 10.1126/science.1077091	74	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87595	10.1371/journal.pone.0087595	http://dx.doi.org/10.1371/journal.pone.0087595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475313	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000330507300206
J	Hawkins, ED; Oliaro, J; Ramsbottom, KM; Ting, SB; Sacirbegovic, F; Harvey, M; Kinwell, T; Ghysdael, J; Johnstone, RW; Humbert, PO; Russell, SM				Hawkins, Edwin D.; Oliaro, Jane; Ramsbottom, Kelly M.; Ting, Stephen B.; Sacirbegovic, Faruk; Harvey, Michael; Kinwell, Tanja; Ghysdael, Jacques; Johnstone, Ricky W.; Humbert, Patrick O.; Russell, Sarah M.			Lethal Giant Larvae 1 Tumour Suppressor Activity Is Not Conserved in Models of Mammalian T and B Cell Leukaemia	PLOS ONE			English	Article							SELF-RENEWAL; PAR COMPLEX; IN-VIVO; DIVISION; POLARITY; EXPRESSION; NOTCH1; HUGL-1; LGL; MUTATIONS	In epithelial and stem cells, lethal giant larvae (Lgl) is a potent tumour suppressor, a regulator of Notch signalling, and a mediator of cell fate via asymmetric cell division. Recent evidence suggests that the function of Lgl is conserved in mammalian haematopoietic stem cells and implies a contribution to haematological malignancies. To date, direct measurement of the effect of Lgl expression on malignancies of the haematopoietic lineage has not been tested. In Lgl1(-/-) mice, we analysed the development of haematopoietic malignancies either alone, or in the presence of common oncogenic lesions. We show that in the absence of Lgl1, production of mature white blood cell lineages and long-term survival of mice are not affected. Additionally, loss of Lgl1 does not alter leukaemia driven by constitutive Notch, c-Myc or Jak2 signalling. These results suggest that the role of Lgl1 in the haematopoietic lineage might be restricted to specific co-operating mutations and a limited number of cellular contexts.	[Hawkins, Edwin D.; Oliaro, Jane; Ramsbottom, Kelly M.; Sacirbegovic, Faruk; Harvey, Michael; Johnstone, Ricky W.; Russell, Sarah M.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Hawkins, Edwin D.; Oliaro, Jane; Ramsbottom, Kelly M.; Sacirbegovic, Faruk; Harvey, Michael; Kinwell, Tanja; Johnstone, Ricky W.; Humbert, Patrick O.; Russell, Sarah M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Ting, Stephen B.] Monash Univ, Australian Ctr Blood Dis, Stem Cell Res Grp, Melbourne, Vic 3004, Australia; [Ting, Stephen B.] Alfred Hlth, Melbourne, Vic, Australia; [Kinwell, Tanja; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Ghysdael, Jacques] Ctr Univ Orsay, Inst Curie, F-91405 Orsay, France; [Ghysdael, Jacques] CNRS, UMR 3306, F-91405 Orsay, France; [Ghysdael, Jacques] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Russell, Sarah M.] Swinburne Univ Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Peter Maccallum Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Swinburne University of Technology	Hawkins, ED (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	e.hawkins@imperial.ac.uk; sarah.russell@petermac.org	Johnstone, Ricky w/H-3748-2014; Humbert, Patrick O/L-4264-2016; Russell, Sarah M/B-9341-2009	Johnstone, Ricky w/0000-0001-7053-9237; Humbert, Patrick O/0000-0002-1366-6691; Russell, Sarah M/0000-0001-5826-9641; Hawkins, Edwin/0000-0002-3686-8261; Oliaro, Jane/0000-0002-2097-6428; Harvey, Michael/0000-0003-1699-5412	Australian National Health and Medical Research Council (NHRMC); Human Frontiers Science Program; Australian Research Council (ARC); Australian Cancer Research Foundation (ACRF)	Australian National Health and Medical Research Council (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program(Human Frontier Science Program); Australian Research Council (ARC)(Australian Research Council); Australian Cancer Research Foundation (ACRF)	The work was funded by the Australian National Health and Medical Research Council (NHRMC, project grants and fellowships to EDH, JO, SMR, POH, RWJ, SBT), the Human Frontiers Science Program, the Australian Research Council (ARC, fellowship to SMR) and the Australian Cancer Research Foundation (ACRF, ACRF Cell Biology Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Carron C, 2000, BLOOD, V95, P3891; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Hagn M, 2012, J IMMUNOL, V188, P3886, DOI 10.4049/jimmunol.1103285; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2796; Heidel FH, 2013, J EXP MED, V210, P15, DOI 10.1084/jem.20120596; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Korshunov A, 2006, ACTA NEUROPATHOL, V111, P465, DOI 10.1007/s00401-006-0057-9; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Sengupta A, 2011, P NATL ACAD SCI USA, V108, P9957, DOI 10.1073/pnas.1103132108; Sripathy S, 2011, MOL CELL BIOL, V31, P2920, DOI 10.1128/MCB.05431-11; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87376	10.1371/journal.pone.0087376	http://dx.doi.org/10.1371/journal.pone.0087376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475281	Green Published, gold			2022-12-27	WOS:000330507300176
J	Kupcinskas, J; Wex, T; Link, A; Leja, M; Bruzaite, I; Steponaitiene, R; Juzenas, S; Gyvyte, U; Ivanauskas, A; Ancans, G; Petrenkiene, V; Skieceviciene, J; Kupcinskas, L; Malfertheiner, P				Kupcinskas, Juozas; Wex, Thomas; Link, Alexander; Leja, Marcis; Bruzaite, Indre; Steponaitiene, Ruta; Juzenas, Simonas; Gyvyte, Ugne; Ivanauskas, Audrius; Ancans, Guntis; Petrenkiene, Vitalija; Skieceviciene, Jurgita; Kupcinskas, Limas; Malfertheiner, Peter			Gene Polymorphisms of Micrornas in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer	PLOS ONE			English	Article							ASSOCIATION; ADENOCARCINOMA; EPIDEMIOLOGY; EXPRESSION; INFECTION; VARIANTS; NETWORKS	Background and aims: MicroRNAs (miRNAs) are known for their function as translational regulators of tumor suppressor or oncogenes. Single nucleotide polymorphisms (SNPs) in miRNAs related genes have been shown to affect the regulatory capacity of miRNAs and were linked with gastric cancer (GC) and premalignant gastric conditions. The purpose of this study was to evaluate potential associations between miRNA-related gene polymorphisms (miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608) and the presence of GC or high risk atrophic gastritis (HRAG) in European population. Methods: Gene polymorphisms were analyzed in 995 subjects (controls: n = 351; GC: n = 363; HRAG: n = 281) of European descent. MiR-27a T>C (rs895819), miR-146a G>C (rs2910164), miR-196a-2 C>T (rs11614913), miR-492 G>C (rs2289030) and miR-608 C>G (rs4919510) SNPs were genotyped by RT-PCR. Results: Overall, SNPs of miRNAs were not associated with the presence of GC or HRAG. We observed a tendency for miR-196a-2 CT genotype to be associated with higher risk of GC when compared to CC genotype, however, the difference did not reach the adjusted P-value (odds ratio (OR) - 1.46, 95% confidence interval (CI) 1.03-2.07, P = 0.032). MiR-608 GG genotype was more frequent in GC when compared to controls (OR -2.34, 95% CI 1.08-5.04), but significance remained marginal (P = 0.029). A similar tendency was observed in a recessive model for miR-608, where CC + CG vs GG genotype comparison showed a tendency for increased risk of GC with OR of 2.44 (95% CI 1.14-5.22, P = 0.021). The genotypes and alleles of miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 SNPs had similar distribution between histological subtypes of GC and were not linked with the presence of diffuse or intestinal-type GC. Conclusions: Gene polymorphisms of miR-27a, miR-146a, miR-196a-2, miR-492, miR-492a and miR-608 were not associated with the presence of HRAG, GC or different histological subtypes of GC in European subjects.	[Kupcinskas, Juozas; Bruzaite, Indre; Steponaitiene, Ruta; Juzenas, Simonas; Gyvyte, Ugne; Ivanauskas, Audrius; Skieceviciene, Jurgita; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania; [Kupcinskas, Juozas; Petrenkiene, Vitalija; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania; [Wex, Thomas; Link, Alexander; Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Wex, Thomas] Dept Mol Genet, Med Lab Clin Chem Microbiol & Infect Dis, Magdeburg, Germany; [Leja, Marcis] Latvian State Univ, Fac Med, LV-1063 Riga, Latvia; [Leja, Marcis; Ancans, Guntis] Digest Dis Ctr GASTRO, Riga, Latvia; [Leja, Marcis; Ancans, Guntis] Riga East Univ Hosp, Riga, Latvia	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Otto von Guericke University; University of Latvia; Riga East University Hospital	Kupcinskas, J (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Kaunas, Lithuania.	j_kupcinskas@yahoo.com	Juzenas, Simonas/F-3187-2018; Kupcinskas, Juozas/AAU-6968-2021	Juzenas, Simonas/0000-0001-9293-0691; Link, Alexander/0000-0002-9514-4562; Kulokiene, Ugne/0000-0002-1130-2472	European Social Fund [VP1-3.1-Angstrom MM-07-K-01-156]; BMBF in the frame of ERA-Net PathoGenoMics project [BMBF-0315905D]; European Fund for Regional Development [2010/0302/2DP/2.1.1.1.0/10/APIA/VIAA/158]	European Social Fund(European Social Fund (ESF)); BMBF in the frame of ERA-Net PathoGenoMics project(Federal Ministry of Education & Research (BMBF)); European Fund for Regional Development(European Commission)	This work was supported by the European Social Fund (No. VP1-3.1-angstrom MM-07-K-01-156) and in part by a grant from the BMBF (BMBF-0315905D) in the frame of ERA-Net PathoGenoMics project. The recruitment of patients in Latvia was supported in part from the project of European Fund for Regional Development (No. 2010/0302/2DP/2.1.1.1.0/10/APIA/VIAA/158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DH, 2013, MOL CARCINOGEN, V52, P39, DOI 10.1002/mc.21962; Bornschein J, 2010, DIGEST DIS, V28, P609, DOI 10.1159/000320061; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CORREA P, 1992, CANCER RES, V52, P6735; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Hishida A, 2011, DIGEST DIS SCI, V56, P1131, DOI 10.1007/s10620-010-1376-1; Huang AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035252; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Kupcinskas L, 2010, EUR J GASTROEN HEPAT, V22, P1189, DOI 10.1097/MEG.0b013e32833cf3d5; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee HC, 2010, J CANCER RES CLIN, V136, P1073, DOI 10.1007/s00432-009-0754-6; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Link A, 2012, DIGEST DIS, V30, P255, DOI 10.1159/000336919; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ryan BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036306; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Song MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061250; Srivastava K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050966; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; von Frowein J, 2011, HEPATOLOGY, V53, P833, DOI 10.1002/hep.24125; Wang F, 2012, PLOS ONE, V7; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang SZ, 2013, MOL CARCINOGEN, V52, P87, DOI [10.1002/mc.22017, 10.1002/mc.21930]; Yang Q, 2012, ONCOGENE; Yoon KA, 2012, J THORAC CARDIOV SUR, V144, P794, DOI 10.1016/j.jtcvs.2012.06.030; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8; Zhu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079334	38	66	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87467	10.1371/journal.pone.0087467	http://dx.doi.org/10.1371/journal.pone.0087467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475294	gold, Green Submitted, Green Published			2022-12-27	WOS:000330507300189
J	Naznin, HA; Kiyohara, D; Kimura, M; Miyazawa, M; Shimizu, M; Hyakumachi, M				Naznin, Hushna Ara; Kiyohara, Daigo; Kimura, Minako; Miyazawa, Mitsuo; Shimizu, Masafumi; Hyakumachi, Mitsuro			Systemic Resistance Induced by Volatile Organic Compounds Emitted by Plant Growth-Promoting Fungi in Arabidopsis thaliana	PLOS ONE			English	Article							ZOYSIAGRASS RHIZOSPHERE; BACTERIAL VOLATILES; POWDERY MILDEW; INDUCTION; PATHOGEN; CUCUMBER; PROTEIN; ACTIVATION; DISEASES; DEFENSE	Volatile organic compounds (VOC) were extracted and identified from plant growth-promoting fungi (PGPF), Phoma sp., Cladosporium sp. and Ampelomyces sp., using gas chromatography-mass spectrometry (GC-MS). Among the three VOC extracted, two VOC blends (emitted from Ampelomyces sp. and Cladosporium sp.) significantly reduced disease severity in Arabidopsis plants against Pseudomonas syringae pv. tomato DC3000 (Pst). Subsequently, m-cresol and methyl benzoate (MeBA) were identified as major active volatile compounds from Ampelomyces sp. and Cladosporium sp., respectively, and found to elicit induced systemic resistance (ISR) against the pathogen. Molecular signaling for disease suppression by the VOC were investigated by treating different mutants and transgenic Arabidopsis plants impaired in salicylic acid (SA) or Jasmonic acid (JA)/ethylene (ET) signaling pathways with m-cresol and MeBA followed by challenge inoculation with Pst. Results show that the level of protection was significantly lower when JA/ET-impaired mutants were treated with MeBA, and in SA-, and JA/ET-disrupted mutants after m-cresol treatment, indicating the involvement of these signal transduction pathways in the ISR primed by the volatiles. Analysis of defense-related genes by real-time qRT-PCR showed that both the SA-and JA-signaling pathways combine in the m-cresol signaling of ISR, whereas MeBA is mainly involved in the JA-signaling pathway with partial recruitment of SA-signals. The ET-signaling pathway was not employed in ISR by the volatiles. Therefore, this study identified two novel volatile components capable of eliciting ISR that may be promising candidates in biological control strategy to protect plants from diseases.	[Naznin, Hushna Ara] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Kiyohara, Daigo; Kimura, Minako; Shimizu, Masafumi; Hyakumachi, Mitsuro] Gifu Univ, Fac Appl Biol Sci, Plant Pathol Lab, Gifu, Japan; [Miyazawa, Mitsuo] Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 577, Japan	Gifu University; Gifu University; Kindai University (Kinki University)	Hyakumachi, M (corresponding author), Gifu Univ, Fac Appl Biol Sci, Plant Pathol Lab, Gifu, Japan.	hyakumac@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MONBUKAGAKUSHO), Japan	Ministry of Education, Culture, Sports, Science and Technology (MONBUKAGAKUSHO), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MONBUKAGAKUSHO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD JS, 1988, CAN J MICROBIOL, V34, P229, DOI 10.1139/m88-043; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chandanie WA, 2006, PLANT SOIL, V286, P209, DOI 10.1007/s11104-006-9038-y; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elad Y, 1998, BIOCONTROL, V43, P241, DOI 10.1023/A:1009919417481; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Gilardi G, 2008, J PLANT DIS PROTECT, V115, P208, DOI 10.1007/BF03356265; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Hossain MM, 2007, PLANT CELL PHYSIOL, V48, P1724, DOI 10.1093/pcp/pcm144; Hyakumachi M., 1994, Soil Microorganisms, P53; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kishimoto K, 2006, PLANT SCI, V170, P715, DOI 10.1016/j.plantsci.2005.11.002; Kiss L, 2003, PEST MANAG SCI, V59, P475, DOI 10.1002/ps.689; Koike N, 2001, EUR J PLANT PATHOL, V107, P523, DOI 10.1023/A:1011203826805; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Lee BR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039425, 10.1371/journal.pone.0048744]; Li QL, 2010, POSTHARVEST BIOL TEC, V58, P157, DOI 10.1016/j.postharvbio.2010.06.003; MATHUR M, 1981, ANGEW BOT, V55, P75; MEERA MS, 1994, PHYTOPATHOLOGY, V84, P1399, DOI 10.1094/Phyto-84-1399; Miyazawa M, 2008, J OLEO SCI, V57, P585, DOI 10.5650/jos.57.585; MORRIS JA, 1979, J AM OIL CHEM SOC, V56, P595, DOI 10.1007/BF02660245; Naznin HA, 2013, MICROBES ENVIRON, V28, P42, DOI 10.1264/jsme2.ME12085; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; ROBERTS MS, 1977, J PHARM PHARMACOL, V29, P677, DOI 10.1111/j.2042-7158.1977.tb11434.x; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Shivanna M.B., 2005, MICROBES ENVIRON, V20, P34, DOI [10.1264/jsme2.20.34, DOI 10.1264/JSME2.20.34]; Shivanna MB, 1996, CROP PROT, V15, P497, DOI 10.1016/0261-2194(96)00004-X; SHIVANNA MB, 1994, CAN J MICROBIOL, V40, P637, DOI 10.1139/m94-101; Song GC, 2013, INT J MOL SCI, V14, P9803, DOI 10.3390/ijms14059803; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Sultana F, 2009, PLANT BIOLOGY, V11, P97, DOI 10.1111/j.1438-8677.2008.00142.x; Sultana F, 2008, CAN J PLANT PATHOL, V30, P196, DOI 10.1080/07060661.2008.10540535; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542, DOI 10.2144/04374BM03; Toda T, 1999, BIOSCI BIOTECH BIOCH, V63, P210, DOI 10.1271/bbb.63.210; Wan MG, 2008, BIOL CONTROL, V46, P552, DOI 10.1016/j.biocontrol.2008.05.015; Yamagiwa Y, 2011, J GEN PLANT PATHOL, V77, P336, DOI 10.1007/s10327-011-0340-z; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220	40	101	104	6	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86882	10.1371/journal.pone.0086882	http://dx.doi.org/10.1371/journal.pone.0086882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475190	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300113
J	Saygitov, RT				Saygitov, Ruslan T.			The Impact of Funding through the RF President's Grants for Young Scientists (the field - Medicine) on Research Productivity: A Quasi-Experimental Study and a Brief Systematic Review	PLOS ONE			English	Review								The impact of grants on research productivity has been investigated by a number of retrospective studies. The results of these studies vary considerably. The objective of my study was to investigate the impact of funding through the RF President's grants for young scientists on the research productivity of awarded applicants. The study compared the number of total articles and citations for awarded and rejected applicants who in 2007 took part in competitions for young candidates of science (CoS's) and doctors of science (DoS's) in the scientific field of medicine. The bibliometric analysis was conducted for the period from 2003 to 2012 (five years before and after the competition). The source of bibliometric data is the eLIBRARY.RU database. The impact of grants on the research productivity of Russian young scientists was assessed using the meta-analytical approach based on data from quasi-experimental studies conducted in other countries. The competition featured 149 CoS's and 41 DoS's, out of which 24 (16%) and 22 (54%) applicants, respectively, obtained funding. No difference in the number of total articles and citations at baseline, as well as in 2008-2012, for awarded and rejected applicants was found. The combination of data from the Russian study and other quasi-experimental studies (6 studies, 10 competitions) revealed a small treatment effect - an increase in the total number of publications over a 4-5-year period after the competition by 1.23 (95% CI 0.48-1.97). However, the relationship between the number of total publications published by applicants before and after the competition revealed that this treatment effect is an effect of the "maturation" of scientists with a high baseline publication activity - not of grant funding.				saygitov@yandex.ru	Saygitov, Ruslan/E-9512-2014	Saygitov, Ruslan/0000-0002-8915-6153				Arora A., 2005, ANN EC STAT, V79-80, P91, DOI DOI 10.2307/20777571; Bohmer S., 2008, 3 IFQ; Bornmann L, 2010, J INFORMETR, V4, P211, DOI 10.1016/j.joi.2009.10.004; Chudnovsky D, 2006, OVEWP1206; Danish Agency for Science Technology and Innovation, 2010, FORSKN VIRK FREMM KA; Danish Agency for Science Technology and Innovation, 2011, EV VIRK FORSKN FRIE; Deeks J J, 2003, Health Technol Assess, V7, piii; Dezhina I, 2005, SCIENCE, V310, P1772, DOI 10.1126/science.1117855; Gelfand M, 2010, TROITSKY VARIANT, V58, P4; Gelfand M, 2011, TROITSKY VARIANT, V72, P4; Gingras Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004048; Gonzalez-Brambila C., 2007, 133 DEP ENG PUB POL; Hall BH, 2007, ECON INNOV NEW TECH, V16, P159, DOI 10.1080/10438590600983010; Hottenrott H, 2011, ZEW DISCUSSION PAPER; Ida T, 2013, SCIENTOMETRICS, V94, P1253, DOI 10.1007/s11192-012-0841-3; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Jacob BA, 2011, RES POLICY, V40, P864, DOI 10.1016/j.respol.2011.04.003; LaLonde JR, 1986, AM ECON REV, V76, P604; Langfeldt L, 2012, 82012 NIFU NORD I ST; MacLehose R, 1999, HEALTH TECHNOL ASSES, V4, P1; Mahoney MC, 2007, ANN FAM MED, V5, P143, DOI 10.1370/afm.628; Marulis LM, 2010, REV EDUC RES, V80, P300, DOI 10.3102/0034654310377087; Melin G., 2006, Science and Public Policy, V33, P702, DOI 10.3152/147154306781778579; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184	24	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86969	10.1371/journal.pone.0086969	http://dx.doi.org/10.1371/journal.pone.0086969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475203	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300121
J	Shaddinger, BC; Xu, YM; Roger, JH; Macphee, CH; Handel, M; Baidoo, CA; Magee, M; Lepore, JJ; Sprecher, DL				Shaddinger, Bonnie C.; Xu, Yanmei; Roger, James H.; Macphee, Colin H.; Handel, Malcolm; Baidoo, Charlotte A.; Magee, Mindy; Lepore, John J.; Sprecher, Dennis L.			Platelet Aggregation Unchanged by Lipoprotein-Associated Phospholipase A(2) Inhibition: Results from an In Vitro Study and Two Randomized Phase I Trials	PLOS ONE			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; CORONARY-HEART-DISEASE; SERUM PAF ACETYLHYDROLASE; MYOCARDIAL-INFARCTION; DEFICIENCY; RISK; DARAPLADIB; STABILIZATION; RATIONALE; DESIGN	Background: We explored the theorized upregulation of platelet-activating factor (PAF)-mediated biologic responses following lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) inhibition using human platelet aggregation studies in an in vitro experiment and in 2 clinical trials. Methods and Results: Full platelet aggregation concentration response curves were generated in vitro to several platelet agonists in human plasma samples pretreated with rilapladib (selective Lp-PLA(2) inhibitor) or vehicle. This was followed by a randomized, double-blind crossover study in healthy adult men (n = 26) employing a single-agonist dose assay of platelet aggregation, after treatment of subjects with 250 mg oral rilapladib or placebo once daily for 14 days. This study was followed by a second randomized, double-blind parallel-group trial in healthy adult men (n = 58) also treated with 250 mg oral rilapladib or placebo once daily for 14 days using a full range of 10 collagen concentrations (0-10 mg/ml) for characterizing EC50 values for platelet aggregation for each subject. Both clinical studies were conducted at the GlaxoSmithKline Medicines Research Unit in the Prince of Wales Hospital, Sydney, Australia. EC50 values derived from multiple agonist concentrations were compared and no pro-aggregant signals were observed during exposure to rilapladib in any of these platelet studies, despite Lp-PLA(2) inhibition exceeding 90%. An increase in collagen-mediated aggregation was observed 3 weeks post drug termination in the crossover study (15.4% vs baseline; 95% confidence interval [CI], 3.9-27.0), which was not observed during the treatment phase and was not observed in the parallel-group study employing a more robust EC50 examination. Conclusions: Lp-PLA(2) inhibition does not enhance platelet aggregation.	[Shaddinger, Bonnie C.; Macphee, Colin H.; Magee, Mindy; Lepore, John J.; Sprecher, Dennis L.] GlaxoSmithKline, Metab Pathways & Cardiovas Therapeut Area, Heart Failure Discovery Performance Unit, King Of Prussia, PA USA; [Xu, Yanmei; Baidoo, Charlotte A.] GlaxoSmithKline, King Of Prussia, PA USA; [Roger, James H.] GlaxoSmithKline, Stat Res Unit, Stockley Pk, England; [Handel, Malcolm] Janssen Cilag Pty Ltd, Macquarie Pk, NSW, Australia	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Sprecher, DL (corresponding author), GlaxoSmithKline, Metab Pathways & Cardiovas Therapeut Area, Heart Failure Discovery Performance Unit, King Of Prussia, PA USA.	Dennis.L.Sprecher@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding for these studies was provided by GlaxoSmithKline (www.gsk.com). Editorial support was also funded by GlaxoSmithKline. In consultation with external academic experts, the funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	BENVENISTE J, 1975, LANCET, V1, P344; BLANK ML, 1981, J BIOL CHEM, V256, P175; CHESNEY CM, 1982, BLOOD, V59, P582; *CLINICALTRIALS, 2008, NCT00799903 CLINICAL; *CLINICALTRIALS, 2009, NCT01000727 CLINICAL; FARR RS, 1980, CLIN IMMUNOL IMMUNOP, V15, P318, DOI 10.1016/0090-1229(80)90044-6; Henig NR, 2000, AM J RESP CRIT CARE, V162, P523, DOI 10.1164/ajrccm.162.2.9911084; HWANG SB, 1990, J LIPID MEDIATOR, V2, P123; Ito S, 2002, J HUM GENET, V47, P99, DOI 10.1007/s100380200009; Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901; Liu JB, 2011, CIRC RES, V108, P469, DOI 10.1161/CIRCRESAHA.110.228742; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Naoki K, 2004, BIOCHEM BIOPH RES CO, V317, P205, DOI 10.1016/j.bbrc.2004.03.031; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093; SAWYER DB, 1989, BIOCHIM BIOPHYS ACTA, V987, P129, DOI 10.1016/0005-2736(89)90464-1; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SNYDER F, 1995, BBA-LIPID LIPID MET, V1254, P231, DOI 10.1016/0005-2760(94)00192-2; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; Triggiani M, 1997, AM J RESP CRIT CARE, V156, P94, DOI 10.1164/ajrccm.156.1.9608084; Tsukioka K, 1996, J INVEST ALLERG CLIN, V6, P22; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Vedin O, 2013, EUR J PREV CARDIOL, V20, P678, DOI 10.1177/2047487312444995; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Yoshida H, 1996, AM J HEMATOL, V53, P158, DOI 10.1002/(SICI)1096-8652(199611)53:3<158::AID-AJH2>3.3.CO;2-8	32	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e83094	10.1371/journal.pone.0083094	http://dx.doi.org/10.1371/journal.pone.0083094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475026	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300012
J	Yang, AX; Chong, NJ; Jiang, YF; Catalano, J; Puri, RK; Khleif, SN				Yang, Amy X.; Chong, Numju; Jiang, Yufei; Catalano, Jennifer; Puri, Raj K.; Khleif, Samir N.			Molecular Characterization of Antigen-Peptide Pulsed Dendritic Cells: Immature Dendritic Cells Develop a Distinct Molecular Profile when Pulsed with Antigen Peptide	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OLIGONUCLEOTIDE MICROARRAYS; INTERFERON-GAMMA; GENE-EXPRESSION; CERVICAL-CANCER; TUMOR-ANTIGEN; IN-VITRO; MATURATION; INDUCTION; IMMUNITY	As dendritic cells (DCs) are the most potent professional antigen-presenting cells, they are being tested as cancer vaccines for immunotherapy of established cancers. Although numerous studies have characterized DCs by their phenotype and function, few have identified potential molecular markers of antigen presentation prior to vaccination of host. In this study we generated pre-immature DC (piDC), immature DC (iDC), and mature DC (mDC) from human peripheral blood monocytes (PBMC) obtained from HLA-A2 healthy donors, and pulsed them with human papillomavirus E7 peptide (p11-20), a class I HLA-A2 binding antigen. We then characterized DCs for cell surface phenotype and gene expression profile by microarray technology. We identified a set of 59 genes that distinguished three differentiation stages of DCs (piDC, iDC and mDC). When piDC, iDC and mDC were pulsed with E7 peptide for 2 hrs, the surface phenotype did not change, however, iDCs rather than mDCs showed transcriptional response by up-regulation of a set of genes. A total of 52 genes were modulated in iDC upon antigen pulsing. Elongation of pulse time for iDCs to 10 and 24 hrs did not significantly bring further changes in gene expression. The E7 peptide up-modulated immune response (KPNA7, IGSF6, NCR3, TREM2, TUBAL3, IL8, NFKBIA), pro-apoptosis (BTG1, SEMA6A, IGFBP3 and SRGN), anti-apoptosis (NFKBIA), DNA repair (MRPS11, RAD21, TXNRD1), and cell adhesion and cell migration genes (EPHA1, PGF, IL8 and CYR61) in iDCs. We confirmed our results by Q-PCR analysis. The E7 peptide but not control peptide (PADRE) induced up-regulation of NFKB1A gene only in HLA-A2 positive iDCs and not in HLA-A2 negative iDCs. These results suggest that E7 up-regulation of genes is specific and HLA restricted and that these genes may represent markers of antigen presentation and help rapidly assess the quality of dendritic cells prior to administration to the host.	[Yang, Amy X.; Catalano, Jennifer; Puri, Raj K.] US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Chong, Numju; Jiang, Yufei; Khleif, Samir N.] NCI, Vaccine Branch, Bethesda, MD 20892 USA; [Khleif, Samir N.] Georgia Regent Univ, Ctr Canc, Augusta, GA USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Georgia; Augusta University	Puri, RK (corresponding author), US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	raj.puri@fda.hhs.gov	jiang, yu/HGU-0029-2022					Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beatty P, 2012, ONCOIMMUNOLOGY, V1, P263, DOI 10.4161/onci.18950; Carlos CA, 2005, J IMMUNOL, V175, P1628, DOI 10.4049/jimmunol.175.3.1628; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Cools N, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-49; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Han J, 2005, GENOMICS, V86, P252, DOI 10.1016/j.ygeno.2005.04.009; Han TH, 2009, J IMMUNOTHER, V32, P399, DOI 10.1097/CJI.0b013e31819e1773; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lindstedt M, 2002, INT IMMUNOL, V14, P1203, DOI 10.1093/intimm/dxf082; McIlroy D, 2005, J LEUKOCYTE BIOL, V78, P794, DOI 10.1189/jlb.0105029; Messmer D, 2003, INT IMMUNOL, V15, P491, DOI 10.1093/intimm/dxg052; Moschella F, 2001, BRIT J HAEMATOL, V114, P444, DOI 10.1046/j.1365-2141.2001.02953.x; Murakami M, 1999, CANCER RES, V59, P1184; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santin AD, 1999, J VIROL, V73, P5402, DOI 10.1128/JVI.73.7.5402-5410.1999; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; Soumelis V, 2006, EUR J IMMUNOL, V36, P2286, DOI 10.1002/eji.200636026; Tsukui T, 1996, CANCER RES, V56, P3967; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Yang AX, 2006, MOL BIOTECHNOL, V34, P303, DOI 10.1385/MB:34:3:303	26	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86306	10.1371/journal.pone.0086306	http://dx.doi.org/10.1371/journal.pone.0086306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475103	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300052
J	Cuypers, K; Thijs, H; Meesen, RLJ				Cuypers, Koen; Thijs, Herbert; Meesen, Raf L. J.			Optimization of the Transcranial Magnetic Stimulation Protocol by Defining a Reliable Estimate for Corticospinal Excitability	PLOS ONE			English	Article							MOTOR-EVOKED-POTENTIALS; LONGITUDINAL DATA-ANALYSIS; BRAIN-STIMULATION; MUSCLE; CORTEX; VARIABILITY; RESPONSES; OUTPUT; AGE	The goal of this study was to optimize the transcranial magnetic stimulation (TMS) protocol for acquiring a reliable estimate of corticospinal excitability (CSE) using single-pulse TMS. Moreover, the minimal number of stimuli required to obtain a reliable estimate of CSE was investigated. In addition, the effect of two frequently used stimulation intensities [110% relative to the resting motor threshold (rMT) and 120% rMT] and gender was evaluated. Thirty-six healthy young subjects (18 males and 18 females) participated in a double-blind crossover procedure. They received 2 blocks of 40 consecutive TMS stimuli at either 110% rMT or 120% rMT in a randomized order. Based upon our data, we advise that at least 30 consecutive stimuli are required to obtain the most reliable estimate for CSE. Stimulation intensity and gender had no significant influence on CSE estimation. In addition, our results revealed that for subjects with a higher rMT, fewer consecutive stimuli were required to reach a stable estimate of CSE. The current findings can be used to optimize the design of similar TMS experiments.	[Cuypers, Koen; Meesen, Raf L. J.] Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Biomed Res Inst, Diepenbeek, Belgium; [Cuypers, Koen; Meesen, Raf L. J.] Katholieke Univ Leuven, Motor Control Lab, Res Ctr Movement Control & Neuroplast, Dept Biomed Kinesiol,Grp Biomed Sci, Heverlee, Belgium; [Thijs, Herbert] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, BioStat 1, Diepenbeek, Belgium; [Thijs, Herbert] Univ Louvain, Interuniv Inst Biostat & Stat Bioinformat, BioStat 1, Louvain, Belgium	Hasselt University; KU Leuven; Hasselt University; Hasselt University	Meesen, RLJ (corresponding author), Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Biomed Res Inst, Diepenbeek, Belgium.	raf.meesen@uhasselt.be	Meesen, Raf L/F-2582-2019; Cuypers, Koen/N-9918-2018	Meesen, Raf L/0000-0002-7938-3758; 	Flanders Fund for Scientific Research [G075810]; Special Research Fund UHasselt	Flanders Fund for Scientific Research(FWO); Special Research Fund UHasselt	This work is supported by the Flanders Fund for Scientific Research (G075810). Koen Cuypers is supported by the Special Research Fund UHasselt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccolieri A, 2004, J PHYSIOL-LONDON, V558, P685, DOI 10.1113/jphysiol.2004.064774; Choudhury KR, 2011, IRISH J MED SCI, V180, P873, DOI 10.1007/s11845-011-0722-4; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Cuypers K, 2013, NEUROSCI LETT; Darling WG, 2006, EXP BRAIN RES, V174, P376, DOI 10.1007/s00221-006-0468-9; Ellaway PH, 1998, ELECTROMYOGR MOTOR C, V109, P104, DOI 10.1016/S0924-980X(98)00007-1; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Fujiyama H, 2012, J COGNITIVE NEUROSCI, V24, P1253, DOI 10.1162/jocn_a_00201; Funase K, 1999, NEUROSCI LETT, V271, P25, DOI 10.1016/S0304-3940(99)00467-X; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Julkunen P, 2009, NEUROIMAGE, V44, P790, DOI 10.1016/j.neuroimage.2008.09.040; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; LAN NC, 1994, HORM BEHAV, V28, P537, DOI 10.1006/hbeh.1994.1052; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; Lewis GN, 2013, CLIN NEUROPHYSIOL; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Magistris MR, 1999, BRAIN, V122, P265, DOI 10.1093/brain/122.2.265; Magistris MR, 1998, BRAIN, V121, P437, DOI 10.1093/brain/121.3.437; Mantovani A, 2013, PSYCHIAT RES; Mars RB, 2007, EXP BRAIN RES, V182, P125, DOI 10.1007/s00221-007-1055-4; Meesen RLJ, 2011, HUM BRAIN MAPP, V32, P872, DOI 10.1002/hbm.21075; MEYER BU, 1991, ELECTROEN CLIN NEURO, V81, P38, DOI 10.1016/0168-5597(91)90102-4; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pennisi G, 2002, CLIN NEUROPHYSIOL, V113, P1536, DOI 10.1016/S1388-2457(02)00255-9; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; Rosler KM, 2002, CLIN NEUROPHYSIOL, V113, P1680, DOI 10.1016/S1388-2457(02)00263-8; Sahota Preeti, 2005, Neurol India, V53, P197; Smith AE, 2011, J APPL PHYSIOL, V110, P206, DOI 10.1152/japplphysiol.00403.2010; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Vaalto S, 2011, HUM BRAIN MAPP, V32, P1692, DOI 10.1002/hbm.21137; Veniero D, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00352; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86380	10.1371/journal.pone.0086380	http://dx.doi.org/10.1371/journal.pone.0086380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475111	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800041
J	Boyero, L; Cardinale, BJ; Bastian, M; Pearson, RG				Boyero, Luz; Cardinale, Bradley J.; Bastian, Mikis; Pearson, Richard G.			Biotic vs. Abiotic Control of Decomposition: A Comparison of the Effects of Simulated Extinctions and Changes in Temperature	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; LITTER DECOMPOSITION; BIODIVERSITY LOSS; DIVERSITY; RICHNESS; RESPONSES; STREAMS; EVENNESS; GROWTH	The loss of species is known to have significant effects on ecosystem functioning, but only recently has it been recognized that species loss might rival the effects of other forms of environmental change on ecosystem processes. There is a need for experimental studies that explicitly manipulate species richness and environmental factors concurrently to determine their relative impacts on key ecosystem processes such as plant litter decomposition. It is crucial to understand what factors affect the rate of plant litter decomposition and the relative magnitude of such effects because the rate at which plant litter is lost and transformed to other forms of organic and inorganic carbon determines the capacity for carbon storage in ecosystems and the rate at which greenhouse gasses such as carbon dioxide are outgassed. Here we compared how an increase in water temperature of 5 degrees C and loss of detritivorous invertebrate and plant litter species affect decomposition rates in a laboratory experiment simulating stream conditions. Like some prior studies, we found that species identity, rather than species richness per se, is a key driver of decomposition, but additionally we showed that the loss of particular species can equal or exceed temperature change in its impact on decomposition. Our results indicate that the loss of particular species can be as important a driver of decomposition as substantial temperature change, but also that predicting the relative consequences of species loss and other forms of environmental change on decomposition requires knowledge of assemblages and their constituent species' ecology and ecophysiology.	[Boyero, Luz] CSIC, Donana Biol Stn, Wetland Ecol Dept, E-41080 Seville, Spain; [Boyero, Luz; Bastian, Mikis; Pearson, Richard G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Pearson, Richard G.] James Cook Univ, TropWater, Townsville, Qld 4811, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); James Cook University; University of Michigan System; University of Michigan; James Cook University	Boyero, L (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Leioa, Spain.	luz.boyero@ehu.es	Boyero, Luz/N-1719-2019; Pearson, Richard/GQH-2760-2022; Boyero, Luz/L-5822-2014; Cardinale, Bradley J/I-7076-2013	Boyero, Luz/0000-0001-7366-9299; Boyero, Luz/0000-0001-7366-9299; Pearson, Richard/0000-0001-6047-031X	MINECO [CGL2010-16285]; James Cook University	MINECO(Spanish Government); James Cook University	The study was funded by project CGL2010-16285 from the Spanish Ministry for Science and Innovation (currently MINECO) to LB, and internal research grants from James Cook University to LB and RGP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bastian M, 2008, AUSTRAL ECOL, V33, P301, DOI 10.1111/j.1442-9993.2007.01817.x; Bastian M, 2007, J TROP ECOL, V23, P219, DOI 10.1017/S0266467406003920; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Boyero L, 2006, MAR FRESHWATER RES, V57, P201, DOI 10.1071/MF05052; Boyero L, 2007, ECOL RES, V22, P551, DOI 10.1007/s11284-006-0303-6; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruder A, 2011, FUNCT ECOL, V25, P1269, DOI 10.1111/j.1365-2435.2011.01903.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CEBRIAN J, 1995, SCIENCE, V268, P1606, DOI 10.1126/science.268.5217.1606; Cheshire K, 2005, FRESHWATER BIOL, V50, P748, DOI 10.1111/j.1365-2427.2005.01355.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Ferreira V, 2012, FRESHW SCI, V31, P945, DOI 10.1899/11-062.1; Fugere V, 2012, J ANIMAL ECOLOGY; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Hector Andy, 2009, P94; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; IRONS JG, 1994, FRESHWATER BIOL, V32, P401, DOI 10.1111/j.1365-2427.1994.tb01135.x; Kominoski JS, 2009, FRESHWATER BIOL, V54, P1461, DOI 10.1111/j.1365-2427.2009.02196.x; McKie BG, 2008, J ANIM ECOL, V77, P495, DOI 10.1111/j.1365-2656.2008.01357.x; Mckie BG, 2009, OECOLOGIA, V160, P757, DOI 10.1007/s00442-009-1336-7; Perkins DM, 2010, ADV ECOL RES, V43, P177, DOI 10.1016/S0065-2504(10)43005-6; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reiss J, 2011, J ANIM ECOL, V80, P1145, DOI 10.1111/j.1365-2656.2011.01857.x; Ruesink JL, 2001, OIKOS, V93, P221, DOI 10.1034/j.1600-0706.2001.930206.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Swan CM, 2006, OECOLOGIA, V147, P469, DOI 10.1007/s00442-005-0297-8; TILMAN D, 1992, OECOLOGIA, V89, P257, DOI 10.1007/BF00317226; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Wolfe R, 2002, CAN MED ASSOC J, V166, P65	38	22	23	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87426	10.1371/journal.pone.0087426	http://dx.doi.org/10.1371/journal.pone.0087426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466351	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000330288000207
J	Feraille, E; Dizin, E; Roth, I; Derouette, JP; Szanto, I; Martin, PY; de Seigneux, S; Hasler, U				Feraille, Eric; Dizin, Eva; Roth, Isabelle; Derouette, Jean-Paul; Szanto, Ildiko; Martin, Pierre-Yves; de Seigneux, Sophie; Hasler, Udo			NADPH Oxidase 4 Deficiency Reduces Aquaporin-2 mRNA Expression in Cultured Renal Collecting Duct Principal Cells via Increased PDE3 and PDE4 Activity	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-A; LONG-TERM REGULATION; SMOOTH-MUSCLE-CELLS; REACTIVE OXYGEN; SODIUM-TRANSPORT; INDUCED ACTIVATION; REDOX REGULATION; NAD(P)H OXIDASE; AQP2 EXPRESSION	The final control of renal water reabsorption occurs in the collecting duct (CD) and relies on regulated expression of aquaporin-2 (AQP2) in principal CD cells. AQP2 transcription is primarily induced by type 2 vasopressin receptor (V2R)-cAMP-protein kinase A (PKA) signaling but also by other factors, including TonEBP and NF-kappa B. NAPDH oxidase 4 (NOX4) represents a major source of reactive oxygen species (ROS) in the kidney. Because NOX-derived ROS may alter PKA, TonEBP and NF-kappa B activity, we examined the effects of NOX4 depletion on AQP2 expression. Depleted NOX4 expression by siRNA (siNOX4) in mpkCCD(cl4) cells attenuated increased AQP2 mRNA expression by arginine vasopressin (AVP) but not by hypertonicity, which induces both TonEBP and NF-kappa B activity. AVP-induced AQP2 expression was similarly decreased by the flavoprotein inhibitor diphenyleneiodonium. siNOX4 altered neither TonEBP nor NF-kappa B activity but attenuated AVP-inducible cellular cAMP concentration, PKA activity and CREB phosphorylation as well as AQP2 mRNA expression induced by forskolin, a potent activator of adenylate cyclase. The repressive effect of siNOX4 on AVP-induced AQP2 mRNA expression was abolished by the non-selective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine (IBMX) and was significantly decreased by selective PDE antagonists cilostamide and rolipram, but not vinpocetine, which respectively target PDE3, PDE4 and PDE1. Thus, by inhibiting PDE3 and PDE4 activity NOX4-derived ROS may contribute to V2R-cAMP-PKA signaling and enhance AQP2 transcription.	[Feraille, Eric; Dizin, Eva; Roth, Isabelle; Derouette, Jean-Paul; Szanto, Ildiko; Hasler, Udo] Univ Med Ctr, Dept Cellular Physiol, Geneva, Switzerland; [Feraille, Eric; Dizin, Eva; Roth, Isabelle; Derouette, Jean-Paul; Szanto, Ildiko; Hasler, Udo] Univ Med Ctr, Dept Metab, Geneva, Switzerland; [Martin, Pierre-Yves; de Seigneux, Sophie] Univ Geneva, Dept Med Specialties, Serv Nephrol, Geneva, Switzerland; [Szanto, Ildiko] Univ Geneva, Dept Med Specialties, Serv Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Hasler, U (corresponding author), Univ Med Ctr, Dept Cellular Physiol, Geneva, Switzerland.	Udo.Hasler@unige.ch	Szanto, Ildiko/F-5856-2011	Szanto, Ildiko/0000-0003-3566-7991; Feraille, Eric/0000-0003-1656-8365	Swiss National Science Foundation [31003A_138408/1]; Foundation Novartis pour la Recherche en Sciences Medico-Biologiques; Fondation Ernest Boninchi; Fondation Schmidheiny; Amgen	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Novartis pour la Recherche en Sciences Medico-Biologiques; Fondation Ernest Boninchi; Fondation Schmidheiny; Amgen(Amgen)	This work was supported by a Swiss National Science Foundation Grant 31003A_138408/1 and grants from the Foundation Novartis pour la Recherche en Sciences Medico-Biologiques, Fondation Ernest Boninchi, Fondation Schmidheiny and Amgen to UH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Babilonia E, 2007, J AM SOC NEPHROL, V18, P2037, DOI 10.1681/ASN.2006121333; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BengisGarber C, 1996, CELL SIGNAL, V8, P291, DOI 10.1016/0898-6568(96)00052-6; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Bouley R, 2005, AM J PHYSIOL-RENAL, V288, pF1103, DOI 10.1152/ajprenal.00337.2004; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Cai Q, 2010, AM J PHYSIOL-RENAL, V299, pF712, DOI 10.1152/ajprenal.00690.2009; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chapman AB, 2007, J AM SOC NEPHROL, V18, P1399, DOI 10.1681/ASN.2007020155; Cheng JF, 2007, EXP BIOL MED, V232, P38; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2006, J MEMBRANE BIOL, V212, P119, DOI 10.1007/s00232-006-0871-y; Fenton RA, 2002, AM J PHYSIOL-RENAL, V282, pF630, DOI 10.1152/ajprenal.00264.2001; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Hasler U, 2009, AM J PHYSIOL-CELL PH, V296, pC641, DOI 10.1152/ajpcell.00655.2008; Hoare GS, 1999, AM J PHYSIOL-HEART C, V277, pH1975, DOI 10.1152/ajpheart.1999.277.5.H1975; Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Markadieu N, 2009, AM J PHYSIOL-RENAL, V296, pF1428, DOI 10.1152/ajprenal.90397.2008; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Muzaffar S, 2011, EUR J PHARMACOL, V658, P187, DOI 10.1016/j.ejphar.2011.02.020; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nguyen MV, 2013, BIOCH PHARM; Nielsen J, 2006, AM J PHYSIOL-RENAL, V290, pF438, DOI 10.1152/ajprenal.00158.2005; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Radin MJ, 2012, VET CLIN PATH, V41, P455, DOI 10.1111/j.1939-165x.2012.00488.x; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Schenk LK, 2012, J AM SOC NEPHROL, V23, P1008, DOI 10.1681/ASN.2011070738; Schreck C, 2011, AM J PHYSIOL-REG I, V300, pR1023, DOI 10.1152/ajpregu.00618.2010; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775, DOI 10.1152/ajprenal.1995.269.6.F775; Torres VE, 2004, NEPHRON EXP NEPHROL, V98, pE1, DOI 10.1159/000079926; Umenishi F, 2006, BBA-BIOMEMBRANES, V1758, P1100, DOI 10.1016/j.bbamem.2006.06.001; Wilson JL, 2013, CLIN EXP NEPHROL; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yu MJ, 2009, P NATL ACAD SCI US; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005	65	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87239	10.1371/journal.pone.0087239	http://dx.doi.org/10.1371/journal.pone.0087239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466344	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000201
J	Shepard, SS; Davis, CT; Bahl, J; Rivailler, P; York, IA; Donis, RO				Shepard, Samuel S.; Davis, C. Todd; Bahl, Justin; Rivailler, Pierre; York, Ian A.; Donis, Ruben O.			LABEL: Fast and Accurate Lineage Assignment with Assessment of H5N1 and H9N2 Influenza A Hemagglutinins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD; MUTATION-RATES; SOUTHERN CHINA; EVOLUTION; VIRUS; CLASSIFICATION; CIRCULATION; PLACEMENT; EMERGENCE	The evolutionary classification of influenza genes into lineages is a first step in understanding their molecular epidemiology and can inform the subsequent implementation of control measures. We introduce a novel approach called Lineage Assignment By Extended Learning (LABEL) to rapidly determine cladistic information for any number of genes without the need for time-consuming sequence alignment, phylogenetic tree construction, or manual annotation. Instead, LABEL relies on hidden Markov model profiles and support vector machine training to hierarchically classify gene sequences by their similarity to pre-defined lineages. We assessed LABEL by analyzing the annotated hemagglutinin genes of highly pathogenic (H5N1) and low pathogenicity (H9N2) avian influenza A viruses. Using the WHO/FAO/OIE H5N1 evolution working group nomenclature, the LABEL pipeline quickly and accurately identified the H5 lineages of uncharacterized sequences. Moreover, we developed an updated clade nomenclature for the H9 hemagglutinin gene and show a similarly fast and reliable phylogenetic assessment with LABEL. While this study was focused on hemagglutinin sequences, LABEL could be applied to the analysis of any gene and shows great potential to guide molecular epidemiology activities, accelerate database annotation, and provide a data sorting tool for other large-scale bioinformatic studies.	[Shepard, Samuel S.; Davis, C. Todd; Rivailler, Pierre; York, Ian A.; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Bahl, Justin] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Lab Virus Evolut, Singapore, Singapore; [Bahl, Justin] Univ Texas Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA	Centers for Disease Control & Prevention - USA; National University of Singapore; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Shepard, SS (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	vfn4@cdc.gov; rvd6@cdc.gov	York, Ian/X-9351-2019; Bahl, Justin/A-4728-2011	York, Ian/0000-0002-3478-3344; Bahl, Justin/0000-0001-7572-4300				Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO, 2012, H5N1 HPAI GLOB OV; Fox J, 2011, R COMPANION APPL REG, Vxxii; Franc V, 2005, THESIS CZECH TU PRAG; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; Gower JC, 1980, CURRENT CONTENTS AGR, V14-14; Graf A. B. A., 2001, Pattern Recognition. 23rd DAGM Symposium. Proceedings (Lecture Notes in Computer Science Vol.2191), P277; Han J., 2011, DATA MINING CONCEPTS, V2nd; Jackwood MW, 2007, AVIAN DIS, V51, P448, DOI 10.1637/7536-032706R.1; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kayali G, 2011, EMERG INFECT DIS, V17, P2306, DOI 10.3201/eid1712.110683; Kovacova A, 2002, VIRUS GENES, V24, P57, DOI 10.1023/A:1014038120979; Lee YJ, 2007, VIROLOGY, V359, P313, DOI 10.1016/j.virol.2006.09.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Lu G, 2007, OPTIONS CONTROL INFL; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Moon HJ, 2010, ARCH VIROL, V155, P229, DOI 10.1007/s00705-009-0577-4; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2010, J GEN VIROL, V91, P1984, DOI 10.1099/vir.0.020750-0; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; OIE, 2012, OUTBR HIGHL PATH AV; Pandit A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S26; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2021, R LANGUAGE ENV STAT; Read I, 2007, INTERSPEECH 2007: 8TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION, VOLS 1-4, P2085; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Shepard SS, 2012, NUCLEIC ACIDS RES, V40, P4765, DOI 10.1093/nar/gks154; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Nguyen T, 2012, VIROLOGY, V432, P405, DOI 10.1016/j.virol.2012.06.021; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2010, ANT GEN CHAR INFL A; WHO, 2012, CUM NUMB CONF HUM CA; WHO/OIE/FAO H5N1 Evolution Working Group, 2008, Emerg Infect Dis, V14, pe1, DOI 10.3201/eid1407.071681; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86921	10.1371/journal.pone.0086921	http://dx.doi.org/10.1371/journal.pone.0086921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466291	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000172
J	Niehus, S; Smith, TK; Azzouz, N; Campos, MA; Dubremetz, JF; Gazzinelli, RT; Schwarz, RT; Debierre-Grockiego, F				Niehus, Sebastian; Smith, Terry K.; Azzouz, Nahid; Campos, Marco A.; Dubremetz, Jean-Francois; Gazzinelli, Ricardo T.; Schwarz, Ralph T.; Debierre-Grockiego, Francoise			Virulent and Avirulent Strains of Toxoplasma gondii Which Differ in Their Glycosylphosphatidylinositol Content Induce Similar Biological Functions in Macrophages	PLOS ONE			English	Article							MOLECULAR-WEIGHT ANTIGEN; SIGNAL-TRANSDUCTION; SURFACE-ANTIGENS; TNF-ALPHA; HOST; PROTEIN; TRYPANOSOMA; ACTIVATION; INFECTION; EFFECTORS	Glycosylphosphatidylinositols (GPIs) from several protozoan parasites are thought to elicit a detrimental stimulation of the host innate immune system aside their main function to anchor surface proteins. Here we analyzed the GPI biosynthesis of an avirulent Toxoplasma gondii type 2 strain (PTG) by metabolic radioactive labeling. We determined the biological function of individual GPI species in the PTG strain in comparison with previously characterized GPI-anchors of a virulent strain (RH). The GPI intermediates of both strains were structurally similar, however the abundance of two of six GPI intermediates was significantly reduced in the PTG strain. The side-by-side comparison of GPI-anchor content revealed that the PTG strain had only similar to 34% of the protein-free GPIs as well as similar to 70% of the GPI-anchored proteins with significantly lower rates of protein N-glycosylation compared to the RH strain. All mature GPIs from both strains induced comparable secretion levels of TNF-alpha and IL-12p40, and initiated TLR4/MyD88-dependent NF-kappa Bp65 activation in macrophages. Taken together, these results demonstrate that PTG and RH strains differ in their GPI biosynthesis and possess significantly different GPI-anchor content, while individual GPI species of both strains induce similar biological functions in macrophages.	[Niehus, Sebastian; Azzouz, Nahid; Schwarz, Ralph T.; Debierre-Grockiego, Francoise] Univ Marburg, Inst Virol, Parasitol Lab, D-35032 Marburg, Germany; [Niehus, Sebastian] UPR 9022 CNRS, Inst Mol & Cellular Biol, Strasbourg, France; [Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Campos, Marco A.; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Res Ctr Rene Rachou, Immunopathol Lab, Belo Horizonte, MG, Brazil; [Dubremetz, Jean-Francois] Univ Montpellier 2, UMR CNRS 5235, Montpellier, France; [Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts Med Sch, Div Infect Dis & Immunol, Dept Med, Worcester, MA USA; [Schwarz, Ralph T.] Univ Lille, UMR CNRS 8576, Unit Struct & Funct Glycobiol, Lille, France; [Debierre-Grockiego, Francoise] Univ Tours, UMR Infectiol & Publ Hlth 1282, Tours, France; [Debierre-Grockiego, Francoise] INRA, F-37380 Nouzilly, France	Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of St Andrews; Fundacao Oswaldo Cruz; Universite de Montpellier; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Tours; INRAE	Niehus, S (corresponding author), Univ Marburg, Inst Virol, Parasitol Lab, D-35032 Marburg, Germany.	s.niehus@unistra.fr	Campos, Marco A/C-4000-2013; Debierre-Grockiego, Francoise/AAD-4322-2021; Campos, Marco Antonio/AAU-6229-2021	Campos, Marco A/0000-0003-4683-0176; Campos, Marco Antonio/0000-0003-4683-0176; Gazzinelli, Ricardo/0000-0003-2427-7699	Deutsche Forschungsgemeinschaft; NIH [R01 AI071319]; PROBRAL of Deutscher Akademischer Austausch Dienst/CAPES; Wellcome Trust Senior Research Fellowship [067441]; Wellcome Trust [086658, 093228]; CNPq	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PROBRAL of Deutscher Akademischer Austausch Dienst/CAPES; Wellcome Trust Senior Research Fellowship(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Deutsche Forschungsgemeinschaft (R. T. S.), NIH grant number R01 AI071319 (R. T. G. and R. T. S.) and PROBRAL of Deutscher Akademischer Austausch Dienst/CAPES (R. T. G. and R. T. S.). T. K. S. is supported by a Wellcome Trust Senior Research Fellowship (067441), and Wellcome Trust grants (086658) and (093228). R. T. G. and M. A. C. are research fellows from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Azzouz N, 2005, ANAL BIOCHEM, V343, P152, DOI 10.1016/j.ab.2005.04.030; Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Boothroyd JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003296; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Debierre-Grockiego F, 2010, J BIOL CHEM, V285, P32744, DOI 10.1074/jbc.M110.137588; Delude RL, 1998, J IMMUNOL, V161, P3001; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; GRIMWOOD BG, 1979, EXP PARASITOL, V48, P282, DOI 10.1016/0014-4894(79)90110-3; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Khan A, 2011, MBIO, V2, DOI 10.1128/mBio.00228-11; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; KHAN IA, 1988, J INFECT DIS, V157, P979, DOI 10.1093/infdis/157.5.979; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; MacRae JI, 2005, GLYCOBIOLOGY, V15, P131, DOI 10.1093/glycob/cwh149; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; MENON AK, 1990, J BIOL CHEM, V265, P9033; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Niehus S, 2012, IMMUNOBIOLOGY, V217, P61, DOI 10.1016/j.imbio.2011.08.001; Pekari K, 2001, J ORG CHEM, V66, P7432, DOI 10.1021/jo015840q; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard AM, 2009, TRENDS PARASITOL, V25, P491, DOI 10.1016/j.pt.2009.07.009; Rachinel N, 2004, J IMMUNOL, V173, P2725, DOI 10.4049/jimmunol.173.4.2725; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Smith TK, 2007, J BIOL CHEM, V282, P32032, DOI 10.1074/jbc.M703784200; STRIEPEN B, 1992, Biochemical Society Transactions, V20, p296S; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; TACHADO SD, 1994, BIOCHEM BIOPH RES CO, V205, P984, DOI 10.1006/bbrc.1994.2763; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; TOMAVO S, 1992, J BIOL CHEM, V267, P11721; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Wichroski MJ, 2003, EUKARYOT CELL, V2, P1132, DOI 10.1128/EC.2.5.1132-1136.2003; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	60	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85386	10.1371/journal.pone.0085386	http://dx.doi.org/10.1371/journal.pone.0085386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489660	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000013
J	Alamili, M; Bendtzen, K; Lykkesfeldt, J; Rosenberg, J; Gogenur, I				Alamili, Mahdi; Bendtzen, Klaus; Lykkesfeldt, Jens; Rosenberg, Jacob; Gogenur, Ismail			Pronounced Inflammatory Response to Endotoxaemia during Nighttime: A Randomised Cross-Over Trial	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; OXIDATIVE STRESS; MENSTRUAL-CYCLE; FREE-RADICALS; IN-VIVO; CYTOKINE RESPONSE; CIRCADIAN-RHYTHM; IMMUNE-SYSTEM; SEPTIC SHOCK; MALONDIALDEHYDE	Background: Circadian variation in bodily functions has been shown to impact health in acute and chronic medical conditions. Little is known about the relationship between circadian rhythm and sepsis in humans. We aimed to investigate circadian variations in the host response in a human endotoxaemia model. Design and Methods: A cross-over study, where 12 healthy young men received E. coli endotoxin (lipopolysaccharide, LPS) 0.3 ng/kg at 12 noon and, on another day, at 12 midnight. Blood samples were analysed for pro-and anti-inflammatory cytokines: tumour-necrosis factor (TNF)-alpha, soluble TNF receptors (sTNF-R)-1 and -2, interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1Ra), IL-6, and IL-10 as well as YKL-40 and the oxidative stress markers malondialdehyde (MDA), ascorbic acid (AA) and dehydroascorbic acid (DHA) before and at 2, 4, 6 and 8 hours after LPS administration. Results: The levels of MDA and IL-10 where significantly higher during the day time (P<0.05) whereas levels of TNF-alpha, sTNF-RI, sTNF-RII, IL-1Ra, IL-6, and YKL-40 were higher (P<0.01 for all comparisons) during the night time. No significant differences were seen in the levels of AA and DHA. Conclusion: A day-night difference in the acute phase response to endotoxaemia exists in healthy volunteers with a more pronounced inflammatory response during the night time. This circadian difference in the response to endotoxaemia may play an important role in the clinical setting and should be investigated further.	[Alamili, Mahdi; Rosenberg, Jacob; Gogenur, Ismail] Univ Copenhagen, Herlev Hosp, Dept Surg Gastroenterol, DK-2730 Herlev, Denmark; [Bendtzen, Klaus] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Dept Rheumatol, Copenhagen, Denmark; [Lykkesfeldt, Jens] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Alamili, M (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg Gastroenterol, DK-2730 Herlev, Denmark.	mahdi_alamili@hotmail.com	Lykkesfeldt, Jens/A-1072-2011	Lykkesfeldt, Jens/0000-0002-6514-8407; Gogenur, Ismail/0000-0002-3753-268X; Rosenberg, Jacob/0000-0002-0063-1086; Alamili, Mahdi/0000-0002-2693-5184	Aase og Ejnar Danielsens Fond; A. P. Moller Foundation for the Advancement of Medical Science	Aase og Ejnar Danielsens Fond; A. P. Moller Foundation for the Advancement of Medical Science	The scientific work was supported by grants from Aase og Ejnar Danielsens Fond and The A. P. Moller Foundation for the Advancement of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamili M, 2013, CHRONOBIOLOL INT, DOI [10.3109/07420528.2013. 808653, DOI 10.3109/07420528.2013.808653)]; Alamili M, 2010, DAN MED BULL, V57; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Baker FC, 2007, SLEEP MED, V8, P613, DOI 10.1016/j.sleep.2006.09.011; Bhattacharyya J, 2004, CURR MED CHEM, V11, P359, DOI 10.2174/0929867043456098; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BRACKETT DJ, 1989, FREE RADICAL RES COM, V7, P315, DOI 10.3109/10715768909087957; Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Erikstrup C, 2006, CLIN EXP IMMUNOL, V144, P94, DOI 10.1111/j.1365-2249.2006.03042.x; Fried E, 2011, CURR OPIN CRIT CARE, V17, P396, DOI 10.1097/MCC.0b013e328348bee2; Habbal OA, 2009, INT REV IMMUNOL, V28, P93, DOI 10.1080/08830180802645050; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hattori N, 2009, SHOCK, V32, P393, DOI 10.1097/SHK.0b013e31819e2c0c; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hermann C, 2006, EUR J IMMUNOL, V36, P371, DOI 10.1002/eji.200535470; Hodgin KE, 2008, CURR PHARM DESIGN, V14, P1833, DOI 10.2174/138161208784980590; HRUSHESKY WJM, 1994, J EXP MED, V180, P1059, DOI 10.1084/jem.180.3.1059; Johansen JS, 2005, CLIN EXP IMMUNOL, V140, P343, DOI 10.1111/j.1365-2249.2005.02763.x; Kanabrocki EL, 2002, CHRONOBIOL INT, V19, P423, DOI 10.1081/CBI-120002914; Karatas F, 2002, ANAL BIOCHEM, V311, P76, DOI 10.1016/S0003-2697(02)00387-1; Karsch FJ, 2002, STRESS, V5, P101, DOI 10.1080/10253890290027868; Konecna L, 2000, BRAIN BEHAV IMMUN, V14, P49, DOI 10.1006/brbi.1999.0570; KOSUGI H, 1994, BIOL PHARM BULL, V17, P1645; Kucukakin B, 2010, EUR J VASC ENDOVASC, V40, P461, DOI [10.1016/j.ejvs.2010.06.014, 10.1016/.j.ejvs.2010.06.014]; Kucukakin B, 2010, ACTA ANAESTH SCAND, V54, P1121, DOI 10.1111/j.1399-6576.2010.02294.x; Kvaslerud T, 2010, ACTA ANAESTH SCAND, V54, P1157, DOI 10.1111/j.1399-6576.2010.02296.x; Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Marpegan L, 2009, CHRONOBIOL INT, V26, P1430, DOI 10.3109/07420520903408358; Morera AL, 2007, J PINEAL RES, V43, P313, DOI 10.1111/j.1600-079X.2007.00467.x; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Pollmacher T, 1996, J INFECT DIS, V174, P1040, DOI 10.1093/infdis/174.5.1040; Reiter RJ, 1998, ANN MED, V30, P103, DOI 10.3109/07853899808999391; Sakaguchi S, 2006, FEMS IMMUNOL MED MIC, V47, P167, DOI 10.1111/j.1574-695X.2006.00072.x; Salvemini D, 2002, FREE RADICAL BIO MED, V33, P1173, DOI 10.1016/S0891-5849(02)00961-9; Schwarz E, 2000, CYTOKINE, V12, P413, DOI 10.1006/cyto.1999.0570; Tatsch-Dias MDO, 2013, NEUROIMMUNOMODULAT, V20, P205, DOI 10.1159/000347160; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Unlu A, 2001, CLIN CHEM LAB MED, V39, P491, DOI 10.1515/CCLM.2001.081	43	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87413	10.1371/journal.pone.0087413	http://dx.doi.org/10.1371/journal.pone.0087413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475284	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300179
J	Cheema, AK; Suman, S; Kaur, P; Singh, R; Fornace, AJ; Datta, K				Cheema, Amrita K.; Suman, Shubhankar; Kaur, Prabhjit; Singh, Rajbir; Fornace, Albert J., Jr.; Datta, Kamal			Long-Term Differential Changes in Mouse Intestinal Metabolomics after gamma and Heavy Ion Radiation Exposure	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PROSTAGLANDIN E-2; PYRUVIC-ACID; D-ASPARTATE; CANCER; EXPRESSION; BIOMARKERS; METABOLISM; RECEPTOR; SERUM	Tissue consequences of radiation exposure are dependent on radiation quality and high linear energy transfer (high-LET) radiation, such as heavy ions in space is known to deposit higher energy in tissues and cause greater damage than low-LET gamma radiation. While radiation exposure has been linked to intestinal pathologies, there are very few studies on long-term effects of radiation, fewer involved a therapeutically relevant gamma radiation dose, and none explored persistent tissue metabolomic alterations after heavy ion space radiation exposure. Using a metabolomics approach, we report long-term metabolomic markers of radiation injury and perturbation of signaling pathways linked to metabolic alterations in mice after heavy ion or c radiation exposure. Intestinal tissues (C57BL/6J, female, 6 to 8 wks) were analyzed using ultra performance liquid chromatography coupled with electrospray quadrupole time-of-flight mass spectrometry (UPLC-QToF-MS) two months after 2 Gy gamma radiation and results were compared to an equitoxic Fe-56 (1.6 Gy) radiation dose. The biological relevance of the metabolites was determined using Ingenuity Pathway Analysis, immunoblots, and immunohistochemistry. Metabolic profile analysis showed radiation-type-dependent spatial separation of the groups. Decreased adenine and guanosine and increased inosine and uridine suggested perturbed nucleotide metabolism. While both the radiation types affected amino acid metabolism, the Fe-56 radiation preferentially altered dipeptide metabolism. Furthermore, Fe-56 radiation caused upregulation of 'prostanoid biosynthesis' and 'eicosanoid signaling', which are interlinked events related to cellular inflammation and have implications for nutrient absorption and inflammatory bowel disease during space missions and after radiotherapy. In conclusion, our data showed for the first time that metabolomics can not only be used to distinguish between heavy ion and gamma radiation exposures, but also as a radiation-risk assessment tool for intestinal pathologies through identification of biomarkers persisting long after exposure.	[Cheema, Amrita K.; Suman, Shubhankar; Kaur, Prabhjit; Singh, Rajbir; Fornace, Albert J., Jr.; Datta, Kamal] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Cheema, Amrita K.; Suman, Shubhankar; Kaur, Prabhjit; Singh, Rajbir; Fornace, Albert J., Jr.; Datta, Kamal] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Fornace, Albert J., Jr.] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia	Georgetown University; Georgetown University; King Abdulaziz University	Datta, K (corresponding author), Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA.	kd257@georgetown.edu	Singh, Rajbir/HHN-9064-2022; kaur, prabhjit/HHS-3727-2022; Fornace, Albert/A-7407-2008; Suman, Shubhankar/H-4610-2011	Fornace, Albert/0000-0001-9695-085X; Suman, Shubhankar/0000-0002-9197-0461; Cheema, Amrita/0000-0003-4877-7583	NASA [NNX13AD58G, NNX09AU95G]; National Cancer Institute (NCI) [P30CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by NASA Grant# NNX13AD58G and NNX09AU95G. The authors acknowledge the Histopathology and Tissue Shared Resources for histology services and Proteomics and Metabolomics Shared Resource for metabolomics services, which are in part supported by Award Number P30CA051008 from the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULSEBRO.KA, 1965, BIOCHEM BIOPH RES CO, V18, P165, DOI 10.1016/0006-291X(65)90734-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks AL, 2001, RADIAT RES, V155, P353, DOI 10.1667/0033-7587(2001)155[0353:REOHIP]2.0.CO;2; BURNS GA, 1995, J AUTONOM NERV SYST, V55, P207, DOI 10.1016/0165-1838(95)00043-W; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CASTER WO, 1956, RADIAT RES, V5, P189, DOI 10.2307/3570367; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Costedio MM, 2007, DIS COLON RECTUM, V50, P376, DOI 10.1007/s10350-006-0763-3; Coy SL, 2011, INT J RADIAT BIOL, V87, P802, DOI 10.3109/09553002.2011.556177; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta Francis A, 2003, Gravit Space Biol Bull, V16, P11; CURTIS SB, 1992, ADV SPACE RES-SERIES, V12, P407, DOI 10.1016/0273-1177(92)90137-M; Dassesse T, 2006, EUR UROL, V50, P1021, DOI 10.1016/j.eururo.2006.01.036; Datta K, 2005, P NATL ACAD SCI USA, V102, P10569, DOI 10.1073/pnas.0503975102; Datta K, 2013, PLOS ONE, V8; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Datta K, 2012, INT J RADIAT BIOL, V88, P213, DOI 10.3109/09553002.2012.639434; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Drafta D S, 1981, Endocrinologie, V19, P115; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; EBERHART CE, 1995, GASTROENTEROLOGY, V109, P285, DOI 10.1016/0016-5085(95)90296-1; Farthmann E. H., 1994, Strahlentherapie und Onkologie, V170, P437; Fukunaga Y, 2010, NEUROREPORT, V21, P772, DOI 10.1097/WNR.0b013e32833bfd17; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Ghosh SP, 2013, MOL BIOSYST, V9, P723, DOI 10.1039/c3mb25454b; GILLILAND IC, 1951, BMJ-BRIT MED J, V1, P14, DOI 10.1136/bmj.1.4696.14; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Hamilton SA, 2006, J APPL PHYSIOL, V101, P789, DOI 10.1152/japplphysiol.01078.2005; Hayatsu K, 2009, J PHYS SOC JPN, V78, P149, DOI 10.1143/JPSJS.78SA.149; Hess JR, 2012, NUTR CLIN PRACT, V27, P281, DOI 10.1177/0884533611434933; Hess LM, 2004, CANCER EPIDEM BIOMAR, V13, P861; HOLLAND RE, 1993, BIOCHEM PHARMACOL, V45, P43, DOI 10.1016/0006-2952(93)90375-7; Horio M, 2013, NEUROCHEM INT, V62, P843, DOI 10.1016/j.neuint.2013.02.015; HUBEL KA, 1976, AM J PHYSIOL, V231, P252, DOI 10.1152/ajplegacy.1976.231.1.252; Hunter MH, 2000, AM FAM PHYSICIAN, V62, P1079; Hyland K, 2007, J NUTR, V137, p1568S, DOI 10.1093/jn/137.6.1568S; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Johnson Louis Banka, 2004, BMC Surg, V4, P10, DOI 10.1186/1471-2482-4-10; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Laiakis EC, 2012, RADIAT RES, V177, P187, DOI 10.1667/RR2771.1; Lee DY, 2012, RADIAT RES, V178, P551, DOI 10.1667/RR2990.1; Lee MS, 2001, CANCER RES, V61, P3290; Liu HX, 2013, RADIAT PROT DOSIM, V154, P9, DOI 10.1093/rpd/ncs138; Liu T, 2012, P NATL ACAD SCI USA, V109, P12692, DOI 10.1073/pnas.1207816109; MATHEWS CK, 1982, P NATL ACAD SCI-BIOL, V79, P302, DOI 10.1073/pnas.79.2.302; Matsui Y, 2012, CANCER SCI, V103, P700, DOI 10.1111/j.1349-7006.2012.02200.x; MAXWELL WJ, 1990, DIGESTION, V47, P160, DOI 10.1159/000200492; MUNRO AF, 1951, J PHYSIOL-LONDON, V112, P84, DOI 10.1113/jphysiol.1951.sp004510; Nakanishi M, 2011, CANCER PREV RES, V4, P1198, DOI 10.1158/1940-6207.CAPR-11-0188; Obenaus A, 2008, RADIAT RES, V169, P149, DOI 10.1667/RR1135.1; Okunieff P, 2008, CANCER METAST REV, V27, P363, DOI 10.1007/s10555-008-9138-7; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Patterson AD, 2010, MASS SPECTROM REV, V29, P503, DOI 10.1002/mas.20272; Pendyala L, 1997, CLIN CANCER RES, V3, P793; Peng Y, 2009, RADIAT RES, V171, P474, DOI 10.1667/RR1547.1; Peterson JW, 1998, LAB INVEST, V78, P523; Platt BS, 1939, BIOCHEM J, V33, P1525; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; PUGH S, 1994, GUT, V35, P675, DOI 10.1136/gut.35.5.675; Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013; Rola R, 2005, RADIAT RES, V164, P556, DOI 10.1667/RR3412.1; ROSEN IB, 1964, CAN MED ASSOC J, V91, P681; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Sandig H, 2007, J LEUKOCYTE BIOL, V81, P372, DOI 10.1189/jlb.0706424; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Sheng HM, 1998, CANCER RES, V58, P362; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Silfen ME, 2003, J CLIN ENDOCR METAB, V88, P4682, DOI 10.1210/jc.2003-030617; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Smith T, 2011, J NEUROCHEM, V118, P187, DOI 10.1111/j.1471-4159.2011.07305.x; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Snyder R D, 1985, Basic Life Sci, V31, P163; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Suman S, 2012, RAD ENV BIOPHYS; Suman S, 2012, INT J RADIAT ONCOL, V84, P500, DOI 10.1016/j.ijrobp.2011.12.033; Tessner TG, 2004, CARCINOGENESIS, V25, P37, DOI 10.1093/carcin/bgg183; Tseng BP, 2013, ANTIOXID REDOX SIGNA; Tucker JD, 2004, RADIAT RES, V161, P648, DOI 10.1667/RR3177; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; vanderHulst RRWJ, 1997, ANN SURG, V225, P112, DOI 10.1097/00000658-199701000-00013; Vistad I, 2009, INT J RADIAT ONCOL, V73, P1141, DOI 10.1016/j.ijrobp.2008.05.064; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]; ZIFRONI A, 1983, GUT, V24, P659, DOI 10.1136/gut.24.7.659	95	44	46	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87079	10.1371/journal.pone.0087079	http://dx.doi.org/10.1371/journal.pone.0087079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475228	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300135
J	David, FPA; Delafontaine, J; Carat, S; Ross, FJ; Lefebvre, G; Jarosz, Y; Sinclair, L; Noordermeer, D; Rougemont, J; Leleu, M				David, Fabrice P. A.; Delafontaine, Julien; Carat, Solenne; Ross, Frederick J.; Lefebvre, Gregory; Jarosz, Yohan; Sinclair, Lucas; Noordermeer, Daan; Rougemont, Jacques; Leleu, Marion			HTSstation: A Web Application and Open-Access Libraries for High-Throughput Sequencing Data Analysis	PLOS ONE			English	Article							CHIP-SEQ DATA; CONFORMATION; GENOME; TOOLS; SUITE	The HTSstation analysis portal is a suite of simple web forms coupled to modular analysis pipelines for various applications of High-Throughput Sequencing including ChIP-seq, RNA-seq, 4C-seq and re-sequencing. HTSstation offers biologists the possibility to rapidly investigate their HTS data using an intuitive web application with heuristically pre-defined parameters. A number of open-source software components have been implemented and can be used to build, configure and run HTS analysis pipelines reactively. Besides, our programming framework empowers developers with the possibility to design their own workflows and integrate additional third-party software. The HTSstation web application is accessible at http://htsstation.epfl.ch.	[David, Fabrice P. A.; Delafontaine, Julien; Carat, Solenne; Ross, Frederick J.; Lefebvre, Gregory; Jarosz, Yohan; Sinclair, Lucas; Noordermeer, Daan; Rougemont, Jacques; Leleu, Marion] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [David, Fabrice P. A.; Delafontaine, Julien; Carat, Solenne; Ross, Frederick J.; Lefebvre, Gregory; Jarosz, Yohan; Sinclair, Lucas; Rougemont, Jacques; Leleu, Marion] SIB, Lausanne, Switzerland; [Noordermeer, Daan; Leleu, Marion] ISREC, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Swiss Institute Experimental Cancer Research	Rougemont, J (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	jacques.rougemont@epfl.ch; marion.leleu@epfl.ch	Dumont, Solenne/L-3023-2015; Noordermeer, Daan/F-3306-2011	Dumont, Solenne/0000-0003-3237-7382; Lefebvre, Greg/0000-0001-7519-2316; Sinclair, Lucas/0000-0003-4134-3571; Noordermeer, Daan/0000-0002-9296-7002	SystemsX.ch; Swiss Initiative in Systems Biology, through the SyBIT; CycliX; LipidX; DynamiX; ERC grant SystemsHox.ch; Swiss National Science Foundation Sinergia [CRSI33_130662]; EPFL	SystemsX.ch; Swiss Initiative in Systems Biology, through the SyBIT; CycliX; LipidX; DynamiX; ERC grant SystemsHox.ch; Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); EPFL	This work has been supported by SystemsX.ch, the Swiss Initiative in Systems Biology, through the SyBIT (JD, FJR, LS, YJ), CycliX(JR), LipidX (FPAD) and DynamiX (JR) projects, by the ERC grant SystemsHox.ch to Denis Duboule (DN, ML), by a Swiss National Science Foundation Sinergia Grant CRSI33_130662 to Daniel Constam (SC), and by the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lee KP, 2012, GENE DEV, V26, P1984, DOI 10.1101/gad.194266.112; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Leleu M, 2010, BRIEF FUNCT GENOMICS, V9, P466, DOI 10.1093/bfgp/elq022; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Preti M, 2010, MOL CELL, V38, P614, DOI 10.1016/j.molcel.2010.04.016; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rougemont J, 2012, METHODS MOL BIOL, V786, P263, DOI 10.1007/978-1-61779-292-2_16; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	56	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85879	10.1371/journal.pone.0085879	http://dx.doi.org/10.1371/journal.pone.0085879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475057	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300028
J	Fujita, H; Aoki, H; Ajioka, I; Yamazaki, M; Abe, M; Oh-Nishi, A; Sakimura, K; Sugihara, I				Fujita, Hirofumi; Aoki, Hanako; Ajioka, Itsuki; Yamazaki, Maya; Abe, Manabu; Oh-Nishi, Arata; Sakimura, Kenji; Sugihara, Izumi			Detailed Expression Pattern of Aldolase C (Aldoc) in the Cerebellum, Retina and Other Areas of the CNS Studied in Aldoc-Venus Knock-In Mice	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; ZEBRIN-II; MOUSE CEREBELLUM; PURKINJE-CELLS; FUNCTIONAL-ORGANIZATION; PARASAGITTAL BANDS; ZONAL ORGANIZATION; TRANSGENIC MICE; RAT CEREBELLUM; CORTICAL ZONES	Aldolase C (Aldoc, also known as "zebrin II"), a brain type isozyme of a glycolysis enzyme, is expressed heterogeneously in subpopulations of cerebellar Purkinje cells (PCs) that are arranged longitudinally in a complex striped pattern in the cerebellar cortex, a pattern which is closely related to the topography of input and output axonal projections. Here, we generated knock-in Aldoc-Venus mice in which Aldoc expression is visualized by expression of a fluorescent protein, Venus. Since there was no obvious phenotypes in general brain morphology and in the striped pattern of the cerebellum in mutants, we made detailed observation of Aldoc expression pattern in the nervous system by using Venus expression in Aldoc-Venus heterozygotes. High levels of Venus expression were observed in cerebellar PCs, cartwheel cells in the dorsal cochlear nucleus, sensory epithelium of the inner ear and in all major types of retinal cells, while moderate levels of Venus expression were observed in astrocytes and satellite cells in the dorsal root ganglion. The striped arrangement of PCs that express Venus to different degrees was carefully traced with serial section alignment analysis and mapped on the unfolded scheme of the entire cerebellar cortex to re-identify all individual Aldoc stripes. A longitudinally striped boundary of Aldoc expression was first identified in the mouse flocculus, and was correlated with the climbing fiber projection pattern and expression of another compartmental marker molecule, heat shock protein 25 (HSP25). As in the rat, the cerebellar nuclei were divided into the rostrodorsal negative and the caudoventral positive portions by distinct projections of Aldoc-positive and negative PC axons in the mouse. Identification of the cerebellar Aldoc stripes in this study, as indicated in sample coronal and horizontal sections as well as in sample surface photos of whole-mount preparations, can be referred to in future experiments.	[Fujita, Hirofumi; Aoki, Hanako; Sugihara, Izumi] Tokyo Med & Dent Univ, Grad Sch, Dept Syst Neurophysiol, Bunkyo Ku, Tokyo, Japan; [Ajioka, Itsuki; Sugihara, Izumi] Tokyo Med & Dent Univ, Grad Sch, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Oh-Nishi, Arata] Natl Inst Radiol Sci, Mol Neuroimaging Program, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan; [Fujita, Hirofumi] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Fujita, Hirofumi] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Niigata University; National Institutes for Quantum Science & Technology; Salk Institute; Johns Hopkins University	Sugihara, I (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Syst Neurophysiol, Bunkyo Ku, Tokyo, Japan.	isugihara.phy1@tmd.ac.jp	Yamazaki, Maya/C-6952-2012; Abe, Manabu/A-9221-2008; Fujita, Hirofumi/Q-6196-2017; Fujita, Hirofumi/HGB-4305-2022	Fujita, Hirofumi/0000-0001-9630-2756; Fujita, Hirofumi/0000-0001-9630-2756; Oh-Nishi, Arata/0000-0001-5427-4400	Japan Society for the Promotion of Science [23.5291, 25430032]; BBSRC [BB/G01227X/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [25430032, 24700321, 26430035] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23.5291 to HF, 25430032 to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, DEVELOPMENT, V120, P2081; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; AKINTUNDE A, 1994, J CHEM NEUROANAT, V7, P75, DOI 10.1016/0891-0618(94)90009-4; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CAFFE AR, 1994, J COMP NEUROL, V348, P291, DOI 10.1002/cne.903480210; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Canete-Soler R, 2005, J NEUROSCI, V25, P4353, DOI 10.1523/JNEUROSCI.0885-05.2005; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fujita H, 2012, J NEUROSCI, V32, P15688, DOI 10.1523/JNEUROSCI.1710-12.2012; Fujita H, 2012, J COMP NEUROL, V520, P656, DOI 10.1002/cne.22760; Fujita H, 2010, J COMP NEUROL, V518, P1764, DOI 10.1002/cne.22301; Gebre SA, 2012, BRAIN STRUCT FUNCT, V217, P165, DOI 10.1007/s00429-011-0339-4; GRAVEL C, 1987, J COMP NEUROL, V265, P294, DOI 10.1002/cne.902650211; HALL B, 2009, CURR PROTOC CELL BIO, V44; Hallem JS, 1999, NEUROSCIENCE, V93, P1083, DOI 10.1016/S0306-4522(99)00144-X; Hanani M, 2002, NEUROSCIENCE, V114, P279, DOI 10.1016/S0306-4522(02)00279-8; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; LANNOO MJ, 1991, J COMP NEUROL, V310, P215, DOI 10.1002/cne.903100207; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; LEONARD CS, 1988, J NEUROPHYSIOL, V60, P2073, DOI 10.1152/jn.1988.60.6.2073; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; MUGNAINI E, 1987, P NATL ACAD SCI USA, V84, P8692, DOI 10.1073/pnas.84.23.8692; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Ozol K, 1999, J COMP NEUROL, V412, P95; Pham NQ, 2011, J COMP NEUROL, V519, P874, DOI 10.1002/cne.22555; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Romito-DiGiacomo RR, 2005, MOL BRAIN RES, V133, P47, DOI 10.1016/j.molbrainres.2004.09.030; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Sillitoe RV, 2004, J ANAT, V204, P257, DOI 10.1111/j.0021-8782.2004.00282.x; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2004, J COMP NEUROL, V470, P113, DOI 10.1002/cne.10952; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Szaro BG, 2010, TRENDS NEUROSCI, V33, P27, DOI 10.1016/j.tins.2009.10.002; TAN J, 1995, J COMP NEUROL, V356, P23, DOI 10.1002/cne.903560103; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; Terada N, 2004, J COMP NEUROL, V469, P119, DOI 10.1002/cne.11002; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; Voogd J, 2003, J NEUROSCI, V23, P4645; Voogd J, 1997, PROG BRAIN RES, V114, P21; Voogd J., 2004, RAT NERVOUS SYSTEM, V3rd, P205; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Walther EU, 1998, P NATL ACAD SCI USA, V95, P2615, DOI 10.1073/pnas.95.5.2615; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Welsh JP, 2002, ADV NEUROL, V89, P331	58	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86679	10.1371/journal.pone.0086679	http://dx.doi.org/10.1371/journal.pone.0086679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475166	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300101
J	Mir, R; Leon, J				Mir, Ricardo; Leon, Jose			Pathogen and Circadian Controlled 1 (PCC1) Protein Is Anchored to the Plasma Membrane and Interacts with Subunit 5 of COP9 Signalosome in Arabidopsis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FLOWERING TIME; PLANT DEVELOPMENT; FLORAL INDUCTION; FT PROTEIN; GIBBERELLIN; LIGHT; DEFENSE; LIGASES; THALIANA	The Pathogen and Circadian Controlled 1 (PCC1) gene, previously identified and further characterized as involved in defense to pathogens and stress-induced flowering, codes for an 81-amino acid protein with a cysteine-rich C-terminal domain. This domain is essential for homodimerization and anchoring to the plasma membrane. Transgenic plants with the beta-glucuronidase (GUS) reporter gene under the control of 1.1 kb promoter sequence of PCC1 gene display a dual pattern of expression. At early post-germination, PCC1 is expressed only in the root vasculature and in the stomata guard cells of cotyledons. During the transition from vegetative to reproductive development, PCC1 is strongly expressed in the vascular tissue of petioles and basal part of the leaf, and it further spreads to the whole limb in fully expanded leaves. This developmental pattern of expression together with the late flowering phenotype of long-day grown RNA interference (iPCC1) plants with reduced PCC1 expression pointed to a regulatory role of PCC1 in the photoperiod-dependent flowering pathway. iPCC1 plants are defective in light perception and signaling but are not impaired in the function of the core CO-FT module of the photoperiod-dependent pathway. The regulatory effect exerted by PCC1 on the transition to flowering as well as on other reported phenotypes might be explained by a mechanism involving the interaction with the subunit 5 of the COP9 signalosome (CSN).	[Mir, Ricardo; Leon, Jose] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Leon, J (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	jleon@ibmcp.upv.es	Moreno, Ricardo Mir/AAC-9447-2022; León, José/C-4756-2016	Moreno, Ricardo Mir/0000-0003-1506-4683; León, José/0000-0002-7332-1572	Ministerio de Ciencia e Innovacion of Spain [BIO2008-00839, BIO2011-27526, CSD2007-0057]; FPU program of the Ministerio de Educacion y Ciencia (Spain)	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU program of the Ministerio de Educacion y Ciencia (Spain)(German Research Foundation (DFG))	This work was funded by grants BIO2008-00839, BIO2011-27526 and CSD2007-0057 from Ministerio de Ciencia e Innovacion of Spain to J.L. A fellowship/contract of the FPU program of the Ministerio de Educacion y Ciencia (Spain) funded R.M. work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arc E, 2011, PROTEOMICS, V11, P1606, DOI 10.1002/pmic.201000641; Bastian R, 2010, PLANT SIGNAL BEHAV, V5, P224, DOI 10.4161/psb.5.3.10718; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galvao VC, 2012, DEVELOPMENT, V139, P4072, DOI 10.1242/dev.080879; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kuramata M, 2009, PLANT CELL PHYSIOL, V50, P106, DOI 10.1093/pcp/pcn175; Kwok SF, 1999, J MOL BIOL, V285, P85, DOI 10.1006/jmbi.1998.2315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Lozano-Juste J, 2011, PLANT PHYSIOL, V156, P1410, DOI 10.1104/pp.111.177741; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mir R, 2013, J EXP BOT, V64, P3385, DOI 10.1093/jxb/ert177; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nezames CD, 2012, PLANT PHYSIOL, V160, P38, DOI 10.1104/pp.112.198879; Nordgard O, 2001, BIOCHIMIE, V83, P969, DOI 10.1016/S0300-9084(01)01329-3; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Sauerbrunn N, 2004, PLANTA, V218, P552, DOI 10.1007/s00425-003-1143-z; Schwechheimer C, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00107; Segarra S, 2010, PLANT CELL ENVIRON, V33, P11, DOI 10.1111/j.1365-3040.2009.02045.x; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Stratmann JW, 2012, PLANT SCI, V185, P50, DOI 10.1016/j.plantsci.2011.10.004; Venancio TM, 2010, BIOINFORMATICS, V26, P149, DOI 10.1093/bioinformatics/btp647; Wang F, 2011, CELL RES, V21, P1286, DOI 10.1038/cr.2011.118; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Weidler G, 2012, PLANT CELL, V24, P2610, DOI 10.1105/tpc.112.098210; Wigge PA, 2011, CURR BIOL, V21, pR374, DOI 10.1016/j.cub.2011.03.038; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006	51	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87216	10.1371/journal.pone.0087216	http://dx.doi.org/10.1371/journal.pone.0087216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475254	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300155
J	Morawetz, C; Kirilina, E; Baudewig, J; Heekeren, HR				Morawetz, Carmen; Kirilina, Evgeniya; Baudewig, Juergen; Heekeren, Hauke R.			Relationship between Personality Traits and Brain Reward Responses when Playing on a Team	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; NEURAL BASIS; COOPERATION; PERFORMANCE; AMYGDALA; CORTEX; NEUROBIOLOGY; NEUROSCIENCE; MECHANISMS; REPUTATION	Cooperation is an integral part of human social life and we often build teams to achieve certain goals. However, very little is currently understood about emotions with regard to cooperation. Here, we investigated the impact of social context (playing alone versus playing on a team) on emotions while winning or losing a game. We hypothesized that activity in the reward network is modulated by the social context and that personality characteristics might impact team play. We conducted an event-related functional magnetic resonance imaging experiment that involved a simple game of dice. In the team condition, the participant played with a partner against another two-person team. In the single-player condition, the participant played alone against another player. Our results revealed that reward processing in the right amygdala was modulated by the social context. The main effect of outcome (gains versus losses) was associated with increased responses in the reward network. We also found that differences in the reward-related neural response due to social context were associated with specific personality traits. When playing on a team, increased activity in the amygdala during winning was a unique function of openness, while decreased activity in the ventromedial prefrontal cortex and ventral striatum during losing was associated with extraversion and conscientiousness, respectively. In conclusion, we provide evidence that working on a team influences the affective value of a negative outcome by attenuating the negative response associated with it in the amygdala. Our results also show that brain reward responses in a social context are affected by personality traits related to teamwork.	[Morawetz, Carmen; Heekeren, Hauke R.] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Kirilina, Evgeniya] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, Berlin, Germany; [Baudewig, Juergen] Univ Kiel, Dept Radiol, Kiel, Germany	Free University of Berlin; Free University of Berlin; University of Kiel	Morawetz, C (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	carmen.morawetz@fu-berlin.de	Morawetz, Carmen/G-9485-2017	Heekeren, Hauke/0000-0001-7912-6826; Morawetz, Carmen/0000-0003-3607-7627				Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Barrick MR, 1998, J APPL PSYCHOL, V83, P377, DOI 10.1037/0021-9010.83.3.377; Barry B, 1997, J APPL PSYCHOL, V82, P62, DOI 10.1037/0021-9010.82.1.62; Bault N, 2011, P NATL ACAD SCI USA, V108, P16044, DOI 10.1073/pnas.1100892108; Bault N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003477; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Boyd R, 2006, SCIENCE, V314, P1555, DOI 10.1126/science.1136841; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Costa PT, 2007, REVISED NEO PERSONAL; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Doherty JPO, 2004, REWARD REPRESENTATIO, P769, DOI [10.1016/j.conb.2004.10.016, DOI 10.1016/J.C0NB.2004.10.016]; Driskell JE, 2006, GROUP DYN-THEOR RES, V10, P249, DOI 10.1037/1089-2699.10.4.249; Dvash J, 2010, HUM BRAIN MAPP, V31, P1741, DOI 10.1002/hbm.20972; Engelen B, 2008, THEOR PSYCHOL, V18, P527, DOI 10.1177/0959354308091842; Fareri DS, 2012, J NEUROSCI, V32, P9045, DOI 10.1523/JNEUROSCI.0610-12.2012; Fareri DS, 2013, SOC COGN AFFECT NEUR; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gawronski B, 2007, PERSPECT PSYCHOL SCI, V2, P181, DOI 10.1111/j.1745-6916.2007.00036.x; Gerhard U., 1999, GOTTINGEN HOGREFE, V28, P145, DOI [10.1026//0084-5345.28.2.145, DOI 10.1026//0084-5345.28.2.145]; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Haselhuhn MP, 2005, COGNITIVE BRAIN RES, V23, P24, DOI 10.1016/j.cogbrainres.2005.01.005; Henrich J, 2006, COGN SYST RES, V7, P220, DOI 10.1016/j.cogsys.2005.11.010; Hogan R, 1997, HDB PERSONALITY PSYC, P681; Hollenbeck JR, 2002, J APPL PSYCHOL, V87, P599, DOI 10.1037//0021-9010.87.3.599; Hooker CI, 2008, NEUROPSYCHOLOGIA, V46, P2709, DOI 10.1016/j.neuropsychologia.2008.05.005; Huettel SA, 2012, PHILOS T R SOC B, V367, P680, DOI 10.1098/rstb.2011.0264; Kennis M, 2013, NEUROSCI BIOBEHAV R, V37, P73, DOI 10.1016/j.neubiorev.2012.10.012; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Larsen R., 2009, PERSONALITY PSYCHOL, V4th ed.; LePine JA, 1997, J APPL PSYCHOL, V82, P803, DOI 10.1037/0021-9010.82.5.803; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; Levallois C, 2012, NAT REV NEUROSCI, V13, P789, DOI 10.1038/nrn3354; Levine D. S., 2002, BRAIN MIND, V3, P9; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P452, DOI 10.1037//0022-3514.79.3.452; Lucas RE, 2001, J PERS SOC PSYCHOL, V81, P343, DOI 10.1037//0022-3514.81.2.343; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Meshi D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00439; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Neuman GA, 1999, J APPL PSYCHOL, V84, P376, DOI 10.1037/0021-9010.84.3.376; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park SQ, 2011, J NEUROSCI, V31, P9307, DOI 10.1523/JNEUROSCI.4973-10.2011; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Philiastides MG, 2010, P NATL ACAD SCI USA, V107, P9430, DOI 10.1073/pnas.1001732107; Richerson PJ, 2003, DAHL WS ENV, P357; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Smits DJM, 2006, EUR J PERSONALITY, V20, P255, DOI 10.1002/per.583; Stallen M, 2013, NEUROSCIENTIST, V19, P292, DOI 10.1177/1073858412469728; Talairach J., 1988, COPLANAR STEREOTAXIC; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	78	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87277	10.1371/journal.pone.0087277	http://dx.doi.org/10.1371/journal.pone.0087277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475262	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300160
J	Samrat, SK; Li, W; Singh, S; Kumar, R; Agrawal, B				Samrat, Subodh Kumar; Li, Wen; Singh, Shakti; Kumar, Rakesh; Agrawal, Babita			Alternate Reading Frame Protein (F Protein) of Hepatitis C Virus: Paradoxical Effects of Activation and Apoptosis on Human Dendritic Cells Lead to Stimulation of T Cells	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; CORE PROTEIN; FUNCTIONAL IMPAIRMENT; EXPRESSION; ANTIGENS; INDUCE; FAS; NS3; REPLICATION; HCV	Hepatitis C virus (HCV) leads to chronic infection in the majority of infected individuals due to lack, failure, or inefficiency of generated adaptive immune responses. In a minority of patients, acute infection is followed by viral clearance. The immune correlates of viral clearance are not clear yet but have been extensively investigated, suggesting that multispecific and multifunctional cellular immunity is involved. The generation of cellular immunity is highly dependent upon how antigen presenting cells (APCs) process and present various viral antigens. Various structural and non-structural HCV proteins derived from the open reading frame (ORF) have been implicated in modulation of dendritic cells (DCs) and APCs. Besides the major ORF proteins, the HCV core region also encodes an alternate reading frame protein (ARFP or F), whose function in viral pathogenesis is not clear. In the current studies, we sought to determine the role of HCV-derived ARFP in modulating dendritic cells and stimulation of T cell responses. Recombinant adenovirus vectors containing F or core protein derived from HCV (genotype 1a) were prepared and used to endogenously express these proteins in dendritic cells. We made an intriguing observation that endogenous expression of F protein in human DCs leads to contrasting effects on activation and apoptosis of DCs, allowing activated DCs to efficiently internalize apoptotic DCs. These in turn result in efficient ability of DCs to process and present antigen and to prime and stimulate F protein derived peptide-specific T cells from HCV-naive individuals. Taken together, our findings suggest important aspects of F protein in modulating DC function and stimulating T cell responses in humans.	[Samrat, Subodh Kumar; Li, Wen; Singh, Shakti; Agrawal, Babita] Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada; [Kumar, Rakesh] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Agrawal, B (corresponding author), Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada.	bagrawal@ualberta.ca	Samrat, Subodh/AAA-2083-2021; samrat, subodh/AAN-1043-2021; singh, shakti/D-4070-2014	Samrat, Subodh/0000-0002-8600-3901; singh, shakti/0000-0001-6521-0998	Canadian Institutes of Health Research; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions	This work was supported by grants from the Canadian Institutes of Health Research. BA is a recipient of a senior scholar award from the Alberta Heritage Foundation for Medical Research (now Alberta Innovates-Health Solutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Ahonen CL, 2008, BLOOD, V111, P3116, DOI 10.1182/blood-2007-09-114371; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Blackard JT, 2006, HEPATOLOGY, V44, P15, DOI 10.1002/hep.21283; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Burgel B, 2011, J VIRAL HEPATITIS, V18, P562, DOI 10.1111/j.1365-2893.2010.01339.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Fletcher NF, 2012, J VIRAL HEPATITIS, V19, P301, DOI 10.1111/j.1365-2893.2012.01591.x; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Gould E., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003; Honda M, 2000, HEPATOLOGY, V31, P1351, DOI 10.1053/jhep.2000.7985; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Iannello A, 2011, VIRAL IMMUNOL, V24, P11, DOI 10.1089/vim.2010.0083; Jahan S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-522; Jain S, 2010, PLOS ONE, V6; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 1999, J IMMUNOL, V162, P5584; Kanto T, 2004, J GASTROENTEROL, V39, P811, DOI 10.1007/s00535-004-1413-y; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Krishnadas DK, 2010, INT IMMUNOL, V22, P491, DOI 10.1093/intimm/dxq033; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; LANFORD RE, 1995, J VIROL, V69, P8079, DOI 10.1128/JVI.69.12.8079-8083.1995; Larsson M, 2004, J VIROL, V78, P6151, DOI 10.1128/JVI.78.12.6151-6161.2004; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Lau AH, 2003, GUT, V52, P307, DOI 10.1136/gut.52.2.307; Li W, 2006, J GEN VIROL, V87, P61, DOI 10.1099/vir.0.81364-0; Li W, 2008, INT IMMUNOL, V20, P89, DOI 10.1093/intimm/dxm121; Li W, 2006, J IMMUNOL, V176, P6065, DOI 10.4049/jimmunol.176.10.6065; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Longman RS, 2004, BLOOD, V103, P1026, DOI 10.1182/blood-2003-04-1339; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nieda M, 2001, IMMUNOLOGY, V102, P137, DOI 10.1046/j.1365-2567.2001.01175.x; Nogueira CV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000478; Pachiadakis L, 2005, LANCET INFECT DIS, V5, P296, DOI 10.1016/S1473-3099(05)70114-6; Piccioli D, 2005, J HEPATOL, V42, P61, DOI 10.1016/j.jhep.2004.09.014; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rollier C, 2003, HEPATOLOGY, V38, P851, DOI 10.1053/jhep.2003.50426; Ruggieri A, 1997, VIROLOGY, V229, P68, DOI 10.1006/viro.1996.8420; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Scarlett UK, 2009, CANCER RES, V69, P7329, DOI 10.1158/0008-5472.CAN-09-0835; Servet-Delprat C, 2000, J VIROL, V74, P4387, DOI 10.1128/JVI.74.9.4387-4393.2000; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takaki A, 2010, J VIRAL HEPATITIS, V17, P555, DOI 10.1111/j.1365-2893.2009.01213.x; Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387; Tu ZK, 2012, INT IMMUNOL, V24, P97, DOI 10.1093/intimm/dxr104; Varaklioti A, 2002, J BIOL CHEM, V277, P17713, DOI 10.1074/jbc.M201722200; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Wertheimer AM, 2007, HEPATOLOGY, V45, P1422, DOI 10.1002/hep.21637; World Health Organization, 2011, WHO REP; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yakushijin T, 2006, HEPATOL RES, V34, P156, DOI 10.1016/j.hepres.2005.12.010; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86567	10.1371/journal.pone.0086567	http://dx.doi.org/10.1371/journal.pone.0086567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475147	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300083
J	Sega, EI; Leveson-Gower, DB; Florek, M; Schneidawind, D; Luong, RH; Negrin, RS				Sega, Emanuela I.; Leveson-Gower, Dennis B.; Florek, Mareike; Schneidawind, Dominik; Luong, Richard H.; Negrin, Robert S.			Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; TGF-BETA; EFFECTOR FUNCTION; CUTTING EDGE; IN-VIVO; CD223; SUPPRESSION; EXPRESSION; CD4(+)	Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg) function in murine GVHD with the hypothesis that Lag-3 engagement diminishes alloreactive T cell responses after bone marrow transplantation. We demonstrate that Lag-3 deficient Tcon (Lag-3(-/-) Tcon) induce significantly more severe GVHD than wild type (WT) Tcon and that the absence of Lag-3 on CD4 but not CD8 T cells is responsible for exacerbating GVHD. Lag-30(-/-) Tcon exhibited increased activation and proliferation as indicated by CFSE and bioluminescence imaging analyses and higher levels of activation markers such as CD69, CD107a, granzyme B, and Ki-67 as well as production of IL-10 and IFN-g early after transplantation. Lag-3(-/-) Tcon were less responsive to suppression by WT Treg as compared to WT Tcon. The absence of Lag-3, however, did not impair Treg function as both Lag-3(-/-) and WT Treg equally suppress the proliferation of Tcon in vitro and in vivo and protect against GVHD. Further, we demonstrate that allogeneic Treg acquire recipient MHC class II molecules through a process termed trogocytosis. As MHC class II is a ligand for Lag-3, we propose a novel suppression mechanism employed by Treg involving the acquisition of host MHC-II followed by the engagement of Lag-3 on T cells. These studies demonstrate for the first time the biologic function of Lag-3 expression on conventional and regulatory T cells in GVHD and identify Lag-3 as an important regulatory molecule involved in alloreactive T cell proliferation and activation after bone marrow transplantation.	[Sega, Emanuela I.; Leveson-Gower, Dennis B.; Florek, Mareike; Schneidawind, Dominik; Negrin, Robert S.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Luong, Richard H.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Negrin, RS (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	negrs@stanford.edu	Schneidawind, Dominik/AAR-4509-2020		National Heart, Lung and Blood Institute [P01HL075462]; National Cancer Institute [P01CA49605]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075462] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung and Blood Institute (P01HL075462) and the National Cancer Institute (P01CA49605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Banovic T, 2005, BLOOD, V106, P2206, DOI 10.1182/blood-2005-01-0062; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Buisson S, 2005, IMMUNOLOGY, V114, P369, DOI 10.1111/j.1365-2567.2004.02087.x; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cohen JL, 2006, CURR OPIN IMMUNOL, V18, P580, DOI 10.1016/j.coi.2006.07.007; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Colonna L, 2011, BIOL BLOOD MARROW TR, V17, pS58, DOI 10.1016/j.bbmt.2010.10.020; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; HUARD B, 1994, IMMUNOGENETICS, V39, P213; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Leveson-Gower DB, 2011, BLOOD, V117, P3220, DOI 10.1182/blood-2010-08-303008; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Lucas CL, 2011, BLOOD, V117, P5532, DOI 10.1182/blood-2010-11-318675; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nguyen VH, 2007, BLOOD, V109, P2649, DOI 10.1182/blood-2006-08-044529; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Reddy P, 2008, MOUSE MODELS GRAFT V; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Veenstra RG, 2012, BLOOD, V120, P682, DOI 10.1182/blood-2011-10-387977; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	43	51	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86551	10.1371/journal.pone.0086551	http://dx.doi.org/10.1371/journal.pone.0086551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475140	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300077
J	Soliai, MM; Meyer, SE; Udall, JA; Elzinga, DE; Hermansen, RA; Bodily, PM; Hart, AA; Coleman, CE				Soliai, Marcus M.; Meyer, Susan E.; Udall, Joshua A.; Elzinga, David E.; Hermansen, Russell A.; Bodily, Paul M.; Hart, Aaron A.; Coleman, Craig E.			De novo Genome Assembly of the Fungal Plant Pathogen Pyrenophora semeniperda	PLOS ONE			English	Article							REPENTIS-WHEAT INTERACTION; DIELS-ALDER REACTION; TRITICI-REPENTIS; TRANSPOSABLE ELEMENTS; BROMUS-TECTORUM; TAN SPOT; CHROMOSOME REARRANGEMENTS; GENE-EXPRESSION; TOXB GENE; SEQUENCE	Pyrenophora semeniperda (anamorph Drechslera campulata) is a necrotrophic fungal seed pathogen that has a wide host range within the Poaceae. One of its hosts is cheatgrass (Bromus tectorum), a species exotic to the United States that has invaded natural ecosystems of the Intermountain West. As a natural pathogen of cheatgrass, P. semeniperda has potential as a biocontrol agent due to its effectiveness at killing seeds within the seed bank; however, few genetic resources exist for the fungus. Here, the genome of P. semeniperda isolate assembled from sequence reads of 454 pyrosequencing is presented. The total assembly is 32.5 Mb and includes 11,453 gene models encoding putative proteins larger than 24 amino acids. The models represent a variety of putative genes that are involved in pathogenic pathways typically found in necrotrophic fungi. In addition, extensive rearrangements, including inter-and intrachromosomal rearrangements, were found when the P. semeniperda genome was compared to P. tritici-repentis, a related fungal species.	[Soliai, Marcus M.; Udall, Joshua A.; Elzinga, David E.; Hermansen, Russell A.; Bodily, Paul M.; Hart, Aaron A.; Coleman, Craig E.] Brigham Young Univ, Provo, UT 84602 USA; [Meyer, Susan E.] US Forest Serv, USDA, Rocky Mt Res Stn, Shrub Sci Lab, Provo, UT USA	Brigham Young University; United States Department of Agriculture (USDA); United States Forest Service	Coleman, CE (corresponding author), Brigham Young Univ, Provo, UT 84602 USA.	craig_coleman@byu.edu		Soliai, Marcus/0000-0003-3458-0739	CSREES, National Research Initiative, United States Department of Agriculture [2008-35320-18677]	CSREES, National Research Initiative, United States Department of Agriculture	This research was funded by grant 2008-35320-18677 from CSREES, National Research Initiative, United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhaddour R, 2009, MOL PLANT PATHOL, V10, P201, DOI 10.1111/j.1364-3703.2008.00520.x; Amaike S, 2008, PLANT PATHOL, V57, P623, DOI 10.1111/j.1365-3059.2007.01821.x; Beckstead J, 2007, ANN BOT-LONDON, V99, P907, DOI 10.1093/aob/mcm028; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Boose D, 2011, MYCOLOGIA, V103, P85, DOI 10.3852/09-310; BRITTLEBANK C. C., 1924, Transactions of the British Mycological Society, V10, P123; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Ciuffetti LM, 1999, PHYTOPATHOLOGY, V89, P444, DOI 10.1094/PHYTO.1999.89.6.444; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; De Wolf ED, 1998, CAN J PLANT PATHOL, V20, P349, DOI 10.1080/07060669809500404; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Ellwood SR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r109; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Evidente A, 2002, PHYTOCHEMISTRY, V60, P45, DOI 10.1016/S0031-9422(02)00071-7; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hood ME, 2005, GENETICS, V170, P1081, DOI 10.1534/genetics.105.042564; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; KREITLOW KW, 1964, PHYTOPATHOLOGY, V54, P353; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Krzywinski MI, 2009, GENOME RES; KUPIEC M, 1988, GENETICS, V119, P549; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ladeveze V, 1998, P ROY SOC B-BIOL SCI, V265, P1157, DOI 10.1098/rspb.1998.0412; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LAMARI L, 1991, PHYTOPATHOLOGY, V81, P1092, DOI 10.1094/Phyto-81-1092; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Liu ZH, 2011, MOL PLANT PATHOL, V12, P1, DOI 10.1111/j.1364-3703.2010.00649.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Medd RW, 2005, BIOCONTROL SCI TECHN, V15, P21, DOI 10.1080/09583150410001720635; Medd RW, 2003, AUSTRALAS PLANT PATH, V32, P539, DOI 10.1071/AP03059; Meyer SE, 2007, WEED RES, V47, P54, DOI 10.1111/j.1365-3180.2007.00537.x; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Nelson EB, 1994, TURF GRASS TRENDS, V3, P11; Nelson EB, 1994, TURF GRASS TRENDS, V3, P1; O' Gara PJ, 1915, PHYTOPATHOLOGY, V5, P323; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Oikawa H, 2004, NAT PROD REP, V21, P321, DOI 10.1039/b305068h; OIKAWA H, 1992, J CHEM SOC PERK T 1, P2955, DOI 10.1039/p19920002955; Pain A, 2008, NAT REV MICROBIOL, V6, P572, DOI 10.1038/nrmicro1964; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Raices M, 2002, BBA-GENE STRUCT EXPR, V1576, P15, DOI 10.1016/S0167-4781(02)00243-9; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Schumann J, 2007, J AM CHEM SOC, V129, P9564, DOI 10.1021/ja072884t; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; SHABEER A, 1988, PLANT DIS, V72, P599, DOI 10.1094/PD-72-0599; Singh PK, 2008, PHYTOPATHOLOGY, V98, P702, DOI 10.1094/PHYTO-98-6-0702; Smit A, 1996, REPEATMASKER OPEN 30; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Strelkov SE, 2002, CAN J PLANT PATHOL, V24, P29, DOI 10.1080/07060660109506967; Tekauz A., 1980, Canadian Journal of Plant Pathology, V2, P152; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; WALLACE H. A. H., 1959, CANADIAN JOUR BOT, V37, P509, DOI 10.1139/b59-043; Wanchanthuek P, 2006, TOPICS CURRENT GENET; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wostemeyer J, 2002, CURR GENET, V41, P189, DOI 10.1007/s00294-002-0306-y; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805	73	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87045	10.1371/journal.pone.0087045	http://dx.doi.org/10.1371/journal.pone.0087045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475219	gold, Green Published			2022-12-27	WOS:000330507300129
J	Tran, BX; Nguyen, TV; Pham, QD; Nguyen, PD; Khuu, NV; Nguyen, NP; Bui, DH; Phan, HTT; Nguyen, LT				Bach Xuan Tran; Thuong Vu Nguyen; Quang Duy Pham; Phuc Duy Nguyen; Nghia Van Khuu; Nhung Phuong Nguyen; Duc Hoang Bui; Huong Thu Thi Phan; Long Thanh Nguyen			HIV Infection, Risk Factors, and Preventive Services Utilization among Female Sex Workers in the Mekong Delta Region of Vietnam	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS	Background: Risk behaviors among female sex workers (FSW) are considerable drivers of HIV infections in Vietnam, especially transmission between high-risk and low-risk groups. We assessed HIV prevalence and its correlates among FSWs, and the use of preventive services among this community in the Mekong Delta region, southern Vietnam. Methods: A cross-sectional survey of 1,999 FSWs was carried out in five provinces including Ben Tre, Hau Giang, Kien Giang, Tien Giang, and Vinh Long between June, 2006 and June, 2007. We interviewed participants face-to-face in order to elicit information about their lives and potential risk factors, and we tested their sera to determine their HIV status. We then performed multivariate logistic regression analyses to investigate factors associated with HIV infection. Results: Seventeen percent of the participating FSWs were street-based sex workers (SSWs) and the rest (83%) were entertainment establishment-based sex workers (ESWs). Unprotected sex with regular and casual clients in the past month was frequent among study participants (40.5% and 33.5% respectively). However, few respondents (1.3%) had ever injected drugs. Only 2.1% (95% confidence interval (CI): 1.6%-2.8%) of FSWs were found to be infected with HIV. HIV prevalence among SSWs was greater than among ESWs (3.8% vs. 1.8%, p = 0.02, respectively). Increased risk for HIV infection was significantly associated with the number of clients per month (adjusted odd ratio (aOR) = 2.65, 95% CI: 1.26-5.59). Conclusions: Interventions to reduce unsafe sex and drug injection, and to increase uptake of HIV testing among FSWs are necessary. Differences in HIV prevalence and its correlates by type of sex work emphasize the importance of constrained contexts in shaping risk behaviors among FSWs; that should be considered in designing HIV prevention programs.	[Bach Xuan Tran] Hanoi Med Univ, Hanoi, Vietnam; [Thuong Vu Nguyen; Quang Duy Pham; Phuc Duy Nguyen; Nghia Van Khuu] Inst Pasteur, Ho Chi Minh City, Vietnam; [Nhung Phuong Nguyen] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Duc Hoang Bui; Huong Thu Thi Phan; Long Thanh Nguyen] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; University of Texas System; University of Texas Health Science Center Houston	Tran, BX (corresponding author), Hanoi Med Univ, Hanoi, Vietnam.	bach@hmu.edu.vn; nguyenthuong@yahoo.com	Nguyen, Nhung/J-8012-2019; Nguyen, Thuong/AAU-8692-2020	Nguyen, Nhung/0000-0002-8661-9597; 				Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Ford K, 2000, AIDS CARE, V12, P523, DOI 10.1080/095401200750003716; Ghys Peter D, 2003, AIDS, V17 Suppl 4, pS45, DOI 10.1097/00002030-200317004-00005; (ICRW) ICfRoW, 2004, UND HIV AIDS REL STI; Medhi GK, 2012, AIDS CARE, V24, P369, DOI 10.1080/09540121.2011.608787; Ministry of Health M, 2009, HIV EST PROJ 2007 20; Nemoto T, 2008, AIDS EDUC PREV, V20, P435, DOI 10.1521/aeap.2008.20.5.435; Nguyen TA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-37; Nguyen TV, 2008, SEX TRANSM DIS, V35, P935, DOI 10.1097/OLQ.0b013e3181812d03; Nguyen T, 2009, AIDS BEHAV, V13, P873, DOI 10.1007/s10461-008-9499-5; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Thuong NV, 2005, SEX TRANSM INFECT, V81, P477, DOI 10.1136/sti.2005.016097; Thuong NV, 2005, SEX TRANSM DIS, V32, P550, DOI 10.1097/01.olq.0000175415.06716.6d; Thuy NTT, 1998, AIDS, V12, P425, DOI 10.1097/00002030-199804000-00012; Tran TN, 2005, JAIDS-J ACQ IMM DEF, V39, P581; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2012, HIV SEX WORK COLL IN; Vietnam, 2012, VIETN AIDS RESP PROG; Wang HB, 2012, SEX TRANSM DIS, V39, P835, DOI 10.1097/OLQ.0b013e318266b241	20	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86267	10.1371/journal.pone.0086267	http://dx.doi.org/10.1371/journal.pone.0086267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475096	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800036
J	Guillemin, C; Provencal, N; Suderman, M; Cote, SM; Vitaro, F; Hallett, M; Tremblay, RE; Szyf, M				Guillemin, Claire; Provencal, Nadine; Suderman, Matthew; Cote, Sylvana M.; Vitaro, Frank; Hallett, Michael; Tremblay, Richard E.; Szyf, Moshe			DNA Methylation Signature of Childhood Chronic Physical Aggression in T Cells of Both Men and Women	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-RECEPTOR; SALIVARY CORTISOL; MAJOR DEPRESSION; CHROMATIN-STRUCTURE; PRENATAL EXPOSURE; BEHAVIOR PROBLEMS; GENETIC-VARIATION; CHILDREN; LIFE	Background: High frequency of physical aggression is the central feature of severe conduct disorder and is associated with a wide range of social, mental and physical health problems. We have previously tested the hypothesis that differential DNA methylation signatures in peripheral T cells are associated with a chronic aggression trajectory in males. Despite the fact that sex differences appear to play a pivotal role in determining the development, magnitude and frequency of aggression, most of previous studies focused on males, so little is known about female chronic physical aggression. We therefore tested here whether or not there is a signature of physical aggression in female DNA methylation and, if there is, how it relates to the signature observed in males. Methodology/Principal Findings: Methylation profiles were created using the method of methylated DNA immunoprecipitation (MeDIP) followed by microarray hybridization and statistical and bioinformatic analyses on T cell DNA obtained from adult women who were found to be on a chronic physical aggression trajectory (CPA) between 6 and 12 years of age compared to women who followed a normal physical aggression trajectory. We confirmed the existence of a well-defined, genome-wide signature of DNA methylation associated with chronic physical aggression in the peripheral T cells of adult females that includes many of the genes similarly associated with physical aggression in the same cell types of adult males. Conclusions: This study in a small number of women presents preliminary evidence for a genome-wide variation in promoter DNA methylation that associates with CPA in women that warrant larger studies for further verification. A significant proportion of these associations were previously observed in men with CPA supporting the hypothesis that the epigenetic signature of early life aggression in females is composed of a component specific to females and another common to both males and females.	[Guillemin, Claire; Provencal, Nadine; Suderman, Matthew; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Guillemin, Claire; Provencal, Nadine; Cote, Sylvana M.; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Guillemin, Claire; Provencal, Nadine; Cote, Sylvana M.; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Guillemin, Claire; Provencal, Nadine; Suderman, Matthew; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Cote, Sylvana M.; Tremblay, Richard E.] INSERM, U669, Paris, France; [Suderman, Matthew; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Cote, Sylvana M.] Univ Montreal, Sch Social & Prevent Med, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; University College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Universite de Montreal; Universite de Montreal	Tremblay, RE (corresponding author), Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada.	richard.tremblay@ucd.ie; moshe.szyf@mcgill.ca	Cote, Silvana Maria/O-1356-2014; Tremblay, Richard E./O-1360-2014; Côté, Sylvana M./T-4600-2019	Côté, Sylvana M./0000-0001-7944-0647; Provencal, Nadine/0000-0002-2079-8393; Hallett, Michael/0000-0001-6738-6786; Suderman, Matthew/0000-0002-2715-9930	Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR; Genes, Environment and Health Training Program from CIHR; Canadian Institutes of Health Research [MOP-42411]; Social Sciences Humanities Research Council of Canada; Quebec Health Research Fund (FRSQ); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research	Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR; Genes, Environment and Health Training Program from CIHR; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Quebec Health Research Fund (FRSQ)(Fonds de la Recherche en Sante du Quebec); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a fellowship from the Quebec Training Network in Perinatal Research (QTNPR) Program from CIHR to CG, a fellowship from the Genes, Environment and Health Training Program from CIHR to NP, grants from the Canadian Institutes of Health Research, the Social Sciences Humanities Research Council of Canada, the Quebec Health Research Fund (FRSQ) and the Quebec Social Science and Culture Fund (FQRSC) to RET and SMC, grants from the Canadian Institutes of Health Research MOP-42411 to MS, the Sackler Program in Psychobiology and Epigenetics at McGill University and from the Canadian Institute for Advanced Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Arsenio WF, 2004, MONOGR SOC RES CHILD, P1, DOI [DOI 10.1111/J.0037-976X.2004.00312.X, 10.1111/j.0037-976X.2004.00312.x]; Baillargeon RH, 2007, DEV PSYCHOL, V43, P13, DOI 10.1037/0012-1649.43.1.13; Bauer ME, 2010, NEUROIMMUNOMODULAT, V17, P192, DOI 10.1159/000258721; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Birger M, 2003, ISR MED ASSOC J, V5, P653; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Brendgen M, 2008, CHILD DEV, V79, P13, DOI 10.1111/j.1467-8624.2007.01108.x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; CAIRNS RB, 1989, DEV PSYCHOL, V25, P320, DOI 10.1037/0012-1649.25.2.320; Campbell R, 2006, INJURY PREV, V12, P6, DOI 10.1136/ip.2006.012450; Coccaro EF, 1997, PSYCHIAT RES, V73, P1, DOI 10.1016/S0165-1781(97)00108-X; Cote S. M., 2007, EUR J CRIM POLICY RE, V13, P183, DOI DOI 10.1007/S10610-007-9046-3; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Craig IW, 2007, BIOESSAYS, V29, P227, DOI 10.1002/bies.20538; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Essex MJ, 2013, CHILD DEV, V84, P58, DOI 10.1111/j.1467-8624.2011.01641.x; Fontaine N, 2008, ARCH GEN PSYCHIAT, V65, P320, DOI 10.1001/archgenpsychiatry.2007.41; Gammie SC, 2008, NEUROSCIENCE, V157, P502, DOI 10.1016/j.neuroscience.2008.09.026; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; Hassanain M, 2005, BRAIN RES, V1048, P1, DOI 10.1016/j.brainres.2005.04.086; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Higley JD, 1996, BIOL PSYCHIAT, V40, P1067, DOI 10.1016/S0006-3223(95)00675-3; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kawamura A, 2001, JPN CIRC J, V65, P858, DOI 10.1253/jcj.65.858; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Keck ME, 2002, NEUROPSYCHOPHARMACOL, V26, P94, DOI 10.1016/S0893-133X(01)00351-7; Kinnally EL, 2011, BRAIN BEHAV IMMUN, V25, P1548, DOI 10.1016/j.bbi.2011.05.001; KITAY JI, 1961, ENDOCRINOLOGY, V68, P818, DOI 10.1210/endo-68-5-818; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Loney BR, 2006, J CHILD PSYCHOL PSYC, V47, P30, DOI 10.1111/j.1469-7610.2005.01444.x; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mill J, 2008, J CHILD PSYCHOL PSYC, V49, P1020, DOI 10.1111/j.1469-7610.2008.01909.x; Misener VL, 2008, NEUROPSYCHOBIOLOGY, V58, P71, DOI 10.1159/000159775; Murani E, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-74; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P143, DOI 10.1017/S0954579411000605; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Noh YH, 2008, DIABETES-METAB RES, V24, P384, DOI 10.1002/dmrr.849; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Pavlov KA, 2012, J APPL GENET, V53, P61, DOI 10.1007/s13353-011-0069-6; Perez-Rodriguez MM, 2010, J PSYCHIATR RES, V44, P1075, DOI 10.1016/j.jpsychires.2010.03.014; Pesce M, 2011, J BIOL REG HOMEOS AG, V25, P323; Popma A, 2007, BIOL PSYCHIAT, V61, P405, DOI 10.1016/j.biopsych.2006.06.006; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071691; Provencal N, 2012, J NEUROSCI, V32, P15626, DOI 10.1523/JNEUROSCI.1470-12.2012; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Serbin LA, 1998, DEV PSYCHOL, V34, P1246, DOI 10.1037/0012-1649.34.6.1246; Shirtcliff EA, 2005, DEV PSYCHOPATHOL, V17, P167, DOI 10.1017/S0954579405050091; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Suomi SJ, 2006, ANN NY ACAD SCI, V1094, P52, DOI 10.1196/annals.1376.006; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; TUINIER S, 1995, INT CLIN PSYCHOPHARM, V10, P147, DOI 10.1097/00004850-199510030-00003; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002	83	63	65	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86822	10.1371/journal.pone.0086822	http://dx.doi.org/10.1371/journal.pone.0086822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475181	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800062
J	Hagiwara, M; Kokubu, E; Sugiura, S; Komatsu, T; Tada, H; Isoda, R; Tanigawa, N; Kato, Y; Ishida, N; Kobayashi, K; Nakashima, M; Ishihara, K; Matsushita, K				Hagiwara, Makoto; Kokubu, Eitoyo; Sugiura, Shinsuke; Komatsu, Toshinori; Tada, Hiroyuki; Isoda, Ryutaro; Tanigawa, Naomi; Kato, Yoshiko; Ishida, Naoyuki; Kobayashi, Kaoru; Nakashima, Misako; Ishihara, Kazuyuki; Matsushita, Kenji			Vinculin and Rab5 Complex Is Requited for Uptake of Staphyrococcus aureus and Interleukin-6 Expression	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; HERPES-SIMPLEX-VIRUS; STAPHYLOCOCCUS-AUREUS; ALPHA-CATENIN; BINDING-PROTEIN; FOCAL-ADHESION; ACTIVATE VINCULIN; STRUCTURAL BASIS; CELL-ADHESION	Vinculin, a 116-kDa membrane cytoskeletal protein, is an important molecule for cell adhesion; however, little is known about its other cellular functions. Here, we demonstrated that vinculin binds to Rab5 and is required for Staphylococcus aureus (S. aureus) uptake in cells. Viunculin directly bound to Rab5 and enhanced the activation of S. aureus uptake. Overexpression of active vinculin mutants enhanced S. aureus uptake, whereas over-expression of an inactive vinculin mutant decreased S. aureus uptake. Vinculin bound to Rab5 at the N-terminal region (1-258) of vinculin. Vinculin and Rab5 were involved in the S. aureus-induced phosphorylation of MAP kinases (p38, Erk, and JNK) and IL-6 expression. Finally, vinculin and Rab5 knockdown reduced infection of S. aureus, phosphorylation of MAPKs and IL-6 expression in murine lungs. Our results suggest that vinculin binds to Rab5 and that these two molecules cooperatively enhance bacterial infection and the inflammatory response.	[Hagiwara, Makoto; Sugiura, Shinsuke; Komatsu, Toshinori; Tada, Hiroyuki; Isoda, Ryutaro; Tanigawa, Naomi; Kato, Yoshiko; Ishida, Naoyuki; Kobayashi, Kaoru; Nakashima, Misako; Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Aichi, Japan; [Kokubu, Eitoyo; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiba, Japan	National Center for Geriatrics & Gerontology; Tokyo Dental College	Matsushita, K (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu, Aichi, Japan.	kmatsu30@ncgg.go.jp		Ishihara, Kazuyuki/0000-0002-6567-807X	Grants-in-Aid for Scientific Research [24592778] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Acosta EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044835; Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Almeida RA, 1996, J DAIRY SCI, V79, P1021, DOI 10.3168/jds.S0022-0302(96)76454-8; Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen XQ, 2012, CELL RES, V22, P677, DOI 10.1038/cr.2011.197; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Deakin NO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037990; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Diez G, 2011, BIOCHEM BIOPH RES CO, V406, P85, DOI 10.1016/j.bbrc.2011.01.115; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Epp N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067307; Fabrowski P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3244; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Grosz M, 2014, CELL MICROBIOL, V16, P451, DOI 10.1111/cmi.12233; Hagiwara M, 2013, BIOCHEM BIOPH RES CO, V439, P413, DOI 10.1016/j.bbrc.2013.08.018; Hagiwara M, 2011, BIOCHEM BIOPH RES CO, V407, P615, DOI 10.1016/j.bbrc.2011.03.082; Hagiwara M, 2010, ANAL BIOCHEM, V397, P262, DOI 10.1016/j.ab.2009.10.032; Hagiwara M, 2009, Z NATURFORSCH C, V64, P303; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Hauck CR, 2012, CURR OPIN CELL BIOL, V24, P637, DOI 10.1016/j.ceb.2012.07.004; Hoffmann C, 2011, EUR J CELL BIOL, V90, P891, DOI 10.1016/j.ejcb.2011.03.001; Hollinshead M, 2012, EMBO J, V31, P4204, DOI 10.1038/emboj.2012.262; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hu CT, 2013, CELL SIGNAL, V25, P1539, DOI 10.1016/j.cellsig.2013.03.022; Huang SN, 2003, J PHARMACOL EXP THER, V306, P681, DOI 10.1124/jpet.103.051581; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022877; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kajiho H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030575; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Kimizuka R, 2003, MICROBES INFECT, V5, P1357, DOI 10.1016/j.micinf.2003.09.015; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Leclerc EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017816; Lee JJ, 2013, J BIOL CHEM, V288, P28049, DOI 10.1074/jbc.M113.491555; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Liu WM, 2010, MOL CELL BIOL, V30, P1783, DOI 10.1128/MCB.01003-09; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Macovei A, 2013, J VIROL, V87, P6415, DOI 10.1128/JVI.00393-13; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Mustafi S, 2013, INFECT IMMUN, V81, P2426, DOI 10.1128/IAI.00387-13; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Paulsel AL, 2013, J BIOL CHEM, V288, P18162, DOI 10.1074/jbc.M113.457069; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Polyzos KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041870; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shen K, 2011, J BIOL CHEM, V286, P45103, DOI 10.1074/jbc.M111.244293; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Thomas C, 2013, DEV BIOL; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Tuo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072123; Umemoto T, 2009, BIOCHEM BIOPH RES CO, V387, P191, DOI 10.1016/j.bbrc.2009.07.009; Wiederkehr A, 2001, YEAST, V18, P759, DOI 10.1002/yea.726; Woller B, 2011, BBA-MOL CELL RES, V1813, P1198, DOI 10.1016/j.bbamcr.2011.03.005; Zamir E, 2001, J CELL SCI, V114, P3583; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009226; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zwaenepoel O, 2012, FASEB J, V26, P691, DOI 10.1096/fj.11-189753	94	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87373	10.1371/journal.pone.0087373	http://dx.doi.org/10.1371/journal.pone.0087373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466349	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000205
J	Husni, NR; Jones, AR; Simmons, AL; Corkey, BE				Husni, Nicholas R.; Jones, Albert R.; Simmons, Amber L.; Corkey, Barbara E.			Fibroblasts From Type 1 Diabetics Exhibit Enhanced Ca2+ Mobilization after TNF or Fat Exposure	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BETA-CELL DESTRUCTION; FACTOR-ALPHA; GENE-EXPRESSION; ARACHIDONIC-ACID; BRADYKININ; CYTOKINES; COA; INTERLEUKIN-1; POTENTIATION	The effects of cytokine and fatty acid treatment on signal transduction in dermal fibroblasts from type 1 diabetics and matched controls were compared. Chronic exposure to TNF, accentuated Ca2+ mobilization in response to bradykinin (BK) in cells from both controls and diabetics; responses were three-fold greater in cells from diabetics than in controls. Similarly, with chronic exposure to IL-1 beta, BK-induced Ca2+ mobilization was accentuated in cells from type 1 diabetics compared to the controls. Pretreatment with the protein synthesis inhibitor cycloheximide or the protein kinase C inhibitor calphostin C prior to the addition of TNF completely abrogated the TNF-induced increment in peak bradykinin response. Ca2+ transients induced by depleting endoplasmic reticulum (ER) Ca2+ with thapsigargin were also greater in TNF treated fibroblasts than in untreated cells, with greater increases in cells from diabetics. Exposing fibroblasts for 48 hours to 2 mM oleate also increased both the peak bradykinin response and the TNF-induced increment in peak response, which were significantly greater in diabetics than controls. These data indicate that cells from diabetic patients acquire elevated ER Ca2+ stores in response to both cytokines and free fatty acids, and thus exhibit greater sensitivity to environmental inflammatory stimuli and elevated lipids.	[Husni, Nicholas R.; Jones, Albert R.; Simmons, Amber L.; Corkey, Barbara E.] Boston Univ, Sch Med, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Boston University	Corkey, BE (corresponding author), Boston Univ, Sch Med, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	bcorkey@bu.edu			NIH [PO1 DK46200]; JDRF #Juvenile Diabetes Foundation [198230]; Zoltan Kohn endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK056690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF #Juvenile Diabetes Foundation; Zoltan Kohn endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH PO1 DK46200, JDRF #Juvenile Diabetes Foundation (Grant #198230); and Zoltan Kohn endowment to BEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMRANI Y, 1995, BRIT J PHARMACOL, V114, P4, DOI 10.1111/j.1476-5381.1995.tb14896.x; AZAD K, 1994, ARCH DIS CHILD, V71, P108, DOI 10.1136/adc.71.2.108; Bassi A, 1996, J CLIN ENDOCR METAB, V81, P1650, DOI 10.1210/jc.81.4.1650; BATHON JM, 1994, J IMMUNOL, V153, P2600; Beyan H, 2010, DIABETES, V59, P1751, DOI 10.2337/db09-1433; Bolinder J, 1996, DIABETOLOGIA, V39, P845, DOI 10.1007/s001250050519; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; Burch R M, 1992, Agents Actions Suppl, V38 ( Pt 2), P87; BURCH RM, 1992, LIFE SCI, V50, P829, DOI 10.1016/0024-3205(92)90201-Y; CAMPBELL IL, 1989, J CELL BIOCHEM, V40, P57, DOI 10.1002/jcb.240400107; Caramori ML, 2012, DIABETES, V61, P739, DOI 10.2337/db11-0617; CHOSICH N, 1994, AUTOIMMUNITY, V18, P163, DOI 10.3109/08916939409007992; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cohen N, 1996, AM J PHYSIOL-ENDOC M, V271, pE284, DOI 10.1152/ajpendo.1996.271.2.E284; COOPER JT, 1974, ATHEROSCLEROSIS, V20, P41, DOI 10.1016/0021-9150(74)90077-X; Coppieters K. T., 2012, COLD SPRING HARB PER, V2, P1, DOI [10.1101/cshperspect.a007682, DOI 10.1101/cshperspect.a007682]; Cotran RS, 1989, ROBBINS PATHOLOGIC B, P994; Cummins N, 2009, CURR MOL MED, V9, P495, DOI 10.2174/156652409788167078; DEENEY JT, 1992, J BIOL CHEM, V267, P19840; DellaPuca R, 1996, P SOC EXP BIOL MED, V212, P174; ESPERSEN GT, 1993, APMIS, V101, P703, DOI 10.1111/j.1699-0463.1993.tb00168.x; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; FERRO TJ, 1993, AM J PHYSIOL, V264, pL7, DOI 10.1152/ajplung.1993.264.1.L7; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Graber MN, 1996, J BIOL CHEM, V271, P883, DOI 10.1074/jbc.271.2.883; GRUNFELD C, 1988, J LIPID RES, V29, P1327; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUSTAFSONSVARD C, 1993, SCAND J GASTROENTERO, V28, P323, DOI 10.3109/00365529309090250; GUY GR, 1991, J BIOL CHEM, V266, P14343; Guy J, 2009, DIABETES CARE, V32, P416, DOI 10.2337/dc08-1775; HARRISON LC, 1989, DIABETES, V38, P815, DOI 10.2337/diabetes.38.7.815; Hennig B, 1996, AM J CLIN NUTR, V63, P322, DOI 10.1093/ajcn/63.3.322; Hussain MJ, 1996, DIABETOLOGIA, V39, P60; KILPATRICK LE, 1989, METABOLISM, V38, P73, DOI 10.1016/0026-0495(89)90183-2; KUNO K, 1994, J LEUKOCYTE BIOL, V56, P542, DOI 10.1002/jlb.56.5.542; LERNER UH, 1992, AGENTS ACTIONS, V37, P44, DOI 10.1007/BF01987889; LIU NG, 1994, J BIOL CHEM, V269, P28635; MEHTA V, 1993, LYMPHOKINE CYTOK RES, V12, P255; NACHIAPPAN V, 1994, SHOCK, V1, P123, DOI 10.1097/00024382-199402000-00007; ONEILL LAJ, 1989, EUR J PHARMACOL, V166, P131, DOI 10.1016/0014-2999(89)90052-6; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; SCHUTZE S, 1994, J LEUKOCYTE BIOL, V56, P533, DOI 10.1002/jlb.56.5.533; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Tang C, 2013, ENDOCRINOLOGY, V154, P89, DOI 10.1210/en.2012-1720; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Yaney GC, 2000, ENDOCRINOLOGY, V141, P1989, DOI 10.1210/en.141.6.1989	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87068	10.1371/journal.pone.0087068	http://dx.doi.org/10.1371/journal.pone.0087068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466329	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000190
J	Piras, P; Evangelista, A; Gabriele, S; Nardinocchi, P; Teresi, L; Torromeo, C; Schiariti, M; Varano, V; Puddu, PE				Piras, Paolo; Evangelista, Antonietta; Gabriele, Stefano; Nardinocchi, Paola; Teresi, Luciano; Torromeo, Concetta; Schiariti, Michele; Varano, Valerio; Puddu, Paolo Emilio			4D-Analysis of Left Ventricular Heart Cycle Using Procrustes Motion Analysis	PLOS ONE			English	Article							SHAPE; ECHOCARDIOGRAPHY; MODEL; MORPHOMETRICS; MODULARITY; STATEMENT; FRAMEWORK; COMMITTEE; SOCIETY	The aim of this study is to investigate human left ventricular heart morphological changes in time among 17 healthy subjects. Preliminarily, 2 patients with volumetric overload due to aortic insufficiency were added to our analyses. We propose a special strategy to compare the shape, orientation and size of cardiac cycle's morphological trajectories in time. We used 3D data obtained by Speckle Tracking Echocardiography in order to detect semi-automated and homologous landmarks clouds as proxies of left ventricular heart morphology. An extended Geometric Morphometrics toolkit in order to distinguish between intra-and inter-individual shape variations was used. Shape of trajectories with inter-individual variation were compared under the assumption that trajectories attributes, estimated at electrophysiologically homologous times are expressions of left ventricular heart function. We found that shape analysis as commonly applied in Geometric Morphometrics studies fails in identifying a proper morpho-space to compare the shape of morphological trajectories in time. To overcome this problem, we performed a special type of Riemannian Parallel Transport, called "linear shift''. Whereas the two patients with aortic insufficiency were not differentiated in the static shape analysis from the healthy subjects, they set apart significantly in the analyses of motion trajectory's shape and orientation. We found that in healthy subjects, the variations due to inter-individual morphological differences were not related to shape and orientation of morphological trajectories. Principal Component Analysis showed that volumetric contraction, torsion and twist are differently distributed on different axes. Moreover, global shape change appeared to be more correlated with endocardial shape change than with the epicardial one. Finally, the total shape variation occurring among different subjects was significantly larger than that observable across properly defined morphological trajectories.	[Piras, Paolo] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Evangelista, Antonietta] Osped San Giovanni Calibita Fatebefratelli, Rome, Italy; [Piras, Paolo; Torromeo, Concetta; Schiariti, Michele; Puddu, Paolo Emilio] Univ Roma La Sapienza, Dipartimento Sci Cardiovasc Resp Nefrol Anestesio, I-00185 Rome, Italy; [Gabriele, Stefano; Varano, Valerio] Univ Roma Tre, Dept Architettura, Rome, Italy; [Gabriele, Stefano; Teresi, Luciano; Varano, Valerio] Univ Roma Tre, LaMS Modeling & Simulat Lab, Rome, Italy; [Nardinocchi, Paola] Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, I-00185 Rome, Italy; [Teresi, Luciano] Univ Roma Tre, Dipartimento Matemat & Fis, Rome, Italy; [Piras, Paolo] Ctr Evolutionary Ecol, Rome, Italy	Roma Tre University; Sapienza University Rome; Roma Tre University; Roma Tre University; Sapienza University Rome; Roma Tre University	Piras, P (corresponding author), Univ Roma Tre, Dipartimento Sci, Rome, Italy.	ppiras@uniroma3.it	Gabriele, Stefano/J-1091-2019; nardinocchi, paola/C-9454-2009; schiariti, michele/W-4393-2018; Gabriele, Stefano/G-5280-2010; Puddu, Paolo Emilio/G-6180-2012	Gabriele, Stefano/0000-0001-8264-2792; schiariti, michele/0000-0001-5077-8134; Gabriele, Stefano/0000-0001-8264-2792; Puddu, Paolo Emilio/0000-0002-6191-7838; Teresi, Luciano/0000-0002-5178-8120; Piras, Paolo/0000-0001-9832-2742; Nardinocchi, Paola/0000-0002-9972-1662; Varano, Valerio/0000-0003-0298-6398; TORROMEO, Concetta/0000-0003-0936-2780	MIUR (the Italian Ministry of University and Research); Sapienza - Universita di Roma [N. C26A11STT5]	MIUR (the Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Sapienza - Universita di Roma	This work is supported by MIUR (the Italian Ministry of University and Research) through the Project PRIN2009 "Mathematics and Mechanics of Biological Assemblies and Soft Tissues'' and by "Sapienza - Universita di Roma'' through the grant N. C26A11STT5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2007, J BIOMECH, V40, P437, DOI 10.1016/j.jbiomech.2005.12.004; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Bejdova S, 2012, J CRANIO MAXILL SURG, V40, P201, DOI 10.1016/j.jcms.2011.04.013; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1986, STAT SCI, V1, P181, DOI [10.1214/ss/1177013696, DOI 10.1214/SS/1177013696]; Buckley PF, 1999, BIOL PSYCHIAT, V45, P62, DOI 10.1016/S0006-3223(98)00067-5; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chatzigianni A, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.017; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Escoufier Y., 1973, BIOMETRICS, V29, P751, DOI DOI 10.2307/2529140; Evangelista A, 2011, PROG BIOPHYS MOL BIO, V107, P112, DOI 10.1016/j.pbiomolbio.2011.07.008; Filzmoser P, 2013, MVOUTLIER MULTIVARIA; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Huckemann S, 2010, ARXIV10020616V1; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kuhl HP, 2004, J AM COLL CARDIOL, V43, P2083, DOI 10.1016/j.jacc.2004.01.037; Kume A, 2007, BIOMETRIKA, V94, P513, DOI 10.1093/biomet/asm047; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Le HL, 2003, J LOND MATH SOC, V68, P511, DOI 10.1112/S0024610703004393; Maffessanti F, 2009, ULTRASOUND MED BIOL, V35, P1953, DOI 10.1016/j.ultrasmedbio.2009.08.008; Marquez EJ, 2008, EVOLUTION, V62, P2688, DOI 10.1111/j.1558-5646.2008.00476.x; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Piras P, 2010, EVOL ECOL RES, V12, P897; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Roohi SF, 2013, INT J COMPUT ASS RAD, V8, P335, DOI 10.1007/s11548-012-0787-1; Salgo IS, 2012, J AM SOC ECHOCARDIOG, V25, P80, DOI 10.1016/j.echo.2011.09.014; Sugeng L, 2003, HEART, V89, P29; Yang L, 2008, I S BIOMED IMAGING, P221, DOI 10.1109/ISBI.2008.4540972; Yeung F, 1998, ULTRASOUND MED BIOL, V24, P427, DOI 10.1016/S0301-5629(97)00281-0; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zheng Y, 2007, P 11 IEEE INT C COMP	39	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86896	10.1371/journal.pone.0086896	http://dx.doi.org/10.1371/journal.pone.0086896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466282	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000166
J	Xiao, J; Zhong, H; Zhou, Y; Yu, F; Gao, Y; Luo, YJ; Tang, ZY; Guo, ZB; Guo, EY; Gan, X; Zhang, M; Zhang, YP				Xiao, Jun; Zhong, Huan; Zhou, Yi; Yu, Fan; Gao, Yun; Luo, Yongju; Tang, Zhanyang; Guo, Zhongbao; Guo, Enyan; Gan, Xi; Zhang, Ming; Zhang, Yaping			Identification and Characterization of MicroRNAs in Ovary and Testis of Nile Tilapia (Oreochromis niloticus) by Using Solexa Sequencing Technology	PLOS ONE			English	Article							SMALL RNAS; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; MIRNA EXPRESSION; MESSENGER-RNA; CLONING; GENES; PIWI; BIOGENESIS; GERMLINE	MicroRNAs (miRNAs) are endogenous non-coding small RNAs which play important roles in the regulation of gene expression by cleaving or inhibiting the translation of target gene transcripts. Thereinto, some specific miRNAs show regulatory activities in gonad development via translational control. In order to further understand the role of miRNA-mediated posttranscriptional regulation in Nile tilapia (Oreochromis niloticus) ovary and testis, two small RNA libraries of Nile tilapia were sequenced by Solexa small RNA deep sequencing methods. A total of 9,731,431 and 8,880,497 raw reads, representing 5,407,800 and 4,396,281 unique sequences were obtained from the sexually mature ovaries and testes, respectively. After comparing the small RNA sequences with the Rfam database, 1,432,210 reads in ovaries and 984,146 reads in testes were matched to the genome sequence of Nile tilapia. Bioinformatic analysis identified 764 mature miRNA, 209 miRNA-5p and 202 miRNA-3p were found in the two libraries, of which 525 known miRNAs are both expressed in the ovary and testis of Nile tilapia. Comparison of expression profiles of the testis, miR-727, miR-129 and miR-29 families were highly expressed in tilapia ovary. Additionally, miR-132, miR-212, miR-33a and miR-135b families, showed significant higher expression in testis compared with that in ovary. Furthermore, the expression patterns of the miRNAs were analyzed in different developmental stages of gonad. The result showed different expression patterns were observed during development of testis and ovary. In addition, the identification and characterization of differentially expressed miRNAs in the ovaries and testis of Nile tilapia provides important information on the role of miRNA in the regulation of the ovarian and testicular development and function. This data will be helpful to facilitate studies on the regulation of miRNAs during teleosts reproduction.	[Xiao, Jun; Zhong, Huan; Zhou, Yi; Luo, Yongju; Tang, Zhanyang; Guo, Zhongbao; Guo, Enyan; Gan, Xi] Guangxi Acad Fisheries Sci, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Guangxi, Peoples R China; [Xiao, Jun; Zhong, Huan; Zhang, Ming] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Anim Reprod Inst, Nanning 530004, Guangxi, Peoples R China; [Yu, Fan] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Genet Breeding Aquat Anim, Wuxi, Jiangsu, Peoples R China; [Xiao, Jun; Gao, Yun; Zhang, Yaping] Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Xiao, Jun; Gao, Yun; Zhang, Yaping] Kunming Inst Zool, Lab Mol Biol Domest Anim, Kunming, Yunnan, Peoples R China	Guangxi University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Gan, X (corresponding author), Guangxi Acad Fisheries Sci, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Guangxi, Peoples R China.	ganxicn@126.com; mingzhang@gxu.edu.cn			National Natural Science Foundation of China [31260637]; China Postdoctoral Science Foundation Funded Project [2013M531915]; China Agriculture Research System [CARS-49]; Science and Technology Research Program [1123006-1]; Public Welfare Special funds of Guangxi [2060302CXIF-2011-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); China Agriculture Research System; Science and Technology Research Program; Public Welfare Special funds of Guangxi	This research was supported by National Natural Science Foundation of China (31260637), China Postdoctoral Science Foundation Funded Project (2013M531915), China Agriculture Research System (No. CARS-49), Science and Technology Research Program (No. 1123006-1) and Public Welfare Special funds of Guangxi (No. 2060302CXIF-2011-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berishvili G, 2010, GEN COMP ENDOCR, V167, P128, DOI 10.1016/j.ygcen.2010.01.023; Bizuayehu TT, 2012, SEX DEV, V6, P257, DOI 10.1159/000341378; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Chang XT, 1997, J MOL ENDOCRINOL, V18, P57, DOI 10.1677/jme.0.0180057; Coward K, 2000, REV FISH BIOL FISHER, V10, P1, DOI 10.1023/A:1008942318272; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huang CW, 2012, J ANIM SCI, V90, P4266, DOI 10.2527/jas.2012-5142; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Juanchich A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105361; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Kim SC, 2011, 3D RES, V2, DOI 10.1007/3DRes.02(2011)6; Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Li SC, 2011, GENOMICS, V98, P453, DOI 10.1016/j.ygeno.2011.08.008; Ma H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039649; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; McFarlane L, 2010, SEX DEV, V3, P302, DOI 10.1159/000284688; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Shirak A, 2006, GENETICS, V174, P1573, DOI 10.1534/genetics.106.059030; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Ucar A, 2011, CELL CYCLE, V10, P563, DOI 10.4161/cc.10.4.14737; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wilczynska A, 2009, RNA, V15, P337, DOI 10.1261/rna.1422509; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhang JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-478; Zhang XD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-157; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	59	28	31	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86821	10.1371/journal.pone.0086821	http://dx.doi.org/10.1371/journal.pone.0086821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466258	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000152
J	Chen, YS; Wu, HC; Shien, JH; Chiu, HH; Lee, LH				Chen, Yu San; Wu, Hsing Chieh; Shien, Jui Hung; Chiu, Hua Hsien; Lee, Long Huw			Cloning and Characterization of a 7 Transmembrane Receptor from the Adherent Cells of Chicken Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							AVIAN REOVIRUS S1133; PROTEIN SIGMA-A; 7-TRANSMEMBRANE RECEPTORS; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; MACROPHAGES; DETERMINES; EXPRESSION; PROFILES; SEQUENCE	A cDNA encoding a 7 transmembrane (7TM) receptor gene from the adherent cells of chicken peripheral blood mononuclear cells (PBMC) was cloned and characterized. The open reading frame of the chicken-7TM (Ch-7TM) receptor gene was 1008 nucleotides long, encoding a protein of 335 amino acid residues with a molecular mass of approximately 37.1 kDa. Hydrophobic stretches indicated the presence of 7 TM domains. Moreover, the complete nucleotide sequences encoding 7TM of duck (Du-7TM) and goose (Go-7TM), corresponding to the open reading frame of Ch-7TM, were determined. Each of the Du-and Go-7TM encoding regions comprised 990 nucleotides, representing an 18-nucleotide deletion in alignment with the Ch-7TM encoding region, resulting in a 6-amino-acid deletion at the 3'-end. No signal peptides were predicted. Six phosphorylation sites were predicted and conserved for all three 7TMs. The proteins of the three 7TMs were similar, with 11 conserved cysteine residues. No glycosylation sites could be predicted. The results of the pairwise comparisons indicated that the Ch-7TM encoding region and Ch-7TM protein were the least similar to those of Du- and Go-7TMs. These results were in accordance with those of the phylogenetic analysis, which indicated that the Du-and Go-7TM encoding regions clustered, but were separated from the Ch-7TM encoding region. Monoclonal antibody B28D5 was prepared from spleens of mice immunized with the bacterially expressed N-terminal (55 amino acid residues) region of the Ch-7TM protein for further use. Double staining with B28D5 and KUL01 suggested that Ch-7TM was expressed in subsets of the adherent cells, among which a subset that was recognized with both antibodies was likely of monocyte and macrophage lineage. However, the fluorescence intensities of B28D5 and, particularly, KUL01 decreased after the adherent cells were incubated for additional 48 h.	[Chen, Yu San; Wu, Hsing Chieh; Shien, Jui Hung; Lee, Long Huw] Natl Chung Hsing Univ, Coll Vet Med, Dept Vet Med, Taichung 40227, Taiwan; [Chiu, Hua Hsien] Fooyin Univ, Dept Biotechnol, Coll Environm & Life Sci, Kaohsiung, Taiwan	National Chung Hsing University; Fooyin University	Chiu, HH (corresponding author), Fooyin Univ, Dept Biotechnol, Coll Environm & Life Sci, Kaohsiung, Taiwan.	SC055@mail.fy.edu.tw; lhlee@mail.nchu.edu.tw			National Science Council, Rep. of China [NSC100-2313-B005-030-MY3]	National Science Council, Rep. of China(Ministry of Science and Technology, Taiwan)	This research work was supported by the National Science Council (NSC100-2313-B005-030-MY3), Rep. of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Dietert R. R., 1991, Avian cellular immunology., P71; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Hou HS, 2001, VIROLOGY, V282, P168, DOI 10.1006/viro.2001.0814; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Pai WC, 2003, VET MICROBIOL, V91, P309, DOI 10.1016/S0378-1135(02)00308-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Poh TY, 2008, J BIOL CHEM, V283, P16408, DOI 10.1074/jbc.M800998200; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Sleeman JE, 2001, J CELL SCI, V114, P4407; SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J; Su BS, 2010, PROCESS BIOCHEM, V45, P1057, DOI 10.1016/j.procbio.2010.03.021; Van Furth R, 1992, ENCY IMMUNOLOGY, P1092; Van Furth R, 1970, MONONUCLEAR PHAGOCYT, P1; Wu YF, 2007, VET IMMUNOL IMMUNOP, V116, P37, DOI 10.1016/j.vetimm.2006.12.010; Yin HS, 2000, VIROLOGY, V266, P33, DOI 10.1006/viro.1999.0020	20	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86880	10.1371/journal.pone.0086880	http://dx.doi.org/10.1371/journal.pone.0086880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466279	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100230
J	Jia, LL; Kang, YM; Wang, FX; Li, HB; Zhang, Y; Yu, XJ; Qi, J; Suo, YP; Tian, ZJ; Zhu, ZM; Zhu, GQ; Qin, DN				Jia, Lin-Lin; Kang, Yu-Ming; Wang, Fu-Xin; Li, Hong-Bao; Zhang, Yan; Yu, Xiao-Jing; Qi, Jie; Suo, Yu-Ping; Tian, Zhen-Jun; Zhu, Zhiming; Zhu, Guo-Qing; Qin, Da-Nian			Exercise Training Attenuates Hypertension and Cardiac Hypertrophy by Modulating Neurotransmitters and Cytokines in Hypothalamic Paraventricular Nucleus	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; FACTOR-KAPPA-B; II-INDUCED HYPERTENSION; INDUCED HEART-FAILURE; OXIDATIVE STRESS; TRACTUS-SOLITARII; AEROBIC EXERCISE; BLOOD-PRESSURE; GABA RELEASE; BRAIN	Aims: Regular exercise as an effective non-pharmacological antihypertensive therapy is beneficial for prevention and control of hypertension, but the central mechanisms are unclear. In this study, we hypothesized that chronic exercise training (ExT) delays the progression of hypertension and attenuates cardiac hypertrophy by up-regulating anti-inflammatory cytokines, reducing pro-inflammatory cytokines (PICs) and restoring the neurotransmitters balance in the hypothalamic paraventricular nucleus (PVN) in young spontaneously hypertensive rats (SHR). In addition, we also investigated the involvement of nuclear factor-kappa B (NF-kappa B) p65 and NAD(P) H oxidase in exercise-induced effects. Methods and results: Moderate-intensity ExT was administrated to young normotensive Wistar-Kyoto (WKY) and SHR rats for 16 weeks. SHR rats had a significant increase in mean arterial pressure and cardiac hypertrophy. SHR rats also had higher levels of glutamate, norepinephrine (NE), phosphorylated IKK beta, NF-kappa B p65 activity, NAD(P) H oxidase subunit gp91(phox), PICs and the monocyte chemokine protein-1 (MCP-1), and lower levels of gamma-aminobutyric acid (GABA) and interleukin-10 (IL-10) in the PVN. These SHR rats also exhibited higher renal sympathetic nerve activity (RSNA), and higher plasma levels of PICs, and lower plasma IL-10. However, ExT ameliorates all these changes in SHR rats. Conclusion: These findings suggest that there are the imbalances between excitatory and inhibitory neurotransmitters and between pro-and anti-inflammatory cytokines in the PVN of SHR rats, which at least partly contributing to sympathoexcitation, hypertension and cardiac hypertrophy; chronic exercise training attenuates hypertension and cardiac hypertrophy by restoring the balances between excitatory and inhibitory neurotransmitters and between pro-and anti-inflammatory cytokines in the PVN; NF-kappa B and oxidative stress in the PVN may be involved in these exercise-induced effects.	[Jia, Lin-Lin; Kang, Yu-Ming; Li, Hong-Bao; Zhang, Yan; Yu, Xiao-Jing; Qi, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Cardiovasc Res Ctr, Xian 710049, Peoples R China; [Qin, Da-Nian] Shantou Univ, Coll Med, Dept Physiol, Shantou, Peoples R China; [Wang, Fu-Xin] Jiamusi Univ, Affiliated Hosp 1, Dept Neurol, Jiamusi, Peoples R China; [Zhu, Zhiming] Third Mil Med Univ, Dept Hypertens & Endocrinol, Ctr Hypertens & Metab Dis, Chongqing Inst Hypertens,Daping Hosp, Chongqing, Peoples R China; [Tian, Zhen-Jun] Shaanxi Normal Univ, Sch Phys Educ, Inst Sports & Exercise Biol, Xian, Peoples R China; [Suo, Yu-Ping] Shanxi Prov Peoples Hosp, Dept Obstet & Gynecol, Taiyuan, Peoples R China; [Zhu, Guo-Qing] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Xi'an Jiaotong University; Shantou University; Jiamusi University; Army Medical University; Shaanxi Normal University; Shanxi People's Hospital; Nanjing Medical University	Kang, YM (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Cardiovasc Res Ctr, Xian 710049, Peoples R China.	ykang@mail.xjtu.edu.cn; dnqin@stu.edu.cn	Li, Hong-Bao/ACO-9139-2022	Zhu, Guo-Qing/0000-0002-3132-9592; Tian, Zhenjun/0000-0002-8747-6161	National Basic Research Program of China [2012CB517805]; National Natural Science Foundation of China [31271254, 81170248, 81070199, 31171095, 31171141]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program of China (No. 2012CB517805) and National Natural Science Foundation of China (Nos. 31271254, 81170248, 81070199, 31171095, 31171141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Barber M, 2003, BRAIN RES, V964, P128, DOI 10.1016/s0006-8993(02)04091-X; Bertagnolli M, 2008, AM J HYPERTENS, V21, P1188, DOI 10.1038/ajh.2008.270; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Casillas JM, 2007, ANN READAPT MED PHYS, V50, P403, DOI DOI 10.1016/j.annrmp.2007.03.008; Chen QH, 2003, HYPERTENSION, V42, P725, DOI 10.1161/01.HYP.0000085197.20043.44; Cornelissen Veronique A., 2005, Journal of Hypertension, V23, P251; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Ferguson AV, 2000, EXP PHYSIOL, V85, p153S, DOI 10.1111/j.1469-445X.2000.tb00019.x; Goldberg MJ, 2012, J HUM HYPERTENS, V26, P644, DOI 10.1038/jhh.2011.95; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hamer M, 2006, SPORTS MED, V36, P109, DOI 10.2165/00007256-200636020-00002; Hirooka Y, 2008, AUTON NEUROSCI-BASIC, V142, P20, DOI 10.1016/j.autneu.2008.06.001; Kang YM, 2008, CARDIOVASC RES, V79, P671, DOI 10.1093/cvr/cvn119; Kang YM, 2006, CIRC RES, V99, P758, DOI 10.1161/01.RES.0000244092.95152.86; Kang YM, 2011, BASIC RES CARDIOL, V106, P1087, DOI 10.1007/s00395-011-0215-7; Kang YM, 2011, BASIC RES CARDIOL, V106, P473, DOI 10.1007/s00395-011-0155-2; Kang YM, 2009, CARDIOVASC RES, V83, P737, DOI 10.1093/cvr/cvp160; Kang YM, 2009, CARDIOVASC RES, V82, P503, DOI 10.1093/cvr/cvp073; Kishi T, 2001, HYPERTENSION, V38, P896, DOI 10.1161/hyp.38.4.896; Kishi T, 2012, CLIN EXP HYPERTENS, V34, P278, DOI 10.3109/10641963.2012.681084; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Li YF, 2005, METH MOLEC MED, V112, P59; Lin YZ, 2005, BRAIN RES, V1058, P161, DOI 10.1016/j.brainres.2005.07.070; Lindley TE, 2004, CIRC RES, V94, P402, DOI 10.1161/01.RES.0000112964.40701.93; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Mariappan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046568; Michelini LC, 2009, EXP PHYSIOL, V94, P947, DOI 10.1113/expphysiol.2009.047449; Nishihara M, 2012, J HYPERTENS, V30, P97, DOI 10.1097/HJH.0b013e32834e1df4; Pescatello LS, 2004, J HYPERTENS, V22, P1881, DOI 10.1097/00004872-200410000-00009; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Potts JT, 2006, EXP PHYSIOL, V91, P59, DOI 10.1113/expphysiol.2005.032227; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Tasker JG, 1998, ADV EXP MED BIOL, V449, P117; Wang S, 2006, FASEB J, V20, P1537, DOI 10.1096/fj.05-5547fje; Yu XJ, 2013, CARDIOVASC TOXICOL, V13, P381, DOI 10.1007/s12012-013-9219-x; Zheng H, 2005, AM J PHYSIOL-HEART C, V288, pH2332, DOI 10.1152/ajpheart.00473.2004	41	38	43	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85481	10.1371/journal.pone.0085481	http://dx.doi.org/10.1371/journal.pone.0085481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24482680	gold, Green Submitted, Green Published			2022-12-27	WOS:000330237000038
J	Jacobs, AC; Blanchard, CE; Catherman, SC; Dunman, PM; Murata, Y				Jacobs, Anna C.; Blanchard, Catlyn E.; Catherman, Seana C.; Dunman, Paul M.; Murata, Yoshihiko			An Ribonuclease T2 Family Protein Modulates Acinetobacter baumannii Abiotic Surface Colonization	PLOS ONE			English	Article							ENVIRONMENTAL CONTAMINATION; BIOFILM FORMATION; SURVIVAL; RNASE; CALCOACETICUS; RESISTANCE; OUTBREAK; GROWTH; PILI	Acinetobacter baumannii is an emerging bacterial pathogen of considerable medical concern. The organism's transmission and ability to cause disease has been associated with its propensity to colonize and form biofilms on abiotic surfaces in health care settings. To better understand the genetic determinants that affect biomaterial attachment, we performed a transposon mutagenesis analysis of abiotic surface-colonization using A. baumannii strain 98-37-09. Disruption of an RNase T2 family gene was found to limit the organism's ability to colonize polystyrene, polypropylene, glass, and stainless steel surfaces. DNA microarray analyses revealed that in comparison to wild type and complemented cells, the RNase T2 family mutant exhibited reduced expression of 29 genes, 15 of which are predicted to be associated with bacterial attachment and surface-associated motility. Motility assays confirmed that RNase T2 mutant displays a severe motility defect. Taken together, our results indicate that the RNase T2 family protein identified in this study is a positive regulator of A. baumannii's ability to colonize inanimate surfaces and motility. Moreover, the enzyme may be an effective target for the intervention of biomaterial colonization, and consequently limit the organism's transmission within the hospital setting.	[Jacobs, Anna C.; Blanchard, Catlyn E.; Dunman, Paul M.] Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Catherman, Seana C.; Murata, Yoshihiko] Univ Rochester Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY USA	University of Rochester; University of Rochester	Dunman, PM (corresponding author), Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	paul_dunman@urmc.rochester.edu; yoshihiko_murata@urmc.rochester.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NIDCR NIH HHS [T90 DE021985] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Acquati F, 2013, P NATL ACAD SCI USA, V110, P8140, DOI 10.1073/pnas.1222079110; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Aygun G, 2002, J HOSP INFECT, V52, P259, DOI 10.1053/jhin.2002.1300; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402, DOI 10.1086/646061; Grupper M, 2007, INFECT CONT HOSP EP, V28, P293, DOI 10.1086/512629; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; HIRAI Y, 1991, J HOSP INFECT, V19, P191, DOI 10.1016/0195-6701(91)90223-U; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Jacobs AC, 2012, FEMS IMMUNOL MED MIC, V64, P403, DOI 10.1111/j.1574-695X.2011.00926.x; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Lappann M, 2010, MED MICROBIOL IMMUN, V199, P173, DOI 10.1007/s00430-010-0149-y; Levin AS, 2001, INFECT CONT HOSP EP, V22, P717, DOI 10.1086/501852; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Luhtala N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041111; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; Manian FA, 2013, AM J INFECT CONTROL, V41, P384, DOI 10.1016/j.ajic.2012.04.321; Markogiannakis A, 2008, INFECT CONT HOSP EP, V29, P410, DOI 10.1086/533545; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; MURRAY BE, 1982, ANN INTERN MED, V96, P176, DOI 10.7326/0003-4819-96-2-176; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; MUSA EK, 1990, J HOSP INFECT, V15, P219, DOI 10.1016/0195-6701(90)90029-N; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Schwartz B, 2007, CANCER RES, V67, P5258, DOI 10.1158/0008-5472.CAN-07-0129; Shin JH, 2013, PLOS ONE, V8; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004	35	17	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85729	10.1371/journal.pone.0085729	http://dx.doi.org/10.1371/journal.pone.0085729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489668	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000017
J	Coates, RC; Podell, S; Korobeynikov, A; Lapidus, A; Pevzner, P; Sherman, DH; Allen, EE; Gerwick, L; Gerwick, WH				Coates, R. Cameron; Podell, Sheila; Korobeynikov, Anton; Lapidus, Alla; Pevzner, Pavel; Sherman, David H.; Allen, Eric E.; Gerwick, Lena; Gerwick, William H.			Characterization of Cyanobacterial Hydrocarbon Composition and Distribution of Biosynthetic Pathways	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALGAE; GREEN; DECARBONYLASE; LIPIDS	Cyanobacteria possess the unique capacity to naturally produce hydrocarbons from fatty acids. Hydrocarbon compositions of thirty-two strains of cyanobacteria were characterized to reveal novel structural features and insights into hydrocarbon biosynthesis in cyanobacteria. This investigation revealed new double bond (2- and 3-heptadecene) and methyl group positions (3-, 4- and 5-methylheptadecane) for a variety of strains. Additionally, results from this study and literature reports indicate that hydrocarbon production is a universal phenomenon in cyanobacteria. All cyanobacteria possess the capacity to produce hydrocarbons from fatty acids yet not all accomplish this through the same metabolic pathway. One pathway comprises a two-step conversion of fatty acids first to fatty aldehydes and then alkanes that involves a fatty acyl ACP reductase (FAAR) and aldehyde deformylating oxygenase (ADO). The second involves a polyketide synthase (PKS) pathway that first elongates the acyl chain followed by decarboxylation to produce a terminal alkene (olefin synthase, OLS). Sixty-one strains possessing the FAAR/ADO pathway and twelve strains possessing the OLS pathway were newly identified through bioinformatic analyses. Strains possessing the OLS pathway formed a cohesive phylogenetic clade with the exception of three Moorea strains and Leptolyngbya sp. PCC 6406 which may have acquired the OLS pathway via horizontal gene transfer. Hydrocarbon pathways were identified in one-hundred-forty-two strains of cyanobacteria over a broad phylogenetic range and there were no instances where both the FAAR/ADO and the OLS pathways were found together in the same genome, suggesting an unknown selective pressure maintains one or the other pathway, but not both.	[Coates, R. Cameron; Podell, Sheila; Allen, Eric E.; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Korobeynikov, Anton; Lapidus, Alla; Pevzner, Pavel] St Petersburg Acad Univ, Russian Acad Sci, Algorithm Biol Lab, St Petersburg, Russia; [Korobeynikov, Anton] St Petersburg State Univ, Dept Math & Mech, St Petersburg 199034, Russia; [Lapidus, Alla] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bionformat, St Petersburg 199034, Russia; [Pevzner, Pavel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; Saint Petersburg State University; Saint Petersburg State University; University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gerwick, WH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	wgerwick@ucsd.edu	Lapidus, Alla L/I-4348-2013; Korobeynikov, Anton/D-3555-2009	Lapidus, Alla L/0000-0003-0427-8731; Korobeynikov, Anton/0000-0002-2937-9259	CEC [500-10-039]; NIH [CA108874, GM067550]; NSF [MCB-1149552]; International Cooperative Biodiversity Group [TW007404]; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550] Funding Source: NIH RePORTER	CEC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); International Cooperative Biodiversity Group; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from CEC 500-10-039, NIH CA108874, NIH GM067550, NSF MCB-1149552 (EEA). DHS acknowledges support from the International Cooperative Biodiversity Group TW007404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 2010, ORG GEOCHEM, V41, P1207, DOI 10.1016/j.orggeochem.2010.07.007; BALABAN AT, 1983, PURE APPL CHEM, V55, P199, DOI 10.1351/pac198855020199; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Creton B, 2010, ENERG FUEL, V24, P5396, DOI 10.1021/ef1008456; Dembitsky VM, 1999, J CHROMATOGR A, V862, P221, DOI 10.1016/S0021-9673(99)00930-9; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS MW, 1991, ARCH BIOCHEM BIOPHYS, V287, P268, DOI 10.1016/0003-9861(91)90478-2; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Donia MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017897; Engene N, 2013, J PHYCOL, V49, P1095, DOI 10.1111/jpy.12115; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; FEHLER SWG, 1972, BIOCHEMISTRY-US, V11, P2411, DOI 10.1021/bi00763a004; FEHLER SWG, 1970, BIOCHEMISTRY-US, V9, P418, DOI 10.1021/bi00804a032; GELPI E, 1970, PHYTOCHEMISTRY, V9, P603, DOI 10.1016/S0031-9422(00)85700-3; Gu LC, 2009, J AM CHEM SOC, V131, P16033, DOI 10.1021/ja9071578; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; HAN J, 1969, J AM CHEM SOC, V91, P5156, DOI 10.1021/ja01046a037; HAN J, 1968, P NATL ACAD SCI USA, V59, P59, DOI 10.1073/pnas.59.1.29; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Liu AQ, 2013, APPL ENERG, V111, P383, DOI 10.1016/j.apenergy.2013.05.008; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McCarthy JG, 2012, ACS CHEM BIOL, V7, P1994, DOI 10.1021/cb300385m; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; PAOLETTI C, 1976, LIPIDS, V11, P258, DOI 10.1007/BF02544051; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Pohnert G, 2002, NAT PROD REP, V19, P108, DOI 10.1039/a806888g; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Ridley CP, 2010, Biosynthesis of 1-alkenes in engineered microorganisms, Patent No. [12/821,107, 12821107]; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Sandrock C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-348; Sato N, 2009, ADV PHOTOSYNTH RESP, V30, P157; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Sharma N, 2010, J APPL PHYCOL, V23, P1; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; VINCENTI M, 1987, ANAL CHEM, V59, P694, DOI 10.1021/ac00132a003; Williamson RT, 2002, J ORG CHEM, V67, P7927, DOI 10.1021/jo020240s; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294	48	112	113	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85140	10.1371/journal.pone.0085140	http://dx.doi.org/10.1371/journal.pone.0085140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475038	Green Published, gold			2022-12-27	WOS:000330507300017
J	Duarte, IC; Ferreira, C; Marques, J; Castelo-Branco, M				Duarte, Isabel Catarina; Ferreira, Carlos; Marques, Joao; Castelo-Branco, Miguel			Anterior/Posterior Competitive Deactivation/Activation Dichotomy in the Human Hippocampus as Revealed by a 3D Navigation Task	PLOS ONE			English	Article							HUMAN SPATIAL NAVIGATION; HUMAN BRAIN; NEGATIVE BOLD; RELATIONAL MEMORY; COGNITIVE MAPS; VISUAL-CORTEX; SPECIALIZATION; SEGMENTATION; ACTIVATION; RETRIEVAL	Anterior/posterior long axis specialization is thought to underlie the organization of the hippocampus. However it remains unclear whether antagonistic mechanisms differentially modulate processing of spatial information within the hippocampus. We used fMRI and a virtual reality 3D paradigm to study encoding and retrieval of spatial memory during active visuospatial navigation, requiring positional encoding and retrieval of object landmarks during the path. Both encoding and retrieval elicited BOLD activation of the posterior most portion of hippocampus, while concurrent deactivations (recently shown to reflect decreases in neural responses) were found in the most anterior regions. Encoding elicited stronger activity in the posterior right than the left hippocampus. The former structure also showed significantly stronger activity for allocentric vs. egocentric processing during retrieval. The anterior vs. posterior pattern mimics, from a functional point, although at much distinct temporal scales, the previous anatomical findings in London taxi drivers, whereby posterior enlargement was found at the cost of an anterior decrease, and the mirror symmetric findings observed in blind people, in whom the right anterior hippocampus was found to be larger, at the cost of a smaller posterior hippocampus, as compared with sighted people. In sum, we found a functional dichotomy whereby the anterior/posterior hippocampus shows antagonistic processing patterns for spatial encoding and retrieval of 3D spatial information. To our knowledge, this is the first study reporting such a dynamical pattern in a functional study, which suggests that differential modulation of neural responses within the human hippocampus reflects distinct roles in spatial memory processing.	[Duarte, Isabel Catarina; Ferreira, Carlos; Marques, Joao; Castelo-Branco, Miguel] ICNAS, Brain Imaging Network Grid, Oporto, Portugal; [Duarte, Isabel Catarina; Ferreira, Carlos; Marques, Joao; Castelo-Branco, Miguel] Univ Coimbra, Inst Biomed Imaging & Life Sci, Coimbra, Portugal	Universidade de Coimbra	Castelo-Branco, M (corresponding author), ICNAS, Brain Imaging Network Grid, Oporto, Portugal.	mcbranco@fmed.uc.pt	Cipriano Ferreira, Carlos Daniel/K-6094-2014; Duarte, Isabel Catarina/AAY-1534-2020; Duarte, Isabel Catarina/GQA-4258-2022; Castelo-Branco, Miguel/F-3866-2019; MARQUES, JOAO CARLOS/L-9478-2014	Cipriano Ferreira, Carlos Daniel/0000-0002-0629-7146; Duarte, Isabel Catarina/0000-0002-5620-2424; Duarte, Isabel Catarina/0000-0002-5620-2424; Castelo-Branco, Miguel/0000-0003-4364-6373; MARQUES, JOAO CARLOS/0000-0001-8865-8189	Foundation for Science and Technology Portugal [Compete/PEst-C/SAU/UI3282/2011, CENTRO-07-ST24-FEDER-00205]; Bial Foundation [132, 133/2013]	Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation)	This work was supported by grant from the Foundation for Science and Technology Portugal (Grant Compete/PEst-C/SAU/UI3282/2011), Grant "From Molecules to Man": CENTRO-07-ST24-FEDER-00205, and Bial Foundation Grants 132 and 133/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Bernardino I, 2013, J INT NEUROPSYCH SOC, V19, P54, DOI 10.1017/S1355617712000963; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Catenoix H, 2011, CLIN NEUROPHYSIOL, V122, P2488, DOI 10.1016/j.clinph.2011.05.007; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Czisch M, 2002, NEUROIMAGE, V16, P251, DOI 10.1006/nimg.2002.1071; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Hashimoto R, 2012, HIPPOCAMPUS, V22, P141, DOI 10.1002/hipo.20878; Hirshhorn M, 2012, NEUROPSYCHOLOGIA, V50, P3094, DOI 10.1016/j.neuropsychologia.2012.08.008; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Lepore N, 2009, NEUROIMAGE, V46, P949, DOI 10.1016/j.neuroimage.2009.01.071; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Nadel L, 2004, NEUROPSYCHOLOGY, V18, P473, DOI 10.1037/0894-4105.18.3.473; Nadel L, 2013, J COGNITIVE NEUROSCI, V25, P22, DOI 10.1162/jocn_a_00313; Noordzij ML, 2006, COGNITION, V100, P321, DOI 10.1016/j.cognition.2005.05.006; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Talairach J., 1988, COPLANAR STEREOTAXIC; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	36	22	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86213	10.1371/journal.pone.0086213	http://dx.doi.org/10.1371/journal.pone.0086213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475088	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300043
J	Eckerdt, F; Perez-Neut, M; Colamonici, OR				Eckerdt, Frank; Perez-Neut, Mathew; Colamonici, Oscar R.			LIN-9 Phosphorylation on Threonine-96 Is Required for Transcriptional Activation of LIN-9 Target Genes and Promotes Cell Cycle Progression	PLOS ONE			English	Article							B-MYB; DEPENDENT KINASES; REPRESSOR COMPLEX; DREAM COMPLEX; G(2)/M GENES; EXPRESSION; DROSOPHILA; CDK3; QUIESCENCE; PROTEINS	Cell cycle transitions are governed by the timely expression of cyclins, the activating subunits of Cyclin-dependent kinases (Cdks), which are responsible for the inactivation of the pocket proteins. Overexpression of cyclins promotes cell proliferation and cancer. Therefore, it is important to understand the mechanisms by which cyclins regulate the expression of cell cycle promoting genes including subsequent cyclins. LIN-9 and the pocket proteins p107 and p130 are members of the DREAM complex that in G0 represses cell cycle genes. Interestingly, little is know about the regulation and function of LIN-9 after phosphorylation of p107, p130 by Cyclin D/Cdk4 disassembles the DREAM complex in early G1. In this report, we demonstrate that cyclin E1/Cdk3 phosphorylates LIN-9 on Thr-96. Mutating Thr-96 to alanine inhibits activation of cyclins A2 and B1 promoters, whereas a phosphomimetic Asp mutant strongly activates their promoters and triggers accelerated entry into G2/M phase in 293T cells. Taken together, our data suggest a novel role for cyclin E1 beyond G1/S and into S/G2 phase, most likely by inducing the expression of subsequent cyclins A2 and B1 through LIN-9.	[Eckerdt, Frank; Perez-Neut, Mathew; Colamonici, Oscar R.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colamonici, OR (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	ocolamon@uic.edu			National Institutes of Medical Sciences [GM81562]; Public Health Service Grants from National Institutes of Health [RO1GM81562]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081562] Funding Source: NIH RePORTER	National Institutes of Medical Sciences; Public Health Service Grants from National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Medical Sciences Grant GM81562. This work was supported by Public Health Service Grants RO1GM81562 (ORC) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall EL, 2004, GENE DEV, V18, P1667, DOI 10.1101/gad.1206604; Braun K, 1998, ONCOGENE, V17, P2259, DOI 10.1038/sj.onc.1202145; Braun K, 1998, DNA CELL BIOL, V17, P789, DOI 10.1089/dna.1998.17.789; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hengstschlager M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hofmann F, 1996, GENE DEV, V10, P851, DOI 10.1101/gad.10.7.851; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sandoval R, 2006, EXP CELL RES, V312, P2465, DOI 10.1016/j.yexcr.2006.04.002; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Siu KT, 2012, CELL CYCLE, V11, P57, DOI 10.4161/cc.11.1.18775; Song J, 2010, ONCOGENE, V29, P1976, DOI 10.1038/onc.2009.485; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Zariwala M, 1998, ONCOGENE, V17, P2787, DOI 10.1038/sj.onc.1202505; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87620	10.1371/journal.pone.0087620	http://dx.doi.org/10.1371/journal.pone.0087620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475316	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300209
J	Kerr, RR; Grayden, DB; Thomas, DA; Gilson, M; Burkitt, AN				Kerr, Robert R.; Grayden, David B.; Thomas, Doreen A.; Gilson, Matthieu; Burkitt, Anthony N.			Coexistence of Reward and Unsupervised Learning During the Operant Conditioning of Neural Firing Rates	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; NEURONAL NETWORKS; SPIKE; MODEL; MODULATION; REINFORCEMENT; STDP; SENSITIVITY	A fundamental goal of neuroscience is to understand how cognitive processes, such as operant conditioning, are performed by the brain. Typical and well studied examples of operant conditioning, in which the firing rates of individual cortical neurons in monkeys are increased using rewards, provide an opportunity for insight into this. Studies of reward-modulated spike-timing-dependent plasticity (RSTDP), and of other models such as R-max, have reproduced this learning behavior, but they have assumed that no unsupervised learning is present (i.e., no learning occurs without, or independent of, rewards). We show that these models cannot elicit firing rate reinforcement while exhibiting both reward learning and ongoing, stable unsupervised learning. To fix this issue, we propose a new RSTDP model of synaptic plasticity based upon the observed effects that dopamine has on long-term potentiation and depression (LTP and LTD). We show, both analytically and through simulations, that our new model can exhibit unsupervised learning and lead to firing rate reinforcement. This requires that the strengthening of LTP by the reward signal is greater than the strengthening of LTD and that the reinforced neuron exhibits irregular firing. We show the robustness of our findings to spike-timing correlations, to the synaptic weight dependence that is assumed, and to changes in the mean reward. We also consider our model in the differential reinforcement of two nearby neurons. Our model aligns more strongly with experimental studies than previous models and makes testable predictions for future experiments.	[Kerr, Robert R.; Grayden, David B.; Gilson, Matthieu; Burkitt, Anthony N.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Kerr, Robert R.; Grayden, David B.; Gilson, Matthieu; Burkitt, Anthony N.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia; [Kerr, Robert R.; Grayden, David B.; Burkitt, Anthony N.] Univ Melbourne, NICTA, Victoria Res Lab, Melbourne, Vic, Australia; [Grayden, David B.; Burkitt, Anthony N.] Bion Inst, Melbourne, Vic, Australia; [Thomas, Doreen A.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic, Australia; [Gilson, Matthieu] RIKEN Brain Sci Inst, Lab Neural Circuit Theory, Saitama, Japan	University of Melbourne; University of Melbourne; Australian National University; University of Melbourne; Bionics Institute; University of Melbourne; RIKEN	Kerr, RR (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia.	r.kerr@pgrad.unimelb.edu.au	Burkitt, Anthony/N-9077-2013; Grayden, David B/L-5782-2018; Thomas, Doreen/F-4408-2016	Burkitt, Anthony/0000-0001-5672-2772; Grayden, David B/0000-0002-5497-7234; Gilson, Matthieu/0000-0002-6726-7207; Thomas, Doreen/0000-0002-8141-3362	Australian Research Council (ARC) [DP1096699]; Victorian Government; Australian Federal and Victorian State Governments; Australian Research Council through the ICT Centre of Excellence program, National ICT Australia (NICTA)	Australian Research Council (ARC)(Australian Research Council); Victorian Government; Australian Federal and Victorian State Governments; Australian Research Council through the ICT Centre of Excellence program, National ICT Australia (NICTA)(Australian Research Council)	Funding is acknowledged from the Australian Research Council (ARC Discovery Project DP1096699). The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. This work was supported by the Australian Federal and Victorian State Governments and the Australian Research Council through the ICT Centre of Excellence program, National ICT Australia (NICTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOHRNSTE.GW, 1969, J AM STAT ASSOC, V64, P1439, DOI 10.2307/2286081; Burkitt AN, 2001, BIOL CYBERN, V85, P247, DOI 10.1007/s004220100262; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Christodoulou C, 2011, NEURAL COMPUT, V23, P656, DOI 10.1162/NECO_a_00090; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gerstner W, 2002, BIOL CYBERN, V87, P404, DOI 10.1007/s00422-002-0353-y; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gilson M, 2010, BIOL CYBERN, V103, P365, DOI 10.1007/s00422-010-0405-7; Gilson M, 2009, BIOL CYBERN, V101, P427, DOI 10.1007/s00422-009-0346-1; Gilson M, 2009, BIOL CYBERN, V101, P81, DOI [10.1007/S00422-009-0319-4, 10.1007/s00422-009-0319-4]; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Gutig R, 2003, J NEUROSCI, V23, P3697; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Herzog MH, 2012, VISION RES, V61, P95, DOI 10.1016/j.visres.2011.11.001; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kerr RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002897; Kobayashi S, 2010, J NEUROPHYSIOL, V103, P1843, DOI 10.1152/jn.00173.2009; Kuhn A, 2003, NEURAL COMPUT, V15, P67, DOI 10.1162/089976603321043702; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meffin H, 2006, PHYS REV E, V73, P384; Moreno-Bote R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028101; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nargeot R, 1999, J NEUROPHYSIOL, V81, P1983, DOI 10.1152/jn.1999.81.4.1983; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Salgado H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00417; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shouval HZ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00019; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sugisaki E, 2011, NEUROSCIENCE, V192, P91, DOI 10.1016/j.neuroscience.2011.06.064; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	50	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87123	10.1371/journal.pone.0087123	http://dx.doi.org/10.1371/journal.pone.0087123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475240	Green Published, gold			2022-12-27	WOS:000330507300145
J	Stampar, SN; Maronna, MM; Kitahara, MV; Reimer, JD; Morandini, AC				Stampar, Sergio N.; Maronna, Maximiliano M.; Kitahara, Marcelo V.; Reimer, James D.; Morandini, Andre C.			Fast-Evolving Mitochondrial DNA in Ceriantharia: A Reflection of Hexacorallia Paraphyly?	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENTS; LEVEL RELATIONSHIPS; MULTIPLE ALIGNMENT; PHYLUM CNIDARIA; RAPID EVOLUTION; GENE-TRANSFER; ANTHOZOA; GENOME	The low evolutionary rate of mitochondrial genes in Anthozoa has challenged their utility for phylogenetic and systematic purposes, especially for DNA barcoding. However, the evolutionary rate of Ceriantharia, one of the most enigmatic "orders'' within Anthozoa, has never been specifically examined. In this study, the divergence of mitochondrial DNA of Ceriantharia was compared to members of other Anthozoa and Medusozoa groups. In addition, nuclear markers were used to check the relative phylogenetic position of Ceriantharia in relation to other Cnidaria members. The results demonstrated a pattern of divergence of mitochondrial DNA completely different from those estimated for other anthozoans, and phylogenetic analyses indicate that Ceriantharia is not included within hexacorallians in most performed analyses. Thus, we propose that the Ceriantharia should be addressed as a separate clade.	[Stampar, Sergio N.] Univ Estadual Paulista, Lab Biol Aquat LABIA, Fac Ciencias & Letras Assis, Dept Ciencias Biol, Sao Paulo, Brazil; [Stampar, Sergio N.; Morandini, Andre C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Maronna, Maximiliano M.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Kitahara, Marcelo V.] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil; [Reimer, James D.] Univ Ryukyus, Fac Sci, Mol Invertebrate Systemat & Ecol Lab, Nishihara, Okinawa 90301, Japan	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of the Ryukyus	Stampar, SN (corresponding author), Univ Estadual Paulista, Lab Biol Aquat LABIA, Fac Ciencias & Letras Assis, Dept Ciencias Biol, Sao Paulo, Brazil.	stampar@assis.unesp.br	Stampar, Sergio N/K-2334-2012; Reimer, James Davis/AAP-1331-2020; Stampar, Sergio N/C-3193-2014; Maronna, Maximiliano M/G-9432-2016; Maronna, Maximiliano/AAY-6734-2020; Fapesp, Biota/F-8655-2017; Stampar, Sergio N/AAC-2019-2020; Kitahara, Marcelo Visentini/D-5560-2011; Morandini, André Carrara/A-9892-2012; Morandini, Andre Carrara/AAC-2320-2020	Stampar, Sergio N/0000-0002-9782-1619; Stampar, Sergio N/0000-0002-9782-1619; Maronna, Maximiliano M/0000-0002-2590-639X; Maronna, Maximiliano/0000-0002-2590-639X; Fapesp, Biota/0000-0002-9887-8449; Stampar, Sergio N/0000-0002-9782-1619; Kitahara, Marcelo Visentini/0000-0003-4011-016X; Morandini, André Carrara/0000-0003-3747-8748; Morandini, Andre Carrara/0000-0003-3747-8748	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/01771]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROEX) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia IB-USP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Universal [481549/2012-9]; Rising Star Program; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus; Sao Paulo Research Foundation (FAPESP) [2012/01771, 2010/50174-7, 2006/56211-6, 2011/17537]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROEX) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia IB-USP(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Universal; Rising Star Program; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2012/01771, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROEX) through the Programa de Pos-Graduacao em Zoologia do Departamento de Zoologia IB-USP and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Universal 481549/2012-9 to SNS and JDR was supported by the Rising Star Program and the International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus. This work was partly supported by grants 2012/01771 (SNS), 2010/50174-7 (ACM), 2006/56211-6(MMM) and 2011/17537 (MVK), Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anisimova M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-161; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; BORCHSENIUS F, 2009, FASTGAP 1 2; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Brockman SA, 2012, GENOME BIOL EVOL, V4, P994, DOI 10.1093/gbe/evs074; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Culligan KM, 2000, NUCLEIC ACIDS RES, V28, P463, DOI 10.1093/nar/28.2.463; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P733, DOI 10.1017/S0025315405011641; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; FERRIS SD, 1983, GENETICS, V105, P681; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Goloboff P, 2008, CLADISTICS, V24, P91; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgins D, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P68; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kohn AB, 2012, MOL PHYLOGENET EVOL, V63, P203, DOI 10.1016/j.ympev.2011.12.009; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Lee MSY, 2003, SYST BIOL, V52, P15, DOI 10.1080/10635150390132650; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Molodtsova TN, 2004, HYDROBIOLOGIA, V530, P261, DOI 10.1007/s10750-004-2671-7; Ogata H, 2011, ISME J, V5, P1143, DOI 10.1038/ismej.2010.210; Ortman BD, 2010, DEEP-SEA RES PT II, V57, P2148, DOI 10.1016/j.dsr2.2010.09.017; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V69, P339, DOI 10.1016/j.ympev.2013.07.016; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; Pont-Kingdon G, 1998, J MOL EVOL, V46, P419, DOI 10.1007/PL00006321; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Schierwater B, 2013, MOL PHYLOGENET EVOL, V69, P311, DOI 10.1016/j.ympev.2013.08.009; Schmidt HA, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P381; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Smith DR, 2013, GENOME BIOL EVOL, V5, P905, DOI 10.1093/gbe/evt059; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stampar SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041091; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandamme AM, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P3, DOI 10.1109/WSE.2009.5630966; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Venton D, 2013, GENOME BIOL EVOL, V5, P1115, DOI 10.1093/gbe/evt080; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Won JH, 2001, CORAL REEFS, V20, P39; Zwickl D. J, 2006, GENETIC ALGORITHM AP	73	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86612	10.1371/journal.pone.0086612	http://dx.doi.org/10.1371/journal.pone.0086612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475157	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300093
J	Xiao, WK; Bai, YY; Ye, P; Luo, LM; Liu, DJ; Wu, HM; Bai, J				Xiao, Wenkai; Bai, Yongyi; Ye, Ping; Luo, Leiming; Liu, Dejun; Wu, Hongmei; Bai, Jie			Plasma Homocysteine Is Associated with Aortic Arterial Stiffness but not Wave Reflection in Chinese Hypertensive Subjects	PLOS ONE			English	Article							BLOOD-PRESSURE; CORONARY ATHEROSCLEROSIS; DISEASE RISK; PROGRESSION; THICKNESS; VELOCITY; STROKE; LEVEL	Objective: Elevated plasma total homocysteine (tHcy) acts synergistically with hypertension to exert a multiplicative effect on cardiovascular diseases risk. The aim of this study was to determine the relationship between tHcy concentration and blood pressure, and to evaluate the role of plasma tHcy in arterial stiffness and wave reflection in hypertension. Methods: In this cross-sectional study, a community-based sample of 1680 subjects (mean age 61.6 years) was classified into four groups according to tHcy level (< 21.6 vs. >= 21.6 mu mol/l) and blood pressure (hypertensive vs. normotensive). Levels of plasma tHcy and other biochemical parameters (e. g., lipids, glucose) were determined. Central arterial blood pressure, reflected pressure wave, and carotid-femoral pulse wave velocity (cf-PWV) were assessed by tonometry within 2 days of obtaining the blood specimen. Results: Neither peripheral nor central blood pressure differed according to tHcy levels in normotensive and hypertensive subjects. Differences in cf-PWV according to tHcy were observed only in hypertensive subjects; differences in cf-PWV in normotensive subjects were not significant after adjusting for confounding factors. Central augmentation index did not differ according to tHcy level in either normotensive or hypertensive subjects. Results of univariate analysis revealed significant correlations between blood pressure parameters and tHcy concentration only among normotensive subjects; however, these correlations were not significant in a partial correlation analysis. Results of multiple regression analysis showed that plasma tHcy levels were independently correlated with cf-PWV in hypertensive subjects (beta = 0.713, P = 0.004). The independent relationship between tHcy and central augmentation index was not significant by further multiple analyses in normotensive or hypertensive individuals. Conclusions: Plasma tHcy level is strongly and independently correlated with arterial stiffness measured as cf-PWV only in hypertensive subjects. Thus, hypertension is a major link between tHcy and aortic arterial stiffness.	[Xiao, Wenkai; Bai, Yongyi; Ye, Ping; Luo, Leiming; Liu, Dejun; Wu, Hongmei] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Bai, Jie] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Ye, P (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	yeping301@sina.com	Luo, Leiming/AAD-5533-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Key National Basic Research Program of China [2012CB517503, 2013CB530804]; Nature Science Foundation of China [81270941]	Key National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Key National Basic Research Program of China (2012CB517503, 2013CB530804) and Nature Science Foundation of China (81270941). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan F, 2007, METABOLISM, V56, P1390, DOI 10.1016/j.metabol.2007.05.010; Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Blacher J, 1998, ARTERIOSCL THROM VAS, V18, P535, DOI 10.1161/01.ATV.18.4.535; Bortolotto LA, 1999, HYPERTENSION, V34, P837, DOI 10.1161/01.HYP.34.4.837; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; de Bree A, 2006, INT J CARDIOL, V113, P332, DOI 10.1016/j.ijcard.2005.11.045; Eikelboom JW, 2000, STROKE, V31, P1069, DOI 10.1161/01.STR.31.5.1069; Filipovsky J, 2005, BLOOD PRESSURE, V14, P45, DOI 10.1080/08037050510008814; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hu Da-yi, 2008, Zhonghua Nei Ke Za Zhi, V47, P976; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059371; Katsuda S, 2013, AM J HYPERTENS, V26, P311, DOI 10.1093/ajh/hps037; Kim BJ, 2011, CLIN EXP HYPERTENS, V33, P411, DOI 10.3109/10641963.2010.549274; Kumar M, 2008, NEUROCHEM INT, V53, P214, DOI 10.1016/j.neuint.2008.07.008; Lim U, 2002, AM J EPIDEMIOL, V156, P1105, DOI 10.1093/aje/kwf157; London GM, 2004, J AM COLL CARDIOL, V43, P92, DOI 10.1016/j.jacc.2003.07.039; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Miller A, 2000, HEART VESSELS, V15, P135, DOI 10.1007/s003800070030; Mizrahi EH, 2003, ISRAEL MED ASSOC J, V5, P791; Moat Stuart J, 2005, Semin Vasc Med, V5, P172, DOI 10.1055/s-2005-872402; Montalescot G, 1997, INT J CARDIOL, V60, P295, DOI 10.1016/S0167-5273(97)00099-5; Nakhai-Pour HR, 2007, J HUM HYPERTENS, V21, P942, DOI 10.1038/sj.jhh.1002247; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Oberoi S, 2013, AM J ROENTGENOL, V200, P798, DOI 10.2214/AJR.12.8653; Pannier BM, 2002, AM J HYPERTENS, V15, P743, DOI 10.1016/S0895-7061(02)02962-X; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sen U, 2010, CELL BIOCHEM BIOPHYS, V57, P49, DOI 10.1007/s12013-010-9079-y; Sharman JE, 2009, HYPERTENSION, V54, P1099, DOI 10.1161/HYPERTENSIONAHA.109.133066; Sundstrom J, 2003, HYPERTENSION, V42, P1100, DOI 10.1161/01.HYP.0000101690.58391.13; SuttonTyrrell K, 1997, CIRCULATION, V96, P1745, DOI 10.1161/01.CIR.96.6.1745; Tabara Y, 2007, HYPERTENS RES, V30, P895, DOI 10.1291/hypres.30.895; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; Tousoulis D, 2008, J AM COLL NUTR, V27, P379, DOI 10.1080/07315724.2008.10719714; Troughton JA, 2007, ATHEROSCLEROSIS, V191, P90, DOI 10.1016/j.atherosclerosis.2006.05.014; Tsai JC, 2005, ATHEROSCLEROSIS, V182, P121, DOI 10.1016/j.atherosclerosis.2005.01.038; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; van Dijk SC, 2013, J HYPERTENS, V31, P952, DOI 10.1097/HJH.0b013e32835eb6b9; Verbeke F, 2011, CLIN J AM SOC NEPHRO, V6, P153, DOI 10.2215/CJN.05120610; Vyssoulis G, 2010, J HUM HYPERTENS, V24, P183, DOI 10.1038/jhh.2009.50; Wang Hai-li, 2012, Zhonghua Yi Xue Za Zhi, V92, P1183; Weber T, 2012, HYPERTENSION, V60, P534, DOI 10.1161/HYPERTENSIONAHA.112.194571; Woodside JV, 2004, ATHEROSCLEROSIS, V177, P337, DOI 10.1016/j.atherosclerosis.2004.07.001; Yasmin, 2004, AM J HYPERTENS, V17, P292, DOI 10.1016/j.amjhyper.2003.12.002; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Yingchoncharoen T, 2012, HEART ASIA, V4, P77, DOI 10.1136/heartasia-2011-010079	48	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85938	10.1371/journal.pone.0085938	http://dx.doi.org/10.1371/journal.pone.0085938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475061	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300030
J	Chen, FF; Wang, M; Bai, J; Liu, QH; Xi, YG; Li, W; Zheng, JN				Chen, Feifei; Wang, Meng; Bai, Jin; Liu, Qinghua; Xi, Yaguang; Li, Wang; Zheng, Junnian			Role of RUNX3 in Suppressing Metastasis and Angiogenesis of Human Prostate Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TISSUE INHIBITOR; BREAST-CANCER; MATRIX METALLOPROTEINASES; COLORECTAL-CANCER; TUMOR-METASTASIS; GASTRIC-CANCER; EXPRESSION; INACTIVATION; METHYLATION	RUNX3 (runt-related transcription factor-3) has been reported to suppress tumor tumorigenesis and metastasis in different human cancers. In this study, we used tissue microarray (TMA) to determine the significance of RUNX3 in prostate cancer progession. Our results showed ectopic expression of RUNX3 in prostate cancer tissues when compared with tumor adjacent normal prostate tissues, and reduced RUNX3 staining was significantly correlated with TNM stage. Moreover, we demonstrated that RUNX3 overexpression inhibited prostate cancer cell migration and invasion resulting from the elevated upregulation of tissue inhibitor of matrix metalloproteinase-2 (TIMP-2), which subsequently inhibited metalloproteinase-2 (MMP-2) expression and activity in vitro. Knock down of RUNX3 expression broke up the balance of TIMP-2/MMP-2, whereas silence of TIMP-2 resulted in the inhibition of MMP-2 expression in prostate cells. We also showed that restoration of RUNX3 decreased vascular endothelial growth factor (VEGF) secretion and suppressed endothelial cell growth and tube formation. Strikingly, RUNX3 was demonstrated to inhibit tumor metastasis and angiogenesis in vivo. Altogether, our results support the tumor suppressive role of RUNX3 in human prostate cancer, and provide insights into development of targeted therapy for this disease.	[Chen, Feifei; Wang, Meng; Bai, Jin; Xi, Yaguang; Zheng, Junnian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China; [Liu, Qinghua] Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China; [Xi, Yaguang] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Li, Wang; Zheng, Junnian] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; University of South Alabama; Xuzhou Medical University	Li, W (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	lizhixin88mm@163.com; jnzheng@xzmc.edu.cn		Xi, Yaguang/0000-0003-3681-9352	National Natural Science Foundation of China [81302207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by a grant from the National Natural Science Foundation of China (No. 81302207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Chen FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056241; Chen Y, 2011, INT J CANCER, V129, P1586, DOI 10.1002/ijc.25831; Chung MS, 2013, JPN J CLIN ONCOL, V43, P184, DOI 10.1093/jjco/hys196; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ellis Lee M, 2006, Clin Adv Hematol Oncol, V4, P1; Ellis LM, 2006, CLIN ADV HEMATOL ONC, V4, P11; Folkman J, 1997, EXS, V79, P1; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Hsu PI, 2009, ANN SURG ONCOL, V16, P1686, DOI 10.1245/s10434-009-0428-2; Hussain Z, 2013, GENET MOL RES, V12, P1106, DOI 10.4238/2013.April.10.6; Ito Kosei, 2012, Seikagaku, V84, P278; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee CWL, 2010, CANCER RES, V70, P4243, DOI 10.1158/0008-5472.CAN-09-3805; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Mei PJ, 2011, J CANCER RES CLIN, V137, P1823, DOI 10.1007/s00432-011-1063-4; Mocarska Agnieszka, 2012, Pol Merkur Lekarski, V33, P357; Nagase H, 1997, BIOL CHEM, V378, P151; O'Hurley G, 2011, HISTOPATHOLOGY, V59, P1240, DOI 10.1111/j.1365-2559.2011.04073.x; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Ohlmann CH, 2012, UROLOGE, V51, P363, DOI 10.1007/s00120-012-2827-4; Pal S, 2001, CANCER RES, V61, P6952; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Sakakura C, 2005, CLIN CANCER RES, V11, P6479, DOI 10.1158/1078-0432.CCR-05-0729; Shi Q, 2001, CANCER RES, V61, P4143; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Waleh NS, 2010, CANCER LETT, V289, P111, DOI 10.1016/j.canlet.2009.08.006; Wang QW, 2011, CELL BIOL INT, V35, P897, DOI 10.1042/CBI20100744; Wang QW, 2009, UROLOGY, V73, P1119, DOI 10.1016/j.urology.2008.02.060; White KY, 2009, J PROTEOME RES, V8, P620, DOI 10.1021/pr8007545; Xie KP, 2004, CYTOKINE GROWTH F R, V15, P297, DOI 10.1016/j.cytogfr.2004.04.003; Zhang L, 2010, J ORAL PATHOL MED, V39, P94, DOI 10.1111/j.1600-0714.2009.00812.x; Zhang Xiao-Yi, 2005, Zhonghua Nan Ke Xue, V11, P359; Zhang XY, 2005, ZHONGHUA NAN KE XUE, V11, P364; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838	45	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86917	10.1371/journal.pone.0086917	http://dx.doi.org/10.1371/journal.pone.0086917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475196	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800069
J	Ibuka, Y; Li, M; Vietri, J; Chapman, GB; Galvani, AP				Ibuka, Yoko; Li, Meng; Vietri, Jeffrey; Chapman, Gretchen B.; Galvani, Alison P.			Free-Riding Behavior in Vaccination Decisions: An Experimental Study	PLOS ONE			English	Article							INFLUENZA VACCINATION; PREDICTORS; PRIVATE; PARENTS; HEALTH	Individual decision-making regarding vaccination may be affected by the vaccination choices of others. As vaccination produces externalities reducing transmission of a disease, it can provide an incentive for individuals to be free-riders who benefit from the vaccination of others while avoiding the cost of vaccination. This study examined an individual's decision about vaccination in a group setting for a hypothetical disease that is called "influenza'' using a computerized experimental game. In the game, interactions with others are allowed. We found that higher observed vaccination rate within the group during the previous round of the game decreased the likelihood of an individual's vaccination acceptance, indicating the existence of free-riding behavior. The free-riding behavior was observed regardless of parameter conditions on the characteristics of the influenza and vaccine. We also found that other predictors of vaccination uptake included an individual's own influenza exposure in previous rounds increasing the likelihood of vaccination acceptance, consistent with existing empirical studies. Influenza prevalence among other group members during the previous round did not have a statistically significant effect on vaccination acceptance in the current round once vaccination rate in the previous round was controlled for.	[Ibuka, Yoko] Tohoku Univ, Grad Sch Econ, Sendai, Miyagi 980, Japan; [Li, Meng] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Vietri, Jeffrey] Kantar Hlth, Hlth Econ & Outcomes Res, Princeton, NJ USA; [Chapman, Gretchen B.] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA; [Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Tohoku University; University of Colorado System; University of Colorado Denver; Rutgers State University New Brunswick; Yale University	Ibuka, Y (corresponding author), Tohoku Univ, Grad Sch Econ, Sendai, Miyagi 980, Japan.	ibuka@econ.tohoku.ac.jp	Ibuka, Yoko/AAW-5135-2020	Ibuka, Yoko/0000-0001-5505-8988; Chapman, Gretchen/0000-0002-1146-480X	National Science Foundation [SBE-0624117]; Direct For Social, Behav & Economic Scie [1227306, 1227390] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the National Science Foundation SBE-0624117 (http://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson R, 2004, ACTA PAEDIATR, V93, P1232, DOI 10.1080/08035250410033970; ANDERSON R M, 1991; Barham T, 2009, J HEALTH ECON, V28, P611, DOI 10.1016/j.jhealeco.2008.12.010; Boulier BL, 2007, BE J ECON ANAL POLI, V7; Brewer NT, 2006, CLIN INFECT DIS, V43, P1379, DOI 10.1086/508466; BRITO DL, 1991, J PUBLIC ECON, V45, P69, DOI 10.1016/0047-2727(91)90048-7; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chapman GB, 2012, PSYCHOL SCI, V23, P1008, DOI 10.1177/0956797612437606; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Connolly T, 2003, ORGAN BEHAV HUM DEC, V91, P186, DOI 10.1016/S0749-5978(03)00057-8; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Francis PJ, 2004, J ECON DYN CONTROL, V28, P2037, DOI 10.1016/j.jedc.2003.08.001; Francis PJ, 1997, J PUBLIC ECON, V63, P383, DOI 10.1016/S0047-2727(96)01586-1; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Geoffard PY, 1997, AM ECON REV, V87, P222; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Jaccard James., 2001, INTERACTION EFFECTS, DOI 10.4135/9781412984515; Kagel JH, 1995, HDB EXPT EC; Leyland AH, 2001, MULTILEVEL MODELLING; Li YC, 2004, HEALTH SERV RES, V39, P905, DOI 10.1111/j.1475-6773.2004.00264.x; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; Philipson T, 1996, J HUM RESOUR, V31, P611, DOI 10.2307/146268; Serpell L, 2006, VACCINE, V24, P4041, DOI 10.1016/j.vaccine.2006.02.037; Stiglitz J, 2000, EC PUBLIC SECTOR	26	65	65	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87164	10.1371/journal.pone.0087164	http://dx.doi.org/10.1371/journal.pone.0087164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475246	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800088
J	Paliwal, V; Raju, SC; Modak, A; Phale, PS; Purohit, HJ				Paliwal, Vasundhara; Raju, Sajan C.; Modak, Arnab; Phale, Prashant S.; Purohit, Hemant J.			Pseudomonas putida CSV86: A Candidate Genome for Genetic Bioaugmentation	PLOS ONE			English	Article							PREFERENTIAL UTILIZATION; AROMATIC-COMPOUNDS; TRANSCRIPTIONAL REGULATOR; DEGRADATION; PATHWAY; NAHR; INSERTION; GLUCOSE; PROTEIN; BIODEGRADATION	Pseudomonas putida CSV86, a plasmid-free strain possessing capability to transfer the naphthalene degradation property, has been explored for its metabolic diversity through genome sequencing. The analysis of draft genome sequence of CSV86 (6.4 Mb) revealed the presence of genes involved in the degradation of naphthalene, salicylate, benzoate, benzylalcohol, p-hydroxybenzoate, phenylacetate and p-hydroxyphenylacetate on the chromosome thus ensuring the stability of the catabolic potential. Moreover, genes involved in the metabolism of phenylpropanoid and homogentisate, as well as heavy metal resistance, were additionally identified. Ability to grow on vanillin, veratraldehyde and ferulic acid, detection of inducible homogentisate dioxygenase and growth on aromatic compounds in the presence of heavy metals like copper, cadmium, cobalt and arsenic confirm in silico observations reflecting the metabolic versatility. In silico analysis revealed the arrangement of genes in the order: tRNA(Gly), integrase followed by nah operon, supporting earlier hypothesis of existence of a genomic island (GI) for naphthalene degradation. Deciphering the genomic architecture of CSV86 for aromatic degradation pathways and identification of elements responsible for horizontal gene transfer (HGT) suggests that genetic bioaugmentation strategies could be planned using CSV86 for effective bioremediation.	[Paliwal, Vasundhara; Purohit, Hemant J.] CSIR Natl Environm Engn Res Inst, Environm Genom Div, Nagpur, Maharashtra, India; [Raju, Sajan C.] Univ Helsinki, MEM Grp, Dept Biosci, Helsinki, Finland; [Modak, Arnab; Phale, Prashant S.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI); University of Helsinki; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Purohit, HJ (corresponding author), CSIR Natl Environm Engn Res Inst, Environm Genom Div, Nagpur, Maharashtra, India.	hemantdrd@hotmail.com	Modak, Arnab/J-2448-2014	modak, arnab/0000-0001-7262-0143; Raju, Sajan/0000-0002-4443-9504	Council of Scientific & Industrial Research [ESC0108]; DST, Government of India	Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); DST, Government of India(Department of Science & Technology (India))	The authors are grateful to the Council of Scientific and Industrial Research (CSIR) for their facilities. The study has been supported through a grant from the Council of Scientific & Industrial Research, project number ESC0108 (Supra-Institutional Network Project). PSP thanks DST, Government of India, for a research grant. AM also thanks the CSIR, Government of India, for SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Basu A, 2003, APPL MICROBIOL BIOT, V62, P579, DOI 10.1007/s00253-003-1305-8; Basu A, 2008, BIODEGRADATION, V19, P83, DOI 10.1007/s10532-007-9117-7; Basu A, 2007, J BACTERIOL, V189, P7556, DOI 10.1128/JB.01235-07; Basu A, 2006, FEMS MICROBIOL LETT, V259, P311, DOI 10.1111/j.1574-6968.2006.00285.x; Behlau F, 2011, APPL ENVIRON MICROB, V77, P4089, DOI 10.1128/AEM.03043-10; Boyd EF, 2009, TRENDS MICROBIOL, V17, P47, DOI 10.1016/j.tim.2008.11.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Cebolla A, 1997, J BIOL CHEM, V272, P3986, DOI 10.1074/jbc.272.7.3986; Christie-Oleza JA, 2008, INT MICROBIOL, V11, P101, DOI 10.2436/20.1501.01.49; Dias Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-96; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Ikuma K, 2013, APPL MICROBIOL BIOT, V97, P395, DOI 10.1007/s00253-012-3949-8; Jimenez J. I., 2010, HDB HYDROCARBON LIPI, P1297, DOI DOI 10.1007/978-3-540-77587-4_91; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Jung CM, 2011, J APPL MICROBIOL, V110, P1449, DOI 10.1111/j.1365-2672.2011.04995.x; KANAMARU K, 1993, FEBS LETT, V330, P99, DOI 10.1016/0014-5793(93)80928-N; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapley A, 1999, BIORESOURCE TECHNOL, V67, P241, DOI 10.1016/S0960-8524(98)00121-7; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kivisaar M, 2009, MOL MICROBIOL, V74, P777, DOI 10.1111/j.1365-2958.2009.06905.x; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; MAHAJAN MC, 1994, ARCH MICROBIOL, V161, P425, DOI 10.1007/BF00288954; Malik A., 2013, MANAGEMENT MICROBIAL, P289; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Moreno R, 2008, J BACTERIOL, V190, P1539, DOI 10.1128/JB.01604-07; Mrozik A, 2010, MICROBIOL RES, V165, P363, DOI 10.1016/j.micres.2009.08.001; NICHOLS NN, 1995, J BACTERIOL, V177, P7033, DOI 10.1128/jb.177.24.7033-7040.1995; Obayori O.S., 2010, SCI RES ESSAYS, V5, P4093; Ooka T, 2009, GENOME RES, V19, P1809, DOI 10.1101/gr.089615.108; Paliwal V, 2012, APPL BIOCHEM BIOTECH, V166, P903, DOI 10.1007/s12010-011-9479-5; Park HH, 2005, BBA-GEN SUBJECTS, V1725, P247, DOI 10.1016/j.bbagen.2005.05.015; Park W, 2002, MICROBIOL-SGM, V148, P2319, DOI 10.1099/00221287-148-8-2319; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Phale P.S., 2013, GENOME ANNOUNCEMENTS, V1, P234, DOI DOI 10.1128/GEN0MEA.00234-12; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; Ravatn R, 1998, J BACTERIOL, V180, P5505, DOI 10.1128/JB.180.21.5505-5514.1998; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; SCHELL MA, 1989, J BACTERIOL, V171, P1952, DOI 10.1128/jb.171.4.1952-1959.1989; Shintani M., 2013, MANAG MICROB RESOUR, P167, DOI [10.1007/978-94-007-5931-2_8, DOI 10.1007/978-94-007-5931-2_8]; Shrivastava R, 2011, J BIOREMED BIODEGRAD, V02, P2, DOI [DOI 10.4172/2155-6199.1000120, 10.4172/2155-6199.1000120]; Shrivastava R, 2011, ARCH MICROBIOL, V193, P553, DOI 10.1007/s00203-011-0697-6; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Sizova O I, 2010, Prikl Biokhim Mikrobiol, V46, P45; SOFIA HJ, 1994, NUCLEIC ACIDS RES, V22, P2576, DOI 10.1093/nar/22.13.2576; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Thangaraj K, 2008, BIORESOURCE TECHNOL, V99, P2488, DOI 10.1016/j.biortech.2007.04.053; Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004	60	34	34	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84000	10.1371/journal.pone.0084000	http://dx.doi.org/10.1371/journal.pone.0084000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475028	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800004
J	Poillet, L; Pernodet, N; Boyer-Guittaut, M; Adami, P; Borg, C; Jouvenot, M; Delage-Mourroux, R; Despouy, G				Poillet, Laura; Pernodet, Nicolas; Boyer-Guittaut, Michael; Adami, Pascale; Borg, Christophe; Jouvenot, Michele; Delage-Mourroux, Regis; Despouy, Gilles			QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells	PLOS ONE			English	Article							SULFHYDRYL OXIDASE 1; METABOLIC STRESS; PROTEIN; EXPRESSION; GENES; DEATH; IDENTIFICATION; TUMORIGENESIS; INVASION; CLONING	The QSOX1 protein (Quiescin Sulfhydryl oxidase 1) catalyzes the formation of disulfide bonds and is involved in the folding and stability of proteins. More recently, QSOX1 has been associated with tumorigenesis and protection against cellular stress. It has been demonstrated in our laboratory that QSOX1 reduces proliferation, migration and invasion of breast cancer cells in vitro and reduces tumor growth in vivo. In addition, QSOX1 expression has been shown to be induced by oxidative or ER stress and to prevent cell death linked to these stressors. Given the function of QSOX1 in these two processes, which have been previously linked to autophagy, we wondered whether QSOX1 might be regulated by autophagy inducers and play a role in this catabolic process. To answer this question, we used in vitro models of breast cancer cells in which QSOX1 was overexpressed (MCF-7) or extinguished (MDA-MB-231). We first showed that QSOX1 expression is induced following amino acid starvation and maintains cellular homeostasis. Our results also indicated that QSOX1 inhibits autophagy through the inhibition of autophagosome/lysosome fusion. Moreover, we demonstrated that inhibitors of autophagy mimic the effect of QSOX1 on cell invasion, suggesting that its role in this process is linked to the autophagy pathway. Previously published data demonstrated that extinction of QSOX1 promotes tumor growth in NOG mice. In this study, we further demonstrated that QSOX1 null tumors present lower levels of the p62 protein. Altogether, our results demonstrate for the first time a role of QSOX1 in autophagy in breast cancer cells and tumors.	[Poillet, Laura; Pernodet, Nicolas; Boyer-Guittaut, Michael; Adami, Pascale; Jouvenot, Michele; Delage-Mourroux, Regis; Despouy, Gilles] Univ Franche Comte, UFR Sci & Tech, F-25030 Besancon, Doubs, France; [Borg, Christophe] Univ Franche Comte, INSERM, UMR 1098, F-25030 Besancon, Doubs, France	Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Despouy, G (corresponding author), Univ Franche Comte, UFR Sci & Tech, F-25030 Besancon, Doubs, France.	gilles.despouy@univ-fcomte.fr	Guittaut, Michael/ABE-4274-2021; DELAGE-MOURROUX, Régis/ABE-1424-2021; Despouy, Gilles/ABE-1702-2021	Guittaut, Michael/0000-0001-9540-5593; DELAGE-MOURROUX, Régis/0000-0002-7145-5948; Poillet, Laura/0000-0002-6756-173X; Gilles, Despouy/0000-0001-9250-9821	Region de Franche-Comte; Ministere de l'enseignement superieur et de la recherche	Region de Franche-Comte(Region Bourgogne-Franche-Comte); Ministere de l'enseignement superieur et de la recherche	Laura Poillet is supported by a fellowship from the Region de Franche-Comte. This work was supported by grant from the Ministere de l'enseignement superieur et de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2012, CELL CYCLE, V11, P3718, DOI 10.4161/cc.22147; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Arduino DM, 2012, HUM MOL GENET, V21, P4680, DOI 10.1093/hmg/dds309; Benayoun B, 2001, J BIOL CHEM, V276, P13830, DOI 10.1074/jbc.M010933200; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Debnath J, 2011, J MAMMARY GLAND BIOL, V16, P173, DOI 10.1007/s10911-011-9223-3; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032; Hellebrekers DMEI, 2006, CANCER RES, V66, P10770, DOI 10.1158/0008-5472.CAN-06-1609; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Katchman BA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3407; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee DY, 2013, EMBO REP, V14, P373, DOI 10.1038/embor.2013.22; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Lozy F, 2012, SEMIN CELL DEV BIOL, V23, P395, DOI 10.1016/j.semcdb.2012.01.005; Macintosh RL, 2012, CELL CYCLE, V11, P2022, DOI 10.4161/cc.20424; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, METHOD ENZYMOL, V453, P53, DOI 10.1016/S0076-6879(08)04004-4; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Musard JF, 2001, BIOCHEM BIOPH RES CO, V287, P83, DOI 10.1006/bbrc.2001.5440; N'Diaye EN, 2009, AUTOPHAGY, V5, P573, DOI 10.4161/auto.5.4.8312; Pernodet N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3341; Puissant A, 2012, AM J CANCER RES, V2, P397; Puissant A, 2010, AUTOPHAGY, V6, P655, DOI 10.4161/auto.6.5.12126; Soloviev M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057327; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	57	12	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86641	10.1371/journal.pone.0086641	http://dx.doi.org/10.1371/journal.pone.0086641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475161	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800054
J	Ragert, M; Fairhurst, MT; Keller, PE				Ragert, Marie; Fairhurst, Merle T.; Keller, Peter E.			Segregation and Integration of Auditory Streams when Listening to Multi-Part Music	PLOS ONE			English	Article							RIGHT PARIETAL LOBE; INTRAPARIETAL SULCUS; POSTERIOR PARIETAL; PLANUM TEMPORALE; MENTAL ROTATION; TIME PERCEPTION; HUMAN BRAIN; CORTEX; ATTENTION; ACTIVATION	In our daily lives, auditory stream segregation allows us to differentiate concurrent sound sources and to make sense of the scene we are experiencing. However, a combination of segregation and the concurrent integration of auditory streams is necessary in order to analyze the relationship between streams and thus perceive a coherent auditory scene. The present functional magnetic resonance imaging study investigates the relative role and neural underpinnings of these listening strategies in multi-part musical stimuli. We compare a real human performance of a piano duet and a synthetic stimulus of the same duet in a prioritized integrative attention paradigm that required the simultaneous segregation and integration of auditory streams. In so doing, we manipulate the degree to which the attended part of the duet led either structurally (attend melody vs. attend accompaniment) or temporally (asynchronies vs. no asynchronies between parts), and thus the relative contributions of integration and segregation used to make an assessment of the leader-follower relationship. We show that perceptually the relationship between parts is biased towards the conventional structural hierarchy in western music in which the melody generally dominates (leads) the accompaniment. Moreover, the assessment varies as a function of both cognitive load, as shown through difficulty ratings and the interaction of the temporal and the structural relationship factors. Neurally, we see that the temporal relationship between parts, as one important cue for stream segregation, revealed distinct neural activity in the planum temporale. By contrast, integration used when listening to both the temporally separated performance stimulus and the temporally fused synthetic stimulus resulted in activation of the intraparietal sulcus. These results support the hypothesis that the planum temporale and IPS are key structures underlying the mechanisms of segregation and integration of auditory streams, respectively.	[Ragert, Marie; Fairhurst, Merle T.; Keller, Peter E.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany; [Fairhurst, Merle T.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Early Social Dev, Leipzig, Germany; [Keller, Peter E.] Univ Western Sydney, MARCS Inst, Mus Cognit & Act Grp, Sydney, NSW, Australia	Max Planck Society; Max Planck Society; Western Sydney University	Ragert, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Res Grp Mus Cognit & Act, Leipzig, Germany.	uhlig@cbs.mpg.de		Keller, Peter/0000-0001-7579-6515	Max Planck Society; FAZIT-Stiftung	Max Planck Society(Max Planck Society); FAZIT-Stiftung	This research was supported by the Max Planck Society. MR's contribution was partially supported by the FAZIT-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2007, HEARING RES, V229, P225, DOI 10.1016/j.heares.2007.01.011; Alexander I, 2005, COGN NEUROPSYCHOL, V22, P306, DOI 10.1080/02643290442000356; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bigand E, 2000, INT J PSYCHOL, V35, P270, DOI 10.1080/002075900750047987; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Brown SW, 1997, PERCEPTION PSYCHOPHY, V59; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Bueti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002481; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Chandrasekaran B, 2010, MUSIC PERCEPT, V27, P297, DOI 10.1525/MP.2010.27.4.297; Deike S, 2004, NEUROREPORT, V15, P1511, DOI 10.1097/01.wnr.0000132919.12990.34; Eger E, 2007, CEREB CORTEX, V17, P2123, DOI 10.1093/cercor/bhl119; Erickson R., 1975, SOUND STRUCTURE MUSI; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Fox WC, 1948, NOTES, V6, P46; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Keller P.E., 2001, PSYCHOL MUSIC, V29, P20, DOI DOI 10.1177/0305735601291003; Keller PE, 2005, MUSIC PERCEPT, V22, P629, DOI 10.1525/mp.2005.22.4.629; Keller PE, 2014, EXPRESSIVEN IN PRESS; Keller PE, 2010, MUSIC PERCEPT, V28, P27, DOI 10.1525/MP.2010.28.1.27; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Marozeau J, 2013, MUSIC PERCEPT, V30, P259, DOI 10.1525/mP.2012.30.3.259; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Parbery-Clark A, 2011, NEUROPSYCHOLOGIA, V49, P3338, DOI 10.1016/j.neuropsychologia.2011.08.007; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; RASCH RA, 1979, ACUSTICA, V43, P121; RASCH RA, 1978, ACUSTICA, V40, P21; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strait DL, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00113; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Tagg P, 2003, CONTINUUM ENCY POPUL, P628; Tagg P, 2003, CONTINUUM ENCY POPUL, P567; Uhlig M, 2013, NEUROIMAGE, V77, P52, DOI 10.1016/j.neuroimage.2013.03.051; VanRullen R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002911; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wright J.K., 1987, CONTEMP MUSIC REV, V2, P63, DOI [10.1080/07494468708567054, DOI 10.1080/07494468708567054]; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140	62	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e84085	10.1371/journal.pone.0084085	http://dx.doi.org/10.1371/journal.pone.0084085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475030	Green Published, gold			2022-12-27	WOS:000330339800006
J	Yu, SF; Gao, F; Yu, J; Yan, S; Wu, J; Zhang, M; Wang, WL; Zheng, SS				Yu, Songfeng; Gao, Feng; Yu, Jun; Yan, Sheng; Wu, Jian; Zhang, Min; Wang, Weilin; Zheng, Shusen			De novo Cancers Following Liver Transplantation: A Single Center Experience in China	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; INCREASED RISK; RENAL-TRANSPLANTATION; MALIGNANCIES; RECIPIENTS; CYCLOSPORINE; TACROLIMUS; NEOPLASIA; SURVIVAL; IMPACT	Background: De novo cancers are a growing problem that has become one of the leading causes of late mortality after liver transplantation. The incidences and risk factors varied among literatures and fewer concerned the Eastern population. Aims: The aim of this study was to examine the incidence and clinical features of de novo cancers after liver transplantation in a single Chinese center. Methods: 569 patients who received liver transplantation and survived for more than 3 months in a single Chinese center were retrospectively reviewed. Results: A total of 18 de novo cancers were diagnosed in 17 recipients (13 male and 4 female) after a mean of 41 +/- 26 months, with an overall incidence of 3.2%, which was lower than that in Western people. Of these, 8 (3.32%) cases were from 241 recipients with malignant liver diseases before transplant, while 10 (3.05%) cases were from 328 recipients with benign diseases. The incidence rates were comparable, p = 0.86. Furthermore, 2 cases developed in 1 year, 5 cases in 3 years and 11 cases over 3 years. The most frequent cancers developed after liver transplantation were similar to those in the general Chinese population but had much higher incidence rates. Conclusions: Liver transplant recipients were at increased risk for developing de novo cancers. The incidence rates and pattern of de novo cancers in Chinese population are different from Western people due to racial and social factors. Pre-transplant malignant condition had no relationship to de novo cancer. Exact risk factors need further studies.	[Yu, Songfeng; Gao, Feng; Yu, Jun; Yan, Sheng; Wu, Jian; Zhang, Min; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Songfeng; Gao, Feng; Yu, Jun; Yan, Sheng; Wu, Jian; Zhang, Min; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Songfeng; Gao, Feng; Yu, Jun; Yan, Sheng; Wu, Jian; Zhang, Min; Wang, Weilin; Zheng, Shusen] Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National ST Major Project [2012ZX10002017]; National High Technology Research and Development Program 863 [2012AA021002]; Major Program of Science and Technology Bureau of Zhejiang Province [2009R50038]	National ST Major Project; National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Major Program of Science and Technology Bureau of Zhejiang Province	This study was supported by the National S&T Major Project (No. 2012ZX10002017), the National High Technology Research and Development Program 863 (No. 2012AA021002) and the Major Program of Science and Technology Bureau of Zhejiang Province (No. 2009R50038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarani U, 2010, DIGEST LIVER DIS, V42, P55, DOI 10.1016/j.dld.2009.04.017; Benlloch S, 2004, AM J TRANSPLANT, V4, P596, DOI 10.1111/j.1600-6143.2004.00380.x; Chak E, 2010, LIVER INT, V30, P1247, DOI 10.1111/j.1478-3231.2010.02303.x; Chatrath H, 2013, CLIN TRANSPLANT, V27, P582, DOI 10.1111/ctr.12171; Chen WQ, 2012, CHINA CANC, V21, P161; Chiang YJ, 2004, TRANSPL P, V36, P2150, DOI 10.1016/j.transproceed.2004.08.013; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Ettorre GM, 2013, TRANSPL P, V45, P2729, DOI 10.1016/j.transproceed.2013.07.050; Euvrard S, 2006, J HEPATOL, V44, P27, DOI 10.1016/j.jhep.2005.10.010; Faria LC, 2008, GASTROENTEROLOGY, V134, P1890, DOI 10.1053/j.gastro.2008.02.064; Fung JJ, 2001, LIVER TRANSPLANT, V7, pS109, DOI 10.1053/jlts.2001.28645; Haagsma EB, 2001, J HEPATOL, V34, P84, DOI 10.1016/S0168-8278(00)00077-5; Herrero JI, 2005, LIVER TRANSPLANT, V11, P89, DOI 10.1002/lt.20319; Herrero JI, 2003, AM J TRANSPLANT, V3, P1407, DOI 10.1046/j.1600-6143.2003.00227.x; Herrero JI, 2009, LIVER TRANSPLANT, V15, pS90, DOI 10.1002/lt.21898; Jain A, 2002, ANN SURG, V236, P429, DOI 10.1097/00000658-200210000-00005; Jain A, 2009, TRANSPLANTATION, V88, P706, DOI 10.1097/TP.0b013e3181b3918e; Jonas S, 1997, CANCER, V80, P1141, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8; Kaneko J, 2013, TRANSPLANTATION, V95, P1142, DOI 10.1097/TP.0b013e318288ca83; Kelly DM, 1998, CANCER-AM CANCER SOC, V83, P1237, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1237::AID-CNCR25>3.3.CO;2-K; Menachem Y, 2003, J CLIN GASTROENTEROL, V36, P436, DOI 10.1097/00004836-200305000-00016; Merion RM, 2010, SEMIN LIVER DIS, V30, P411, DOI 10.1055/s-0030-1267541; Na R, 2013, AM J TRANSPLANT, V13, P174, DOI 10.1111/j.1600-6143.2012.04302.x; Park HW, 2012, TRANSPL P, V44, P802, DOI 10.1016/j.transproceed.2012.01.027; PENN I, 1994, CANCER DETECT PREV, V18, P241; Popov Z, 2007, TRANSPL P, V39, P2589, DOI 10.1016/j.transproceed.2007.08.022; Saigal S, 2002, LIVER TRANSPLANT, V8, P482, DOI 10.1053/jlts.2002.32977; Sampaio MS, 2012, TRANSPLANTATION, V94, P990, DOI 10.1097/TP.0b013e318270bc7b; Samuel D, 2011, LIVER TRANSPLANT, V17, pS6, DOI 10.1002/lt.22423; Sapisochin G, 2011, HEPATOL INT, V5, P707, DOI 10.1007/s12072-010-9231-1; STARZL TE, 1984, LANCET, V1, P583; Wimmer CD, 2013, TRANSPL INT, V26, P999, DOI 10.1111/tri.12165; Xiol X, 2001, LIVER TRANSPLANT, V7, P971, DOI 10.1053/jlts.2001.28744; Yao FY, 2006, CLIN TRANSPLANT, V20, P617, DOI 10.1111/j.1399-0012.2006.00527.x; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	35	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85651	10.1371/journal.pone.0085651	http://dx.doi.org/10.1371/journal.pone.0085651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475047	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800014
J	Iniesta, AA				Iniesta, Antonio A.			ParABS System in Chromosome Partitioning in the Bacterium Myxococcus xanthus	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; INDUCIBLE GENE-EXPRESSION; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; CELL-CYCLE; PSEUDOMONAS-AERUGINOSA; COMPREHENSIVE SET; DNA-REPLICATION; SEGREGATION; PROTEIN	Chromosome segregation is an essential cellular function in eukaryotic and prokaryotic cells. The ParABS system is a fundamental player for a mitosis-like process in chromosome partitioning in many bacterial species. This work shows that the social bacterium Myxococcus xanthus also uses the ParABS system for chromosome segregation. Its large prokaryotic genome of 9.1 Mb contains 22 parS sequences near the origin of replication, and it is shown here that M. xanthus ParB binds preferentially to a consensus parS sequence in vitro. ParB and ParA are essential for cell viability in M. xanthus as in Caulobacter crescentus, but unlike in many other bacteria. Absence of ParB results in anucleate cells, chromosome segregation defects and loss of viability. Analysis of ParA subcellular localization shows that it clusters at the poles in all cells, and in some, in the DNA-free cell division plane between two chromosomal DNA masses. This ParA localization pattern depends on ParB but not on FtsZ. ParB inhibits the nonspecific interaction of ParA with DNA, and ParA colocalizes with chromosomal DNA only when ParB is depleted. The subcellular localization of ParB suggests a single ParB-parS complex localized at the edge of the nucleoid, next to a polar ParA cluster, with a second ParB-parS complex migrating after the replication of parS takes place to the opposite nucleoid edge, next to the other polar ParA cluster.	Univ Murcia, Fac Biol, Dept Genet & Microbiol, Area Genet, Murcia, Spain	University of Murcia	Iniesta, AA (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Area Genet, Campus Reg Excelencia Int Campus Mare Nostrum, Murcia, Spain.	ainiesta@um.es	Iniesta, Antonio A/G-7798-2015	Iniesta, Antonio A/0000-0002-7629-1057	Ministerio de Economia y Competitividad, Government of Spain [BFU2011-255422, RYC-2009-04190]	Ministerio de Economia y Competitividad, Government of Spain	Source of funding: Ministerio de Economia y Competitividad, http://www.mineco.gob.es/portal/site/mineco/. Government of Spain Grants BFU2011-255422 and RYC-2009-04190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bartosik AA, 2009, MICROBIOL-SGM, V155, P1080, DOI 10.1099/mic.0.024661-0; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; Dubarry N, 2006, J BACTERIOL, V188, P1489, DOI 10.1128/JB.188.4.1489-1496.2006; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; Elias-Arnanz M, 2011, CURR OPIN MICROBIOL, V14, P128, DOI 10.1016/j.mib.2010.12.009; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gomez-Santos N, 2012, APPL ENVIRON MICROB, V78, P2515, DOI 10.1128/AEM.07502-11; Harms A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003802; Iniesta AA, 2012, J BACTERIOL, V194, P5875, DOI 10.1128/JB.01110-12; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000380; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Koch MK, 2011, MOL MICROBIOL, V80, P1031, DOI 10.1111/j.1365-2958.2011.07629.x; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lesterlin C, 2012, EMBO J, V31, P3468, DOI 10.1038/emboj.2012.194; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; ORNDORFF P, 1983, J BACTERIOL, V154, P772, DOI 10.1128/JB.154.2.772-779.1983; Perez-Marin MC, 2004, J BIOL CHEM, V279, P33093, DOI 10.1074/jbc.M405225200; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; RUIZVAZQUEZ R, 1984, J BACTERIOL, V160, P818; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Treuner-Lange A, 2013, MOL MICROBIOL, V87, P235, DOI 10.1111/mmi.12094; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Vallet-Gely I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003492; Velicer GJ, 2009, ANNU REV MICROBIOL, V63, P599, DOI 10.1146/annurev.micro.091208.073158; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Zhang Y, 2012, FEMS MICROBIOL REV, V36, P149, DOI 10.1111/j.1574-6976.2011.00307.x	61	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86897	10.1371/journal.pone.0086897	http://dx.doi.org/10.1371/journal.pone.0086897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466283	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100231
J	Abada, PB; Howell, SB				Abada, Paolo B.; Howell, Stephen B.			Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; RETINOIC ACID; MESENCHYMAL TRANSITION; MARKER NANOG; IN-VITRO; EXPRESSION; APOPTOSIS; TUMORS; LINE; CHEMORESISTANCE	Although testicular germ cell tumors are generally quite responsive to treatment with cisplatin, a small fraction of them acquire resistance during therapy. Even when cisplatin treatment is successful the patient is often left with a residual teratoma at the site of the primary tumor suggesting that cisplatin may trigger differentiation in some tumors. Using the human embryonal carcinoma cell line NTera2/D1, we confirmed that exposure to the differentiating agent retinoic acid produced a reduction in pluripotency markers NANOG and POU5F1 (Oct3/4) and an acute concentration-dependent increase in resistance to both cisplatin and paclitaxel that reached as high as 18-fold for cisplatin and 61-fold for paclitaxel within four days. A two day exposure to cisplatin also produced a concentration-dependent decrease in the expression of the NANOG and POU5F1 and increased expression of three markers whose levels increase with differentiation including Nestin, SCG10 and Fibronectin. In parallel, exposure to cisplatin induced up to 6.2-fold resistance to itself and 104-fold resistance to paclitaxel. Paclitaxel did not induce differentiation or resistance to either itself or cisplatin. Neither retinoic acid nor cisplatin induced resistance in cervical or prostate cancer cell lines or other germ cell tumor lines in which they failed to alter the expression of NANOG and POU5F1. Forced expression of NANOG prevented the induction of resistance to cisplatin by retinoic acid. We conclude that cisplatin can acutely induce resistance to itself and paclitaxel by triggering a differentiation response in pluripotent germ cell tumor cells.	[Howell, Stephen B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Howell, SB (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	showell@ucsd.edu			Alex's Lemonade Stand Foundation;  [T32 CA121938];  [R01 CA152185]; NATIONAL CANCER INSTITUTE [T32CA121938, P30CA023100, R01CA152185] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by a grant from the Alex's Lemonade Stand Foundation and grants T32 CA121938 and R01 CA152185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; ANDREWS PW, 1988, BIOCHIM BIOPHYS ACTA, V948, P17, DOI 10.1016/0304-419X(88)90003-0; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Chadalavada Rajendrakumar S. V., 2005, Functional & Integrative Genomics, V5, P59, DOI 10.1007/s10142-005-0132-7; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Choi SC, 2012, J CELL PHYSIOL, V227, P3678, DOI 10.1002/jcp.24076; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; di Pietro A, 2005, INT J BIOCHEM CELL B, V37, P2437, DOI 10.1016/j.biocel.2005.06.014; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gagliardi AR, 2008, CANCER CAUSE CONTROL, V19, P615, DOI 10.1007/s10552-008-9126-9; Gutekunst M, 2013, CANCER RES, V73, P1460, DOI 10.1158/0008-5472.CAN-12-2876; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; HOGAN B, 1977, NATURE, V270, P515, DOI 10.1038/270515a0; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Houldsworth J, 2001, CELL TISSUE RES, V303, P371; Izumiya M, 2012, ANTICANCER RES, V32, P3847; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Katoh M, 2002, INT J MOL MED, V10, P683; KELLAND LR, 1992, CANCER RES, V52, P1710; Lee M, 2012, INT J GYNECOL CANCER, V22, P1489, DOI 10.1097/IGJ.0b013e3182738307; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Looijenga LHJ, 2011, INT J ANDROL, V34, pE234, DOI 10.1111/j.1365-2605.2011.01157.x; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Mayer F, 2003, CLIN CANCER RES, V9, P767; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mueller T, 2006, TUMOR BIOL, V27, P71, DOI 10.1159/000092324; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Przyborski SA, 2004, STEM CELLS DEV, V13, P400, DOI 10.1089/1547328041797507; Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simonatto M, 2007, J CELL PHYSIOL, V213, P642, DOI 10.1002/jcp.21275; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Timmer-Bosscha H, 1998, CANCER CHEMOTH PHARM, V41, P469, DOI 10.1007/s002800050769; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Werner S, 2013, J BIOL CHEM; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781	51	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87444	10.1371/journal.pone.0087444	http://dx.doi.org/10.1371/journal.pone.0087444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475288	Green Published, gold			2022-12-27	WOS:000330507300183
J	Brim, H; Abu-Asab, MS; Nouraie, M; Salazar, J; DeLeo, J; Razjouyan, H; Mokarram, P; Schaffer, AA; Naghibhossaini, F; Ashktorab, H				Brim, Hassan; Abu-Asab, Mones S.; Nouraie, Mehdi; Salazar, Jose; DeLeo, Jim; Razjouyan, Hadi; Mokarram, Pooneh; Schaffer, Alejandro A.; Naghibhossaini, Fakhraddin; Ashktorab, Hassan			An Integrative CGH, MSI and Candidate Genes Methylation Analysis of Colorectal Tumors	PLOS ONE			English	Article							CANCER DCC GENE; MICROSATELLITE INSTABILITY; COLON-CANCER; CLINICOPATHOLOGICAL FEATURES; CHROMOSOMAL INSTABILITY; SUPPRESSOR GENES; ABNORMALITIES; MUTATIONS; BREAST; HEREDITARY	Background: Different DNA aberrations processes can cause colorectal cancer (CRC). Herein, we conducted a comprehensive molecular characterization of 27 CRCs from Iranian patients. Materials and Methods: Array CGH was performed. The MSI phenotype and the methylation status of 15 genes was established using MSP. The CGH data was compared to two established lists of 41 and 68 cancer genes, respectively, and to CGH data from African Americans. A maximum parsimony cladogram based on global aberrations was established. Results: The number of aberrations seem to depend on the MSI status. MSI-H tumors displayed the lowest number of aberrations. MSP revealed that most markers were methylated, except RNF182 gene. P16 and MLH1 genes were primarily methylated in MSI-H tumors. Seven markers with moderate to high frequency of methylation (SYNE1, MMP2, CD109, EVL, RET, LGR and PTPRD) had very low levels of chromosomal aberrations. All chromosomes were targeted by aberrations with deletions more frequent than amplifications. The most amplified markers were CD248, ERCC6, ERGIC3, GNAS, MMP2, NF1, P2RX7, SFRS6, SLC29A1 and TBX22. Most deletions were noted for ADAM29, CHL1, CSMD3, FBXW7, GALNS, MMP2, NF1, PRKD1, SMAD4 and TP53. Aberrations targeting chromosome X were primarily amplifications in male patients and deletions in female patients. A finding similar to what we reported for African American CRC patients. Conclusion: This first comprehensive analysis of CRC Iranian tumors reveals a high MSI rate. The MSI tumors displayed the lowest level of chromosomal aberrations but high frequency of methylation. The MSI-L were predominantly targeted with chromosomal instability in a way similar to the MSS tumors. The global chromosomal aberration profiles showed many similarities with other populations but also differences that might allow a better understanding of CRC's clinico-pathological specifics in this population.	[Brim, Hassan; Nouraie, Mehdi; Ashktorab, Hassan] Howard Univ, Coll Med, Med & Canc Ctr, Dept Pathol, Washington, DC 20059 USA; [Abu-Asab, Mones S.; Salazar, Jose] NEI, Histopathol Core, NIH, Bethesda, MD 20892 USA; [DeLeo, Jim] NIH, Sect Biomed Comp, Ctr Clin, Bethesda, MD 20892 USA; [Razjouyan, Hadi] Drexel Univ, Coll Med, Monmouth Med Ctr, Dept Med, Long Branch, NJ USA; [Mokarram, Pooneh; Naghibhossaini, Fakhraddin] Shiraz Univ Med Sci, Dept Biochem, Shiraz, Iran; [Schaffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Drexel University; Shiraz University of Medical Science; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Brim, H (corresponding author), Howard Univ, Coll Med, Med & Canc Ctr, Dept Pathol, Washington, DC 20059 USA.	hbrim@howard.edu; hashktorab@howard.edu	Nouraie, Seyed Mehdi/O-4071-2018; Mokarram, Pooneh/E-1613-2012; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Ashktorab, hassan/AAJ-2908-2020; Naghibalhossaini, Fakhraddin/I-1650-2018	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Mokarram, Pooneh/0000-0002-9717-0473; Naghibalhossaini, Fakhraddin/0000-0003-4573-502X	National Cancer Institute (NCI), National Institutes of Health (NIH); Intramural Research Program of the NIH, NCI; National Library of Medicine; Research Centers in Minority Institutions (RCMI);  [CA102681]; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Grant #CA102681, funded by the National Cancer Institute (NCI), National Institutes of Health (NIH), by the Intramural Research Program of the NIH, NCI and National Library of Medicine, and by Research Centers in Minority Institutions (RCMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Abu-Asab M, 2012, FORSCH KOMPLEMENTMED, V19, P42, DOI 10.1159/000335190; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Ashktorab H, 2013, NOVEL MUTATION HYPOM; Ashktorab H, 2011, GASTROENTEROLOGY, V138, P304; Ashktorab H, 2008, GASTROENTEROLOGY, P134; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Ashktorab H, 2009, DIGEST DIS SCI, V54, P1985, DOI 10.1007/s10620-009-0866-5; BARDI G, 1995, GENE CHROMOSOME CANC, V12, P97, DOI 10.1002/gcc.2870120204; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Brim H, 2012, PLOS ONE IN PRESS; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Buffart TE, 2012, ONCOLOGIST, V17, P653, DOI 10.1634/theoncologist.2010-0379; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Carethers JM, 2011, GASTROENTEROLOGY; Cheng Y, 2012, LAB INVEST; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Goel A, 2003, CANCER RES, V63, P1608; GRAZIANO SL, 1991, GENE CHROMOSOME CANC, V3, P283, DOI 10.1002/gcc.2870030407; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim A, 2012, J BREAST CANCER, V15, P24, DOI 10.4048/jbc.2012.15.1.24; Krig SR, 2010, ONCOGENE, V29, P5500, DOI 10.1038/onc.2010.289; Krzyminska A, 2011, ENDOKRYNOL POL, V62, P224; Kumar K, 2009, CLIN CANC R IN PRESS, P68; Kumar K, 2009, CAN1 GENE METHYLATIO; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; Niyaz M, 2012, MOL MED REP; Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5; O'Boyle K, 2003, CANCER INVEST, V21, P484, DOI 10.1081/CNV-120018241; Park HD, 2013, AM J MED GENET A, V161A, P509, DOI 10.1002/ajmg.a.35298; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Simon R, 2001, CANCER RES, V61, P4514; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Vasconcelos DS, 2013, GENET MOL RES, V12, P2594, DOI 10.4238/2013.January.4.15; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-74; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Yu YP, 2012, AM J PATHOL, V180, P2240, DOI 10.1016/j.ajpath.2012.03.008; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhao J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0465-3	57	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e82185	10.1371/journal.pone.0082185	http://dx.doi.org/10.1371/journal.pone.0082185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475022	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300008
J	Nguyen, C; Bahar, MH; Baker, G; Andrew, NR				Chi Nguyen; Bahar, Md Habibullah; Baker, Greg; Andrew, Nigel R.			Thermal Tolerance Limits of Diamondback Moth in Ramping and Plunging Assays	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; SUB-ANTARCTIC CATERPILLAR; COLD-SHOCK INJURY; CLIMATE-CHANGE; TEMPERATURE TOLERANCE; PRINGLEOPHAGA-MARIONI; RESPONSES; INSECTS; VARIABILITY; DEPEND	Thermal sensitivity is a crucial determinant of insect abundance and distribution. The way it is measured can have a critical influence on the conclusions made. Diamondback moth (DBM), Plutella xylostella (L.) (Lepidoptera: Plutellidae) is an important insect pest of cruciferous crops around the world and the thermal responses of polyphagous species are critical to understand the influences of a rapidly changing climate on their distribution and abundance. Experiments were carried out to the lethal temperature limits (ULT0 and LLT0: temperatures where there is no survival) as well as Upper and Lower Lethal Temperature (ULT25 and LLT25) (temperature where 25% DBM survived) of lab-reared adult DBM population to extreme temperatures attained by either two-way ramping (ramping temperatures from baseline to LT25 and ramping back again) or sudden plunging method. In this study the ULT0 for DBM was recorded as 42.6 degrees C and LLT0 was recorded as -16.5 degrees C. DBM had an ULT25 of 41.8 degrees C and LLT25 of -15.2 degrees C. The duration of exposure to extreme temperatures had significant impacts on survival of DBM, with extreme temperatures and/or longer durations contributing to higher lethality. Comparing the two-way ramping temperature treatment to that of direct plunging temperature treatment, our study clearly demonstrated that DBM was more tolerant to temperature in the two-way ramping assay than that of the plunging assay for cold temperatures, but at warmer temperatures survival exhibited no differences between ramping and plunging. These results suggest that DBM will not be put under physiological stress from a rapidly changing climate, rather access to host plants in marginal habitats has enabled them to expand their distribution. Two-way temperature ramping enhances survival of DBM at cold temperatures, and this needs to be examined across a range of taxa and life stages to determine if enhanced survival is widespread incorporating a ramping recovery method.	[Chi Nguyen; Bahar, Md Habibullah; Andrew, Nigel R.] Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia; [Bahar, Md Habibullah] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Baker, Greg] South Australian Res & Dev Inst, SARDI Entomol Unit, Adelaide, SA, Australia	University of New England; Agriculture & Agri Food Canada; South Australian Research & Development Institute (SARDI)	Andrew, NR (corresponding author), Univ New England, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia.	nigel.andrew@une.edu.au	Andrew, Nigel/B-7162-2008	Andrew, Nigel/0000-0002-2850-2307	Grains Research Development Corporation (GRDC) project [UNE00013]; Vietnam Government Scholarship	Grains Research Development Corporation (GRDC) project; Vietnam Government Scholarship	The work was funded by a Grains Research Development Corporation (GRDC) project (UNE00013) to NRA. Chi Nguyen was supported by a Vietnam Government Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Andrew Nigel R., 2013, P311; Andrew NR, 2013, J INSECT PHYSIOL, V59, P870, DOI 10.1016/j.jinsphys.2013.06.003; Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Andrew NR, 2011, PHYSIOL ENTOMOL, V36, P385, DOI 10.1111/j.1365-3032.2011.00800.x; ANDREW NR, 2013, LIVING WARMER WORLD, P38; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bahar MH, 2012, ENVIRON ENTOMOL, V41, P1653, DOI 10.1603/EN12156; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Begon M., 2009, ECOLOGY INDIVIDUALS; BoM, 2012, TEMP PERC; CABI, 2012, CROP PROT COMP; Chanthy P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00465; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; CHEN CP, 1987, PHYSIOL ZOOL, V60, P297, DOI 10.1086/physzool.60.3.30162282; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Crawley M.J., 2007, R BOOK; Duran J, 2013, GLOBAL CHANGE BIOL, V19, P2826, DOI 10.1111/gcb.12238; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Findsen A, 2013, J EXP BIOL; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; Gu HN, 2009, ENVIRON ENTOMOL, V38, P524, DOI 10.1603/022.038.0303; HARCOURT D. G., 1957, CANADIAN ENT, V89, P554; Hill MP, 2013, GLOBAL ECOL BIOGEOGR, V22, P942, DOI 10.1111/geb.12059; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Honda K, 1993, HIBERNATION MIGRATIO, P43; Khani A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8301; Klok CJ, 1997, J INSECT PHYSIOL, V43, P685, DOI 10.1016/S0022-1910(97)00001-2; KNIGHT JD, 1986, CRYO-LETT, V7, P194; Lee Richard E. Jr, 2010, P35, DOI 10.1017/CBO9780511675997.003; Lighton JRB, 2004, J EXP BIOL, V207, P1903, DOI 10.1242/jeb.00970; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Nyamukondiwa C, 2010, PHYSIOL ENTOMOL, V35, P255, DOI 10.1111/j.1365-3032.2010.00736.x; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; Patterson DT, 1999, CLIMATIC CHANGE, V43, P711, DOI 10.1023/A:1005549400875; Petavy G, 2004, EVOL ECOL RES, V6, P873; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; Powell SJ, 2004, J INSECT PHYSIOL, V50, P277, DOI 10.1016/j.jinsphys.2004.01.003; R Development Core Team, 2012, R LANG ENV STAT COMP; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Rozsypal J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061745; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; SCHOWALTER T. D., 2006, INSECT ECOLOGY ECOSY; Sehnal F, 1991, INSECTS LOW TEMPERAT; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Sinclair BJ, 2004, J EXP BIOL, V207, P1287, DOI 10.1242/jeb.00880; Sinclair BJ, 2003, J INSECT PHYSIOL, V49, P1049, DOI 10.1016/j.jinsphys.2003.08.002; Sorensen JG, 2013, J EXP BIOL, V216, P809, DOI 10.1242/jeb.076356; Speight MR, 1999, ECOLOGY INSECTS CONC; SPSS, 2009, PASW STAT 18 0 POL E; STEVENSON RD, 1985, AM NAT, V126, P362, DOI 10.1086/284423; SYSTAT, 2012, SIGMAPLOT 12; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; YAMADA H, 1983, JPN J APPL ENTOMOL Z, V27, P17, DOI 10.1303/jjaez.27.17; Zalucki MP, 2009, AUST J ENTOMOL, V48, P85, DOI 10.1111/j.1440-6055.2009.00690.x; Zhang W, 2013, PLOS, V8	68	32	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87535	10.1371/journal.pone.0087535	http://dx.doi.org/10.1371/journal.pone.0087535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475303	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300197
J	Kastberger, G; Hoetzl, T; Maurer, M; Kranner, I; Weiss, S; Weihmann, F				Kastberger, Gerald; Hoetzl, Thomas; Maurer, Michael; Kranner, Ilse; Weiss, Sara; Weihmann, Frank			Speeding Up Social Waves. Propagation Mechanisms of Shimmering in Giant Honeybees	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; COLONY DEFENSE; DORSATA; MOTION	Shimmering is a defence behaviour in giant honeybees (Apis dorsata), whereby bees on the nest surface flip their abdomen upwards in a Mexican wave-like process. However, information spreads faster than can be ascribed to bucket bridging, which is the transfer of information from one individual to an adjacent one. We identified a saltatoric process that speeds up shimmering by the generation of daughter waves, which subsequently merge with the parental wave, producing a new wave front. Motion patterns of individual "focus'' bees (n = 10,894) and their shimmering-active neighbours (n = 459,558) were measured with high-resolution video recording and stereoscopic imaging. Three types of shimmering-active surface bees were distinguished by their communication status, termed "agents'': "Bucket-bridging'' agents comprised 74.98% of all agents, affected 88.17% of their neighbours, and transferred information at a velocity of v = 0.317 +/- 0.015 m/s. "Chain-tail'' agents comprised 9.20% of the agents, were activated by 6.35% of their neighbours, but did not motivate others to participate in the wave. "Generator agents'' comprised 15.82% of agents, showed abdominal flipping before the arrival of the main wave front, and initiated daughter waves. They affected 6.75% of their neighbourhood and speeded up the compound shimmering process compared to bucket bridging alone by 41.5% to v = 0.514 +/- 0.019 m/s. The main direction of shimmering was reinforced by 35.82% of agents, whereas the contribution of the complementing agents was fuzzy. We discuss that the saltatoric process could enable the bees to instantly recruit larger cohorts to participate in shimmering and to respond rapidly to changes in flight direction of preying wasps. A third, non-exclusive explanation is that at a distance of up to three metres from the nest the acceleration of shimmering could notably contribute to the startle response in mammals and birds.	[Kastberger, Gerald; Hoetzl, Thomas; Weiss, Sara; Weihmann, Frank] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Maurer, Michael] Graz Univ Technol, Inst Comp Graph & Vis, A-8010 Graz, Austria; [Kranner, Ilse] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	University of Graz; Graz University of Technology; University of Innsbruck	Kastberger, G (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	gerald.kastberger@uni-graz.at	Kranner, Ilse/B-1039-2011	Kranner, Ilse/0000-0003-4959-9109	Austrian Science Fund (FWF) [P 20515-B16]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding for the paper was granted by the Austrian Science Fund (FWF Project P 20515-B16, entitled "Social waves in giant honeybees''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2005, ANIMAL BEHAV; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2011, ANIM BEHAV, V76, P201; Beni G., 1989, P NATO ADV WORKSH RO; Bonabeau E, 1999, SWARM INTELLIGENCE N; BUTLER CG, 1954, WORLD HONEYBEE; Camazine S., 2003, SELF ORG BIOL SYSTEM; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cressey D, 2011, NATURE NEWS BLOG; Downer J, 2012, PEREGRINE FALCON HUN; Droll JA, 2011, THINK FAST VELOCITY, V17; Farkas I, 2002, NATURE, V419, P131, DOI 10.1038/419131a; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; GOODWIN B, 2001, LEOPARD CHANGED ITS; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; Hoffmann T, 2011, SPREEUWENSPEKTAKEL H; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA, DOI DOI 10.1017/CBO9780511618536; Itti L, 2001, OPT ENG, V40, P1784, DOI 10.1117/1.1389063; Johnson SB, 2001, CONNECTED LIVES ANTS; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 1999, NATL GEOGRAPHIC; Kastberger G, 2013, NATURWISSENSCH UNPUB; Kastberger G, 2013, NATURWISSENSCHAFTEN, V100, P595, DOI 10.1007/s00114-013-1056-z; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Kastberger G, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-3; Kastberger G, 2011, HONEYBEES OF ASIA, P397, DOI 10.1007/978-3-642-16422-4_18; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Kauffman S, 1993, ORIGINS ORDER SELF O; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; Mason Z., 2002, P ICAL 2003 8 INT C, P371; Morse R.A, 1969, PHILIPPINE ASS ENTOM, V1, P1; Olson P. L., 1996, FORENSIC ASPECTS DRI; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Parrish JK, 2005, SELF ORG EVOLUTION S; Phillips O.M., 1977, DYNAMICS UPPER OCEAN, V2nd ed.; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; Procaccini A, 2011, ANIM BEHAV, V82, P759, DOI 10.1016/j.anbehav.2011.07.006; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; ROEPKE W., 1930, Mededelingen van de Landbouwhogeschool, V34, P1; Schmelzer E, 2009, NATURWISSENSCHAFTEN, V96, P1431, DOI 10.1007/s00114-009-0605-y; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; VIRMANI S, 1989, IEEE T POWER SYST, V4, P1373, DOI 10.1109/59.41687; Weihmann Frank, 2012, Insects, V3, P833, DOI 10.3390/insects3030833; Woyke J, 2008, J INSECT BEHAV, V21, P481, DOI 10.1007/s10905-008-9144-1; Zitterbart DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020260; Zupanc GKH, 2010, BEHAV NEUROBIOLOGY I	52	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86315	10.1371/journal.pone.0086315	http://dx.doi.org/10.1371/journal.pone.0086315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475104	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300053
J	Thavagnanam, S; Parker, JC; McBrien, ME; Skibinski, G; Shields, MD; Heaney, LG				Thavagnanam, Surendran; Parker, Jeremy C.; McBrien, Michael E.; Skibinski, Grzegorz; Shields, Michael D.; Heaney, Liam G.			Nasal Epithelial Cells Can Act as a Physiological Surrogate for Paediatric Asthma Studies	PLOS ONE			English	Article							ALLERGIC RHINITIS; GENE-EXPRESSION; IL-13; CULTURE; KINASE; GAMMA; DIFFERENTIATION; HYPERPLASIA; RECEPTOR; RELEASE	Introduction: Differentiated paediatric epithelial cells can be used to study the role of epithelial cells in asthma. Nasal epithelial cells are easier to obtain and may act as a surrogate for bronchial epithelium in asthma studies. We assessed the suitability of nasal epithelium from asthmatic children to be a surrogate for bronchial epithelium using air-liquid interface cultures. Methods: Paired nasal and bronchial epithelial cells from asthmatic children (n = 9) were differentiated for 28 days under unstimulated and IL-13-stimulated conditions. Morphological and physiological markers were analysed using immunocytochemistry, transepithelial-electrical-resistance, Quantitative Real-time-PCR, ELISA and multiplex cytokine/chemokine analysis. Results: Physiologically, nasal epithelial cells from asthmatic children exhibit similar cytokine responses to stimulation with IL-13 compared with paired bronchial epithelial cells. Morphologically however, nasal epithelial cells differed significantly from bronchial epithelial cells from asthmatic patients under unstimulated and IL-13-stimulated conditions. Nasal epithelial cells exhibited lower proliferation/differentiation rates and lower percentages of goblet and ciliated cells when unstimulated, while exhibiting a diminished and varied response to IL-13. Conclusions: We conclude that morphologically, nasal epithelial cells would not be a suitable surrogate due to a significantly lower rate of proliferation and differentiation of goblet and ciliated cells. Physiologically, nasal epithelial cells respond similarly to exogenous stimulation with IL-13 in cytokine production and could be used as a physiological surrogate in the event that bronchial epithelial cells are not available.	[Parker, Jeremy C.; Skibinski, Grzegorz; Shields, Michael D.; Heaney, Liam G.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [McBrien, Michael E.] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, Dept Anaesthet, Belfast BT12 6BA, Antrim, North Ireland; [Shields, Michael D.] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, Dept Paediat, Belfast BT12 6BA, Antrim, North Ireland; [Thavagnanam, Surendran] Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia	Queens University Belfast; Universiti Malaya	Shields, MD (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	m.shields@qub.ac.uk		thavagnanam, surendran/0000-0002-4414-7915	Northern Ireland Chest Heart and Stroke Association; Irish Thoracic Soceity/Boehringer Ingleheim Fellowship; Public Health Agency [RRG/3244/05] Funding Source: researchfish	Northern Ireland Chest Heart and Stroke Association; Irish Thoracic Soceity/Boehringer Ingleheim Fellowship; Public Health Agency	This study was funded by Northern Ireland Chest Heart and Stroke Association and Surendran Thavagnanam was employed on an Irish Thoracic Soceity/Boehringer Ingleheim Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Bousquet J, 2003, ALLERGY, V58, P691, DOI 10.1034/j.1398-9995.2003.00105.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Coyle PV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-41; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; DEVALIA JL, 1991, ALLERGY PROC, V12, P71, DOI 10.2500/108854191779011783; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; GAGA M, 2001, EUR RESP MON, V18, P1; Gomperts BN, 2007, AM J RESP CELL MOL, V37, P339, DOI 10.1165/rcmb.2006-0400OC; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Haitchi HM, 2011, AM J RESP CRIT CARE, V183, pA2771; Hellings PW, 2009, IMMUNOL ALLERGY CLIN, V29, P733, DOI 10.1016/j.iac.2009.08.001; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Jeffery Peter K, 2006, BMC Pulm Med, V6 Suppl 1, pS5, DOI 10.1186/1471-2466-6-S1-S5; Kim CH, 2002, ACTA OTO-LARYNGOL, V122, P638, DOI 10.1080/000164802320396321; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Legget JJ, 2004, EUR RESPIR J, V24, P100; Levine SJ, 1997, J IMMUNOL, V158, P5949; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Malavia NK, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-27; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Miyahara S, 2006, J ALLERGY CLIN IMMUN, V118, P1110, DOI 10.1016/j.jaci.2006.06.014; Nakaya M, 2007, LARYNGOSCOPE, V117, P881, DOI 10.1097/MLG.0b013e318033f9b0; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Ouyang Yuhui, 2010, Allergol Int, V59, P313, DOI 10.2332/allergolint.10-SC-0172; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pringle EJ, 2012, PEDIATR PULM, V47, P1215, DOI 10.1002/ppul.22672; Puddicombe SM, 2003, AM J RESP CELL MOL, V28, P61, DOI 10.1165/rcmb.4715; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Skowron M, 2003, CHEST S, V123, P3; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Thavagnanam S, 2010, PEDIAT ALLERG IMM-UK, V21, P1002, DOI 10.1111/j.1399-3038.2010.01052.x; Wagner JG, 2008, CLIN EXP ALLERGY, V38, P501, DOI 10.1111/j.1365-2222.2007.02855.x; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	44	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85802	10.1371/journal.pone.0085802	http://dx.doi.org/10.1371/journal.pone.0085802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475053	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300025
J	Xu, HJ; Guan, J; Yi, HL; Yin, SK				Xu, Huajun; Guan, Jian; Yi, Hongliang; Yin, Shankai			A Systematic Review and Meta-Analysis of the Association between Serotonergic Gene Polymorphisms and Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Review							5-HT2A RECEPTOR GENE; CHINESE HAN POPULATION; HYPOPNEA SYNDROME; OBESITY; REGION; 2A	Background: 5-Hydroxytryptamine receptor (5-HTR) and 5-hydroxytryptamine transporter (5-HTT) gene polymorphisms have been reported to be associated with susceptibility to obstructive sleep apnea syndrome (OSAS). The associations, derived from sporadic, inconsistent, small-sample-size studies, need to be evaluated further in a meta-analysis. Methods: Relevant studies were identified by searching PubMed, Embase, The Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang, and Weipu. Eligible data were extracted from each included study. Odds ratios (ORs) were calculated using a fixed-effects or a random-effects model. The ORs and 95% confidence interval (CI) were used to assess the strength of the association between serotonergic gene polymorphisms and OSAS in the dominant and recessive models, as well as alleles. The Q statistic was used to evaluate homogeneity and Begg's test was used to assess publication bias. Results: Eight studies were finally included in the meta-analysis of the association between 5-HTR2A gene variants (including 102T/C and 1438G/A), 5-HTT gene polymorphisms (including 5-HTT gene-linked promoter region (5-HTTLRP), and serotonin transporter intron 2 variable number tandem repeat (STin2VNTR) and OSAS risk. The G allele of 5-HTR2A 1438G/A, long 5-HTTLPR, and 10-tandem-repeats STin2VNTR were shown to increase OSAS susceptibility, with ORs of 2.33 (A vs. G, 95% CI 1.48-3.66), 1.24 (L vs. S, 95% CI: 1.04-1.49), and 2.87 (10 vs. 12, 95% CI: 1.38-5.97), respectively. These significant differences were determined in both dominant and recessive models. Of the 5-HTR2A 1438G/A gene polymorphism, the AA genotype increased the OSAS risk, with an OR of 4.21 (95% CI: 2.83-6.25) in a recessive model in male OSAS patients, but no significant association was found in females. Conclusions: Our meta-analysis demonstrated that polymorphisms in the 5-HTR2A 1438G/A and 5-HTT genes contributed to susceptibility to OSAS. The A allele of the 1438G/A gene polymorphism is predominantly distributed in males and increased the OSAS risk significantly.	[Xu, Huajun; Guan, Jian; Yi, Hongliang; Yin, Shankai] Shanghai Jiao Tong Univ, Otolaryngol Inst, Affiliated Peoples Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Guan, J (corresponding author), Shanghai Jiao Tong Univ, Otolaryngol Inst, Affiliated Peoples Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China.	guanjian06@sohu.com; skyin@sjtu.edu.cn			science and technical committee of Shanghai in China [07JC14029]; Shanghai Shen-Kang Hospital Management Center Project of Shanghai [SHDC12010209]	science and technical committee of Shanghai in China; Shanghai Shen-Kang Hospital Management Center Project of Shanghai	This study was supported by grants-in-aid from science and technical committee of Shanghai in China (07JC14029) and Shanghai Shen-Kang Hospital Management Center Project of Shanghai (SHDC12010209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayazit YA, 2006, ORL-J OTO-RHIN-LARYN, V68, P123, DOI 10.1159/000091216; Chen H, 2013, SLEEP BREATH; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; Esterling LE, 1998, AM J MED GENET, V81, P37, DOI 10.1002/(SICI)1096-8628(19980207)81:1<37::AID-AJMG7>3.3.CO;2-B; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Heils A, 1996, J NEUROCHEM, V66, P2621; Hilaire G, 2010, RESP PHYSIOL NEUROBI, V174, P76, DOI 10.1016/j.resp.2010.08.017; Jean-Louis G, 2008, J CLIN SLEEP MED, V4, P261; Larkin EK, 2010, AM J RESP CRIT CARE, V182, P947, DOI 10.1164/rccm.201002-0192OC; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Maia S, 2010, J SLEEP RES, V19, P130; MANTEL N, 1959, J NATL CANCER I, V22, P719; Masuda K, 2004, J VET MED SCI, V66, P965, DOI 10.1292/jvms.66.965; de Carvalho TBO, 2013, SLEEP BREATH, V17, P57, DOI 10.1007/s11325-012-0645-y; Palmer LJ, 2003, AM J HUM GENET, V72, P340, DOI 10.1086/346064; Piatto VB, 2011, BRAZ J OTORHINOLAR, V77, P348, DOI 10.1590/S1808-86942011000300013; Sakai K, 2005, INTERNAL MED, V44, P928, DOI 10.2169/internalmedicine.44.928; SAUDOU F, 1994, NEUROCHEM INT, V25, P503, DOI 10.1016/0197-0186(94)90150-3; Schroder CM, 2013, INT J GERIATR PSYCHI; Sood S, 2007, J APPL PHYSIOL, V102, P2240, DOI 10.1152/japplphysiol.01229.2006; Sorli JV, 2008, APPETITE, V50, P260, DOI 10.1016/j.appet.2007.07.011; Veasey Sigrid C, 2003, Am J Respir Med, V2, P21; Yilmaz M, 2005, LARYNGOSCOPE, V115, P832, DOI 10.1097/01.MLG.0000157334.88700.E6; Yin GP, 2012, ACTA OTO-LARYNGOL, V132, P203, DOI 10.3109/00016489.2011.628951; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Yue Wei-hua, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P533; Yue WH, 2008, SLEEP, V31, P1535, DOI 10.1093/sleep/31.11.1535; Zhao Y, 2013, GENE; Zhu Jian-yong, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P912; Zhu JY, 2008, INT J RESP, V28, P142	31	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86460	10.1371/journal.pone.0086460	http://dx.doi.org/10.1371/journal.pone.0086460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475124	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300066
J	Zhang, XJ; Chang, W; Lee, P; Wang, YH; Yang, M; Li, J; Kumbar, SG; Yu, XJ				Zhang, Xiaojun; Chang, Wei; Lee, Paul; Wang, Yuhao; Yang, Min; Li, Jun; Kumbar, Sangamesh G.; Yu, Xiaojun			Polymer-Ceramic Spiral Structured Scaffolds for Bone Tissue Engineering: Effect of Hydroxyapatite Composition on Human Fetal Osteoblasts	PLOS ONE			English	Article							IN-VITRO; OCTACALCIUM PHOSPHATE; POLYCAPROLACTONE; REGENERATION; FABRICATION; PERSPECTIVES; MATRICES; POROSITY; BEARING; REPAIR	For successful bone tissue engineering, a scaffold needs to be osteoconductive, porous, and biodegradable, thus able to support attachment and proliferation of bone cells and guide bone formation. Recently, hydroxyapatites (HA), a major inorganic component of natural bone, and biodegrade polymers have drawn much attention as bone scaffolds. The present study was designed to investigate whether the bone regenerative properties of nano-HA/polycaprolactone (PCL) spiral scaffolds are augmented in an HA dose dependent manner, thereby establishing a suitable composition as a bone formation material. Nano-HA/PCL spiral scaffolds were prepared with different weight ratios of HA and PCL, while porosity was introduced by a modified salt leaching technique. Human fetal osteoblasts (hFOBs) were cultured on the nano-HA/PCL spiral scaffolds up to 14 days. Cellular responses in terms of cell adhesion, viability, proliferation, differentiation, and the expression of bone-related genes were investigated. These scaffolds supported hFOBs adhesion, viability and proliferation. Cell proliferation trend was quite similar on polymer-ceramic and neat polymer spiral scaffolds on days 1, 7, and 14. However, the significantly increased amount of alkaline phosphatase (ALP) activity and mineralized matrix synthesis was evident on the nano-HA/PCL spiral scaffolds. The HA composition in the scaffolds showed a significant effect on ALP and mineralization. Bone phenotypic markers such as bone sialoprotein (BSP), osteonectin (ON), osteocalcin (OC), and type I collagen (Col-1) were semi-quantitatively estimated by reverse transcriptase polymerase chain reaction analysis. All of these results suggested the osteoconductive characteristics of HA/PCL nanocomposite and cell maturation were HA dose dependent. For instance, HA: PCL = 1: 4 group showed significantly higher ALP mineralization and elevated levels of BSP, ON, OC and Col-I expression as compared other lower or higher ceramic ratios. Amongst the different nano-HA/PCL spiral scaffolds, the 1: 4 weight ratio of HA and PCL is shown to be the most optimal composition for bone tissue regeneration.	[Zhang, Xiaojun; Chang, Wei; Lee, Paul; Wang, Yuhao; Yang, Min; Li, Jun; Yu, Xiaojun] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Zhang, Xiaojun] Fourth Mil Med Univ, Sch Biomed Engn, Dept Math & Phys, Xian 710032, Shaanxi, Peoples R China; [Kumbar, Sangamesh G.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT USA	Stevens Institute of Technology; Air Force Military Medical University; University of Connecticut	Yu, XJ (corresponding author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.	xyu@stevens.edu	Chang, Wei/E-6581-2019; zhang, jin/GXV-9154-2022; /P-6752-2014	/0000-0001-7672-4783	Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation	Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation	This study was supported by the Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8; Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]; Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528; Chang C, 2013, CARBOHYD POLYM, V91, P7, DOI 10.1016/j.carbpol.2012.07.070; Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024; Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1; Eosoly S, 2012, MAT SCI ENG C-MATER, V32, P2250, DOI 10.1016/j.msec.2012.06.011; Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022; Gross KA, 2004, BIOMATERIALS, V25, P4955, DOI 10.1016/j.biomaterials.2004.01.046; Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460; Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105; Jayabalan M, 2010, ACTA BIOMATER, V6, P763, DOI 10.1016/j.actbio.2009.09.015; Johari N, 2012, COMPOS PART B-ENG, V43, P1671, DOI 10.1016/j.compositesb.2012.01.013; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kawai T, 2009, TISSUE ENG PT A, V15, P23, DOI 10.1089/ten.tea.2008.0141; Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260; Kim HW, 2005, BIOMATERIALS, V26, P4395, DOI 10.1016/j.biomaterials.2004.11.008; Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514; KITSUGI T, 1993, BIOMATERIALS, V14, P216, DOI 10.1016/0142-9612(93)90026-X; Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394; Liu X, 2013, ACTA BIOMATER, V9, P4889, DOI 10.1016/j.actbio.2012.08.029; Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Ozkan S, 2009, BIOMATERIALS, V30, P4336, DOI 10.1016/j.biomaterials.2009.04.050; Phipps MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040831; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Ren J, 2008, J MATER SCI-MATER M, V19, P1075, DOI 10.1007/s10856-007-3181-8; Rossi AL, 2012, BONE, V50, P301, DOI 10.1016/j.bone.2011.10.022; Sachlos E., 2003, European Cells & Materials, V5, P29; Saiz E, 2013, DENT MATER, V29, P103, DOI 10.1016/j.dental.2012.08.001; Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018; Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002; Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015; Valmikinathan CM, 2008, J NEURAL ENG, V5, P422, DOI 10.1088/1741-2560/5/4/007; Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045; Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591; Wang YY, 2010, POLYM DEGRAD STABIL, V95, P207, DOI 10.1016/j.polymdegradstab.2009.11.023; Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004; Xiao XF, 2009, J MATER SCI-MATER M, V20, P2375, DOI 10.1007/s10856-009-3810-5; Xie C, 2012, J MATER SCI-MATER M, V23, P853, DOI 10.1007/s10856-011-4535-9; Yu HY, 2008, J BIOMED MATER RES B, V86B, P541, DOI 10.1002/jbm.b.31054; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107; Zhang LH, 2010, TISSUE ENG PART C-ME, V16, P71, DOI [10.1089/ten.tec.2008.0688, 10.1089/ten.TEC.2008.0688]	43	34	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85871	10.1371/journal.pone.0085871	http://dx.doi.org/10.1371/journal.pone.0085871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475056	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300027
J	Faivre-Moskalenko, C; Bernaud, J; Thomas, A; Tartour, K; Beck, Y; Iazykov, M; Danial, J; Lourdin, M; Muriaux, D; Castelnovo, M				Faivre-Moskalenko, Cendrine; Bernaud, Julien; Thomas, Audrey; Tartour, Kevin; Beck, Yvonne; Iazykov, Maksym; Danial, John; Lourdin, Morgane; Muriaux, Delphine; Castelnovo, Martin			RNA Control of HIV-1 Particle Size Polydispersity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL CAPSID PROTEIN; RETROVIRUS PARTICLES; LENTIVIRAL VECTOR; CELLULAR RNAS; GENE DELIVERY; IN-VIVO; GAG; VIRIONS; GENOMES	HIV-1, an enveloped RNA virus, produces viral particles that are known to be much more heterogeneous in size than is typical of non-enveloped viruses. We present here a novel strategy to study HIV-1 Viral Like Particles (VLP) assembly by measuring the size distribution of these purified VLPs and subsequent viral cores thanks to Atomic Force Microscopy imaging and statistical analysis. This strategy allowed us to identify whether the presence of viral RNA acts as a modulator for VLPs and cores size heterogeneity in a large population of particles. These results are analyzed in the light of a recently proposed statistical physics model for the self-assembly process. In particular, our results reveal that the modulation of size distribution by the presence of viral RNA is qualitatively reproduced, suggesting therefore an entropic origin for the modulation of RNA uptake by the nascent VLP.	[Faivre-Moskalenko, Cendrine; Bernaud, Julien; Beck, Yvonne; Iazykov, Maksym; Danial, John; Castelnovo, Martin] Univ Lyon, Phys Lab, Ecole Normale Super Lyon, Lyon, France; [Thomas, Audrey; Muriaux, Delphine] CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, Montpellier, France; [Thomas, Audrey; Tartour, Kevin; Lourdin, Morgane; Muriaux, Delphine] Univ Lyon, INSERM, U758, Ecole Normale Super Lyon, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Castelnovo, M (corresponding author), Univ Lyon, Phys Lab, Ecole Normale Super Lyon, Lyon, France.	martin.castelnovo@ens-lyon.fr		Castelnovo, Martin/0000-0003-1118-7360	Fondation Simone et Cino Del Duca (Institut de France); CNRS (Centre National de Recherche Scientifique); ANRS (Agence Nationale pour le Recherche sur le Sida)	Fondation Simone et Cino Del Duca (Institut de France); CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANRS (Agence Nationale pour le Recherche sur le Sida)	Funders for this work are the Fondation Simone et Cino Del Duca (Institut de France), CNRS (Centre National de Recherche Scientifique), and ANRS (Agence Nationale pour le Recherche sur le Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; BANCROFT JB, 1967, VIROLOGY, V32, P354, DOI 10.1016/0042-6822(67)90284-X; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Cadena-Nava RD, 2012, J VIROL, V86, P3318, DOI 10.1128/JVI.06566-11; Carlson LA, 2012, P NATL ACAD SCI USA, V109, P16928, DOI 10.1073/pnas.1211759109; Castelnovo M, 2003, EUROPHYS LETT, V62, P841, DOI 10.1209/epl/i2003-00449-1; Castelnovo M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035028; Cimarelli A, 2000, J VIROL, V74, P3046, DOI 10.1128/JVI.74.7.3046-3057.2000; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Dordor A, 2011, FUTURE MICROBIOL, V6, P1159, DOI [10.2217/FMB.11.100, 10.2217/fmb.11.100]; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Goff PH, 2012, J VIROL, V86, P10852, DOI 10.1128/JVI.01298-12; Goicochea NL, 2011, J MOL BIOL, V410, P667, DOI 10.1016/j.jmb.2011.04.012; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Hu YF, 2008, BIOPHYS J, V94, P1428, DOI 10.1529/biophysj.107.117473; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kuznetsov YG, 2002, BIOPHYS J, V83, P3665, DOI 10.1016/S0006-3495(02)75366-6; Lavelle L, 2009, J PHYS CHEM B, V113, P3813, DOI 10.1021/jp8079765; Mirambeau G, 2010, RNA BIOL, V7, P724, DOI 10.4161/rna.7.6.13777; Montel F, 2007, BIOPHYS J, V93, P566, DOI 10.1529/biophysj.107.105569; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Sens P, 1996, MACROMOLECULES, V29, P4880, DOI 10.1021/ma951553a; Siber A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021910; Ting CL, 2011, P NATL ACAD SCI USA, V108, P16986, DOI 10.1073/pnas.1109307108; Wang SW, 2004, J VIROL, V78, P716, DOI 10.1128/JVI.78.2.716-723.2004; Zandi R, 2009, BIOPHYS J, V96, P9, DOI 10.1529/biophysj.108.137489; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	35	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e83874	10.1371/journal.pone.0083874	http://dx.doi.org/10.1371/journal.pone.0083874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475027	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800003
J	Le, TT; Urasaki, Y; Pizzorno, G				Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe			Uridine Prevents Fenofibrate-Induced Fatty Liver	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL PROTEIN HYPERACETYLATION; RAMAN SCATTERING MICROSCOPY; LYSINE ACETYLATION; DEPENDENT DEACETYLASE; BETA-OXIDATION; SIR2 HOMOLOG; METABOLISM; ACID; DISEASE	Uridine, a pyrimidine nucleoside, can modulate liver lipid metabolism although its specific acting targets have not been identified. Using mice with fenofibrate-induced fatty liver as a model system, the effects of uridine on liver lipid metabolism are examined. At a daily dosage of 400 mg/kg, fenofibrate treatment causes reduction of liver NAD(+)/NADH ratio, induces hyper-acetylation of peroxisomal bifunctional enzyme (ECHD) and acyl-CoA oxidase 1 (ACOX1), and induces excessive accumulation of long chain fatty acids (LCFA) and very long chain fatty acids (VLCFA). Uridine co-administration at a daily dosage of 400 mg/kg raises NAD(+)/NADH ratio, inhibits fenofibrate-induced hyper-acetylation of ECHD, ACOX1, and reduces accumulation of LCFA and VLCFA. Our data indicates a therapeutic potential for uridine co-administration to prevent fenofibrate-induced fatty liver.	[Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe] Nevada Canc Inst, Las Vegas, NV USA; [Le, Thuc T.; Urasaki, Yasuyo; Pizzorno, Giuseppe] Desert Res Inst, Las Vegas, NV USA	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Le, TT (corresponding author), Nevada Canc Inst, Las Vegas, NV USA.	thuc@uchicago.edu; giuseppe.pizzorno@dri.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), and the Vons Breast Cancer Research Award (TTL and GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2006, POSTGRAD MED J, V82, P315, DOI 10.1136/pgmj.2005.042200; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; BALFOUR JA, 1990, DRUGS, V40, P260, DOI 10.2165/00003495-199040020-00007; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brunmair B, 2004, J PHARMACOL EXP THER, V311, P109, DOI 10.1124/jpet.104.068312; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Grieco A, 2005, Eur Rev Med Pharmacol Sci, V9, P261; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; McKeage K, 2011, DRUGS, V71, P1917, DOI 10.2165/11208090-000000000-00000; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; Samburova V, 2013, J AM OIL CHEM SOC, V90, P53, DOI 10.1007/s11746-012-2138-3; Saydoff JA, 2003, BRAIN RES, V994, P44, DOI 10.1016/j.brainres.2003.09.049; Saydoff JA, 2013, J ALZHEIMERS DIS; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Traut TW, 1996, PROG NUCLEIC ACID RE, V53, P1, DOI 10.1016/S0079-6603(08)60142-7; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038418; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yamamoto T, 2011, CLIN CHIM ACTA, V412, P1712, DOI 10.1016/j.cca.2011.06.006; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	61	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87179	10.1371/journal.pone.0087179	http://dx.doi.org/10.1371/journal.pone.0087179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475249	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800089
J	Marshall, CD; Wieskotten, S; Hanke, W; Hanke, FD; Marsh, A; Kot, B; Dehnhardt, G				Marshall, Christopher D.; Wieskotten, Sven; Hanke, Wolf; Hanke, Frederike D.; Marsh, Alyssa; Kot, Brian; Dehnhardt, Guido			Feeding Kinematics, Suction, and Hydraulic Jetting Performance of Harbor Seals (Phoca vitulina)	PLOS ONE			English	Article							FUNCTIONAL DESIGN; NURSE SHARK; BEHAVIOR; MECHANISM; CAPABILITIES; ODONTOCETI; MORPHOLOGY; MOVEMENTS; EVOLUTION; APPARATUS	The feeding kinematics, suction and hydraulic jetting capabilities of captive harbor seals (Phoca vitulina) were characterized during controlled feeding trials. Feeding trials were conducted using a feeding apparatus that allowed a choice between biting and suction, but also presented food that could be ingested only by suction. Subambient pressure exerted during suction feeding behaviors was directly measured using pressure transducers. The mean feeding cycle duration for suction-feeding events was significantly shorter (0.15+/-0.09 s; P<0.01) than biting feeding events (0.18+/-0.08 s). Subjects feeding in-water used both a suction and a biting feeding mode. Suction was the favored feeding mode (84% of all feeding events) compared to biting, but biting comprised 16% of feeding events. In addition, seals occasionally alternated suction with hydraulic jetting, or used hydraulic jetting independently, to remove fish from the apparatus. Suction and biting feeding modes were kinematically distinct regardless of feeding location (in-water vs. on-land). Suction was characterized by a significantly smaller gape (1.3+/-0.23 cm; P<0.001) and gape angle (12.9+/-2.02 degrees), pursing of the rostral lips to form a circular aperture, and pursing of the lateral lips to occlude lateral gape. Biting was characterized by a large gape (3.63+/-0.21 cm) and gape angle (28.8+/-1.80 degrees; P<0.001) and lip curling to expose teeth. The maximum subambient pressure recorded was 48.8 kPa. In addition, harbor seals were able to jet water at food items using suprambient pressure, also known as hydraulic jetting. The maximum hydraulic jetting force recorded was 53.9 kPa. Suction and hydraulic jetting where employed 90.5% and 9.5%, respectively, during underwater feeding events. Harbor seals displayed a wide repertoire of behaviorally flexible feeding strategies to ingest fish from the feeding apparatus. Such flexibility of feeding strategies and biomechanics likely forms the basis of their opportunistic, generalized feeding ecology and concomitant breadth of diet.	[Marshall, Christopher D.; Marsh, Alyssa; Kot, Brian] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Wieskotten, Sven; Hanke, Wolf; Hanke, Frederike D.; Dehnhardt, Guido] Univ Rostock, Inst Biosci, Sensory & Cognit Ecol Grp, D-18055 Rostock, Germany	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; University of Rostock	Marshall, CD (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	marshalc@tamug.edu	Marshall, Christopher/AAF-9097-2019; Hanke, Frederike/AAF-5023-2021	Hanke, Frederike/0000-0002-1737-3861	Texas A&M University International Research Travel Assistance Grant; VolkswagenStiftung; DAAD German Academic Student Exchange Scholarship (Deutscher Akademischer Austausch Dienst, DAAD); Cologne Zoo; Texas A&M University Department of Marine Biology; University of Rostock Institute of Biosciences; University of Bochum Department of Biology	Texas A&M University International Research Travel Assistance Grant; VolkswagenStiftung(Volkswagen); DAAD German Academic Student Exchange Scholarship (Deutscher Akademischer Austausch Dienst, DAAD); Cologne Zoo; Texas A&M University Department of Marine Biology; University of Rostock Institute of Biosciences; University of Bochum Department of Biology	This work was supported by a Texas A&M University International Research Travel Assistance Grant to CDM, a VolkswagenStiftung grant to GD, a DAAD German Academic Student Exchange Scholarship (Deutscher Akademischer Austausch Dienst, DAAD), the Cologne Zoo, the Texas A&M University Department of Marine Biology, the University of Rostock Institute of Biosciences, and the University of Bochum Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2002, Oryctos, V4, P83; BERTA A, 2006, MARINE MAMMALS EVOLU; Bigg M.A., 1981, HDB MARINE MAMMALS, V2, P1; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bloodworth BE, 2007, J ANAT, V211, P78, DOI 10.1111/j.1469-7580.2007.00755.x; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Bromaghin JF, 2013, FISH B-NOAA, V111, P13, DOI 10.7755/FB.111.1.2; Brown SL, 2012, J MAR BIOL ASSOC UK, V92, P1711, DOI 10.1017/S0025315411002050; Burns JJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P533; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Deban Stephen M., 2000, P65, DOI 10.1016/B978-012632590-4/50004-6; Dehnhardt G, 1996, ANIM LEARN BEHAV, V24, P366, DOI 10.3758/BF03199008; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Fay FH, 1982, FISH WILDL SERV PUBL, V74; Germain LR, 2012, MAR MAMMAL SCI, V28, P542, DOI 10.1111/j.1748-7692.2011.00516.x; Gibb AC, 2005, ZOOLOGY, V108, P141, DOI 10.1016/j.zool.2005.03.004; GORDON KR, 1984, J MORPHOL, V182, P179, DOI 10.1002/jmor.1051820206; Grant R, 2013, J COMP PHYSIOL A, V199, P521, DOI 10.1007/s00359-013-0797-7; Grant RA, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00039; Hartmann MJ, 2001, AUTON ROBOT, V11, P249, DOI 10.1023/A:1012439023425; Heyning John E., 1996, Contributions in Science (Los Angeles), V464, P1; Higham TE, 2006, J EXP BIOL, V209, P2713, DOI 10.1242/jeb.02315; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Hoover A.A., 1988, P125; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; KASTELEIN R A, 1991, Aquatic Mammals, V17, P156; Kastelein R.A., 1997, P279; KASTELEIN R A, 1990, Aquatic Mammals, V16, P101; KASTELEIN R A, 1988, Aquatic Mammals, V14, P123; Kastelein R.A., 1989, Aquatic Mammals, V15, P3; KASTELEIN RA, 1994, Z SAUGETIERKD, V59, P105; Kavanagh AS, 2010, J MAR BIOL ASS UK, V90; King J.E., 1972, P81; King JE., 1983, SEALS WORLD BRIT MUS; KLAGES NTW, 1990, POLAR BIOL, V10, P403; Lauder G.V., 1985, P210; Lauder George V., 1993, P113; LAUDER GV, 1980, J EXP BIOL, V88, P49; LAUDER GV, 1985, FORTS ZOOL, V30, P179; LAUDER GV, 1988, J EXP BIOL, V134, P219; LAUDER GV, 1986, ZOOL J LINN SOC-LOND, V88, P277, DOI 10.1111/j.1096-3642.1986.tb01191.x; LAUDER GV, 1979, J ZOOL, V187, P543; Marshall CD, 1998, MAR MAMMAL SCI, V14, P274, DOI 10.1111/j.1748-7692.1998.tb00716.x; Marshall CD, 2000, J MAMMAL, V81, P649, DOI 10.1644/1545-1542(2000)081<0649:FHAAFC>2.3.CO;2; Marshall CD, 2003, J ZOOL, V259, P245, DOI 10.1017/S0952836902003205; MARSHALL CD, 2001, 14 BIENN C BIOL MAR; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; Matott MP, 2005, ENVIRON BIOL FISH, V74, P163, DOI 10.1007/s10641-005-7435-3; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Motta PJ, 2002, COPEIA, P24, DOI 10.1643/0045-8511(2002)002[0024:KAOSFI]2.0.CO;2; MULLER M, 1982, J THEOR BIOL, V95, P49, DOI 10.1016/0022-5193(82)90287-9; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; Parrish FA, 2002, MAR MAMMAL SCI, V18, P244, DOI 10.1111/j.1748-7692.2002.tb01031.x; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Peterson SH, 2012, PLOS ONE, DOI [10.1371/journal.pone.0039046, DOI 10.1371/J0URNAL.P0NE.0039046]; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; Rice D. W., 1998, SPECIAL PUBLICATION, V4; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Sharples RJ, 2009, MAR ECOL PROG SER, V390, P265, DOI 10.3354/meps08232; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; Wainwright P, 2007, INTEGR COMP BIOL, V47, P96, DOI 10.1093/icb/icm032; Wainwright PC, 2007, J R SOC INTERFACE, V4, P553, DOI 10.1098/rsif.2006.0197; Werth A, 2000, MAR MAMMAL SCI, V16, P299, DOI 10.1111/j.1748-7692.2000.tb00926.x; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; Wilga CD, 2007, INTEGR COMP BIOL, V47, P55, DOI 10.1093/icb/icm029	77	42	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86710	10.1371/journal.pone.0086710	http://dx.doi.org/10.1371/journal.pone.0086710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475170	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800056
J	Menon, P; Kiernan, MC; Vucic, S				Menon, Parvathi; Kiernan, Matthew C.; Vucic, Steve			Cortical Dysfunction Underlies the Development of the Split-Hand in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THRESHOLD TRACKING TECHNIQUES; HUMAN PERIPHERAL-NERVE; AXONAL EXCITABILITY PROPERTIES; SILENT PERIOD; INTRACORTICAL INHIBITION; GLUTAMATE TRANSPORTER; MOTOR AXONS; MOUSE MODEL; ALS	The split-hand phenomenon, a specific feature of amyotrophic lateral sclerosis (ALS), refers to preferential wasting of abductor pollicis brevis (APB) and first dorsal interosseous (FDI) with relative preservation of abductor digiti minimi (ADM). The pathophysiological mechanisms underlying the split-hand phenomenon remain elusive and resolution of this issue would provide unique insights into ALS pathophysiology. Consequently, the present study dissected out the relative contribution of cortical and peripheral processes in development of the split-hand phenomenon in ALS. Cortical and axonal excitability studies were undertaken on 26 ALS patients, with motor responses recorded over the APB, FDI and ADM muscles. Results were compared to 21 controls. Short interval intracortical inhibition (SICI), a biomarker of cortical excitability, was significantly reduced across the range of intrinsic hand muscles (APB(SICI ALS) 0.3 +/- 2.0%, APB(SICI controls) 16.0 +/- 1.9%, P<0.0001; FDISICI ALS 2.7 +/- 1.7%, FDI (SICI controls) 14.8 +/- 1.9%, P<0.0001; ADM(SICI ALS) 2.6 +/- 1.5%, ADM (SICI) (controls) 9.7 +/- 2.2%, P<0.001), although the reduction was most prominent when recorded over APB/FDI. Changes in SICI were accompanied by a significant increase in motor evoked potential amplitude and reduction of cortical silent period duration, all indicative of cortical hyperexcitability, and these were most prominent from the APB/FDI. At a peripheral level, a significant increase in strength-duration time constant and reduction in depolarising threshold electrotonus were evident in ALS, although these changes did not follow a split-hand distribution. Cortical dysfunction contributed to development of the split-hand in ALS, thereby implying an importance of cortical hyperexcitability in ALS pathogenesis.	[Menon, Parvathi; Vucic, Steve] Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW 2006, Australia; [Kiernan, Matthew C.; Vucic, Steve] Neurosci Res Australia, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia	University of Sydney; Neuroscience Research Australia; University of Sydney	Vucic, S (corresponding author), Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW 2006, Australia.	s.vucic@neura.edu.au	Kiernan, Matthew C/E-4460-2011	Kiernan, Matthew/0000-0001-9054-026X; Vucic, Steve/0000-0002-8323-873X	Motor Neuron Disease Research Institute of Australia [MNDRIA]; National Health and Medical Research Council of Australia [510233, 1024915]	Motor Neuron Disease Research Institute of Australia [MNDRIA]; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding support from the Motor Neuron Disease Research Institute of Australia [MNDRIA], National Health and Medical Research Council of Australia (Project)grant numbers 510233 and 1024915] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1999, J PHYSIOL-LONDON, V514, P895, DOI 10.1111/j.1469-7793.1999.895ad.x; Bae JS, 2013, NEUROSCI LETT, V541, P150, DOI 10.1016/j.neulet.2013.03.003; Bae JS, 2009, MUSCLE NERVE, V39, P350, DOI 10.1002/mus.21107; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Bostock Hugh, 1995, P311; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; EISEN A, 1992, MUSCLE NERVE, V15, P219, DOI 10.1002/mus.880150215; Eisen A, 2012, J NEUROL NEUROSUR PS, V83, P399, DOI 10.1136/jnnp-2011-301456; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; FRIEDMAN AP, 1950, J NERV MENT DIS, V111, P1, DOI 10.1097/00005053-195011110-00001; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kanai K, 2006, BRAIN, V129, P953, DOI 10.1093/brain/awl024; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Komissarow L, 2004, CLIN NEUROPHYSIOL, V115, P356, DOI 10.1016/j.clinph.2003.10.003; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Kuwabara S, 2008, MUSCLE NERVE, V37, P426, DOI 10.1002/mus.20949; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Menon P, 2014, MUSCLE NERVE, V49, P836, DOI 10.1002/mus.24072; Menon P, 2013, CLIN NEUROPHYSIOL, V124, P410, DOI 10.1016/j.clinph.2012.07.025; MILLS KR, 1986, ELECTROEN CLIN NEURO, V63, P582, DOI 10.1016/0013-4694(86)90145-8; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; OBrien M.D, 2004, AID EXAMINATION PERI, P1; PROUT AJ, 1994, MUSCLE NERVE, V17, P217, DOI 10.1002/mus.880170213; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shibuya K, 2013, J NEUROL NEUROSUR PS, V84, P969, DOI 10.1136/jnnp-2012-304109; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Stetkarova I, 2012, CLIN NEUROP IN PRESS; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P1458, DOI 10.1016/j.clinph.2006.04.016; Vucic S, 2013, J NEUROL NEUROSUR PS, V84, P1161, DOI 10.1136/jnnp-2012-304019; Vucic S, 2013, BRAIN, V136, P1361, DOI 10.1093/brain/awt085; Vucic S, 2011, CLIN NEUROPHYSIOL, V122, P1860, DOI 10.1016/j.clinph.2010.12.062; Vucic S, 2010, J NEUROL NEUROSUR PS, V81, P222, DOI 10.1136/jnnp.2009.183079; Weber M, 2000, J NEUROL SCI, V180, P66, DOI 10.1016/S0022-510X(00)00430-5; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Wilbourn AJ, 2000, MUSCLE NERVE, V23, P138, DOI 10.1002/(SICI)1097-4598(200001)23:1<138::AID-MUS22>3.0.CO;2-7; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	52	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87124	10.1371/journal.pone.0087124	http://dx.doi.org/10.1371/journal.pone.0087124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475241	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800086
J	Newberg, AB; Serruya, M; Gepty, A; Intenzo, C; Lewis, T; Amen, D; Russell, DS; Wintering, N				Newberg, Andrew B.; Serruya, Mijail; Gepty, Andrew; Intenzo, Charles; Lewis, Todd; Amen, Daniel; Russell, David S.; Wintering, Nancy			Clinical Comparison of Tc-99m Exametazime and I-123 Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DOPAMINE TRANSPORTER DENSITY; EMISSION COMPUTED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; POSTTRAUMATIC HEADACHE; MIGRAINE; CONCUSSION; SEQUELAE; PAIN; CT	Background: This study evaluated the clinical interpretations of single photon emission computed tomography (SPECT) using a cerebral blood flow and a dopamine transporter tracer in patients with chronic mild traumatic brain injury (TBI). The goal was to determine how these two different scan might be used and compared to each other in this patient population. Methods and Findings: Twenty-five patients with persistent symptoms after a mild TBI underwent SPECT with both Tc-99m exametazime to measure cerebral blood flow (CBF) and I-123 ioflupane to measure dopamine transporter (DAT) binding. The scans were interpreted by two expert readers blinded to any case information and were assessed for abnormal findings in comparison to 10 controls for each type of scan. Qualitative CBF scores for each cortical and subcortical region along with DAT binding scores for the striatum were compared to each other across subjects and to controls. In addition, symptoms were compared to brain scan findings. TBI patients had an average of 6 brain regions with abnormal perfusion compared to controls who had an average of 2 abnormal regions (p<0.001). Patient with headaches had lower CBF in the right frontal lobe, and higher CBF in the left parietal lobe compared to patients without headaches. Lower CBF in the right temporal lobe correlated with poorer reported physical health. Higher DAT binding was associated with more depressive symptoms and overall poorer reported mental health. There was no clear association between CBF and DAT binding in these patients. Conclusions: Overall, both scans detected abnormalities in brain function, but appear to reflect different types of physiological processes associated with chronic mild TBI symptoms. Both types of scans might have distinct uses in the evaluation of chronic TBI patients depending on the clinical scenario.	[Newberg, Andrew B.; Gepty, Andrew; Wintering, Nancy] Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA; [Serruya, Mijail] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Intenzo, Charles] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Lewis, Todd] Magee Mem Rehabilitat Ctr, Philadelphia, PA USA; [Amen, Daniel] Amen Clin Inc, Newport Beach, CA USA; [Russell, David S.] Inst Neurodegenerat Disorders, New Haven, CT USA; [Russell, David S.] Yale Univ, Sch Med, New Haven, CT USA	Jefferson University; Jefferson University; Jefferson University; Yale University	Newberg, AB (corresponding author), Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA.	Andrew.newberg@jefferson.edu			GE Healthcare, Princeton, NJ	GE Healthcare, Princeton, NJ(General ElectricGE Healthcare)	This work was supported by a grant from GE Healthcare, Princeton, NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Amen Daniel G, 2011, Open Neuroimag J, V5, P40, DOI 10.2174/1874440001105010040; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Amsterdam JD, 2012, J AFFECT DISORDERS, V141, P425, DOI 10.1016/j.jad.2012.03.007; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Basoglu T, 1996, J NUCL MED, V37, P1172; Baulieu F, 2001, J NEUROIMAGING, V11, P112, DOI 10.1111/j.1552-6569.2001.tb00020.x; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; BELYI BI, 1987, INT J NEUROSCI, V32, P799, DOI 10.3109/00207458709043334; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; DiPiero V, 1997, PAIN, V70, P185, DOI 10.1016/S0304-3959(96)03318-0; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jean-Bay E, 2000, J Neurosci Nurs, V32, P169; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kjeldgaard D, 2013, CEPHALALGIA; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McNair D.M., 1992, REVISED MANUAL PROFI; Moss A, FUNCTIONAL BRAIN IMA; Murakami T, 2013, AM J GERIAT PSYCHIAT, V21, P840, DOI 10.1016/j.jagp.2013.01.057; Musiek ES, 2012, ALZHEIMERS DEMENT, V8, P51, DOI 10.1016/j.jalz.2011.06.003; Newberg A, 2007, NUCL MED COMMUN, V28, P3, DOI 10.1097/MNM.0b013e328013dc9d; Newberg AB, 2012, J NUCL MED, V53, P902, DOI 10.2967/jnumed.111.099606; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; SCHLAKE HP, 1990, EUR NEUROL, V30, P153, DOI 10.1159/000117334; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	54	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87009	10.1371/journal.pone.0087009	http://dx.doi.org/10.1371/journal.pone.0087009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475210	Green Published, gold			2022-12-27	WOS:000330339800075
J	Schottdorf, M; Eglen, SJ; Wolf, F; Keil, W				Schottdorf, Manuel; Eglen, Stephen J.; Wolf, Fred; Keil, Wolfgang			Can Retinal Ganglion Cell Dipoles Seed Iso-Orientation Domains in the Visual Cortex?	PLOS ONE			English	Article							STRIATE CORTEX; RECEPTIVE-FIELDS; RETINOTOPIC ORGANIZATION; FUNCTIONAL ARCHITECTURE; COLUMNAR ARCHITECTURE; PATTERN-FORMATION; CAT; MAPS; UNIVERSALITY; TOPOGRAPHY	It has been argued that the emergence of roughly periodic orientation preference maps (OPMs) in the primary visual cortex (V1) of carnivores and primates can be explained by a so-called statistical connectivity model. This model assumes that input to V1 neurons is dominated by feed-forward projections originating from a small set of retinal ganglion cells (RGCs). The typical spacing between adjacent cortical orientation columns preferring the same orientation then arises via Moire 'Interference between hexagonal ON/OFF RGC mosaics. While this Moire-Interference critically depends on long-range hexagonal order within the RGC mosaics, a recent statistical analysis of RGC receptive field positions found no evidence for such long-range positional order. Hexagonal order may be only one of several ways to obtain spatially repetitive OPMs in the statistical connectivity model. Here, we investigate a more general requirement on the spatial structure of RGC mosaics that can seed the emergence of spatially repetitive cortical OPMs, namely that angular correlations between so-called RGC dipoles exhibit a spatial structure similar to that of OPM autocorrelation functions. Both in cat beta cell mosaics as well as primate parasol receptive field mosaics we find that RGC dipole angles are spatially uncorrelated. To help assess the level of these correlations, we introduce a novel point process that generates mosaics with realistic nearest neighbor statistics and a tunable degree of spatial correlations of dipole angles. Using this process, we show that given the size of available data sets, the presence of even weak angular correlations in the data is very unlikely. We conclude that the layout of ON/OFF ganglion cell mosaics lacks the spatial structure necessary to seed iso-orientation domains in the primary visual cortex.	[Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Univ Gottingen, Inst Nonlinear Dynam, D-37073 Gottingen, Germany; [Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Schottdorf, Manuel; Wolf, Fred; Keil, Wolfgang] Bernstein Focus Neurotechnol, Gottingen, Germany; [Schottdorf, Manuel] Univ Wurzburg, Inst Theoret Phys, D-97070 Wurzburg, Germany; [Eglen, Stephen J.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge Computat Biol Inst, Cambridge CB3 9EW, England; [Keil, Wolfgang] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Max Planck Society; University of Gottingen; University of Wurzburg; University of Cambridge; Rockefeller University	Keil, W (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	wkeil@mail.rockefeller.edu	Eglen, Stephen/AAF-9008-2020; Wolf, Fred/D-5771-2011	Eglen, Stephen/0000-0001-8607-8025; Wolf, Fred/0000-0002-7068-3762; Schottdorf, Manuel/0000-0002-5468-4255	HFSP; BMBF; DFG; MPG [SFB 889, BFL 01GQ0921, 01GQ0922, BCCN 01GQ0430, 01GQ1005B, 01GQ07113, BFNT 01GQ0811]; National Science Foundation [PHY05-51164]; Wellcome Trust [083205/B/07/Z]	HFSP(Human Frontier Science Program); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); MPG(Max Planck Society); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome Trust)	This work was supported by the HFSP (http://www.hfsp.org), BMBF (http://www.bmbf.de), DFG (http://www.dfg.de), and the MPG (http://www.mpg.de); Grant numbers SFB 889, BFL 01GQ0921, 01GQ0922, BCCN 01GQ0430, 01GQ1005B, 01GQ07113 and BFNT 01GQ0811. This work was supported in part by the National Science Foundation (http://www.nsf.gov), grant number PHY05-51164. SJE was supported by a Wellcome Trust program grant (083205/B/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Amidror I, 2009, COMPUT IMAGING VIS, V38, P1; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Buzas P, 1998, BRAIN RES PROTOC, V3, P199, DOI 10.1016/S1385-299X(98)00041-5; Chapman B, 1996, J NEUROSCI, V16, P6443; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DIGGLE PJ, 1986, J NEUROSCI METH, V18, P115, DOI 10.1016/0165-0270(86)90115-9; DJAVADIAN RL, 1983, ACTA NEUROBIOL EXP, V43, P251; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Eglen SJ, 2005, VISUAL NEUROSCI, V22, P859, DOI 10.1017/S0952523805226147; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Giacomantonio CE, 2007, J NEUROSCI, V27, P4935, DOI 10.1523/JNEUROSCI.1261-06.2007; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hore VRA, 2012, VISUAL NEUROSCI, V29, P283, DOI 10.1017/S0952523812000338; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kaschube M, 2002, J NEUROSCI, V22, P7206; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kaschube M, 2009, P NATL ACAD SCI USA, V106, P17205, DOI 10.1073/pnas.0901615106; Keil W, 2011, NEURAL SYSTEMS CIRCU, V1, P1, DOI DOI 10.1186/2042-1001-1-17; Keil W, 2012, SCIENCE, V336, DOI 10.1126/science.1206416; Keil W, 2010, P NATL ACAD SCI USA, V107, P12293, DOI 10.1073/pnas.0913020107; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Paik SB, 2012, SOC NEUR ANN M; Paik SB, 2012, P NATL ACAD SCI USA, V109, P7091, DOI 10.1073/pnas.1118926109; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; Rathjen S, 2003, EXP BRAIN RES, V149, P151, DOI 10.1007/s00221-002-1342-z; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Schnabel M, 2007, EUR PHYS J-SPEC TOP, V145, P137, DOI 10.1140/epjst/e2007-00152-5; Shmuel A, 2000, P NATL ACAD SCI USA, V97, P5568, DOI 10.1073/pnas.97.10.5568; SOODAK RE, 1986, P NATL ACAD SCI USA, V83, P9259, DOI 10.1073/pnas.83.23.9259; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; SWINDALE NV, 1982, PROC R SOC SER B-BIO, V215, P211, DOI 10.1098/rspb.1982.0038; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; von der Malsburg C, 1973, Kybernetik, V14, P85; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Wolf F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208701; Wolf F, 2003, J PHYSIOL-PARIS, V97, P253, DOI 10.1016/j.jphysparis.2003.09.018; Yousef T, 1999, EUR J NEUROSCI, V11, P4291, DOI 10.1046/j.1460-9568.1999.00863.x; Zhan XJ, 2000, VISUAL NEUROSCI, V17, P23, DOI 10.1017/S0952523800171032	56	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86139	10.1371/journal.pone.0086139	http://dx.doi.org/10.1371/journal.pone.0086139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475081	Green Submitted, gold, Green Published			2022-12-27	WOS:000330339800030
J	Slabbert, E; Jacobs, SM; Jacobs, K				Slabbert, Etienne; Jacobs, Shayne Martin; Jacobs, Karin			The Soil Bacterial Communities of South African Fynbos Riparian Ecosystems Invaded by Australian Acacia Species	PLOS ONE			English	Article							MICROBIAL DIVERSITY; ALIEN PLANTS; MANAGEMENT; VEGETATION; SALIGNA; NITRATE; GENERA; ZONES; SETS	Riparian ecosystem along rivers and streams are characterised by lateral and longitudinal ecological gradients and, as a result, harbour unique biodiversity. Riparian ecosystems in the fynbos of the Western Cape, South Africa, are characterised by seasonal dynamics, with summer droughts followed by high flows during winter. The unique hydrology and geomorphology of riparian ecosystems play an important role in shaping these ecosystems. The riparian vegetation in the Western Cape has, however, largely been degraded due to the invasion of non-indigenous plants, in particular Acacia mearnsii, A. saligna and A. dealbata. This study investigated the effect of hydrology and invasion on the bacterial communities associated with fynbos riparian ecosystems. Bacterial communities were characterised with automated ribosomal intergenic spacer analysis (ARISA) and 454 16S rDNA pyrosequencing. Chemical and physical properties of soil within sites were also determined and correlated with community data. Sectioning across the lateral zones revealed significant differences in community composition, and the specific bacterial taxa influenced. Results also showed that the bacterial community structure could be linked to Acacia invasion. The presence of invasive Acacia was correlated with specific bacterial phyla. However, high similarity between cleared and pristine sites suggests that the effect of Acacia on the soil bacterial community structure may not be permanent. This study demonstrates how soil bacterial communities are influenced by hydrological gradients associated with riparian ecosystems and the impact of Acacia invasion on these communities.	[Slabbert, Etienne; Jacobs, Karin] Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, Western Cape, South Africa; [Jacobs, Shayne Martin] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Jacobs, K (corresponding author), Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, Western Cape, South Africa.	kj@sun.ac.za		Jacobs, Karin/0000-0003-3972-5343	South African Water Research Commission (WRC); National Research Foundation (NRF)	South African Water Research Commission (WRC); National Research Foundation (NRF)	This research was supported by the South African Water Research Commission (WRC) and the National Research Foundation (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], [No title captured]; Ardley JK, 2010, 9 EUR NITR FIX C 6 1; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Boucher C, 2002, ENV FLOWS 2002; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Brinson Mark M., 1999, P265, DOI 10.1017/CBO9780511613029.010; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crow TR, 2000, RIPARIAN MANAGEMENT IN FORESTS OF THE CONTINENTAL EASTERN UNITED STATES, P43; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Decamps H, 2004, POL J ECOL, V52, P3; Dedysh SN, 1998, APPL ENVIRON MICROB, V64, P922; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esler KJ, 2008, S AFR J BOT, V74, P397, DOI 10.1016/j.sajb.2008.01.168; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferreira LV, 1999, OECOLOGIA, V120, P582, DOI 10.1007/s004420050893; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Holmes PM, 1997, J APPL ECOL, V34, P317, DOI 10.2307/2404879; Holmes PM, 2005, S AFR J SCI, V101, P553; Holmes PM, 1999, RESTOR ECOL, V7, P215, DOI 10.1046/j.1526-100X.1999.72015.x; IMHOFF JF, 1984, INT J SYST BACTERIOL, V34, P340, DOI 10.1099/00207713-34-3-340; Jiang L, 2008, ECOLOGY, V89, P1931, DOI 10.1890/07-1263.1; Johnson DB, 2009, ADV MICROB PHYSIOL, V54, P201, DOI 10.1016/S0065-2911(08)00003-9; Joubert C, 2003, THESIS U PRETORIA PR; Keeney D.R, 1982, AGRON MONOGR, P643; Krause S, 2013, FEMS MICROBIOLOGY EC, V1, P1; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Legendre P., 2012, NUMERICAL ECOLOGY; Li T, 2002, J ECONOMETRICS, V110, P1, DOI 10.1016/S0304-4076(02)00120-3; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lorenzo P, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009082; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MCDONALD IR, 1995, APPL ENVIRON MICROB, V61, P116, DOI 10.1128/AEM.61.1.116-121.1995; Morris TL, 2011, DIVERS DISTRIB, V17, P898, DOI 10.1111/j.1472-4642.2011.00802.x; MUCINA L., 2006, STRUCTURIST, P617; Muller AK, 2002, MICROB ECOL, V44, P49, DOI 10.1007/s00248-001-0042-8; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1990, MAN BIOSPH, V4, P295; Ranalli AJ, 2010, J HYDROL, V389, P406, DOI 10.1016/j.jhydrol.2010.05.045; Ranjard L, 2000, RES MICROBIOL, V151, P167, DOI 10.1016/S0923-2508(00)00136-4; Reinecke MK, 2007, NATURE INVASION RIPA; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Roberts DW., 2012, LABDSV ORDINATION MU; Rodriguez-Echeverria S, 2011, DIVERS DISTRIB, V17, P946, DOI 10.1111/j.1472-4642.2011.00787.x; Rowntree KM, 2001, ASSESSING ECOLOGICAL; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sieben EJJ, 2009, J VEG SCI, V20, P17, DOI 10.1111/j.1654-1103.2009.03989.x; Slabbert E, 2010, MOL ECOL, V19, P1031, DOI 10.1111/j.1365-294X.2009.04517.x; Wang JJ, 2013, ISME J, V7, P1310, DOI 10.1038/ismej.2013.30; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; Yelenik SG, 2004, RESTOR ECOL, V12, P44, DOI 10.1111/j.1061-2971.2004.00289.x; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	62	26	28	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86560	10.1371/journal.pone.0086560	http://dx.doi.org/10.1371/journal.pone.0086560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475145	Green Published, gold			2022-12-27	WOS:000330339800053
J	Kim, BJ; Scott, DA				Kim, Bum Jun; Scott, Daryl A.			Mouse Model Reveals the Role of RERE in Cerebellar Foliation and the Migration and Maturation of Purkinje Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE; GENETIC-REGULATION; MICE LACKING; EXPRESSION; PATTERN; COMPLEXITY; PROTEINS; SYSTEM; GROWTH; MATH1	Nuclear receptors and their coregulators play a critical role in brain development by regulating the spatiotemporal expression of their target genes. The arginine-glutamic acid dipeptide repeats gene (Rere) encodes a nuclear receptor coregulator previously known as Atrophin 2. In the developing cerebellum, RERE is expressed in the molecular layer, the Purkinje cell layer and the granule cell layer but not in granule cell precursors. To study RERE's role in cerebellar development, we used RERE-deficient embryos bearing a null allele (om) and a hypomorphic allele (eyes3) of Rere (Rere(om/eyes3)). In contrast to wild-type embryos, formation of the principal fissures in these RERE-deficient embryos was delayed and the proliferative activity of granule cell precursors (GCPs) was reduced at E18.5. This reduction in proliferation was accompanied by a decrease in the expression of sonic hedgehog (SHH), which is secreted from Purkinje cells and is required for normal GCP proliferation. The maturation and migration of Purkinje cells in Rere(om/eyes3) embryos was also delayed with decreased numbers of post-migratory Purkinje cells in the cerebellum. During the postnatal period, RERE depletion caused incomplete division of lobules I/II and III due to truncated development of the precentral fissure in the cerebellar vermis, abnormal development of lobule crus I and lobule crus II in the cerebellar hemispheres due to attenuation of the intercrural fissure, and decreased levels of Purkinje cell dendritic branching. We conclude that RERE-deficiency leads to delayed development of the principal fissures and delayed maturation and migration of Purkinje cells during prenatal cerebellar development and abnormal cerebellar foliation and Purkinje cell maturation during postnatal cerebellar development.	[Kim, Bum Jun; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu			Carloine Wiess Law Fund for Molecular Medicine	Carloine Wiess Law Fund for Molecular Medicine	This research was funded, in part, by the Carloine Wiess Law Fund for Molecular Medicine. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 1997, DEV CEREBELLAR SYSTE; Armstrong CL, 2000, BIOCHEM CELL BIOL, V78, P551, DOI 10.1139/bcb-78-5-551; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; Jensen P, 2002, J NEUROSCI, V22, P8110; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Kim BJ, 2009, DEV BIOL, V326, P378, DOI 10.1016/j.ydbio.2008.11.001; LARSELL O, 1952, J COMP NEUROL, V97, P281, DOI 10.1002/cne.900970204; Larsell O., 1970, COMP ANATOMY HISTOLO; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Ma S, 2012, J NEUROSCI, V32, P14979, DOI 10.1523/JNEUROSCI.1282-12.2012; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; McNeill EM, 2011, DEV BIOL, V353, P331, DOI 10.1016/j.ydbio.2011.03.008; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Millen KJ, 1995, DEVELOPMENT, V121, P3935; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Qin J, 2007, DEV DYNAM, V236, P810, DOI 10.1002/dvdy.21060; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Ullmann JFP, 2012, NEUROIMAGE, V62, P1408, DOI 10.1016/j.neuroimage.2012.05.061; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Vogel MW, 1996, DEV BRAIN RES, V96, P210; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WELKER WI, 1990, ARCH ITAL BIOL, V128, P87; Yamamoto M, 1999, MECH DEVELOP, V84, P143, DOI 10.1016/S0925-4773(99)00054-4; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; Young KA, 2002, BEHAV BRAIN RES, V132, P145, DOI 10.1016/S0166-4328(01)00413-2; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	44	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87518	10.1371/journal.pone.0087518	http://dx.doi.org/10.1371/journal.pone.0087518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466353	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000209
J	Burillo, A; Rodriguez-Sanchez, B; Ramiro, A; Cercenado, E; Rodriguez-Creixems, M; Bouza, E				Burillo, Almudena; Rodriguez-Sanchez, Belen; Ramiro, Ana; Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio			Gram-Stain Plus MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) for a Rapid Diagnosis of Urinary Tract Infection	PLOS ONE			English	Article							DIRECT IDENTIFICATION; BLOOD CULTURES; BACTERIA; SAMPLES; IMPACT; TESTS; EPIDEMIOLOGY; MICROSCOPY; PATHOGENS; ASSAY	Microbiological confirmation of a urinary tract infection (UTI) takes 24-48 h. In the meantime, patients are usually given empirical antibiotics, sometimes inappropriately. We assessed the feasibility of sequentially performing a Gram stain and MALDI-TOF MS mass spectrometry (MS) on urine samples to anticipate clinically useful information. In May-June 2012, we randomly selected 1000 urine samples from patients with suspected UTI. All were Gram stained and those yielding bacteria of a single morphotype were processed for MALDI-TOF MS. Our sequential algorithm was correlated with the standard semiquantitative urine culture result as follows: Match, the information provided was anticipative of culture result; Minor error, the information provided was partially anticipative of culture result; Major error, the information provided was incorrect, potentially leading to inappropriate changes in antimicrobial therapy. A positive culture was obtained in 242/1000 samples. The Gram stain revealed a single morphotype in 207 samples, which were subjected to MALDI-TOF MS. The diagnostic performance of the Gram stain was: sensitivity (Se) 81.3%, specificity (Sp) 93.2%, positive predictive value (PPV) 81.3%, negative predictive value (NPV) 93.2%, positive likelihood ratio (+LR) 11.91, negative likelihood ratio (-LR) 0.20 and accuracy 90.0% while that of MALDI-TOF MS was: Se 79.2%, Sp 73.5, +LR 2.99, -LR 0.28 and accuracy 78.3%. The use of both techniques provided information anticipative of the culture result in 82.7% of cases, information with minor errors in 13.4% and information with major errors in 3.9%. Results were available within 1 h. Our serial algorithm provided information that was consistent or showed minor errors for 96.1% of urine samples from patients with suspected UTI. The clinical impacts of this rapid UTI diagnosis strategy need to be assessed through indicators of adequacy of treatment such as a reduced time to appropriate empirical treatment or earlier withdrawal of unnecessary antibiotics.	[Burillo, Almudena; Rodriguez-Sanchez, Belen; Ramiro, Ana; Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain; [Burillo, Almudena; Cercenado, Emilia; Bouza, Emilio] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio] Red Espanola Invest Patol Infecciosa REIPI RD06 0, Seville, Spain; [Rodriguez-Sanchez, Belen; Cercenado, Emilia; Rodriguez-Creixems, Marta; Bouza, Emilio] CIBER Enfermedades Resp CIBERES CB06 06 0058, Palma De Mallorca, Islas Baleares, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Burillo, A (corresponding author), Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	burilloa@arrakis.es	Rodríguez-Sánchez, Belén/AAF-4046-2021; Bouza, Emilio/D-8661-2014; Rodriguez-Sanchez, Belen/AAQ-8542-2021	Bouza, Emilio/0000-0001-6967-9267; Rodriguez-Sanchez, Belen/0000-0002-9625-427X; Burillo, Almudena/0000-0003-2545-4204				Bjornholt JV, 2011, CLIN MICROBIOL INFEC, V17, pS66; Bouza E, 2001, CLIN MICROBIOL INFEC, V7, P523, DOI 10.1046/j.1198-743x.2001.00326.x; Bronnestam R, 1999, APMIS, V107, P437, DOI 10.1111/j.1699-0463.1999.tb01578.x; Cheng JW, 2013, AJMR AM J MICROBIOLO, P71; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Clarridge JE, 1998, CUMITECH 2B LAB DIAG; Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204; CROUT FV, 1984, DIAGN MICR INFEC DIS, V2, P179, DOI 10.1016/0732-8893(84)90028-2; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P1007, DOI 10.1111/j.1469-0691.2010.03339.x; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; GOULDEN B. E., 1968, N Z VET J, V16, P1, DOI 10.1080/00480169.1968.33737; Hartley S, 2013, INFECT CONT HOSP EP, V34, P1204, DOI 10.1086/673449; Ho YP, 2011, MASS SPECTROM REV, V30, P1203, DOI 10.1002/mas.20320; Hoyos-Mallecot Y, 2013, ENFERM INFEC MICR CL, V31, P152, DOI 10.1016/j.eimc.2012.09.003; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Johnson H, 2011, J CLIN MICROBIOL, V49, P4031, DOI 10.1128/JCM.05447-11; JORGENSEN JH, 1975, AM J CLIN PATHOL, V63, P142; KALLENIUS G, 1981, CHEMOTHERAPY, V27, P99, DOI 10.1159/000237963; Kohling HL, 2012, J MED MICROBIOL, V61, P339, DOI 10.1099/jmm.0.032284-0; Kuijper EJ, 2003, EUR J CLIN MICROBIOL, V22, P228, DOI 10.1007/s10096-003-0892-8; Kulkarni S, 2013, CLIN BIOCHEM, DOI [10.1016/j.clinbiochem.2013.09.010, DOI 10.1016/J.CLINBI0CHEM.2013.09.010]; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; LEWIS JF, 1976, J CLIN MICROBIOL, V4, P372; Loonen AJM, 2012, EUR J CLIN MICROBIOL, V31, P1575, DOI 10.1007/s10096-011-1480-y; McIsaac WJ, 2011, MED DECIS MAKING, V31, P405, DOI 10.1177/0272989X10391671; Pezzlo M, 2010, CLIN PROCEDURES HDB, V3.12.11-13.12.31; ROBINS DG, 1975, LANCET, V1, P476; Rodriguez-Sanchez B, 2012, INT C ANT AG CHEM SA; Rodriguez-Sanchez B, 2013, CLIN MICROBIOL INFEC; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; St John A, 2006, AM J CLIN PATHOL, V126, P428, DOI 10.1309/C69RW1BT7E4QAFPV; STANECK J L, 1985, Diagnostic Microbiology and Infectious Disease, V3, p51S, DOI 10.1016/0732-8893(85)90053-7; Sundqvist M, 2009, J ANTIMICROB CHEMOTH, V64, P227, DOI 10.1093/jac/dkp181; TILTON RE, 1980, J CLIN MICROBIOL, V11, P157, DOI 10.1128/JCM.11.2.157-161.1980; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Wang XH, 2013, J MICROBIOL METH, V92, P231, DOI 10.1016/j.mimet.2012.12.016; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; Wiwanitkit V, 2005, UROL RES, V33, P220, DOI 10.1007/s00240-004-0457-z	45	50	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86915	10.1371/journal.pone.0086915	http://dx.doi.org/10.1371/journal.pone.0086915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466289	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100232
J	Shalwala, M; Zhu, SG; Das, A; Salloum, FN; Xi, L; Kukreja, RC				Shalwala, Mona; Zhu, Shu-Guang; Das, Anindita; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.			Sirtuin 1 (SIRT1) Activation Mediates Sildenafil Induced Delayed Cardioprotection against Ischemia-Reperfusion Injury in Mice	PLOS ONE			English	Article							CARDIAC MYOCYTES; POTENTIAL ROLE; CELL-DEATH; LIFE-SPAN; RESVERATROL; HEART; RESTRICTION; DEACETYLASE; INHIBITION; MECHANISM	Background: It has been well documented that phosphodiesterase-5 inhibitor, sildenafil (SIL) protects against myocardial ischemia/reperfusion (I-R) injury. SIRT1 is part of the class III Sirtuin family of histone deacetylases that deacetylates proteins involved in cellular stress response including those related to I-R injury. Objective/Hypothesis: We tested the hypothesis that SIL-induced cardioprotection may be mediated through activation of SIRT1. Methods: Adult male ICR mice were treated with SIL (0.7 mg/kg, i.p.), Resveratrol (RSV, 5 mg/kg, a putative activator of SIRT1 used as the positive control), or saline (0.2 mL). The hearts were harvested 24 hours later and homogenized for SIRT1 activity analysis. Results: Both SIL- and RSV-treated mice had increased cardiac SIRT1 activity (P<0.001) as compared to the saline-treated controls 24 hours after drug treatment. In isolated ventricular cardiomyocytes, pretreatment with SIL (1 mu M) or RSV (1 mu M) for one hour in vitro also upregulated SIRT1 activity (P<0.05). We further examined the causative relationship between SIRT1 activation and SIL-induced late cardioprotection. Pretreatment with SIL (or RSV) 24 hours prior to 30 min ischemia and 24 hours of reperfusion significantly reduced infarct size, which was associated with a significant increase in SIRT1 activity (P<0.05). Moreover, sirtinol (a SIRT1 inhibitor, 5 mg/kg, i.p.) given 30 min before I-R blunted the infarct-limiting effect of SIL and RSV (P<0.001). Conclusion: Our study shows that activation of SIRT1 following SIL treatment plays an essential role in mediating the SIL-induced cardioprotection against I-R injury. This newly identified SIRT1-activating property of SIL may have enormous therapeutic implications.	[Shalwala, Mona; Zhu, Shu-Guang; Das, Anindita; Salloum, Fadi N.; Xi, Lei; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, VCU Pauley Heart Ctr, Richmond, VA 23284 USA; [Shalwala, Mona] Touro Coll Osteopath Med, New York, NY USA; [Zhu, Shu-Guang] Guangdong Pharmaceut Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Virginia Commonwealth University; Guangdong Pharmaceutical University	Kukreja, RC (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, VCU Pauley Heart Ctr, Richmond, VA 23284 USA.	rakesh@vcu.edu	Salloum, Fadi N/C-2391-2008; Xi, Lei/A-3078-2008; Das, Anindita/K-8003-2013	Salloum, Fadi N/0000-0002-8947-9315; Xi, Lei/0000-0002-7569-3329; Das, Anindita/0000-0003-4422-7277	National Institutes of Health [HL51045, HL79424, HL118808]; American Heart Association [10SDG3770011, 0530157N, 0765273U]; Health Ministry of Guangdong Province, China [A2013320]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051045, R01HL051045, R01HL079424, R01HL118808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Health Ministry of Guangdong Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by research grants from the National Institutes of Health (HL51045, HL79424, HL118808 to Dr. R. C. Kukreja) and from the American Heart Association (National Scientist Development Grants 10SDG3770011 to Dr. F.N. Salloum and 0530157N to Dr. L. Xi; Mid-Atlantic Beginning Grant-in-Aid 0765273U to Dr. A. Das) and from the Health Ministry of Guangdong Province, China (Medical Research Grant A2013320 to Dr. S. G. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Bradamante S, 2000, INT J TISSUE REACT, V22, P1; Bradamante S, 2003, EUR J PHARMACOL, V465, P115, DOI 10.1016/S0014-2999(03)01441-9; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; Nadtochiy SM, 2011, AM J PHYSIOL-HEART C, V301, pH1506, DOI 10.1152/ajpheart.00587.2011; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Paffett ML, 2012, VASC PHARMACOL, V56, P64, DOI 10.1016/j.vph.2011.11.002; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pillarisetti Sivaram, 2008, Recent Pat Cardiovasc Drug Discov, V3, P156, DOI 10.2174/157489008786263989; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Shalwala M, 2010, CIRCULATION, V122; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Zhu SG, 2012, J CELL MOL MED, V16, P950, DOI 10.1111/j.1582-4934.2011.01376.x	23	46	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86977	10.1371/journal.pone.0086977	http://dx.doi.org/10.1371/journal.pone.0086977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466304	Green Published, gold			2022-12-27	WOS:000330283100239
J	Pimenova, AA; Thathiah, A; De Strooper, B; Tesseur, I				Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina			Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling	PLOS ONE			English	Article							5-HT4 RECEPTOR; ALPHA-SECRETASE; ADENYLATE-CYCLASE; KINASE CK2; ALZHEIMERS-DISEASE; C ISOZYMES; IN-VITRO; BETA; ACTIVATION; CELLS	Proteolytic processing of the amyloid precursor protein (APP) by the beta- and gamma-secretases releases the amyloid-beta peptide (A beta), which deposits in senile plaques and contributes to the etiology of Alzheimer's disease (AD). The alpha-secretase cleaves APP in the A beta peptide sequence to generate soluble APP alpha (sAPP alpha). Upregulation of alpha-secretase activity through the 5-hydroxytryptamine 4 (5-HT4) receptor has been shown to reduce A beta production, amyloid plaque load and to improve cognitive impairment in transgenic mouse models of AD. Consequently, activation of 5-HT4 receptors following agonist stimulation is considered to be a therapeutic strategy for AD treatment; however, the signaling cascade involved in 5-HT4 receptor-stimulated proteolysis of APP remains to be determined. Here we used chemical and siRNA inhibition to identify the proteins which mediate 5-HT4d receptor-stimulated alpha-secretase activity in the SH-SY5Y human neuronal cell line. We show that G protein and Src dependent activation of phospholipase C are required for alpha-secretase activity, while, unexpectedly, adenylyl cyclase and cAMP are not involved. Further elucidation of the signaling pathway indicates that inositol triphosphate phosphorylation and casein kinase 2 activation is also a prerequisite for alpha-secretase activity. Our findings provide a novel route to explore the treatment of AD through 5-HT4 receptor-induced alpha-secretase activation.	[Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina] Leuven Res Inst Neurosci & Dis LIND, Louvain, Belgium; [Pimenova, Anna A.; Thathiah, Amantha; De Strooper, Bart; Tesseur, Ina] VIB Ctr Biol Dis, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be; ina.tesseur@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Pimenova, Anna/0000-0003-3342-8778	Fund for Scientific Research Flanders, KU Leuven, Federal Office for Scientific Affairs [IAP P7/16]; Flemish Government, VIB, IWT	Fund for Scientific Research Flanders, KU Leuven, Federal Office for Scientific Affairs; Flemish Government, VIB, IWT	This work was supported by the Fund for Scientific Research Flanders, KU Leuven, Federal Office for Scientific Affairs (IAP P7/16), a Methusalem grant of the Flemish Government, VIB, IWT. BDS is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Ansanay H, 1996, EUR J PHARMACOL, V298, P165, DOI 10.1016/0014-2999(95)00786-5; Bandyopadhyay S, 2007, CURR MED CHEM, V14, P2848, DOI 10.2174/092986707782360060; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bockaert J, 2008, NEUROPHARMACOLOGY, V55, P922, DOI 10.1016/j.neuropharm.2008.05.013; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cachard-Chastel M, 2007, BRIT J PHARMACOL, V150, P883, DOI 10.1038/sj.bjp.0707178; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; Cho S, 2007, EXP NEUROL, V203, P274, DOI 10.1016/j.expneurol.2006.07.021; Cochet M, 2013, ACS CHEM NEUROSCI, V4, P130, DOI 10.1021/cn300095t; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; CONSOLO S, 1994, NEUROREPORT, V5, P1230, DOI 10.1097/00001756-199406020-00018; Contesse V, 1996, MOL PHARMACOL, V49, P481; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; Farlow MR, 2007, AM J MED, V120, P388, DOI 10.1016/j.amjmed.2006.08.036; GALARDY RE, 1994, ANN NY ACAD SCI, V732, P315, DOI 10.1111/j.1749-6632.1994.tb24746.x; Gao YS, 2002, EUR J PHARMACOL, V436, P227, DOI 10.1016/S0014-2999(02)01261-X; Gao Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702106200; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hashimoto G, 2012, J ALZHEIMERS DIS, V32, P437, DOI 10.3233/JAD-2012-111235; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; JACOBSON PB, 1995, J PHARMACOL EXP THER, V275, P995; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; JOLLES J, 1992, J NEUROCHEM, V58, P2326, DOI 10.1111/j.1471-4159.1992.tb10981.x; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; LeBlanc AC, 1998, J NEUROSCI, V18, P2907; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; LEGRAND AB, 1990, BIOCHEM PHARMACOL, V40, P1103, DOI 10.1016/0006-2952(90)90499-B; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lenzken SC, 2010, J ALZHEIMERS DIS, V20, P1133, DOI 10.3233/JAD-2010-090232; Lezoualc'h F, 2003, EXP GERONTOL, V38, P159, DOI 10.1016/S0531-5565(02)00157-2; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Lumbreras M, 2006, AMINO ACIDS, V31, P449, DOI 10.1007/s00726-005-0272-z; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Marambaud P, 1999, BRIT J PHARMACOL, V126, P1186, DOI 10.1038/sj.bjp.0702406; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matsumoto M, 2001, J PHARMACOL EXP THER, V296, P676; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Micale V, 2006, BRAIN RES, V1121, P207, DOI 10.1016/j.brainres.2006.08.108; MILLIGAN G, 1989, BIOCHEM J, V262, P643, DOI 10.1042/bj2620643; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; ONODA JM, 1987, BIOCHEM PHARMACOL, V36, P1907, DOI 10.1016/0006-2952(87)90487-4; OUADID H, 1991, J MOL CELL CARDIOL, V23, P41, DOI 10.1016/0022-2828(91)90037-M; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Robert S, 2005, FEBS LETT, V579, P1136, DOI 10.1016/j.febslet.2005.01.010; Robert SJ, 2001, J BIOL CHEM, V276, P44881, DOI 10.1074/jbc.M109008200; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Shen F, 2011, NEUROPHARMACOLOGY, V61, P69, DOI 10.1016/j.neuropharm.2011.02.026; SHEN KF, 1990, BRAIN RES, V531, P1, DOI 10.1016/0006-8993(90)90751-V; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Solyakov L, 2004, J BIOL CHEM, V279, P43403, DOI 10.1074/jbc.M403239200; Spencer JP, 2004, NEUROSCIENCE, V129, P49, DOI 10.1016/j.neuroscience.2004.06.070; Tesseur I, 2013, NEUROBIOL AGING, V34, P1779, DOI 10.1016/j.neurobiolaging.2013.01.020; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; TSCHAIKOWSKY K, 1994, BRIT J PHARMACOL, V113, P664, DOI 10.1111/j.1476-5381.1994.tb17043.x; VandenWyngaert I, 1997, J NEUROCHEM, V69, P1810; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Zien P, 2005, BBA-PROTEINS PROTEOM, V1754, P271, DOI 10.1016/j.bbapap.2005.07.039	85	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87014	10.1371/journal.pone.0087014	http://dx.doi.org/10.1371/journal.pone.0087014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466315	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500288
J	Ba, HJ; Chen, HS; Su, Z; Du, ML; Chen, QL; Li, YH; Ma, HM				Ba, Hong-Jun; Chen, Hong-Shan; Su, Zhe; Du, Min-Lian; Chen, Qiu-Li; Li, Yan-Hong; Ma, Hua-Mei			Associations between Serum Apelin-12 Levels and Obesity-Related Markers in Chinese Children	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MESSENGER-RNA EXPRESSION; INSULIN-RESISTANCE; PLASMA APELIN; ENDOGENOUS LIGAND; RISK; APJ; TRIGLYCERIDES; ADOLESCENTS; LIPOLYSIS	Objective: To investigate possible correlations between apelin-12 levels and obesity in children in China and associations between apelin-12 and obesity-related markers, including lipids, insulin sensitivity and insulin resistance index (HOMA-IR). Methods: Forty-eight obese and forty non-obese age-and gender-matched Chinese children were enrolled between June 2008 and June 2009. Mean age was 10.42 +/- 2.03 and 10.86 +/- 2.23 years in obesity and control groups, respectively. Main outcome measures were apelin-12, BMI, lipids, glucose and insulin. HOMA-IR was calculated for all subjects. Results: All obesity group subjects had significantly higher total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), insulin levels and HOMA-IR (all P<0.05). In separate analyses, obese girls had significantly higher LDL-C, insulin and HOMA-IR than controls, and obese boys had significantly higher TC, TG, insulin and HOMA-IR than controls (all P<0.05). Apelin-12 levels were significantly higher in obese girls compared to controls (P = 0.024), and correlated positively with TG in all obese subjects. Among obese girls, apelin-12 levels correlated positively with TG, insulin and HOMA-IR after adjusting for age and BMI. In all boys (obese and controls) apelin-12 was positively associated with fasting plasma glucose (FPG). No significant correlations were found in either group between apelin-12 levels and other characteristics after adjusting for age, sex, and BMI. Conclusions: Apelin-12 levels are significantly higher in obese vs. non-obese girls in China and correlate significantly with obesity-related markers insulin, HOMA-IR, and TG. Increased apelin-12 levels may be involved in the pathological mechanism of childhood obesity.	[Ba, Hong-Jun; Chen, Hong-Shan; Su, Zhe; Du, Min-Lian; Chen, Qiu-Li; Li, Yan-Hong; Ma, Hua-Mei] Sun Yat Sen Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, HS (corresponding author), Sun Yat Sen Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	hongshand@163.com	li, yan/GTI-4638-2022		Technology Program of Guangdong Province in China [2007B031500006]	Technology Program of Guangdong Province in China	This study was supported by Grant 2007B031500006 from the Technology Program of Guangdong Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslanian S, 2002, HORM RES, V57, P19, DOI 10.1159/000053308; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Caprio S, 2001, PEDIAT ENDOCRINO S1, P487; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Cekmez F, 2011, EUR CYTOKINE NETW, V22, P32, DOI 10.1684/ecn.2011.0279; Cheng-ye JI, 2010, CHIN J SCH HLTH, V31, P257; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Erdem G, 2008, EXP CLIN ENDOCR DIAB, V116, P289, DOI 10.1055/s-2007-1004564; Goazigo ARL, 2007, AM J PHYSIOL-ENDOC M, V292, pE7, DOI 10.1152/ajpendo.00521.2005; Heinonen MV, 2005, REGUL PEPTIDES, V130, P7, DOI 10.1016/j.regpep.2005.05.003; Heinonen MV, 2009, NUTR METABOLISM CARD; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Kralisch S, 2007, REGUL PEPTIDES, V139, P84, DOI 10.1016/j.regpep.2006.10.009; Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270; Li L, 2006, EXP CLIN ENDOCR DIAB, V114, P544, DOI 10.1055/s-2006-948309; Liu WJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-780; Love-Osborne K, 2006, PEDIATR DIABETES, V7, P205, DOI 10.1111/j.1399-5448.2006.00179.x; Machura E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/760691; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Mesmin C, 2011, J PROTEOME RES, V10, P5222, DOI 10.1021/pr200725x; Pietrobelli A, 2008, ANGIOLOGY S2, P30; Rashid Mitchell N, 2003, Prev Cardiol, V6, P42, DOI 10.1111/j.1520-037X.2003.01358.x; Reinehr T, 2011, METABOLISM, V60, P1349, DOI 10.1016/j.metabol.2011.02.005; Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Taheri S, 2002, BIOCHEM BIOPH RES CO, V291, P1208, DOI 10.1006/bbrc.2002.6575; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; Tapan S, 2010, J PEDIATR ENDOCR MET, V23, P1039, DOI 10.1515/jpem.2010.165; Tasci I, 2007, EXP CLIN ENDOCR DIAB, V115, P428, DOI 10.1055/s-2007-971067; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Ten S, 2004, J CLIN ENDOCR METAB, V89, P2526, DOI 10.1210/jc.2004-0276; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Wei L, 2005, REGUL PEPTIDES, V132, P27, DOI 10.1016/j.regpep.2005.08.003; Weiss R, 2008, DIABETES CARE, V31, pS310, DOI 10.2337/dc08-s273; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Zannolli R, 1996, ACTA PAEDIATR, V85, P1368, DOI 10.1111/j.1651-2227.1996.tb13928.x	40	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86577	10.1371/journal.pone.0086577	http://dx.doi.org/10.1371/journal.pone.0086577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475149	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300085
J	Bae, EH; Choi, HS; Joo, SY; Kim, IJ; Kim, CS; Choi, JS; Ma, SK; Lee, J; Kim, SW				Bae, Eun Hui; Choi, Hong Sang; Joo, Soo Yeon; Kim, In Jin; Kim, Chang Seong; Choi, Joon Seok; Ma, Seong Kwon; Lee, JongUn; Kim, Soo Wan			Farnesoid X Receptor Ligand Prevents Cisplatin-Induced Kidney Injury by Enhancing Small Heterodimer Partner	PLOS ONE			English	Article							RENAL INTERSTITIAL FIBROSIS; NUCLEAR RECEPTOR; TERMINAL KINASE; CELL APOPTOSIS; KAPPA-B; ACID; RATS; IDENTIFICATION; INFLAMMATION; INHIBITION	The farnesoid X receptor (FXR) is mainly expressed in liver, intestine and kidney. We investigated whether 6-ethyl chenodeoxycholic acid (6ECDCA), a semisynthetic derivative of chenodeoxycholic aicd (CDCA, an FXR ligand), protects against kidney injury and modulates small heterodimer partner (SHP) in cisplatin-induced kidney injury. Cisplatin inhibited SHP protein expression in the kidney of cisplatin-treated mice and human proximal tubular (HK2) cells; this effect was counteracted by FXR ligand. Hematoxylin and eosin staining revealed the presence of tubular casts, obstructions and dilatations in cisplatin-induced kidney injury, which was attenuated by FXR ligand. FXR ligand also attenuated protein expression of transforming growth factor-beta 1 (TGF-beta 1), Smad signaling, and the epithelial-to-mesenchymal transition process, inflammatory markers and cytokines, and apoptotic markers in cisplatin-treated mice. Cisplatin induced NF-kappa B activation in HK2 cell; this effect was attenuated by pretreatment with FXR ligand. In SHP knockdown by small interfering RNA, cisplatin-induced activation of TGF-beta 1, p-JNK and Bax/Bcl-2 ratio was not attenuated, while SHP overexpression and FXR ligand inhibited expression of these proteins in cisplatin-pretreated HK2 cells. In conclusion, FXR ligand, 6ECDCA prevents cisplatin-induced kidney injury, the underlying mechanism of which may be associated with anti-fibrotic, anti-inflammatory, and anti-apoptotic effects through SHP induction.	[Bae, Eun Hui; Choi, Hong Sang; Kim, Chang Seong; Choi, Joon Seok; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ Med Sch, Dept Internal Med, Kwangju, South Korea; [Joo, Soo Yeon; Kim, In Jin; Lee, JongUn] Chonnam Natl Univ Med Sch, Dept Physiol, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ Med Sch, Dept Internal Med, Kwangju, South Korea.	skimw@chonnam.ac.kr			National Research Foundation of Korea (NRF) [2011-0030132]; Korea government (MSIP); Korea Research Foundation; Korean Government (MOEHRD, Basic Research Promotion Fund) [KRF-20100008732]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation, 2011-0030132) funded by the Korea government (MSIP), by Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-20100008732), and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Claudel T, 2004, EXPERT OPIN INV DRUG, V13, P1135, DOI 10.1517/13543784.13.9.1135; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Hu ZJ, 2012, KIDNEY BLOOD PRESS R, V36, P85, DOI 10.1159/000341485; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Jung GS, 2009, J AM SOC NEPHROL, V20, P2162, DOI 10.1681/ASN.2008121232; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Liu YM, 2012, J PHARMACOL EXP THER, V341, P725, DOI 10.1124/jpet.111.191247; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Park JW, 2012, EUR J PHARMACOL, V683, P301, DOI 10.1016/j.ejphar.2012.03.019; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Rinna A, 2008, AM J RESP CELL MOL, V39, P97, DOI 10.1165/rcmb.2007-0371OC; Rosenau C, 2004, J BIOMOL SCREEN, V9, P334, DOI 10.1177/1087057103261446; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamate J, 2005, TOXICOL PATHOL, V33, P207, DOI 10.1080/01926230490523978; YAMATE J, 1995, J COMP PATHOL, V112, P27, DOI 10.1016/S0021-9975(05)80087-8; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064	30	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86553	10.1371/journal.pone.0086553	http://dx.doi.org/10.1371/journal.pone.0086553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475141	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300078
J	Golberg, A; Linshiz, G; Kravets, I; Stawski, N; Hillson, NJ; Yarmush, ML; Marks, RS; Konry, T				Golberg, Alexander; Linshiz, Gregory; Kravets, Ilia; Stawski, Nina; Hillson, Nathan J.; Yarmush, Martin L.; Marks, Robert S.; Konry, Tania			Cloud-Enabled Microscopy and Droplet Microfluidic Platform for Specific Detection of Escherichia coli in Water	PLOS ONE			English	Article							DRINKING-WATER; SYSTEMS; BURDEN; DISEASES; QUALITY; AMPLIFICATION; ENUMERATION; SANITATION; BACTERIA; HYGIENE	We report an all-in-one platform - ScanDrop - for the rapid and specific capture, detection, and identification of bacteria in drinking water. The ScanDrop platform integrates droplet microfluidics, a portable imaging system, and cloud-based control software and data storage. The cloud-based control software and data storage enables robotic image acquisition, remote image processing, and rapid data sharing. These features form a "cloud'' network for water quality monitoring. We have demonstrated the capability of ScanDrop to perform water quality monitoring via the detection of an indicator coliform bacterium, Escherichia coli, in drinking water contaminated with feces. Magnetic beads conjugated with antibodies to E. coli antigen were used to selectively capture and isolate specific bacteria from water samples. The bead-captured bacteria were co-encapsulated in pico-liter droplets with fluorescently-labeled anti-E. coli antibodies, and imaged with an automated custom designed fluorescence microscope. The entire water quality diagnostic process required 8 hours from sample collection to online-accessible results compared with 2-4 days for other currently available standard detection methods.	[Golberg, Alexander; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Burns Inst, Boston, MA USA; [Linshiz, Gregory; Stawski, Nina; Hillson, Nathan J.] Joint BioEnergy Inst, Fuels Synth Div, Emeryville, CA USA; [Linshiz, Gregory; Stawski, Nina; Hillson, Nathan J.] Lawrence Berkeley Natl Labs, Phys BioSci Div, Berkeley, CA USA; [Linshiz, Gregory; Hillson, Nathan J.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Kravets, Ilia] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Marks, Robert S.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Marks, Robert S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Marks, Robert S.] NRF CREATE Program Nanomat Energy & Water Managem, Singapore, Singapore; [Konry, Tania] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm Bouve, Coll Hlth Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Technion Israel Institute of Technology; Rutgers State University New Brunswick; Ben Gurion University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Northeastern University	Konry, T (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm Bouve, Coll Hlth Sci, Boston, MA 02115 USA.	t.konry@neu.edu	MARKS, ROBERT/AAS-4746-2020; Golberg, Alexander/M-9563-2017	Golberg, Alexander/0000-0001-8782-8879; Yarmush, Martin/0000-0003-4986-8444; Marks, Robert/0000-0002-9697-3805	Shriners Foundation [85120-BOS]; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; Singapore National Research Foundation; Campus for Research Excellence And Technological Enterprise (CREATE) program for the project 'Nanomaterials for Energy and Water Management'; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	Shriners Foundation; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); Singapore National Research Foundation(National Research Foundation, Singapore); Campus for Research Excellence And Technological Enterprise (CREATE) program for the project 'Nanomaterials for Energy and Water Management'; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	AG and MY acknowledge Shriners Foundation Grant #85120-BOS for the support of this work. The portion of this work conducted by the Joint BioEnergy Institute, and the U.S. Department of Energy Joint Genome Institute, was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy (Contract No. DE-AC02-05CH11231). This research is funded in part by the Singapore National Research Foundation and the publication is supported under the Campus for Research Excellence And Technological Enterprise (CREATE) program for the project 'Nanomaterials for Energy and Water Management'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhalim I, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3081031; Abdulhalim I., 2008, J ELECTROMAGN, V28, P213; Abu-Rabeah K, 2009, BIOSENS BIOELECTRON, V24, P3461, DOI 10.1016/j.bios.2009.04.042; Al-Bayatti KK, 2012, J ENV PUBLIC HLTH, V2012; Allevi RP, 2013, J WATER HEALTH, V11, P244, DOI 10.2166/wh.2013.152; [Anonymous], 2005, EX WAT WAST 9020 QUA; Baroud CN, 2010, LAB CHIP, V10, P2032, DOI 10.1039/c001191f; Bogomolny E, 2013, ANALYST, V138, P4112, DOI 10.1039/c3an00254c; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Buffi N, 2011, LAB CHIP, V11, P2369, DOI 10.1039/c1lc20274j; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; EPA, 2006, TOT COL RUL REQ; Fewtrell L., 2001, WATER QUALITY GUIDEL; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Gwimbi P, 2011, AFR HEALTH SCI, V11, P474; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; Handique K, 2001, J MICROMECH MICROENG, V11, P548, DOI 10.1088/0960-1317/11/5/316; Jafari N, 2011, J RES MED SCI, V16, P956; Johnson PE, 2006, CYTOM PART A, V69A, P1212, DOI 10.1002/cyto.a.20351; Kao MC, 2010, ANAL LETT, V43, P1756, DOI 10.1080/00032711003654005; Karabchevsky A, 2012, J NANOPHOTONICS, V6; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Langer V, 2011, ANAL BIOANAL CHEM, V399, P1041, DOI 10.1007/s00216-010-4414-0; Leclerc H, 2003, EMERG I WATER INFECT, P80; Levy K, 2012, AM J TROP MED HYG, V86, P499, DOI 10.4269/ajtmh.2012.11-0263; Lewin S, 2007, SAMJ S AFR MED J, V97, P755; Liebes Y, 2009, TALANTA, V80, P338, DOI 10.1016/j.talanta.2009.06.070; Liebes Y, 2009, SENSOR ACTUAT B-CHEM, V140, P568, DOI 10.1016/j.snb.2009.04.050; Linshiz G, 2013, ACS SYNTH BIOL, V2, P216, DOI 10.1021/sb300075t; Liu YM, 2008, APPL ENVIRON MICROB, V74, P1502, DOI 10.1128/AEM.02125-07; Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017; Mairhofer J, 2009, SENSORS-BASEL, V9, P4804, DOI 10.3390/s90604804; Mandeville KL, 2009, WORLD J GASTROENTERO, V15, P2839, DOI 10.3748/wjg.15.2839; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Niu XZ, 2012, BIOCHEM SOC T, V40, P615, DOI 10.1042/BST20120005; Noble Rachel T., 2005, Journal of Water and Health, V3, P381; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Rompre A, 2002, J MICROBIOL METH, V49, P31, DOI 10.1016/S0167-7012(01)00351-7; Sabat G, 2000, APPL ENVIRON MICROB, V66, P844, DOI 10.1128/AEM.66.2.844-849.2000; Sarkar R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-87; Sarrazin F, 2007, CHEM ENG SCI, V62, P1042, DOI 10.1016/j.ces.2006.10.013; Setterington EB, 2012, BIOSENSORS-BASEL, V2, P15, DOI 10.3390/bios2010015; Shalabney A, 2011, LASER PHOTONICS REV, V5, P571, DOI 10.1002/lpor.201000009; Stoler J, 2012, HEALTH PLACE, V18, P250, DOI 10.1016/j.healthplace.2011.09.020; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Sun H, 2009, BIOSENS BIOELECTRON, V24, P1405, DOI 10.1016/j.bios.2008.08.008; Tantawiwat Suwalee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P162; Teschke K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-767; Tsen HY, 1998, J APPL MICROBIOL, V85, P554, DOI 10.1046/j.1365-2672.1998.853535.x; WHO, 2006, GUIDL DRINK WAT QUAL; Xiao XL, 2013, CAN J MICROBIOL, V59, P157, DOI 10.1139/cjm-2012-0577; Yang K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001483; Zourob Mohammed, 2008, P139, DOI 10.1007/978-0-387-75113-9_8	57	34	35	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86341	10.1371/journal.pone.0086341	http://dx.doi.org/10.1371/journal.pone.0086341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475107	Green Published, gold			2022-12-27	WOS:000330507300055
J	Mostafa, AA; Codner, D; Hirasawa, K; Komatsu, Y; Young, MN; Steimle, V; Drover, S				Mostafa, Ahmed A.; Codner, Dianne; Hirasawa, Kensuke; Komatsu, Yumiko; Young, Matthew N.; Steimle, Viktor; Drover, Sheila			Activation of ER alpha Signaling Differentially Modulates IFN-gamma Induced HLA-Class II Expression in Breast Cancer Cells	PLOS ONE			English	Article							MHC CLASS-II; ESTROGEN-RECEPTOR-ALPHA; PROTEIN-COUPLED RECEPTOR; BARE LYMPHOCYTE SYNDROME; GROWTH-FACTOR RECEPTOR; REGULATORY-FACTOR-I; KINASE-C-ALPHA; TRANSACTIVATOR CIITA; ANTIGEN-EXPRESSION; TRANSCRIPTIONAL ACTIVATION	The coordinate regulation of HLA class II (HLA-II) is controlled by the class II transactivator, CIITA, and is crucial for the development of anti-tumor immunity. HLA-II in breast carcinoma is associated with increased IFN-gamma levels, reduced expression of the estrogen receptor (ER) and reduced age at diagnosis. Here, we tested the hypothesis that estradiol (E-2) and ER alpha signaling contribute to the regulation of IFN-gamma inducible HLA-II in breast cancer cells. Using a panel of established ER- and ER+ breast cancer cell lines, we showed that E-2 attenuated HLA-DR in two ER+ lines (MCF-7 and BT-474), but not in T47D, while it augmented expression in ER 2 lines, SK-BR-3 and MDA-MB-231. To further study the mechanism(s), we used paired transfectants: ER alpha(+) MC2 (MDA-MB-231 c10A transfected with the wild type ER alpha gene) and ER alpha(-) VC5 (MDA-MB-231 c10A transfected with the empty vector), treated or not with E-2 and IFN-gamma. HLA-II and CIITA were severely reduced in MC2 compared to VC5 and were further exacerbated by E-2 treatment. Reduced expression occurred at the level of the IFN-gamma inducible CIITA promoter IV. The anti-estrogen ICI 182,780 and gene silencing with ESR1 siRNA reversed the E-2 inhibitory effects, signifying an antagonistic role for activated ER alpha on CIITA pIV activity. Moreover, STAT1 signaling, necessary for CIITA pIV activation, and selected STAT1 regulated genes were variably downregulated by E-2 in transfected and endogenous ER alpha positive breast cancer cells, whereas STAT1 signaling was noticeably augmented in ER alpha(-) breast cancer cells. Collectively, these results imply immune escape mechanisms in ER alpha(+) breast cancer may be facilitated through an ER alpha suppressive mechanism on IFN-gamma signaling.	[Mostafa, Ahmed A.; Codner, Dianne; Hirasawa, Kensuke; Komatsu, Yumiko; Young, Matthew N.; Drover, Sheila] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Res Grp, St John, NF, Canada; [Steimle, Viktor] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	Memorial University Newfoundland; University of Sherbrooke	Drover, S (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Res Grp, St John, NF, Canada.	sdrover@mun.ca		Mostafa, Ahmed/0000-0001-5672-0144	Canadian Institute of Health Research [ROP 82352]; Canadian Breast Cancer Foundation/Atlantic Chapter [R08-D11, R09-F20]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation/Atlantic Chapter	This work was supported by Canadian Institute of Health Research (www.cihr-irsc.gc.ca) grant number ROP 82352 and Canadian Breast Cancer Foundation/Atlantic Chapter (http://www.cbcf.org/atlantic/Pages/default.aspx) grant numbers R08-D11 and R09-F20. AAM was supported by a Health Professionals fellowship from Canadian Institute of Health Research Regional Partnership Program (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla RS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-154; Accolla RS, 2010, BREAST J, V16, pS42, DOI 10.1111/j.1524-4741.2010.01003.x; Adamski J, 2005, MOL ENDOCRINOL, V19, P113, DOI 10.1210/me.2004-0270; Adamski J, 2004, MOL ENDOCRINOL, V18, P1963, DOI 10.1210/me.2004-0098; Ahmed CMI, 2006, J IMMUNOL, V177, P315, DOI 10.4049/jimmunol.177.1.315; Aka JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031532; Andersen P, 2008, INT J CANCER, V122, P342, DOI 10.1002/ijc.23109; Armstrong TD, 1998, J IMMUNOL, V160, P661; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; BERNARD DJ, 1986, ANTICANCER RES, V6, P79; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; Bustin SA, 2001, TUMOR BIOL, V22, P294, DOI 10.1159/000050630; Cabrera T, 1996, HUM IMMUNOL, V50, P127, DOI 10.1016/0198-8859(96)00145-0; Calabro A, 2009, BREAST CANCER RES TR, V116, P69, DOI 10.1007/s10549-008-0105-3; Camacho-Carvajal MM, 2004, INT IMMUNOL, V16, P65, DOI 10.1093/intimm/dxh010; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; CONCHA A, 1995, EUR J IMMUNOGENET, V22, P299, DOI 10.1111/j.1744-313X.1995.tb00246.x; Duong V, 2006, ONCOGENE, V25, P1799, DOI 10.1038/sj.onc.1209102; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Gough DJ, 2007, J BIOL CHEM, V282, P938, DOI 10.1074/jbc.M607674200; Hake SB, 2003, EUR J IMMUNOL, V33, P2361, DOI 10.1002/eji.200323795; Hardy PO, 2009, IMMUNOLOGY, V128, pe652, DOI 10.1111/j.1365-2567.2009.03055.x; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Holling TM, 2006, BIOCHEM PHARMACOL, V72, P1570, DOI 10.1016/j.bcp.2006.06.034; JABRANEFERRAT N, 1990, INT J CANCER, V45, P1169, DOI 10.1002/ijc.2910450630; Jang ER, 2004, ONCOGENE, V23, P1724, DOI 10.1038/sj.onc.1207315; Johnson H.M., 2011, J CLIN CELL IMMUNOL, V2, DOI [10.4172/2155-9899.1000112, DOI 10.4172/2155-9899.1000112]; Kanaseki T, 2003, J IMMUNOL, V170, P4980, DOI 10.4049/jimmunol.170.10.4980; Kaur S, 2005, J INTERF CYTOK RES, V25, P780, DOI 10.1089/jir.2005.25.780; Kennedy AM, 2005, ENDOCRINOLOGY, V146, P201, DOI 10.1210/en.2004-0486; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lee YJ, 1996, J IMMUNOL, V157, P1559; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Londhe P, 2012, INT J CANCER, V131, pE437, DOI 10.1002/ijc.26478; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martins I, 2007, EUR J IMMUNOL, V37, P788, DOI 10.1002/eji.200636620; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; MAUDSLEY DJ, 1991, BIOCHEM SOC T, V19, P291, DOI 10.1042/bst0190291; Meazza R, 2003, EUR J IMMUNOL, V33, P1183, DOI 10.1002/eji.200323712; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Morrow AN, 2011, J IMMUNOL, V186, P1685, DOI 10.4049/jimmunol.1001359; Muhlethaler-Mottet A, 2004, J BIOL CHEM, V279, P40529, DOI 10.1074/jbc.M406585200; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Oldford SA, 2004, INT J CANCER, V112, P399, DOI 10.1002/ijc.20441; Oldford SA, 2006, INT IMMUNOL, V18, P1591, DOI 10.1093/intimm/dxl092; Otten LA, 1998, EUR J IMMUNOL, V28, P473, DOI 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E; Pietras RJ, 2007, CLIN CANCER RES, V13, P4672, DOI 10.1158/1078-0432.CCR-07-1373; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Renoir JM, 2012, STEROIDS, V77, P1249, DOI 10.1016/j.steroids.2012.07.019; Rohn W, 1999, J IMMUNOL, V162, P886; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sastre-Serra J, 2012, CELL PHYSIOL BIOCHEM, V29, P261, DOI 10.1159/000337607; Schwartz JL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/912102; SEDLAK J, 1992, NEOPLASMA, V39, P269; Setterblad N, 1997, IMMUNOGENETICS, V46, P318, DOI 10.1007/s002510050278; Shi B, 2006, INT J BIOCHEM CELL B, V38, P544, DOI 10.1016/j.biocel.2005.07.012; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Spurrell DR, 2004, HUM IMMUNOL, V65, P1516, DOI 10.1016/j.humimm.2004.09.005; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; TABIBZADEH SS, 1990, J CLIN ENDOCR METAB, V71, P740, DOI 10.1210/jcem-71-3-740; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tonetti DA, 2003, J STEROID BIOCHEM, V87, P47, DOI 10.1016/j.jsbmb.2003.07.003; Truax AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036013; Tzortzakaki E, 2003, MOL ENDOCRINOL, V17, P2509, DOI 10.1210/me.2002-0439; van der Stoep N, 2002, J IMMUNOL, V169, P5061, DOI 10.4049/jimmunol.169.9.5061; Vladusic EA, 2000, ONCOL REP, V7, P157; Warabi M, 2000, PATHOL RES PRACT, V196, P807, DOI 10.1016/S0344-0338(00)80080-1; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhou Q, 2009, ENDOCR-RELAT CANCER, V16, P319, DOI 10.1677/ERC-08-0305; Zhou Q, 2009, BREAST CANCER RES TR, V117, P443, DOI 10.1007/s10549-008-0148-5; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000; Zhu YL, 2006, INT J ONCOL, V28, P67; Zika E, 2005, P NATL ACAD SCI USA, V102, P16321, DOI 10.1073/pnas.0505045102	86	39	40	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87377	10.1371/journal.pone.0087377	http://dx.doi.org/10.1371/journal.pone.0087377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475282	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300177
J	Nogueira, SSC; Abreu, SA; Peregrino, H; Nogueira, SLG				Nogueira, Selene S. C.; Abreu, Shauana A.; Peregrino, Helderes; Nogueira-Filho, Sergio L. G.			The Effects of Feeding Unpredictability and Classical Conditioning on Pre-Release Training of White-Lipped Peccary (Mammalia, Tayassuidae)	PLOS ONE			English	Article							COLLARED PECCARY; BEHAVIOR; WELFARE; ANIMALS; SCHEDULES; PATTERNS; REWARD	Some authors have suggested that environmental unpredictability, accompanied by some sort of signal for behavioral conditioning, can boost activity or foster exploratory behavior, which may increase post-release success in re-introduction programs. Thus, using white-lipped peccary (Tayassu pecari), a vulnerable Neotropical species, as a model, we evaluated an unpredictable feeding schedule. Associating this with the effect of classical conditioning on behavioral activities, we assessed the inclusion of this approach in pre-release training protocols. The experimental design comprised predictable feeding phases (control phases: C-1, C-2 and C-3) and unpredictable feeding phases (U-1-signaled and U-2-non-signaled). The animals explored more during the signaled and non-signaled unpredictable phases and during the second control phase (C-2) than during the other two predictable phases (C-1 and C-3). The peccaries also spent less time feeding during the signaled unpredictable phase (U-1) and the following control phase (C-2) than during the other phases. Moreover, they spent more time in aggressive encounters during U-1 than the other experimental phases. However, the animals did not show differences in the time they spent on affiliative interactions or in the body weight change during the different phases. The signaled unpredictability, besides improving foraging behavior, showing a prolonged effect on the next control phase (C-2), also increased the competition for food. The signaled feeding unpredictability schedule, mimicking wild conditions by eliciting the expression of naturalistic behaviors in pre-release training, may be essential to fully prepare them for survival in the wild.	[Nogueira, Selene S. C.; Abreu, Shauana A.; Nogueira-Filho, Sergio L. G.] Univ Estadual Santa Cruz, Lab Etol Aplicada, Ilheus, BA, Brazil; [Peregrino, Helderes] Univ Fed Rio Grande do Norte, Lab Fisiol Comportamento, BR-59072970 Natal, RN, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal do Rio Grande do Norte	Nogueira, SSC (corresponding author), Univ Estadual Santa Cruz, Lab Etol Aplicada, Ilheus, BA, Brazil.	selene.nogueira@pq.cnpq.br	Nogueira, Selene/I-1843-2013; Nogueira-Filho, Sérgio L.G./F-6264-2014; Nogueira, Selene/W-5237-2019	Nogueira, Selene/0000-0001-8078-4172; Nogueira, Selene/0000-0001-8078-4172; Nogueira-Filho, Sergio/0000-0001-5392-0773	CNPq [476741/2010-6, 300587/2009-0, 306154/2010-2]; CAPES/PNPD [2951/2010]; CAPES/PROCAD-NF [794-2009]; UESC; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/PROCAD-NF(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UESC; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was under the auspices of CNPq # 476741/2010-6, CAPES/PNPD#2951/2010; CAPES/PROCAD-NF # 794-2009 and UESC. Sergio Nogueira-Filho and Selene Nogueira were supported by CNPq (Process # 300587/2009-0 and 306154/2010-2, respectively). S. A. A. was supported by CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2007, LEARNING BEHAV CONT; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Beck Benjamin, 1995, P155; Carlstead K, 2010, WILD MAMMALS CAPTIVI, P317; Dubost G, 2001, MAMM BIOL, V66, P65; Figueira MD, 2003, REV BRAS ZOOTECN, V32, P191, DOI 10.1590/S1516-35982003000100024; Fragoso JMV, 1998, BIOTROPICA, V30, P458, DOI 10.1111/j.1744-7429.1998.tb00080.x; Frantzen MAJ, 2001, BIOL CONSERV, V100, P253, DOI 10.1016/S0006-3207(01)00046-5; GALLAGHER JF, 1984, J WILDLIFE MANAGE, V48, P749, DOI 10.2307/3801422; Gilbert-Norton LB, 2009, APPL ANIM BEHAV SCI, V120, P179, DOI 10.1016/j.applanim.2009.06.007; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Heffner C. L., 2004, RES METHODS ED PSYCH; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Keuroghlian A, 2013, IUCN 2013 IUCN RED L; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; McPhee M. Elsbeth, 2010, P303; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Nogueira SSC, 2011, APPL ANIM BEHAV SCI, V132, P193, DOI 10.1016/j.applanim.2011.04.002; Nogueira Selene S.C., 2007, Suiform Soundings, V7, P9; Nogueira-Filho S.L, 2004, PEOPLE NATURE WILDLI, P171; Nogueira-Filho S. L. G., 1999, REV ETOL, V1, P89; Nogueira-Filho Sergio L.G., 2012, Suiform Soundings, V11, P21; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Perlman JE, 2012, APPL ANIM BEHAV SCI, V137, P114, DOI 10.1016/j.applanim.2011.11.003; Reading R.P., 2013, ZOO BIOL, V9999, P1; Shettleworth S. J., 2009, COGNITION EVOLUTION; Sowls LK., 1997, JAVELINAS OTHER PECC, V2, P325; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Stoinski TS, 2004, AM J PRIMATOL, V62, P1, DOI 10.1002/ajp.20002; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Timberlake W., 1995, PERSPECTIVES ETHOLOG, V2, P211; Toates F, 2004, APPL ANIM BEHAV SCI, V86, P173, DOI 10.1016/j.applanim.2004.02.010; Ulyan MJ, 2006, APPL ANIM BEHAV SCI, V101, P154, DOI 10.1016/j.applanim.2006.01.010; Waitt C, 2001, APPL ANIM BEHAV SCI, V75, P75, DOI 10.1016/S0168-1591(01)00174-5; Watters JV, 2007, APPL ANIM BEHAV SCI, V102, P364, DOI 10.1016/j.applanim.2006.05.036; Watters JV, 2009, ZOO BIOL, V28, P609, DOI 10.1002/zoo.20284; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	39	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86080	10.1371/journal.pone.0086080	http://dx.doi.org/10.1371/journal.pone.0086080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475072	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300035
J	Sessa, L; Gatti, E; Zeni, F; Antonelli, A; Catucci, A; Koch, M; Pompilio, G; Fritz, G; Raucci, A; Bianchi, ME				Sessa, Luca; Gatti, Elena; Zeni, Filippo; Antonelli, Antonella; Catucci, Alessandro; Koch, Michael; Pompilio, Giulio; Fritz, Guenter; Raucci, Angela; Bianchi, Marco E.			The Receptor for Advanced Glycation End-Products (RAGE) Is Only Present in Mammals, and Belongs to a Family of Cell Adhesion Molecules (CAMs)	PLOS ONE			English	Article							STRUCTURAL BASIS; ENDPRODUCTS RAGE; CLUSTAL-W; I-TASSER; PROTEIN; MARKER; ALIGNMENT; LIGANDS; ATHEROSCLEROSIS; CLASSIFICATION	The human receptor for advanced glycation endproducts (RAGE) is a multiligand cell surface protein belonging to the immunoglobulin superfamily, and is involved in inflammatory and immune responses. Most importantly, RAGE is considered a receptor for HMGB1 and several S100 proteins, which are Damage-Associated Molecular Pattern molecules (DAMPs) released during tissue damage. In this study we show that the Ager gene coding for RAGE first appeared in mammals, and is closely related to other genes coding for cell adhesion molecules (CAMs) such as ALCAM, BCAM and MCAM that appeared earlier during metazoan evolution. RAGE is expressed at very low levels in most cells, but when expressed at high levels, it mediates cell adhesion to extracellular matrix components and to other cells through homophilic interactions. Our results suggest that RAGE evolved from a family of CAMs, and might still act as an adhesion molecule, in particular in the lung where it is highly expressed or under pathological conditions characterized by an increase of its protein levels.	[Sessa, Luca; Gatti, Elena; Antonelli, Antonella; Catucci, Alessandro; Bianchi, Marco E.] San Raffaele Univ & Res Inst, Chromatin Dynam Unit, Milan, Italy; [Zeni, Filippo; Pompilio, Giulio; Raucci, Angela] Ctr Cardiol Monzino, Lab Vasc Biol & Regenerat Med, Milan, Italy; [Koch, Michael; Fritz, Guenter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany	Vita-Salute San Raffaele University; IRCCS Centro Cardiologico Monzino; University of Freiburg	Raucci, A (corresponding author), Ctr Cardiol Monzino, Lab Vasc Biol & Regenerat Med, Milan, Italy.	araucci@ccfm.it; bianchi.marco@hsr.it	Pompilio, Giulio/J-6701-2014; Antonelli, Antonella/AAN-1856-2020; ANTONELLI, ANTONELLA/C-6238-2011; Raucci, Angela/K-3722-2018; Fritz, Guenter/E-2933-2013; Bianchi, Marco Emilio/K-3417-2018	Pompilio, Giulio/0000-0003-2581-5735; Fritz, Guenter/0000-0002-4571-8812; Bianchi, Marco Emilio/0000-0002-5329-6445; Antonelli, Antonella/0000-0003-1497-3586; Raucci, Angela/0000-0003-1333-9671	Italian Association for Cancer research (AIRC) [IG-10411]; Italian Mininstry of Health [RF-027B]; Fondazione Monzino and Centro Cardiologico Monzino-IRCCS [RC 2011-2013]; Heisenberg fellowship of the Deutsche Forschungsgemeinschaft [FR 1488/3-2]	Italian Association for Cancer research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Mininstry of Health; Fondazione Monzino and Centro Cardiologico Monzino-IRCCS; Heisenberg fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Italian Association for Cancer research (AIRC, IG-10411) and the Italian Mininstry of Health (RF-027B) to MEB, and by Fondazione Monzino and Centro Cardiologico Monzino-IRCCS (RC 2011-2013). GF is supported by a Heisenberg fellowship of the Deutsche Forschungsgemeinschaft (FR 1488/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	Allmen EU, 2008, PROSTATE, V68, P748, DOI 10.1002/pros.20736; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2011, PYMOL MOL GRAPHICS S; Barile GR, 2007, CURR MOL MED, V7, P758, DOI 10.2174/156652407783220778; Barth K, 2005, HISTOCHEM CELL BIOL, V123, P239, DOI 10.1007/s00418-004-0727-4; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Briot R, 2009, CHEST, V135, P269, DOI 10.1378/chest.08-0919; Clynes R, 2007, CURR MOL MED, V7, P743; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Francavilla C, 2009, SEMIN CANCER BIOL, V19, P298, DOI 10.1016/j.semcancer.2009.05.004; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Frommhold D, 2010, BLOOD, V116, P841, DOI 10.1182/blood-2009-09-244293; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Higgins D G, 1994, Methods Mol Biol, V25, P307; Holm L., 2012, NUCLEIC ACIDS RES, V38, pW545; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xu D, 2013, ACS CHEM BIOL; Yamamoto H, 2007, CURR MOL MED, V7, P752, DOI 10.2174/156652407783220769; Yan SD, 2009, J ALZHEIMERS DIS, V16, P833, DOI 10.3233/JAD-2009-1030; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Yatime L, 2013, FEBS J; Zen K, 2007, J IMMUNOL, V178, P2483, DOI 10.4049/jimmunol.178.4.2483; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	61	93	94	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86903	10.1371/journal.pone.0086903	http://dx.doi.org/10.1371/journal.pone.0086903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475194	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300116
J	Shigematsu, H; Iida, K; Nakano, M; Chaudhuri, P; Iida, H; Nagayama, K				Shigematsu, Hideki; Iida, Kazuko; Nakano, Masataka; Chaudhuri, Pratima; Iida, Hidetoshi; Nagayama, Kuniaki			Structural Characterization of the Mechanosensitive Channel Candidate MCA2 from Arabidopsis thaliana	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEIN; ELECTRON-MICROSCOPY; CA2+ INFLUX; CALCIUM; VISUALIZATION; TOMOGRAPHY; TOUCH	mechanosensitive channel. The plasma membrane protein MCA1 and its paralog MCA2 from Arabidopsis thaliana are involved in mechanical stress-induced Ca2+ influx and are thus considered as candidates for such channels or their regulators. Both MCA1 and MCA2 were functionally expressed in Sf9 cells using a baculovirus system in order to elucidate their molecular natures. Because of the abundance of protein in these cells, MCA2 was chosen for purification. Purified MCA2 in a detergent-solubilized state formed a tetramer, which was confirmed by chemical cross-linking. Single-particle analysis of cryo-electron microscope images was performed to depict the overall shape of the purified protein. The three-dimensional structure of MCA2 was reconstructed at a resolution of 26 angstrom from 5,500 particles and appears to comprise a small transmembrane region and large cytoplasmic region.	[Shigematsu, Hideki; Chaudhuri, Pratima; Iida, Hidetoshi; Nagayama, Kuniaki] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Biomembrane Lab, Setagaya Ku, Tokyo 113, Japan; [Nakano, Masataka; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan; [Nagayama, Kuniaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Nagayama, Kuniaki] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Metropolitan Institute of Medical Science; Tokyo Gakugei University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Iida, H (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	iida@u-gakugei.ac.jp; nagayama@nips.ac.jp	Iida, Hidetoshi/AAO-5506-2020; Shigematsu, Hideki/E-1052-2017; Nagayama, Kuniaki/O-2522-2018	Shigematsu, Hideki/0000-0003-3951-8651; Chaudhuri (Chattopadhyay), Pratima/0000-0002-5723-4428	Ministry of Education, Culture, Sports, Science, and Technology of Japan [13GS0016, 21026009, 23120509, 25120708]; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Corporation; Scientific Research on Priority Areas [21370017]; Novartis Foundation (Japan) for the Promotion of Science [KEN20-191]; Frontiers of Membrane Protein Research (a Joint Project between the Institute for Protein Research, Osaka University); Okazaki Institute for Integrative Bioscience	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Corporation; Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Novartis Foundation (Japan) for the Promotion of Science(Novartis); Frontiers of Membrane Protein Research (a Joint Project between the Institute for Protein Research, Osaka University); Okazaki Institute for Integrative Bioscience(National Institutes of Natural Sciences (NINS) - Japan)	This study was partly supported by a Grant-in-Aid for Creative Scientiyc Research (No. 13GS0016 to K. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Corporation to K.N. It was also supported by Grants-in-Aid for Scientific Research (B) (No. 21370017 to H.I.) and for Scientific Research on Priority Areas (Nos. 19045009, 21026009, 23120509 and 25120708 to H.I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Novartis Foundation (Japan) for the Promotion of Science (No. KEN20-191 to H.I.); and a grant for the Frontiers of Membrane Protein Research (a Joint Project between the Institute for Protein Research, Osaka University and Okazaki Institute for Integrative Bioscience) to K. N. and H. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Clemens S, 1998, P NATL ACAD SCI USA, V95, P12043, DOI 10.1073/pnas.95.20.12043; Cleverley RM, 2008, MOL MEMBR BIOL, V25, P625, DOI 10.1080/09687680802448530; Dai W, 2013, NATURE, V502, P707, DOI 10.1038/nature12604; Danev R, 2008, J STRUCT BIOL, V161, P211, DOI 10.1016/j.jsb.2007.10.015; Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; DING JP, 1993, PLANT J, V3, P83, DOI 10.1111/j.1365-313X.1993.tb00013.x; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fukuda Y, 2012, J STRUCT BIOL, V177, P484, DOI 10.1016/j.jsb.2011.11.018; Furuichi T, 2012, PLANT SIGNAL BEHAV, V7, P1022, DOI 10.4161/psb.20783; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Hosogi N, 2011, J STRUCT BIOL, V173, P67, DOI 10.1016/j.jsb.2010.08.004; Hosokawa F, 2005, J ELECTRON MICROSC, V54, P317, DOI 10.1093/jmicro/dfi049; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Jensen GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040336; Jimenez-Preitner M, 2011, CELL METAB, V14, P658, DOI 10.1016/j.cmet.2011.08.008; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kurusu T, 2013, TRENDS PLANT SCI, V18, P227, DOI 10.1016/j.tplants.2012.12.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maksaev G, 2012, P NATL ACAD SCI USA, V109, P19015, DOI 10.1073/pnas.1213931109; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Mio K, 2009, STRUCTURE, V17, P266, DOI 10.1016/j.str.2008.12.007; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006; Nagayama Kuniaki, 2009, Biophys Rev, V1, P37, DOI 10.1007/s12551-008-0006-z; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakano M, 2011, PLANT CELL PHYSIOL, V52, P1915, DOI 10.1093/pcp/pcr131; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tada T, 2003, J BIOL CHEM, V278, P9647, DOI 10.1074/jbc.M206993200; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; TREWAVAS A, 1994, PLANT MOL BIOL, V26, P1329, DOI 10.1007/BF00016478; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veley KM, 2012, CURR BIOL, V22, P408, DOI 10.1016/j.cub.2012.01.027; Venturi E, 2011, BIOCHEMISTRY-US, V50, P2623, DOI 10.1021/bi1019447; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yamaguchi M, 2008, J STRUCT BIOL, V162, P271, DOI 10.1016/j.jsb.2008.01.009; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371	47	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87724	10.1371/journal.pone.0087724	http://dx.doi.org/10.1371/journal.pone.0087724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475319	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300211
J	Yang, CC; Iwasaki, W				Yang, Ching-Chia; Iwasaki, Wataru			MetaMetaDB: A Database and Analytic System for Investigating Microbial Habitability	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; RNA GENE DATABASE; FUNCTIONAL-ANALYSIS; METAGENOMICS; PROJECT	MetaMetaDB (http://mmdb.aori.u-tokyo.ac.jp/) is a database and analytic system for investigating microbial habitability, i.e., how a prokaryotic group can inhabit different environments. The interaction between prokaryotes and the environment is a key issue in microbiology because distinct prokaryotic communities maintain distinct ecosystems. Because 16S ribosomal RNA (rRNA) sequences play pivotal roles in identifying prokaryotic species, a system that comprehensively links diverse environments to 16S rRNA sequences of the inhabitant prokaryotes is necessary for the systematic understanding of the microbial habitability. However, existing databases are biased to culturable prokaryotes and exhibit limitations in the comprehensiveness of the data because most prokaryotes are unculturable. Recently, metagenomic and 16S rRNA amplicon sequencing approaches have generated abundant 16S rRNA sequence data that encompass unculturable prokaryotes across diverse environments; however, these data are usually buried in large databases and are difficult to access. In this study, we developed MetaMetaDB (Meta-Metagenomic DataBase), which comprehensively and compactly covers 16S rRNA sequences retrieved from public datasets. Using MetaMetaDB, users can quickly generate hypotheses regarding the types of environments a prokaryotic group may be adapted to. We anticipate that MetaMetaDB will improve our understanding of the diversity and evolution of prokaryotes.	[Yang, Ching-Chia; Iwasaki, Wataru] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	University of Tokyo	Yang, CC (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	chia@aori.u-tokyo.ac.jp; iwasaki@aori.u-tokyo.ac.jp	Iwasaki, Wataru/O-4917-2014	Iwasaki, Wataru/0000-0002-9169-9245; Yang, Ching-chia/0000-0003-0760-9209	CREST Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science [23710231]	CREST Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the CREST Program from the Japan Science and Technology Agency and Grant-in-Aid for Young Scientists (B) [grant number 23710231] from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kirchman DL, 2012, Processes in Microbial Ecology, P79; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	40	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87126	10.1371/journal.pone.0087126	http://dx.doi.org/10.1371/journal.pone.0087126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475242	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300146
J	Zhou, Z; Gao, X; Wang, YY; Zhou, HL; Wu, C; Paranhos-Baccala, G; Vernet, G; Guo, L; Wang, JW				Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Paranhos-Baccala, Glaucia; Vernet, Guy; Guo, Li; Wang, Jianwei			Conserved B-Cell Epitopes among Human Bocavirus Species Indicate Potential Diagnostic Targets	PLOS ONE			English	Article							YOUNG-CHILDREN; INFECTION; SEROEPIDEMIOLOGY; IDENTIFICATION; HEMAGGLUTININ; ANTIBODIES	Background: Human bocavirus species 1-4 (HBoV1-4) have been associated with respiratory and enteric infections in children. However, the immunological mechanisms in response to HBoV infections are not fully understood. Though previous studies have shown cross-reactivities between HBoV species, the epitopes responsible for this phenomenon remain unknown. In this study, we used genomic and immunologic approaches to identify the reactive epitopes conserved across multiple HBoV species and explored their potential as the basis of a novel diagnostic test for HBoVs. Methodology/Principal Findings: We generated HBoV1-3 VP2 gene fragment phage display libraries (GFPDLs) and used these libraries to analyze mouse antisera against VP2 protein of HBoV1, 2, and 3, and human sera positive for HBoVs. Using this approach, we mapped four epitope clusters of HBoVs and identified two immunodominant peptides-P1 ((1)MSDTDIQDQQPDTVDAPQNT(20)), and P2 ((162)EHAYPNASHPWDEDVMPDL(180))-that are conserved among HBoV1-4. To confirm epitope immunogenicity, we immunized mice with the immunodominant P1 and P2 peptides identified in our screen and found that they elicited high titer antibodies in mice. These two antibodies could only recognize the VP2 of HBoV 1-4 in Western blot assays, rather than those of the two other parvoviruses human parvovirus B19 and human parvovirus 4 (PARV4). Based on our findings, we evaluated epitope-based peptide-IgM ELISAs as potential diagnostic tools for HBoVs IgM antibodies. We found that the P1+P2-IgM ELISA showed a higher sensitivity and specificity in HBoVs IgM detection than the assays using a single peptide. Conclusions/Significance: The identification of the conserved B-cell epitopes among human bocavirus species contributes to our understanding of immunological cross-reactivities of HBoVs, and provides important insights for the development of HBoV diagnostic tools.	[Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Guo, Li; Wang, Jianwei] CAMS, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China; [Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Guo, Li; Wang, Jianwei] CAMS, IPB, CAMS Fdn Merieux, Christophe Merieux Lab, Beijing, Peoples R China; [Zhou, Zhuo; Gao, Xin; Wang, Yaying; Zhou, Hongli; Wu, Chao; Guo, Li; Wang, Jianwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Guo, L (corresponding author), CAMS, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China.	gnyny0803@163.com; wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559; zhou, zhuo/0000-0001-5862-9854	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2012ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and by the National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2012ZX10004-206) (http://www.nmp.gov.cn). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Blessing K, 2009, PEDIATR INFECT DIS J, V28, P1018, DOI 10.1097/INF.0b013e3181a854ae; Dubois ME, 2012, VECTOR-BORNE ZOONOT, V12, P400, DOI 10.1089/vbz.2011.0779; Guo L, 2012, PLOS ONE, V7; Guo L, 2011, EMERG INFECT DIS, V17, P1775, DOI 10.3201/eid1709.110078; Hustedt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038206; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kantola K, 2008, CLIN INFECT DIS, V46, P540, DOI 10.1086/526532; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Meriluoto M, 2012, EMERG INFECT DIS, V18, P264, DOI 10.3201/eid1802.111293; Mitui MT, 2012, CLIN INFECT DIS, V54, P964, DOI 10.1093/cid/cir957; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ursic T, 2011, J CLIN MICROBIOL, V49, P1179, DOI 10.1128/JCM.02362-10; Verma N, 2012, J VIROL, V86, P5515, DOI 10.1128/JVI.07085-11; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023374	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86960	10.1371/journal.pone.0086960	http://dx.doi.org/10.1371/journal.pone.0086960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475201	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300120
J	Chen, X; Ren, BA; Chen, M; Liu, MX; Ren, W; Wang, QX; Zhang, LX; Yan, GY				Chen, Xing; Ren, Biao; Chen, Ming; Liu, Ming-Xi; Ren, Wei; Wang, Quan-Xin; Zhang, Li-Xin; Yan, Gui-Ying			ASDCD: Antifungal Synergistic Drug Combination Database	PLOS ONE			English	Article							CHINESE MEDICINE; THERAPY; ANTAGONISM; CHEMOTHERAPY; INHIBITOR; BIOLOGY	Finding effective drugs to treat fungal infections has important clinical significance based on high mortality rates, especially in an immunodeficient population. Traditional antifungal drugs with single targets have been reported to cause serious side effects and drug resistance. Nowadays, however, drug combinations, particularly with respect to synergistic interaction, have attracted the attention of researchers. In fact, synergistic drug combinations could simultaneously affect multiple subpopulations, targets, and diseases. Therefore, a strategy that employs synergistic antifungal drug combinations could eliminate the limitations noted above and offer the opportunity to explore this emerging bioactive chemical space. However, it is first necessary to build a powerful database in order to facilitate the analysis of drug combinations. To address this gap in our knowledge, we have built the first Antifungal Synergistic Drug Combination Database (ASDCD), including previously published synergistic antifungal drug combinations, chemical structures, targets, target-related signaling pathways, indications, and other pertinent data. Its current version includes 210 antifungal synergistic drug combinations and 1225 drug-target interactions, involving 105 individual drugs from more than 12,000 references. ASDCD is freely available at http://ASDCD.amss.ac.cn.	[Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Xing; Liu, Ming-Xi; Ren, Wei; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Ren, Biao; Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ren, Biao; Zhang, Li-Xin] Chinese Acad Sci, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Chen, Ming; Zhang, Li-Xin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Wang, Quan-Xin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, LX (corresponding author), Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	zhanglixin@im.ac.cn; yangy@amss.ac.cn	Ren, Biao/P-1067-2015; Chen, Xing/G-6844-2016	Ren, Biao/0000-0003-4215-2873; Chen, Xing/0000-0001-9028-5342; Zhang, Lixin/0000-0003-0894-9520	National 863 Project [2006AA09Z402, 2007AA09Z443]; Key Project for International Cooperation [2007DFB31620]; National Natural Science Foundation of China [10531070, 10721101, 11021161, 11301517, 11371355, 30973665, 30700015, 30901849, 30910376, 30911120484, 81011120046, 30911120483]; National Key Technology RD Program [2007BAI26B02]; CAS Pillar Program [KSCX2-YW-R-164]; Important National Science & Technology Specific Projects [2008ZX09401-05, 2009ZX09302-004]; National Center for Mathematics and Interdisciplinary Sciences, CAS; Hundred Talents Program;  [KJCX-YW-S7]	National 863 Project(National High Technology Research and Development Program of China); Key Project for International Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); CAS Pillar Program; Important National Science & Technology Specific Projects; National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences); Hundred Talents Program(Chinese Academy of Sciences); 	This work was supported by grants from National 863 Project (2006AA09Z402, 2007AA09Z443), Key Project for International Cooperation (2007DFB31620), National Natural Science Foundation of China (10531070, 10721101, 11021161, 11301517, 11371355, 30973665, 30700015, 30901849, 30910376, 30911120484, 81011120046 and 30911120483), National Key Technology R&D Program (2007BAI26B02), the CAS Pillar Program (KSCX2-YW-R-164), Important National Science & Technology Specific Projects (2008ZX09401-05, 2009ZX09302-004), KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. L. Z also received funding from the Hundred Talents Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Biavatti MW, 2009, BRAZ J PHARM SCI, V45, P371, DOI 10.1590/S1984-82502009000300002; Biran A, 2011, INT J CANCER, V128, P691, DOI 10.1002/ijc.25367; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borgert CJ, 2005, THROMB RES, V117, P123, DOI 10.1016/j.thromres.2005.06.008; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hama A, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/840486; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; JAWETZ E, 1953, PHARMACOL REV, V5, P175; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725; KROGSTAD DJ, 1986, ANTIBIOTICS LAB MED; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Levinson AD, 2010, SCIENCE, V328, P137, DOI 10.1126/science.1189749; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; Mukherjee PK, 2005, CLIN MICROBIOL REV, V18, P163, DOI 10.1128/CMR.18.1.163-194.2005; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Parameswaran R, 2011, LEUKEMIA, V25, P1314, DOI 10.1038/leu.2011.76; Raez LE, 2006, CURR OPIN ONCOL, V18, P156; Rossi S., 2006, AUSTR MED HDB, P2; Sagar SM, 2008, CURR ONCOL, V15, P42, DOI 10.3747/co.2008.197; von Minckwitz G, 2007, EXPERT OPIN PHARMACO, V8, P485, DOI 10.1517/14656566.8.4.485; Wei Y, 2010, CLIN CANCER RES, V16, P3923, DOI 10.1158/1078-0432.CCR-10-0032; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xu Y, 2009, J PROTEOME RES, V8, P5296, DOI 10.1021/pr9005074; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Yun O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000720; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104; ZHU YP, 1995, PHARM WORLD SCI, V17, P103, DOI 10.1007/BF01872386; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	43	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86499	10.1371/journal.pone.0086499	http://dx.doi.org/10.1371/journal.pone.0086499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475134	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800051
J	Yu, CH; Yu, CC				Yu, Chuan-Hang; Yu, Cheng-Chia			Photodynamic Therapy with 5-Aminolevulinic acid (ALA) Impairs Tumor Initiating and Chemo-Resistance Property in Head and Neck Cancer-Derived Cancer Stem Cells	PLOS ONE			English	Article							ORAL VERRUCOUS HYPERPLASIA; METASTASIS; APOPTOSIS; NANOG	Background: Head and neck cancer (HNC) ranks the fourth leading malignancy and cancer death in male population in Taiwan. Despite recent therapeutic advances, the prognosis for HNC patients is still dismal. New strategies are urgently needed to improve the chemosensitization to conventional chemotherapeutic drugs and clinical responses of HNC patients. Studies have demonstrated that topical 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) is being used in the treatment of various human premalignant and malignant lesions with some encouraging clinical outcomes. However, the molecular mechanisms of ALA-PDT in the therapeutic effect in HNC tumorigenesis and whether ALA-PDT as chemosensitizer for HNC treatment remain unclear. Accumulating data support cancer stem cells (CSCs) contributes chemoresistance in HNC. Based on the previous studies, the purpose of the study is to investigate the effect of ALA-PDT on CSCs and chemosensitization property in HNC. Methodology/Principal Finding: CSCs marker ALDH1 activity of HNC cells with ALA-PDT treatment as assessed by the Aldefluor assay flow cytometry analysis. Secondary Sphere-forming self-renewal, stemness markers expression, and invasiveness of HNC-CSCs with ALA-PDT treatment were presented. We observed that the treatment of ALA-PDT significantly down-regulated the ALDH1 activity and CD44 positivity of HNC-CSCs. Moreover, ALA-PDT reduced self-renewal property and stemness signatures expression (Oct4 and Nanog) in sphere-forming HNC-CSCs. ALA-PDT sensitized highly tumorigenic HNC-CSCs to conventional chemotherapies. Lastly, synergistic effect of ALA-PDT and Cisplatin treatment attenuated invasiveness/colongenicity property in HNC-CSCs. Conclusion/Significance: Our results provide insights into the clinical prospect of ALA-PDT as a potential chemo-adjuvant therapy against head and neck cancer through eliminating CSCs property.	[Yu, Chuan-Hang; Yu, Cheng-Chia] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yu, Chuan-Hang; Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Yu, CH (corresponding author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.	d94422004@ntu.edu.tw; ccyu@csmu.edu.tw			National Science Council [100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 - MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This study is supported by research grant from National Science Council (100-2632-B-040-001-MY3, 101-2314-B-040-016, 102-2628-B-040 -001 - MY3).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HM, 2005, LASER SURG MED, V37, P114, DOI 10.1002/lsm.20214; Chen HM, 2004, ORAL ONCOL, V40, P630, DOI 10.1016/j.oraloncology.2003.12.010; Chen HM, 2011, J ORAL PATHOL MED, V40, P483, DOI 10.1111/j.1600-0714.2010.00973.x; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Chen YC, 2010, ORAL ONCOL, V46, P158, DOI 10.1016/j.oraloncology.2009.11.007; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Green B, 2013, BRIT J ORAL MAX SURG, V51, P283, DOI 10.1016/j.bjoms.2012.11.011; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Korkaya H, 2010, NAT CELL BIOL, V12, P419, DOI 10.1038/ncb0510-419; Lisnjak IO, 2005, EXP ONCOL, V27, P333; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Lo WL, 2011, J PATHOL, V223, P482, DOI 10.1002/path.2826; Lou PJ, 2004, BRIT J CANCER, V91, P441, DOI 10.1038/sj.bjc.6601993; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang TH, 2007, ORAL ONCOL, V43, P358, DOI 10.1016/j.oraloncology.2006.04.007; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Yu CC, 2011, J ONCOL, V2011, DOI 10.1155/2011/609259; Yu CC, 2011, ORAL ONCOL, V47, P202, DOI 10.1016/j.oraloncology.2010.12.001; Yu CH, 2008, ORAL ONCOL, V44, P595, DOI 10.1016/j.oraloncology.2007.08.016; Yu CH, 2013, J ORAL PATHOL MED, V42, P257, DOI 10.1111/jop.12007	30	31	33	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87129	10.1371/journal.pone.0087129	http://dx.doi.org/10.1371/journal.pone.0087129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475244	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800087
J	Du, PF; Wang, LS				Du, Pufeng; Wang, Lusheng			Predicting Human Protein Subcellular Locations by the Ensemble of Multiple Predictors via Protein-Protein Interaction Network with Edge Clustering Coefficients	PLOS ONE			English	Article							RECENT PROGRESS; LOCALIZATION; CLASSIFIER; GENOME; GENE; TRANSLOCATION; CONSTRUCTION; SIGNALP; SINGLE; SCALE	One of the fundamental tasks in biology is to identify the functions of all proteins to reveal the primary machinery of a cell. Knowledge of the subcellular locations of proteins will provide key hints to reveal their functions and to understand the intricate pathways that regulate biological processes at the cellular level. Protein subcellular location prediction has been extensively studied in the past two decades. A lot of methods have been developed based on protein primary sequences as well as protein-protein interaction network. In this paper, we propose to use the protein-protein interaction network as an infrastructure to integrate existing sequence based predictors. When predicting the subcellular locations of a given protein, not only the protein itself, but also all its interacting partners were considered. Unlike existing methods, our method requires neither the comprehensive knowledge of the protein-protein interaction network nor the experimentally annotated subcellular locations of most proteins in the protein-protein interaction network. Besides, our method can be used as a framework to integrate multiple predictors. Our method achieved 56% on human proteome in absolute-true rate, which is higher than the state-of-the-art methods.	[Du, Pufeng] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Du, Pufeng; Wang, Lusheng] City Univ Hong Kong, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China	Tianjin University; City University of Hong Kong	Du, PF (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China.	PufengDu@gmail.com; cswangl@cityu.edu.hk	Du, Pu-Feng/R-9002-2019	Wang, Lusheng/0000-0002-4344-8791; /0000-0001-9897-3932	National Science Foundation of China [NSFC 61005041]; Research Grants Council of the Hong Kong Special Administrative Region, China [CityU 122511]; Specialized Research Fund for the Doctoral Program of Higher Education [SRFDP 20100032120039]; Tianjin Science Foundation [12JCQNJC02300]; China Postdoctoral Science Foundation [2012T50240, 2013M530114]; Seed Foundation of Tianjin University [60302006, 60302024]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Science Foundation(Natural Science Foundation of Tianjin); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Seed Foundation of Tianjin University	This work was supported by National Science Foundation of China (NSFC 61005041), a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (CityU 122511), Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP 20100032120039), Tianjin Science Foundation (No. 12JCQNJC02300), China Postdoctoral Science Foundation (2012T50240 and 2013M530114) and the Seed Foundation of Tianjin University (No. 60302006 and 60302024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Cai CX, 2001, J CELL SCI, V114, P2327; Casadio Rita, 2008, Briefings in Functional Genomics & Proteomics, V7, P63, DOI 10.1093/bfgp/eln003; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Coelho LP, 2013, BIOINFORMATICS; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Du PF, 2013, EXPERT REV PROTEOMIC, V10, P227, DOI [10.1586/epr.13.16, 10.1586/EPR.13.16]; Du PF, 2011, EXPERT REV PROTEOMIC, V8, P391, DOI [10.1586/EPR.11.20, 10.1586/epr.11.20]; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emanuelsson Olof, 2002, Brief Bioinform, V3, P361, DOI 10.1093/bib/3.4.361; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Jiang JQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S20; Kumar G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S9; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lee K, 2013, GENOME RES, V23, P1283, DOI 10.1101/gr.155499.113; Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Lin JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-157; Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f; Liu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm562; Magnus M, 2012, BBA-PROTEINS PROTEOM, V1824, P1425, DOI 10.1016/j.bbapap.2012.05.018; Mintz-Oron S, 2009, BIOINFORMATICS, V25, pI247, DOI 10.1093/bioinformatics/btp209; Mondal AM, 2010, IEEE INT C BIOINFORM, P142, DOI 10.1109/BIBM.2010.5706553; MUNKRES KD, 1970, P NATL ACAD SCI USA, V67, P263, DOI 10.1073/pnas.67.1.263; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Park S, 2009, J PROTEOME RES, V8, P3367, DOI 10.1021/pr900018z; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reece J. B., 2011, CAMPBELL BIOL, V10th, P321; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shin CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-28; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b	62	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86879	10.1371/journal.pone.0086879	http://dx.doi.org/10.1371/journal.pone.0086879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466278	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000163
J	Kuwana, M; Okazaki, Y; Ikeda, Y				Kuwana, Masataka; Okazaki, Yuka; Ikeda, Yasuo			Detection of Circulating B Cells Producing Anti-GPIb Autoantibodies in Patients with Immune Thrombocytopenia	PLOS ONE			English	Article							PLATELET GLYCOPROTEIN IB; PURPURA; CRITERIA; PATHOGENESIS; ANTIBODIES; DIAGNOSIS; ASSAY; SITE	Background: We previously reported that an enzyme-linked immunospot (ELISPOT) assay for detecting anti-GPIIb/IIIa antibody-secreting B cells is a sensitive method for identifying patients with immune thrombocytopenia (ITP). Here we assessed the clinical significance of measuring circulating B cells producing antibodies to GPIb, another major platelet autoantigen. Methods: Anti-GPIb and anti-GPIIb/IIIa antibody-producing B cells were simultaneously measured using ELISPOT assays in 32 healthy controls and 226 consecutive thrombocytopenic patients, including 114 with primary ITP, 25 with systemic lupus erythematosus (SLE), 30 with liver cirrhosis, 39 with post-hematopoietic stem cell transplantation (post-HSCT), and 18 non-ITP controls (aplastic anemia and myelodysplastic syndrome). Results: There were significantly more circulating anti-GPIb and anti-GPIIb/IIIa antibody-producing B cells in primary ITP, SLE, liver cirrhosis, and post-HSCT patients than in healthy controls (P<0.05 for all comparisons). For diagnosing primary ITP, the anti-GPIb ELISPOT assay had 43% sensitivity and 89% specificity, whereas the anti-GPIIb/IIIa ELISPOT assay had 86% sensitivity and 83% specificity. When two tests were combined, the sensitivity was slightly improved to 90% without a reduction in specificity. In primary ITP patients, the anti-GPIb antibody response was associated with a low platelet count, lack of Helicobacter pylori infection, positive anti-nuclear antibody, and poor therapeutic response to intravenous immunoglobulin. Conclusion: The ELISPOT assay for detecting anti-GPIb antibody-secreting B cells is useful for identifying patients with ITP, but its utility for diagnosing ITP is inferior to the anti-GPIIb/IIIa ELISPOT assay. Nevertheless, detection of the anti-GPIb antibody response is useful for subtyping patients with primary ITP.	[Kuwana, Masataka; Okazaki, Yuka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Ikeda, Yasuo] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	Keio University; Waseda University	Kuwana, M (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan.	kuwanam@z5.keio.jp			Japanese Ministry of Health, Welfare and Labor	Japanese Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a research grant on intractable diseases by the Japanese Ministry of Health, Welfare and Labor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi A, 2006, HAEMATOLOGICA, V91, P1436; Berchtold P, 1997, BRIT J HAEMATOL, V96, P477, DOI 10.1046/j.1365-2141.1997.d01-2064.x; Brighton TA, 1996, BLOOD, V88, P194; Cauwenberghs N, 2001, THROMB HAEMOSTASIS, V85, P679, DOI 10.1055/s-0037-1615653; Daridon C, 2012, BLOOD, V120, P5021, DOI 10.1182/blood-2012-04-424648; Erlinger S, 1999, OXFORD TXB CLIN HEPA, V2, P629; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Go RS, 2007, HAEMATOLOGICA, V92, P283, DOI 10.3324/haematol.10667; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Guinan EC, 1997, HEMATOL ONCOL CLIN N, V11, P1025, DOI 10.1016/S0889-8588(05)70481-0; HOU M, 1995, EUR J HAEMATOL, V55, P307; Kajihara M, 2003, HEPATOLOGY, V37, P1267, DOI 10.1053/jhep.2003.50209; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kuwana M, 2003, AM J MED, V114, P322, DOI 10.1016/S0002-9343(02)01522-X; Kuwana M, 2006, J THROMB HAEMOST, V4, P1936, DOI 10.1111/j.1538-7836.2006.02091.x; Kuwana M, 2006, RHEUMATOLOGY, V45, P851, DOI 10.1093/rheumatology/kel010; Kuwana M, 2002, J IMMUNOL, V168, P3675, DOI 10.4049/jimmunol.168.7.3675; Kuwana M, 2009, J THROMB HAEMOST, V7, P322, DOI 10.1111/j.1538-7836.2008.03161.x; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mahevas M, 2013, J CLIN INVEST, V123, P432, DOI 10.1172/JCI65689; McMillan R, 2003, J THROMB HAEMOST, V1, P485, DOI 10.1046/j.1538-7836.2003.00091.x; McMillan R, 2007, SEMIN HEMATOL, V44, pS3, DOI 10.1053/j.seminhematol.2007.11.002; MURATA M, 1991, J BIOL CHEM, V266, P15474; NOMURA S, 1991, ACTA HAEMATOL-BASEL, V86, P25; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Stasi R, 2012, SEMIN THROMB HEMOST, V38, P454, DOI 10.1055/s-0032-1305780; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Warner MN, 1999, BRIT J HAEMATOL, V104, P442, DOI 10.1046/j.1365-2141.1999.01218.x; Yamazaki R, 2006, BONE MARROW TRANSPL, V38, P377, DOI 10.1038/sj.bmt.1705444	29	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86943	10.1371/journal.pone.0086943	http://dx.doi.org/10.1371/journal.pone.0086943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466297	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100237
J	Alstott, J; Bullmore, ET; Plenz, D				Alstott, Jeff; Bullmore, Edward T.; Plenz, Dietmar			powerlaw: A Python Package for Analysis of Heavy-Tailed Distributions	PLOS ONE			English	Article							NEURONAL AVALANCHES	Power laws are theoretically interesting probability distributions that are also frequently used to describe empirical data. In recent years, effective statistical methods for fitting power laws have been developed, but appropriate use of these techniques requires significant programming and statistical insight. In order to greatly decrease the barriers to using good statistical methods for fitting power law distributions, we developed the powerlaw Python package. This software package provides easy commands for basic fitting and statistical analysis of distributions. Notably, it also seeks to support a variety of user needs by being exhaustive in the options available to the user. The source code is publicly available and easily extensible.	[Alstott, Jeff; Plenz, Dietmar] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA; [Alstott, Jeff; Bullmore, Edward T.] Univ Cambridge, Behav & Clin Neurosci Inst, Brain Mapping Unit, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Cambridge	Alstott, J (corresponding author), NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA.	alstottjd@mail.nih.gov	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283	National Institute of MentalHealth; Wellcome Trust; Medical Research Council (UK); National Institutes of Health-Oxford-Cambridge Scholarship Program; GlaxoSmithKline (GSK); Medical Research Council [G1000183B, G0001354, G0001354B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER	National Institute of MentalHealth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health-Oxford-Cambridge Scholarship Program; GlaxoSmithKline (GSK)(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of the National Institute of MentalHealth. The Behavioural and Clinical Neuroscience Institute, University of Cambridge, is supported by the Wellcome Trust and the Medical Research Council (UK). J.A. is supported by the National Institutes of Health-Oxford-Cambridge Scholarship Program. E. B. is employed half-time by the University of Cambridge, UK, and half-time by GlaxoSmithKline (GSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would also like to declare one of the authors, Ed Bullmore, is employed half-time by GlaxoSmithKline (GSK), a commercial funder. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Asmussen S., 2003, APPL PROBABILITY QUE, Vsecond; Beggs JM, 2003, J NEUROSCI, V23, P11167; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Ginsburg A, 2012, PLFIT; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Malevergne Y, 2005, QUANT FINANC, V5, P379, DOI 10.1080/14697680500151343; Malevergne Y, 2009, GIBRATS LAW CITIES U, P7; Michel M, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/51; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, POWER LAWS PARETO DI; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	14	397	402	9	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85777	10.1371/journal.pone.0085777	http://dx.doi.org/10.1371/journal.pone.0085777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489671	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000016
J	van Berkel, J; Boot, CRL; Proper, KI; Bongers, PM; van der Beek, AJ				van Berkel, Jantien; Boot, Cecile R. L.; Proper, Karin I.; Bongers, Paulien M.; van der Beek, Allard J.			Effectiveness of a Worksite Mindfulness-Related Multi-Component Health Promotion Intervention on Work Engagement and Mental Health: Results of a Randomized Controlled Trial	PLOS ONE			English	Article							STRESS REDUCTION; ENERGY-BALANCE; WORKPLACE; BENEFITS	Objectives: The aim of the present study was to evaluate the effectiveness of a worksite mindfulness-related multicomponent health promotion intervention on work engagement, mental health, need for recovery and mindfulness. Methods: In a randomized controlled trial design, 257 workers of two research institutes participated. The intervention group (n = 129) received a targeted mindfulness-related training, followed by e-coaching. The total duration of the intervention was 6 months. Data on work engagement, mental health, need for recovery and mindfulness were collected using questionnaires at baseline and after 6 and 12 months follow-up. Effects were analyzed using linear mixed effect models. Results: There were no significant differences in work engagement, mental health, need for recovery and mindfulness between the intervention and control group after either 6- or 12-months follow-up. Additional analyses in mindfulness-related training compliance subgroups (high and low compliance versus the control group as a reference) and subgroups based on baseline work engagement scores showed no significant differences either. Conclusions: This study did not show an effect of this worksite mindfulness-related multi-component health promotion intervention on work engagement, mental health, need for recovery and mindfulness after 6 and 12 months.	[van Berkel, Jantien; Boot, Cecile R. L.; Proper, Karin I.; van der Beek, Allard J.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van Berkel, Jantien; Boot, Cecile R. L.; Proper, Karin I.; Bongers, Paulien M.; van der Beek, Allard J.] TNO VU Univ Med Ctr, Res Ctr Phys Act Work & Hlth, Amsterdam, Netherlands; [Bongers, Paulien M.] TNO Qual Life, Dept Work & Employment, Hoofddorp, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Organization Applied Science Research	Boot, CRL (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	crl.boot@vumc.nl		van der Beek, Allard/0000-0002-4672-9062	Fonds Nuts Ohra (Nuts Ohra Foundation)	Fonds Nuts Ohra (Nuts Ohra Foundation)	This project is part of a research intervention, "Vitality In Practice'', which is financed by Fonds Nuts Ohra (Nuts Ohra Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Demerouti E, 2006, OCCUPATIONAL HLTH PS; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Hakanen JJ, 2012, J AFFECT DISORD; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Klatt MD, 2009, HEALTH EDUC BEHAV, V36, P601, DOI 10.1177/1090198108317627; Mcdaid D, 2007, EPIDEMIOL PSICHIAT S, V16, P294, DOI 10.1017/S1121189X00002463; Ouweneel APE, 2012, THESIS U UTRECHT, P173; Ouweneel APE, 2012, DO IT YOURSELF ONLIN, P147; Ouweneel APE, 2012, INTRO EXPLORING LIT, P9; Ouweneel E, 2009, GEDRAG ORG, V22; Schaufeli W., 2004, UTRECHT U UTRECHT; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Strijk JE, 2012, SCAND J WORK ENV HEA, P3311; Torp S, 2012, HLTH PROMOT INT; Vaez M, 2007, SOC PSYCH PSYCH EPID, V42, P381, DOI 10.1007/s00127-007-0189-9; van Berkel J, 2013, J OCCUP ENVIRON MED, V55, P31, DOI 10.1097/JOM.0b013e318269e5a6; van Berkel J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-736; Van der Zee KI, 1993, METEN ALGEMENE GEZON; van Veldhoven M, 2003, OCCUP ENVIRON MED, V60, P3; World Health Organization, 2010, MENT HLTH WELL BEING; Xanthopoulou D, 2009, J OCCUP ORGAN PSYCH, V82, P183, DOI 10.1348/096317908X285633; Xanthopoulou D, 2009, J VOCAT BEHAV, V74, P235, DOI 10.1016/j.jvb.2008.11.003	24	57	58	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84118	10.1371/journal.pone.0084118	http://dx.doi.org/10.1371/journal.pone.0084118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489648	Green Published, gold			2022-12-27	WOS:000330510000005
J	Bona, A; Papai, Z; Maasz, G; Toth, GA; Jambor, E; Schmidt, J; Toth, C; Farkas, C; Mark, L				Bona, Agnes; Papai, Zoltan; Maasz, Gabor; Toth, Gabor A.; Jambor, Eva; Schmidt, Janos; Toth, Csaba; Farkas, Csilla; Mark, Laszlo			Mass Spectrometric Identification of Ancient Proteins as Potential Molecular Biomarkers for a 2000-Year-Old Osteogenic Sarcoma	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; SPECIES IDENTIFICATION; CELL-LINE; TUMOR; BONE; OSTEOSARCOMA; EXPRESSION; CARCINOMA; REVEALS; PALEOPATHOLOGY	Osteosarcoma is the most common primary malignant tumor of bone usually occurring in young adolescent and children. This disease has a poor prognosis, because of the metastases in the period of tumor progression, which are usually developed previous to the clinical diagnosis. In this paper, a 2000-year-old ancient bone remain with osteogenic sarcoma was analyzed searching for tumor biomarkers which are closely related to this disease. After a specific extraction SDS-PAGE gel electrophoresis followed by tryptic digestion was performed. After the digestion the samples were measured using MALDI TOF/TOF MS. Healthy bone samples from same archaeological site were used as control samples. Our results show that in the pathological skeletal remain several well known tumor biomarkers are detected such as annexin A10, BCL-2-like protein, calgizzarin, rho GTPase-activating protein 7, HSP beta-6 protein, transferrin and vimentin compared to the control samples. The identified protein biomarkers can be useful in the discovery of malignant bone lesions such as osteosarcoma in the very early stage of the disease from paleoanthropological remains.	[Bona, Agnes; Papai, Zoltan; Maasz, Gabor; Jambor, Eva; Schmidt, Janos; Mark, Laszlo] Univ Pecs, Inst Biochem & Med Chem, Dept Analyt Biochem, Pecs, Hungary; [Maasz, Gabor; Schmidt, Janos; Mark, Laszlo] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Maasz, Gabor; Jambor, Eva; Schmidt, Janos; Mark, Laszlo] Univ Pecs, Imaging Ctr Life & Mat Sci, Pecs, Hungary; [Maasz, Gabor; Mark, Laszlo] PTE MTA Human Reprod Res Grp, Pecs, Hungary; [Toth, Gabor A.] Univ West Hungary, Inst Biol, Szombathely, Hungary; [Toth, Csaba] Univ Teaching Hosp Markusovszky, Dept Pathol, Szombathely, Hungary; [Farkas, Csilla] Vas Cty Museums Directorate, Dept Archaeol, Szombathely, Hungary	University of Pecs; University of Pecs; University of Pecs	Mark, L (corresponding author), Univ Pecs, Inst Biochem & Med Chem, Dept Analyt Biochem, Pecs, Hungary.	laszlo.mark@aok.pte.hu	Tóth, Gábor/I-5860-2017; Maász, Gábor/B-7913-2019; Mark, Laszlo/F-7375-2010; Maasz, Gabor/L-1043-2019	Tóth, Gábor/0000-0003-4077-5399; Maász, Gábor/0000-0001-5524-1424; Mark, Laszlo/0000-0002-9301-8159; Maasz, Gabor/0000-0001-5524-1424; Bona, Agnes/0000-0002-4485-9568	Hungarian National Scientific Research Foundation [K72592, D048294, PD 78599]; DDEK Kft. [TIOP 1.3.1-10/12010-0008, TIOP 1.3.1-07/1, TAMOP-4.2.2.A-11/1/KONV-2012-0053]; SciEx Kft.; PTE AOK KA; European Union; State of Hungary; European Social Fund	Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); DDEK Kft.; SciEx Kft.; PTE AOK KA; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This study was supported by the Hungarian National Scientific Research Foundation (OTKA Grant No. K72592, D048294, PD 78599), TIOP 1.3.1-10/12010-0008, TIOP 1.3.1-07/1, TAMOP-4.2.2.A-11/1/KONV-2012-0053, DDEK Kft., SciEx Kft. and PTE AOK KA 2009, 2011 and 2013. This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4. A/2-11/1-2012-0001 National Excellence Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Aufderheide AC, 1997, J PALEOPATHOLOGY, V9, P101; Beckingsale TB, 2010, ORTHOPAEDICS TRAUMA, V24, P321; BLONDIAUX J, 1986, REV NORD, V68, P385, DOI 10.3406/rnord.1986.4220; Bolden JE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.9; Boros-Major A, 2011, J ARCHAEOL SCI, V38, P197, DOI 10.1016/j.jas.2010.09.008; Brothwell D, 1981, DIGGING BONES, P139; Brothwell D., 1967, DIS ANTIQUITY, P320; Buckley M, 2008, J ARCHAEOL SCI, V35, P1756, DOI 10.1016/j.jas.2007.11.022; Buckley M, 2008, ANAL BIOCHEM, V374, P325, DOI 10.1016/j.ab.2007.12.002; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Campillo D, 1976, LESIONES PATOLOGICAS, P93; Capasso L, 1992, J PALEOPATHOLOGY, V4, P55; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; DASTUGUE J, 1965, B ASSOC FR ETUD CANC, V52, P69; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Folio C, 2009, J PROTEOME RES, V8, P3882, DOI 10.1021/pr900113w; Gerszten E, 1991, HUMAN PALEOPATHOLOGY, P257; Jozsa L, 2006, PALEOPATHOLOGIA, P74; Kang JH, 2006, J PROTEOME RES, V5, P2620, DOI 10.1021/pr060111i; KELLN EE, 1967, ORAL SURG ORAL MED O, V23, P78, DOI 10.1016/0030-4220(67)90488-4; Kim JK, 2010, ONCOL REP, V24, P607, DOI 10.3892/or_00000898; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Knussmann R, 1988, ANTHROPOLOGIE, P421; Li GD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-150; Li N, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-122; Li Y, 2010, CANCER GENET CYTOGEN, V198, P97, DOI 10.1016/j.cancergencyto.2010.01.003; Melle C, 2006, INT J ONCOL, V28, P195; Nielsen-Marsh CM, 2009, J ARCHAEOL SCI, V36, P1758, DOI 10.1016/j.jas.2009.04.004; Nielsen-Marsh CM, 2005, P NATL ACAD SCI USA, V102, P4409, DOI 10.1073/pnas.0500450102; Niforou Katerina N., 2008, Cancer Genomics & Proteomics, V5, P63; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Ottina E, 2012, EXP CELL RES, V318, P1291, DOI 10.1016/j.yexcr.2012.01.021; Rehman I, 2004, HUM PATHOL, V35, P1385, DOI 10.1016/j.humpath.2004.07.015; Ruffer MA, 1914, J PATHOL BACTERIOL, V18, P480; Schultz M, 2007, INT J CANCER, V121, P2591, DOI 10.1002/ijc.23073; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Strouhal E., 1996, J PALEOPATHOL, V8, P5; Suehara Yoshiyuki, 2012, Sarcoma, V2012, P425636, DOI 10.1155/2012/425636; SUZUKI T, 1987, AM J PHYS ANTHROPOL, V74, P309, DOI 10.1002/ajpa.1330740305; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Willimott S, 2012, J BIOL CHEM, V287, P2608, DOI 10.1074/jbc.M111.285718; Yang XY, 2011, CANCER RES, V71, P2916, DOI 10.1158/0008-5472.CAN-10-2158; Zhang T, 2009, CANCER LETT, V283, P59, DOI 10.1016/j.canlet.2009.03.025; Zhao Chun-Hong, 2006, Genomics Proteomics & Bioinformatics, V4, P10, DOI 10.1016/S1672-0229(06)60011-9	46	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87215	10.1371/journal.pone.0087215	http://dx.doi.org/10.1371/journal.pone.0087215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475253	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330507300154
J	Buscariollo, DL; Fang, XF; Greenwood, V; Xue, HL; Rivkees, SA; Wendler, CC				Buscariollo, Daniela L.; Fang, Xiefan; Greenwood, Victoria; Xue, Huiling; Rivkees, Scott A.; Wendler, Christopher C.			Embryonic Caffeine Exposure Acts via A1 Adenosine Receptors to Alter Adult Cardiac Function and DNA Methylation in Mice	PLOS ONE			English	Article							METABOLIC SYNDROME; GENE; EXPRESSION; HEART; RISK; HYPERTROPHY; EPIGENOMICS; CONSUMPTION; TRIMESTER; ALCOHOL	Evidence indicates that disruption of normal prenatal development influences an individual's risk of developing obesity and cardiovascular disease as an adult. Thus, understanding how in utero exposure to chemical agents leads to increased susceptibility to adult diseases is a critical health related issue. Our aim was to determine whether adenosine A1 receptors (A1ARs) mediate the long-term effects of in utero caffeine exposure on cardiac function and whether these long-term effects are the result of changes in DNA methylation patterns in adult hearts. Pregnant A1AR knockout mice were treated with caffeine (20 mg/kg) or vehicle (0.09% NaCl) i.p. at embryonic day 8.5. This caffeine treatment results in serum levels equivalent to the consumption of 2-4 cups of coffee in humans. After dams gave birth, offspring were examined at 8-10 weeks of age. A1AR+/+ offspring treated in utero with caffeine were 10% heavier than vehicle controls. Using echocardiography, we observed altered cardiac function and morphology in adult mice exposed to caffeine in utero. Caffeine treatment decreased cardiac output by 11% and increased left ventricular wall thickness by 29% during diastole. Using DNA methylation arrays, we identified altered DNA methylation patterns in A1AR+/+ caffeine treated hearts, including 7719 differentially methylated regions (DMRs) within the genome and an overall decrease in DNA methylation of 26%. Analysis of genes associated with DMRs revealed that many are associated with cardiac hypertrophy. These data demonstrate that A1ARs mediate in utero caffeine effects on cardiac function and growth and that caffeine exposure leads to changes in DNA methylation.	[Buscariollo, Daniela L.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Fang, Xiefan; Rivkees, Scott A.; Wendler, Christopher C.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA; [Greenwood, Victoria] Univ Connecticut, Storrs, CT USA; [Xue, Huiling] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida; University of Connecticut; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wendler, CC (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA.	cwendler@ufl.edu	Fang, Xiefan/G-1186-2015	Fang, Xiefan/0000-0002-7804-7832	NIH [R01 HD058086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from NIH R01 HD058086 (Scott Rivkees and Christopher Wendler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkader TS, 2012, J APPL TOXICOL; Balkau B, 2007, DIABETES METAB, V33, P405, DOI 10.1016/j.diabet.2007.08.001; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Brent RL, 2011, BIRTH DEFECTS RES B, V92, P152, DOI 10.1002/bdrb.20288; Browne ML, 2006, EPIDEMIOLOGY, V17, P324, DOI 10.1097/01.ede.0000208476.36988.44; Buscariollo DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028296; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Christian MS, 2001, TERATOLOGY, V64, P51, DOI 10.1002/tera.1047; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; Cnattingius S, 2003, FOOD CHEM TOXICOL, V41, P1202, DOI 10.1016/S0278-6915(03)00103-0; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cooper-Dehoff RM, 2007, CLIN CARDIOL, V30, P593, DOI 10.1002/clc.7; Curtis LH, 2007, DIABETES CARE, V30, P2553, DOI 10.2337/dc07-0460; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Espinoza-Lewis RA, 2012, CURR TOP DEV BIOL, V100, P279, DOI 10.1016/B978-0-12-387786-4.00009-9; Fang XF, 2013, ENVIRON TOXICOL PHAR, V36, P40, DOI 10.1016/j.etap.2013.02.014; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; IMAMURA S, 1992, CIRC RES, V71, P1031, DOI 10.1161/01.RES.71.5.1031; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KOOS BJ, 1994, AM J PHYSIOL, V266, pR215, DOI 10.1152/ajpregu.1994.266.1.R215; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LARROQUE B, 1993, AM J EPIDEMIOL, V137, P941, DOI 10.1093/oxfordjournals.aje.a116764; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Matsuoka R, 1987, Am J Med Genet Suppl, V3, P433; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Obunai K, 2007, MED CLIN N AM, V91, P1169, DOI 10.1016/j.mcna.2007.06.003; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Palmke N, 2011, METHODS, V53, P175, DOI 10.1016/j.ymeth.2010.07.006; Ping J, 2012, CHEM-BIOL INTERACT, V195, P68, DOI 10.1016/j.cbi.2011.11.001; Qiao Q, 2007, ANN CLIN BIOCHEM, V44, P232, DOI 10.1258/000456307780480963; RIVKEES SA, 1995, DEV BRAIN RES, V89, P202, DOI 10.1016/0165-3806(95)00120-3; Rivkees SA, 2001, MOL GENET METAB, V74, P160, DOI 10.1006/mgme.2001.3217; Rivkees SA, 2012, ARTERIOSCL THROM VAS, V32, P851, DOI 10.1161/ATVBAHA.111.226811; Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf; ROSS CP, 1986, HISTOL HISTOPATHOL, V1, P13; Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7; Simon DK, 2008, CLIN NEUROPHARMACOL, V31, P189, DOI 10.1097/WNF.0b013e31815a3f03; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; Wendler CC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-57; Wendler CC, 2009, FASEB J, V23, P1272, DOI 10.1096/fj.08-124941; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; Workman C, 2002, GENOME BIOL, V3; Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497; Yeh CH, 2012, DRUG CHEM TOXICOL; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	62	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87547	10.1371/journal.pone.0087547	http://dx.doi.org/10.1371/journal.pone.0087547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475304	Green Published, gold			2022-12-27	WOS:000330507300198
J	Coan, AC; Campos, BM; Yasuda, CL; Kubota, BY; Bergo, FPG; Guerreiro, CAM; Cendes, F				Coan, Ana C.; Campos, Brunno M.; Yasuda, Clarissa L.; Kubota, Bruno Y.; Bergo, Felipe P. G.; Guerreiro, Carlos A. M.; Cendes, Fernando			Frequent Seizures Are Associated with a Network of Gray Matter Atrophy in Temporal Lobe Epilepsy with or without Hippocampal Sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ABNORMALITIES	Objective: Patients with temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS) have diffuse subtle gray matter (GM) atrophy detectable by MRI quantification analyses. However, it is not clear whether the etiology and seizure frequency are associated with this atrophy. We aimed to evaluate the occurrence of GM atrophy and the influence of seizure frequency in patients with TLE and either normal MRI (TLE-NL) or MRI signs of HS (TLE-HS). Methods: We evaluated a group of 172 consecutive patients with unilateral TLE-HS or TLE-NL as defined by hippocampal volumetry and signal quantification (122 TLE-HS and 50 TLE-NL) plus a group of 82 healthy individuals. Voxel-based morphometry was performed with VBM8/SPM8 in 3T MRIs. Patients with up to three complex partial seizures and no generalized tonic-clonic seizures in the previous year were considered to have infrequent seizures. Those who did not fulfill these criteria were considered to have frequent seizures. Results: Patients with TLE-HS had more pronounced GM atrophy, including the ipsilateral mesial temporal structures, temporal lobe, bilateral thalami and pre/post-central gyri. Patients with TLE-NL had more subtle GM atrophy, including the ipsilateral orbitofrontal cortex, bilateral thalami and pre/post-central gyri. Both TLE-HS and TLE-NL showed increased GM volume in the contralateral pons. TLE-HS patients with frequent seizures had more pronounced GM atrophy in extra-temporal regions than TLE-HS with infrequent seizures. Patients with TLE-NL and infrequent seizures had no detectable GM atrophy. In both TLE-HS and TLE-NL, the duration of epilepsy correlated with GM atrophy in extra-hippocampal regions. Conclusion: Although a diffuse network GM atrophy occurs in both TLE-HS and TLE-NL, this is strikingly more evident in TLE-HS and in patients with frequent seizures. These findings suggest that neocortical atrophy in TLE is related to the ongoing seizures and epilepsy duration, while thalamic atrophy is more probably related to the original epileptogenic process.	[Coan, Ana C.; Campos, Brunno M.; Yasuda, Clarissa L.; Kubota, Bruno Y.; Bergo, Felipe P. G.; Guerreiro, Carlos A. M.; Cendes, Fernando] Univ Estadual Campinas, Dept Neurol, Neuroimaging Lab, Campinas, SP, Brazil	Universidade Estadual de Campinas	Cendes, F (corresponding author), Univ Estadual Campinas, Dept Neurol, Neuroimaging Lab, Campinas, SP, Brazil.	fcendes@unicamp.br	Coan, Ana Carolina/AAA-7887-2020; Cendes, Fernando/C-1301-2012; yasuda, clarissa l/B-7934-2013; de Campos, Brunno Machado/L-8423-2013; Coan, Ana Carolina/F-4982-2012; yasuda, clarissa lin/D-4599-2018; Bergo, Felipe/K-9662-2015	Coan, Ana Carolina/0000-0002-2888-929X; Cendes, Fernando/0000-0001-9336-9568; yasuda, clarissa l/0000-0001-9084-7173; de Campos, Brunno Machado/0000-0003-1261-8257; Coan, Ana Carolina/0000-0002-2888-929X; yasuda, clarissa lin/0000-0001-9084-7173; Bergo, Felipe/0000-0003-3305-5617	Sao Paulo Research Foundation (FAPESP) [2005/56578-4, 2009/54552-9, 2011/03477-7]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Sao Paulo Research Foundation (FAPESP), grants 2005/56578-4, 2009/54552-9, and 2011/03477-7. Dr. Cendes received support from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barron DS, 2013, NEUROIMAGE-CLIN, V2, P25, DOI 10.1016/j.nicl.2012.11.004; Bell ML, 2009, EPILEPSIA, V50, P2053, DOI 10.1111/j.1528-1167.2009.02079.x; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bernhardt BC, 2010, NEUROLOGY, V74, P1776, DOI 10.1212/WNL.0b013e3181e0f80a; Bilevicius E, 2010, NEUROLOGY, V75, P1695, DOI 10.1212/WNL.0b013e3181fc29dd; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonilha L, 2006, EPILEPSIA, V47, P908, DOI 10.1111/j.1528-1167.2006.00548.x; Bonilha L, 2005, NEUROIMAGE, V25, P1016, DOI 10.1016/j.neuroimage.2004.11.050; Bonilha L, 2004, ARCH NEUROL-CHICAGO, V61, P1379, DOI 10.1001/archneur.61.9.1379; Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038; Coan AC, 2013, AJNR AM J NEURORADIO; Coan AC, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00166; Cohen-Gadol AA, 2005, J NEUROSURG, V102, P902, DOI 10.3171/jns.2005.102.5.0902; Diehl B, 2003, EPILEPSIA, V44, P559, DOI 10.1046/j.1528-1157.2003.36202.x; Eriksson SH, 2009, HUM BRAIN MAPP, V30, P3351, DOI 10.1002/hbm.20757; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HAUSER WA, 1992, EPILEPSY SURGERY, P133; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Keller SS, 2004, NEUROIMAGE, V23, P860, DOI 10.1016/j.neuroimage.2004.07.030; Keller SS, 2002, J NEUROL NEUROSUR PS, V73, P648, DOI 10.1136/jnnp.73.6.648; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Labate A, 2011, NAT REV NEUROL, V7, P237, DOI 10.1038/nrneurol.2010.212; Labate A, 2011, EPILEPSIA, V52, P712, DOI 10.1111/j.1528-1167.2011.03038.x; Labate A, 2010, EPILEPSIA, V51, P506, DOI 10.1111/j.1528-1167.2009.02310.x; Li JP, 2012, EPILEPSY RES, V98, P97, DOI 10.1016/j.eplepsyres.2011.10.002; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; Morita ME, 2012, NEUROLOGY, V79, P2349, DOI 10.1212/WNL.0b013e318278b63f; Mueller SG, 2009, NEUROIMAGE, V46, P353, DOI 10.1016/j.neuroimage.2009.02.020; Mueller SG, 2006, EPILEPSIA, V47, P900, DOI 10.1111/j.1528-1167.2006.00512.x; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Van Paesschen W, 2003, BRAIN, V126, P1103, DOI 10.1093/brain/awg108; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Yasuda CL, 2010, NEUROLOGY, V74, P1062, DOI 10.1212/WNL.0b013e3181d76b72	39	45	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85843	10.1371/journal.pone.0085843	http://dx.doi.org/10.1371/journal.pone.0085843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475055	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300026
J	Grossman, Z; Schapiro, JM; Levy, I; Elbirt, D; Chowers, M; Riesenberg, K; Olstein-Pops, K; Shahar, E; Istomin, V; Asher, I; Gottessman, BS; Shemer, Y; Elinav, H; Hassoun, G; Rosenberg, S; Averbuch, D; Machleb-Guri, K; Kra-Oz, Z; Radian-Sade, S; Rudich, H; Ram, D; Maayan, S; Agmon-Levin, N; Sthoeger, Z				Grossman, Zehava; Schapiro, Jonathan M.; Levy, Itzchak; Elbirt, Daniel; Chowers, Michal; Riesenberg, Klaris; Olstein-Pops, Karen; Shahar, Eduardo; Istomin, Valery; Asher, Ilan; Gottessman, Bat-Sheva; Shemer, Yonat; Elinav, Hila; Hassoun, Gamal; Rosenberg, Shira; Averbuch, Diana; Machleb-Guri, Keren; Kra-Oz, Zipi; Radian-Sade, Sara; Rudich, Hagit; Ram, Daniela; Maayan, Shlomo; Agmon-Levin, Nancy; Sthoeger, Zev			Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; COMBINATION THERAPY; CONTAINING REGIMENS; TREATMENT RESPONSE; MUTATION PATTERNS; PROTEASE GENE; CLADE-C; LOPINAVIR; INFECTION	Background: Analysis of potentially different impact of Lopinavir/Ritonavir (LPV/r) on non-B subtypes is confounded by dissimilarities in the conditions existing in different countries. We retrospectively compared its impact on populations infected with subtypes B and C in Israel, where patients infected with different subtypes receive the same treatment. Methods: Clinical and demographic data were reported by physicians. Resistance was tested after treatment failure. Statistical analyses were conducted using SPSS. Results: 607 LPV/r treated patients (365 male) were included. 139 had HIV subtype B, 391 C, and 77 other subtypes. At study end 429 (71%) were receiving LPV/r. No significant differences in PI treatment history and in median viral-load (VL) at treatment initiation and termination existed between subtypes. MSM discontinued LPV/r more often than others even when the virologic outcome was good (p = 0.001). VL was below detection level in 81% of patients for whom LPV/r was first PI and in 67% when it was second (P = 0.001). Median VL decrease from baseline was 1.9 +/- 0.1 logs and was not significantly associated with subtype. Median CD4 increase was: 162 and 92cells/ml, respectively, for patients receiving LPV/r as first and second PI (P = 0.001), and 175 and 98, respectively, for subtypes B and C (P, 0.001). Only 52 (22%) of 237 patients genotyped while under LPV/r were fully resistant to the drug; 12(5%) were partially resistant. In48%, population sequencing did not reveal resistance to any drug notwithstanding the virologic failure. No difference was found in the rates of resistance development between B and C (p = 0.16). Conclusions: Treatment with LPV/r appeared efficient and tolerable in both subtypes, B and C, but CD4 recovery was significantly better in virologically suppressed subtype-B patients. In both subtypes, LPV/r was more beneficial when given as first PI. Mostly, reasons other than resistance development caused discontinuation of treatment.	[Grossman, Zehava] Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; [Schapiro, Jonathan M.; Levy, Itzchak] Sheba Med Ctr, Ramat Gan, Israel; [Elbirt, Daniel; Asher, Ilan; Rosenberg, Shira; Machleb-Guri, Keren; Radian-Sade, Sara; Agmon-Levin, Nancy; Sthoeger, Zev] Kaplan Med Ctr, Rehovot, Israel; [Chowers, Michal; Gottessman, Bat-Sheva] Meir Med Ctr, Kefar Sava, Israel; [Riesenberg, Klaris; Shemer, Yonat] Soroka Med Ctr, IL-84101 Beer Sheva, Israel; [Olstein-Pops, Karen; Elinav, Hila; Averbuch, Diana; Maayan, Shlomo] Hadassah Med Ctr, IL-91120 Jerusalem, Israel; [Shahar, Eduardo; Hassoun, Gamal; Kra-Oz, Zipi] Rambam Med Ctr, Haifa, Israel; [Istomin, Valery] Hillel Yaffe Med Ctr, Hadera, Israel; [Rudich, Hagit; Ram, Daniela] MOH, PHL, Natl HIV Reference Lab, Ramat Gan, Israel	Tel Aviv University; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology	Grossman, Z (corresponding author), Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.	zehava.grossman@gmail.com	RIESENBERG, KLARIS/F-1132-2012; Averbuch, Dina/ABA-6433-2020	Chowers, Michal/0000-0001-6148-254X				Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; [Anonymous], 2017, 2013 UNAIDS REP GLOB; ANRS AC11 Resistance Study Group, 2012, HIV 1 GEN DRUG RES I; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Averbuch D, 2006, PEDIATR INFECT DIS J, V25, P1049, DOI 10.1097/01.inf.0000243211.36690.d5; Avidor B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057789; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Barber TJ, 2012, J ANTIMICROB CHEMOTH, V67, P995, DOI 10.1093/jac/dkr569; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Buonaguro FM, 1996, ANTIBIOT CHEMOTHER, V48, P39; Cane PA, 2001, J CLIN MICROBIOL, V39, P2652, DOI 10.1128/JCM.39.7.2652-2654.2001; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Champenois K, 2008, J MED VIROL, V80, P1871, DOI 10.1002/jmv.21315; Chemtob D, 2004, INT J STD AIDS, V15, P691, DOI 10.1258/0956462041944321; Conradie F, 2004, AIDS, V18, P1084, DOI 10.1097/00002030-200404300-00024; Cornelissen M, 1997, J VIROL, V71, P6348, DOI 10.1128/JVI.71.9.6348-6358.1997; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; De Wit S, 2004, AIDS, V18, P2330, DOI 10.1097/00002030-200411190-00016; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Di Giambenedetto S, 2009, ANTIVIR THER, V14, P359; Diaz RS, 2008, JAIDS-J ACQ IMM DEF, V47, P399, DOI 10.1097/QAI.0b013e31815b0d48; Falloon J, 2000, CLIN INFECT DIS, V30, P313, DOI 10.1086/313667; Friend J, 2004, AIDS, V18, P1965, DOI 10.1097/00002030-200409240-00016; Government SA, 2007, S AFR GUID, P76; Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Hamers RL, 2013, LANCET INFECT DIS, V13, P196, DOI 10.1016/S1473-3099(13)70012-4; Hamers RL, 2012, INT J EPIDEMIOL, V41, P43, DOI 10.1093/ije/dyq192; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kantor R, 2001, NUCLEIC ACIDS RES, V29, P296, DOI 10.1093/nar/29.1.296; Kempf DJ, 2001, J VIROL, V75, P7462, DOI 10.1128/JVI.75.16.7462-7469.2001; King J, 2008, AIDS, V22, P1709, DOI 10.1097/QAD.0b013e32830163ad; Levison JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032144; Levy I, 2011, CLIN INFECT DIS, V52, P1363, DOI 10.1093/cid/cir244; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lockman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001236; Lodwick RK, 2008, AIDS, V22, P1039, DOI 10.1097/QAD.0b013e3282fec415; MAAYAN S, 1994, AIDS, V8, P133, DOI 10.1097/00002030-199401000-00024; Maillard A, 2007, J CLIN VIROL, V38, P131, DOI 10.1016/j.jcv.2006.11.011; Maroldo L, 2010, J INT AIDS SOC S4, pP30; Murphy RL, 2008, HIV CLIN TRIALS, V9, P1, DOI 10.1310/hct0901-1; Parkin NT, 2003, AIDS, V17, P955, DOI 10.1097/00002030-200305020-00003; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; POLLACK S, 1994, ACTA PAEDIATR, V83, P19, DOI 10.1111/j.1651-2227.1994.tb13327.x; Pulido F, 2008, J ANTIMICROB CHEMOTH, V61, P1359, DOI 10.1093/jac/dkn103; Quinnan GV, 1999, AIDS RES HUM RETROV, V15, P561, DOI 10.1089/088922299311088; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2005, J INFECT DIS, V192, P456, DOI 10.1086/431601; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Taiwo B, 2010, DRUGS, V70, P1629, DOI 10.2165/11538020-000000000-00000; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; WHO, 2008, WORLD HLTH REPORT 20; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003	70	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86239	10.1371/journal.pone.0086239	http://dx.doi.org/10.1371/journal.pone.0086239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475093	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300047
J	Kidia, KK; Mupambireyi, Z; Cluver, L; Ndhlovu, CE; Borok, M; Ferrand, RA				Kidia, Khameer K.; Mupambireyi, Zivai; Cluver, Lucie; Ndhlovu, Chiratidzo E.; Borok, Margaret; Ferrand, Rashida A.			HIV Status Disclosure to Perinatally-Infected Adolescents in Zimbabwe: A Qualitative Study of Adolescent and Healthcare Worker Perspectives	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; BARRIERS	Introduction & Objectives: Due to the scale up of antiretroviral therapy, increasing numbers of HIV-infected children are living into adolescence. As these children grow and surpass the immediate threat of death, the issue of informing them of their HIV status arises. This study aimed to understand how perinatally-infected adolescents learn about their HIV-status as well as to examine their preferences for the disclosure process. Methods: In-depth interviews were conducted with 31 (14 male, 17 female) perinatally-infected adolescents aged 16-20 at an HIV clinic in Harare, Zimbabwe, and focused on adolescents' experiences of disclosure. In addition, 15 (1 male, 14 female) healthcare workers participated in two focus groups that were centred on healthcare workers' practices surrounding disclosure in the clinic. Purposive sampling was used to recruit participants. A coding frame was developed and major themes were extracted using grounded theory methods. Results: Healthcare workers encouraged caregivers to initiate disclosure in the home environment. However, many adolescents preferred disclosure to take place in the presence of healthcare workers at the clinic because it gave them access to accurate information as well as an environment that made test results seem more credible. Adolescents learned more specific information about living with an HIV-positive status and the meaning of that status from shared experiences among peers at the clinic. Conclusions: HIV-status disclosure to adolescents is distinct from disclosure to younger children and requires tailored, age-appropriate guidelines. Disclosure to this age group in a healthcare setting may help overcome some of the barriers associated with caregivers disclosing in the home environment and make the HIV status seem more credible to an adolescent. The study also highlights the value of peer support among adolescents, which could help reduce the burden of psychosocial care on caregivers and healthcare workers.	[Kidia, Khameer K.; Cluver, Lucie] Univ Oxford, Oxford, England; [Mupambireyi, Zivai] UCL, London, England; [Mupambireyi, Zivai] Ctr Sexual Hlth & HIV AIDS Res, Harare, Zimbabwe; [Cluver, Lucie] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Ndhlovu, Chiratidzo E.; Borok, Margaret] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Ferrand, Rashida A.] London Sch Hyg & Trop Med, London WC1, England; [Ferrand, Rashida A.] Biomed Res & Training Inst, Harare, Zimbabwe	University of Oxford; University of London; University College London; University of Cape Town; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine; Biomedical Research Training Institute	Kidia, KK (corresponding author), Univ Oxford, Oxford, England.	kkidia@gmail.com	; Ndhlovu, Chiratidzo Ellen/N-8763-2013	Cluver, Lucie/0000-0002-0418-835X; Ndhlovu, Chiratidzo Ellen/0000-0001-7863-7974	Godfrey Lienhardt Grant	Godfrey Lienhardt Grant	This study was financed in part by a Godfrey Lienhardt Grant to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrive E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033690; Barbour R., 2007, DOING FOCUS GROUPS; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; De Bacts AJ, 2008, SOC SCI MED, V66, P479, DOI 10.1016/j.socscimed.2007.08.028; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Ferguson J, 2013, 7 INT AIDS SOC C; FunckBrentano I, 1995, PSYCHIAT ENFANT, V38, P109; Glaser B.G., 1968, DISCOV GROUNDED THEO; Greeff M, 2008, QUAL HEALTH RES, V18, P311, DOI 10.1177/1049732307311118; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Instone S L, 2000, J Pediatr Health Care, V14, P235, DOI 10.1067/mph.2000.107338; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Liampputtong P, 2013, QUALITATIVE RES METH; LIPSON M, 1994, J DEV BEHAV PEDIATR, V15, pS61; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; MAYER RE, 1983, J EDUC PSYCHOL, V75, P40, DOI 10.1037/0022-0663.75.1.40; Mellins C.A., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [https://doi.org/10.1177/1359104502007001008, DOI 10.1177/1359104502007001008, 10.1177/1359104502007001008]; Ministry of Health & Child Welfare, 2008, ZIMB NAT GUID HIV TE; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Muller AD, 2011, AIDS CARE, V23, P129, DOI 10.1080/09540121003758523; Open Society, 2009, BEST PRACT GUID HIV; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Remien RH, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000298104.02356.b3; Riekert KA, 1999, CHILD HEALTH CARE, V28, P201, DOI 10.1207/s15326888chc2803_1; Skhosana Nokuthula L, 2006, Afr J AIDS Res, V5, P17, DOI 10.2989/16085900609490363; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; Strauss A., 1990, BASICS QUALITATIVE R; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; UNAIDS, 2012, GLOB REP WORLD AIDS; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; WHO, 2013, HIV AD GUID HIV TEST; Wiener L, 1998, HIV SOCIAL WORK PRAC, P327; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wiener LS, 2006, J ADOLESCENT HEALTH, V38, P307, DOI 10.1016/j.jadohealth.2005.03.024; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; Yoshioka MR, 2001, AIDS PATIENT CARE ST, V15, P77, DOI 10.1089/108729101300003672	41	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87322	10.1371/journal.pone.0087322	http://dx.doi.org/10.1371/journal.pone.0087322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475271	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330507300167
J	Liang, GY; Lian, CJ; Huang, D; Gao, WJ; Liang, AJ; Peng, Y; Ye, W; Wu, ZZ; Su, PQ; Huang, DS				Liang, Guoyan; Lian, Chengjie; Huang, Di; Gao, Wenjie; Liang, Anjing; Peng, Yan; Ye, Wei; Wu, Zizhao; Su, Peiqiang; Huang, Dongsheng			Endoplasmic Reticulum Stress-Unfolding Protein Response-Apoptosis Cascade Causes Chondrodysplasia in a col2a1 p.Gly1170Ser Mutated Mouse Model	PLOS ONE			English	Article							DISPROPORTIONATE MICROMELIA DMM; SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; CARTILAGE COLLAGEN FIBRILS; II PROCOLLAGEN COL2A1; TRANSGENIC MICE; SKELETAL DEVELOPMENT; PHENOTYPIC SPECTRUM; DELETED GENE; ER STRESS; OSTEOARTHRITIS	The collagen type II alpha 1 (COL2A1) mutation causes severe skeletal malformations, but the pathogenic mechanisms of how this occurs are unclear. To understand how this may happen, a col2a1 p.Gly1170Ser mutated mouse model was constructed and in homozygotes, the chondrodysplasia phenotype was observed. Misfolded procollagen was largely synthesized and retained in dilated endoplasmic reticulum and the endoplasmic reticulum stress (ERS)-unfolded protein response (UPR)-apoptosis cascade was activated. Apoptosis occurred prior to hypertrophy, prevented the formation of a hypertrophic zone, disrupted normal chondrogenic signaling pathways, and eventually caused chondrodysplasia. Heterozygotes had normal phenotypes and endoplasmic reticulum stress intensity was limited with no abnormal apoptosis detected. Our results suggest that earlier chondrocyte death was related to the ERS-UPR-apoptosis cascade and that this was the chief cause of chondrodysplaia. The col2a1 p.Gly1170Ser mutated mouse model offered a novel connection between misfolded collagen and skeletal malformation. Further investigation of this mouse mutant model can help us understand mechanisms of type II collagenopathies.	[Liang, Guoyan; Lian, Chengjie; Gao, Wenjie; Liang, Anjing; Peng, Yan; Ye, Wei; Wu, Zizhao; Huang, Dongsheng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Di] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510275, Guangdong, Peoples R China; [Su, Peiqiang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Su, PQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China.	spq88007@yahoo.com.cn; huangdongshen18@hotmail.com	Liang, Guoyan/AEL-4482-2022; Lian, Cheng/HHS-1095-2022	Lian, Cheng/0000-0002-9016-832X	National Natural Science Foundation of China [81371907, 30971587, 81071703]; Fundamental Research Funds for the Central Universities [11ykzd10]; Science Foundation of Guangdong Province [2010B031600224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (No. 81371907, No. 30971587 and No. 81071703), the Fundamental Research Funds for the Central Universities (No. 11ykzd10), and the Science Foundation of Guangdong Province (2010B031600224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2002, OSTEOARTHR CARTILAGE, V10, P808, DOI 10.1053/joca.2002.0830; Barbieri O, 2003, AM J PHYSIOL-CELL PH, V285, pC1504, DOI 10.1152/ajpcell.00579.2002; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bomsta BD, 2006, OSTEOARTHR CARTILAGE, V14, P477, DOI 10.1016/j.joca.2005.11.011; BROWN KS, 1981, J EMBRYOL EXP MORPH, V62, P165; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chiu LH, 2012, J CELL PHYSIOL, V227, P2412, DOI 10.1002/jcp.22976; Chiu LH, 2011, J CELL PHYSIOL, V226, P1981, DOI 10.1002/jcp.22530; Chung HJ, 2009, J MOL BIOL, V390, P306, DOI 10.1016/j.jmb.2009.05.004; Donahue LR, 2003, J BONE MINER RES, V18, P1612, DOI 10.1359/jbmr.2003.18.9.1612; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; EYRE DR, 1991, J CLIN INVEST, V87, P357, DOI 10.1172/JCI114994; Fernandes RJ, 2003, MATRIX BIOL, V22, P449, DOI 10.1016/S0945-053X(03)00077-5; FOSTER MJ, 1994, ANAT REC, V238, P454, DOI 10.1002/ar.1092380404; Furuichi T, 2011, MAMM GENOME, V22, P318, DOI 10.1007/s00335-011-9329-3; Gaiser KG, 2002, J BONE MINER RES, V17, P39, DOI 10.1359/jbmr.2002.17.1.39; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; HELMINEN HJ, 1993, J CLIN INVEST, V92, P582, DOI 10.1172/JCI116625; Hintze V, 2008, HUM MUTAT, V29, P841, DOI 10.1002/humu.20736; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; Jensen DA, 2011, HUM MUTAT, V32, P794, DOI 10.1002/humu.21506; Kannu P, 2012, J PAEDIATR CHILD H, V48, pE38, DOI 10.1111/j.1440-1754.2010.01979.x; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maddox BK, 1997, MATRIX BIOL, V16, P93, DOI 10.1016/S0945-053X(97)90038-X; Maddox BK, 1997, DEV DYNAM, V208, P170, DOI 10.1002/(SICI)1097-0177(199702)208:2<170::AID-AJA4>3.0.CO;2-F; METSARANTA M, 1992, J CELL BIOL, V118, P203, DOI 10.1083/jcb.118.1.203; Nieminen J, 2008, CALCIFIED TISSUE INT, V82, P229, DOI 10.1007/s00223-008-9110-0; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Pace JM, 1997, DEV DYNAM, V208, P25; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Saamanen AMK, 2000, OSTEOARTHR CARTILAGE, V8, P248, DOI 10.1053/joca.2000.0298; Sahlman J, 2004, ARTHRITIS RHEUM-US, V50, P3153, DOI 10.1002/art.20552; Schneiderbauer MM, 2004, CELL SIGNAL, V16, P1133, DOI 10.1016/j.cellsig.2004.03.004; Seegmiller RE, 2008, J HISTOCHEM CYTOCHEM, V56, P1003, DOI 10.1369/jhc.2008.951673; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Su PQ, 2008, ARTHRITIS RHEUM-US, V58, P1701, DOI 10.1002/art.23491; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640	41	23	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86894	10.1371/journal.pone.0086894	http://dx.doi.org/10.1371/journal.pone.0086894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475193	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300115
J	Marquis, M; Boulet, S; Mathien, S; Rousseau, J; Thebault, P; Daudelin, F; Rooney, J; Turgeon, B; Beauchamp, C; Meloche, S; Labrecque, N				Marquis, Miriam; Boulet, Salix; Mathien, Simon; Rousseau, Justine; Thebault, Pamela; Daudelin, Francois; Rooney, Julie; Turgeon, Benjamin; Beauchamp, Claudine; Meloche, Sylvain; Labrecque, Nathalie			The Non-Classical MAP Kinase ERK3 Controls T Cell Activation	PLOS ONE			English	Article							SIGNAL-REGULATED KINASES; HUMAN CDC14A PHOSPHATASE; DIFFERENTIAL REGULATION; CHROMOSOME SEGREGATION; EXPRESSION; MK5; PHOSPHORYLATION; PROLIFERATION; RECEPTOR; MEMORY	The classical mitogen-activated protein kinases (MAPKs) ERK1 and ERK2 are activated upon stimulation of cells with a broad range of extracellular signals (including antigens) allowing cellular responses to occur. ERK3 is an atypical member of the MAPK family with highest homology to ERK1/2. Therefore, we evaluated the role of ERK3 in mature T cell response. Mouse resting T cells do not transcribe ERK3 but its expression is induced in both CD4(+) and CD8(+) T cells following T cell receptor (TCR)-induced T cell activation. This induction of ERK3 expression in T lymphocytes requires activation of the classical MAPK ERK1 and ERK2. Moreover, ERK3 protein is phosphorylated and associates with MK5 in activated primary T cells. We show that ERK3-deficient T cells have a decreased proliferation rate and are impaired in cytokine secretion following in vitro stimulation with low dose of anti-CD3 antibodies. Our findings identify the atypical MAPK ERK3 as a new and important regulator of TCR-induced T cell activation.	[Marquis, Miriam; Boulet, Salix; Thebault, Pamela; Daudelin, Francois; Rooney, Julie; Beauchamp, Claudine; Labrecque, Nathalie] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Marquis, Miriam; Labrecque, Nathalie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Rousseau, Justine; Turgeon, Benjamin; Meloche, Sylvain] Univ Montreal, Dept Pharmacol & Mol Biol, Quebec City, PQ, Canada; [Labrecque, Nathalie] Univ Montreal, Dept Med, Quebec City, PQ, Canada; [Mathien, Simon; Rousseau, Justine; Turgeon, Benjamin; Meloche, Sylvain] Univ Montreal, Inst Res Immunol & Canc, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Labrecque, N (corresponding author), Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada.	nathalie.labrecque@umontreal.ca		Rousseau, Justine/0000-0002-3554-2673; Boulet, Salix/0000-0002-8446-8908	Natural Sciences and Engineering Council of Canada [262146-2009]; Canadian Institutes for Health Research [MOP-93729]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Natural Sciences and Engineering Council of Canada (grant number 262146-2009) to NL and by a grant from the Canadian Institutes for Health Research (MOP-93729) to SM. SM holds the Canada Research Chair in Cellular Signaling. SB holds a post-doctoral fellowship from the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Anhe GE, 2006, MOL CELL ENDOCRINOL, V251, P33, DOI 10.1016/j.mce.2006.02.012; Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Chan S, 1998, J EXP MED, V188, P2321, DOI 10.1084/jem.188.12.2321; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Deleris P, 2011, J BIOL CHEM, V286, P6470, DOI 10.1074/jbc.M110.181529; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Hoeflich KP, 2006, INT J ONCOL, V29, P839; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mathieu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030139; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Ostiguy V, 2007, J LEUKOCYTE BIOL, V82, P645, DOI 10.1189/jlb.0806494; Perander M, 2008, FRONT BIOSCI-LANDMRK, V13, P4617; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rousseau J, 2010, MOL CELL BIOL, V30, P5752, DOI 10.1128/MCB.01147-10; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sun MY, 2006, BIOCHEM BIOPH RES CO, V340, P209, DOI 10.1016/j.bbrc.2005.12.003; Terra R, 2002, J IMMUNOL, V169, P684, DOI 10.4049/jimmunol.169.2.684; Turgeon B, 2002, GENOMICS, V80, P673, DOI 10.1006/geno.2002.7013; Turgeon B, 2000, BIOCHEM J, V346, P169, DOI 10.1042/0264-6021:3460169; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695	45	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86681	10.1371/journal.pone.0086681	http://dx.doi.org/10.1371/journal.pone.0086681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475167	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300102
J	Olt, J; Mburu, P; Johnson, SL; Parker, A; Kuhn, S; Bowl, M; Marcotti, W; Brown, SDM				Olt, Jennifer; Mburu, Philomena; Johnson, Stuart L.; Parker, Andy; Kuhn, Stephanie; Bowl, Mike; Marcotti, Walter; Brown, Steve D. M.			The Actin-Binding Proteins Eps8 and Gelsolin Have Complementary Roles in Regulating the Growth and Stability of Mechanosensory Hair Bundles of Mammalian Cochlear Outer Hair Cells	PLOS ONE			English	Article							FAST ADAPTATION; MYOSIN-XVA; STEREOCILIA; WHIRLIN; MOUSE; INNER; ELONGATION; LOCALIZATION; CHANNELS; DEAFNESS	Sound transduction depends upon mechanosensitive channels localized on the hair-like bundles that project from the apical surface of cochlear hair cells. Hair bundles show a stair-case structure composed of rows of stereocilia, and each stereocilium contains a core of tightly-packed and uniformly-polarized actin filaments. The growth and maintenance of the stereociliary actin core are dynamically regulated. Recently, it was shown that the actin-binding protein gelsolin is expressed in the stereocilia of outer hair cells (OHCs) and in its absence they become long and straggly. Gelsolin is part of a whirlin scaffolding protein complex at the stereocilia tip, which has been shown to interact with other actin regulatory molecules such as Eps8. Here we investigated the physiological effects associated with the absence of gelsolin and its possible overlapping role with Eps8. We found that, in contrast to Eps8, gelsolin does not affect mechanoelectrical transduction during immature stages of development. Moreover, OHCs from gelsolin knockout mice were able to mature into fully functional sensory receptors as judged by the normal resting membrane potential and basolateral membrane currents. Mechanoelectrical transducer current in gelsolin-Eps8 double knockout mice showed a profile similar to that observed in the single mutants for Eps8. We propose that gelsolin has a non-overlapping role with Eps8. While Eps8 is mainly involved in the initial growth of stereocilia in both inner hair cells (IHCs) and OHCs, gelsolin is required for the maintenance of mature hair bundles of low-frequency OHCs after the onset of hearing.	[Olt, Jennifer; Johnson, Stuart L.; Kuhn, Stephanie; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Mburu, Philomena; Parker, Andy; Bowl, Mike; Brown, Steve D. M.] MRC, Mammalian Genet Unit, Harwell, Berks, England	University of Sheffield	Marcotti, W (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	marcotti@sheffield.ac.uk; S.Brown@har.mrc.ac.uk		, Stephanie/0000-0001-6633-9478; Bowl, Michael/0000-0001-7971-445X	Wellcome Trust [091895]; MRC; MRC [MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684175] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (091895) to W.M. and by the MRC to S.D.M.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Furness DN, 2013, P NATL ACAD SCI USA, V110, P13898, DOI 10.1073/pnas.1304644110; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Johnson SL, 2012, J NEUROSCI, V32, P10479, DOI 10.1523/JNEUROSCI.0803-12.2012; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Mburu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011627; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87331	10.1371/journal.pone.0087331	http://dx.doi.org/10.1371/journal.pone.0087331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475274	Green Accepted, gold, Green Published			2022-12-27	WOS:000330507300169
J	Pancoska, P; Kirkwood, JM; Bouros, S; Spyropoulou-Vlachou, M; Pectasides, E; Tsoutsos, D; Polyzos, A; Markopoulos, C; Panagiotou, P; Castana, O; Bafaloukos, D; Fountzilas, G; Gogas, H				Pancoska, Petr; Kirkwood, John M.; Bouros, Spyros; Spyropoulou-Vlachou, Maria; Pectasides, Eirini; Tsoutsos, Dimosthenis; Polyzos, Aristidis; Markopoulos, Christos; Panagiotou, Petros; Castana, Ourania; Bafaloukos, Dimitrios; Fountzilas, George; Gogas, Helen			A New Mathematical Model for the Interpretation of Translational Research Evaluating Six CTLA-4 Polymorphisms in High-Risk Melanoma Patients Receiving Adjuvant Interferon	PLOS ONE			English	Article							GENE; THERAPY; SUSCEPTIBILITY; SURVIVAL	Adjuvant therapy of stage IIB/III melanoma with interferon reduces relapse and mortality by up to 33% but is accompanied by toxicity-related complications. Polymorphisms of the CTLA-4 gene associated with autoimmune diseases could help in identifying interferon treatment benefits. We previously genotyped 286 melanoma patients and 288 healthy (unrelated) individuals for six CTLA-4 polymorphisms (SNP). Previous analyses found no significant differences between the distributions of CTLA-4 polymorphisms in the melanoma population vs. controls, no significant difference in relapse free and overall survivals among patients and no correlation between autoimmunity and specific alleles. We report new analysis of these CTLA-4 genetic profiles, using Network Phenotyping Strategy (NPS). It is graph-theory based method, analyzing the SNP patterns. Application of NPS on CTLA-4 polymorphism captures allele relationship pattern for every patient into 6-partite mathematical graph P. Graphs P are combined into weighted 6-partite graph S, which subsequently decomposed into reference relationship profiles (RRP). Finally, every individual CTLA-4 genotype pattern is characterized by the graph distances of P from eight identified RRP's. RRP's are subgraphs of S, collecting equally frequent binary allele co-occurrences in all studied loci. If S topology represents the genetic "dominant model'', the RRP's and their characteristic frequencies are identical to expectation-maximization derived haplotypes and maximal likelihood estimates of their frequencies. The graph-representation allows showing that patient CTLA-4 haplotypes are uniquely different from the controls by absence of specific SNP combinations. New function-related insight is derived when the 6-partite graph reflects allelic state of CTLA-4. We found that we can use differences between individual P and specific RRPs to identify patient subpopulations with clearly different polymorphic patterns relatively to controls as well as to identify patients with significantly different survival.	[Pancoska, Petr] Univ Pittsburgh, Dept Med, Ctr Clin Pharmacol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Kirkwood, John M.] Univ Pittsburgh, Dept Med, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA USA; [Bouros, Spyros; Pectasides, Eirini; Polyzos, Aristidis; Markopoulos, Christos; Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, GR-11527 Athens, Greece; [Spyropoulou-Vlachou, Maria] Gen Hosp Athens, Natl Tissue Typing Ctr, Dept Immunol, Athens, Greece; [Tsoutsos, Dimosthenis; Panagiotou, Petros] G Gennimatas Gen Hosp Athens, Dept Plast Surg & Microsurg, Athens, Greece; [Castana, Ourania] Evangelismos Gen Hosp Athens, Dept Plast Surg, Athens, Greece; [Bafaloukos, Dimitrios; Fountzilas, George] Data Off, Hellen Cooperat Oncol Grp, Athens, Greece	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Athens Medical School; National & Kapodistrian University of Athens; General Hospital of N. Ionia Agia Olga; Hellenic Cooperative Oncology Group	Gogas, H (corresponding author), Univ Athens, Sch Med, Dept Med 1, GR-11527 Athens, Greece.	hgogas@hol.gr	Fountzilas, George/ABF-2139-2020; Markopoulos, Christos/AAD-8501-2019	Markopoulos, Christos/0000-0002-5072-6390; Fountzilas, George/0000-0001-8045-2186; Pancoska, Petr/0000-0002-6724-8559	European Research Council-CZ LL1201 program CORES (Complex Structures: Regularity in Combinatorics and Discrete Mathematics); National Institutes of Health [P50CA121973]; NATIONAL CANCER INSTITUTE [P50CA121973] Funding Source: NIH RePORTER	European Research Council-CZ LL1201 program CORES (Complex Structures: Regularity in Combinatorics and Discrete Mathematics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P. Pancoska was supported in part by European Research Council-CZ LL1201 program CORES (Complex Structures: Regularity in Combinatorics and Discrete Mathematics). JMK was supported by National Institutes of Health grant P50CA121973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks D, 1998, J CLASSIF, V15, P199, DOI 10.1007/s003579900031; Carr BI, 2011, HEPATO-GASTROENTEROL, V58, P1334, DOI 10.5754/hge11029; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; Gogas H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-108; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Kirkwood JM, 2002, CANCER-AM CANCER SOC, V95, P1101, DOI 10.1002/cncr.10775; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Mocellin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008955.pub2; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Pancoska P, 2012, ARXIV12062070QBIOOT; Pancoska P, 2011, DIGEST DIS SCI, V56, P3078, DOI 10.1007/s10620-011-1687-x; Pancoska P, 2010, SEMIN ONCOL, V37, P170, DOI 10.1053/j.seminoncol.2010.03.008; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040805; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86375	10.1371/journal.pone.0086375	http://dx.doi.org/10.1371/journal.pone.0086375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475110	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300058
J	Woods, SR; Archer, SR; Schwinning, S				Woods, Steven R.; Archer, Steven R.; Schwinning, Susan			Seedling Responses to Water Pulses in Shrubs with Contrasting Histories of Grassland Encroachment	PLOS ONE			English	Article							MESQUITE PROSOPIS-GLANDULOSA; BIOLOGICAL SOIL CRUSTS; RELATIVE GROWTH-RATE; HERBACEOUS BIOMASS; PLANT; GERMINATION; ESTABLISHMENT; VEGETATION; COMPONENTS; INVASION	Woody plant encroachment into grasslands has occurred worldwide, but it is unclear why some tree and shrub species have been markedly more successful than others. For example, Prosopis velutina has proliferated in many grasslands of the Sonoran Desert in North America over the past century, while other shrub species with similar growth form and life history, such as Acacia greggii, have not. We conducted a glasshouse experiment to assess whether differences in early seedling development could help explain why one species and not the other came to dominate many Sonoran Desert grasslands. We established eight watering treatments mimicking a range of natural precipitation patterns and harvested seedlings 16 or 17 days after germination. A. greggii had nearly 7 times more seed mass than P. velutina, but P. velutina emerged earlier (by 3.0 +/- 0.3 d) and grew faster (by 8.7 +/- 0.5 mg d(-1)). Shoot mass at harvest was higher in A. greggii (99 +/- 6 mg seedling(-1)) than in P. velutina (74 +/- 2 mg seedling(-1)), but there was no significant difference in root mass (54 +/- 3 and 49 +/- 2 mg seedling(-1), respectively). Taproot elongation was differentially sensitive to water supply: under the highest initial watering pulse, taproots were 52 +/- 19 mm longer in P. velutina than in A. greggii. Enhanced taproot elongation under favorable rainfall conditions could give nascent P. velutina seedlings growth and survivorship advantages by helping reduce competition with grasses and maintain contact with soil water during drought. Conversely, A. greggii's greater investment in mass per seed appeared to provide little return in early seedling growth. We suggest that such differences in recruitment traits and their sensitivities to environmental conditions may help explain ecological differences between species that are highly similar as adults and help identify pivotal drivers of shrub encroachment into grasslands.	[Woods, Steven R.; Archer, Steven R.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Schwinning, Susan] Texas State Univ, Dept Biol, San Marcos, TX USA	University of Arizona; Texas State University System; Texas State University San Marcos	Woods, SR (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	srwoods@email.arizona.edu	Schwinning, Susanne/G-6412-2015	Schwinning, Susanne/0000-0002-9740-0291; Woods, Steven/0000-0002-3402-8090; Zucker-Scharff, Thomas/0000-0002-1790-7405	U.S. National Science Foundation [DEB-0531691, DEB-0531687]	U.S. National Science Foundation(National Science Foundation (NSF))	This study was funded by the U.S. National Science Foundation grants DEB-0531691 and DEB-0531687. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott L. B., 1995, General Technical Report - Intermountain Research Station, USDA Forest Service, P37; Ali H. H., 2012, Pakistan Journal of Weed Science Research, V18, P423; Archer S., 1994, Ecological implications of livestock herbivory in the west.., P13; Arshad M. A., 1992, American Journal of Alternative Agriculture, V7, P25, DOI 10.1017/S0889189300004410; Astegiano J, 2010, ACTA OECOL, V36, P454, DOI 10.1016/j.actao.2010.06.001; Barger NN, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001506; Baskin C. C., 2000, SEEDS ECOLOGY BIOGEO; BEATLEY JC, 1974, ECOLOGY, V55, P856, DOI 10.2307/1934421; BECKER R, 1980, J AGR FOOD CHEM, V28, P22, DOI 10.1021/jf60227a024; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bowers J. E., 1993, SHRUBS TREES SW DESE; Bowers JE, 2004, PLANT ECOL, V172, P107, DOI 10.1023/B:VEGE.0000026026.34760.1b; Breckenfeld DJ, 2003, US FOR SERV RMRS-P, P157; BROWN JR, 1990, OIKOS, V57, P366, DOI 10.2307/3565966; Brown JR, 1999, ECOLOGY, V80, P2385, DOI 10.1890/0012-9658(1999)080[2385:SIOGRI]2.0.CO;2; BROWN JR, 1988, VEGETATIO, V73, P73, DOI 10.1007/BF00031854; BROWN JR, 1989, OECOLOGIA, V80, P19, DOI 10.1007/BF00789926; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; de Dios VR, 2012, PERSPECT PLANT ECOL, V14, P275, DOI 10.1016/j.ppees.2012.03.002; EARLE F. R., 1962, ECON BOT, V16, P221, DOI 10.1007/BF02860181; Fehmi JS, 2013, ENVIRON MONIT ASSESS, DOI 101007/s10661-013-3384-z.; Ferrauto G, 2013, PLANT BIOSYSTEMS INT, DOI 101080/112635042013845265; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Graham EH, 1941, MISC PUBLICATION USD, V412; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; HARDING GB, 1991, S AFR J SCI, V87, P188; Harper J. L, 1977, POPULATION BIOL PLAN; Hastings J. R., 1972, ATLAS SOME PLANT DIS; Hultine KR, 2006, TREE PHYSIOL, V26, P313, DOI 10.1093/treephys/26.3.313; ISELY D, 1969, SIDA Contributions to Botany, V3, P365; JONES Q, 1966, ECON BOT, V20, P127, DOI 10.1007/BF02904010; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; Karaguzel O, 2004, PAKISTAN J BOT, V36, P65; Khurana E, 2004, J TROP ECOL, V20, P385, DOI 10.1017/S026646740400135X; Kneuper CL, 2003, J RANGE MANAGE, V56, P255, DOI 10.2307/4003815; Leishman M. R., 2000, SEEDS ECOLOGY REGENE, P31, DOI [DOI 10.1126/science.1156831, DOI 10.1079/9780851994321.0031]; Leon MF, 2011, J VEG SCI, V22, P120, DOI 10.1111/j.1654-1103.2010.01224.x; Loik ME, 2004, OECOLOGIA, V141, P269, DOI 10.1007/s00442-004-1570-y; McClaran MP, 2003, US FOR SERV RMRS-P, P16; McPherson Guy R., 1995, P130; Mukhtar HAM, 1961, THESIS U ARIZONA TUC; Negri MC, 2003, ENVIR SC T, P233; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Patane C, 2006, J ARID ENVIRON, V67, P165, DOI 10.1016/j.jaridenv.2006.02.001; PAULSEN HAROLD A., 1950, JOUR RANGE MANAGEMENT, V3, P281, DOI 10.2307/3894350; PETRINOV.LF, 1969, PSYCHOL BULL, V71, P43, DOI 10.1037/h0026861; PHILLIPS WS, 1963, ECOLOGY, V44, P424, DOI 10.2307/1932198; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Robinson TP, 2008, J ARID ENVIRON, V72, P175, DOI 10.1016/j.jaridenv.2007.05.011; SALA OE, 1981, OECOLOGIA, V48, P327, DOI 10.1007/BF00346489; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Schwinning S, 2003, OECOLOGIA, V136, P252, DOI 10.1007/s00442-003-1255-y; Shaik S, 2008, SEED SCI TECHNOL, V36, P795, DOI 10.15258/sst.2008.36.3.31; Swanborough P, 1996, FUNCT ECOL, V10, P176, DOI 10.2307/2389841; TIEDEMANN AR, 1977, J RANGE MANAGE, V30, P361, DOI 10.2307/3897722; Turner R.M., 1995, SONORAN DESERT PLANT; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; VINES RA, 1960, TREES SHRUBS WOODY V; Ward JP, 2006, WEED SCI, V54, P720, DOI 10.1614/WS-05-163R1.1; Warren SD, 2001, ECOL STU AN, V150, P327; Watson IW, 1997, J ECOL, V85, P833, DOI 10.2307/2960605; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; Wheeler CW, 2007, ECOL APPL, V17, P1911, DOI 10.1890/06-1580.1; Wiegand K, 2004, OECOLOGIA, V141, P363, DOI 10.1007/s00442-003-1439-5; Wilson TB, 1998, J ARID ENVIRON, V38, P541, DOI 10.1006/jare.1998.0362; Woods SR, 2011, PLANT ECOL, V212, P507, DOI 10.1007/s11258-010-9841-7; Wythers KR, 1999, SOIL SCI SOC AM J, V63, P1341, DOI 10.2136/sssaj1999.6351341x; Young J., 1992, SEEDS WOODY PLANTS N; Zare Salman, 2011, Journal of Forestry Research (Harbin), V22, P35, DOI 10.1007/s11676-011-0121-8; ZIMMERMAN RC, 1969, 485D US GEOL SURV PR, P51	79	7	8	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87278	10.1371/journal.pone.0087278	http://dx.doi.org/10.1371/journal.pone.0087278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475263	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300161
J	Zayner, JP; Sosnick, TR				Zayner, Josiah P.; Sosnick, Tobin R.			Factors That Control the Chemistry of the LOV Domain Photocycle	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; AVENA-SATIVA; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; STRUCTURAL-CHANGES; BINDING DOMAINS; PHOTOTROPIN 1; MECHANISM	Algae, plants, bacteria and fungi contain Light-Oxygen-Voltage (LOV) domains that function as blue light sensors to control cellular responses to light. All LOV domains contain a bound flavin chromophore that is reduced upon photon absorption and forms a reversible, metastable covalent bond with a nearby cysteine residue. In Avena sativa LOV2 (AsLOV2), the photocycle is accompanied by an allosteric conformational change that activates the attached phototropin kinase in the full-length protein. Both the conformational change and formation of the cysteinyl-flavin adduct are stabilized by the reduction of the N5 atom in the flavin's isoalloxazine ring. In this study, we perform a mutational analysis to investigate the requirements for LOV2 to photocycle. We mutated all the residues that interact with the chromophore isoalloxazine ring to inert functional groups but none could fully inhibit the photocycle except those to the active-site cysteine. However, electronegative side chains in the vicinity of the chromophore accelerate the N5 deprotonation and the return to the dark state. Mutations to the N414 and Q513 residues identify a potential water gate and H2O coordination sites. These residues affect the electronic nature of the chromophore and photocycle time by helping catalyze the N5 reduction leading to the completion of the photocycle. In addition, we demonstrate that dehydration leads to drastically slower photocycle times. Finally, to investigate the requirements of an active-site cysteine for photocycling, we moved the nearby cysteine to alternative locations and found that some variants can still photocycle. We propose a new model of the LOV domain photocycle that involves all of these components.	[Zayner, Josiah P.; Sosnick, Tobin R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sosnick, Tobin R.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Sosnick, TR (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	trsosnic@uchicago.edu	Freed, Karl F/J-7764-2018	Freed, Karl F/0000-0001-6240-2599; Zayner, Josiah/0000-0003-3590-3341	US National Institutes of Health [GM088668, 5T32GM007183-34]; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088668, T32GM007183, R01GM055694] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research and training grants from the US National Institutes of Health (GM088668 to T. R. S. and M. Glotzer, 5T32GM007183-34 to B. Glick), and the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust (to T. R. S., M. Glotzer and E. Weiss). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Alexandre MTA, 2008, PHYS CHEM CHEM PHYS, V10, P6693, DOI 10.1039/b810040c; Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Alexandre MTA, 2009, BIOPHYS J, V97, P238, DOI 10.1016/j.bpj.2009.03.047; Chan RH, 2012, J PHYS CHEM B, V116, P10609, DOI 10.1021/jp304934t; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Circolone F, 2012, J MOL BIOL, V417, P362, DOI 10.1016/j.jmb.2012.01.056; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; FREDDOLINO PL, 2013, PHOTOCHEM PHOTOBIOL; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kennis JTM, 2004, J AM CHEM SOC, V126, P4512, DOI 10.1021/ja031840r; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lanzl K, 2010, PHYS CHEM CHEM PHYS, V12, P6594, DOI 10.1039/b922408d; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Neiss C, 2003, PHOTOCHEM PHOTOBIOL, V77, P101, DOI 10.1562/0031-8655(2003)077<0101:AIQCIO>2.0.CO;2; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Song SH, 2011, BIOCHEMISTRY-US, V50, P2411, DOI 10.1021/bi200198x; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Yamamoto A, 2008, BIOCHEMISTRY-US, V47, P922, DOI 10.1021/bi701851v; Zayner JP, 2013, BIOPHYS J, V105, P1027, DOI 10.1016/j.bpj.2013.07.010; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	37	72	71	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87074	10.1371/journal.pone.0087074	http://dx.doi.org/10.1371/journal.pone.0087074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475227	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300134
J	Dacosta-Aguayo, R; Grana, M; Fernandez-Andujar, M; Lopez-Cancio, E; Caceres, C; Bargallo, N; Barrios, M; Clemente, I; Monserrat, PT; Sas, MA; Davalos, A; Auer, T; Mataro, M				Dacosta-Aguayo, Rosalia; Grana, Manuel; Fernandez-Andujar, Marina; Lopez-Cancio, Elena; Caceres, Cynthia; Bargallo, Nuria; Barrios, Maite; Clemente, Immaculada; Toran Monserrat, Pere; Alzamora Sas, Maite; Davalos, Antoni; Auer, Tibor; Mataro, Maria			Structural Integrity of the Contralesional Hemisphere Predicts Cognitive Impairment in Ischemic Stroke at Three Months	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; FOCAL CEREBRAL-ISCHEMIA; TENSOR IMAGING DETECTS; DIFFUSION ANISOTROPY; MOTOR FUNCTION; TRACT; DEGENERATION; MECHANISMS; EVOLUTION; PERFUSION	After stroke, white matter integrity can be affected both locally and distally to the primary lesion location. It has been shown that tract disruption in mirror's regions of the contralateral hemisphere is associated with degree of functional impairment. Fourteen patients suffering right hemispheric focal stroke (S) and eighteen healthy controls (HC) underwent Diffusion Weighted Imaging (DWI) and neuropsychological assessment. The stroke patient group was divided into poor (SP; n = 8) and good (SG; n = 6) cognitive recovery groups according to their cognitive improvement from the acute phase (72 hours after stroke) to the subacute phase (3 months post-stroke). Whole-brain DWI data analysis was performed by computing Diffusion Tensor Imaging (DTI) followed by Tract Based Spatial Statistics (TBSS). Assessment of effects was obtained computing the correlation of the projections on TBSS skeleton of Fractional Anisotropy (FA) and Radial Diffusivity (RD) with cognitive test results. Significant decrease of FA was found only in right brain anatomical areas for the S group when compared to the HC group. Analyzed separately, stroke patients with poor cognitive recovery showed additional significant FA decrease in several left hemisphere regions; whereas SG patients showed significant decrease only in the left genu of corpus callosum when compared to the HC. For the SG group, whole brain analysis revealed significant correlation between the performance in the Semantic Fluency test and the FA in the right hemisphere as well as between the performance in the Grooved Pegboard Test (GPT) and theTrail Making Test-part A and the FA in the left hemisphere. For the SP group, correlation analysis revealed significant correlation between the performance in the GPT and the FA in the right hemisphere.	[Fernandez-Andujar, Marina; Clemente, Immaculada; Mataro, Maria] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Dacosta-Aguayo, Rosalia; Grana, Manuel] Univ Basque Country UPV EHU, Grp Computat Intelligence, San Sebastian, Spain; [Lopez-Cancio, Elena; Caceres, Cynthia; Davalos, Antoni] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, E-08193 Barcelona, Spain; [Fernandez-Andujar, Marina; Clemente, Immaculada; Mataro, Maria] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Diagnost Ctr Image, Barcelona, Spain; [Bargallo, Nuria] Imatge Platform IDIBAPS, Barcelona, Spain; [Barrios, Maite] Univ Barcelona, Dept Methodol Behav Sci, Barcelona, Spain; [Auer, Tibor] MRC Cognit & Brain Sci Unit, Cambridge, England; [Toran Monserrat, Pere; Alzamora Sas, Maite] Inst Univ Invest Atencio Primaria IDIAP Jordi Gol, Primary Healthcare Res Support Unit, Metropolitana Nord, Santa Coloma De Gramenet, Spain	University of Barcelona; University of Basque Country; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Mataro, M (corresponding author), Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain.	mmataro@ub.edu	Torán-Monserrat, Pere/AAY-4396-2021; Hernandez, María/GYU-3543-2022; Bargallo, Nuria/G-6854-2016; Clemente, I Concepcion/H-5399-2013; Romay, Manuel M. Graña/L-1341-2014; Mataro, Maria/B-4524-2011; Barrios, Maite/J-5738-2013; Dacosta-Aguayo, Rosalia/L-8708-2014	Torán-Monserrat, Pere/0000-0002-9865-7427; Bargallo, Nuria/0000-0001-6284-5402; Clemente, I Concepcion/0000-0003-0728-0925; Romay, Manuel M. Graña/0000-0001-7373-4097; Mataro, Maria/0000-0002-9946-2656; Barrios, Maite/0000-0003-1979-0818; Dacosta-Aguayo, Rosalia/0000-0003-1861-365X; Auer, Tibor/0000-0001-5153-1424	Ministry of Science and Innovation (MICINN) [PSI2009-11519, BES-2010-031833]; Ministry of Economy and Competitiveness (MINECO) [TIN2011-23823]; UFI, Spain [11/07]; Medical Research Council [MC_U105579212] Funding Source: researchfish; MRC [MC_U105579212] Funding Source: UKRI	Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness (MINECO)(Spanish Government); UFI, Spain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project has been made possible primarily through the efforts of the authors' recruited patients and healthy controls participants who voluntarily accepted to enroll in this project. This study was supported by the grants PSI2009-11519 to MM, the grant Formacio Personal Investigador (FPI), BES-2010-031833 to MF from the Ministry of Science and Innovation (MICINN), grant TIN2011-23823 from the Ministry of Economy and Competitiveness (MINECO) and UFI 11/07 to MG, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2003, J NEUROL NEUROSUR PS, V74, P1152, DOI 10.1136/jnnp.74.8.1152; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson JLR, 2007, NONLINEAR REGISTRATI; Antenor-Dorsey JAV, 2013, DIABETES, V62, P581, DOI 10.2337/db12-0696; Beaulieu C, 1999, ANN NEUROL, V46, P568, DOI 10.1002/1531-8249(199910)46:4<568::AID-ANA4>3.0.CO;2-R; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bhagat YA, 2008, MAGN RESON IMAGING, V26, P683, DOI 10.1016/j.mri.2008.01.015; Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Burgmans S, 2010, NEUROIMAGE, V49, P2083, DOI 10.1016/j.neuroimage.2009.10.035; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Chui HC, 2007, NEUROL CLIN, V25, P717, DOI 10.1016/j.ncl.2007.04.003; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Dacosta-Aguayo R, 2012, J INT NEUROPSYCHOLOG; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dihne M, 2002, STROKE, V33, P3006, DOI 10.1161/01.STR.0000039406.64644.CB; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; Englund E, 2002, CEREBROVASC DIS, V13, P11, DOI 10.1159/000049144; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Goodglass H., 1983, BOSTON NAMING TEST; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Irving EA, 2001, ACTA NEUROPATHOL, V102, P627, DOI 10.1007/s004010100416; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P11; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Johanse-Berg H, 2010, FRONTIERS SYSTEMS NE, V4, P1; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kumar R, 2012, J NEUROSCI RES, V90, P346, DOI 10.1002/jnr.22757; Kumar R, 2010, J NEUROSCI RES, V88, P2146, DOI 10.1002/jnr.22385; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Leritz EC, 2010, NEUROPSYCHOLOGY, V24, P199, DOI 10.1037/a0018108; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Maniega SM, 2004, J NEUROL NEUROSUR PS, V75, P1714, DOI 10.1136/jnnp.2003.033852; Marks MP, 1999, NEUROLOGY, V52, P1792, DOI 10.1212/WNL.52.9.1792; Miralbell J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.020; Molko N, 2002, STROKE, V33, P2902, DOI 10.1161/01.STR.0000041681.25514.22; Morales Gonzalez J M, 1992, Arch Neurobiol (Madr), V55, P262; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Sullivan M, 2004, NEUROLOGY, V62, P702, DOI 10.1212/01.WNL.0000113760.72706.D2; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Perantie DC, 2011, DIABETES, V60, P3006, DOI 10.2337/db11-0589; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; SKRIVER EB, 1990, ACTA RADIOL, V31, P431; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Strauss E, 2006, COMPENDIUM NEUROPSYC; Strub R, 2000, MENTAL STATUS EXAMIN; SYKOVA E, 1994, J CEREBR BLOOD F MET, V14, P301, DOI 10.1038/jcbfm.1994.37; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van Duinkerken E, 2012, DIABETOLOGIA, V55, P1218, DOI 10.1007/s00125-012-2488-2; Wang CS, 2006, NEUROBIOL AGING, V27, P1827, DOI 10.1016/j.neurobiolaging.2005.10.008; Watanabe T, 2001, J NEUROSURG, V94, P955, DOI 10.3171/jns.2001.94.6.0955; Wechsler D, 1999, WECHSLER ADULT INTEL; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	84	41	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86119	10.1371/journal.pone.0086119	http://dx.doi.org/10.1371/journal.pone.0086119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475078	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800029
J	Kim, K; Mall, C; Taylor, SL; Hitchcock, S; Zhang, C; Wettersten, HI; Jones, AD; Chapman, A; Weiss, RH				Kim, Kyoungmi; Mall, Christine; Taylor, Sandra L.; Hitchcock, Stacie; Zhang, Chen; Wettersten, Hiromi I.; Jones, A. Daniel; Chapman, Arlene; Weiss, Robert H.			Mealtime, Temporal, and Daily Variability of the Human Urinary and Plasma Metabolomes in a Tightly Controlled Environment	PLOS ONE			English	Article							KIDNEY CANCER-DETECTION; BIOMARKER DISCOVERY; PHENOTYPES; PROFILES; STANDARDIZATION; METABONOMICS; CHALLENGES; CRITERIA; GENDER; AGE	While metabolomics has tremendous potential for diagnostic biomarker and therapeutic target discovery, its utility may be diminished by the variability that occurs due to environmental exposures including diet and the influences of the human circadian rhythm. For successful translation of metabolomics findings into the clinical setting, it is necessary to exhaustively define the sources of metabolome variation. To address these issues and to measure the variability of urinary and plasma metabolomes throughout the day, we have undertaken a comprehensive inpatient study in which we have performed nontargeted metabolomics analysis of blood and urine in 26 volunteers (13 healthy subjects with no known disease and 13 healthy subjects with autosomal dominant polycystic kidney disease not taking medication). These individuals were evaluated in a clinical research facility on two separate occasions, over three days, while on a standardized, weight-based diet. Subjects provided pre- and post-prandial blood and urine samples at the same time of day, and all samples were analyzed by "fast lane" LC-MS-based global metabolomics. The largest source of variability in blood and urine metabolomes was attributable to technical issues such as sample preparation and analysis, and less variability was due to biological variables, meals, and time of day. Higher metabolome variability was observed after the morning as compared to the evening meal, yet day-to-day variability was minimal and urine metabolome variability was greater than that of blood. Thus we suggest that blood and urine are suitable biofluids for metabolomics studies, though nontargeted mass spectrometry alone may not offer sufficient precision to reveal subtle changes in the metabolome. Additional targeted analyses may be needed to support the data from nontargeted mass spectrometric analyses. In light of these findings, future metabolomics studies should consider these sources of variability to allow for appropriate metabolomics testing and reliable clinical translation of metabolomics data.	[Mall, Christine; Wettersten, Hiromi I.; Weiss, Robert H.] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; [Kim, Kyoungmi; Taylor, Sandra L.] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Hitchcock, Stacie; Chapman, Arlene] Emory Univ, Dept Internal Med, Div Nephrol, Atlanta, GA 30322 USA; [Zhang, Chen; Jones, A. Daniel] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Jones, A. Daniel] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Emory University; Michigan State University; Michigan State University	Weiss, RH (corresponding author), Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA.	rhweiss@ucdavis.edu	Jones, Arthur D/C-2670-2013	Taylor, Sandra/0000-0001-7811-812X; Jones, A. Daniel/0000-0002-7408-6690	NIH [1R01CA135401-01A1, 1R01DK082690-01A1]; Medical Service of the US Department of Veterans' Affairs; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454, UL1 TR000002]; Michigan AgBioResearch; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA135401] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Service of the US Department of Veterans' Affairs; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Michigan AgBioResearch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants 1R01CA135401-01A1 and 1R01DK082690-01A1 and the Medical Service of the US Department of Veterans' Affairs (all to RHW), by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454 (to Emory University) and UL1 TR000002 (to UC Davis), and by Michigan AgBioResearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud OA, 2012, CLIN CHEM, V59, P138; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Fan TWM, 2004, CURR OPIN MOL THER, V6, P584; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8; Gu LP, 2010, PLANT J, V61, P579, DOI 10.1111/j.1365-313X.2009.04083.x; Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Llorach R, 2009, J PROTEOME RES, V8, P5060, DOI 10.1021/pr900470a; Llorach-Asuncion R, 2010, J PHARMACEUT BIOMED, V51, P373, DOI 10.1016/j.jpba.2009.06.033; McShane LM, 2013, NATURE, V502, P317, DOI 10.1038/nature12564; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Rasmussen LG, 2011, METABOLOMICS, V7, P71, DOI 10.1007/s11306-010-0234-7; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Van Dorsten FA, 2006, J AGR FOOD CHEM, V54, P6929, DOI 10.1021/jf061016x; Wallace M, 2010, HUM REPROD, V25, P949, DOI 10.1093/humrep/deq011; Walsh MC, 2007, AM J CLIN NUTR, V86, P1687; Walsh MC, 2006, AM J CLIN NUTR, V84, P531, DOI 10.1093/ajcn/84.3.531; Wang YL, 2005, J AGR FOOD CHEM, V53, P191, DOI 10.1021/jf0403282; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Winnike JH, 2009, AM J CLIN NUTR, V90, P1496, DOI 10.3945/ajcn.2009.28234; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	29	54	54	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86223	10.1371/journal.pone.0086223	http://dx.doi.org/10.1371/journal.pone.0086223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475090	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800034
J	Hammer, TJ; McMillan, WO; Fierer, N				Hammer, Tobin J.; McMillan, W. Owen; Fierer, Noah			Metamorphosis of a Butterfly-Associated Bacterial Community	PLOS ONE			English	Article							MANDUCA-SEXTA; GUT BACTERIA; MICROBIAL DIVERSITY; HOST-PLANT; HELICONIUS; MIDGUT; LEPIDOPTERA; SYMBIONTS; EVOLUTIONARY; WOLBACHIA	Butterflies are charismatic insects that have long been a focus of biological research. They are also habitats for microorganisms, yet these microbial symbionts are little-studied, despite their likely importance to butterfly ecology and evolution. In particular, the diversity and composition of the microbial communities inhabiting adult butterflies remain uncharacterized, and it is unknown how the larval (caterpillar) and adult microbiota compare. To address these knowledge gaps, we used Illumina sequencing of 16S rRNA genes from internal bacterial communities associated with multiple life stages of the neotropical butterfly Heliconius erato. We found that the leaf-chewing larvae and nectar-and pollen-feeding adults of H. erato contain markedly distinct bacterial communities, a pattern presumably rooted in their distinct diets. Larvae and adult butterflies host relatively small and similar numbers of bacterial phylotypes, but few are common to both stages. The larval microbiota clearly simplifies and reorganizes during metamorphosis; thus, structural changes in a butterfly's bacterial community parallel those in its own morphology. We furthermore identify specific bacterial taxa that may mediate larval and adult feeding biology in Heliconius and other butterflies. Although male and female Heliconius adults differ in reproductive physiology and degree of pollen feeding, bacterial communities associated with H. erato are not sexually dimorphic. Lastly, we show that captive and wild individuals host different microbiota, a finding that may have important implications for the relevance of experimental studies using captive butterflies.	[Hammer, Tobin J.; Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hammer, Tobin J.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Hammer, Tobin J.; McMillan, W. Owen] Smithsonian Trop Res Inst, Panama City, Panama	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Smithsonian Institution; Smithsonian Tropical Research Institute	Hammer, TJ (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	tobin.hammer@colorado.edu		FIERER, NOAH/0000-0002-6432-4261; McMillan, W. Owen/0000-0003-2805-2745	Chancellor's Fellowship from the University of Colorado; National Science Foundation [DEB-640279, IOS-1052541, NSF-CAREER 0953331]; Direct For Biological Sciences [1257689] Funding Source: National Science Foundation	Chancellor's Fellowship from the University of Colorado; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	T.J.H. was supported by a Chancellor's Fellowship from the University of Colorado. The National Science Foundation provided grants to W.O.M. (DEB-640279 and IOS-1052541) and N.F. (NSF-CAREER 0953331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; APPEL HM, 1995, J INSECT PHYSIOL, V41, P241, DOI 10.1016/0022-1910(94)00106-Q; Arias-Cordero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051557; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Belda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021751; Boggs C.L., 2003, BUTTERFLIES ECOLOGY; Brinkmann N, 2008, APPL ENVIRON MICROB, V74, P7189, DOI 10.1128/AEM.01464-08; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; BUCHER GE, 1963, J INSECT PATHOL, V5, P336; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Clarke KR, 2006, PRIMER V6 PRIMER E; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Eberhard SH, 2009, ANN ENTOMOL SOC AM, V102, P1105, DOI 10.1603/008.102.0619; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2013, INT J SYST EVOL MICR, DOI [10.1099/ijs.0.049569-0, DOI 10.1099/IJS.0.049569-0)]; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Engler-Chaouat HS, 2007, J CHEM ECOL, V33, P25, DOI 10.1007/s10886-006-9207-8; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; GILBERT LE, 1972, P NATL ACAD SCI USA, V69, P1403, DOI 10.1073/pnas.69.6.1403; Grimaldi David, 2005, pi; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hennig W., 1981, INSECT PHYLOGENY; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; JUDY KJ, 1969, ANN ENTOMOL SOC AM, V62, P1438, DOI 10.1093/aesa/62.6.1438; Kim JY, 2013, INT J SYST EVOL MICR, V63, P1766, DOI 10.1099/ijs.0.041871-0; KINGSLEY VV, 1972, J INVERTEBR PATHOL, V20, P51, DOI 10.1016/0022-2011(72)90081-X; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Lauzon CR, 2009, ANN ENTOMOL SOC AM, V102, P85, DOI 10.1603/008.102.0109; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Lowe T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0304; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Munoz Astrid G, 2011, BMC Evol Biol, V11, P358, DOI 10.1186/1471-2148-11-358; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; R Core Team, 2021, R LANGUAGE ENV STAT; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Russell V, 1996, J INSECT PHYSIOL, V42, P65, DOI 10.1016/0022-1910(95)00083-6; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; SCHULTZ JC, 1986, OECOLOGIA, V71, P133, DOI 10.1007/BF00377332; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SMILEY J, 1978, SCIENCE, V201, P745, DOI 10.1126/science.201.4357.745; Steinhaus EA, 1941, J BACTERIOL, V42, P757, DOI 10.1128/JB.42.6.757-790.1941; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Tagami Y, 2004, INSECT MOL BIOL, V13, P359, DOI 10.1111/j.0962-1075.2004.00492.x; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Walters JR, 2012, ECOL ENTOMOL, V37, P257, DOI 10.1111/j.1365-2311.2012.01360.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Whiting MF, 2004, ASSEMBLING THE TREE OF LIFE, P345; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Zaspel JM, 2008, ANN ENTOMOL SOC AM, V101, P1050, DOI 10.1603/0013-8746-101.6.1050	80	103	106	3	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86995	10.1371/journal.pone.0086995	http://dx.doi.org/10.1371/journal.pone.0086995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466308	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000181
J	Schultz, MA; Hagan, SS; Datta, A; Zhang, YG; Freeman, ML; Sikka, SC; Abdel-Mageed, AB; Mondal, D				Schultz, Michelle A.; Hagan, Sharika S.; Datta, Amrita; Zhang, Yiguo; Freeman, Michael L.; Sikka, Suresh C.; Abdel-Mageed, Asim B.; Mondal, Debasis			Nrf1 and Nrf2 Transcription Factors Regulate Androgen Receptor Transactivation in Prostate Cancer Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; TRAMP MICE; NUCLEAR TRANSLOCATION; ENDOPLASMIC-RETICULUM; EXPRESSION; PROGRESSION; ACTIVATION; MECHANISMS; GENES; ELECTROPHILES	Despite androgen deprivation therapy (ADT), persistent androgen receptor (AR) signaling enables outgrowth of castration resistant prostate cancer (CRPC). In prostate cancer (PCa) cells, ADT may enhance AR activity through induction of oxidative stress. Herein, we investigated the roles of Nrf1 and Nrf2, transcription factors that regulate antioxidant gene expression, on hormone-mediated AR transactivation using a syngeneic in vitro model of androgen dependent (LNCaP) and castration resistant (C4-2B) PCa cells. Dihydrotestosterone (DHT) stimulated transactivation of the androgen response element (ARE) was significantly greater in C4-2B cells than in LNCaP cells. DHT-induced AR transactivation was coupled with higher nuclear translocation of p65-Nrf1 in C4-2B cells, as compared to LNCaP cells. Conversely, DHT stimulation suppressed total Nrf2 levels in C4-2B cells but elevated total Nrf2 levels in LNCaP cells. Interestingly, siRNA mediated silencing of Nrf1 attenuated AR transactivation while p65-Nrf1 overexpression enhanced AR transactivation. Subsequent studies showed that Nrf1 physically interacts with AR and enhances AR's DNA-binding activity, suggesting that the p65-Nrf1 isoform is a potential AR coactivator. In contrast, Nrf2 suppressed AR-mediated transactivation by stimulating the nuclear accumulation of the p120-Nrf1 which suppressed AR transactivation. Quantitative RT-PCR studies further validated the inductive effects of p65-Nrf1 isoform on the androgen regulated genes, PSA and TMPRSS2. Therefore, our findings implicate differential roles of Nrf1 and Nrf2 in regulating AR transactivation in PCa cells. Our findings also indicate that the DHT-stimulated increase in p65-Nrf1 and the simultaneous suppression of both Nrf2 and p120-Nrf1 ultimately facilitates AR transactivation in CRPC cells.	[Schultz, Michelle A.; Mondal, Debasis] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Hagan, Sharika S.; Datta, Amrita; Sikka, Suresh C.; Abdel-Mageed, Asim B.] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA; [Zhang, Yiguo] Chongqing Univ, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; [Schultz, Michelle A.; Freeman, Michael L.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA	Tulane University; Tulane University; Chongqing University; Vanderbilt University	Mondal, D (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	dmondal@tulane.edu		Datta, Amrita/0000-0003-2029-8134; SIKKA, Suresh/0000-0003-3998-4978; Zhang, Yiguo/0000-0003-3910-2779; Abdel-Mageed, Asim/0000-0001-8590-783X	Department of Defense [PC080811, PC081598]; National Institute of Health [T32-CA093240]; Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE [T32CA093240] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by funds from the Department of Defense; PC080811 (D. M.), PC081598 (AA), and National Institute of Health, T32-CA093240 (MF), and from the Louisiana Cancer Research Consortium (DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Cancer Society, 2012, CANC FACTS FIG 2012; Chen ME, 1998, J BIOL CHEM, V273, P17618, DOI 10.1074/jbc.273.28.17618; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Cheung KL, 2014, MOL CARCINOGEN, V53, P77, DOI 10.1002/mc.21950; Chhipa RR, 2009, MOL CANCER RES, V7, P1543, DOI 10.1158/1541-7786.MCR-08-0546; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Culig Z, 2012, WORLD J UROL, V30, P297, DOI 10.1007/s00345-011-0797-6; Davis R, 2003, BIOCHEM BIOPH RES CO, V309, P937, DOI 10.1016/j.bbrc.2003.08.096; Fajardo AM, 2012, PROSTATE, V72, P612, DOI 10.1002/pros.21464; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Han WN, 2012, J BIOL CHEM, V287, P18788, DOI 10.1074/jbc.M112.363614; Huang Y, 2012, J NUTR, V142, P818, DOI 10.3945/jn.111.153114; Husberg C, 2003, BBA-MOL CELL RES, V1640, P143, DOI 10.1016/S0167-4889(03)00041-7; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Keum YS, 2009, PHARM RES-DORDR, V26, P2324, DOI 10.1007/s11095-009-9948-5; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee S, 2012, FREE RADICAL BIO MED, V53, P807, DOI 10.1016/j.freeradbiomed.2012.05.038; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Lu JP, 2010, PROSTATE CANCER P D, V13, P39, DOI 10.1038/pcan.2009.24; Lu WQ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001326; McPhaul MJ, 2008, BEST PRACT RES CL EN, V22, P373, DOI 10.1016/j.beem.2008.02.006; Mehraein-Ghomi F, 2010, CANCER RES, V70, P4560, DOI 10.1158/0008-5472.CAN-09-3596; Nadiminty N, 2012, WORLD J UROL, V30, P287, DOI 10.1007/s00345-011-0771-3; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Schultz Michelle A, 2010, Cancers (Basel), V2, P1354, DOI 10.3390/cancers2021354; Shiota M, 2010, ONCOGENE, V29, P237, DOI 10.1038/onc.2009.322; Shiota M, 2012, J UROLOGY, V187, P707, DOI 10.1016/j.juro.2011.09.147; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tam NNC, 2003, AM J PATHOL, V163, P2513, DOI 10.1016/S0002-9440(10)63606-1; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Vis AN, 2009, BJU INT, V104, P438, DOI 10.1111/j.1464-410X.2009.08695.x; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Yamaoka M, 2010, CLIN CANCER RES, V16, P4319, DOI 10.1158/1078-0432.CCR-10-0255; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yossepowitch O, 2007, J UROLOGY, V178, P1238, DOI 10.1016/j.juro.2007.05.145; Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575	51	48	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87204	10.1371/journal.pone.0087204	http://dx.doi.org/10.1371/journal.pone.0087204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466341	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100252
J	Tang, S; Lv, YJ; Chen, HB; Adam, A; Cheng, YF; Hartung, J; Bao, ED				Tang, Shu; Lv, Yingjun; Chen, Hongbo; Adam, Abdelnasir; Cheng, Yanfen; Hartung, Joerg; Bao, Endong			Comparative Analysis of alpha B-Crystallin Expression in Heat-Stressed Myocardial Cells In Vivo and In Vitro	PLOS ONE			English	Article							SHOCK PROTEINS; INDUCED APOPTOSIS; UNITED-STATES; DEATH; TISSUES; HSP27; HYPERTHERMIA; HEATSTROKE; DISEASE; MICE	Relationships between alpha B-crystallin expression patterns and pathological changes of myocardial cells after heat stress were examined in vitro and in vivo in this study using the H9C2 cell line and Sprague-Dawley rats, respectively. Histopathological lesions, characterized by acute degeneration, karyopyknosis and loss of a defined nucleus, became more severe in rat hearts over the course of heat stress treatment from 20 min to 100 min. The expression of alpha B-crystallin in rat hearts showed a significant decrease (P<0.05) throughout the heat stress treatment period, except at the 40 min time point. Likewise, decreased alpha B-crystallin expression was also observed in the H9C2 cell line exposed to a high temperature in vitro, although its expression recovered to normal levels at later time points (80 and 100 min) and the cellular damage was less severe. The results suggest that alpha B-crystallin is mobilized early after exposure to a high temperature to interact with damaged proteins but that the myocardial cells cannot produce sufficient alpha B-crystallin for protection against heat stress. Lower alpha B-crystallin expression levels were accompanied by obvious cell/tissue damage, suggesting that the abundance of this protein is associated with protective effects in myocardial cells in vitro and in vivo. Thus, alpha B-crystallin is a potential biomarker of heat stress.	[Tang, Shu; Lv, Yingjun; Chen, Hongbo; Adam, Abdelnasir; Cheng, Yanfen; Bao, Endong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Hartung, Joerg] Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany	Nanjing Agricultural University; University of Veterinary Medicine Hannover, Foundation	Bao, ED (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	b_endong@njau.edu.cn			National Key Basic Research Program of China (973 Program) [2014CB138502]; National Natural Science Foundation of China [31372403]; National Department Public Benefit Research Foundation (Agriculture) [201003060-11]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate research and innovation projects in Jiangsu Province; Sino-German Agricultural Cooperation Project of the Federal Ministry of Food, the Agriculture and Consumer Production, Berlin, Germany	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation (Agriculture); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate research and innovation projects in Jiangsu Province; Sino-German Agricultural Cooperation Project of the Federal Ministry of Food, the Agriculture and Consumer Production, Berlin, Germany	This work was supported by grants from the National Key Basic Research Program of China (973 Program) (2014CB138502), the National Natural Science Foundation of China (31372403), the National Department Public Benefit Research Foundation (Agriculture) (201003060-11), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Graduate research and innovation projects in Jiangsu Province and the Sino-German Agricultural Cooperation Project of the Federal Ministry of Food, the Agriculture and Consumer Production, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bettaieb A, 2008, BIOCHEM CELL BIOL, V86, P521, DOI 10.1139/O08-136; Bhairab N, 2007, J MOL BIOL, V366, P756; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bouchama A, 1996, CRIT CARE MED, V24, P1173, DOI 10.1097/00003246-199607000-00018; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Chang CP, 2003, CLIN EXP PHARMACOL P, V30, P387, DOI 10.1046/j.1440-1681.2003.03847.x; Chiral M, 2004, PEDIATR RES, V56, P775, DOI 10.1203/01.PDR.0000142732.09325.61; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; David JC, 2001, BIOL NEONATE, V79, P131, DOI 10.1159/000047079; Djabali K, 1997, J CELL SCI, V110, P2759; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; ELLIS FP, 1972, ENVIRON RES, V5, P1, DOI 10.1016/0013-9351(72)90019-9; Eshel GM, 2001, AM J FOREN MED PATH, V22, P100, DOI 10.1097/00000433-200103000-00022; Evans JR, 2010, BREAST CANCER RES TR, V122, P159, DOI 10.1007/s10549-009-0542-7; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Genth-Zotz S, 2004, INT J CARDIOL, V96, P397, DOI 10.1016/j.ijcard.2003.08.008; Geraert PA, 1996, BRIT J NUTR, V75, P195, DOI 10.1079/BJN19960124; GERNOLD M, 1993, DEV GENET, V14, P103, DOI 10.1002/dvg.1020140204; GHAZNAWI HI, 1987, ANN SAUDI MED, V7, P323, DOI 10.5144/0256-4947.1987.323; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Herbst J, 2011, J FORENSIC SCI, V56, P1062, DOI 10.1111/j.1556-4029.2011.01760.x; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jeong WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045754; Jester JV, 2008, SEMIN CELL DEV BIOL, V19, P82, DOI 10.1016/j.semcdb.2007.09.015; JONES TS, 1982, JAMA-J AM MED ASSOC, V247, P3327, DOI 10.1001/jama.247.24.3327; KAMPINGA HH, 1994, BIOCHEM BIOPH RES CO, V204, P1170, DOI 10.1006/bbrc.1994.2586; Kardys I, 2008, CLIN CHEM, V54, P139, DOI 10.1373/clinchem.2007.094961; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KNOWLTON AA, 1991, J CLIN INVEST, V87, P139, DOI 10.1172/JCI114963; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; LI Z, 2004, CURR PROTOC IMMUNOL, V1; Liu L, 2007, EUR J HEART FAIL, V9, P762, DOI 10.1016/j.ejheart.2007.03.007; Lushnikova EL, 2000, B EXP BIOL MED+, V130, P810; Lutsch G, 1997, CIRCULATION, V96, P3466; MARBER MS, 1995, CIRCULATION, V92, P1061; Nakano M, 1996, AM J PHYSIOL-HEART C, V270, pH1231, DOI 10.1152/ajpheart.1996.270.4.H1231; Nakano M, 1997, CIRCULATION, V95, P1523; Perng MD, 1999, J CELL SCI, V112, P2099; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Ricci JE, 2001, EUR CYTOKINE NETW, V12, P126; ROSENTHAL A, 1971, AM J CARDIOL, V27, P162, DOI 10.1016/0002-9149(71)90253-0; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Scheers-Masters JR, 2004, PEDIATRICS, V113, pE586, DOI 10.1542/peds.113.6.e586; SCHOENIGER LO, 1994, SHOCK, V1, P31, DOI 10.1097/00024382-199401000-00006; Su Shih-Ping, 2011, Mol Vis, V17, P2798; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Yu JM, 2008, CELL STRESS CHAPERON, V13, P327, DOI 10.1007/s12192-008-0031-7; ZAK R, 1974, CIRC RES, V35, P17; Zhang M, 2012, J VET SCI, V13, P253, DOI 10.4142/jvs.2012.13.3.253; Zhao BJ, 2012, J PHYSIOL BIOCHEM, V68, P485, DOI 10.1007/s13105-012-0161-3; Zhu L, 2009, CELL STRESS CHAPERON, V14, P61, DOI 10.1007/s12192-008-0055-z	62	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86937	10.1371/journal.pone.0086937	http://dx.doi.org/10.1371/journal.pone.0086937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466295	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100236
J	Tang, WZ; Cui, JG; Shan, BQ; Wang, C; Zhang, WQ				Tang, Wenzhong; Cui, Jingguo; Shan, Baoqing; Wang, Chao; Zhang, Wenqiang			Heavy Metal Accumulation by Periphyton Is Related to Eutrophication in the Hai River Basin, Northern China	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SPATIAL-DISTRIBUTION; SURFACE SEDIMENTS; RISK-ASSESSMENT; WATER-QUALITY; BOHAI BAY; BIOACCUMULATION; POLLUTION; GROWTH; LAKE	The Hai River Basin (HRB) is one of the most polluted river basins in China. The basin suffers from various types of pollutants including heavy metals and nutrients due to a high population density and rapid economic development in this area. We assessed the relationship between heavy metal accumulation by periphyton playing an important role in fluvial food webs and eutrophication in the HRB. The concentrations of the unicellular diatoms (type A), filamentous algae with diatoms (type B), and filamentous algae (type C) varied along the river, with type A dominating upstream, and types B then C increasing in concentration further downstream, and this was consistent with changes in the trophic status of the river. The mean heavy metal concentrations in the type A, B and C organisms were Cr: 18, 18 and 24 mg/kg, respectively, Ni: 9.2, 10 and 12 mg/kg, respectively, Cu: 8.4, 19 and 29 mg/kg, respectively, and Pb: 11, 9.8 and 7.1 mg/kg respectively. The bioconcentration factors showed that the abilities of the organisms to accumulate Cr, Ni and Pb decreased in the order type A, type B, then type C, but their abilities to accumulate Cu increased in that order. The Ni concentration was a good predictor of Cr, Cu and Pb accumulation by all three periphyton types. Our study shows that heavy metal accumulation by periphyton is associated with eutrophication in the rivers in the HRB.	[Tang, Wenzhong; Shan, Baoqing; Wang, Chao; Zhang, Wenqiang] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Cui, Jingguo] Beijing Sound Environm Engn Co Ltd, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Shan, BQ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	bqshan@rcees.ac.cn	Tang, Wenzhong/AAM-6971-2020	Tang, Wenzhong/0000-0001-8347-8592	National Natural Science Foundation of China [21107126]; One-Three-Fiver Program of Research Center for Eco-Environmental Sciences [YSW2013B02]; National Water Pollution Control Program [2012ZX07203-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One-Three-Fiver Program of Research Center for Eco-Environmental Sciences; National Water Pollution Control Program	This work was supported by the National Natural Science Foundation of China (No. 21107126), the One-Three-Fiver Program of Research Center for Eco-Environmental Sciences (No. YSW2013B02), and the National Water Pollution Control Program (No. 2012ZX07203-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aji K, 2008, HYDROL PROCESS, V22, P63, DOI 10.1002/hyp.6640; Anishchenko OV, 2010, CENT EUR J BIOL, V5, P125, DOI 10.2478/s11535-009-0060-y; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Biggs B.J.F., 2000, STREAM PERIPHYTON MO; Bowes MJ, 2012, SCI TOTAL ENVIRON, V434, P201, DOI 10.1016/j.scitotenv.2011.09.082; Buck S., 2000, NUTR CRITERIA TECHNI; CAIRNS J, 1986, ENVIRON MONIT ASSESS, V6, P207, DOI 10.1007/BF00396790; Chakravarty R, 2012, BIORESOURCE TECHNOL, V108, P176, DOI 10.1016/j.biortech.2011.12.100; China E. P. A, 2002, MONITORING ANAL METH; Cui JG, 2012, J ENVIRON SCI, V24, P1723, DOI 10.1016/S1001-0742(11)60976-5; Dodds WK, 2006, LIMNOL OCEANOGR, V51, P671, DOI 10.4319/lo.2006.51.1_part_2.0671; Doshi H, 2008, CURR MICROBIOL, V56, P246, DOI 10.1007/s00284-007-9070-z; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Gold C, 2002, WATER RES, V36, P3654, DOI 10.1016/S0043-1354(02)00051-9; Hauer F.R., 2011, METHODS STREAM ECOLO; Hill WR, 1996, CAN J FISH AQUAT SCI, V53, P812, DOI 10.1139/cjfas-53-4-812; Hu BQ, 2013, ENVIRON SCI POLLUT R, V20, P4099, DOI 10.1007/s11356-012-1332-z; Huang HJ, 2011, BIORESOURCE TECHNOL, V102, P10346, DOI 10.1016/j.biortech.2011.08.117; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; KELLY MG, 1995, HYDROBIOLOGIA, V302, P179, DOI 10.1007/BF00032108; Kelly MG, 1998, ENVIRON CONSERV, V25, P22, DOI 10.1017/S037689299800006X; Maltais MJ, 1997, CAN J BOT, V75, P1556, DOI 10.1139/b97-868; Moreira-Santos M, 2004, ENVIRON TOXICOL CHEM, V23, P1549, DOI 10.1897/03-389; Morin S, 2008, ENVIRON POLLUT, V151, P532, DOI 10.1016/j.envpol.2007.04.023; NEWMAN MC, 1989, ENVIRON POLLUT, V60, P83, DOI 10.1016/0269-7491(89)90222-4; NIELSEN ES, 1971, PHYSIOL PLANTARUM, V24, P480, DOI 10.1111/j.1399-3054.1971.tb03522.x; Qiu YW, 2011, ECOTOX ENVIRON SAFE, V74, P284, DOI 10.1016/j.ecoenv.2010.10.008; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Sekar R, 2002, FRESHWATER BIOL, V47, P1893, DOI 10.1046/j.1365-2427.2002.00936.x; STERNER RW, 1993, ECOLOGY, V74, P2351, DOI 10.2307/1939587; Suresh G, 2012, ECOTOX ENVIRON SAFE, V84, P117, DOI 10.1016/j.ecoenv.2012.06.027; Tang WZ, 2010, J HAZARD MATER, V176, P945, DOI 10.1016/j.jhazmat.2009.11.131; Vis C, 1998, ENVIRON POLLUT, V101, P13, DOI 10.1016/S0269-7491(98)00042-6; WANG HK, 1984, ENVIRON SCI TECHNOL, V18, P106, DOI 10.1021/es00120a011	34	13	16	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86458	10.1371/journal.pone.0086458	http://dx.doi.org/10.1371/journal.pone.0086458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24482681	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100170
J	Wittmann, J; Dreiseikelmann, B; Rohde, C; Rohde, M; Sikorski, J				Wittmann, Johannes; Dreiseikelmann, Brigitte; Rohde, Christine; Rohde, Manfred; Sikorski, Johannes			Isolation and Characterization of Numerous Novel Phages Targeting Diverse Strains of the Ubiquitous and Opportunistic Pathogen Achromobacter xylosoxidans	PLOS ONE			English	Article							SUBSP XYLOSOXIDANS; CYSTIC-FIBROSIS; STAPHYLOCOCCUS-AUREUS; EMERGING PATHOGEN; BACTERIOPHAGES; OUTBREAK; INFECTIONS; BACTEREMIA; ENDOCARDITIS; SEQUENCE	The clinical relevance of nosocomially acquired infections caused by multi-resistant Achromobacter strains is rapidly increasing. Here, a diverse set of 61 Achromobacter xylosoxidans strains was characterized by MultiLocus Sequence Typing and Phenotype MicroArray technology. The strains were further analyzed in regard to their susceptibility to 35 antibiotics and to 34 different and newly isolated bacteriophages from the environment. A large proportion of strains were resistant against numerous antibiotics such as cephalosporines, aminoglycosides and quinolones, whereas piperacillin-tazobactam, ticarcillin, mezlocillin and imipenem were still inhibitory. We also present the first expanded study on bacteriophages of the genus Achromobacter that has been so far a blank slate with respect to phage research. The phages were isolated mainly from several waste water treatment plants in Germany. Morphological analysis of all of these phages by electron microscopy revealed a broad diversity with different members of the order Caudovirales, including the families Siphoviridae, Myoviridae, and Podoviridae. A broad spectrum of different host ranges could be determined for several phages that lysed up to 24 different and in part highly antibiotic resistant strains. Molecular characterisation by DNA restriction analysis revealed that all phages contain linear double-stranded DNA. Their restriction patterns display distinct differences underlining their broad diversity.	[Wittmann, Johannes; Rohde, Christine] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Microorganisms, Braunschweig, Germany; [Dreiseikelmann, Brigitte] Univ Bielefeld, Fac Biol, Dept Microbiol Genetechnol, D-33615 Bielefeld, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Cent Facil Microscopy, Braunschweig, Germany; [Sikorski, Johannes] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Microbial Ecol & Divers Res, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Bielefeld; Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Wittmann, J (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Microorganisms, Braunschweig, Germany.	johannes.wittmann@dsmz.de	Sikorski, Johannes/AAX-1960-2020; Sikorski, Johannes/AAD-9775-2019	Sikorski, Johannes/0000-0002-1890-5540; 	Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures	Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures	This work was supported by Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures funded this research through the employment of Johannes Wittmann, Christine Rohde and Johannes Sikorski, who contributed to all aspects of the study. There are no external funders who could have had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Ackermann HW, 2000, VIRUS TAXONOMY CLASS, P69; Ahmed MS, 2009, CLIN NEPHROL, V71, P350; Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Bador J, 2013, ANTIMICROB AGENTS CH, V57, P603, DOI 10.1128/AAC.01243-12; Behrens-Muller B, 2012, INFECT CONT HOSP EP, V33, P180, DOI 10.1086/663710; Beilstein F, 2006, RES MICROBIOL, V157, P213, DOI 10.1016/j.resmic.2005.07.005; Borysowski J, 2011, BIODRUGS, V25, P347, DOI 10.2165/11595610-000000000-00000; Busse HJ, 2005, BERGEYS MANUAL SYSTE, P658, DOI DOI 10.1007/0-387-29298-5_; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capparelli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011720; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; D'Herelle F, 2007, RES MICROBIOL, V158, P553, DOI 10.1016/j.resmic.2007.07.005; Davies JC, 2007, SEMIN RESP CRIT CARE, V28, P312, DOI 10.1055/s-2007-981652; Duggan JM, 1996, CLIN INFECT DIS, V23, P569, DOI 10.1093/clinids/23.3.569; Fard RMN, 2011, LETT APPL MICROBIOL, V52, P559, DOI 10.1111/j.1472-765X.2011.03043.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Festini F, 2007, PEDIATR PULM, V42, P779, DOI 10.1002/ppul.20630; FLEMING A, 1980, REV INFECT DIS, V2, P129; Fouts DE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-165; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Ho YN, 2012, J HAZARD MATER, V219, P43, DOI 10.1016/j.jhazmat.2012.03.035; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jencova V, 2004, INT BIODETER BIODEGR, V54, P175, DOI 10.1016/j.ibiod.2004.03.007; Jencova V, 2008, RES MICROBIOL, V159, P118, DOI 10.1016/j.resmic.2007.11.018; Jha P, 2009, MICROB ECOL, V58, P179, DOI 10.1007/s00248-009-9485-0; JONES PT, 1981, J GEN VIROL, V53, P275, DOI 10.1099/0022-1317-53-2-275; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Karumidze N, 2013, CURR MICROBIOL, V66, P251, DOI 10.1007/s00284-012-0264-7; Kindt R, 2005, TREE DIVERSITY ANAL; Lambiase A, 2011, EUR J CLIN MICROBIOL, V30, P973, DOI 10.1007/s10096-011-1182-5; LEVESQUE R, 1983, CAN J MICROBIOL, V29, P819, DOI 10.1139/m83-133; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma Y, 2009, J ENVIRON MANAGE, V90, P831, DOI 10.1016/j.jenvman.2008.01.014; Manckoundia P, 2011, MED SCI MONITOR, V17, pCS63, DOI 10.12659/MSM.881796; MARTINO P, 1990, REV INFECT DIS, V12, P250; Traglia GM, 2012, CURR MICROBIOL, V65, P673, DOI 10.1007/s00284-012-0213-5; Merabishvili M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052709; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olshtain-Pops K, 2011, J UROLOGY, V185, P144, DOI 10.1016/j.juro.2010.08.093; OLSON DA, 1982, WESTERN J MED, V136, P153; Park Jung Hyun, 2012, Korean J Ophthalmol, V26, P49, DOI 10.3341/kjo.2012.26.1.49; Pirnay JP, 2012, FUTURE VIROL, V7, P379, DOI 10.2217/FVL.12.24; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Reddy AK, 2009, CORNEA, V28, P1100, DOI 10.1097/ICO.0b013e3181a1658f; REINA J, 1988, J CLIN PATHOL, V41, P920, DOI 10.1136/jcp.41.8.920-c; REVERDY ME, 1984, J CLIN MICROBIOL, V19, P140, DOI 10.1128/JCM.19.2.140-143.1984; Ridderberg W, 2012, J CLIN MICROBIOL, V50, P2688, DOI 10.1128/JCM.00728-12; Ridderberg W, 2011, J CYST FIBROS, V10, P466, DOI 10.1016/j.jcf.2011.07.004; Rigvava S, 2013, CAN J MICROBIOL, V59, P18, DOI 10.1139/cjm-2012-0385; ROLSTON KVI, 1990, J ANTIMICROB CHEMOTH, V26, P857, DOI 10.1093/jac/26.6.857; Seal BS, 2013, POULTRY SCI, V92, P526, DOI 10.3382/ps.2012-02708; SPEAR JB, 1988, J CLIN MICROBIOL, V26, P598, DOI 10.1128/JCM.26.3.598-599.1988; Strnad H, 2011, J BACTERIOL, V193, P791, DOI 10.1128/JB.01299-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tena D, 2005, EUR J CLIN MICROBIOL, V24, P727, DOI 10.1007/s10096-005-0028-4; Tena D, 2008, SCAND J INFECT DIS, V40, P84, DOI 10.1080/00365540701558714; THOMSON JA, 1974, J GEN VIROL, V22, P153, DOI 10.1099/0022-1317-22-1-153; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; van Hal S, 2008, J MED MICROBIOL, V57, P525, DOI 10.1099/jmm.0.47496-0; Vu-Thien H, 1998, EUR J CLIN MICROBIOL, V17, P724, DOI 10.1007/s100960050168; Walker RD, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.1.1; WOODS DR, 1975, J GEN MICROBIOL, V88, P86, DOI 10.1099/00221287-88-1-86; YABUUCHI E, 1971, JPN J MICROBIOL, V15, P477, DOI 10.1111/j.1348-0421.1971.tb00607.x; Yamamoto M, 2012, J ANTIMICROB CHEMOTH, V67, P2110, DOI 10.1093/jac/dks179; ZIVIN R, 1981, J MOL BIOL, V152, P335, DOI 10.1016/0022-2836(81)90246-1	77	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86935	10.1371/journal.pone.0086935	http://dx.doi.org/10.1371/journal.pone.0086935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466294	gold, Green Published, Green Submitted			2022-12-27	WOS:000330283100235
J	Rebolj, M; Preisler, S; Ejegod, DM; Rygaard, C; Lynge, E; Bonde, J				Rebolj, Matejka; Preisler, Sarah; Ejegod, Ditte Moller; Rygaard, Carsten; Lynge, Elsebeth; Bonde, Jesper			Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening	PLOS ONE			English	Article							HYBRID CAPTURE 2; RISK HUMAN-PAPILLOMAVIRUS; COBAS 4800 HPV; INTRAEPITHELIAL NEOPLASIA; ABNORMAL SMEARS; MESSENGER-RNA; DNA TESTS; WOMEN; PERFORMANCE; CYTOLOGY	We aimed to determine the disagreement in primary cervical screening between four human papillomavirus assays: Hybrid Capture 2, cobas, CLART, and APTIMA. Material from 5,064 SurePath samples of women participating in routine cervical screening in Copenhagen, Denmark, was tested with the four assays. Positive agreement between the assays was measured as the conditional probability that the results of all compared assays were positive given that at least one assay returned a positive result. Of all 5,064 samples, 1,679 (33.2%) tested positive on at least one of the assays. Among these, 41% tested positive on all four. Agreement was lower in women aged >= 30 years (30%, vs. 49% at <30 years), in primary screening samples (29%, vs. 38% in follow-up samples), and in women with concurrent normal cytology (22%, vs. 68% with abnormal cytology). Among primary screening samples from women aged 30-65 years (n = 2,881), 23% tested positive on at least one assay, and 42 to 58% of these showed positive agreement on any compared pair of the assays. While 4% of primary screening samples showed abnormal cytology, 6 to 10% were discordant on any pair of assays. A literature review corroborated our findings of considerable disagreement between human papillomavirus assays. This suggested that the extent of disagreement in primary screening is neither population-nor storage media-specific, leaving assay design differences as the most probable cause. The substantially different selection of women testing positive on the various human papillomavirus assays represents an unexpected challenge for the choice of an assay in primary cervical screening, and for follow up of in particular HPV positive/cytology normal women.	[Rebolj, Matejka; Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Preisler, Sarah; Ejegod, Ditte Moller; Rygaard, Carsten; Bonde, Jesper] Univ Copenhagen, Hvidovre Hosp, Dept Pathol, DK-2650 Hvidovre, Denmark; [Preisler, Sarah; Ejegod, Ditte Moller; Bonde, Jesper] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rebolj, M (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	mare@sund.ku.dk	Bonde, Jesper/AAN-5930-2020	Rebolj, Matejka/0000-0001-9597-645X; Lynge, Elsebeth/0000-0003-4785-5236; Bonde, Jesper/0000-0003-4853-6747	Danish Strategic Research Council [10092793]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	Genomica, the manufacturer of the CLART HPV2 Assay; Hologic/Gen-Probe, the manufacturer of the APTIMA HPV Assay; Roche, the manufacturer of the cobas HPV Test; and Qiagen, the manufacturer of the Hybrid Capture 2 Assay, provided tests, instrumentation, and limited co-funding for laboratory material. According to the contract between the manufacturers, Hvidovre University Hospital, and University of Copenhagen, all four manufacturers had the right to comment on a draft version of this manuscript, but had no editorial rights. MR and SP were funded by the Danish Strategic Research Council (grant number: 10092793; URL:http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danishcouncil-for-strategic-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers worked independently of the funders.	Arbyn M, 2013, INT J CANCER, V132, P101, DOI 10.1002/ijc.27636; Berkhof J, 2010, INT J CANCER, V127, P2147, DOI 10.1002/ijc.25211; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Clad A, 2011, J CLIN MICROBIOL, V49, P1071, DOI 10.1128/JCM.01674-10; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Eklund C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12; Gage JC, 2012, J CLIN MICROBIOL, V50, P61, DOI 10.1128/JCM.05989-11; Garcia-Sierra N, 2009, J CLIN MICROBIOL, V47, P2165, DOI 10.1128/JCM.00402-09; Getman D, 2009, J CLIN VIROL, V45, pS49, DOI 10.1016/S1386-6532(09)70008-3; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Ki EY, 2013, INT J MED SCI, V10, P119, DOI 10.7150/ijms.5460; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; Lapierre SG, 2012, J CLIN MICROBIOL, V50, P1240, DOI 10.1128/JCM.06656-11; Lloveras B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058153; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Mesher D, 2013, EUR J CANC IN PRESS; Monsonego J, 2011, INT J CANCER, V129, P691, DOI 10.1002/ijc.25726; Park Y, 2012, J CLIN MICROBIOL, V50, P2359, DOI 10.1128/JCM.00337-12; Pista A, 2011, J MED VIROL, V83, P272, DOI 10.1002/jmv.21952; Ramanakumar AV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-326; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Reuschenbach M, 2010, GYNECOL ONCOL, V119, P98, DOI 10.1016/j.ygyno.2010.06.011; Ronco G, 2013, LANCET; Snijders PJF, 2003, J PATHOL, V201, P1, DOI 10.1002/path.1433; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Stoler MH, 2013, AM J OBSTET GYNECOL, V208, p144e1; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; Wong AA, 2012, J CLIN MICROBIOL, V50, P25, DOI 10.1128/JCM.05400-11; Wu RF, 2010, INT J GYNECOL CANCER, V20, P1411, DOI 10.1111/IGC.0b013e3181f29547	32	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86835	10.1371/journal.pone.0086835	http://dx.doi.org/10.1371/journal.pone.0086835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24466262	Green Published, gold, Green Submitted			2022-12-27	WOS:000330240500140
J	Arbeille, P; Provost, R; Vincent, N; Aubert, A				Arbeille, Philippe; Provost, Romain; Vincent, Nicole; Aubert, Andre			Adaptation of the Main Peripheral Artery and Vein to Long Term Confinement (MARS 500)	PLOS ONE			English	Article							HEAD-DOWN TILT; VITAMIN-D; GROUP-DYNAMICS; SPACE-FLIGHT; BED REST; IMPACT; RISK	Purpose: The objective was to check if 520 days in confinement (MARS 500), may affect the main peripheral arterial diameter and wall thickness and the main vein size. Method: Common carotid (CC) femoral artery (FA) portal vein (PV), jugular (JG), femoral vein (FV) and tibial vein were assessed during MARS 500 by echography, performed by the subjects. A hand free volumic echographic capture method and a delayed 3D reconstruction software developed by our lab were used for collecting and measuring the vascular parameters. Results: During the MARS 500 experiment the subjects performed 6 sessions among which 80% of the echographic data were of sufficient quality to be processed. No significant change was found for the Common carotid, Jugular vein, femoral artery, femoral vein, portal vein, and tibial vein diameter. CC and FA IMT (intima media thickness) were found significantly increased (14% to 28% P<0.05) in all the 6 subjects, during the confinement period and also at +2 days after the confinement period, but there was no significant difference 6 month later compare to pre MARS 500. Conclusion: The experiment confirmed that even untrained to performing echography the subjects were able to capture enough echographic data to reconstruct the vessel image from which the parameters were measured. The increase in both CC and FA IMT should be in relation with the stress generated by the confined environment or absence of solar radiation, as there was no change in gravity, temperature and air in the MARS 500 module, and minor changes in physical exercise and nutrition.	[Arbeille, Philippe; Provost, Romain] Univ Hosp Trousseau, Med Physiol Spatiale UMPS CERCOM, Tours, France; [Vincent, Nicole] CRIP Lab Informat, Fac Med, Paris, France; [Aubert, Andre] Katholieke Univ Leuven, O&N Lab Expt Cardiol, Univ Hosp Gasthuisberg, Louvain, Belgium	CHU Tours; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; University Hospital Leuven	Arbeille, P (corresponding author), Univ Hosp Trousseau, Med Physiol Spatiale UMPS CERCOM, Tours, France.	arbeille@ed.univ-tours.fr			CNES (French Space Agency) [4800000601]; ESA (European space agency); Belgian federal office of scientific affairs through ESA-PRODEX grant	CNES (French Space Agency)(Centre National D'etudes Spatiales); ESA (European space agency)(European Space Agency); Belgian federal office of scientific affairs through ESA-PRODEX grant	This work was supported by CNES (French Space Agency), grant 4800000601, ESA (European space agency), and the Belgian federal office of scientific affairs through ESA-PRODEX grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/853175; Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Arbeille P, 2008, J APPL PHYSIOL, V104, P938, DOI 10.1152/japplphysiol.01021.2007; Arbeille P, 2001, EUR J APPL PHYSIOL, V86, P157, DOI 10.1007/s004210100473; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Baldassarre D, 2012, J AM COLL CARDIOL; Bernd L, 1996, ADV SPACE BIOL MED, V5, P157; Bogh MKB, 2012, SCAND J CLIN LAB INV, V72, P24, DOI 10.3109/00365513.2012.681929; Brazhe N A, 2011, Aviakosm Ekolog Med, V45, P40; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Cazes C, 1996, Adv Space Biol Med, V5, P245, DOI 10.1016/S1569-2574(08)60063-5; Cicarma E, 2009, ANTICANCER RES, V29, P3495; Cooper DC, 2010, PSYCHOSOM MED, V72, P122, DOI 10.1097/PSY.0b013e3181cdbfc0; de Labriolle A, 2009, ULTRASOUND MED BIOL, V35, P1436, DOI 10.1016/j.ultrasmedbio.2009.03.013; Dorfman TA, 2007, J APPL PHYSIOL, V103, P8, DOI 10.1152/japplphysiol.01162.2006; Eskov K N, 1996, Adv Space Biol Med, V5, P233, DOI 10.1016/S1569-2574(08)60062-3; Gunga H C, 1996, Adv Space Biol Med, V5, P39, DOI 10.1016/S1569-2574(08)60052-0; Heo SH, 2013, J NEUROL, V260, P122, DOI 10.1007/s00415-012-6599-y; Hockey G R, 1996, Adv Space Biol Med, V5, P309, DOI 10.1016/S1569-2574(08)60067-2; Larina I M, 1999, Hum Physiol, V25, P574; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; MAILLET A, 1993, AVIAT SPACE ENVIR MD, V64, P287; Nichiporuk I A, 1995, Aviakosm Ekolog Med, V29, P58; Plante GE, 2002, METABOLISM, V51, P25, DOI 10.1053/meta.2002.33187; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Rizzolatti G, 1993, Adv Space Biol Med, V3, P151; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Safarova AF, 2012, KARDIOLOGIYA, V52, P22; Schneider S, 2013, BEHAV BRAIN RES, V236, P1, DOI 10.1016/j.bbr.2012.08.022; Su TC, 2012, J ATHEROSCLER THROMB, V19, P872, DOI 10.5551/jat.10728; Uchakin P. N., 2006, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P15; Vaernes R J, 1993, Adv Space Biol Med, V3, P35; van de Luijtgaarden KM, 2012, EUR J VASC ENDOVASC, V44, P301, DOI 10.1016/j.ejvs.2012.06.017; Vigo DE, 2012, AVIAT SPACE ENVIR MD, V83, P125, DOI 10.3357/ASEM.3120.2012; Wadley AJ, 2012, AGE; Wan L, 2011, AVIAT SPACE ENVIR MD, V82, P711, DOI 10.3357/ASEM.2986.2011; Weiss K, 1998, ACTA ASTRONAUT, V43, P235	38	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e83063	10.1371/journal.pone.0083063	http://dx.doi.org/10.1371/journal.pone.0083063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475025	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300011
J	King, JR; Gramfort, A; Schurger, A; Naccache, L; Dehaene, S				King, Jean-Remi; Gramfort, Alexandre; Schurger, Aaron; Naccache, Lionel; Dehaene, Stanislas			Two Distinct Dynamic Modes Subtend the Detection of Unexpected Sounds	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY; NOVELTY; RESPONSES; P300; MMN; INFORMATION; ATTENTION; STIMULI; HUMANS	The brain response to auditory novelty comprises two main EEG components: an early mismatch negativity and a late P300. Whereas the former has been proposed to reflect a prediction error, the latter is often associated with working memory updating. Interestingly, these two proposals predict fundamentally different dynamics: prediction errors are thought to propagate serially through several distinct brain areas, while working memory supposes that activity is sustained over time within a stable set of brain areas. Here we test this temporal dissociation by showing how the generalization of brain activity patterns across time can characterize the dynamics of the underlying neural processes. This method is applied to magnetoencephalography (MEG) recordings acquired from healthy participants who were presented with two types of auditory novelty. Following our predictions, the results show that the mismatch evoked by a local novelty leads to the sequential recruitment of distinct and short-lived patterns of brain activity. In sharp contrast, the global novelty evoked by an unexpected sequence of five sounds elicits a sustained state of brain activity that lasts for several hundreds of milliseconds. The present results highlight how MEG combined with multivariate pattern analyses can characterize the dynamics of human cortical processes.	[King, Jean-Remi; Schurger, Aaron; Dehaene, Stanislas] INSERM U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [King, Jean-Remi; Gramfort, Alexandre; Schurger, Aaron; Dehaene, Stanislas] CEA, NeuroSpin Ctr, Inst BioImaging, Gif Sur Yvette, France; [King, Jean-Remi; Naccache, Lionel] INSERM, Inst Cerveau & Moelle Epiniere Res Ctr ICM, Paris, France; [Gramfort, Alexandre] Lab Traitement & Commun Informat LTCI, Ctr Natl Rech Sci CNRS, Inst Mines Telecom, Telecom ParisTech, Paris, France; [Gramfort, Alexandre] Commissariat Energie Atom CEA, Inst Natl Rech Informat & Automat INRIA, Gif Sur Yvette, France; [Naccache, Lionel] Grp Hosp Pitie Salpetriere, Dept Neurophysiol, AP HP, F-75634 Paris, France; [Naccache, Lionel] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Dehaene, Stanislas] Univ Paris 11, Orsay, France; [Dehaene, Stanislas] Coll France, F-75231 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; IMT Atlantique; Institut Polytechnique de Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	King, JR (corresponding author), INSERM U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	jeanremi.king@gmail.com	Schurger, Aaron/Y-4459-2018	Schurger, Aaron/0000-0003-2985-3253; naccache, lionel/0000-0002-2874-1009; Gramfort, Alexandre/0000-0001-9791-4404	Direction Generale de l'Armement (DGA); Institut National de la Sante Et de la Recherche Medicale (INSERM); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); European Research Council senior grant "NeuroConsc"; INSERM; Fondation pour la Recherche Medicale (FRM); Bettencourt-Schueller Foundation; Region ile-de-France	Direction Generale de l'Armement (DGA)(General Electric); Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); European Research Council senior grant "NeuroConsc"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Bettencourt-Schueller Foundation; Region ile-de-France(Region Ile-de-France)	This work was supported by Direction Generale de l'Armement (DGA) to JRK, Institut National de la Sante Et de la Recherche Medicale (INSERM), by Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), and a European Research Council senior grant "NeuroConsc" to SD. The Neurospin MEG facility was sponsored by grants from INSERM, CEA, Fondation pour la Recherche Medicale (FRM), the Bettencourt-Schueller Foundation, and the Region ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Carlson T. A., 2011, J VIS, V11, P1, DOI [10.1167/11.10.9, DOI 10.1167/11.10.9.INTR0DUCTI0N]; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chennu S, 2013, J NEUROSCI, V33, P11194, DOI 10.1523/JNEUROSCI.0114-13.2013; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Duncan KK, 2010, HUM BRAIN MAPP, V31, P1003, DOI 10.1002/hbm.20912; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Friston KJ, 2013, NEUROIMAGE, V81, P503, DOI 10.1016/j.neuroimage.2013.02.057; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; Fuster JM, 2008, PREFRONTAL CORTEX, DOI [10.1016/S0896-6273(00)80673-X., DOI 10.1016/S0896-6273(00)80673-X]; Garcia JO, 2013, CURR BIOL, V23, P515, DOI 10.1016/j.cub.2013.02.013; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; Gramfort A, 2013, MNE SOFTWARE PROCESS; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Ingre Michael, 2013, Neuroimage, V81, P496, DOI 10.1016/j.neuroimage.2013.03.030; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lindquist Martin A, 2013, Neuroimage, V81, P499, DOI 10.1016/j.neuroimage.2013.02.056; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2010, BRAIN RES REV, V64, P123, DOI 10.1016/j.brainresrev.2010.03.001; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Platt JC, 2000, ADV NEUR IN, P61; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Ramkumar P, 2013, J NEUROSCI, V33, P7691, DOI 10.1523/JNEUROSCI.3905-12.2013; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Sandberg K, 2013, J COGNITIVE NEUROSCI, V25, P969, DOI 10.1162/jocn_a_00353; Schurger A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-122; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Wacongne C, 2011, P NATL ACAD SCI USA, V108, P20754, DOI 10.1073/pnas.1117807108; Wakeman DG, 2010, BIOMAG C; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P8850, DOI 10.1073/pnas.1100999108	55	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85791	10.1371/journal.pone.0085791	http://dx.doi.org/10.1371/journal.pone.0085791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475052	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300024
J	Longman, MR; Ranieri, A; Avkiran, M; Snabaitis, AK				Longman, Michael R.; Ranieri, Antonella; Avkiran, Metin; Snabaitis, Andrew K.			Regulation of PP2A(C) Carboxylmethylation and Cellular Localisation by Inhibitory Class G-Protein Coupled Receptors in Cardiomyocytes	PLOS ONE			English	Article							BETA-GAMMA-DIMERS; PHOSPHATASE 2A; CATALYTIC SUBUNIT; DEPENDENT ACTIVATION; CARBOXYL-TERMINUS; KINASE PATHWAY; CORE ENZYME; PHOSPHORYLATION; STIMULATION; METHYLATION	The enzymatic activity of the type 2A protein phosphatase (PP2A) holoenzyme, a major serine/threonine phosphatase in the heart, is conferred by its catalytic subunit (PP2A(C)). PP2A(C) activity and subcellular localisation can be regulated by reversible carboxylmethylation of its C-terminal leucine309 (leu309) residue. Previous studies have shown that the stimulation of adenosine type 1 receptors (A1. Rs) induces PP2A(C) carboxylmethylation and altered subcellular distribution in adult rat ventricular myocytes (ARVM). In the current study, we show that the enzymatic components that regulate the carboxylmethylation status of PP2A(C), leucine carboxylmethyltransferase-1 (LCMT-1) and phosphatase methylesterase-1 (PME-1) are abundantly expressed in, and almost entirely localised in the cytoplasm of ARVM. The stimulation of Gi-coupled A1. Rs with N 6 -cyclopentyladenosine (CPA), and of other Gi-coupled receptors such as muscarinic M-2 receptors (stimulated with carbachol) and angiotensin II AT2 receptors (stimulated with CGP42112) in ARVM, induced PP2A(C) carboxylmethylation at leu309 in a concentration-dependent manner. Exposure of ARVM to 10 mM CPA increased the cellular association between PP2A(C) and its methyltransferase LCMT-1, but not its esterase PME-1. Stimulation of A1. Rs with 10 mu M CPA increased the phosphorylation of protein kinase B at ser473, which was abolished by the PI3K inhibitor LY294002 (20 mu M), thereby confirming that PI3K activity is upregulated in response to A1. R stimulation by CPA in ARVM. A1. R-induced PP2A(C) translocation to the particulate fraction was abrogated by adenoviral expression of the alpha subunit (G(alpha t1)) coupled to the transducin G-protein coupled receptor. A similar inhibitory effect on A1. R-induced PP2A(C) translocation was also seen with LY294002 (20 mu M). These data suggest that in ARVM, A1. R-induced PP2A(C) translocation to the particulate fraction occurs through a GiPCR-G beta gamma-PI3K mediated intracellular signalling pathway, which may involve elevated PP2A(C) carboxylmethylation at leu309.	[Longman, Michael R.; Snabaitis, Andrew K.] Univ Kingston, Fac Sci Engn & Comp, Sch Pharm & Chem, Kingston Upon Thames KT1 2EE, Surrey, England; [Ranieri, Antonella; Avkiran, Metin; Snabaitis, Andrew K.] Kings Coll London, British Heart Fdn Ctr, Cardiovasc Div, Rayne Inst,St Thomas Hosp, London WC2R 2LS, England	Kingston University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Snabaitis, AK (corresponding author), Univ Kingston, Fac Sci Engn & Comp, Sch Pharm & Chem, Kingston Upon Thames KT1 2EE, Surrey, England.	a.snabaitis@kingston.ac.uk		snabaitis, andrew/0000-0003-0061-1111; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation Intermediate Basic Science Research Fellowship [FS/04/053]	British Heart Foundation Intermediate Basic Science Research Fellowship	This work was funded by a British Heart Foundation Intermediate Basic Science Research Fellowship (FS/04/053) to AKS. MRL is currently funded by Kingston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Fahimi-Vahid M, 2002, J MOL CELL CARDIOL, V34, P441, DOI 10.1006/jmcc.2002.1525; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Fenton RA, 2010, AM J PHYSIOL-HEART C, V298, pH1671, DOI 10.1152/ajpheart.01028.2009; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hippe HJ, 2007, CIRC RES, V100, P1191, DOI 10.1161/01.RES.0000264058.28808.cc; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kowluru A, 1996, ENDOCRINOLOGY, V137, P2315, DOI 10.1210/en.137.6.2315; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LEE J, 1993, J BIOL CHEM, V268, P19192; Liu QH, 2003, AM J PHYSIOL-HEART C, V285, pH97, DOI 10.1152/ajpheart.00956.2002; Liu QH, 2002, AM J PHYSIOL-HEART C, V283, pH1314, DOI 10.1152/ajpheart.00343.2002; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Murthy KS, 2008, J PHARMACOL EXP THER, V325, P183, DOI 10.1124/jpet.107.132928; Nicklin S A, 1999, Methods Mol Med, V30, P271, DOI 10.1385/1-59259-247-3:271; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; SCHRAMM M, 1984, SCIENCE, V225, P1350, DOI 10.1126/science.6147897; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Snabaitis AK, 2006, J BIOL CHEM, V281, P20252, DOI 10.1074/jbc.M600268200; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Tikh EI, 2008, J CELL PHYSIOL, V216, P83, DOI 10.1002/jcp.21375; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Torrent L, 2012, CURR ALZHEIMER RES, V9, P248, DOI 10.2174/156720512799361682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Vettel C, 2012, J MOL CELL CARDIOL, V53, P165, DOI 10.1016/j.yjmcc.2012.04.015; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	52	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86234	10.1371/journal.pone.0086234	http://dx.doi.org/10.1371/journal.pone.0086234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475092	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330507300046
J	Loonen, AJM; de Jager, CPC; Tosserams, J; Kusters, R; Hilbink, M; Wever, PC; van den Brule, AJC				Loonen, Anne J. M.; de Jager, Cornelis P. C.; Tosserams, Janna; Kusters, Ron; Hilbink, Mirrian; Wever, Peter C.; van den Brule, Adriaan J. C.			Biomarkers and Molecular Analysis to Improve Bloodstream Infection Diagnostics in an Emergency Care Unit	PLOS ONE			English	Article							SERUM PROCALCITONIN; SEVERE SEPSIS; SEPTIC SHOCK; PCR; BACTEREMIA; MANAGEMENT; CULTURE; IDENTIFICATION; GUIDELINES; MARKER	Molecular pathogen detection from blood is still expensive and the exact clinical value remains to be determined. The use of biomarkers may assist in preselecting patients for immediate molecular testing besides blood culture. In this study, 140 patients with >= 2 SIRS criteria and clinical signs of infection presenting at the emergency department of our hospital were included. C-reactive protein (CRP), neutrophil-lymphocyte count ratio (NLCR), procalcitonin (PCT) and soluble urokinase plasminogen activator receptor (suPAR) levels were determined. One ml EDTA blood was obtained and selective pathogen DNA isolation was performed with MolYsis (Molzym). DNA samples were analysed for the presence of pathogens, using both the MagicPlex Sepsis Test (Seegene) and SepsiTest (Molzym), and results were compared to blood cultures. Fifteen patients had to be excluded from the study, leaving 125 patients for further analysis. Of the 125 patient samples analysed, 27 presented with positive blood cultures of which 7 were considered to be contaminants. suPAR, PCT, and NLCR values were significantly higher in patients with positive blood cultures compared to patients without (p < 0.001). Receiver operating characteristic curves of the 4 biomarkers for differentiating bacteremia from non-bacteremia showed the highest area under the curve (AUC) for PCT (0.806 (95% confidence interval 0.699-0.913)). NLCR, suPAR and CRP resulted in an AUC of 0.770, 0.793, and 0.485, respectively. When compared to blood cultures, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for SepsiTest and MagicPlex Sepsis Test were 11%, 96%, 43%, 80%, and 37%, 77%, 30%, 82%, respectively. In conclusion, both molecular assays perform poorly when one ml whole blood is used from emergency care unit patients. NLCR is a cheap, fast, easy to determine, and rapidly available biomarker, and therefore seems most promising in differentiating BSI from non-BSI patients for subsequent pathogen identification using molecular diagnostics.	[Loonen, Anne J. M.; van den Brule, Adriaan J. C.] Jeroen Bosch Hosp, Lab Mol Diagnost, Shertogenbosch, Netherlands; [de Jager, Cornelis P. C.; Tosserams, Janna] Jeroen Bosch Hosp, Dept Intens Care & Emergency Med, Shertogenbosch, Netherlands; [Kusters, Ron] Jeroen Bosch Hosp, Dept Clin Chem & Haematol, Shertogenbosch, Netherlands; [Hilbink, Mirrian] Jeroen Bosch Hosp, Jeroen Bosch Acad, Shertogenbosch, Netherlands; [Wever, Peter C.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Loonen, Anne J. M.; van den Brule, Adriaan J. C.] Fontys Univ Appl Sci, Dept Med Mol Diagnost, Eindhoven, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis	van den Brule, AJC (corresponding author), Jeroen Bosch Hosp, Lab Mol Diagnost, Shertogenbosch, Netherlands.	a.v.d.brule@jbz.nl						Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Emonet S, 2011, EXPERT REV ANTI-INFE, V9, P707, DOI [10.1586/eri.11.84, 10.1586/ERI.11.84]; Eugen-Olsen J, 2011, J INTERN MED, V270, P29, DOI 10.1111/j.1365-2796.2011.02372.x; Fitting C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038916; Giamarellos-Bourboulis EJ, 2001, CLIN INFECT DIS, V32, P1718, DOI 10.1086/320744; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Grace CJ, 2001, CLIN INFECT DIS, V32, P1651, DOI 10.1086/320527; Hoenigl M, 2013, CLIN BIOCHEM, V46, P225, DOI 10.1016/j.clinbiochem.2012.11.004; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Koch A, 2012, J INTERN MED, V272, P243, DOI 10.1111/j.1365-2796.2012.02568.x; Kuhn C, 2011, J CLIN MICROBIOL, V49, P2919, DOI 10.1128/JCM.00830-11; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Lodes U, 2012, LANGENBECK ARCH SURG, V397, P447, DOI 10.1007/s00423-011-0870-z; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; MCKENZIE R, 1987, DIAGN MICR INFEC DIS, V8, P165, DOI 10.1016/0732-8893(87)90167-2; Mencacci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053279; Peters RPH, 2009, J CLIN MICROBIOL, V47, P3308, DOI 10.1128/JCM.01071-09; Petrikkos GL, 2005, EUR J CLIN MICROBIOL, V24, P272, DOI 10.1007/s10096-005-1312-z; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Serra J, 2012, CRIT CARE, V16, P21; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 2008, LANGENBECK ARCH SURG, V393, P817, DOI 10.1007/s00423-008-0343-1; Vincent JL, 2011, CRIT CARE CLIN, V27, P241, DOI 10.1016/j.ccc.2010.12.010; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Zadroga R, 2013, CLIN INFECT DIS, V56, P790, DOI 10.1093/cid/cis1021; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	35	115	128	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87315	10.1371/journal.pone.0087315	http://dx.doi.org/10.1371/journal.pone.0087315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475269	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300166
J	Nejepinska, J; Malik, R; Wagner, S; Svoboda, P				Nejepinska, Jana; Malik, Radek; Wagner, Susan; Svoboda, Petr			Reporters Transiently Transfected into Mammalian Cells Are Highly Sensitive to Translational Repression Induced by dsRNA Expression	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INITIATION FACTOR-II; PROTEIN-KINASE PKR; GENE-EXPRESSION; MOUSE OOCYTES; MESSENGER-RNAS; HAIRPIN RNA; PHOSPHORYLATION; TRANSCRIPTION; INTERFERENCE	In mammals, double-stranded RNA (dsRNA) can mediate sequence-specific RNA interference, activate sequence-independent interferon response, or undergo RNA editing by adenosine deaminases. We showed that long hairpin dsRNA expression had negligible effects on mammalian somatic cells-expressed dsRNA was slightly edited, poorly processed into siRNAs, and it did not activate the interferon response. At the same time, we noticed reduced reporter expression in transient co-transfections, which was presumably induced by expressed dsRNA. Since transient co-transfections are frequently used for studying gene function, we systematically explored the role of expressed dsRNA in this silencing phenomenon. We demonstrate that dsRNA expressed from transiently transfected plasmids strongly inhibits the expression of co-transfected reporter plasmids but not the expression of endogenous genes or reporters stably integrated in the genome. The inhibition is concentration-dependent, it is found in different cell types, and it is independent of transfection method and dsRNA sequence. The inhibition occurs at the level of translation and involves protein kinase R, which binds the expressed dsRNA. Thus, dsRNA expression represents a hidden danger in transient transfection experiments and must be taken into account during interpretation of experimental results.	[Nejepinska, Jana; Malik, Radek; Svoboda, Petr] ASCR, Inst Mol Genet, Vvi, Prague, Czech Republic; [Wagner, Susan] ASCR, Inst Microbiol, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Svoboda, P (corresponding author), ASCR, Inst Mol Genet, Vvi, Prague, Czech Republic.	svobodap@img.cas.cz	Wagner, Susan/K-8240-2014; Wagner, Susan/ABA-1307-2021; Svoboda, Petr/G-3890-2012; Urbanova, Jana/G-2748-2014; Malik, Radek/G-3578-2014	Svoboda, Petr/0000-0002-4370-3705; Urbanova, Jana/0000-0001-9778-6289; Malik, Radek/0000-0002-6783-1146; Wagner, Susan/0000-0002-7492-7541	Czech Science Foundation [GACR 204/09/0085, AV0Z50520514, RVO 68378050, GACR P305/12/G034]; EMBO Young Investigator Program [1488/2006]	Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	The main support was provided by the Czech Science Foundation grant (GACR 204/09/0085), institutional support AV0Z50520514 and RVO 68378050 to P.S., J.N., and R.M.; the EMBO Young Investigator Program (Installation grant 1488/2006) to P.S.; all authors are members of the Centrum of Excellence supported by the Czech Science Foundation (GACR P305/12/G034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; DeCerbo J, 2005, CURR OPIN CELL BIOL, V17, P302, DOI 10.1016/j.ceb.2005.04.008; Flemr M, 2013, CELL, V155, P807, DOI 10.1016/j.cell.2013.10.001; Gantier MP, 2007, J INTERF CYTOK RES, V27, P789, DOI 10.1089/jir.2006.0152; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Gommans WM, 2008, BIOCHEM BIOPH RES CO, V377, P170, DOI 10.1016/j.bbrc.2008.09.109; Gong CG, 2013, NAT STRUCT MOL BIOL, V20, P1214, DOI 10.1038/nsmb.2664; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Kaname T, 2001, GENE, V266, P147, DOI 10.1016/S0378-1119(01)00375-4; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; Nejepinska J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043283; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Rubin CM, 2002, NUCLEIC ACIDS RES, V30, P3253, DOI 10.1093/nar/gkf419; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sambrook J, 2006, COLD SPRING HARB PRO, V2006, P4455, DOI DOI 10.1101/PDB.PR0T4455; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Svoboda P, 2001, BIOCHEM BIOPH RES CO, V287, P1099, DOI 10.1006/bbrc.2001.5707; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Svoboda P, 2004, NUCLEIC ACIDS RES, V32, P3601, DOI 10.1093/nar/gkh697; Terenzi F, 1999, NUCLEIC ACIDS RES, V27, P4369, DOI 10.1093/nar/27.22.4369; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang Y, 2009, J MOL BIOL, V393, P777, DOI 10.1016/j.jmb.2009.08.070; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87517	10.1371/journal.pone.0087517	http://dx.doi.org/10.1371/journal.pone.0087517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475301	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300195
J	Piao, HX; Yang, AT; Sun, YM; Kong, YY; Wu, XN; Zhang, YZ; Ding, B; Wang, BE; Jia, JD; You, H				Piao, Hong-Xin; Yang, Ai-Ting; Sun, Ya-Meng; Kong, Yuan-Yuan; Wu, Xiao-Ning; Zhang, Ying-Zhe; Ding, Bo; Wang, Bao-En; Jia, Ji-Dong; You, Hong			Increasing Newly Diagnosed Rate and Changing Risk Factors of HCV in Yanbian Prefecture, a High Endemic Area in China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GLOBAL EPIDEMIOLOGY; INFECTION; TRANSMISSION	Background: The newly diagnosed rate of HCV infection is increasing in China. However, the risk factors have not been fully identified. Here, a survey was performed in Yanbian Prefecture, a high-endemic area in China. Methods: We identified newly diagnosed HCV infection in 2007-2011, using the local National Disease Supervision Information Management System from the Chinese Center for Disease Control and Prevention. We determined the risk factors using a case-control survey by questionnaire. Results: Yanbian Prefecture had a rapid increase in the yearly newly diagnosed rate of HCV infection from 32.6 to 72.1/100.000 from the year 2007 to 2011. People aged 50-64 years had a high HCV infection of 43.4%, but only 0.3% of cases were reported in those aged less than 20 years. Cosmetic treatment, family history, blood transfusion, and dental treatment were independent risk factors for HCV infection. Unexpectedly, cosmetic treatments [ odd ratio (OR) = 5.15, 95% confidence interval (CI) = 2.31-11.48, P = 0.00] and family history (OR = 4.68, 95% CI = 2.67-8.75, P = 0.00) showed a higher risk than the conventional risk factors of blood transfusion (OR = 4.49, 95% CI = 1.95-10.37, P = 0.001) and dental treatment (OR = 2.98, 95% CI = 1.42-6.25, P = 0.00). To further analyze the intrafamilial transmission, we found that spouses of HCV patients had an increased risk for acquiring HCV (OR = 5.75, 95% CI: 1.94-17.07), without significant association between either HCV RNA viral load (P = 0.29) or genotype (P = 0.43). Conclusions: HCV infection was increased in Yanbian Prefecture. Cosmetic treatment was a higher risk factor than medical procedure. HCV infection had a clear family clustering phenomenon, especially between spouses.	[Piao, Hong-Xin; Yang, Ai-Ting; Sun, Ya-Meng; Kong, Yuan-Yuan; Wu, Xiao-Ning; Wang, Bao-En; Jia, Ji-Dong; You, Hong] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China; [Piao, Hong-Xin; Zhang, Ying-Zhe; Ding, Bo] Yanbian Univ, Affiliated Hosp, Yanji, Jilin, Peoples R China	Capital Medical University; Yanbian University	You, H (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China.	youhong30@sina.com	You, Hong/G-6686-2011		Program for National Science and Technology Major Project [2013ZX10002004]; Key Project from the Education Bureau of Beijing [KZ201210025024]; Project of Education Department of Jilin Province [611010057]; Chinese Foundation for Hepatitis Prevention and Control [TQGB2011023]	Program for National Science and Technology Major Project; Key Project from the Education Bureau of Beijing; Project of Education Department of Jilin Province; Chinese Foundation for Hepatitis Prevention and Control	This work was supported by Program for National Science and Technology Major Project (2013ZX10002004), Key Project from the Education Bureau of Beijing (KZ201210025024), Project of Education Department of Jilin Province (611010057) and Chinese Foundation for Hepatitis Prevention and Control (TQGB2011023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Amin Janiki, 2004, Commun Dis Intell Q Rep, V28, P517; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Fukuizumi K, 1997, SCAND J INFECT DIS, V29, P345, DOI 10.3109/00365549709011828; Guo W, 2011, PRACTICAL PREVENTIVE, V18, P51; Hajiani E, 2006, WORLD J GASTROENTERO, V12, P7025, DOI 10.3748/wjg.v12.i43.7025; He Y, 2011, J MED VIROL, V83, P616, DOI 10.1002/jmv.22010; Health Protection Agency, 2009, HEP C UK REP; Jokhio A. H., 2010, Eastern Mediterranean Health Journal, V16, P1079; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Kim YS, 1998, INT J EPIDEMIOL, V27, P525, DOI 10.1093/ije/27.3.525; Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1; Liu FF, 2009, EMERG INFECT DIS, V15, P1819, DOI [10.3201/eid1511.0900263, 10.3201/eid1511.090263]; Lu Jian, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P448; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Okayama A, 2002, J VIRAL HEPATITIS, V9, P43, DOI 10.1046/j.1365-2893.2002.00331.x; Shan H, 2007, TRANSFUSION, V47, P2011, DOI 10.1111/j.1537-2995.2007.01424.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Sun CA, 2001, J MED VIROL, V65, P30, DOI 10.1002/jmv.1097; Zhang MD, 2005, EMERG INFECT DIS, V11, P17, DOI 10.3201/eid1101.031005	22	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86190	10.1371/journal.pone.0086190	http://dx.doi.org/10.1371/journal.pone.0086190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475084	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300041
J	Shi, C; Boehme, S; Bentley, AH; Hartmann, EK; Klein, KU; Bodenstein, M; Baumgardner, JE; David, M; Ullrich, R; Markstaller, K				Shi, Chang; Boehme, Stefan; Bentley, Alexander H.; Hartmann, Erik K.; Klein, Klaus U.; Bodenstein, Marc; Baumgardner, James E.; David, Matthias; Ullrich, Roman; Markstaller, Klaus			Assessment of Regional Ventilation Distribution: Comparison of Vibration Response Imaging (VRI) with Electrical Impedance Tomography (EIT)	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; LUNG VENTILATION; SOUNDS; PIGS; STETHOSCOPE; AGREEMENT; MODEL; ARDS; CT	Background: Vibration response imaging (VRI) is a bedside technology to monitor ventilation by detecting lung sound vibrations. It is currently unknown whether VRI is able to accurately monitor the local distribution of ventilation within the lungs. We therefore compared VRI to electrical impedance tomography (EIT), an established technique used for the assessment of regional ventilation. Methodology/Principal Findings: Simultaneous EIT and VRI measurements were performed in the healthy and injured lungs (ALI; induced by saline lavage) at different PEEP levels (0, 5, 10, 15 mbar) in nine piglets. Vibration energy amplitude (VEA) by VRI, and amplitudes of relative impedance changes (rel.Delta Z) by EIT, were evaluated in seven regions of interest (ROIs). To assess the distribution of tidal volume (V-T) by VRI and EIT, absolute values were normalized to the V-T obtained by simultaneous spirometry measurements. Redistribution of ventilation by ALI and PEEP was detected by VRI and EIT. The linear correlation between pooled V-T by VEA and rel.Delta Z was R-2 = 0.96. Bland-Altman analysis showed a bias of -1.07 +/- 24.71 ml and limits of agreement of -49.05 to +47.36 ml. Within the different ROIs, correlations of V-T-distribution by EIT and VRI ranged between R-2 values of 0.29 and 0.96. ALI and PEEP did not alter the agreement of V-T between VRI and EIT. Conclusions/Significance: Measurements of regional ventilation distribution by VRI are comparable to those obtained by EIT.	[Shi, Chang; Boehme, Stefan; Bentley, Alexander H.; Hartmann, Erik K.; Klein, Klaus U.; Bodenstein, Marc; David, Matthias; Markstaller, Klaus] Johannes Gutenberg Univ Mainz, Dept Anaesthesiol, Med Ctr, D-55122 Mainz, Germany; [Boehme, Stefan; Klein, Klaus U.; Ullrich, Roman; Markstaller, Klaus] Med Univ Vienna, Dept Anaesthesia Gen Intens Care & Pain Managemen, Vienna, Austria; [Shi, Chang] Natl Beijing Ctr Drug Safety Evaluat & Res, Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Baumgardner, James E.] Oscillogy LLC, Folsom, PA USA	Johannes Gutenberg University of Mainz; Medical University of Vienna; Academy of Military Medical Sciences - China	Boehme, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anaesthesiol, Med Ctr, D-55122 Mainz, Germany.	stefan_boehme@web.de	Ullrich, Roman/J-8826-2019	Ullrich, Roman/0000-0003-1405-319X; Klein, Klaus Ulrich/0000-0001-7446-0542	German Research Foundation [DFG PAK 415]; G.E. Healthcare Inc., Milwaukee, USA;  [Ma 2398/6-1];  [Ma 2398/7-1]	German Research Foundation(German Research Foundation (DFG)); G.E. Healthcare Inc., Milwaukee, USA; ; 	The study was funded by German Research Foundation grant No. DFG PAK 415; Ma 2398/6-1, Ma 2398/7-1 and in part by G.E. Healthcare Inc., Milwaukee, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker HD, 2009, RESPIRATION, V77, P236, DOI 10.1159/000181147; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Charleston-Villalobos S, 2004, MED BIOL ENG COMPUT, V42, P618, DOI 10.1007/BF02347543; Cochrane CG, 1999, CHEST, V116, p85S, DOI 10.1378/chest.116.suppl_1.85S; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Dellinger RP, 2007, CRIT CARE, V11, DOI 10.1186/cc5706; Frerichs I, 2003, INTENS CARE MED, V29, P2312, DOI 10.1007/s00134-003-2029-z; Frerichs I, 2002, J APPL PHYSIOL, V93, P660, DOI 10.1152/japplphysiol.00081.2002; HAHN G, 1995, PHYSIOL MEAS, V16, pA161, DOI 10.1088/0967-3334/16/3A/016; Hickling KG, 1998, AM J RESP CRIT CARE, V158, P194, DOI 10.1164/ajrccm.158.1.9708049; Hinz J, 2003, CHEST, V124, P314, DOI 10.1378/chest.124.1.314; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kompis M, 2001, CHEST, V120, P1309, DOI 10.1378/chest.120.4.1309; Kunst PWA, 1998, PHYSIOL MEAS, V19, P481, DOI 10.1088/0967-3334/19/4/003; Lev S, 2009, CRIT CARE, V13, DOI 10.1186/cc7871; Markstaller K, 2003, BRIT J ANAESTH, V91, P699, DOI 10.1093/bja/aeg246; Pasterkamp H, 1997, AM J RESP CRIT CARE, V156, P974, DOI 10.1164/ajrccm.156.3.9701115; Pulletz S, 2006, PHYSIOL MEAS, V27, pS115, DOI 10.1088/0967-3334/27/5/S10; Richard JC, 2009, CRIT CARE, V13, DOI 10.1186/cc7900; Stenqvist O, 2003, BRIT J ANAESTH, V91, P92, DOI 10.1093/bja/aeg141; Vena A, 2006, CLIN PHYSIOL FUNCT I, V26, P45, DOI 10.1111/j.1475-097X.2005.00652.x; Victorino JA, 2004, AM J RESP CRIT CARE, V169, P791, DOI 10.1164/rccm.200301-133OC; Yigla M, 2008, AM J ROENTGENOL, V191, P845, DOI 10.2214/AJR.07.3151; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	25	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86638	10.1371/journal.pone.0086638	http://dx.doi.org/10.1371/journal.pone.0086638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475160	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300096
J	Tkalec, M; Stefanic, PP; Cvjetko, P; Sikic, S; Pavlica, M; Balen, B				Tkalec, Mirta; Stefanic, Petra Peharec; Cvjetko, Petra; Sikic, Sandra; Pavlica, Mirjana; Balen, Biljana			The Effects of Cadmium-Zinc Interactions on Biochemical Responses in Tobacco Seedlings and Adult Plants	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; DNA-DAMAGE; SUBCELLULAR-DISTRIBUTION; SUPEROXIDE-DISMUTASE; PRIMARY LEAVES; ASCORBIC-ACID; TOXICITY; GROWTH; PROTEIN	The objective of the present study was to investigate the effects of cadmium-zinc (Cd-Zn) interactions on their uptake, oxidative damage of cell macromolecules (lipids, proteins, DNA) and activities of antioxidative enzymes in tobacco seedlings as well as roots and leaves of adult plants. Seedlings and plants were exposed to Cd (10 mu M and 15 mu M) and Zn (25 mu M and 50 mu M) as well as their combinations (10 mu M or 15 mu M Cd with either 25 mu M or 50 mu M Zn). Measurement of metal accumulation exhibited that Zn had mostly positive effect on Cd uptake in roots and seedlings, while Cd had antagonistic effect on Zn uptake in leaves and roots. According to examined oxidative stress parameters, in seedlings and roots individual Cd treatments induced oxidative damage, which was less prominent in combined treatments, indicating that the presence of Zn alleviates oxidative stress. However, DNA damage found in seedlings, and lower glutathione reductase (GR) and superoxide dismutase (SOD) activity recorded in both seedlings and roots, after individual Zn treatments, indicate that Zn accumulation could impose toxic effects. In leaves, oxidative stress was found after exposure to Cd either alone or in combination with Zn, thus implying that in this tissue Zn did not have alleviating effects. In conclusion, results obtained in different tobacco tissues suggest tissue-dependent Cd-Zn interactions, which resulted in activation of different mechanisms involved in the protection against metal stress.	[Tkalec, Mirta] Univ Zagreb, Fac Sci, Dept Bot, Zagreb 41000, Croatia; [Stefanic, Petra Peharec; Cvjetko, Petra; Pavlica, Mirjana; Balen, Biljana] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia; [Sikic, Sandra] Inst Publ Hlth Dr Andrija Stampar, Dept Ecol, Zagreb, Croatia	University of Zagreb; University of Zagreb	Balen, B (corresponding author), Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia.	bbalen@zg.biol.pmf.hr	Stefanic, Petra peharec/AAC-8128-2019	Stefanic, Petra peharec/0000-0003-4889-6910; Tkalec, Mirta/0000-0003-4733-828X	Ministry of Science, Education and Sports of the Republic of Croatia [119-1191196-1200]; University of Zagreb	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); University of Zagreb	The financial support of this work was provided by The Ministry of Science, Education and Sports of the Republic of Croatia (119-1191196-1200) as well as by the University of Zagreb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; [Anonymous], 2009, 11885 EN ISO; [Anonymous], 2002, 13657 EN; Aravind P, 2003, PLANT PHYSIOL BIOCH, V41, P391, DOI 10.1016/S0981-9428(03)00035-4; Aravind P, 2009, J TRACE ELEM MED BIO, V23, P50, DOI 10.1016/j.jtemb.2008.10.002; Aravind Parameswaran, 2005, Braz. J. Plant Physiol., V17, P3, DOI 10.1590/S1677-04202005000100002; Arora A, 2002, CURR SCI INDIA, V82, P1227; Balen B, 2011, ECOTOXICOLOGY, V20, P815, DOI 10.1007/s10646-011-0633-1; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Bueno P, 2002, PLANT GROWTH REGUL, V36, P161, DOI 10.1023/A:1015044705137; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Cao YY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/576189; Cherif J, 2011, J ENVIRON SCI, V23, P837, DOI 10.1016/S1001-0742(10)60415-9; Cuypers A, 2001, PLANT PHYSIOL BIOCH, V39, P657, DOI 10.1016/S0981-9428(01)01276-1; Cvjetko P, 2010, ARH HIG RADA TOKSIKO, V61, P287, DOI 10.2478/10004-1254-61-2010-2059; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Dixit V, 2001, J EXP BOT, V52, P1101, DOI 10.1093/jexbot/52.358.1101; DUDKA S, 1994, WATER AIR SOIL POLL, V76, P333, DOI 10.1007/BF00482710; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gallego SM, 1996, PLANT SCI, V121, P151, DOI 10.1016/S0168-9452(96)04528-1; Gichner T, 1999, ENVIRON MOL MUTAGEN, V33, P279, DOI 10.1002/(SICI)1098-2280(1999)33:4<279::AID-EM4>3.0.CO;2-K; Gichner T, 2004, MUTAT RES-GEN TOX EN, V559, P49, DOI 10.1016/j.mrgentox.2003.12.008; Gichner T, 2008, ENVIRON EXP BOT, V62, P113, DOI 10.1016/j.envexpbot.2007.07.013; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; GREGER M, 1995, ENVIRON EXP BOT, V35, P215, DOI 10.1016/0098-8472(94)00047-9; Hassan MJ, 2005, J PLANT NUTR SOIL SC, V168, P255, DOI 10.1002/jpln.200420403; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Lefevre I, 2009, PLANT GROWTH REGUL, V59, P1, DOI 10.1007/s10725-009-9382-z; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin CW, 2005, PLANT PHYSIOL BIOCH, V43, P963, DOI 10.1016/j.plaphy.2005.10.001; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Lloret F, 2004, GLOBAL CHANGE BIOL, V10, P248, DOI 10.1111/j.1365-2486.2004.00725.x; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORAGHAN JT, 1993, PLANT SOIL, V150, P61, DOI 10.1007/BF00779176; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nan ZR, 2002, SCI TOTAL ENVIRON, V285, P187, DOI 10.1016/S0048-9697(01)00919-6; Okamoto OK, 1996, J PHYCOL, V32, P74, DOI 10.1111/j.0022-3646.1996.00074.x; Pandey N, 2012, RUSS J PLANT PHYSL+, V59, P198, DOI 10.1134/S1021443712010141; Parlak KU, 2012, ECOTOX ENVIRON SAFE, V85, P52, DOI 10.1016/j.ecoenv.2012.08.023; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; Perronnet K, 2003, PLANT SOIL, V249, P19, DOI 10.1023/A:1022560711597; Ramos I, 2002, PLANT SCI, V162, P761, DOI 10.1016/S0168-9452(02)00017-1; Romero-Puertas MC, 2002, PLANT CELL ENVIRON, V25, P677, DOI 10.1046/j.1365-3040.2002.00850.x; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Shah K, 1998, J PLANT PHYSIOL, V152, P448, DOI 10.1016/S0176-1617(98)80262-9; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Shan ShiHua, 2012, Journal of Agricultural Science (Toronto), V4, P142; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Siedlecka A, 2002, PHYSIOLOGY AND BIOCHEMISTRY OF METAL TOXICITY AND TOLERANCE IN PLANTS, P303; Stefanic PP, 2012, ARH HIG RADA TOKSIKO, V63, P321, DOI 10.2478/10004-1254-63-2012-2173; Tkalec M, 2008, ACTA PHYSIOL PLANT, V30, P881, DOI 10.1007/s11738-008-0194-y; Tran TA, 2013, TURK J BOT, V37, P698, DOI 10.3906/bot-1209-8; Ullrich SM, 1999, APPL GEOCHEM, V14, P187, DOI 10.1016/S0883-2927(98)00042-0; Unyayar S, 2006, MUTAGENESIS, V21, P77, DOI 10.1093/mutage/gel001; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Valverde M, 2001, MUTAGENESIS, V16, P265, DOI 10.1093/mutage/16.3.265; Wang C, 2009, CHEMOSPHERE, V76, P938, DOI 10.1016/j.chemosphere.2009.04.038; Wang JA, 2010, J ENVIRON SCI-CHINA, V22, P1916, DOI 10.1016/S1001-0742(09)60339-9; Weckx JEJ, 1996, PHYSIOL PLANTARUM, V96, P506, DOI 10.1111/j.1399-3054.1996.tb00465.x; Wilde KL, 2006, ARCH ENVIRON CON TOX, V51, P174, DOI 10.1007/s00244-004-0256-0; Wu FB, 2005, CHEMOSPHERE, V60, P1437, DOI 10.1016/j.chemosphere.2005.01.071; Wu FB, 2002, J PLANT NUTR, V25, P2745, DOI 10.1081/PLN-120015536; Wu FB, 2003, COMMUN SOIL SCI PLAN, V34, P2003, DOI 10.1081/CSS-120023233; Yang XE, 2004, J PLANT NUTR, V27, P1963, DOI [10.1081/LPLA-200030082, 10.1081/PLN-200030082]; Zrobek-Sokolnik A, 2009, ACTA PHYSIOL PLANT, V31, P43, DOI 10.1007/s11738-008-0197-8	72	94	109	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87582	10.1371/journal.pone.0087582	http://dx.doi.org/10.1371/journal.pone.0087582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475312	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300205
J	Wang, YQ; Wang, LF; Liu, X; Zhang, YZ; Yu, LP; Zhang, F; Liu, LS; Cai, J; Yang, XC; Wang, XY				Wang, Yongqin; Wang, Lefeng; Liu, Xin; Zhang, Yongzhi; Yu, Liping; Zhang, Fan; Liu, Lisheng; Cai, Jun; Yang, Xinchun; Wang, Xingyu			Genetic Variants Associated with Myocardial Infarction and the Risk Factors in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SUSCEPTIBILITY LOCUS; SELECTIN; PLASMA; ABO	Background: Recent genome-wide association (GWA) studies in Caucasians identified multiple single nucleotide polymorphisms (SNPs) associated with coronary artery disease (CAD). The associations of those SNPs with myocardial infarction (MI) have not been replicated in Asian populations. Among those previously identified SNPs, we selected nine (rs10953541, rs1122608, rs12190287, rs12413409, rs1412444, rs1746048, rs3798220, rs4977574, rs579459, in or near genes 7q22, LDLR, TCF21, CYP17A1, LIPA, CXCL12, LPA, CDKN2A, ABO, respectively) because of the relatively high minor allele frequencies in Chinese individuals and tested the associations of the SNPs with MI and MI related risk factors in Chinese population. Methods and Results: We conducted a case-control association study on a cohort of 2365 MI patients and 2678 unrelated controls from the Chinese population. Genotyping of 9 SNPs were performed by the TaqMan Real Time PCR method. After age, sex, and BMI adjustment, we observed the SNPs rs12190287, rs12413409, rs1412444, rs1746048 and rs4977574, were significantly associated with MI in additive models and rs12190287, rs12413409, rs4977574 were significantly associated with phenotypes of MI at the same time. We also found three SNPs rs1122608, rs3798220 and rs579459 were significantly associated with risk factors of MI, although they had no association with MI in Chinese population. Conclusion: Results of this study indicate that 5 SNPs were associated with MI and 3 SNPs were associated with associated with lipoprotein levels but not with MI in a Chinese population. The present study supports some CAD-related genes in Caucasian as important genes for MI in a Chinese population.	[Wang, Yongqin; Zhang, Yongzhi; Wang, Xingyu] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Cardiol, Shantou, Guangdong, Peoples R China; [Wang, Yongqin; Liu, Xin; Zhang, Yongzhi; Liu, Lisheng; Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China; [Wang, Lefeng; Liu, Xin; Yu, Liping; Zhang, Fan; Cai, Jun; Yang, Xinchun; Wang, Xingyu] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Yongqin] Baotou Med Coll, Sch Basic Courses, Baotou, Neimenggu, Peoples R China	Shantou University; Chinese Hypertension League; Capital Medical University; Baotou Medical College	Cai, J (corresponding author), Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China.	caijun7879@hotmail.com; yxc6229@sina.com; xingyuw@yahoo.com			Beijing Hypertension League Institute, INTERHEART Founding sources; National Natural Science Foundation of China [81370314, 8127184]; Qin Wenbin Technology Education Foundation of Baotou Medical College [201302]; Population Health Research Insitute	Beijing Hypertension League Institute, INTERHEART Founding sources; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qin Wenbin Technology Education Foundation of Baotou Medical College; Population Health Research Insitute	This study was supported by the Beijing Hypertension League Institute, INTERHEART Founding sources, the National Natural Science Foundation of China (Grant Number 81370314 and 8127184), Qin Wenbin Technology Education Foundation of Baotou Medical College (Grant Number 201302), and the Population Health Research Insitute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Li Y, 2007, CIRC-CARDIOVASC GENE, V4, P565; Liu X, 2009, ATHEROSCLEROSIS, V206, P199, DOI 10.1016/j.atherosclerosis.2009.02.004; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pare G, 2008, PLOS GENET, V4; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	24	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86332	10.1371/journal.pone.0086332	http://dx.doi.org/10.1371/journal.pone.0086332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475106	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300054
J	Cui, XR; Abduljalil, A; Manor, BD; Peng, CK; Novak, V				Cui, Xingran; Abduljalil, Amir; Manor, Brad D.; Peng, Chung-Kang; Novak, Vera			Multi-Scale Glycemic Variability: A Link to Gray Matter Atrophy and Cognitive Decline in Type 2 Diabetes	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; INSULIN-SECRETION; ULTRADIAN OSCILLATIONS; CIRCADIAN RHYTHMICITY; GLUCOSE; VASOREACTIVITY; DEMENTIA	Objective: Type 2 diabetes mellitus (DM) accelerates brain aging and cognitive decline. Complex interactions between hyperglycemia, glycemic variability and brain aging remain unresolved. This study investigated the relationship between glycemic variability at multiple time scales, brain volumes and cognition in type 2 DM. Research Design and Methods: Forty-three older adults with and 26 without type 2 DM completed 72-hour continuous glucose monitoring, cognitive tests and anatomical MRI. We described a new analysis of continuous glucose monitoring, termed Multi-Scale glycemic variability (Multi-Scale GV), to examine glycemic variability at multiple time scales. Specifically, Ensemble Empirical Mode Decomposition was used to identify five unique ultradian glycemic variability cycles (GVC(1-5)) that modulate serum glucose with periods ranging from 0.5-12 hrs. Results: Type 2 DM subjects demonstrated greater variability in GVC(3-5) (period 2.0-12 hrs) than controls (P<0.0001), during the day as well as during the night. Multi-Scale GV was related to conventional markers of glycemic variability (e. g. standard deviation and mean glycemic excursions), but demonstrated greater sensitivity and specificity to conventional markers, and was associated with worse long-term glycemic control (e. g. fasting glucose and HbA1c). Across all subjects, those with greater glycemic variability within higher frequency cycles (GVC(1-3); 0.5-2.0 hrs) had less gray matter within the limbic system and temporo-parietal lobes (e. g. cingulum, insular, hippocampus), and exhibited worse cognitive performance. Specifically within those with type 2 DM, greater glycemic variability in GVC(2-3) was associated with worse learning and memory scores. Greater variability in GVC(5) was associated with longer DM duration and more depression. These relationships were independent of HbA1c and hypoglycemic episodes. Conclusions: Type 2 DM is associated with dysregulation of glycemic variability over multiple scales of time. These time-scale-dependent glycemic fluctuations might contribute to brain atrophy and cognitive outcomes within this vulnerable population.	[Cui, Xingran; Peng, Chung-Kang] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Abduljalil, Amir] Ohio State Univ, Dept Radiol, Wright Ctr Innovat, Columbus, OH 43210 USA; [Manor, Brad D.] Hebrew SeniorLife, Inst Aging Res, Roslindale, MA USA; [Manor, Brad D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02215 USA; [Peng, Chung-Kang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Novak, Vera] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Stroke,Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Novak, V (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Stroke,Dept Neurol, Boston, MA 02215 USA.	vnovak@bidmc.harvard.edu	Peng, Chung-Kang/E-1489-2011; Peng, Chung-Kang/N-1308-2019	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833	National Institutes of Health (NIH)-National Institute on Aging (NIA) [1R01-AG-0287601-A2]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5R21-DK-084463-02]; American Diabetes Association (ADA) [1-06-CR-25]; National Science Council of Taiwan [NSC 100-2911-I-008-001]; Harvard Catalyst [1KL2RR025757-04]; Harvard Clinical and Translational Science Center (NIH) [KL2 RR 025757]; Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 101-2911-I-008-001]; China Scholarship Council, China (CSC) [2010695013]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources) [8UL1TR000170-05]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [8UL1TR000170-05]; Harvard University and its affiliated academic health care centers; Wright Center of Innovation, Dept. of radiology, The Ohio State University; National Central University, Taiwan [NSC 101-2911-I-008-001]; Harvard Clinical and Translational Science Center (National Center for Research Resources) [1KL2RR025757-04]; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [8KL2TR000168-05];  [NIDDK-5R21-DK-084463-02];  [NIA-1R01-AG-0287601-A2];  [ADA(1-06-CR-25)]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170, KL2TR000168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084463] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association (ADA)(American Diabetes Association); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; China Scholarship Council, China (CSC)(China Scholarship Council); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University and its affiliated academic health care centers; Wright Center of Innovation, Dept. of radiology, The Ohio State University; National Central University, Taiwan; Harvard Clinical and Translational Science Center (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was conducted with the support of the National Institutes of Health (NIH)-National Institute on Aging (NIA) (1R01-AG-0287601-A2); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5R21-DK-084463-02) American Diabetes Association (ADA)(1-06-CR-25), the National Science Council of Taiwan (NSC 100-2911-I-008-001), a KL2 Medical Research Investigator Training (MeRIT) award (1KL2RR025757-04) from the Harvard Catalyst and the Harvard Clinical and Translational Science Center (NIH Award KL2 RR 025757). This work was also sponsored by the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 101-2911-I-008-001) and by China Scholarship Council, China (CSC, File No. 2010695013). This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. The authors acknowledge contributions of Clinical Research Center nursing and MRI staff. X. C. received scholarship from China Scholarship Council, China (CSC, File No. 2010695013). A. A. received support from Wright Center of Innovation, Dept. of radiology, The Ohio State University. C. K. P. received support from National Central University, Taiwan (NSC 101-2911-I-008-001). V.N. has received grants from the NIDDK-5R21-DK-084463-02; NIA-1R01-AG-0287601-A2 and ADA(1-06-CR-25), related to this study, and V. N, B. M., received salaries from these grants. B. M. received a KL2 Medical Research Investigator Training (MeRIT) award (1KL2RR025757-04) from The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8KL2TR000168-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arvanitakis Z, 2006, DIABETES CARE, V29, P560, DOI 10.2337/diacare.29.03.06.dc05-1901; Benton AL, 1976, MULTILINGUAL APHASIA; Bode Bruce, 2004, Diabetes Technol Ther, V6, P105, DOI 10.1089/152091504773731285; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cui XR, 2014, GAIT POSTURE, V39, P495, DOI 10.1016/j.gaitpost.2013.08.036; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; D'Agostino E, 2004, LECT NOTES COMPUT SC, V3216, P745; Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366; Gyaw T A, 1994, Biomed Sci Instrum, V30, P63; Hajjar I, 2009, AM J HYPERTENS; Hajjar I, 2010, HYPERTENSION, V56, P859, DOI 10.1161/HYPERTENSIONAHA.110.160002; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kalsbeek A, 2011, FEBS LETT, V585, P1412, DOI 10.1016/j.febslet.2011.03.021; Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005; Klonoff DC, 2011, J CLIN ENDOCR METAB, V96, P2968, DOI 10.1210/jc.2010-2756; Kohnert KD, 2011, J ENDOCRINOL METAB, V1, P64, DOI 10.4021/jem21w; KOLOPP M, 1986, CHRONOBIOL INT, V3, P265, DOI 10.3109/07420528609079544; Kreier F, 2007, EXP GERONTOL, V42, P22, DOI 10.1016/j.exger.2006.07.004; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; Mager DE, 2007, J PHARMACOL EXP THER, V321, P423, DOI 10.1124/jpet.106.113183; Manor B, 2012, DIABETES CARE, V35, P1907, DOI 10.2337/dc11-2463; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Novak V, 2011, DIABETES CARE, V34, P2438, DOI 10.2337/dc11-0969; Novak V, 2009, MAGN RESON IMAGING, V27, P752, DOI 10.1016/j.mri.2009.01.010; Schaefer A, 2003, DIABETES CARE, V26, P168, DOI 10.2337/diacare.26.1.168; Scheen AJ, 1996, DIABETOLOGIA, V39, P564, DOI 10.1007/BF00403303; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; ShannahoffKhalsa DS, 1997, AM J PHYSIOL-REG I, V272, pR962, DOI 10.1152/ajpregu.1997.272.3.R962; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Siegelaar SE, 2011, CRIT CARE, V15, DOI 10.1186/cc10440; SIMON C, 1991, DIABETOLOGIA, V34, P435, DOI 10.1007/BF00403183; Simon C, 2002, DIABETES, V51, pS258, DOI 10.2337/diabetes.51.2007.S258; Slotkin J, 2012, NIH TOOLBOX COGNITIO; Strachan MWJ, 2008, BRIT MED J, V336, P6, DOI 10.1136/bmj.39386.664016.BE; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Strachan MWJ, 2008, BRIT MED BULL, V88, P131, DOI 10.1093/bmb/ldn042; Tiehuis AM, 2008, DIABETOLOGIA, V51, P1321, DOI 10.1007/s00125-008-1041-9; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; VELDHUIS JD, 1989, AM J PHYSIOL, V257, pE5, DOI 10.1152/ajpendo.1989.257.1.E6; Williamson JD, 2007, AM J CARDIOL, V99, p112I, DOI 10.1016/j.amjcard.2007.03.029; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047	46	50	51	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86284	10.1371/journal.pone.0086284	http://dx.doi.org/10.1371/journal.pone.0086284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475100	Green Published, gold			2022-12-27	WOS:000330339800039
J	Gupta, R; Kumar, V; Kushawaha, PK; Tripathi, CP; Joshi, S; Sahasrabuddhe, AA; Mitra, K; Sundar, S; Siddiqi, MI; Dube, A				Gupta, Reema; Kumar, Vikash; Kushawaha, Pramod Kumar; Tripathi, Chandradev Pati; Joshi, Sumit; Sahasrabuddhe, Amogh Anant; Mitra, Kalyan; Sundar, Shyam; Siddiqi, Mohammad Imran; Dube, Anuradha			Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis	PLOS ONE			English	Article							INDIAN KALA-AZAR; INTERFERON-GAMMA PRODUCTION; T-CELL RESPONSES; NITRIC-OXIDE; IFN-GAMMA; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; IMMUNE-RESPONSES; CUTANEOUS LEISHMANIASIS; SYSTEMIC CANDIDIASIS; DISEASE PROGRESSION	Th1 immune responses play an important role in controlling Visceral Leishmaniasis (VL) hence, Leishmania proteins stimulating T-cell responses in host, are thought to be good vaccine targets. Search of such antigens eliciting cellular responses in Peripheral blood mononuclear cells (PBMCs) from cured/exposed/Leishmania patients and hamsters led to the identification of two enzymes of glycolytic pathway in the soluble lysate of a clinical isolate of Leishmania donovani Enolase (LdEno) and aldolase (LdAld) as potential Th1 stimulatory proteins. The present study deals with the molecular and immunological characterizations of LdEno and LdAld. The successfully cloned and purified recombinant proteins displayed strong ability to proliferate lymphocytes of cured hamsters' along with significant nitric-oxide production and generation of Th1-type cytokines (IFN-gamma and IL-12) from stimulated PBMCs of cured/endemic VL patients. Assessment of their prophylactic potentials revealed similar to 90% decrease in parasitic burden in rLdEno vaccinated hamsters against Leishmania challenge, strongly supported by an increase in mRNA expression levels of iNOS, IFN-gamma, TNF-alpha and IL-12 transcripts along with extreme down-regulation of TGF-beta, IL-4 and IL-10. However, animals vaccinated with rLdAld showed comparatively lesser prophylactic efficacy (similar to 65%) with inferior immunological response. Further, with a possible implication in vaccine design against VL, identification of potential T-cell epitopes of both the proteins was done using computational approach. Additionally, in-silico 3-D modelling of the proteins was done in order to explore the possibility of exploiting them as potential drug targets. The comparative molecular and immunological characterizations strongly suggest rLdEno as potential vaccine candidate against VL and supports the notion of its being effective T-cell stimulatory protein.	[Gupta, Reema; Kushawaha, Pramod Kumar; Tripathi, Chandradev Pati; Joshi, Sumit; Dube, Anuradha] CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Kumar, Vikash; Sahasrabuddhe, Amogh Anant; Siddiqi, Mohammad Imran] CSIR Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow, Uttar Pradesh, India; [Mitra, Kalyan] CSIR Cent Drug Res Inst, Div Elect Microscopy, Lucknow, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com	TRIPATHI, CHANDRA DEV/S-5617-2019	Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology, New Delhi; CSIR-CDRI's Supra-institutional network project [SIP-0026]; University Grants Commission, New Delhi, India	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR-CDRI's Supra-institutional network project; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by Department of Biotechnology, New Delhi and CSIR-CDRI's Supra-institutional network project (SIP-0026). RG and PKK are the recipients of fellowships from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2008, MOL BIOCHEM PARASIT, V158, P52, DOI 10.1016/j.molbiopara.2007.11.011; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Avilan L, 2000, MOL BIOCHEM PARASIT, V110, P183, DOI 10.1016/S0166-6851(00)00269-3; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Basu MK, 2005, CRIT REV MICROBIOL, V31, P145, DOI 10.1080/10408410591005101; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; BERTHIAUME L, 1993, J BIOL CHEM, V268, P10826; Bhowmick S, 2009, INFECT IMMUN, V77, P1514, DOI 10.1128/IAI.01739-07; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bretscher P A, 1997, Behring Inst Mitt, P153; BURNS JM, 1991, J IMMUNOL, V146, P742; Calcagno M, 2002, PARASITOL RES, V88, P972, DOI 10.1007/s00436-002-0688-2; Chen N, 2012, VACCINE, V30, P3478, DOI 10.1016/j.vaccine.2012.02.075; Choi CM, 2001, J INVEST DERM SYMP P, V6, P175, DOI 10.1046/j.0022-202x.2001.00038.x; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; Dalby A, 1999, PROTEIN SCI, V8, P291; de Walque S, 1999, MOL BIOCHEM PARASIT, V103, P279, DOI 10.1016/S0166-6851(99)00140-1; DING AH, 1988, J IMMUNOL, V141, P2407; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Dube A, 1998, PARASITOLOGY, V116, P219, DOI 10.1017/S0031182097002175; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Esgleas M, 2009, FEMS MICROBIOL LETT, V294, P82, DOI 10.1111/j.1574-6968.2009.01551.x; Eswar N, 2006, CURR PROTOC BIOINFOR, V5; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Fragaki K, 2001, VACCINE, V19, P1701, DOI 10.1016/S0264-410X(00)00398-4; Gan W, PARASITOL RES, V106, P873; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2006, INDIAN J MED RES, V123, P439; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; GHOSE AC, 1980, CLIN EXP IMMUNOL, V40, P318; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; Giotto MTD, 2003, J MOL BIOL, V331, P653, DOI 10.1016/S0022-2836(03)00752-6; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Harrop R, 1999, PARASITOLOGY, V118, P583, DOI 10.1017/S003118209900431X; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; JAGANNATHAN V, 1956, BIOCHEM J, V63, P94, DOI 10.1042/bj0630094; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Caceres AJ, 2010, MOL BIOCHEM PARASIT, V169, P50, DOI 10.1016/j.molbiopara.2009.09.001; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kenney RT, 1998, J INFECT DIS, V177, P815, DOI 10.1086/517817; Khabiri AR, 2007, PARASITOL RES, V100, P629, DOI 10.1007/s00436-006-0301-1; Khabiri AR, 2006, EXP PARASITOL, V112, P184, DOI 10.1016/j.exppara.2005.11.005; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; Kumari S, 2008, VACCINE; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748; LIEW F Y, 1991, Behring Institute Mitteilungen, P239; LIEW FY, 1991, IMMUNOL LETT, V30, P193, DOI 10.1016/0165-2478(91)90024-5; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1990, J IMMUNOL, V144, P4794; LIEW FY, 1990, J EXP MED, V172, P1359, DOI 10.1084/jem.172.5.1359; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maldonado J, 2006, EXP MOL PATHOL, V80, P289, DOI 10.1016/j.yexmp.2005.06.005; Marques HH, 2008, IMMUNOBIOLOGY, V213, P437, DOI 10.1016/j.imbio.2007.10.002; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; McCarthy JS, 2002, INFECT IMMUN, V70, P851, DOI 10.1128/IAI.70.2.851-858.2002; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 1998, INFECT IMMUN, V66, P18, DOI 10.1128/IAI.66.1.18-27.1998; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Misra A, 2001, VACCINE, V19, P3485, DOI 10.1016/S0264-410X(01)00058-5; Montagnoli C, 2004, MED MYCOL, V42, P319, DOI 10.1080/13693780310001644653; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nozaki Y, 1997, INFECT IMMUN, V65, P3644, DOI 10.1128/IAI.65.9.3644-3647.1997; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Palm JED, 2003, J INFECT DIS, V187, P1849, DOI 10.1086/375356; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Quinones W, 2007, EXP PARASITOL, V116, P241, DOI 10.1016/j.exppara.2007.01.008; REINER SL, 1994, PARASITOL TODAY, V10, P485, DOI 10.1016/0169-4758(94)90162-7; RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x; RUSSO DM, 1991, J IMMUNOL, V147, P3575; RUTTER WJ, 1964, FED PROC, V23, P1248; SALIBA E, 1993, T ROY SOC TROP MED H, V87, P633, DOI 10.1016/0035-9203(93)90267-T; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; Sato K, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P79; SCOTT DA, 1987, BIOCHEM PHARMACOL, V36, P2043, DOI 10.1016/0006-2952(87)90508-9; SCOTT P, 1987, ANN INST PASTEUR IMM, V138, P771, DOI 10.1016/S0769-2625(87)80036-3; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Singh N, 2009, J ANTIMICROB CHEMOTH; SRIVASTAVA IK, 1990, J IMMUNOL, V144, P1497; Tripathi P, 2006, CLIN EXP IMMUNOL, V143, P380, DOI 10.1111/j.1365-2249.2005.03000.x; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; WARREN HS, 1986, ANNU REV IMMUNOL, V4, P369, DOI 10.1146/annurev.iy.04.040186.002101; Wasunna MK, 2005, AM J TROP MED HYG, V73, P871, DOI 10.4269/ajtmh.2005.73.871; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105	95	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86073	10.1371/journal.pone.0086073	http://dx.doi.org/10.1371/journal.pone.0086073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475071	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800025
J	Hargreaves, KR; Kropinski, AM; Clokie, MRJ				Hargreaves, Katherine R.; Kropinski, Andrew M.; Clokie, Martha R. J.			What Does the Talking? Quorum Sensing Signalling Genes Discovered in a Bacteriophage Genome	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; MOLECULAR CHARACTERIZATION; SEQUENCE; PROPHAGES; STRAINS; VIRULENCE; EPIDEMIOLOGY; EXPRESSION; ARTEMIS; SYSTEM	The transfer of novel genetic material into the genomes of bacterial viruses (phages) has been widely documented in several host-phage systems. Bacterial genes are incorporated into the phage genome and, if retained, subsequently evolve within them. The expression of these phage genes can subvert or bolster bacterial processes, including altering bacterial pathogenicity. The phage phiCDHM1 infects Clostridium difficile, a pathogenic bacterium that causes nosocomial infections and is associated with antibiotic treatment. Genome sequencing and annotation of phiCDHM1 shows that despite being closely related to other C. difficile myoviruses, it has several genes that have not been previously reported in any phage genomes. Notably, these include three homologs of bacterial genes from the accessory gene regulator (agr) quorum sensing (QS) system. These are; a pre-peptide (AgrD) of an autoinducing peptide (AIP), an enzyme which processes the prepeptide (AgrB) and a histidine kinase (AgrC) that detects the AIP to activate a response regulator. Phylogenetic analysis of the phage and C. difficile agr genes revealed that there are three types of agr loci in this species. We propose that the phage genes belonging to a third type, agr3, and have been horizontally transferred from the host. AgrB and AgrC are transcribed during the infection of two different strains. In addition, the phage agrC appears not to be confined to the phiCDHM1 genome as it was detected in genetically distinct C. difficile strains. The discovery of QS gene homologs in a phage genome presents a novel way in which phages could influence their bacterial hosts, or neighbouring bacterial populations. This is the first time that these QS genes have been reported in a phage genome and their distribution both in C. difficile and phage genomes suggests that the agr3 locus undergoes horizontal gene transfer within this species.	[Hargreaves, Katherine R.; Clokie, Martha R. J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, West Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Leicester; Public Health Agency of Canada; University of Guelph	Clokie, MRJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	mrjc1@leicester.ac.uk	Kropinski, Andrew M/H-7130-2016	Kropinski, Andrew M/0000-0002-6871-6799; Hargreaves, Katherine/0000-0002-9441-3601; Clokie, Martha/0000-0002-6069-8936	MRC [G0700855]; Laboratory for Foodborne Zoonoses; Medical Research Council [G0700855] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Laboratory for Foodborne Zoonoses; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MRC New Investigator Award (G0700855) and MRC Centenary Fellowship (University of Leicester) and A-base funding from the Laboratory for Foodborne Zoonoses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2005, EVOL BIOINFORM, V1, P97; Abedon ST, 2011, SOIL BIOL, V23, P37, DOI 10.1007/978-3-642-14512-4_2; Adriaenssens EM, 2012, J VIROL, V86, P6369, DOI 10.1128/JVI.00641-12; AlSaif N, 1996, J MED MICROBIOL, V45, P133, DOI 10.1099/00222615-45-2-133; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Boyer M, 2008, APPL ENVIRON MICROB, V74, P861, DOI 10.1128/AEM.02099-07; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Carter GP, 2005, J MED MICROBIOL, V54, P119, DOI 10.1099/jmm.0.45817-0; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cooksley CM, 2010, APPL ENVIRON MICROB, V76, P4448, DOI 10.1128/AEM.03038-09; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; Goh S, 2007, MICROBIOL-SGM, V153, P676, DOI 10.1099/mic.0.2006/002436-0; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Govind R, 2009, J VIROL, V83, P12037, DOI 10.1128/JVI.01256-09; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; Hargreaves KR, 2013, APPL ENVIRON MICROB, V79, P6236, DOI 10.1128/AEM.01849-13; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Horgan M, 2010, GENE, V462, P34, DOI 10.1016/j.gene.2010.04.010; Hoyland-Kroghsbo NM, 2013, MBIO, V4, DOI 10.1128/mBio.00362-12; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kraemer JA, 2012, CELL, V149, P1488, DOI 10.1016/j.cell.2012.04.034; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Lan SF, 2009, APPL ENVIRON MICROB, V75, P2659, DOI 10.1128/AEM.02483-08; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Leblanc C, 2009, ENV MICROBIOL REP, V1, P499, DOI 10.1111/j.1758-2229.2009.00055.x; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; Mayer MJ, 2010, APPL ENVIRON MICROB, V76, P5415, DOI 10.1128/AEM.00989-10; Meessen-Pinard M, 2012, APPL ENVIRON MICROB, V78, P7662, DOI 10.1128/AEM.02275-12; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller MA, 2010, VET RES, V41, DOI 10.1051/vetres/2009049; NAGY E, 1991, APMIS, V99, P321, DOI 10.1111/j.1699-0463.1991.tb05156.x; Norman KN, 2009, ANAEROBE, V15, P256, DOI 10.1016/j.anaerobe.2009.09.006; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sekulovic O, 2011, J BACTERIOL, V193, P2726, DOI 10.1128/JB.00787-10; Shan JY, 2012, APPL ENVIRON MICROB, V78, P6027, DOI 10.1128/AEM.01311-12; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wuster A, 2008, J BACTERIOL, V190, P743, DOI 10.1128/JB.01135-07	66	71	77	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85131	10.1371/journal.pone.0085131	http://dx.doi.org/10.1371/journal.pone.0085131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475037	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800009
J	Powell, A; Smith, DJ; Hepburn, LJ; Jones, T; Berman, J; Jompa, J; Bell, JJ				Powell, Abigail; Smith, David J.; Hepburn, Leanne J.; Jones, Timothy; Berman, Jade; Jompa, Jamaluddin; Bell, James J.			Reduced Diversity and High Sponge Abundance on a Sedimented Indo-Pacific Reef System: Implications for Future Changes in Environmental Quality	PLOS ONE			English	Article							CORAL-REEF; ECOLOGICAL INTERACTIONS; MODEL SELECTION; CARIBBEAN REEFS; CLIMATE-CHANGE; PATTERNS; FISHES; BIODIVERSITY; ASSEMBLAGES; POPULATIONS	Although coral reef health across the globe is declining as a result of anthropogenic impacts, relatively little is known of how environmental variability influences reef organisms other than corals and fish. Sponges are an important component of coral reef fauna that perform many important functional roles and changes in their abundance and diversity as a result of environmental change has the potential to affect overall reef ecosystem functioning. In this study, we examined patterns of sponge biodiversity and abundance across a range of environments to assess the potential key drivers of differences in benthic community structure. We found that sponge assemblages were significantly different across the study sites, but were dominated by one species Lamellodysidea herbacea (42% of all sponges patches recorded) and that the differential rate of sediment deposition was the most important variable driving differences in abundance patterns. Lamellodysidea herbacea abundance was positively associated with sedimentation rates, while total sponge abundance excluding Lamellodysidea herbacea was negatively associated with rates of sedimentation. Overall variation in sponge assemblage composition was correlated with a number of variables although each variable explained only a small amount of the overall variation. Although sponge abundance remained similar across environments, diversity was negatively affected by sedimentation, with the most sedimented sites being dominated by a single sponge species. Our study shows how some sponge species are able to tolerate high levels of sediment and that any transition of coral reefs to more sedimented states may result in a shift to a low diversity sponge dominated system, which is likely to have subsequent effects on ecosystem functioning.	[Powell, Abigail; Jones, Timothy; Berman, Jade; Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Smith, David J.; Hepburn, Leanne J.] Univ Essex, Coral Reef Res Unit, Colchester CO4 3SQ, Essex, England; [Jompa, Jamaluddin] Hasanuddin Univ, Res & Dev Ctr Marine Coastal & Small Isl, Makassar, Indonesia	Victoria University Wellington; University of Essex; Universitas Hasanuddin	Powell, A (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	abi.powell@gmail.com	Jompa, Jamaluddin/AAD-9280-2021	Jompa, Jamaluddin/0000-0001-9740-333X; Smith, David/0000-0003-1886-8193; Bell, James/0000-0001-9996-945X; Hepburn, Leanne/0000-0002-5109-7127	Commonwealth Scholarship; Operation Wallacea	Commonwealth Scholarship; Operation Wallacea	Abigail Powell was supported by a Commonwealth Scholarship for postgraduate study (http://www.csfp-online.org/). Operation Wallacea provided financial assistance for travel and fieldwork related costs (http://opwall.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts LAM, 1998, MAR ECOL PROG SER, V175, P241, DOI 10.3354/meps175241; Aerts LAM, 2000, MAR ECOL-P S Z N I, V21, P191, DOI 10.1046/j.1439-0485.2000.00685.x; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; Bell JJ, 2008, MAR BIOL, V155, P563, DOI 10.1007/s00227-008-1036-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2007, MAR ECOL PROG SER, V339, P73, DOI 10.3354/meps339073; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bell James J., 2000, Diversity and Distributions, V6, P283, DOI 10.1046/j.1472-4642.2000.00091.x; Bell JJ, 2004, J MAR BIOL ASSOC UK, V84, P581, DOI 10.1017/S0025315404009580h; Bell JJ, 2003, BIOL BULL-US, V205, P144, DOI 10.2307/1543235; Berman J., 2012, THESIS VICTORIA U WE; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Carballo JL, 2006, ECOSCIENCE, V13, P119, DOI 10.2980/1195-6860(2006)13[119:EONSOT]2.0.CO;2; Carballo JL, 2007, ECOSCIENCE, V14, P92, DOI 10.2980/1195-6860(2007)14[92:ACOSAP]2.0.CO;2; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Cleary DFR, 2007, J MAR BIOL ASSOC UK, V87, P1669, DOI 10.1017/S0025315407052770; Clifton J, 2010, ENVIRON SCI ENG TECH, P1; Crabbe MJC, 2005, CORAL REEFS, V24, P437, DOI 10.1007/s00338-005-0004-6; Cullen LC, 2010, ENVIRON SCI ENG TECH, P171; Curtis-Quick J, 2013, THESIS U ESSEX; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; Disalvo Louis H., 2007, Atoll Research Bulletin, V545-555, P1; Dunlap M, 1998, MAR ECOL-P S Z N I, V19, P325, DOI 10.1111/j.1439-0485.1998.tb00471.x; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; Eagle JV, 2004, J ZOOL, V264, P33, DOI 10.1017/S0952836904005473; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; English S., 1997, SURVEY MANUAL TROPIC; Exton DA, 2010, ENVIRON SCI ENG TECH, P193; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Ginn BK, 2000, ESTUAR COAST SHELF S, V50, P403, DOI 10.1006/ecss.1999.0563; HIATT RW, 1960, ECOL MONOGR, V30, P66; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hodgson G., 1988, OCCASIONAL PAPERS E, V7, P1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Ilan M, 1995, BIOL BULL, V189, P363, DOI 10.2307/1542154; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kavanagh KD, 2006, ENVIRON BIOL FISH, V76, P387, DOI 10.1007/s10641-006-9044-1; Knapp ISS, 2013, MAR POLLUT BULL, V66, P209, DOI 10.1016/j.marpolbul.2012.08.017; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kowalke J, 2000, J EXP MAR BIOL ECOL, V247, P85, DOI 10.1016/S0022-0981(00)00141-6; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Maldonado M, 1999, MAR ECOL PROG SER, V185, P239, DOI 10.3354/meps185239; Maldonado M, 2008, MAR BIOL, V154, P631, DOI 10.1007/s00227-008-0956-5; McMellor S, 2007, THESIS U ESSEX; McMellor S, 2010, ENVIRON SCI ENG TECH, P11; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Nagelkerken I, 2009, J FISH BIOL, V75, P1123, DOI 10.1111/j.1095-8649.2009.02303.x; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; Powell Abigail L., 2010, Open Marine Biology Journal, V4, P31; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts DE, 2006, MAR ECOL PROG SER, V321, P19, DOI 10.3354/meps321019; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; Salinas-de-Leon P, 2013, MAR BIOL, V160, P97, DOI 10.1007/s00227-012-2066-7; Schils T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046639; Schubauer JP, 1985, NEW PERSPECTIVES SPO, P443; Suchanek T.H., 1983, Symposia Series for Undersea Research, V1, P55; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Williams EH, 1999, GLOBAL CHANGE BIOL, V5, P839, DOI 10.1046/j.1365-2486.1999.00272.x; Wulff J, 2001, B MAR SCI, V69, P831; Wulff J.L., 2000, ATOLL RES B, V477, P251, DOI DOI 10.5479/SI.00775630.477; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2005, J ANIM ECOL, V74, P313, DOI 10.1111/j.1365-2656.2005.00925.x	77	42	43	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85253	10.1371/journal.pone.0085253	http://dx.doi.org/10.1371/journal.pone.0085253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475041	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330339800011
J	Prior, C; Perez-Gracia, JL; Garcia-Donas, J; Rodriguez-Antona, C; Guruceaga, E; Esteban, E; Suarez, C; Castellano, D; del Alba, AG; Lozano, MD; Carles, J; Climent, MA; Arranz, JA; Gallardo, E; Puente, J; Bellmunt, J; Gurpide, A; Lopez-Picazo, JM; Hernandez, AG; Mellado, B; Martinez, E; Moreno, F; Font, A; Calvo, A				Prior, Celia; Luis Perez-Gracia, Jose; Garcia-Donas, Jesus; Rodriguez-Antona, Cristina; Guruceaga, Elizabeth; Esteban, Emilio; Suarez, Cristina; Castellano, Daniel; Gonzalez del Alba, Aranzazu; Dolores Lozano, Maria; Carles, Joan; Angel Climent, Miguel; Angel Arranz, Jose; Gallardo, Enrique; Puente, Javier; Bellmunt, Joaquim; Gurpide, Alfonso; Maria Lopez-Picazo, Jose; Gonzalez Hernandez, Alvaro; Mellado, Begona; Martinez, Esther; Moreno, Fernando; Font, Albert; Calvo, Alfonso			Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							1ST-LINE SUNITINIB; CANCER-PATIENTS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; SURVIVAL; TARGETS; ASSOCIATIONS; PROGRESSION; INTERFERON; SELECTION	Purpose: To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance. Methods: We screened 673 microRNAs using TaqMan Low-density-Arrays (TLDAs) in tumors from MRCC patients with extreme phenotypes of marked efficacy and resistance to sunitinib, selected from an identification cohort (n = 41). The most relevant differentially expressed microRNAs were selected using bioinformatics-based target prediction analysis and quantified by qRT-PCR in tumors from patients presenting similar phenotypes selected from an independent cohort (n = 101). In vitro experiments were conducted to study the role of miR-942 in sunitinib resistance. Results: TLDAs identified 64 microRNAs differentially expressed in the identification cohort. Seven candidates were quantified by qRT-PCR in the independent series. MiR-942 was the most accurate predictor of sunitinib efficacy (p = 0.0074). High expression of miR-942, miR-628-5p, miR-133a, and miR-484 was significantly associated with decreased time to progression and overall survival. These microRNAs were also overexpressed in the sunitinib resistant cell line Caki-2 in comparison with the sensitive cell line. MiR-942 overexpression in Caki-2 up-regulates MMP-9 and VEGF secretion which, in turn, promote HBMEC endothelial migration and sunitinib resistance. Conclusions: We identified differentially expressed microRNAs in MRCC patients presenting marked sensitivity or resistance to sunitinib. MiR-942 was the best predictor of efficacy. We describe a novel paracrine mechanism through which high miR-942 levels in MRCC cells up-regulates MMP-9 and VEGF secretion to enhance endothelial migration and sunitinib resistance. Our results support further validation of these miRNA in clinical confirmatory studies.	[Prior, Celia; Calvo, Alfonso] Univ Navarra, CIMA, Div Oncol, E-31080 Pamplona, Spain; [Luis Perez-Gracia, Jose; Gurpide, Alfonso; Maria Lopez-Picazo, Jose] Univ Navarra Clin, Dept Oncol, Pamplona, Spain; [Garcia-Donas, Jesus] Fdn Hosp Alcorcon, Madrid, Spain; [Rodriguez-Antona, Cristina] CNIO, Human Canc Genet Programme, Madrid, Spain; [Guruceaga, Elizabeth] Univ Navarra, CIMA, Prote Genom & Bioinformat Unit, E-31080 Pamplona, Spain; [Esteban, Emilio] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain; [Suarez, Cristina; Carles, Joan] Hosp Univ Vall de Hebron, Dept Med Oncol, Barcelona, Spain; [Castellano, Daniel] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain; [Gonzalez del Alba, Aranzazu] Hosp Univ Son Espases, Dept Med Oncol, Palma De Mallorca, Spain; [Dolores Lozano, Maria] Univ Navarra, Univ Navarra Clin, Dept Pathol, E-31080 Pamplona, Spain; [Angel Climent, Miguel] Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain; [Angel Arranz, Jose] Hosp Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain; [Gallardo, Enrique] Parc Tauli Sabadell Hosp Univ, Dept Med Oncol, Sabadell, Spain; [Puente, Javier; Moreno, Fernando] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain; [Bellmunt, Joaquim] Univ Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Gonzalez Hernandez, Alvaro] Univ Navarra Clin, Dept Biochem, Pamplona, Spain; [Mellado, Begona] Hosp Clin Barcelona, Dept Med Oncol, IDIBAPS, Barcelona, Spain; [Martinez, Esther] Hosp Jaen, Dept Med Oncol, Jaen, Spain; [Font, Albert] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Med Oncol Serv, Badalona, Spain	University of Navarra; University of Navarra; Alcorcon Foundation University Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Navarra; Central University Hospital Asturias; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre; Hospital Universitari Son Espases; University of Navarra; Instituto Valenciano De Oncologia; General University Gregorio Maranon Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Catalan Institute of Oncology; Hospital Germans Trias i Pujol	Perez-Gracia, JL (corresponding author), Univ Navarra Clin, Dept Oncol, Pamplona, Spain.	jlgracia@unav.es	Lopez-Picazo, Jose Maria/J-2829-2017; Calvo, Alfonso/V-7945-2017; Bellmunt, Joaquim/B-8151-2019; Esteban, Emilio/AAB-2188-2019; Lozano, Maria D/ABD-9613-2020; Perez-Gracia, Jose Luis/I-8372-2017; Rodriguez-Antona, Cristina/E-1073-2011; Guruceaga, Elizabeth/B-1796-2008	Lopez-Picazo, Jose Maria/0000-0002-8814-3000; Calvo, Alfonso/0000-0003-4074-4242; Bellmunt, Joaquim/0000-0003-2328-3421; Esteban, Emilio/0000-0002-2980-5254; Lozano, Maria D/0000-0002-6796-9380; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Guruceaga, Elizabeth/0000-0003-0547-681X; Prior, Celia/0000-0001-5590-702X; Gallardo, Enrique/0000-0002-1375-3488; Carles, Joan/0000-0002-9983-5934; Garcia-Donas, Jesus/0000-0001-7731-3601; PUENTE, JAVIER/0000-0002-6910-1331				Bellmunt J, 2011, ANN ONCOL, V22, P2646, DOI 10.1093/annonc/mdr023; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolstad B, 2005, BIOINFORMATICS COMPU; Catena R, 2011, CANCER RES, V71, P164, DOI 10.1158/0008-5472.CAN-10-1708; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gamez-Pozo A, 2012, NEOPLASIA, V14, P1144, DOI 10.1593/neo.12734; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Jadhav U, 2004, INT J ONCOL, V25, P1407; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Perez-Gracia JL, 2010, CLIN TRANSL ONCOL, V12, P174, DOI 10.1007/s12094-010-0487-7; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-5; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Moro L, 2008, CANCER SCI, V99, P553, DOI 10.1111/j.1349-7006.2007.00719.x; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nebert DW, 2000, EUR J PHARMACOL, V410, P107, DOI 10.1016/S0014-2999(00)00809-8; Perez-Gracia JL, 2009, BRIT J CANCER, V101, P1876, DOI 10.1038/sj.bjc.6605409; Perez-Gracia JL, 2002, CANCER-AM CANCER SOC, V95, P1605, DOI 10.1002/cncr.10877; Powers MP, 2011, DIAGN MOL PATHOL, V20, P63, DOI 10.1097/PDM.0b013e3181efe2a9; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zhang G, 2006, PHARMACOGENET GENOM, V16, P401, DOI 10.1097/01.fpc.0000204995.99429.0f; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	34	71	77	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86263	10.1371/journal.pone.0086263	http://dx.doi.org/10.1371/journal.pone.0086263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475095	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800035
J	Rao, SAM; Srinivasan, S; Patric, IRP; Hegde, AS; Chandramouli, BA; Arimappamagan, A; Santosh, V; Kondaiah, P; Rao, MRS; Somasundaram, K				Rao, Soumya Alige Mahabala; Srinivasan, Sujaya; Patric, Irene Rosita Pia; Hegde, Alangar Sathyaranjandas; Chandramouli, Bangalore Ashwathnarayanara; Arimappamagan, Arivazhagan; Santosh, Vani; Kondaiah, Paturu; Rao, Manchanahalli R. Sathyanarayana; Somasundaram, Kumaravel			A 16-Gene Signature Distinguishes Anaplastic Astrocytoma from Glioblastoma	PLOS ONE			English	Article							POTENTIAL SERUM BIOMARKERS; GENE-EXPRESSION; MALIGNANT GLIOMAS; MOLECULAR SUBTYPES; STRONG PREDICTOR; IN-VIVO; CLASSIFICATION; IDENTIFICATION; PROGRESSION; SURVIVAL	Anaplastic astrocytoma (AA; Grade III) and glioblastoma (GBM; Grade IV) are diffusely infiltrating tumors and are called malignant astrocytomas. The treatment regimen and prognosis are distinctly different between anaplastic astrocytoma and glioblastoma patients. Although histopathology based current grading system is well accepted and largely reproducible, intratumoral histologic variations often lead to difficulties in classification of malignant astrocytoma samples. In order to obtain a more robust molecular classifier, we analysed RT-qPCR expression data of 175 differentially regulated genes across astrocytoma using Prediction Analysis of Microarrays (PAM) and found the most discriminatory 16-gene expression signature for the classification of anaplastic astrocytoma and glioblastoma. The 16-gene signature obtained in the training set was validated in the test set with diagnostic accuracy of 89%. Additionally, validation of the 16-gene signature in multiple independent cohorts revealed that the signature predicted anaplastic astrocytoma and glioblastoma samples with accuracy rates of 99%, 88%, and 92% in TCGA, GSE1993 and GSE4422 datasets, respectively. The protein-protein interaction network and pathway analysis suggested that the 16-genes of the signature identified epithelial-mesenchymal transition (EMT) pathway as the most differentially regulated pathway in glioblastoma compared to anaplastic astrocytoma. In addition to identifying 16 gene classification signature, we also demonstrated that genes involved in epithelial-mesenchymal transition may play an important role in distinguishing glioblastoma from anaplastic astrocytoma.	[Rao, Soumya Alige Mahabala; Srinivasan, Sujaya; Patric, Irene Rosita Pia; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol Dev & Genet, Bangalore 560012, Karnataka, India; [Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Hegde, Alangar Sathyaranjandas] Sri Sathya Sai Inst Higher Med Sci, Bangalore, Karnataka, India; [Chandramouli, Bangalore Ashwathnarayanara; Arimappamagan, Arivazhagan] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Santosh, Vani] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India; [Rao, Manchanahalli R. Sathyanarayana] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol Dev & Genet, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by a grant from Council of Scientific and Industrial Research, Government of India under the New Millennium Indian Technology Leadership Initiative program. Kumaravel Somasundaram thanks Department of Biotechnology, Government of India for financial support. Soumya Alige Mahabala Rao gratefully acknowledges Senior Research Fellowship from Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Arivazhagan A, 2012, J NEURO-ONCOL, V107, P289, DOI 10.1007/s11060-011-0758-3; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Bozinov O, 2008, NEUROSURG REV, V31, P83, DOI 10.1007/s10143-007-0107-3; CBTRUS, 2008, CBTRUS STAT REP PRIM; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Engel S, 1999, J NEUROIMMUNOL, V99, P13, DOI 10.1016/S0165-5728(99)00062-4; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Genkai N, 2006, ONCOL REP, V15, P1569; Godard S, 2003, CANCER RES, V63, P6613; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Kahlert UD, 2013, CANCER LETT, V331, P131, DOI 10.1016/j.canlet.2012.12.010; Khazenzon NM, 2003, MOL CANCER THER, V2, P985; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Stupp R, 2007, CRIT REV ONCOL HEMAT, V63, P72, DOI 10.1016/j.critrevonc.2007.03.003; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478	49	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85200	10.1371/journal.pone.0085200	http://dx.doi.org/10.1371/journal.pone.0085200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475040	Green Published, Green Accepted, gold			2022-12-27	WOS:000330339800010
J	Smittenaar, P; Prichard, G; FitzGerald, THB; Diedrichsen, J; Dolan, RJ				Smittenaar, Peter; Prichard, George; FitzGerald, Thomas H. B.; Diedrichsen, Joern; Dolan, Raymond J.			Transcranial Direct Current Stimulation of Right Dorsolateral Prefrontal Cortex Does Not Affect Model-Based or Model-Free Reinforcement Learning in Humans	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; WORKING-MEMORY; MAJOR DEPRESSION; DECISION-MAKING; HUMAN BRAIN; SYSTEMS; FACILITATION; BEHAVIOR; CHOICE; RISK	There is broad consensus that the prefrontal cortex supports goal-directed, model-based decision-making. Consistent with this, we have recently shown that model-based control can be impaired through transcranial magnetic stimulation of right dorsolateral prefrontal cortex in humans. We hypothesized that an enhancement of model-based control might be achieved by anodal transcranial direct current stimulation of the same region. We tested 22 healthy adult human participants in a within-subject, double-blind design in which participants were given Active or Sham stimulation over two sessions. We show Active stimulation had no effect on model-based control or on model-free ('habitual') control compared to Sham stimulation. These null effects are substantiated by a power analysis, which suggests that our study had at least 60% power to detect a true effect, and by a Bayesian model comparison, which favors a model of the data that assumes stimulation had no effect over models that assume stimulation had an effect on behavioral control. Although we cannot entirely exclude more trivial explanations for our null effect, for example related to (faults in) our experimental setup, these data suggest that anodal transcranial direct current stimulation over right dorsolateral prefrontal cortex does not improve model-based control, despite existing evidence that transcranial magnetic stimulation can disrupt such control in the same brain region.	[Smittenaar, Peter; FitzGerald, Thomas H. B.; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Prichard, George; Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; University of London; University College London	Smittenaar, P (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England.	petersmittenaar@gmail.com	Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532; FitzGerald, Thomas/0000-0002-3855-1591; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [098362/Z/12/Z, 092859/Z/10/Z, 091593/Z/10/Z]; James S. McDonnell Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); James S. McDonnell Foundation	R.J. Dolan is supported by a Wellcome Trust Senior Investigator Award 098362/Z/12/Z. P. Smittenaar is supported by a 4-year Wellcome Trust PhD studentship 092859/Z/10/Z. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. J. More information about the Wellcome Trust at http://www.wellcome.ac.uk/. Diedrichsen is supported by a Scholar Award from the James S. McDonnell Foundation. More information about the James S. McDonnell Foundation at http://www.jsmf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; [Anonymous], 2007, LME4 LINEAR MIXED EF; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hojsgaard S, 2012, NEWSLETTER R PROJECT, V6/2, P47; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; Kahneman D., 2011, THINKING FAST SLOW; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Penny WD, 2012, NEUROIMAGE, V59, P319, DOI 10.1016/j.neuroimage.2011.07.039; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Smittenaar P, 2014, NEURON IN PRESS; Stagg CJ, 2013, J NEUROSCI, V33, P11425, DOI 10.1523/JNEUROSCI.3887-12.2013; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109	44	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86850	10.1371/journal.pone.0086850	http://dx.doi.org/10.1371/journal.pone.0086850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475185	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000330339800064
J	Hong, S; Song, MR				Hong, Seulgi; Song, Mi-Ryoung			STAT3 but Not STAT1 Is Required for Astrocyte Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING SPINAL-CORD; SIGNALING PATHWAY; CYTOKINE STIMULATION; FETAL-BRAIN; DNA-BINDING; ACTIVATION; GLIOGENESIS; INTERFERON; TRANSCRIPTION	The JAK-STAT signaling pathway has been implicated in astrocyte differentiation. Both STAT1 and STAT3 are expressed in the central nervous system and are thought to be important for glial differentiation, as mainly demonstrated in vitro; however direct in vivo evidence is missing. We investigated whether STAT1 and STAT3 are essential for astrocyte development by testing the STAT responsiveness of astrocyte progenitors. STAT3 was absent in the ventricular zone where glial progenitors are born but begins to appear at the marginal zone at E16.5. At E18.5, both phospho-STAT1 and phospho-STAT3 were present in glial fibrillary acidic protein (GFAP)-expressing white matter astrocytes. Overexpression of STAT3 by electroporation of chicks in ovo induced increased numbers of astrocyte progenitors in the spinal cord. Likewise, elimination of STAT3 in Stat3 conditional knockout (cKO) mice resulted in depletion of white matter astrocytes. Interestingly, elimination of STAT1 in Stat1 null mice did not inhibit astrocyte differentiation and deletion of Stat1 failed to aggravate the glial defects in Stat3 cKO mice. Measuring the activity of STAT binding elements and the gfap promoter in the presence of various STAT mutants revealed that transactivation depended on the activity of STAT3 not STAT1. No synergistic interaction between STAT1 and STAT3 was observed. Cortical progenitors of Stat1 null; Stat3 cKO mice generated astrocytes when STAT3 or the splice variant Stat3 beta was supplied, but not when STAT1 was introduced. Together, our results suggest that STAT3 is necessary and sufficient for astrocyte differentiation whereas STAT1 is dispensable.	[Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Bioimaging Res Ctr, Sch Life Sci, Kwangju, South Korea; Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Song, MR (corresponding author), Gwangju Inst Sci & Technol, Bioimaging Res Ctr, Sch Life Sci, Kwangju, South Korea.	msong@gist.ac.kr			NRF (National Research Foundation of Korea) [2011-0029179, 2010-0007109]; Cell Dynamics Research Center, NRF [2009-0070938]	NRF (National Research Foundation of Korea)(National Research Foundation of Korea); Cell Dynamics Research Center, NRF(Ministry of Science & Technology (MOST), Republic of Korea)	Support for MRS and this research were provided by grants from NRF (National Research Foundation of Korea) (2011-0029179; 2010-0007109), the Cell Dynamics Research Center, NRF (2009-0070938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1999, COLD SPRING HARB SYM, V64, P425, DOI 10.1101/sqb.1999.64.425; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dewilde S, 2008, FRONT BIOSCI-LANDMRK, V13, P6501, DOI 10.2741/3170; Haan S, 2005, CELL SIGNAL, V17, P1542, DOI 10.1016/j.cellsig.2005.03.010; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hemmann U, 1996, J BIOL CHEM, V271, P12999, DOI 10.1074/jbc.271.22.12999; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kang K, 2013, J BIOL CHEM, V288, P2580, DOI 10.1074/jbc.M112.398263; Kang K, 2010, BIOCHEM BIOPH RES CO, V395, P324, DOI 10.1016/j.bbrc.2010.03.174; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; LAI CF, 1995, J BIOL CHEM, V270, P23254, DOI 10.1074/jbc.270.40.23254; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Novak U, 1996, J BIOL CHEM, V271, P18350, DOI 10.1074/jbc.271.31.18350; Rajan P, 1998, J NEUROSCI, V18, P3620; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Sanz E, 2008, GLIA, V56, P190, DOI 10.1002/glia.20602; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Schaefer LK, 1999, BIOCHEM BIOPH RES CO, V266, P481, DOI 10.1006/bbrc.1999.1853; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Takeda K, 1998, J IMMUNOL, V161, P4652; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanner DC, 2011, J NEUROSCI, V31, P6235, DOI 10.1523/JNEUROSCI.5905-10.2011; Thyrell L, 2007, EXP CELL RES, V313, P4015, DOI 10.1016/j.yexcr.2007.08.007; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126	40	47	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86851	10.1371/journal.pone.0086851	http://dx.doi.org/10.1371/journal.pone.0086851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466267	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000157
J	Yamamoto, T; Hayama, Y; Hidano, A; Kobayashi, S; Muroga, N; Ishikawa, K; Ogura, A; Tsutsui, T				Yamamoto, Takehisa; Hayama, Yoko; Hidano, Arata; Kobayashi, Sota; Muroga, Norihiko; Ishikawa, Kiyoyasu; Ogura, Aki; Tsutsui, Toshiyuki			Sampling Strategies in Antimicrobial Resistance Monitoring: Evaluating How Precision and Sensitivity Vary with the Number of Animals Sampled per Farm	PLOS ONE			English	Article							ESCHERICHIA-COLI; SURVEILLANCE	Because antimicrobial resistance in food-producing animals is a major public health concern, many countries have implemented antimicrobial monitoring systems at a national level. When designing a sampling scheme for antimicrobial resistance monitoring, it is necessary to consider both cost effectiveness and statistical plausibility. In this study, we examined how sampling scheme precision and sensitivity can vary with the number of animals sampled from each farm, while keeping the overall sample size constant to avoid additional sampling costs. Five sampling strategies were investigated. These employed 1, 2, 3, 4 or 6 animal samples per farm, with a total of 12 animals sampled in each strategy. A total of 1,500 Escherichia coli isolates from 300 fattening pigs on 30 farms were tested for resistance against 12 antimicrobials. The performance of each sampling strategy was evaluated by bootstrap resampling from the observational data. In the bootstrapping procedure, farms, animals, and isolates were selected randomly with replacement, and a total of 10,000 replications were conducted. For each antimicrobial, we observed that the standard deviation and 2.5-97.5 percentile interval of resistance prevalence were smallest in the sampling strategy that employed 1 animal per farm. The proportion of bootstrap samples that included at least 1 isolate with resistance was also evaluated as an indicator of the sensitivity of the sampling strategy to previously unidentified antimicrobial resistance. The proportion was greatest with 1 sample per farm and decreased with larger samples per farm. We concluded that when the total number of samples is pre-specified, the most precise and sensitive sampling strategy involves collecting 1 sample per farm.	[Yamamoto, Takehisa; Hayama, Yoko; Hidano, Arata; Kobayashi, Sota; Muroga, Norihiko; Tsutsui, Toshiyuki] Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan; [Ishikawa, Kiyoyasu; Ogura, Aki] Minist Agr Forestry & Fisheries, Food Safety & Consumer Affairs Bur, Anim Prod Safety Div, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Ministry of Agriculture Forestry & Fisheries - Japan	Yamamoto, T (corresponding author), Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan.	mtbook@affrc.go.jp	Hidano, Arata/S-1719-2019	Hidano, Arata/0000-0003-1707-5319	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection of the Ministry of Agriculture, Forestry, and Fisheries of Japan	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection of the Ministry of Agriculture, Forestry, and Fisheries of Japan	This study was supported by the Regulatory Research Projects for Food Safety, Animal Health and Plant Protection of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun E, 2002, MICROB DRUG RESIST, V8, P385, DOI 10.1089/10766290260469660; *CLIN LAB STAND I, 2006, M02A9 CLIN LAB STAND; Dunlop RH, 1999, EPIDEMIOL INFECT, V122, P485, DOI 10.1017/S0950268899002411; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EFSA (European Food Safety Authority), 2012, TECHN SPEC HARM MON; Kijima-Tanaka M, 2003, J ANTIMICROB CHEMOTH, V51, P447, DOI 10.1093/jac/dkg014; MAFF (Ministry of Agriculture Forestry and Fisheries Japan), 2009, REP JAP VET ANT RES; OIE, 2018, TERR AN HLTH COD; Persoons D, 2011, MICROB DRUG RESIST, V17, P513, DOI 10.1089/mdr.2011.0048; R Core Team, 2021, R LANGUAGE ENV STAT; Regula G, 2005, PREV VET MED, V70, P29, DOI 10.1016/j.prevetmed.2005.02.017; Silley P, 2012, REV SCI TECH OIE, V31, P105; Vieira AR, 2008, J ANTIMICROB CHEMOTH, V62, P535, DOI 10.1093/jac/dkn210; Villarroel A, 2006, AM J VET RES, V67, P951, DOI 10.2460/ajvr.67.6.951	14	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87147	10.1371/journal.pone.0087147	http://dx.doi.org/10.1371/journal.pone.0087147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466335	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000194
J	Yuan, J; Yeung, DKW; Mok, GSP; Bhatia, KS; Wang, YXJ; Ahuja, AT; King, AD				Yuan, Jing; Yeung, David Ka Wai; Mok, Greta S. P.; Bhatia, Kunwar S.; Wang, Yi-Xiang J.; Ahuja, Anil T.; King, Ann D.			Non-Gaussian Analysis of Diffusion Weighted Imaging in Head and Neck at 3T: A Pilot Study in Patients with Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INCOHERENT MOTION MODEL; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; WATER DIFFUSION; GRADIENT SENSITIZATION; TREATMENT RESPONSE; KURTOSIS; PERFUSION; MRI	Purpose: To technically investigate the non-Gaussian diffusion of head and neck diffusion weighted imaging (DWI) at 3 Tesla and compare advanced non-Gaussian diffusion models, including diffusion kurtosis imaging (DKI), stretched-exponential model (SEM), intravoxel incoherent motion (IVIM) and statistical model in the patients with nasopharyngeal carcinoma (NPC). Materials and Methods: After ethics approval was granted, 16 patients with NPC were examined using DWI performed at 3T employing an extended b-value range from 0 to 1500 s/mm(2). DWI signals were fitted to the mono-exponential and non-Gaussian diffusion models on primary tumor, metastatic node, spinal cord and muscle. Non-Gaussian parameter maps were generated and compared to apparent diffusion coefficient (ADC) maps in NPC. Results: Diffusion in NPC exhibited non-Gaussian behavior at the extended b-value range. Non-Gaussian models achieved significantly better fitting of DWI signal than the mono-exponential model. Non-Gaussian diffusion coefficients were substantially different from mono-exponential ADC both in magnitude and histogram distribution. Conclusion: Non-Gaussian diffusivity in head and neck tissues and NPC lesions could be assessed by using non-Gaussian diffusion models. Non-Gaussian DWI analysis may reveal additional tissue properties beyond ADC and holds potentials to be used as a complementary tool for NPC characterization.	[Yuan, Jing; Yeung, David Ka Wai; Bhatia, Kunwar S.; Wang, Yi-Xiang J.; Ahuja, Anil T.; King, Ann D.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Yuan, Jing] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Mok, Greta S. P.] Univ Macau, Dept Elect & Comp Engn, Taipa, Macau, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of Macau	Yuan, J (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	jyuanbwh@gmail.com	Mok, Greta/AAC-5207-2021; Wang, Yi Xiang/I-5952-2016; Ahuja, Anil T/H-4031-2017; King, Ann D/C-9845-2011; Yuan, Jing/E-4236-2013	Wang, Yi Xiang/0000-0001-5697-0717; Ahuja, Anil T/0000-0002-0726-5402; King, Ann D/0000-0002-5280-8349; Yuan, Jing/0000-0001-8112-3608	Hong Kong GRF [CUHK418811, SEG_CUHK02]; China NSFC [81201076]	Hong Kong GRF(Hong Kong Research Grants Council); China NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by contract grant sponsor: Hong Kong GRF grant CUHK418811, SEG_CUHK02 and China NSFC grant 81201076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; Blockx I, 2012, NEUROIMAGE, V63, P653, DOI 10.1016/j.neuroimage.2012.06.032; Concia M, 2013, INVEST RADIOL; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Friedrich KM, 2008, EUR J RADIOL, V68, P493, DOI 10.1016/j.ejrad.2007.10.011; Galban CJ, 2009, TRANSL ONCOL, V2, P184, DOI 10.1593/tlo.09175; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Hall MG, 2008, MAGN RESON MED, V59, P447, DOI 10.1002/mrm.21453; Holzapfel K, 2009, EUR J RADIOL, V72, P381, DOI 10.1016/j.ejrad.2008.09.034; Hori M, 2012, MAGN RESON MED SCI, V11, P221, DOI 10.2463/mrms.11.221; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Jansen JFA, 2010, AM J NEURORADIOL, V31, P741, DOI 10.3174/ajnr.A1919; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; King AD, 2010, EUR RADIOL, V20, P2213, DOI 10.1007/s00330-010-1769-8; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kwee TC, 2010, J MAGN RESON IMAGING, V31, P531, DOI 10.1002/jmri.22070; LEBIHAN D, 1988, MAGNET RESON MED, V7, P346, DOI 10.1002/mrm.1910070312; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Lu YG, 2012, J MAGN RESON IMAGING, V36, P1088, DOI 10.1002/jmri.23770; Maeda M, 2008, J NEURORADIOLOGY, V35, P71, DOI 10.1016/j.neurad.2008.01.080; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Penner AH, 2013, EUR RADIOL, V23, P2773, DOI 10.1007/s00330-013-2869-z; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Thoeny HC, 2012, RADIOLOGY, V263, P19, DOI 10.1148/radiol.11101821; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Vandecaveye V, 2010, NEURORADIOLOGY, V52, P773, DOI 10.1007/s00234-010-0743-0; Vandecaveye V, 2009, RADIOLOGY, V251, P134, DOI 10.1148/radiol.2511080128; Vanhoutte G, 2013, MAGN RESON MED, V69, P1115, DOI 10.1002/mrm.24680; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578; Yuan J, 2013, IEEE ENG MED BIO, P4406, DOI 10.1109/EMBC.2013.6610523; Yuan J, 2012, ACTA RADIOL, V53, P675, DOI 10.1258/ar.2012.120108; Zhang QW, 2013, IEEE ENG MED BIO, P511, DOI 10.1109/EMBC.2013.6609549; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	45	64	73	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87024	10.1371/journal.pone.0087024	http://dx.doi.org/10.1371/journal.pone.0087024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466318	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000185
J	Yang, R; Guo, L; Wang, P; Huang, L; Tang, Y; Wang, WH; Chen, K; Ye, JC; Lu, CY; Wu, YF; Shen, HY				Yang, Rui; Guo, Lan; Wang, Peng; Huang, Lin; Tang, Yong; Wang, Wenhao; Chen, Keng; Ye, Jichao; Lu, Ciyong; Wu, Yanfeng; Shen, Huiyong			Epidemiology of Spinal Cord Injuries and Risk Factors for Complete Injuries in Guangdong, China: A Retrospective Study	PLOS ONE			English	Article							OUTCOMES; REHABILITATION; CANADA; MULTICENTER; MEDICINE; PROFILE	Background: Spinal cord injuries are highly disabling and deadly injuries. Currently, few studies focus on non-traumatic spinal cord injuries, and there is little information regarding the risk factors for complete injuries. This study aims to describe the demographics and the injury characteristics for both traumatic and non-traumatic spinal cord injuries and to explore the risk factors for complete spinal cord injuries. Methods: A retrospective study was performed by reviewing the medical records of 3,832 patients with spinal cord injuries who were first admitted to the sampled hospitals in Guangdong, China. The demographics and injury characteristics of the patients were described and compared between the different groups using the chi-square test. Logistic regression was conducted to analyze the risk factors for complete spinal cord injuries. Results: The proportion of patients increased from 7.0% to 14.0% from 2003 to 2011. The male-to-female ratio was 3.0: 1. The major cause of spinal cord injuries was traffic accidents (21.7%). Many of the injured were workers (36.2%), peasants (22.8%), and unemployed people (13.9%); these occupations accounted for 72.9% of the total sample. A multivariate logistic regression model revealed that the OR (95% CI) for male gender compared to female gender was 1.25 (1.07-1.89), the OR (95% CI) for having a spinal fracture was 1.56 (1.35-2.60), the OR (95% CI) for having a thoracic injury was 1.23 (1.10-2.00), and the OR (95% CI) for having complications was 2.47 (1.96-3.13). Conclusion: The proportion of males was higher than the proportion of females. Workers, peasants and the unemployed comprised the high-risk occupational categories. Male gender, having a spinal fracture, having a thoracic injury, and having complications were the major risk factors for a complete injury. We recommend that preventive measures should focus on high-risk populations, such as young males.	[Yang, Rui; Wang, Peng; Huang, Lin; Tang, Yong; Wang, Wenhao; Chen, Keng; Ye, Jichao; Shen, Huiyong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Yanfeng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Lan; Lu, Ciyong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wu, YF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China.	wuyanfengcn@126.com; shenh.y.@163.com		Chen, Keng/0000-0002-1198-8005	Department of Health of Guangdong Province, People's Republic of China [C2010021]	Department of Health of Guangdong Province, People's Republic of China	This study was supported by Department of Health of Guangdong Province, People's Republic of China (C2010021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Albert T, 2005, SPINAL CORD, V43, P357, DOI 10.1038/sj.sc.3101717; Behrman AL, 2012, DEV MED CHILD NEUROL, V54, P1078, DOI 10.1111/j.1469-8749.2012.04440.x; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Chien LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039264; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Chun-xia H, 2007, CHINESE J REHABILITA, V13, P1011; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; Dahlberg A, 2005, SPINAL CORD, V43, P47, DOI 10.1038/sj.sc.3101616; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Erdogan MO, 2013, ULUS TRAVMA ACIL CER, V19, P49, DOI 10.5505/tjtes.2013.74501; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Galvin J, 2013, SPINE PHILA PA 1976; Gittler MS, 2002, ARCH PHYS MED REHAB, V83, pS65, DOI 10.1053/apmr.2002.32160; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Karacan I, 2000, SPINAL CORD, V38, P697, DOI 10.1038/sj.sc.3101064; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Kirshblum SC, 2007, ARCH PHYS MED REHAB, V88, pS62, DOI 10.1016/j.apmr.2006.12.003; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; New PW, 2011, SPINAL CORD, V49, P397, DOI 10.1038/sc.2010.77; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; RICHARDS JS, 1991, J PEDIATR PSYCHOL, V16, P595; Scivoletto G, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-42; Shin JC, 2013, ANN REHABIL MED-ARM, V37, P50, DOI 10.5535/arm.2013.37.1.50	31	32	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e84733	10.1371/journal.pone.0084733	http://dx.doi.org/10.1371/journal.pone.0084733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489652	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000008
J	Bontems, F; Fish, RJ; Borlat, I; Lembo, F; Chocu, S; Chalmel, F; Borg, JP; Pineau, C; Neerman-Arbez, M; Bairoch, A; Lane, L				Bontems, Franck; Fish, Richard J.; Borlat, Irene; Lembo, Frederique; Chocu, Sophie; Chalmel, Frederic; Borg, Jean-Paul; Pineau, Charles; Neerman-Arbez, Marguerite; Bairoch, Amos; Lane, Lydie			C2orf62 and TTC17 Are Involved in Actin Organization and Ciliogenesis in Zebrafish and Human	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; REGULATORY SUBUNIT RII; LEFT-RIGHT ASYMMETRY; ANCHORING PROTEINS; PRIMARY CILIA; CELL-SHAPE; GENE; IDENTIFICATION; EXPRESSION; ALIGNMENT	Vertebrate genomes contain around 20,000 protein-encoding genes, of which a large fraction is still not associated with specific functions. A major task in future genomics will thus be to assign physiological roles to all open reading frames revealed by genome sequencing. Here we show that C2orf62, a highly conserved protein with little homology to characterized proteins, is strongly expressed in testis in zebrafish and mammals, and in various types of ciliated cells during zebrafish development. By yeast two hybrid and GST pull-down, C2orf62 was shown to interact with TTC17, another uncharacterized protein. Depletion of either C2orf62 or TTC17 in human ciliated cells interferes with actin polymerization and reduces the number of primary cilia without changing their length. Zebrafish embryos injected with morpholinos against C2orf62 or TTC17, or with mRNA coding for the C2orf62 C-terminal part containing a RII dimerization/docking (R2D2) - like domain show morphological defects consistent with imperfect ciliogenesis. We provide here the first evidence for a C2orf62-TTC17 axis that would regulate actin polymerization and ciliogenesis.	[Bontems, Franck; Borlat, Irene; Bairoch, Amos; Lane, Lydie] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland; [Fish, Richard J.; Neerman-Arbez, Marguerite] Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland; [Lembo, Frederique; Borg, Jean-Paul] INSERM, U1068, CRCM, F-13258 Marseille, France; [Lembo, Frederique; Borg, Jean-Paul] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Lembo, Frederique; Borg, Jean-Paul] CNRS, UMR7258, Marseille, France; [Lembo, Frederique; Borg, Jean-Paul] Aix Marseille Univ, Marseille, France; [Chocu, Sophie; Chalmel, Frederic; Pineau, Charles] INSERM, IRSET, U1085, Rennes, France; [Bairoch, Amos; Lane, Lydie] SIB Swiss Inst Bioinformat, Geneva, Switzerland	University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Institute of Bioinformatics	Bontems, F (corresponding author), Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland.	Franck.bontems@unige.ch; Lydie.lane@isb-sib.ch	Lane, Lydie/AAQ-4896-2021; Chalmel, Frederic/M-1297-2016; Borg, Jean-Paul/AAX-8096-2020; Pineau, Charles G/D-9185-2013; Chalmel, Frédéric/AAM-1079-2021; Chalmel, Frédéric/L-5360-2018; Bairoch, Amos/X-7411-2019; , Protim/C-4687-2012	Lane, Lydie/0000-0002-9818-3030; Borg, Jean-Paul/0000-0001-8418-3382; Pineau, Charles G/0000-0002-7461-5433; Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Bairoch, Amos/0000-0003-2826-6444; Neerman-Arbez, Marguerite/0000-0002-9351-4195	La Ligue Contre le Cancer (Label Ligue); EUCAAD (FP7 program); Institut Paoli-Calmettes; Faculty of Medicine of the University of Geneva	La Ligue Contre le Cancer (Label Ligue); EUCAAD (FP7 program); Institut Paoli-Calmettes; Faculty of Medicine of the University of Geneva	JPB's lab is supported by La Ligue Contre le Cancer (Label Ligue 2010), EUCAAD (FP7 program), and Institut Paoli-Calmettes. AB's lab is supported by the Faculty of Medicine of the University of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2012, HUM MOL GENET, V21, P1272, DOI 10.1093/hmg/ddr557; Alieva I B, 1999, Membr Cell Biol, V12, P895; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaiz O, 2009, DATABASE-OXFORD, V2009, P14; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Carr DW, 2001, J BIOL CHEM, V276, P17332, DOI 10.1074/jbc.M011252200; CARR DW, 1991, J BIOL CHEM, V266, P14188; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Com E, 2006, MOL REPROD DEV, V73, P866, DOI 10.1002/mrd.20453; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Diviani D, 2001, J CELL SCI, V114, P1431; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; Fiedler SE, 2012, CYTOSKELETON, V69, P22, DOI 10.1002/cm.20539; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hawkins TA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-42; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Hoyer-Fender S, 2012, ATLAS GENET CYTOGEN, V16, P306, DOI [10.4267/2042/47311, DOI 10.4267/2042/47311]; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; KANE DA, 1993, DEVELOPMENT, V119, P447; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Klos Dehring DA, 2013, DEV CELL, P1; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Popgeorgiev N, 2011, DEV CELL, V20, P663, DOI 10.1016/j.devcel.2011.03.016; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ravanelli AM, 2011, DEV BIOL, V350, P101, DOI 10.1016/j.ydbio.2010.11.023; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Taniguchi H, 2012, J PROTEOMICS, V75, P5342, DOI [10.1016/j.jprot.2012.06.013, DOI 10.1016/J.JPR0T.2012.06.013]; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Yan XM, 2013, EXP CELL RES, V319, P147, DOI 10.1016/j.yexcr.2012.08.009; Yuan SL, 2013, ANNU REV GENET, V47, P353, DOI 10.1146/annurev-genet-111212-133243	85	14	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86476	10.1371/journal.pone.0086476	http://dx.doi.org/10.1371/journal.pone.0086476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475127	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300069
J	Degasperi, A; Birtwistle, MR; Volinsky, N; Rauch, J; Kolch, W; Kholodenko, BN				Degasperi, Andrea; Birtwistle, Marc R.; Volinsky, Natalia; Rauch, Jens; Kolch, Walter; Kholodenko, Boris N.			Evaluating Strategies to Normalise Biological Replicates of Western Blot Data	PLOS ONE			English	Article							ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE-GELS; QUANTITATIVE DATA; INTERNAL CONTROL; BETA-ACTIN; MODEL; ERROR; NITROCELLULOSE; PROTEINS	Western blot data are widely used in quantitative applications such as statistical testing and mathematical modelling. To ensure accurate quantitation and comparability between experiments, Western blot replicates must be normalised, but it is unclear how the available methods affect statistical properties of the data. Here we evaluate three commonly used normalisation strategies: (i) by fixed normalisation point or control; (ii) by sum of all data points in a replicate; and (iii) by optimal alignment of the replicates. We consider how these different strategies affect the coefficient of variation (CV) and the results of hypothesis testing with the normalised data. Normalisation by fixed point tends to increase the mean CV of normalised data in a manner that naturally depends on the choice of the normalisation point. Thus, in the context of hypothesis testing, normalisation by fixed point reduces false positives and increases false negatives. Analysis of published experimental data shows that choosing normalisation points with low quantified intensities results in a high normalised data CV and should thus be avoided. Normalisation by sum or by optimal alignment redistributes the raw data uncertainty in a mean-dependent manner, reducing the CV of high intensity points and increasing the CV of low intensity points. This causes the effect of normalisations by sum or optimal alignment on hypothesis testing to depend on the mean of the data tested; for high intensity points, false positives are increased and false negatives are decreased, while for low intensity points, false positives are decreased and false negatives are increased. These results will aid users of Western blotting to choose a suitable normalisation strategy and also understand the implications of this normalisation for subsequent hypothesis testing.	[Degasperi, Andrea; Volinsky, Natalia; Rauch, Jens; Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland; [Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland	University College Dublin; Icahn School of Medicine at Mount Sinai; University College Dublin; University College Dublin	Degasperi, A (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland.	andrea.degasperi@ucd.ie	Rauch, Jens/G-6210-2016; Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Degasperi, Andrea/AAG-1315-2019	Rauch, Jens/0000-0002-5120-9547; Degasperi, Andrea/0000-0001-6879-0596; Birtwistle, Marc/0000-0002-0341-0705; Kolch, Walter/0000-0001-5777-5016; Kholodenko, Boris/0000-0002-9483-4975	Science Foundation Ireland [06/CE/B1129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Science Foundation Ireland under Grant No. 06/CE/B1129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2007, ELECTROPHORESIS, V28, P3163, DOI 10.1002/elps.200700002; Bartlett MS, 1935, P CAMB PHILOS SOC, V31, P223; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONEAU CA, 1960, PSYCHOL BULL, V57, P49, DOI 10.1037/h0041412; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Bruning U, 2012, CELL MOL LIFE SCI, V69, P1319, DOI 10.1007/s00018-011-0876-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Heidebrecht F, 2009, J IMMUNOL METHODS, V345, P40, DOI 10.1016/j.jim.2009.03.018; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Lange F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-13; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu NK, 2006, J NEUROTRAUM, V23, P1794, DOI 10.1089/neu.2006.23.1794; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Rauch J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00868; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Speed TP, 2003, STAT ANAL GENE EXPRE, Vxiii; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Witt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040274; Wu YH, 2012, ANAL BIOCHEM, V423, P15, DOI 10.1016/j.ab.2012.01.012; Zar, 2011, BIOSTAT ANAL; Zhang RF, 2012, ANAL BIOCHEM, V427, P116, DOI 10.1016/j.ab.2012.05.008	27	129	130	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87293	10.1371/journal.pone.0087293	http://dx.doi.org/10.1371/journal.pone.0087293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475266	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300164
J	Gray, R; Ho, C; Spence, C				Gray, Rob; Ho, Cristy; Spence, Charles			A Comparison of Different Informative Vibrotactile Forward Collision Warnings: Does the Warning Need to Be Linked to the Collision Event?	PLOS ONE			English	Article							SENSORY SUBSTITUTION; SENSITIVITY; TACTILE; MOTION; LEVEL	Recent research demonstrates that auditory and vibrotactile forward collision warnings presenting a motion signal (e. g., looming or apparent motion across the body surface) can facilitate speeded braking reaction times (BRTs). The purpose of the present study was to expand on this work by directly comparing warning signals in which the motion conveyed was constant across all collision events with signals in which the speed of motion was dependent on the closing velocity (CV). Two experiments were conducted using a simulated car-following task and BRTs were measured. In Experiment 1, increasing intensity (looming) vibrotactile signals were presented from a single tactor attached to the driver's waist. When the increase in intensity was CV-linked, BRTs were significantly faster as compared to a no-warning condition, however, they were not significantly different from constant intensity and CV-independent looming warnings. In Experiment 2, a vertical array of three tactors was used to create motion either towards (upwards) or away (downwards) from the driver's head. When the warning signal presented upwards motion that was CV-linked, BRTs were significantly faster than all other warning types. Downwards warnings led to a significantly higher number of brake activations in false alarm situations as compared to upwards moving warnings. The effectiveness of dynamic tactile collision warnings would therefore appear to depend on both the link between the warning and collision event and on the directionality of the warning signal.	[Gray, Rob] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Ho, Cristy; Spence, Charles] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Birmingham; University of Oxford	Gray, R (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	r.gray.2@bham.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/J008001/1]; Engineering and Physical Sciences Research Council [EP/J008001/1] Funding Source: researchfish; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; EPSRC [EP/J008001/1] Funding Source: UKRI; MRC [MR/K00414X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by a grant (EP/J008001/1) from the Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bach-y-Rita P, 1972, BRAIN MECH SENSORY S, DOI 10.1068/p010491; Bertossa F, 2008, PERCEPT MOTOR SKILL, V107, P323, DOI 10.2466/PMS.107.2.323-335; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Diaz A, 2012, HUM MOVEMENT SCI, V31, P1571, DOI 10.1016/j.humov.2012.05.006; Freiberg K, 2001, BRIT J DEV PSYCHOL, V19, P1, DOI 10.1348/026151001165903; Graham R, 1999, ERGONOMICS, V42, P1233, DOI 10.1080/001401399185108; Gray R, 2011, HUM FACTORS, V53, P63, DOI 10.1177/0018720810397833; Hall DA, 2003, CURR BIOL, V13, pR91, DOI 10.1016/S0960-9822(03)00034-4; Hirst S., 1997, ERGONOMICS SAFETY IN, P203; Ho C, IEEE T HAPT IN PRESS, DOI [10.1109/TOH.2013.62, DOI 10.1109/T0H.2013.62]; Ho C., 2008, MULTISENSORY DRIVER; Ho C., 2013, P 7 INT DRIV S HUM F, P551; Ho C, 2007, HUM FACTORS, V49, P1107, DOI 10.1518/001872007X249965; HONG X, 1989, VISION RES, V29, P809, DOI 10.1016/0042-6989(89)90093-X; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Loomis J.M., 1992, PRESENCE-TELEOP VIRT, V1, P113, DOI [DOI 10.1162/PRES.1992.1.1.113, 10.1162/pres.1992.1.1.113]; McKeown D, 2007, HUM FACTORS, V49, P417, DOI 10.1518/001872007X200067; Meng F, DYNAMIC VIBROT UNPUB; Mohebbi R, 2009, HUM FACTORS, V51, P102, DOI 10.1177/0018720809333517; Navarro J, 2007, HUM FACTORS, V49, P950, DOI 10.1518/001872007X230280; REGAN D, 1994, VISION RES, V34, P163, DOI 10.1016/0042-6989(94)90329-8; Regan M. A., 2009, DRIVER DISTRACTION T; Scott JJ, 2008, HUM FACTORS, V50, P264, DOI 10.1518/001872008X250674; SHAW B K, 1991, Ecological Psychology, V3, P253, DOI 10.1207/s15326969eco0303_4; Siegle JH, 2010, PERCEPTION, V39, P208, DOI 10.1068/p6366; Spence C, 2012, PSYCHOLOGIST, V25, P664; Straughn SM, 2009, IEEE T HAPTICS, V2, P111, DOI 10.1109/ToH.2009.15; Van Erp JBF, 2004, TRANSPORT RES F-TRAF, V7, P247, DOI 10.1016/j.trf.2004.09.003; YONAS A, 1977, PERCEPT PSYCHOPHYS, V21, P97, DOI 10.3758/BF03198713	30	19	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87070	10.1371/journal.pone.0087070	http://dx.doi.org/10.1371/journal.pone.0087070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475225	Green Published, gold			2022-12-27	WOS:000330507300133
J	Munoz, WA; Lee, M; Miller, RK; Ahmed, Z; Ji, H; Link, TM; Lee, GR; Kloc, M; Ladbury, JE; McCrea, PD				Munoz, William A.; Lee, Moonsup; Miller, Rachel K.; Ahmed, Zamal; Ji, Hong; Link, Todd M.; Lee, Gilbert R.; Kloc, Malgorzata; Ladbury, John E.; McCrea, Pierre D.			Plakophilin-3 Catenin Associates with the ETV1/ER81 Transcription Factor to Positively Modulate Gene Activity	PLOS ONE			English	Article							BETA-CATENIN; DESMOSOMAL PLAQUE; EPITHELIAL-CELLS; DNA-BINDING; ACTIN CYTOSKELETON; SIGNALING PATHWAY; PROSTATE-CANCER; WNT SIGNALS; C-JUN; ETS	Members of the plakophilin-catenin sub-family (Pkp-1, -2, and -3) facilitate the linkage of desmosome junctional components to each other (e. g. desmosomal cadherins to desmoplakin) and the intermediate-filament cytoskeleton. Pkps also contribute to desmosomal stabilization and the trafficking of its components. The functions of Pkps outside of the desmosome are less well studied, despite evidence suggesting their roles in mRNA regulation, small-GTPase modulation (e. g. mid-body scission) during cell division, and cell survival following DNA damage. Pkp-catenins are further believed to have roles in the nucleus given their nuclear localization in some contexts and the known nuclear roles of structurally related catenins, such as beta-catenin and p120-catenin. Further, Pkp-catenin activities in the nuclear compartment have become of increased interest with the identification of interactions between Pkp2-catenin and RNA Pol III and Pkp1 with single-stranded DNA. Consistent with earlier reports suggesting possible nuclear roles in development, we previously demonstrated prominent nuclear localization of Pkp3 in Xenopus naive ectoderm ("animal cap") cells and recently resolved a similar localization in mouse embryonic stem cells. Here, we report the association and positive functional interaction of Pkp3 with a transcription factor, Ets variant gene 1 (ETV1), which has critical roles in neural development and prominent roles in human genetic disease. Our results are the first to report the interaction of a sequence-specific transcription factor with any Pkp. Using Xenopus laevis embryos and mammalian cells, we provide evidence for the Pkp3: ETV1 complex on both biochemical and functional levels.	[Munoz, William A.; Lee, Moonsup; Miller, Rachel K.; Ahmed, Zamal; Ji, Hong; Link, Todd M.; Lee, Gilbert R.; Kloc, Malgorzata; Ladbury, John E.; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Munoz, William A.; Lee, Moonsup; Ladbury, John E.; McCrea, Pierre D.] Univ Texas Grad Sch Biomed Sci Houston, Program Genes & Dev, Houston, TX USA; [Ahmed, Zamal; Link, Todd M.; Lee, Gilbert R.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Kloc, Malgorzata] Houston Methodist Res Inst, Houston Methodist, Dept Surg, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	McCrea, PD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	pdmccrea@mdanderson.org	Kloc, Malgorzata/AAF-6982-2020	Ladbury, John/0000-0002-6328-7200; Miller, Rachel/0000-0001-6381-7198; Link, Todd/0000-0003-1939-9755	NIH [RO1GM52112]; Cancer Prevention and Research Institute of Texas Research Training Award [RP101502]; National Cancer Institute [CA-16672]; University of Texas Graduate School of Biomedical Science (GSBS) - Houston; NIH Career Development Award [K01 DK092320]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Research Training Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas Graduate School of Biomedical Science (GSBS) - Houston; NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (RO1GM52112 to P. D. M.; and Research Supplement to Promote Diversity in Health-Related Research to W.A.M.). W. A. M. was further supported from a Cancer Prevention and Research Institute of Texas Research Training Award (RP101502). The University of Texas Graduate School of Biomedical Science (GSBS) - Houston for assisting with financial support of W. A. M. National Cancer Institute Core Grant (CA-16672) to MD Anderson Cancer Center. R. K. M. was supported by a NIH Career Development Award (K01 DK092320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, P NATL ACAD SCI USA, V108, P12497, DOI 10.1073/pnas.1109940108; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bass-Zubek AE, 2009, CURR OPIN CELL BIOL, V21, P708, DOI 10.1016/j.ceb.2009.07.002; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Breuninger S, 2010, AM J PATHOL, V176, P2509, DOI 10.2353/ajpath.2010.090737; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Cho K, 2010, J CELL SCI, V123, P4128, DOI 10.1242/jcs.072041; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; de Nooij JC, 2013, NEURON, V77, P1055, DOI 10.1016/j.neuron.2013.01.015; Demirag GG, 2012, MED ONCOL, V29, P1518, DOI 10.1007/s12032-011-0071-1; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Fuchs B, 2003, FEBS LETT, V553, P104, DOI 10.1016/S0014-5793(03)00984-0; Gallicano GI, 2001, DEVELOPMENT, V128, P929; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Hall C, 2009, CELL COMMUN ADHES, V16, P15, DOI 10.1080/15419060903009329; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hobbs RP, 2012, J INVEST DERMATOL, V132, P482, DOI 10.1038/jid.2011.318; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hofmann I, 2000, J CELL SCI, V113, P2471; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong JY, 2012, J CELL SCI, V125, P561, DOI 10.1242/jcs.086173; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Hong TT, 2011, DEV DYNAM, V240, P2680, DOI 10.1002/dvdy.22765; Hulpiau P, 2013, PROG MOL BIOL TRANSL, V116, P71, DOI 10.1016/B978-0-12-394311-8.00004-2; Klymkowsky MW, 1999, MICROSC RES TECHNIQ, V45, P43, DOI 10.1002/(SICI)1097-0029(19990401)45:1<43::AID-JEMT4>3.3.CO;2-3; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; McEwen Abbye E, 2012, Subcell Biochem, V60, P171, DOI 10.1007/978-94-007-4186-7_8; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Miller RK, 2013, PROG MOL BIOL TRANSL, V116, P387, DOI 10.1016/B978-0-12-394311-8.00017-0; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montross WT, 2000, J CELL SCI, V113, P1759; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Munchberg SR, 1999, MECH DEVELOP, V80, P53, DOI 10.1016/S0925-4773(98)00193-2; Munoz WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034342; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Oh S, 2013, CANC RES; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Rain JC, 2009, METHODS, V47, P291, DOI 10.1016/j.ymeth.2009.02.002; RAYGALLET D, 1995, ONCOGENE, V11, P303; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schmidt A, 2005, EUR J CELL BIOL, V84, P189, DOI 10.1016/j.ejcb.2004.12.020; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Wolf A, 2013, J CELL SCI, V126, P1832, DOI 10.1242/jcs.118992; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135	80	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86784	10.1371/journal.pone.0086784	http://dx.doi.org/10.1371/journal.pone.0086784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475179	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300109
J	Wangroongsarb, P; Kohda, T; Jittaprasartsin, C; Suthivarakom, K; Kamthalang, T; Umeda, K; Sawanpanyalert, P; Kozaki, S; Ikuta, K				Wangroongsarb, Piyada; Kohda, Tomoko; Jittaprasartsin, Chutima; Suthivarakom, Karun; Kamthalang, Thanitchi; Umeda, Kaoru; Sawanpanyalert, Pathom; Kozaki, Shunji; Ikuta, Kazuyoshi			Molecular Characterization of Clostridium botulinum Isolates from Foodborne Outbreaks in Thailand, 2010	PLOS ONE			English	Article							NEUROTOXIN TYPE-A; GENETIC-CHARACTERIZATION; MONOCLONAL-ANTIBODIES; COMPLEX GENES; B NEUROTOXIN; IDENTIFICATION; TOXIN; SEQUENCE; STRAINS; PCR	Background: Thailand has had several foodborne outbreaks of botulism, one of the biggest being in 2006 when laboratory investigations identified the etiologic agent as Clostridium botulinum type A. Identification of the etiologic agent from outbreak samples is laborious using conventional microbiological methods and the neurotoxin mouse bioassay. Advances in molecular techniques have added enormous information regarding the etiology of outbreaks and characterization of isolates. We applied these methods in three outbreaks of botulism in Thailand in 2010. Methodology/Principal Findings: A total of 19 cases were involved (seven each in Lampang and Saraburi and five in Maehongson provinces). The first outbreak in Lampang province in April 2010 was associated with C. botulinum type F, which was detected by conventional methods. Outbreaks in Saraburi and Maehongson provinces occurred in May and December were due to C. botulinum type A1(B) and B that were identified by conventional methods and molecular techniques, respectively. The result of phylogenetic sequence analysis showed that C. botulinum type A1(B) strain Saraburi 2010 was close to strain Iwate 2007. Molecular analysis of the third outbreak in Maehongson province showed C. botulinum type B8, which was different from B1-B7 subtype. The nontoxic component genes of strain Maehongson 2010 revealed that ha33, ha17 and botR genes were close to strain Okra (B1) while ha70 and ntnh genes were close to strain 111 (B2). Conclusion/Significance: This study demonstrates the utility of molecular genotyping of C. botulinum and how it contributes to our understanding the epidemiology and variation of boNT gene. Thus, the recent botulism outbreaks in Thailand were induced by various C. botulinum types.	[Wangroongsarb, Piyada; Jittaprasartsin, Chutima; Suthivarakom, Karun; Kamthalang, Thanitchi] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Kohda, Tomoko; Kozaki, Shunji] Osaka Prefecture Univ, Dept Vet Sci, Osaka, Japan; [Umeda, Kaoru] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan; [Sawanpanyalert, Pathom] Dept Med Sci, Nonthaburi, Thailand; [Ikuta, Kazuyoshi] Osaka Univ, Dept Virol, Osaka, Japan	Ministry of Public Health - Thailand; Osaka Metropolitan University; Osaka University	Ikuta, K (corresponding author), Osaka Univ, Dept Virol, Osaka, Japan.	ikuta@biken.osaka-u.ac.jp			Department of Medical Science, Ministry of Public Health; Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS)	Department of Medical Science, Ministry of Public Health; Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS)	This work was supported in part by Department of Medical Science, Ministry of Public Health co-operated wtih Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS) with no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda E, 1997, LETT APPL MICROBIOL, V25, P186, DOI 10.1046/j.1472-765X.1997.00204.x; Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; BINZ T, 1990, J BIOL CHEM, V265, P9153; Brett MM, 1998, LETT APPL MICROBIOL, V26, P81, DOI 10.1046/j.1472-765X.1998.00283.x; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P389; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P437; Chow SK, 2012, TOXINS, V4, P430, DOI 10.3390/toxins4060430; CORDOBA JJ, 1995, SYST APPL MICROBIOL, V18, P13, DOI 10.1016/S0723-2020(11)80443-1; De Medici D, 2009, APPL ENVIRON MICROB, V75, P6457, DOI 10.1128/AEM.00805-09; Dowell Jr VR, 1987, CDC LAB MANUAL; EKLUND MW, 1972, NATURE-NEW BIOL, V235, P16, DOI 10.1038/newbio235016a0; EKLUND MW, 1988, APPL ENVIRON MICROB, V54, P1405, DOI 10.1128/AEM.54.6.1405-1408.1988; Franciosa G, 2004, APPL ENVIRON MICROB, V70, P7192, DOI 10.1128/AEM.70.12.7192-7199.2004; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; Hatheway C, 1994, THERAPY BOTULINUM TO, P93; Hatheway C.L., 1988, LAB DIAGNOSIS INFECT, P111; Hatheway CL, 1995, CURR TOP MICROBIOL, V195, P55; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Holdeman L.V., 1975, ANAEROBE LAB MANUAL; Hutson RA, 1996, J BIOL CHEM, V271, P10786, DOI 10.1074/jbc.271.18.10786; INOUE K, 1970, JPN J MICROBIOL, V14, P87, DOI 10.1111/j.1348-0421.1970.tb00495.x; Jacobson MJ, 2011, APPL ENVIRON MICROB, V77, P4217, DOI 10.1128/AEM.00201-11; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Kalb SR, 2012, ANAL BIOANAL CHEM, V403, P215, DOI 10.1007/s00216-012-5767-3; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P951, DOI 10.1016/j.fct.2008.02.006; Kongsaengdao S, 2006, CLIN INFECT DIS, V43, P1247, DOI 10.1086/508176; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindstrom M, 2001, APPL ENVIRON MICROB, V67, P5694, DOI 10.1128/AEM.67.12.5694-5699.2001; Lindstrom MK, 1999, FEMS IMMUNOL MED MIC, V24, P267, DOI 10.1111/j.1574-695X.1999.tb01293.x; Lou J, 2010, PROTEIN ENG DES SEL, V23, P311, DOI 10.1093/protein/gzq001; Macdonald TE, 2011, APPL ENVIRON MICROB, V77, P8625, DOI 10.1128/AEM.05155-11; Maslanka S.E., 2011, BOTULINUM J, V2, P72, DOI [10.1504/TBJ.2011.041817, DOI 10.1504/TBJ.2011.041817]; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; Mowry MC, 2004, PROTEIN EXPRES PURIF, V37, P399, DOI 10.1016/j.pep.2004.06.022; Mukherjee J, 2012, TOXINS, V4, P1565, DOI 10.3390/toxins4121565; Nakamura K, 2012, INFECT IMMUN, V80, P2886, DOI 10.1128/IAI.00302-12; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161, DOI 10.1111/j.1348-0421.1995.tb02184.x; Popoff MR, 1995, CURR TOP MICROBIOL, V195, P1; Raffestin Stephanie, 2009, P1; Raphael BH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-245; Raphael BH, 2010, APPL ENVIRON MICROB, V76, P4805, DOI 10.1128/AEM.03109-09; Roe DE, 2002, CLIN INFECT DIS, V35, pS36, DOI 10.1086/341918; Sharma SK, 2006, APPL ENVIRON MICROB, V72, P1231, DOI 10.1128/AEM.72.2.1231-1238.2006; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; SONNABEND WF, 1987, APPL ENVIRON MICROB, V53, P1880, DOI 10.1128/AEM.53.8.1880-1884.1987; Swaddiwudhipong Witaya, 2000, Journal of the Medical Association of Thailand, V83, P1021; Szilagyi M, 2000, TOXICON, V38, P381, DOI 10.1016/S0041-0101(99)00168-3; Takeshi K, 1996, MICROBIOL IMMUNOL, V40, P5, DOI 10.1111/j.1348-0421.1996.tb03310.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Umeda K, 2010, MICROBIOL IMMUNOL, V54, P308, DOI 10.1111/j.1348-0421.2010.00213.x; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; WHELAN SM, 1992, APPL ENVIRON MICROB, V58, P2345, DOI 10.1128/AEM.58.8.2345-2354.1992; Woudstra C, 2012, APPL ENVIRON MICROB, V78, P3120, DOI 10.1128/AEM.07568-11; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	62	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e77792	10.1371/journal.pone.0077792	http://dx.doi.org/10.1371/journal.pone.0077792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475015	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300002
J	D'Souza, G; Cullen, K; Bowie, J; Thorpe, R; Fakhry, C				D'Souza, Gypsyamber; Cullen, Kevin; Bowie, Janice; Thorpe, Roland; Fakhry, Carole			Differences in Oral Sexual Behaviors by Gender, Age, and Race Explain Observed Differences in Prevalence of Oral Human Papillomavirus Infection	PLOS ONE			English	Article							UNITED-STATES; OROPHARYNGEAL CANCER; TRENDS; HEAD; SURVIVAL; NATION; BURDEN; SAMPLE	Purpose: This study explores whether gender, age and race differences in oral sexual behavior account for the demographic distribution of oral human papillomavirus infection (HPV) and HPV-positive oropharyngeal cancer (HPV-OSCC) Methods: This analysis included 2,116 men and 2,140 women from NHANES (2009-10) who answered a behavioral questionnaire and provided an oral-rinse sample for HPV detection. Weighted prevalence estimates and prevalence ratios (PR) were calculated for sexual behaviors and oral HPV infection by gender, age-cohort (20-29, 30-44, 45-59, 60-69), and race, and contrasted with incidence rate ratios (IRR) of OSCC from SEER 2009. Multivariate logistic regression was used to evaluate predictors of oral sexual behavior and oral HPV16 infection. Results: Differences in oral sexual behavior were observed by gender, age-cohort and race. Most men (85.4%) and women (83.2%) had ever performed oral sex, but men had more lifetime oral and vaginal sexual partners and higher oral HPV16 prevalence than women (each p<0.001). 60-69 year olds (yo) were less likely than 45-59 or 30-44 (yo) to have performed oral sex (72.7%, 84.8%, and 90.3%, p<0.001), although oral HPV16 prevalence was similar. Prevalence ratios (PR) of ever oral sex in men vs. women (PR = 1.03), and 45-59 vs. 30-44 year-old men (PR = 0.96) were modest relative to ratios for oral HPV16 infection (PRs = 1.3-6.8) and OSCC (IRR = 4.7-8.1). In multivariate analysis, gender, age-cohort, and race were significant predictors of oral sexual behavior. Oral sexual behavior was the primary predictor of oral HPV16 infection; once this behavior was adjusted for, age-cohort and race were no longer associated with oral HPV16. Conclusion: There are differences in oral sexual behaviors when considering gender, age-cohort and race which explain observed epidemiologic differences in oral HPV16 infection across these groups.	[D'Souza, Gypsyamber; Fakhry, Carole] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [D'Souza, Gypsyamber; Fakhry, Carole] Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Cullen, Kevin] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Bowie, Janice] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Thorpe, Roland] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Thorpe, Roland] Johns Hopkins Bloomberg Sch Publ Hlth, Hopkins Ctr Hlth Dispar Solut, Baltimore, MD USA; [Fakhry, Carole] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Greater Baltimore Medical Center	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	gdsouza@jhsph.edu; cfakhry@jhmi.edu			NCI NIH HHS [P30 CA134274] Funding Source: Medline; NIDCR NIH HHS [P50 DE019032, R01 DE021395] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021395, P50DE019032] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Agius PA, 2010, AUST NZ J PUBL HEAL, V34, P476, DOI 10.1111/j.1753-6405.2010.00593.x; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], NHANES 2009 10 NAT H; Aral SO, 2005, SEX TRANSM DIS, V32, P710, DOI 10.1097/01.olq.0000175370.08709.72; Bajos N, 2010, AIDS, V24, P1185, DOI 10.1097/QAD.0b013e328336ad52; Broutian TR, 2010, J CLIN VIROLOGY OFFI; Chaturvedi AK, 2013, J CLIN ONCOL; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cole L, 2012, PLOS ONE, V7, DOI [DOI 10.1371/journal.pone.0032657, 10. 1371/journal.pone.0032657]; Copen CE, 2012, PREVALENCE TIMING OR; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gates GJ, 2000, FAM PLANN PERSPECT, V32, P295, DOI 10.2307/2648198; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Herlitz C, 2009, SEX HEALTH, V6, P272, DOI 10.1071/SH08095; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Leichliter JS, 2007, J INFECT DIS, V196, P1852, DOI 10.1086/522867; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Satterwhite CL, 2007, SEX TRANSM DIS, V34, P815, DOI 10.1097/OLQ.0b013e31805c751d; Settle K, 2009, CANCER PREV RES, V2, P776, DOI 10.1158/1940-6207.CAPR-09-0149; Surveillance E, 2013, SEER STAT DAT UNPUB; Tobian AAR, 2011, INT J CANCER, V129, P2970, DOI 10.1002/ijc.25957; TURNER CF, 1995, SEX TRANSM DIS, V22, P173, DOI 10.1097/00007435-199505000-00009; Weinberger PM, 2010, LARYNGOSCOPE, V120, P1531, DOI 10.1002/lary.20984	30	131	132	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86023	10.1371/journal.pone.0086023	http://dx.doi.org/10.1371/journal.pone.0086023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475067	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800022
J	Kaul, TK; Rodrigues, PR; Ogungbe, IV; Kapahi, P; Gill, MS				Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo V.; Kapahi, Pankaj; Gill, Matthew S.			Bacterial Fatty Acids Enhance Recovery from the Dauer Larva in Caenorhabditis elegans	PLOS ONE			English	Article							GUANYLYL CYCLASE DAF-11; C-ELEGANS; DEVELOPMENTAL VARIANT; SIGNALING PATHWAY; INSULIN; PHEROMONE; TEMPERATURE; RESISTANCE; MEMBER; FOOD	The dauer larva is a specialized dispersal stage in the nematode Caenorhabditis elegans that allows the animal to survive starvation for an extended period of time. The dauer does not feed, but uses chemosensation to identify new food sources and to determine whether to resume reproductive growth. Bacteria produce food signals that promote recovery of the dauer larva, but the chemical identities of these signals remain poorly defined. We find that bacterial fatty acids in the environment augment recovery from the dauer stage under permissive conditions. The effect of increased fatty acids on different dauer constitutive mutants indicates a role for insulin peptide secretion in coordinating recovery from the dauer stage in response to fatty acids. These data suggest that worms can sense the presence of fatty acids in the environment and that elevated levels can promote recovery from dauer arrest. This may be important in the natural environment where the dauer larva needs to determine whether the environment is appropriate to support reproductive growth following dauer exit.	[Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo V.; Gill, Matthew S.] Scripps Res Inst Scripps Florida, Dept Metab & Aging, Jupiter, FL 33458 USA; [Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA	Scripps Research Institute; State University System of Florida; University of Florida; Buck Institute for Research on Aging	Gill, MS (corresponding author), Scripps Res Inst Scripps Florida, Dept Metab & Aging, Jupiter, FL 33458 USA.	mgill@scripps.edu		Gill, Matthew/0000-0003-0818-8792	National Institutes of Health [AG036992, AG038688]; NATIONAL INSTITUTE ON AGING [R01AG045835, R01AG036992, R01AG038688] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health Grants AG036992 (MSG) and AG038688 (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bargmann CI, 2006, C ELEGANS RES COMMUN, DOI [10.1895/worm-book.1.123.1, DOI 10.1895/W0RM-B00K.1.123.1]; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Dauer Hu PJ, 2007, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/W0RMB00K.1.144.1]; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Ludewig AH, 2013, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.155.1, DOI 10.1895/W0RMB00K.1.155.1]; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Ouellet J, 2008, DEVELOPMENT, V135, P2583, DOI 10.1242/dev.012435; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	30	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86979	10.1371/journal.pone.0086979	http://dx.doi.org/10.1371/journal.pone.0086979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475206	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800074
J	Neupane, K; Solanki, A; Sosova, I; Belov, M; Woodside, MT				Neupane, Krishna; Solanki, Allison; Sosova, Iveta; Belov, Miro; Woodside, Michael T.			Diverse Metastable Structures Formed by Small Oligomers of alpha-Synuclein Probed by Force Spectroscopy	PLOS ONE			English	Article							SINGLE-MOLECULE FLUORESCENCE; PROTEIN AGGREGATION; PATHOGENIC MUTATIONS; PARKINSONS-DISEASE; ENERGY LANDSCAPE; OPTICAL TWEEZERS; FIBRIL FORMATION; AFM; NEUROTOXICITY; EQUILIBRIA	Oligomeric aggregates are widely suspected as toxic agents in diseases caused by protein aggregation, yet they remain poorly characterized, partly because they are challenging to isolate from a heterogeneous mixture of species. We developed an assay for characterizing structure, stability, and kinetics of individual oligomers at high resolution and sensitivity using single-molecule force spectroscopy, and applied it to observe the formation of transient structured aggregates within single oligomers of alpha-synuclein, an intrinsically-disordered protein linked to Parkinson's disease. Measurements of the molecular extension as the proteins unfolded under tension in optical tweezers revealed that even small oligomers could form numerous metastable structures, with a surprisingly broad range of sizes. Comparing the structures formed in monomers, dimers and tetramers, we found that the average mechanical stability increased with oligomer size. Most structures formed within a minute, with size-dependent rates. These results provide a new window onto the complex alpha-synuclein aggregation landscape, characterizing the microscopic structural heterogeneity and kinetics of different pathways.	[Neupane, Krishna; Solanki, Allison; Woodside, Michael T.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Sosova, Iveta; Belov, Miro; Woodside, Michael T.] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; National Research Council Canada	Woodside, MT (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.	michael.woodside@nrc-cnrc.gc.ca			Canadian Institutes of Health Research [NHG 91374]; nanoWorks program of Alberta Innovates; National Institute for Nanotechnology; Alberta Innovates; Alberta Innovates [201200841] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); nanoWorks program of Alberta Innovates; National Institute for Nanotechnology; Alberta Innovates; Alberta Innovates	This work was supported by Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) grant reference number NHG 91374, the nanoWorks program of Alberta Innovates (www.albertainnovates.ca), and the National Institute for Nanotechnology (www.nint.ualberta.ca). A. S. acknowledges fellowship support from Alberta Innovates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dong JJ, 2010, NAT STRUCT MOL BIOL, V17, P1422, DOI 10.1038/nsmb.1954; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Elms PJ, 2012, P NATL ACAD SCI USA, V109, P3796, DOI 10.1073/pnas.1115519109; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fauerbach JA, 2012, BIOPHYS J, V102, P1127, DOI 10.1016/j.bpj.2012.01.051; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2010, ANGEW CHEM INT EDIT, V49, P3469, DOI 10.1002/anie.201000378; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Gebhardt JCM, 2010, P NATL ACAD SCI USA, V107, P2013, DOI 10.1073/pnas.0909854107; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hervas R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001335; Hillger F, 2007, J FLUORESC, V17, P759, DOI 10.1007/s10895-007-0187-z; Hoffmann A, 2013, PHYS CHEM CHEM PHYS, V15, P7934, DOI 10.1039/c3cp44564j; Hoffmann A, 2011, ANGEW CHEM INT EDIT, V50, P12643, DOI 10.1002/anie.201104033; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jagannathan B, 2012, P NATL ACAD SCI USA, V109, P17820, DOI 10.1073/pnas.1201800109; Jonsson SA, 2013, BIOPHYS J, V104, P2725, DOI 10.1016/j.bpj.2013.05.003; Kellermayer MSZ, 2003, BBA-BIOENERGETICS, V1604, P105, DOI 10.1016/S0005-2728(03)00029-X; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Krasnoslobodtsev AV, 2013, BIOCHEMISTRY-US, V52, P7377, DOI 10.1021/bi401037z; Krasnoslobodtsev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038099; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Li MS, 2004, POLYMER, V45, P573, DOI 10.1016/j.polymer.2003.10.066; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Thirumalai D, 2010, ANNU REV BIOPHYS, V39, P159, DOI 10.1146/annurev-biophys-051309-103835; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yu H, 2013, PRION, V7, P140, DOI 10.4161/pri.23303; Yu H, 2012, P NATL ACAD SCI USA, V109, P14452, DOI 10.1073/pnas.1206190109; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006	72	41	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86495	10.1371/journal.pone.0086495	http://dx.doi.org/10.1371/journal.pone.0086495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475132	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800050
J	Dabbs, RA; Wilson, MR				Dabbs, Rebecca A.; Wilson, Mark R.			Expression and Purification of Chaperone-Active Recombinant Clusterin	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEAT-SHOCK PROTEINS; EXTRACELLULAR CHAPERONE; IDENTIFIES VARIANTS; ALZHEIMERS-DISEASE; AMYLOID FORMATION; STRESS; RETROTRANSLOCATION; GLYCOSYLATION; COMPLEXES	Clusterin was the first described secreted mammalian chaperone and is implicated as being a key player in both intra- and extracellular proteostasis. Its unique combination of structural features and biological chaperone activity has, however, previously made it very challenging to express and purify the protein in a correctly processed and chaperone-active form. While there are multiple reports in the literature describing the use of recombinant clusterin, all of these reports suffer from one or more of the following shortcomings: details of the methods used to produce the protein are poorly described, the product is incompletely (if at all) characterised, and purity (if shown) is in many cases inadequate. The current report provides the first well validated method to economically produce pure chaperone-active recombinant clusterin. The method was developed after trialling expression in cultured bacterial, yeast, insect and mammalian cells, and involves the expression of recombinant clusterin from stably transfected HEK293 cells in protein-free medium. The product is expressed at between 7.5 and 10 mu g/ml of culture, and is readily purified by a combination of immunoaffinity, cation exchange and size exclusion chromatography. The purified product was shown to be glycosylated, correctly proteolytically cleaved into alpha- and beta-subunits, and have chaperone activity similar to that of human plasma clusterin. This new method creates the opportunity to use mutagenesis and metabolic labelling approaches in future studies to delineate functionally important sites within clusterin, and also provides a theoretically unlimited supply of recombinant clusterin which may in the future find applications in the development of therapeutics.	[Dabbs, Rebecca A.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	mrw@uow.edu.au	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Dabbs, Rebecca/0000-0001-6227-7329	ARC [DP0773555, DP0984341]	ARC(Australian Research Council)	This work was partly supported by ARC Discovery Projects DP0773555 and DP0984341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bajari TM, 2003, FASEB J, V17, P1505, DOI 10.1096/fj.02-1106fje; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHOIMIURA NH, 1992, J BIOCHEM, V112, P557, DOI 10.1093/oxfordjournals.jbchem.a123938; Guan QN, 2012, SURGERY, V151, P364, DOI 10.1016/j.surg.2011.09.032; Hakkoum D, 2008, J NEUROCHEM, V106, P1791, DOI 10.1111/j.1471-4159.2008.05519.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Heller AR, 2003, SHOCK, V20, P166, DOI 10.1097/01.shk.0000075569.93053.b3; Humphreys D, 1997, BIOCHEMISTRY-US, V36, P15233, DOI 10.1021/bi9703507; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; [马晓 Ma Xiao], 2013, [肿瘤, Tumor], V33, P597; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; Stewart EM, 2007, STRUCTURAL FUNCTIONA; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	29	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86989	10.1371/journal.pone.0086989	http://dx.doi.org/10.1371/journal.pone.0086989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466307	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000180
J	Fowler, T; Ghatak, P; Price, DH; Conaway, R; Conaway, J; Chiang, CM; Bradner, JE; Shilatifard, A; Roy, AL				Fowler, Trent; Ghatak, Payel; Price, David H.; Conaway, Ronald; Conaway, Joan; Chiang, Cheng-Ming; Bradner, James E.; Shilatifard, Ali; Roy, Ananda L.			Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; BET BROMODOMAIN INHIBITION; PRIMARY RESPONSE GENES; C-MYC; TRANSCRIPTION ELONGATION; SELECTIVE-INHIBITION; LYMPHOMAS; OVEREXPRESSION; CHROMATIN; COMPLEX	High level MYC expression is associated with almost all human cancers. JQ1, a chemical compound that inhibits MYC expression is therapeutically effective in preclinical animal models in midline carcinoma, and Burkitt's lymphoma (BL). Here we show that JQ1 does not inhibit MYC expression to a similar extent in all tumor cells. The BL cells showed a similar to 90% decrease in MYC transcription upon treatment with JQ1, however, no corresponding reduction was seen in several non-BL cells. Molecularly, these differences appear due to requirements of Brd4, the most active version of the Positive Transcription Elongation Factor B (P-TEFb) within the Super Elongation Complex (SEC), and transcription factors such as Gdown1, and MED26 and also other unknown cell specific factors. Our study demonstrates that the regulation of high levels of MYC expression in different cancer cells is driven by unique regulatory mechanisms and that such exclusive regulatory signatures in each cancer cells could be employed for targeted therapeutics.	[Fowler, Trent; Ghatak, Payel; Roy, Ananda L.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Conaway, Ronald; Conaway, Joan; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Bradner, James E.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Genet Program, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Program Immunol, Boston, MA 02111 USA	Tufts University; University of Iowa; Stowers Institute for Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University; Tufts University	Roy, AL (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	ananda.roy@tufts.edu		Conaway, Joan/0000-0002-2786-0663; Price, David/0000-0002-5597-385X	NIH [CA103867]; CPRIT [RP110471]; Welch Foundation [I-1805]; American Heart Association [12GRNT12180023]; NATIONAL CANCER INSTITUTE [R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds to C-M. C (NIH CA103867, CPRIT RP110471, and Welch Foundation I-1805), and A. L. R (American Heart Association, 12GRNT12180023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; CLEMENTS GB, 1975, INT J CANCER, V16, P125, DOI 10.1002/ijc.2910160114; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DOOLEY S, 1994, INT J ONCOL, V5, P65; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fowler T, 2013, J BIOL CHEM, V288, P14906, DOI 10.1074/jbc.M113.454355; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Kellner WA, 2013, NUCL ACIDS RES; KIM KJ, 1979, J IMMUNOL, V122, P549; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Levens David, 2010, Genes Cancer, V1, P547; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; MAGUIRE RT, 1983, P NATL ACAD SCI-BIOL, V80, P1947, DOI 10.1073/pnas.80.7.1947; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Miyoshi S, 2009, International Patent, Patent No. [PCT/JP2008/073864, 2008073864]; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; PUCK TT, 1956, J EXP MED, V104, P427, DOI 10.1084/jem.104.3.427; Pulvertaft JV, 1964, LANCET, V1, P238; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Schrader A, 2012, INT J CANCER, V131, pE348, DOI 10.1002/ijc.26423; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; SELVANAYAGAM P, 1988, BLOOD, V71, P30; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; TAKADA K, 1989, J VIROL, V63, P445, DOI 10.1128/JVI.63.1.445-449.1989; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wilda M, 2004, GENE CHROMOSOME CANC, V41, P178, DOI 10.1002/gcc.20063; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Young RM, 2008, FUTURE ONCOL, V4, P591, DOI 10.2217/14796694.4.5.591; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	53	47	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87003	10.1371/journal.pone.0087003	http://dx.doi.org/10.1371/journal.pone.0087003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466310	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000182
J	Zhang, MY; Shan, HY; Chang, P; Wang, T; Dong, WW; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Chang, Pan; Wang, Tao; Dong, Wenwen; Chen, Xiping; Tao, Luyang			Hydrogen Sulfide Offers Neuroprotection on Traumatic Brain Injury in Parallel with Reduced Apoptosis and Autophagy in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CYSTATHIONINE-BETA-SYNTHASE; CENTRAL-NERVOUS-SYSTEM; INDUCED CELL-DEATH; ALZHEIMERS-DISEASE; HEAD-INJURY; RAT MODEL; CONTRIBUTES; MECHANISMS; STRATEGIES	Hydrogen sulfide (H2S), a novel gaseous mediator, has been recognized as an important neuromodulator and neuroprotective agent in the central nervous system. The present study was undertaken to study the effects of exogenous H2S on traumatic brain injury (TBI) and the underlying mechanisms. The effects of exogenous H2S on TBI were examined by using measurement of brain edema, behavior assessment, propidium iodide (PI) staining, and Western blotting, respectively. Compared to TBI groups, H2S pretreatment had reduced brain edema, improved motor performance and ameliorated performance in Morris water maze test after TBI. Immunoblotting results showed that H2S pretreatment reversed TBI-induced cleavage of caspase-3 and decline of Bcl-2, suppressed LC3-II, Beclin-1 and Vps34 activation and maintained p62 level in injured cortex and hippocampus post TBI. The results suggest a protective effect and therapeutic potential of H2S in the treatment of brain injury and the protective effect against TBI may be associated with regulating apoptosis and autophagy.	[Zhang, Mingyang; Chang, Pan; Wang, Tao; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Coll Med, Dept Forens Sci, Suzhou, Peoples R China; [Zhang, Mingyang; Chang, Pan; Wang, Tao; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Coll Med, Lab Brain Injury, Suzhou, Peoples R China; [Zhang, Mingyang] Nantong Univ, Coll Med, Dept Forens Sci, Nantong, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Nantong University	Chen, XP (corresponding author), Soochow Univ, Coll Med, Dept Forens Sci, Suzhou, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of China [30872666, 81172911, 81301039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants 30872666, 81172911 and 81301039 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Florian B, 2008, NEUROSCI LETT, V438, P180, DOI 10.1016/j.neulet.2008.04.020; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kajta M, 2004, POL J PHARMACOL, V56, P689; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karlsson O, 2011, BEHAV BRAIN RES, V219, P310, DOI 10.1016/j.bbr.2011.01.056; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Martelli A, 2012, MED RES REV, V32, P1093, DOI 10.1002/med.20234; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P1, DOI 10.1016/j.proghi.2008.10.002; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SLIVKA A, 1987, BRAIN RES, V409, P275, DOI 10.1016/0006-8993(87)90712-8; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wong PTH, 2006, J NEUROPATH EXP NEUR, V65, P109, DOI 10.1097/01.jnen.0000199571.96472.c7; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	46	72	76	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87241	10.1371/journal.pone.0087241	http://dx.doi.org/10.1371/journal.pone.0087241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466346	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000203
J	Palomba, ML; Piersanti, K; Ziegler, CGK; Decker, H; Cotari, JW; Bantilan, K; Rijo, I; Gardner, JR; Heaney, M; Bemis, D; Balderas, R; Malek, SN; Seymour, E; Zelenetz, AD; van den Brink, MRM; Altan-Bonnet, G				Palomba, M. Lia; Piersanti, Kelly; Ziegler, Carly G. K.; Decker, Hugo; Cotari, Jesse W.; Bantilan, Kurt; Rijo, Ivelise; Gardner, Jeff R.; Heaney, Mark; Bemis, Debra; Balderas, Robert; Malek, Sami N.; Seymour, Erlene; Zelenetz, Andrew D.; van den Brink, Marcel R. M.; Altan-Bonnet, Gregoire			Multidimensional Single-Cell Analysis of BCR Signaling Reveals Proximal Activation Defect As a Hallmark of Chronic Lymphocytic Leukemia B Cells	PLOS ONE			English	Article							TYROSINE KINASE; CD38 EXPRESSION; LYMPHOMA; RECEPTOR; APOPTOSIS; SURVIVAL; SYK; TRANSDUCTION; VARIABILITY; INHIBITION	Purpose: Chronic Lymphocytic Leukemia (CLL) is defined by a perturbed B-cell receptor-mediated signaling machinery. We aimed to model differential signaling behavior between B cells from CLL and healthy individuals to pinpoint modes of dysregulation. Experimental Design: We developed an experimental methodology combining immunophenotyping, multiplexed phosphospecific flow cytometry, and multifactorial statistical modeling. Utilizing patterns of signaling network covariance, we modeled BCR signaling in 67 CLL patients using Partial Least Squares Regression (PLSR). Results from multidimensional modeling were validated using an independent test cohort of 38 patients. Results: We identified a dynamic and variable imbalance between proximal (pSYK, pBTK) and distal (pPLC gamma 2, pBLNK, ppERK) phosphoresponses. PLSR identified the relationship between upstream tyrosine kinase SYK and its target, PLC gamma 2, as maximally predictive and sufficient to distinguish CLL from healthy samples, pointing to this juncture in the signaling pathway as a hallmark of CLL B cells. Specific BCR pathway signaling signatures that correlate with the disease and its degree of aggressiveness were identified. Heterogeneity in the PLSR response variable within the B cell population is both a characteristic mark of healthy samples and predictive of disease aggressiveness. Conclusion: Single-cell multidimensional analysis of BCR signaling permitted focused analysis of the variability and heterogeneity of signaling behavior from patient-to-patient, and from cell-to-cell. Disruption of the pSYK/pPLC gamma 2 relationship is uncovered as a robust hallmark of CLL B cell signaling behavior. Together, these observations implicate novel elements of the BCR signal transduction as potential therapeutic targets.	[Palomba, M. Lia; Piersanti, Kelly; Bantilan, Kurt; Rijo, Ivelise; Gardner, Jeff R.; Heaney, Mark; Zelenetz, Andrew D.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Div Hematol, New York, NY 10021 USA; [Palomba, M. Lia; Piersanti, Kelly; Ziegler, Carly G. K.; Decker, Hugo; Cotari, Jesse W.; Bemis, Debra; Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Ctr Canc Syst Biol, New York, NY 10021 USA; [Ziegler, Carly G. K.; Decker, Hugo; Cotari, Jesse W.; Bemis, Debra; Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Program Computat Biol, New York, NY 10021 USA; [Balderas, Robert] BD Biosci, San Diego, CA USA; [Malek, Sami N.; Seymour, Erlene] Univ Michigan Hlth Syst, Div Hematol Oncol, Ann Arbor, MI USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Div Hematol, 1275 York Ave, New York, NY 10021 USA.	m-van-den-brink@ski.mskcc.org; altanbog@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022; Seymour, Erlene Kuizon/AFP-2481-2022	Altan-Bonnet, Gregoire/0000-0002-7283-3162; Cotari, Jesse/0000-0002-6026-8469; Seymour, Erlene/0000-0003-0242-4352; Ziegler, Carly/0000-0002-8279-7150	NIH [U54 CA148967, K08 CA118260, R01-HL069929, R01-CA107096, NIH R01- AI080455, AI083408]; Lymphoma Foundation; Laskin Charitable Foundation; DOD-USAMRAA award [W81XWH-09-1-0294]; RERF-NIAID; MSKCC Experimental Therapeutics Center; Alex's Lemonade Stand; MSKCC Geoffrey Beene Cancer Research Center; Peter Solomon Fund; NSF [0848030]; NATIONAL CANCER INSTITUTE [R01CA107096, U54CA148967, K08CA118260] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621, R01AI080455, R56AI083408, R01AI083408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Foundation; Laskin Charitable Foundation; DOD-USAMRAA award; RERF-NIAID; MSKCC Experimental Therapeutics Center; Alex's Lemonade Stand; MSKCC Geoffrey Beene Cancer Research Center; Peter Solomon Fund; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH U54 CA148967 (MLP, KP, CZ, DB, JWC, MvdB, GA-B) Lymphoma Foundation (MLP) NIH K08 CA118260 (MLP) The Laskin Charitable Foundation (MLP) NIH R01-HL069929 (MvdB) NIH R01-CA107096 (MvdB) NIH R01- AI080455 (MvdB) DOD-USAMRAA award W81XWH-09-1-0294 (MvdB) RERF-NIAID (MvdB) MSKCC Experimental Therapeutics Center (MvdB) Lymphoma Foundation (MvdB) Alex's Lemonade Stand (MvdB) MSKCC Geoffrey Beene Cancer Research Center (MvdB) Peter Solomon Fund (MvdB) NSF 0848030 (JWC, GA-B) NIH AI083408 (CZ, GA-B) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Agnelli L, 2012, BLOOD, V120, P1274, DOI 10.1182/blood-2012-01-405555; Amrein PC, 2011, CLIN CANCER RES, V17, P2977, DOI 10.1158/1078-0432.CCR-10-2879; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Behbehani GK, 2012, CYTOM PART A, V81A, P552, DOI 10.1002/cyto.a.22075; Blix ES, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-478; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Cotari JW, 2013, CURR OPIN BIOTECH, V24, P760, DOI 10.1016/j.copbio.2013.05.002; Cotari JW, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003240; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dighiero G, 2000, NEW ENGL J MED, V343, P1799, DOI 10.1056/NEJM200012143432410; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Grzybowska-Izydorczyk O, 2010, EUR J CANCER, V46, P800, DOI 10.1016/j.ejca.2009.11.023; Hoellenriegel J, 2011, BLOOD; Ibrahim S, 2001, BLOOD, V98, P181, DOI 10.1182/blood.V98.1.181; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; JP Sharman JI, 2007, ASCO M; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; Ralfkiaer U, 2011, BLOOD, V118, P5891, DOI 10.1182/blood-2011-06-358382; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schliep S, 2004, EXP HEMATOL, V32, P556, DOI 10.1016/j.exphem.2004.03.006; Song Z, CLIN CANC RES, V16, P587; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Zupo S, 1996, BLOOD, V88, P1365, DOI 10.1182/blood.V88.4.1365.bloodjournal8841365	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e79987	10.1371/journal.pone.0079987	http://dx.doi.org/10.1371/journal.pone.0079987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489640	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000003
J	Amorim, F; Carvalho, SB; Honrado, J; Rebelo, H				Amorim, Francisco; Carvalho, Silvia B.; Honrado, Joao; Rebelo, Hugo			Designing Optimized Multi-Species Monitoring Networks to Detect Range Shifts Driven by Climate Change: A Case Study with Bats in the North of Portugal	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; POTENTIAL IMPACTS; FORAGING HABITATS; DISTRIBUTIONS; CHIROPTERA; IDENTIFICATION; SUITABILITY; PREDICTIONS; PHENOLOGY; RESPONSES	Here we develop a framework to design multi-species monitoring networks using species distribution models and conservation planning tools to optimize the location of monitoring stations to detect potential range shifts driven by climate change. For this study, we focused on seven bat species in Northern Portugal (Western Europe). Maximum entropy modelling was used to predict the likely occurrence of those species under present and future climatic conditions. By comparing present and future predicted distributions, we identified areas where each species is likely to gain, lose or maintain suitable climatic space. We then used a decision support tool (the Marxan software) to design three optimized monitoring networks considering: a) changes in species likely occurrence, b) species conservation status, and c) level of volunteer commitment. For present climatic conditions, species distribution models revealed that areas suitable for most species occur in the north-eastern part of the region. However, areas predicted to become climatically suitable in the future shifted towards west. The three simulated monitoring networks, adaptable for an unpredictable volunteer commitment, included 28, 54 and 110 sampling locations respectively, distributed across the study area and covering the potential full range of conditions where species range shifts may occur. Our results show that our framework outperforms the traditional approach that only considers current species ranges, in allocating monitoring stations distributed across different categories of predicted shifts in species distributions. This study presents a straightforward framework to design monitoring schemes aimed specifically at testing hypotheses about where and when species ranges may shift with climatic changes, while also ensuring surveillance of general population trends.	[Amorim, Francisco; Carvalho, Silvia B.; Honrado, Joao; Rebelo, Hugo] Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO InBIO, Vairao, Portugal; [Honrado, Joao] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Rebelo, Hugo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Universidade do Porto; Universidade do Porto; University of Bristol	Amorim, F (corresponding author), Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO InBIO, Vairao, Portugal.	famorim@cibio.up.pt	Rebelo, Hugo/C-9005-2009; Carvalho, Silvia/AAE-9566-2020; Carvalho, Silvia B/J-3343-2013; Amorim, Francisco/L-7376-2013; Honrado, Joao/L-8365-2013	Rebelo, Hugo/0000-0002-7118-4068; Carvalho, Silvia/0000-0003-4368-4708; Carvalho, Silvia B/0000-0003-4368-4708; Amorim, Francisco/0000-0002-7731-9242; Honrado, Joao/0000-0001-8443-4276	Fundacao para a Ciencia e Tecnologia [PTDC/AGR-AAM/104819/2008, SFRH/BPD/65418/2009, SFRH/BPD/74423/2010]; QREN/ON2 in the context of project "SIMBioN-Biodiversity Information and Monitoring System for Northern Portugal" [ON2:3-2-14-1-1192]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); QREN/ON2 in the context of project "SIMBioN-Biodiversity Information and Monitoring System for Northern Portugal"	This research was funded by Fundacao para a Ciencia e Tecnologia through FEDER/COMPETE, under project "EcoSensing" (PTDC/AGR-AAM/104819/2008), and by QREN/ON2 in the context of project "SIMBioN-Biodiversity Information and Monitoring System for Northern Portugal" (ON2:3-2-14-1-1192). Hugo Rebelo and Silvia B. Carvalho were funded by Fundacao para a Ciencia e Tecnologia (grants SFRH/BPD/65418/2009 and SFRH/BPD/74423/2010 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; [Anonymous], 2013, 2013 18 ADV COMM M; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Atlas Equipa, 2008, ATL AV NID PORT 1999; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ball IR, 2000, MARXAN V1 8 2 MARINE, V67; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Battersby J., 2010, GUIDELINES SURVEILLA; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Braunisch V, 2008, ECOL MODEL, V214, P153, DOI 10.1016/j.ecolmodel.2008.02.001; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Conroy MJ, 2011, BIOL CONSERV, V144, P1204, DOI 10.1016/j.biocon.2010.10.019; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Franklin J., 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Franklin J, 2011, AM J BOT, V98, P559, DOI 10.3732/ajb.1000292; Game ET, 2008, MARXAN USER MANUAL M; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kunz TH, 2003, BAT ECOLOGY, P3; KUNZ TH, 1975, J MAMMAL, V56, P907, DOI 10.2307/1379662; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; Lundy M, 2010, J BIOGEOGR, V37, P2232, DOI 10.1111/j.1365-2699.2010.02384.x; Macdonald DW, 2007, KEY TOPICS CONSERVAT; Manley PN, 2004, ECOL APPL, V14, P296, DOI 10.1890/02-5249; McComb B, 2010, MONITORING ANIMAL POPULATIONS AND THEIR HABITATS: A PRACTITIONERS GUIDE, P1, DOI 10.1201/9781420070583; McDonald-Madden E, 2011, TRENDS ECOL EVOL, V26, P108, DOI 10.1016/j.tree.2010.12.005; McDonald-Madden E, 2010, TRENDS ECOL EVOL, V25, P547, DOI 10.1016/j.tree.2010.07.002; Metzger MJ, 2013, ECOL INDIC, V33, P26, DOI 10.1016/j.ecolind.2012.11.009; Mitchell-Jones T, 2007, PROTECTING MANAGING; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; O'Shea TJ, 2003, USGSBRDITR20030003; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rainho A, 2011, CHAVE IDENTIFICACAO, P16; Rainho A, 2007, ACTA CHIROPTEROL, V9, P171, DOI 10.3161/1733-5329(2007)9[171:SFHOBI]2.0.CO;2; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Roche N, 2011, ANIM CONSERV, V14, P642, DOI 10.1111/j.1469-1795.2011.00470.x; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Sachanowicz K, 2006, ACTA CHIROPTEROL, V8, P543, DOI 10.3161/1733-5329(2006)8[543:FREOPK]2.0.CO;2; Santos F. D., 2002, CLIMATE CHANGE PORTU; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suarez-Seoane S, 2008, ECOL MODEL, V219, P17, DOI 10.1016/j.ecolmodel.2008.07.035; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Verburg PH, 2008, ANN REGIONAL SCI, V42, P57, DOI 10.1007/s00168-007-0136-4; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; WALSH A., 2001, FINAL REPORT 2001 BA; Walsh AL, 1996, J APPL ECOL, V33, P519, DOI 10.2307/2404981; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walters CL, 2012, J APPL ECOL, V49, P1064, DOI 10.1111/j.1365-2664.2012.02182.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WEBB PI, 1995, J ZOOL, V235, P269; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	83	30	30	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87291	10.1371/journal.pone.0087291	http://dx.doi.org/10.1371/journal.pone.0087291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475265	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300163
J	Gao, W; Gulliford, M; Bennett, MI; Murtagh, FEM; Higginson, IJ				Gao, Wei; Gulliford, Martin; Bennett, Michael I.; Murtagh, Fliss E. M.; Higginson, Irene J.			Managing Cancer Pain at the End of Life with Multiple Strong Opioids: A Population-Based Retrospective Cohort Study in Primary Care	PLOS ONE			English	Article							LAST 3 MONTHS; ADJUVANT ANALGESICS; PREVALENCE; MANAGEMENT	Background: End-of-life cancer patients commonly receive more than one type of strong opioid. The three-step analgesic ladder framework of the World Health Organisation (WHO) provides no guidance on multiple opioid prescribing and there is little epidemiological data available to inform practice. This study aims to investigate the time trend of such cases and the associated factors. Methods: Strong opioid prescribing in the last three months of life of cancer patients were extracted from the General Practice Research Database (GPRD). The outcome variable was the number of different types of prescribed non-rescue doses of opioids (1 vs 2-4, referred to as a complex case). Associated factors were evaluated using prevalence ratios (PR) derived from multivariate log-binomial model, adjusting for clustering effects and potential confounding variables. Results: Overall, 26.4% (95% CI: 25.6-27.1%) of 13,427 cancer patients (lung 41.7%, colorectal 19.1%, breast 18.6%, prostate 15.5%, head and neck 5.0%) were complex cases. Complex cases increased steadily over the study period (1.02% annually, 95% CI: 0.42-1.61%, p = 0.048) but with a small dip (7.5% reduction, 95% CI: -0.03 to 17.8%) around the period of the Shipman case, a British primary care doctor who murdered his patients with opioids. The dip significantly affected the correlation of the complex cases with persistent increasing background opioid prescribing (weighted correlation coefficients pre-, post-Shipman periods: 0.98(95% CI: 0.67-1.00), p = 0.011; 0.14 (95% CI: -0.85 to 0.91), p = 0.85). Multivariate adjusted analysis showed that the complex cases were predominantly associated with year of death (PRs vs 2000: 1.05-1.65), not other demographic and clinical factors except colorectal cancer (PR vs lung cancer: 1.24, 95% CI: 1.12-1.37). Conclusion: These findings suggest that prescribing behaviour, rather than patient factors, plays an important role in multiple opioid prescribing at the end of life; highlighting the need for training and education that goes beyond the well-recognised WHO approach for clinical practitioners.	[Gao, Wei; Murtagh, Fliss E. M.; Higginson, Irene J.] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Gulliford, Martin] Kings Coll London, Sch Med, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Bennett, Michael I.] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Palliat Care, Leeds, W Yorkshire, England	University of London; King's College London; University of London; King's College London; University of Leeds	Gao, W (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	wei.gao@kcl.ac.uk	Bennett, Michael I/A-1620-2009; Gulliford, Martin C/I-8606-2018; Gao, Wei/G-8653-2011; Murtagh, Fliss E M/C-3216-2009; Higginson, Irene Julie/C-7309-2012	Bennett, Michael I/0000-0002-8369-8349; Gulliford, Martin C/0000-0003-1898-9075; Gao, Wei/0000-0001-8298-3415; Murtagh, Fliss E M/0000-0003-1289-3726; Higginson, Irene Julie/0000-0002-3687-1313	NCRI-NIHR COMPASS Collaborative (the UK National Cancer Research Institute Supportive and Palliative Care Research Collaborative); National Institute for Health Research [NF-SI-0611-10209] Funding Source: researchfish	NCRI-NIHR COMPASS Collaborative (the UK National Cancer Research Institute Supportive and Palliative Care Research Collaborative); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is supported by the NCRI-NIHR COMPASS Collaborative (the UK National Cancer Research Institute Supportive and Palliative Care Research Collaborative). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MI, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2806; Bennett Michael I, 2011, Curr Opin Support Palliat Care, V5, P20, DOI 10.1097/SPC.0b013e328342c607; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Claseem A, 2008, ANN INTERN MED, V148, P141, DOI 10.7326/0003-4819-148-2-200801150-00009; Costantini M, 2009, ANN ONCOL, V20, P729, DOI 10.1093/annonc/mdn700; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Droney J, 2012, CURR OPIN SUPPORT PA, V6, P10, DOI 10.1097/SPC.0b013e32834f6a07; Finch R, 2004, SHIPMAN HAS MADE GPS; Gao W, 2011, BRIT J CANCER, V104, P1704, DOI 10.1038/bjc.2011.150; Gardiner C, 2012, J PAIN SYMPTOM MANAG; Higginson IJ, 2012, J CLIN ONCOL; Jacobsen Ramune, 2007, J Opioid Manag, V3, P207; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lussier D, 2004, ONCOLOGIST, V9, P571, DOI 10.1634/theoncologist.9-5-571; Mercadante S, 2012, J PAIN SYMPTOM MANAG; Mercadante S, 2006, J PAIN SYMPTOM MANAG, V32, P413, DOI 10.1016/j.jpainsymman.2006.05.015; Mercadante S, 2012, J PALLIAT MED, V15, P347, DOI 10.1089/jpm.2011.0198; Mercadante S, 2011, PALLIATIVE MED, V25, P504, DOI 10.1177/0269216311406577; Mitra R, 2012, AM J HOSP PALLIAT ME, V29, P70, DOI 10.1177/1049909111413256; Moksnes K, 2012, EUR J CLIN PHARMACOL, V68, P1147, DOI 10.1007/s00228-012-1228-3; NICE, 2011, OP PALL CAR SAF EFF; Oldenmenger WH, 2009, EUR J CANCER, V45, P1370, DOI 10.1016/j.ejca.2009.01.007; Portenoy RK, 2011, LANCET, V377, P2236, DOI 10.1016/S0140-6736(11)60236-5; Potter VT, 2003, PSYCHO-ONCOLOGY, V12, P153, DOI 10.1002/pon.627; Raijmakers NJ, 2012, SUPPORT CARE CANC; Rurup Mette L, 2010, BMC Palliat Care, V9, P23, DOI 10.1186/1472-684X-9-23; Skollerud LM, 2012, SUPPORT CARE CANC; Smith D J, 2004, REGULATION CONTROLLE; The Information Centre NHS, 2006, HOSP PRESCR 2005 ENG; Zeppetela G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004311.pub2	31	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e79266	10.1371/journal.pone.0079266	http://dx.doi.org/10.1371/journal.pone.0079266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475016	gold, Green Published			2022-12-27	WOS:000330507300003
J	Grassi-Oliveira, R; Cogo-Moreira, H; Salum, GA; Brietzke, E; Viola, TW; Manfro, GG; Kristensen, CH; Arteche, AX				Grassi-Oliveira, Rodrigo; Cogo-Moreira, Hugo; Salum, Giovanni Abrahao; Brietzke, Elisa; Viola, Thiago Wendt; Manfro, Gisele Gus; Kristensen, Christian Haag; Arteche, Adriane Xavier			Childhood Trauma Questionnaire (CTQ) in Brazilian Samples of Different Age Groups: Findings from Confirmatory Factor Analysis	PLOS ONE			English	Article							SHORT-FORM; PSYCHOMETRIC PROPERTIES; MEASUREMENT EQUIVALENCE; RELIABILITY; VALIDITY; VERSION; VALIDATION; ABUSE; TRANSLATION; NEGLECT	The Childhood Trauma Questionnaire (CTQ) is internationally accepted as a key tool for the assessment of childhood abuse and neglect experiences. However, there are relative few psychometric studies available and some authors have proposed two different factor solutions. We examined the dimensional structure and internal consistency of the Brazilian version of the CTQ. A total of 1,925 participants from eight different clinical and non-clinical samples including adolescents, adults and elders were considered in this study. First, we performed Confirmatory Factor Analysis to investigate the goodness of fit of the two proposed competitive factor structure models for the CTQ. We also investigated the internal consistency of all factors. Second, multi-group analyses were used to investigate measurement invariance and population heterogeneity across age groups and sex. Our findings revealed that the alternative factor structure as opposed to the original factor structure was the most appropriate model within adolescents and adults Brazilian samples. We provide further evidence for the validity and reliability of the CTQ within the Brazilian samples and report that the alternative model showed an improvement in fit indexes and may be a better alternative over the original model.	[Grassi-Oliveira, Rodrigo; Kristensen, Christian Haag; Arteche, Adriane Xavier] Pontifical Catholic Univ Rio Grande Sul PUCRS, Postgrad Program Psychol, Ctr Studies & Res Traumat Stress, Porto Alegre, RS, Brazil; [Cogo-Moreira, Hugo] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Salum, Giovanni Abrahao; Brietzke, Elisa; Manfro, Gisele Gus] Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil; [Viola, Thiago Wendt] Pontificia Univ Catolica Rio Grande do Sul, Ctr Studies & Res Traumat Stress, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Grassi-Oliveira, R (corresponding author), Pontifical Catholic Univ Rio Grande Sul PUCRS, Postgrad Program Psychol, Ctr Studies & Res Traumat Stress, Porto Alegre, RS, Brazil.	rodrigo.grassi@pucrs.br	Cogo-Moreira, Hugo/U-6442-2019; Viola, Thiago W/N-2294-2014; Kristensen, Christian H/F-1538-2015; Manfro, Gisele/V-1167-2019; Manfro, Gisele G/B-7020-2009; Cogo-Moreira, Hugo/GSD-6132-2022; Brietzke, Elisa/G-9559-2012; Cogo-Moreira, Hugo/E-4602-2011; Salum, Giovanni Abrahao/A-7849-2010; Grassi-Oliveira, R/G-2623-2012	Cogo-Moreira, Hugo/0000-0001-9411-9237; Kristensen, Christian H/0000-0002-8273-2146; Manfro, Gisele/0000-0002-0109-7591; Manfro, Gisele G/0000-0002-0109-7591; Cogo-Moreira, Hugo/0000-0001-9411-9237; Brietzke, Elisa/0000-0003-2697-1342; Cogo-Moreira, Hugo/0000-0001-9411-9237; Salum, Giovanni Abrahao/0000-0002-7537-7289; Grassi-Oliveira, R/0000-0001-9911-5921; Viola, Thiago/0000-0001-5446-1695; Arteche, Adriane/0000-0002-2586-4900	CAPES Foundation	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by CAPES Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bollen Kenneth A., 1989, STRUCTURAL EQUATIONS; Daalder AL, 2011, PSYCHOL REP, V108, P856, DOI 10.2466/02.10.13.16.PR0.108.3.856-860; DAVISSHARTS J, 1986, ADV NURS SCI, V9, P58, DOI 10.1097/00012272-198610000-00008; DRASGOW F, 1984, PSYCHOL BULL, V95, P134, DOI 10.1037/0033-2909.95.1.134; English DJ, 2005, CHILD MALTREATMENT, V10, P190, DOI 10.1177/1077559505275178; FINKELHOR D, 1988, CHILD ABUSE NEGLECT, V12, P3, DOI 10.1016/0145-2134(88)90003-8; Garrusi B, 2009, PSYCHOL REP, V104, P509, DOI 10.2466/PR0.104.2.509-516; Gerdner A, 2009, NORD J PSYCHIAT, V63, P160, DOI 10.1080/08039480802514366; Grassi-Oliveira R, 2006, REV SAUDE PUBL, V40, P249, DOI 10.1590/S0034-89102006000200010; Hernandez A, 2013, J INTERPERS VIOLENCE, V28, P1498, DOI 10.1177/0886260512468240; Hoyle R.H., 2012, HDB STRUCTURAL EQUAT; JORESKOG KG, 1971, PSYCHOMETRIKA, V36, P109, DOI 10.1007/bf02291393; Kim D, 2013, SCHIZOPHR RES, V144, P93, DOI 10.1016/j.schres.2012.12.020; Kim D, 2011, PSYCHIAT INVEST, V8, P305, DOI 10.4306/pi.2011.8.4.305; KORBIN JE, 1991, CHILD ABUSE NEGLECT, V15, P67, DOI 10.1016/0145-2134(91)90010-B; Krugman RD, 2012, CH KEMPE 50 YEAR LEG; Loehlin JC, 2004, LATENT VARIABLE MODE; Muthen B., 2010, MPLUS USERS GUIDE; Paquette Daniel, 2004, Sante Ment Que, V29, P201; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Raykov T, 2012, STRUCT EQU MODELING, V19, P495, DOI 10.1080/10705511.2012.687675; Rencher A. C., 2003, METHODS MULTIVARIATE; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Thombs BD, 2007, J PSYCHOSOM RES, V63, P391, DOI 10.1016/j.jpsychores.2007.04.010; Thombs BD, 2009, CHILD ABUSE NEGLECT, V33, P518, DOI 10.1016/j.chiabu.2009.03.001; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Villano Cherie L, 2004, J Trauma Dissociation, V5, P33; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Wingenfeld K., 2010, PSYCHOTHER PSYCHOSOM, V60, pe13, DOI [DOI 10.1055/S-0030-1253494, 10.1055/s-0030-1253494]; Wright KD, 2001, DEPRESS ANXIETY, V13, P179, DOI 10.1002/da.1034	36	87	88	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87118	10.1371/journal.pone.0087118	http://dx.doi.org/10.1371/journal.pone.0087118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475237	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300144
J	Kruta, I; Landman, NH; Cochran, JK				Kruta, Isabelle; Landman, Neil H.; Cochran, J. Kirk			A New Approach for the Determination of Ammonite and Nautilid Habitats	PLOS ONE			English	Article							WESTERN INTERIOR SEAWAY; NORTH-AMERICA; ISOTOPE FRACTIONATION; STABLE-ISOTOPES; NEW-CALEDONIA; OXYGEN; CARBON; DELTA-C-13; PALEOTEMPERATURES; RECONSTRUCTION	Externally shelled cephalopods were important elements in open marine habitats throughout Earth history. Paleotemperatures calculated on the basis of the oxygen isotope composition of their shells can provide insights into ancient marine systems as well as the ecology of this important group of organisms. In some sedimentary deposits, however, the aragonitic shell of the ammonite or nautilid is poorly or not preserved at all, while the calcitic structures belonging to the jaws are present. This study tests for the first time if the calcitic jaw structures in fossil cephalopods can be used as a proxy for paleotemperature. We first analyzed the calcitic structures on the jaws of Recent Nautilus and compared the calculated temperatures of precipitation with those from the aragonitic shell in the same individuals. Our results indicate that the jaws of Recent Nautilus are secreted in isotopic equilibrium, and the calculated temperatures approximately match those of the shell. We then extended our study to ammonites from the Upper Cretaceous (Campanian) Pierre Shale of the U. S. Western Interior and the age-equivalent Mooreville Chalk of the Gulf Coastal Plain. In the Pierre Shale, jaws occur in situ inside the body chambers of well-preserved Baculites while in the Mooreville Chalk, the jaw elements appear as isolated occurrences in the sediment and the aragonitic shell material is not preserved. For the Pierre Shale specimens, the calculated temperatures of well-preserved jaw material match those of well-preserved shell material in the same individual. Analyses of the jaw elements in the Mooreville Chalk permit a comparison of the paleotemperatures between the two sites, and show that the Western Interior is warmer than the Gulf Coast at that time. In summary, our data indicate that the calcitic jaw elements of cephalopods can provide a reliable geochemical archive of the habitat of fossil forms.	[Kruta, Isabelle; Landman, Neil H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Kruta, Isabelle] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Cochran, J. Kirk] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	American Museum of Natural History (AMNH); Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kruta, I (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	ikruta@amnh.org			AMNH Lerner Gray Postgraduate doctoral fellowship; N.D. Newell Fund (AMNH)	AMNH Lerner Gray Postgraduate doctoral fellowship; N.D. Newell Fund (AMNH)	IK was funded by AMNH Lerner Gray Postgraduate doctoral fellowship. Funding for isotopic analyses was provided by the N.D. Newell Fund (AMNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMON WD, 1992, VELIGER, V35, P52; Auclair AC, 2004, CHEM GEOL, V207, P91, DOI 10.1016/j.chemgeo.2004.02.006; BOWEN R, 1963, EXPERIENTIA, V19, P268, DOI 10.1007/BF02151377; Cochran JK, 2010, AM J SCI, V310, P69, DOI 10.2475/02.2010.01; Cochran JK, 2003, PALAEOGEOGR PALAEOCL, V191, P45, DOI 10.1016/S0031-0182(02)00642-9; COCHRAN JK, 1981, PALEOBIOLOGY, V7, P469, DOI 10.1017/S0094837300025525; CROCKER KC, 1985, GEOCHIM COSMOCHIM AC, V49, P2527, DOI 10.1016/0016-7037(85)90120-6; Dennis KJ, 2013, EARTH PLANET SC LETT, V362, P51, DOI 10.1016/j.epsl.2012.11.036; Dunstan AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016312; Fatherree JW, 1998, PALAIOS, V13, P376, DOI 10.2307/3515325; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; He S, 2005, PALAEOGEOGR PALAEOCL, V217, P67, DOI 10.1016/j.palaeo.2004.11.016; HOUSE MR, 1993, AMMONOIDEA ENV ECOLO, V47, P13; Kruta I, 2009, LETHAIA, V42, P312, DOI 10.1111/j.1502-3931.2009.00154.x; Landman NH, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P257, DOI 10.1007/978-1-4020-6806-5_13; Landman NH, 2012, GEOLOGY, V40, P507, DOI 10.1130/G32782.1; LANDMAN NH, 1983, PALEOBIOLOGY, V9, P269, DOI 10.1017/S0094837300007685; LANDMAN NH, 1994, PALEOBIOLOGY, V20, P40, DOI 10.1017/S009483730001112X; Lecuyer C., 2006, eEarth, V1, P1; LOWENSTAM HA, 1984, PALEOBIOLOGY, V10, P268, DOI 10.1017/S0094837300008198; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; Moriya K, 2003, GEOLOGY, V31, P167, DOI 10.1130/0091-7613(2003)031<0167:DHOLCA>2.0.CO;2; ONEIL JR, 1969, J CHEM PHYS, V51, P5547, DOI 10.1063/1.1671982; Price GD, 1997, PALAEOGEOGR PALAEOCL, V129, P315, DOI 10.1016/S0031-0182(96)00058-2; Schlogl J, 2011, PALAEOGEOGR PALAEOCL, V308, P330, DOI 10.1016/j.palaeo.2011.05.037; Seuss B, 2012, PALAEOGEOGR PALAEOCL, V319, P1, DOI 10.1016/j.palaeo.2011.12.008; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; TAYLOR BE, 1983, PALAEOGEOGR PALAEOCL, V41, P1, DOI 10.1016/0031-0182(83)90072-X; TOURTELOT HA, 1969, GEOL SOC AM BULL, V80, P1903, DOI 10.1130/0016-7606(1969)80[1903:DOOACI]2.0.CO;2; Wierzbowski H, 2007, PALAEOGEOGR PALAEOCL, V254, P523, DOI 10.1016/j.palaeo.2007.07.010; Wierzbowski H, 2011, PALAEOGEOGR PALAEOCL, V299, P250, DOI 10.1016/j.palaeo.2010.11.006; Zakharov YD, 2006, GEOSCI J, V10, P331, DOI 10.1007/BF02910374; [No title captured]	34	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87479	10.1371/journal.pone.0087479	http://dx.doi.org/10.1371/journal.pone.0087479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475295	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300190
J	Kwasniewska, J; Mikolajczyk, A				Kwasniewska, Jolanta; Mikolajczyk, Agnieszka			Influence of the Presence of B Chromosomes on DNA Damage in Crepis capillaris	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; ETHYL METHANESULFONATE; A-CHROMOSOME; COMET ASSAY; MUTATION; PLANT; METHYLATION; BREAKAGE; MUTAGENS; DEPENDS	The sensitivity of different plant species to mutagenic agents is related to the DNA content and organization of the chromatin, which have been described in ABCW and bodyguard hypotheses, respectively. Plant species that have B chromosomes are good models for the study of these hypotheses. This study presents an analysis of the correlation between the occurrence of B chromosomes and the DNA damage that is induced by the chemical mutagen, maleic hydrazide (MH), in Crepis capillaris plants using comet assay. The presence of B chromosomes has a detectable impact on the level of DNA damage. The level of DNA damage after MH treatment was correlated with the number of B chromosomes and it was observed that it increased significantly in plants with 3B chromosomes. We did not find evidence of the protective role from chemical mutagens of the constitutive heterochromatin for euchromatin in relation to DNA damage. The DNA damage involving the 25S rDNA sequences was analyzed using the comet-FISH technique. Fragmentation within or near the 25S rDNA involved the loci on the A and B chromosomes. The presence of B chromosomes in C. capillaris cells had an influence on the level of DNA damage that involves the 25S rDNA region.	[Kwasniewska, Jolanta; Mikolajczyk, Agnieszka] Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Kwasniewska, J (corresponding author), Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland.	jolanta.kwasniewska@us.edu.pl	Mikolajczyk, Agnieszka/I-4854-2014; Kwasniewska, Jolanta/ABF-1547-2020	Kwasniewska, Jolanta/0000-0002-8965-8727	National Science Centre, Poland [3178/B/P01/2011/40]	National Science Centre, Poland(National Science Centre, Poland)	National Science Centre, Poland an agreement 3178/B/P01/2011/40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON S, 1973, NATURE, V245, P460, DOI 10.1038/245460a0; Banaei-Moghaddam AM, 2013, PLANT CELL, V25, P2536, DOI 10.1105/tpc.113.111856; Bandyopadhyay A, 2011, ECOTOX ENVIRON SAFE, V74, P860, DOI 10.1016/j.ecoenv.2010.12.002; Camacho JPM, 2004, CYTOGENET GENOME RES, V106, P147, DOI 10.1159/000080118; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; DELGADO M, 1995, CHROMOSOME RES, V3, P487, DOI 10.1007/BF00713963; Delgado M, 2004, CYTOGENET GENOME RES, V106, P320, DOI 10.1159/000079306; Evans G.M., 1972, CHROMOSOMES TODAY, V3, P24; Gichner T, 2003, MUTAT RES-GEN TOX EN, V535, P187, DOI 10.1016/S1383-5718(02)00320-0; Gichner T, 1998, MUTAT RES-FUND MOL M, V401, P143, DOI 10.1016/S0027-5107(98)00003-7; Gichner T, 2008, ENVIRON EXP BOT, V62, P113, DOI 10.1016/j.envexpbot.2007.07.013; Goklap FD, 2002, B SERISI, V3, P141; Grant WF, 1998, MUTAT RES-REV MUTAT, V410, P291, DOI 10.1016/S1383-5742(98)00004-0; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Houben A, 2013, PLANT GENOME DIVERSI, V2, P149, DOI DOI 10.1007/978-3-7091-1160-4_10; HSU TC, 1975, GENETICS, V79, P137; Jones RN, 2008, ANN BOT-LONDON, V101, P767, DOI 10.1093/aob/mcm167; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Juchimiuk J, 2006, FOLIA HISTOCHEM CYTO, V44, P127; Kasamatsu T, 1996, MUTAT RES-GENET TOX, V369, P1, DOI 10.1016/S0165-1218(96)90041-5; Kwasniewska J, 2012, ENVIRON MOL MUTAGEN, V53, P369, DOI 10.1002/em.21699; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; Luchniak P, 2002, FOLIA HISTOCHEM CYTO, V40, P325; MALUSZYNSKA J, 1989, HEREDITY, V62, P59, DOI 10.1038/hdy.1989.8; Maluszynska J, 2003, FOLIA HISTOCHEM CYTO, V41, P101; Maluszynska J., 1990, B CHROMOSOMES CREPIS; Minkevich I G, 2007, Bioorg Khim, V33, P474; Plewa MJ, 1983, MAIZE GEN COOP NEWSL, V57, P147; Rapp A, 2000, J PHOTOCH PHOTOBIO B, V56, P109, DOI 10.1016/S1011-1344(00)00052-X; SCHALET AP, 1978, MUTAT RES, V49, P313, DOI 10.1016/0027-5107(78)90104-5; Shaposhnikov S, 2009, MUTAGENESIS, V24, P383, DOI 10.1093/mutage/gep021; Shu Q.Y., 2009, INDUCED MUTATIONS GE; UNDERBRI.AG, 1968, RADIAT BOT, V8, P205, DOI 10.1016/S0033-7560(68)80019-5; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Vosa C.G., 1973, NOBEL S CHROMOSOME I, P156; Weber DF, 2007, MAYDICA, V52, P109	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87337	10.1371/journal.pone.0087337	http://dx.doi.org/10.1371/journal.pone.0087337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475276	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300171
J	Brunet, C; Chandrasekaran, R; Barra, L; Giovagnetti, V; Corato, F; Ruban, AV				Brunet, Christophe; Chandrasekaran, Raghu; Barra, Lucia; Giovagnetti, Vasco; Corato, Federico; Ruban, Alexander V.			Spectral Radiation Dependent Photoprotective Mechanism in the Diatom Pseudo-nitzschia multistriata	PLOS ONE			English	Article							PHAEODACTYLUM-TRICORNUTUM; FLUCTUATING LIGHT; XANTHOPHYLL CYCLE; MARINE DIATOMS; PHYTOPLANKTON; ENERGY; BACILLARIOPHYCEAE; RESPONSES; ACCLIMATION; VARIABILITY	Phytoplankton, such as diatoms, experience great variations of photon flux density (PFD) and light spectrum along the marine water column. Diatoms have developed some rapidly-regulated photoprotective mechanisms, such as the xanthophyll cycle activation (XC) and the non-photochemical chlorophyll fluorescence quenching (NPQ), to protect themselves from photooxidative damages caused by excess PFD. In this study, we investigate the role of blue fluence rate in combination with red radiation in shaping photoacclimative and protective responses in the coastal diatom Pseudo-nitzschia multistriata. This diatom was acclimated to four spectral light conditions (blue, red, blue-red, blue-red-green), each of them provided with low and high PFD. Our results reveal that the increase in the XC pool size and the amplitude of NPQ is determined by the blue fluence rate experienced by cells, while cells require sensing red radiation to allow the development of these processes. Variations in the light spectrum and in the blue versus red radiation modulate either the photoprotective capacity, such as the activation of the diadinoxanthin-diatoxanthin xanthophyll cycle, the diadinoxanthin de-epoxidation rate and the capacity of non-photochemical quenching, or the pigment composition of this diatom. We propose that spectral composition of light has a key role on the ability of diatoms to finely balance light harvesting and photoprotective capacity.	[Brunet, Christophe; Chandrasekaran, Raghu; Barra, Lucia; Giovagnetti, Vasco; Corato, Federico] Stn Zool Anton Dohrn, Lab Ecol & Evolut Plankton, Naples, Italy; [Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Stazione Zoologica Anton Dohrn di Napoli; University of London; Queen Mary University London	Brunet, C (corresponding author), Stn Zool Anton Dohrn, Lab Ecol & Evolut Plankton, Naples, Italy.	christophe.brunet@szn.it	brunet, christophe/AAD-7817-2021; barra, lucia/AGG-7397-2022	Giovagnetti, Vasco/0000-0002-3298-4310; Chandrasekaran, Raghu/0000-0002-7329-0323	Stazione Zoologica Anton Dohrn; BBSRC [BB/L019027/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L019027/1] Funding Source: researchfish	Stazione Zoologica Anton Dohrn; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Stazione Zoologica Anton Dohrn. R.C.'s PhD is funded by Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet C., 2011, PHYTOPLANKTON PIGMEN, P445, DOI [10.1017/CBO9780511732263.017, DOI 10.1017/CBO9780511732263.017]; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Cao S, 2013, J BASIC MICROB, DOI [10.1002/jobm.201200315, DOI 10.1002/J0BM.201200315]; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; D'Alelio D, 2010, LIMNOL OCEANOGR, V55, P106, DOI 10.4319/lo.2010.55.1.0106; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; DRING MJ, 1988, ANNU REV PLANT PHYS, V39, P157, DOI 10.1146/annurev.pp.39.060188.001105; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski GP, 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; FALKOWSKI PG, 1984, J PLANKTON RES, V6, P295, DOI 10.1093/plankt/6.2.295; Fisher AE, 1996, J PHYCOL, V32, P353, DOI 10.1111/j.0022-3646.1996.00353.x; Fujiki T, 2002, J PLANKTON RES, V24, P859, DOI 10.1093/plankt/24.9.859; Gildenhoff N, 2010, BBA-BIOENERGETICS, V1797, P543, DOI 10.1016/j.bbabio.2010.01.024; Giovagnetti V, 2012, EUR J PHYCOL, V47, P408, DOI 10.1080/09670262.2012.733030; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Gundermann K, 2013, BBA-BIOENERGETICS, V1827, P303, DOI 10.1016/j.bbabio.2012.10.017; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; LOPEZFIGUEROA F, 1992, MAR ECOL-P S Z N I, V13, P285, DOI 10.1111/j.1439-0485.1992.tb00356.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; McLachlan DH, 2009, J PHYCOL, V45, P592, DOI 10.1111/j.1529-8817.2009.00681.x; MOREL A, 1987, LIMNOL OCEANOGR, V32, P1066, DOI 10.4319/lo.1987.32.5.1066; Mouget JL, 2004, J PHOTOCH PHOTOBIO B, V75, P1, DOI 10.1016/j.jphotobiol.2004.04.002; Nagao R, 2013, J PHYS CHEM B, V117, P6888, DOI 10.1021/jp403923q; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; ROENNEBERG T, 1988, NATURE, V334, P432, DOI 10.1038/334432a0; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; Shiihira-Ishikawa I, 2007, PHOTOCHEM PHOTOBIOL, V83, P1101, DOI 10.1111/j.1751-1097.2007.00167.x; Six C, 2008, LIMNOL OCEANOGR, V53, P255, DOI 10.4319/lo.2008.53.1.0255; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Zapata M, 2004, MAR ECOL PROG SER, V270, P83, DOI 10.3354/meps270083; Zapata M, 2011, J PHYCOL, V47, P1274, DOI 10.1111/j.1529-8817.2011.01055.x	51	44	45	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87015	10.1371/journal.pone.0087015	http://dx.doi.org/10.1371/journal.pone.0087015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475212	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800077
J	Franze, G; Lavrentyev, PJ				Franze, Gayantonia; Lavrentyev, Peter J.			Microzooplankton Growth Rates Examined across a Temperature Gradient in the Barents Sea	PLOS ONE			English	Article							CILIATE MESODINIUM-RUBRUM; DINOFLAGELLATE DINOPHYSIS-ACUMINATA; COMMUNITY STRUCTURE; MYRIONECTA-RUBRA; GRAZING IMPACT; ARCTIC-OCEAN; VERTICAL-DISTRIBUTION; PHYTOPLANKTON GROWTH; MARINE-PHYTOPLANKTON; WEST GREENLAND	Growth rates (mu) of abundant microzooplankton species were examined in field experiments conducted at ambient sea temperatures (-1.8-9.0 degrees C) in the Barents Sea and adjacent waters (70-78.5 degrees N). The maximum species-specific mu of ciliates and athecate dinoflagellates (0.33-1.67 d(-1) and 0.52-1.14 d(-1), respectively) occurred at temperatures below 5 degrees C and exceeded the mu(max) predicted by previously published, laboratory culture-derived equations. The opposite trend was found for thecate dinoflagellates, which grew faster in the warmer Atlantic Ocean water. Mixotrophic ciliates and dinoflagellates grew faster than their heterotrophic counterparts. At sub-zero temperatures, microzooplankton mu(max) matched those predicted for phytoplankton by temperature-dependent growth equations. These results indicate that microzooplankton protists may be as adapted to extreme Arctic conditions as their algal prey.	[Franze, Gayantonia; Lavrentyev, Peter J.] Univ Akron, Dept Biol, Akron, OH 44325 USA	University System of Ohio; University of Akron	Lavrentyev, PJ (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	peter3@uakron.edu	Franze, Gayantonia/AAI-7305-2020; Franzé, Gayantonia/H-8378-2019; Lavrentyev, Peter/Q-7449-2017	Franze, Gayantonia/0000-0003-0028-4739; Lavrentyev, Peter/0000-0001-5635-7920	National Science Foundation [ARC-0909372]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation (Award ARC-0909372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANSE K, 1982, LIMNOL OCEANOGR, V27, P1059, DOI 10.4319/lo.1982.27.6.1059; Berard-Therriault L, 1999, PUBLICATION SPECIAL; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; BOOTH BC, 1993, PROG OCEANOGR, V32, P57, DOI 10.1016/0079-6611(93)90009-3; Brush MJ, 2002, MAR ECOL PROG SER, V238, P31, DOI 10.3354/meps238031; Bundy MH, 2005, CAN J FISH AQUAT SCI, V62, P2371, DOI 10.1139/F05-111; Calbet A, 2011, J PLANKTON RES, V33, P687, DOI 10.1093/plankt/fbq142; Campbell RG, 2009, DEEP-SEA RES PT II, V56, P1274, DOI 10.1016/j.dsr2.2008.10.027; Caron DA, 2008, LIMNOL OCEANOGR, V53, P2048; Carvalho WF, 2008, HARMFUL ALGAE, V7, P174, DOI 10.1016/j.hal.2007.07.002; Chen BZ, 2012, LIMNOL OCEANOGR, V57, P519, DOI 10.4319/lo.2012.57.2.0519; Crawford DW, 1997, AQUAT MICROB ECOL, V13, P267, DOI 10.3354/ame013267; Dolan JR, 2000, FRESHWATER BIOL, V45, P227, DOI 10.1046/j.1365-2427.2000.00659.x; Duarte CM, 2012, NAT CLIM CHANGE, V2, P60, DOI 10.1038/nclimate1386; Eddie B, 2008, MAR ECOL PROG SER, V354, P107, DOI 10.3354/meps07243; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; First MR, 2009, AQUAT MICROB ECOL, V54, P255, DOI 10.3354/ame01271; Franze G, 2013, MAR BIOL, V160, P3103, DOI 10.1007/s00227-013-2298-1; GARRISON DL, 1986, POLAR BIOL, V6, P237, DOI 10.1007/BF00443401; GILSTAD M, 1990, MAR ECOL PROG SER, V64, P169, DOI 10.3354/meps064169; Hansen BW, 2000, J MAR BIOL ASSOC UK, V80, P37; HANSEN PJ, 1991, MAR ECOL PROG SER, V69, P201, DOI 10.3354/meps069201; HANSEN PJ, 1992, MAR BIOL, V114, P327, DOI 10.1007/BF00349535; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Herfort L, 2011, ESTUAR COAST SHELF S, V95, P440, DOI 10.1016/j.ecss.2011.10.015; Holding JM, 2013, BIOGEOSCIENCES, V10, P357, DOI 10.5194/bg-10-357-2013; Ikavalko J, 1997, POLAR BIOL, V17, P473, DOI 10.1007/s003000050145; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Ji RB, 2007, MAR ECOL PROG SER, V344, P49, DOI 10.3354/meps06952; Kim S, 2008, AQUAT MICROB ECOL, V51, P301, DOI 10.3354/ame01203; Kjaeret AH, 2000, SARSIA, V85, P453, DOI 10.1080/00364827.2000.10414594; Kofoid C. A., 1921, MEMOIRS U CALIFORNIA, DOI [10.5962/bhl.title.24995, DOI 10.5962/BHL.TITLE.24995]; KOFOID CHARLES A., 1929, UNIV CALIF PUBL ZOOL, V34, P1; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Landry MR, 2004, ICES J MAR SCI, V61, P501, DOI 10.1016/j.icesjms.2004.03.011; Levinsen H, 2000, MAR ECOL PROG SER, V204, P65, DOI 10.3354/meps204065; Levinsen H, 1999, AQUAT MICROB ECOL, V16, P217, DOI 10.3354/ame016217; Levinsen H, 2002, LIMNOL OCEANOGR, V47, P427, DOI 10.4319/lo.2002.47.2.0427; Levinsen H, 2000, MAR ECOL PROG SER, V206, P119, DOI 10.3354/meps206119; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; Lombard F, 2010, LIMNOL OCEANOGR, V55, P77, DOI 10.4319/lo.2010.55.1.0077; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Matishov GG, 2000, NOAA INT OCEAN ATLAS, V2; McManus GB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00321; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Menden-Deuer S, 2010, MAR ECOL PROG SER, V420, P57, DOI 10.3354/meps08855; Modigh M, 2009, J PLANKTON RES, V31, P853, DOI 10.1093/plankt/fbp035; Moeller HV, 2011, J PHYCOL, V47, P324, DOI 10.1111/j.1529-8817.2010.00954.x; Moller EF, 2006, DEEP-SEA RES PT I, V53, P76, DOI 10.1016/j.dsr.2005.09.007; Montagnes DJS, 2003, AQUAT MICROB ECOL, V32, P307, DOI 10.3354/ame032307; MONTAGNES DJS, 1988, MAR BIOL, V99, P21, DOI 10.1007/BF00644973; MULLER H, 1993, ARCH HYDROBIOL, V126, P315; Myung G, 2006, AQUAT MICROB ECOL, V44, P175, DOI 10.3354/ame044175; NIELSEN TG, 1994, LIMNOL OCEANOGR, V39, P508, DOI 10.4319/lo.1994.39.3.0508; NIELSON TG, 1994, LIMNOL OCEANOGR, V39, P1423; Nikiforov EG, 1980, PATTERNS LARGE SCALE; Olson MB, 2002, DEEP-SEA RES PT II, V49, P5969, DOI 10.1016/S0967-0645(02)00329-6; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Paffenhofer GA, 2007, MAR ECOL-EVOL PERSP, V28, P243, DOI 10.1111/j.1439-0485.2007.00162.x; Perez MT, 1997, MAR ECOL PROG SER, V155, P89, DOI 10.3354/meps155089; PUTT M, 1990, DEEP-SEA RES, V37, P1713, DOI 10.1016/0198-0149(90)90073-5; Rat'kova TN, 2002, J MARINE SYST, V38, P47, DOI 10.1016/S0924-7963(02)00169-0; Riisgaard K, 2009, MAR ECOL PROG SER, V381, P51, DOI 10.3354/meps07953; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Rose JM, 2013, POLAR BIOL, V36, P645, DOI 10.1007/s00300-013-1291-y; Sakshaug E., 2009, ECOSYSTEM BARENTS SE; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Scott F.J., 2005, ANTARCTIC MARINE PRO; Seuthe L, 2011, AQUAT MICROB ECOL, V64, P253, DOI 10.3354/ame01525; Seuthe L, 2011, POLAR BIOL, V34, P751, DOI 10.1007/s00300-010-0930-9; Sherr EB, 2013, DEEP SEA RES 2; SimeNgando T, 1997, J MARINE SYST, V11, P163, DOI 10.1016/S0924-7963(96)00036-X; Sjoqvist CO, 2011, J EUKARYOT MICROBIOL, V58, P365, DOI 10.1111/j.1550-7408.2011.00559.x; Smalley GW, 2002, J EUKARYOT MICROBIOL, V49, P63, DOI 10.1111/j.1550-7408.2002.tb00343.x; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; Smolyar I, 2003, ICES J MAR SCI, V60, P836, DOI 10.1016/S1054-3139(03)00071-7; Steidinger Karen A., 1996, P387, DOI 10.1016/B978-012693015-3/50006-1; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; STOECKER DK, 1985, MAR ECOL PROG SER, V25, P159, DOI 10.3354/meps025159; Strom SL, 2006, MAR ECOL PROG SER, V328, P75, DOI 10.3354/meps328075; Struder-Kypke MC, 2001, USER FRIENDLY KEY CO; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Teoh ML, 2013, J APPL PHYCOL, V25, P285, DOI 10.1007/s10811-012-9863-8; Turner JT, 2001, MAR ECOL PROG SER, V221, P209, DOI 10.3354/meps221209; Wassmann P, 2011, OCEANOGRAPHY, V24, P220, DOI 10.5670/oceanog.2011.74; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Yih W, 2004, AQUAT MICROB ECOL, V36, P165, DOI 10.3354/ame036165	89	23	24	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86429	10.1371/journal.pone.0086429	http://dx.doi.org/10.1371/journal.pone.0086429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475119	gold, Green Published			2022-12-27	WOS:000330339800043
J	Hiley, L; Fang, NX; Micalizzi, GR; Bates, J				Hiley, Lester; Fang, Ning-Xia; Micalizzi, Gino R.; Bates, John			Distribution of Gifsy-3 and of Variants of ST64B and Gifsy-1 Prophages amongst Salmonella enterica Serovar Typhimurium Isolates: Evidence that Combinations of Prophages Promote Clonality	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BACTERIOPHAGE; RESISTANCE; REGION; PHAGES; GENES	Salmonella isolates harbour a range of resident prophages which can influence their virulence and ability to compete and survive in their environment. Phage gene profiling of a range of phage types of Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) indicates a significant level of correlation of phage gene profile with phage type as well as correlation with genotypes determined by a combination of multi-locus variable-number tandem repeat (VNTR) typing and clustered regularly interspaced short palindromic repeats (CRISPR) typing. Variation in phage gene profiles appears to be partly linked to differences in composition of variants of known prophages. We therefore conducted a study of the distribution of variants of ST64B and Gifsy-1 prophages and coincidently the presence of Gifsy-3 prophage in a range of S. Typhimurium phage types and genotypes. We have discovered two variants of the DT104 variant of ST64B and at least two new variants of Gifsy-1 as well as variants of related phage genes. While there is definite correlation between phage type and the prophage profile based on ST64B and Gifsy-1 variants we find stronger correlation between the VNTR/CRISPR genotype and prophage profile. Further differentiation of some genotypes is obtained by addition of the distribution of Gifsy-3 and a sequence variant of the substituted SB26 gene from the DT104 variant of ST64B. To explain the correlation between genotype and prophage profile we propose that suites of resident prophages promote clonality possibly through superinfection exclusion systems.	[Hiley, Lester] Queensland Dept Hlth, Publ Hlth Microbiol Lab, Forens Serv, Brisbane, Qld, Australia; Queensland Dept Hlth, Publ Hlth Microbiol Lab, Sci Serv, Brisbane, Qld, Australia	Queensland Health; Queensland Health	Hiley, L (corresponding author), Queensland Dept Hlth, Publ Hlth Microbiol Lab, Forens Serv, Brisbane, Qld, Australia.	Lester.Hiley@health.qld.gov.au			general laboratory operational funds; Queensland Department of Health	general laboratory operational funds; Queensland Department of Health	This study was funded from general laboratory operational funds provided by Queensland Department of Health. The funders had a notionally supportive role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Bossi L, 2005, PHAGES THEIR ROLE BA; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cooke FJ, 2007, J CLIN MICROBIOL, V45, P2590, DOI 10.1128/JCM.00729-07; Cooke FJ, 2008, J BACTERIOL, V190, P8155, DOI 10.1128/JB.00636-08; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Fang NX, 2012, J MICROBIOL METH, V88, P19, DOI 10.1016/j.mimet.2011.10.002; Figueroa-Bossi N, 2004, J BACTERIOL, V186, P4038, DOI 10.1128/JB.186.12.4038-4041.2004; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; FigueroaBossi N, 1997, MOL MICROBIOL, V25, P161, DOI 10.1046/j.1365-2958.1997.4451807.x; Harker KS, 2011, EPIDEMIOL INFECT, V139, P1254, DOI 10.1017/S0950268810002281; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hermans APHM, 2006, MICROBIOL-SGM, V152, P2137, DOI 10.1099/mic.0.28850-0; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Lemire S, 2008, ADV M C M, P159, DOI 10.1017/CBO9780511541520.008; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Luo YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040645; Luo YQ, 2011, J BACTERIOL, V193, P4035, DOI 10.1128/JB.05224-11; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Mmolawa PT, 2002, INT J MED MICROBIOL, V291, P633, DOI 10.1078/1438-4221-00178; Peters T, 2010, J CLIN MICROBIOL, V48, P3375, DOI 10.1128/JCM.00109-10; Ross IL, 2005, J CLIN MICROBIOL, V43, P1604, DOI 10.1128/JCM.43.4.1604-1611.2005; Schmieger H, 1999, J BACTERIOL, V181, P1630, DOI 10.1128/JB.181.5.1630-1635.1999; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; STANLEY J, 1993, J GEN MICROBIOL, V139, P1133, DOI 10.1099/00221287-139-6-1133; Sulakvelidze Andrew M. Kropinski Alexander, 2007, V394, P133, DOI 10.1007/978-1-59745-512-1_9; Thornley CN, 2003, EMERG INFECT DIS, V9, P493, DOI 10.3201/eid0904.020439; Tucker CP, 2004, INT J MED MICROBIOL, V294, P59, DOI 10.1016/j.ijmm.2003.12.001; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86203	10.1371/journal.pone.0086203	http://dx.doi.org/10.1371/journal.pone.0086203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475087	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800033
J	Huang, J; Zhang, Y; Zhong, HG; Fan, ZN; Jiang, GB; Shen, YZ; Song, HM; Tao, ZJ; Wang, KJ				Huang, Jin; Zhang, Yin; Zhong, Hengao; Fan, Zhining; Jiang, Guobin; Shen, Yingzhou; Song, Hanming; Tao, Zhijian; Wang, Kuangjing			Comparison of Endoscopic Submuscosal Implantation vs. Surgical Intramuscular Implantation of VX2 Fragments for Establishing a Rabbit Esophageal Tumor Model for Mimicking Human Esophageal Squamous Carcinoma	PLOS ONE			English	Article							CELL CARCINOMA; GROWTH-PATTERN; CANCER; STENT; MICE; INHIBITOR; STRICTURE	Purpose: This study was undertaken to establish a rabbit esophageal tumor model for mimicking human esophageal squamous carcinoma (ESC) by endoscopic and surgical implantation of VX2 tumors. Methods: Fragments of a VX2 tumour were endoscopically implanted in the submucosal layer of the thoracic esophagus of 32 New Zealand white rabbits, while 34 animals received surgical implantation into the muscular layer. Then, the animals were studied endoscopically and pathologically. The safety and efficiency of the two methods and the pathological features of the animal models were analyzed. Results: Both the endoscopic and the surgical method had a relatively high success rate of tumor implantation [93.7% (30/ 32) vs. 97.1% (33/34)] and tumor growth [86.7% (26/30) vs. 81.8% (27/33)], and the variation in the results was not statistically significant (P > 0.05). Compared with those produced by the surgical method, the models produced by the endoscopic method had a higher rate of severe esophageal stricture [61.5% (16/26) vs. 29.6% (8/27)] and of intra-luminal tumor growth [73.1% (19/26) vs. 37.0% (10/27)], and had a lower rate of tumor invasion of adjacent organs [53.8% (14/26) vs. 81.5% (22/27)]; all of these results were statistically significant (P < 0.05). However, the difference in the survival time and the rates of tumor regional/distant metastasis [38.5% (10/26) vs. 51.8% (14/27)] between the two methods were not statistically significant (P > 0.05). Conclusion: The endoscopic and surgical methods are both safe and effective for establishment of VX2 tumors in the rabbit esophagus. The models produced by the two methods have different pathologic features mimicking that of human ESC. We recommend the models for studies on surgical procedures and minimally invasive treatments.	[Huang, Jin; Zhang, Yin; Zhong, Hengao; Fan, Zhining; Jiang, Guobin] Nanjing Med Univ, Digest Med Ctr, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Huang, Jin; Shen, Yingzhou; Song, Hanming; Tao, Zhijian; Wang, Kuangjing] Renming Hosp Ma Anshan, Div Digest Dis, Ma Anshan City, Anhui, Peoples R China	Nanjing Medical University	Fan, ZN (corresponding author), Nanjing Med Univ, Digest Med Ctr, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China.	fanzhining5834@hotmail.com			National Science Foundation of China [81172266/H1617]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under Grant No. 81172266/H1617 (www.nsfc.gov.cn/nsfc/cen/bsdt/jggb.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharat A, 2012, SURG CLIN N AM, V92, P1179, DOI 10.1016/j.suc.2012.07.012; Bruners P, 2010, CARDIOVASC INTER RAD, V33, P127, DOI 10.1007/s00270-009-9583-x; Chávez Rossell Miguel, 2005, Rev. gastroenterol. Perú, V25, P76; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Ji JS, 2011, GASTROINTEST ENDOSC, V74, P148, DOI 10.1016/j.gie.2011.03.1252; Kim EY, 2013, RADIOLOGY, V267, P396, DOI 10.1148/radiol.12120361; Moriyama M, 2013, ANTICANCER RES, V33, P175; Nishikawa T, 2013, CANCER BIOL THER, V14, P230, DOI 10.4161/cbt.23294; Ooki A, 2007, WORLD J SURG, V31, P2184, DOI 10.1007/s00268-007-9198-9; Pauli EM, 2012, SURG ENDOSC, V26, P3500, DOI 10.1007/s00464-012-2373-6; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Schubert D, 2012, CHIRURG, V83, P712, DOI 10.1007/s00104-011-2265-7; Seddik H, 2011, PRESSE MED, V40, P889, DOI 10.1016/j.lpm.2011.01.007; SELBIE FR, 1948, BRIT J CANCER, V2, P48, DOI 10.1038/bjc.1948.7; Sheyhedin I, 2000, LASER SURG MED, V26, P83, DOI 10.1002/(SICI)1096-9101(2000)26:1<83::AID-LSM12>3.0.CO;2-1; Soetikno Roy, 2010, Gastrointest Endosc Clin N Am, V20, P497, DOI 10.1016/j.giec.2010.03.008; Stewart EE, 2012, RADIOLOGY, V264, P68, DOI 10.1148/radiol.12110674; Sun JH, 2012, EXP THER MED, V3, P386, DOI 10.3892/etm.2011.435; Talukdar FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060996; Thomas GR, 2006, INT J CANCER, V118, P2379, DOI 10.1002/ijc.21695; Tian F, 2012, PATHOL RES PRACT, V208, P32, DOI 10.1016/j.prp.2011.10.011; Tu M, 2009, J SURG RES, V154, P284, DOI 10.1016/j.jss.2008.06.019; Alvarado MVY, 2011, J VASC INTERV RADIOL, V22, P1758, DOI 10.1016/j.jvir.2011.08.025; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Von Rahden BHA, 2006, VIRCHOWS ARCH, V448, P862, DOI 10.1007/s00428-006-0185-6; Zhou JM, 2009, PROG NAT SCI, V19, P1713, DOI 10.1016/j.pnsc.2009.07.013	26	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85326	10.1371/journal.pone.0085326	http://dx.doi.org/10.1371/journal.pone.0085326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475043	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800012
J	Huisman, MG; van Leeuwen, BL; Ugolini, G; Montroni, I; Spiliotis, J; Stabilini, C; Carino, ND; Farinella, E; de Bock, GH; Audisio, RA				Huisman, Monique G.; van Leeuwen, Barbara L.; Ugolini, Giampaolo; Montroni, Isacco; Spiliotis, John; Stabilini, Cesare; Carino, Nicola de'Liguori; Farinella, Eriberto; de Bock, Geertruida H.; Audisio, Riccardo A.			"Timed Up & Go": A Screening Tool for Predicting 30-Day Morbidity in Onco-Geriatric Surgical Patients? A Multicenter Cohort Study	PLOS ONE			English	Article							AGED 75 YEARS; ELDERLY-PATIENTS; COLORECTAL-CANCER; OLDER PATIENTS; PREOPERATIVE ASSESSMENT; PREVENT DELIRIUM; MOBILITY; SURGERY; FRAILTY; COMPLICATIONS	Objective: To determine the predictive value of the "Timed Up & Go" (TUG), a validated assessment tool, on a prospective cohort study and to compare these findings to the ASA classification, an instrument commonly used for quantifying patients' physical status and anesthetic risk. Background: In the onco-geriatric surgical population it is important to identify patients at increased risk of adverse postoperative outcome to minimize the risk of over-and under-treatment and improve outcome in this population. Methods: 280 patients >= 70 years undergoing elective surgery for solid tumors were prospectively recruited. Primary endpoint was 30-day morbidity. Pre-operatively TUG was administered and ASA-classification was registered. Data were analyzed using multivariable logistic regression analyses to estimate odds ratios (OR) and 95% confidence intervals (95%-CI). Absolute risks and area under the receiver operating characteristic curves (AUC's) were calculated. Results: 180 (64.3%) patients (median age: 76) underwent major surgery. 55 (20.1%) patients experienced major complications. 50.0% of patients with high TUG and 25.6% of patients with ASA >= 3 experienced major complications (absolute risks). TUG and ASA were independent predictors of the occurrence of major complications (TUG: OR 3.43; 95%-CI = 1.14-10.35. ASA1 vs. 2: OR 5.91; 95%-CI = 0.93-37.77. ASA1 vs. 3&4:OR 12.77; 95%-CI = 1.84-88.74). AUC(TUG) was 0.64 (95%-CI = 0.55-0.73, p = 0.001) and AUC(ASA) was 0.59 (95%-CI = 0.51-0.67, p = 0.04). Conclusions: Twice as many onco-geriatric patients at risk of post-operative complications, who might benefit from pre-operative interventions, are identified using TUG than when using ASA.	[Huisman, Monique G.; van Leeuwen, Barbara L.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Ugolini, Giampaolo; Montroni, Isacco] S Orsola Malphighi Hosp, Dept Surg, Bologna, Italy; [Spiliotis, John] Metaxa Canc Hosp, Dept Surg, Piraeus, Greece; [Spiliotis, John] Reg Univ Hosp Patras, Patras, Greece; [Stabilini, Cesare] San Martino Univ Hosp, Dept Surg, Genoa, Italy; [Carino, Nicola de'Liguori] North Manchester Gen Hosp, Dept Surg, Manchester, Lancs, England; [Farinella, Eriberto] S Maria Hosp, Dept Surg, Perugia, Italy; [Farinella, Eriberto] Luton & Dunstable Hosp, Luton, Beds, England; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Audisio, Riccardo A.] Univ Liverpool, St Helens Teaching Hosp, Dept Surg, St Helens, England	University of Groningen; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Patras; University of Genoa; IRCCS AOU San Martino IST; University of Groningen; University of Liverpool	Huisman, MG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands.	m.g.huisman@umcg.nl	Ugolini, Giampaolo/AAD-1248-2022; de Bock, Geertruida Hendrika/F-6529-2014	de Bock, Geertruida Hendrika/0000-0003-3104-4471; Audisio, Riccardo A./0000-0002-7538-4809; van Leeuwen, Barbara/0000-0002-6745-4424				Aronson Wendy L, 2003, AANA J, V71, P265; Audisio RA, 2008, CRIT REV ONCOL HEMAT, V65, P156, DOI 10.1016/j.critrevonc.2007.11.001; Audisio RA, 2005, ONCOLOGIST, V10, P262, DOI 10.1634/theoncologist.10-4-262; Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224; Bischoff HA, 2003, AGE AGEING, V32, P315, DOI 10.1093/ageing/32.3.315; Brouquet A, 2010, ANN SURG, V251, P759, DOI 10.1097/SLA.0b013e3181c1cfc9; Brunello A, 2009, CANCER TREAT REV, V35, P487, DOI 10.1016/j.ctrv.2009.04.005; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dalton JE, 2010, SCAND J CLIN LAB INV, V70, P59, DOI 10.3109/00365513.2010.493389; Davis DHJ, 2011, ARCH GERONTOL GERIAT, V53, P79, DOI 10.1016/j.archger.2010.06.013; De werkgroep 'Prevalentie van Kanker' van de Signaleringscommissie Kanker van KWF Kankerbestrijding, 2004, SIGN KANK KWF KANK K; Dekker JWT, 2011, ANN SURG ONCOL, V18, P1533, DOI 10.1245/s10434-011-1671-x; Dekker JW, 2012, EUR J SURG ONCOL; Extermann M, 2007, J CLIN ONCOL, V25, P1824, DOI 10.1200/JCO.2007.10.6559; Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0; Harari D, 2007, AGE AGEING, V36, P190, DOI 10.1093/ageing/afl163; Hempenius L, 2011, INT J GERIATR PSYCH, V26, P441, DOI 10.1002/gps.2560; Heriot AG, 2006, DIS COLON RECTUM, V49, P816, DOI 10.1007/s10350-006-0523-4; Ingemarsson AH, 2003, J REHABIL MED, V35, P76; Kim MJ, 2010, GERIATR GERONTOL INT, V10, P302, DOI 10.1111/j.1447-0594.2010.00614.x; Kim MJ, 2010, ARCH GERONTOL GERIAT, V51, P192, DOI 10.1016/j.archger.2009.10.007; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kristjansson SR, 2010, CRIT REV ONCOL HEMAT, V76, P208, DOI 10.1016/j.critrevonc.2009.11.002; Laflamme GY, 2012, J BONE JOINT SURG AM, V94A, P1175, DOI 10.2106/JBJS.J.01952; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rizzo JA, 2001, MED CARE, V39, P740, DOI 10.1097/00005650-200107000-00010; Robinson TN, 2011, J AM COLL SURGEONS, V213, P37, DOI 10.1016/j.jamcollsurg.2011.01.056; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Ronning B, 2010, AGE AGEING, V39, P758, DOI 10.1093/ageing/afq123; Rutten HJT, 2008, LANCET ONCOL, V9, P494, DOI 10.1016/S1470-2045(08)70129-3; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Tan K, 2009, INT J COLORECTAL DIS, V24, P185, DOI 10.1007/s00384-008-0615-9; YANCIK R, 1994, CANCER, V74, P1995, DOI 10.1002/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y	35	98	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86863	10.1371/journal.pone.0086863	http://dx.doi.org/10.1371/journal.pone.0086863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475186	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800065
J	Dai, W; Yao, Y; Zhou, Q; Sun, CF				Dai, Wei; Yao, Yuan; Zhou, Qing; Sun, Chang-fu			Ubiquitin-Specific Peptidase 22, a Histone Deubiquitinating Enzyme, Is a Novel Poor Prognostic Factor for Salivary Adenoid Cystic Carcinoma	PLOS ONE			English	Article							EXPRESSION; METASTASIS; INVASION; CANCER	Salivary Adenoid Cystic Carcinoma (SACC) is characterized by a high rate of local recurrence and infiltration, strong invasion to peripheral nerves or late distant metastasis. Our aim was to investigate the expression of Ubiquitin-specific protease 22 (USP22) in SACC patients and its possible relationship to the outcome of the disease. A total of 135 SACC tissues and adjacent non-cancerous tissues which were diagnosed between 2002 and 2007 were enrolled in this study. Immunohistochemistry was used to compare the expression pattern of USP22 in SACC and adjacent non-cancerous groups, and the prognostic significance was assessed by Kaplan-Meier analysis and Cox proportional hazards regression in SACC patients. The rate of high expression of USP22 was significantly higher in SACC group than that in adjacent non-cancerous group. High expression of USP22 was significantly correlated with histological subtype, lymph node metastasis, grade, Ki-67 and SOX2 expression. Furthermore, USP22 acts as an oncogene by regulation the BMI-1 pathway and c-Myc pathway. SACC patients with high USP22 expression showed the poorer overall survival (OS) and disease-free survival (DFS) than those patients with low USP22 expression. In multivariate analysis, only lymph node metastasis and USP22 expression were the independent prognostic factors for OS and DFS in SACC. Our study provides evidence that USP22 expression is an independent prognostic factor for SACC patients.	[Dai, Wei; Zhou, Qing; Sun, Chang-fu] China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Dept Oral & Maxillofacial Surg, Shenyang, Liaoning, Peoples R China; [Yao, Yuan] Peoples Hosp Liaoning Prov, Dept Gastroenterol, Shenyang, Liaoning, Peoples R China	China Medical University	Dai, W (corresponding author), China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Dept Oral & Maxillofacial Surg, Shenyang, Liaoning, Peoples R China.	cmudaiwei@gmail.com	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [81301835, 31271364, 31171259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by Grants from the National Natural Science Foundation of China (Nos. 81301835, 31271364 and 31171259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen AM, 2006, INT J RADIAT ONCOL, V66, P152, DOI 10.1016/j.ijrobp.2006.04.014; Chen W, 2012, MOL MED REP, V6, P755, DOI 10.3892/mmr.2012.1003; Gao M, 2013, INT J ORAL MAX SURG, V42, P923, DOI 10.1016/j.ijom.2013.04.006; Godge P, 2012, CONTEMP CLIN DENT, V3, P223, DOI 10.4103/0976-237X.96838; Li J, 2012, J CANCER RES CLIN, V138, P1291, DOI 10.1007/s00432-012-1191-5; Li Y, 2013, ANAT REC HOBOKEN, DOI [10.1002/ar.22754, DOI 10.1002/AR.22754.PUBMED:23873832]; Liang B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0497-8; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Ning J, 2012, EUR J HISTOCHEM, V56, P289, DOI 10.4081/ejh.2012.e46; Piao SL, 2013, ORAL ONCOL, V49, P796, DOI 10.1016/j.oraloncology.2013.03.454; Piao SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042540; Sussman RT, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.469783, DOI 10.1074/JBC.M113.469783.PUBMED:23760504]; Tang QL, 2011, ORAL ONCOL, V47, P365, DOI 10.1016/j.oraloncology.2011.02.022; Wang H, 2013, TUMOR BIOL, V34, P1635, DOI 10.1007/s13277-013-0696-0; Wu HM, 2012, MOL MED REP, V6, P271, DOI 10.3892/mmr.2012.911; Xu H, 2012, INT J COLORECTAL DIS, V27, P21, DOI 10.1007/s00384-011-1275-8; Xue F, 2005, J ORAL PATHOL MED, V34, P295, DOI 10.1111/j.1600-0714.2005.00312.x; Yang M, 2013, TUMOR BIOL, DOI [10.1007/s13277-013-1121-4, DOI 10.1007/S13277-013-1121-4.PUBMED:23979981]; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhou CC, 2012, J ORAL PATHOL MED, V41, P424, DOI 10.1111/j.1600-0714.2011.01114.x; Zhou CX, 2006, ONCOL REP, V16, P505	21	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87148	10.1371/journal.pone.0087148	http://dx.doi.org/10.1371/journal.pone.0087148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466336	gold, Green Submitted, Green Published			2022-12-27	WOS:000330288000195
J	Dulle, JE; Stein, KC; True, HL				Dulle, Jennifer E.; Stein, Kevin C.; True, Heather L.			Regulation of the Hsp104 Middle Domain Activity Is Critical for Yeast Prion Propagation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE HSP104; AAA PLUS DISAGGREGASE; PROTEIN DISAGGREGATION; PSI+ PRION; ENVIRONMENTAL-STRESS; MOLECULAR CHAPERONE; AGGREGATED PROTEINS; GENETIC-VARIATION; COMMON MECHANISM; BINDING DOMAIN	Molecular chaperones play a significant role in preventing protein misfolding and aggregation. Indeed, some protein conformational disorders have been linked to changes in the chaperone network. Curiously, in yeast, chaperones also play a role in promoting prion maintenance and propagation. While many amyloidogenic proteins are associated with disease in mammals, yeast prion proteins, and their ability to undergo conformational conversion into a prion state, are proposed to play a functional role in yeast biology. The chaperone Hsp104, a AAA+ ATPase, is essential for yeast prion propagation. Hsp104 fragments large prion aggregates to generate a population of smaller oligomers that can more readily convert soluble monomer and be transmitted to daughter cells. Here, we show that the middle (M) domain of Hsp104, and its mobility, plays an integral part in prion propagation. We generated and characterized mutations in the M-domain of Hsp104 that are predicted to stabilize either a repressed or de-repressed conformation of the M-domain (by analogy to ClpB in bacteria). We show that the predicted stabilization of the repressed conformation inhibits general chaperone activity. Mutation to the de-repressed conformation, however, has differential effects on ATP hydrolysis and disaggregation, suggesting that the M-domain is involved in coupling these two activities. Interestingly, we show that changes in the M-domain differentially affect the propagation of different variants of the [PSI+] and [RNQ+] prions, which indicates that some prion variants are more sensitive to changes in the M-domain mobility than others. Thus, we provide evidence that regulation of the M-domain of Hsp104 is critical for efficient prion propagation. This shows the importance of elucidating the function of the M-domain in order to understand the role of Hsp104 in the propagation of different prions and prion variants.	[Dulle, Jennifer E.; Stein, Kevin C.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	True, HL (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	heather.true@wustl.edu		Stein, Kevin/0000-0002-0622-8319	NIH [GM72778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM072778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the NIH GM72778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Biter AB, 2012, J STRUCT BIOL, V179, P172, DOI 10.1016/j.jsb.2012.05.007; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; Derkatch IL, 1999, CURR GENET, V35, P59, DOI 10.1007/s002940050433; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; DeSantis ME, 2012, CHEM BIOL, V19, P1400, DOI 10.1016/j.chembiol.2012.09.013; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Dulle J, 2013, PRION, V7; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Huang VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079582; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kryndushkin DS, 2002, J BIOL CHEM, V277, P23702, DOI 10.1074/jbc.M111547200; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	75	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87521	10.1371/journal.pone.0087521	http://dx.doi.org/10.1371/journal.pone.0087521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466354	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000210
J	Jiang, CL; Niu, JZ; Li, M; Teng, Y; Wang, HX; Zhang, YQ				Jiang, Changli; Niu, Junzhou; Li, Meng; Teng, Yi; Wang, Huixuan; Zhang, Yingqi			Tumor Vasculature-Targeted Recombinant Mutated Human TNF-alpha Enhanced the Antitumor Activity of Doxorubicin by Increasing Tumor Vessel Permeability in Mouse Xenograft Models	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ALPHA-V-BETA-3; PENETRATION; EXPRESSION; INTEGRINS; TOXICITY; DELIVERY; BINDING; GROWTH; CANCER	Objective: Increasing evidence suggests that, when used in combination, tumor necrosis factor-alpha (TNF-alpha) synergizes with traditional chemotherapeutic drugs to exert a heightened antitumor effect. The present study investigated the antitumor efficacy of recombinant mutated human TNF-alpha specifically targeted to the tumor vasculature (RGD-rmhTNF-alpha) combined with the chemotherapeutic agent doxorubicin in 2 murine allografted tumor models. Methods: Mice bearing hepatoma or sarcoma allografted tumors were treated with various doses of RGD-rmhTNF-alpha alone or in combination with doxorubicin (2 mg/kg). We then evaluated tumor growth and tumor vessel permeability as well as intratumoral levels of RGD-rmhTNF-alpha and doxorubicin. Results: RGD-rmhTNF-alpha treatment enhanced the permeability of the tumor vessels and increased intratumoral doxorubicin levels. In addition, intratumoral RGD-rmhTNF-alpha levels were significantly higher than that of rmhTNF-alpha. In both of the tested tumor models, administering RGD-rmhTNF-alpha in combination with doxorubicin resulted in an enhanced antitumor response compared to either treatment alone. Double-agent combination treatment of doxorubicin with 50,000 IU/kg RGD-rmhTNF-alpha induced stronger antitumor effects on H22 allografted tumor-bearing mice than the single doxorubicin agent alone. Moreover, doxorubicin with 10,000 IU/kg RGD-rmhTNF-alpha synergized to inhibit tumor growth in S180 allografted tumor-bearing mice. Conclusions: These results suggest that targeted delivery of low doses of RGD-rmhTNF-alpha into the tumor vasculature increases the antitumor efficacy of chemotherapeutic drugs.	[Jiang, Changli; Teng, Yi; Wang, Huixuan] Chengdu Mil Area, Kunming Gen Hosp, Clin Lab, Army Ctr Mol Biol Anal, Kunming, Yunnna, Peoples R China; [Jiang, Changli; Li, Meng; Zhang, Yingqi] Fourth Mil Med Univ, Sch Pharm, Dept Biopharmaceut, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Niu, Junzhou] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi, Peoples R China	Kunming General Hospital; Air Force Military Medical University; Air Force Military Medical University	Wang, HX (corresponding author), Chengdu Mil Area, Kunming Gen Hosp, Clin Lab, Army Ctr Mol Biol Anal, Kunming, Yunnna, Peoples R China.	dywang43@163.com; zhangyqh@fmmu.edu.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [31200657]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the grant from the National Natural Science Foundation of China (Grant No. 31200657). http://159.226.244.22/portal/Proj_List.asp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello L, 2001, NEUROSURGERY, V49, P380, DOI 10.1097/00006123-200108000-00022; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; de Wilt JHW, 2000, BRIT J CANCER, V82, P1000, DOI 10.1054/bjoc.1999.1032; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Holig P, 2004, PROTEIN ENG DES SEL, V17, P433, DOI 10.1093/protein/gzh055; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; KEMENY N, 1990, CANCER, V66, P659, DOI 10.1002/1097-0142(19900815)66:4<659::AID-CNCR2820660410>3.0.CO;2-2; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Kristensen CA, 1996, BRIT J CANCER, V74, P533, DOI 10.1038/bjc.1996.397; Lejeune F J, 2006, Bull Cancer, V93, pE90; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Li M, 2010, ANTI-CANCER DRUG, V21, P243, DOI 10.1097/CAD.0b013e328333d5ce; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; NAKAMURA S, 1991, INT J CANCER, V48, P744, DOI 10.1002/ijc.2910480519; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sacchi A, 2006, CLIN CANCER RES, V12, P175, DOI 10.1158/1078-0432.CCR-05-1147; SCHWARTZ HS, 1973, BIOCHEM MED METAB B, V7, P396, DOI 10.1016/0006-2944(73)90060-4; Sengupta S, 2001, J EXP CLIN CANC RES, V20, P585; Shin NK, 1998, BIOCHEM MOL BIOL INT, V44, P1075; Taeger G, 2008, INT J HYPERTHER, V24, P193, DOI 10.1080/02656730701868387; Temming K, 2005, DRUG RESIST UPDATE, V8, P381, DOI 10.1016/j.drup.2005.10.002; Varner Judith A, 1995, CELL COMMUNICATION A, V3, P367; Wang H, 2006, PROTEIN EXPRES PURIF, V45, P60, DOI 10.1016/j.pep.2005.05.009; Yan S, CANC INVEST, V28, P85; Yan Z, 2006, CYTOTHERAPY, V8, P415, DOI 10.1080/14653240600845278	29	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87036	10.1371/journal.pone.0087036	http://dx.doi.org/10.1371/journal.pone.0087036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466321	gold, Green Published			2022-12-27	WOS:000330283100245
J	Shen, WJ; Song, M; Liu, J; Qiu, GR; Li, TR; Hu, YJ; Liu, HB				Shen, Wenjing; Song, Min; Liu, Jie; Qiu, Guangrong; Li, Tianren; Hu, Yanjie; Liu, Hongbo			MiR-26a Promotes Ovarian Cancer Proliferation and Tumorigenesis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; GROWTH; REPRESSION; CARCINOMA; SURVIVAL; EZH2	MicroRNAs (miRNAs) important for posttranscriptional gene expression are involved in the initiation and progression of human cancer. In this study, we reported that miR-26a was over-expressed in human EOC specimens and the expression level of extracellular miR-26a in plasma can distinguish patients from healthy controls in EOC. Ectopic expression of miR-26a in ovarian cancer (OC) cells increased cell proliferation and clonal formation. This growth promoting effect of OC cell growth was mediated by miR-26a inhibition of the posttranscription of ER-alpha. Furthermore, inhibition of miR-26a suppressed the tumor formation generated by injecting OC cells in nude mice. Our results suggest that aberrantly expressed miR-26a may contribute to OC development.	[Shen, Wenjing; Li, Tianren; Hu, Yanjie] China Med Univ, Dept Gynecol, Affiliated Hosp 1, Shenyang, Peoples R China; [Song, Min] China Med Univ, Inst Pathol & Pathophysiol, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Song, Min] China Med Univ, Inst Pathol & Pathophysiol, Coll Basic Med Sci, Shenyang, Peoples R China; [Liu, Jie] China Med Univ, Expt Technol Ctr, Shenyang, Peoples R China; [Qiu, Guangrong] China Med Univ, Dept Med Genet, Shenyang, Peoples R China; [Liu, Hongbo] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Shen, WJ (corresponding author), China Med Univ, Dept Gynecol, Affiliated Hosp 1, Shenyang, Peoples R China.	wenjing0326@163.com; songmin6@sohu.com			NNSF(National Natural Science Foundation) of China [30571836]; Science Foundation of the Education Department of Liaoning Province of China [L2010681]; Science Foundation of Science and Technology Bureau of Liaoning Province of China [201202259]	NNSF(National Natural Science Foundation) of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Education Department of Liaoning Province of China; Science Foundation of Science and Technology Bureau of Liaoning Province of China	This work was sponsored by grants from the Project No. 30571836 from the NNSF(National Natural Science Foundation) of China. In addition, the work presented is part of projects with Project No. L2010681 financially supported by Science Foundation of the Education Department of Liaoning Province of China, and Project No. 201202259 financially supported by Science Foundation of Science and Technology Bureau of Liaoning Province of China. Author Min Song contributed to experimental conceiving and design, guidance and discussion of the project, so she is the co-correspondence author of this paper. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Cunat S, 2004, GYNECOL ONCOL, V94, P25, DOI 10.1016/j.ygyno.2004.03.026; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujii Yoichi Robertus, 2009, Open Virol J, V3, P37, DOI 10.2174/1874357900903010037; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Halon A, 2011, PATHOL ONCOL RES, V17, P511, DOI 10.1007/s12253-010-9340-0; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hecht JL, 2009, CANCER EPIDEM BIOMAR, V18, P1624, DOI 10.1158/1055-9965.EPI-08-1214; Hoskins WJ, 1995, J CELL BIOCHEM, P189; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	33	50	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86871	10.1371/journal.pone.0086871	http://dx.doi.org/10.1371/journal.pone.0086871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466274	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100228
J	Weier, K; Penner, IK; Magon, S; Amann, M; Naegelin, Y; Andelova, M; Derfuss, T; Stippich, C; Radue, EW; Kappos, L; Sprenger, T				Weier, Katrin; Penner, Iris K.; Magon, Stefano; Amann, Michael; Naegelin, Yvonne; Andelova, Michaela; Derfuss, Tobias; Stippich, Christoph; Radue, Ernst-Wilhelm; Kappos, Ludwig; Sprenger, Till			Cerebellar Abnormalities Contribute to Disability Including Cognitive Impairment in Multiple Sclerosis	PLOS ONE			English	Article							SERIAL ADDITION TEST; BRAIN ATROPHY; FOLLOW-UP; FATIGUE; DYSFUNCTION; PERSONALITY; DEPRESSION; DISORDER; SCALE; GRAY	The cerebellum is known to be involved not only in motor but also cognitive and affective processes. Structural changes in the cerebellum in relation to cognitive dysfunction are an emerging topic in the field of neuro-psychiatric disorders. In Multiple Sclerosis (MS) cerebellar motor and cognitive dysfunction occur in parallel, early in the onset of the disease, and the cerebellum is one of the predilection sites of atrophy. This study is aimed at determining the relationship between cerebellar volumes, clinical cerebellar signs, cognitive functioning and fatigue in MS. Cerebellar volumetry was conducted using T1-weighted MPRAGE magnetic resonance imaging of 172 MS patients. All patients underwent a clinical and brief neuropsychological assessment (information processing speed, working memory), including fatigue testing. Patients with and without cerebellar signs differed significantly regarding normalized cerebellar total volume (nTCV), normalized brain volume (nBV) and whole brain T2 lesion volume (LV). Patients with cerebellar dysfunction likewise performed worse in cognitive tests. A regression analysis indicated that age and nTCV explained 26.3% of the variance in SDMT (symbol digit modalities test) performance. However, only age, T2 LV and nBV remained predictors in the full model (r(2) = 0.36). The full model for the prediction of PASAT (Paced Auditory Serial Addition Test) scores (r(2) = 0.23) included age, cerebellar and T2 LV. In the case of fatigue, only age and nBV (r(2) = 0.17) emerged as significant predictors. These data support the view that cerebellar abnormalities contribute to disability, including cognitive impairment in MS. However, this contribution does not seem to be independent of, and may even be dominated by wider spread MS pathology as reflected by nBV and T2 LV.	[Weier, Katrin; Penner, Iris K.; Magon, Stefano; Amann, Michael; Naegelin, Yvonne; Andelova, Michaela; Derfuss, Tobias; Kappos, Ludwig; Sprenger, Till] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Penner, Iris K.] Univ Basel, Dept Cognit Psychol & Methodol, Basel, Switzerland; [Amann, Michael; Stippich, Christoph; Sprenger, Till] Univ Basel Hosp, Dept Radiol, Div Neuroradiol, CH-4031 Basel, Switzerland; [Radue, Ernst-Wilhelm] Univ Basel Hosp, Med Image Anal Ctr MIAC AG, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Weier, K (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	katrin.weier@usb.ch		Derfuss, Tobias/0000-0001-8656-4250; Andelova, Michaela/0000-0002-3812-7483; Sprenger, Till/0000-0002-5390-819X; Magon, Stefano/0000-0003-1517-7581; Penner, Iris-Katharina/0000-0002-6746-1034	University of Basel [DMS2172]	University of Basel	K. Weier received funding from the University of Basel (research grant "Nachwuchsforderung Klinische Forschung" - DMS2172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Anderson VM, 2011, MULT SCLER J, V17, P1079, DOI 10.1177/1352458511403528; Anderson VM, 2009, MULT SCLER, V15, P811, DOI 10.1177/1352458508101934; Bakshi R, 1999, NEUROLOGY, V53, P1151, DOI 10.1212/WNL.53.5.1151; Benedict RHB, 2004, J NEUROIMAGING, V14, p36S, DOI 10.1111/j.1552-6569.2004.tb00277.x; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bobholz Julie A, 2008, Handb Clin Neurol, V89, P705, DOI 10.1016/S0072-9752(07)01263-8; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Calabrese M, 2010, J NEUROL NEUROSUR PS, V81, P401, DOI 10.1136/jnnp.2009.177733; Calabrese P, 2007, J NEUROL, V254, P18, DOI 10.1007/s00415-007-2006-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Eriksson M, 2003, MULT SCLER J, V9, P260, DOI 10.1191/1352458503ms914oa; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Forn C, 2011, J CLIN EXP NEUROPSYC, V33, P42, DOI 10.1080/13803395.2010.481620; Hill SK, 2009, SCHIZOPHR RES, V113, P167, DOI 10.1016/j.schres.2009.04.020; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, J NEUROL SCI, V233, P55, DOI 10.1016/j.jns.2005.03.027; Kutzelnigg A, 2007, BRAIN PATHOL, V17, P38, DOI 10.1111/j.1750-3639.2006.00041.x; MILLER DH, 1992, J NEUROL NEUROSUR PS, V55, P341, DOI 10.1136/jnnp.55.5.341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penner IK, 2009, MULT SCLER J, V15, P1509, DOI 10.1177/1352458509348519; Penner IK, 2007, MULT SCLER, V13, P1161, DOI 10.1177/1352458507079267; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Scherer P, 2004, NERVENARZT, V75, P984, DOI 10.1007/s00115-004-1729-0; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tedeschi G, 2007, J NEUROL SCI, V263, P15, DOI 10.1016/j.jns.2007.07.004; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Weier K, 2012, J NEUROL; Williams J, 2006, MULT SCLER J, V12, P599, DOI 10.1177/1352458506070752; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	38	61	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86916	10.1371/journal.pone.0086916	http://dx.doi.org/10.1371/journal.pone.0086916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466290	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100233
J	Tang, L; Cheng, GL; Xu, ZH				Tang, Li; Cheng, Guo-Lin; Xu, Zhong-Hua			Association between Estrogen Receptor alpha Gene (ESR1) PvuII (C/T) and XbaI (A/G) Polymorphisms and Hip Fracture Risk: Evidence from a Meta-Analysis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OSTEOPOROSIS; WOMEN; CANCER; OSTEOARTHRITIS; HETEROGENEITY; DISEASE; REDUCE	Background and Objective: Genetic factors are important in the pathogenesis of fractures. Notably, estrogen receptor alpha(ESR1) has been suggested as a possible candidate gene for hip fractures; however, published studies of ESR1 gene polymorphisms have been hampered by small sample sizes and inconclusive or ambiguous results. The aim of this meta-analysis is to investigate the associations between two novel common ESR1 polymorphisms (intron 1 polymorphisms PvuII-rs2234693: C > T and XbaI-rs9340799: A > G) and hip fracture. Methods: Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of the association. Results: Five case-control and three cohort studies were assessed, including a total of 1,838 hip fracture cases and 14,972 healthy controls. This meta-analysis revealed that the PvuII T allele is a highly significant risk factor for hip fracture susceptibility, with an effect magnitude similar in male and pre-menopausal and post-menopausal female patients. In stratified analysis based on ethnicity, the PvuII T allele remained significantly correlated with increased risk of hip fracture in Caucasian populations; this correlation, however, was not found in Asian populations. Unlike the PvuII polymorphism, we did not find significant differences in the XbaI (A > G) polymorphism allele or genotype distributions of hip fracture patients and controls. We also found no obvious association between the XbaI polymorphism and hip fracture in any of the racial or gender subgroups. Conclusion: Our findings show that the ESR1 PvuII T allele may increase the risk of hip fracture and that the XbaI polymorphism is not associated with hip fracture.	[Tang, Li; Cheng, Guo-Lin; Xu, Zhong-Hua] Jiangsu Univ, Jintan Hosp, Dept Orthoped, Changzhou, Peoples R China	Jiangsu University	Tang, L (corresponding author), Jiangsu Univ, Jintan Hosp, Dept Orthoped, Changzhou, Peoples R China.	tanglijintan@126.com						Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Aerssens J, 2000, OSTEOPOROSIS INT, V11, P583, DOI 10.1007/s001980070079; Beavan S, 1998, NEW ENGL J MED, V339, P351, DOI 10.1056/NEJM199807303390517; Carroll C, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15160; Chudyk AM, 2012, CLIN RHEUMATOL, V31, P749, DOI 10.1007/s10067-012-1970-z; Cummings SR, 1998, NEW ENGL J MED, V339, P733, DOI 10.1056/NEJM199809103391104; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Dincel E, 2008, CLINICS, V63, P645, DOI 10.1590/S1807-59322008000500013; Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239; Faulkner KG, 2000, J BONE MINER RES, V15, P183, DOI 10.1359/jbmr.2000.15.2.183; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Hawkes WG, 2006, J GERONTOL A-BIOL, V61, P495, DOI 10.1093/gerona/61.5.495; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Ioannidis JPA, 2002, J BONE MINER RES, V17, P2048, DOI 10.1359/jbmr.2002.17.11.2048; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Koh WP, 2009, AM J EPIDEMIOL, V170, P901, DOI 10.1093/aje/kwp220; Ladd AMGZ, 2008, BREAST CANCER RES TR, V107, P415, DOI 10.1007/s10549-007-9562-3; Lei MM, 2010, J INT MED RES, V38, P1575, DOI 10.1177/147323001003800502; Lian K, 2007, OSTEOARTHR CARTILAGE, V15, P972, DOI 10.1016/j.joca.2007.02.020; Martinez-Reig M, 2012, J AM MED DIR ASSOC, V13, P770, DOI 10.1016/j.jamda.2012.07.011; Massart F, 2012, JOINT BONE SPINE; Massart F, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-32; McKeen HD, 2010, CANCER RES, V70, P1090, DOI 10.1158/0008-5472.CAN-09-2515; Nguyen TV, 2000, J BONE MINER RES, V15, P392, DOI 10.1359/jbmr.2000.15.3.392; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; PIERRAT B, 1994, GENE, V143, P193, DOI 10.1016/0378-1119(94)90096-5; Pulkkinen P, 2011, BONE, V49, P600, DOI 10.1016/j.bone.2011.07.022; Quevedo I, 2008, REV MED CHILE, V136, P475, DOI /S0034-98872008000400008; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2004, J BONE MINER RES, V19, P1280, DOI 10.1359/JBMR.040405; Sakoda LC, 2011, CANCER EPIDEMIOL, V35, P48, DOI 10.1016/j.canep.2010.08.005; Sandhu A, 2012, OSTEOPOROS INT; Shin A, 2003, BREAST CANCER RES TR, V80, P127, DOI 10.1023/A:1024439202528; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sundermann EE, 2010, MENOPAUSE, V17, P874, DOI 10.1097/gme.0b013e3181df4a19; Tural S, 2013, GENE, V515, P167, DOI 10.1016/j.gene.2012.10.041; Valero C, 2008, OSTEOPOROSIS INT, V19, P787, DOI 10.1007/s00198-007-0491-0; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; [王长海 Wang Changhai], 2012, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V18, P210; Wehren Lois E, 2003, Curr Osteoporos Rep, V1, P78, DOI 10.1007/s11914-003-0013-8; Wei GJ, 2012, GENET TEST MOL BIOMA, V16, P636, DOI 10.1089/gtmb.2011.0316; WOLINSKY FD, 1994, J GERONTOL, V49, pS165, DOI 10.1093/geronj/49.4.S165; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	48	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82806	10.1371/journal.pone.0082806	http://dx.doi.org/10.1371/journal.pone.0082806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24482673	Green Submitted, gold, Green Published			2022-12-27	WOS:000328740300071
J	Giannoni, A; Baruah, R; Leong, T; Rehman, MB; Pastormerlo, LE; Harrell, FE; Coats, AJS; Francis, DP				Giannoni, Alberto; Baruah, Resham; Leong, Tora; Rehman, Michaela B.; Pastormerlo, Luigi Emilio; Harrell, Frank E.; Coats, Andrew J. S.; Francis, Darrel P.			Do Optimal Prognostic Thresholds in Continuous Physiological Variables Really Exist? Analysis of Origin of Apparent Thresholds, with Systematic Review for Peak Oxygen Consumption, Ejection Fraction and BNP	PLOS ONE			English	Review							CONGESTIVE-HEART-FAILURE; BRAIN NATRIURETIC PEPTIDE; CARDIAC TROPONIN-T; RISK STRATIFICATION; RATE-VARIABILITY; CARDIOVASCULAR MORTALITY; VENTRICULAR-ARRHYTHMIAS; INDEPENDENT PREDICTOR; AMBULATORY PATIENTS; EXERCISE CAPACITY	Background: Clinicians are sometimes advised to make decisions using thresholds in measured variables, derived from prognostic studies. Objectives: We studied why there are conflicting apparently-optimal prognostic thresholds, for example in exercise peak oxygen uptake (pVO(2)), ejection fraction (EF), and Brain Natriuretic Peptide (BNP) in heart failure (HF). Data Sources and Eligibility Criteria: Studies testing pVO(2), EF or BNP prognostic thresholds in heart failure, published between 1990 and 2010, listed on Pubmed. Methods: First, we examined studies testing pVO(2), EF or BNP prognostic thresholds. Second, we created repeated simulations of 1500 patients to identify whether an apparently-optimal prognostic threshold indicates step change in risk. Results: 33 studies (8946 patients) tested a pVO(2) threshold. 18 found it prognostically significant: the actual reported threshold ranged widely (10-18 ml/kg/min) but was overwhelmingly controlled by the individual study population's mean pVO(2) (r = 0.86, p<0.00001). In contrast, the 15 negative publications were testing thresholds 199% further from their means (p = 0.0001). Likewise, of 35 EF studies (10220 patients), the thresholds in the 22 positive reports were strongly determined by study means (r = 0.90, p<0.0001). Similarly, in the 19 positives of 20 BNP studies (9725 patients): r = 0.86 (p<0.0001). Second, survival simulations always discovered a "most significant" threshold, even when there was definitely no step change in mortality. With linear increase in risk, the apparently-optimal threshold was always near the sample mean (r = 0.99, p<0.001). Limitations: This study cannot report the best threshold for any of these variables; instead it explains how common clinical research procedures routinely produce false thresholds. Key Findings: First, shifting (and/or disappearance) of an apparently-optimal prognostic threshold is strongly determined by studies' average pVO(2), EF or BNP. Second, apparently-optimal thresholds always appear, even with no step in prognosis. Conclusions: Emphatic therapeutic guidance based on thresholds from observational studies may be ill-founded. We should not assume that optimal thresholds, or any thresholds, exist.	[Giannoni, Alberto; Baruah, Resham; Leong, Tora; Coats, Andrew J. S.; Francis, Darrel P.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England; [Giannoni, Alberto; Pastormerlo, Luigi Emilio] Fdn Toscana G Monasterio, Dept Cardiovasc Med, Pisa, Italy; [Coats, Andrew J. S.] Univ E Anglia, Norfolk & Norwich Hosp, Norwich NR4 7TJ, Norfolk, England; [Rehman, Michaela B.] Univ Poitiers Hosp, Dept Cardiol, Poitiers, France; [Harrell, Frank E.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Imperial College London; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of East Anglia; CHU Poitiers; Universite de Poitiers; Vanderbilt University	Giannoni, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England.	alberto.giannoni@gmail.com	Giannoni, Alberto/K-3255-2016	Giannoni, Alberto/0000-0001-9314-2005; Pastormerlo, Luigi Emilio/0000-0003-2403-3766	British Heart Foundation [PG/07/065, FS/10/038]; British Heart Foundation [FS/10/38/28268] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	RB (PG/07/065) and DPF (FS/10/038) were supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Andreas S, 1996, AM J CARDIOL, V78, P1260, DOI 10.1016/S0002-9149(96)00608-X; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Arena R, 2006, INT J CARDIOL, V106, P88, DOI 10.1016/j.ijcard.2004.12.071; Arena R, 2008, AM HEART J, V156, P982, DOI 10.1016/j.ahj.2008.06.024; Arena R, 2010, INT J CARDIOL, V138, P166, DOI 10.1016/j.ijcard.2008.08.010; Arslan S, 2007, TEX HEART I J, V34, P166; Banner NR, 2011, HEART, V97, P1520, DOI 10.1136/heartjnl-2011-300048; Bard RL, 2006, J HEART LUNG TRANSPL, V25, P589, DOI 10.1016/j.healun.2005.11.448; Bertinchant JP, 2005, CLIN CHIM ACTA, V352, P143, DOI 10.1016/j.cccn.2004.09.009; Bettencourt P, 2004, INT J CARDIOL, V93, P45, DOI 10.1016/S0167-5273(03)00115-3; Bloomfield DM, 2006, J AM COLL CARDIOL, V47, P456, DOI 10.1016/j.jacc.2005.11.026; Chomsky DB, 1996, CIRCULATION, V94, P3176, DOI 10.1161/01.CIR.94.12.3176; Christ M, 2007, EUR J CLIN INVEST, V37, P834, DOI 10.1111/j.1365-2362.2007.01871.x; Clark AL, 2000, INT J CARDIOL, V73, P61, DOI 10.1016/S0167-5273(99)00223-5; Cleland JG, 2013, EUR HEART J IN PRESS; Cohen-Solal A, 1997, HEART, V78, P572, DOI 10.1136/hrt.78.6.572; Cohen-Solal A, 2009, J AM COLL CARDIOL, V53, P2343, DOI 10.1016/j.jacc.2009.02.058; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Corra U, 2002, AM HEART J, V143, P418, DOI 10.1067/mhj.2002.120772; Davies LC, 2000, HEART, V83, P147, DOI 10.1136/heart.83.2.147; de Groote P, 2004, AM HEART J, V148, P349, DOI 10.1016/j.ahj.2004.03.044; Dhaliwal AS, 2009, J CARD FAIL, V15, P293, DOI 10.1016/j.cardfail.2008.11.007; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Dini FL, 2008, EUR J HEART FAIL, V10, P573, DOI 10.1016/j.ejheart.2008.04.003; Dini FL, 2007, AM HEART J, V154, P172, DOI 10.1016/j.ahj.2007.03.033; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; El-Saed Aiman, 2009, Clin Cardiol, V32, pE33, DOI 10.1002/clc.20490; Francis DP, 2000, EUR HEART J, V21, P154, DOI 10.1053/euhj.1999.1863; Frantz RP, 2007, J CARD FAIL, V13, P437, DOI 10.1016/j.cardfail.2007.03.007; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Ghio S, 2000, AM J CARDIOL, V85, P837, DOI 10.1016/S0002-9149(99)00877-2; Giannuzzi P, 1996, J AM COLL CARDIOL, V28, P383, DOI 10.1016/0735-1097(96)00163-5; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Guazzi M, 2005, EUR HEART J, V26, P472, DOI 10.1093/eurheartj/ehi060; Guazzi M, 2007, J AM COLL CARDIOL, V50, P299, DOI 10.1016/j.jacc.2007.03.042; Guazzi M, 2007, AM HEART J, V153, P859, DOI 10.1016/j.ahj.2007.02.034; Hansen A, 2001, J AM COLL CARDIOL, V37, P1049, DOI 10.1016/S0735-1097(00)01211-0; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; HILSENBECK SG, 1992, BREAST CANCER RES TR, V22, P197, DOI 10.1007/BF01840833; Hulsmann M, 2005, EUR J HEART FAIL, V7, P552, DOI 10.1016/j.ejheart.2004.12.001; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Isnard R, 2000, AM J CARDIOL, V86, P417, DOI 10.1016/S0002-9149(00)00957-7; ITOH A, 1992, INTERNAL MED, V31, P304, DOI 10.2169/internalmedicine.31.304; Izawa KP, 2009, EUR J CARDIOV PREV R, V16, P21, DOI 10.1097/HJR.0b013e32831269a3; Junger J, 2005, EUR J HEART FAIL, V7, P261, DOI 10.1016/j.ejheart.2004.05.011; Karvanen J, 2009, STAT MED, V28, P1957, DOI 10.1002/sim.3591; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Lamblin N, 2005, EUR HEART J, V26, P2245, DOI 10.1093/eurheartj/ehi501; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; Martinez-Selles M, 2003, EUR HEART J, V24, P2046, DOI 10.1016/j.ehj.2003.07.007; Masson S, 2006, CLIN CHEM, V52, P1528, DOI 10.1373/clinchem.2006.069575; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P1024, DOI 10.1016/j.healun.2006.06.008; MEHTA D, 1992, AM HEART J, V124, P1608, DOI 10.1016/0002-8703(92)90080-F; Mejhert M, 2002, HEART, V88, P239, DOI 10.1136/heart.88.3.239; Metra M, 1999, J AM COLL CARDIOL, V33, P943, DOI 10.1016/S0735-1097(98)00672-X; Moertl D, 2009, J CARD FAIL, V15, P233, DOI 10.1016/j.cardfail.2008.11.002; MUDGE GH, 1993, J AM COLL CARDIOL, V22, P21, DOI 10.1016/0735-1097(93)90812-F; Nanas SN, 2006, EUR J HEART FAIL, V8, P420, DOI 10.1016/j.ejheart.2005.10.003; Neglia D, 2002, CIRCULATION, V105, P186, DOI 10.1161/hc0202.102119; Niebauer J, 1999, INT J CARDIOL, V70, P245, DOI 10.1016/S0167-5273(99)00088-1; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Nishio Y, 2007, CIRC J, V71, P631, DOI 10.1253/circj.71.631; O'Neill JO, 2005, CIRCULATION, V111, P2313, DOI 10.1161/01.CIR.0000164270.72123.18; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; OMLAND T, 1995, AM J CARDIOL, V76, P230, DOI 10.1016/S0002-9149(99)80071-X; Osman AF, 2000, J AM COLL CARDIOL, V36, P2126, DOI 10.1016/S0735-1097(00)00985-2; PARAMESHWAR J, 1992, AM HEART J, V123, P421, DOI 10.1016/0002-8703(92)90656-G; Parissis JT, 2009, EUR J HEART FAIL, V11, P967, DOI 10.1093/eurjhf/hfp125; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Peterson LR, 2003, J HEART LUNG TRANSPL, V22, P1141, DOI 10.1016/S1053-2498(02)01225-1; Petersson M, 2005, EUR HEART J, V26, P906, DOI 10.1093/eurheartj/ehi184; Pfister R, 2008, EUR J HEART FAIL, V10, P315, DOI 10.1016/j.ejheart.2008.01.009; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; Raphael CE, 2009, HEART, V95, P56, DOI 10.1136/hrt.2007.134973; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; Robbins M, 1999, CIRCULATION, V100, P2411, DOI 10.1161/01.CIR.100.24.2411; Rossi A, 2007, HEART, V93, P1420, DOI 10.1136/hrt.2006.101261; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; ROUL G, 1995, EUR HEART J, V16, P1387, DOI 10.1093/oxfordjournals.eurheartj.a060747; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Sachdeva A, 2010, AM J CARDIOL, V106, P830, DOI 10.1016/j.amjcard.2010.04.045; SAXON LA, 1993, AM J CARDIOL, V72, P62, DOI 10.1016/0002-9149(93)90220-7; Schalcher C, 2003, CHEST, V124, P580, DOI 10.1378/chest.124.2.580; SCHULGEN G, 1994, AM J EPIDEMIOL, V140, P172, DOI 10.1093/oxfordjournals.aje.a117227; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Smilde TDJ, 2009, CLIN RES CARDIOL, V98, P233, DOI 10.1007/s00392-009-0747-0; Sun T, 2007, INTERN MED J, V37, P168, DOI 10.1111/j.1445-5994.2006.01296.x; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Szabo BM, 1997, AM J CARDIOL, V79, P978, DOI 10.1016/S0002-9149(97)00026-X; Szachniewicz J, 2003, INT J CARDIOL, V90, P303, DOI 10.1016/S0167-5273(02)00574-0; SZLACHCIC J, 1985, AM J CARDIOL, V55, P1037, DOI 10.1016/0002-9149(85)90742-8; VANDENBROEK SAJ, 1992, AM J CARDIOL, V70, P359, DOI 10.1016/0002-9149(92)90619-A; von Haehling S, 2007, J AM COLL CARDIOL, V50, P1973, DOI 10.1016/j.jacc.2007.08.012; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098; Wainer H., 2006, CHANCE, V19, P49, DOI DOI 10.1080/09332480.2006.10722771; Watanabe J, 2005, J CARD FAIL, V11, P50, DOI 10.1016/j.cardfail.2004.06.434; Whalley GA, 2008, EUR HEART J, V29, P509, DOI 10.1093/eurheartj/ehm647; Wijbenga JAM, 1998, EUR HEART J, V19, P1719, DOI 10.1053/euhj.1998.1148; Williams SG, 2001, EUR HEART J, V22, P1496, DOI 10.1053/euhj.2000.2547; Yu CM, 1999, EUR J HEART FAIL, V1, P59, DOI 10.1016/S1388-9842(98)00010-5	105	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e81699	10.1371/journal.pone.0081699	http://dx.doi.org/10.1371/journal.pone.0081699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475020	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300006
J	Kallis, YN; Scotton, CJ; MacKinnon, AC; Goldin, RD; Wright, NA; Iredale, JP; Chambers, RC; Forbes, SJ				Kallis, Yiannis N.; Scotton, Christopher J.; MacKinnon, Alison C.; Goldin, Robert D.; Wright, Nicholas A.; Iredale, John P.; Chambers, Rachel C.; Forbes, Stuart J.			Proteinase Activated Receptor 1 Mediated Fibrosis in a Mouse Model of Liver Injury: A Role for Bone Marrow Derived Macrophages	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; THROMBIN RECEPTOR; LUNG INFLAMMATION; EXPRESSION; MONOCYTES; FIBROGENESIS; RECRUITMENT; THERAPY	Liver fibrosis results from the co-ordinated actions of myofibroblasts and macrophages, a proportion of which are of bone marrow origin. The functional effect of such bone marrow-derived cells on liver fibrosis is unclear. We examine whether changing bone marrow genotype can down-regulate the liver's fibrotic response to injury and investigate mechanisms involved. Proteinase activated receptor 1 (PAR1) is up-regulated in fibrotic liver disease in humans, and deficiency of PAR1 is associated with reduced liver fibrosis in rodent models. In this study, recipient mice received bone marrow transplantation from PAR1-deficient or wild-type donors prior to carbon tetrachloride-induced liver fibrosis. Bone marrow transplantation alone from PAR1-deficient mice was able to confer significant reductions in hepatic collagen content and activated myofibroblast expansion on wild-type recipients. This effect was associated with a decrease in hepatic scar-associated macrophages and a reduction in macrophage recruitment from the bone marrow. In vitro, PAR1 signalling on bone marrow-derived macrophages directly induced their chemotaxis but did not stimulate proliferation. These data suggest that the bone marrow can modulate the fibrotic response of the liver to recurrent injury. PAR1 signalling can contribute to this response by mechanisms that include the regulation of macrophage recruitment.	[Kallis, Yiannis N.] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London, England; [Scotton, Christopher J.; Chambers, Rachel C.] UCL, Ctr Inflammat & Tissue Repair, London, England; [MacKinnon, Alison C.; Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Goldin, Robert D.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England; [Wright, Nicholas A.] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, London, England; [Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	Imperial College London; University of London; University College London; University of Edinburgh; Imperial College London; University of London; Queen Mary University London; University of Edinburgh	Forbes, SJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Wright, Nicholas/HHY-7227-2022; Wright, Nicholas/AAF-1448-2020	Goldin, Robert/0000-0001-5184-4519; Chambers, Rachel/0000-0003-1370-9417; Iredale, John/0000-0003-2174-5127; Wright, Nicholas/0000-0002-5525-3457; Forbes, Stuart/0000-0003-3715-2561	MRC Clinical Research Training Fellowship [G0500428]; Wellcome Trust Programme Grant [071124]; MRC [G0901697, G0800340, G0600033, G0500428, G1000868] Funding Source: UKRI; Cancer Research UK [14895] Funding Source: researchfish; Medical Research Council [G0600033, G1000868, G0901697, G0500428, G0800340] Funding Source: researchfish	MRC Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for YNK SJF came from the MRC Clinical Research Training Fellowship (G0500428), www.mrc.ac.uk. For CJS RCC: Wellcome Trust Programme Grant (071124), www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Anstee QM, 2008, J THROMB HAEMOST; Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Duplantier JG, 2004, GUT, V53, P1682, DOI 10.1136/gut.2003.032136; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Gaca MDA, 2002, J HEPATOL, V36, P362, DOI 10.1016/S0168-8278(01)00285-9; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Howell DCJ, 2005, AM J PATHOL, V166, P1353, DOI 10.1016/S0002-9440(10)62354-1; Ide M, 2005, J COMP PATHOL, V133, P92, DOI 10.1016/j.jcpa.2005.01.011; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Luyendyk JP, 2010, AM J PATHOL, V176, P177, DOI 10.2353/ajpath.2010.090672; Marra F, 1998, HEPATOLOGY, V27, P462, DOI 10.1002/hep.510270221; Martinelli A, 2007, J GASTROENTEROL HEPA; Rullier A, 2006, VIRCHOWS ARCH, V448, P46, DOI 10.1007/s00428-005-0078-0; Rullier A, 2008, AM J PHYSIOL-GASTR L, V294, pG226, DOI 10.1152/ajpgi.00444.2007; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Schaffner A, 2005, J LEUKOCYTE BIOL, V78, P202, DOI 10.1189/jlb.0105024; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wright M, 2003, GUT, V52, P1206, DOI 10.1136/gut.52.8.1206	32	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86241	10.1371/journal.pone.0086241	http://dx.doi.org/10.1371/journal.pone.0086241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475094	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300048
J	Steinhauf, D; Rodriguez, A; Vlachakis, D; Virgo, G; Maksimov, V; Kristell, C; Olsson, I; Linder, T; Kossida, S; Bongcam-Rudloff, E; Bjerling, P				Steinhauf, Daniel; Rodriguez, Alejandro; Vlachakis, Dimitrios; Virgo, Gordon; Maksimov, Vladimir; Kristell, Carolina; Olsson, Ida; Linder, Tomas; Kossida, Sophia; Bongcam-Rudloff, Erik; Bjerling, Pernilla			Silencing Motifs in the Clr2 Protein from Fission Yeast, Schizosaccharomyces pombe	PLOS ONE			English	Article							MATING-TYPE REGION; HETEROCHROMATIN; RNAI; EFFICIENT; TRANSCRIPTION; LOCALIZATION; MAINTENANCE; EXPRESSION; NUCLEATION; MUTATIONS	The fission yeast, Schizosaccharomyces pombe, is a well-established model for heterochromatin formation, but the exact sequence of events for initiation remains to be elucidated. The essential factors involved include RNA transcribed from repeated sequences together with the methyltransferase Clr4. In addition, histone deacetylases, like Clr3, found in the SHREC complex are also necessary for transcriptional silencing. Clr2 is another crucial factor required for heterochromatin formation found in the SHREC complex. The function of Clr2 has been difficult to establish due to the lack of conserved domains or homology to proteins of known molecular function. Using a bioinformatics approach, three conserved motifs in Clr2 were identified, which contained amino acids important for transcriptional repression. Analysis of clr2 mutant strains revealed a major role for Clr2 in mating-type and rDNA silencing, and weaker effects on centromeric silencing. The effect on mating-type silencing showed variegation in several of the strains with mutated versions of Clr2 indicating an establishment or maintenance defect. Moreover, the critical amino acids in Clr2 were also necessary for transcriptional repression in a minimal system, by the tethering of Clr4 upstream of a reporter gene, inserted into the euchromatic part of the genome. Finally, in silico modeling suggested that the mutations in Clr2 cause disruption of secondary structures in the Clr2 protein. Identification of these critical amino acids in the protein provides a useful tool to explore the molecular mechanism behind the role of Clr2 in heterochromatin formation.	[Steinhauf, Daniel; Rodriguez, Alejandro; Virgo, Gordon; Maksimov, Vladimir; Kristell, Carolina; Olsson, Ida; Bjerling, Pernilla] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Vlachakis, Dimitrios; Kossida, Sophia] Acad Athens, Biomed Res Fdn, Bioinformat & Med Informat Lab, Athens, Greece; [Linder, Tomas] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, SLU Global Bioinformat Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden	Uppsala University; Academy of Athens; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Bjerling, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	Pernilla.Bjerling@imbim.uu.se	Linder, Tomas/AAN-3433-2020; Linder, Tomas/B-2492-2009; Vlachakis, Dimitrios/O-4323-2018; Kossida, Sofia/ABG-3526-2020	Linder, Tomas/0000-0001-5365-0494; Linder, Tomas/0000-0001-5365-0494; Vlachakis, Dimitrios/0000-0003-1823-6102; Bongcam-Rudloff, Erik/0000-0002-1947-8288; Maksimov, Vladimir/0000-0002-4029-8257	Swedish Cancer Society [2011/360]; Swedish Research Council [521-2011-2437]; Goran Gustafsson Fundation [289452]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Fundation	The work was supported by the Swedish Cancer Society, grant number 2011/360, http://www.cancerfonden.se; the Swedish Research Council, grant number 521-2011-2437, http://www.vr.se; the Goran Gustafsson Fundation, http://www.gustafssonsstiftelse.se/uu_kth/ALLBIO, FP7, grant number 289452, http://www.allbioinformatics.eu/doku.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arcangioli B, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P129; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bjerling P, 2004, NUCLEIC ACIDS RES, V32, P4421, DOI 10.1093/nar/gkh780; Bjerling P, 2002, BRAZ J MED BIOL RES, V35, P499, DOI 10.1590/S0100-879X2002000500001; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Buscaino A, 2013, EMBO J; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; EKWALL K, 1994, GENETICS, V136, P53; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kaiser Chris, 1994; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sellis D, 2009, BIOINFORM BIOL INSIG, V3, P99; Shanker S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001174; Suga M, 2003, CURR GENET, V43, P206, DOI 10.1007/s00294-003-0385-4; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Thon G, 1999, GENETICS, V151, P945; THON G, 1994, GENETICS, V138, P29; Thon G, 2002, GENETICS, V161, P611; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86948	10.1371/journal.pone.0086948	http://dx.doi.org/10.1371/journal.pone.0086948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475199	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300119
J	Tsai, YG; Lee, CY; Lin, TY; Lin, CY				Tsai, Yi-Giien; Lee, Chia-Ying; Lin, Tze-Yi; Lin, Ching-Yuang			CD8(+) Treg Cells Associated with Decreasing Disease Activity after Intravenous Methylprednisolone Pulse Therapy in Lupus Nephritis with Heavy Proteinuria	PLOS ONE			English	Article							REGULATORY T-CELLS; MEDIATED SUPPRESSION; GRANZYME-B; ERYTHEMATOSUS; INDUCTION; TOLERANCE; ACTIVATION; MECHANISMS; GENERATION; EXPRESSION	We focus on the role of CD8(+) Treg cell in Intravenous methyl-prednisolone (IVMP) pulse therapy in forty patients with active Class III/IV childhood lupus nephritis (LN) with heavy proteinuria. IVMP therapy for five days. From peripheral blood mononuclear cells (PBMCs) and renal tissues, we saw IVMP therapy definitely restoring both CD4(+)CD25(+)FoxP3(+) and CD8(+)CD25(+)Foxp3(+) Treg cell number plus greater expression with intracellular IL-10 and granzyme B in CD8(+)FoxP3(+) Treg from PBMCs. IVMP-treated CD8(+)CD25(+) Treg cells directly suppressed CD4(+) T proliferation and induced CD4(+) CD45RO(+) apoptosis. Histologically, CD4(+)FoxP3(+) as well as CD8(+)FoxP3(+) Treg cells appeared in renal tissue of LN patients before IVMP by double immunohistochemical stain. CD8(+)FoxP3(+) Treg cells increased in 10 follow-up renal biopsy specimens after IVMP. Reverse correlation of serum anti-C1q antibody and FoxP3(+) Treg cells in PBMNCs (r = -0.714, P<0.01). After IVMP, serum anti-C1q antibody decrease accompanied increase of CD4(+) FoxP3(+) Treg cells. CD8(+) Treg cells reduced interferon-r response in PBMCs to major peptide autoepitopes from nucleosomes after IVMP therapy; siRNA of FoxP3 suppressed granzyme B expression while decreasing CD8(+)CD25(+)Treg-induced CD4(+)CD45RO(+) apoptosis. Renal activity of LN by SLEDAI-2k in childhood LN was significantly higher than two weeks after IVMP (P<0.01). CD8(+)FoxP3(+) Treg cells return in post-IVMP therapy and exert crucial immune modulatory effect to control autoimmune response in LN.	[Tsai, Yi-Giien] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Tsai, Yi-Giien] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Chia-Ying; Lin, Ching-Yuang] China Med Univ Hosp, Div Pediat Nephrol, Taichung, Taiwan; [Lin, Tze-Yi] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ, Coll Med, Taichung, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lin, CY (corresponding author), China Med Univ Hosp, Div Pediat Nephrol, Taichung, Taiwan.	cylin@mail.cmuh.org.tw			National Science Council, Taiwan [NSC 98-2314-B-039-006-MY3, 98-2314-B-371-001-MY2, NSC 100-2314-B-371 -005]; China Medium University Hospital [DMR-100-180]; Changhua Christian Hospital	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); China Medium University Hospital; Changhua Christian Hospital	This work was partially supported by grants from the National Science Council, Taiwan (NSC 98-2314-B-039-006-MY3, 98-2314-B-371-001-MY2, NSC 100-2314-B-371 -005); and China Medium University Hospital (DMR-100-180), Changhua Christian Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; Brunner HI, 2002, ARTHRITIS RHEUM, V46, P436, DOI 10.1002/art.10072; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; Datta SK, 2005, J MOL MED, V83, P267, DOI 10.1007/s00109-004-0624-2; David S, 1997, NEPHROL DIAL TRANSPL, V12, P51, DOI 10.1093/ndt/12.1.51; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Endharti AT, 2011, J IMMUNOL, V186, P41, DOI 10.4049/jimmunol.1000800; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gladman DD, 2000, J RHEUMATOL, V27, P377; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Hass C, 1998, J IMMUNOL, V160, P3173; HAY EM, 1993, Q J MED, V86, P447; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Joetham A, 2008, J IMMUNOL, V180, P7117, DOI 10.4049/jimmunol.180.11.7117; Kaliyaperumal A, 2002, J IMMUNOL, V168, P2530, DOI 10.4049/jimmunol.168.5.2530; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Keino H, 2006, INVEST OPHTH VIS SCI, V47, P1533, DOI 10.1167/iovs.04-1454; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Ling Y, 2007, EUR J HAEMATOL, V79, P310, DOI 10.1111/j.1600-0609.2007.00917.x; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; Nakatani K, 2004, KIDNEY INT, V65, P1290, DOI 10.1111/j.1523-1755.2004.00537.x; Navarro J, 2006, J NEUROIMMUNOL, V176, P153, DOI 10.1016/j.jneuroim.2006.03.022; Polcher M, 2010, CANCER IMMUNOL IMMUN, V59, P909, DOI 10.1007/s00262-010-0817-1; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SERON D, 1991, NEPHROL DIAL TRANSPL, V6, P917, DOI 10.1093/ndt/6.12.917; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Siegmund K, 2009, J IMMUNOL, V182, P2124, DOI 10.4049/jimmunol.0802271; Skaggs BJ, 2008, HUM IMMUNOL, V69, P790, DOI 10.1016/j.humimm.2008.08.284; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Suen JL, 2009, IMMUNOLOGY, V127, P196, DOI 10.1111/j.1365-2567.2008.02937.x; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Tower C, 2011, NAT REV RHEUMATOL, V7, P124, DOI 10.1038/nrrheum.2010.124; Tsai YG, 2010, J IMMUNOL, V184, P7229, DOI 10.4049/jimmunol.1000083; Tucci M, 2008, CLIN EXP IMMUNOL, V154, P247, DOI 10.1111/j.1365-2249.2008.03758.x; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Wang RF, 2008, HUM IMMUNOL, V69, P811, DOI 10.1016/j.humimm.2008.08.276; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; Wu HY, 2004, LUPUS, V13, P192, DOI 10.1191/0961203303lu1002oa; Yamada A, 2009, J ALLERGY CLIN IMMUN, V123, P889, DOI 10.1016/j.jaci.2008.12.1115; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Zhang L, 2009, J IMMUNOL, V183, P6346, DOI 10.4049/jimmunol.0901773	51	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e81344	10.1371/journal.pone.0081344	http://dx.doi.org/10.1371/journal.pone.0081344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475019	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300005
J	Coats, RO; Wilson, AD; Snapp-Childs, W; Fath, AJ; Bingham, GP				Coats, Rachel O.; Wilson, Andrew D.; Snapp-Childs, Winona; Fath, Aaron J.; Bingham, Geoffrey P.			The 50s Cliff: Perceptuo-Motor Learning Rates across the Lifespan	PLOS ONE			English	Article							RHYTHMIC MOVEMENT COORDINATION; PHASE-TRANSITIONS; 3-D SHAPE; PERCEPTION; MOTION; AGE; MODEL; INFORMATION; STABILITY; FEEDBACK	We recently found that older adults show reduced learning rates when learning a new pattern of coordinated rhythmic movement. The purpose of this study was to extend that finding by examining the performance of all ages across the lifespan from the 20 s through to the 80 s to determine how learning rates change with age. We tested whether adults could learn to produce a novel coordinated rhythmic movement (90 degrees relative phase) in a visually guided unimanual task. We determined learning rates to quantify changes in learning with age and to determine at what ages the changes occur. We found, as before, that learning rates of participants in their 70 s and 80 s were half those of participants in their 20 s. We also found a gradual slow decline in learning rate with age until approximately age 50, when there was a sudden drop to a reduced learning rate for the 60 though 80 year olds. We discuss possible causes for the "50 s cliff'' in perceptuo-motor learning rates and suggest that age related deficits in perception of complex motions may be the key to understanding this result.	[Coats, Rachel O.] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England; [Wilson, Andrew D.] Leeds Metropolitan Univ, Sch Social Psychol & Commun Sci, Leeds LS1 3HE, W Yorkshire, England; [Snapp-Childs, Winona; Fath, Aaron J.; Bingham, Geoffrey P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Leeds; Leeds Beckett University; Indiana University System; Indiana University Bloomington	Coats, RO (corresponding author), Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England.	r.o.a.coats@leeds.ac.uk	Coats, Rachel/AAH-6980-2019; Wilson, Andrew/A-7891-2008	Coats, Rachel/0000-0003-4415-408X; Wilson, Andrew/0000-0002-0459-0728; Snapp-Childs, Winona/0000-0003-4354-7092; Fath, Aaron J/0000-0003-3451-2306				Andersen GJ, 2012, WIRES COGN SCI, V3, P403, DOI 10.1002/wcs.1167; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Bingham GP, 2004, ECOL PSYCHOL, V16, P45, DOI 10.1207/s15326969eco1601_6; Bingham GP, 2004, THEORIES TIME TO CON; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Coats RO, 2013, EXP BRAIN RES, V225, P75, DOI 10.1007/s00221-012-3349-4; de Rekeneire N, 2003, J AM GERIATR SOC, V51, P841, DOI 10.1046/j.1365-2389.2003.51267.x; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kleiner M., 2007, PERC 36 ECVP S; Kovacs AJ, 2009, NEUROSCI LETT, V455, P162, DOI 10.1016/j.neulet.2009.02.046; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; Norman JF, 2004, PSYCHOL AGING, V19, P506, DOI 10.1037/0882-7974.19.3.506; Norman JF, 2003, PERCEPTION, V32, P85, DOI 10.1068/p3478; Norman JF, 2000, PERCEPTION, V29, P1335, DOI 10.1068/p3111; Pedhazur E. J., 1982, MULTIPLE REGRESSION; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Serrien DJ, 2000, J GERONTOL B-PSYCHOL, V55, pP295, DOI 10.1093/geronb/55.5.P295; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Snowden RJ, 2006, PERCEPTION, V35, P9, DOI 10.1068/p5399; SPIRDUSO WW, 1995, PHYS DIMENSIONS AGIN, P5; Swinnen SP, 1998, COGN NEUROPSYCHOL, V15, P439, DOI 10.1080/026432998381104; Temprado JJ, 2003, HUM MOVEMENT SCI, V22, P339, DOI 10.1016/S0167-9457(03)00049-6; Wenderoth N, 2002, MOTOR CONTROL, V6, P166, DOI 10.1123/mcj.6.2.166; Wilson AD, 2005, EXP BRAIN RES, V165, P351, DOI 10.1007/s00221-005-2301-2; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2008, PERCEPT PSYCHOPHYS, V70, P465, DOI 10.3758/PP.70.3.465; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Wishart LR, 2002, ACTA PSYCHOL, V110, P247, DOI 10.1016/S0001-6918(02)00036-7; YAMANISHI J, 1980, BIOL CYBERN, V37, P219, DOI 10.1007/BF00337040; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	36	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85758	10.1371/journal.pone.0085758	http://dx.doi.org/10.1371/journal.pone.0085758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298QQ	24475051	Green Published, gold			2022-12-27	WOS:000330339800016
J	Dunty, WC; Kennedy, MWL; Chalamalasetty, RB; Campbell, K; Yamaguchi, TP				Dunty, William C., Jr.; Kennedy, Mark W. L.; Chalamalasetty, Ravindra B.; Campbell, Kenneth; Yamaguchi, Terry P.			Transcriptional Profiling of Wnt3a Mutants Identifies Sp Transcription Factors as Essential Effectors of the Wnt/beta-catenin Pathway in Neuromesodermal Stem Cells	PLOS ONE			English	Article							BETA-CATENIN; PARAXIAL MESODERM; NEGATIVE REGULATOR; AXIAL PROGENITORS; MOUSE; GENE; SEGMENTATION; BRACHYURY; TARGET; SPECIFICATION	Neuromesodermal (NM) stem cells reside in the primitive streak (PS) of gastrulating vertebrate embryos and generate precursors of the spinal cord and musculoskeletal system. Although Wnt3a/beta-catenin signaling is crucial for NM stem cell maintenance and differentiation, few key transcriptional effectors have been identified. Through a concerted transcriptional profiling and genetic approach we have determined that two Zn2+-finger transcription factors, Sp5 and Sp8, are regulated by Wnt3a in the PS, and are essential for neural and musculoskeletal patterning. These results identify Sp5 and Sp8 as pivotal downstream effectors of Wnt3a, and suggest that they are essential for the self-renewal and differentiation of NM stem cells.	[Dunty, William C., Jr.; Kennedy, Mark W. L.; Chalamalasetty, Ravindra B.; Yamaguchi, Terry P.] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Campbell, Kenneth] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cincinnati Children's Hospital Medical Center	Yamaguchi, TP (corresponding author), NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA.	yamagute@mail.nih.gov	Campbell, Kenneth/ABC-3570-2021		Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Biris KK, 2007, DEV DYNAM, V236, P3167, DOI 10.1002/dvdy.21342; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Merrill BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007971; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Treichel D, 2003, GENE DEV, V17, P2630, DOI 10.1101/gad.274103; Treichel D, 2001, MECH DEVELOP, V101, P175, DOI 10.1016/S0925-4773(00)00544-X; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yoon JK, 2000, GENE DEV, V14, P3204, DOI 10.1101/gad.850000; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	39	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87018	10.1371/journal.pone.0087018	http://dx.doi.org/10.1371/journal.pone.0087018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475213	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800078
J	Lahaye, SEP; Eens, M; Darras, VM; Pinxten, R				Lahaye, Stefanie E. P.; Eens, Marcel; Darras, Veerle M.; Pinxten, Rianne			Bare-Part Color in Female Budgerigars Changes from Brown to Structural Blue following Testosterone Treatment but Is Not Strongly Masculinized	PLOS ONE			English	Article							SUPERB FAIRY-WRENS; FOOTED BOOBY; MELOPSITTACUS-UNDULATUS; SEXUAL-DIFFERENTIATION; IMMUNE ACTIVATION; BILL COLOR; SHORT-TERM; PLUMAGE; REFLECTANCE; SIGNALS	Whereas several studies have shown that experimentally increased levels of the androgenic steroid testosterone can affect female behavior, fewer studies have focused on the activational effects of exogenous testosterone on female morphology. With respect to colorful displays in birds, almost exclusively the effects of testosterone manipulation on female carotenoid-based colorations have been studied. Other color types such as structural colors (i.e. UV, blue and violet colors that result from differential light reflection in the nanostructures of the tissue) remain largely unstudied. Here, we investigated the short-and long-term effects of exogenous testosterone on the expression of structural bare-part coloration in female budgerigars, Melopsittacus undulatus. In this parrot species, bare-part coloration is expressed in the cere, a structure over the beak which is brown in females and structural blue in males. We experimentally increased plasma testosterone levels in testosterone-treated females (T-females) compared to controls (C-females) and we performed weekly spectrophotometric measurements of the cere for five weeks after implantation and one measurement after ten weeks. We also estimated the extent to which testosterone masculinized female cere color by comparing the experimental females with untreated males. We found significant effects of testosterone on cere color from week four after implantation onwards. T-females expressed significantly bluer ceres than C-females with higher values for brightness and UV reflectance. T-female cere color, however, remained significantly less blue than in males, while values for brightness and UV reflectance were significantly higher in T-females than in males. Our quantitative results show that exogenous testosterone induces the expression of structural blue color in females but does not strongly masculinize female cere coloration. We provide several potential pathways for the action of testosterone on structural color.	[Lahaye, Stefanie E. P.; Eens, Marcel; Pinxten, Rianne] Univ Antwerp, Res Grp Ethol, Antwerp, Belgium; [Darras, Veerle M.] Katholieke Univ Leuven, Lab Comparat Endocrinol, Louvain, Belgium	University of Antwerp; KU Leuven	Lahaye, SEP (corresponding author), Univ Antwerp, Res Grp Ethol, Antwerp, Belgium.	stefanie.lahaye@uantwerpen.be	Eens, Marcel/AAC-8466-2020		FWO-Flanders; University of Antwerp	FWO-Flanders(FWO); University of Antwerp	Stefanie E. P. Lahaye was funded by a PhD grant of FWO-Flanders. Marcel Eens and Rianne Pinxten were funded by the University of Antwerp and supported by FWO-Flanders (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Appeltants D, 2003, NEUROSCIENCE, V121, P801, DOI 10.1016/S0306-4522(03)00496-2; Ardia DR, 2010, HORM BEHAV, V58, P526, DOI 10.1016/j.yhbeh.2010.04.004; Arnold AP, 1996, HORM BEHAV, V30, P495, DOI 10.1006/hbeh.1996.0053; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; BALTHAZART J, 1995, TRENDS ENDOCRIN MET, V6, P21, DOI 10.1016/1043-2760(94)00098-O; Balthazart J, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1745; Baltz AP, 1996, ETHOLOGY, V102, P109; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Brockway B. F., 1964, Behaviour, V22, P193, DOI 10.1163/156853964X00021; Casagrande S, 2011, J COMP PHYSIOL A, V197, P1, DOI 10.1007/s00359-010-0579-4; Cox RM, 2005, COPEIA, P597; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Eda-Fujiwara H, 2003, J ETHOL, V21, P23, DOI 10.1007/s10164-002-0075-6; Eens M, 2000, HORM BEHAV, V37, P126, DOI 10.1006/hbeh.1999.1569; Ekstrom JMM, 2007, IBIS, V149, P313, DOI 10.1111/j.1474-919X.2006.00632.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fusani L, 2008, HORM BEHAV, V54, P227, DOI 10.1016/j.yhbeh.2008.04.004; Giraudeau M, 2010, P ROY SOC LOND B BIO, V278, P781; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Grill CP, 2000, BIOL J LINN SOC, V69, P121, DOI 10.1006/bijl.1999.0360; HAUSBERGER M, 1995, ETHOLOGY, V99, P193; Hegyi G, 2007, J AVIAN BIOL, V38, P698, DOI 10.1111/j.2007.0908-8857.04075.x; Heinsohn R, 2003, J ZOOL, V259, P197, DOI 10.1017/S0952836902003138; Sarasola JH, 2011, J ORNITHOL, V152, P473, DOI 10.1007/s10336-010-0606-9; Hill EG, 2006, BIRD COLORATION; Hill G. E., 2006, BIRD COLORATION, VII; Hill Geoffrey E., 2006, P137; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Juniper T, 1998, PARROTS GUIDE PARROT; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Kimball Rebecca T., 2006, P431; Knuttel H, 2001, J EXP BIOL, V204, P2447; KRINER E, 1991, ETHOLOGY, V87, P37; Lahaye SEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074005; Lahaye SEP, 2012, GEN COMP ENDOCR, V178, P82, DOI 10.1016/j.ygcen.2012.04.021; Lindsay WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026067; Littell R. C, 1996, SAS SYSTEM MIXED MOD; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Lupu CA, 2000, J AVIAN MED SURG, V14, P237, DOI 10.1647/1082-6742(2000)014[0237:EOSEOT]2.0.CO;2; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2006, PHYSIOL BEHAV, V88, P347, DOI 10.1016/j.physbeh.2006.04.003; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; McGraw KJ, 2006, BIRD COLORARION, P354; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; Montgomerie R., 2006, BIRD COLORATION, P90; Morales J, 2012, BEHAV ECOL SOCIOBIOL, V66, P135, DOI 10.1007/s00265-011-1261-8; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Mougeot F, 2006, BIOL LETTERS, V2, P173, DOI 10.1098/rsbl.2005.0434; MUNDINGER PC, 1972, AUK, V89, P403, DOI 10.2307/4084214; Negro JJ, 2001, FUNCT ECOL, V15, P297, DOI 10.1046/j.1365-2435.2001.00526.x; Nespor AA, 1996, HORM BEHAV, V30, P162, DOI 10.1006/hbeh.1996.0020; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Pearn SM, 2003, P ROY SOC B-BIOL SCI, V270, P859, DOI 10.1098/rspb.2002.2315; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters A, 2007, IBIS, V149, P121; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Rosen RF, 2006, ETHOLOGY, V112, P1008, DOI 10.1111/j.1439-0310.2006.01257.x; Siitari H, 2007, AM NAT, V169, pS81, DOI 10.1086/510140; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Taysom AJ, 2011, J EVOLUTION BIOL, V24, P303, DOI 10.1111/j.1420-9101.2010.02166.x; Torres R, 2005, ANIM BEHAV, V69, P59, DOI 10.1016/j.anbehav.2004.03.008; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; Van Hout AJM, 2010, GEN COMP ENDOCR, V168, P505, DOI 10.1016/j.ygcen.2010.06.012; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Vroonen J, 2012, BIOL J LINN SOC, V107, P182, DOI 10.1111/j.1095-8312.2012.01915.x; Whitaker B, 1990, THESIS STATE U NEW J	77	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86849	10.1371/journal.pone.0086849	http://dx.doi.org/10.1371/journal.pone.0086849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475184	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800063
J	Liao, JM; Li, X; Wong, TY; Wang, JJ; Khor, CC; Tai, ES; Aung, T; Teo, YY; Cheng, CY				Liao, Jiemin; Li, Xiang; Wong, Tien-Yin; Wang, Jie Jin; Khor, Chiea Chuen; Tai, E. Shyong; Aung, Tin; Teo, Yik-Ying; Cheng, Ching-Yu			Impact of Measurement Error on Testing Genetic Association with Quantitative Traits	PLOS ONE			English	Article							SAMPLE-SIZE CALCULATIONS; BLOOD-PRESSURE; EYE DISEASES; POWER; MISCLASSIFICATION; METHODOLOGY; VARIABILITY; PHENOTYPE; GENOTYPE; LINKAGE	Measurement error of a phenotypic trait reduces the power to detect genetic associations. We examined the impact of sample size, allele frequency and effect size in presence of measurement error for quantitative traits. The statistical power to detect genetic association with phenotype mean and variability was investigated analytically. The non-centrality parameter for a non-central F distribution was derived and verified using computer simulations. We obtained equivalent formulas for the cost of phenotype measurement error. Effects of differences in measurements were examined in a genome-wide association study (GWAS) of two grading scales for cataract and a replication study of genetic variants influencing blood pressure. The mean absolute difference between the analytic power and simulation power for comparison of phenotypic means and variances was less than 0.005, and the absolute difference did not exceed 0.02. To maintain the same power, a one standard deviation (SD) in measurement error of a standard normal distributed trait required a one-fold increase in sample size for comparison of means, and a three-fold increase in sample size for comparison of variances. GWAS results revealed almost no overlap in the significant SNPs (p<10(-5)) for the two cataract grading scales while replication results in genetic variants of blood pressure displayed no significant differences between averaged blood pressure measurements and single blood pressure measurements. We have developed a framework for researchers to quantify power in the presence of measurement error, which will be applicable to studies of phenotypes in which the measurement is highly variable.	[Liao, Jiemin; Wong, Tien-Yin; Khor, Chiea Chuen; Aung, Tin; Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Liao, Jiemin; Wong, Tien-Yin; Khor, Chiea Chuen; Tai, E. Shyong; Aung, Tin; Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Liao, Jiemin; Li, Xiang; Wong, Tien-Yin; Aung, Tin; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Li, Xiang; Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Wong, Tien-Yin; Tai, E. Shyong; Teo, Yik-Ying; Cheng, Ching-Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia; [Khor, Chiea Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong; Cheng, Ching-Yu] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Cheng, CY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore.	ching-yu_cheng@nuhs.edu.sg	Wang, Jie Jin/P-1499-2014; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Cheng, Ching-Yu/Y-2229-2019	Wang, Jie Jin/0000-0001-9491-4898; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Khor, Chiea Chuen/0000-0002-1128-4729	National Medical Research Council [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council, Singapore [09/1/35/19/616]; NMRC [CSA/033/2012, CSA/008/2009]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); NMRC(National Medical Research Council, Singapore)	SiMES and SCES are funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and CG/SERI/2010) and Biomedical Research Council (grants 09/1/35/19/616), Singapore. Ching-Yu Cheng is supported by an award from NMRC (CSA/033/2012) and E-Shyong Tai is supported by an award from NMRC (CSA/008/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barendse W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-232; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Bollinger CR, 2005, J LABOR ECON, V23, P235, DOI 10.1086/428028; Buonaccorsi JP, 2011, STAT METHODS MED RES; Chen XH, 2005, REV ECON STUD, V72, P343, DOI 10.1111/j.1467-937X.2005.00335.x; Cheng KF, 2009, HUM HERED, V67, P77, DOI 10.1159/000179556; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; COCHRAN WG, 1968, TECHNOMETRICS, V10, P637, DOI 10.2307/1267450; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Devine OJ, 1998, STAT MED, V17, P1375, DOI 10.1002/(SICI)1097-0258(19980630)17:12<1375::AID-SIM857>3.0.CO;2-D; Diem P, 2004, ARCH MED RES, V35, P145, DOI 10.1016/j.arcmed.2003.10.003; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Fan Q, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002402; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fuller W.A., 2009, MEASUREMENT ERROR MO; Gordon D, 2005, BIOINFORMATICS, V21, P3935, DOI 10.1093/bioinformatics/bti643; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; Hardin JW, 2003, STATA J, V3, P361, DOI 10.1177/1536867X0300300406; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Kleinbaum DG, 2007, APPL REGRESSION ANAL, Vxxi; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Lam AKC, 2001, OPHTHAL PHYSL OPT, V21, P477, DOI 10.1046/j.1475-1313.2001.00611.x; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Li H, 2008, OPHTHALMOLOGY, V115, P796, DOI 10.1016/j.ophtha.2007.07.006; Li X, 2012, INVEST OPHTH VIS SCI, V53, P3082, DOI 10.1167/iovs.12-9967; Lindstrom S, 2009, HUM HERED, V68, P171, DOI 10.1159/000224637; Lynch M., 1998, GENETICS ANAL QUANTI; MANOLIO TA, 1988, AM J HYPERTENS, V1, pS161, DOI 10.1093/ajh/1.3.161S; PANNARALE G, 1993, HYPERTENSION, V22, P591, DOI 10.1161/01.HYP.22.4.591; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2012, R LANG ENV STAT COMP; Samuels DC, 2009, TRENDS GENET, V25, P486, DOI 10.1016/j.tig.2009.09.008; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; Visscher PM, 2010, BEHAV GENET, V40, P728, DOI 10.1007/s10519-010-9362-0; Wojczynski MK, 2008, ADV GENET, V60, P75, DOI 10.1016/S0065-2660(07)00404-X; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	43	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87044	10.1371/journal.pone.0087044	http://dx.doi.org/10.1371/journal.pone.0087044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475218	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800080
J	Lorente-Cebrian, S; Mejhert, N; Kulyte, A; Laurencikiene, J; Astrom, G; Heden, P; Ryden, M; Arner, P				Lorente-Cebrian, Silvia; Mejhert, Niklas; Kulyte, Agne; Laurencikiene, Jurga; Astrom, Gaby; Heden, Per; Ryden, Mikael; Arner, Peter			MicroRNAs Regulate Human Adipocyte Lipolysis: Effects of miR-145 Are Linked to TNF-alpha	PLOS ONE			English	Article							NF-KAPPA-B; STIMULATES LIPOLYSIS; PROTEIN; KINASE; TARGETS; LIPASE	MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and have multiple effects in various tissues including adipose inflammation, a condition characterized by increased local release of the pro-lipolytic cytokine tumor necrosis factor-alpha (TNF-alpha). Whether miRNAs regulate adipocyte lipolysis is unknown. We set out to determine whether miRNAs affect adipocyte lipolysis in human fat cells. To this end, eleven miRNAs known to be present in human adipose tissue were over-expressed in human in vitro differentiated adipocytes followed by assessments of TNF-alpha and glycerol levels in conditioned media after 48 h. Three miRNAs (miR-145, -26a and let-7d) modulated both parameters in parallel. However, while miR-26a and let-7d decreased, miR-145 increased both glycerol release and TNF-alpha secretion. Further studies were focused therefore on miR-145 since this was the only stimulator of lipolysis and TNF-alpha secretion. Time-course analysis demonstrated that miR-145 over-expression up-regulated TNF-alpha expression/secretion followed by increased glycerol release. Increase in TNF-alpha production by miR-145 was mediated via activation of p65, a member of the NF-kappa B complex. In addition, miR-145 down-regulated the expression of the protease ADAM17, resulting in an increased fraction of membrane bound TNF-alpha, which is the more biologically active form of TNF-alpha. MiR-145 overexpression also increased the phosphorylation of activating serine residues in hormone sensitive lipase and decreased the mRNA expression of phosphodiesterase 3B, effects which are also observed upon TNF-alpha treatment in human adipocytes. We conclude that miR-145 regulates adipocyte lipolysis via multiple mechanisms involving increased production and processing of TNF-alpha in fat cells.	[Lorente-Cebrian, Silvia; Mejhert, Niklas; Kulyte, Agne; Laurencikiene, Jurga; Astrom, Gaby; Ryden, Mikael; Arner, Peter] Karolinska Inst, Lipid Lab, Dept Med Huddinge H7, Stockholm, Sweden; [Heden, Per] Akad Kliniken, Stockholm, Sweden	Karolinska Institutet	Lorente-Cebrian, S (corresponding author), Karolinska Inst, Lipid Lab, Dept Med Huddinge H7, Stockholm, Sweden.	Silvia.Lorente-Cebrian@ki.se; peter.arner@ki.se	Lorente-Cebrián, Silvia/N-2578-2019	Lorente-Cebrián, Silvia/0000-0002-1033-6152; Mejhert, Niklas/0000-0003-1785-833X; Arner, Peter/0000-0002-6208-6220; Kulyte, Agne/0000-0001-7745-2767; , Jurga/0000-0002-7032-2924	Swedish Research Council; Swedish Diabetes Foundation; Diabetes Program at Karolinska Institute; Swedish Cancer Foundation; Diabetes Wellness; Swedish Society of Medicine; Tore Nilsson Foundation; Foundation for Gamla Tjanarinnor; EASD/Lilly program; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0010187, NNF12OC1016371] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Diabetes Program at Karolinska Institute; Swedish Cancer Foundation; Diabetes Wellness; Swedish Society of Medicine; Tore Nilsson Foundation; Foundation for Gamla Tjanarinnor; EASD/Lilly program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by several grants from Swedish Research Council, The Swedish Diabetes Foundation, the Diabetes Program at Karolinska Institute, the Swedish Cancer Foundation, Diabetes Wellness, the Swedish Society of Medicine, Tore Nilsson Foundation, Foundation for Gamla Tjanarinnor and EASD/Lilly program and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Chen L, 2013, CELL BIOL INT, V37, P533, DOI 10.1002/cbin.10063; Clausen Trine Schnedler, 2009, Journal of Pharmacological and Toxicological Methods, V60, P281, DOI 10.1016/j.vascn.2009.03.001; Doberstein K, 2013, NEOPLASIA, V15, P218, DOI 10.1593/neo.121222; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kulyte A, 2002, MOL BIOL CELL, V13, P4195, DOI 10.1091/mbc.E02-03-0128; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Lorente-Cebrian S, 2011, OBESITY FACTS, V4, P365, DOI 10.1159/000334036; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pachler C, 2007, AM J PHYSIOL-ENDOC M, V293, pE690, DOI 10.1152/ajpendo.00034.2007; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; van Harmelen Vanessa, 2005, Methods Mol Med, V107, P125; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Williams MD, 2012, EXP DIABETES RES, DOI 10.1155/2012/484696; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yang XW, 2013, HEPATOLOGY RES OFFIC; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	30	70	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86800	10.1371/journal.pone.0086800	http://dx.doi.org/10.1371/journal.pone.0086800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475180	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800061
J	Hua, LS; Wang, J; Li, MX; Sun, XM; Zhang, LZ; Lei, CZ; Lan, XY; Fang, XT; Zhao, X; Chen, H				Hua, Liushuai; Wang, Jing; Li, Mingxun; Sun, Xiaomei; Zhang, Liangzhi; Lei, Chuzhao; Lan, Xianyong; Fang, Xingtang; Zhao, Xin; Chen, Hong			An Asp7Gly Substitution in PPARG Is Associated with Decreased Transcriptional Activation Activity	PLOS ONE			English	Article							PRO12ALA POLYMORPHISM; GENE POLYMORPHISMS; GAMMA; ADIPOCYTE; ADIPOGENESIS; PPAR-GAMMA-2; EXPRESSION; REGULATORS; CATTLE	As the master regulator of adipogenesis, peroxisome proliferator-activated receptor gamma (PPARG) is required for the accumulation of adipose tissue and hence contributes to obesity. A previous study showed that the substitution of +20A>G in PPARG changed the 7th amino acid from Asp to Gly, creating a mutant referred to as PPARG Asp7Gly. In this study, association analysis indicated that PPARG Asp7Gly was associated with lower body height, body weight and heart girth in cattle (P<0.05). Overexpression of PPARG in NIH3T3-L1 cells showed that the Asp7Gly substitution may cause a decrease in its adipogenic ability and the mRNA levels of CIDEC (cell death-inducing DFFA-like effector c) and aP2, which are all transcriptionally activated by PPARG during adipocyte differentiation. A dual-luciferase reporter assay was used to analyze the promoter activity of CIDEC. The results confirmed that the mutant PPARG exhibited weaker transcriptional activation activity than the wild type (P<0.05). These findings likely explain the associations between the Asp7Gly substitution and the body measurements. Additionally, the Asp7Gly mutation may be used in molecular marker assisted selection (MAS) of cattle breeding in the future.	[Hua, Liushuai; Wang, Jing; Li, Mingxun; Sun, Xiaomei; Zhang, Liangzhi; Lei, Chuzhao; Lan, Xianyong; Zhao, Xin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Hua, Liushuai; Wang, Jing] South China Inst Endangered Anim, Guangdong Entomol Inst, Guangdong Prov Publ Lab Wild Anim Conservat & Man, Guangzhou, Guangdong, Peoples R China; [Fang, Xingtang] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Zhao, Xin/M-4312-2015; Li, Mingxun/Y-7161-2019; WANG, JINGYI/GSJ-1241-2022	Zhao, Xin/0000-0002-1078-7332; 	National Natural Science Foundation of China [31272408]; National 863 Program of China [2013AA102505]; Program of National Beef Cattle and Yak Industrial Technology System [CARS-38]; College Industrialization Project of Jiangsu Province [JHB2012-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Program of National Beef Cattle and Yak Industrial Technology System; College Industrialization Project of Jiangsu Province	This study was supported by the National Natural Science Foundation of China (Grant No. 31272408), URL: http://www.nsfc.gov.cn/; National 863 Program of China (Grant No. 2013AA102505), URL: http://www.863.gov.cn/; Program of National Beef Cattle and Yak Industrial Technology System (Grant No. CARS-38), URL: http://www.beefsys.com/; College Industrialization Project of Jiangsu Province (JHB2012-32), URL: http://www.ec.js.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Doney A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-21; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; He K, 2013, MAMM GENOME, V24, P322, DOI 10.1007/s00335-013-9460-4; Hua LS, 2011, AFR J BIOTECHNOL, V10, P2785; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V377, P297, DOI 10.1016/j.bbrc.2008.09.129; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Rathod MA, 2009, OBESITY, V17, P657, DOI 10.1038/oby.2008.630; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055	21	0	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86954	10.1371/journal.pone.0086954	http://dx.doi.org/10.1371/journal.pone.0086954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466299	gold, Green Published, Green Submitted			2022-12-27	WOS:000330288000175
J	Kurka, H; Ehrenreich, A; Ludwig, W; Monot, M; Rupnik, M; Barbut, F; Indra, A; Dupuy, B; Liebl, W				Kurka, Hedwig; Ehrenreich, Armin; Ludwig, Wolfgang; Monot, Marc; Rupnik, Maja; Barbut, Frederic; Indra, Alexander; Dupuy, Bruno; Liebl, Wolfgang			Sequence Similarity of Clostridium difficile Strains by Analysis of Conserved Genes and Genome Content Is Reflected by Their Ribotype Affiliation	PLOS ONE			English	Article							IDENTIFICATION; EVOLUTION; MARKERS; DNA	PCR-ribotyping is a broadly used method for the classification of isolates of Clostridium difficile, an emerging intestinal pathogen, causing infections with increased disease severity and incidence in several European and North American countries. We have now carried out clustering analysis with selected genes of numerous C. difficile strains as well as gene content comparisons of their genomes in order to broaden our view of the relatedness of strains assigned to different ribotypes. We analyzed the genomic content of 48 C. difficile strains representing 21 different ribotypes. The calculation of distance matrix-based dendrograms using the neighbor joining method for 14 conserved genes (standard phylogenetic marker genes) from the genomes of the C. difficile strains demonstrated that the genes from strains with the same ribotype generally clustered together. Further, certain ribotypes always clustered together and formed ribotype groups, i.e. ribotypes 078, 033 and 126, as well as ribotypes 002 and 017, indicating their relatedness. Comparisons of the gene contents of the genomes of ribotypes that clustered according to the conserved gene analysis revealed that the number of common genes of the ribotypes belonging to each of these three ribotype groups were very similar for the 078/033/126 group (at most 69 specific genes between the different strains with the same ribotype) but less similar for the 002/017 group (86 genes difference). It appears that the ribotype is indicative not only of a specific pattern of the amplified 16S-23S rRNA intergenic spacer but also reflects specific differences in the nucleotide sequences of the conserved genes studied here. It can be anticipated that the sequence deviations of more genes of C. difficile strains are correlated with their PCR-ribotype. In conclusion, the results of this study corroborate and extend the concept of clonal C. difficile lineages, which correlate with ribotypes affiliation.	[Kurka, Hedwig; Ehrenreich, Armin; Ludwig, Wolfgang; Liebl, Wolfgang] Tech Univ Munich, Dept Microbiol, Freising Weihenstephan, Germany; [Monot, Marc; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Rupnik, Maja] Inst Publ Hlth Maribor, Ljubljana, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, Ljubljana, Slovenia; [Rupnik, Maja] Ctr Excellence Cipkebip, Ljubljana, Slovenia; [Barbut, Frederic] Fac Med Pierre & Marie Curie, Natl Reference Lab Clostridium Difficile, Paris, France; [Barbut, Frederic] Hop St Antoine, AP HP, F-75571 Paris, France; [Indra, Alexander] AGES Austrian Agcy Hlth & Food Safety, Inst Med Microbiol & Hyg, Vienna, Austria	Technical University of Munich; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Maribor; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Liebl, W (corresponding author), Tech Univ Munich, Dept Microbiol, Freising Weihenstephan, Germany.	wliebl@wzw.tum.de	Barbut, frederic/AAF-4952-2021; Liebl, Wolfgang/D-3766-2014; Monot, Marc/F-3058-2015	Liebl, Wolfgang/0000-0002-8421-2478; Monot, Marc/0000-0003-0738-7335; Ehrenreich, Armin/0000-0001-9580-3620	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support of this work (collaborative project CDIFFGEN - Pathogenomics of increased Clostridium difficile virulence) within the framework ERA-NET PathoGenoMics 2 by the German Federal Ministry of Education and Research (BMBF) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barbut F, 2012, CLIN INFECT DIS, V55, P1669, DOI 10.1093/cid/cis790; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Cheknis AK, 2009, ANAEROBE, V15, P230, DOI 10.1016/j.anaerobe.2009.09.001; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Gorbach SL, 1999, NEW ENGL J MED, V341, P1690, DOI 10.1056/NEJM199911253412211; He M, 2012, NAT GENET; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Indra A, 2010, J MED MICROBIOL, V59, P1317, DOI 10.1099/jmm.0.020792-0; Janezic S, 2010, SPRINGER PROTOCOLS M; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Knetsch CW, 2012, INFECT GENET EVOL, V12, P1577, DOI 10.1016/j.meegid.2012.06.003; Knetsch CW, 2011, MICROBIOL-SGM, V157, P3113, DOI 10.1099/mic.0.051953-0; Kuijper EJ, 2009, METHODS MOL BIOL, V551, P159, DOI 10.1007/978-1-60327-999-4_13; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W, 2010, MOLECULAR PHYLOGENY OF MICROORGANISMS, P65; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86535	10.1371/journal.pone.0086535	http://dx.doi.org/10.1371/journal.pone.0086535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24482682	Green Published, gold			2022-12-27	WOS:000330288000108
J	Schulze, H; Deutscher, A; Tziridis, K; Scheich, H				Schulze, Holger; Deutscher, Anke; Tziridis, Konstantin; Scheich, Henning			Unilateral Auditory Cortex Lesions Impair or Improve Discrimination Learning of Amplitude Modulated Sounds, Depending on Lesion Side	PLOS ONE			English	Article							GERBIL MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; FUNCTIONAL-ORGANIZATION; SUPERIOR COLLICULUS; TONES; PERCEPTION; LATERALIZATION; REPRESENTATION; INTERFERENCE; PERIODICITY	A fundamental principle of brain organization is bilateral symmetry of structures and functions. For spatial sensory and motor information processing, this organization is generally plausible subserving orientation and coordination of a bilaterally symmetric body. However, breaking of the symmetry principle is often seen for functions that depend on convergent information processing and lateralized output control, e. g. left hemispheric dominance for the linguistic speech system. Conversely, a subtle splitting of functions into hemispheres may occur if peripheral information from symmetric sense organs is partly redundant, e. g. auditory pattern recognition, and therefore allows central conceptualizations of complex stimuli from different feature viewpoints, as demonstrated e. g. for hemispheric analysis of frequency modulations in auditory cortex (AC) of mammals including humans. Here we demonstrate that discrimination learning of rapidly but not of slowly amplitude modulated tones is non-uniformly distributed across both hemispheres: While unilateral ablation of left AC in gerbils leads to impairment of normal discrimination learning of rapid amplitude modulations, right side ablations lead to improvement over normal learning. These results point to a rivalry interaction between both ACs in the intact brain where the right side competes with and weakens learning capability maximally attainable by the dominant left side alone.	[Schulze, Holger; Tziridis, Konstantin] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Schulze, Holger; Deutscher, Anke; Scheich, Henning] Leibniz Inst Neurobiol, Magdeburg, Germany	University of Erlangen Nuremberg; Leibniz Institut fur Neurobiologie (LIN)	Schulze, H (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	Holger.Schulze@uk-erlangen.de			Deutsche Forschungsgemeinschaft (DFG) [SCHU 1272/2-1, SCHU 1272/2-2];  [SFB TR 31]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	This work was supported by SFB TR 31 and by grant SCHU 1272/2-1,2 of the Deutsche Forschungsgemeinschaft (DFG) to Holger Schulze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Boatman D, 2004, COGNITION, V92, P47, DOI 10.1016/j.cognition.2003.09.010; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Brechmann A, 2007, CEREB CORTEX, V17, P2544, DOI 10.1093/cercor/bhl160; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Deutscher A, 2006, J NEUROSCI METH, V156, P136, DOI 10.1016/j.jneumeth.2006.02.009; Deutscher A, 2006, NEUROREPORT, V17, P853, DOI 10.1097/01.wnr.0000221837.20255.62; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Kohlmetz C, 2003, NEUROCASE, V9, P86, DOI 10.1076/neur.9.1.86.14372; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Lomber SG, 2007, J NEUROPHYSIOL, V97, P979, DOI 10.1152/jn.00767.2006; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Ohl FW, 1999, LEARN MEMORY, V6, P347; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Pujol J, 2001, NEUROIMAGE, V13, P68, DOI 10.1006/nimg.2000.0662; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Samson S, 2003, ANN NY ACAD SCI, V999, P144, DOI 10.1196/annals.1284.016; SCHEICH H, 1993, EUR J NEUROSCI, V5, P898, DOI 10.1111/j.1460-9568.1993.tb00941.x; Scheich H, 2007, HEARING RES, V229, P213, DOI 10.1016/j.heares.2007.01.025; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Schulze H, 1999, NEUROSCI LETT, V261, P13, DOI 10.1016/S0304-3940(98)00991-4; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; Walker KMM, 2011, HEARING RES, V271, P74, DOI 10.1016/j.heares.2010.04.015; Weddell RA, 2004, BRAIN COGNITION, V55, P497, DOI 10.1016/j.bandc.2004.02.075; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; Wetzel W, 2008, P NATL ACAD SCI USA, V105, P6753, DOI 10.1073/pnas.0707844105; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	35	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87159	10.1371/journal.pone.0087159	http://dx.doi.org/10.1371/journal.pone.0087159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466338	Green Published, gold			2022-12-27	WOS:000330288000196
J	Caruso, VC; Balaban, E				Caruso, Valeria C.; Balaban, Evan			Pitch and Timbre Interfere When Both Are Parametrically Varied	PLOS ONE			English	Article							DIMENSIONS; FREQUENCY; STRENGTH; PERCEPTION; CONTEXT; SIZE; TONE	Pitch and timbre perception are both based on the frequency content of sound, but previous perceptual experiments have disagreed about whether these two dimensions are processed independently from each other. We tested the interaction of pitch and timbre variations using sequential comparisons of sound pairs. Listeners judged whether two sequential sounds were identical along the dimension of either pitch or timbre, while the perceptual distances along both dimensions were parametrically manipulated. Pitch and timbre variations perceptually interfered with each other and the degree of interference was modulated by the magnitude of changes along the un-attended dimension. These results show that pitch and timbre are not orthogonal to each other when both are assessed with parametrically controlled variations.	[Caruso, Valeria C.] SISSA, Cognit Neurosci Sect, I-34014 Trieste, Italy; [Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada; [Caruso, Valeria C.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	International School for Advanced Studies (SISSA); McGill University; Duke University	Caruso, VC (corresponding author), SISSA, Cognit Neurosci Sect, I-34014 Trieste, Italy.	v.caruso@duke.edu	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433	SISSA Cognitive Neuroscience Sector PHD program	SISSA Cognitive Neuroscience Sector PHD program	Research and publication support was provided by the SISSA Cognitive Neuroscience Sector PHD program (http://www.sissa.it/cns/) and Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAL AL, 1985, MEM COGNITION, V13, P405, DOI 10.3758/BF03198453; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Handel S, 1995, HEARING, P425; KRUMHANSL CL, 1992, J EXP PSYCHOL HUMAN, V18, P739, DOI 10.1037/0096-1523.18.3.739; Macmillan NA, 2005, DETECTION THEORY USE; Marozeau J, 2003, J ACOUST SOC AM, V114, P2946, DOI 10.1121/1.1618239; Marozeau J, 2007, J ACOUST SOC AM, V121, P383, DOI 10.1121/1.2384910; MELARA RD, 1990, PERCEPT PSYCHOPHYS, V48, P169, DOI 10.3758/BF03207084; MELARA RD, 1990, J EXP PSYCHOL HUMAN, V16, P398, DOI 10.1037/0096-1523.16.2.398; MELARA RD, 1990, PERCEPT PSYCHOPHYS, V47, P307, DOI 10.3758/BF03210870; MILLER JR, 1975, J ACOUST SOC AM, V58, P711, DOI 10.1121/1.380719; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; PITT MA, 1994, J EXP PSYCHOL HUMAN, V20, P976, DOI 10.1037/0096-1523.20.5.976; PLATT JR, 1985, PERCEPT PSYCHOPHYS, V38, P543, DOI 10.3758/BF03207064; Russo FA, 2005, PERCEPT PSYCHOPHYS, V67, P559, DOI 10.3758/BF03193514; SEMAL C, 1993, J ACOUST SOC AM, V94, P1315, DOI 10.1121/1.408159; SEMAL C, 1991, J ACOUST SOC AM, V89, P2404, DOI 10.1121/1.400928; Shofner WP, 2002, PERCEPT PSYCHOPHYS, V64, P437, DOI 10.3758/BF03194716; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SINGH PG, 1992, J ACOUST SOC AM, V92, P2650, DOI 10.1121/1.404381; SINGH PG, 1987, J ACOUST SOC AM, V82, P886, DOI 10.1121/1.395287; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Sokal R. R, 1981, BIOMETRY; Soloudre GA, 2004, P 116 AES CONV BERL; Starr GE, 1997, J ACOUST SOC AM, V102, P486, DOI 10.1121/1.419722; Warrier CM, 2002, PERCEPT PSYCHOPHYS, V64, P198, DOI 10.3758/BF03195786; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Yost WA, 1998, J ACOUST SOC AM, V104, P2349, DOI 10.1121/1.423746; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593	30	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e87065	10.1371/journal.pone.0087065	http://dx.doi.org/10.1371/journal.pone.0087065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24466328	Green Submitted, Green Published, gold			2022-12-27	WOS:000330244500291
J	Cai, ZGG; Wang, RM				Cai, Zhenguang G.; Wang, Ruiming			Numerical Magnitude Affects Temporal Memories but Not Time Encoding	PLOS ONE			English	Article							INTERNAL CLOCK; SPEEDING-UP; HUMANS; SPACE; DURATION; PERCEPTION; THINK	Previous research has suggested that the perception of time is influenced by concurrent magnitude information (e. g., numerical magnitude in digits, spatial distance), but the locus of the effect is unclear, with some findings suggesting that concurrent magnitudes such as space affect temporal memories and others suggesting that numerical magnitudes in digits affect the clock speed during time encoding. The current paper reports 6 experiments in which participants perceived a stimulus duration and then reproduced it. We showed that though a digit of a large magnitude (e. g., 9), relative to a digit of a small magnitude (e. g., 2), led to a longer reproduced duration when the digits were presented during the perception of the stimulus duration, such a magnitude effect disappeared when the digits were presented during the reproduction of the stimulus duration. These findings disconfirm the account that large numerical magnitudes accelerate the speed of an internal clock during time encoding, as such an account incorrectly predicts that a large numerical magnitude should lead to a shorter reproduced duration when presented during reproduction. Instead, the findings suggest that numerical magnitudes, like other magnitudes such as space, affect temporal memories when numerical magnitudes and temporal durations are concurrently held in memory. Under this account, concurrent numerical magnitudes have the chance to influence the memory of the perceived duration when they are presented during perception but not when they are presented at the reproduction stage.	[Cai, Zhenguang G.] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Wang, Ruiming] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	University of Plymouth; South China Normal University	Cai, ZGG (corresponding author), Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England.	zhenguangcai@gmal.com	Cai, Zhenguang G/B-3765-2016	Cai, Zhenguang G/0000-0002-4097-6038	National Excellent Doctoral Dissertation of P. R. China [201204]; Ministry of Education of P. R. China [13JJD190006]	National Excellent Doctoral Dissertation of P. R. China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Ministry of Education of P. R. China(Ministry of Education, China)	The research was supported by the National Excellent Doctoral Dissertation of P. R. China (201204) and a humanities and social science research base project from the Ministry of Education of P. R. China (13JJD190006), both to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bausenhart KM, 2014, ACTA PSYCHO IN PRESS; Block RA, 2008, PSYCHOLOGY OF TIME, P367, DOI 10.1016/B978-0-08046-977-5.00012-0; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cai ZGG, 2013, PSYCHON B REV, V20, P973, DOI 10.3758/s13423-013-0414-3; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chang AYC, 2011, PSYCHOL SCI, V22, P1567, DOI 10.1177/0956797611418837; DELONG AJ, 1981, SCIENCE, V213, P681, DOI 10.1126/science.7256273; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Grondin S, 2005, J EXP PSYCHOL HUMAN, V31, P869, DOI 10.1037/0096-1523.31.5.869; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gu BM, 2011, LECT NOTES ARTIF INT, V6789, P67, DOI 10.1007/978-3-642-21478-3_6; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jones LA, 2004, Q J EXP PSYCHOL-B, V57, P55, DOI 10.1080/02724990344000088; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; MARICQ AV, 1983, PSYCHOPHARMACOLOGY, V79, P10, DOI 10.1007/BF00433008; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; MECK WH, 1987, BEHAV NEUROSCI, V101, P465, DOI 10.1037/0735-7044.101.4.465; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Ortega L, 2008, BEHAV PROCESS, V78, P380, DOI 10.1016/j.beproc.2008.02.004; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wearden JH, 2007, Q J EXP PSYCHOL, V60, P1616, DOI 10.1080/17470210601121916; Wearden JH, 1999, BEHAV PROCESS, V45, P3, DOI 10.1016/S0376-6357(99)00006-6; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wearden JH, 1999, BEHAV PROCESS, V46, P63, DOI 10.1016/S0376-6357(99)00004-2; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	34	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e83159	10.1371/journal.pone.0083159	http://dx.doi.org/10.1371/journal.pone.0083159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489646	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000330570000006
J	Nagasawa, Y; Iio, K; Fukuda, S; Date, Y; Iwatani, H; Yamamoto, R; Horii, A; Inohara, H; Imai, E; Nakanishi, T; Ohno, H; Rakugi, H; Isaka, Y				Nagasawa, Yasuyuki; Iio, Kenichiro; Fukuda, Shinji; Date, Yasuhiro; Iwatani, Hirotsugu; Yamamoto, Ryohei; Horii, Arata; Inohara, Hidenori; Imai, Enyu; Nakanishi, Takeshi; Ohno, Hiroshi; Rakugi, Hiromi; Isaka, Yoshitaka			Periodontal Disease Bacteria Specific to Tonsil in IgA Nephropathy Patients Predicts the Remission by the Treatment	PLOS ONE			English	Article							HAEMOPHILUS-PARAINFLUENZAE ANTIGEN; CANDIDATE GENE APPROACH; STEROID PULSE THERAPY; SYSTEMIC INFLAMMATION; OXFORD CLASSIFICATION; RHEUMATOID-ARTHRITIS; HELICOBACTER-PYLORI; CLINICAL REMISSION; RENAL-DISEASE; ASSOCIATION	Background: Immunoglobulin (Ig) A nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world. Some bacteria were reported to be the candidate of the antigen or the pathogenesis of IgAN, but systematic analysis of bacterial flora in tonsil with IgAN has not been reported. Moreover, these bacteria specific to IgAN might be candidate for the indicator which can predict the remission of IgAN treated by the combination of tonsillectomy and steroid pulse. Methods and Findings: We made a comprehensive analysis of tonsil flora in 68 IgAN patients and 28 control patients using Denaturing gradient gel electrophoresis methods. We also analyzed the relationship between several bacteria specific to the IgAN and the prognosis of the IgAN. Treponema sp. were identified in 24% IgAN patients, while in 7% control patients (P = 0.062). Haemophilus segnis were detected in 53% IgAN patients, while in 25% control patients (P = 0.012). Campylobacter rectus were identified in 49% IgAN patients, while in 14% control patients (P = 0.002). Multiple Cox proportional-hazards model revealed that Treponema sp. or Campylobactor rectus are significant for the remission of proteinuria (Hazard ratio 2.35, p = 0.019). There was significant difference in remission rates between IgAN patients with Treponema sp. and those without the bacterium (p = 0.046), and in remission rates between IgAN patients with Campylobacter rectus and those without the bacterium (p = 0.037) by Kaplan-Meier analysis. Those bacteria are well known to be related with the periodontal disease. Periodontal bacteria has known to cause immune reaction and many diseases, and also might cause IgA nephropathy. Conclusion: This insight into IgAN might be useful for diagnosis of the IgAN patients and the decision of treatment of IgAN.	[Nagasawa, Yasuyuki; Iio, Kenichiro; Iwatani, Hirotsugu; Yamamoto, Ryohei; Imai, Enyu; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Nagasawa, Yasuyuki; Nakanishi, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Kidney & Dialysis, Nishinomiya, Hyogo 6638501, Japan; [Fukuda, Shinji; Date, Yasuhiro; Ohno, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Fukuda, Shinji; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Date, Yasuhiro] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Horii, Arata; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otolaryngol, Suita, Osaka, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Osaka University; Hyogo College of Medicine; RIKEN; Yokohama City University; Waseda University; Osaka University; Keio University	Nagasawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan.	nagasawa@kid.med.osaka-u.ac.jp	Ohno, Hiroshi/L-7899-2014; DATE, Yasuhiro/V-3630-2018; YAMAMOTO, Ryohei/AAU-3059-2021	Ohno, Hiroshi/0000-0001-8776-9661; DATE, Yasuhiro/0000-0001-9645-4370; YAMAMOTO, Ryohei/0000-0003-2610-9824; Rakugi, Hiromi/0000-0001-6508-4338; Horii, Arata/0000-0002-6036-0492; Fukuda, Shinji/0000-0001-5161-9880	Research Conference of IgA nephropathy [21790809, 22590891]; Osaka kidney bank [OK-3]	Research Conference of IgA nephropathy; Osaka kidney bank	This study was supported by grant-in-aid for Young Scientists B (21790809), grant-in-aid for Scientific Research C (22590891), grant from Research Conference of IgA nephropathy, and grant from Osaka kidney bank (OK-3, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali J, 2011, AUTOIMMUN REV, V10, P426, DOI 10.1016/j.autrev.2010.04.005; Appel GB, 2006, KIDNEY INT, V69, P1939, DOI 10.1038/sj.ki.5000434; Arbes SJ, 1999, J DENT RES, V78, P1777, DOI 10.1177/00220345990780120301; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Craig RG, 2007, NEPHROL DIAL TRANSPL, V22, P312, DOI 10.1093/ndt/gfl604; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Goto T, 2008, CLIN IMMUNOL, V126, P260, DOI 10.1016/j.clim.2007.11.003; Holmes LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060352; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Iio K, 2010, BIOCHEM BIOPH RES CO, V393, P565, DOI 10.1016/j.bbrc.2010.01.120; Iwama H, 1998, AM J KIDNEY DIS, V32, P785, DOI 10.1016/S0272-6386(98)70134-9; Iwatani H, 2012, BIOCHEM BIOPH RES CO, V428, P339, DOI 10.1016/j.bbrc.2012.10.049; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Khalaf H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045192; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040495; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kobayashi N, 2008, J PERIODONTAL RES, V43, P156, DOI 10.1111/j.1600-0765.2007.01005.x; Kodama S, 2001, CLIN EXP IMMUNOL, V123, P301, DOI 10.1046/j.1365-2249.2001.01431.x; Komatsu H, 2008, CLIN J AM SOC NEPHRO, V3, P1301, DOI 10.2215/CJN.00310108; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Kshirsagar AV, 2005, AM J KIDNEY DIS, V45, P650, DOI 10.1053/j.ajkd.2004.12.009; Kusano K, 2007, HUM PATHOL, V38, P1788, DOI 10.1016/j.humpath.2007.04.012; Lau SKP, 2004, J CLIN MICROBIOL, V42, P877, DOI 10.1128/JCM.42.2.877-880.2004; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Mai TV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010559; March AKD, 1997, CLIN IMMUNOL IMMUNOP, V84, P158, DOI 10.1006/clin.1997.4389; Miyazaki M, 2007, CONTRIB NEPHROL, V157, P94, DOI 10.1159/000102310; Muyzer G, 1998, MOL MICROBIAL ECOLOG, V344; Nagasawa Y, 2012, HYPERTENS RES, V35, P261, DOI 10.1038/hr.2011.205; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Nakajima T, 2009, ODONTOLOGY, V97, P84, DOI 10.1007/s10266-009-0104-9; Nakano K, 2011, ORAL DIS, V17, P370, DOI 10.1111/j.1601-0825.2010.01759.x; Novak J, 2012, SEMIN IMMUNOPATHOL, V34, P365, DOI 10.1007/s00281-012-0306-z; Ogura Y, 2000, AM J KIDNEY DIS, V36, P47, DOI 10.1053/ajkd.2000.8264; Okuda K, 2003, J PERIODONTOL, V74, P123, DOI 10.1902/jop.2003.74.1.123; Pettersson E, 1997, J INTERN MED, V242, P349, DOI 10.1046/j.1365-2796.1997.00194.x; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shinzawa M, 2012, CLIN EXP NEPHROL, V16, P250, DOI 10.1007/s10157-011-0553-7; Siqueira JF, 2004, ORAL MICROBIOL IMMUN, V19, P336, DOI 10.1111/j.1399-302x.2004.00156.x; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Xie YS, 2004, KIDNEY INT, V65, P1135, DOI 10.1111/j.1523-1755.2004.00486.x; Xie YS, 2003, KIDNEY INT, V63, P1861, DOI 10.1046/j.1523-1755.2003.00935.x; Xu F, ATHEROSCLEROSIS, V218, P536; Yamamoto C, 2002, NEPHRON, V90, P320, DOI 10.1159/000049068; Yamamoto R, 2012, NEPHROL DIAL TRANSPL, V27, P1020, DOI 10.1093/ndt/gfr369; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Yamamoto R, 2009, NEPHROL DIAL TRANSPL, V24, P3686, DOI 10.1093/ndt/gfp210; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zhou XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061208; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018788	67	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e81636	10.1371/journal.pone.0081636	http://dx.doi.org/10.1371/journal.pone.0081636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489644	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000003
J	Cacan, E; Ali, MW; Boyd, NH; Hooks, SB; Greer, SF				Cacan, Ercan; Ali, Mourad W.; Boyd, Nathaniel H.; Hooks, Shelley B.; Greer, Susanna F.			Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; CPG-BINDING PROTEIN; HUMAN BREAST-CANCER; DNA METHYLATION; PREDICT PROGNOSIS; CELL-GROWTH; REGULATOR; TARGET; GENE; METHYLTRANSFERASE	RGS10 is an important regulator of cell survival and chemoresistance in ovarian cancer. We recently showed that RGS10 transcript expression is suppressed during acquired chemoresistance in ovarian cancer. The suppression of RGS10 is due to DNA hypermethylation and histone deacetylation, two important mechanisms that contribute to silencing of tumor suppressor genes during cancer progression. Here, we fully investigate the molecular mechanisms of epigenetic silencing of RGS10 expression in chemoresistant A2780-AD ovarian cancer cells. We identify two important epigenetic regulators, HDAC1 and DNMT1, that exhibit aberrant association with RGS10 promoters in chemoresistant ovarian cancer cells. Knockdown of HDAC1 or DNMT1 expression, and pharmacological inhibition of DNMT or HDAC enzymatic activity, significantly increases RGS10 expression and cisplatin-mediated cell death. Finally, DNMT1 knock down also decreases HDAC1 binding to the RGS10 promoter in chemoresistant cells, suggesting HDAC1 recruitment to RGS10 promoters requires DNMT1 activity. Our results suggest that HDAC1 and DNMT1 contribute to the suppression of RGS10 during acquired chemoresistance and support inhibition of HDAC1 and DNMT1 as an adjuvant therapeutic approach to overcome ovarian cancer chemoresistance.	[Cacan, Ercan; Boyd, Nathaniel H.; Greer, Susanna F.] Georgia State Univ, Dept Biol, Div Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Ali, Mourad W.; Hooks, Shelley B.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; Georgia State University; University System of Georgia; University of Georgia	Greer, SF (corresponding author), Georgia State Univ, Dept Biol, Div Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	sgreer@gsu.edu	Cacan, Ercan/AAC-1204-2019; Cacan, Ercan/I-7279-2019	Cacan, Ercan/0000-0002-3487-9493; Ali, Mourad Wagdy/0000-0003-3263-9055; Hooks, Shelley/0000-0003-4702-0490	American Cancer Society [RSG-09-067-01-LB]; NATIONAL CANCER INSTITUTE [R15CA151006] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grant # RSG-09-067-01-LB from the American Cancer Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060185; ANDREWS PA, 1985, CANCER RES, V45, P6250; Arts J, 2007, BRIT J CANCER, V97, P1344, DOI 10.1038/sj.bjc.6604025; Ballestar E, 2002, CARCINOGENESIS, V23, P1103, DOI 10.1093/carcin/23.7.1103; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bodle CR, 2013, FUTURE MED CHEM, V5, P995, DOI 10.4155/fmc.13.91; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Cai Y., 2013, ONCOGENE; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Carafa V, 2011, RECENT PAT ANTI-CANC, V6, P131, DOI 10.2174/157489211793980088; Carrieri A, 2013, CURR TOP MED CHEM, V13, P1069, DOI 10.2174/15680266113139990028; Dear RF, 2010, ASIA-PAC J CLIN ONCO, V6, P66, DOI 10.1111/j.1743-7563.2009.01263.x; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Espino PS, 2005, J CELL BIOCHEM, V94, P1088, DOI 10.1002/jcb.20387; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Falchook GS, 2013, INVEST NEW DRUGS; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Garcia-Bernal D, 2011, J IMMUNOL, V187, P1264, DOI 10.4049/jimmunol.1002960; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Giacinti L, 2008, CLIN TER, V159, P347; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/ol.2012.1057; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herzog TJ, 2011, GYNECOL ONCOL, V120, P454, DOI 10.1016/j.ygyno.2010.11.008; Hooks SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-289; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Hurst JH, 2009, PHARMACOLOGY, V83, P333, DOI 10.1159/000217582; Ito K, 2000, METH MOLEC MED, V44, P309, DOI 10.1385/1-59259-072-1:309; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jones P.L., 2001, METH MOL B, V181, P297, DOI 10.1385/1-59259-211-2:297; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lee JK, 2012, J NEUROCHEM, V122, P333, DOI 10.1111/j.1471-4159.2012.07780.x; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liu B, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-7; LOUIE KG, 1985, CANCER RES, V45, P2110; Lu JB, 2008, EUR J PHARMACOL, V601, P66, DOI 10.1016/j.ejphar.2008.10.044; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Meng CF, 2011, MOL MED REP, V4, P1273, DOI 10.3892/mmr.2011.557; Meng FL, 2013, INT J ONCOL, V43, P495, DOI 10.3892/ijo.2013.1960; MODEST EJ, 1974, CANCER CHEMOTH REP 1, V58, P35; Muller BM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-215; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rivero G, 2013, PSYCHOPHARMACOLOGY, V226, P177, DOI 10.1007/s00213-012-2888-5; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100; Terasawa K, 2004, CLIN CANCER RES, V10, P2000, DOI 10.1158/1078-0432.CCR-0932-03; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang C, 2011, J NAT PROD, V74, P2031, DOI 10.1021/np200324x; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xie Y, 2013, BIOCHEM PHARMACOL, V85, P1454, DOI 10.1016/j.bcp.2013.03.001; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	79	63	64	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87455	10.1371/journal.pone.0087455	http://dx.doi.org/10.1371/journal.pone.0087455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475290	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300185
J	Chyau, CC; Ker, YB; Chang, CH; Huang, SH; Wang, HE; Peng, CC; Peng, RY				Chyau, Charng-Cherng; Ker, Yaw-Bee; Chang, Chi-Huang; Huang, Shiau-Huei; Wang, Hui-Er; Peng, Chiung-Chi; Peng, Robert Y.			Schisandra chinensis Peptidoglycan-Assisted Transmembrane Transport of Lignans Uniquely Altered the Pharmacokinetic and Pharmacodynamic Mechanisms in Human HepG2 Cell Model	PLOS ONE			English	Article							DIBENZOCYCLOOCTADIENE LIGNANS; GOMISIN N; HYALURONAN; BINDING; FRUIT; RATS; POLYSACCHARIDES; HEPATOTOXICITY; IDENTIFICATION; INHIBITORS	Schisandra chinensis (Turz Baill) (S. chinensis) (SC) fruit is a hepatoprotective herb containing many lignans and a large amount of polysaccharides. A novel polysaccharide (called SC-2) was isolated from SC of MW 841 kDa, which exhibited a protein-to-polysaccharide ratio of 0.4089, and showed a characteristic FTIR spectrum of a peptidoglycan. Powder X-ray diffraction revealed microcrystalline structures within SC-2. SC-2 contained 10 monosaccharides and 15 amino acids (essential amino acids of 78.12% w/w). In a HepG2 cell model, SC-2 was shown by MTT and TUNEL assay to be completely non-cytotoxic. A kinetic analysis and fluorescence-labeling technique revealed no intracellular disposition of SC-2. Combined treatment of lignans with SC-2 enhanced the intracellular transport of schisandrin B and deoxyschisandrin but decreased that of gomisin C, resulting in alteration of cell-killing bioactivity. The Second Law of Thermodynamics allows this type of unidirectional transport. Conclusively, SC-2 alters the transport and cell killing capability by a "Catcher-Pitcher Unidirectional Transport Mechanism".	[Chyau, Charng-Cherng; Chang, Chi-Huang; Huang, Shiau-Huei; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Taiwan; [Ker, Yaw-Bee; Wang, Hui-Er] Hungkuang Univ, Dept Food & Appl Technol, Taichung, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Peng, Robert Y.] Taipei Med Univ, Res Inst Med Sci, Taipei, Taiwan	Hungkuang University; Hungkuang University; Taipei Medical University; Taipei Medical University	Peng, CC (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	misspeng@ms2.hinet.net; ypeng@seed.net.tw			National Science Council of Taiwan [NSC-97-2313-B-241-002-MY3, NSC-100-2313-B-241-004]; Taipei Medical University [TMU101-AE1-B11, TMU102-SHH-11]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by grants from the National Science Council of Taiwan (NSC-97-2313-B-241-002-MY3 and NSC-100-2313-B-241-004). Additional support was received from Taipei Medical University (TMU101-AE1-B11 and TMU102-SHH-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borisov AB, 2000, ANAT RECORD, V258, P305; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang CY, 2009, PHYTOTHER RES, V23, P251, DOI 10.1002/ptr.2602; Chen Y, 2012, INT J BIOL MACROMOL, V50, P844, DOI 10.1016/j.ijbiomac.2011.11.015; Chiu PY, 2007, BIOL PHARM BULL, V30, P1108, DOI 10.1248/bpb.30.1108; Cyong JC, 2000, AM J CHINESE MED, V28, P351, DOI 10.1142/S0192415X00000416; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FUJIHASHI T, 1995, ANTIMICROB AGENTS CH, V39, P2000, DOI 10.1128/AAC.39.9.2000; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gnabre J, 2010, J CHROMATOGR B, V878, P2693, DOI 10.1016/j.jchromb.2010.08.005; Ip SP, 1996, PHARMACOL TOXICOL, V78, P413, DOI 10.1111/j.1600-0773.1996.tb00228.x; Ip SP, 1997, BIOCHEM PHARMACOL, V54, P317, DOI 10.1016/S0006-2952(97)00164-0; Iwata H, 2004, DRUG METAB DISPOS, V32, P1351, DOI 10.1124/dmd.104.000646; Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X; Kaneo Y, 2000, INT J PHARM, V201, P59, DOI 10.1016/S0378-5173(00)00405-1; Ker YB, 2005, J AGR FOOD CHEM, V53, P7052, DOI 10.1021/jf0510034; Kim SR, 2004, J NEUROSCI RES, V76, P397, DOI 10.1002/jnr.20089; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; La Torre GL, 2006, FOOD CHEM, V94, P640, DOI 10.1016/j.foodchem.2005.02.007; Lee IS, 1999, BIOL PHARM BULL, V22, P265, DOI 10.1248/bpb.22.265; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Lu Y, 2009, J CHROMATOGR A, V1216, P1980, DOI 10.1016/j.chroma.2008.09.070; Ma WH, 2009, BIOORG MED CHEM LETT, V19, P4958, DOI 10.1016/j.bmcl.2009.07.078; Min HY, 2008, BIOORG MED CHEM LETT, V18, P523, DOI 10.1016/j.bmcl.2007.11.082; Oh SY, 2010, BIOSCI BIOTECH BIOCH, V74, P285, DOI 10.1271/bbb.90597; Opletal L, 2010, CESKA SLOV FARM, V50, P219; Opletal L, 2010, CESKA SLOV FARM, V50, P173; Peng CH, 2010, EUR J PHARM BIOPHARM, V75, P154, DOI 10.1016/j.ejpb.2010.03.004; Polyakov NE, 2010, NSTI NANOTECH, V3, P312; Shihorka V, 2001, J PHARM PHARM SCI, V4, P138; Tanaka T, 2004, INT J PHARM, V286, P9, DOI 10.1016/j.ijpharm.2004.07.031; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Victor R, 1999, INT J CANCER, V82, P77, DOI 10.1002/(SICI)1097-0215(19990702)82:1<77::AID-IJC14>3.0.CO;2-Q; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Xie YA, 2010, J ETHNOPHARMACOL, V131, P290, DOI 10.1016/j.jep.2010.06.038; Yan F, 2009, PHYTOMEDICINE, V16, P805, DOI 10.1016/j.phymed.2009.02.004; Yim SY, 2009, MOL MED REP, V2, P725, DOI 10.3892/mmr_00000163; Yin FZ, 2010, ACTA CHROMATOGR, V22, P609, DOI 10.1556/AChrom.22.2010.4.10; Zhu M, 2000, PLANTA MED, V66, P521, DOI 10.1055/s-2000-11202	40	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e85165	10.1371/journal.pone.0085165	http://dx.doi.org/10.1371/journal.pone.0085165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475039	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300018
J	Pachur, T; Schooler, LJ; Stevens, JR				Pachur, Thorsten; Schooler, Lael J.; Stevens, Jeffrey R.			We'll Meet Again: Revealing Distributional and Temporal Patterns of Social Contact	PLOS ONE			English	Article							EVOLUTION; SPREAD; NETWORKS; MEMORY	What are the dynamics and regularities underlying social contact, and how can contact with the people in one's social network be predicted? In order to characterize distributional and temporal patterns underlying contact probability, we asked 40 participants to keep a diary of their social contacts for 100 consecutive days. Using a memory framework previously used to study environmental regularities, we predicted that the probability of future contact would follow in systematic ways from the frequency, recency, and spacing of previous contact. The distribution of contact probability across the members of a person's social network was highly skewed, following an exponential function. As predicted, it emerged that future contact scaled linearly with frequency of past contact, proportionally to a power function with recency of past contact, and differentially according to the spacing of past contact. These relations emerged across different contact media and irrespective of whether the participant initiated or received contact. We discuss how the identification of these regularities might inspire more realistic analyses of behavior in social networks (e.g., attitude formation, cooperation).	[Pachur, Thorsten] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [Schooler, Lael J.] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Stevens, Jeffrey R.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA	Max Planck Society; Max Planck Society; University of Nebraska System; University of Nebraska Lincoln	Pachur, T (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany.	pachur@mpib-berlin.mpg.de	Stevens, Jeffrey R/C-4619-2011; Pachur, Thorsten/AAC-7980-2019	Stevens, Jeffrey R/0000-0003-2375-1360; Pachur, Thorsten/0000-0001-6391-4107	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 1998, ATOMIC COMPONENTS TH; ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; ANDERSON JR, 1989, PSYCHOL REV, V96, P703, DOI 10.1037/0033-295X.96.4.703; ANDERSON R M, 1991; [Anonymous], 2009, PAND H1N1 2009 UPD 7; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bailey NTJ, 1975, MATH THEORY INFECT D; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Copher J, 2002, INTERNET EVERYDAY LI, V263-288; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hills TT, 2012, J EXP PSYCHOL LEARN, V38, P218, DOI 10.1037/a0025161; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Krasnow MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01747; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Maynard Smith J., 1982, pi; Milardo R.M., 1988, FAMILIES SOCIAL NETW; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pachur T, 2013, SIMPLE HEURISTICS SO, P199; Pachur T, 2013, J EXP SOC PSYCHOL, V49, P1059, DOI 10.1016/j.jesp.2013.07.004; Pachur T, 2012, J EXP PSYCHOL-APPL, V18, P314, DOI 10.1037/a0028279; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Ramasco JJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066106; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; World Health Organization, 2009, PAND H1N1 2009 UPD 8; Yan G, 2005, CHINESE PHYS LETT, V22, P510, DOI 10.1088/0256-307X/22/2/068; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	39	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86081	10.1371/journal.pone.0086081	http://dx.doi.org/10.1371/journal.pone.0086081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475073	Green Published, gold			2022-12-27	WOS:000330507300036
J	Ren, MX; Bu, ZJ				Ren, Ming-Xun; Bu, Zhao-Jun			Is There 'Anther-Anther Interference' within a Flower? Evidences from One-by-One Stamen Movement in an Insect-Pollinated Plant	PLOS ONE			English	Article							POLLEN REMOVAL; REPRODUCTIVE SUCCESS; FLORAL EVOLUTION; SELECTION; STIGMAS; ANGIOSPERMS; STRATEGIES; AVOIDANCE; DISPERSAL; REVOLVER	The selective pressure imposed by maximizing male fitness (pollen dispersal) in shaping floral structures is increasingly recognized and emphasized in current plant sciences. To maximize male fitness, many flowers bear a group of stamens with temporally separated anther dehiscence that prolongs presentation of pollen grains. Such an advantage, however, may come with a cost resulting from interference of pollen removal by the dehisced anthers. This interference between dehisced and dehiscing anthers has received little attention and few experimental tests to date. Here, using one-by-one stamen movement in the generalist-pollinated Parnassia palustris, we test this hypothesis by manipulation experiments in two years. Under natural conditions, the five fertile stamens in P. palustris flowers elongate their filaments individually, and anthers dehisce successively one-by-one. More importantly, the anther-dehisced stamen bends out of the floral center by filament deflexion before the next stamen's anther dehiscence. Experimental manipulations show that flowers with dehisced anther remaining at the floral center experience shorter (1/3-1/2 less) visit durations by pollen-collecting insects (mainly hoverflies and wasps) because these 'hungry' insects are discouraged by the scant and non-fresh pollen in the dehisced anther. Furthermore, the dehisced anther blocks the dehiscing anther's access to floral visitors, resulting in a nearly one third decrease in their contact frequency. As a result, pollen removal of the dehiscing anther decreases dramatically. These results provide the first direct experimental evidence that anther-anther interference is possible in a flower, and that the selection to reduce such interferences can be a strong force in floral evolution. We also propose that some other floral traits, usually interpreted as pollen dispensing mechanisms, may function, at least partially, as mechanisms to promote pollen dispersal by reducing interferences between dehisced and dehiscing anthers.	[Ren, Ming-Xun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Bu, Zhao-Jun] NE Normal Univ, Inst Peat & Mire Res, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Northeast Normal University - China	Bu, ZJ (corresponding author), NE Normal Univ, Inst Peat & Mire Res, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Peoples R China.	buzhaojun@nenu.edu.cn			National Natural Science Foundation of China [30970459, 31170356, 40971036, 41371103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China to M. X. R. (grant numbers 30970459 and 31170356) and Z.J.B. (grant numbers 40971036 and 41371103) (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; BELL G, 1985, PROC R SOC SER B-BIO, V224, P223, DOI 10.1098/rspb.1985.0031; BROWN DK, 1981, AM J BOT, V68, P361, DOI 10.2307/2442772; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; Conner JK, 2009, ANN BOT-LONDON, V103, P1547, DOI 10.1093/aob/mcp071; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fetscher AE, 2001, P ROY SOC B-BIOL SCI, V268, P525, DOI 10.1098/rspb.2000.1395; Foerste AF, 1888, BOT GAZ, V13, P151, DOI 10.1086/326286; Gong YB, 2009, P ROY SOC B-BIOL SCI, V276, P4013, DOI 10.1098/rspb.2009.1254; Gu C., 2001, FLORA CHINA, P358; Han Y, 2008, ANN BOT-LONDON, V102, P473, DOI 10.1093/aob/mcn102; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1993, ECOLOGY, V74, P1059, DOI 10.2307/1940476; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Henning T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041121; Kudo G, 2003, FUNCT ECOL, V17, P349, DOI 10.1046/j.1365-2435.2003.00736.x; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; Matthews ML, 2005, BOT J LINN SOC, V149, P129, DOI 10.1111/j.1095-8339.2005.00445.x; Morgan MT, 1997, TRENDS ECOL EVOL, V12, P231, DOI 10.1016/S0169-5347(97)01045-8; PERCIVAL M, 1965, NEW PHYTOL, V64, P1, DOI 10.1111/j.1469-8137.1965.tb05370.x; Ren MX, 2012, ANN BOT-LONDON, V110, P1017, DOI 10.1093/aob/mcs181; Ren Ming-Xun, 2010, Chinese Journal of Plant Ecology, V34, P867, DOI 10.3773/j.issn.1005-264x.2010.07.012; Ren MX, 2010, INT J PLANT SCI, V171, P275, DOI 10.1086/650157; Ren Ming-Xun, 2009, Zhiwu Shengtai Xuebao, V33, P222, DOI 10.3773/j.issn.1005-264x.2009.01.024; Sandvik SM, 2003, CAN J BOT, V81, P49, DOI [10.1139/b03-006, 10.1139/B03-006]; STANTON ML, 1986, SCIENCE, V232, P1625, DOI 10.1126/science.232.4758.1625; Thomson James D., 2000, Plant Species Biology, V15, P11, DOI 10.1046/j.1442-1984.2000.00026.x; WEBB CJ, 1986, NEW ZEAL J BOT, V24, P163, DOI 10.1080/0028825X.1986.10409726; Weigend M, 2006, PLANT BIOLOGY, V8, P120, DOI 10.1055/s-2005-873034; Weigend M, 2010, BIOL J LINN SOC, V100, P124, DOI 10.1111/j.1095-8312.2010.01419.x	33	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86581	10.1371/journal.pone.0086581	http://dx.doi.org/10.1371/journal.pone.0086581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475150	Green Submitted, gold, Green Published			2022-12-27	WOS:000330507300086
J	Shan, C; Mei, ZL; Duan, JL; Chen, HY; Feng, HF; Cai, WM				Shan, Chi; Mei, Zhiling; Duan, Jianli; Chen, Haiying; Feng, Huafeng; Cai, Weiming			OsGA2ox5, a Gibberellin Metabolism Enzyme, Is Involved in Plant Growth, the Root Gravity Response and Salt Stress	PLOS ONE			English	Article							RICE ORYZA-SATIVA; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; CYTOCHROME-P450 MONOOXYGENASE; FUNCTIONAL EXPRESSION; GREEN-REVOLUTION; GENE; BIOSYNTHESIS; MUTANT; OVEREXPRESSION	Gibberellin (GA) 2-oxidases play an important role in the GA catabolic pathway through 2 beta-hydroxylation. There are two classes of GA2oxs, i.e., a larger class of C-19-GA2oxs and a smaller class of C-20-GA2oxs. In this study, the gene encoding a GA 2-oxidase of rice, Oryza sativa GA 2-oxidase 5 (OsGA2ox5), was cloned and characterized. BLASTP analysis showed that OsGA2ox5 belongs to the C-20-GA2oxs subfamily, a subfamily of GA2oxs acting on C-20-GAs (GA(12), GA(53)). Subcellular localization of OsGA2ox5-YFP in transiently transformed onion epidermal cells revealed the presence of this protein in both of the nucleus and cytoplasm. Real-time PCR analysis, along with GUS staining, revealed that OsGA2ox5 is expressed in the roots, culms, leaves, sheaths and panicles of rice. Rice plants overexpressing OsGA2ox5 exhibited dominant dwarf and GA-deficient phenotypes, with shorter stems and later development of reproductive organs than the wild type. The dwarfism phenotype was partially rescued by the application of exogenous GA(3) at a concentration of 10 mu M. Ectopic expression of OsGA2ox5 cDNA in Arabidopsis resulted in a similar phenotype. Real-time PCR assays revealed that both GA synthesis-related genes and GA signaling genes were expressed at higher levels in transgenic rice plants than in wild-type rice; OsGA3ox1, which encodes a key enzyme in the last step of the bioactive GAs synthesis pathway, was highly expressed in transgenic rice. The roots of OsGA2ox5-ox plants exhibited increased starch granule accumulation and gravity responses, revealing a role for GA in root starch granule development and gravity responses. Furthermore, rice and Arabidopsis plants overexpressing OsGA2ox5 were more resistant to high-salinity stress than wild-type plants. These results suggest that OsGA2ox5 plays important roles in GAs homeostasis, development, gravity responses and stress tolerance in rice.	[Shan, Chi; Mei, Zhiling; Duan, Jianli; Chen, Haiying; Cai, Weiming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Feng, Huafeng] E China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai Key Lab Funct Mat Chem, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; East China University of Science & Technology	Cai, WM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	wmcai@sibs.ac.cn	Duan, Jianli/GOP-3297-2022	Duan, Jianli/0000-0001-7347-4774	National Basic Research Program of China [2011CB710902]; National Natural Science Foundation of China [31070237]; National Scientific Program [2012AA101103-04]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA04020202-15]; China Manned Space Flight Technology Project	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific Program; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China Manned Space Flight Technology Project	This work was supported by the National Basic Research Program of China (2011CB710902), National Natural Science Foundation of China (31070237), the National Scientific Program (2012AA101103-04), Strategic Priority Research Program of the Chinese Academy of Sciences (XDA04020202-15) and the China Manned Space Flight Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSCH MB, 1990, PLANTA, V181, P358, DOI 10.1007/BF00195888; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Harberd NP, 1998, BIOESSAYS, V20, P1001, DOI 10.1002/(SICI)1521-1878(199812)20:12&lt;1001::AID-BIES6&gt;3.0.CO;2-O; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; King RW, 2003, ANNU REV PLANT BIOL, V54, P307, DOI 10.1146/annurev.arplant.54.031902.135029; Lange T, 1998, PLANTA, V204, P409, DOI 10.1007/s004250050274; Lee DJ, 2005, PLANT PHYSIOL, V138, P243, DOI 10.1104/pp.104.056499; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Rebers M, 1999, PLANT J, V17, P241, DOI 10.1046/j.1365-313X.1999.00366.x; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Scott A, 1999, BIOTECHNIQUES, V26, P1125, DOI 10.2144/99266st04; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Suo HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045568; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhang YY, 2008, CELL RES, V18, P412, DOI 10.1038/cr.2008.28; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	47	64	76	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87110	10.1371/journal.pone.0087110	http://dx.doi.org/10.1371/journal.pone.0087110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475234	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300141
J	Guo, Y; Zhang, Y; Hong, K; Luo, FY; Gu, QP; Lu, NH; Bai, AP				Guo, Yuan; Zhang, Yi; Hong, Kai; Luo, Fengyan; Gu, Qiuping; Lu, Nonghua; Bai, Aiping			AMPK Inhibition Blocks ROS-NF kappa B Signaling and Attenuates Endotoxemia-Induced Liver Injury	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; COMPOUND-C; INFLAMMATORY RESPONSES; MACROPHAGES; COLITIS; SEPSIS; EXPRESSION; CELLS; POLARIZATION; PATHOGENESIS	Background: AMP-activated protein kinase (AMPK) is an important enzyme in regulation of cellular energy homeostasis. We have previously shown that AMPK activation by 5-aminoimidazole-4-carboxamide (AICAR) results in suppression of immune responses, indicating the pivotal role of AMPK in immune regulation. However, the cellular mechanism underpinning AMPK inhibition on immune response remains largely to be elucidated. The study aimed to investigate the effects of AMPK inhibition on reactive oxygen species (ROS)-nuclear factor kappa B (NF kappa B) signaling and endotoxemia-induced liver injury. Methodology/Principal Findings: RAW 264.7 cells were pretreated with AMPK activator or inhibitor, followed by LPS challenge. In addition, LPS was injected intraperitoneally into mice to induce systemic inflammation. The parameters of liver injury and immune responses were determined, and survival of mice was monitored respectively. LPS challenge in RAW 264.7 cells resulted in AMPK activation which was then inhibited by compound C treatment. Both AMPK activation by AICAR or inhibition by compound C diminished LPS-induced ROS generation, inhibited phosphorylation of IKK, I kappa B, and NF kappa B p65, and consequently, decreased TNF production of RAW 264.7 cells. AICAR or compound C treatment decreased ALT, AST, and TNF levels in serum, reduced CD68 expression and MPO activity in liver tissue of mice with endotoxemia. Moreover, AICAR or compound C treatment improved survival of endotoxemic mice. Conclusions: AICAR or compound C treatment attenuates LPS-induced ROS-NF kappa B signaling, immune responses and liver injury. Strategies to activate or inhibit AMPK signaling may provide alternatives to the current clinical approaches to inhibit immune responses of endotoxemia.	[Guo, Yuan; Zhang, Yi; Hong, Kai; Luo, Fengyan; Gu, Qiuping; Lu, Nonghua; Bai, Aiping] Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanchang, Peoples R China; [Guo, Yuan] Nanchang Univ, Dept Pharm, Affiliated Hosp 1, Nanchang, Peoples R China	Nanchang University; Nanchang University	Bai, AP (corresponding author), Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanchang, Peoples R China.	baiap@163.com			National Natural Science Foundation of China [81270472, 81070310]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China [2011ZX09302-007-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China	Supported by National Natural Science Foundation of China, No. 81270472 and No. 81070310, and National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China (No. 2011ZX09302-007-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordi B, 2013, LEUKEMIA, V27, P1019, DOI 10.1038/leu.2012.338; Bai A, 2007, SCAND J IMMUNOL, V66, P538, DOI 10.1111/j.1365-3083.2007.02011.x; Bai A, 2009, CLIN EXP IMMUNOL, V156, P353, DOI 10.1111/j.1365-2249.2009.03894.x; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Bauer M, 2013, CURR OPIN CRIT CARE, V19, P123, DOI 10.1097/MCC.0b013e32835eba6d; Bradley EA, 2010, ARTERIOSCL THROM VAS, V30, P1137, DOI 10.1161/ATVBAHA.110.204404; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fortin CF, 2010, SHOCK, V33, P344, DOI 10.1097/SHK.0b013e3181c0f068; Gasparini C, 2012, CURR PHARM DESIGN, V18, P5735, DOI 10.2174/138161212803530763; Hadad SM, 2008, CRIT REV ONCOL HEMAT, V67, P1, DOI 10.1016/j.critrevonc.2008.01.007; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; Hirsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030956; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Kim YM, 2011, ATHEROSCLEROSIS, V219, P57, DOI 10.1016/j.atherosclerosis.2011.06.043; Langelueddecke C, 2012, CELL PHYSIOL BIOCHEM, V29, P75, DOI 10.1159/000337589; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Moon EY, 2011, CELL SIGNAL, V23, P1479, DOI 10.1016/j.cellsig.2011.05.001; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	37	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86881	10.1371/journal.pone.0086881	http://dx.doi.org/10.1371/journal.pone.0086881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475189	Green Submitted, gold, Green Published			2022-12-27	WOS:000330339800067
J	Jaafar, FM; Belhouchet, M; Belaganahalli, M; Tesh, RB; Mertens, PPC; Attoui, H				Jaafar, Fauziah Mohd; Belhouchet, Mourad; Belaganahalli, Manjunatha; Tesh, Robert B.; Mertens, Peter P. C.; Attoui, Houssam			Full-Genome Characterisation of Orungo, Lebombo and Changuinola Viruses Provides Evidence for Co-Evolution of Orbiviruses with Their Arthropod Vectors	PLOS ONE			English	Article							OUTER-CAPSID PROTEINS; GRASS CARP REOVIRUS; DOUBLE-STRANDED-RNA; BLUETONGUE VIRUS; FAMILY REOVIRIDAE; COMPLETE SEQUENCE; EXPERIMENTAL-INFECTION; PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; MOLECULAR SEQUENCES	The complete genomes of Orungo virus (ORUV), Lebombo virus (LEBV) and Changuinola virus (CGLV) were sequenced, confirming that they each encode 11 distinct proteins (VP1-VP7 and NS1-NS4). Phylogenetic analyses of cell-attachment protein 1' outer-capsid protein 19 (OC1), show that orbiviruses fall into three large groups, identified as: VP2(OC1), in which OC1 is the 2nd largest protein, including the Culicoides transmitted orbiviruses; VP3(OC1), which includes the mosquito transmitted orbiviruses; and VP4(OC1) which includes the tick transmitted viruses. Differences in the size of OC1 between these groups, places the T2 'subcore-shell protein' as the third largest protein 'VP3(T2)' in the first of these groups, but the second largest protein 'VP3(T2)' in the other two groups. ORUV, LEBV and CGLV all group with the Culicoides-borne VP2(OC1)/VP3(T2) viruses. The G+C content of the ORUV, LEBV and CGLV genomes is also similar to that of the Culicoides-borne, rather than the mosquito-borne, or tick borne orbiviruses. These data suggest that ORUV and LEBV are Culicoides-rather than mosquito-borne. Multiple isolations of CGLV from sand flies suggest that they are its primary vector. OC1 of the insect-borne orbiviruses is approximately twice the size of the equivalent protein of the tick borne viruses. Together with internal sequence similarities, this suggests its origin by duplication (concatermerisation) of a smaller OC1 from an ancestral tick-borne orbivirus. Phylogenetic comparisons showing linear relationships between the dates of evolutionary-separation of their vector species, and genetic-distances between tick-, mosquito- or Culicoides-borne virus-groups, provide evidence for co-evolution of the orbiviruses with their arthropod vectors.	[Jaafar, Fauziah Mohd; Belhouchet, Mourad; Belaganahalli, Manjunatha; Mertens, Peter P. C.; Attoui, Houssam] Pirbright Inst, Dept Vector Borne Viral Dis, Pirbright, Surrey, England; [Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Texas System; University of Texas Medical Branch Galveston	Attoui, H (corresponding author), Pirbright Inst, Dept Vector Borne Viral Dis, Pirbright, Surrey, England.	houssam.attoui@pirbright.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	BBSRC; Defra; Wellcome Trust; European Commission (OrbiVac) [245266, 222633-2, K1303206]; National Institutes of Health [HHSN272201000040I/HHSN27200004/D04]; BBSRC [BBS/E/I/00001720] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001720] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (OrbiVac)(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to acknowledge funding from BBSRC. Defra, Wellcome Trust, the European Commission (OrbiVac - Grant no.: 245266; WildTech - Grant no.: 222633-2; EMIDA grant OrbiNet - K1303206). PM is a Jenner Investigator. RBT was supported by National Institutes of Health contract HHSN272201000040I/HHSN27200004/D04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H., 2011, VIRUS TAXONOMY, P497; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Azar D, 2003, MEM I OSWALDO CRUZ, V98, P35, DOI 10.1590/S0074-02762003000900007; Azar D, 1999, PALAEONTOLOGY, V42, P1101, DOI 10.1111/1475-4983.00112; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Borkent A, 2001, LEPTOCONOPS DIPTERA, P1; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; BROWN SE, 1991, J GEN VIROL, V72, P1065, DOI 10.1099/0022-1317-72-5-1065; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Cao DJ, 2008, J VIROL, V82, P6073, DOI 10.1128/JVI.00121-08; CDC, 2010, INT CAT ARB INCL OTH; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; DAROSA APAT, 1984, INTERVIROLOGY, V21, P38; DEMAULA CD, 1993, VIROLOGY, V195, P292, DOI 10.1006/viro.1993.1377; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Lara-Ramirez EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017300; ESTEBAN R, 1988, J VIROL, V62, P1278, DOI 10.1128/JVI.62.4.1278-1285.1988; Force A, 1999, GENETICS, V151, P1531; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Gibbs A., 1995, MOL BASIS VIRUS EVOL, P76; Gomez SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r39; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grimaldi David, 2005, pi; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GROGAN WL, 1988, J PALEONTOL, V62, P808; Hennig L, 2001, PREP BIOCHEM BIOTECH, V31, P201; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HUNDLEY F, 1985, VIROLOGY, V143, P88, DOI 10.1016/0042-6822(85)90099-6; Jaafar FM, 2008, VIROLOGY, V373, P310, DOI 10.1016/j.virol.2007.12.006; Jaafar FM, 2004, J GEN VIROL, V85, P2237, DOI 10.1099/vir.0.80019-0; Klompen JSH, 1996, ANNU REV ENTOMOL, V41, P141, DOI 10.1146/annurev.en.41.010196.001041; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Manole V, 2012, J VIROL, V86, P7858, DOI 10.1128/JVI.00517-12; Mertens PPC, 2005, VIRUS TAXONOMY, P447; MONATH TP, 1980, AM J TROP MED HYG, V29, P912, DOI 10.4269/ajtmh.1980.29.912; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; MOSS SR, 1987, VIROLOGY, V157, P137, DOI 10.1016/0042-6822(87)90322-9; Nuttall PA, 2009, FRONT BIOSCI-LANDMRK, V14, P2466, DOI 10.2741/3390; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SEYMOUR C, 1983, AM J TROP MED HYG, V32, P1435, DOI 10.4269/ajtmh.1983.32.1435; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomori O, 1976, Niger Med J, V6, P135; TOMORI O, 1978, J MED ENTOMOL, V14, P523, DOI 10.1093/jmedent/14.5.523; TOMORI O, 1977, NIGERIAN MED J, V7, P5; TOMORI O, 1977, ACTA VIROL, V21, P133; TOMORI O, 1976, TROP GEOGR MED, V28, P233; TOMORI O, 1976, ARCH VIROL, V51, P285, DOI 10.1007/BF01317932; TOMORI O, 1978, T ROY SOC TROP MED H, V72, P230, DOI 10.1016/0035-9203(78)90199-2; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	68	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86392	10.1371/journal.pone.0086392	http://dx.doi.org/10.1371/journal.pone.0086392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475112	Green Submitted, Green Published, gold			2022-12-27	WOS:000330339800042
J	Tam, WWS; Wong, TW; Ng, L; Wong, SYS; Kung, KKL; Wong, AHS				Tam, Wilson W. S.; Wong, Tze Wai; Ng, Lorna; Wong, Samuel Y. S.; Kung, Kenny K. L.; Wong, Andromeda H. S.			Association between Air Pollution and General Outpatient Clinic Consultations for Upper Respiratory Tract Infections in Hong Kong	PLOS ONE			English	Article							COARSE PARTICULATE MATTER; SHORT-TERM ASSOCIATIONS; HOSPITAL ADMISSIONS; DISEASES; VISITS; MORTALITY; HEALTH; FINE; PARTICLES; LONDON	Background and Objectives: Many studies have shown the adverse effects of air pollution on respiratory health, but few have examined the effects of air pollution on service utilisation in the primary care setting. The aim of this study was to examine the association between air pollution and the daily number of consultations due to upper respiratory tract infections (URTIs) in general outpatient clinics (GOPCs) in Hong Kong. Methods: Daily data on the numbers of consultations due to URTIs in GOPCs, the concentrations of major air pollutants, and the mean values of metrological variables were retrospectively collected over a 3-year period (2008-2010, inclusive). Generalised additive models were constructed to examine the association between air pollution and the daily number of consultations, and to derive the relative risks and 95% confidence intervals (95% CI) of GOPC consultations for a unit increase in the concentrations of air pollutants. Results: The mean daily consultations due to URTIs in GOPCs ranged from 68.4 to 253.0 over the study period. The summary relative risks (and 95% CI) of daily consultations in all GOPCs for the air pollutants PM10, NO2, O-3, and SO2 were 1.005 (1.002, 1.009), 1.010 (1.006, 1.013), 1.009 (1.006, 1.012), and 1.004 (1.000, 1.008) respectively, per 10 mu g/m(3) increase in the concentration of each pollutant. Conclusion: Significant associations were found between the daily number of consultations due to URTIs in GOPCs and the concentrations of air pollutants, implying that air pollution incurs a substantial morbidity and increases the burden of primary health care services.	[Tam, Wilson W. S.; Wong, Tze Wai; Wong, Samuel Y. S.; Kung, Kenny K. L.; Wong, Andromeda H. S.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Tam, Wilson W. S.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Municipal Key Lab Hlth Risk Anal, Shenzhen, Guangdong, Peoples R China; [Ng, Lorna] Kwong Wah Hosp, Gen Outpatient Clin, Yaumatei, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Kwong Wah Hospital	Wong, TW (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	twwong@cuhk.edu.hk	WONG, Samuel Yeung Shan/D-7311-2013; Tam, Wilson/K-1664-2019; Kung, Kenny/A-2381-2015; TAM, Wilson W.S./H-5890-2019	WONG, Samuel Yeung Shan/0000-0003-0934-6385; Kung, Kenny/0000-0002-2063-126X; TAM, Wilson W.S./0000-0003-0641-3060; /0000-0002-3059-0334				Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Bell ML, 2008, AM J EPIDEMIOL, V168, P1301, DOI 10.1093/aje/kwn252; Bremner SA, 1999, OCCUP ENVIRON MED, V56, P237, DOI 10.1136/oem.56.4.237; Chang CJ, 2012, INVEST OPHTH VIS SCI, V53, P429, DOI 10.1167/iovs.11-8253; Cheung NT, 2001, INT J MED INFORM, V62, P113, DOI 10.1016/S1386-5056(01)00155-1; Ciencewicki J, 2007, INHAL TOXICOL, V19, P1135, DOI 10.1080/08958370701665434; Duffy ME, 2006, CLIN NURSE SPEC, V20, P273, DOI 10.1097/00002800-200611000-00005; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Hajat S, 2002, OCCUP ENVIRON MED, V59, P294, DOI 10.1136/oem.59.5.294; Hajat S, 2001, AM J EPIDEMIOL, V153, P704, DOI 10.1093/aje/153.7.704; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Host S, 2008, OCCUP ENVIRON MED, V65, P544, DOI 10.1136/oem.2007.036194; Hwang JS, 2002, AM J EPIDEMIOL, V155, P1, DOI 10.1093/aje/155.1.1; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kan HD, 2003, ARCH ENVIRON HEALTH, V58, P360; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Li Y, 2010, SCI TOTAL ENVIRON, V408, P1226, DOI 10.1016/j.scitotenv.2009.11.035; Lo YYC LC, 2011, HONG KONG MED J, V17, P7; Ng LV, 2009, HONG KONG PRACTITION, V31, P10; Oiamo TH, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-71; Ostro BD, 1999, ENVIRON HEALTH PERSP, V107, P69, DOI 10.2307/3434291; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Qiu H, 2012, ENVIRON HEALTH PERSP, V120, P572, DOI 10.1289/ehp.1104002; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Reist M, 1998, FEBS LETT, V423, P231, DOI 10.1016/S0014-5793(98)00099-4; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Scapellato ML, 2007, CRIT REV TOXICOL, V37, P461, DOI 10.1080/10408440701385622; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Sinclair AH, 2004, J AIR WASTE MANAGE, V54, P1212, DOI 10.1080/10473289.2004.10470979; Uysal N, 2003, CURR OPIN PULM MED, V9, P144, DOI 10.1097/00063198-200303000-00009; WHO WHO, 2004, RESP CAR PRIM CAR SE, P121; Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1195, DOI 10.1289/ehp.11257; Wong TW, 2006, THORAX, V61, P585, DOI 10.1136/thx.2005.051730; Wood SN, 2006, GEN ADDITIVE MODELS, Vxvii; World Health Organization, 2006, WHO AIR QUAL GUID PA; World Organization of National Colleges Academies and Academic Associations of General Practitioners/Family Physicians, 1998, ICPC 2 INT CLASS PRI, Vx; Yam CHK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-255	38	24	27	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86913	10.1371/journal.pone.0086913	http://dx.doi.org/10.1371/journal.pone.0086913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466288	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000171
J	Toska, J; Sun, Y; Carbonell, DA; Foster, ANS; Jacobs, MR; Pearlman, E; Rietsch, A				Toska, Jonida; Sun, Yan; Carbonell, Dalina Alvarez; Foster, Altreisha N. -S.; Jacobs, Michael R.; Pearlman, Eric; Rietsch, Arne			Diversity of Virulence Phenotypes among Type III Secretion Negative Pseudomonas aeruginosa Clinical Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CYSTIC-FIBROSIS; CONTACT-LENS; CORNEAL INFECTION; PROTEIN SECRETION; EPITHELIAL-CELLS; IN-VIVO; KERATITIS; SYSTEM; PNEUMONIA	Pseudomonas aeruginosa is a frequent cause of acute infections. The primary virulence factor that has been linked to clinical disease is the type III secretion system, a molecular syringe that delivers effector proteins directly into host cells. Despite the importance of type III secretion in dictating clinical outcomes and promoting disease in animal models of infections, clinical isolates often do not express the type III secretion system in vitro. Here we screened 81 clinical P. aeruginosa isolates for secretion of type III secretion system substrates by western blot. Non-expressing strains were also subjected to a functional test assaying the ability to intoxicate epithelial cells in vitro, and to survive and cause disease in a murine model of corneal infection. 26 of 81 clinical isolates were found to be type III secretion negative by western blot. 17 of these 26 non-expressing strains were tested for their ability to cause epithelial cell rounding. Of these, three isolates caused epithelial cell rounding in a type III secretion system dependent manner, and one strain was cytotoxic in a T3SS-independent manner. Five T3SS-negative isolates were also tested for their ability to cause disease in a murine model of corneal infection. Of these isolates, two strains caused severe corneal disease in a T3SS-independent manner. Interestingly, one of these strains caused significant disease (inflammation) despite being cleared. Our data therefore show that P. aeruginosa clinical isolates can cause disease in a T3SS-independent manner, demonstrating the existence of novel modifiers of clinical disease.	[Toska, Jonida; Carbonell, Dalina Alvarez; Rietsch, Arne] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Sun, Yan; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Foster, Altreisha N. -S.; Jacobs, Michael R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Foster, Altreisha N. -S.; Jacobs, Michael R.] Univ Hosp Case Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Rietsch, A (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	arne.rietsch@case.edu		Rietsch, Arne/0000-0002-1556-7064	NIH [R01 EY22052, RO1 EY14362, P30 EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY022052, R01EY014362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was funded by NIH grant R01 EY22052 (AR), RO1 EY14362 (EP) and P30 EY11373 (EP). (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon I, 2009, INFECT IMMUN, V77, P3264, DOI 10.1128/IAI.00111-09; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Bradbury RS, 2010, J MED MICROBIOL, V59, P881, DOI 10.1099/jmm.0.018283-0; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Cowell BA, 2003, MICROBIOL-SGM, V149, P2291, DOI 10.1099/mic.0.26280-0; Cowell BA, 2003, CORNEA, V22, P131, DOI 10.1097/00003226-200303000-00010; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Diaz MH, 2010, INFECT IMMUN, V78, P1447, DOI 10.1128/IAI.01134-09; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; Engel LS, 1998, INVEST OPHTH VIS SCI, V39, P662; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hobden JA, 1996, IMMUNOL CELL BIOL, V74, P258, DOI 10.1038/icb.1996.46; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Jain M, 2008, TRANSL RES, V152, P257, DOI 10.1016/j.trsl.2008.10.003; Karthikeyan RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064867; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P3892, DOI 10.1167/iovs.02-1302; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Stapleton F, 2007, OPTOMETRY VISION SCI, V84, P257, DOI 10.1097/OPX.0b013e3180485d5f; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Tang A, 2013, INVEST OPHTH VIS SCI, V54, P2821, DOI 10.1167/iovs.13-11788; TWINING SS, 1993, INVEST OPHTH VIS SCI, V34, P2699; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; VASIL ML, 1991, ANTIBIOT CHEMOTHER, V44, P34; Wareham DW, 2007, INT J MED MICROBIOL, V297, P227, DOI 10.1016/j.ijmm.2007.02.004; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Winstanley C, 2005, J MED MICROBIOL, V54, P519, DOI 10.1099/jmm.0.46005-0; Wong-Beringer A, 2008, CLIN MICROBIOL INFEC, V14, P330, DOI 10.1111/j.1469-0691.2007.01939.x; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zhou HJ, 2008, CRIT CARE MED, V36, P2495, DOI 10.1097/CCM.0b013e318183f3f8	54	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86829	10.1371/journal.pone.0086829	http://dx.doi.org/10.1371/journal.pone.0086829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466261	Green Published, Green Submitted, gold			2022-12-27	WOS:000330288000154
J	Cai, XL; Liu, CB; Mou, SH				Cai, Xianli; Liu, Chibo; Mou, Sihua			Association between Fat Mass- and Obesity-Associated (FTO) Gene Polymorphism and Polycystic Ovary Syndrome: A Meta-Analysis	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; WOMEN; VARIANTS; WEIGHT; IMPACT; INDEX	Aims: Many studies have investigated the relationship between FTO gene polymorphism and polycystic ovary syndrome (PCOS) susceptibility but revealed mixed results. In this study, we aimed to perform a meta-analysis to clarify this association. Methods: Published literature from PubMed, Embase and CNKI was retrieved. Meta-analysis was performed to calculate pooled odds ratio (OR) with 95% confidence interval (CI) using the random-or fix-effects model. Results: A total of 5 studies (4778 cases and 4272 controls) were included in our meta-analysis. The results suggested that FTO rs9939609 polymorphism (or its proxy) was marginally associated with PCOS risk after adjustment for body mass index (BMI) (OR = 1.26; 95% CI: 1.02-1.55). However, the marginal association was not stable after sensitivity analysis. In the subgroup analysis by ethnicity, the association was significant in East Asians (OR = 1.43, 95% CI = 1.30-1.59) but not in Caucasians (OR = 1.04, 95% CI = 0.85-1.29). Conclusions: Our present meta-analysis indicated that FTO rs9939609 polymorphism (or its proxy) might not be associated with risk of PCOS in overall population. However, in East Asians, there might be a direct association between FTO variant and PCOS risk, which is independent of BMI (adiposity).	[Cai, Xianli] Taizhou Municipal Hosp, Dept Gynaecol, Taizhou, Peoples R China; [Liu, Chibo; Mou, Sihua] Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Peoples R China	Taizhou University; Taizhou University	Mou, SH (corresponding author), Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Peoples R China.	sihuamou@163.com						Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Attaoua R, 2008, BIOCHEM BIOPH RES CO, V373, P230, DOI 10.1016/j.bbrc.2008.06.039; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; Barber TM, 2008, DIABETOLOGIA, V51, P1153, DOI 10.1007/s00125-008-1028-6; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; CLEMENT K, 2007, OBESITY GENOMICS POS, P19; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamanti-Kandarakis E, 2006, TRENDS MOL MED, V12, P324, DOI 10.1016/j.molmed.2006.05.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gambineri A, 2002, INT J OBESITY, V26, P883, DOI 10.1038/sj.ijo.0801994; Gu JP, 2012, CHINESE J CLIN MED, V19, P213; Hatziagelaki E, 2012, HORM METAB RES, V44, P810, DOI 10.1055/s-0032-1321817; Kim JJ, 2012, CLIN ENDOCRINOL, V77, P439, DOI 10.1111/j.1365-2265.2012.04389.x; Kosova G, 2012, MOL CELL ENDOCRINOL, DOI [10.1016/j.mce.2012.10.00, DOI 10.1016/J.MCE.2012.10.00]; Kowalska I, 2009, DIABETES METAB, V35, P328, DOI 10.1016/j.diabet.2009.03.004; Kowalska I, 2012, CLIN ENDOCRINOL, V77, P120, DOI 10.1111/j.1365-2265.2012.04379.x; Legro RS, 2000, ANN NY ACAD SCI, V900, P193, DOI 10.1111/j.1749-6632.2000.tb06230.x; Li CY, 2010, DIABETES CARE, V33, P1618, DOI 10.2337/dc09-1788; Li T, 2013, PLOS ONE, V8; MANTEL N, 1959, J NATL CANCER I, V22, P719; Saxena R, 2013, ACTA DIABETOL, V50, P451, DOI 10.1007/s00592-012-0383-4; Shi YH, 2007, NEUROENDOCRINOL LETT, V28, P807; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wehr E, 2010, METABOLISM, V59, P575, DOI 10.1016/j.metabol.2009.08.023; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4361, DOI 10.1210/jc.2006-1191; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wojciechowski P, 2012, DIABETOLOGIA, V55, P2636, DOI 10.1007/s00125-012-2638-6; Yan Q, 2009, ENDOCRINE, V36, P377, DOI 10.1007/s12020-009-9257-0; 2004, HUMAN REPROD OXFORD, V81, P19	35	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86972	10.1371/journal.pone.0086972	http://dx.doi.org/10.1371/journal.pone.0086972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466303	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100238
J	Chattopadhyay, S; Kessler, SP; Colucci, JA; Yamashita, M; deS Senanayake, P; Sen, GC				Chattopadhyay, Saurabh; Kessler, Sean P.; Colucci, Juliana Almada; Yamashita, Michifumi; deS Senanayake, Preenie; Sen, Ganes C.			Tissue-Specific Expression of Transgenic Secreted ACE in Vasculature Can Restore Normal Kidney Functions, but Not Blood Pressure, of Ace-/- Mice	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; CLEAVAGE-SECRETION; DISTAL ECTODOMAIN; PHOSPHORYLATION; FERTILITY; SYSTEM	Angiotensin-converting enzyme (ACE) regulates normal blood pressure and fluid homeostasis through its action in the renin-angiotensin-system (RAS). Ace-/- mice are smaller in size, have low blood pressure and defective kidney structure and functions. All of these defects are cured by transgenic expression of somatic ACE (sACE) in vascular endothelial cells of Ace-/- mice. sACE is expressed on the surface of vascular endothelial cells and undergoes a natural cleavage secretion process to generate a soluble form in the body fluids. Both the tissue-bound and the soluble forms of ACE are enzymatically active, and generate the vasoactive octapeptide Angiotensin II (Ang II) with equal efficiency. To assess the relative physiological roles of the secreted and the cell-bound forms of ACE, we expressed, in the vascular endothelial cells of Ace-/- mice, the ectodomain of sACE, which corresponded to only the secreted form of ACE. Our results demonstrated that the secreted form of ACE could normalize kidney functions and RAS integrity, growth and development of Ace-/- mice, but not their blood pressure. This study clearly demonstrates that the secreted form of ACE cannot replace the tissue-bound ACE for maintaining normal blood pressure; a suitable balance between the tissue-bound and the soluble forms of ACE is essential for maintaining all physiological functions of ACE.	[Chattopadhyay, Saurabh; Kessler, Sean P.; Colucci, Juliana Almada; Yamashita, Michifumi; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA; [deS Senanayake, Preenie] Cleveland Clin, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sen, GC (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA.	seng@ccf.org	Colucci, Juliana/B-4513-2012; YAMASHITA, Michifumi/AFT-3479-2022; Chattopadhyay, Saurabh/I-4091-2019	Colucci, Juliana/0000-0003-3078-0514; Chattopadhyay, Saurabh/0000-0002-2930-1523; Yamashita, Michifumi/0000-0001-6221-8900	National Institutes of Health [HL-48258]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health grant HL-48258. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudrie V, 2007, AM J PHYSIOL-REG I, V292, pR904, DOI 10.1152/ajpregu.00488.2006; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Chattopadhyay S, 2005, J BIOL CHEM, V280, P33847, DOI 10.1074/jbc.M501718200; Chattopadhyay S, 2008, BIOCHEMISTRY-US, V47, P8335, DOI 10.1021/bi800702a; Cole J, 2000, J Renin Angiotensin Aldosterone Syst, V1, P137, DOI 10.3317/jraas.2000.016; CORVOL P, 1995, J HYPERTENS, V13, pS3, DOI 10.1097/00004872-199509003-00002; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; Esther CR, 1996, LAB INVEST, V74, P953; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Guimaraes PB, 2011, HYPERTENSION, V57, P965, DOI 10.1161/HYPERTENSIONAHA.110.167171; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; Hsueh WA, 2011, J CLIN HYPERTENS, V13, P224, DOI 10.1111/j.1751-7176.2011.00449.x; Inoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078736; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kessler SP, 2007, FASEB J, V21, P156, DOI 10.1096/fj.06-6678com; Kessler SP, 2000, J BIOL CHEM, V275, P26259, DOI 10.1074/jbc.M004006200; Kessler SP, 2003, J BIOL CHEM, V278, P21105, DOI 10.1074/jbc.M3023472000; Kessler SP, 2002, J BIOL CHEM, V277, P4271, DOI 10.1074/jbc.M109474200; Kessler SP, 2005, J AM SOC NEPHROL; Kohlstedt K, 2006, MOL PHARMACOL, V69, P19, DOI 10.1124/mol.105.016733; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Kohlstedt K, 2002, CIRC RES, V91, P749, DOI 10.1161/01.RES.0000038114.17939.C8; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Miyazaki M, 2006, J PHARMACOL SCI, V100, P391, DOI 10.1254/jphs.CPJ06008X; Navar LG, 1996, PHYSIOL REV, V76, P425, DOI 10.1152/physrev.1996.76.2.425; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; Ramaraj P, 1998, J CLIN INVEST, V102, P371, DOI 10.1172/JCI3545; Riordan JF, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-225; Sadhukhan R, 1998, P NATL ACAD SCI USA, V95, P138, DOI 10.1073/pnas.95.1.138; Safer R. L., 1981, BIOCH REGULATION BLO, P123; Santhamma KR, 2000, J BIOL CHEM, V275, P23253, DOI 10.1074/jbc.M000593200; Santhamma KR, 2004, J BIOL CHEM, V279, P40227, DOI 10.1074/jbc.M407176200; Senanayake PD, 1998, PEPTIDES, V19, P1685, DOI 10.1016/S0196-9781(98)00123-5; Siragy HM, 2003, ENDOCRINOLOGY, V144, P2229, DOI 10.1210/en.2003-0010; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Sturrock ED, 2012, HDB PROTEOLYTIC ENZY; Varagic J, 2013, AM J HYPERTENS; WEI L, 1991, J BIOL CHEM, V266, P5540	44	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87484	10.1371/journal.pone.0087484	http://dx.doi.org/10.1371/journal.pone.0087484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475296	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300191
J	Crippa, E; Lusa, L; De Cecco, L; Marchesi, E; Calin, GA; Radice, P; Manoukian, S; Peissel, B; Daidone, MG; Gariboldi, M; Pierotti, MA				Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Calin, George Adrian; Radice, Paolo; Manoukian, Siranoush; Peissel, Bernard; Daidone, Maria Grazia; Gariboldi, Manuela; Pierotti, Marco Alessandro			miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MESSENGER-RNA; GENETIC SUSCEPTIBILITY; MICRORNA SIGNATURES; PROTEINS; DIFFERENTIATION; GLIOBLASTOMA; INHIBITOR; TAMOXIFEN; GENOMICS	A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its "in silico" predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class.	[Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Radice, Paolo; Daidone, Maria Grazia; Gariboldi, Manuela] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Radice, Paolo; Gariboldi, Manuela] Fdn Ist FIRC Oncol Mol, Milan, Italy; [Lusa, Lara] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Manoukian, Siranoush; Peissel, Bernard] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Pierotti, Marco Alessandro] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; University of Ljubljana; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Gariboldi, M (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	manuela.gariboldi@istitutotumori.mi.it	Radice, Paolo/O-3119-2013; Lusa, Lara/C-6692-2015; Pierotti, Marco Alessandro/AAC-4728-2022; Daidone, Maria Grazia/E-9232-2017; Peissel, Bernard/E-8187-2017; Calin, George/E-9390-2011; manoukian, siranoush/E-7132-2017; De Cecco, Loris/K-7036-2016; Gariboldi, Manuela/K-4744-2016	Radice, Paolo/0000-0001-6298-4111; Lusa, Lara/0000-0002-8981-2421; Pierotti, Marco Alessandro/0000-0002-7431-8332; Daidone, Maria Grazia/0000-0002-4786-1321; Peissel, Bernard/0000-0001-9233-3571; manoukian, siranoush/0000-0002-6034-7562; De Cecco, Loris/0000-0002-7066-473X; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615; Gariboldi, Manuela/0000-0001-8406-165X	AIRC (Associazione Italiana Ricerca Cancro); Ministero della Salute	AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy)	This work was supported by grants to MA Pierotti from AIRC (Associazione Italiana Ricerca Cancro) and by Ministero della Salute (Tumori Femminili). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2009, EXPERT REV ANTICANC, V9, P1103, DOI 10.1586/ERA.09.38; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bradbury AR, 2007, REV ENDOCR METAB DIS, V8, P255, DOI 10.1007/s11154-007-9038-0; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Da Silva L, 2010, MODERN PATHOL, V23, pS46, DOI 10.1038/modpathol.2010.37; de Candia P, 2006, HUM PATHOL, V37, P1032, DOI 10.1016/j.humpath.2006.03.004; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; He YJ, 2013, EXP THER MED, V5, P813, DOI 10.3892/etm.2013.915; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jen Y, 1996, DEV DYNAM, V207, P235; Kamalian L, 2008, CLIN CANCER RES, V14, P2318, DOI 10.1158/1078-0432.CCR-07-4716; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; Lacroix M, 2005, BREAST CANCER RES TR, V89, P297, DOI 10.1007/s10549-004-2172-4; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manoukian S, 2007, EUR J CANCER, V43, P601, DOI 10.1016/j.ejca.2006.09.024; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park Se-Jin, 2011, Lab Anim Res, V27, P333, DOI 10.5625/lar.2011.27.4.333; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piffanelli A, 1991, Ann Ist Super Sanita, V27, P523; Roldan G, 2006, CANCER BIOL THER, V5, P505, DOI 10.4161/cbt.5.5.2597; RONCHI E, 1986, TUMORI, V72, P251, DOI 10.1177/030089168607200305; Savad S, 2012, ASIAN PAC J CANCER P, V13, P873, DOI 10.7314/APJCP.2012.13.3.873; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Venneti S, 2011, AM J SURG PATHOL, V35, P1463, DOI 10.1097/PAS.0b013e318224d2cd; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zeng WF, 2010, J CANCER, V1, P1	48	52	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87039	10.1371/journal.pone.0087039	http://dx.doi.org/10.1371/journal.pone.0087039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475217	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300128
J	Kawana-Tachikawa, A; Llibre, JM; Bravo, I; Escrig, R; Mothe, B; Puig, J; Puertas, MC; Martinez-Picado, J; Blanco, J; Manzardo, C; Miro, JM; Iwamoto, A; Pozniak, AL; Gatell, JM; Clotet, B; Brander, C				Kawana-Tachikawa, Ai; Llibre, Josep M.; Bravo, Isabel; Escrig, Roser; Mothe, Beatriz; Puig, Jordi; Puertas, Maria C.; Martinez-Picado, Javier; Blanco, Julia; Manzardo, Christian; Miro, Jose M.; Iwamoto, Aikichi; Pozniak, Anton L.; Gatell, Jose M.; Clotet, Bonaventura; Brander, Christian		MARAVIBOOST Investigators	Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; CCR5; ANTAGONIST; EXPRESSION; RECOVERY; SUPPRESSION; LYMPHOCYTES; RESISTANCE	Background: The effect of maraviroc on the maintenance and the function of HIV-1-specific T cell responses remains unknown. Methods: Subjects recently infected with HIV-1 were randomized to receive anti-retroviral treatment with or without maraviroc intensification for 48 weeks, and were monitored up to week 60. PBMC and in vitro-expanded T cells were tested for responses to the entire HIV proteome by ELISpot analyses. Intracellular cytokine staining assays were conducted to monitor the (poly)-functionality of HIV-1-specific T cells. Analyses were performed at baseline and week 24 after treatment start, and at week 60 (3 months after maraviroc discontinuation). Results: Maraviroc intensification was associated with a slower decay of virus-specific T cell responses over time compared to the non-intensified regimen in both direct ex-vivo as well as in in-vitro expanded cells. The effector function profiles of virus-specific CD8(+) T cells were indistinguishable between the two arms and did not change over time between the groups. Conclusions: Maraviroc did not negatively impact any of the measured parameters, but was rather associated with a prolonged maintenance of HIV-1-specific T cell responses. Maraviroc, in addition to its original effect as viral entry inhibitor, may provide an additional benefit on the maintenance of virus-specific T cells which may be especially important for future viral eradication strategies.	[Kawana-Tachikawa, Ai; Mothe, Beatriz; Puertas, Maria C.; Martinez-Picado, Javier; Blanco, Julia; Clotet, Bonaventura; Brander, Christian] Autonomous Univ Barcelona, Irsicaixa AIDS Res Inst HIVACAT, Badalona, Spain; [Kawana-Tachikawa, Ai; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan; [Llibre, Josep M.; Bravo, Isabel; Escrig, Roser; Mothe, Beatriz; Puig, Jordi; Clotet, Bonaventura] UAB, Univ Hosp Germans Trias i Pujol, Lluita SIDA Fdn, HIV Unit, Badalona, Spain; [Mothe, Beatriz; Martinez-Picado, Javier; Blanco, Julia; Clotet, Bonaventura; Brander, Christian] Univ Vic, Vic, Spain; [Martinez-Picado, Javier; Brander, Christian] ICREA, Barcelona, Spain; [Manzardo, Christian; Miro, Jose M.; Gatell, Jose M.] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Pozniak, Anton L.] Chelsea & Westminster Hosp, HIV GUM Dept, London, England	Autonomous University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa; University of Tokyo; Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Imperial College London	Brander, C (corresponding author), Autonomous Univ Barcelona, Irsicaixa AIDS Res Inst HIVACAT, Badalona, Spain.	cbrander@irsicaixa.es	Blanco, Julià/A-5347-2008; Martinez-Picado, Javier/G-5507-2012; Gatell, Jose M/ABC-3607-2020; Suñe, Tomàs Pumarola/F-7583-2017; Pumarola, Tomàs/AAB-5532-2019; Puertas, Maria/G-3251-2016; Massanella, Marta/P-8619-2016	Blanco, Julià/0000-0002-2225-0217; Martinez-Picado, Javier/0000-0002-4916-2129; Suñe, Tomàs Pumarola/0000-0002-5171-7461; Pumarola, Tomàs/0000-0002-5171-7461; Puertas, Maria/0000-0002-6750-2318; Massanella, Marta/0000-0002-3326-151X; Mothe, Beatriz/0000-0001-9975-407X; Brander, Christian/0000-0002-0548-5778	HIVACAT; Catalan program for the development of therapeutic and preventive HIV vaccines; European AIDS Treatment Network [LSHP-CT-2006-037570]; Pfizer Inc; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid (Spain); Spanish Network for AIDS Research (RIS) [ISCIII-RETICRD06/006]; Japan Society for the Promotion of Science for the "Institutional Program for Young Researcher Overseas Visits; ICREA Funding Source: Custom	HIVACAT; Catalan program for the development of therapeutic and preventive HIV vaccines; European AIDS Treatment Network; Pfizer Inc(Pfizer); Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid (Spain)(Instituto de Salud Carlos III); Spanish Network for AIDS Research (RIS); Japan Society for the Promotion of Science for the "Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ICREA(ICREA)	This work was funded by HIVACAT, the Catalan program for the development of therapeutic and preventive HIV vaccines, the European AIDS Treatment Network (NEAT - FP6, contract LSHP-CT-2006-037570) and Pfizer Inc, and an unrestricted grant from ViiV to support the sub-study to the original Maraviboost clinical phase III trial, which was also sponsored by ViiV. The Hospital Clinic-IDIBAPS cohort was supported in part by the "Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid (Spain),'' Spanish Network for AIDS Research (RIS; ISCIII-RETICRD06/006). A.K- T was funded by the Japan Society for the Promotion of Science for the "Institutional Program for Young Researcher Overseas Visits.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Antoniou Tony, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P192, DOI 10.1177/1545109711424967; Arberas H, 2013, J ANTIMICROB CHEMOTH, V68, P577, DOI 10.1093/jac/dks432; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bihl FK, 2005, J TRANSL MED, V3; Camargo JF, 2009, J IMMUNOL, V182, P171, DOI 10.4049/jimmunol.182.1.171; Canestri A, 2010, AIDS, V24, P2887, DOI 10.1097/QAD.0b013e3283402bc1; Romero-Sanchez MC, 2012, ANTIMICROB AGENTS CH, V56, P5858, DOI 10.1128/AAC.01406-12; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Cossarini F, 2012, J ANTIMICROB CHEMOTH, V67, P2474, DOI 10.1093/jac/dks216; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Cuzin L, 2012, JAIDS-J ACQ IMM DEF, V61, P557, DOI 10.1097/QAI.0b013e318273015f; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Funderburg N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013188; Gasser O, 2013, HIV MED, V14, P241, DOI 10.1111/j.1468-1293.2012.01040.x; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gramegna P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028499; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gutierrez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027864; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Lecuroux C, 2009, AIDS, V23, P1649, DOI 10.1097/QAD.0b013e32832e6634; Lisi L, 2012, J NEUROCHEM, V120, P106, DOI 10.1111/j.1471-4159.2011.07549.x; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lopez M, 2008, EUR J IMMUNOL, V38, P1548, DOI 10.1002/eji.200738054; Nozza S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037032; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Puertas MC, 2013, AIDS IN PRESS; Pulido I, 2012, J INFECTION, V64, P417, DOI 10.1016/j.jinf.2011.12.017; Reshef R, 2012, NEW ENGL J MED, V367, P135, DOI 10.1056/NEJMoa1201248; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Ruiz-Riol M, 2013, EUR J IMMUNOL, V43, P1545, DOI 10.1002/eji.201242732; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Spiegel HML, 2000, J INFECT DIS, V182, P88, DOI 10.1086/315639; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; Westrop SJ, 2012, MOL MED, V18, P1240, DOI 10.2119/molmed.2012.00206; Wilkin TJ, 2012, J INFECT DIS, V206, P534, DOI 10.1093/infdis/jis376	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87334	10.1371/journal.pone.0087334	http://dx.doi.org/10.1371/journal.pone.0087334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475275	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300170
J	Wan, GH; Wu, CL; Chen, YF; Huang, SH; Wang, YL; Chen, CW				Wan, Gwo-Hwa; Wu, Chieh-Liang; Chen, Yi-Fang; Huang, Sheng-Hsiu; Wang, Yu-Ling; Chen, Chun-Wan			Particle Size Concentration Distribution and Influences on Exhaled Breath Particles in Mechanically Ventilated Patients	PLOS ONE			English	Article								Humans produce exhaled breath particles (EBPs) during various breath activities, such as normal breathing, coughing, talking, and sneezing. Airborne transmission risk exists when EBPs have attached pathogens. Until recently, few investigations had evaluated the size and concentration distributions of EBPs from mechanically ventilated patients with different ventilation mode settings. This study thus broke new ground by not only evaluating the size concentration distributions of EBPs in mechanically ventilated patients, but also investigating the relationship between EBP level and positive expiratory end airway pressure (PEEP), tidal volume, and pneumonia. This investigation recruited mechanically ventilated patients, with and without pneumonia, aged 20 years old and above, from the respiratory intensive care unit of a medical center. Concentration distributions of EBPs from mechanically ventilated patients were analyzed with an optical particle analyzer. This study finds that EBP concentrations from mechanically ventilated patients during normal breathing were in the range 0.47-2,554.04 particles/breath (0.001-4.644 particles/mL). EBP concentrations did not differ significantly between the volume control and pressure control modes of the ventilation settings in the mechanically ventilated patients. The patient EBPs were sized below 5 mu m, and 80% of them ranged from 0.3 to 1.0 mu m. The EBPs concentrations in patients with high PEEP (> 5 cmH(2)O) clearly exceeded those in patients with low PEEP (<= 5 cmH(2)O). Additionally, a significant negative association existed between pneumonia duration and EBPs concentration. However, tidal volume was not related to EBPs concentration.	[Wan, Gwo-Hwa] Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan; [Wu, Chieh-Liang] Taichung Vet Gen Hosp, Dept Internal Med, Chiayi Branch, Chiayi, Taiwan; [Chen, Yi-Fang] Chung Shan Med Univ Hosp, Dept Resp Therapy, Taichung, Taiwan; [Huang, Sheng-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Wang, Yu-Ling] Taichung Vet Gen Hosp, Dept Resp Therapy, Taichung, Taiwan; [Chen, Chun-Wan] Council Labor Affairs, Inst Occupat Safety & Hlth, New Taipei City, Taiwan	Chang Gung University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taiwan University; Taichung Veterans General Hospital	Wan, GH (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan.	ghwan@mail.cgu.edu.tw		HUANG, SHENG-HSIU/0000-0003-1372-0480	Institute of Occupational Safety and Health of Taiwan [GMRPD1A0051, GMRPD1B0051]	Institute of Occupational Safety and Health of Taiwan	This study was supported by grants GMRPD1A0051 and GMRPD1B0051 from the Institute of Occupational Safety and Health of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Cheng CK, 2010, EDUC COMPET GLOB WOR, P1; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Edward DA, 2006, INHALING CATIONIC AE; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Holmgren H, 2013, RESP PHYSIOL NEUROBI, V185, P228, DOI 10.1016/j.resp.2012.10.010; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610	18	19	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87088	10.1371/journal.pone.0087088	http://dx.doi.org/10.1371/journal.pone.0087088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475230	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300137
J	Wilkinson, R; Wang, XJ; Kassianos, AJ; Zuryn, S; Roper, KE; Osborne, A; Sampangi, S; Francis, L; Raghunath, V; Healy, H				Wilkinson, Ray; Wang, Xiangju; Kassianos, Andrew J.; Zuryn, Steven; Roper, Kathrein E.; Osborne, Andrew; Sampangi, Sandeep; Francis, Leo; Raghunath, Vishwas; Healy, Helen			Laser Capture Microdissection and Multiplex-Tandem PCR Analysis of Proximal Tubular Epithelial Cell Signaling in Human Kidney Disease	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; INJURY MOLECULE-1 KIM-1; MESENCHYMAL TRANSITION; DIABETIC-NEPHROPATHY; VEGF-A; BETA; TRANSCRIPTION; RESPONSES; FIBROSIS; C3	Interstitial fibrosis, a histological process common to many kidney diseases, is the precursor state to end stage kidney disease, a devastating and costly outcome for the patient and the health system. Fibrosis is historically associated with chronic kidney disease (CKD) but emerging evidence is now linking many forms of acute kidney disease (AKD) with the development of CKD. Indeed, we and others have observed at least some degree of fibrosis in up to 50% of clinically defined cases of AKD. Epithelial cells of the proximal tubule (PTEC) are central in the development of kidney interstitial fibrosis. We combine the novel techniques of laser capture microdissection and multiplex-tandem PCR to identify and quantitate "real time'' gene transcription profiles of purified PTEC isolated from human kidney biopsies that describe signaling pathways associated with this pathological fibrotic process. Our results: (i) confirm previous in-vitro and animal model studies; kidney injury molecule-1 is up-regulated in patients with acute tubular injury, inflammation, neutrophil infiltration and a range of chronic disease diagnoses, (ii) provide data to inform treatment; complement component 3 expression correlates with inflammation and acute tubular injury, (iii) identify potential new biomarkers; proline 4-hydroxylase transcription is down-regulated and vimentin is up-regulated across kidney diseases, (iv) describe previously unrecognized feedback mechanisms within PTEC; Smad-3 is down-regulated in many kidney diseases suggesting a possible negative feedback loop for TGF-beta in the disease state, whilst tight junction protein-1 is up-regulated in many kidney diseases, suggesting feedback interactions with vimentin expression. These data demonstrate that the combined techniques of laser capture microdissection and multiplex-tandem PCR have the power to study molecular signaling within single cell populations derived from clinically sourced tissue.	[Wilkinson, Ray; Wang, Xiangju; Kassianos, Andrew J.; Zuryn, Steven; Roper, Kathrein E.; Osborne, Andrew; Sampangi, Sandeep; Healy, Helen] Pathol Queensland, Conjoint Kidney Res Lab, Brisbane, Qld, Australia; [Wilkinson, Ray; Wang, Xiangju; Kassianos, Andrew J.; Zuryn, Steven; Roper, Kathrein E.; Osborne, Andrew; Sampangi, Sandeep; Raghunath, Vishwas; Healy, Helen] Royal Brisbane & Womens Hosp, Dept Renal Med, Brisbane, Qld, Australia; [Francis, Leo] Pathol Queensland, Brisbane, Qld, Australia; [Wilkinson, Ray] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Wilkinson, Ray] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT); University of Queensland	Wilkinson, R (corresponding author), Pathol Queensland, Conjoint Kidney Res Lab, Brisbane, Qld, Australia.	ray.wilkinson@qimr.edu.au	Wilkinson, Ray/J-3171-2014; Healy, Helen/G-2686-2010; Zuryn, Steven/C-7967-2018; Kassianos, Andrew/I-6767-2015	Healy, Helen/0000-0003-4342-5300; Zuryn, Steven/0000-0002-3551-6790; Kassianos, Andrew/0000-0002-0994-3588	Chemical Pathology, Queensland Health; SERTF Trust Fund, Queensland Health; Private Practice Trust Fund, RBWH, Queensland	Chemical Pathology, Queensland Health; SERTF Trust Fund, Queensland Health; Private Practice Trust Fund, RBWH, Queensland	Funding provided by Chemical Pathology, Queensland Health; SERTF Trust Fund, Queensland Health; Private Practice Trust Fund, RBWH, Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Blakey GL, 2004, J MOL HISTOL, V35, P581; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Denker BM, 2011, J AM SOC NEPHROL, V22, P622, DOI 10.1681/ASN.2010090922; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Fogo AB, 1999, EXP NEPHROL, V7, P147; Galichon P, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-11; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Kassianos AJ, 2013, NEPHROL DIAL TRANSPL, V28, P303, DOI 10.1093/ndt/gfs136; Kida Y, 2007, J HISTOCHEM CYTOCHEM, V55, P661, DOI 10.1369/jhc.6A7157.2007; Kwon SH, 2013, CLIN EXP NEPHROL, V17, P359, DOI 10.1007/s10157-012-0707-2; Langham RG, 2008, DIABETOLOGIA, V51, P668, DOI 10.1007/s00125-008-0927-x; Li YJ, 2007, J AM SOC NEPHROL, V18, P2534, DOI 10.1681/ASN.2007030315; Lima WR, 2010, J AM SOC NEPHROL, V21, P478, DOI 10.1681/ASN.2009070698; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Poncelet AC, 2007, J BIOL CHEM, V282, P15534, DOI 10.1074/jbc.M701991200; Prabakaran T, 2012, NEPHROL DIAL TRANSPL, V27, P3156, DOI 10.1093/ndt/gfr794; Prakoura N, 2013, AM J PATHOL, V183, P1474, DOI 10.1016/j.ajpath.2013.07.014; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shalamanova L, 2007, AM J PHYSIOL-RENAL, V292, pF1846, DOI 10.1152/ajprenal.00265.2006; Sheerin NS, 2008, FASEB J, V22, P1065, DOI 10.1096/fj.07-8719com; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Takase O, 2008, KIDNEY INT; Teteris SA, 2007, KIDNEY INT, V71, P1044, DOI 10.1038/sj.ki.5002176; Vaidya VS, 2011, KIDNEY INT, V79, P464, DOI 10.1038/ki.2010.404; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; WELCH TR, 1993, J CLIN INVEST, V92, P1451, DOI 10.1172/JCI116722; Wilkinson R, 2011, NEPHROL DIAL TRANSPL, V26, P1483, DOI 10.1093/ndt/gfq677; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang XJ, 2008, AM J SURG PATHOL, V32, P177, DOI 10.1097/PAS.0b013e318150df1d; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Zhang C, 2004, CELL BIOL INT, V28, P863, DOI 10.1016/j.cellbi.2004.09.003; Zheng GP, 2005, KIDNEY INT, V67, pS96, DOI 10.1111/j.1523-1755.2005.09423.x; Zhou WD, 2001, KIDNEY INT, V59, P1227, DOI 10.1046/j.1523-1755.2001.0590041227.x; Zoja C, 2003, J AM SOC NEPHROL, V14, pS36, DOI 10.1097/01.ASN.0000068626.23485.E0	45	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87345	10.1371/journal.pone.0087345	http://dx.doi.org/10.1371/journal.pone.0087345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475278	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300173
J	Xia, H; Wang, XJ; Zhou, Q; Shi, HZ; Tong, ZH				Xia, Huan; Wang, Xiao-Juan; Zhou, Qiong; Shi, Huan-Zhong; Tong, Zhao-Hui			Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis	PLOS ONE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; 1ST CHOICE MANAGEMENT; QUALITY-OF-LIFE; CHEMICAL PLEURODESIS; BREAST-CARCINOMA; BLEOMYCIN; SLURRY; CATHETER; TETRACYCLINE; POUDRAGE	Background: Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still not clear whether talc pleurodesis is more effective than other local therapies. We performed a meta-analysis to evaluate the efficacy and safety of talc pleurodesis in the management of malignant pleural effusion. Methods: PubMed, Embase, and Web of Science were searched for English-language studies of clinical controlled trials comparing talc pleurodesis with control therapies until August 8, 2013. Success rate and incidence of adverse events were evaluated. Relative risks were estimated using random-or fixed-effects model and statistical heterogeneity was assessed using I-2 test. Results: Twenty trials involving 1,525 patients with malignant pleural effusion were included. The success rate of talc pleurodesis was significantly higher than that of control therapies (relative risk, 1.21; 95% confidence interval, 1.01-1.45; p = 0.035) with similar adverse events. In addition, thoracoscopic talc poudrage was more effective than bedside talc slurry (relative risk, 1.12; 95% confidence interval, 1.01-1.23; p = 0.026). Conclusions: The current evidences suggested the benefit for talc pleurodesis in the treatment of malignant pleural effusion. Talc pleurodesis, especially thoracoscopic talc poudrage pleurodesis, should be performed in patients with malignant pleural effusion, especially those with life-expectancy longer than one month.	[Xia, Huan; Wang, Xiao-Juan; Shi, Huan-Zhong; Tong, Zhao-Hui] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Inst Resp Med, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Zhou, Qiong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Resp & Crit Care Med, Wuhan 430074, Peoples R China; [Shi, Huan-Zhong] Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Huazhong University of Science & Technology; Capital Medical University	Tong, ZH (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Beijing Inst Resp Med, Dept Resp & Crit Care Med, Beijing, Peoples R China.	tongzhaohuicy@sina.com			Beijing High-Grade Talents Health Technology Fund [2011-2-06]; Beijing Municipal Science & Technology Commission [Z131107002213107]	Beijing High-Grade Talents Health Technology Fund; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported in part by a grant from the Beijing High-Grade Talents Health Technology Fund (NO. 2011-2-06) and in part by a grant from Beijing Municipal Science & Technology Commission (NO. Z131107002213107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, RESPIROLOGY, V16, P1064, DOI 10.1111/j.1440-1843.2011.01999.x; Antony VB, 2000, AM J RESP CRIT CARE, V162, P1987, DOI 10.1164/ajrccm.162.5.ats8-00; Bernard A, 2002, ANN THORAC SURG, V74, P213, DOI 10.1016/S0003-4975(02)03599-3; Brega-Massone PP, 2004, SURG LAPARO ENDO PER, V14, P73, DOI 10.1097/00129689-200404000-00005; Brega-Massone PP, 2004, THORAC CARDIOV SURG, V52, P191, DOI 10.1055/s-2004-820869; Burrows CM, 2000, CHEST, V117, P73, DOI 10.1378/chest.117.1.73; Clarke MJ., 2001, SYSTEMATIC REV HLTH, P109; Crnjac A, 2004, EUR J CARDIO-THORAC, V26, P432, DOI 10.1016/j.ejcts.2004.03.010; Crnjac A, 2010, ZDR VESTN, V79, P272; Das Sibes Kumar, 2008, J Indian Med Assoc, V106, P589; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; Demmy TL, 2012, J NATL COMPR CANC NE, V10, P975, DOI 10.6004/jnccn.2012.0102; Diacon AH, 2000, AM J RESP CRIT CARE, V162, P1445, DOI 10.1164/ajrccm.162.4.2002030; Diez-Porres L, 2008, PALLIATIVE MED, V22, P775, DOI 10.1177/0269216308095020; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FENTIMAN IS, 1986, EUR J CANCER CLIN ON, V22, P1079, DOI 10.1016/0277-5379(86)90009-X; FENTIMAN IS, 1983, CANCER, V52, P737, DOI 10.1002/1097-0142(19830815)52:4<737::AID-CNCR2820520428>3.0.CO;2-8; Haddad FJ, 2004, WORLD J SURG, V28, P749, DOI 10.1007/s00268-004-7269-8; HAMED H, 1989, BRIT J SURG, V76, P1266, DOI 10.1002/bjs.1800761214; HARTMAN DL, 1993, J THORAC CARDIOV SUR, V105, P743; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kastelik JA, 2013, LUNG, V191, P165, DOI 10.1007/s00408-012-9445-1; Khaleeq G, 2008, RESP MED, V102, P939, DOI 10.1016/j.rmed.2008.01.022; Kilic D, 2005, SURG TODAY, V35, P634, DOI 10.1007/s00595-005-2996-5; Kuzdzal Jaroslaw, 2003, Med Sci Monit, V9, pPI54; Lee P., 2012, CHEST, V142, P20; Lee P, 2012, CHEST, V142, P15, DOI 10.1378/chest.12-1085; Light RW, 2012, CHEST, V142, P17, DOI 10.1378/chest.12-1087; Light RW, 2000, AM J RESP CRIT CARE, V162, P2024, DOI 10.1164/ajrccm.162.6.pc09-00b; Lynch TJ, 1996, INT J ONCOL, V8, P183; Maceachern P, 2011, RESPIROLOGY, V16, P747, DOI 10.1111/j.1440-1843.2011.01986.x; Martinez-Moragon E, 1998, RESPIRATION, V65, P108, DOI 10.1159/000029240; Mohsen TA, 2011, EUR J CARDIO-THORAC, V40, P282, DOI 10.1016/j.ejcts.2010.09.005; Najmunnisa N, 2007, EUR RESPIR J, V29, P761, DOI 10.1183/09031936.00061606; Nasreen N, 2000, AM J RESP CRIT CARE, V161, P595, DOI 10.1164/ajrccm.161.2.9904123; Noppen M, 1997, ACTA CLIN BELG, V52, P258, DOI 10.1080/17843286.1997.11718587; Ohm C, 2003, AM SURGEON, V69, P198; Ong K C, 2000, Respirology, V5, P99, DOI 10.1046/j.1440-1843.2000.00235.x; Ozyurtkan MO, 2010, EUR J INTERN MED, V21, P30, DOI 10.1016/j.ejim.2009.09.012; Paschoalini MD, 2005, CHEST, V128, P684, DOI 10.1378/chest.128.2.684; Rehse DH, 1999, AM J SURG, V177, P437, DOI 10.1016/S0002-9610(99)00075-6; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Rodriguez-Panadero F, 2012, RESPIRATION, V83, P91, DOI 10.1159/000335419; Saha SK, 2008, J INDIAN MED ASSOC, V106, P592; Shaw P, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002916.PUB2; SORENSEN PG, 1984, EUR J RESPIR DIS, V65, P131; Spiegler PA, 2003, CHEST, V123, P1895, DOI 10.1378/chest.123.6.1895; Stefani A, 2006, EUR J CARDIO-THORAC, V30, P827, DOI 10.1016/j.ejcts.2006.10.002; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035629; Tan C, 2006, EUR J CARDIO-THORAC, V29, P829, DOI 10.1016/j.ejcts.2005.12.025; Terra RM, 2009, CHEST, V136, P361, DOI 10.1378/chest.08-2448; Tremblay A, 2006, CHEST, V129, P362, DOI 10.1378/chest.129.2.362; Ukale V, 2004, RESP MED, V98, P1166, DOI 10.1016/j.rmed.2004.04.008; Ukale V, 2004, LUNG CANCER-J IASLC, V43, P323, DOI 10.1016/j.lungcan.2003.09.014; Yim APC, 1996, ANN THORAC SURG, V62, P1655, DOI 10.1016/S0003-4975(96)00808-9; Zimmer PW, 1997, CHEST, V112, P430, DOI 10.1378/chest.112.2.430	57	63	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87060	10.1371/journal.pone.0087060	http://dx.doi.org/10.1371/journal.pone.0087060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475222	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300131
J	Zong, L; Seto, Y				Zong, Liang; Seto, Yasuyuki			CpG Island Methylator Phenotype, Helicobacter pylori, Epstein-Barr Virus, and Microsatellite Instability and Prognosis in Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ABERRANT DNA METHYLATION; PROMOTER HYPERMETHYLATION; E-CADHERIN; INFECTION; P16(INK4A); CARCINOMAS; ACCUMULATION; ASSOCIATION; PROGRESSION; ACTIVATION	Background: The controversy of CpG island methylator phenotype (CIMP) in gastric cancer persists, despite the fact that many studies have been conducted on its relation with helicobacter pylori (H. pylori), Epstein-Barr virus (EBV), and microsatellite instability (MSI) and prognosis. To drive a more precise estimate of this postulated relationship, a metaanalysis was performed based on existing relevant studies. Methods: We combined individual patient data from 12 studies which involved 1000 patients with gastric cancer, which met the criteria. We tabulated and analyzed parameters from each study, including H. pylori, EBV, MSI, and clinical information of patients. Results: The overall OR for H. pylori infection in CIMP positive group vs. negative group revealed that significantly elevated risks of positive H. pylori infection in the former were achieved (OR 2.23 95% CI, 1.25-4.00; P = 0.007, P-heterogeneity = 0.05). Similarly, strong relation between EBV infection and CIMP was achieved by OR 51.27 (95% CI, 9.39-279.86; P<0.00001, P-heterogeneity = 0.39). The overall OR for MSI in CIMP positive group vs. negative group was 4.44 (95% CI, 1.17-16.88; P = 0.03, P-heterogeneity = 0.01). However, there did not appear to be any correlations with clinical parameters such as tumor site, pathological type, cell differentiation, TNM stage, distant metastasis, lymph node metastasis, and 5-year survival. Conclusions: The meta-analysis highlights the strong relation of CIMP with H. pylori, EBV, and MSI, but CIMP can not be used as a prognostic marker for gastric cancer.	[Zong, Liang; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan	University of Tokyo	Seto, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan.	seto-tky@umin.ac.jp						An CH, 2005, CLIN CANCER RES, V11, P656; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Chang MS, 2006, CLIN CANCER RES, V12, P2995, DOI 10.1158/1078-0432.CCR-05-1601; Chen HY, 2012, CANCER SCI, V103, P73, DOI 10.1111/j.1349-7006.2011.02129.x; Eads CA, 2001, CANCER RES, V61, P3410; Enomoto S, 2007, CANCER SCI, V98, P1853, DOI 10.1111/j.1349-7006.2007.00625.x; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fukayama M, 2008, CANCER SCI, V99, P1726, DOI 10.1111/j.1349-7006.2008.00888.x; Hsieh CJ, 1998, CANCER RES, V58, P3942; Huang FY, 2012, CANCER-AM CANCER SOC, V118, P4969, DOI 10.1002/cncr.27519; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jo P, 2012, SURGERY, V151, P564, DOI 10.1016/j.surg.2011.08.013; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Kim H, 2003, J PATHOL, V200, P23, DOI 10.1002/path.1325; Kim HC, 2005, J CANCER RES CLIN, V131, P733, DOI 10.1007/s00432-005-0017-0; Kondo T, 2009, INT J ONCOL, V35, P547, DOI 10.3892/ijo_00000366; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kusano M, 2006, CANCER-AM CANCER SOC, V106, P1467, DOI 10.1002/cncr.21789; La Rosa S, 2012, AM J SURG PATHOL, V36, P601, DOI 10.1097/PAS.0b013e318242e21c; Liu JB, 2012, WORLD J GASTROENTERO, V18, P5129, DOI 10.3748/wjg.v18.i36.5129; Nakajima T, 2010, J GASTROENTEROL, V45, P37, DOI 10.1007/s00535-009-0142-7; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Oshimo Y, 2004, INT J CANCER, V110, P212, DOI 10.1002/ijc.20090; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Oue N, 2002, J PATHOL, V198, P55, DOI 10.1002/path.1170; Pai RK, 2012, AM J SURG PATHOL, V36, P744, DOI 10.1097/PAS.0b013e31824430d7; Park SY, 2010, VIRCHOWS ARCH, V457, P415, DOI 10.1007/s00428-010-0962-0; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Rashid A, 2004, GASTROENTEROLOGY, V127, P1578, DOI 10.1053/j.gastro.2004.09.007; Seo SY, 2008, CANCER LETT, V270, P66, DOI 10.1016/j.canlet.2008.04.043; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P5438; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Waki T, 2002, AM J PATHOL, V161, P399, DOI 10.1016/S0002-9440(10)64195-8; Watanabe N, 2006, CURR TOP MICROBIOL, V310, P199; Zhang KL, 2008, TRANSL ONCOL, V1, P28, DOI 10.1593/tlo.07103; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	38	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86097	10.1371/journal.pone.0086097	http://dx.doi.org/10.1371/journal.pone.0086097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475075	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300037
J	Meckbach, D; Bauer, J; Pflugfelder, A; Meier, F; Busch, C; Eigentler, TK; Capper, D; von Deimling, A; Mittelbronn, M; Perner, S; Ikenberg, K; Hantschke, M; Buttner, P; Garbe, C; Weide, B				Meckbach, Diana; Bauer, Juergen; Pflugfelder, Annette; Meier, Friedegund; Busch, Christian; Eigentler, Thomas K.; Capper, David; von Deimling, Andreas; Mittelbronn, Michel; Perner, Sven; Ikenberg, Kristian; Hantschke, Markus; Buettner, Petra; Garbe, Claus; Weide, Benjamin			Survival According to BRAF-V600 Tumor Mutations - An Analysis of 437 Patients with Primary Melanoma	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; BRAF V600E MUTATION; METASTATIC MELANOMA; NRAS MUTATIONS; CUTANEOUS MELANOMA; CANCER; FREQUENCIES; INHIBITION; GENE	The prognostic impact of BRAF-V600 tumor mutations in stage I/II melanoma patients has not yet been analyzed in detail. We investigated primary tumors of 437 patients diagnosed between 1989 and 2006 by Sanger sequencing. Mutations were detected in 38.7% of patients and were associated with age, histological subtype as well as mitotic rate. The mutational rate was 36.7% in patients with disease-free course and 51.7% in those with subsequent distant metastasis (p = 0.031). No difference in overall survival (p = 0.119) but a trend for worse distant-metastasis-free survival (p = 0.061) was observed in BRAF mutant compared to BRAF wild-type patients. Independent prognostic factors for overall survival were tumor thickness, mitotic rate and ulceration. An interesting significant prognostic impact was observed in patients with tumor thickness of 1 mm or less, with the mutation present in 6 of 7 patients dying from melanoma. In conclusion, no significant survival differences were found according to BRAF-V600 tumor mutations in patients with primary melanoma but an increasing impact of the mutational status was observed in the subgroup of patients with tumor thickness of 1 mm or less. A potential role of the mutational status as a prognostic factor especially in this subgroup needs to be investigated in larger studies.	[Meckbach, Diana; Bauer, Juergen; Pflugfelder, Annette; Meier, Friedegund; Busch, Christian; Eigentler, Thomas K.; Garbe, Claus; Weide, Benjamin] Univ Med Ctr Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany; [Capper, David; von Deimling, Andreas; Weide, Benjamin] German Canc Res Ctr, Heidelberg, Germany; [Weide, Benjamin] German Canc Consortium DKTK, Heidelberg, Germany; [Capper, David; von Deimling, Andreas] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [Mittelbronn, Michel] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, D-60054 Frankfurt, Germany; [Perner, Sven] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany; [Ikenberg, Kristian] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Hantschke, Markus] Dermatopathol Friedrichshafen, Friedrichshafen, Germany; [Buettner, Petra] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Goethe University Frankfurt; University of Bonn; University of Zurich; University Zurich Hospital; James Cook University	Weide, B (corresponding author), Univ Med Ctr Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany.	benjamin.weide@med.uni-tuebingen.de	von Deimling, Andreas/F-7774-2013; Capper, David/I-8500-2014; Eigentler, Thomas/K-8570-2015; Pflugfelder, Annette/Q-2659-2016; Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021; Bauer, Jurgen/B-4656-2008	von Deimling, Andreas/0000-0002-5863-540X; Capper, David/0000-0003-1945-497X; Eigentler, Thomas/0000-0003-0019-2770; Garbe, Claus/0000-0001-8530-780X; Bauer, Jurgen/0000-0001-8789-1536; Mittelbronn, Michel/0000-0002-2998-052X				Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Ardekani GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047054; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Capper D, 2012, ACTA NEUROPATHOL, V123, P223, DOI 10.1007/s00401-011-0887-y; Chang David Z, 2004, J Transl Med, V2, P46, DOI 10.1186/1479-5876-2-46; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greaves WO, 2013, J MOL DIAGN, V15, P220, DOI 10.1016/j.jmoldx.2012.10.002; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Lasithiotakis KG, 2010, MELANOMA RES, V20, P163, DOI 10.1097/CMR.0b013e328335a8dd; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Moreau S, 2012, ANN SURG ONCOL, V19, P4314, DOI 10.1245/s10434-012-2457-5; Satyamoorthy K, 2003, CANCER RES, V63, P756; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; Thomas NE, 2007, CANCER EPIDEM BIOMAR, V16, P991, DOI 10.1158/1055-9965.EPI-06-1038; Thompson JF, 2011, J CLIN ONCOL, V29, P2199, DOI 10.1200/JCO.2010.31.5812; von Moos R, 2012, ANN ONCOL, V23, P531, DOI 10.1093/annonc/mdr126	31	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86194	10.1371/journal.pone.0086194	http://dx.doi.org/10.1371/journal.pone.0086194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475086	Green Published, gold, Green Accepted			2022-12-27	WOS:000330339800032
J	Williams, R; Ma, XY; Schott, RK; Mohammad, N; Ho, CY; Li, CF; Chang, BSW; Demetriou, M; Dennis, JW				Williams, Ryan; Ma, Xiangyuan; Schott, Ryan K.; Mohammad, Naveed; Ho, Chi Yip; Li, Carey F.; Chang, Belinda S. W.; Demetriou, Michael; Dennis, James W.			Encoding Asymmetry of the N-Glycosylation Motif Facilitates Glycoprotein Evolution	PLOS ONE			English	Article							CODING-SEQUENCE EVOLUTION; PROTEIN EVOLUTION; MORPHOLOGICAL EVOLUTION; FUNCTIONAL DIVERGENCE; ENDOPLASMIC-RETICULUM; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; LYSINE ACETYLATION; CELL; SELECTION	Protein N-glycosylation is found in all domains of life and has a conserved role in glycoprotein folding and stability. In animals, glycoproteins transit through the Golgi where the N-glycans are trimmed and rebuilt with sequences that bind lectins, an innovation that greatly increases structural diversity and redundancy of glycoprotein-lectin interaction at the cell surface. Here we ask whether the natural tension between increasing diversity (glycan-protein interactions) and site multiplicity (backup and status quo) might be revealed by a phylogenic examination of glycoproteins and NXS/T(X not equal P) N-glycosylation sites. Site loss is more likely by mutation at Asn encoded by two adenosine (A)-rich codons, while site gain is more probable by generating Ser or Thr downstream of an existing Asn. Thus mutations produce sites at novel positions more frequently than the reversal of recently lost sites, and therefore more paths though sequence space are made available to natural selection. An intra-species comparison of secretory and cytosolic proteins revealed a departure from equilibrium in sequences one-mutation-away from NXS/T and in (A) content, indicating strong selective pressures and exploration of N-glycosylation positions during vertebrate evolution. Furthermore, secretory proteins have evolved at rates proportional to N-glycosylation site number, indicating adaptive interactions between the N-glycans and underlying protein. Given the topology of the genetic code, mutation of (A) is more often nonsynonomous, and Lys, another target of many PTMs, is also encoded by two (A)-rich codons. An examination of acetyl-Lys sites in proteins indicated similar evolutionary dynamics, consistent with asymmetry of the target and recognition portions of modified sites. Our results suggest that encoding asymmetry is an ancient mechanism of evolvability that increases diversity and experimentation with PTM site positions. Strong selective pressures on PTMs may have contributed to the A+T -> G+C shift in genome-wide nucleotide composition during metazoan radiation.	[Williams, Ryan; Ma, Xiangyuan; Mohammad, Naveed; Ho, Chi Yip; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Ma, Xiangyuan; Dennis, James W.] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Ma, Xiangyuan; Dennis, James W.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Schott, Ryan K.; Chang, Belinda S. W.] Univ Toronto, Dept Ecol & Evolutionary, Toronto, ON, Canada; [Li, Carey F.; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Li, Carey F.; Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California Irvine; University of California System; University of California Irvine	Dennis, JW (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	DENNIS@lunenfeld.ca	Dennis, James/E-7268-2013	Schott, Ryan/0000-0002-4015-3955; Demetriou, Michael/0000-0002-2224-7798	Genome Canada through the OGI; MRI-Ontario Research Fund Global Leadership Round in Genomics Life Sciences [ORF-GL2]; CIHR [MOP-62975]; National Institute of Allergy and Infectious Disease, National Institutes of Health; CFL [R01AI082266, T32AI060573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573, R01AI082266] Funding Source: NIH RePORTER	Genome Canada through the OGI; MRI-Ontario Research Fund Global Leadership Round in Genomics Life Sciences; CIHR(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CFL; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by grants from Genome Canada through the OGI, and funding from MRI-Ontario Research Fund Global Leadership Round in Genomics & Life Sciences (ORF-GL2) and CIHR (MOP-62975) to JWD), and The National Institute of Allergy and Infectious Disease, National Institutes of Health to MD and CFL (R01AI082266, T32AI060573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Cambray G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000256; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Draghi JA, 2011, GENETICS, V187, P1139, DOI 10.1534/genetics.110.125997; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Hall BG, 2008, MOL BIOL EVOL, V25, P688, DOI 10.1093/molbev/msn008; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kimura M., 1983, NEUTRAL THEORY MOL E; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; LIN GL, 1992, DEV COMP IMMUNOL, V16, P153, DOI 10.1016/0145-305X(92)90015-5; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Ma BY, 2004, BIOCHEM BIOPH RES CO, V317, P60, DOI 10.1016/j.bbrc.2004.03.012; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Manna B, 2009, GENE, V434, P50, DOI 10.1016/j.gene.2008.12.013; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Philip WH, 2011, GENETICS POPULATIONS; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shang J, 2007, J CELL BIOL, V176, P605, DOI 10.1083/jcb.200607007; Singh H, 2011, BIOCHEM SOC T, V39, P1592, DOI 10.1042/BST20110699; Soylemez O, 2012, GENOME BIOL EVOL, V4, P1213, DOI 10.1093/gbe/evs096; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Tlusty T, 2008, P NATL ACAD SCI USA, V105, P8238, DOI 10.1073/pnas.0710274105; Umashankar V, 2007, BIOINFORMATION, V2, P62; Varki A, 2011, COLD SPRING HARBOR P, V3; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Weadick CJ, 2012, MOL BIOL EVOL, V29, P1297, DOI 10.1093/molbev/msr311; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	72	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86088	10.1371/journal.pone.0086088	http://dx.doi.org/10.1371/journal.pone.0086088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475074	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800026
J	Wu, YM; Chen, X; Zhou, Q; He, QZ; Kang, JH; Zheng, J; Wang, K; Duan, T				Wu, Yanming; Chen, Xiao; Zhou, Qian; He, Qizhi; Kang, Jiuhong; Zheng, Jing; Wang, Kai; Duan, Tao			ITE and TCDD Differentially Regulate the Vascular Remodeling of Rat Placenta via the Activation of AhR	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; LIGAND; ANGIOGENESIS; ANGIOPOIETIN-2; EXPRESSION; HYPOXIA; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; VASCULOGENESIS; INHIBITION; INDUCTION	Vascular remodeling in the placenta is essential for normal fetal development. The previous studies have demonstrated that in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, an environmental toxicant) induces the intrauterine fetal death in many species via the activation of aryl hydrocarbon receptor (AhR). In the current study, we compared the effects of 2-(19H-indole-39-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) and TCDD on the vascular remodeling of rat placentas. Pregnant rats on gestational day (GD) 15 were randomly assigned into 5 groups, and were exposed to a single dose of 1.6 and 8.0 mg/kg body weight (bw) ITE, 1.6 and 8.0 mg/kg bw TCDD, or an equivalent volume of the vehicle, respectively. The dams were sacrificed on GD20 and the placental tissues were gathered. The intrauterine fetal death was observed only in 8.0 mg/kg bw TCDD-exposed group and no significant difference was seen in either the placental weight or the fetal weight among all these groups. The immunohistochemical and histological analyses revealed that as compared with the vehicle-control, TCDD, but not ITE, suppressed the placental vascular remodeling, including reduced the ratio of the placental labyrinth zone to the basal zone thickness (at least 0.71 fold of control), inhibited the maternal sinusoids dilation and thickened the trophoblastic septa. However, no marked difference was observed in the density of fetal capillaries in the labyrinth zone among these groups, although significant differences were detected in the expression of angiogenic growth factors between ITE and TCDD-exposed groups, especially Angiopoietin-2 (Ang-2), Endoglin, Interferon-gamma (IFN-gamma) and placenta growth factor (PIGF). These results suggest ITE and TCDD differentially regulate the vascular remodeling of rat placentas, as well as the expression of angiogenic factors and their receptors, which in turn may alter the blood flow in the late gestation and partially resulted in intrauterine fetal death.	[Wu, Yanming; Chen, Xiao; Zhou, Qian; Kang, Jiuhong; Wang, Kai; Duan, Tao] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [Duan, Tao] Tongji Univ, Dept Obstet, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [He, Qizhi] Tongji Univ, Dept Pathol, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China; [Kang, Jiuhong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zheng, Jing] Univ Wisconsin, Dept Ob Gyn, Madison, WI USA	Tongji University; Tongji University; Tongji University; Tongji University; University of Wisconsin System; University of Wisconsin Madison	Wang, K (corresponding author), Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China.	kaiwangcn@yahoo.com; tduan@yahoo.com		Wu, Yanming/0000-0003-3357-3051	Shanghai Natural Science Foundation [11ZR1428700]; National Natural Science Foundation of China [81100429, 81270703]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by Shanghai Natural Science Foundation (No.11ZR1428700) (to KW) and National Natural Science Foundation of China (No. 81100429 & (No. 81270703) (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chantraine F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.083; Dewerchin M, 2012, COLD SPRING HARB PER, V2; Emond C, 2004, TOXICOL SCI, V80, P115, DOI 10.1093/toxsci/kfh117; ESKENAZI B, 1995, ENVIRON HEALTH PERSP, V103, P143, DOI 10.2307/3432460; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Furukawa S, 2011, J TOXICOL PATHOL, V24, P95, DOI 10.1293/tox.24.95; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Goldman-Wohl DS, 2000, MOL HUM REPROD, V6, P81, DOI 10.1093/molehr/6.1.81; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Henry EC, 2010, TOXICOL SCI, V114, P90, DOI 10.1093/toxsci/kfp285; Ishimura R, 2006, TOXICOL SCI, V91, P265, DOI 10.1093/toxsci/kfj138; Ishimura R, 2002, TOXICOL APPL PHARM, V185, P197, DOI 10.1006/taap.2002.9539; Ishimura R, 2009, BIOCHEM PHARMACOL, V77, P660, DOI 10.1016/j.bcp.2008.10.030; Ivnitski-Steele I, 2005, CARDIOVASC TOXICOL, V5, P215, DOI 10.1385/CT:5:2:215; Ivnitski-Steele ID, 2003, BIRTH DEFECTS RES A, V67, P496, DOI 10.1002/bdra.10074; Jiang YZ, 2010, J HISTOCHEM CYTOCHEM, V58, P679, DOI 10.1369/jhc.2010.955955; Kawakami T, 2006, TOXICOL APPL PHARM, V212, P224, DOI 10.1016/j.taap.2005.08.007; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Laug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045430; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mizutani T, 2004, ENDOCR J, V51, P569, DOI 10.1507/endocrj.51.569; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Pocar P, 2005, REPRODUCTION, V129, P379, DOI 10.1530/rep.1.00294; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; REYNOLDS LP, 1995, J ANIM SCI, V73, P1839; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Zygmunt M, 2003, EUR J OBSTET GYN R B, V110, pS10, DOI 10.1016/S0301-2115(03)00168-4	41	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86549	10.1371/journal.pone.0086549	http://dx.doi.org/10.1371/journal.pone.0086549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475139	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800052
J	Hunter, MC; O'Hagan, KL; Kenyon, A; Dhanani, KCH; Prinsloo, E; Edkins, AL				Hunter, Morgan C.; O'Hagan, Kyle L.; Kenyon, Amy; Dhanani, Karim C. H.; Prinsloo, Earl; Edkins, Adrienne L.			Hsp90 Binds Directly to Fibronectin (FN) and Inhibition Reduces the Extracellular Fibronectin Matrix in Breast Cancer Cells	PLOS ONE			English	Article							SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; EXPRESSION; SURFACE; HSP90-ALPHA; INVASION; RECEPTOR; IDENTIFICATION; MOTILITY; COLLAGEN	Heat shock protein 90 (Hsp90) has been identified in the extracellular space and has been shown to chaperone a finite number of extracellular proteins involved in cell migration and invasion. We used chemical cross-linking and immunoprecipitation followed by tandem mass spectrometry (MS/MS) to isolate a complex containing Hsp90 and the matrix protein fibronectin (FN) from breast cancer cells. Further analysis showed direct binding of Hsp90 to FN using an in vitro co-immunoprecipitation assay, a solid phase binding assay and surface plasmon resonance (SPR) spectroscopy. Confocal microscopy showed regions of co-localisation of Hsp90 and FN in breast cancer cell lines. Exogenous Hsp90 beta was shown to increase the formation of extracellular FN matrix in the Hs578T cell line, whilst knockdown or inhibition of Hsp90 led to a reduction in the levels of both soluble and insoluble FN and could be partially rescued by addition of exogenous Hsp90b. Treatment of cells with novobiocin led to internalization of FN into vesicles that were positive for the presence of the lysosomal marker, LAMP-1. Taken together, the direct interaction between FN and Hsp90, as well as the decreased levels of both soluble and insoluble FN upon Hsp90 inhibition or knockdown, suggested that FN may be a new client protein for Hsp90 and that Hsp90 was involved in FN matrix assembly and/or stability. The identification of FN as a putative client protein of Hsp90 suggests a role for Hsp90 in FN matrix stability, which is important for a number of fundamental cellular processes including embryogenesis, wound healing, cell migration and metastasis.	[Hunter, Morgan C.; O'Hagan, Kyle L.; Kenyon, Amy; Dhanani, Karim C. H.; Prinsloo, Earl; Edkins, Adrienne L.] Rhodes Univ, Biomed Biotechnol Res Unit, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, Eastern Cape, South Africa	Rhodes University	Edkins, AL (corresponding author), Rhodes Univ, Biomed Biotechnol Res Unit, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	a.edkins@ru.ac.za	Prinsloo, Earl/F-9737-2012; Edkins, Adrienne L/C-8704-2012	Prinsloo, Earl/0000-0002-3048-4304; Edkins, Adrienne L/0000-0002-3615-6651; O'Hagan, Kyle/0000-0003-0460-4410; Kenyon, Amy/0000-0001-9248-576X	National Research Foundation of South Africa (NRF CSUR) [UID 70974]; Medical Research Council of South Africa and Research Council Rhodes University; NRF; German Academic Exchange Service (DAAD); Rhodes University	National Research Foundation of South Africa (NRF CSUR); Medical Research Council of South Africa and Research Council Rhodes University; NRF; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Rhodes University	This work was supported by grants from the National Research Foundation of South Africa (NRF CSUR grant UID 70974), Medical Research Council (MRC SIR grant) of South Africa and Research Council Rhodes University. M.C.H, A.K. and K.L. O.H. were supported by postgraduate fellowships from the NRF and the German Academic Exchange Service (DAAD) and a Henderson Fellowship from Rhodes University. K.C. H.D was supported by the NRF and by a Henderson Fellowship from Rhodes University. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Alfano L, 2010, J CLIN ENDOCR METAB, V95, P3552, DOI 10.1210/jc.2009-2315; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cid C, 2003, FASEB J, V17, P409, DOI 10.1096/fj.03-0606fje; Cid C, 2009, CELL STRESS CHAPERON, V14, P321, DOI 10.1007/s12192-008-0076-7; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; CRAWFORD DC, 1994, CIRC RES, V74, P727, DOI 10.1161/01.RES.74.4.727; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Falsone SF, 2009, J BIOL CHEM, V284, P31190, DOI 10.1074/jbc.M109.057240; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grammatikakis N, 2002, J BIOL CHEM, V277, P8312, DOI 10.1074/jbc.M109200200; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hebert C, 1999, J CELL BIOCHEM, V73, P248, DOI 10.1002/(SICI)1097-4644(19990501)73:2<248::AID-JCB11>3.0.CO;2-A; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Liu XG, 2011, ONCOL REP, V25, P1343, DOI 10.3892/or.2011.1202; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Ngubo M, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-34; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; OLDEN K, 1977, CELL, V11, P957, DOI 10.1016/0092-8674(77)90307-5; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prescott MF, 1999, ANN NY ACAD SCI, V878, P179, DOI 10.1111/j.1749-6632.1999.tb07683.x; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Redlak MJ, 2011, DIGEST DIS SCI, V56, P323, DOI 10.1007/s10620-010-1294-2; Reitan NK, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026015; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Sanchez MC, 2006, EXP EYE RES, V83, P1378, DOI 10.1016/j.exer.2006.07.016; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Theodoraki M, 2013, BIOCHIM BIOPHYS ACTA, V1823, P683, DOI [10.1016/j.bbamcr.2011.08.006.Quality, DOI 10.1016/J.BBAMCR.2011.08.006.QUALITY]; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; VANDERWESTHUYZEN DR, 1984, ARTERIOSCLEROSIS, V4, P238, DOI 10.1161/01.ATV.4.3.238; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Wang XQ, 2005, ACTA BIOCH BIOPH SIN, V37, P379, DOI 10.1111/j.1745-7270.2005.00051.x; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	72	38	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86842	10.1371/journal.pone.0086842	http://dx.doi.org/10.1371/journal.pone.0086842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466266	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100224
J	Faghih, RT; Dahleh, MA; Adler, GK; Klerman, EB; Brown, EN				Faghih, Rose T.; Dahleh, Munther A.; Adler, Gail K.; Klerman, Elizabeth B.; Brown, Emery N.			Deconvolution of Serum Cortisol Levels by Using Compressed Sensing	PLOS ONE			English	Article							MODEL; FOCUSS	The pulsatile release of cortisol from the adrenal glands is controlled by a hierarchical system that involves corticotropin releasing hormone (CRH) from the hypothalamus, adrenocorticotropin hormone (ACTH) from the pituitary, and cortisol from the adrenal glands. Determining the number, timing, and amplitude of the cortisol secretory events and recovering the infusion and clearance rates from serial measurements of serum cortisol levels is a challenging problem. Despite many years of work on this problem, a complete satisfactory solution has been elusive. We formulate this question as a non-convex optimization problem, and solve it using a coordinate descent algorithm that has a principled combination of (i) compressed sensing for recovering the amplitude and timing of the secretory events, and (ii) generalized cross validation for choosing the regularization parameter. Using only the observed serum cortisol levels, we model cortisol secretion from the adrenal glands using a second-order linear differential equation with pulsatile inputs that represent cortisol pulses released in response to pulses of ACTH. Using our algorithm and the assumption that the number of pulses is between 15 to 22 pulses over 24 hours, we successfully deconvolve both simulated datasets and actual 24-hr serum cortisol datasets sampled every 10 minutes from 10 healthy women. Assuming a one-minute resolution for the secretory events, we obtain physiologically plausible timings and amplitudes of each cortisol secretory event with R 2 above 0.92. Identification of the amplitude and timing of pulsatile hormone release allows (i) quantifying of normal and abnormal secretion patterns towards the goal of understanding pathological neuroendocrine states, and (ii) potentially designing optimal approaches for treating hormonal disorders.	[Faghih, Rose T.; Dahleh, Munther A.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Faghih, Rose T.; Dahleh, Munther A.] MIT, Lab Informat & Decis Syst, Cambridge, MA 02139 USA; [Faghih, Rose T.; Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Adler, Gail K.; Klerman, Elizabeth B.; Brown, Emery N.] Harvard Univ, Sch Med, Boston, MA USA; [Adler, Gail K.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Klerman, Elizabeth B.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Faghih, RT (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	rfaghih@mit.edu			NSF Graduate Fellowship; NSF [0836720]; NIH [P01-AG09975, K24-HL105664, RC2-HL101340, R01-HL-11408, HFP01603, DP1 OD003646, K24 HL103845, R01AR43130, M01RR20635, K01AG00661, R01GM 53559]; National Space Biomedical Research Institute through NASA [HFP02802, NCC 9-58]; NASA [NCC9-58]; NSBRI;  [EFRI-0735956]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101340, K24HL105664, R01HL114088, K24HL103845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975, K01AG000661] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	NSF Graduate Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute through NASA; NASA(National Aeronautics & Space Administration (NASA)); NSBRI; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RTF's work was supported in part by the NSF Graduate Fellowship. For this work ENB is supported in part by NIH DP1 OD003646 and NSF 0836720. MAD is supported in part by EFRI-0735956 while EBK is supported in part by NIH P01-AG09975, K24-HL105664, RC2-HL101340, R01-HL-11408, and HFP01603 and HFP02802 from the National Space Biomedical Research Institute through NASA NCC 9-58. Finally, GKA is supported in part by NIH K24 HL103845. Clinical studies were performed on the Brigham and Women's Hospital General Clinical Research Center. Grants supporting the original data collection include NIH R01AR43130 (GKA), M01RR20635 (BWH GCRC), K01AG00661 (EBK), R01GM 53559 (ENB), and NASA NCC9-58 with the NSBRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attouch H, 2010, MATH OPER RES, V35, P438, DOI 10.1287/moor.1100.0449; Boufounos P, 2007, 2007 IEEE/SP 14TH WORKSHOP ON STATISTICAL SIGNAL PROCESSING, VOLS 1 AND 2, P299, DOI 10.1109/SSP.2007.4301267; Brown EN, 2001, AM J PHYSIOL-ENDOC M, V280, pE450, DOI 10.1152/ajpendo.2001.280.3.E450; Conrad M, 2009, J BIOL PHYS, V35, P149, DOI 10.1007/s10867-009-9134-3; Faghih RT, 2011, IEEE ENG MED BIO, P716, DOI 10.1109/IEMBS.2011.6090162; Faghih RT, 2010, THESIS MIT; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Gorodnitsky IF, 1997, IEEE T SIGNAL PROCES, V45, P600, DOI 10.1109/78.558475; HANSEN PC, 2000, ADV COMPUTATIONAL BI, V4, P119; He Z, 2012, 12025470 ARXIV; Johnson TD, 2003, BIOMETRICS, V59, P650, DOI 10.1111/1541-0420.00075; Keenan DM, 2005, J THEOR BIOL, V236, P242, DOI 10.1016/j.jtbi.2005.03.008; Kettyle William M., 1998, ENDOCRINE PATHOPHYSI; Klerman EB, 2001, J CLIN ENDOCR METAB, V86, P1034, DOI 10.1210/jc.86.3.1034; Murray J., 2005, THESIS U CALIFORNIA; ROELFSEMA F, 1993, J CLIN ENDOCR METAB, V77, P234, DOI 10.1210/jc.77.1.234; Sarabdjitsingh RA, 2012, PHYSIOL BEHAV, V106, P73, DOI 10.1016/j.physbeh.2011.09.017; VELDHUIS JD, 1989, AM J PHYSIOL, V257, pE5, DOI 10.1152/ajpendo.1989.257.1.E6; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Vidal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039001; Vinther F, 2011, J MATH BIOL, V63, P663, DOI 10.1007/s00285-010-0384-2; Vis DJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE146, DOI 10.1152/ajpendo.00048.2009; Zdunek R, 2008, IEEE T SIGNAL PROCES, V56, P4752, DOI 10.1109/TSP.2008.928160	23	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85204	10.1371/journal.pone.0085204	http://dx.doi.org/10.1371/journal.pone.0085204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489656	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000011
J	Chen, J; Huang, DE; Chen, W; Guo, CW; Wei, B; Wu, CC; Peng, Z; Fan, J; Hou, ZB; Fang, YS; Wang, YF; Kitazato, K; Yu, GY; Zou, CB; Qian, CW; Xiong, S				Chen, Jia; Huang, Dane; Chen, Wei; Guo, Chaowan; Wei, Bo; Wu, Chongchao; Peng, Zhou; Fan, Jun; Hou, Zhibo; Fang, Yongsheng; Wang, Yifei; Kitazato, Kaio; Yu, Guoying; Zou, Chunbin; Qian, Chuiwen; Xiong, Sheng			Linker-Extended Native Cyanovirin-N Facilitates PEGylation and Potently Inhibits HIV-1 by Targeting the Glycan Ligand	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-FUSION; INACTIVATING PROTEIN; BINDING; ENVELOPE; OLIGOSACCHARIDES; INFECTION; MANNOSE; MUTANTS; INVITRO	Cyanovirin-N (CVN) potently inhibits human immunodeficiency virus type 1 (HIV-1) infection, but both cytotoxicity and immunogenicity have hindered the translation of this protein into a viable therapeutic. A molecular docking analysis suggested that up to 12 residues were involved in the interaction of the reverse parallel CVN dimer with the oligosaccharide targets, among which Leu-1 was the most prominent hot spot residue. This finding provided a possible explanation for the lack of anti-HIV-1 activity observed with N-terminal PEGylated CVN. Therefore, linker-CVN (LCVN) was designed as a CVN derivative with a flexible and hydrophilic linker (Gly(4)Ser)(3) at the N-terminus. The N-terminal alpha-amine of LCVN was PEGylated to create 10 K PEG-aldehyde (ALD)-LCVN. LCVN and 10 K PEG-ALD-LCVN retained the specificity and affinity of CVN for high mannose N-glycans. Moreover, LCVN exhibited significant anti-HIV-1 activity with attenuated cytotoxicity in the HaCaT keratinocyte cell line and MT-4 T lymphocyte cell lines. 10 K PEG-ALD-LCVN also efficiently inactivated HIV-1 with remarkably decreased cytotoxicity and pronounced cell-to-cell fusion inhibitory activity in vitro. The linker-extended CVN and the mono-PEGylated derivative were determined to be promising candidates for the development of an anti-HIV-1 agent. This derivatization approach provided a model for the PEGylation of biologic candidates without introducing point mutations.	[Chen, Jia; Chen, Wei; Wei, Bo; Wu, Chongchao; Peng, Zhou; Hou, Zhibo; Fang, Yongsheng; Wang, Yifei; Qian, Chuiwen; Xiong, Sheng] Jinan Univ, Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Chen, Jia; Chen, Wei; Wei, Bo; Wu, Chongchao; Peng, Zhou; Hou, Zhibo; Fang, Yongsheng; Wang, Yifei; Qian, Chuiwen; Xiong, Sheng] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Huang, Dane] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Dane] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Chaowan; Kitazato, Kaio] Nagasaki Univ, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Fan, Jun] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 606, Japan; [Yu, Guoying; Zou, Chunbin; Xiong, Sheng] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Huang, Dane] Guangdong Prov Inst Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Sun Yat Sen University; Sun Yat Sen University; Nagasaki University; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Guangzhou University of Chinese Medicine	Qian, CW (corresponding author), Jinan Univ, Inst Biomed, Guangzhou, Guangdong, Peoples R China.	litmony@sina.com; xiongsheng@jnu.edu.cn	Guo, Chaowan/AFI-6708-2022; Guo, Chaowan/AAF-3876-2022; Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	Ministry of Science and Technology of China [2012ZX09103-301-033, 2012ZX09202301-001]; Jinan University [11611206]; National Natural Science Foundation of China [30873082]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Jinan University(Jinan University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "National Project for Significant New Drug Development'' of the Ministry of Science and Technology of China (2012ZX09103-301-033, 2012ZX09202301-001), the Central University Scientific Research Funding of Jinan University (11611206) and the National Natural Science Foundation of China (30873082), as provided to Xiong S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P1014, DOI 10.1021/ja005714o; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Botos I, 2002, BIOCHEM BIOPH RES CO, V294, P184, DOI 10.1016/S0006-291X(02)00455-2; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BUCKHEIT RW, 1994, AIDS RES HUM RETROV, V10, P1497, DOI 10.1089/aid.1994.10.1497; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Contarino M, 2013, ANTIMICROB AGENTS CH, V57, P4743, DOI 10.1128/AAC.00309-13; Corine Sandstro m, 2005, BIOCHEMISTRY-US, V43, P13926; Gao XL, 2010, APPL MICROBIOL BIOT, V85, P1051, DOI 10.1007/s00253-009-2078-5; GEYER H, 1988, J BIOL CHEM, V263, P11760; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; KATOH H, 1993, J BIOCHEM-TOKYO, V113, P118, DOI 10.1093/oxfordjournals.jbchem.a123994; Katoh M, 1993, Nihon Ronen Igakkai Zasshi, V30, P953; Kelley BS, 2002, J AM CHEM SOC, V124, P3210, DOI 10.1021/ja025537m; Liu YA, 2009, BIOPOLYMERS, V92, P194, DOI 10.1002/bip.21173; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; NAKASHIMA H, 1988, J CLIN MICROBIOL, V26, P1229, DOI 10.1128/JCM.26.6.1229-1232.1988; NEMOTO Y, 1993, J CELL BIOL, V123, P963, DOI 10.1083/jcb.123.4.963; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Sandstrom C, 2008, BIOCHEMISTRY-US, V47, P3625, DOI 10.1021/bi702200m; Shattock R, 2004, LANCET, V363, P1002, DOI 10.1016/S0140-6736(04)15876-5; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shattock RJ, 2011, SCIENCE, V333, P42, DOI 10.1126/science.1206399; TOCHIKURA TS, 1988, VIROLOGY, V164, P542, DOI 10.1016/0042-6822(88)90570-3; Vorontsov II, 2009, BIOPHYS J, V97, P2532, DOI 10.1016/j.bpj.2009.08.011; Xiong S, 2010, APPL MICROBIOL BIOT, V86, P805, DOI 10.1007/s00253-010-2470-1; Zappe H, 2008, ADV DRUG DELIVER REV, V60, P79, DOI 10.1016/j.addr.2007.05.016	33	9	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86455	10.1371/journal.pone.0086455	http://dx.doi.org/10.1371/journal.pone.0086455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475123	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330507300065
J	Mali, I; Vandewege, MW; Davis, SK; Forstner, MRJ				Mali, Ivana; Vandewege, Michael W.; Davis, Scott K.; Forstner, Michael R. J.			Magnitude of the Freshwater Turtle Exports from the US: Long Term Trends and Early Effects of Newly Implemented Harvest Management Regimes	PLOS ONE			English	Article							LIVED ORGANISMS; CONSERVATION; TRADE; REPTILES; CHINA; IDENTIFICATION; DEMOGRAPHICS; AMPHIBIANS; TORTOISES; MARKET	Unregulated commercial harvest remains a major threat for turtles across the globe. Due to continuing demand from Asian markets, a significant number of turtles are exported from the United States of America ( US). Beginning in 2007, several southeastern states in the US implemented restrictions on the commercial harvest of turtles, in order to address the unsustainable take. We have summarized freshwater turtle exports from the US between 2002 and 2012 and demonstrated that the magnitude of turtle exports from the US remained high although the exports decreased throughout the decade. Louisiana and California were the major exporters. The majority of exports were captive bred, and from two genera, Pseudemys and Trachemys. We review the changes over the decade and speculate that the increase in export of wild turtles out of Louisiana after 2007 could be a consequence of strict regulations in surrounding states ( e. g., Alabama, Florida). We suggest that if wild turtle protection is a goal for conservation efforts, then these states should work together to develop comprehensive regulation reforms pertaining to the harvest of wild turtles.	[Mali, Ivana; Forstner, Michael R. J.] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Vandewege, Michael W.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Davis, Scott K.] Turtle Survival Alliance, Ft Worth, TX USA	Texas State University System; Texas State University San Marcos; Mississippi State University	Mali, I (corresponding author), SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	im1040@txstate.edu			Texas State University-San Marcos, Texas, USA	Texas State University-San Marcos, Texas, USA	Funding for this study received from Texas State University-San Marcos, Texas, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabama Department of Conservation and Natural Resources, 2012, 2012 2013 REG REL GA; Association of Fish and Wildlife Agencies, 2011, STAT UN LEG AUTH US; Behler J.L., 1997, P CONS REST MAN TORT; Brown DJ, 2011, J WILDLIFE MANAGE, V75, P486, DOI 10.1002/jwmg.73; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Ceballos CP, 2004, WILDLIFE SOC B, V32, P881, DOI 10.2193/0091-7648(2004)032[0881:TTINAE]2.0.CO;2; Center for Biological Diversity, 2012, SO MIDW FRESHW TURTL; Chen TH, 2010, ORYX, V44, P261, DOI 10.1017/S0030605310000013; Cheung SM, 2006, AQUAT CONSERV, V16, P751, DOI 10.1002/aqc.803; Close Lisa M., 1997, Chelonian Conservation and Biology, V2, P563; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CONGDON JD, 1994, AM ZOOL, V34, P397; Duc Le Dien, 1995, INVESTIGATIONS TORTO; Ernst CH, 2009, TURTLES US CANADA; Georgia Department of Natural Resources, 2012, 2012 2013 HUNT SEAS; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gong SP, 2009, ORYX, V43, P213, DOI 10.1017/S0030605308000902; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hong ML, 2008, APPL HERPETOL, V5, P173; Hughes DW, 1999, AQUACULT ECON MANAG, V3, P250; KLEMENS MW, 1995, BIODIVERS CONSERV, V4, P281, DOI 10.1007/BF00055974; Lindsay MK, 2013, AMPHIBIA-REPTILIA, V34, P75, DOI 10.1163/15685381-00002871; Louisiana State University AgCenter, 2012, AGR BACKB LOUIS EC; Meng Xianlin, 2002, Turtle and Tortoise Newsletter, V5, P15; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; Reed RN, 2003, CONSERVATION STATUS; Roman J, 2000, ANIM CONSERV, V3, P61, DOI 10.1017/S1367943000000743; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Sokal R.R., 2012, BIOMETRY; Telecky Teresa M., 2001, Turtle and Tortoise Newsletter, V4, P8; Texas Parks and Wildlife Department, 2007, TEX TURTL REG TITL 2; Turtle Conservation Coalition, 2011, TURTL TROUBL WORLDS; United States Fish and Wildlife Service, 2012, LAW ENF STOR NEWS RE; Zhou ZH, 2008, CHELONIAN CONSERV BI, V7, P28, DOI 10.2744/CCB-0662.1	35	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86478	10.1371/journal.pone.0086478	http://dx.doi.org/10.1371/journal.pone.0086478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475128	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300070
J	Nebuloni, L; Kuhn, GA; Vogel, J; Muller, R				Nebuloni, Laura; Kuhn, Gisela A.; Vogel, Johannes; Mueller, Ralph			A Novel In Vivo Vascular Imaging Approach for Hierarchical Quantification of Vasculature Using Contrast Enhanced Micro-Computed Tomography	PLOS ONE			English	Article							MICROCOMPUTED TOMOGRAPHY; BONE; ANGIOGENESIS; CAPILLARIES	The vasculature of body tissues is continuously subject to remodeling processes originating at the micro-vascular level. The formation of new blood vessels (angiogenesis) is essential for a number of physiological and pathophysiological processes such as tissue regeneration, tumor development and the integration of artificial tissues. There are currently no time-lapsed in vivo imaging techniques providing information on the vascular network at the capillary level in a non-destructive, three-dimensional and high-resolution fashion. This paper presents a novel imaging framework based on contrast enhanced micro-computed tomography (micro-CT) for hierarchical in vivo quantification of blood vessels in mice, ranging from largest to smallest structures. The framework combines for the first time a standard morphometric approach with densitometric analysis. Validation tests showed that the method is precise and robust. Furthermore, the framework is sensitive in detecting different perfusion levels after the implementation of a murine ischemia-reperfusion model. Correlation with both histological data and micro-CT analysis of vascular corrosion casts confirmed accuracy of the method. The newly developed time-lapsed imaging approach shows high potential for in vivo monitoring of a number of different physiological and pathological conditions in angiogenesis and vascular development.	[Nebuloni, Laura; Kuhn, Gisela A.; Mueller, Ralph] ETH, Inst Biomech, Zurich, Switzerland; [Vogel, Johannes] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Vogel, Johannes] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Muller, R (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.	ram@ethz.ch	Müller, Ralph/A-1198-2008; Nebuloni, Laura/I-8154-2014	Müller, Ralph/0000-0002-5811-7725; Nebuloni, Laura/0000-0001-5660-1233; Vogel, Johannes/0000-0003-4181-4521	European Union [AngioScaff FP7-NMP-2008-214402]	European Union(European Commission)	Funding from the European Union for the project "Angiogenesis-inducing bioactive and bioresponsive scaffolds in tissue engineering'' (AngioScaff FP7-NMP-2008-214402) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood K, 2003, FIXATION TISSUE PROC, P141; Beckmann N, 2003, J NEUROSCI, V23, P8453; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Kemp RA, 2010, J NUCL MED, V51, p18S, DOI 10.2967/jnumed.109.068148; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Folarin AA, 2010, MICROVASC RES, V80, P89, DOI 10.1016/j.mvr.2010.03.007; Ford NL, 2006, INVEST RADIOL, V41, P384, DOI 10.1097/01.rli.0000197981.66537.48; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Haubner R, 2006, EUR J NUCL MED MOL I, V33, pS54, DOI 10.1007/s00259-006-0136-0; Heinzer S, 2008, NEUROIMAGE, V39, P1549, DOI 10.1016/j.neuroimage.2007.10.054; Heinzer S, 2006, NEUROIMAGE, V32, P626, DOI 10.1016/j.neuroimage.2006.03.043; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Krucker T, 2006, MICROSC RES TECHNIQ, V69, P138, DOI 10.1002/jemt.20263; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lee TY, 2002, TRENDS BIOTECHNOL, V20, pS3, DOI 10.1016/S0167-7799(02)02035-8; Li WM, 2006, CIRCULATION, V113, P2445, DOI 10.1161/CIRCULATIONAHA.105.586818; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Nebuloni L, 2013, ACAD RADIOL IN PRESS; Nebuloni L, 2013, ACAD RADIOL, V20, P1247, DOI 10.1016/j.acra.2013.06.003; Neeman M, 2000, CANCER METAST REV, V19, P39, DOI 10.1023/A:1026583911941; Ortiz MC, 2000, KIDNEY INT, V58, P1632, DOI 10.1046/j.1523-1755.2000.00324.x; ROSENBLATT JD, 1987, STAIN TECHNOL, V62, P85, DOI 10.3109/10520298709107973; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; Smith AH, 2011, J CARDIOVASC TRANSL, V4, P404, DOI 10.1007/s12265-011-9282-2; Team RDC, 2010, R LANG ENV STAT COMP; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Ulrich D, 1997, ST HEAL T, V40, P97; Wunder A, 2008, BASIC RES CARDIOL, V103, P182, DOI 10.1007/s00395-008-0712-5	34	30	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86562	10.1371/journal.pone.0086562	http://dx.doi.org/10.1371/journal.pone.0086562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475146	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330507300082
J	Reddy, UK; Almeida, A; Abburi, VL; Alaparthi, SB; Unselt, D; Hankins, G; Park, M; Choi, D; Nimmakayala, P				Reddy, Umesh K.; Almeida, Aldo; Abburi, Venkata L.; Alaparthi, Suresh Babu; Unselt, Desiree; Hankins, Gerald; Park, Minkyu; Choi, Doil; Nimmakayala, Padma			Identification of Gene-Specific Polymorphisms and Association with Capsaicin Pathway Metabolites in Capsicum annuum L. Collections	PLOS ONE			English	Article							CINNAMOYL-COA REDUCTASE; DIFFERENTIAL EXPRESSION; PUNGENT PRINCIPLE; BIOSYNTHESIS; PEPPER; FRUITS; ACID; ACCUMULATION; EVOLUTIONARY; PLACENTA	Pepper (Capsicum annuum L.) is an economically important crop with added nutritional value. Production of capsaicin is an important quantitative trait with high environmental variance, so the development of markers regulating capsaicinoid accumulation is important for pepper breeding programs. In this study, we performed association mapping at the gene level to identify single nucleotide polymorphisms (SNPs) associated with capsaicin pathway metabolites in a diverse Capsicum annuum collection during two seasons. The genes Pun1, CCR, KAS and HCT were sequenced and matched with the whole-genome sequence draft of pepper to identify SNP locations and for further characterization. The identified SNPs for each gene underwent candidate gene association mapping. Association mapping results revealed Pun1 as a key regulator of major metabolites in the capsaicin pathway mainly affecting capsaicinoids and precursors for acyl moieties of capsaicinoids. Six different SNPs in the promoter sequence of Pun1 were found associated with capsaicin in plants from both seasons. Our results support that CCR is an important control point for the flux of p-coumaric acid to specific biosynthesis pathways. KAS was found to regulate the major precursors for acyl moieties of capsaicinoids and may play a key role in capsaicinoid production. Candidate gene association mapping of Pun1 suggested that the accumulation of capsaicinoids depends on the expression of Pun1, as revealed by the most important associated SNPs found in the promoter region of Pun1.	[Reddy, Umesh K.; Almeida, Aldo; Abburi, Venkata L.; Alaparthi, Suresh Babu; Unselt, Desiree; Hankins, Gerald; Nimmakayala, Padma] West Virginia State Univ, Gus R Douglass Inst, Institute, WV USA; [Reddy, Umesh K.; Almeida, Aldo; Abburi, Venkata L.; Alaparthi, Suresh Babu; Unselt, Desiree; Hankins, Gerald; Nimmakayala, Padma] West Virginia State Univ, Dept Biol, Institute, WV USA; [Park, Minkyu; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Coll Agr & Life Sci, Seoul, South Korea	West Virginia State University; West Virginia State University; Seoul National University (SNU)	Reddy, UK (corresponding author), West Virginia State Univ, Gus R Douglass Inst, Institute, WV USA.	ureddy@wvstateu.edu	Choi, Doil/F-5002-2011; Robles, Aldo Ricardo Almeida/P-9348-2019	Robles, Aldo Ricardo Almeida/0000-0001-5284-8992; Unselt, Desiree/0000-0003-1489-8854	USDA-NIFA [2010-38821-21574]; Office of Integrative Activities [1003907] Funding Source: National Science Foundation	USDA-NIFA(United States Department of Agriculture (USDA)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This project was supported by USDA-NIFA (Contract #2010-38821-21574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abburi L, 2013, LINKAGE DISEQUILIBRI; Aluru MR, 2003, J EXP BOT, V54, P1655, DOI 10.1093/jxb/erg176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT DJ, 1968, J CHEM SOC C, P442, DOI 10.1039/j39680000442; Blum E, 2003, THEOR APPL GENET, V108, P79, DOI 10.1007/s00122-003-1405-y; Blum E, 2002, GENOME, V45, P702, DOI 10.1139/G02-031; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; COLLINS MD, 1995, HORTSCIENCE, V30, P137, DOI 10.21273/HORTSCI.30.1.137; Dehesh K, 2001, PLANT PHYSIOL, V125, P1103, DOI 10.1104/pp.125.2.1103; Abraham-Juarez MD, 2008, PLANTA, V227, P681, DOI 10.1007/s00425-007-0651-7; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; FUJIWAKE H, 1982, AGR BIOL CHEM TOKYO, V46, P2591, DOI 10.1080/00021369.1982.10865477; FUNK C, 1990, PLANT PHYSIOL, V94, P95, DOI 10.1104/pp.94.1.95; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Han K, 2013, MOL BREEDING, V31, P537, DOI 10.1007/s11032-012-9811-y; Handrick V, 2010, ANAL BIOANAL CHEM, V398, P2789, DOI 10.1007/s00216-010-4129-2; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; HOLM S, 1979, SCAND J STAT, V6, P65; IWAI K, 1979, AGR BIOL CHEM TOKYO, V43, P2493, DOI 10.1080/00021369.1979.10863843; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kim M, 2001, MOL CELLS, V11, P213; KOPP B, 1981, PLANTA MED, V43, P272, DOI 10.1055/s-2007-971508; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Lee R J, 1996, J Am Optom Assoc, V67, P548; LEETE E, 1968, J AM CHEM SOC, V90, P6837, DOI 10.1021/ja01026a049; LEFEBVRE V, 1995, GENOME, V38, P112, DOI 10.1139/g95-014; Leonard JM, 1998, PLANT J, V13, P621, DOI 10.1046/j.1365-313X.1998.00066.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marzo VD, 2004, EUROPEAN J BIOCH, V271, P1813; Mazourek M, 2009, PLANT PHYSIOL, V150, P1806, DOI 10.1104/pp.109.136549; McCormack PL, 2010, DRUGS, V70, P1831, DOI 10.2165/11206050-000000000-00000; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Pichon M, 1998, PLANT MOL BIOL, V38, P671, DOI 10.1023/A:1006060101866; Rao SR, 2000, J BIOTECHNOL, V76, P137, DOI 10.1016/S0168-1656(99)00177-7; Rozen S, 1998, PRIMER3; Stellari GM, 2010, HEREDITY, V104, P460, DOI 10.1038/hdy.2009.131; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Yumnam JS, 2012, PLANT MOL BIOL REP, V30, P1470, DOI 10.1007/s11105-012-0466-y; Zewdie Y, 2001, BIOCHEM SYST ECOL, V29, P161, DOI 10.1016/S0305-1978(00)00041-7	47	25	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86393	10.1371/journal.pone.0086393	http://dx.doi.org/10.1371/journal.pone.0086393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475113	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300059
J	Gelir, E; Budak, MT; Ardic, S				Gelir, Ethem; Budak, Murat Timur; Ardic, Sadik			The Relationship between CPAP Usage and Corneal Thickness	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; REM-SLEEP; HEALTHY-SUBJECTS; HYPOXIA; DENSITY; WEAR	The purpose of this study was to determine whether there is a correlation between CPAP usage and corneal thickness in patients with sleep disordered breathing. Full-night polysomnography (PSG) recordings were collected. Ten patients had undergone PSG recordings with continuous positive airway pressure (CPAP), and seven patients had undergone PSG recordings without CPAP. We measured corneal thickness by ultrasonic pachymeter before sleep and ten minutes after waking. We also measured visual acuity with a routine ophthalmologic eye chart before and after sleep. We asked patients to fill out a post-sleep questionnaire to get their subjective opinions. In the without-CPAP group, corneal thickness increased significantly during sleep in both eyes (left, p = 0.0025; right, p<0.0001). In the with-CPAP group, corneal thickness did not increase significantly (p>0.05 for both left and right cornea). There was no significant difference in visual acuity tests (p>0.05 for both left and right eye) between the two groups. According to our results, there is a significant increase in corneal thickness in the without-CPAP group. Our data show that a low percentage of Rapid Eye Movement (REM) sleep may cause an increase in corneal thickness, which can indicate poor corneal oxygenation. In fact, many sleep-disordered breathing (SDB) patients have low REM. Since a contact lens may cause low corneal oxygenation, SDB patients with contact lenses should be monitored carefully for their corneal thickness.	[Gelir, Ethem; Budak, Murat Timur] Hacettepe Univ, Sch Med, Dept Physiol, Ankara, Turkey; [Ardic, Sadik] SGK Ankara Educ Hosp, Sleep Lab, Dept Pulm Med, Ankara, Turkey	Hacettepe University; Ankara Training & Research Hospital	Gelir, E (corresponding author), Hacettepe Univ, Sch Med, Dept Physiol, Ankara, Turkey.	egelir@hacettepe.edu.tr						Aloia M S, 2001, Sleep Breath, V5, P13, DOI 10.1007/s11325-001-0013-9; ANTONIOLI M, 1981, SLEEP, V4, P221, DOI 10.1093/sleep/4.2.221; BONNET M, 1993, SLEEP, V16, P748; Bornstein SK., 1982, SLEEPING WAKING DISO, P183; Buchanan P, 2011, PRINCIPLES PRACTICE, V5th, P1233; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; du Toit R, 2003, CORNEA, V22, P205, DOI 10.1097/00003226-200304000-00004; Faulkner W, 1997, CORNEA FUNDAMENTALS, P279; Feige B, 2002, NEUROPSYCHOPHARMACOL, V26, P246, DOI 10.1016/S0893-133X(01)00314-1; Feng PF, 2001, SLEEP, V24, P645, DOI 10.1093/sleep/24.6.645; Ferini-Strambi L, 2003, BRAIN RES BULL, V61, P87, DOI 10.1016/S0361-9230(03)00068-6; Ferini-Strambi L, 2013, INT J PSYCHOPHYSIOL; FISHER C, 1965, ARCH GEN PSYCHIAT, V12, P29; HAJAK G, 1994, SLEEP, V17, P11, DOI 10.1093/sleep/17.1.11; HEDBYS BO, 1966, EXP EYE RES, V5, P221, DOI 10.1016/S0014-4835(66)80010-6; Heller H, 1988, CLIN PHYSL SLEEP, P145; HOHAGEN F, 1993, NEUROPSYCHOPHARMACOL, V9, P225, DOI 10.1038/npp.1993.58; HOLDEN BA, 1985, INVEST OPHTH VIS SCI, V26, P1489; Horner RL, 1998, SLEEP, V21, P847; Jalbert I, 2009, EYE, V23, P1282, DOI 10.1038/eye.2008.307; JOHNSON MH, 1985, AM J OPTOM PHYS OPT, V62, P768; Karacan I, 1965, THESIS NEW YORK U BR; KING D, 1981, PSYCHIAT RES, V5, P267, DOI 10.1016/0165-1781(81)90073-1; Kleitman N., 1963, SLEEP WAKEFULNESS; KLYCE SD, 1981, J PHYSIOL-LONDON, V321, P49, DOI 10.1113/jphysiol.1981.sp013971; Kohlhaas M, 2006, ARCH OPHTHALMOL-CHIC, V124, P471, DOI 10.1001/archopht.124.4.471; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Maurice DM, 1998, EXP EYE RES, V66, P139, DOI 10.1006/exer.1997.0444; Moezzi AM, 2011, EYE CONTACT LENS, V37, P61, DOI 10.1097/ICL.0b013e31820e0bc3; Moghimi S, 2013, SLEEP MED, V14, P53, DOI 10.1016/j.sleep.2012.07.004; PESSAH MA, 1972, SCIENCE, V178, P773, DOI 10.1126/science.178.4062.773; POLSE KA, 1970, ARCH OPHTHALMOL-CHIC, V84, P505; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; SALZ JJ, 1983, OPHTHALMIC SURG LAS, V14, P750; Tai LY, 2013, CORNEA, V32, P766, DOI 10.1097/ICO.0b013e318269938d; Wellman A, 2011, PRINCIPLES PRACTICE, P1140	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87274	10.1371/journal.pone.0087274	http://dx.doi.org/10.1371/journal.pone.0087274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475261	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800092
J	Miranzo-Navarro, D; Magor, KE				Miranzo-Navarro, Domingo; Magor, Katharine E.			Activation of Duck RIG-I by TRIM25 Is Independent of Anchored Ubiquitin	PLOS ONE			English	Article							ANTIVIRAL SIGNAL-TRANSDUCTION; INNATE IMMUNE-RESPONSE; POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; ADAPTER PROTEIN; RNA RECOGNITION; VIRAL-RNA; INFLUENZA; LIGASE; VIRUS	Retinoic acid inducible gene I (RIG-I) is a viral RNA sensor crucial in defense against several viruses including measles, influenza A and hepatitis C. RIG-I activates type-I interferon signalling through the adaptor for mitochondrial antiviral signaling (MAVS). The E3 ubiquitin ligase, tripartite motif containing protein 25 (TRIM25), activates human RIG-I through generation of anchored K63-linked polyubiquitin chains attached to lysine 172, or alternatively, through the generation of unanchored K63-linked polyubiquitin chains that interact non-covalently with RIG-I CARD domains. Previously, we identified RIG-I of ducks, of interest because ducks are the host and natural reservoir of influenza viruses, and showed it initiates innate immune signaling leading to production of interferon-beta (IFN-beta). We noted that K172 is not conserved in RIG-I of ducks and other avian species, or mouse. Because K172 is important for both mechanisms of activation of human RIG-I, we investigated whether duck RIG-I was activated by TRIM25, and if other residues were the sites for attachment of ubiquitin. Here we show duck RIG-I CARD domains are ubiquitinated for activation, and ubiquitination depends on interaction with TRIM25, as a splice variant that cannot interact with TRIM25 is not ubiquitinated, and cannot be activated. We expressed GST-fusion proteins of duck CARD domains and characterized TRIM25 modifications of CARD domains by mass spectrometry. We identified two sites that are ubiquitinated in duck CARD domains, K167 and K193, and detected K63 linked polyubiquitin chains. Site directed mutagenesis of each site alone, does not alter the ubiquitination profile of the duck CARD domains. However, mutation of both sites resulted in loss of all attached ubiquitin and polyubiquitin chains. Remarkably, the double mutant duck RIG-I CARD still interacts with TRIM25, and can still be activated. Our results demonstrate that anchored ubiquitin chains are not necessary for TRIM25 activation of duck RIG-I.	Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Magor, KE (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	kmagor@ualberta.ca	Magor, Katharine/A-2664-2014	Magor, Katharine/0000-0002-9331-1486	Canadian Institutes of Health Research [CIHR MOP 125865]; Natural Sciences and Engineering Research Council [RGPIN 228035]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Canadian Institutes of Health Research grant CIHR MOP 125865 to KEM, and Natural Sciences and Engineering Research Council Discovery Grant RGPIN 228035 to KEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MRW, 2013, MOL IMMUNOL, V54, P89, DOI 10.1016/j.molimm.2012.10.038; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Feng M, 2013, PROTEIN CELL, V4, P142, DOI 10.1007/s13238-012-2088-4; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Maelfait J, 2012, MICROBIOL MOL BIOL R, V76, P33, DOI 10.1128/MMBR.05012-11; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Marblestone JG, 2012, BBA-MOL CELL RES, V1823, P2094, DOI 10.1016/j.bbamcr.2012.06.013; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; O'Neill LAJ, 2011, CELL, V147, P259, DOI 10.1016/j.cell.2011.09.027; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sick C, 1998, J BIOL CHEM, V273, P9749, DOI 10.1074/jbc.273.16.9749; Spackman Erica, 2008, V436, P1, DOI 10.1007/978-1-59745-279-3_1; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Takamatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053578; Vanderven HA, 2012, MOL IMMUNOL, V51, P316, DOI 10.1016/j.molimm.2012.03.034; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, CUM NUMB CONF HUM CA; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	49	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86968	10.1371/journal.pone.0086968	http://dx.doi.org/10.1371/journal.pone.0086968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466302	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000178
J	Weiss, D; Neuner, B; Gorzelniak, K; Bremer, A; Rudack, C; Walter, M				Weiss, Daniel; Neuner, Bruno; Gorzelniak, Kerstin; Bremer, Alexis; Rudack, Claudia; Walter, Michael			Platelet Glycoproteins and Fibrinogen in Recovery from Idiopathic Sudden Hearing Loss	PLOS ONE			English	Article							KOZAK SEQUENCE POLYMORPHISM; CORONARY-ARTERY DISEASE; NONFATAL MYOCARDIAL-INFARCTION; THROMBOPHILIC RISK-FACTORS; IB-ALPHA; THROMBUS FORMATION; YOUNGER PATIENTS; GPIB-ALPHA; GENE; ASSOCIATION	Background: The pathomechanism and location of idiopathic sudden sensorineural hearing loss (ISSHL) is unclear. In a previous case-control study, we found elevated fibrinogen concentrations and a higher prevalence of T allele carriers of the glycoprotein (Gp) Ia C807T polymorphism in ISSHL patients. Methodology: 127 patients with ISSHL (mean age 53.3 years, 48.8% females), who underwent a standard therapy with high dose steroids, pentoxifyllin and sterofundine over 8 days were included. We examined the influence of GpIa genotype and fibrinogen (BclI-, A312-, HaeIII-) genotype and fibrinogen plasma levels on hearing recovery after 8 weeks (change from baseline: 0 dB = no recovery, >0 to 10 dB = moderate recovery, >10 dB = good recovery). In a subsample of 59 patients with ISSHL, we further studied the association of platelet glycoprotein GpIa, Ib and IIIa densities on hearing recovery as well as the possible effect-modification of platelet glycoproteins on hearing recovery by plasma fibrinogen. Results: In univariate analysis, neither the GpIa genotype nor fibrinogen genotype (all p > 0.1) but lower fibrinogen levels (p = 0.029), less vertigo (p = 0.002) and lower GpIIIa receptor density (p > 0.037, n = 59) were associated with hearing recovery. In multivariate analysis, fibrinogen significantly modified the effect of GPIa receptor density on good hearing recovery (effect-modification on multiplicative scale OR = 0.45 (95% confidence interval (0.21-0.94)), p = 0.03). GPIb receptor density below the mean was associated with a 2-fold increase in good hearing recovery both in patients with fibrinogen levels above (p = 0.04) as well as in patients with fibrinogen levels below the mean (p = 0.06). There was no indication for an effect-modification (p = 0.97). Conclusions: The findings suggest a vascular/rheological origin of ISSHL with unique features of thrombosis in the inner ear artery that may include complex interrelationships among platelet glycoproteins and plasma fibrinogen.	[Weiss, Daniel; Bremer, Alexis; Rudack, Claudia] Univ Munster, Dept Otorhinolaryngol Head & Neck Surg, D-48149 Munster, Germany; [Neuner, Bruno] Charite, Campus Virchow Klinikum, Dept Anaesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Neuner, Bruno] Charite, D-13353 Berlin, Germany; [Gorzelniak, Kerstin] Unfallkrankenhaus Berlin, Inst Lab Med, Berlin, Germany; [Walter, Michael] Charite, Campus Virchow Klinikum, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; [Walter, Michael] Charite Vivantes Serv GmbH, Lab Berlin, Berlin, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Labor Berlin - Charite Vivantes GmbH	Walter, M (corresponding author), Charite, Campus Virchow Klinikum, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany.	m.walter@charite.de			Landesversicherungsanstalt Rheinprovinz (LVA); Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL, Bonn, Germany)	Landesversicherungsanstalt Rheinprovinz (LVA); Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL, Bonn, Germany)	Landesversicherungsanstalt Rheinprovinz (LVA)" (to MW), and the Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL, Bonn, Germany) (to MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P721; Cadoni G, 2006, ANN OTO RHINOL LARYN, V115, P195, DOI 10.1177/000348940611500307; Cadroy Y, 2001, BLOOD, V98, P3159, DOI 10.1182/blood.V98.10.3159; Carlsson LE, 1999, BLOOD, V93, P3583, DOI 10.1182/blood.V93.11.3583.410k34_3583_3586; Chau JK, 2012, OTOLARYNG CLIN N AM, V45, P941, DOI 10.1016/j.otc.2012.06.002; Conlin AE, 2007, ARCH OTOLARYNGOL, V133, P573, DOI 10.1001/archotol.133.6.573; Croft SA, 2000, BLOOD, V95, P2183; deMaat MPM, 1996, ATHEROSCLEROSIS, V121, P185, DOI 10.1016/0021-9150(95)05716-1; Douglas H, 2002, HEART, V87, P70, DOI 10.1136/heart.87.1.70; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Frank MB, 2001, BLOOD, V97, P875, DOI 10.1182/blood.V97.4.875; Fuse T, 2002, ORL J OTO-RHINO-LARY, V64, P6, DOI 10.1159/000049079; HAMSTEN A, 1987, LANCET, V2, P988; Heiden C, 2000, HNO, V48, P621, DOI 10.1007/s001060050626; Hirano Koji, 1999, Auris Nasus Larynx, V26, P111, DOI 10.1016/S0385-8146(98)00072-8; Huy PTB, 2002, ORL-J OTO-RHIN-LARYN, V64, P120; Ishida F, 2000, BRIT J HAEMATOL, V111, P1247, DOI 10.1046/j.1365-2141.2000.02479.x; Kannel WB, 2005, LIPIDS, V40, P1215, DOI 10.1007/s11745-005-1488-8; Kenny D, 2002, J THROMB THROMBOLYS, V13, P13, DOI 10.1023/A:1015307823578; Kim H. J., 2013, J NEUROL; Klemm E, 2009, LARYNGO RHINO OTOL, V88, P524, DOI 10.1055/s-0028-1128133; KLEMM E, 1989, HNO-Praxis, V14, P295; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Koc A, 2003, J OTOLARYNGOL, V32, P308, DOI 10.2310/7070.2003.11288; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Lu Jeffrey T, 2004, Rev Cardiovasc Med, V5, P189; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; Meisel C, 2001, J AM COLL CARDIOL, V38, P1023, DOI 10.1016/S0735-1097(01)01475-9; Nakashima T, 2000, OTOLARYNG HEAD NECK, V123, P593, DOI 10.1067/mhn.2000.109486; Nascetti S, 2001, EUR J EPIDEMIOL, V17, P953, DOI 10.1023/A:1016216808365; Pellikka M, 2008, J THROMB THROMBOLYS, V26, P91, DOI 10.1007/s11239-007-0072-2; Reiner A P, 2001, Rev Clin Exp Hematol, V5, P262, DOI 10.1046/j.1468-0734.2001.00045.x; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; Santoso S, 1999, BLOOD, V93, P2449, DOI 10.1182/blood.V93.8.2449.408k34_2449_2453; Selmani Z, 2001, ACTA OTO-LARYNGOL, P10; Suckfull M, 2002, LANCET, V360, P1811, DOI 10.1016/S0140-6736(02)11768-5; Tamhankar Madhura, 2004, Curr Treat Options Neurol, V6, P55, DOI 10.1007/s11940-004-0039-y; Valbonesi M, 2004, INT J ARTIF ORGANS, V27, P806, DOI 10.1177/039139880402700911	39	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86898	10.1371/journal.pone.0086898	http://dx.doi.org/10.1371/journal.pone.0086898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466284	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000167
J	Chen, XH; Yin, SY; Hu, C; Chen, XM; Jiang, K; Ye, SM; Feng, XW; Fan, SF; Xie, HY; Zhou, L; Zheng, SS				Chen, Xinhua; Yin, Shengyong; Hu, Chen; Chen, Xinmei; Jiang, Kai; Ye, Shuming; Feng, Xiaowen; Fan, Shifeng; Xie, Haiyang; Zhou, Lin; Zheng, Shusen			Comparative Study of Nanosecond Electric Fields In Vitro and In Vivo on Hepatocellular Carcinoma Indicate Macrophage Infiltration Contribute to Tumor Ablation In Vivo	PLOS ONE			English	Article							SELF-DESTRUCT; MELANOMAS; NANOELECTROABLATION; THERAPY; MODEL	Background and Aim: Recurrence and metastasis are associated with poor prognosis in hepatocellular carcinoma even in the patients who have undergone radical resection. Therefore, effective treatment is urgently needed for improvement of patients' survival. Previously, we reported that nanosecond pulse electric fields (nsPEFs) can ablate melanoma by induction of apoptosis and inhibition of angiogenesis. This study aims to investigate the in vivo ablation strategy by comparing the dose effect of nanosecond electric fields in vitro and in vivo on hepatocellular carcinoma. Materials and Methods: Four hepatocellular carcinoma cell lines HepG2, SMMC7721, Hep1-6, and HCCLM3 were pulsed to test the anti-proliferation and anti-migration ability of 100 ns nsPEFs in vitro. The animal model of human subdermal xenograft HCCLM3 cells into BALB/c nude mouse was used to test the anti-tumor growth and macrophage infiltration in vivo. Results: In vitro assays showed anti-tumor effect of nsPEFs is dose-dependant. But the in vivo study showed the strategy of low dose and multiple treatments is superior to high dose single treatment. The macrophages infiltration significantly increased in the tumors which were treated by multiple low dose nsPEFs. Conclusion: The low dose multiple nsPEFs application is more efficient than high dose single treatment in inhibiting the tumor volume in vivo, which is quite different from the dose-effect relationship in vitro. Beside the electric field strength, the macrophage involvement must be considered to account for effect variability and toxicology in vivo.	[Chen, Xinhua; Yin, Shengyong; Hu, Chen; Feng, Xiaowen; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1,Key Lab Combined Multiorgan Tra, Minist Publ Hlth,Dept Hepatobiliary & Pancreat Su, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Xinmei] Shandong Tradit Chinese Med Univ, Dept Pharm, Jinan, Shandong, Peoples R China; [Jiang, Kai; Ye, Shuming] Zhejiang Univ, Coll Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Kai; Ye, Shuming] Zhejiang Univ, Coll Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Shifeng] Xinjiang Nanosecond Pulse Technol Inst, Urumqi, Xinjiang, Peoples R China	Zhejiang University; Shandong University of Traditional Chinese Medicine; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1,Key Lab Combined Multiorgan Tra, Minist Publ Hlth,Dept Hepatobiliary & Pancreat Su, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn		Chen, Xinmei/0000-0001-7549-7793	National Natural Science Foundation of China [3070078, 81372425, 81000962]; National ST Major Project [2012ZX10002017]; National Basic Research Program of China (973 Program) [2009CB522403]; Zhejiang Medical Research Funding [2008B079, LY13H180003]; SRF for ROCS, SEM [J20120279]; Xinjiang Science and Technology Bureau Project [2013911131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Zhejiang Medical Research Funding; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Xinjiang Science and Technology Bureau Project	The research is supported by National Natural Science Foundation of China (No. 3070078, 81372425, 81000962), National S&T Major Project (No. 2012ZX10002017), National Basic Research Program of China (973 Program No. 2009CB522403), Zhejiang Medical Research Funding (No. 2008B079, No. LY13H180003). SRF for ROCS, SEM (No. J20120279) and Xinjiang Science and Technology Bureau Project (No. 2013911131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Beebe SJ, 2011, IEEE ENG MED BIO, P6861, DOI 10.1109/IEMBS.2011.6091692; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2011, IN VIVO, V25, P23; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Chen XH, 2009, MELANOMA RES, V19, P361, DOI 10.1097/CMR.0b013e32832f1558; Kwon S, 2013, BIOMED OPT EXPRESS, V4, P967, DOI 10.1364/BOE.4.000967; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2013, INT J CANCER, V132, P1933, DOI 10.1002/ijc.27860; Nuccitelli R, 2012, PIGM CELL MELANOMA R, V25, P618, DOI 10.1111/j.1755-148X.2012.01027.x; Nuccitelli R, 2012, BIOCHEM BIOPH RES CO, V424, P446, DOI 10.1016/j.bbrc.2012.06.129; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213	16	18	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86421	10.1371/journal.pone.0086421	http://dx.doi.org/10.1371/journal.pone.0086421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475118	Green Published, Green Submitted, gold			2022-12-27	WOS:000330507300064
J	Hu, ZH; Zhou, J; Li, ZW; Xiang, J; Qian, Z; Wu, J; Zhang, M; Zheng, SS				Hu, Zhenhua; Zhou, Jie; Li, Zhiwei; Xiang, Jie; Qian, Ze; Wu, Jian; Zhang, Min; Zheng, Shusen			Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria	PLOS ONE			English	Article							LONG-TERM SURVIVAL; SELECTION CRITERIA; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; CIRRHOSIS; HEPATECTOMY; STRATEGY; TUMOR; SIZE	Background: Salvage liver transplantation (SLT) has recently been proposed for recurrent hepatocellular carcinoma after liver resection; however, criteria for candidate assessment in SLT have not been thoroughly evaluated. Methods and Findings: We retrospectively analyzed outcomes and factors affecting survival of 53 recipients who received SLT in the Liver Transplantation Center, The First Affiliated Hospital of Zhejiang University between 2004 and 2012. Thirty recipients fulfilled the Hangzhou criteria, of which 16 also fulfilled the Milan criteria, while the remaining 23 exceeded both criteria. The 1-year, 3-year and 5-year overall survival rates and tumor-free survival rates were both superior in patients fulfilling Milan or Hangzhou criteria compared with those exceeding the criteria. For recipients outside Milan criteria but within Hangzhou criteria, the 1-year, 3-year overall survival rates were 70.1%, 70.1%, similar to recipients within Milan criteria, with the 1-year, 3-year and 5-year overall survival of 93.8%%, 62.1% and 62.1% (P = 0.586). The tumor-free survival rates were also similar between these two subgroups, with 51.9% and 51.9% vs. 85.6%, 85.6% and 64.2% during the same time interval, respectively (P = 0.054). Cox regression analysis identified Hangzhou criteria (within vs. outside, hazard ratio (HR) 0.376) and diameter of the largest tumor (HR 3.523) to be independent predictors for overall survival. The only predictor for tumor-free survival was diameter of the largest tumor (HR 22.289). Conclusions: Hangzhou criteria safely expanded the candidate pool and are feasible in assessment of candidates for SLT. This is helpful in donor liver allocation in transplant practice.	[Hu, Zhenhua; Zhou, Jie; Li, Zhiwei; Xiang, Jie; Qian, Ze; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Li, Zhiwei; Xiang, Jie; Qian, Ze; Wu, Jian; Zhang, Min; Zheng, Shusen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Li, Zhiwei; Xiang, Jie; Qian, Ze; Wu, Jian; Zhang, Min; Zheng, Shusen] Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National ST Major Project [2012ZX10002017]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]; National Natural Science Foundation of China [81200331]	National ST Major Project; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by grants from National S&T Major Project (No. 2012ZX10002017), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 81121002) and the National Natural Science Foundation of China (Grant No. 81200331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Audet M, 2009, LIVER TRANSPLANT, V15, P822, DOI 10.1002/lt.21765; Beighiti J, 2003, ANN SURG, V238, P885, DOI 10.1097/01.sla.0000098621.74851.65; Bismuth H, 1999, SEMIN LIVER DIS, V19, P311, DOI 10.1055/s-2007-1007120; Chen YJ, 2000, GASTROENTEROLOGY, V119, P431, DOI 10.1053/gast.2000.9373; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; De Carlis L, 2003, J AM COLL SURGEONS, V196, P887, DOI 10.1016/S1072-7515(03)00140-6; Facciuto ME, 2008, ANN SURG ONCOL, V15, P1383, DOI 10.1245/s10434-008-9851-z; Germani G, 2011, LIVER TRANSPLANT, V17, pS58, DOI 10.1002/lt.22336; Gruttadauria S, 2010, UPDATES SURG-ITALY, V62, P149, DOI 10.1007/s13304-010-0030-y; Hu ZH, 2012, LIVER TRANSPLANT, V18, P1316, DOI 10.1002/lt.23521; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036587; Laurent C, 2005, J AM COLL SURGEONS, V201, P656, DOI 10.1016/j.jamcollsurg.2005.05.027; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Mergental H, 2010, TRANSPL INT, V23, P662, DOI 10.1111/j.1432-2277.2010.01076.x; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Ochiai T, 2004, J CANCER RES CLIN, V130, P197, DOI 10.1007/s00432-003-0533-8; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; TAKAYASU K, 1989, CANCER, V64, P1848, DOI 10.1002/1097-0142(19891101)64:9<1848::AID-CNCR2820640916>3.0.CO;2-5; Toso C, 2009, HEPATOLOGY, V49, P832, DOI 10.1002/hep.22693; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	24	6	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87222	10.1371/journal.pone.0087222	http://dx.doi.org/10.1371/journal.pone.0087222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475255	gold, Green Published, Green Submitted			2022-12-27	WOS:000330507300156
J	Olkkonen, M; Allred, SR				Olkkonen, Maria; Allred, Sarah R.			Short-Term Memory Affects Color Perception in Context	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; PSYCHOMETRIC FUNCTION; CONSTANCY; REPRESENTATIONS; MECHANISMS; CONTRAST	Color-based object selection-for instance, looking for ripe tomatoes in the market-places demands on both perceptual and memory processes: it is necessary to form a stable perceptual estimate of surface color from a variable visual signal, as well as to retain multiple perceptual estimates in memory while comparing objects. Nevertheless, perceptual and memory processes in the color domain are generally studied in separate research programs with the assumption that they are independent. Here, we demonstrate a strong failure of independence between color perception and memory: the effect of context on color appearance is substantially weakened by a short retention interval between a reference and test stimulus. This somewhat counterintuitive result is consistent with Bayesian estimation: as the precision of the representation of the reference surface and its context decays in memory, prior information gains more weight, causing the retained percepts to be drawn toward prior information about surface and context color. This interaction implies that to fully understand information processing in real-world color tasks, perception and memory need to be considered jointly.	[Olkkonen, Maria; Allred, Sarah R.] Rutgers State Univ, Dept Psychol, Camden, NJ 08102 USA	Rutgers State University Camden; Rutgers State University New Brunswick	Olkkonen, M (corresponding author), Univ Penn, Dept Psychol, Ctr Cognit Neurosci, 3815 Walnut St, Philadelphia, PA 19104 USA.	mariaol@sas.upenn.edu	Olkkonen, Maria/AAW-6469-2020	Olkkonen, Maria/0000-0001-7962-2256	National Science Foundation (NSF CAREER) [BCS 0954749]	National Science Foundation (NSF CAREER)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation (http://www.nsf.gov/; NSF CAREER BCS 0954749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Allen EC, 2011, J EXP PSYCHOL LEARN, V37, P1014, DOI 10.1037/a0023257; Allred SR, 2013, J VISION, V13, DOI 10.1167/13.7.18; AREND L, 1986, J OPT SOC AM A, V3, P1743, DOI 10.1364/JOSAA.3.001743; Ashourian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019551; Baumann O, 2008, EXP BRAIN RES, V188, P363, DOI 10.1007/s00221-008-1366-0; Bauml KH, 1999, VISION RES, V39, P1531, DOI 10.1016/S0042-6989(98)00192-8; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Brainard D.H., 2002, ENCY IMAGING SCI TEC, P172, DOI DOI 10.1002/0471443395.IMG011; Brainard DH, 2006, J VISION, V6, P1267, DOI 10.1167/6.11.10; Brainard DH, 2011, J VISION, V11, DOI 10.1167/11.5.1; Brainard DH, 1997, J OPT SOC AM A, V14, P2091, DOI 10.1364/JOSAA.14.002091; BRAINARD DH, 1992, J OPT SOC AM A, V9, P1433, DOI 10.1364/JOSAA.9.001433; Brainard DH, 2012, VISUAL NEUR IN PRESS; Burnham RW, 1955, J APPL PSYCHOL, V39, P164, DOI 10.1037/h0046790; Collins M, 1932, B J PSYCHOL-GEN SECT, V22, P344, DOI 10.1111/j.2044-8295.1932.tb00635.x; de Fez MD, 2001, COLOR RES APPL, V26, P458, DOI 10.1002/col.1066; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Hamwi V, 1955, J PSYCHOL, V39, P183, DOI 10.1080/00223980.1955.9916168; Hansen T, 2007, J VISION, V7, DOI 10.1167/7.4.2; Harding G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035950; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hurlbert A, 2003, PROG BRAIN RES, V144, P147, DOI 10.1016/S0079-6123(03)14401-0; Huttenlocher J, 2000, J EXP PSYCHOL GEN, V129, P220, DOI 10.1037//0096-3445.129.2.220; Iglesias J. E., 2013, MED IMAGE ANAL; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jin EW, 1996, J OPT SOC AM A, V13, P1981, DOI 10.1364/JOSAA.13.001981; Jogan M, 2013, EFFICIENT U IN PRESS; Kang MS, 2011, PSYCHON B REV, V18, P860, DOI 10.3758/s13423-011-0126-5; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; Ling YZ, 2008, J OPT SOC AM A, V25, P1215, DOI 10.1364/JOSAA.25.001215; Linnell KJ, 2002, PERCEPTION, V31, P151, DOI 10.1068/p03sp; Lotto RB, 2000, P NATL ACAD SCI USA, V97, P12834, DOI 10.1073/pnas.210369597; Mamassian P, 2002, NEU INF PRO, P13; Nemes VA, 2010, OPHTHAL PHYSL OPT, V30, P594, DOI 10.1111/j.1475-1313.2010.00772.x; Nemes VA, 2012, J VISION, V12, DOI 10.1167/12.1.26; Newhall SM, 1957, J OPT SOC AM, V47, P216; NILSSON TH, 1981, J EXP PSYCHOL HUMAN, V7, P141, DOI 10.1037/0096-1523.7.1.141; Olkkonen M, 2010, J VISION, V10, DOI 10.1167/10.9.16; Olsson H, 2005, P NATL ACAD SCI USA, V102, P8776, DOI 10.1073/pnas.0500810102; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Scocchia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059217; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Shevell SK, 1998, VISION RES, V38, P1561, DOI 10.1016/S0042-6989(98)00006-6; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Uchikawa K, 1998, OPT REV, V5, P59, DOI 10.1007/s10043-998-0059-z; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Xing Y, 2013, J NEUROSCI, V33, P10301, DOI 10.1523/JNEUROSCI.3754-12.2013; Yang JN, 2002, VISION RES, V42, P1979, DOI 10.1016/S0042-6989(02)00098-6; Zaidi Q, 2008, VISION RES, V48, P2673, DOI 10.1016/j.visres.2008.06.026	59	36	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86488	10.1371/journal.pone.0086488	http://dx.doi.org/10.1371/journal.pone.0086488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	24475131	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330507300071
J	Zhao, MM; Chen, P; Dong, YB; Zhu, XJ; Zhang, XL				Zhao, Mengmeng; Chen, Pin; Dong, Yanbin; Zhu, Xianji; Zhang, Xilong			Relationship between Rad51 G135C and G172T Variants and the Susceptibility to Cancer: A Meta-Analysis Involving 54 Case-Control Studies	PLOS ONE			English	Article							DNA-REPAIR GENES; STRAND BREAK REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISMS; RISK; XRCC3; ASSOCIATION; PATHWAY; HEAD; NECK; VARIABILITY	Background: The associations between Rad51 gene polymorphisms (G135C and G172T) and risk of cancer have been investigated, but the results were inconclusive. To get a comprehensive evaluation of the association above, we performed a meta-analysis of published studies. Methods: A computerized search of PubMed, Embase and Web of Knowledge databases for all relevant studies was performed and the data were analyzed in a meta-analysis. The overall odds ratio (OR) with the 95% confidence interval (95% CI) was calculated to assess the strength of the association between Rad51 polymorphisms and cancer risk. Data were analyzed using fixed-or random-effects model when appropriate. Sensitivity analysis and publication bias test were also estimated. Results: Overall, a total of 54 case-control studies were included in the current meta-analysis, among which 42 studies with 19,142 cases and 20,363 controls for RAD51 G135C polymorphism and 12 studies with 6,646 cases and 6,783 controls for G172T polymorphism. For G135C polymorphism, the pooled results indicated that significantly increased risk was found in overall cancers (homozygote model: OR = 1.776, 95% CI = 1.288-2.449; allelic genetic model: OR = 1.169, 95% CI = 1.016-1.345; recessive model: OR = 1.946, 95% CI = 1.336-2.835), especially in breast cancer (homozygote model: OR = 1.498, 95% CI = 1.026-2.189; recessive model: OR = 1.732, 95% CI = 1.170-2.562). For G172T polymorphism, a decreased cancer risk was observed in head and neck cancer (homozygote model: OR = 0.621, 95% CI = 0.460-0.837; allelic genetic model: OR = 0.824, 95% CI = 0.716-0.948; recessive model: OR = 0.639, 95% CI = 0.488-0.837). Conclusions: Our results suggested that the Rad51 G135C polymorphism is a candidate for susceptibility to overall cancers, especially to breast cancer, and that the Rad51 G172T might play a protective role in the development of head and neck cancer.	[Zhao, Mengmeng; Dong, Yanbin; Zhu, Xianji; Zhang, Xilong] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Chen, Pin] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhang, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	zhangxilong1952@163.com			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This research was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Bastos HN, 2009, THYROID, V19, P1067, DOI 10.1089/thy.2009.0099; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bhatla D, 2008, LEUKEMIA, V22, P265, DOI 10.1038/sj.leu.2405000; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Costa S, 2007, BREAST CANCER RES TR, V103, P209, DOI 10.1007/s10549-006-9364-z; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon VS, 2011, UROL ONCOL-SEMIN ORI, V29, P641, DOI 10.1016/j.urolonc.2009.08.013; Dixon K, 2004, SEMIN CANCER BIOL, V14, P441, DOI 10.1016/j.semcancer.2004.06.007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Figueroa JD, 2007, CARCINOGENESIS, V28, P1788, DOI 10.1093/carcin/bgm132; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Gresner P, 2012, GENE, V504, P166, DOI 10.1016/j.gene.2012.05.030; Hamdy MS, 2011, J INVEST MED, V59, P1124, DOI 10.2310/JIM.0b013e3182281da3; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; He YZ, 2013, TUMOUR BIOL; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jakubowska A, 2007, CANCER EPIDEM BIOMAR, V16, P270, DOI 10.1158/1055-9965.EPI-06-0562; Jakubowska A, 2009, EUR J CANCER, V45, P837, DOI 10.1016/j.ejca.2008.10.021; Jara L, 2007, CANCER GENET CYTOGEN, V178, P65, DOI 10.1016/j.cancergencyto.2007.05.024; Jara L, 2010, BREAST CANCER RES TR, V122, P813, DOI 10.1007/s10549-009-0709-2; Karpenshif Y, 2012, DNA REPAIR, V11, P781, DOI 10.1016/j.dnarep.2012.07.001; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Krupa R, 2011, MOL BIOL REP, V38, P1163, DOI 10.1007/s11033-010-0214-z; Krupa R, 2009, EXP MOL PATHOL, V87, P32, DOI 10.1016/j.yexmp.2009.04.005; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Liu L, 2011, LEUKEMIA RES, V35, P1020, DOI 10.1016/j.leukres.2011.01.014; Lu JC, 2007, CARCINOGENESIS, V28, P988, DOI 10.1093/carcin/bgl225; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mucha Bartosz, 2012, Pol Przegl Chir, V84, P358, DOI 10.2478/v10035-012-0060-x; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Richardson C, 2005, CANCER LETT, V218, P127, DOI 10.1016/j.canlet.2004.08.009; Rollinson S, 2007, LEUKEMIA RES, V31, P169, DOI 10.1016/j.leukres.2006.05.028; Romanowicz H, 2010, POL J PATHOL, V61, P206; Romanowicz-Makowska H., 2006, Experimental Oncology, V28, P156; Romanowicz-Makowska Hanna, 2005, Polish Journal of Pathology, V56, P161; Romanowicz-Makowska H, 2012, ARCH MED SCI, V8, P1065, DOI 10.5114/aoms.2012.32417; Romanowicz-Makowska H, 2012, POL J PATHOL, V63, P193, DOI 10.5114/PJP.2012.31505; Romanowicz-Makowska H, 2012, J OBSTET GYNAECOL RE, V38, P918, DOI 10.1111/j.1447-0756.2011.01811.x; Seedhouse C, 2004, CLIN CANCER RES, V10, P2675, DOI 10.1158/1078-0432.CCR-03-0372; Silva SN, 2010, CANCER EPIDEMIOL, V34, P85, DOI 10.1016/j.canep.2009.11.002; Sliwinski T, 2005, BREAST CANCER RES TR, V94, P105, DOI 10.1007/s10549-005-0672-5; Smolarz B, 2013, POL J PATHOL, V64, P39, DOI 10.5114/PJP.2013.34602; Sun HM, 2011, BREAST CANCER RES TR, V125, P157, DOI 10.1007/s10549-010-0922-z; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Synowiec E, 2008, MUTAT RES-FUND MOL M, V648, P65, DOI 10.1016/j.mrfmmm.2008.09.014; Tarasov V A, 2006, Dokl Biol Sci, V406, P66, DOI 10.1134/S0012496606010182; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vispe S, 1997, BIOCHIMIE, V79, P587, DOI 10.1016/S0300-9084(97)82007-X; Voso MT, 2007, ANN ONCOL, V18, P1523, DOI 10.1093/annonc/mdm191; Wang LE, 2004, CANCER RES, V64, P5560, DOI 10.1158/0008-5472.CAN-03-2181; Webb PM, 2005, CANCER EPIDEM BIOMAR, V14, P319, DOI 10.1158/1055-9965.EPI-04-0335; Werbrouck J, 2008, MUTAT RES-GEN TOX EN, V656, P74, DOI 10.1016/j.mrgentox.2008.07.013; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L; Zhang LH, 2012, ONCOL LETT, V3, P351, DOI 10.3892/ol.2011.463	65	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87259	10.1371/journal.pone.0087259	http://dx.doi.org/10.1371/journal.pone.0087259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475258	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300158
J	Betts, DH; Bain, NT; Madan, P				Betts, Dean H.; Bain, Nathan T.; Madan, Pavneesh			The p66(Shc) Adaptor Protein Controls Oxidative Stress Response in Early Bovine Embryos	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; IN-VITRO FERTILIZATION; PREIMPLANTATION EMBRYO; LIFE-SPAN; OXYGEN CONCENTRATION; SIGNALING PATHWAY; DEVELOPMENTAL COMPETENCE; SUPEROXIDE-DISMUTASE; RNA INTERFERENCE; CELL-DEATH	The in vitro production of mammalian embryos suffers from high frequencies of developmental failure due to excessive levels of permanent embryo arrest and apoptosis caused by oxidative stress. The p66Shc stress adaptor protein controls oxidative stress response of somatic cells by regulating intracellular ROS levels through multiple pathways, including mitochondrial ROS generation and the repression of antioxidant gene expression. We have previously demonstrated a strong relationship with elevated p66Shc levels, reduced antioxidant levels and greater intracellular ROS generation with the high incidence of permanent cell cycle arrest of 2-4 cell embryos cultured under high oxygen tensions or after oxidant treatment. The main objective of this study was to establish a functional role for p66Shc in regulating the oxidative stress response during early embryo development. Using RNA interference in bovine zygotes we show that p66Shc knockdown embryos exhibited increased MnSOD levels, reduced intracellular ROS and DNA damage that resulted in a greater propensity for development to the blastocyst stage. P66Shc knockdown embryos were stress resistant exhibiting significantly reduced intracellular ROS levels, DNA damage, permanent 2-4 cell embryo arrest and diminished apoptosis frequencies after oxidant treatment. The results of this study demonstrate that p66Shc controls the oxidative stress response in early mammalian embryos. Small molecule inhibition of p66Shc may be a viable clinical therapy to increase the developmental potential of in vitro produced mammalian embryos.	[Betts, Dean H.; Bain, Nathan T.; Madan, Pavneesh] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Betts, Dean H.] Lawson Hlth Res Inst, Childrens Hlth Res Inst, London, ON, Canada	University of Guelph; Western University (University of Western Ontario)	Betts, DH (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada.	dean.betts@schulich.uwo.ca	Betts, Dean H/B-7414-2015	Betts, Dean H/0000-0002-5528-9142	Canadian Institutes of Health Research (CIHR) [MOP-86453]; Natural Sciences and Engineering Research Council of Canada (NSERC) [250191-2007]; Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)	This research was supported by a grant to DHB and PM from the Canadian Institutes of Health Research (CIHR; MOP-86453), and grants from the Natural Sciences and Engineering Research Council of Canada (NSERC; 250191-2007) and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) to DHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Anckaert E, 2013, HUM REPROD UPDATE, V19, P52, DOI 10.1093/humupd/dms042; Bain NT, 2013, MOL REPROD DEV, V80, P22, DOI 10.1002/mrd.22128; Bain NT, 2011, REPROD FERT DEVELOP, V23, P561, DOI 10.1071/RD10148; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chauhan MS, 1999, J DAIRY SCI, V82, P918, DOI 10.3168/jds.S0022-0302(99)75310-5; Clarke GN, 2006, HUM REPROD, V21, P1645, DOI 10.1093/humrep/del067; DeYulia GJ, 2005, BIOCHEM BIOPH RES CO, V334, P38, DOI 10.1016/j.bbrc.2005.06.056; Dumoulin JCM, 1999, HUM REPROD, V14, P465, DOI 10.1093/humrep/14.2.465; European Society of Human Reproduction and Embryology, 2012, SCIENCEDAILY; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Favetta LA, 2004, MOL HUM REPROD, V10, P383, DOI 10.1093/molehr/gah057; Favetta LA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-132; Favetta LA, 2007, FREE RADICAL BIO MED, V42, P1201, DOI 10.1016/j.freeradbiomed.2007.01.018; Feugang JM, 2004, THERIOGENOLOGY, V61, P71, DOI 10.1016/S0093-691X(03)00191-2; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Francia P, 2009, J MOL MED, V87, P885, DOI 10.1007/s00109-009-0499-3; Galan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062135; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Hachiya M, 2005, RADIAT RES, V163, P271, DOI 10.1667/RR3306; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Hall V, 2013, VET J, V197, P128, DOI 10.1016/j.tvjl.2013.05.026; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hardy K, 2001, P NATL ACAD SCI USA, V98, P1655, DOI 10.1073/pnas.98.4.1655; Harvey AJ, 2007, ANIM REPROD SCI, V98, P113, DOI 10.1016/j.anireprosci.2006.10.008; Hashimoto S, 2000, MOL REPROD DEV, V57, P353, DOI 10.1002/1098-2795(200012)57:4&lt;353::AID-MRD7&gt;3.0.CO;2-R; Held E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102921; Jurisicova A, 2004, REPRODUCTION, V128, P281, DOI 10.1530/rep.1.00241; Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036; Keskintepe L, 1996, BIOL REPROD, V55, P333, DOI 10.1095/biolreprod55.2.333; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kovacic B, 2008, REPROD BIOMED ONLINE, V17, P229, DOI 10.1016/S1472-6483(10)60199-X; Lai KMV, 2000, GENE DEV, V14, P1132; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Lebiedzinska Magdalena, 2010, Postepy Biochem, V56, P165; Leidenfrost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022121; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Madan P, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P469; Marteil G, 2009, REPROD BIOL, V9, P203, DOI 10.1016/S1642-431X(12)60027-8; Matwee C, 2000, ZYGOTE, V8, P57, DOI 10.1017/S0967199400000836; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Migliaccio E, 2006, ANTIOXID REDOX SIGN, V8, P600, DOI 10.1089/ars.2006.8.600; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Munne S, 2006, REPROD BIOMED ONLINE, V12, P234, DOI 10.1016/S1472-6483(10)60866-8; NAGAO Y, 1994, THERIOGENOLOGY, V41, P681, DOI 10.1016/0093-691X(94)90177-K; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2004, J BIOL CHEM, V279, P43900, DOI 10.1074/jbc.M403936200; Natalicchio Annalisa, 2011, Archives of Physiology and Biochemistry, V117, P116, DOI 10.3109/13813455.2011.562513; Natalicchio A, 2009, AM J PHYSIOL-ENDOC M, V296, pE228, DOI 10.1152/ajpendo.90347.2008; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Orsi NM, 2001, MOL REPROD DEV, V59, P44, DOI 10.1002/mrd.1006; Pani G, 2011, ANTIOXID REDOX SIGN, V15, P1715, DOI 10.1089/ars.2010.3499; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; Paradis F, 2005, MOL REPROD DEV, V70, P111, DOI 10.1002/mrd.20193; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Purdom S, 2003, BIOGERONTOLOGY, V4, P181, DOI 10.1023/A:1025123413403; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Rodriguez-Martinez H, 2012, REPROD DOMEST ANIM, V47, P21, DOI 10.1111/j.1439-0531.2011.01961.x; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Sokal R.R., 2012, BIOMETRY; Souza JM, 2013, ANIM REPROD SCI; STEINBRECHER UP, 1988, BIOCHIM BIOPHYS ACTA, V959, P20, DOI 10.1016/0005-2760(88)90145-2; Stroud B, 2012, YEAR 2011 WORLDWIDE; Thomas MR, 2010, FERTIL STERIL, V94, P543, DOI 10.1016/j.fertnstert.2009.03.051; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Zhang AJ, 2012, J ASSIST REPROD GEN, V29, P313, DOI 10.1007/s10815-012-9712-3; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432	82	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86978	10.1371/journal.pone.0086978	http://dx.doi.org/10.1371/journal.pone.0086978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475205	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800073
J	Lodder, SS; Askamp, J; van Putten, MJAM				Lodder, Shaun S.; Askamp, Jessica; van Putten, Michel J. A. M.			Computer-Assisted Interpretation of the EEG Background Pattern: A Clinical Evaluation	PLOS ONE			English	Article							QUANTITATIVE EEG; SPIKE DETECTION; AUTOMATIC EEG; BRAIN; DATABASE; ELECTROENCEPHALOGRAM; RELIABILITY; EPILEPSY; SYSTEM	Objective: Interpretation of the EEG background pattern in routine recordings is an important part of clinical reviews. We evaluated the feasibility of an automated analysis system to assist reviewers with evaluation of the general properties in the EEG background pattern. Methods: Quantitative EEG methods were used to describe the following five background properties: posterior dominant rhythm frequency and reactivity, anterior-posterior gradients, presence of diffuse slow-wave activity and asymmetry. Software running the quantitative methods were given to ten experienced electroencephalographers together with 45 routine EEG recordings and computer-generated reports. Participants were asked to review the EEGs by visual analysis first, and afterwards to compare their findings with the generated reports and correct mistakes made by the system. Corrected reports were returned for comparison. Results: Using a gold-standard derived from the consensus of reviewers, inter-rater agreement was calculated for all reviewers and for automated interpretation. Automated interpretation together with most participants showed high (kappa > 0.6) agreement with the gold standard. In some cases, automated analysis showed higher agreement with the gold standard than participants. When asked in a questionnaire after the study, all participants considered computer-assisted interpretation to be useful for every day use in routine reviews. Conclusions: Automated interpretation methods proved to be accurate and were considered to be useful by all participants. Significance: Computer-assisted interpretation of the EEG background pattern can bring consistency to reviewing and improve efficiency and inter-rater agreement.	[Lodder, Shaun S.; Askamp, Jessica; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum, Dept Neurol & Clin Neurophysiol, Enschede, Netherlands	University of Twente; Medical Spectrum Twente	Lodder, SS (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	s.s.lodder@utwente.nl	van Putten, Michel J.A.M./D-6519-2018	van Putten, Michel J.A.M./0000-0001-8319-3626				Anderson NR, 2010, J CLIN NEUROPHYSIOL, V27, P453, DOI 10.1097/WNP.0b013e3181fe0b6f; Anderson Nicholas R, 2008, Am J Electroneurodiagnostic Technol, V48, P166; Aurlien H, 2007, CLIN NEUROPHYSIOL, V118, P1369, DOI 10.1016/j.clinph.2007.02.027; Aurlien H, 2004, CLIN NEUROPHYSIOL, V115, P665, DOI 10.1016/j.clinph.2003.10.019; Aurlien H, 1999, CLIN NEUROPHYSIOL, V110, P986, DOI 10.1016/S1388-2457(99)00037-1; Azuma H, 2003, PSYCHIAT CLIN NEUROS, V57, P485, DOI 10.1046/j.1440-1819.2003.01152.x; Babiloni C, 2011, J ALZHEIMERS DIS, V26, P331, DOI 10.3233/JAD-2011-101710; Beniczky S, 2013, EPILEPSIA, V54, P1112, DOI 10.1111/epi.12135; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burke JF, 2013, ANN NEUROL, V73, P679, DOI 10.1002/ana.23865; Cloostermans MC, 2011, CLIN NEUROPHYSIOL, V122, P2100, DOI 10.1016/j.clinph.2011.02.035; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Foreman B, 2012, ANN UPDATE INTENSIVE; Friedman D, 2010, CURR CLIN NEUROL, P21, DOI 10.1007/978-1-60327-532-3_2; Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018; Halford JJ, 2009, CLIN NEUROPHYSIOL, V120, P1909, DOI 10.1016/j.clinph.2009.08.007; Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012; Kurtz P, 2009, CURR OPIN CRIT CARE, V15, P99, DOI 10.1097/MCC.0b013e3283294947; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lodder SS, 2013, CLIN NEUROPHYSIOL, V124, P228, DOI 10.1016/j.clinph.2012.07.007; Moretti D V, 2012, Int J Alzheimers Dis, V2012, P917537, DOI 10.1155/2012/917537; Mukhopadhyay S, 1998, IEEE T BIO-MED ENG, V45, P180, DOI 10.1109/10.661266; NAKAMURA M, 1992, ELECTROEN CLIN NEURO, V82, P423, DOI 10.1016/0013-4694(92)90047-L; Nakamura M, 2002, INT J ADAPT CONTROL, V16, P25, DOI 10.1002/acs.662; Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001; Scherg M, 2012, EPILEPSIA, V53, P1196, DOI 10.1111/j.1528-1167.2012.03503.x; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421; Snaedal J, 2012, DEMENT GERIATR COGN, V34, P51, DOI 10.1159/000339996; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stevenson NJ, 2013, ANN BIOMED ENG, V41, P775, DOI 10.1007/s10439-012-0710-5; Strzelczyk A, 2012, EPILEPSY BEHAV, V23, P451, DOI 10.1016/j.yebeh.2012.01.021; van Putten MJAM, 2008, J CLIN NEUROPHYSIOL, V25, P63, DOI 10.1097/WNP.0b013e31816bdf85; van Putten MJAM, 2004, CLIN NEUROPHYSIOL, V115, P1189, DOI 10.1016/j.clinph.2003.12.002; van Putten MJAM, 2003, J CLIN NEUROPHYSIOL, V20, P320, DOI 10.1097/00004691-200309000-00004; Wilson SB, 2002, CLIN NEUROPHYSIOL, V113, P1873, DOI 10.1016/S1388-2457(02)00297-3; Zhang X, 2011, MED BIOL ENG COMPUT, V49, P171, DOI 10.1007/s11517-010-0688-9	38	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85966	10.1371/journal.pone.0085966	http://dx.doi.org/10.1371/journal.pone.0085966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475064	Green Published, gold			2022-12-27	WOS:000330339800020
J	Qin, R; Zhou, JX; Chen, C; Xu, T; Yan, Y; Ma, YS; Zheng, ZL; Shen, YP; Lu, YC; Fu, D; Chen, JX				Qin, Rong; Zhou, Jingxu; Chen, Chao; Xu, Tao; Yan, Yong; Ma, Yushui; Zheng, Zongli; Shen, Yiping; Lu, Yicheng; Fu, Da; Chen, Juxiang			LIN28 Is Involved in Glioma Carcinogenesis and Predicts Outcomes of Glioblastoma Multiforme Patients	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR RECEPTOR; BINDING PROTEIN LIN28; GERM-CELL TUMORS; PROMOTES TRANSFORMATION; MALIGNANT GLIOMAS; OVARIAN-CANCER; MICRORNA; EXPRESSION; LET-7	LIN28, an evolutionarily conversed RNA binding protein which can bind to the terminal loops of let-7 familymicroRNA precursors and block their processing to maturation, is highly expressed in several subsets of tumors that carry poor prognoses, such as ovarian carcinoma, hepatocellular carcinoma, colon carcinoma and germ cell carcinoma. However, there has been no study on the expression of LIN28 in glioma tissues or their importance as a prognostic predictor of glioma patients. This study aimed to examine the expression of LIN28 in glioma and correlate the results to patient outcome. We found that LIN28 expression was significantly higher in the group of patients with a poor prognosis compared to patients with a good prognosis by gene microarray. Log-rank analysis showed patients with higher LIN28 expression level in tumor had a shorter progression-free survival and overall survival times compared to those with lower LIN28 expression level. Similar results were also obtained from the tissue microarray analysis. Univariate andmultivariate analyses showed high LIN28 expression was an independent prognostic factor for a shorter progression-free survival and overall survival in GBM patients. Furthermore in vitro experiments showed that down-regulation of LIN28 in U251 and U373 cells caused cell cycle arrest in the G1 phase, delayed cell proliferation, increased apoptosis, and resulted in fewer colonies compared to controls. Summarily, our data provides a potential target for cancer therapy as an approach to overcome the poor options currently available for GBM patients.	[Qin, Rong; Chen, Chao; Xu, Tao; Yan, Yong; Lu, Yicheng; Chen, Juxiang] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Jingxu] PLA, Hosp 101, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Ma, Yushui; Fu, Da] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China; [Ma, Yushui; Fu, Da] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zheng, Zongli; Chen, Juxiang] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shen, Yiping] Harvard Univ, Sch Med, Dept Lab Med, Childrens Hosp Boston, Boston, MA USA	Naval Medical University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Fu, D (corresponding author), Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China.	fu800da900@126.com; juxiangchen.cz@gmail.com	ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022; zheng, zongli/C-7309-2008; zheng, zongli/B-2917-2011	zheng, zongli/0000-0003-4849-4903	National Nature Science Foundation of China [81272781, 81201535]; Program for academic leaders in health sciences [XBR2011030]; "Shu Guang" project in Shanghai [11SG37]; Nature Science Foundation of Shanghai [12ZR1436000]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP203]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for academic leaders in health sciences; "Shu Guang" project in Shanghai; Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by National Nature Science Foundation of China (NO. 81272781, 81201535), Program for academic leaders in health sciences (No. XBR2011030) and "Shu Guang" project (No. 11SG37) in Shanghai, Nature Science Foundation of Shanghai (12ZR1436000) and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NATURE, V455, P1061; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195; Chi AS, 2007, EXPERT OPIN THER TAR, V11, P473, DOI 10.1517/14728222.11.4.473; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hagerstrand D, 2011, NEURO-ONCOLOGY, V13, P1178, DOI 10.1093/neuonc/nor113; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Saiki Y, 2009, ANN SURG ONCOL, V16, P2638, DOI 10.1245/s10434-009-0567-5; Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	34	31	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86446	10.1371/journal.pone.0086446	http://dx.doi.org/10.1371/journal.pone.0086446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475120	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800044
J	Suyama, K; Watanabe, M; Sakabe, K; Otomo, A; Okada, Y; Terayama, H; Imai, T; Mochida, J				Suyama, Kaori; Watanabe, Masahiko; Sakabe, Kou; Otomo, Asako; Okada, Yoshinori; Terayama, Hayato; Imai, Takeshi; Mochida, Joji			GRP78 Suppresses Lipid Peroxidation and Promotes Cellular Antioxidant Levels in Glial Cells following Hydrogen Peroxide Exposure	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SPINAL-CORD-INJURY; UNFOLDED PROTEIN RESPONSE; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; NEUROBLASTOMA-CELLS; EPITHELIAL-CELLS; INDUCTION; NQO1; GLUTATHIONE	Oxidative stress, caused by the over production of reactive oxygen species (ROS), has been shown to contribute to cell damage associated with neurotrauma and neurodegenerative diseases. ROS mediates cell damage either through direct oxidation of lipids, proteins and DNA or by acting as signaling molecules to trigger cellular apoptotic pathways. The 78 kDa glucose-regulated protein (GRP78) is an ER chaperone that has been suggested to protect cells against ROS-induced damage. However, the protective mechanism of GRP78 remains unclear. In this study, we used C6 glioma cells transiently overexpressing GRP78 to investigate the protective effect of GRP78 against oxidative stress (hydrogen peroxide)-induced injury. Our results showed that the overexpression of GRP78 significantly protected cells from ROS-induced cell damage when compared to non-GRP78 overexpressing cells, which was most likely due to GRP78-overexpressing cells having higher levels of glutathione (GSH) and NAD(P)H:quinone oxidoreductase 1 (NQO1), two antioxidants that protect cells against oxidative stress. Although hydrogen peroxide treatment increased lipid peroxidation in non-GRP78 overexpressing cells, this increase was significantly reduced in GRP78-overexpressing cells. Overall, these results indicate that GRP78 plays an important role in protecting glial cells against oxidative stress via regulating the expression of GSH and NQO1.	[Suyama, Kaori; Sakabe, Kou; Terayama, Hayato] Tokai Univ, Sch Med, Dept Anat & Cellular Biol, Isehara, Kanagawa 25911, Japan; [Watanabe, Masahiko; Imai, Takeshi; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped Surg, Isehara, Kanagawa 25911, Japan; [Otomo, Asako] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Okada, Yoshinori] Tokai Univ, Teaching & Res Support Ctr, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University; Tokai University	Watanabe, M (corresponding author), Tokai Univ, Sch Med, Dept Orthoped Surg, Isehara, Kanagawa 25911, Japan.	masahiko@is.icc.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019	Otomo, Asako/0000-0002-7849-4309	Research and Study Program of Tokai University Educational System General Research Organization; Tokai University School of Medicine Research Aid; Grants-in-Aid for Scientific Research [26460809, 25830040] Funding Source: KAKEN	Research and Study Program of Tokai University Educational System General Research Organization; Tokai University School of Medicine Research Aid; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Research and Study Program of Tokai University Educational System General Research Organization and 2012 Tokai University School of Medicine Research Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragno M, 2000, DIABETES, V49, P1924, DOI 10.2337/diabetes.49.11.1924; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Bar-Am O, 2009, J MOL NEUROSCI, V37, P135, DOI 10.1007/s12031-008-9139-6; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Elmann A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/157598; GOMER CJ, 1991, CANCER RES, V51, P6574; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; HEDLEY D, 1992, CYTOMETRY, V13, P686, DOI 10.1002/cyto.990130704; Higo T, 2010, NEURON, V68, P865, DOI 10.1016/j.neuron.2010.11.010; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jia ZQ, 2008, BRAIN RES, V1197, P159, DOI 10.1016/j.brainres.2007.12.044; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lim JH, 2008, PHARMACOL RES, V57, P325, DOI 10.1016/j.phrs.2008.03.004; Liu DX, 1999, FREE RADICAL BIO MED, V27, P478, DOI 10.1016/S0891-5849(99)00073-8; Long DJ, 2002, CANCER RES, V62, P3030; Lucas JH, 2002, J NEUROTRAUM, V19, P763, DOI 10.1089/08977150260139138; Mohammad MK, 2012, TOXICOL APPL PHARM, V265, P73, DOI 10.1016/j.taap.2012.09.021; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; Suyama K, 2011, NEUROSCI LETT, V504, P271, DOI 10.1016/j.neulet.2011.09.045; Tiffany-Castiglioni E, 2012, NEUROTOXICOLOGY, V33, P545, DOI 10.1016/j.neuro.2012.02.007; Timblin CR, 1998, FREE RADICAL BIO MED, V24, P632, DOI 10.1016/S0891-5849(97)00325-0; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Yen CC, 2011, ARCH TOXICOL, V85, P565, DOI 10.1007/s00204-011-0709-y; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yoshida T, 2008, CANCER CHEMOTH PHARM, V61, P559, DOI 10.1007/s00280-007-0503-y; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	37	20	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86951	10.1371/journal.pone.0086951	http://dx.doi.org/10.1371/journal.pone.0086951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475200	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800071
J	Tiono, AB; Kangoye, DT; Rehman, AM; Kargougou, DG; Kabore, Y; Diarra, A; Ouedraogo, E; Nebie, I; Ouedraogo, A; Okech, B; Milligan, P; Sirima, SB				Tiono, Alfred B.; Kangoye, David T.; Rehman, Andrea M.; Kargougou, Desire G.; Kabore, Youssouf; Diarra, Amidou; Ouedraogo, Esperance; Nebie, Issa; Ouedraogo, Alphonse; Okech, Brenda; Milligan, Paul; Sirima, Sodiomon B.			Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; RESISTANCE	Background: The aim of this study was to determine the incidence and seasonal pattern of malaria in children in South-West Burkina Faso, and to compare, in a randomized trial, characteristics of cases detected by active and passive surveillance. This study also enabled the planning of a malaria vaccine trial. Methods: Households with young children, located within 5 kilometers of a health facility, were randomized to one of two malaria surveillance methods. In the first group, children were monitored actively. Each child was visited twice weekly; tympanic temperature was measured, and if the child had a fever or history of fever, a malaria rapid diagnostic test was performed and a blood smear collected. In the second group, children were monitored passively. The child's parent or caregiver was asked to bring the child to the nearest clinic if he was unwell. Follow up lasted 13 months from September 2009. Results: Incidence of malaria (Fever with parasitaemia >= 5,000/mu L) was 1.18 episodes/child/year in the active cohort and 0.89 in the passive cohort (rate ratio 1.32, 95% CI 1.13-1.54). Malaria cases in the passive cohort were more likely to have high grade fever; but parasite densities were similar in the two groups. Incidence was highly seasonal; when a specific case definition was used, about 60% of cases occurred within the 4 months June-September. Conclusion: Passive case detection required at least a 30%-40% increase in the sample size for vaccine trials, compared to active detection, to achieve the same power. However we did not find any evidence that parasite densities were higher with passive than with active detection. The incidence of malaria is highly seasonal and meets the WHO criteria for Seasonal Malaria Chemoprevention (SMC). At least half of the malaria cases in these children could potentially be prevented if SMC was effectively deployed.	[Tiono, Alfred B.; Kangoye, David T.; Kargougou, Desire G.; Kabore, Youssouf; Diarra, Amidou; Ouedraogo, Esperance; Nebie, Issa; Ouedraogo, Alphonse; Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso; [Rehman, Andrea M.; Milligan, Paul] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Okech, Brenda] Statens Serum Inst, DK-2300 Copenhagen, Denmark	University of London; London School of Hygiene & Tropical Medicine; Statens Serum Institut	Sirima, SB (corresponding author), CNRFP, Ouagadougou, Burkina Faso.	s.sirima.cnlp@fasonet.bf	Rehman, Andrea M/H-1351-2015; Rehman, Andrea/AAP-3172-2020; OUEDRAOGO, Alphonse/F-7859-2019; Milligan, Paul/D-8985-2017	Rehman, Andrea M/0000-0001-9967-5822; Rehman, Andrea/0000-0001-9967-5822; Milligan, Paul/0000-0003-3430-3395; Nebie, Issa/0000-0003-3051-3600; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Ouedraogo, Alphonse/0000-0002-3520-6637; Tiono, B. Alfred/0000-0002-5104-3946	European and Developing Countries Clinical Trials Partnership (EDCTP) [IP.2007.31100.001, CB.07.41700.007.b]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) under grants IP.2007.31100.001 & CB.07.41700.007.b. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ANN STAT 2008 BURK; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; De Allegri M, 2013, INT J HEALTH PLAN M, V28, P102, DOI 10.1002/hpm.2116; Diarra A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-103; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Esen M, 2009, VACCINE, V27, P6862, DOI 10.1016/j.vaccine.2009.09.011; Konate AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023391; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Mordmuller B, 2010, VACCINE, V28, P6698, DOI 10.1016/j.vaccine.2010.07.085; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050036; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; SNOW RW, 1989, ANN TROP MED PARASIT, V83, P321, DOI 10.1080/00034983.1989.11812350; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2012, POLICY RECOMMENDATIO	19	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86936	10.1371/journal.pone.0086936	http://dx.doi.org/10.1371/journal.pone.0086936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475198	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330339800070
J	Tun, HM; Mauroo, NF; Yuen, CS; Ho, JCW; Wong, MT; Leung, FCC				Tun, Hein Min; Mauroo, Nathalie France; Yuen, Chan San; Ho, John Chi Wang; Wong, Mabel Ting; Leung, Frederick Chi-Ching			Microbial Diversity and Evidence of Novel Homoacetogens in the Gut of Both Geriatric and Adult Giant Pandas (Ailuropoda melanoleuca)	PLOS ONE			English	Article							EUKARYOTIC DIVERSITY; FECAL FLORA; GENE; SEQUENCES; POPULATIONS; COMMUNITY; REVEAL; BAMBOO; FUNGI; RUMEN	Recent studies have described the bacterial community residing in the guts of giant pandas, together with the presence of lignocellulolytic enzymes. However, a more comprehensive understanding of the intestinal microbial composition and its functional capacity in giant pandas remains a major goal. Here, we conducted a comparison of bacterial, fungal and homoacetogenic microbial communities from fecal samples taken from two geriatric and two adult captive giant pandas. 16S rDNA amplicon pyrosequencing revealed that Firmicutes and Proteobacteria are the most abundant microbiota in both geriatric and adult giant pandas. However, members of phylum Actinobacteria found in adult giant pandas were absent in their geriatric counterparts. Similarly, ITS1 amplicon pyrosequencing identified developmental changes in the most abundant fungal classes from Sordariomycetes in adult pandas to Saccharomycetes in geriatric pandas. Geriatric pandas exhibited significantly higher abundance of a potential probiotic fungus (Candida tropicalis) as compared to adult pandas, indicating their importance in the normal digestive physiology of aged pandas. Our study also reported the presence of a lignocellulolytic white-rot fungus, Perenniporia medulla-panis, and the evidence of novel homoacetogens residing in the guts of giant pandas.	[Tun, Hein Min; Ho, John Chi Wang; Wong, Mabel Ting; Leung, Frederick Chi-Ching] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Mauroo, Nathalie France] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Yuen, Chan San] Ocean Pk Corp, Clin Lab, Vet Ctr, Hong Kong, Hong Kong, Peoples R China; [Mauroo, Nathalie France] Hong Kong Wildlife Hlth Fdn, Hong Kong, Hong Kong, Peoples R China; [Leung, Frederick Chi-Ching] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	University of Hong Kong; University of Hong Kong; Nanjing Agricultural University	Leung, FCC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk	Tun, Hein/ACR-0815-2022; Tun, Hein Min/F-4150-2011	Tun, Hein/0000-0001-7597-5062; Tun, Hein Min/0000-0001-7597-5062; Mauroo, Nathalie/0000-0002-0311-9897	Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE); Bioinformatics Center fund from Nanjing Agricultural University	Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE); Bioinformatics Center fund from Nanjing Agricultural University	This study was partially supported by the Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE) and a Bioinformatics Center fund from Nanjing Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; BENNO Y, 1989, APPL ENVIRON MICROB, V55, P1100, DOI 10.1128/AEM.55.5.1100-1105.1989; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burland T G, 2000, Methods Mol Biol, V132, P71; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi ZM, 2010, APPL MICROBIOL BIOT, V86, P1227, DOI 10.1007/s00253-010-2483-9; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gadanho M, 2003, ANTON LEEUW INT J G, V84, P217, DOI 10.1023/A:1026038213195; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen RL, 2010, ZOO BIOL, V29, P470, DOI 10.1002/zoo.20280; Henderson G, 2010, APPL ENVIRON MICROB, V76, P2058, DOI 10.1128/AEM.02580-09; HIRAYAMA K, 1989, J APPL BACTERIOL, V67, P411, DOI 10.1111/j.1365-2672.1989.tb02511.x; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359, DOI 10.1128/AEM.31.3.359-375.1976; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Janssen DL, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P353, DOI 10.1017/CBO9780511542244.016; LAMOT E, 1976, Z ALLG MIKROBIOL, V16, P345, DOI 10.1002/jobm.3630160503; Leaphart AB, 2001, APPL ENVIRON MICROB, V67, P1392, DOI 10.1128/AEM.67.3.1392-1395.2001; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Loucks Colby, 2004, P149; MAINKA SA, 1994, ZOO BIOL, V13, P13, DOI 10.1002/zoo.1430130104; Matsui H, 2011, CURR MICROBIOL, V62, P1, DOI 10.1007/s00284-010-9661-y; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Nilsson RH, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-1; Ottesen EA, 2011, APPL ENVIRON MICROB, V77, P3461, DOI 10.1128/AEM.02657-10; Ottesen EA, 2010, APPL ENVIRON MICROB, V76, P4909, DOI 10.1128/AEM.00299-10; Pankratov T A, 2006, Dokl Biol Sci, V410, P428, DOI 10.1134/S0012496606050243; Pointing SB, 2005, MYCOL RES, V109, P115, DOI 10.1017/S0953756204001376; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Sadhu S, 2011, CURR MICROBIOL, V62, P1050, DOI 10.1007/s00284-010-9816-x; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Scott KP, 2012, PHARM RES; Swaisgood RR, 2011, INTEGR ZOOL, V6, P290, DOI 10.1111/j.1749-4877.2011.00250.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; van Elsas JD, 2000, J MICROBIOL METH, V43, P133, DOI 10.1016/S0167-7012(00)00212-8; Visser AA, 2012, MICROB ECOL, V63, P975, DOI 10.1007/s00248-011-9987-4; Wei GF, 2007, MICROB ECOL, V54, P194, DOI 10.1007/s00248-007-9225-2; Williams CL, 2012, J ANIM PHYSL ANIM NU; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	54	25	33	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e79902	10.1371/journal.pone.0079902	http://dx.doi.org/10.1371/journal.pone.0079902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475017	Green Published, Green Submitted, gold			2022-12-27	WOS:000330339800002
J	Bosticardo, M; Musio, S; Fontana, E; Angiari, S; Draghici, E; Constantin, G; Poliani, PL; Pedotti, R; Villa, A				Bosticardo, Marita; Musio, Silvia; Fontana, Elena; Angiari, Stefano; Draghici, Elena; Constantin, Gabriela; Poliani, Pietro L.; Pedotti, Rosetta; Villa, Anna			Development of Central Nervous System Autoimmunity Is Impaired in the Absence of Wiskott-Aldrich Syndrome Protein	PLOS ONE			English	Article							CD8(+) T-CELLS; P-SELECTIN; IN-VITRO; WASP; ANTIGEN; ACTIVATION; MUTATIONS; CYTOKINE; ROLES; EXPRESSION	Wiskott-Aldrich Syndrome protein (WASP) is a key regulator of the actin cytoskeleton in hematopoietic cells. Defective expression of WASP leads to multiple abnormalities in different hematopoietic cells. Despite severe impairment of T cell function, WAS patients exhibit a high prevalence of autoimmune disorders. We attempted to induce EAE, an animal model of organ-specific autoimmunity affecting the CNS that mimics human MS, in Was(-/-) mice. We describe here that Was(-/-) mice are markedly resistant against EAE, showing lower incidence and milder score, reduced CNS inflammation and demyelination as compared to WT mice. Microglia was only poorly activated in Was(-/-) mice. Antigen-induced T-cell proliferation, Th-1 and -17 cytokine production and integrin-dependent adhesion were increased in Was(-/-) mice. However, adoptive transfer of MOG-activated T cells from Was(-/-) mice in WT mice failed to induce EAE. Was(-/-) mice were resistant against EAE also when induced by adoptive transfer of MOG-activated T cells from WT mice. Was(+/-) heterozygous mice developed an intermediate clinical phenotype between WT and Was(-/-) mice, and they displayed a mixed population of WASP-positive and -negative T cells in the periphery but not in their CNS parenchyma, where the large majority of inflammatory cells expressed WASP. In conclusion, in absence of WASP, T-cell responses against a CNS autoantigen are increased, but the ability of autoreactive T cells to induce CNS autoimmunity is impaired, most probably because of an inefficient T-cell transmigration into the CNS and defective CNS resident microglial function.	[Bosticardo, Marita; Draghici, Elena; Villa, Anna] Ist Sci San Raffaele, TIGET, I-20132 Milan, Italy; [Musio, Silvia; Pedotti, Rosetta] Fdn IRCCS Neurol Inst C Besta, Neuroimmunol & Neuromuscular Disorders Unit, Milan, Italy; [Fontana, Elena; Poliani, Pietro L.] Univ Brescia, Pathol Unit, Dept Mol & Translat Med, Brescia, Italy; [Angiari, Stefano; Constantin, Gabriela] Univ Verona, Sect Gen Pathol, Dept Pathol & Diag, I-37100 Verona, Italy; [Villa, Anna] CNR, Ist Ric Genet & Biomed, Milan Unit, I-20133 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Brescia; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Pedotti, R (corresponding author), Fdn IRCCS Neurol Inst C Besta, Neuroimmunol & Neuromuscular Disorders Unit, Milan, Italy.	rpedotti@istituto-besta.it; villa.anna@hsr.it	Bosticardo, Marita/ABA-2688-2021; Musio, Silvia/K-3072-2016; Fontana, Elena/K-3845-2016; POLIANI, Pietro Luigi/E-8145-2010	Bosticardo, Marita/0000-0002-1771-4523; Musio, Silvia/0000-0002-8051-7389; Fontana, Elena/0000-0001-8853-3335; POLIANI, Pietro Luigi/0000-0002-5662-8978; Angiari, Stefano/0000-0003-4434-2224; Constantin, Gabriela/0000-0001-8978-3539; Villa, Anna/0000-0003-4428-9013	Italian Telethon Foundation; AISM-FISM; Ministero della Salute - Grant Giovani Ricercatori; European Research Council [261079-NEUROTRAFFICKING]; National Multiple Sclerosis Society (NMSS), New York, NY, USA; Fondazione Cariverona; Research Fellowship FISM - Fondazione Italiana Sclerosi Multipla [cod. 2011/B/6]	Italian Telethon Foundation(Fondazione Telethon); AISM-FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Ministero della Salute - Grant Giovani Ricercatori; European Research Council(European Research Council (ERC)European Commission); National Multiple Sclerosis Society (NMSS), New York, NY, USA(National Multiple Sclerosis Society); Fondazione Cariverona(Fondazione Cariverona); Research Fellowship FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by grants from Italian Telethon Foundation (to AV), AISM-FISM (to RP and GC), Ministero della Salute - Grant Giovani Ricercatori (to RP and MB); European Research Council grant 261079-NEUROTRAFFICKING (GC); National Multiple Sclerosis Society (NMSS), New York, NY, USA (GC); Fondazione Cariverona (GC). SM is supported by a Research Fellowship FISM - Fondazione Italiana Sclerosi Multipla - cod. 2011/B/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2007, CLIN IMMUNOL, V124, P41, DOI 10.1016/j.clim.2007.02.001; Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781; Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Battistini L, 2003, BLOOD, V101, P4775, DOI 10.1182/blood-2002-10-3309; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bosticardo M, 2011, J ALLERGY CLIN IMMUN, V127, P1376, DOI 10.1016/j.jaci.2011.03.030; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; Dupuis-Girod S, 2003, PEDIATRICS, V111, pE622, DOI 10.1542/peds.111.5.e622; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Lafouresse F, 2012, IMMUNOLOGY, V137, P183, DOI 10.1111/j.1365-2567.2012.03620.x; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Morales-Tirado V, 2010, BLOOD, V115, P3498, DOI 10.1182/blood-2009-07-235754; Musio S, 2006, J IMMUNOL, V176, P17, DOI 10.4049/jimmunol.176.1.17; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; Notarangelo LD, 2002, BLOOD, V99, P2268, DOI 10.1182/blood.V99.6.2268; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Pulecio J, 2008, J IMMUNOL, V181, P1135, DOI 10.4049/jimmunol.181.2.1135; Sato M, 2007, INT IMMUNOL, V19, P901, DOI 10.1093/intimm/dxm074; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; Westerberg LS, 2012, BLOOD; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329	48	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86942	10.1371/journal.pone.0086942	http://dx.doi.org/10.1371/journal.pone.0086942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466296	Green Submitted, gold, Green Published			2022-12-27	WOS:000330288000173
J	Kim, S; Rhee, K				Kim, Seongjae; Rhee, Kunsoo			Importance of the CEP215-Pericentrin Interaction for Centrosome Maturation during Mitosis	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; CDK5RAP2; PERICENTRIN; PROTEIN; RECRUITMENT; ATTACHMENT; CENTRIOLES; REVEALS; DOMAIN	At the onset of mitosis, the centrosome undergoes maturation, which is characterized by a drastic expansion of the pericentriolar material (PCM) and a robust increase in microtubule-organizing activity. CEP215 is one of the major PCM components which accumulates at the centrosome during mitosis. The depletion phenotypes indicate that CEP215 is essential for centrosome maturation and bipolar spindle formation. Here, we performed a series of knockdown-rescue experiments to link the protein-protein interaction properties of CEP215 to its biological functions. The results showed that CEP215 and pericentrin, another major PCM component, is interdependent for their accumulation at the spindle poles during mitosis. As a result, The CEP215-pericentrin interaction is required for centrosome maturation and subsequent bipolar spindle formation during mitosis. On the other hand, CEP215 interaction with c-tubulin is dispensable for centrosome maturation. Our results provide an insight how PCM components are assembled to form a spindle pole during mitosis.	[Kim, Seongjae; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr		Kim, Seongjae/0000-0002-9592-6556	BioImaging Research Center at GIST; Basic Research Program [2012R1A2A201003512]; Science Research Center Program [2011-0006425]; Brain Korea 21 Project	BioImaging Research Center at GIST; Basic Research Program; Science Research Center Program; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This study was supported by grants from the BioImaging Research Center at GIST; the Basic Research Program (Grant Number 2012R1A2A201003512) and the Science Research Center Program (Grant Number 2011-0006425). Seongjae Kim was supported by the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gillingham AK, 2000, EMBO REP, V1, P524; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hassan MJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-58; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lee S, 2010, CELL CYCLE, V9, P775, DOI 10.4161/cc.9.4.10667; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Pagnamenta AT, 2012, AM J MED GENET A, V158A, P2577, DOI 10.1002/ajmg.a.35558; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Samejima I, 2008, J CELL SCI, V121, P3971, DOI 10.1242/jcs.038414; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	34	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87016	10.1371/journal.pone.0087016	http://dx.doi.org/10.1371/journal.pone.0087016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24466316	Green Submitted, gold, Green Published			2022-12-27	WOS:000330283100244
J	Foley, KA; Ossenkopp, KP; Kavaliers, M; MacFabe, DF				Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin; MacFabe, Derrick F.			Pre- and Neonatal Exposure to Lipopolysaccharide or the Enteric Metabolite, Propionic Acid, Alters Development and Behavior in Adolescent Rats in a Sexually Dimorphic Manner	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; AUTISM SPECTRUM DISORDER; FETAL-BRAIN DEVELOPMENT; BODY-WEIGHT REGULATION; ANXIETY-LIKE BEHAVIOR; CHAIN FATTY-ACIDS; VALPROIC ACID; GENE-EXPRESSION; PRENATAL STRESS; BACTERIAL-ENDOTOXIN	Alterations in the composition of the gut microbiome and/or immune system function may have a role in the development of autism spectrum disorders (ASD). The current study examined the effects of prenatal and early life administration of lipopolysaccharide (LPS), a bacterial mimetic, and the short chain fatty acid, propionic acid (PPA), a metabolic fermentation product of enteric bacteria, on developmental milestones, locomotor activity, and anxiety-like behavior in adolescent male and female offspring. Pregnant Long-Evans rats were subcutaneously injected once a day with PPA (500 mg/kg) on gestation days G12-16, LPS (50 mu g/kg) on G15-16, or vehicle control on G12-16 or G15-16. Male and female offspring were injected with PPA (500 mg/kg) or vehicle twice a day, every second day from postnatal days (P) 10-18. Physical milestones and reflexes were monitored in early life with prenatal PPA and LPS inducing delays in eye opening. Locomotor activity and anxiety were assessed in adolescence (P40-42) in the elevated plus maze (EPM) and open-field. Prenatal and postnatal treatments altered behavior in a sex-specific manner. Prenatal PPA decreased time spent in the centre of the open-field in males and females while prenatal and postnatal PPA increased anxiety behavior on the EPM in female rats. Prenatal LPS did not significantly influence those behaviors. Evidence for the double hit hypothesis was seen as females receiving a double hit of PPA (prenatal and postnatal) displayed increased repetitive behavior in the open-field. These results provide evidence for the hypothesis that by-products of enteric bacteria metabolism such as PPA may contribute to ASD, altering development and behavior in adolescent rats similar to that observed in ASD and other neurodevelopmental disorders.	[Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Foley, Kelly A.; Ossenkopp, Klaus-Peter; Kavaliers, Martin; MacFabe, Derrick F.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Ossenkopp, Klaus-Peter; Kavaliers, Martin] Univ Western Ontario, Dept Psychol, Kilee Patchell Evans Autism Res Grp, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychol, Div Dev Disabil, Kilee Patchell Evans Autism Res Grp, London, ON, Canada; [MacFabe, Derrick F.] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Foley, KA (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON, Canada.	kfoley6@uwo.ca	Ossenkopp, Klaus-Peter/A-4810-2008; Foley, Kitty-Rose/C-8800-2018; Tonge, Bruce/T-8036-2018	Ossenkopp, Klaus-Peter/0000-0001-7391-3239; Foley, Kitty-Rose/0000-0002-1956-4995; Girdler, Sonya/0000-0001-7992-0800; Tonge, Bruce/0000-0002-4236-9688	GoodLife Children's Charities; Autism Research Institute (ARI); Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship	GoodLife Children's Charities; Autism Research Institute (ARI); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was supported by contributions from GoodLife Children's Charities and Autism Research Institute (ARI) to Derrick MacFabe and by Natural Science and Engineering Research Council of Canada Grants to Klaus-Peter Ossenkopp and Martin Kavaliers. Kelly Foley was supported by the Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Al-Owain M, 2013, JIMD REP, V7, P63, DOI 10.1007/8904_2012_143; Baharnoori M, 2012, SCHIZOPHRENIA BULL, V38, P444, DOI 10.1093/schbul/sbq098; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bennet R, 2002, INFECTION, V30, P158, DOI 10.1007/s15010-002-2140-z; Bloise E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065728; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Brusque AM, 1999, PHARMACOL BIOCHEM BE, V64, P529, DOI 10.1016/S0091-3057(99)00127-6; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; DAWSON DA, 1991, TERATOLOGY, V44, P531, DOI 10.1002/tera.1420440507; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Dendrinos G, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00068; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-142; Enayati M, 2012, BRAIN RES BULL, V87, P295, DOI 10.1016/j.brainresbull.2011.08.015; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Feliz Brady, 2003, Arch Pathol Lab Med, V127, pe325; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Goehler LE, 2008, BRAIN BEHAV IMMUN, V22, P354, DOI 10.1016/j.bbi.2007.08.009; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hanstock TL, 2004, PHYSIOL BEHAV, V82, P357, DOI 10.1016/j.physbeh.2004.04.002; Howland JG, 2012, NEUROSCIENCE, V201, P184, DOI 10.1016/j.neuroscience.2011.11.011; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Iwasa T, 2010, INT J DEV NEUROSCI, V28, P119, DOI 10.1016/j.ijdevneu.2009.08.015; Lin YL, 2012, BRAIN BEHAV IMMUN, V26, P459, DOI 10.1016/j.bbi.2011.12.003; Lynn DA, 2009, DEV PSYCHOBIOL, V51, P513, DOI 10.1002/dev.20386; Lyte M, 1998, PHYSIOL BEHAV, V65, P63, DOI 10.1016/S0031-9384(98)00145-0; MacFabe D., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI 10.3844/ajbbsp.2008.146.166; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Mitchell S, 2011, DEV DISABIL RES REV, V17, P130, DOI 10.1002/ddrr.1107; Muhammad A, 2011, BRAIN RES, V1400, P53, DOI 10.1016/j.brainres.2011.05.038; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Nouel D, 2012, EUR NEUROPSYCHOPHARM, V22, P300, DOI 10.1016/j.euroneuro.2011.08.001; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Oblak AL, 2010, J NEUROCHEM, V114, P1414, DOI 10.1111/j.1471-4159.2010.06858.x; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Oskvig DB, 2012, BRAIN BEHAV IMMUN, V26, P623, DOI 10.1016/j.bbi.2012.01.015; Ossenkopp Klaus-Peter, 1996, P33; Ossenkopp KP, 2012, BEHAV BRAIN RES, V227, P134, DOI 10.1016/j.bbr.2011.10.045; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reynolds S, 2012, DEV NEUROSCI-BASEL, V34, P258, DOI 10.1159/000336646; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Ryabinin AE, 1999, PHARMACOL BIOCHEM BE, V63, P143, DOI 10.1016/S0091-3057(98)00239-1; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spencer SJ, 2007, AM J PHYSIOL-REG I, V293, pR581, DOI 10.1152/ajpregu.00262.2007; Stilling RM, 2014, GENES BRAIN BEHAV, V13, P69, DOI 10.1111/gbb.12109; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tenk CM, 2008, INT J DEV NEUROSCI, V26, P331, DOI 10.1016/j.ijdevneu.2008.01.001; Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x; Tjellstrom B, 2012, SCAND J GASTROENTERO, V47, P1454, DOI 10.3109/00365521.2012.703234; Ushigome F, 2001, EUR J PHARMACOL, V417, P169, DOI 10.1016/S0014-2999(01)00912-8; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Weinstock M, 2011, STRESS, V14, P604, DOI 10.3109/10253890.2011.588294; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhao JP, 2013, P NATL ACAD SCI USA, V110, P707, DOI 10.1073/pnas.1215854110	77	90	94	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e87072	10.1371/journal.pone.0087072	http://dx.doi.org/10.1371/journal.pone.0087072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	25259577	Green Published, gold, Green Submitted			2022-12-27	WOS:000330283100249
J	Fernandez, J; Wilson, RA				Fernandez, Jessie; Wilson, Richard A.			Characterizing Roles for the Glutathione Reductase, Thioredoxin Reductase and Thioredoxin Peroxidase-Encoding Genes of Magnaporthe oryzae during Rice Blast Disease	PLOS ONE			English	Article							PLANT INFECTION; SACCHAROMYCES-CEREVISIAE; TRIGGERED IMMUNITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; NADPH OXIDASES; CELL-DEATH; FUNGUS; METABOLISM; INVASION	Understanding how pathogenic fungi adapt to host plant cells is of major concern to securing global food production. The hemibiotrophic rice blast fungus Magnaporthe oryzae, cause of the most serious disease of cultivated rice, colonizes leaf cells asymptomatically as a biotroph for 4-5 days in susceptible rice cultivars before entering its destructive necrotrophic phase. During the biotrophic growth stage, M. oryzae remains undetected in the plant while acquiring nutrients and growing cell-to-cell. Which fungal processes facilitate in planta growth and development are still being elucidated. Here, we used gene functional analysis to show how components of the NADPH-requiring glutathione and thioredoxin antioxidation systems of M. oryzae contribute to disease. Loss of glutathione reductase, thioredoxin reductase and thioredoxin peroxidase-encoding genes resulted in strains severely attenuated in their ability to grow in rice cells and that failed to produce spreading necrotic lesions on the leaf surface. Glutathione reductase, but not thioredoxin reductase or thioredoxin peroxidase, was shown to be required for neutralizing plant generated reactive oxygen species (ROS). The thioredoxin proteins, but not glutathione reductase, were shown to contribute to cell-wall integrity. Furthermore, glutathione and thioredoxin gene expression, under axenic growth conditions, was dependent on both the presence of glucose and the M. oryzae sugar/NADPH sensor Tps1, thereby suggesting how glucose availability, NADPH production and antioxidation might be connected. Taken together, this work identifies components of the fungal glutathione and thioredoxin antioxidation systems as determinants of rice blast disease that act to facilitate biotrophic colonization of host cells by M. oryzae.	[Fernandez, Jessie; Wilson, Richard A.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Wilson, RA (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	rwilson10@unl.edu	Fernandez, Jessie/AAR-3477-2021	Fernandez, Jessie/0000-0002-0897-2707	National Science Foundation [IOS-1145347]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (IOS-1145347). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Donofrio NM, 2014, NEW PHYTOL, V201, P367, DOI 10.1111/nph.12623; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandez J, 2012, MOL PLANT MICROBE IN, V25, P1286, DOI 10.1094/MPMI-12-11-0326; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Gassmann W, 2012, MOL PLANT MICROBE IN, V25, P862, DOI 10.1094/MPMI-01-12-0024-IA; Giraldo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2996; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001335; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kupferschmidt K, 2012, SCIENCE, V337, P636, DOI 10.1126/science.337.6095.636; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15	51	43	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87300	10.1371/journal.pone.0087300	http://dx.doi.org/10.1371/journal.pone.0087300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24955977	Green Published, gold			2022-12-27	WOS:000330339800093
J	Mishra, AM; Bai, XX; Sanganahalli, BG; Waxman, SG; Shatillo, O; Grohn, O; Hyder, F; Pitkanen, A; Blumenfeld, H				Mishra, Asht Mangal; Bai, Xiaoxiao; Sanganahalli, Basavaraju G.; Waxman, Stephen G.; Shatillo, Olena; Grohn, Olli; Hyder, Fahmeed; Pitkanen, Asla; Blumenfeld, Hal			Decreased Resting Functional Connectivity after Traumatic Brain Injury in the Rat	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; TONIC-CLONIC SEIZURES; POSTTRAUMATIC EPILEPSY; WAG/RIJ RATS; FMRI; EPILEPTOGENESIS; MODEL; MRI; FLUCTUATIONS; NETWORKS	Traumatic brain injury (TBI) contributes to about 10% of acquired epilepsy. Even though the mechanisms of post-traumatic epileptogenesis are poorly known, a disruption of neuronal networks predisposing to altered neuronal synchrony remains a viable candidate mechanism. We tested a hypothesis that resting state BOLD-fMRI functional connectivity can reveal network abnormalities in brain regions that are connected to the lesioned cortex, and that these changes associate with functional impairment, particularly epileptogenesis. TBI was induced using lateral fluid-percussion injury in seven adult male Sprague-Dawley rats followed by functional imaging at 9.4T 4 months later. As controls we used six sham-operated animals that underwent all surgical operations but were not injured. Electroencephalogram (EEG)-functional magnetic resonance imaging (fMRI) was performed to measure resting functional connectivity. A week after functional imaging, rats were implanted with bipolar skull electrodes. After recovery, rats underwent pentyleneterazol (PTZ) seizure-susceptibility test under EEG. For image analysis, four pairs of regions of interests were analyzed in each hemisphere: ipsilateral and contralateral frontal and parietal cortex, hippocampus, and thalamus. High-pass and low-pass filters were applied to functional imaging data. Group statistics comparing injured and sham-operated rats and correlations over time between each region were calculated. In the end, rats were perfused for histology. None of the rats had epileptiform discharges during functional imaging. PTZ-test, however revealed increased seizure susceptibility in injured rats as compared to controls. Group statistics revealed decreased connectivity between the ipsilateral and contralateral parietal cortex and between the parietal cortex and hippocampus on the side of injury as compared to sham-operated animals. Injured animals also had abnormal negative connectivity between the ipsilateral and contralateral parietal cortex and other regions. Our data provide the first evidence on abnormal functional connectivity after experimental TBI assessed with resting state BOLD-fMRI.	[Mishra, Asht Mangal; Bai, Xiaoxiao; Waxman, Stephen G.; Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Blumenfeld, Hal] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Mishra, Asht Mangal; Sanganahalli, Basavaraju G.; Hyder, Fahmeed; Blumenfeld, Hal] Yale Univ, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Waxman, Stephen G.] Ctr Neurosci & Regenerat Res, West Haven, CT USA; [Grohn, Olli] Univ Eastern Finland, Biomed NMR Res Grp, Biomed Imaging Unit, Kuopio, Finland; [Shatillo, Olena; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Yale University; Yale University; Yale University; Yale University; Yale University; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Blumenfeld, H (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	hal.blumenfeld@yale.edu	khan, yusuf/AAQ-9470-2021; Sanganahalli, Basavaraju G/C-3296-2008; khan, yusuf/E-6726-2015; MISHRA, AWDHESH/U-1920-2019; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; Waxman, Stephen/Z-2507-2019; Hyder, Fahmeed/A-2644-2015	Sanganahalli, Basavaraju G/0000-0002-0851-6621; khan, yusuf/0000-0001-6986-4657; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Waxman, Stephen/0000-0001-5718-7177; Hyder, Fahmeed/0000-0001-7822-4002; /0000-0002-3312-3264	National Institutes of Health (NIH) [R01 NS049307]; NIH [R01 NS066974]; Epilepsy Foundation Postdoctoral Research and Training Award [123505]; Yale QNMR Pilot study; Betsy and Jonathan Blattmachr family; Academy of Finland; Sigrid Juselius Foundation;  [P30 NS052519]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation Postdoctoral Research and Training Award; Yale QNMR Pilot study; Betsy and Jonathan Blattmachr family; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); 	This work was supported by National Institutes of Health (NIH) R01 NS049307 (HB), NIH R01 NS066974 (HB), Epilepsy Foundation Postdoctoral Research and Training Award ID: 123505 (AMM), Yale QNMR Pilot study (AMM), P30 NS052519 (FH), the Betsy and Jonathan Blattmachr family (HB), the Academy of Finland (AP, OG), and by the Sigrid Juselius Foundation (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2011, NEUROLOGY, V76, P1960, DOI 10.1212/WNL.0b013e31821e54de; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Coggan JS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065002; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; El-Hassar L, 2007, EPILEPSIA, V48, P131, DOI 10.1111/j.1528-1167.2007.01301.x; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franken ND, 2008, VET ANAESTH ANALG, V35, P424, DOI 10.1111/j.1467-2995.2008.00404.x; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hettinger PC, 2011, J NEUROSCI METH, V200, P106, DOI 10.1016/j.jneumeth.2011.06.018; Immonen R, 2013, J NEUROTRAUM, P1; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Khubchandani M, 2003, MAGNET RESON MED, V49, P962, DOI 10.1002/mrm.10441; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lemieux L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00012; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mishra AM, 2009, EPILEPSIA, V50, P362; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P589, DOI 10.1097/01.WCB.0000117688.98763.23; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Sachdev RNS, 2003, NEUROIMAGE, V19, P742, DOI 10.1016/S1053-8119(03)00093-4; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	41	114	121	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95280	10.1371/journal.pone.0095280	http://dx.doi.org/10.1371/journal.pone.0095280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24748279	Green Published, Green Submitted, gold			2022-12-27	WOS:000335226500074
J	Zhang, P; Guan, P; Bai, XL; Song, ZP				Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping			New Aspects of HERG K+ Channel Function Depending upon Cardiac Spatial Heterogeneity	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENTS; I-KR; OUTWARD CURRENT; TRANSIENT; REPOLARIZATION; IMPAIRMENT; DEPENDENCE; ARRHYTHMIA; MYOCYTES; CELLS	HERG K+ channel, the genetic counterpart of rapid delayed rectifier K+ current in cardiac cells, is responsible for many cases of inherited and drug-induced long QT syndromes. HERG has unusual biophysical properties distinct from those of other K+ channels. While the conventional pulse protocols in patch-clamp studies have helped us elucidate these properties, their limitations in assessing HERG function have also been progressively noticed. We employed AP-clamp techniques using physiological action potential waveforms recorded from various regions of canine heart to study HERG function in HEK293 cells and identified several novel aspects of HERG function. We showed that under AP-clamp IHERG increased gradually with membrane repolarization, peaked at potentials around 20-30 mV more negative than revealed by pulse protocols and at action potential duration (APD) to 60%-70% full repolarization, and fell rapidly at the terminal phase of repolarization. We found that the rising phase of IHERG was conferred by removal of inactivation and the decaying phase resulted from a fall in driving force, which were all determined by the rate of membrane repolarization. We identified regional heterogeneity and transmural gradient of IHERG when quantified with the area covered by IHERG trace. In addition, we observed regional and transmural differences of IHERG in response to dofetilide blockade. Finally, we characterized the influence of HERG function by selective inhibition of other ion currents. Based on our results, we conclude that the distinct biophysical properties of HERG reported by AP-clamp confer its unique function in cardiac repolarization thereby in antiarrhythmia and arrhythmogenesis.	[Zhang, Pen; Guan, Ping; Bai, Xiao-Lu; Song, Zhi-Ping] Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China		Song, ZP (corresponding author), Minhang Cent Hosp, Dept Cardiol, Shanghai, Peoples R China.	zpsong.dcmch@sina.com						Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Corr PB, 1995, CARDIAC ELECTROPHYSI, P182; Di Diego JM, 2003, CIRCULATION, V108, P1027, DOI 10.1161/01.CIR.0000085066.05180.40; Gintant GA, 2000, AM J PHYSIOL-HEART C, V278, pH806, DOI 10.1152/ajpheart.2000.278.3.H806; Goldhaber, 1998, J Cardiovasc Pharmacol Ther, V3, P37, DOI 10.1177/107424849800300105; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; LITOVSKY SH, 1989, J AM COLL CARDIOL, V14, P1053, DOI 10.1016/0735-1097(89)90490-7; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SICOURI S, 1991, CIRC RES, V68, P1729, DOI 10.1161/01.RES.68.6.1729; Taglialatela M, 1998, BIOCHEM PHARMACOL, V55, P1741, DOI 10.1016/S0006-2952(98)00002-1; Tsuji Y, 2000, CARDIOVASC RES, V48, P300, DOI 10.1016/S0008-6363(00)00180-2; Wang HZ, 2000, CIRCULATION, V102, P1165, DOI 10.1161/01.CIR.102.10.1165; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang JX, 2001, CIRCULATION, V104, P2645, DOI 10.1161/hc4701.100513; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WANG ZG, 1993, CIRC RES, V73, P276, DOI 10.1161/01.RES.73.2.276; Yue LX, 1999, CIRC RES, V84, P776; Yue LX, 2000, CARDIOVASC RES, V46, P151, DOI 10.1016/S0008-6363(99)00430-7; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	31	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e72181	10.1371/journal.pone.0072181	http://dx.doi.org/10.1371/journal.pone.0072181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475014	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300001
J	Kyriacos, U; Jelsma, J; James, M; Jordan, S				Kyriacos, Una; Jelsma, Jennifer; James, Michael; Jordan, Sue			Monitoring Vital Signs: Development of a Modified Early Warning Scoring (Mews) System for General Wards in a Developing Country	PLOS ONE			English	Article							MEDICAL EMERGENCY TEAM; AT-RISK PATIENTS; CRITICAL-CARE; PERFORMANCE EVALUATION; PHYSIOLOGICAL TRACK; CONSENSUS METHODS; TRIGGER SYSTEMS; ADVERSE EVENTS; NOMINAL GROUP; ADMISSIONS	Objective: The aim of the study was to develop and validate, by consensus, the construct and content of an observations chart for nurses incorporating a modified early warning scoring (MEWS) system for physiological parameters to be used for bedside monitoring on general wards in a public hospital in South Africa. Methods: Delphi and modified face-to-face nominal group consensus methods were used to develop and validate a prototype observations chart that incorporated an existing UK MEWS. This informed the development of the Cape Town ward MEWS chart. Participants: One specialist anaesthesiologist, one emergency medicine specialist, two critical care nurses and eight senior ward nurses with expertise in bedside monitoring (N = 12) were purposively sampled for consensus development of the MEWS. One general surgeon declined and one neurosurgeon replaced the emergency medicine specialist in the final round. Results: Five consensus rounds achieved >= 70% agreement for cut points in five of seven physiological parameters respiratory and heart rates, systolic BP, temperature and urine output. For conscious level and oxygen saturation a relaxed rule of <70% agreement was applied. A reporting algorithm was established and incorporated in the MEWS chart representing decision rules determining the degree of urgency. Parameters and cut points differed from those in MEWS used in developed countries. Conclusions: A MEWS for developing countries should record at least seven parameters. Experts from developing countries are best placed to stipulate cut points in physiological parameters. Further research is needed to explore the ability of the MEWS chart to identify physiological and clinical deterioration.	[Kyriacos, Una] Univ Cape Town, Div Nursing & Midwifery, Dept Hlth & Rehabil Sci, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa; [Jelsma, Jennifer] Univ Cape Town, Dept Hlth & Rehabil Sci, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa; [James, Michael] Univ Cape Town, Dept Anaesthesiol, Groote Schuur Hosp, ZA-7700 Rondebosch, South Africa; [Jordan, Sue] Swansea Univ, Sch Human & Hlth Sci, Swansea, W Glam, Wales	University of Cape Town; University of Cape Town; University of Cape Town; Swansea University	Kyriacos, U (corresponding author), Univ Cape Town, Div Nursing & Midwifery, Dept Hlth & Rehabil Sci, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa.	una.kyriacos@uct.ac.za	jordan, sue/O-1297-2019; Kyriacos, Una/I-4634-2013	jordan, sue/0000-0002-5691-2987; Kyriacos, Una/0000-0003-1611-8014	University of Cape Town Research Development Fund; Faculty of Health Sciences Research Committee	University of Cape Town Research Development Fund; Faculty of Health Sciences Research Committee	This work was supported by the University of Cape Town Research Development Fund and the Faculty of Health Sciences Research Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews T, 2005, J ADV NURS, V52, P473, DOI 10.1111/j.1365-2648.2005.03615.x; [Anonymous], 2007, ACT HLTH POLICY MODI; Ball C, 2003, BRIT MED J, V327, P1014, DOI 10.1136/bmj.327.7422.1014; Barbetti Julie, 2008, Nurs Crit Care, V13, P80, DOI 10.1111/j.1478-5153.2007.00258.x; Barlow GD, 2006, CLIN MED, V6, P422, DOI 10.7861/clinmedicine.6-4-422b; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Carney O, 1996, J ADV NURS, V23, P1024, DOI 10.1046/j.1365-2648.1996.09623.x; Carter CA, 2008, S AFRICAN J CRITICAL, V24; Chaboyer W, 2008, AM J CRIT CARE, V17, P255; Cioffi J, 2000, J ADV NURS, V32, P108, DOI 10.1046/j.1365-2648.2000.01414.x; Cioffi J, 2000, HEART LUNG, V29, P262, DOI 10.1067/mhl.2000.108327; Cuthbertson BH, 2007, CRIT CARE MED, V35, P402, DOI 10.1097/01.CCM.0000254826.10520.87; Duckitt RW, 2007, BRIT J ANAESTH, V98, P769, DOI 10.1093/bja/aem097; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Francis C, 2007, OCCUP ENVIRON MED, V64, P361, DOI 10.1136/oem.2006.028902; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Gao H, 2006, CRITICAL CARE, V10, pP415; Gao HY, 2007, INTENS CARE MED, V33, P667, DOI 10.1007/s00134-007-0532-3; Gardner-Thorpe J, 2006, ANN ROY COLL SURG, V88, P571, DOI 10.1308/003588406X130615; Green Anna Louise, 2006, Intensive Crit Care Nurs, V22, P274, DOI 10.1016/j.iccn.2006.04.004; Guttmann A, 2006, PEDIATRICS, V118, P114, DOI 10.1542/peds.2005-3029; Harrison GA, 2005, RESUSCITATION, V65, P149, DOI 10.1016/j.resuscitation.2004.11.017; Harrison GA, 2006, RESUSCITATION, V71, P327, DOI 10.1016/j.resuscitation.2006.05.008; Hartman ND, 2006, INTENSIVE CARE MEDICINE: ANNUAL UPDATE 2006, P309, DOI 10.1007/0-387-35096-9_29; Hogan Jacqueline, 2006, Br J Nurs, V15, P489; Jacques T, 2006, RESUSCITATION, V69, P175, DOI 10.1016/j.resuscitation.2005.08.015; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kyriacos U, 2011, J NURS MANAGE, V19, P311, DOI 10.1111/j.1365-2834.2011.01246.x; Luton & Dunstable Trust Hospitals, COL BAND EARL WARN C; McLiveney F, 2008, OBSTETRIC EARLY WARN; McLiveney F, 2008, OBSTET EARLY WARNING; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Moll HA, 2010, J CLIN EPIDEMIOL, V63, P384, DOI 10.1016/j.jclinepi.2009.07.009; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Morgan RJM, 2007, BRIT J ANAESTH, V99, P747, DOI 10.1093/bja/aem286; Morrice Amanda, 2007, Intensive Crit Care Nurs, V23, P23, DOI 10.1016/j.iccn.2006.07.001; Naylor CD, 1998, NEW ENGL J MED, V338, P1918, DOI 10.1056/NEJM199806253382612; NHS, 2003, DOH MOD AG CRIT CAR; NHS NICE, 2007, AC ILL PAT HOSP; Parissopoulos S, 2005, ICUS NURSING WEB J, P1; Paterson R, 2006, CLIN MED, V6, P281, DOI 10.7861/clinmedicine.6-3-281; PILL J, 1971, SOCIO ECON PLAN SCI, V5, P57, DOI 10.1016/0038-0121(71)90041-3; Potter M., 2004, NZ J PHYSIOTHER, V32, P126; Rotondi AJ, 1997, CRIT CARE CLIN, V13, P417, DOI 10.1016/S0749-0704(05)70319-5; ROWE G, 1991, TECHNOL FORECAST SOC, V39, P235, DOI 10.1016/0040-1625(91)90039-I; Royal College of Physicians, 2012, NATL EARLY WARNING S; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; Smith G, 2005, RESUSCITATION GUIDEL; Smith GB, 2008, RESUSCITATION, V79, P11, DOI 10.1016/j.resuscitation.2008.05.004; Smith GB, 2008, RESUSCITATION, V77, P170, DOI 10.1016/j.resuscitation.2007.12.004; Stenhouse C., 2000, BRIT J ANAESTH, V84, p663P, DOI [10.1093/bja/84.5.663, DOI 10.1093/BJA/84.5.663]; Subbe CP, 2007, INTENS CARE MED, V33, P619, DOI 10.1007/s00134-006-0516-8; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; Vella K, 2000, BRIT MED J, V320, P976, DOI 10.1136/bmj.320.7240.976; Wallis L, 2006, EMERG MED J, V23, P291, DOI 10.1136/emj.2005.025312	61	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87073	10.1371/journal.pone.0087073	http://dx.doi.org/10.1371/journal.pone.0087073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475226	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800083
J	Li, X; Zhang, Y; Xia, M; Gulbins, E; Boini, KM; Li, PL				Li, Xiang; Zhang, Yang; Xia, Min; Gulbins, Erich; Boini, Krishna M.; Li, Pin-Lan			Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; NALP3 INFLAMMASOME; SIGNALING PATHWAY; OXIDATIVE STRESS; CHOLESTEROL; CELLS; ATHEROSCLEROSIS; CONTRIBUTE; CRYSTALS	Although Nlrp3 inflammasome activation in macrophages has been shown to be critical for the development of atherosclerosis upon atherogenic stimuli, it remains unknown whether activated Nlrp3 inflammasomes by other non-atherogenic stimuli induce alterations in macrophages that may contribute in the concert with other factors to atherogenesis. Thus, the present study tested the hypothesis that activation of Nlrp3 inflammasomes by ATP, which is a classical non-lipid danger stimulus, enhances the migration of macrophage and increases lipids deposition in macrophages accelerating foam cell formation. We first demonstrated that extracellular ATP (2.5 mM) markedly increased the formation and activation of Nlrp3 inflammasomes in bone marrow macrophages (BMMs) from wild type (Asc(+/+)) mice resulting in activation of caspase-1 and IL-1 beta production. In these Asc(+/+) macrophages, such stimulation of inflammasomes by non-lipid ATP was similar to those induced by atherogenic stimuli such as cholesterol crystals or 7-ketocholesterol. Both non-lipid and lipid forms of stimuli induced formation and activation of Nlrp3 inflammasomes, which were prevented by Asc gene deletion. Interestingly, Asc(+/+) BMMs had dramatic lipids accumulation after stimulation with ATP. Further, we demonstrated that large amount of cholesterol was accumulated in lysosomes of Asc(+/+) BMMs when inflammasomes were activated by ATP. Such intracellular and lysosomal lipids deposition was not observed in Asc(-/-) BMMs and also prevented by caspase-1 inhibitor WEHD. In addition, in vitro and in vivo experiments revealed that migration of Asc(+/+) BMMs increased due to stimulation of Nlrp3 inflammasomes, which was markedly attenuated in Asc(-/-) BMMs. Together, these results suggest that activation of Nlrp3 inflammasomes remarkably increases the susceptibility of macrophages to lipid deposition and their migration ability. Such novel action of inflammasomes may facilitate entry or retention of macrophages into the arterial wall, where they form foam cells and ultimately induce atherosclerosis.	[Li, Xiang; Zhang, Yang; Xia, Min; Boini, Krishna M.; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Gulbins, Erich] Univ Duisburg Essen, Med Sch Essen, Dept Mol Biol, Essen, Germany	Virginia Commonwealth University; University of Duisburg Essen	Li, PL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	pli@vcu.edu	Xia, Min/C-2084-2012; Gulbins, Erich/L-6989-2014; Han, Zhong Chao/D-7157-2016	Gulbins, Erich/0000-0002-3117-1342; Han, Zhong Chao/0000-0002-2687-7682	National Institutes of Health [HL-57244, HL-075316, HL-091464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057244, R01HL075316, R01HL091464, R01HL057244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (HL-57244, HL-075316, and HL-091464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CHABRAOUI F, 1993, J IMMUNOL METHODS, V165, P225, DOI 10.1016/0022-1759(93)90348-B; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; HALEY NJ, 1977, LAB INVEST, V37, P287; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Herijgers N, 2000, ARTERIOSCL THROM VAS, V20, P1961, DOI 10.1161/01.ATV.20.8.1961; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jerome WG, 1998, J LIPID RES, V39, P1362; Johnston TP, 2006, EUR J PHARMACOL, V536, P232, DOI 10.1016/j.ejphar.2006.03.019; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rodriguez G, 2009, INVEST CLIN, V50, P109; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Wei YM, 2013, J PHARMACOL EXP THER, V345, P170, DOI 10.1124/jpet.112.201442; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yancey PG, 1998, J LIPID RES, V39, P1349; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	39	142	149	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87552	10.1371/journal.pone.0087552	http://dx.doi.org/10.1371/journal.pone.0087552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475307	Green Published, gold			2022-12-27	WOS:000330507300200
J	Ritze, Y; Bardos, G; Claus, A; Ehrmann, V; Bergheim, I; Schwiertz, A; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Schwiertz, Andreas; Bischoff, Stephan C.			Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CACO-2 CELL MONOLAYERS; GUT MICROBIOTA; INTESTINAL PERMEABILITY; HEPATIC STEATOSIS; PROBIOTICS; OBESITY; FRUCTOSE; BARRIER; FLORA	Objective: Experimental evidence revealed that obesity-associated non-alcoholic fatty liver disease (NAFLD) is linked to changes in intestinal permeability and translocation of bacterial products to the liver. Hitherto, no reliable therapy is available except for weight reduction. Within this study, we examined the possible effect of the probiotic bacterial strain Lactobacillus rhamnosus GG (LGG) as protective agent against experimental NAFLD in a mouse model. Methods: Experimental NAFLD was induced by a high-fructose diet over eight weeks in C57BL/J6 mice. Fructose was administered via the drinking water containing 30% fructose with or without LGG at a concentration resulting in approximately 5x10(7) colony forming units/g body weight. Mice were examined for changes in small intestinal microbiota, gut barrier function, lipopolysaccharide (LPS) concentrations in the portal vein, liver inflammation and fat accumulation in the liver. Results: LGG increased beneficial bacteria in the distal small intestine. Moreover, LGG reduced duodenal I kappa B protein levels and restored the duodenal tight junction protein concentration. Portal LPS (P <= 0.05) was reduced and tended to attenuate TNF-alpha, IL-8R and IL-1 beta mRNA expression in the liver feeding a high-fructose diet supplemented with LGG. Furthermore liver fat accumulation and portal alanine-aminotransferase concentrations (P <= 0.05) were attenuated in mice fed the high-fructose diet and LGG. Conclusions: We show for the first time that LGG protects mice from NAFLD induced by a high-fructose diet. The underlying mechanisms of protection likely involve an increase of beneficial bacteria, restoration of gut barrier function and subsequent attenuation of liver inflammation and steatosis.	[Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Bischoff, Stephan C.] Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany; [Bergheim, Ina] Univ Jena, Dept Nutr Sci, Jena, Germany; [Schwiertz, Andreas] MVZ Inst Microecol, Herborn, Germany	University Hohenheim; Friedrich Schiller University of Jena	Bischoff, SC (corresponding author), Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany.	bischoff.stephan@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research [FKZ: 01GI0843]; Institute Danone	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute Danone(Danone Nutricia)	This work was supported by grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843) to S. C. Bischoff and the Institute Danone research grant 2010 to Y. Ritze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Donato KA, 2010, MICROBIOL-SGM, V156, P3288, DOI 10.1099/mic.0.040139-0; Dukowicz Andrew C, 2007, Gastroenterol Hepatol (N Y), V3, P112; ELLWOOD KC, 1993, P SOC EXP BIOL MED, V202, P440, DOI 10.3181/00379727-202-43556; Gratz SW, 2010, WORLD J GASTROENTERO, V16, P403, DOI 10.3748/wjg.v16.i4.403; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haub S, 2011, J PHARMACOL EXP THER, V339, P790, DOI 10.1124/jpet.111.181834; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Ji YS, 2012, BENEF MICROBES, V3, P13, DOI 10.3920/BM2011.0046; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Le Roy T, 2012, GUT; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee Sang Kil, 2012, Korean J Gastroenterol, V60, P86; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Park SK, 2012, HEPATOLOGY; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Solga SF, 2004, HEPATOLOGY, V39, P1197, DOI 10.1002/hep.20220; Spiller R, 2008, ALIMENT PHARM THER, V28, P385, DOI 10.1111/j.1365-2036.2008.03750.x; Spruss A, 2009, J NUTR BIOCHEM, V20, P657, DOI 10.1016/j.jnutbio.2009.05.006; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vieira LQ, 2008, J CLIN GASTROENTEROL, V42, pS168, DOI 10.1097/MCG.0b013e31818063d4; Wagnerberger S, 2012, J NUTR BIOCH; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Wood Natalie J, 2012, Nat Rev Gastroenterol Hepatol, V9, P123, DOI 10.1038/nrgastro.2012.21; Xu RY, 2012, J CLIN BIOCHEM NUTR, V50, P72, DOI 10.3164/jcbn.11-38; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zhang LY, 2006, J PEDIATR GASTR NUTR, V42, P545, DOI 10.1097/01.mpg.0000221905.68781.4a	50	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e80169	10.1371/journal.pone.0080169	http://dx.doi.org/10.1371/journal.pone.0080169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475018	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300004
J	Tang, YN; Li, X; Yao, YF; Ferguson, DK; Li, CS				Tang, Ye-Na; Li, Xiao; Yao, Yi-Feng; Ferguson, David Kay; Li, Cheng-Sen			Environmental Reconstruction of Tuyoq in the Fifth Century and Its Bearing on Buddhism in Turpan, Xinjiang, China	PLOS ONE			English	Article							YANGHAI TOMBS; POLLEN; L.; QUATERNARY; PLATEAU; UPLIFT; BP	The Thousand Buddha Grottoes of Tuyoq, Turpan, Xinjiang, China were once a famous Buddhist temple along the ancient Silk Road which was first constructed in the Fifth Century (A.D.). Although archaeological researches about the Grottoes have been undertaken for over a century, the ancient environment has remained enigmatic. Based on seven clay samples from the Grottoes' adobes, pollen and leaf epidermis were analyzed to decipher the vegetation and climate of Fifth Century Turpan, and the environmental landscape was reconstructed in three dimensions. The results suggest that temperate steppe vegetation dominated the Tuyoq region under a warmer and wetter environment with more moderate seasonality than today, as the ancient mean annual temperature was 15.3 degrees C, the mean annual precipitation was approximately 1000 mm and the temperature difference between coldest and warmest months was 24 degrees C using Co-existence Approach. Taken in the context of wheat and grape cultivation as shown by pollen of Vitis and leaf epidermis of Triticum, we infer that the Tuyoq region was an oasis with booming Buddhism in the Fifth Century, which was probably encouraged by a 1 degrees C warmer temperature with an abundant water supply compared to the coeval world that experienced the 1.4 k BP cooling event.	[Tang, Ye-Na; Yao, Yi-Feng; Ferguson, David Kay; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Xiao] Renmin Univ China, Sch Chinese Class, Beijing, Peoples R China; [Ferguson, David Kay] Univ Vienna, Dept Paleontol, Vienna, Austria	Chinese Academy of Sciences; Institute of Botany, CAS; Renmin University of China; University of Vienna	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yaoyf@ibcas.ac.cn; lics@ibcas.ac.cn		Rajwa, Bartek/0000-0001-7540-8236; Bhunia, Arun/0000-0003-3640-1554; Bae, Euiwon/0000-0001-6095-3223	China National Key Basic Research Program [2014CB954201]	China National Key Basic Research Program(National Basic Research Program of China)	This research was supported by China National Key Basic Research Program (2014CB954201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdirahman H, 2009, J CHINA HYDROL, V29, P50; Andersen TS, 1972, GRANA, V12, P79, DOI 10.1080/00173137209428830; Anjum Perveen, 2006, World Applied Sciences Journal, V1, P60; [Anonymous], LAND CLIM DAT CHIN 1; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Cai LB, 1995, ACTA BOT BOREAL OCCI, V15, P323; [罗传秀 LUO Chuanxiu], 2007, [干旱区地理, Arid Land Geography], V30, P536; Chen S.L., 1993, MICROMORPHOLOGICAL A; Chen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045137; Cheng J., 2006, HOLOCENE VEGETATION, P283; DRIESSEN MNBM, 1989, GRANA, V28, P115, DOI 10.1080/00173138909429962; Editorial office, 2007, CHIN CULT HERIT, P80; Editorial office, 2012, HIST REF, V22, P24; ELLIS R P, 1979, Bothalia, V12, P641; Fan ZL, 1995, ARID ZONE RES S, V12, P308; Ferguson DK, 2007, CR PALEVOL, V6, P423, DOI 10.1016/j.crpv.2007.09.018; [葛全胜 Ge Quansheng], 2002, [第四纪研究, Quaternary Sciences], V22, P166; IBCAS (Institute of Botany the Chinese Academy of Sciences), 1976, SPOR PTER PHYT SIN; IDBMC, 1983, LAND CLIM DAT CHIN 2, p[4, 126]; IDBMC (Information Department of Beijing Meteorological Center), 1983, LAND CLIM DAT CHIN 6; IDBMC (INFORMATION DEPARTMENT OF BEIJING METEOROLOGICAL CENTER), 1984, LAND CLIM DAT CHIN 3; IDBMC (Information Department of Beijing Meteorological Center), 1984, LAND CLIM DAT CHIN 4, V4-6, P99; IDBMC (INFORMATION DEPARTMENT OF BEIJING METEOROLOGICAL CENTER), 1984, LAND CLIM DAT CHIN 5; JAT (Joint Archaeological Team of Research Center for Frontier Archaeology of the Institute of Archaeology Chinese Academy of Social Sciences and Academia Turfanica and Kizil Research Institute), 2011, ARCHAEOLOGY, V7, P27; JAT (Joint Archaeological Team of Research Center for Frontier Archaeology of the Institute of Archaeology Chinese Academy of Social Sciences and Academia Turfanica and Kizil Research Institute), 2012, ARCHAEOLOGY, P7; Jiang H, 2007, J PALAEOGEOGR, V5, P551; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2009, J ARCHAEOL SCI, V36, P1458, DOI 10.1016/j.jas.2009.02.010; Klementz Dmitriy A., 1899, NACHRICHTEN KAISERLI; Le Coq VA, 1913, CHOSTSCHO; Li JF, 1985, P QUAT XINJ AR AR, P1; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; LI WY, 1998, QUATERNARY VEGETATIO; Li X., 1993, ARID LAND GEOGRAPHY, V16, P63; Li XQ, 1999, ACTA BOT SIN, V41, P782; Lin M, 1996, CULT RELIC, V12, P54; Lin XL, 2008, THESIS SHANDONG NORM; Luo CX, 2008, ARID LAND GEOGR, V28, P272; Ma QingWen, 2005, Bulletin of Botanical Research, V25, P307; Ma YX, 2004, B BOT RES, V24; [毛礼米 MAO Limi], 2011, [微体古生物学报, Acta Micropalaeontologica Sinica], V28, P169; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Mokushiki K, 1999, XIYU KAO GU TU PU; Moore P.D., 1991, BLACKWELL SCI PUBLI; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; PAGE J S, 1978, Kew Bulletin, V32, P313, DOI 10.2307/4117102; Pan W, 2003, URANIUM GEOL, V19, P332; Qiu ZW, 2012, ECON BOT, V66, P255, DOI 10.1007/s12231-012-9204-5; [舒强 SHU Qiang], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P95; The editorial board of Chinese Frescoes Corpus, 1995, CORP CHIN ART CLASS; Wang FX, 1995, POLLEN FLORA CHINA; Wang S, 2000, GAOCHANG HIST TRANSP, P85; Weng Cheng-Yu, 1993, Acta Botanica Sinica, V35, P69; Wu Z. Y., 1999, SEED PLANTS CHINA; Xi YZ, 1994, YUSHANIA, V11, P119; Xie XM, 1994, J INN MONG NORM U NA, V1, P53; Yan S., 1991, ARID LAND GEOGR, V14, P1; Yan S, 1989, ARID ZONE RES, V6, P26; Yao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039780; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2003, J ARID ENVIRON, V55, P545, DOI 10.1016/S0140-1963(02)00283-5; Zhao Y, 2012, HOLOCENE, V22, P1385, DOI 10.1177/0959683612449762; Zhong Wei, 2001, Arid Land Geography, V24, P212; Zhou XJ, 1989, J ARID REGIONS RES, V1, P9; 蔡联炳, 1996, 西北植物学报, V16, P65	67	40	43	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86363	10.1371/journal.pone.0086363	http://dx.doi.org/10.1371/journal.pone.0086363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	25136836	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300057
J	Arancibia, S; Espinoza, C; Salazar, F; Del Campo, M; Tampe, R; Zhong, TY; De Ioannes, P; Moltedo, B; Ferreira, J; Lavelle, EC; Manubens, A; De Ioannes, AE; Becker, MI				Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ferreira, Jorge; Lavelle, Ed C.; Manubens, Augusto; De Ioannes, Alfredo E.; Ines Becker, Maria			A Novel Immunomodulatory Hemocyanin from the Limpet Fissurella latimarginata Promotes Potent Anti-Tumor Activity in Melanoma	PLOS ONE			English	Article							RAPANA-THOMASIANA-HEMOCYANIN; CONCHOLEPAS HEMOCYANIN; DENDRITIC CELLS; BLADDER-CANCER; IMMUNE-RESPONSE; SUBUNIT ORGANIZATION; CONJUGATE VACCINES; RECENT PROGRESS; N-GLYCANS; IN-VIVO	Hemocyanins, the huge oxygen-transporting glycoproteins of some mollusks, are used as immunomodulatory proteins with proven anti-cancer properties. The biodiversity of hemocyanins has promoted interest in identifying new anti-cancer candidates with improved immunological properties. Hemocyanins promote Th1 responses without known side effects, which make them ideal for long-term sustained treatment of cancer. In this study, we evaluated a novel hemocyanin from the limpet/gastropod Fissurella latimarginata (FLH). This protein has the typical hollow, cylindrical structure of other known hemocyanins, such as the keyhole limpet hemocyanin (KLH) and the Concholepas hemocyanin (CCH). FLH, like the KLH isoforms, is composed of a single type of polypeptide with exposed N- and O-linked oligosaccharides. However, its immunogenicity was significantly greater than that of KLH and CCH, as FLH induced a stronger humoral immune response and had more potent anti-tumor activity, delaying tumor growth and increasing the survival of mice challenged with B16F10 melanoma cells, in prophylactic and therapeutic settings. Additionally, FLH-treated mice demonstrated increased IFN-gamma production and higher numbers of tumor-infiltrating CD4(+) lymphocytes. Furthermore, in vitro assays demonstrated that FLH, but not CCH or KLH, stimulated the rapid production of pro-inflammatory cytokines (IL-6, IL-12, IL-23 and TNF-alpha) by dendritic cells, triggering a pro-inflammatory milieu that may explain its enhanced immunological activity. Moreover, this effect was abolished when deglycosylated FLH was used, suggesting that carbohydrates play a crucial role in the innate immune recognition of this protein. Altogether, our data demonstrate that FLH possesses increased anti-tumor activity in part because it activates a more potent innate immune response in comparison to other known hemocyanins. In conclusion, FLH is a potential new marine adjuvant for immunization and possible cancer immunotherapy.	[Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ines Becker, Maria] Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile; [Ferreira, Jorge; Ines Becker, Maria] Univ Chile, Inst Ciencias Biomed ICBM, Clin & Mol Pharmacol Program, Santiago, Chile; [Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland; [Manubens, Augusto; De Ioannes, Alfredo E.] Biosonda Corp, Dept Res & Dev, Santiago, Chile	Universidad de Chile; Trinity College Dublin	Becker, MI (corresponding author), Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile.	mariaines.becker@fucited.cl	Becker, María/R-8252-2019; Salazar, Fabian/AAW-2488-2020; Lavelle, Ed/A-1716-2008; Brito de Azevedo, Eduardo/M-4266-2013; Hortal, Joaquin/A-1531-2008; Lobo, Jorge/E-2309-2013; Gabriel, Rosalina/F-1598-2013; Coelho dos Santos, Ana Margarida/E-7598-2010; Patino, Jairo/J-9595-2014; Borges, Paulo/B-2780-2008	Lavelle, Ed/0000-0002-3167-1080; Brito de Azevedo, Eduardo/0000-0001-5172-7742; Hortal, Joaquin/0000-0002-8370-8877; Lobo, Jorge/0000-0002-3152-4769; Gabriel, Rosalina/0000-0002-3550-8010; Manubens, Augusto/0000-0002-7931-4314; Coelho dos Santos, Ana Margarida/0000-0002-9197-792X; Patino, Jairo/0000-0001-5532-166X; Borges, Paulo/0000-0002-8448-7623; Salazar Lizama, Fabian/0000-0001-5139-2292	Fundacion COPEC-Universidad Catolica [CQ057]; FONDECYT [1110651]	Fundacion COPEC-Universidad Catolica; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was partially supported by research grants from Fundacion COPEC-Universidad Catolica No. CQ057 and FONDECYT 1110651 to Maria Ines Becker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancibia S., 2012, HEMOCYANINS IMMUNOTH, VINTECH; Arancibia S, 2012, EUR J IMMUNOL, V42, P688, DOI 10.1002/eji.201142011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; CEROTTINI JC, 1971, J IMMUNOL, V106, P732; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Dolashka-Angelova P, 2008, IMMUNOL INVEST, V37, P822, DOI 10.1080/08820130802403366; Gathuru JK, 2005, VACCINE, V23, P4727, DOI 10.1016/j.vaccine.2005.05.007; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gebauer W, 1999, ARCH BIOCHEM BIOPHYS, V372, P128, DOI 10.1006/abbi.1999.1478; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Harris Jr, 1999, METH MOL B, V117, P13; HERSCOWITZ HB, 1972, IMMUNOLOGY, V22, P51; Idakieva K, 2008, J FLUORESC, V18, P715, DOI 10.1007/s10895-008-0338-x; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Kato K, 1972, BIOCHEM BIOPH RES CO, V371, P698; Kim SK, 2000, VACCINE, V19, P530, DOI 10.1016/S0264-410X(00)00195-X; Kochenderfer JN, 2007, EXP BIOL MED, V232, P1128, DOI 10.3181/0702-MR-42; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; Lamm DL, 2003, J CLIN ONCOL, V21, P4259, DOI 10.1200/JCO.2003.08.099; Lammers RJM, 2012, J CLIN ONCOL, V30, P2273, DOI 10.1200/JCO.2011.39.2936; Leyton P, 2005, J CHIL CHEM SOC, V50, P725, DOI 10.4067/S0717-97072005000400014; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; MOLTO LM, 1991, EUR UROL, V19, P74; MULE JJ, 1986, J IMMUNOL, V136, P3899; Musselli C, 2001, J CANCER RES CLIN, V127, pR20, DOI 10.1007/BF01470995; Oliva H, 2002, HYBRIDOMA HYBRIDOM, V21, P365, DOI 10.1089/153685902761022715; Paccagnella M, 2004, MICRON, V35, P21, DOI 10.1016/j.micron.2003.10.007; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Ponder WF, 2008, PHYLOGENY EVOLUTION; Presicce P, 2008, MOL IMMUNOL, V45, P1136, DOI 10.1016/j.molimm.2007.07.020; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Ragupathi G, 2002, VACCINE, V20, P1030, DOI 10.1016/S0264-410X(01)00451-0; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Rizvi I, 2007, AM J SURG, V194, P628, DOI 10.1016/j.amjsurg.2007.08.005; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Shimizu K, 2001, CANCER RES, V61, P2618; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Strioga M, 2013, INNATE IMMUN-LONDON, V19, P98, DOI 10.1177/1753425912449549; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tchorbanov A, 2008, INT IMMUNOPHARMACOL, V8, P1033, DOI 10.1016/j.intimp.2008.03.008; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Vliet SJ, 2008, J IMMUNOL, V181, P3148, DOI 10.4049/jimmunol.181.5.3148; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; WIRGUIN I, 1995, CANCER IMMUNOL IMMUN, V40, P307, DOI 10.1007/BF01519630; Zhang SL, 1996, CANCER RES, V56, P3315	60	56	59	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87240	10.1371/journal.pone.0087240	http://dx.doi.org/10.1371/journal.pone.0087240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	25003186	Green Published, gold, Green Submitted			2022-12-27	WOS:000330288000202
J	Wang, J; Bian, YJ; Wang, ZR; Li, D; Wang, CM; Li, QZ; Gao, XJ				Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun			MicroRNA-152 Regulates DNA Methyltransferase 1 and Is Involved in the Development and Lactation of Mammary Glands in Dairy Cows	PLOS ONE			English	Article							GENE-EXPRESSION; METHYLATION; MILK; TARGETS; CANCER; CELLS; DNMT1; GROWTH; RNAS; 3B	MicroRNAs (miRNAs) are a class of small non-coding, endogenous regulatory RNAs that function by controlling gene expression at the post-transcriptional level. Using small RNA sequencing and qRT-PCR techniques, we found that the expression of miR-152 was significantly increased during lactation in the mammary glands of dairy cows producing high quality milk compared with that in cows producing low quality milk. Furthermore, DNA methyltransferase 1 (DNMT1), which is a target of miR-152, was inversely correlated with the expression levels of miR-152 in the mammary glands of dairy cows. Dairy cow mammary epithelial cells (DCMECs) were used as in vitro cell models to study the function of miR-152. The forced expression of miR-152 in DCMECs resulted in a marked reduction of DNMT1 at both mRNA and protein levels. This in turn led to a decrease in global DNA methylation and increased the expression of two lactation-related genes, serine/threonine protein kinase Akt (Akt) and peroxisome proliferator-activated receptor gamma (Ppar gamma). In contrast, inhibition of miR-152 showed the opposite results. By using an electronic Coulter counter (CASY-TT) and flow cytometer, we discovered that miR-152 enhanced the viability and multiplication capacity of DCMECs. In conclusion, miR-152 plays an important role in the development and lactation processes in the mammary glands of dairy cows. Our data provide insights into dairy cow mammary gland development and lactation.	[Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, CM (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	wangcm-1@163.com		HONG, SEUNGUG/0000-0002-6228-3312; Bose, Shambunath/0000-0003-0737-5713; Wang, jing-hua/0000-0002-2034-7429	Major State Basic Research Development Program of China (973 Program) [2011CB100804]; Heilongjiang Department of Education Project Program [1154z1004]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Heilongjiang Department of Education Project Program	This study was supported by Major State Basic Research Development Program of China (973 Program, No. 2011CB100804); Heilongjiang Department of Education Project Program, No. 1154z1004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hassler MR, 2012, BIOCHIMIE, V94, P2297, DOI 10.1016/j.biochi.2012.05.029; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061658; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Liu XF, 2012, IN VITRO CELL DEV-AN, V48, P554, DOI 10.1007/s11626-012-9545-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Xiang Y, 2013, ONCOGENE; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	41	90	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101358	10.1371/journal.pone.0101358	http://dx.doi.org/10.1371/journal.pone.0101358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24475077	Green Submitted, Green Published, gold			2022-12-27	WOS:000341354100077
J	Schwendicke, F; Meyer-Lueckel, H; Stolpe, M; Dorfer, CE; Paris, S				Schwendicke, Falk; Meyer-Lueckel, Hendrik; Stolpe, Michael; Doerfer, Christof Edmund; Paris, Sebastian			Costs and Effectiveness of Treatment Alternatives for Proximal Caries Lesions	PLOS ONE			English	Article							RESIN INFILTRATION; CLINICAL-TRIAL; FOLLOW-UP; HEALTH; EFFICACY; SWEDEN; RESTORATIONS; PROGRESSION; UNCERTAINTY; PREVALENCE	Objectives: Invasive therapy of proximal caries lesions initiates a cascade of re-treatment cycles with increasing loss of dental hard tissue. Non-and micro-invasive treatment aim at delaying this cascade and may thus reduce both the health and economic burden of such lesions. This study compared the costs and effectiveness of alternative treatments of proximal caries lesions. Methods: A Markov-process model was used to simulate the events following the treatment of a proximal posterior lesion (E2/D1) in a 20-year-old patient in Germany. We compared three interventions (non-invasive; micro-invasive using resin infiltration; invasive using composite restoration). We calculated the risk of complications of initial and possible follow-up treatments and modelled time-dependent non-linear transition probabilities. Costs were calculated based on item-fee catalogues in Germany. Monte-Carlo-microsimulations were performed to compare cost-effectiveness of non-versus micro-invasive treatment and to analyse lifetime costs of all three treatments. Results: Micro-invasive treatment was both more costly and more effective than non-invasive therapy, with ceiling-value-thresholds for willingness-to-pay between 16.73 (sic) for E2 and 1.57 (sic) for D1 lesions. Invasive treatment was the most costly strategy. Calculated costs and effectiveness were sensitive to lesion stage, patient's age, discounting rate and assumed initial treatment costs. Conclusions: Non-and micro-invasive treatments have lower long-term costs than invasive therapy of proximal lesions. Micro-invasive therapy had the highest cost-effectiveness for treating D1 lesions in young patients. Decision makers with a willingness-to-pay over 16.73 (sic) and 1.57 (sic) for E2 and D1 lesions, respectively, will find micro-invasive treatment more cost-effective than non-invasive therapy.	[Schwendicke, Falk; Paris, Sebastian] Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany; [Meyer-Lueckel, Hendrik] Rhein Westfal TH Aachen, Dept Operat Dent Periodontol & Prevent Dent, Aachen, Germany; [Stolpe, Michael] Kiel Inst World Econ, Kiel, Germany; [Doerfer, Christof Edmund] Univ Kiel, Clin Conservat Dent & Periodontol, Kiel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel	Schwendicke, F (corresponding author), Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.	falk.schwendicke@charite.de	Doerfer, Christof/E-4041-2010	Doerfer, Christof/0000-0002-2508-8075; Stolpe, Michael/0000-0003-4623-0066; Paris, Sebastian/0000-0002-1302-8761; Schwendicke, Falk/0000-0003-1223-1669	DMG (Hamburg)	DMG (Hamburg)	The study was funded by the authors and their institutions. Publication costs were covered by DMG (Hamburg), who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DMG was informed of this study after its finalization and decided to support its publication.	Antoft P, 1999, COMMUNITY DENT HLTH, V16, P80; Barmer-GEK, 2013, DENT REP; BRANTLEY CF, 1995, J AM DENT ASSOC, V126, P1407, DOI 10.14219/jada.archive.1995.0052; Briggs AH, 2002, ANNU REV PUBL HEALTH, V23, P377, DOI 10.1146/annurev.publhealth.23.100901.140534; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ekstrand KR, 2010, CARIES RES, V44, P41, DOI 10.1159/000275573; Forsling JO, 1999, SWED DENT J, V23, P59; GKV-Spitzenverband, 2013, OFF STAT JAN; Haak R, 2012, CARIES MANAGEMENT SC, P87; IQWIG, 2009, APPR REC SCI BOARD I; KZBV, 2013, CAT FEES; Martignon S, 2006, CARIES RES, V40, P382, DOI 10.1159/000094282; Martignon S, 2012, J DENT RES, V91, P288, DOI 10.1177/0022034511435328; Martignon S, 2010, CLIN ORAL INVEST, V14, P383, DOI 10.1007/s00784-009-0306-0; Mejare I, 1999, CARIES RES, V33, P93, DOI 10.1159/000016502; Mejare I, 1998, CARIES RES, V32, P10, DOI 10.1159/000016424; Mejare I, 2004, CARIES RES, V38, P130, DOI 10.1159/000075937; Meyer-Lueckel H, 2012, CARIES RES, V46, P544, DOI 10.1159/000341807; Pallesen U, 2013, J DENT, V41, P297, DOI 10.1016/j.jdent.2012.11.021; Paris S, 2010, J DENT RES, V89, P823, DOI 10.1177/0022034510369289; Paris S, 2007, DENT MATER J, V26, P582, DOI 10.4012/dmj.26.582; Pitts N, 2011, Adv Dent Res, V23, P211, DOI 10.1177/0022034511402016; Qvist V, 2008, DENT CARIES DIS ITS, V2; Schiffner U, 2009, COMMUNITY DENT HLTH, V26, P18, DOI 10.1922/CDH_2392Schiffner05; Statistisches Bundesamt, 2013, MORT TABL 2009 2011; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09	26	41	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86992	10.1371/journal.pone.0086992	http://dx.doi.org/10.1371/journal.pone.0086992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	25229410	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300124
J	Wang, YP; Nie, JX; Yap, PT; Li, G; Shi, F; Geng, XJ; Guo, L; Shen, DG				Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Geng, Xiujuan; Guo, Lei; Shen, Dinggang		Alzheimers Dis Neuroimaging Initia	Knowledge-Guided Robust MRI Brain Extraction for Diverse Large-Scale Neuroimaging Studies on Humans and Non-Human Primates	PLOS ONE			English	Article							SKULL STRIPPING PROBLEM; ALZHEIMERS-DISEASE; AUTOMATIC SEGMENTATION; GRAY-MATTER; IMAGES; CLASSIFICATION; REGISTRATION; ALGORITHM; VOLUMES; CORTEX	Accurate and robust brain extraction is a critical step in most neuroimaging analysis pipelines. In particular, for the large-scale multi-site neuroimaging studies involving a significant number of subjects with diverse age and diagnostic groups, accurate and robust extraction of the brain automatically and consistently is highly desirable. In this paper, we introduce population-specific probability maps to guide the brain extraction of diverse subject groups, including both healthy and diseased adult human populations, both developing and aging human populations, as well as non-human primates. Specifically, the proposed method combines an atlas-based approach, for coarse skull-stripping, with a deformable-surface-based approach that is guided by local intensity information and population-specific prior information learned from a set of real brain images for more localized refinement. Comprehensive quantitative evaluations were performed on the diverse large-scale populations of ADNI dataset with over 800 subjects (55 similar to 90 years of age, multi-site, various diagnosis groups), OASIS dataset with over 400 subjects (18 similar to 96 years of age, wide age range, various diagnosis groups), and NIH pediatrics dataset with 150 subjects (5 similar to 18 years of age, multi-site, wide age range as a complementary age group to the adult dataset). The results demonstrate that our method consistently yields the best overall results across almost the entire human life span, with only a single set of parameters. To demonstrate its capability to work on non-human primates, the proposed method is further evaluated using a rhesus macaque dataset with 20 subjects. Quantitative comparisons with popularly used state-of-the-art methods, including BET, Two-pass BET, BET-B, BSE, HWA, ROBEX and AFNI, demonstrate that the proposed method performs favorably with superior performance on all testing datasets, indicating its robustness and effectiveness.	[Wang, Yaping; Guo, Lei] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi Provinc, Peoples R China; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Geng, Xiujuan] NIDA, Neuroimaging Res Branch, Baltimore, MD USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Northwestern Polytechnical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Li, Gang/D-3324-2013; Geng, Xiujuan/AAR-4306-2020	Shen, Dinggang/0000-0002-7934-5698; Li, Gang/0000-0001-9585-1382; Geng, Xiujuan/0000-0003-4953-0208	NIH [EB008374, EB006733, EB009634, AG041721, MH100217, AG042599]; National Natural Science Foundation of China [61273362, 61333017]; National Research Foundation grant of Korea [2012-005741]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB006733, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217, P50MH071616, R01MH056584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021910, K01AG030514, P50AG005681, R01AG041721, P01AG003991, P30AG010129, R01AG042599, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation grant of Korea(National Research Foundation of Korea); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB008374, EB006733, EB009634, AG041721, MH100217, AG042599, National Natural Science Foundation of China (No. 61273362, No. 61333017), and National Research Foundation grant of Korea (No. 2012-005741). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. ADNI data collection and sharing for this project was supported by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904), P30 AG010129, K01 AG030514, the Dana Foundation. OASIS data collection and sharing for this project was supported by P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MS, 1998, IEEE T MED IMAGING, V17, P98, DOI 10.1109/42.668699; BOMANS M, 1990, IEEE T MED IMAGING, V9, P177, DOI 10.1109/42.56342; BRUMMER ME, 1993, IEEE T MED IMAGING, V12, P153, DOI 10.1109/42.232244; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Chiverton J, 2007, COMPUT BIOL MED, V37, P342, DOI 10.1016/j.compbiomed.2006.04.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fennema-Notestine C, 2006, HUM BRAIN MAPP, V27, P99, DOI 10.1002/hbm.20161; Germond L, 2000, ARTIF INTELL MED, V20, P77, DOI 10.1016/S0933-3657(00)00054-3; Hahn HK, 2000, LECT NOTES COMPUT SC, V1935, P134; HOHNE KH, 1992, J COMPUT ASSIST TOMO, V16, P285, DOI 10.1097/00004728-199203000-00019; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huh S, 2002, COMPUT BIOL MED, V32, P311, DOI 10.1016/S0010-4825(02)00023-9; Iglesias JE, 2011, IEEE T MED IMAGING; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee C, 1998, COMPUT BIOL MED, V28, P309, DOI 10.1016/S0010-4825(98)00013-4; Lemieux L, 1999, MAGN RESON MED, V42, P127, DOI 10.1002/(SICI)1522-2594(199907)42:1<127::AID-MRM17>3.0.CO;2-O; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Miura N, 2002, J COMPUT ASSIST TOMO, V26, P927, DOI 10.1097/00004728-200211000-00012; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rehm K, 2004, NEUROIMAGE, V22, P1262, DOI 10.1016/j.neuroimage.2004.03.011; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Sadananthan SA, 2010, NEUROIMAGE, V49, P225, DOI 10.1016/j.neuroimage.2009.08.050; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shan ZY, 2002, NEUROIMAGE, V17, P1587, DOI 10.1006/nimg.2002.1287; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Vercauteren T., 2007, LNCS, V10, P319, DOI DOI 10.1016/J.NEUR0IMAGE.2008.10.040; Wang Y, 2012, GROUPWISE SEGMENTATI, P185; Wang YP, 2013, I S BIOMED IMAGING, P1364; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuang AH, 2006, NEUROIMAGE, V32, P79, DOI 10.1016/j.neuroimage.2006.03.019	49	298	308	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e77810	10.1371/journal.pone.0077810	http://dx.doi.org/10.1371/journal.pone.0077810			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489639	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000002
J	Ritze, Y; Bardos, G; D'Haese, JG; Ernst, B; Thurnheer, M; Schultes, B; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; D'Haese, Jan G.; Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd; Bischoff, Stephan C.			Effect of High Sugar Intake on Glucose Transporter and Weight Regulating Hormones in Mice and Humans	PLOS ONE			English	Article							FOOD-INTAKE; SWEETENED BEVERAGES; ENERGY-EXPENDITURE; FRUCTOSE; APPETITE; HEALTH; GLUT2; CHOLECYSTOKININ; ABSORPTION; SATIETY	Objective: Sugar consumption has increased dramatically over the last decades in Western societies. Especially the intake of sugar-sweetened beverages seems to be a major risk for the development of obesity. Thus, we compared liquid versus solid high-sugar diets with regard to dietary intake, intestinal uptake and metabolic parameters in mice and partly in humans. Methods: Five iso-caloric diets, enriched with liquid (in water 30% vol/vol) or solid (in diet 65% g/g) fructose or sucrose or a control diet were fed for eight weeks to C57bl/6 mice. Sugar, liquid and caloric intake, small intestinal sugar transporters (GLUT2/5) and weight regulating hormone mRNA expression, as well as hepatic fat accumulation were measured. In obese versus lean humans that underwent either bariatric surgery or small bowel resection, we analyzed small intestinal GLUT2, GLUT5, and cholecystokinin expression. Results: In mice, the liquid high-sucrose diet caused an enhancement of total caloric intake compared to the solid high-sucrose diet and the control diet. In addition, the liquid high-sucrose diet increased expression of GLUT2, GLUT5, and cholecystokinin expression in the ileum (P<0.001). Enhanced liver triglyceride accumulation was observed in mice being fed the liquid high-sucrose or -fructose, and the solid high-sucrose diet compared to controls. In obese, GLUT2 and GLUT5 mRNA expression was enhanced in comparison to lean individuals. Conclusions: We show that the form of sugar intake (liquid versus solid) is presumably more important than the type of sugar, with regard to feeding behavior, intestinal sugar uptake and liver fat accumulation in mice. Interestingly, in obese individuals, an intestinal sugar transporter modulation also occurred when compared to lean individuals.	[Ritze, Yvonne; Bardos, Gyoengyi; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany; [D'Haese, Jan G.] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany; [Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd] Interdisciplinary Obes Ctr, Rorschach, Switzerland	University Hohenheim; Technical University of Munich	Ritze, Y (corresponding author), Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany.	yvonne.ritze@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research [FKZ: 01GI0843]	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research	This work was supported with grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Atwater WO, 1900, STATE CONNECTICUT 12, V1899, P73; Atwater WO, 1903, CONN STORRS AGR EXPT, P123; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Bellissimo N, 2003, J NUTR, V133, P2319, DOI 10.1093/jn/133.7.2319; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bielohuby M, 2010, BRIT J NUTR, V103, P1525, DOI 10.1017/S000711450999345X; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Chaput JP, 2014, CURR OBES REP, V3, P54, DOI 10.1007/s13679-013-0086-3; Coelho SB, 2006, NUTRITION, V22, P585, DOI 10.1016/j.nut.2006.03.012; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Daousi C, 2009, CLIN ENDOCRINOL, V71, P195, DOI 10.1111/j.1365-2265.2008.03451.x; Date Y, 2012, METHOD ENZYMOL, V514, P261, DOI 10.1016/B978-0-12-381272-8.00016-7; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Dumoulin V, 1998, ENDOCRINOLOGY, V139, P3780, DOI 10.1210/en.139.9.3780; Dyer J, 2007, BIOCHEM SOC T, V35, P1191, DOI 10.1042/BST0351191; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; FLIPOT P, 1971, CAN J ANIM SCI, V51, P801, DOI 10.4141/cjas71-108; Ford CN, 2013, J ACAD NUTR DIET, V113, P35, DOI 10.1016/j.jand.2012.08.022; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Holmes AD, 1918, US DEP AGR B, V687, P1; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Melanson KJ, 2008, AM J CLIN NUTR, V88, p1738S, DOI 10.3945/ajcn.2008.25825E; Must A, 2009, INT J OBESITY, V33, P705, DOI 10.1038/ijo.2009.60; Pereira MA, 2006, INT J OBESITY, V30, pS28, DOI 10.1038/sj.ijo.0803489; Rizkalla SW, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-82; Rubner M, 1885, I Z BIOL, V21, P250; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Siervo M, 2013, PUBLIC HEALTH NUTR, P1; SOUTHGATE DA, 1970, BRIT J NUTR, V24, P517, DOI 10.1079/BJN19700050; Stolarczyk E, 2010, AM J PHYSIOL-ENDOC M, V298, pE1078, DOI 10.1152/ajpendo.00737.2009; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tobin V, 2008, DIABETES, V57, P555, DOI 10.2337/db07-0928; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weed DL, 2011, AM J CLIN NUTR, V94, P1340, DOI 10.3945/ajcn.111.015875; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003	51	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101702	10.1371/journal.pone.0101702	http://dx.doi.org/10.1371/journal.pone.0101702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	24475018	Green Submitted, gold, Green Published			2022-12-27	WOS:000338763800034
J	Mishra, AK; Muthamilarasan, M; Khan, Y; Parida, SK; Prasad, M				Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Khan, Yusuf; Parida, Swarup Kumar; Prasad, Manoj			Genome-Wide Investigation and Expression Analyses of WD40 Protein Family in the Model Plant Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENE-EXPRESSION; SEQUENCE; ARABIDOPSIS; STRESS; EVOLUTION; REPEAT; RICE; ARCHITECTURE; RECOGNITION	WD40 proteins play a crucial role in diverse protein-protein interactions by acting as scaffolding molecules and thus assisting in the proper activity of proteins. Hence, systematic characterization and expression profiling of these WD40 genes in foxtail millet would enable us to understand the networks of WD40 proteins and their biological processes and gene functions. In the present study, a genome-wide survey was conducted and 225 potential WD40 genes were identified. Phylogenetic analysis categorized the WD40 proteins into 5 distinct sub-families (I-V). Gene Ontology annotation revealed the biological roles of the WD40 proteins along with its cellular components and molecular functions. In silico comparative mapping with sorghum, maize and rice demonstrated the orthologous relationships and chromosomal rearrangements including duplication, inversion and deletion of WD40 genes. Estimation of synonymous and non-synonymous substitution rates revealed its evolutionary significance in terms of gene-duplication and divergence. Expression profiling against abiotic stresses provided novel insights into specific and/or overlapping expression patterns of SiWD40 genes. Homology modeling enabled three-dimensional structure prediction was performed to understand the molecular functions of WD40 proteins. Although, recent findings had shown the importance of WD40 domains in acting as hubs for cellular networks during many biological processes, it has invited a lesser research attention unlike other common domains. Being a most promiscuous interactors, WD40 domains are versatile in mediating critical cellular functions and hence this genome-wide study especially in the model crop foxtail millet would serve as a blue-print for functional characterization of WD40s in millets and bioenergy grass species. In addition, the present analyses would also assist the research community in choosing the candidate WD40s for comprehensive studies towards crop improvement of millets and biofuel grasses.	[Mishra, Awdhesh Kumar; Muthamilarasan, Mehanathan; Khan, Yusuf; Parida, Swarup Kumar; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/AAQ-9470-2021; Sanganahalli, Basavaraju G/C-3296-2008; khan, yusuf/E-6726-2015; MISHRA, AWDHESH/U-1920-2019; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; Waxman, Stephen/Z-2507-2019; Hyder, Fahmeed/A-2644-2015	Sanganahalli, Basavaraju G/0000-0002-0851-6621; khan, yusuf/0000-0001-6986-4657; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Waxman, Stephen/0000-0001-5718-7177; Hyder, Fahmeed/0000-0001-7822-4002; /0000-0002-3312-3264	NIPGR; Council of Scientific and Industrial Research; University Grants Commission, New Delhi, India	NIPGR; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India)	The authors work in this area was supported by the core grant of NIPGR. AKM and MM acknowledge the award of Senior Research Fellowship and Junior Research Fellowship from Council of Scientific and Industrial Research and University Grants Commission, New Delhi, India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Cochrane G, 2013, NUCLEIC ACIDS RES, V41, pD30, DOI 10.1093/nar/gks1175; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gupta S, 2013, PLANT BREEDING, V132, P367, DOI 10.1111/pbr.12070; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jayaraman A, 2008, MOL BIOTECHNOL, V40, P241, DOI 10.1007/s12033-008-9081-4; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2011, PROTOPLASMA, V248, P817, DOI 10.1007/s00709-010-0257-y; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mishra AK, 2012, J PLANT BIOCHEM BIOT, V21, pS32, DOI 10.1007/s13562-012-0134-1; Mishra AK, 2012, GENOMICS, V100, P252, DOI 10.1016/j.ygeno.2012.06.012; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, PLANT SIGNAL BEHAV, V6, P1588, DOI 10.4161/psb.6.10.17130; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	64	114	121	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86852	10.1371/journal.pone.0086852	http://dx.doi.org/10.1371/journal.pone.0086852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24748279	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000158
J	Liang, XH; Chen, J; Liu, YX; He, CL; Li, TY				Liang, Xiaohua; Chen, Jie; Liu, Youxue; He, Chunling; Li, Tingyu			The Effect of Hypertension and Diabetes Management in Southwest China: A Before- and After-Intervention Study	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; SYSTEMATIC ANALYSIS; HUMAN-RESOURCES; HEALTH; CARE; CHOLESTEROL; PREVALENCE; BURDEN; TRENDS	Background: Non-communicable diseases are leading causes of disease burden in middle income countries. Little evidence exists to determine if the primary healthcare system can effectively manage non-communicable diseases. The purpose of this study was to examine the effectiveness of hypertension and diabetes management by the primary healthcare system. Methods: We used individual level data from the 2009 National Basic Public Health Services System to assess the effectiveness of hypertension and diabetes interventions on fasting plasma glucose, and blood pressure. We analyzed the associations between fasting plasma glucose, systolic or diastolic blood pressure and risk factors. The estimated average intervention effect on data balanced with confounding variables was assessed. Results: 9543 individuals who had data for fasting plasma glucose, systolic blood pressure and diastolic blood pressure were included in this analysis. This study included 6681 patients with hypertension and 2222 with diabetes. The intervention lowered mean fasting plasma glucose by 0.5 mmol/L (0.4-0.6), lowered mean systolic blood pressure by 3.5 mm Hg (3.2-3.7), and lowered diastolic blood pressure by 2.9 mm Hg (2.7-3.2). Individuals who received medicinal treatment had 1.3 mmHg (0.8 to 1.8, P<0.01) lower diastolic blood pressure and 0.6 mmol/L (0.5-0.8, P<0.01) lower fasting plasma glucose than those who did not receive medicine. Generalized linear model indicated that medicinal treatment and baseline systolic blood pressure were significant positive predictors of change in systolic blood pressure. Age, living in urban areas and diabetic complications were significant negative predictors of change for systolic blood pressure. Conclusion: The National Basic Public Health Services System in China using trained community healthcare workers and well-established guidelines can be effectively implement non-communicable disease prevention and management care paradigms.	[Liang, Xiaohua; Chen, Jie; Liu, Youxue; Li, Tingyu] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China; [Liang, Xiaohua; He, Chunling] Ctr Dis Control & Prevent Jiulongpo Dist, Chongqing, Peoples R China	Chongqing Medical University	Li, TY (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing,Minist Educ Key Lab Chil, Chongqing, Peoples R China.	tyli@vip.sina.com		Liu, Youxue/0000-0003-4493-4350	Chongqing Municipal Health Bureau [2012-2-453, 2012-2-518, 2009-1-39]; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission [2012-1, 2013-1]	Chongqing Municipal Health Bureau; Biomedical Project from Chongqing Jiulongpo Science and Technology Commission	This work was supported by three grants [2012-2-453/2012-2-518/2009-1-39, http://www.cqwsj.gov.cn/] from Chongqing Municipal Health Bureau, and by two grants [2012-1/2013-1] of Biomedical Project from Chongqing Jiulongpo Science and Technology Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JK, 2013, J CARDIOVASC NURS; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Cuddy Mary Linda Stotter, 2005, J Pract Nurs, V55, P17; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Frankenberg E, 1995, Health Transit Rev, V5, P143; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Huizinga MM, 2006, INDIAN J MED RES, V124, P481; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Linnet K, 1999, CLIN CHEM, V45, P314; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Low W H H, 2013, Med J Malaysia, V68, P129; Mitchell AD, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-29; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Omboni S, 2013, J HYPERTENS, V31, P455, DOI 10.1097/HJH.0b013e32835ca8dd; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Schmidt B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1017; Stewart S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7156; Thyregod HMaP, 2011, INTR GEN GEN LIN MOD; Tussing-Humphreys L, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120286; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	33	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2014	9	3							e91801	10.1371/journal.pone.0091801	http://dx.doi.org/10.1371/journal.pone.0091801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9MJ	24632720	Green Submitted, Green Published, gold			2022-12-27	WOS:000332858400090
J	Liang, XS; Gao, YA; Zhang, XY; Tian, YQ; Zhang, ZX; Gao, LH				Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong			Effect of Optimal Daily Fertigation on Migration of Water and Salt in Soil, Root Growth and Fruit Yield of Cucumber (Cucumis sativus L.) in Solar-Greenhouse	PLOS ONE			English	Article							USE EFFICIENCY; PHOSPHORUS LEVEL; NITROGEN; IRRIGATION; NITRATE; FREQUENCY; TOMATO; ARCHITECTURE; MANAGEMENT; CHLORIDE	Inappropriate and excessive irrigation and fertilization have led to the predominant decline of crop yields, and water and fertilizer use efficiency in intensive vegetable production systems in China. For many vegetables, fertigation can be applied daily according to the actual water and nutrient requirement of crops. A greenhouse study was therefore conducted to investigate the effect of daily fertigation on migration of water and salt in soil, and root growth and fruit yield of cucumber. The treatments included conventional interval fertigation, optimal interval fertigation and optimal daily fertigation. Generally, although soil under the treatment optimal interval fertigation received much lower fertilizers than soil under conventional interval fertigation, the treatment optimal interval fertigation did not statistically decrease the economic yield and fruit nutrition quality of cucumber when compare to conventional interval fertigation. In addition, the treatment optimal interval fertigation effectively avoided inorganic nitrogen accumulation in soil and significantly (P < 0.05) increased the partial factor productivity of applied nitrogen by 88% and 209% in the early-spring and autumn-winter seasons, respectively, when compared to conventional interval fertigation. Although soils under the treatments optimal interval fertigation and optimal daily fertigation received the same amount of fertilizers, the treatment optimal daily fertigation maintained the relatively stable water, electrical conductivity and mineral nitrogen levels in surface soils, promoted fine root (< 1.5 mm diameter) growth of cucumber, and eventually increased cucumber economic yield by 6.2% and 8.3% and partial factor productivity of applied nitrogen by 55% and 75% in the early-spring and autumn-winter seasons, respectively, when compared to the treatment optimal interval fertigation. These results suggested that optimal daily fertigation is a beneficial practice for improving crop yield and the water and fertilizers use efficiency in solar greenhouse.	[Liang, Xinshu; Gao, Yinan; Zhang, Xiaoying; Tian, Yongqiang; Zhang, Zhenxian; Gao, Lihong] China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China	China Agricultural University	Gao, LH (corresponding author), China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing 100094, Peoples R China.	gaolh@cau.edu.cn		Liu, Youxue/0000-0003-4493-4350	earmarked fund for Modern Agro-industry Technology Research System in China [CARS-25]; Chinese Ministry of Water Resources [201001061]	earmarked fund for Modern Agro-industry Technology Research System in China; Chinese Ministry of Water Resources	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System in China (CARS-25) and the Special Fund for Research in the Public Interest provided by the Chinese Ministry of Water Resources (201001061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2010, ACTA AGR BOREALI OCC, P188; Belder P, 2005, FIELD CROP RES, V93, P169, DOI 10.1016/j.fcr.2004.09.022; Boomsma CR, 2009, AGRON J, V101, P1426, DOI 10.2134/agronj2009.0082; Cabello MJ, 2009, AGR WATER MANAGE, V96, P866, DOI 10.1016/j.agwat.2008.11.006; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chen Qing, 2005, China Vegetables, P57; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; Gao LH, 2010, HORTTECHNOLOGY, V20, P626, DOI 10.21273/HORTTECH.20.3.626; [高艳明 Gao Yanming], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P121; Garnett T, 2009, PLANT CELL ENVIRON, V32, P1272, DOI 10.1111/j.1365-3040.2009.02011.x; Guo RY, 2008, ENVIRON POLLUT, V151, P443, DOI 10.1016/j.envpol.2007.04.008; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; JACKSON TL, 1966, SOIL SCI SOC AM PRO, V30, P70, DOI 10.2136/sssaj1966.03615995003000010026x; Jokinen K, 2011, SCI HORTIC-AMSTERDAM, V130, P808, DOI 10.1016/j.scienta.2011.09.008; KOCH GW, 1988, PLANT CELL ENVIRON, V11, P755, DOI 10.1111/j.1365-3040.1988.tb01160.x; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2012, PHILOS T R SOC B, V367, P1598, DOI 10.1098/rstb.2011.0243; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Matsuo N, 2009, PLANT PROD SCI, V12, P514, DOI 10.1626/pps.12.514; Mi GH, 2010, SCI CHINA LIFE SCI, V53, P1369, DOI 10.1007/s11427-010-4097-y; Pei XB, 2002, ZHONGGUO NONG YE KE, V35, P1510; Rajput TBS, 2006, AGR WATER MANAGE, V79, P293, DOI 10.1016/j.agwat.2005.03.009; Shen J, 2012, J EXP BOT; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Silber A, 2005, PLANT SOIL, V270, P135, DOI 10.1007/s11104-004-1311-3; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; [孙丽萍 SUN Liping], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P173; Thompson RB, 2007, AGR WATER MANAGE, V89, P261, DOI 10.1016/j.agwat.2007.01.013; Tian YQ, 2010, NUTR CYCL AGROECOSYS, V88, P429, DOI 10.1007/s10705-010-9367-3; Wang H, 2006, CRIT REV PLANT SCI, V25, P279, DOI 10.1080/07352680600709917; [汪建飞 Wang Jianfei], 2005, [土壤通报, Journal of Soil Science], V36, P708; WANG XZ, 1991, CHINESE B BOT, V8, P34; Wang YS, 2010, FUNCT PLANT BIOL, V37, P175, DOI 10.1071/FP09181; Wei Yan, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P67; Xu G, 2004, PLANT SOIL, V263, P297, DOI 10.1023/B:PLSO.0000047743.19391.42; Yoshida Chie, 2011, Horticultural Research (Japan), V10, P325, DOI 10.2503/hrj.10.325; Yu ShuFang, 2000, China Vegetables, P10; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang LD, 2012, SCI HORTIC-AMSTERDAM, V138, P43, DOI 10.1016/j.scienta.2012.02.003; Zhao ShuMei, 2001, Transactions of the Chinese Society of Agricultural Engineering, V17, P171; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	46	50	58	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86975	10.1371/journal.pone.0086975	http://dx.doi.org/10.1371/journal.pone.0086975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24632720	Green Submitted, Green Published, gold			2022-12-27	WOS:000330507300122
J	Peng, Z; Wang, CX; Fang, EH; Lu, XM; Wang, GB; Tong, Q				Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang			Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy	PLOS ONE			English	Article							OVERCOME DRUG-RESISTANCE; IN-VITRO; TEMPERATURE; GENE; RNA; ADENOCARCINOMA; NANOPARTICLES; EXPRESSION; RELEASE; CELLS	In previous a study, we had developed a novel thermosensitive magnetic delivery system based on liposomes. This study aimed to evaluate the efficiency of this system for the co-delivery of both drugs and genes to the same cell and its antitumor effects on gastric cancer. Doxorubicin (DOX) and SATB1 shRNA vector were loaded into the co-delivery system, and in vitro DOX thermosensitive release activity, targeted gene silencing efficiency, targeted cellular uptake, in vitro cytotoxicity, as well as in vivo anti-tumor activity were determined. The results showed that this co-delivery system had desirable targeted delivery efficacy, DOX thermosensitive release and SATB1 gene silencing. Moreover, the co-delivery of DOX and SATB1 shRNA exhibited enhanced activity to inhibit gastric cancer cell growth in vitro and in vivo, compared to single delivery. In conclusion, the novel thermosensitive magnetic drug and gene co-delivery system has promising application in combined chemotherapy and gene therapy for gastric cancer.	[Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wang, GB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	guobinwang1954@gmail.com; qiangtong@hust.edu.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Alexiou C, 2000, CANCER RES, V60, P6641; Chen J, 2013, DRUG DEV IND PHARM, V39, P197, DOI 10.3109/03639045.2012.668912; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GABER MH, 1995, PHARMACEUT RES, V12, P1407, DOI 10.1023/A:1016206631006; Heger Z, 2013, INT J MOL SCI, V14, P21629, DOI 10.3390/ijms141121629; Huang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Juergen S, 2012, FUNDAMENTALS APPL CO, P291; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kono K, 2004, METHODS ENZYMOL, V387, P73; Li Wei, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P432; Liu CX, 2013, BIOMATERIALS, V34, P2547, DOI 10.1016/j.biomaterials.2012.12.038; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mir R, 2012, CURR DRUG TARGETS, V13, P1603, DOI 10.2174/138945012803530008; Mykhaylyk O, 2010, METHODS MOL BIOL, V605, P487, DOI 10.1007/978-1-60327-360-2_34; Park SC, 2013, GUT LIVER, V7, P385, DOI 10.5009/gnl.2013.7.4.385; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002; Pradhan P, 2010, METHODS MOL BIOL, V605, P279, DOI 10.1007/978-1-60327-360-2_19; Shen JA, 2012, BIOMATERIALS, V33, P8613, DOI 10.1016/j.biomaterials.2012.08.007; Shim G, 2011, J CONTROL RELEASE, V155, P60, DOI 10.1016/j.jconrel.2010.10.017; Skeel R, 2011, HDB CANC CHEMOTHERAP; Stebbing J, 2002, CANCER TREAT REV, V28, P121, DOI 10.1053/ctrv.2002.0262; Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Wang CM, 2011, BIOCHEM BIOPH RES CO, V410, P537, DOI 10.1016/j.bbrc.2011.06.019; Xiao YL, 2012, NANOSCALE, V4, P7185, DOI 10.1039/c2nr31853a; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhao F, 2014, BIOMATERIALS, V35, P1050, DOI 10.1016/j.biomaterials.2013.10.044; Zheng XL, 2009, INT J PHARMACEUT, V366, P211, DOI 10.1016/j.ijpharm.2008.09.019; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534; Zhu XD, 2010, ONCOL LETT, V1, P407, DOI 10.3892/ol_00000071	39	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92924	10.1371/journal.pone.0092924	http://dx.doi.org/10.1371/journal.pone.0092924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24416238	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500056
J	Peng, Z; Zhu, Y; Wang, QQ; Gao, J; Li, YL; Li, YY; Ge, S; Shen, L				Peng, Zhi; Zhu, Yan; Wang, Qianqian; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin			Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							HEPATOCYTE GROWTH-FACTOR; C-MET; FACTOR-RECEPTOR; POOR-PROGNOSIS; E-CADHERIN; GENE; OVEREXPRESSION; MARKER; CARCINOMA; P53	Background and Aims: MET, the hepatocyte growth factor receptor, is a receptor tyrosine kinase overexpressed and activated in a subset of gastric cancer. Several studies investigated the relationship between MET amplification and expression with the clinical outcome in patients with gastric cancer, but yielded conflicting results. We performed a systematic review and meta-analysis to determine the influence of MET amplification and expression on prognosis in gastric cancer. Methods: MEDLINE and EMBASE were searched for studies that explored the association between MET amplification and expression with survival in patients with gastric cancer up to 1 April, 2013. Data of individual hazard ratios (HRs) and 95% confidence intervals (CIs) for meta-analyses were extracted from the publications and combined in pooled HRs. Results: Fourteen studies involving 2,258 patients with gastric cancer were included. It was suggested that MET overexpression had an unfavorable impact on survival of patients with gastric cancer, with HRs (95% CIs) of 2.57 (95% CI: 1.97-3.35) overall, 2.82 (95% CI: 1.86-4.27) among studies using amplification for measure scale of MET and 2.42 (95% CI: 1.66-3.54) for expression. The magnitude of association was reduced whereas remained statistically significant in high quality studies or in larger sample size studies and corresponding HRs were 2.18(1.76, 2.70) and 2.35(1.93, 2.87), respectively, without significant heterogeneity. Conclusion: The findings from present study indicated that higher MET gene amplification and expression in gastric cancer was an indicator of poor prognosis.	[Peng, Zhi; Zhu, Yan; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin] Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China; [Wang, Qianqian] Peking Univ, Clin Med Coll 4, Beijing Jishuitan Hosp, Dept Epidemiol, Beijing 100871, Peoples R China	Peking University; Peking University	Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China.	lin100@medmail.com.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172110]; National High Technology Research and Development Program [2006AA 02A 402-B02, 2012AA 02A 504]; China Postdoctoral Scientific Fund [2013M530494]; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); China Postdoctoral Scientific Fund; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	This work was supported by National Natural Science Foundation of China (No. 81172110), National High Technology Research and Development Program (No. 2006AA 02A 402-B02, 2012AA 02A 504), China Postdoctoral Scientific Fund (2013M530494) and Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya H, 2010, INVEST CLIN, V51, P369; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Bamias A, 2010, CANCER CHEMOTH PHARM, V65, P1009, DOI 10.1007/s00280-010-1256-6; Bang YJ, 2010, LANCET, V376, P1302; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drebber U, 2008, ONCOL REP, V19, P1477; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ge SH, 2011, CHINESE J CANCER RES, V23, P153, DOI 10.1007/s11670-011-0153-9; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang TJ, 2001, ACTA ONCOL, V40, P638; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jatoi Ismail, 2010, Curr Probl Surg, V47, P750, DOI 10.1067/j.cpsurg.2010.06.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li Y, 2012, J SURG ONCOL, V106, P304, DOI 10.1002/jso.23008; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakajima M, 1999, CANCER, V85, P1894; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wu H, 2009, CONSERV GENET RESOUR, V1, P1, DOI 10.1007/s12686-009-9000-4; Yonemura Y, 1996, INT J ONCOL, V8, P555; Yonemura Y, 1997, ONCOL REP, V4, P743; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111; Zhuang X, 2000, Zhonghua Bing Li Xue Za Zhi, V29, P409	44	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84502	10.1371/journal.pone.0084502	http://dx.doi.org/10.1371/journal.pone.0084502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416238	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500132
J	Fan, YT; Cheng, YW				Fan, Yang-Teng; Cheng, Yawei			Atypical Mismatch Negativity in Response to Emotional Voices in People with Autism Spectrum Conditions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ASPERGER-SYNDROME; CHILDREN; SPEECH; BRAIN; PERCEPTION; ATTENTION; DISCRIMINATION; LANGUAGE; DISORDER	Autism Spectrum Conditions (ASC) are characterized by heterogeneous impairments of social reciprocity and sensory processing. Voices, similar to faces, convey socially relevant information. Whether voice processing is selectively impaired remains undetermined. This study involved recording mismatch negativity (MMN) while presenting emotionally spoken syllables dada and acoustically matched nonvocal sounds to 20 subjects with ASC and 20 healthy matched controls. The people with ASC exhibited no MMN response to emotional syllables and reduced MMN to nonvocal sounds, indicating general impairments of affective voice and acoustic discrimination. Weaker angry MMN amplitudes were associated with more autistic traits. Receiver operator characteristic analysis revealed that angry MMN amplitudes yielded a value of 0.88 (p<.001). The results suggest that people with ASC may process emotional voices in an atypical fashion already at the automatic stage. This processing abnormality can facilitate diagnosing ASC and enable social deficits in people with ASC to be predicted.	[Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Rehabil, Yilan, Taiwan; [Cheng, Yawei] Taipei City Hosp, Dept Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Cheng, YW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	ywcheng2@ym.edu.tw			Ministry of Science and Technology [MOST 103-2401-H-010-003-MY3]; National Yang-Ming University Hospital [RD2014-003]; Health Department of Taipei City Government [10301-62-009]; Ministry of Education (Aim for the Top University Plan)	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital; Health Department of Taipei City Government; Ministry of Education (Aim for the Top University Plan)(Ministry of Education, Taiwan)	The study was funded by the Ministry of Science and Technology (MOST 103-2401-H-010-003-MY3), National Yang-Ming University Hospital (RD2014-003), Health Department of Taipei City Government (10301-62-009), and Ministry of Education (Aim for the Top University Plan). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Boersma Paul, 2002, GLOT INT, V5, P341; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Fan YT, 2013, NEUROREPORT, V24, P457, DOI 10.1097/WNR.0b013e32836169b9; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; Griffin R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-61; Grossmann T, 2012, SOC NEUROSCI-UK, V7, P369, DOI 10.1080/17470919.2011.628758; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; HOBSON RP, 1989, BRIT J DEV PSYCHOL, V7, P237, DOI 10.1111/j.2044-835X.1989.tb00803.x; Hung AY, 2014, NEUROREPORT, V25, P464, DOI 10.1097/WNR.0000000000000115; Hung AY, 2013, J CHILD PSYCHOL PSYC, V54, P1016, DOI 10.1111/jcpp.12076; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jansson-Verkasalo E, 2003, NEUROSCI LETT, V338, P197, DOI 10.1016/S0304-3940(02)01405-2; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; LINCOLN AJ, 1993, J AUTISM DEV DISORD, V23, P37, DOI 10.1007/BF01066417; Locke J.L., 1993, CHILDS PATH SPOKEN L; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestro S, 2002, J AM ACAD CHILD PSY, V41, P1239, DOI 10.1097/00004583-200210000-00014; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Roberts TPL, 2011, BIOL PSYCHIAT, V70, P263, DOI 10.1016/j.biopsych.2011.01.015; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schirmer A, 2008, NEUROIMAGE, V40, P1402, DOI 10.1016/j.neuroimage.2008.01.018; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; Seri S, 1999, CLIN NEUROPHYSIOL, V110, P1825, DOI 10.1016/S1388-2457(99)00137-6; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sussman ES, 2013, BRAIN TOPOGR; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winer B.J., 1991, STAT PRINCIPLES EXPT	67	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102471	10.1371/journal.pone.0102471	http://dx.doi.org/10.1371/journal.pone.0102471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	24475058	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200061
J	Zhu, LL; Fan, Y; Zou, QH; Wang, J; Gao, JH; Niu, ZD				Zhu, Linlin; Fan, Yang; Zou, Qihong; Wang, Jue; Gao, Jia-Hong; Niu, Zhendong			Temporal Reliability and Lateralization of the Resting-State Language Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; TEST-RETEST RELIABILITY; HUMAN BRAIN; CORTICAL ORGANIZATION; ALZHEIMERS-DISEASE; COMPONENT ANALYSIS; CINGULATE CORTEX; FMRI; SCHIZOPHRENIA; ASYMMETRIES	The neural processing loop of language is complex but highly associated with Broca's and Wernicke's areas. The left dominance of these two areas was the earliest observation of brain asymmetry. It was demonstrated that the language network and its functional asymmetry during resting state were reproducible across institutions. However, the temporal reliability of resting-state language network and its functional asymmetry are still short of knowledge. In this study, we established a seed-based resting-state functional connectivity analysis of language network with seed regions located at Broca's and Wernicke's areas, and investigated temporal reliability of language network and its functional asymmetry. The language network was found to be temporally reliable in both short-and long-term. In the aspect of functional asymmetry, the Broca's area was found to be left lateralized, while the Wernicke's area is mainly right lateralized. Functional asymmetry of these two areas revealed high short-and long-term reliability as well. In addition, the impact of global signal regression (GSR) on reliability of the resting-state language network was investigated, and our results demonstrated that GSR had negligible effect on the temporal reliability of the resting-state language network. Our study provided methodology basis for future cross-culture and clinical researches of resting-state language network and suggested priority of adopting seed-based functional connectivity for its high reliability.	[Zhu, Linlin; Niu, Zhendong] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing 100081, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Wang, Jue] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China	Beijing Institute of Technology; Peking University; Peking University; Hangzhou Normal University; Peking University	Zou, QH (corresponding author), Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China.	zouqihong@pku.edu.cn; zniu@bit.edu.cn			China's National Strategic Basic Research Program (973) [2012CB720700]; National Key Technology R D Program [2011BAI12B01]; Natural Science Foundation of China [81201142, 81227003]	China's National Strategic Basic Research Program (973); National Key Technology R D Program(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China's National Strategic Basic Research Program (973) (2012CB720700), the National Key Technology R& D Program (2011BAI12B01), and the Natural Science Foundation of China (81201142, 81227003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2013, NEUROIMAGE; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; Dollfus S, 2005, BIOL PSYCHIAT, V57, P1020, DOI 10.1016/j.biopsych.2005.01.009; Dronkers NF, 2011, NEUROLOGY, V76, pA162; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Fiecas M, 2013, NEUROIMAGE, V65, P231, DOI 10.1016/j.neuroimage.2012.09.052; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HEILMAN KM, 1976, CORTEX, V12, P258, DOI 10.1016/S0010-9452(76)80007-X; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2007, LATERALITY, V12, P87, DOI 10.1080/13576500600959247; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jung WH, 2012, PLOS ONE, V7; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; KERTESZ A, 1986, CORTEX, V22, P117, DOI 10.1016/S0010-9452(86)80036-3; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Kollndorfer K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00095; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEMAY M, 1978, J COMPUT ASSIST TOMO, V2, P471; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narr KL, 2001, AM J PSYCHIAT, V158, P244, DOI 10.1176/appi.ajp.158.2.244; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Petridou N, 2009, MAGN RESON IMAGING, V27, P1046, DOI 10.1016/j.mri.2009.02.006; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Proverbio AM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-116; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, P3; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo X-N, 2012, NEUROIMAGE; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	90	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85880	10.1371/journal.pone.0085880	http://dx.doi.org/10.1371/journal.pone.0085880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475058	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800018
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
